PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Post, A; Kendall, M; Koncan, D; Cournoyer, J; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, MD; Marshall, S				Post, Andrew; Kendall, Marshall; Koncan, David; Cournoyer, Janie; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael D.; Marshall, Shawn			Characterization of persistent concussive syndrome using injury reconstruction and finite element modelling	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Persistent concussive syndrome; Brain injury; Biomechanics; Concussion	TRAUMATIC BRAIN-INJURY; IMPACT; TISSUE; FALLS	Concussions occur 1.7 million times a year in North America, and account for approximately 75% of all traumatic brain injuries (TBI). Concussions usually cause transient symptoms but 10 to 20% of patients can have symptoms that persist longer than a month. The purpose of this research was to use reconstructions and finite element modeling to determine the brain tissue stresses and strains that occur in impacts that led to persistent post concussive symptoms (PCS) in hospitalized patients. A total of 21 PCS patients had their head impacts reconstructed using computational, physical and finite element methods. The dependent variables measured were maximum principal strain, von Mises stress (VMS), strain rate, and product of strain and strain rate. For maximum principal strain alone there were large regions of brain tissue incurring 30 to 40% strain. This large field of strain was also evident when using strain rate, product of strain and strain rate. In addition, VMS also showed large magnitudes of stress throughout the cerebrum tissues. The distribution of strains throughout the brain tissues indicated peak responses were always present in the grey matter (0.481), with the white matter showing significantly lower strains (0.380) (p <0.05). The impact conditions of the PCS cases were severe in nature, with impacts against non-compliant surfaces (concrete, steel, ice) resulting in higher brain deformation. PCS biomechanical parameters were shown to fit between those that have been shown to cause transient post concussive symptoms and those that lead to actual pathologic damage like contusion, however, values of all metrics were characterized by large variance and high average responses. This data supports the theory that there exists a progressive continuum of impacts that lead to a progressive continuum of related severity of injury from transient symptoms to pathological damage. (C) 2014 Elsevier Ltd. All rights reserved.	[Post, Andrew; Kendall, Marshall; Koncan, David; Cournoyer, Janie; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Marshall, Shawn] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Post, Andrew/0000-0002-5960-5552; Cusimano, Michael/0000-0002-9989-0650; Cournoyer, Janie/0000-0001-9043-7756			Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Di Mascio M, 2013, J STRENGTH COND RES, V27, P909, DOI 10.1519/JSC.0b013e31825ff099; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; GENNARELLI TA, 1971, 15TH P STAPP CAR CRA, P797; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J., 2008, THESIS ROYAL I TECHN; Holbourn A.H.S., 1943, MECH HEAD INJURIES; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2013, J NEUROL PSYCHAIT, V5, P181; Karton C, 2013, J ASTM INT, DOI [10.1520/STP155220120175, DOI 10.1520/STP155220120175]; Kendall M., 2012, P IRCOBI C DUBL IR; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Margaret K.Y., 2005, CLIN NEUROPSYCHOL, V116, P780; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; MILLER RT, 1998, 42 STAPP CAR CRASH C, P155; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Nahum A, 1977, 21 STAPP CAR CRASH C; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2013, THESIS U OTTAWA; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rojas IL, 2009, AM J SPORT MED, V37, P558, DOI 10.1177/0363546508328105; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	36	43	45	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2015	41						325	335		10.1016/j.jmbbm.2014.07.034			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	AW3XW	WOS:000346217400031	25154550	Green Submitted			2022-02-06	
J	Neuhaus, W; Gaiser, F; Mahringer, A; Franz, J; Riethmuller, C; Forster, C				Neuhaus, Winfried; Gaiser, Fabian; Mahringer, Anne; Franz, Jonas; Riethmueller, Christoph; Foerster, Carola			The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						blood-brain barrier; in vitro; stroke; oxygen/glucose deprivation; ischemia; traumatic brain injury; cerebEND; C6	CAPILLARY ENDOTHELIAL-CELLS; BINDING CASSETTE TRANSPORTERS; PLASMINOGEN ACTIVATOR TPA; TIGHT JUNCTION COMPLEXES; P-GLYCOPROTEIN; GLIAL-CELLS; MATRIX METALLOPROTEINASES; CEREBRAL-ISCHEMIA; UP-REGULATION; EXPRESSION	Stabilization of the blood-brain barrier during and after stroke can lead to less adverse outcome. For elucidation of underlying mechanisms and development of novel therapeutic strategies validated in vitro disease models of the blood-brain barrier could be very helpful. To mimic in vitro stroke conditions we have established a blood-brain barrier in vitro model based on mouse cell line cerebEND and applied oxygen/glucose deprivation (OGD). The role of astrocytes in this disease model was investigated by using cell line C6. Transwell studies pointed out that addition of astrocytes during OGD increased the barrier damage significantly in comparison to the endothelial monoculture shown by changes of transendothelial electrical resistance as well as fluorescein permeability data. Analysis on mRNA and protein levels by qPCR, western blotting and immunofluorescence microscopy of tight junction molecules claudin-3,-5,-12, occludin and ZO-1 revealed that their regulation and localisation is associated with the functional barrier breakdown. Furthermore, soluble factors of astrocytes, OGD and their combination were able to induce changes of functionality and expression of ABC-transporters Abcb1a (P-gp), Abcg2 (bcrp), and Abcc4 (mrp4). Moreover, the expression of proteases (matrixmetalloproteinases MMP-2, MMP-3, MMP-9, and t-PA) as well as of their endogenous inhibitors (TIMP-1, TIMP-3, PAI-1) was altered by astrocyte factors and OGD which resulted in significant changes of total MMP and t-PA activity. Morphological rearrangements induced by OGD and treatment with astrocyte factors were confirmed at a nanometer scale using atomic force microscopy. In conclusion, astrocytes play a major role in blood-brain barrier breakdown during OGD in vitro.	[Neuhaus, Winfried] Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria; [Neuhaus, Winfried; Gaiser, Fabian; Foerster, Carola] Univ Hosp Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany; [Mahringer, Anne] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Pharmaceut Technol & Biopharm, Heidelberg, Germany; [Franz, Jonas; Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany		Neuhaus, W (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Althanstr 14, A-1090 Vienna, Austria.	winfried.neuhaus@univie.ac.at; foerster_c@ukw.de		Neuhaus, Winfried/0000-0002-6552-7183; Franz, Jonas/0000-0001-7523-6622	European Union Seventh Framework Programme (FP7) [HEALTH-F2-2009- 241778]	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. HEALTH-F2-2009- 241778 to Carola Forster. We are very grateful to Anja Neuhoff for her excellent technical support. The funding organization has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Berezowski V, 2004, BRAIN RES, V1018, P1, DOI 10.1016/j.brainres.2004.05.092; Berezowski Vincent, 2012, Int J Cell Biol, V2012, P176287, DOI 10.1155/2012/176287; Boveri M, 2005, GLIA, V51, P187, DOI 10.1002/glia.20189; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Brouns R, 2011, EUR NEUROL, V65, P23, DOI 10.1159/000321965; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Ceruti S, 2011, NEUROCHEM INT, V59, P259, DOI 10.1016/j.neuint.2011.05.013; Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Dazert P, 2006, NEUROSCIENCE, V142, P1071, DOI 10.1016/j.neuroscience.2006.07.056; Deli Maria A., 1996, Keio Journal of Medicine, V45, P183; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; ElHafny B, 1997, NEUROSCI LETT, V236, P107, DOI 10.1016/S0304-3940(97)00679-4; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Gaillard PJ, 2000, PHARMACEUT RES, V17, P1198, DOI 10.1023/A:1026406528530; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Joo F, 1996, PROG NEUROBIOL, V48, P255, DOI 10.1016/0301-0082(95)00046-1; Jungmann P, 2008, PFLUG ARCH EUR J PHY, V455, P1007, DOI 10.1007/s00424-007-0352-x; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Krafft PR, 2013, STROKE, V44, P1743, DOI 10.1161/STROKEAHA.111.000427; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lazarowski A, 2007, J NEUROL SCI, V258, P84, DOI 10.1016/j.jns.2007.03.004; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Lenglet S, 2014, THROMB HAEMOSTASIS, V112, P363, DOI 10.1160/TH14-01-0007; Lundquist S, 2002, PHARMACEUT RES, V19, P976, DOI 10.1023/A:1016462205267; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; NEUHAUS J, 1991, ANN NY ACAD SCI, V633, P578; Neuhaus W, 2006, PHARM RES, V23, P1491, DOI 10.1007/s11095-006-0256-z; Neuhaus W, 2012, DIFFERENTIATION, V84, P294, DOI 10.1016/j.diff.2012.08.006; Neuhaus W, 2012, NEUROSCI LETT, V506, P44, DOI 10.1016/j.neulet.2011.10.045; Neuhaus W, 2008, J PHARM SCI-US, V97, P5158, DOI 10.1002/jps.21371; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Patak P, 2011, CURR PHARM DESIGN, V17, P2787, DOI 10.2174/138161211797440195; Pfefferkorn T, 2003, STROKE, V34, P2025, DOI 10.1161/01.STR.0000083051.93319.28; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Redzic ZB, 2015, INT J STROKE, V10, P407, DOI 10.1111/ijs.12197; Reichel V, 2010, J NEUROCHEM, V115, P200, DOI 10.1111/j.1471-4159.2010.06915.x; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Shin JA, 2015, BRAIN STRUCT FUNCT, V220, P13, DOI 10.1007/s00429-013-0632-5; Silwedel C, 2006, J NEUROIMMUNOL, V179, P37, DOI 10.1016/j.jneuroim.2006.06.019; Spudich A, 2006, NAT NEUROSCI, V9, P487, DOI 10.1038/nn1676; Strecker JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025863; Takeshita T, 2014, MOL CELL NEUROSCI, V60, P1, DOI 10.1016/j.mcn.2014.01.006; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thoelking G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265102; Torok M, 2003, EXP BRAIN RES, V153, P356, DOI 10.1007/s00221-003-1620-4; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Ueno M, 2009, NEUROPATH APPL NEURO, V35, P147, DOI 10.1111/j.1365-2990.2008.00966.x; VanGilder RL, 2011, PHARMACOL THERAPEUT, V130, P239, DOI 10.1016/j.pharmthera.2010.12.004; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Willis CL, 2013, NEUROSCIENCE, V250, P773, DOI 10.1016/j.neuroscience.2013.06.061; Willis CL, 2004, GLIA, V48, P1, DOI 10.1002/glia.20049; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851	66	43	45	1	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	OCT 28	2014	8								352	10.3389/fncel.2014.00352			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS9AW	WOS:000344536800004	25389390	gold, Green Published			2022-02-06	
J	Sekhon, MS; McBeth, P; Zou, J; Qiao, L; Kolmodin, L; Henderson, WR; Reynolds, S; Griesdale, DEG				Sekhon, Mypinder S.; McBeth, Paul; Zou, Jie; Qiao, Lu; Kolmodin, Leif; Henderson, William R.; Reynolds, Steve; Griesdale, Donald E. G.			Association Between Optic Nerve Sheath Diameter and Mortality in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Optic nerve sheath diameter; Computed tomography; Traumatic brain injury; Intracranial pressure; Cerebral spinal fluid	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; HYPERTENSION; IMPACT; ULTRASONOGRAPHY; EPIDEMIOLOGY; VALIDATION; DISABILITY; ULTRASOUND; SONOGRAPHY	Increased intracranial pressure (ICP) is associated with worse outcomes following traumatic brain injury (TBI). Studies have confirmed that ICP is correlated with optic nerve sheath diameter (ONSD) on ultrasound. The aim of our study was to assess the independent relationship between ONSD measured using CT and mortality in a population of patients admitted with severe TBI. We conducted a retrospective cohort study of patients with a TBI requiring ICP monitoring admitted to the ICU between April 2006 and May 2012 to two neurotrauma centers. ONSD was independently measured by two physicians blinded to patient outcomes. Multivariable logistic regression modeling was used to assess an association between ONSD and hospital mortality. A total of 220 patients were included in the analysis. Overall, the cohort had a mean age of 35 (SD 17) years and 171 of 220 (79 %) were male. The median admission GCS was 6 (IQR 3-8). Intra-class correlation coefficient between raters for ONSD measurements was 0.92 (95 % CI 0.90-0.94, P < 0.0001). On multivariable analysis, each 1 mm increase in ONSD was associated with a twofold increase in hospital mortality (OR 2.0, 95 % CI 1.2-3.2, P = 0.007). Using linear regression, ONSD was independently associated with increased ICP in the first 48 h after admission (beta = 4.4, 95 % CI 2.5-6.3, P < 0.0001). In patients with TBI, ONSD measured on CT scanning was independently associated with ICP and mortality.	[Sekhon, Mypinder S.; McBeth, Paul; Zou, Jie; Qiao, Lu; Kolmodin, Leif; Henderson, William R.; Griesdale, Donald E. G.] Univ British Columbia, Div Crit Care Med, Dept Med, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Reynolds, Steve] Univ British Columbia, Dept Crit Care Med, Royal Columbian Hosp, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada		Sekhon, MS (corresponding author), Univ British Columbia, Div Crit Care Med, Dept Med, Vancouver Gen Hosp, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	mypindersekhon@gmail.com	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624	VGH & UBC Hospital Foundation Best of Health Fund	We would like to acknowledge the staff of the Vancouver General and Royal Columbian Hospitals for their support in the completion of this study. Dr. Griesdale is funded by the VGH & UBC Hospital Foundation Best of Health Fund.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	33	43	46	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					245	252		10.1007/s12028-014-0003-y			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900011	24969027				2022-02-06	
J	Quintard, H; Lorivel, T; Gandin, C; Lazdunski, M; Heurteaux, C				Quintard, H.; Lorivel, T.; Gandin, C.; Lazdunski, M.; Heurteaux, C.			MLC901, A TRADITIONAL CHINESE MEDICINE INDUCES NEUROPROTECTIVE AND NEUROREGENERATIVE BENEFITS AFTER TRAUMATIC BRAIN INJURY IN RATS	NEUROSCIENCE			English	Article						NeuroAid; traumatic brain injury; neurogenesis; cognitive deficits; aquaporins; VEGF	EPISODIC-LIKE MEMORY; NEUROAID EFFICACY; STROKE RECOVERY; TEMPORAL-ORDER; DOUBLE-BLIND; MLC601 NEUROAID(R); CELLULAR EDEMA; RECOGNITION; MODERATE; DAMAGE	Traumatic brain injury (TBI) is a frequent and clinically highly heterogeneous neurological disorder with large socioeconomic consequences. NeuroAid (MLC601 and MLC901), a Traditional Medicine used in China for patients after stroke has been previously reported to induce neuroprotection and neuroplasticity. This study was designed to evaluate the neuroprotective and neuroregenerative effects of MLC901 in a rat model of TBI. TBI was induced by a moderate lateral fluid percussion applied to the right parietal cortex. MLC901 was injected intraperitoneally at 2 h post-TBI, and then administered in drinking water at a concentration of 10 mg/ml until sacrifice of the animals. The cognitive deficits induced by TBI were followed by using the "what-where-when'' task, which allows the measurement of episodic-like memory. MLC901 treatment decreased brain lesions induced by TBI. It prevented the serum increase of S-100 beta (S100B) and neuron-specific enolase (NSE), which may be markers to predict the neurologic outcome in human patients with TBI. MLC901 reduced the infarct volume when injected up to 2 h post-TBI, prevented edema formation and assisted its resolution, probably via the regulation of aquaporin 4. These positive MLC901 effects were associated with an upregulation of vascular endothelial growth factor (VEGF) as well as an increase of endogenous hippocampal neurogenesis and gliogenesis around the lesion. Furthermore, MLC901 reduced cognitive deficits induced by TBI. Rats subjected to TBI displayed a suppression of temporal order memory, which was restored by MLC901. This work provides evidence that MLC901 has neuroprotective and neurorestorative actions, which lead to an improvement in the recovery of cognitive functions in a model of traumatic brain injury. (C) 2014 The Authors. Published by Elsevier Ltd. on behalf of IBRO. This is an open access article under the CC BY-NC-ND license.	[Quintard, H.; Lorivel, T.; Gandin, C.; Lazdunski, M.; Heurteaux, C.] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Quintard, H.] CHU Nice, Hop St Roch, F-06000 Nice, France		Heurteaux, C (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	heurteau@ipmc.cnrs.fr	HEURTEAUX, Catherine/M-4947-2016	HEURTEAUX, Catherine/0000-0002-9741-9777	Centre National de la Recherche Scientifique (CNRS)Centre National de la Recherche Scientifique (CNRS); CNRS/CHU NiceCentre National de la Recherche Scientifique (CNRS)	The authors are very grateful to D. Picard (Moleac Singapore) for discussions concerning the program and the follow-up of the clinical effects of MLC601 and for providing MLC901 capsules. They are grateful to P. Ferrari for NSE and S100B dosing in the Biochemistry department of the Nice University Hospital (CHU). We are grateful to Dr A. Patel for carefully reading the manuscript. This work is supported by the Centre National de la Recherche Scientifique (CNRS). HQ is very grateful for the financial support of CNRS/CHU Nice.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Barbosa FF, 2010, BEHAV BRAIN RES, V215, P326, DOI 10.1016/j.bbr.2009.11.028; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Conte V., 2003, EUR J TRAUMA, V7, P335; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Du AL, 2013, CHINESE MED J-PEKING, V126, P2934, DOI 10.3760/cma.j.issn.0366-6999.20121193; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Harandi AA, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/721613; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Howland JG, 2008, HIPPOCAMPUS, V18, P251, DOI 10.1002/hipo.20396; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kong KH, 2009, CEREBROVASC DIS, V28, P514, DOI 10.1159/000247001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Navarro JC, 2014, SESS AC STROK NEW TR; Navarro JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/506387; Ozawa T, 2014, BEHAV BRAIN RES, V263, P210, DOI 10.1016/j.bbr.2014.01.034; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Siddiqui FJ, 2013, CEREBROVASC DIS, V35, P8, DOI 10.1159/000346231; Siow CHC, 2008, EUR NEUROL, V60, P264, DOI 10.1159/000155220; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Venketasubramanian N, 2009, INT J STROKE, V4, P54, DOI 10.1111/j.1747-4949.2009.00237.x; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398	76	43	44	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 26	2014	277						72	86		10.1016/j.neuroscience.2014.06.047			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO6VA	WOS:000341488700008	24993477	hybrid			2022-02-06	
J	Xu, JG; Wang, HD; Lu, XY; Ding, K; Zhang, L; He, J; Wei, WT; Wu, Y				Xu, Jianguo; Wang, Handong; Lu, Xinyu; Ding, Ke; Zhang, Li; He, Jin; Wei, Wuting; Wu, Yong			Posttraumatic administration of luteolin protects mice from traumatic brain injury: Implication of autophagy and inflammation	BRAIN RESEARCH			English	Article						Traumatic brain injury; Luteolin; Neuroprotection; Autophagy; Inflammation	NF-KAPPA-B; RAW 264.7 CELLS; NEUROPROTECTION; EXPRESSION; MODEL; MODULATION; FLAVONOIDS; RESPONSES; ISCHEMIA; DISEASE	Secondary brain insult induced by traumatic brain injury (TBI), including excitotoxicity, oxidative stress, inflammatory response, and neuronal degeneration, is sensitive to therapeutic interventions; therefore, searching for neuroprotective agents represents a promising therapeutic strategy for TBI treatment. Luteolin, a member of the flavonoid family, has recently been proven to modulate autophagy. However, whether it activates autophagy after TBI thereby alleviating the secondary insult is not yet understood. Here, we aimed to evaluate the neuroprotection of luteolin against TBI and the potential role of autophagy where it is involved. For this purpose, mice were randomly divided into four groups and then subjected to TBI. The treatment mice received luteolin at a dose of 30 mg/kg 30 min post-TBI based on our previous study. We employed western blot, immunofluorescence and quantitative real-time PCR to determine autophagy process and inflammatory response among different groups. Autophagy was found to be enhanced after luteolin treatment according to the expressions of autophagic markers. Furthermore, luteolin decreased nuclear accumulation of p65 induced by TBI, indicating attenuation of inflammation. In line with these observations, luteolin decreased mRNA and protein expressions of pro-inflammatory factors IL-1b and TNF-a. At last, luteolin reduced neuronal degeneration, and alleviated brain edema and blood-brain barrier (BBB) disruption. In conclusion, these results implied that luteolin protected mice brain from traumatic brain injury by inhibiting inflammatory response, and luteolin-induced autophagy might play a pivotal role in its neuroprotection. (C) 2014 Elsevier B.V. All rights reserved.	[Xu, Jianguo; Wang, Handong; Lu, Xinyu; Ding, Ke; Zhang, Li; He, Jin; Wu, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Wei, Wuting] Southern Med Univ Guangzhou, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; Jiangsu Provincial Science and Technology Department [BL2013027]	This work was supported by Grants from the National Natural Science Foundation of China (No. 81371357) and Jiangsu Provincial Science and Technology Department (No. BL2013027).	Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dajas Federico, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P30; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Huang HC, 2010, J AGR FOOD CHEM, V58, P8699, DOI 10.1021/jf101003v; Kim J, 2013, NEUROBIOL DIS, V59, P80, DOI 10.1016/j.nbd.2013.07.011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li L, 2014, FOOD CHEM TOXICOL, V63, P166, DOI 10.1016/j.fct.2013.08.036; Lin XL, 2013, DNA CELL BIOL, V32, P220, DOI 10.1089/dna.2012.1915; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Lv LH, 2011, INFLAMMATION, V34, P620, DOI 10.1007/s10753-010-9271-7; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Miracco C, 2007, INT J ONCOL, V30, P429; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Park CM, 2013, NUTR RES PRACT, V7, P423, DOI 10.4162/nrp.2013.7.6.423; Park CM, 2011, EUR J PHARMACOL, V660, P454, DOI 10.1016/j.ejphar.2011.04.007; Park SH, 2013, FOOD CHEM TOXICOL, V56, P100, DOI 10.1016/j.fct.2013.02.022; Qiao HM, 2012, NEUROCHEM RES, V37, P2014, DOI 10.1007/s11064-012-0822-1; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8; Sawmiller D, 2014, INT J MOL SCI, V15, P895, DOI 10.3390/ijms15010895; Sharma V, 2007, BRAIN RES BULL, V73, P55, DOI 10.1016/j.brainresbull.2007.01.016; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058; Zhao G, 2011, J NUTR BIOCHEM, V22, P929, DOI 10.1016/j.jnutbio.2010.07.014	39	43	44	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 25	2014	1582						237	246		10.1016/j.brainres.2014.07.042			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR1PM	WOS:000343357100023	25093609				2022-02-06	
J	Macauley, SL; Wong, AMS; Shyng, C; Augner, DP; Dearborn, JT; Pearse, Y; Roberts, MS; Fowler, SC; Cooper, JD; Watterson, DM; Sands, MS				Macauley, Shannon L.; Wong, Andrew M. S.; Shyng, Charles; Augner, David P.; Dearborn, Joshua T.; Pearse, Yewande; Roberts, Marie S.; Fowler, Stephen C.; Cooper, Jonathan D.; Watterson, D. Martin; Sands, Mark S.			An Anti-Neuroinflammatory That Targets Dysregulated Glia Enhances the Efficacy of CNS-Directed Gene Therapy in Murine Infantile Neuronal Ceroid Lipofuscinosis	JOURNAL OF NEUROSCIENCE			English	Article						Batten disease; lysosomal storage disease; neurodegeneration; neuroinflammation; neuronal ceroid lipofuscinosis	ATTENUATES SYNAPTIC DYSFUNCTION; BONE-MARROW-TRANSPLANTATION; CYTOKINE UP-REGULATION; MOUSE MODEL; BRAIN; DISEASE; ACTIVATION; PATHOLOGY; SURVIVAL; SEIZURES	Infantile neuronal ceroid lipofuscinosis (INCL) is an inherited neurodegenerative lysosomal storage disease (LSD) caused by a deficiency in palmitoyl protein thioesterase-1 (PPT1). Studies in Ppt1(-/-) mice demonstrate that glial activation is central to the pathogenesis of INCL. Astrocyte activation precedes neuronal loss, while cytokine upregulation associated with microglial reactivity occurs before and concurrent with neurodegeneration. Therefore, we hypothesized that cytokine cascades associated with neuroinflammation are important therapeutic targets for the treatment of INCL. MW01-2-151SRM (MW151) is a blood-brain barrier penetrant, small-molecule anti-neuroinflammatory that attenuates glial cytokine upregulation in models of neuroinflammation such as traumatic brain injury, Alzheimer's disease, and kainic acid toxicity. Thus, we used MW151, alone and in combination with CNS-directed, AAV-mediated gene therapy, as a possible treatment for INCL. MW151 alone decreased seizure susceptibility. When combined with AAV-mediated gene therapy, treated INCL mice had increased life spans, improved motor performance, and eradication of seizures. Combination-treated INCL mice also had decreased brain atrophy, astrocytosis, and microglial activation, as well as intermediary effects on cytokine upregulation. These data suggest that MW151 can attenuate seizure susceptibility but is most effective when used in conjunction with a therapy that targets the primary genetic defect.	[Macauley, Shannon L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Macauley, Shannon L.; Shyng, Charles; Dearborn, Joshua T.; Roberts, Marie S.; Sands, Mark S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Sands, Mark S.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol, Lawrence, KS 66045 USA; [Fowler, Stephen C.] Univ Kansas, Dept Toxicol, Lawrence, KS 66045 USA; [Wong, Andrew M. S.; Augner, David P.; Pearse, Yewande; Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Dept Neurosci,Ctr Cellular Basis Behav, London SE5 9NU, England; [Watterson, D. Martin] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA		Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Campus Box 8007,660 South Euclid Ave, St Louis, MO 63110 USA.	msands@dom.wustl.edu	Shyng, Charles/K-6224-2014; Cooper, Jonathan/V-9962-2019; Shyng, Charles/P-3197-2016	Shyng, Charles/0000-0001-6451-2847; Cooper, Jonathan/0000-0003-1339-4750; Shyng, Charles/0000-0001-6451-2847; Sands, Mark/0000-0002-5559-0832; Dearborn, Joshua/0000-0003-0335-1087; Macauley, Shannon/0000-0002-4292-2703	BDSRA postdoctoral research fellowship;  [NS043205];  [NS056728];  [R01NS056051];  [HD002528]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043205] Funding Source: NIH RePORTER	This work was supported by the following grants: NS043205 (M.S.S.), NS056728 (S.L.M.), R01NS056051 (D.M.W.), HD002528 (S.C.F.), and a BDSRA postdoctoral research fellowship (S.L.M.).	Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Glover LE, 2012, TRANSL STROKE RES, V3, P90, DOI 10.1007/s12975-011-0127-8; Griffey M, 2004, NEUROBIOL DIS, V16, P360, DOI 10.1016/j.nbd.2004.03.005; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Groh J, 2013, BRAIN, V136, P1083, DOI 10.1093/brain/awt020; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hofmann SL, 1999, MOL GENET METAB, V66, P234, DOI 10.1006/mgme.1999.2803; Hu J, 2012, MOL GENET METAB, V107, P213, DOI 10.1016/j.ymgme.2012.05.009; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Karpus WJ, 2008, J NEUROIMMUNOL, V203, P73, DOI 10.1016/j.jneuroim.2008.06.039; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Macauley SL, 2012, ANN NEUROL, V71, P797, DOI 10.1002/ana.23545; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Macauley SL, 2009, EXP NEUROL, V217, P124, DOI 10.1016/j.expneurol.2009.01.022; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Qiao X, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-95; Reddy AS, 2011, J NEUROSCI, V31, P9945, DOI 10.1523/JNEUROSCI.1802-11.2011; Roberts MS, 2012, J INHERIT METAB DIS, V35, P847, DOI 10.1007/s10545-011-9446-x; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009	25	43	43	0	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 24	2014	34	39					13077	13082		10.1523/JNEUROSCI.2518-14.2014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ9CR	WOS:000343140000013	25253854	Bronze, Green Published			2022-02-06	
J	Waljas, M; Iverson, GL; Lange, RT; Liimatainen, S; Hartikainen, KM; Dastidar, P; Soimakallio, S; Ohman, J				Waljas, Minna; Iverson, Grant L.; Lange, Rael T.; Liimatainen, Suvi; Hartikainen, Kaisa M.; Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha			Return to Work Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	3rd Federal Interagency Conference on Traumatic Brain Injury	JUN 13-15, 2011	Washington, DC			mild traumatic brain injury; outcome; return to work	POSTTRAUMATIC-STRESS-DISORDER; MODERATE HEAD-INJURY; ILLNESS PERCEPTIONS; RISK-FACTORS; RELIABILITY; DEPRESSION; SYMPTOMS; CT	Objective: To examine factors relating to return to work (RTW) following mild traumatic brain injury (mTBI). Participants: One hundred and nine patients (Age: M = 37.4 years, SD = 13.2; 52.3% women) who sustained an mTBI. Design: Inception cohort design with questionnaires and neuropsychological testing completed approximately 3 to 4 weeks postinjury. Setting: Emergency Department of Tampere University Hospital, Finland. Main Outcome Measures: Self-report (postconcussion symptoms, depression, fatigue, and general health) and neurocognitive measures (attention and memory). Results: The cumulative RTW rates were as follows: 1 week = 46.8%, 2 weeks = 59.6%, 3 weeks = 67.0%, 4 weeks = 70.6%, 2 months = 91.7%, and 1 year = 97.2%. Four variables were significant predictors of the number of days to RTW: age, multiple bodily injuries, intracranial abnormality at the day of injury, and fatigue ratings (all P <.001). The largest amount of variance accounted for by these variables in the prediction of RTW was at 30 days following injury (P <.001, R-2 = 0.504). Participants who returned to work fewer than 30 days after injury (n = 82, 75.2%) versus more than 30 days (n = 27, 24.8%) did not differ on demographic or neuropsychological variables. Conclusions: The vast majority of this cohort returned to work within 2 months. Predictors of slower RTW included age, multiple bodily injuries, intracranial abnormality at the day of injury, and fatigue.	[Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, FIN-3521 Tampere, Finland; [Waljas, Minna; Hartikainen, Kaisa M.; Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Liimatainen, Suvi] Tampere Univ Hosp, Dept Neurosci & Rehabil & Emergency, Dept Acuta, FIN-3521 Tampere, Finland; [Dastidar, Prasun; Soimakallio, Seppo] Pirkanmaa Hosp Dist, Med Imaging Ctr, Tampere, Finland		Waljas, M (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000, FIN-3521 Tampere, Finland.	minna.waljas@gmail.com		Iverson, Grant/0000-0001-7348-9570; Hartikainen, Kaisa/0000-0001-7278-9635; Ohman, Juha/0000-0002-6592-1367			Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Army Individual Test Battery, 1944, MAN DIR SCOR; Babor T.F., 2001, AUDIT THE ALCOHOL US; Beck A., 1996, MANUAL BDI 2; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hanlon RE, 1999, BRAIN INJURY, V13, P873; HAYS RD, 1995, BEHAV RES METH INSTR, V27, P277, DOI 10.3758/BF03204745; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer R.D, 2012, BRAIN INJURY MED PRI; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Mitrushina M., 2005, NORMATIVE DATA NEURO; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sinclair M., 1992, EVALUATION RELIABILI; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Spreen O, 1991, COMPENDIUM NEUROPSYC; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vuadens P, 2006, COLLECT ACAD EUR MED, P143, DOI 10.1007/2-287-29745-6_10; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WHO, 2001, INT CLASS FUNCT DIS; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson J. T. L, 1996, RECOVERY TRAUMATIC B, P29; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941	50	43	43	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					443	450		10.1097/HTR.0000000000000002			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700013	24263178				2022-02-06	
J	Wen, JF; Qian, SK; Yang, QF; Deng, L; Mo, Y; Yu, YF				Wen, Jianfeng; Qian, Suokai; Yang, Qifan; Deng, Lei; Mo, Ye; Yu, Yuefei			Overexpression of netrin-1 increases the expression of tight junction-associated proteins, claudin-5, occludin, and ZO-1, following traumatic brain injury in rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						traumatic brain injury; blood-brain barrier; tight junctions; netrin-1	BARRIER PERMEABILITY; CEREBRAL EDEMA; CELLS	The function of the blood-brain barrier (BBB) depends on the integrity of tight junction (TJ)-associated proteins. Netrin-1 is known to promote angiogenesis and may also regulate the BBB. To understand the association between netrin-1 and the TJ-associated proteins, the expression levels of proteins involved in maintaining the integrity of the BBB, including netrin-1, claudin-5, occludin and zonula occluden (ZO)-1, were investigated in the present study using quantitative polymerase chain reaction, western blot analysis and immunofluorescence, The aim of the present study was to determine the changes in BBB permeability and whether pZsGreen1-N1 mediated overexpression of netrin-1 increased the expression of the TJ-associated proteins following traumatic brain injury (TB!). The results demonstrated that the levels of mRNA transcription and protein expression of the TJ-associated proteins, claudin-5, occludin and ZO-1, were significantly reduced following TBI. Furthermore, the changes in the expression of these three TJ proteins were consistent with the changes in the BBB permeability, indicating that weakening intercellular junctions leads to BBB opening. The present study also demonstrated that netrin-1 significantly increased the downregulation of claudin-5, occludin and ZO-1 expression levels induced by TBI, which provided a basis for further investigation on the role of netrin-1 in the integrity of TJs and proper functioning of the BBB.	[Wen, Jianfeng; Yu, Yuefei] Nanchang Univ, Changcheng Sub Hosp, Dept Neurosurg, Nanchang 330002, Jiangxi, Peoples R China; [Wen, Jianfeng; Qian, Suokai; Yang, Qifan; Deng, Lei] 94th Hosp PLA, Dept Neurosurg, Nanchang 330002, Jiangxi, Peoples R China; [Mo, Ye] 94th Hosp PLA, Dept Nursing, Nanchang 330002, Jiangxi, Peoples R China; [Yu, Yuefei] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA		Yu, YF (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, 3,601 4th St, Lubbock, TX 79430 USA.	yfyu1963@gmail.com			Medical Research Subject of the 11th Five-Year Plan of Nanjing Military Region [06MA76]	The study was supported by a grant from the Medical Research Subject of the 11th Five-Year Plan of Nanjing Military Region (no. 06MA76).	ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; Bamforth SD, 1999, J CELL SCI, V112, P1879; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Fanning AS, 1999, J AM SOC NEPHROL, V10, P1337; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hirase T, 1997, J CELL SCI, V110, P1603; Honda M, 2006, CELL MOL NEUROBIOL, V26, P109, DOI 10.1007/s10571-006-9028-x; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Zeng Y., 2013, HEAD NECK ONCOL, V5, P6	22	43	47	1	12	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2014	8	3					881	886		10.3892/etm.2014.1818			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AN8KZ	WOS:000340854400035	25120618	gold, Green Submitted, Green Published			2022-02-06	
J	Wilcox, BJ; Machan, JT; Beckwith, JG; Greenwald, RM; Burmeister, E; Crisco, JJ				Wilcox, Bethany J.; Machan, Jason T.; Beckwith, Jonathan G.; Greenwald, Richard M.; Burmeister, Emily; Crisco, Joseph J.			Head-Impact Mechanisms in Men's and Women's Collegiate Ice Hockey	JOURNAL OF ATHLETIC TRAINING			English	Article						impact biomechanics; sport; concussion; sex	INJURY SURVEILLANCE SYSTEM; FOOTBALL PLAYERS; DESCRIPTIVE EPIDEMIOLOGY; CONCUSSION; EXPOSURE; ACCELERATION; MAGNITUDE; SEVERITY; LOCATION	Context: Concussion injury rates in men's and women's ice hockey are reported to be among the highest of all collegiate sports. Quantification of the frequency of head impacts and the magnitude of head acceleration as a function of the different impact mechanisms (eg, head contact with the ice) that occur in ice hockey could provide a better understanding of this high injury rate. Objective: To quantify and compare the per-game frequency and magnitude of head impacts associated with various impact mechanisms in men's and women's collegiate ice hockey players. Design: Cohort study. Setting: Collegiate ice hockey rink. Patients or Other Participants: Twenty-three men and 31 women from 2 National Collegiate Athletic Association Division I ice hockey teams. Main Outcome Measure(s): We analyzed magnitude and frequency (per game) of head impacts per player among impact mechanisms and between sexes using generalized mixed linear models and generalized estimating equations to account for repeated measures within players. Intervention(s): Participants wore helmets instrumented with accelerometers to allow us to collect biomechanical measures of head impacts sustained during play. Video footage from 53 games was synchronized with the biomechanical data. Head impacts were classified into 8 categories: contact with another player; the ice, boards or glass, stick, puck, or goal; indirect contact; and contact from celebrating. Results: For men and women, contact with another player was the most frequent impact mechanism, and contact with the ice generated the greatest-magnitude head accelerations. The men had higher per-game frequencies of head impacts from contact with another player and contact with the boards than did the women (P < .001), and these impacts were greater in peak rotational acceleration (P = .027). Conclusions: Identifying the impact mechanisms in collegiate ice hockey that result in frequent and high-magnitude head impacts will provide us with data that may improve our understanding of the high rate of concussion in the sport and inform injury-prevention strategies.	[Wilcox, Bethany J.; Machan, Jason T.; Crisco, Joseph J.] Brown Univ, Dept Orthopaed, Alpert Med Sch, Bioengn Lab, Providence, RI 02903 USA; [Wilcox, Bethany J.; Machan, Jason T.; Crisco, Joseph J.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Burmeister, Emily] Brown Univ, Dept Athlet Training, Providence, RI 02903 USA; [Beckwith, Jonathan G.; Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Wilcox, BJ (corresponding author), Brown Univ, Dept Orthopaed, Alpert Med Sch, Bioengn Lab, Suite 404,1 Hoppin St, Providence, RI 02903 USA.	Bethany_Wilcox@brown.edu	Machan, Jason T/D-3897-2013; Burmeister, Elizabeth/B-9176-2008	Machan, Jason T/0000-0003-2048-4914; Crisco, Joseph/0000-0002-8786-0905; Burmeister, Elizabeth/0000-0003-2720-2596	National Collegiate Athletic Association; National Collegiate Athletic Association, National Institute of Health [R01HD048638]; National Operating Committee on Standards for Athletic Equipment; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083270, R25GM083270-S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937, R25GM083270] Funding Source: NIH RePORTER	Funding for this study was provided by the National Collegiate Athletic Association, National Institute of Health (R01HD048638), National Operating Committee on Standards for Athletic Equipment, and National Institute of General Medical Sciences (R25GM083270 and R25GM083270-S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, National Collegiate Athletic Association, or National Operating Committee on Standards for Athletic Equipment.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Arndt SR, 2004, P HUMAN FACTOR ERGON, V48, P1973; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hutchison M., 2011, THESIS U TORONTO ONT; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Tegner Y, 1991, Br J Sports Med, V25, P87	30	43	43	2	27	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-AUG	2014	49	4					514	520		10.4085/1062-6050-49.3.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AQ4LO	WOS:000342768700011	25098659	Green Published			2022-02-06	
J	Karimi, A; Navidbakhsh, M; Razaghi, R				Karimi, Alireza; Navidbakhsh, Mandi; Razaghi, Reza			An experimental-finite element analysis on the kinetic energy absorption capacity of polyvinyl alcohol sponge	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Polyvinyl alcohol sponge; Helmet; Finite element; Kinetic energy absorption; Energy loss	UNIAXIAL MECHANICAL-PROPERTIES; PLAQUE VULNERABILITY; PVA HYDROGEL; HELMET; HEALTHY; FOAMS; MODEL	Polyvinyl alcohol (PVA) sponge is in widespread use for biomedical and tissue engineering applications owing to its biocompatibility, availability, relative cheapness, and excellent mechanical properties. This study reports a novel concept of design in energy absorbing materials which consist in the use of PVA sponge as an alternative reinforcement material to enhance the energy loss of impact loads. An experimental study is carried out to measure the mechanical properties of the PVA sponge under uniaxial loading. The kinetic energy absorption capacity of the PVA sponge is computed by a hexahedral finite element (FE) model of the steel ball and bullet through the LS-DYNA code under impact load at three different thicknesses (5, 10, 15 mm). The results show that a higher sponge thickness invokes a higher energy loss of the steel ball and bullet. The highest energy loss of the steel ball and bullet is observed for the thickest sponge with 160 and 35J, respectively. The most common type of traumatic brain injury in which the head subject to impact load causes the brain to move within the skull and consequently brain hemorrhaging. These results suggest the application of the PVA sponge as a great kinetic energy absorber material compared to commonly used expanded polystyrene foams (EPS) to absorb most of the impact energy and reduces the transmitted load. The results might have implications not only for understanding of the mechanical properties of PVA sponge but also for use as an alternative reinforcement material in helmet and packaging material design. (C) 2014 Elsevier B.V. All rights reserved.	[Navidbakhsh, Mandi] Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16846, Iran; Iran Univ Sci & Technol, Sch Mech Engn, Tissue Engn & Biol Syst Res Lab, Tehran 16846, Iran		Navidbakhsh, M (corresponding author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16846, Iran.	mnavid@iust.ac.ir	Razaghi, Reza/S-7173-2019; Navidbakhsh/S-9351-2018	Razaghi, Reza/0000-0002-9563-7535; 	Iran University of Science and Technology	The authors acknowledge the funding supports of this work by the Iran University of Science and Technology.	Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Chen YB, 2010, J BIOMECH, V43, P1131, DOI 10.1016/j.jbiomech.2009.12.009; Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9; Faturechi R, 2014, J BIOMATER TISS ENG, V4, P189, DOI 10.1166/jbt.2014.1156; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Karimi A, 2014, MATER TECHNOL, V29, P90, DOI 10.1179/1753555713Y.0000000115; Karimi A, 2014, PERFUSION-UK, V29, P178, DOI 10.1177/0267659113502835; Karimi A., 2014, INT J DAMAGE MECH; Karimi A., 2014, INT J MATER RES, V105, P1; Karimi A., 2013, CHARACTERIZING MECH, V18, P221; Karimi A., 2014, ARTERY RES; Karimi A, 2014, PERFUSION, DOI 0267659114536761.; Karimi A, 2014, J THERMOPLAST COMPOS, DOI 0892705714533377; Karimi A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40257; Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004; Karimi A, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500136; Karimi A, 2014, J BIOMATER TISS ENG, V4, P46, DOI 10.1166/jbt.2014.1134; Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779; Karimi A, 2013, MAT SCI ENG C-MATER, V33, P2550, DOI 10.1016/j.msec.2013.02.016; Karimi A, 2013, P I MECH ENG H, V227, P148, DOI 10.1177/0954411912461239; Kobayashi H, 2004, MAT SCI ENG C-BIO S, V24, P729, DOI 10.1016/j.msec.2004.08.038; Korteweg W., 2004, [No title captured], Patent No. [US 6711879B2, 6711879]; Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018; Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014; Liu DS, 2003, ENG FAIL ANAL, V10, P581, DOI 10.1016/S1350-6307(03)00040-2; Liu LF, 2012, WATER RES, V46, P1969, DOI 10.1016/j.watres.2012.01.017; MILLS NJ, 1991, ACCIDENT ANAL PREV, V23, P153, DOI 10.1016/0001-4575(91)90045-7; Moscato S, 2008, MICRON, V39, P569, DOI 10.1016/j.micron.2007.06.016; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Setiawan L, 2012, J MEMBRANE SCI, V394, P80, DOI 10.1016/j.memsci.2011.12.026; Shi Y, 2013, WEAR, V305, P280, DOI 10.1016/j.wear.2012.12.020; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Young CD, 1998, BIOMATERIALS, V19, P1745, DOI 10.1016/S0142-9612(98)00083-0; Zhang DK, 2012, J BIONIC ENG, V9, P234, DOI 10.1016/S1672-6529(11)60116-9; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	39	43	44	2	39	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JUN 1	2014	39						253	258		10.1016/j.msec.2014.03.009			6	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	AS0DS	WOS:000343949200034	24863223				2022-02-06	
J	Liu, J; Kou, ZF; Tian, YQ				Liu, Jun; Kou, Zhifeng; Tian, Yongquan			Diffuse axonal injury after traumatic cerebral microbleeds: an evaluation of imaging techniques	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; neuroimaging; traumatic brain injury; cerebral microbleeds; diffuse axonal injury; gradient-recalled-echo; susceptibility weighted imaging; review; neural regeneration	BRAIN-INJURY; OUTCOMES; CELLS; IDENTIFICATION; HYPERTENSION; MODULATION; ACTIVATION; CHILDREN; EFFICACY; FIELD	Previous neuropathological studies regarding traumatic brain injury have primarily focused on changes in large structures, for example, the clinical prognosis after cerebral contusion, intracerebral hematoma, and epidural and subdural hematoma. In fact, many smaller injuries can also lead to severe neurological disorders. For example, cerebral microbleeds result in the dysfunction of adjacent neurons and the disassociation between cortex and subcortical structures. These tiny changes cannot be adequately visualized on CT or conventional MRI. In contrast, gradient echo sequence-based susceptibility-weighted imaging is very sensitive to blood metabolites and microbleeds, and can be used to evaluate traumatic cerebral microbleeds with high sensitivity and accuracy. Cerebral microbleed can be considered as an important imaging marker for diffuse axonal injury with potential relevance for prognosis. For this reason, based on experimental and clinical studies, this study reviews the role of imaging data showing traumatic cerebral microbleeds in the evaluation of cerebral neuronal injury and neurofunctional loss.	[Liu, Jun] Cent South Univ, Xiangya Hosp 2, Dept Radiol, Changsha 410083, Hunan, Peoples R China; [Liu, Jun; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Biomed Engn & Radiol, Detroit, MI USA; [Liu, Jun; Tian, Yongquan] Cent South Univ, Sch Publ Adm, Changsha 410083, Hunan, Peoples R China		Tian, YQ (corresponding author), Cent South Univ, Sch Publ Adm, Changsha 410083, Hunan, Peoples R China.	tianyq@csu.edu.cn	liu, jun/AAW-9645-2020	liu, jun/0000-0002-0344-4745	Hunan Provincial Science and Technology Department [2009FJ3092]	Funding: This study was supported by grants from the State-Funded Construction Projects Key Clinical Specialist (2013-2015) and the Hunan Provincial Science and Technology Department, No. 2009FJ3092.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Cai J, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-306; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chen CT, 2014, HYPERTENSION, V63, P61, DOI 10.1161/HYPERTENSIONAHA.113.01838; Chen CH, 2013, OPT LETT, V38, P3137, DOI 10.1364/OL.38.003137; Chen JJ, 2013, PSYCHIAT RES, V210, P1260, DOI 10.1016/j.psychres.2013.09.007; Costello MG, 2013, J NEUROSCI, V33, P16394, DOI 10.1523/JNEUROSCI.1899-13.2013; Ding YM, 2013, BIOMED OPT EXPRESS, V4, P2518, DOI 10.1364/BOE.4.002518; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fu YY, 2013, CHEM COMMUN, V49, P11266, DOI 10.1039/c3cc46571c; Gao JZ, 2013, INT J MED SCI, V10, P1560, DOI 10.7150/ijms.6611; Gao XH, 2014, MOL BIOL REP, V41, P467, DOI 10.1007/s11033-013-2881-z; GLENSKI JA, 1984, MAYO CLIN PROC, V59, P530, DOI 10.1016/S0025-6196(12)61490-6; Guo Q, 2014, EUR J CLIN MICROBIOL, V33, P465, DOI 10.1007/s10096-013-1979-5; Guo Z, 2013, THER HYPOTHERMIA TEM, V3, P126, DOI 10.1089/ther.2013.0006; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; HOSKING MP, 1989, JAMA-J AM MED ASSOC, V261, P1909; Hou W, 2013, DALTON T, V43, P865; Jiang X, 2013, LECT NOTES COMPUT SC, V8150, P674, DOI 10.1007/978-3-642-40763-5_83; Ju MJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13053; Kang FX, 2013, J ENVIRON QUAL, V42, P1441, DOI 10.2134/jeq2012.0499; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Krishna Ranga, 2012, J Med Case Rep, V6, P66, DOI 10.1186/1752-1947-6-66; Labaceno Gainza D, 1989, Rev Cubana Enferm, V5, P51; Li P, 2013, DIABETES RES CLIN PR, V102, P35, DOI 10.1016/j.diabres.2013.08.009; Li QH, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-415; Lin Sheyu, 2013, Tsitol Genet, V47, P22; Liu Dan, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P584, DOI 10.3760/cma.j.issn.2095-4352.2013.10.003; Liu Q, 2013, ARCH VIROL; Lu QS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-651; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Mori Y, 2014, INT IMMUNOL, V26, P93, DOI 10.1093/intimm/dxt044; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Seghier ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017547; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi L, 2013, CHEM COMMUN, V50, P872; Shi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071242; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Song B, 2013, CIRC J, V77, P2997, DOI 10.1253/circj.CJ-13-0805; Sun CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3717; Sun MY, 2013, ACS APPL MATER INTER, V5, P12681, DOI 10.1021/am4040224; Tao RR, 2014, ANTIOXID REDOX SIGN, V21, P1, DOI 10.1089/ars.2013.5381; Tchekmedyian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079639; Tie GP, 2013, APPL OPTICS, V52, P6645, DOI 10.1364/AO.52.006645; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wang HY, 2014, CYTOTHERAPY, V16, P309, DOI 10.1016/j.jcyt.2013.07.011; Wang L, 2013, ISRN NEUROL, V2013; Wang XY, 2014, FOOD CHEM, V145, P984, DOI 10.1016/j.foodchem.2013.09.021; Wang Y, 2014, J AFFECT DISORDERS, V152, P131, DOI 10.1016/j.jad.2013.08.010; Wang Yu-peng, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P587; WARNER DO, 1988, AM REV RESPIR DIS, V137, P90, DOI 10.1164/ajrccm/137.1.90; WARNER MA, 1988, ANN SURG, V207, P380, DOI 10.1097/00000658-198804000-00003; WARNER MA, 1988, J UROLOGY, V139, P486, DOI 10.1016/S0022-5347(17)42499-2; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wei LJ, 2014, MICROBIOL RES, V169, P469, DOI 10.1016/j.micres.2013.08.002; Wu X, 2013, ACS APPL MATER INTER, V5, P10895, DOI 10.1021/am403092m; Xiao JZ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003325; Xiao ZH, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-200; Xu XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078106; Yang D, 2014, CELL MOL IMMUNOL, V11, P71, DOI 10.1038/cmi.2013.43; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080851; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zeng YB, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4822113; Zhang DM, 2014, ENVIRON POLLUT, V184, P123, DOI 10.1016/j.envpol.2013.08.022; Zhang J, 2014, HUM BRAIN MAPP, V35, P3314, DOI 10.1002/hbm.22404; Zhang S, 2014, AM J EMERG MED, V32, P92, DOI 10.1016/j.ajem.2013.10.009; Zhang ZZ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-229; Zhao Chen, 2013, Zhonghua Yi Xue Za Zhi, V93, P2309; Zhong Xiao-Fei, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P646; Zhou WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072102; Zhu BB, 2013, OPT LETT, V38, P3496, DOI 10.1364/OL.38.003496; Zhu D, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/10/106501; Zhu D., 2013, NEUROIMAGE; Zhu D, 2013, BIOCH PHARM; Zhu DQ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-131; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373; Zhu DM, 2013, IEEE ACM T COMPUT BI, V10, P1469, DOI 10.1109/TCBB.2013.127; Zhu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078501; Zhu DY, 2014, BIO-MED MATER ENG, V24, P741, DOI 10.3233/BME-130862; Zhu D, 2013, BIOORG MED CHEM LETT, V23, P6274, DOI 10.1016/j.bmcl.2013.09.083; Zhu DL, 2013, CHINESE MED J-PEKING, V126, P4072, DOI 10.3760/cma.j.issn.0366-6999.20123345; Zhu X, 2013, EUR ARCH OTORHINOLAR	84	43	45	1	30	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2014	9	12					1222	1230		10.4103/1673-5374.135330			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AL0FY	WOS:000338804000010	25206786	Green Published, gold, Green Submitted			2022-02-06	
J	Schaible, EV; Windschugl, J; Bobkiewicz, W; Kaburov, Y; Dangel, L; Kramer, T; Huang, CS; Sebastiani, A; Luh, C; Werner, C; Engelhard, K; Thal, SC; Schafer, MKE				Schaible, Eva-Verena; Windschuegl, Julia; Bobkiewicz, Wiesia; Kaburov, Yordan; Dangel, Larissa; Kraemer, Tobias; Huang, Changsheng; Sebastiani, Anne; Luh, Clara; Werner, Christian; Engelhard, Kristin; Thal, Serge C.; Schaefer, Michael K. E.			2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1 response after traumatic brain injury in mice	JOURNAL OF NEUROCHEMISTRY			English	Article						2-methoxyestradiol; alternative splicing; cerebral ischemia; HIF-1; neuroprotection; traumatic brain injury	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; PROLYL HYDROXYLASE INHIBITION; TUMOR-NECROSIS-FACTOR; FACTOR-I; HIF-1-ALPHA PROTEIN; GENE-EXPRESSION; FACTOR 1-ALPHA; UP-REGULATION	HIF-1 is pivotal for cellular homeostasis in response to cerebral ischemia. Pharmacological inhibition of HIF-1 may reduce secondary brain damage by targeting post-translational mechanisms associated with its proteasomal degradation and nuclear translocation. This study examined the neuroprotective effects of 2-methoxyestradiol (2ME2), the involved HIF-1-dependent response, and alternative splicing in exon 14 of HIF-1 (HIF-1Ex14) after traumatic brain injury (TBI) in mice. Intraperitoneal 2ME2 administration 30min after TBI caused a dose-dependent reduction in secondary brain damage after 24h. 2ME2 was physiologically tolerated, showed no effects on immune cell brain migration, and mitigated trauma-induced brain expression of neuropathologically relevant HIF-1 target genes encoding for Plasminogen activator inhibitor 1 and tumor necrosis factor alpha. Moreover, TBI-induced expression of pro-apoptotic BNIP3 was attenuated by 2ME2 treatment. Alternatively, spliced HIF-1Ex14 was substantially up-regulated from 6 to 48h after TBI. In vitro, nuclear location and gene transcription activity of HIF-1Ex14 were impaired compared to full-length HIF-1, but no effects on nuclear translocation of the transcriptional complex partner HIF-1 were observed. This study demonstrates that 2ME2 confers neuroprotection after TBI. While the role of alternatively spliced HIF-1Ex14 remains elusive, the in vivo data provide evidence that inhibition of a maladaptive HIF-1-dependent response contributes to the neuroprotective effects of 2ME2. We examined neuroprotective effects of 2-methoxyestradiol (2ME2) and the hypoxia-inducible factor 1- (HIF-1) response following traumatic brain injury in mice. Early 2ME2 administration reduced the secondary brain damage and neuronal HIF-1 probably involving ubiquitin proteasome system-mediated degradation. The up-regulation of neuropathological HIF-1 target genes and pro-apoptotic BNIP3 protein was attenuated. We propose that the inhibition of a maladaptive HIF-1 response may contribute to 2ME2-mediated neuroprotection.	[Schaible, Eva-Verena; Windschuegl, Julia; Bobkiewicz, Wiesia; Kaburov, Yordan; Dangel, Larissa; Kraemer, Tobias; Huang, Changsheng; Sebastiani, Anne; Luh, Clara; Werner, Christian; Engelhard, Kristin; Thal, Serge C.; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Dangel, Larissa; Werner, Christian; Engelhard, Kristin; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de; michael.schaefer@unimedizin-mainz.de	Changsheng, Huang/M-6033-2018; Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Kramer, Tobias/0000-0001-6900-3486; Huang, Changsheng/0000-0003-0535-1865; Schafer, Michael K.E./0000-0001-6055-6244	Focus program Translational Neuroscience, Johannes Gutenberg-University Mainz, Germany	We thank Dr. Jacques Pouyssegur (Nice, France) for providing HA-tagged HIF-1 alpha pcDNA3 expression constructs and M. C. Simon (Philadelphia, United States) for HRE luciferase reporter construct. We are grateful to Dana Pieter and Frieda Kornes for excellent technical assistance. L. D. was supported by a PhD fellowship of the Focus program Translational Neuroscience, Johannes Gutenberg-University Mainz, Germany. Data presented in this manuscript are parts of the doctor theses of J.W. and Y.K. and of the professorial dissertation (Habilitation) of E. V. S. presented to the Medical Faculty of the Johannes Gutenberg-University Mainz, Germany.	Ahn YT, 2010, INT J ONCOL, V37, P1627, DOI 10.3892/ijo_00000817; Althaus J, 2006, NEUROCHEM INT, V48, P687, DOI 10.1016/j.neuint.2005.12.008; Aminova LR, 2008, ANTIOXID REDOX SIGN, V10, P1989, DOI 10.1089/ars.2008.2039; Aminova LR, 2005, J BIOL CHEM, V280, P3996, DOI 10.1074/jbc.M409223200; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Banerjee S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-4; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chauhan D, 2003, ONCOGENE, V22, P6296, DOI 10.1038/sj.onc.1206734; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen CH, 2010, J NEUROSCI RES, V88, P2046, DOI 10.1002/jnr.22361; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen W, 2009, EXP NEUROL, V216, P7, DOI 10.1016/j.expneurol.2008.10.016; Chun YS, 2002, BIOCHEM J, V362, P71, DOI 10.1042/0264-6021:3620071; Chun YS, 2001, J CELL SCI, V114, P4051; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Duncan GS, 2012, P NATL ACAD SCI USA, V109, P21034, DOI 10.1073/pnas.1215558110; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Funakoshi T, 2006, EXP EYE RES, V83, P1102, DOI 10.1016/j.exer.2006.05.016; Gao LG, 2012, J CLIN PATHOL, V65, P872, DOI 10.1136/jclinpath-2012-200828; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gothie E, 2000, J BIOL CHEM, V275, P6922, DOI 10.1074/jbc.275.10.6922; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johansson L, 2000, STROKE, V31, P26, DOI 10.1161/01.STR.31.1.26; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kupershmidt L, 2010, J NEUROCHEM, V113, P363, DOI 10.1111/j.1471-4159.2010.06619.x; LaVallee TM, 2002, CANCER RES, V62, P3691; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Marx M, 2012, NEUROGENETICS, V13, P49, DOI 10.1007/s10048-011-0307-4; Mooberry SL, 2003, DRUG RESIST UPDATE, V6, P355, DOI 10.1016/j.drup.2003.10.001; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ricker JL, 2004, CLIN CANCER RES, V10, P8665, DOI 10.1158/1078-0432.CCR-04-1393; Ross S. A., 1998, BRIT J NEUROSURG, V12, P475; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Sibonga JD, 2003, ENDOCRINOLOGY, V144, P785, DOI 10.1210/en.2002-220632; Singh N, 2012, CELL MOL NEUROBIOL, V32, P491, DOI 10.1007/s10571-012-9803-9; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sumbayev VV, 2003, FEBS LETT, V535, P106, DOI 10.1016/S0014-5793(02)03887-5; Sutherland TE, 2007, DRUG DISCOV TODAY, V12, P577, DOI 10.1016/j.drudis.2007.05.005; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tofovic SP, 2005, J CARDIOVASC PHARM, V46, P430, DOI 10.1097/01.fjc.0000175878.32920.17; Tuttolomondo A, 2009, ATHEROSCLEROSIS, V203, P503, DOI 10.1016/j.atherosclerosis.2008.06.030; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu C, 2013, BIOCHEM BIOPH RES CO, V437, P469, DOI 10.1016/j.bbrc.2013.06.107; Yan JH, 2006, EXP NEUROL, V202, P348, DOI 10.1016/j.expneurol.2006.06.009; Yeh SH, 2011, BRAIN PATHOL, V21, P249, DOI 10.1111/j.1750-3639.2010.00443.x; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Yuan WS, 2013, CARDIOVASC DRUG THER, V27, P17, DOI 10.1007/s10557-012-6428-7; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	88	43	55	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2014	129	6					940	954		10.1111/jnc.12708			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AJ5WI	WOS:000337760500005	24606183	Bronze			2022-02-06	
J	Dettmer, J; Ettel, D; Glang, A; McAvoy, K				Dettmer, Judy; Ettel, Deborah; Glang, Ann; McAvoy, Karen			Building Statewide Infrastructure for Effective Educational Services for Students With TBI: Promising Practices and Recommendations	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						education; interventions; traumatic brain injury; special education; school children	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; PROFESSIONAL-DEVELOPMENT; PARENTAL INVOLVEMENT; SUBSTANCE-ABUSE; SCREENING TOOL; UNITED-STATES; CHILDREN; IDENTIFICATION; RELIABILITY	Objective: To identify promising practices in educational service delivery. Methods: Consensus-building process with a multidisciplinary group of researchers, policy makers, and state Department of Education personnel. Results: This white paper presents the group's consensus on the essential components of a statewide educational infrastructure to support students with traumatic brain injury across the spectrum of injury severity: (a) identification, screening, and assessment practices; (b) systematic communication between medical and educational systems; (c) tracking of child's progress over time; and (d) professional development for school personnel. The white paper also presents key outcomes for measuring success and provides recommendations both for policy change and for furthering research in childhood brain injury.	[Dettmer, Judy] Colorado Dept Human Serv, Div Vocat Rehabil, Brain Injury Program, Denver, CO 80203 USA; [Ettel, Deborah; Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA; [McAvoy, Karen] Rocky Mt Hosp Children, Colorado Dept Educ, Denver, CO USA; [McAvoy, Karen] Rocky Mt Hosp Children, Ctr Concuss, Denver, CO USA		Dettmer, J (corresponding author), Colorado Dept Human Serv, Div Vocat Rehabil, 1575 Sherman St,4th Floor, Denver, CO 80203 USA.	judy.dettmer@state.co.us					Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Benedict EA, 2007, TOP EARLY CHILD SPEC, V27, P174, DOI 10.1177/02711214070270030801; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Borko H., 2004, ED RES, V33, P3, DOI DOI 10.3102/0013189X033008003; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cantor JB, 2006, J HEAD TRAUMA REHAB, V21, P424, DOI 10.1097/00001199-200609000-00039; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carnine D. W., 2006, DESIGNING EFFECTIVE; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; Cleary M., 2010, J SCH HLTH, V81, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Darling-Hammond L., 2009, LEARN PROF, V30, P42; Data Accountability Center, 2011, NUMB STUD AG 6 21 B; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ettel D, 2012, NASDSE TBI SURVEY; Fan XT, 2001, EDUC PSYCHOL REV, V13, P1, DOI 10.1023/A:1009048817385; Faul M, 2010, TRAUMATIC BRAIN INJU; Fixsen D. L., 2005, NATL IMPLEMENTATION, V231; FUCHS LS, 1992, SCHOOL PSYCHOL REV, V21, P45; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Georgia Department of Education, TRAUM BRAIN INJ RUL; GERSTEN RM, 1982, ANAL INTERVEN DEVEL, V2, P305, DOI 10.1016/0270-4684(82)90026-X; Gersten R, 2009, REV EDUC RES, V79, P1202, DOI 10.3102/0034654309334431; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glang A, 2011, FED INT C TBI JUN 13; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gordon WA, 2011, NATO SCI PEACE SEC, V86, P31, DOI 10.3233/978-1-60750-797-0-31; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jeynes WH, 2005, URBAN EDUC, V40, P237, DOI 10.1177/0042085905274540; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; McAvoy K., 2012, COMMUNIQUE, V40, P23; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Noell GH, 1997, SCHOOL PSYCHOL QUART, V12, P77, DOI 10.1037/h0088949; Odom SL, 2009, TOP EARLY CHILD SPEC, V29, P53, DOI 10.1177/0271121408329171; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sailors M, 2010, ELEM SCHOOL J, V110, P301, DOI 10.1086/648980; Savage R. C., 2003, BRAIN INJ SOURCE, V6, P8; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; U.S. Department of Education, 2001, NO CHILD LEFT; US Government Accountability Office, 2008, REP CONGR REQ V A HL; Vaidya AA, 2002, COGNITIVE TECHNOLOGY, V7, P38; Walker NW, 1999, CHILD NEUROPSYCHOL, V5, P137, DOI 10.1076/chin.5.2.137.3168; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; WEEKS M, 1981, J APPL BEHAV ANAL, V14, P449, DOI 10.1901/jaba.1981.14-449; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Yoon KS., 2007, REV EVIDENCE TEACHER; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	68	43	43	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					224	232		10.1097/HTR.0b013e3182a1cd68			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100010	23982791				2022-02-06	
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Ishii, K; Li, L; Takase, K; Kushimoto, S; Takahashi, S				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Ishii, Kiyoshi; Li, Li; Takase, Kei; Kushimoto, Shigeki; Takahashi, Shoki			Early CT Findings to Predict Early Death in Patients with Traumatic Brain Injury: Marshall and Rotterdam CT Scoring Systems Compared in the Major Academic Tertiary Care Hospital in Northeastern Japan	ACADEMIC RADIOLOGY			English	Article						CT; Marshall; Rotterdam; early death; traumatic brain injury	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; CLASSIFICATION; VALIDATION; VOLUME	Rationale and Objectives: Computed tomography (CT) plays a crucial role in early assessment of patients with traumatic brain injury (TBI). Marshall and Rotterdam are the mostly used scoring systems, in which CT findings are grouped differently. We sought to determine the scoring system and initial CT findings predicting the death at hospital discharge (early death) in patients with TBI. Materials and Methods: We included 245 consecutive adult patients with mild-to-severe TB!. Their initial CT and status at hospital discharge (dead or alive) were reviewed, and both CT scores were calculated. We examined whether each score was related to early death; compared the two scoring systems' performance in predicting early death, and identified the CT findings that are independent predictors of early death. Results: More deaths occurred among patients with higher Marshall and Rotterdam scores (both P <.05, Mann-Whitney U test). The areas under the receiver operating characteristic curve (AUCs) indicated that both scoring systems had similarly good discriminative power in predicting early death (Marshall, AUC 0. 85 vs. Rotterdam, AUC =0.85). Basal cistern absence (odds ratio [OR] = 771.5, P <.0001), positive midline shift (OR =56.2, P=.0011), hemorrhagic mass volume >= 25 mL (OR = 12.9, P=.0065), and intraventricular or subarachnoid hemorrhage (OR = 3.8, P =.0395) were independent predictors of early death. Conclusions: Both Marshall and Rotterdam scoring systems can be used to predict early death in patients with TBI. The performance of the Marshall score is-at least equal to that of the Rotterdam score. Thus, although older, the Marshall score-remains useful in predicting patients' prognosis.	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Li, Li; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Nakagawa, Atsuhiro] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency Med, Sendai, Miyagi 9808574, Japan; [Ishii, Kiyoshi] Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan		Mugikura, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mugi@rad.med.tohoku.ac.jp	Mata-Mbemba, Daddy/AAP-3184-2020	Mata-Mbemba, Daddy/0000-0002-0031-6473			Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Harrell FE Jr, 2017, REGRESSION MODELING; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14	20	43	47	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	MAY	2014	21	5					605	611		10.1016/j.acra.2014.01.017			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AF2RH	WOS:000334559200007	24703472				2022-02-06	
J	Powers, KC; Cinelli, ME; Kalmar, JM				Powers, Kaley C.; Cinelli, Michael E.; Kalmar, Jayne M.			Cortical hypoexcitability persists beyond the symptomatic phase of a concussion	BRAIN INJURY			English	Article						Concussion; evoked potentials; sport	TRANSCRANIAL MAGNETIC STIMULATION; SPORTS CONCUSSION; FORCE; ABNORMALITIES; INHIBITION; GLUTAMATE; RECOVERY; GABA; TMS	Primary objective: The purpose of this research was to assess cortical excitability, voluntary activation of muscle and force sensation beyond the initial highly symptomatic period post-concussion (1-4 weeks post-injury). It was hypothesized that reduced excitability of the motor cortex may impair muscle activation and alter perceptions of force and effort. Research design: Eight concussed varsity football players were age-and position-matched with eight healthy teammates to control for training and body size. Healthy controls had not suffered a concussion in the previous 12 months. Methods and procedures: Paired-pulse transcranial magnetic stimulation was used to assess cortical excitability, voluntary activation was calculated using cortical twitch interpolation technique and sense of force was determined using constant-force sensation contractions. Main outcomes and results: The concussed group had lower intra-cortical facilitation (p = 0.036), lower maximal voluntary muscle activation (p = 0.038) and greater perceptions of force (p<0.05), likely due to compensatory increases in upstream drive, than their healthy matched teammates. Conclusions: Taken together, these findings suggest a state of hypoexcitability that persists beyond the immediate acute phase of a concussion and may result in neuromuscular impairments that would call to question the athlete's readiness to return to sport.	[Powers, Kaley C.; Cinelli, Michael E.; Kalmar, Jayne M.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada		Kalmar, JM (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave W,Rm 501, Waterloo, ON N2L 3C5, Canada.	jkalmar@wlu.ca	Cinelli, Michael/ABE-7625-2020	Cinelli, Michael/0000-0002-5802-2590	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [386601]	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant 386601 to J. Kalmar).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Jones LA, 1995, ADV EXP MED BIOL, V384, P305; JONES LA, 1983, EXP NEUROL, V81, P640, DOI 10.1016/0014-4886(83)90332-1; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Plaskett CJ, 2001, J APPL PHYSIOL, V91, P1535, DOI 10.1152/jappl.2001.91.4.1535; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Todd G, 2004, J APPL PHYSIOL, V97, P236, DOI 10.1152/japplphysiol.01336.2003; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vaillancourt DE, 2001, NEUROPSYCHOLOGIA, V39, P1410, DOI 10.1016/S0028-3932(01)00061-6; Welsh SJ, 2007, EXP BRAIN RES, V179, P219, DOI 10.1007/s00221-006-0785-z; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Ziemann U, 2003, SUPPL CLIN NEUROPHYS, V56, P226	30	43	43	2	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					465	471		10.3109/02699052.2014.888759			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900010	24702432				2022-02-06	
J	Sun, D				Sun, Dong			The potential of endogenous neurogenesis for brain repair and regeneration following traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; adult neurogenesis; neural stem cells; cell proliferation; hippocampus; subventricular zone; learning and memory function; regeneration; cognition	ADULT HUMAN BRAIN; ENHANCED HIPPOCAMPAL NEUROGENESIS; ENDOTHELIAL GROWTH-FACTOR; DENTATE GYRUS; CELL-PROLIFERATION; GRANULE CELLS; COGNITIVE RECOVERY; PROGENITOR CELLS; CA3 REGION; NEURONAL DIFFERENTIATION	Traumatic brain injury (TBI) is the leading cause of death and disability of persons under 45 years old in the United States, affecting over 1.5 million individuals each year. It had been thought that recovery from such injuries is severely limited due to the inability of the adult bra in to replace damaged neurons. However, recent studies indicate that the mature mammalian central nervous system (CNS) has the potential to replenish damaged neurons by proliferation and neuronal differentiation of adult neural stem/progenitor cells residing in the neurogenic regions in the brain. Furthermore, increasing evidence indicates that these endogenous stem/progenitor cells may play regenerative and reparative roles in response to CNS injuries or diseases. In support of this notion, heightened levels of cell proliferation and neurogenesis have been observed in response to brain trauma or insults suggesting that the brain has the inherent potential to restore populations of damaged or destroyed neurons. This review will discuss the potential functions of adult neurogenesis and recent development of strategies aiming at harnessing this neurogenic capacity in order to repopulate and repair the injured brain.	Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA		Sun, D (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, POB 980631,Med Coll Virginia Campus, Richmond, VA 23298 USA.	dsun@vcu.edu					ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Banasr M, 2001, EUR J NEUROSCI, V14, P1417, DOI 10.1046/j.0953-816x.2001.01763.x; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1997, J NEUROSCI, V17, P2492; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kirn JR, 1999, J COMP NEUROL, V411, P487; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Murrell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071334; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2004, RADIAT RES, V162, P442, DOI 10.1667/RR3234; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	60	43	46	0	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2014	9	7					688	692		10.4103/1673-5374.131567			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AH0KF	WOS:000335807100003	25206873	Green Published, gold			2022-02-06	
J	Lichtenstein, JD; Moser, RS; Schatz, P				Lichtenstein, Jonathan D.; Moser, Rosemarie Scolaro; Schatz, Philip			Age and Test Setting Affect the Prevalence of Invalid Baseline Scores on Neurocognitive Tests	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion testing; baseline testing; validity; neurocognitive testing; group administration; pediatric concussion; ImPACT	HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; BRAIN-INJURY; CONCUSSION; SPORT; MANAGEMENT; DIAGNOSIS; ZURICH	Background: Prevalence rates of invalid baseline scores on computerized neurocognitive assessments for high school, collegiate, and professional athletes have been published in the literature. At present, there is limited research on the prevalence of invalid baseline scores in pre-high school athletes. Hypothesis: Pre-high school athletes assessed with baseline neurocognitive tests would show higher prevalence rates of invalidity than older youth athletes, and those athletes, regardless of age, who were tested in a large group setting would show a higher prevalence rate of invalidity than athletes tested in a small group setting. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A total of 502 athletes between the ages of 10 and 18 years completed preseason baseline neurocognitive tests in "large" or "small" groups. All athletes completed the online version of ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing). Baseline test results that were "flagged" by the computer software as being of suspect validity and labeled with a "++" symbol were identified for analysis. Participants were retrospectively assigned to 2 independent groups: large group or small group. Test administration of the large group occurred off-site in groups of approximately 10 athletes, and test administration of the small group took place at a private-practice neuropsychology center with only 1 to 3 athletes present. Results: Chi-square analyses identified a significantly greater proportion of participants obtaining invalid baseline results on the basis of age; younger athletes produced significantly more invalid baseline scores (7.0%, 17/244) than older athletes (2.7%, 7/258) (chi(2) (1) = 4.99; P = .021). Log-linear analysis revealed a significant age (10-12 years, 13-18 years) 3 size (small, large) interaction effect (chi(2) (4) = 66.1; P < .001) on the prevalence of invalidity, whereby younger athletes tested in larger groups were significantly more likely to provide invalid results (11.9%) than younger athletes tested in smaller groups (5.4%), older athletes tested in larger groups (2.7%), and older athletes tested in smaller groups (2.7%). Conclusion: Younger athletes tend to exhibit a greater prevalence of invalid baseline results on neurocognitive computerized tests than older youth athletes; the prevalence increases when testing is conducted in a large group and nonclinical setting.	[Lichtenstein, Jonathan D.; Moser, Rosemarie Scolaro; Schatz, Philip] Sports Concuss Ctr New Jersey, Lawrenceville, NJ USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	lichtenstein.jonathan@gmail.com	Meijer, Anna/K-5118-2016		Sports Concussion Center of New Jersey (SCCNJ); SCCNJ	One or more of the authors has declared the following potential conflict of interest or source of funding: Dr Schatz has served as a consultant to ImPACT Applications Inc. However, ImPACT Applications Inc had no role in the conceptualization of this study, the collection or analysis of data, the writing of the article, or the decision to submit it for publication. R. S. M. is an employee of the Sports Concussion Center of New Jersey (SCCNJ), which funded the study; J.D.L. was an employee of SCCNJ at the time of the study. The work performed toward the completion of this study was funded financially by the SCCNJ.	Aubry M, 2002, PHYSICIAN SPORTSMED, V30, P1; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barth JT, 1989, MILD HEAD INJURY, P257; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Butler IJ, 2013, JAMA NEUROL, V70, P636, DOI 10.1001/jamaneurol.2013.2801; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Larini R, MONTCLAIR HIGH SCH F; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, IMPACT VERSION 6 0 C; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, APPL NEUROP IN PRESS; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; New Jersey State Interscholastic Athletic Association, CONC ID MAN RET TO P; Schatz P, 2006, SPORTS NEUROPSYCHOLO, P160; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Schwarz A., 2010, NY TIMES, pB14; SPSS Inc, 2010, IBM SPSS MAC VERS 19; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tabachnick B.G., 2001, USING MULTIVARIATE S; [No title captured]	44	43	43	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2014	42	2					479	484		10.1177/0363546513509225			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	AH6CS	WOS:000336218900035	24243771				2022-02-06	
J	Whyte, J; Rajan, R; Rosenbaum, A; Katz, D; Kalmar, K; Seel, R; Greenwald, B; Zafonte, R; Demarest, D; Brunner, R; Kaelin, D				Whyte, John; Rajan, Riya; Rosenbaum, Amy; Katz, Douglas; Kalmar, Kathleen; Seel, Ron; Greenwald, Brian; Zafonte, Ross; Demarest, David; Brunner, Robert; Kaelin, Darryl			Zolpidem and Restoration of Consciousness	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Consciousness Disorders; Vegetative State; Minimally Conscious State; Zolpidem	PLACEBO-CONTROLLED TRIAL; ANOXIC BRAIN-INJURY; VEGETATIVE STATE; AROUSAL; COMA; EEG; DISORDERS; SCALE	Objective: Zolpidem has been reported to cause temporary recovery of consciousness in vegetative and minimally conscious patients, but how often and why this occurs are unknown. The authors aimed to determine the frequency of this phenomenon and whether it can be predicted from demographic and clinical variables. Design: This is a placebo-controlled, double-blind, single-dose, crossover study performed by caregivers and replicated by trained professionals, for naive participants. Four previously identified responders were also studied to further characterize the clinical drug response. Results: Eighty-four participants with traumatic and nontraumatic disorders of consciousness of at least 4 mos' duration were studied. Four "definite responders" were identified, but no demographic or clinical features were predictive of the response. Indicators of a drug response included increased movement, social interaction, command following, attempts at communication, and functional object use; typically lasted 1-2 hrs; and sometimes ended with increased somnolence. Adverse events were more common on zolpidem than placebo, but most were rated as mild. Conclusions: Approximately 5% (4.8%) of the participants responded to zolpidem, but the responders could not be distinguished in advance from the non-responders. Future research is needed to understand the mechanism of zolpidem in enhancing consciousness and its potential role in treatment and research.	[Whyte, John; Rajan, Riya] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Rosenbaum, Amy] Pk Terrace Care Ctr, Rego Pk Queens, NY USA; [Katz, Douglas] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA; [Katz, Douglas] Braintree Rehabil Hosp, Brain Injury Program, Braintree, MA USA; [Kalmar, Kathleen] Johnson Rehabil Inst Ctr Head Injuries, Edison, NJ USA; [Seel, Ron] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Seel, Ron] Shepherd Ctr, Brain Injury Program, Atlanta, GA USA; [Greenwald, Brian] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Zafonte, Ross] Harvard Univ, Brigham & Womens Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp,Massachusetts Gen Hosp,Med, Boston, MA 02115 USA; [Demarest, David] On With Life, Ankeny, IA USA; [Brunner, Robert] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Kaelin, Darryl] Univ Louisville, Div Phys Med & Rehabil, Louisville, KY 40292 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.			Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research (NIDRR), United States Department of Education [H133G080066]	Supported, in part, by grant no. H133G080066 from the National Institute on Disability and Rehabilitation Research (NIDRR), United States Department of Education (J.W., principal investigator). Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BERLIN I, 1993, J CLIN PSYCHOPHARM, V13, P100; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; CHURCHILL L, 1991, ADV EXP MED BIOL, V295, P101; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Galson S, DRUG SAFETY DRUG APP; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Machado C, 2011, CAN J NEUROL SCI, V38, P341, DOI 10.1017/S0317167100011562; PATAT A, 1994, PSYCHOPHARMACOLOGY, V114, P138, DOI 10.1007/BF02245455; Plum F, 1982, PATHOLOGIC PHYSL SIG; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Schiff ND, 2007, ANN NEUROL, V62, P5, DOI 10.1002/ana.21158; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; SURH LC, 1994, NEW ENGL J MED, V330, P572, DOI 10.1056/NEJM199402243300813; van Lier H, 2004, NEUROPHARMACOLOGY, V47, P163, DOI 10.1016/j.neuropharm.2004.03.017; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0	30	43	45	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2014	93	2					101	113		10.1097/PHM.0000000000000069			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AJ5PD	WOS:000337736200001	24434886				2022-02-06	
J	Wong, J; Mellor, D				Wong, Jessica; Mellor, David			Intimate partner violence and women's health and wellbeing: Impacts, risk factors and responses	CONTEMPORARY NURSE			English	Article						intimate partner violence; physical health; mental health; nursing responses	POSTTRAUMATIC-STRESS-DISORDER; DOMESTIC VIOLENCE; MENTAL-HEALTH; GASTROINTESTINAL DISORDERS; ABUSIVE RELATIONSHIP; PHYSICAL ABUSE; SEXUAL-ABUSE; CHRONIC PAIN; PREVALENCE; CONSEQUENCES	Women have approximately a one in four chance of experiencing intimate partner violence (IPV). Those who do are at increased risk of developing physical and mental health problems including traumatic brain injury, chronic pain, gastrointestinal disorders, depression, post-traumatic stress disorder, and substance-related disorders. Nurses, in whatever situation they work, are therefore highly likely to encounter women who are victims of IPV. This paper explores the prevalence of physical and mental health issues for women with an experience of IPV. Factors that influence a woman's experience of IPV such as culture, remaining in an abusive relationship, and childhood sexual abuse as a risk factor of IPV are also examined. Recommended responses for women with an experience of IPV are discussed.	[Wong, Jessica; Mellor, David] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia		Wong, J (corresponding author), Deakin Univ, Sch Psychol, Melbourne, Vic, Australia.			Mellor, David/0000-0001-5007-5906			Alexander RW, 1998, ARTHRIT CARE RES, V11, P102, DOI 10.1002/art.1790110206; Arndt N., 1982, DISS ABSTR INT B, V42, p3405B; Bostock J, 2009, J COMMUNITY APPL SOC, V19, P95, DOI 10.1002/casp.985; Brown S., 1991, COUNSELING VICTIMS V; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 1997, PSYCHIAT CLIN N AM, V20, P353, DOI 10.1016/S0193-953X(05)70317-8; CAMPBELL R, 1995, PSYCHOL WOMEN QUART, V19, P237, DOI 10.1111/j.1471-6402.1995.tb00290.x; Cascardi M, 1999, J FAM VIOLENCE, V14, P227, DOI 10.1023/A:1022827915757; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Corrigan J. D., 2003, AM J OBSTET GYNECOL, V188, P184; Curry MA, 1998, OBSTET GYNECOL, V92, P530, DOI 10.1016/S0029-7844(98)00258-0; Daigneault I, 2009, CHILD ABUSE NEGLECT, V33, P638, DOI 10.1016/j.chiabu.2009.04.003; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; Desai H D, 2000, J Am Pharm Assoc (Wash), V40, P525; Dienemann J, 2000, Issues Ment Health Nurs, V21, P499; DiLillo D, 2001, J INTERPERS VIOLENCE, V16, P116, DOI 10.1177/088626001016002002; DROSSMAN DA, 1990, ANN INTERN MED, V113, P828, DOI 10.7326/0003-4819-113-11-828; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Gleason W J, 1993, Violence Vict, V8, P53; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; HABER JD, 1985, ADV PAIN RES THER, V9, P889; Harrykissoon SD, 2002, ARCH PEDIAT ADOL MED, V156, P325, DOI 10.1001/archpedi.156.4.325; Hartik L. M., 1978, DISS ABSTR INT B, V40, p893B; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Hegarty K, 2000, MED J AUSTRALIA, V173, P363, DOI 10.5694/j.1326-5377.2000.tb125688.x; Hegarty KL, 2002, AUST NZ J PUBL HEAL, V26, P437, DOI 10.1111/j.1467-842X.2002.tb00344.x; Humphreys C, 2003, BRIT J SOC WORK, V33, P209, DOI 10.1093/bjsw/33.2.209; Huth-Bocks Alissa C, 2002, Violence Vict, V17, P169, DOI 10.1891/vivi.17.2.169.33647; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; KALMUSS DS, 1982, J MARRIAGE FAM, V44, P277, DOI 10.2307/351538; Kim J, 2008, J INTERPERS VIOLENCE, V23, P1465, DOI 10.1177/0886260508314307; Lown EA, 2001, PSYCHOSOM MED, V63, P352, DOI 10.1097/00006842-200105000-00004; McNutt LA, 2002, AM J PREV MED, V22, P84, DOI 10.1016/S0749-3797(01)00407-X; Mehrotra, 1999, VIOLENCE AGAINST WOM, V5, P619, DOI [10.1177/10778019922181400, DOI 10.1177/10778019922181400]; Mouzos J., 2005, HOMICIDE AUSTR 2003; PARKER B, 1993, NURS RES, V42, P173; Perona M, 2005, CLIN GASTROENTEROL H, V3, P436, DOI 10.1016/S1542-3565(04)00776-1; Phillips KE, 2006, J FAM VIOLENCE, V21, P259, DOI 10.1007/s10896-006-9023-5; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Raj Anita, 2002, J Am Med Womens Assoc (1972), V57, P111; RAND MR, 1997, VIOLENCE RELATED INJ; Rhodes NR, 1998, AGGRESS VIOLENT BEH, V3, P391, DOI 10.1016/S1359-1789(97)00025-6; Roberts G., 2006, INTIMATE PARTNER ABU; Roberts GL, 1998, WOMEN HEALTH, V28, P117; Romito P, 2001, VIOLENCE AGAINST WOM, V7, P1429, DOI 10.1177/10778010122183937; RUSBULT CE, 1995, PERS SOC PSYCHOL B, V21, P558, DOI 10.1177/0146167295216002; SASSETTI MR, 1993, PRIMARY CARE, V20, P289; STRUBE MJ, 1988, PSYCHOL BULL, V104, P236, DOI 10.1037/0033-2909.104.2.236; Varvaro F F, 1993, Orthop Nurs, V12, P37, DOI 10.1097/00006416-199301000-00009; Vos T, 2006, B WORLD HEALTH ORGAN, V84, P739, DOI 10.2471/BLT.06.030411; Walker LE, 1979, BATTERED WOMAN; Walker Leonore., 1977, VICTIMOLOGY INT J, V2, P525, DOI [DOI 10.1521/JSCP.23.4.445.40311, 10.1521/jscp.23.4.445.40311]; WARSHAW C, 1996, IMPROVING HLTH CARE; Weinbaum Z, 2001, AM J PREV MED, V21, P313, DOI 10.1016/S0749-3797(01)00363-4; West D, 2004, INTERNATIONAL PERSPECTIVES ON FAMILY VIOLENCE AND ABUSE: A COGNITIVE ECOLOGICAL APPROACH, P361; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; Woods SJ, 2005, J INTERPERS VIOLENCE, V20, P394, DOI 10.1177/0886260504267882; World Health Organization, 2002, WORLD REPORT VIOLENC; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; Yoshihama M, 1994, Violence Vict, V9, P63; Yoshihma M, 2010, CHILD YOUTH SERV REV, V32, P28, DOI 10.1016/j.childyouth.2009.06.013	65	43	44	0	36	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1037-6178	1839-3535		CONTEMP NURSE	Contemp. Nurse.	FEB	2014	46	2					170	179		10.5172/conu.2014.46.2.170			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AX9PO	WOS:000347234500005	24787250				2022-02-06	
J	Theparambil, SM; Ruminot, I; Schneider, HP; Shull, GE; Deitmer, JW				Theparambil, Shefeeq M.; Ruminot, Ivan; Schneider, Hans-Peter; Shull, Gary E.; Deitmer, Joachim W.			The Electrogenic Sodium Bicarbonate Cotransporter NBCe1 Is a High-Affinity Bicarbonate Carrier in Cortical Astrocytes	JOURNAL OF NEUROSCIENCE			English	Article						bicarbonate; glial cells; NBCe1-KO; pH; proton concentration; Xenopus oocytes	CENTRAL-NERVOUS-SYSTEM; SOLUBLE ADENYLYL-CYCLASE; DEPOLARIZATION-INDUCED ALKALINIZATION; TRAUMATIC BRAIN-INJURY; CARBONIC-ANHYDRASE-II; GLIAL-CELLS; NA+-HCO3-COTRANSPORTER; FLUORESCENT PROTEINS; INTRACELLULAR PH; EXTRACELLULAR PH	The electrogenic sodium bicarbonate cotransporter NBCe1 (SLC4A4) is a robust regulator of intracellular H+ and a significant base carrier in many cell types. Using wild-type (WT) and NBCe1-deficient (NBC-KO) mice, we have studied the role of NBCe1 in cortical astrocytes in culture and in situ by monitoring intracellular H+ using the H+-sensitive dye BCECF [2',7' -bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein] in wide-field and confocal microscopy. Adding 0.1-3 mM HCO3- to an O-2-gassed, HEPES-buffered saline solution lowered the intracellular H+ concentration with a K-m of 0.65 mM HCO3- in WT astrocytes, but slowly raised [H+](1) in NBCe1-KO astrocytes. HumanNBCe1 heterologously expressed in Xenopus oocytes could be activated by adding 1-3mM HCO3-, and even by residual HCO3- in a nominally CO2/HCO3--free saline solution. Our results demonstrate a surprisingly high apparent bicarbonate sensitivity mediated by NBCe1 in cortical astrocytes, suggesting that NBCe1 may operate over a wide bicarbonate concentration in these cells.	[Theparambil, Shefeeq M.; Ruminot, Ivan; Schneider, Hans-Peter; Deitmer, Joachim W.] Univ Kaiserslautern, Abt Allgemeine Zool, FB Biol, D-67653 Kaiserslautern, Germany; [Shull, Gary E.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA		Deitmer, JW (corresponding author), Univ Kaiserslautern, Abt Allgemeine Zool, FB Biol, PB 3049, D-67653 Kaiserslautern, Germany.	deitmer@biologie.uni-kl.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DE 231/24-1]; Research Initiative of Membrane Proteins of the University of Kaiserslautern	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DE 231/24-1), and the Research Initiative of Membrane Proteins of the University of Kaiserslautern (to J.W.D.). Weare grateful to Dr. Frank Kirchhoff, Hombur/Saar, Germany, for providing the GFRT transgenic mice; and to Dr. Ursula Seidler, Hannover, Germany, for helping with the breeding of NBCe1-KO mice. We thank Dr. Holger M. Becker, Kaiserslautern, for critically reading an early version of this manuscript.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; BROOKES N, 1994, AM J PHYSIOL-CELL PH, V267, pC1633, DOI 10.1152/ajpcell.1994.267.6.C1633; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DEITMER JW, 1990, J PHYSIOL-LONDON, V421, P617, DOI 10.1113/jphysiol.1990.sp017965; Deitmer JW, 1998, J PHYSIOL-LONDON, V512, P459, DOI 10.1111/j.1469-7793.1998.459be.x; DEITMER JW, 1989, J PHYSIOL-LONDON, V411, P179, DOI 10.1113/jphysiol.1989.sp017567; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; DEITMER JW, 2009, NEW ENCY NEUROSCIENC, V6, P739; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Majumdar D, 2010, NEUROSCIENCE, V171, P951, DOI 10.1016/j.neuroscience.2010.09.037; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; Ransom BR, 2000, PROG BRAIN RES, V125, P217; Romero MF, 1999, ANNU REV PHYSIOL, V61, P699, DOI 10.1146/annurev.physiol.61.1.699; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROSE CR, 1994, J PHYSIOL-LONDON, V481, P1, DOI 10.1113/jphysiol.1994.sp020413; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Svichar N, 2011, J NEUROSCI, V31, P6997, DOI 10.1523/JNEUROSCI.6088-10.2011; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	36	43	44	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JAN 22	2014	34	4					1148	1157		10.1523/JNEUROSCI.2377-13.2014			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298YM	WOS:000330360700009	24453308	Bronze, Green Published			2022-02-06	
J	Rowe, RK; Striz, M; Bachstetter, AD; Van Eldik, LJ; Donohue, KD; O'Hara, BF; Lifshitz, J				Rowe, Rachel K.; Striz, Martin; Bachstetter, Adam D.; Van Eldik, Linda J.; Donohue, Kevin D.; O'Hara, Bruce F.; Lifshitz, Jonathan			Diffuse Brain Injury Induces Acute Post-Traumatic Sleep	PLOS ONE			English	Article							CYTOKINES; WAKE; INTERLEUKIN-1-BETA; PATHOPHYSIOLOGY; ACTIVATION; DISORDERS	Objective: Clinical observations report excessive sleepiness immediately following traumatic brain injury (TBI); however, there is a lack of experimental evidence to support or refute the benefit of sleep following a brain injury. The aim of this study is to investigate acute post-traumatic sleep. Methods: Sham, mild or moderate diffuse TBI was induced by midline fluid percussion injury (mFPI) in male C57BL/6J mice at 9: 00 or 21: 00 to evaluate injury-induced sleep behavior at sleep and wake onset, respectively. Sleep profiles were measured post-injury using a non-invasive, piezoelectric cage system. In separate cohorts of mice, inflammatory cytokines in the neocortex were quantified by immunoassay, and microglial activation was visualized by immunohistochemistry. Results: Immediately after diffuse TBI, quantitative measures of sleep were characterized by a significant increase in sleep (>50%) for the first 6 hours post-injury, resulting from increases in sleep bout length, compared to sham. Acute post-traumatic sleep increased significantly independent of injury severity and time of injury (9: 00 vs 21: 00). The pro-inflammatory cytokine IL-1 beta increased in brain-injured mice compared to sham over the first 9 hours post-injury. Iba-1 positive microglia were evident in brain-injured cortex at 6 hours post-injury. Conclusion: Post-traumatic sleep occurs for up to 6 hours after diffuse brain injury in the mouse regardless of injury severity or time of day. The temporal profile of secondary injury cascades may be driving the significant increase in post-traumatic sleep and contribute to the natural course of recovery through cellular repair.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA; [Rowe, Rachel K.; Van Eldik, Linda J.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Striz, Martin; O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Coll Arts & Sci, Lexington, KY USA; [Donohue, Kevin D.] Univ Kentucky, Dept Elect & Comp Engn, Coll Engn, Lexington, KY USA; [Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA; [Rowe, Rachel K.; Van Eldik, Linda J.; O'Hara, Bruce F.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	jlifshitz@email.arizona.edu		Rowe, Rachel/0000-0002-9034-3159; Bachstetter, Adam/0000-0003-4646-6757	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS072611, R01 NS065052, R01 NS064247, KSCHIRT 10-5A, F32 AG037280]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072611, R01NS064247, R01NS065052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32AG037280] Funding Source: NIH RePORTER	Support provided by National Institutes of Health (NIH) grants R21 NS072611 (JL/BFO), R01 NS065052 (JL), R01 NS064247 (LVE), KSCHIRT 10-5A, F32 AG037280 (ADB). RKR was supported by a Research Supplement to Promote Diversity by the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chikahisa Sachiko, 2011, Front Neurol, V2, P87, DOI 10.3389/fneur.2011.00087; Chokroverty S, 2010, INDIAN J MED RES, V131, P126; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; FAN L, 1995, MOL BRAIN RES, V30, P125; Fang JD, 1998, AM J PHYSIOL-REG I, V274, pR655, DOI 10.1152/ajpregu.1998.274.3.R655; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97, DOI 10.1159/000236827; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCoy JG, 2011, NEUROBIOL LEARN MEM, V96, P564, DOI 10.1016/j.nlm.2011.07.004; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Yasuda T, 2005, SLEEP, V28, P177, DOI 10.1093/sleep/28.2.177; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82507	10.1371/journal.pone.0082507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	WOS:000329862500018	24416145	Green Published, Green Submitted, gold			2022-02-06	
J	Huang, MX; Yurgil, KA; Robb, A; Angeles, A; Diwakar, M; Risbrough, VB; Nichols, SL; Mclay, R; Theilmann, RJ; Song, T; Huang, CW; Lee, RR; Baker, DG				Huang, Ming-Xiong; Yurgil, Kate A.; Robb, Ashley; Angeles, Annemarie; Diwakar, Mithun; Risbrough, Victoria B.; Nichols, Sharon L.; McLay, Robert; Theilmann, Rebecca J.; Song, Tao; Huang, Charles W.; Lee, Roland R.; Baker, Dewleen G.			Voxel-wise resting-state MEG source magnitude imaging study reveals neurocircuitry abnormality in active-duty service members and veterans with PTSD	NEUROIMAGE-CLINICAL			English	Article						MEG; Post-traumatic stress disorder; Amygdala; Ventromedial prefrontal cortex; Orbitofrontal cortex; Precuneous	POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; SIGNAL SPACE SEPARATION; TRAUMATIC BRAIN-INJURY; MIDLINE THETA-RHYTHM; CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; DELTA WAVES; ORBITOFRONTAL CORTEX; HIPPOCAMPAL FUNCTION	Post-traumatic stress disorder (PTSD) is a leading cause of sustained impairment, distress, and poor quality of life in military personnel, veterans, and civilians. Indirect functional neuroimaging studies using PET or fMRI with fear-related stimuli support a PTSD neurocircuitry model that includes amygdala, hippocampus, and ventromedial prefrontal cortex (vmPFC). However, it is not clear if this model can fully account for PTSD abnormalities detected directly by electromagnetic-based source imaging techniques in resting-state. The present study examined resting-state magnetoencephalography (MEG) signals in 25 active-duty service members and veterans with PTSD and 30 healthy volunteers. In contrast to the healthy volunteers, individuals with PTSD showed: 1) hyperactivity from amygdala, hippocampus, posterolateral orbitofrontal cortex (OFC), dorsomedial prefrontal cortex (dmPFC), and insular cortex in high-frequency (i.e., beta, gamma, and high-gamma) bands; 2) hypoactivity from vmPFC, Frontal Pole (FP), and dorsolateral prefrontal cortex (dlPFC) in high-frequency bands; 3) extensive hypoactivity from dlPFC, FP, anterior temporal lobes, precuneous cortex, and sensorimotor cortex in alpha and low-frequency bands; and 4) in individuals with PTSD, MEG activity in the left amygdala and posterolateral OFC correlated positively with PTSD symptom scores, whereas MEG activity in vmPFC and precuneous correlated negatively with symptom score. The present study showed that MEG source imaging technique revealed new abnormalities in the resting-state electromagnetic signals from the PTSD neurocircuitry. Particularly, posterolateral OFC and precuneous may play important roles in the PTSD neurocircuitry model. Published by Elsevier Inc.	[Huang, Ming-Xiong; Yurgil, Kate A.; Robb, Ashley; Angeles, Annemarie; Risbrough, Victoria B.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Huang, Ming-Xiong; Yurgil, Kate A.; Robb, Ashley; Angeles, Annemarie; Risbrough, Victoria B.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Huang, Ming-Xiong; Yurgil, Kate A.; Robb, Ashley; Angeles, Annemarie; Risbrough, Victoria B.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA; [Huang, Ming-Xiong; Diwakar, Mithun; Theilmann, Rebecca J.; Song, Tao; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Yurgil, Kate A.; Risbrough, Victoria B.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Risbrough, Victoria B.; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Nichols, Sharon L.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [McLay, Robert] Naval Med Ctr San Diego, San Diego, CA USA; [Huang, Charles W.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92121 USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019; Risbrough, Victoria/X-3344-2019	Baker, Dewleen/0000-0002-1736-9838; 	Headquarters Marine Corps; Navy BUMED (MRS-II; Navy BUMED) [N62645-11-C-4037]; Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, NURC-022-10F, NEUC-044-06S]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007198] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX000499] Funding Source: NIH RePORTER	This work was supported in part by Headquarters Marine Corps and Navy BUMED to D. G. Baker, M. A. Geyer, M. X. Huang and V. B. Risbrough (MRS-II; Navy BUMED contract # N62645-11-C-4037) and Merit Review Grants from the Department of Veterans Affairs to M. X. Huang (I01-CX000499, NURC-022-10F, NEUC-044-06S). We acknowledge the MRS-II administrative core, Anjana Patel, Andrew De La Rosa, and members of the MRS-II Team, including logistic coordinators, clinician-interviewers, and data collection staff. We thank staff at the Veterans Medical Research Foundation (VRMF). We also thank the Marine, Navy and veteran volunteers for their military service and participation in this study.	American Psychiatric Association, 2004, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson AK, 2003, J NEUROSCI, V23, P5627; [Anonymous], NEUROIMAGE, V20, P2291; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; Babiloni C, 2013, CLIN NEUROPHYSIOL, V124, P837, DOI 10.1016/j.clinph.2012.09.017; Bach DR, 2011, J NEUROSCI, V31, P618, DOI 10.1523/JNEUROSCI.2744-10.2011; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Benedetti F, 2011, BIPOLAR DISORD, V13, P414, DOI 10.1111/j.1399-5618.2011.00938.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bryant RA, 2005, BIOL PSYCHIAT, V58, P111, DOI 10.1016/j.biopsych.2005.03.021; Carlson N.R., 2013, PHYSL BEHAV; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; Cohen D., 2002, P 13 INT C BIOM VDE; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; CZERVIONKE LF, 1988, AM J NEURORADIOL, V9, P1149; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; DECKER DA, 1972, ELECTROEN CLIN NEURO, V33, P303, DOI 10.1016/0013-4694(72)90157-5; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Domsch S, 2013, MAGN RESON IMAGING, V31, P201, DOI 10.1016/j.mri.2012.06.020; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Felmingham KL, 2009, PSYCHIAT RES-NEUROIM, V173, P59, DOI 10.1016/j.pscychresns.2008.12.005; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Geuze E, 2007, PROG BRAIN RES, V167, P293, DOI 10.1016/S0079-6123(07)67026-5; Ghuman AS, 2011, NEUROIMAGE, V56, P69, DOI 10.1016/j.neuroimage.2011.01.046; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gold A.L., 2014, BIOL PSYCHI IN PRESS; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lanius RA, 2007, PSYCHIAT RES-NEUROIM, V155, P45, DOI 10.1016/j.pscychresns.2006.11.006; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lewine J D, 1995, Neuroimaging Clin N Am, V5, P575; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Magruder KM, 2009, PSYCHIAT ANN, V39, P778, DOI 10.3928/00485713-20090728-04; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; MIZUKI Y, 1980, ELECTROEN CLIN NEURO, V49, P345, DOI 10.1016/0013-4694(80)90229-1; MIZUKI Y, 1984, FOLIA PSYCHIAT NEU J, V38, P451; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; NAGATA K, 1985, NEUROSURGERY, V17, P613, DOI 10.1227/00006123-198510000-00014; Nauta WJH, 1979, FUNCTIONAL NEUROSURG, P7; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Rabinak C.A., 2014, DEPRESSION IN PRESS; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Renshaw KD, 2011, J AFFECT DISORDERS, V128, P321, DOI 10.1016/j.jad.2010.07.022; Robinson S., 1999, RECENT ADV BIOMAGNET, P302, DOI DOI 10.1016/J.NEUROIMAGE.2018.05.016; Rosen GM, 2008, CLIN PSYCHOL REV, V28, P837, DOI 10.1016/j.cpr.2007.12.002; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Semple WE, 2000, PSYCHIATRY, V63, P65, DOI 10.1080/00332747.2000.11024895; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Takahashi N, 1997, CLIN ELECTROENCEPHAL, V28, P49, DOI 10.1177/155005949702800109; Talairach J., 1988, COPLANAR STEREOTACTI; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tartaglione A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-145; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S., 2004, NEUROLOGY CLIN NEURO, V35; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Yan XD, 2013, NEUROSCI LETT, V547, P1, DOI 10.1016/j.neulet.2013.04.032	126	43	43	2	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2014	5						408	419		10.1016/j.nicl.2014.08.004			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB5LF	WOS:000349667800044	25180160	Green Published, gold			2022-02-06	
J	Lin, P; Correa, D; Kean, TJ; Awadallah, A; Dennis, JE; Caplan, AI				Lin, Paul; Correa, Diego; Kean, Thomas J.; Awadallah, Amad; Dennis, James E.; Caplan, Arnold I.			Serial Transplantation and Long-term Engraftment of Intra-arterially Delivered Clonally Derived Mesenchymal Stem Cells to Injured Bone Marrow	MOLECULAR THERAPY			English	Article							IN-VIVO DISTRIBUTION; H-2K(B)-TSA58 TRANSGENIC MOUSE; TRAUMATIC BRAIN-INJURY; VERSUS-HOST-DISEASE; STROMAL CELLS; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; DIFFERENTIATION; GROWTH; MICE	It has been hypothesized that mesenchymal stem cells (MSCs) home to sites of injury. Nevertheless, efficient delivery of MSCs to target organs and description of their ultimate fate remain major challenges. We provide evidence that intra-arterially (IA) injected MSCs selectively engraft from the circulation as perivascular cells in the bone marrow (BM) after a localized radiation injury. Luciferase-expressing MSCs, derived from a conditionally immortalized clone (BMC-9) representing a pure population of cells, were arterially delivered into mice irradiated in one leg. Cell distribution was measured by bioluminescent imaging and final destination assessed by luciferase immunolocalization. IA injections resulted in engraftment only in the irradiated leg where cells localize and proliferate abluminal to the BM vasculature, a phenomenon not replicated with intravenous injections or with IA injections of kidney cells harvested from the same donor used for MSCs. Furthermore, MSCs harvested from the engrafted marrow and serially transplanted retain the ability to selectively engraft at sites of injury. This study demonstrates that MSCs can serially engraft at sites of injury from the circulation, that they reside in the perivascular space, and that arterial delivery is more efficient than venous delivery for cell engraftment.	[Lin, Paul] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lin, Paul; Correa, Diego; Awadallah, Amad; Caplan, Arnold I.] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA; [Kean, Thomas J.; Dennis, James E.] Benaroya Res Inst, Seattle, WA USA		Lin, P (corresponding author), Case Western Reserve Univ, Millis Sci Ctr, Rm 113C,2080 Adelbert Rd, Cleveland, OH 44106 USA.	pxl57@case.edu	Kean, Thomas/AAI-8010-2021	Kean, Thomas/0000-0001-6844-3404; Caplan, Arnold/0000-0002-8677-6621	L. David and E. Virginia Baldwin Foundation; NIH/NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR049785]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM007250]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR049785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007250] Funding Source: NIH RePORTER	The authors acknowledge the assistance of Margie Harris for isolating the MSCs, Lori Duesler for help with the animal experiments, Mark Schluchter for his assistance with the statistical analysis, Fred Allen and Lan Wang from the Case Mouse Metabolic Phenotyping Center for help with the animal surgeries, and John Mulvihill from the Radiation Resources Core of CWRU for assistance with irradiating the mice. This research was supported by the L. David and E. Virginia Baldwin Foundation (A.I.C.) and NIH/NIAMS, R01AR049785 (J.E.D.). P.L. was supported in part by NIH T32 GM007250. Equity interest in Biotime, Inc. (J.E.D. and A.I.C.)	Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianco Paolo, 1800, Development, V142, P1023, DOI 10.1242/dev.102210; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Dennis JE, 1996, J CELL PHYSIOL, V167, P523, DOI 10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.0.CO;2-4; Dennis JE, 1996, CONNECT TISSUE RES, V35, P93, DOI 10.3109/03008209609029179; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Fouillard L, 2007, LEUKEMIA, V21, P568, DOI 10.1038/sj.leu.2404550; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; KIRKEBY OJ, 1991, J ORTHOPAED RES, V9, P862, DOI 10.1002/jor.1100090612; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Lin P, 2012, STEM CELL TRANSL MED, V1, P886, DOI 10.5966/sctm.2012-0086; Lu SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054963; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5	48	43	45	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	JAN	2014	22	1					160	168		10.1038/mt.2013.221			9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	282ZI	WOS:000329213500019	24067545	hybrid, Green Published			2022-02-06	
J	Marklund, N; Farrokhnia, N; Hanell, A; Vanmechelen, E; Enblad, P; Zetterberg, H; Blennow, K; Hillered, L				Marklund, Niklas; Farrokhnia, Nina; Hanell, Anders; Vanmechelen, Eugeen; Enblad, Per; Zetterberg, Henrik; Blennow, Kaj; Hillered, Lars			Monitoring of beta-Amyloid Dynamics after Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						A; APP; axonal injury; cerebral MD; energy metabolism; TBI	ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBROSPINAL-FLUID; PRECURSOR PROTEIN; A-BETA; INTRACEREBRAL MICRODIALYSIS; APOLIPOPROTEIN-E; WHITE-MATTER; PEPTIDE; ACCUMULATION	Epidemiological evidence links severe or repeated traumatic brain injury (TBI) to the development of Alzheimer's disease (AD). Accumulation of amyloid precursor protein (APP) occurs with high frequency after TBI, particularly in injured axons, and APP may be cleaved to amyloid- (A) peptides playing key pathophysiological roles in AD. We used cerebral microdialysis (MD) to test the hypothesis that interstitial A levels are altered following TBI and are related to the injury type, cerebral energy metabolism, age of the patient, and level of consciousness. In the present report, we evaluated 10 mechanically ventilated patients (7 male, 3 female, ages 18-76 years) with a severe TBI, who had intracranial pressure and MD monitoring. Each MD sample was analyzed for hourly routine energy metabolic biomarkers (MD-lactate, MD-pyruvate, MD-glucose, and MD-lactate/pyruvate ratio), cellular distress biomarkers (MD-glutamate, MD-glycerol), and MD-urea. The remaining MD samples were analyzed for A1-40 (A40; n=765 samples) and A1-42 (A42; n=765 samples) in pooled 2h fractions up to 14 days post-injury, using the Luminex xMAP technique, allowing detection with high temporal resolution of the key A peptides A40 and A42. Data are presented using medians and 25th and 75th percentiles. Both A40 and A42 were consistently higher in patients with predominately diffuse axonal injury compared with patients with focal TBI at days 1-6 post- injury, A42 being significantly increased at 113-116h post-injury (p<0.05). The A levels did not correlate with the interstitial energy metabolic situation, age of the patient, or the level of consciousness. These results support that interstitial generation of potentially toxic A species may occur following human TBI, particularly related to axonal injury.	[Marklund, Niklas; Farrokhnia, Nina; Hanell, Anders; Enblad, Per; Hillered, Lars] Uppsala Univ, Div Neurosurg, Dept Neurosurg, Uppsala, Sweden; [Vanmechelen, Eugeen] ADx NeuroSci, Ghent, Belgium; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden.	Niklas.Marklund@neuro.uu.se	Vanmechelen, Eugeen/AAA-8005-2019; Hanell, Anders/E-4776-2011	Vanmechelen, Eugeen/0000-0002-9466-5366; Hanell, Anders/0000-0001-9369-3886; Marklund, Niklas/0000-0002-9797-5626; Hillered, Lars/0000-0002-2808-9292	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Swedish Brain Foundation; Selander Foundation; Ahlen Foundation; Uppsala University Hospital	The authors thank Per Bondegard and Inger Stahl-Myllyaho for technical assistance. This work was supported by funds from the Swedish Medical Research Council, Swedish Brain Foundation, Selander Foundation, and Ahlen Foundation, and by funds from the Uppsala University Hospital.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bibl M, 2004, ELECTROPHORESIS, V25, P2912, DOI 10.1002/elps.200305992; Bjerke M., 2010, INT J ALZHEIMERS DIS, V15; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koike MA, 2010, AM J PATHOL, V177, P300, DOI 10.2353/ajpath.2010.090750; Lachno DR, 2009, J NUTR HEALTH AGING, V13, P220, DOI 10.1007/s12603-009-0062-5; Lachno DR, 2012, J ALZHEIMERS DIS, V32, P905, DOI 10.3233/JAD-2012-121075; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Raby CA, 1998, J NEUROCHEM, V71, P2505; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schipke CG, 2011, J ALZHEIMERS DIS, V26, P255, DOI 10.3233/JAD-2011-110329; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Texido L, 2011, NEUROCHEM INT, V59, P954, DOI 10.1016/j.neuint.2011.07.006; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Wang XJ, 2010, J ALZHEIMERS DIS, V21, P813, DOI 10.3233/JAD-2010-100216; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wisniewski HM, 1996, FOLIA NEUROPATHOL, V34, P65; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263	88	43	46	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					42	55		10.1089/neu.2013.2964			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500005	23829439				2022-02-06	
J	Hellewell, SC; Yan, EB; Alwis, DS; Bye, N; Morganti-Kossmann, MC				Hellewell, Sarah C.; Yan, Edwin B.; Alwis, Dasuni S.; Bye, Nicole; Morganti-Kossmann, M. Cristina			Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury (TBI); Traumatic axonal injury; Hypoxia; Erythropoietin; EPO; Neuroprotection	RECOMBINANT-HUMAN-ERYTHROPOIETIN; LATERAL FLUID PERCUSSION; CLOSED-HEAD INJURY; WHITE-MATTER; INTERLEUKIN-1 RECEPTOR; FUNCTIONAL OUTCOMES; SECONDARY INSULTS; SPATIAL MEMORY; MESSENGER-RNA; RATS	Background: Diffuse axonal injury is a common consequence of traumatic brain injury (TBI) and often co-occurs with hypoxia, resulting in poor neurological outcome for which there is no current therapy. Here, we investigate the ability of the multifunctional compound erythropoietin (EPO) to provide neuroprotection when administered to rats after diffuse TBI alone or with post-traumatic hypoxia. Methods: Sprague-Dawley rats were subjected to diffuse traumatic axonal injury (TAI) followed by 30 minutes of hypoxic (Hx, 12% O-2) or normoxic ventilation, and were administered recombinant human EPO-alpha (5000 IU/kg) or saline at 1 and 24 hours post-injury. The parameters examined included: 1) behavioural and cognitive deficit using the Rotarod, open field and novel object recognition tests; 2) axonal pathology (NF-200); 3) callosal degradation (hematoxylin and eosin stain); 3) dendritic loss (MAP2); 4) expression and localisation of the EPO receptor (EpoR); 5) activation/infiltration of microglia/macrophages (CD68) and production of IL-1 beta. Results: EPO significantly improved sensorimotor and cognitive recovery when administered to TAI rats with hypoxia (TAI + Hx). A single dose of EPO at 1 hour reduced axonal damage in the white matter of TAI + Hx rats at 1 day by 60% compared to vehicle. MAP2 was decreased in the lateral septal nucleus of TAI + Hx rats; however, EPO prevented this loss, and maintained MAP2 density over time. EPO administration elicited an early enhanced expression of EpoR 1 day after TAI + Hx compared with a 7-day peak in vehicle controls. Furthermore, EPO reduced IL-1 beta to sham levels 2 hours after TAI + Hx, concomitant to a decrease in CD68 positive cells at 7 and 14 days. Conclusions: When administered EPO, TAI + Hx rats had improved behavioural and cognitive performance, attenuated white matter damage, resolution of neuronal damage spanning from the axon to the dendrite, and suppressed neuroinflammation, alongside enhanced expression of EpoR. These data provide compelling evidence of EPO's neuroprotective capability. Few benefits were observed when EPO was administered to TAI rats without hypoxia, indicating that EPO's neuroprotective capacity is bolstered under hypoxic conditions, which may be an important consideration when EPO is employed for neuroprotection in the clinic.	[Hellewell, Sarah C.; Alwis, Dasuni S.; Bye, Nicole] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3000, Australia; [Hellewell, Sarah C.; Bye, Nicole] Monash Univ, Dept Surg, Melbourne, Vic 3000, Australia; [Yan, Edwin B.; Alwis, Dasuni S.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Morganti-Kossmann, M. Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3000, Australia; [Morganti-Kossmann, M. Cristina] Australian New Zealand Intens Care Res Ctr, Melbourne, Vic 3000, Australia; [Morganti-Kossmann, M. Cristina] Univ Arizona, Dept Child Hlth, Barrow Neurol Inst, Melbourne, Vic 3000, Australia		Hellewell, SC (corresponding author), Alfred Hosp, Natl Trauma Res Inst, Level 4,Burnet Tower,89 Commercial Rd, Melbourne, Vic 3000, Australia.	sarah.hellewell@monash.edu		Morganti-Kossmann, Cristina/0000-0002-0807-2063; Hellewell, Sarah/0000-0002-2179-2209	National Health and Medical Research Council AustraliaNational Health and Medical Research Council of Australia; Victorian Neurotrauma Initiative	The authors would like to thank Dr. Alan Zhang for design of the novel object recognition software, and Alison Conquest and Doreen Agyapomaa for assistance with animal experiments. The authors would also like to acknowledge the generous financial support from the National Health and Medical Research Council Australia and the Victorian Neurotrauma Initiative, with fellowship support for MCMK, EBY & NB.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Albasser MM, 2010, LEARN MEMORY, V17, P407, DOI 10.1101/lm.1879610; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; Basu A, 2002, J NEUROSCI, V22, P6071; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen ZY, 2006, NEURODEGENER DIS, V3, P68, DOI 10.1159/000092096; Chesnut R M, 1995, New Horiz, V3, P366; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghabriel M, 2004, PROCEEDINGS OF THE 7TH INTERNATIONAL NEUROTRAUMA SYMPOSIUM, P89; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; HINO A, 1989, STROKE, V20, P1504, DOI 10.1161/01.STR.20.11.1504; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; KOCHER M, 1990, J CEREBR BLOOD F MET, V10, P564, DOI 10.1038/jcbfm.1990.99; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewczuk P, 2000, NEUROREPORT, V11, P3485, DOI 10.1097/00001756-200011090-00017; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Madan A, 1997, BLOOD CELL MOL DIS, V23, P169, DOI 10.1006/bcmd.1997.0134; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; MASUDA S, 1994, J BIOL CHEM, V269, P19488; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Neumann D, 1996, BIOCHEM J, V313, P391, DOI 10.1042/bj3130391; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rockswold GL, 2006, J NEUROSURG, V104, P170, DOI 10.3171/jns.2006.104.1.170; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Satoh JI, 2002, NEUROPATH APPL NEURO, V28, P95, DOI 10.1046/j.1365-2990.2002.00375.x; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Spandou E, 2004, BRAIN RES, V1021, P167, DOI 10.1016/j.brainres.2004.06.057; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Stoll G, 2002, DETRIMENTAL BENEFICI, V513; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; TERAYAMA Y, 1993, SURG NEUROL, V39, P177, DOI 10.1016/0090-3019(93)90179-5; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Weber A, 2005, NEUROBIOL DIS, V20, P594, DOI 10.1016/j.nbd.2005.04.016; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	91	43	48	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 18	2013	10								156	10.1186/1742-2094-10-156			21	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	298LR	WOS:000330325900001	24344874	Green Published, gold			2022-02-06	
J	Brown, FL; Whittingham, K; Sofronoff, K; Boyd, RN				Brown, Felicity L.; Whittingham, Koa; Sofronoff, Kate; Boyd, Roslyn N.			Parenting a child with a traumatic brain injury: Experiences of parents and health professionals	BRAIN INJURY			English	Article						Family; focus group; parent; qualitative research; traumatic brain injury	FAMILY OUTCOMES; YOUNG-CHILDREN; REHABILITATION; PREDICTORS; ADOLESCENTS; DISTRESS; BURDEN; TBI; DISSEMINATION; DISABILITIES	Objective: To qualitatively explore the experiences, challenges and needs of parents of children with traumatic brain injury (TBI) in order to inform future intervention research through incorporation of participant knowledge and experience. Methods: Parents of children with TBI (n = 10) and experienced health professionals in paediatric rehabilitation (n = 5) took part in focus groups or individual interviews. Audio recordings were transcribed verbatim and an inductive thematic analysis performed. Findings: Participants reported that, beyond the impact of the injury on the child, TBI affects the entire family. Parents need to adjust to and manage their child's difficulties and can also experience significant emotional distress, relationship discord and burden of care, further adding to the challenges of the parenting role. Parents can feel isolated and the importance of empowerment, support and information was emphasized. Coping styles of disengagement and avoidance were often reported, despite acknowledgement that these were not beneficial. Conclusions: Parenting interventions may provide essential support for parents in adjusting to and managing their child's difficulties and the efficacy of existing programmes needs evaluation. Addressing parent emotional adjustment and coping strategies is vital following paediatric TBI, given the impact on parent well-being and the potential negative effects on child outcomes through reduced parenting effectiveness. Group programmes may enable connection and support.	[Brown, Felicity L.; Whittingham, Koa; Sofronoff, Kate] Univ Queensland, Sch Psychol, Fac Social & Behav Sci, Brisbane, Qld, Australia; [Brown, Felicity L.; Whittingham, Koa; Boyd, Roslyn N.] Univ Queensland, Sch Med, Queensland Cerebral Palsy & Rehabil Res Ctr, Brisbane, Qld, Australia; [Brown, Felicity L.] Univ Queensland, Fac Hlth Sci, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia		Brown, FL (corresponding author), Univ Queensland, Dept Psychol, St Lucia, Qld 4072, Australia.	f.brown@psy.uq.edu.au	Boyd, Roslyn N/A-4498-2011; Whittingham, Koa L/C-6766-2009	Boyd, Roslyn N/0000-0002-4919-5975; Whittingham, Koa L/0000-0002-5344-9907; Brown, Felicity/0000-0001-6800-1657	QCMRI [50002]; NHMRCNational Health and Medical Research Council of Australia [631712, 1037220]; Smart State Fellowship; University of Queensland FoundationUniversity of Queensland	The authors acknowledge a QCMRI PhD Scholarship (50002) (FB), an NHMRC postdoctoral fellowship (631712) (KW) and an NHMRC Career Development Fellowship (1037220), Smart State Fellowship and the University of Queensland Foundation support (RB). The authors report no conflicts of interest.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Blackledge JT, 2006, CHILD FAM BEHAV THER, V28, P1, DOI 10.1300/J019v28n01_01; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown FL, 2012, J HEAD TRAUMA REHABI; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Cole WR, 2009, DEV DISABIL RES REV, V15, P159, DOI 10.1002/ddrr.58; Eakes G G, 1998, Image J Nurs Sch, V30, P179; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Glidden LM, 2006, J INTELL DISABIL RES, V50, P949, DOI 10.1111/j.1365-2788.2006.00929.x; Greco LA, 2005, BEHAV THER, V36, P177, DOI 10.1016/S0005-7894(05)80066-8; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lloyd T, 2008, J INTELL DISABIL RES, V52, P37, DOI 10.1111/j.1365-2788.2007.00974.x; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Morse JM, 2002, INT J QUAL METH, V1, P13, DOI DOI 10.1177/160940690200100202; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Samios C, 2009, RES AUTISM SPECT DIS, V3, P358, DOI 10.1016/j.rasd.2008.08.003; Sanders MR, 2012, ANNU REV CLIN PSYCHO, V8, P345, DOI 10.1146/annurev-clinpsy-032511-143104; Sanders MR, 2012, BEHAV THER, V43, P236, DOI 10.1016/j.beth.2011.01.005; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; WEBSTERSTRATTON C, 1990, BEHAV THER, V21, P319, DOI 10.1016/S0005-7894(05)80334-X; Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zinner ES, 1997, ARCH CLIN NEUROPSYCH, V12, P435, DOI 10.1016/S0887-6177(96)00034-0	47	43	43	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1570	1582		10.3109/02699052.2013.841996			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400011	24111604				2022-02-06	
J	Kamper, JE; Pop, V; Fukuda, AM; Ajao, DO; Hartman, RE; Badaut, J				Kamper, Joel E.; Pop, Viorela; Fukuda, Andrew M.; Ajao, David O.; Hartman, Richard E.; Badaut, Jerome			Juvenile traumatic brain injury evolves into a chronic brain disorder: Behavioral and histological changes over 6 months	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Pediatric; Behavior; Neurodegeneration; MRI	CONTROLLED CORTICAL IMPACT; EXPERIMENTAL-MODELS; IMMATURE RAT; NEUROBEHAVIORAL OUTCOMES; CHILDREN; MOTOR; MAZE; PHENOTYPE; ADULTHOOD	Traumatic brain injury (TBI) refers to physical trauma to the brain that can lead to motor and cognitive dysfunctions. TBI is particularly serious in infants and young children, often leading to long-term functional impairments. Although clinical research is useful for quantifying and observing the effects of these injuries, few studies have empirically assessed the long-term effects of juvenile TBI (jTBI) on behavior and histology. After a controlled cortical impact delivered to postnatal 17 day old rats, functional abilities were measured after 3, 5, and 6 months using open field (activity levels), zero maze (anxiety-like behaviors), rotarod (sensorimotor abilities, coordination, and balance), and water maze (spatial learning and memory, swim speed, turn bias). Sensorimotor function was impaired for up to 6 months in jTBI animals, which showed no improvement from repeated test exposure. Although spatial learning was not impaired, spatial memory deficits were observed in jTBI animals starting at 3 months after injury. Magnetic resonance imaging and histological data revealed that the effects of jTBI were evolving for up to 6 months post-injury, with reduced cortical thickness, decreased corpus callosum area and CA1 neuronal cell death in jTBI animals distant to the impact site. These findings suggest that this model of jTBI produces long-term impairments comparable to those reported clinically. Although some deficits were stable over time, the variable nature of other deficits (e.g., memory) as well as changing properties of the lesion itself, suggest that the effects of a single jTBI produce a chronic brain disorder with long-term complications. (C) 2013 Elsevier Inc. All rights reserved.	[Kamper, Joel E.; Hartman, Richard E.] Loma Linda Univ, Dept Psychol, Loma Linda, CA 92354 USA; [Fukuda, Andrew M.; Ajao, David O.; Badaut, Jerome] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA; [Pop, Viorela; Badaut, Jerome] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA		Badaut, J (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat Pharmacol & Physiol, Coleman Pavil,Room A1120,11175 Campus St, Loma Linda, CA 92354 USA.		Kamper, Joel/V-2450-2019; Fukuda, Andrew/ABD-1038-2021	Kamper, Joel/0000-0001-5098-5176; Fukuda, Andrew/0000-0002-7927-6602	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD061946]; Swiss Science FoundationSwiss National Science Foundation (SNSF) [FN 31003A-122166]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061946] Funding Source: NIH RePORTER	The authors thank Dr. Andre Obenaus, Ms. Jacqueline Coats, Mr. Sonny Kim, and Mr. Kamal Ambadipudi for technical help in collecting MRI data. This work was supported in part by the NIH R01HD061946 (to JB) and the Swiss Science Foundation (FN 31003A-122166, to JB).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Ballachey EL, 1932, U CALIFORNIA PUBLICA, V6, P1; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P233, DOI 10.1016/S0091-3057(02)00787-6; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; GRANACHER RP, 2003, NEUROPSYCHIATRIC PSY; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hartman RE, 2011, TRANSL STROKE RES, V2, P433, DOI 10.1007/s12975-011-0132-y; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024	36	43	45	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2013	250						8	19		10.1016/j.expneurol.2013.09.016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	270FZ	WOS:000328305600002	24076005	Green Accepted			2022-02-06	
J	Zhang, YK; Liu, JT; Peng, ZW; Fan, H; Yao, AH; Cheng, P; Liu, L; Ju, G; Kuang, F				Zhang, Yu-Kai; Liu, Jin-Tao; Peng, Zheng-Wu; Fan, Hong; Yao, An-Hui; Cheng, Peng; Liu, Ling; Ju, Gong; Kuang, Fang			Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Hemorrhage; Toll-like receptor 4; Microglia/macrophage; Spinal cord injury; Blood-spinal cord barrier; Rat	TOLL-LIKE RECEPTORS; I-KAPPA-B; SECONDARY INJURY; VASCULAR EVENTS; BRAIN-INJURY; INFLAMMATION; TOLL-LIKE-RECEPTOR-4; CONTRIBUTES; MECHANISMS; INHIBITOR	Background: Hemorrhage is a direct consequence of traumatic injury to the central nervous system and may cause innate immune reactions including cerebral Toll-like receptor (TLR) 4 upregulation which usually leads to poor outcome in the traumatic brain injury. In spinal cord injury (SCI), however, how hemorrhage induces innate immune reaction in spinal parenchyma remains unknown. The present study aimed to see whether blood component and/or other factor(s) induce TLR4 and microglia/macrophages involved innate immune reactions in the rat spinal cord after traumatic injury. Methods: Using the compressive SCI model of the rat, hemorrhage in the spinal cord was identified by hematoxylin-eosin staining. Microglia/macrophage activation, TLR4 expression, and cell apoptosis were investigated by immunohistochemistry. Nuclear factor (NF)-kappa B p50 level of the two segments of the cord was detected by western blotting assay. With carbon powder injection, blood origination of the hematoma was explored. The blood-spinal cord barrier (BSCB) states of the lesion site and the hematoma were compared with immunohistochemistry and tannic acid-ferric chloride staining. Results: Histological observation found blood accumulated in the center of compression lesion site (epicenter) and in the hematoma approximately 1.5 cm away from the epicenter. TLR4 expression, microglia//macrophage activation, and subsequent apoptosis in the area of far-away hematoma were late and weak in comparison to that in epicenter. In addition, TLR4 positive microglia/macrophages appeared to be phagocytotic in the far-away hematoma more obviously than that in the epicenter. Injected carbon powder indicated that accumulated blood of the far-away hematoma originated from the bleeding of the lesion epicenter, and the BSCB around the hematoma was not compromised in the early phase. Accordingly, at 3 days post injury, NF-kappa B p50 was upregulated based on the similar levels of blood component hemoglobin, and cell apoptosis was obvious in the epicenter but not in the far-away hematoma. Conclusion: These data suggest that besides blood component, BSCB compromise and the extent of tissue injury contribute more to TLR4 and microglia/macrophage responses to the spinal cord hemorrhage. Therefore, the innate immune environment is a necessary consideration for the SCI therapy targeting TLR4 and microglia/macrophages.	[Zhang, Yu-Kai; Liu, Jin-Tao; Fan, Hong; Yao, An-Hui; Cheng, Peng; Liu, Ling; Ju, Gong; Kuang, Fang] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; [Zhang, Yu-Kai] 208th Hosp PLA, Dept Neurosurg, Changchun 130011, Peoples R China; [Liu, Jin-Tao] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Peng, Zheng-Wu] Fourth Mil Med Univ, Xijing Hosp, Dept Psychosomat Med, Xian 710032, Peoples R China		Ju, G (corresponding author), Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China.	jugong@fmmu.edu.cn; kuangf@fmmu.edu.cn	Zhang, Xiaolei/E-2761-2012; Peng, Zheng-wu/ABA-5838-2021	Zhang, Xiaolei/0000-0003-0117-7599; Peng, Zheng-wu/0000-0002-8185-0538	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC); Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30500451]; Military 11th Five-year Special-Purpose Program for PLA [082028]; Chinese PLA National Scientific Technological Project [06G089]; Major Project of Military Medicine [08XJZ002]; Military 11th Five-year Development of MedicineNational Key Technology R&D Program [2006K15-G1]	The present work was supported by the National Natural Science Foundation of China, the Natural Science Foundation of China (30500451), the Military 11th Five-year Special-Purpose Program for PLA (082028), the Chinese PLA National Scientific Technological Project (06G089), the Major Project of Military Medicine (08XJZ002), and the Military 11th Five-year Development of Medicine (2006K15-G1).	Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Alonso A, 2011, BRAIN RES, V9, P18; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; FAROOQUE M, 1992, ACTA NEUROPATHOL, V84, P613; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Fitch MT, 1999, J NEUROSCI, V19, P8182; Griffiths MR, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/151097; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Jia LY, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/862197; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Larsen PH, 2007, SCI STKE, V2007, P4; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Maslinska D, 2004, FOLIA NEUROPATHOL, V42, P125; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; Oyinbo CA, 2011, J IMMUNOL, V71, P281; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Pedras-Vasconcelos Joao, 2009, Front Biosci (Elite Ed), V1, P476; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Sinescu Crina, 2010, J Med Life, V3, P254; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Teng WY, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/473276; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Yao AH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591298; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhou ML, 2007, INFLAMM RES, V56, P93, DOI 10.1007/s00011-006-6035-9; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003	42	43	44	2	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	SEP 10	2013	10								112	10.1186/1742-2094-10-112			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	216EJ	WOS:000324264200001	24015844	Green Published, gold			2022-02-06	
J	Miyashita, TL; Timpson, WM; Frye, MA; Gloeckner, GW				Miyashita, Theresa L.; Timpson, William M.; Frye, Melinda A.; Gloeckner, Gene W.			The Impact of an Educational Intervention on College Athletes' Knowledge of Concussions	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussions; college athletes; educational intervention	FOOTBALL PLAYERS; SPORTS CONCUSSION; INJURY; EPIDEMIOLOGY; PREVENTION; DEPRESSION; SYMPTOMS; HEALTH	Objective: The purpose of this study was to determine college athletes' knowledge regarding concussions and to determine if an educational lecture before their sport season would improve their knowledge and reporting of concussions. Design: Cross-sectional study. Setting: University classroom. Participants: Seventy National College Athletic Association Division II men's/women's soccer players and men's/women's basketball players. Interventions: Educational lecture regarding the basics of concussions. Main Outcome Measures: Descriptive statistics, ANOVAs, and a paired sample t test determined the athletes' knowledge of concussion before and after the season and the impact of the educational intervention. Results: A paired sample t test indicated that the athletes scored better on the postseason concussion knowledge assessment [t(49) = 10.34, P < 0.000, d = 1.47]. Conclusions: After an educational intervention, athletes demonstrated an improvement in their knowledge on concussions.	[Miyashita, Theresa L.] Metropolitan State Univ Denver, Dept Human Performance & Sport, Denver, CO 80204 USA; [Timpson, William M.; Frye, Melinda A.; Gloeckner, Gene W.] Colorado State Univ, Sch Educ, Ft Collins, CO 80523 USA		Miyashita, TL (corresponding author), Metropolitan State Univ Denver, Dept Human Performance & Sport, 1201 5th St,CB 25, Denver, CO 80204 USA.	tdelano@msudenver.edu					Arnheim D, 2011, HEAD FACE EYES EARS, P786; Campino A, 2009, ACTA PAEDIATR, V98, P782, DOI 10.1111/j.1651-2227.2009.01234.x; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marineau C, 2007, J AM ACAD PHY ASSIST, V20, P22; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mevsim V, 2009, EUR J CONTRACEP REPR, V14, P144, DOI 10.1080/13625180802451201; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Patel AV, 2007, J ATHL TRAINING, V42, P66; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; [No title captured]	28	43	43	1	40	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2013	23	5					349	353		10.1097/JSM.0b013e318289c321			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	212YD	WOS:000324017900005	23528843				2022-02-06	
J	Jones, A				Jones, Alvin			Test of Memory Malingering: Cutoff Scores for Psychometrically Defined Malingering Groups in a Military Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Test of Memory Malingering; Performance validity; Malingering; Symptom validity	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; RESPONSE BIAS; CLASSIFICATION ACCURACY; REPEATABLE BATTERY; EFFORT INDEX; PERFORMANCE; VALIDATION; MILD; TOMM	This research examined cutoffs for the Test of Memory Malingering (TOMM) in a military sample composed primarily of mTBI patients. The results are consistent with previous research and provide additional evidence that cutoffs higher than those originally recommended for the TOMM can produce excellent classification and diagnostic statistics when a psychometrically defined non-malingering group is compared with three psychometrically defined malingering groups: Probable, Probable to Definite, and Definite Malingering. The groups were formed based on the number of symptom and performance validity tests passed or failed. Cutoffs that were 4-5 points higher for Trial 2 and the Retention Trial than originally recommended produced very low false positive rates (.0 to .06) and excellent positive predictive values (.75 to 1.00) for a base rate of malingering commonly found in TBI patients. Positive likelihood ratios were all above 10 for these two trials indicating excellent ability to rule in malingering. A range of cutoffs for Trial 1 were also examined, and classification and diagnostic statistics are presented for cutoffs ranging from 40 to 44 with results similar to the other TOMM trials.	Womack Army Med Ctr, Dept Brain Injury Med, Ft Bragg, NC 29310 USA		Jones, A (corresponding author), Womack Army Med Ctr, Dept Brain Injury Med, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 29310 USA.	alvin.jones2@us.army.mil					Allen LM, 2001, ARCH CLIN NEUROPSYCH, V16, P846; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Crawford JR, 2009, CLIN NEUROPSYCHOL, V23, P624, DOI 10.1080/13854040802524229; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P., 2004, MANUAL NONVERBAL MED; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Randolph C., 1998, REPEATABLE BATTERY A; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Schroeder R, 2011, RNA BIOL, V8, P1; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	51	43	43	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 1	2013	27	6					1043	1059		10.1080/13854046.2013.804949			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	197RA	WOS:000322867100010	23730741				2022-02-06	
J	Kahl, JE; Calvo, RY; Sise, MJ; Sise, CB; Thorndike, JF; Shackford, SR				Kahl, Jessica E.; Calvo, Richard Y.; Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Shackford, Steven R.			The changing nature of death on the trauma service	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Death; trauma center; innovations; elderly; aging patients	PRACTICE MANAGEMENT GUIDELINES; RESPIRATORY-DISTRESS-SYNDROME; LUNG-PROTECTIVE VENTILATION; EPIDEMIOLOGY; TRANSFUSION; OUTCOMES; SYSTEM; IMPACT; INJURY; RESUSCITATION	BACKGROUND: Recent innovations in care have improved survival following injury. Coincidentally, the population of elderly injured patients with preexisting comorbidities has increased. We hypothesized that this increase in elderly injured patients may have combined with recent care innovations to alter the causes of death after trauma. METHODS: We reviewed demographics, injury characteristics, and cause of death of in-hospital deaths of patients admitted to our Level I trauma service from 2000 through 2011. Cause of death was classified as acute hemorrhagic shock; severe traumatic brain injury or high spinal cord injury; complications of preexisting medical condition only (PM); survivable trauma combined with complications of preexisting medical condition(TCoM); multiple-organ failure, sepsis, or adult respiratory distress syndrome (MOF/S/ARDS), or trauma not otherwise categorized (e. g., asphyxiation). Major trauma care advances implemented on our service during the period were identified, and trends in the causes of death were analyzed. RESULTS: Of the 27,276 admissions, 819 (3%) eligible nonsurvivors were identified for the cause-of-death analyses. Causes of death were severe traumatic brain injury or high spinal cord injury at 44%, acute hemorrhagic shock at 28%, PM at 11%, TCoM at 10%, MOF/S/ARDS at 2%, and trauma not otherwise categorized at 5%. Mean age at death increased across the study interval (range, 47-57 years), while mean Injury Severity Score (ISS) decreased (range, 28-35). There was a significant increase in deaths because of TCoM(3.3-20.9%) and PM(6.7-16.4%), while deaths caused by MOF/S/ARDS decreased from 5% to 0% by 2007. Compared with year 2000, the annual adjusted mortality rate decreased consistently starting in 2009, after the 2002 to 2007 adoption of four major trauma practice guidelines. CONCLUSION: Mortality caused by preexisting medical conditions has increased, while markedly fewer deaths resulted from the complications of injury. Future improvements in outcomes will require improvement in the management of elderly trauma patients with comorbid conditions. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Kahl, Jessica E.; Calvo, Richard Y.; Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Shackford, Steven R.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA 92103 USA		Sise, MJ (corresponding author), Scripps Mercy Hosp, Trauma Serv MER 62, 4077 5th Ave, San Diego, CA 92103 USA.	sise.mike@scrippshealth.org		Calvo, Richard/0000-0001-9147-2668	Haemonetics	Ernest E. Moore, Editor: PI, research grant, Haemonetics. Associate editors: David Hoyt, Ronald Maier, and Steven Shackford have nothing to disclose. Editorial staff: Jennifer Crebs, Jo Fields, and Angela Sauaia have nothing to disclose.	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Bergeron E, 2004, J TRAUMA, V56, P760, DOI 10.1097/01.TA.0000119199.52226.C0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Inaba K, 2010, J AM COLL SURGEONS, V211, P573, DOI 10.1016/j.jamcollsurg.2010.06.392; Laudi S, 2007, INJURY, V38, P1052, DOI 10.1016/j.injury.2007.03.020; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Plurad D, 2007, J TRAUMA, V63, P1, DOI 10.1097/TA.0b013e318068b1ed; Potenza BM, 2004, J TRAUMA, V56, P68, DOI 10.1097/01.TA.0000101490.32972.9F; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 2001, J TRAUMA, V50, P604, DOI 10.1097/00005373-200104000-00003; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Sise CB, 2011, J TRAUMA, V70, P560, DOI 10.1097/TA.0b013e31820c7b79	25	43	45	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2013	75	2					195	201		10.1097/TA.0b013e3182997865			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300FL	WOS:000330449700002	23823614				2022-02-06	
J	Sayed, N; Culver, C; Dams-O'Connor, K; Hammond, F; Diaz-Arrastia, R				Sayed, Nasreen; Culver, Carlee; Dams-O'Connor, Kristen; Hammond, Flora; Diaz-Arrastia, Ramon			Clinical Phenotype of Dementia after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Alzheimer's disease; chronic traumatic encephalopathy; National Alzheimer's Coordinating Center	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK	Traumatic brain injury (TBI) in early to mid-life is associated with an increased risk of dementia in late life. It is unclear whether TBI results in acceleration of Alzheimer's disease (AD)-like pathology or has features of another dementing condition, such as chronic traumatic encephalopathy, which is associated with more-prominent mood, behavior, and motor disturbances than AD. Data from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set was obtained over a 5-year period. Categorical data were analyzed using Fisher's exact test. Continuous parametric data were analyzed using the Student's t-test. Nonparametric data were analyzed using Mann-Whitney's test. Overall, 877 individuals with dementia who had sustained TBI were identified in the NACC database. Only TBI with chronic deficit or dysfunction was associated with increased risk of dementia. Patients with dementia after TBI (n = 62) were significantly more likely to experience depression, anxiety, irritability, and motor disorders than patients with probable AD. Autopsy data were available for 20 of the 62 TBI patients. Of the patients with TBI, 62% met National Institute of Aging-Reagan Institute "high likelihood'' criteria for AD. We conclude that TBI with chronic deficit or dysfunction is associated with an increased odds ratio for dementia. Clinically, patients with dementia associated with TBI were more likely to have symptoms of depression, agitation, irritability, and motor dysfunction than patients with probable AD. These findings suggest that dementia in individuals with a history of TBI may be distinct from AD.	[Sayed, Nasreen; Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Culver, Carlee; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Dams-O'Connor, Kristen] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Hammond, Flora] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA		Diaz-Arrastia, R (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 12725 Twinbrook Pkwy, Rockville, MD 20852 USA.	Ramon.Diaz-Arrastia@usuhs.mil		Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIDRR [H133A020526, U01 AG16976];  [P30 AG12300];  [R01 HD048179]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976, P30AG012300] Funding Source: NIH RePORTER	This work was supported by P30 AG12300 (Core B), R01 HD048179, and NIDRR H133A020526 (to R.D.-A.) and U01 AG16976 (NACC).	Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Faul M., TRAUMATIC BRAIN INJU, P1; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Institute of Medicine Committee on Gulf War Health, 2009, GULF WAR HLTH; Jack CR, 2011, ARCH NEUROL-CHICAGO, V68, P1526, DOI 10.1001/archneurol.2011.183; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Savonenko AV, 2012, NEUROPSYCHOPHARMACOL, V37, P261, DOI 10.1038/npp.2011.211; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Villareal DT, 2003, NEUROLOGY, V61, P661, DOI 10.1212/WNL.61.5.661	18	43	43	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1117	1122		10.1089/neu.2012.2638			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400002	23374007	Green Published			2022-02-06	
J	van Hout, WMMT; Van Cann, EM; Abbink, JH; Koole, R				van Hout, Wouter M. M. T.; Van Cann, Ellen M.; Abbink, Jan H.; Koole, Ronald			An epidemiological study of maxillofacial fractures requiring surgical treatment at a tertiary trauma centre between 2005 and 2010	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Trauma; Fracture; Maxillofacial fracture; Facial skeleton; Neurotrauma; Concomitant injury; Helmet	ETIOLOGY; INJURIES	The epidemiology of maxillofacial fractures shows considerable regional variation as a result of local demographic and socioeconomic factors. We have assessed the epidemiological characteristics of such fractures at our centre in The Netherlands. The medical records of 394 patients who were treated surgically for maxillofacial fractures between 1 January 2005 and 31 December 2010 were analysed retrospectively. The male:female ratio was 3:1. There was a peak incidence in the second and third decades of life among men. The number of injured patients/year remained stable during the selected period. The incidence was highest in the spring and at weekends. Fractures of the mandible and zygoma were the most common. Road traffic crashes were the most common cause of injury (42%) and mainly involved bicycles. A total of 165 (15%) of the patients were intoxicated, and 142 patients (36%) had other serious injuries. Most patients (n = 248, 63%) were treated within a day of presentation. Two hundred and thirty-two patients (59%) spent 4 days or fewer in hospital. The presence of other injuries was associated with a prolonged stay in hospital. Groups at particular risk of maxillofacial fractures are young men and cyclists. The use of helmets by cyclists could achieve a large reduction in injuries to the brain and upper face. (C) 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[van Hout, Wouter M. M. T.; Van Cann, Ellen M.; Abbink, Jan H.; Koole, Ronald] Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg, NL-3584 CX Utrecht, Netherlands		Van Cann, EM (corresponding author), Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg, Heidelberglaan 100,POB 85500, NL-3584 CX Utrecht, Netherlands.	e.m.vancann@umcutrecht.nl		Abbink, Jan Hendrik/0000-0002-6542-0167			Bormann KH, 2009, J ORAL MAXIL SURG, V67, P1251, DOI 10.1016/j.joms.2008.09.022; Buchanan Jessica, 2005, N Z Med J, V118, pU1529; Calderoni DR, 2011, J CRANIO MAXILL SURG, V39, P593, DOI 10.1016/j.jcms.2010.11.018; DEJOY DM, 1992, ACCIDENT ANAL PREV, V24, P237, DOI 10.1016/0001-4575(92)90003-2; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Hutchison IL, 1998, BRIT J ORAL MAX SURG, V36, P3, DOI 10.1016/S0266-4356(98)90739-2; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; van Beek GJ, 1999, INT J ORAL MAX SURG, V28, P424, DOI 10.1016/S0901-5027(99)80055-1	8	43	45	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	JUL	2013	51	5					416	420		10.1016/j.bjoms.2012.11.002			5	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	178WY	WOS:000321479300009	23218202				2022-02-06	
J	Borczuk, P; Penn, J; Peak, D; Chang, YC				Borczuk, Pierre; Penn, Joshua; Peak, David; Chang, Yuchiao			Patients with traumatic subarachnoid hemorrhage are at low risk for deterioration or neurosurgical intervention	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild head trauma; subarachnoid hemorrhage; neurosurgical consultation	MINOR HEAD-INJURY; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; UTILITY; CONSULTATION; MANAGEMENT; RULE	BACKGROUND: Current standard of care for patients with traumatic intracranial hemorrhage (TIH) includes neurosurgical consultation and/or transfer to a trauma center with neurosurgical backup. We hypothesize that a set of low-risk criteria can be applied to such patients to identify those who may not require neurosurgical evaluation. METHODS: This is a cross-sectional study of consecutive emergency department patients in 2009 and 2010 with TIH on computerized tomographic scan owing to blunt head trauma. Patients presented to an urban academic Level I trauma center (volume, 92,000) were older than 15 years and had a Glasgow Coma Scale (GCS) score of 13 or greater. Charts were abstracted using a standardized data form by two emergency physicians. Our principal outcome was deterioration represented by a composite of neurosurgical intervention, clinical deterioration, or worsening computerized tomographic scan result. RESULTS: During the study period, 404 patients were seen with TIH and met our inclusion criteria, and 48 of those patients (11.8%) deteriorated. Patients with isolated subarachnoid hemorrhage, were less likely to deteriorate (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.011-0.58). Characteristics associated with deterioration were subdural hematomas (OR, 2.63; 95% CI, 1.198-5.81) or presenting GCS of less than 15 (OR, 2.12; 95% CI, 1.01-4.43). The use of anticoagulant medications or antiplatelet agents were not associated with deterioration for warfarin, aspirin, or clopidogrel; however bleeding diatheses were corrected with vitamin K, fresh frozen plasma, and platelets as necessary. CONCLUSION: Patients with isolated traumatic subarachnoid hemorrhage are at low risk for deterioration. These individuals may not need neurosurgical consultation or transfer to a trauma center where neurosurgical backup is available. Those patients with subdural hematoma or a GCS of less than 15 have a higher risk of deterioration and require neurosurgical evaluation. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Borczuk, Pierre; Peak, David] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Borczuk, Pierre; Penn, Joshua; Peak, David] Harvard Univ, Sch Med, Div Emergency Med, Boston, MA USA; [Penn, Joshua] Winchester Hosp, Dept Emergency Med, Boston, MA USA		Borczuk, P (corresponding author), Massachusetts Gen Hosp, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	pborczuk@partners.org					Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Barker DE, 2006, AM SURGEON, V72, P1166; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	19	43	43	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2013	74	6					1504	1509		10.1097/TA.0b013e31829215cf			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AB4DO	WOS:000331739800018	23694879				2022-02-06	
J	Kargi, AY; Merriam, GR				Kargi, Atil Y.; Merriam, George R.			Diagnosis and treatment of growth hormone deficiency in adults	NATURE REVIEWS ENDOCRINOLOGY			English	Article							QUALITY-OF-LIFE; GH REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; INTIMA-MEDIA THICKNESS; BONE-MINERAL DENSITY; CARDIOVASCULAR RISK MARKERS; INSULIN TOLERANCE-TEST; LONG-TERM MORTALITY; BODY-COMPOSITION; HYPOPITUITARY PATIENTS	The availability of synthetic recombinant human growth hormone (GH) in potentially unlimited quantities since the 1980s has improved understanding of the many nonstatural effects of GH on metabolism, body composition, physical and psychological function, as well as the consequences of GH deficiency in adult life. Adult GH deficiency is now recognized as a distinct if nonspecific syndrome with considerable adverse health consequences. GH replacement therapy in lower doses than those used in children can reverse many of these abnormalities and restore functional capacities toward or even to normal; if dosed appropriately, GH therapy has few adverse effects. Although some doubts remain about possible long-term risks of childhood GH therapy, most registries of adult GH replacement therapy, albeit limited in study size and duration, have not shown an increased incidence of cancers or of cardiovascular morbidity or mortality.	[Kargi, Atil Y.] Univ Miami, Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Merriam, George R.] Vet Affairs Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Merriam, George R.] Univ Washington, Sch Med, Seattle, WA 98195 USA		Merriam, GR (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Box 356426, Seattle, WA 98195 USA.	merriam@uw.edu			National Institute of Aging, US National Institutes of Health	The authors thank P. Asberry, S. Brickle, M. Kletke and L. Smith for their assistance with the work of the research group. The authors gratefully acknowledge research support from the National Institute of Aging, US National Institutes of Health, and from the facilities and resources of the US Department of Veterans Affairs Puget Sound Health Care System.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aguiar-Oliveira MH, 2010, J CLIN ENDOCR METAB, V95, P714, DOI 10.1210/jc.2009-1879; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; AlShoumer KAS, 1996, EUR J ENDOCRINOL, V135, P559, DOI 10.1530/eje.0.1350559; Andreassen T. T., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P49; Arnold JR, 2009, CLIN ENDOCRINOL, V70, P435, DOI 10.1111/j.1365-2265.2008.03391.x; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; Beauregard C, 2008, J CLIN ENDOCR METAB, V93, P2063, DOI 10.1210/jc.2007-2371; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P179, DOI 10.1111/j.1365-2265.1995.tb01860.x; Bidlingmaier M, 2006, J CLIN ENDOCR METAB, V91, P2926, DOI 10.1210/jc.2006-0514; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Binder G, 2004, HORM RES, V62, P84, DOI 10.1159/000079539; Bravenboer N, 1996, BONE, V18, P551, DOI 10.1016/8756-3282(96)00069-5; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chihara K, 2007, EUR J ENDOCRINOL, V157, P19, DOI 10.1530/EJE-07-0066; Child CJ, 2011, EUR J ENDOCRINOL, V165, P217, DOI 10.1530/EJE-11-0286; Claessen KMJA, 2013, J CLIN ENDOCR METAB, V98, P352, DOI 10.1210/jc.2012-2940; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Clemmons DR, 2010, CURR OPIN ENDOCRINOL, V17, P377, DOI 10.1097/MED.0b013e32833b6bc7; CLEMMONS DR, 1991, ANNU REV NUTR, V11, P393, DOI 10.1146/annurev.nu.11.070191.002141; Climent V, 2007, CURR MED CHEM, V14, P1399, DOI 10.2174/092986707780831195; Colao A, 2004, CLIN ENDOCRINOL, V61, P360, DOI 10.1111/j.1365-2265.2004.02105.x; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3416, DOI 10.1210/jc.2007-2810; Cook DM, 2009, ENDOCR PRACT, V15, P580, DOI 10.4158/EP.15.6.580; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; CUNEO RC, 1993, METABOLISM, V42, P1519, DOI 10.1016/0026-0495(93)90145-E; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DEBOER H, 1994, METABOLISM, V43, P199, DOI 10.1016/0026-0495(94)90245-3; DEBOER H, 1994, J BONE MINER RES, V9, P1319; Drake WM, 2001, CLIN ENDOCRINOL, V54, P525, DOI 10.1046/j.1365-2265.2001.01246.x; Ezzat S, 2002, J CLIN ENDOCR METAB, V87, P2725, DOI 10.1210/jc.87.6.2725; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Giavoli C, 2004, J CLIN ENDOCR METAB, V89, P5397, DOI 10.1210/jc.2004-1114; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gilchrist FJ, 2002, CLIN ENDOCRINOL, V57, P363, DOI 10.1046/j.1365-2265.2002.01608.x; Gleeson HK, 2004, J CLIN ENDOCR METAB, V89, P662, DOI 10.1210/jc.2003-031224; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; Gotherstrom G, 2007, EUR J ENDOCRINOL, V156, P55, DOI 10.1530/eje.1.02317; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hersch EC, 2008, CLIN INTERV AGING, V3, P121; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOLMES SJ, 1995, CLIN ENDOCRINOL, V43, P143, DOI 10.1111/j.1365-2265.1995.tb01908.x; HOLMES SJ, 1995, CLIN ENDOCRINOL, V43, P151, DOI 10.1111/j.1365-2265.1995.tb01909.x; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P2865, DOI 10.1210/jc.81.8.2865; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P1743, DOI 10.1210/jc.87.4.1743; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; JOHANSSON JO, 1995, METABOLISM, V44, P1126, DOI 10.1016/0026-0495(95)90004-7; Jorgensen J O L, 2005, J Endocrinol Invest, V28, P47; Karavitaki N, 2006, CLIN ENDOCRINOL, V64, P556, DOI 10.1111/j.1365-2265.2006.02508.x; Kargi AY, 2012, CURR OPIN ENDOCRINOL, V19, P300, DOI 10.1097/MED.0b013e32835430da; KAUFMAN JM, 1992, J CLIN ENDOCR METAB, V74, P118, DOI 10.1210/jc.74.1.118; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Koltowska-Haggstrom M, 2009, EUR J ENDOCRINOL, V161, pS51, DOI 10.1530/EJE-09-0266; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Leonsson M, 2002, CLIN ENDOCRINOL, V57, P751, DOI 10.1046/j.1365-2265.2002.01663.x; Longobardi S, 1996, J CLIN ENDOCR METAB, V81, P1244, DOI 10.1210/jc.81.3.1244; Losa M, 2008, THYROID, V18, P1249, DOI 10.1089/thy.2008.0266; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Maiter D, 2006, EUR J ENDOCRINOL, V155, P253, DOI 10.1530/eje.1.02209; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Moe KE, 1998, J GERONTOL A-BIOL, V53, pB117, DOI 10.1093/gerona/53A.2.B117; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moller N, 2009, CLIN NUTR, V28, P597, DOI 10.1016/j.clnu.2009.08.015; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Monson JP, 2007, CLIN ENDOCRINOL, V67, P623, DOI 10.1111/j.1365-2265.2007.02935.x; Moock J, 2009, EUR J ENDOCRINOL, V160, P17, DOI 10.1530/EJE-08-0738; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; Murata M, 2003, EUR J ENDOCRINOL, V148, P333, DOI 10.1530/eje.0.1480333; Murray RD, 2004, J CLIN ENDOCR METAB, V89, P1124, DOI 10.1210/jc.2003-030685; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Oliveira JLM, 2007, J CLIN ENDOCR METAB, V92, P4664, DOI 10.1210/jc.2007-1636; Olsson DS, 2009, EUR J ENDOCRINOL, V161, P663, DOI 10.1530/EJE-09-0572; PARKIN JM, 1974, ARCH DIS CHILD, V49, P904, DOI 10.1136/adc.49.11.904; Petersenn S, 2002, EUR J ENDOCRINOL, V146, P667, DOI 10.1530/eje.0.1460667; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; RABEN MS, 1962, NEW ENGL J MED, V266, P31, DOI 10.1056/NEJM196201042660109; RABINOWITZ D, 1963, NATURE, V199, P913, DOI 10.1038/199913a0; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P201, DOI 10.1530/acta.0.1290201; Rosen T, 1997, EUR J ENDOCRINOL, V137, P240, DOI 10.1530/eje.0.1370240; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Sassolas G, 1999, EUR J ENDOCRINOL, V141, P595, DOI 10.1530/eje.0.1410595; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P1518, DOI 10.1210/jc.86.4.1518; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; SHAH A, 1992, BRIT MED J, V304, P173, DOI 10.1136/bmj.304.6820.173; Sherlock M, 2010, ENDOCR REV, V31, P301, DOI 10.1210/er.2009-0033; Sklar CA, 2002, J CLIN ENDOCR METAB, V87, P3136, DOI 10.1210/jc.87.7.3136; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Stochholm K, 2007, HORM RES, V68, P173, DOI 10.1159/000110618; Stochholm K, 2006, EUR J ENDOCRINOL, V155, P61, DOI 10.1530/eje.1.02191; Svensson J, 2003, J CLIN ENDOCR METAB, V88, P2061, DOI 10.1210/jc.2002-020901; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tauber M, 1997, J CLIN ENDOCR METAB, V82, P352, DOI 10.1210/jc.82.2.352; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Toogood AA, 1997, ACTA PAEDIATR, V86, P117; Urushihara H, 2007, EUR J ENDOCRINOL, V156, P637, DOI 10.1530/EJE-07-0016; van der Klaauw AA, 2007, EUR J ENDOCRINOL, V156, P455, DOI 10.1530/EJE-06-0699; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000; Vi TN, 2009, PITUITARY, V12, P125, DOI 10.1007/s11102-008-0101-y; Wacharasindhu S, 1996, CLIN ENDOCRINOL, V45, P553, DOI 10.1046/j.1365-2265.1996.00850.x; WEAVER JU, 1994, CLIN ENDOCRINOL, V41, P639, DOI 10.1111/j.1365-2265.1994.tb01830.x; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022; Wuster C, 2001, J BONE MINER RES, V16, P398, DOI 10.1359/jbmr.2001.16.2.398; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	136	43	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5029	1759-5037		NAT REV ENDOCRINOL	Nat. Rev. Endocrinol.	JUN	2013	9	6					335	345		10.1038/nrendo.2013.77			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	149QK	WOS:000319335900007	23629539				2022-02-06	
J	Lange, RT; Iverson, GL; Brickell, TA; Staver, T; Pancholi, S; Bhagwat, A; French, LM				Lange, Rael T.; Iverson, Grant L.; Brickell, Tracey A.; Staver, Tara; Pancholi, Sonal; Bhagwat, Aditya; French, Louis M.			Clinical Utility of the Conners' Continuous Performance Test-II to Detect Poor Effort in US Military Personnel Following Traumatic Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						mild traumatic brain injury; poor effort; military service members; CPT-II; symptom validity testing	MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; LEARNING TEST INDICATORS; RELIABLE DIGIT SPAN; CARD SORTING TEST; CLASSIFICATION ACCURACY; INADEQUATE EFFORT; CHRONIC PAIN; HEAD-INJURY; MILD	The purpose of this study is to examine the clinical utility of the Conners' Continuous Performance Test (CPT-II) as an embedded marker of poor effort in military personnel undergoing neuropsychological evaluations following traumatic brain injury. Participants were 158 U.S. military service members divided into 3 groups on the basis of brain injury severity and performance (pass/fail) on 2 symptom validity tests: Mild Traumatic Brain Injury (MTBI)-Pass (n = 87), MTBI-Fail (n = 42), and severe traumatic brain injury (STBI)-Pass (n = 29). The MTBI-Fail group performed worse on the majority of CPT-II measures compared with both the MTBI-Pass and STBI-Pass groups. When comparing the MTBI-Fail group and MTBI-Pass groups, the most accurate measure for identifying poor effort was the Commission T score. When selected measures were combined (i.e., Omissions, Commissions, and Perseverations), there was a very small increase in sensitivity (from .26 to .29). When comparing the MTBI-Fail group and STBI-Pass groups, the most accurate measure for identifying poor effort was the Omission and Commissions T score. When selected measures were combined, sensitivity again increased (from .24 to .45). Overall, these results suggest that individual CPT-II measures can be useful for identifying people who are suspected of providing poor effort from those who have provided adequate effort. However, due to low sensitivity and modest negative predictive power values, this measure cannot be used in isolation to detect poor effort, and is largely useful as a test to "rule in," not "rule out" poor effort.	[Lange, Rael T.; Iverson, Grant L.; Brickell, Tracey A.; Pancholi, Sonal; Bhagwat, Aditya; French, Louis M.] Def & Vet Brain Injury Ctr, Dept Res, North Bethesda, MD 20852 USA; [Lange, Rael T.; Brickell, Tracey A.; Bhagwat, Aditya; French, Louis M.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed & Rehabil, Bethesda, MD USA; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Staver, Tara] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Pancholi, Sonal] Ft Belvoir Community Hosp, Ft Belvoir, VA USA; [Bhagwat, Aditya] US PHS, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Lange, RT (corresponding author), Def & Vet Brain Injury Ctr, 11300 Rockville Pike,Suite 1100, North Bethesda, MD 20852 USA.	rlange@dvbic.org	french, louis/AAB-2083-2020	Iverson, Grant/0000-0001-7348-9570; french, louis/0000-0002-9451-0604			Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barney SJ, 2011, CLIN NEUROPSYCHOL, V25, P1145, DOI 10.1080/13854046.2011.595956; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Conners K., 2002, CONNERS CONTINUOUS P; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2007, APPL NEUROPSYCHOL, V14, P267, DOI 10.1080/09084280701719245; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2008, NEUROPSYCHOLOGY HDB, P125; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P412, DOI 10.1080/13803390490520319; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Pearson, 2009, ADV CLIN SOLUTIONS W, P71; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	56	43	44	1	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2013	25	2					339	352		10.1037/a0030915			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	173DR	WOS:000321058800004	23244641				2022-02-06	
J	Haran, FJ; Tierney, R; Wright, WG; Keshner, E; Silter, M				Haran, F. J.; Tierney, R.; Wright, W. G.; Keshner, E.; Silter, M.			Acute Changes in Postural Control after Soccer Heading	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; MTBI; balance; stability; virtual environment	NEURON-SPECIFIC ENOLASE; NEUROPSYCHOLOGICAL IMPAIRMENT; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; DAMAGE S-100B; BRAIN-INJURY; CONCUSSION; PLAYERS; STABILITY; FREQUENCY	This study intended to determine if an acute bout of soccer heading alters postural control and pronounced self-reported symptoms of cerebral concussion. Collegiate soccer players were randomly assigned to one of 2 groups. Each participant completed a baseline postural control assessment prior to heading. Participants either simulated (control group; CG) or performed (experimental group; EG) 10 headers at 11.2 m/s in 10 min. The postural assessment was repeated post heading at hrs 1, 24, and 48. The postural control parameter assessed was the root mean square (RMS) of the center of mass (COM). COM RMS were calculated for the anterior-posterior (AP) and medial-lateral (ML) time series. Compared to the CG, for the AP and ML time series COM RMS values were significantly higher in the EG at hr 24 (p < 0.05). An acute bout of heading results in quantifiable alterations in postural control that are detectable 24 h post heading and dissipate within an additional 24 h. The significant findings may be due to the dynamic postural control assessment that incorporated robust discordant environmental conditions.	[Haran, F. J.; Tierney, R.; Wright, W. G.; Keshner, E.; Silter, M.] Temple Univ, Philadelphia, PA 19122 USA		Haran, FJ (corresponding author), Temple Univ, 120 Pearson Hall, Philadelphia, PA 19122 USA.	fjharan@gmail.com			NIH-NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG26470]; NIH-NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC05235]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG026470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC005235] Funding Source: NIH RePORTER	Supported by NIH-NIA grant AG26470 and NIH-NIDCD grant DC05235. We gratefully acknowledge VRCO, Inc., for the use of the CAVELIB to develop the VE.	Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Higgins MJ, 2009, P I MECH ENG P-J SPO, V223, P117, DOI 10.1243/17543371JSET15; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Slaboda JC, 2009, IEEE ENG MED BIO, P1147, DOI 10.1109/IEMBS.2009.5333916; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Streepey JW, 2007, EXP BRAIN RES, V176, P182, DOI 10.1007/s00221-006-0677-2; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	33	43	43	0	15	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	APR	2013	34	4					350	354		10.1055/s-0032-1304647			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	112TA	WOS:000316615100010	23175178	Bronze			2022-02-06	
J	LaFrance, WC; DeLuca, M; Machan, JT; Fava, JL				LaFrance, W. Curt, Jr.; DeLuca, Marie; Machan, Jason T.; Fava, Joseph L.			Traumatic brain injury and psychogenic nonepileptic seizures yield worse outcomes	EPILEPSIA			English	Article						Traumatic brain injury; Nonepileptic seizures; Risk; Depression; Comorbidity	QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; RECOMMENDATIONS; SEQUELAE; EPILEPSY	Purpose: To investigate the relationship between traumatic brain injury (TBI) and psychogenic nonepileptic seizures (PNES). We hypothesized that PNES with TBI would be associated with more psychiatric comorbidities and disability than PNES without TBI. Methods: In this cross-sectional study comparing patients with PNES with TBI to patients with PNES without TBI, medical records from 255 consecutive patients with electroencephalography (EEG)-confirmed PNES were reviewed to assess variables including demographic, head injury, neurologic, psychiatry, social variables, and quality of life and symptoms scales. Parametric, analysis of covariance (ANCOVA), and logistic regression analyses were performed, to compare psychiatric and function variables between the two study groups while controlling for age and sex. Key Findings: Of the 92 patients with PNES who fulfilled inclusion/exclusion criteria, 41 (44.6%) had a history of TBI. Of the 41 patients with TBI, 30 (73%) met criteria for mild TBI (mTBI). Patients with TBI had more mood disorder diagnoses, were more likely to receive disability, and had lower global functioning than non-TBI patients with PNES, after adjusting for age and sex. Patients with TBI and PNES had significantly increased odds for having major depression, behavioral impulsivity, posttraumatic stress disorder diagnosis, and a trauma/abuse history. Significance: TBI is a significant risk factor in patients with PNES, being associated with increased psychiatric diagnostic comorbidity, symptoms severity, poorer functioning, and increased disability. This study reveals the importance of identifying and addressing the impact of TBI in patients with seizure disorders. Addressing the sequelae of TBI in PNES may be a target to improve functioning.	[LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Neurol, Providence, RI 02903 USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Psychiat, Providence, RI 02903 USA; [LaFrance, W. Curt, Jr.; DeLuca, Marie] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Machan, Jason T.] Rhode Isl Hosp, Dept Biostat, Providence, RI 02903 USA; [Machan, Jason T.] Brown Univ, Dept Med Orthopaed, Providence, RI 02912 USA; [Fava, Joseph L.] Miriam Hosp, Ctr Behav Med, Providence, RI 02906 USA; [Fava, Joseph L.] Miriam Hosp, Ctr Preventat Med, Providence, RI 02906 USA		LaFrance, WC (corresponding author), Rhode Isl Hosp, 593 Eddy St, Providence, RI 02903 USA.	william_lafrance_jr@brown.edu	LaFrance, W Curt/AAN-6707-2021; Machan, Jason T/D-3897-2013	LaFrance, W Curt/0000-0002-4901-3852; Machan, Jason T/0000-0003-2048-4914; Fava, Joseph/0000-0001-7129-7903	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5K23 NS45902]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS045902] Funding Source: NIH RePORTER	This study was funded in part by the NINDS 5K23 NS45902 (PI: LaFrance). Portions of this manuscript were presented in a poster at the 2010 American Academy of Neurology Annual meeting.	ALPER K, 1993, NEUROLOGY, V43, P1950, DOI 10.1212/WNL.43.10.1950; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Duncan R, 2008, NEUROLOGY, V71, P1000, DOI 10.1212/01.wnl.0000326593.50863.21; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Goldstein LH, 2010, NEUROLOGY, V74, P1986, DOI 10.1212/WNL.0b013e3181e39658; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krawetz P, 2001, J NERV MENT DIS, V189, P38, DOI 10.1097/00005053-200101000-00007; LaFrance WC, 2010, NEUROLOGY, V75, P1166, DOI 10.1212/WNL.0b013e3181f4d5a9; LaFrance WC, 2009, NEUROLOGY, V73, P366, DOI 10.1212/WNL.0b013e3181b04c83; LaFrance WC, 2009, EPILEPSY BEHAV, V14, P591, DOI 10.1016/j.yebeh.2009.02.016; LaFrance WC, 2006, NEUROLOGY, V66, P1620, DOI 10.1212/01.wnl.0000224953.94807.be; LaFrance WC, 2002, EPILEPSY BEHAV, V3, pS19, DOI 10.1016/S1525-5069(02)00505-4; Mokleby K, 2002, EPILEPSIA, V43, P193, DOI 10.1046/j.1528-1157.2002.20901.x; National Center for Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Pakalnis A, 2000, J CHILD NEUROL, V15, P78, DOI 10.1177/088307380001500202; Reuber M, 2002, EPILEPSY BEHAV, V3, P249, DOI 10.1016/S1525-5050(02)00004-5; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Szaflarski JP, 2003, EPILEPSIA, V44, P236, DOI 10.1046/j.1528-1157.2003.35302.x; Task Force on DSM-IVTR, 2000, DIAGN STAT MAN MENT; Testa SM, 2007, EPILEPSIA, V48, P973, DOI 10.1111/j.1528-1167.2006.00965.x; VANDONSELAAR CA, 1989, NEUROLOGY, V39, P267, DOI 10.1212/WNL.39.2.267; Vickrey BG., 1993, QUALITY LIFE EPILEPS; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	38	43	43	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2013	54	4					718	725		10.1111/epi.12053			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117PL	WOS:000316965500021	23281644	Bronze			2022-02-06	
J	Luo, CL; Chen, XP; Li, LL; Li, QQ; Li, BX; Xue, AM; Xu, HF; Dai, DK; Shen, YW; Tao, LY; Zhao, ZQ				Luo, Cheng-Liang; Chen, Xi-Ping; Li, Li-Liang; Li, Qian-Qian; Li, Bei-Xu; Xue, Ai-Min; Xu, Hong-Fei; Dai, Ding-Kun; Shen, Yi-Wen; Tao, Lu-Yang; Zhao, Zi-Qin			Poloxamer 188 Attenuates in vitro Traumatic Brain Injury-Induced Mitochondrial and Lysosomal Membrane Permeabilization Damage in Cultured Primary Neurons	JOURNAL OF NEUROTRAUMA			English	Article						cultured primary neurons; mitochondrial and lysosomal membrane permeability; poloxamer 188; traumatic brain injury; in vitro cell shearing device	CATHEPSIN-B CONTRIBUTES; INDUCED CELL-DEATH; CYTOCHROME-C; INDUCED APOPTOSIS; CORTICAL-NEURONS; RECEPTOR; NEUROPROTECTION; AUTOPHAGY; PROTEASE; RELEASE	Acute membrane damage due to traumatic brain injury (TBI) is a critical precipitating event. However, the subsequent effects of the mechanical trauma, including mitochondrial and lysosomal membrane permeability (MOMP and LMP) remain elusive. The main objective of the current study was to assess the role of a putative membrane-resealing agent poloxamer 188 (P188) in MOMP and LMP in response to a well-defined mechanical insult. Using an in vitro cell shearing device (VCSD), mechanical injury resulted in immediate disruption of membrane integrity in cultured primary neurons, and neurons were treated with P188 or a cathepsin B inhibitor (CBI) after VCSD 10 min. The protective effect of P188 on cultured primary neurons was first detected visually with a light microscope, and measured by MTT assay and LDH assay. The validity of monitoring changes in mitochondrial membrane potential (Delta Psi m) was measured by JC-1 staining, and Western blot for cytochrome c and truncated Bid (tBid) in purified mitochondria was also performed. In addition, lysosomal integrity was detected by blotting for cathepsin B and tBid in purified lysosomes. Our results showed post-injury P188 treatment moderated the dissipation of Delta Psi m in mitochondria, and inhibited VCSD-induced cytochrome c release from mitochondria as well as cathepsin B from lysosomes. Cathepsin B inhibition (CBI) could also increase cell viability, maintain mitochondrial membrane potential, and repress VCSD-induced release of cytochrome c from mitochondria to cytosol. Both P188 and CBI treatment decreased the cytosolic accumulation of tBid in supernatant of purified lysosomes, and the amount of mitochondrial localized tBid. These data indicate injured neurons have undergone mitochondrial and lysosomal membrane permeability damage, and the mechanism can be exploited with pharmacological interventions. P188's neuroprotection appears to involve a relationship between cathepsin B and tBid-mediated mitochondrial initiation of cell death.	[Luo, Cheng-Liang; Li, Li-Liang; Li, Bei-Xu; Xue, Ai-Min; Shen, Yi-Wen; Zhao, Zi-Qin] Fudan Univ, Dept Forens Med, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Luo, Cheng-Liang; Chen, Xi-Ping; Xu, Hong-Fei; Dai, Ding-Kun; Tao, Lu-Yang] Soochow Univ, Dept Forens Med, Suzhou 215123, Peoples R China; [Li, Qian-Qian] Wannan Med Coll, Dept Forens Med, Wuhu, Peoples R China		Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, 199 Renai Rd, Suzhou 215123, Peoples R China.	luyang.tao@163.com; zqzhao@shmu.edu.cn	Li, Liliang/AAQ-9877-2020	Li, Liliang/0000-0002-1933-134X	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271379, 81172911, 81172897]; Shanghai Forensic Key Laboratory Foundation [KF1005]	This work was supported by the National Science Foundation of China (No. 81271379, No. 81172911, No. 81172897), and the Shanghai Forensic Key Laboratory Foundation (No. KF1005).	Alexandratou E, 2005, FREE RADICAL BIO MED, V39, P1119, DOI 10.1016/j.freeradbiomed.2005.06.006; Blackman BR, 2000, ANN BIOMED ENG, V28, P363, DOI 10.1114/1.286; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hunt WT, 2010, J NEUROCHEM, V115, P123, DOI 10.1111/j.1471-4159.2010.06908.x; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Repnik U, 2010, MITOCHONDRION, V10, P662, DOI 10.1016/j.mito.2010.07.008; Salvioli S, 2000, CYTOMETRY, V40, P189, DOI 10.1002/1097-0320(20000701)40:3<189::AID-CYTO3>3.0.CO;2-6; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Sung DK, 2010, J NEUROSCI METH, V193, P232, DOI 10.1016/j.jneumeth.2010.08.020; Taguchi T, 2000, Environ Health Prev Med, V4, P217, DOI 10.1007/BF02931261; Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Xin H, 2009, EUR J PHARMACOL, V612, P75, DOI 10.1016/j.ejphar.2009.03.067; Xu ZM, 2008, REV OCCIDENTE, P133; Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174	41	43	43	0	20	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					597	607		10.1089/neu.2012.2425			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300011	23186154				2022-02-06	
B	Coronado, VG; McGuire, LC; Faul, M; Sugerman, DE; Pearson, WS		Zasler, ND; Katz, DI; Zafonte, RD		Coronado, Victor G.; McGuire, Lisa C.; Faul, Mark; Sugerman, David E.; Pearson, William S.			Traumatic Brain Injury Epidemiology and Public Health Issues	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							SPORT-RELATED CONCUSSION; LONG-TERM DISABILITY; GLASGOW COMA SCALE; UNITED-STATES; HIGH-SCHOOL; RISK-FACTORS; HEAD-INJURY; FOLLOW-UP; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION		[Coronado, Victor G.; McGuire, Lisa C.] Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Faul, Mark] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Sugerman, David E.] Ctr Dis Control & Prevent, Div Injury Response, LCDR US Publ Hlth Serv, Atlanta, GA USA; [Pearson, William S.] Ctr Dis Control & Prevent, Div Injury Response, Atlanta, GA USA		Coronado, VG (corresponding author), Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.						Abellera J, 2005, STATES ARE COLLECTIN; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Ahmed N, 2000, PUBLIC HEALTH, V114, P416, DOI 10.1038/sj.ph.1900646; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Association for the Advancement of Automotive Medicine, ABBR INJ SCAL WHAT I; Baker SP, 1982, INJURY FACT BOOK; BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Berry C, 2010, AM SURGEON, V76, P1067; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; CDC, 2010, MMWR-MORBID MORTAL W, V59, P303; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2009, NAT CTR HLTH STAT MU; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cifu DX, REPETITIVE HEAD INJU; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2011, 3 INT C TRAUM BRAIN; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crossman J, 1998, INJURY, V29, P435, DOI 10.1016/S0020-1383(98)00079-5; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cumming RG, 1998, DRUG AGING, V12, P43, DOI 10.2165/00002512-199812010-00005; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Defense and Veterans Brain Injury Center, DOD WORLDW NUMB TRAU; Department of Veterans Affairs/Department of Defense Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU, P17; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; HADDON W, 1980, PUBLIC HEALTH REP, V95, P411; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Johnson R, 2009, STATE INJURY INDICAT; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Losiniecki A, 2010, CURR TREAT OPTION NE, V12, P142, DOI 10.1007/s11940-010-0063-z; Lotfus, 2009, NEUROTRAUMA CRITICAL, P3; Macdonald S, 2005, ADDICT BEHAV, V30, P103, DOI 10.1016/j.addbeh.2004.04.016; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; MacReady N, 2004, CLIN PSYCHIAT NEWS, V32, P55; Maier RV, 2005, J TRAUMA, V59, pS1, DOI 10.1097/01.ta.0000174904.24315.e5; Marr A, 2001, ANN DATA SUBMISSION; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miele VJ, 2009, NEUROTRAUMA CRITICAL; MULLIE A, 1988, LANCET, V1, P137; Murray C. J., 1996, GLOBAL HLTH STAT COM; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; National Council of Youth Sports, 2008, REP TRENDS PART ORG; National Federation of State High School Athletic Associations, 2009 2010 HIGH SCH A; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Runyan CW, 2003, EPIDEMIOL REV, V25, P60, DOI 10.1093/epirev/mxg005; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Schootman M, 2000, BRAIN INJURY, V14, P373; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SEGATORE M, 1992, HEART LUNG, V21, P548; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; [The Congress of the United States Congressional Budget Office], 2012, CBO STUD VET HLTH AD; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Thurman DJ., 1995, GUIDELINES SURVEILLA; United Nations. Security Council, 2010, S2010579 UN SEC COUN; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	117	43	43	0	6	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							84	100					17	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100008					2022-02-06	
J	Lebrun, CM; Mrazik, M; Prasad, AS; Tjarks, BJ; Dorman, JC; Bergeron, MF; Munce, TA; Valentine, VD				Lebrun, Constance M.; Mrazik, Martin; Prasad, Abhaya S.; Tjarks, B. Joel; Dorman, Jason C.; Bergeron, Michael F.; Munce, Thayne A.; Valentine, Verle D.			Sport concussion knowledge base, clinical practises and needs for continuing medical education: a survey of family physicians and cross-border comparison	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SCHOOL FOOTBALL COACHES; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; ATHLETIC-TRAINERS; RUGBY PLAYERS; LINE VALUES; MANAGEMENT; HOCKEY; RETURN; PROFESSIONALS	Context Evolving concussion diagnosis/management tools and guidelines make Knowledge Transfer and Exchange (KTE) to practitioners challenging. Objective Identify sports concussion knowledge base and practise patterns in two family physician populations; explore current/preferred methods of KTE. Design A cross-sectional study. Setting Family physicians in Alberta, Canada (CAN) and North/South Dakota, USA. Participants CAN physicians were recruited by mail: 2.5% response rate (80/3154); US physicians through a database: 20% response rate (109/545). Intervention/instrument Online survey. Main and secondary outcome measures Diagnosis/management strategies for concussions, and current/preferred KTE. Results Main reported aetiologies: sports/recreation (52.5% CAN); organised sports (76.5% US). Most physicians used clinical examination (93.8% CAN, 88.1% US); far fewer used the Sport Concussion Assessment Tool (SCAT1/SCAT2) and balance testing. More US physicians initially used concussion-grading scales (26.7% vs 8.8% CAN, p=0.002); computerised neurocognitive testing (19.8% vs 1.3% CAN; p<0.001) and Standardised Assessment of Concussion (SAC) (21.8% vs 7.5% CAN; p=0.008). Most prescribed physical rest (83.8% CAN, 75.5% US), while fewer recommended cognitive rest (47.5% CAN, 28.4% US; p=0.008). Return-to-play decisions were based primarily on clinical examination (89.1% US, 73.8% CAN; p=0.007); US physicians relied more on neurocognitive testing (29.7% vs 5.0% CAN; p<0.001) and recognised guidelines (63.4% vs 23.8% CAN; p<0.001). One-third of Canadian physicians received KTE from colleagues, websites and medical school training. Leading KTE preferences included Continuing Medical Education (CME) courses and online CME. Conclusions Existing published recommendations regarding diagnosis/management of concussion are not always translated into practise, particularly the recommendation for cognitive rest; predicating enhanced, innovative CME initiatives.	[Lebrun, Constance M.] Univ Alberta, Dept Family Med, Fac Med & Dent, Glen Sather Sports Med Clin,Edmonton Clin, Edmonton, AB T6G 1Z1, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Fac Educ, Edmonton, AB T6G 1Z1, Canada; [Prasad, Abhaya S.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 1Z1, Canada; [Tjarks, B. Joel] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA; [Dorman, Jason C.; Bergeron, Michael F.; Munce, Thayne A.; Valentine, Verle D.] Sanford USD Med Ctr, Sioux Falls, SD USA		Lebrun, CM (corresponding author), Univ Alberta, Dept Family Med, Fac Med & Dent, Glen Sather Sports Med Clin,Edmonton Clin, Level 2,11400 Univ Ave, Edmonton, AB T6G 1Z1, Canada.	ConnieLebrun@med.ualberta.ca	Lebrun, Constance/K-6430-2013				Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2008, 3 INT C CONC SPORT Z; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Canadian Medical Association (CMA), 2011, HEAD INJ SPORT; Canadian Pediatric Society, 2006, ID MAN CHILDR SPORT; Center for Disease Control (CDC) Atlanta, HEADS UP TOOLK PHYS; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; College of Family Physicians of Canada, 2012, ROL FAM PHYS MAN CON; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris AW, 2012, J SCI MED SPORT, V15, P298, DOI 10.1016/j.jsams.2011.12.005; Heck K, EVALUATING MILD HEAD; HODDINOTT SN, 1986, CAN FAM PHYSICIAN, V32, P2366; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kelly JP, 1997, NEUROLOGY, V48, P581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Murphy A, 2012, PM&R, V4, P419, DOI 10.1016/j.pmrj.2012.03.013; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Sarmiento K, 2012, J SCH HLTH, V80, P112; Sawyer RJ, 2012, HLTH PROMOT PRACT, V11, P34; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shrier I, 2012, CLIN J SPORT MED, V22, P211, DOI 10.1097/JSM.0b013e31824cc5f9; Shrier I, 2011, AM J SPORT MED, V39, pNP1, DOI 10.1177/0363546510391053; Sin DD, 2004, CAN FAM PHYSICIAN, V50, P1251; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; ThinkFirst-SportSmart Concussion Education and Awareness Committee, 2010, NEW CONC MAN GUID CO; Wesolowski K, 2010, NEUROLOGY TODAY, V10, P32	58	43	43	0	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2013	47	1					54	59		10.1136/bjsports-2012-091480			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	073SF	WOS:000313762100015	23178923				2022-02-06	
J	Zhou, HH; Liu, Q; Cheng, G; Li, ZB				Zhou, Hai-Hua; Liu, Qi; Cheng, Gu; Li, Zu-Bing			Aetiology, pattern and treatment of mandibular condylar fractures in 549 patients: A 22-year retrospective study	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Condylar fracture; Retrospective Study; Prevalence; Surgical treatment; Open reduction and internal fixation	OPEN REDUCTION; CLOSED TREATMENT; INTERNAL-FIXATION; MAXILLOFACIAL FRACTURES; SUBCONDYLAR FRACTURES; CURRENT THOUGHTS; CLASSIFICATION; INJURIES; MULTICENTER; REFLECTIONS	Purpose: The The purpose of this study was to retrospectively investigate the aetiology, pattern, and treatment of mandibular condylar fractures in our department over the past 22 years. Patients and methods: Data of patients who sustained mandibular condylar fractures from 1988 to 2009 were recorded, including fracture aetiology, pattern of condylar fracture, time, age, sex, associated injury, patient transferred by other clinics, lag time and treatment method. Data analysis included X-2 test, Fisher exact test, t-test, Ridit analysis and Logistic regression analysis. Results: The sample was composed of 549 patients (749 condylar fractures), 404 male and 145 female (male:female = 2.79:1), with a mean age of 30.12 +/- 14.44 years. Road traffic accidents were the most common cause (248, 45.2%). Condylar head fractures were significantly related to a fall at ground level (p = .001). A fall from a height had a 3.19-fold risk of bilateral condylar fractures (odds ratio, 3.19; 95% confidence interval, 1.33 to 7.65; p = .010). A majority of the condylar fractures (693,92.5%) were treated by a surgical procedure. Condylar head were mostly removed (95.0%, p < .001), condylar neck and condylar base fractures were most frequently treated by open reduction and internal fixation with miniplates (74.4%, p < .001). Most of the dislocated condylar fractures were treated by open surgery (96.5%, p = .026). Conclusions: The anatomic position and uni/bilateral pattern of mandibular condylar fractures were positively related to situations when considerable force is involved. Open condylar surgery was based on the level of fracture and degree of displacement or dislocation. (C) 2012 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Zhou, Hai-Hua; Liu, Qi; Cheng, Gu; Li, Zu-Bing] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Sch & Hosp Stomatol, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Cheng, Gu; Li, Zu-Bing] Wuhan Univ, Key Lab Oral Biomed, Sch & Hosp Stomatol, Minist Educ, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Cheng, Gu; Li, Zu-Bing] Wuhan Univ, Dept Oral & Maxillofacial Surg, Coll & Hosp Stomatol, Wuhan 430079, Hubei, Peoples R China		Li, ZB (corresponding author), Wuhan Univ, Dept Oral & Maxillofacial Surg, Coll & Hosp Stomatol, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	lizubing0827@163.com	zhou, haihua/F-5179-2012	zhou, haihua/0000-0002-6838-0113			Abdel-Galil K, 2008, BRIT J ORAL MAX SURG, V46, P482, DOI 10.1016/j.bjoms.2007.11.025; Abdel-Galil K, 2010, BRIT J ORAL MAX SURG, V48, P520, DOI 10.1016/j.bjoms.2009.10.010; AMARATUNGA NAD, 1987, BRIT J ORAL MAX SURG, V25, P391, DOI 10.1016/0266-4356(87)90088-X; Brandt MT, 2003, J ORAL MAXIL SURG, V61, P1324, DOI 10.1016/S0278-2391(03)00735-3; Cenzi R, 2009, J CRANIOFAC SURG, V20, P24, DOI [10.1097/SCS.0b013e31819032a3, 10.1097/scs.0b013e31819032a3]; Czerwinski M, 2008, PLAST RECONSTR SURG, V122, P881, DOI 10.1097/PRS.0b013e3181811a3c; De Riu G, 2001, INT J ORAL MAX SURG, V30, P384, DOI 10.1054/ijom.2001.0103; DERDYN C, 1990, PLAST RECONSTR SURG, V86, P238, DOI 10.1097/00006534-199008000-00005; DERDYN C, 1990, PLAST RECONSTR SURG, V86, P246; DODSON TB, 1988, J ORAL MAXIL SURG, V46, P875, DOI 10.1016/0278-2391(88)90054-7; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P433, DOI 10.1016/j.jcms.2006.07.855; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003; Eggensperger N, 2007, J CRANIO MAXILL SURG, V35, P161, DOI 10.1016/j.jcms.2007.01.002; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Erol BE, 2004, J CRANIO MAXILL SURG, V32, P308, DOI 10.1016/j.jcms.2004.04.006; Furr AM, 2006, LARYNGOSCOPE, V116, P427, DOI 10.1097/01.MLG.0000194844.87268.ED; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; Haug RH, 2007, PLAST RECONSTR SURG, V120, p90S, DOI 10.1097/01.prs.0000260730.43870.1b; He DM, 2009, J ORAL MAXIL SURG, V67, P1672, DOI 10.1016/j.joms.2009.02.012; Hlawitschka M, 2005, INT J ORAL MAX SURG, V34, P597, DOI 10.1016/j.ijom.2005.02.004; Hlawitschka M, 2002, J ORAL MAXIL SURG, V60, P784, DOI 10.1053/joms.2002.33246; Huang YH, 2011, ACCIDENT ANAL PREV, V43, P889, DOI 10.1016/j.aap.2010.11.009; Hyde N, 2002, BRIT J ORAL MAX SURG, V40, P19, DOI 10.1054/bjom.2001.0734; KENT JN, 1990, ORAL MAXILLOFAC SURG, V2, P69; Kermer C, 1998, INT J ORAL MAX SURG, V27, P191, DOI 10.1016/S0901-5027(98)80008-8; Li GH, 1997, AM J PUBLIC HEALTH, V87, P1049, DOI 10.2105/AJPH.87.6.1049; Li Z, 2006, J ORAL MAXIL SURG, V64, P1225, DOI 10.1016/j.joms.2006.04.018; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Long X, 2007, J ORAL MAXIL SURG, V65, P1102, DOI 10.1016/j.joms.2006.06.307; Loukota RA, 2005, BRIT J ORAL MAX SURG, V43, P72, DOI 10.1016/j.bjoms.2004.08.018; MACLENNAN WD, 1952, BRIT J PLAST SURG, V5, P122; Marker P, 2000, BRIT J ORAL MAX SURG, V38, P422, DOI 10.1054/bjom.2000.0457; Marker P, 2000, BRIT J ORAL MAX SURG, V38, P417, DOI 10.1054/bjom.2000.0317; Nussbaum ML, 2008, J ORAL MAXIL SURG, V66, P1087, DOI 10.1016/j.joms.2008.01.025; Roccia F, 2010, J CRANIO MAXILL SURG, V38, P314, DOI 10.1016/j.jcms.2009.10.002; Sawazaki R, 2010, J ORAL MAXIL SURG, V68, P1252, DOI 10.1016/j.joms.2009.03.064; Schneider M, 2008, J ORAL MAXIL SURG, V66, P2537, DOI 10.1016/j.joms.2008.06.107; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Spiessl B, 1972, SPEZIELLE FRAKTURE L, VI/I; STEELE RJC, 1983, LANCET, V2, P341; Thoren H, 1997, BRIT J ORAL MAX SURG, V35, P306, DOI 10.1016/S0266-4356(97)90401-0; Valiati Renato, 2008, Int J Med Sci, V5, P313; Vesnaver A, 2008, J ORAL MAXIL SURG, V66, P2123, DOI 10.1016/j.joms.2008.06.010; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; World Health Organization, 2006, TURN TID INJ VIOL PR; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8; ZIDE MF, 1989, CLIN PLAST SURG, V16, P69; Zide MF, 2001, J ORAL MAXIL SURG, V59, P375, DOI 10.1053/joms.2001.21869	51	43	45	0	15	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182			J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	JAN	2013	41	1					34	41		10.1016/j.jcms.2012.05.007			8	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	082IL	WOS:000314385400008	22727898				2022-02-06	
J	Shenaq, M; Kassem, H; Peng, CY; Schafer, S; Ding, JY; Fredrickson, V; Guthikonda, M; Kreipke, CW; Rafols, JA; Ding, YC				Shenaq, Mohammed; Kassem, Hassan; Peng, Changya; Schafer, Steven; Ding, Jamie Y.; Fredrickson, Vance; Guthikonda, Murali; Kreipke, Christian W.; Rafols, Jose A.; Ding, Yuchuan			Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1 alpha after traumatic brain injury (TBI)	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Marmarou's TBI model; Cerebral edema; Water channels; Cellular injury; FluoroJade; Functional deficits	HYPOXIA-INDUCIBLE-FACTOR; FLUORO-JADE; EDEMA; RAT; MODEL; ANGIOGENESIS; CHANNELS; MOTOR	The present study, using a rodent model of closed-head diffuse traumatic brain injury (TBI), investigated the role of dysregulated aquaporins (AQP) 4 and 9, as well as hypoxia inducible factor - 1 alpha(HIF-1 alpha) on brain edema formation, neuronal injury, and functional deficits. TBI was induced in adult (400-425 g), male Sprague-Dawley rats using a modified Marmarou's head impact-acceleration device (450 g weight dropped from 2 m height). Animals in each treatment group were administered intravenous anti-AQP4 or -AQP9 antibodies or 2-Methoxyestradiol (2ME2, an inhibitor of HIF-1 alpha) 30 min after injury. At 24 h post-TBI. animals (n = 6 each group) were sacrificed to examine the extent of brain edema by water content, as well as protein expression of AQP and HIF-1 alpha by Western immune-blotting. At 48-hours post-TBI, neuronal injury (n = 8 each group) was assessed by FluoroJade (FJ) histochemistry. Spatial learning and memory deficits were evaluated by radial arm maze (n=8 each group) up to 21 days post-TBI. Compared to non-injured controls, significant (p<0.05) increases in the expression of AQP4 and -9 were detected in the brains of injured animals. In addition, significant (p<0.05) brain edema after TBI was associated with increases (p<0.05) both in neuronal injury (9 labeling) and neurobehavioral deficits. Selective inhibition of either AQP4 or -9, or HIF-1 alpha significantly (p<0.05) decreased the expression of the proteins. In addition, inhibition of the AQPs and HIF-1 alpha significantly (p<0.05) ameliorated brain edema, as well as the number of injured neurons in cortical layers II/III and V/VI, striatum and hippocampal regions CA1/CA3. Finally, compared to the non-treated TBI animals, AQP or HIF-1 alpha inhibition significantly (p<0.01) improved neurobehavioral outcomes after TBI. Taken together, the present data supports a causal relation between HIF-AQP mediated cerebral edema, secondary neuronal injury, and tertiary behavioral deficits post-TBI. The data further suggests that upstream modulation of the molecular patho-trajectory effectively ameliorates both neuronal injury and behavioral deficits post-TBI. (C) 2012 Published by Elsevier B.V.	[Shenaq, Mohammed; Kassem, Hassan; Peng, Changya; Fredrickson, Vance; Guthikonda, Murali; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; [Shenaq, Mohammed; Kassem, Hassan; Peng, Changya; Schafer, Steven; Fredrickson, Vance; Guthikonda, Murali; Kreipke, Christian W.; Rafols, Jose A.; Ding, Yuchuan] Coll Engn, Detroit, MI USA; [Schafer, Steven; Kreipke, Christian W.; Rafols, Jose A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Shenaq, Mohammed] Wayne State Univ, Sch Med, Dept Biomed Engn, Detroit, MI 48201 USA; [Ding, Jamie Y.] Princeton Univ, Butler Coll, Princeton, NJ 08544 USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, 550 E Canfield, Detroit, MI 48201 USA.	yding@med.wayne.edu			WSU Neurosurgery Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 39860, NS 064976]; VA RRD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976, R01NS039860] Funding Source: NIH RePORTER	This work was supported partially by the WSU Neurosurgery Fund (YD), NIH NS 39860 (JAR), and NIH NS 064976, VA RRD (CWK).	Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Griesdale DEG, 2004, SURG NEUROL, V61, P418, DOI 10.1016/j.surneu.2003.10.047; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Higashida T, 2011, CURR NEUROVASC RES, V8, P44, DOI 10.2174/156720211794520251; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kreipke CW, 2007, NEUROL RES, V29, P388, DOI 10.1179/016164107X204710; Langdon KD, 2008, EUR J NEUROSCI, V28, P2310, DOI 10.1111/j.1460-9568.2008.06513.x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Timofeeva OA, 2010, BRAIN RES, V1308, P147, DOI 10.1016/j.brainres.2009.10.040; Witt KA, 2005, J NEUROCHEM, V92, P203, DOI 10.1111/j.1471-4159.2004.02871.x	30	43	50	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2012	323	1-2					134	140		10.1016/j.jns.2012.08.036			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037UT	WOS:000311132700023	23040263				2022-02-06	
J	Turner, RC; Naser, ZJ; Bailes, JE; Smith, DW; Fisher, JA; Rosen, CL				Turner, Ryan C.; Naser, Zachary J.; Bailes, Julian E.; Smith, David W.; Fisher, Joseph A.; Rosen, Charles L.			Effect of slosh mitigation on histologic markers of traumatic brain injury Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; slosh; rat; jugular vein compression	AXONAL INJURY; HEAD-INJURY; DOCOSAHEXAENOIC ACID; DENTATE GYRUS; FLUORO-JADE; MODEL; PROGESTERONE; HIPPOCAMPUS; ASTROCYTES; SUPPLEMENTATION	Object. Helmets successfully prevent most cranial fractures and skull traumas, but traumatic brain injury (TBI) and concussions continue to occur with frightening frequency despite the widespread use of helmets on the athletic field and battlefield. Protection against such injury is needed. The object of this study was to determine if slosh mitigation reduces neural degeneration, gliosis, and neuroinflammation. Methods. Two groups of 10 adult male Sprague-Dawley rats were subjected to impact-acceleration TBI. One group of animals was fitted with a collar inducing internal jugular vein (IJV) compression prior to injury, whereas the second group received no such collar prior to injury. All rats were killed 7 days postinjury, and the brains were fixed and embedded in paraffin. Tissue sections were processed and stained for markers of neural degeneration (Fluoro-Jade B), gliosis (glial fibrillary acidic protein), and neuroinflammation (ionized calcium binding adapter molecule 1). Results. Compared with the controls, animals that had undergone IJV compression had a 48.7%-59.1% reduction in degenerative neurons, a 36.8%-45.7% decrease in reactive astrocytes, and a 44.1%-65.3% reduction in microglial activation. Conclusions. The authors concluded that IJV compression, a form of slosh mitigation, markedly reduces markers of neurological injury in a common model of TBI. Based on findings in this and other studies, slosh mitigation may have potential for preventing TBI in the clinical population. (http://thejns.org/doi/abs/10.3171/2012.8.JNS12358)	[Rosen, Charles L.] W Virginia Univ, Sch Med, Dept Neurosurg, Hlth Sci Ctr, Morgantown, WV 26506 USA; [Bailes, Julian E.] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Fisher, Joseph A.] Univ Toronto, Dept Anesthesiol, Univ Hlth Network, Toronto, ON, Canada		Rosen, CL (corresponding author), W Virginia Univ, Sch Med, Dept Neurosurg, Hlth Sci Ctr, 1 Med Ctr Dr,POB 9183, Morgantown, WV 26506 USA.	crosen@hsc.wvu.edu		Turner, Ryan/0000-0001-5523-0645	Mary Babb Randolph Cancer Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20RR016440]; West Virginia University; Department of Neurosurgery; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM81741]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081741] Funding Source: NIH RePORTER	The authors gratefully acknowledge the support of Ms. Penny Humberson as lab manager and Dr. James O'Callaghan and Dr. Diane Miller of the National Institute of Occupational Safety and Health (NIOSH) for providing reagents and supplies. The technical support of Ms. Diana Richardson of NIOSH was essential in preparing tissues for analysis. The authors also thank Dr. Karen Martin, for technical expertise, and the West Virginia University Imaging Facility, which is supported in part by the Mary Babb Randolph Cancer Center and NIH Grant No. P20RR016440.; This work was funded by West Virginia University and the Department of Neurosurgery. Additional financial support was provided by the National Institutes of Health Grant No. 5T32GM81741 (R.C.T.).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bignami A, 1991, GLIAL CELLS CENTRAL; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Fitch MT, 1999, J NEUROSCI, V19, P8182; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Ibrahim R. A., 2001, APPL MECH REV, V54, P133, DOI DOI 10.1115/1.3097293; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAY PRA, 1976, LANCET, V1, P454; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; PATRA P, 1988, SURG RADIOL ANAT, V10, P107, DOI 10.1007/BF02307818; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; VIBULSRETH S, 1987, BRAIN RES, V422, P303, DOI 10.1016/0006-8993(87)90937-1; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Wygnanski-Jaffe T, 2007, EYE, V21, P83, DOI 10.1038/sj.eye.6702163; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	30	43	43	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2012	117	6					1110	1118		10.3171/2012.8.JNS12358			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	042IC	WOS:000311463900018	22998060				2022-02-06	
J	Salinsky, M; Evrard, C; Storzbach, D; Pugh, MJ				Salinsky, Martin; Evrard, Collette; Storzbach, Daniel; Pugh, Mary Jo			Psychiatric comorbidity in veterans with psychogenic seizures	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Psychogenic seizures; Veterans; Post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NONEPILEPTIC SEIZURES; VIDEO-EEG; EPILEPSY; HEALTH; PREVALENCE; DIAGNOSIS; SYMPTOMS; HISTORY	Psychogenic non-epileptic seizures (PNES) are frequently encountered in epilepsy monitoring units (EMU) at Veterans Affairs Medical Centers (VAMCs) and cause significant long-term disability. An understanding of psychiatric factors associated with PNES could aid in earlier diagnosis and treatment. We studied 50 consecutive veterans diagnosed with PNES and 37 veterans diagnosed with epileptic seizures (ES), evaluated at a VAMC EMU. We reviewed all available mental health evaluations prior to EMU evaluation. Univariate comparisons included axis I diagnoses, axis II diagnoses, and psychiatric hospitalizations. Predictive models of seizure classification were evaluated by logistic regression. A diagnosis of post-traumatic stress disorder (PTSD) preceded the diagnosis of PNES in 58% of patients and the diagnosis of ES in 13.5% (p<0.001). On logistic regression, PTSD was the only significant psychiatric diagnosis (odds ratio 9.2). Major depression and alcohol abuse were common diagnoses but did not differentiate PNES and ES groups. Published by Elsevier Inc.	[Salinsky, Martin; Evrard, Collette; Storzbach, Daniel] Portland VA Med Ctr, Portland, OR USA; [Salinsky, Martin] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Pugh, Mary Jo] San Antonio Vet Affairs Med Ctr, San Antonio, TX USA		Salinsky, M (corresponding author), 3181 SW Sam Jackson Pk Rd,CR 120, Portland, OR 97239 USA.	Salinsky@ohsu.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	Portland VA Medical CenterUS Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01HX000717] Funding Source: NIH RePORTER	This material is the result of work supported with resources and the use of facilities at the Portland VA Medical Center.	ALPER K, 1993, NEUROLOGY, V43, P1950, DOI 10.1212/WNL.43.10.1950; Andreski P, 1998, PSYCHIAT RES, V79, P131, DOI 10.1016/S0165-1781(98)00026-2; Arnold LM, 1996, PSYCHOSOMATICS, V37, P438, DOI 10.1016/S0033-3182(96)71531-1; Asmussen SB, 2009, SEIZURE-EUR J EPILEP, V18, P564, DOI 10.1016/j.seizure.2009.05.006; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Buchanan N, 1993, Seizure, V2, P141, DOI 10.1016/S1059-1311(05)80119-0; D'Alessio L, 2006, SEIZURE-EUR J EPILEP, V15, P333, DOI 10.1016/j.seizure.2006.04.003; Dikel TN, 2003, EPILEPSY BEHAV, V4, P644, DOI 10.1016/j.yebeh.2003.08.006; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Kessler R., 1995, ARCH GEN PSYCHIAT, V51, P1048, DOI DOI 10.1001/ARCHPSYC.1995.03950240066012; LaFrance WC, 2008, INT REV NEUROBIOL, V83, P347, DOI 10.1016/S0074-7742(08)00020-2; LEMPERT T, 1990, J NEUROL, V237, P35, DOI 10.1007/BF00319665; Marchetti R, 2010, SEIZURE, V17, P247; Martin R, 2003, NEUROLOGY, V61, P1791, DOI 10.1212/01.WNL.0000098890.13946.F5; Martin RC, 1998, SEIZURE-EUR J EPILEP, V7, P385, DOI 10.1016/S1059-1311(05)80007-X; McKenzie P, 2010, NEUROLOGY, V74, P64, DOI 10.1212/WNL.0b013e3181c7da6a; Pierelli F, 1989, EPILEPSIA, V30, P512; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Selwa LM, 2000, EPILEPSIA, V41, P1330, DOI 10.1111/j.1528-1157.2000.tb04613.x; WALCZAK TS, 1995, EPILEPSIA, V36, P1131, DOI 10.1111/j.1528-1157.1995.tb00472.x	30	43	45	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050			EPILEPSY BEHAV	Epilepsy Behav.	NOV	2012	25	3					345	349		10.1016/j.yebeh.2012.07.013			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	035BM	WOS:000310917000009	23103308				2022-02-06	
J	das Nair, R; Lincoln, NB				das Nair, Roshan; Lincoln, Nadina B.			Evaluation of Rehabilitation of Memory in Neurological Disabilities (ReMiND): a randomized controlled trial	CLINICAL REHABILITATION			English	Article						Memory; cognitive impairment; randomized controlled trial; group; cognitive rehabilitation	OF-THE-LITERATURE; COGNITIVE REHABILITATION; BRAIN-INJURY; MODEL	Objective: The evidence for the effectiveness of memory rehabilitation is inconclusive. The aim was to compare the effectiveness of two group memory rehabilitation programmes with a self-help group control. Design: Single-blind randomized controlled trial. Participants: Participants with memory problems following traumatic brain injury, stroke or multiple sclerosis were recruited from community settings. Interventions: Participants were randomly allocated, in cohorts of four, to compensation or restitution group treatment programmes or a self-help group control. All programmes were manual-based and comprised two individual and ten weekly group sessions. Main measures: Memory functions, mood, and activities of daily living were assessed at baseline and five and seven months after randomization. Results: There were 72 participants (mean age 47.7, SD 10.2 years; 32 men). There was no significant effect of treatment on the Everyday Memory Questionnaire (P = 0.97). At seven months the mean scores were comparable (restitution 36.6, compensation 41.0, self-help 44.1). However, there was a significant difference between groups on the Internal Memory Aids Questionnaire (P = 0.002). The compensation and restitution groups each used significantly more internal memory aids than the self-help group (P < 0.01). There were no statistically significant differences between the groups on measures of mood, adjustment and activities of daily living (P > 0.05). Conclusions: There results show few statistically significant effects of either compensation or restitution memory group treatment as compared with a self-help group control. Further randomized trials of memory rehabilitation are needed.	[das Nair, Roshan; Lincoln, Nadina B.] Univ Nottingham, IWHO, Nottingham NG8 1BB, England		das Nair, R (corresponding author), Univ Nottingham, IWHO, B09,Int House,Jubilee Campus, Nottingham NG8 1BB, England.	roshan.nair@nottingham.ac.uk		das Nair, Roshan/0000-0001-8143-7893	Stroke Association; RemediScience Foundation Ireland [2006/05]; Universities UK (Overseas Research Students Award Scheme); University of Nottingham	The research was supported by grants from The Stroke Association, Remedi (2006/05), Universities UK (Overseas Research Students Award Scheme), and the University of Nottingham.	Baddeley AD, 1994, DOORS PEOPLE TEST VI; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; das Nair R, COCHRANE DA IN PRESS; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; Dirette DK, 1999, J HEAD TRAUMA REHAB, V14, P595, DOI 10.1097/00001199-199912000-00008; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Evans JJ, 2006, J NEUROL, V253, P520, DOI 10.1007/s00415-006-0014-5; Goldberg RJ, 1988, USERS GUIDE GEN HLTH; Held JM, 1999, NEUROSCIENCE REHABIL, P419; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; KATZ DI, 2006, COGNITIVE REHABILITA; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nouri F, 1987, CLIN REHABIL, V1, P233; Powell T, 2003, BRAIN INJURY WORK BO; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; Regard M., 1981, COGNITIVE RIGIDITY F; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Skeel RL, 2001, REHABILITATION NEURO, P53; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Syder D, 1993, SHEFFIELD SCREENING; Wade DT, 2004, BMJ-BRIT MED J, V329, P1398, DOI 10.1136/bmj.329.7479.1398; Wade DT, 2003, CLIN REHABIL, V17, P349, DOI 10.1191/0269215503cr619ed; WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026; Wechsler D, 1998, WECHSLER MEMORY SCAL; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1984, CLIN MANAGEMENT MEMO; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; World Health Organization, 2007, INT CLASS FUNCT DIS	37	43	43	0	28	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	OCT	2012	26	10					894	903		10.1177/0269215511435424			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	004ZN	WOS:000308720200004	22324056	Green Accepted, Green Submitted			2022-02-06	
J	Brekke, EMF; Walls, AB; Schousboe, A; Waagepetersen, HS; Sonnewald, U				Brekke, Eva M. F.; Walls, Anne B.; Schousboe, Arne; Waagepetersen, Helle S.; Sonnewald, Ursula			Quantitative importance of the pentose phosphate pathway determined by incorporation of C-13 from [2-C-13]- and [3-C-13]glucose into TCA cycle intermediates and neurotransmitter amino acids in functionally intact neurons	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cell culture; energy metabolism; free radicals; MR spectroscopy; neurotransmitters	METABOLIC COMPARTMENTATION; GLUCOSE-METABOLISM; GABAERGIC NEURONS; ASTROCYTES; GLUTAMATE; GLUTATHIONE; EXPRESSION; RELEASE; ENZYMES; BRAIN	The brain is highly susceptible to oxidative injury, and the pentose phosphate pathway (PPP) has been shown to be affected by pathological conditions, such as Alzheimer's disease and traumatic brain injury. While this pathway has been investigated in the intact brain and in astrocytes, little is known about the PPP in neurons. The activity of the PPP was quantified in cultured cerebral cortical and cerebellar neurons after incubation in the presence of [2-C-13] glucose or [3-C-13] glucose. The activity of the PPP was several fold lower than glycolysis in both types of neurons. While metabolism of C-13-labeled glucose via the PPP does not appear to contribute to the production of releasable lactate, it contributes to labeling of tricarboxylic acid (TCA) cycle intermediates and related amino acids. Based on glutamate isotopomers, it was calculated that PPP activity accounts for similar to 6% of glucose metabolism in cortical neurons and similar to 4% in cerebellar neurons. This is the first demonstration that pyruvate generated from glucose via the PPP contributes to the synthesis of acetyl CoA for oxidation in the TCA cycle. Moreover, the fact that C-13 labeling from glucose is incorporated into glutamate proves that both the oxidative and the nonoxidative stages of the PPP are active in neurons. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1788-1799; doi:10.1038/jcbfm.2012.85; published online 20 June 2012	[Brekke, Eva M. F.; Walls, Anne B.; Sonnewald, Ursula] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, N-7491 Trondheim, Norway; [Walls, Anne B.; Schousboe, Arne; Waagepetersen, Helle S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark		Sonnewald, U (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, PB 8905, N-7491 Trondheim, Norway.	ursula.sonnewald@ntnu.no		Waagepetersen, Helle/0000-0003-4583-8379; Schousboe, Arne/0000-0001-9600-402X	Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [09-063393, 10-094362]	This work was funded by the Danish Medical Research Council (grant numbers 09-063393 and 10-094362).	Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Appel S H, 1970, J Neurochem, V17, P1619, DOI 10.1111/j.1471-4159.1970.tb11386.x; BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; Bakken IJ, 1997, NEUROSCI LETT, V237, P117, DOI 10.1016/S0304-3940(97)00834-3; BANKI K, 1994, J EXP MED, V180, P1649, DOI 10.1084/jem.180.5.1649; BAUER U, 1982, J NEUROCHEM, V39, P239, DOI 10.1111/j.1471-4159.1982.tb04725.x; BELHAGE B, 1993, NEUROSCIENCE, V54, P1019, DOI 10.1016/0306-4522(93)90592-4; BENYOSEPH O, 1995, J NEUROCHEM, V64, P1336; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Brekke E, 2012, GLIA, V60, P147, DOI 10.1002/glia.21265; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; DREJER J, 1985, NEUROCHEM RES, V10, P49, DOI 10.1007/BF00964771; DREJER J, 1987, J NEUROSCI, V7, P2910; DREJER J, 1989, NEUROCHEM RES, V14, P751, DOI 10.1007/BF00964953; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; EHRHARTBORNSTEIN M, 1991, INT J DEV NEUROSCI, V9, P463, DOI 10.1016/0736-5748(91)90032-H; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; GEDDES JW, 1984, J NEUROCHEM, V42, P16, DOI 10.1111/j.1471-4159.1984.tb09691.x; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275; Hertz L, 1989, DISSECTION TISSUE CU; Hertz L, 1982, NEUROSCIENCE APPROAC, P175; HOSTETLE.KY, 1967, BIOCHEMISTRY-US, V6, P2961, DOI 10.1021/bi00862a001; HOTHERSALL JS, 1982, J NEUROCHEM, V39, P1325, DOI 10.1111/j.1471-4159.1982.tb12574.x; KATZ J, 1966, J BIOL CHEM, V241, P727; KATZ J, 1960, J BIOL CHEM, V235, P2165; KINGSLEYHICKMAN PB, 1990, ANAL BIOCHEM, V185, P235, DOI 10.1016/0003-2697(90)90285-H; LARSSON OM, 1985, INT J DEV NEUROSCI, V3, P177, DOI 10.1016/0736-5748(85)90008-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAWHINNEY TP, 1986, J CHROMATOGR, V358, P231, DOI 10.1016/S0021-9673(01)90333-4; McKenna MC, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P200; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Obel LF, 2012, NEUROTOX RES, V21, P405, DOI 10.1007/s12640-011-9296-1; PATEL MS, 1974, J NEUROCHEM, V22, P717, DOI 10.1111/j.1471-4159.1974.tb04285.x; ROSS BD, 1994, BIOCHEM J, V302, P31, DOI 10.1042/bj3020031; SCHOUSBOE A, 1985, DEV NEUROSCI-BASEL, V7, P252, DOI 10.1159/000112294; Schousboe A., 1989, DISSECTION TISSUE CU, P183; Sickmann HM, 2005, NEUROCHEM RES, V30, P1295, DOI 10.1007/s11064-005-8801-4; Sonnewald U, 2004, NEUROCHEM INT, V45, P305, DOI 10.1016/j.neuint.2003.10.010; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; WHITE CW, 1988, J APPL PHYSIOL, V65, P2607, DOI 10.1152/jappl.1988.65.6.2607; WOOD HG, 1963, BIOCHEM Z, V338, P809; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x; ZUBAIRU S, 1983, J NEUROCHEM, V41, P76, DOI 10.1111/j.1471-4159.1983.tb11816.x	47	43	44	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2012	32	9					1788	1799		10.1038/jcbfm.2012.85			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	000MR	WOS:000308390900013	22714050	Green Published, Bronze			2022-02-06	
J	Dennis, M; Simic, N; Taylor, HG; Bigler, ED; Rubin, K; Vannatta, K; Gerhardt, CA; Stancin, T; Roncadin, C; Yeates, KO				Dennis, Maureen; Simic, Nevena; Taylor, H. Gerry; Bigler, Erin D.; Rubin, Kenneth; Vannatta, Kathryn; Gerhardt, Cynthia A.; Stancin, Terry; Roncadin, Caroline; Yeates, Keith Owen			Theory of Mind in Children with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Intentionality; Childhood head injury; Glasgow Coma Scale; Social cognition; Social problem solving; Error monitoring	CLOSED-HEAD INJURY; INDIVIDUAL-DIFFERENCES; INHIBITORY CONTROL; SPEECH ACTS; DISCOURSE; LANGUAGE; MILD; ADOLESCENTS; PREDICTION; DISORDERS	Theory of mind (ToM) involves thinking about mental states and intentions to understand what other people know and to predict how they will act. We studied ToM in children with traumatic brain injury (TBI) and age-and gender-matched children with orthopedic injuries (OI), using a new three-frame Jack and Jill cartoon task that measures intentional thinking separate from contingent task demands. In the key ToM trials, which required intentional thinking, Jack switched a black ball from one hat to another of a different color, but Jill did not witness the switch; in the otherwise identical non-ToM trials, the switch was witnessed. Overall accuracy was higher in children with OI than in those with TBI. Children with severe TBI showed a larger decline in accuracy on ToM trials, suggesting a specific deficit in ToM among children with severe TBI. Accuracy was significantly higher on trials following errors than on trials following correct responses, suggesting that all groups monitored performance and responded to errors with increased vigilance. TBI is associated with poorer intentional processing in school-age children and adolescents relative to peers with OI; furthermore, children with TBI are challenged specifically by intentional demands, especially when their injury is severe. (JINS, 2012, 18, 908-916)	[Dennis, Maureen] Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Simic, Nevena] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Rubin, Kenneth] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.; Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Cleveland, OH USA; [Roncadin, Caroline] Peel Childrens Ctr, Dept Psychol, Mississauga, ON, Canada		Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maureen.dennis@sickkids.ca	Vannatta, Kathryn/E-4237-2011; Rubin, Kenneth H/M-5276-2018; Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019; Gerhardt, Cynthia/E-3109-2011	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 RO1 HD 04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Preparation of this study was supported by National Institute of Neurological Diseases and Stroke Grant 1 RO1 HD 04946,"Social Outcomes in Pediatric Traumatic Brain Injury." We have no conflicts of interest to declare.	Astington JW, 1999, DEV PSYCHOL, V35, P1311, DOI 10.1037/0012-1649.35.5.1311; BARTSCH K, 1989, CHILD DEV, V60, P946, DOI 10.1111/j.1467-8624.1989.tb03526.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M, 2001, BRAIN COGNITION, V47, P197; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; DENNIS M, 1993, J PEDIATR PSYCHOL, V18, P639, DOI 10.1093/jpepsy/18.5.639; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Filippova E, 2008, CHILD DEV, V79, P126, DOI 10.1111/j.1467-8624.2007.01115.x; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Greenbaum RL, 2009, ALCOHOL CLIN EXP RES, V33, P1656, DOI 10.1111/j.1530-0277.2009.01003.x; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Howard I, 2005, ETHNIC DIS, V15, pS51; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Max J. E., 2005, J AM ACAD CHILD ADOL, V44, P435; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; MELTZOFF AN, 1995, J EXP CHILD PSYCHOL, V59, P497, DOI 10.1006/jecp.1995.1023; MELTZOFF AN, 1999, DEV THEORIES INTENTI; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PREMACK D, 1978, SCIENCE, V202, P532, DOI 10.1126/science.705342; Robinson EJ, 2003, TRENDS COGN SCI, V7, P235, DOI 10.1016/S1364-6613(03)00102-5; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Slaughter, 2003, INDIVIDUAL DIFFERENC; SODIAN B, 1991, CHILD DEV, V62, P468, DOI 10.1111/j.1467-8624.1991.tb01545.x; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; TEASDALE G, 1974, LANCET, V2, P81; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wobbrock J., 2011, P SIGCHI C HUM FACT, P143; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	61	43	43	0	25	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2012	18	5					908	916		10.1017/S1355617712000756			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	999KB	WOS:000308309100013	22846440	Green Accepted			2022-02-06	
J	Max, JE; Wilde, EA; Bigler, ED; MacLeod, M; Vasquez, AC; Schmidt, AT; Chapman, SB; Hotz, G; Yang, TT; Levin, HS				Max, Jeffrey E.; Wilde, Elisabeth A.; Bigler, Erin D.; MacLeod, Marianne; Vasquez, Ana C.; Schmidt, Adam T.; Chapman, Sandra B.; Hotz, Gillian; Yang, Tony T.; Levin, Harvey S.			Psychiatric Disorders After Pediatric Traumatic Brain Injury: A Prospective, Longitudinal, Controlled Study	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PERSONALITY-CHANGE; CEREBRAL TRAUMA; HEAD-INJURIES; CHILDREN; ADOLESCENTS; SYMPTOMATOLOGY; RELIABILITY; LIFETIME; VALIDITY; PREDICTORS	The objective was to examine the effects of traumatic brain injury (TBI), as compared with orthopedic injury (OI), relative to the risk for psychiatric disorder. There has only been one previous prospective study of this nature. Participants were age 7-17 years at the time of hospitalization for either TBI (complicated mild-to-severe) or OI. The study used a prospective, longitudinal, controlled design, with standardized psychiatric assessments conducted at baseline (reflecting pre-injury functioning) and 3 months post-injury. Assessments of pre-injury psychiatric, adaptive functioning, family adversity, and family psychiatric history status were conducted. Severity of injury was assessed by standard clinical scales. The outcome measure was the presence of a psychiatric disorder not present before the injury ("novel"), during the first 3 months after TBI. Enrolled participants (N=141) included children with TBI (N=75) and with OI (N=66). The analyses focused on 118 children (84%) (TBI: N=65; OI: N=53) who returned for follow-up assessment at 3 months. Novel psychiatric disorder (NPD) occurred significantly more frequently in the TBI (32/65; 49%) than the OI (7/53; 13%) group. This difference was not accounted for by pre-injury lifetime psychiatric status; pre-injury adaptive functioning; pre-injury family adversity, family psychiatric history, socioeconomic status, injury severity, or age at injury. Furthermore, none of these variables significantly discriminated between children with TBI who developed, versus those who did not develop, NPD. These findings suggest that children with complicated mild-to-severe TBI are at significantly higher risk than OI-controls for the development of NPD in the first 3 months after injury. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:427-436)	[Max, Jeffrey E.] Univ Calif San Diego, Rady Childrens Hosp, Dept Psychiat, San Diego, CA 92123 USA; [Wilde, Elisabeth A.; MacLeod, Marianne; Vasquez, Ana C.; Schmidt, Adam T.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75230 USA; [Hotz, Gillian] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yang, Tony T.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Max, JE (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, Dept Psychiat, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu			National Institute of Mental Health (NIMH) Grant [K-08 MH01800]; National Institute of Neurological Disorders and Stroke (NINDS) GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800, R01MH085734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by National Institute of Mental Health (NIMH) Grant K-08 MH01800 (Dr. Max) and National Institute of Neurological Disorders and Stroke (NINDS) Grant NS-21889 (Dr. Levin).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BENDER L, 1956, PSYCHOPATHOLOGY CHIL, P66; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; Blau A, 1936, ARCH NEURO PSYCHIATR, V35, P723, DOI 10.1001/archneurpsyc.1936.02260040031003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; DILLON H, 1961, JAMA-J AM MED ASSOC, V175, P86, DOI 10.1001/jama.1961.03040020012003; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Harrington JA, 1958, J MENT SCI, P1205; Hjern B, 1964, ACTA PAEDIATR, P152; Kasanin J, 1929, J NERV MENT DIS, V69, P385, DOI 10.1097/00005053-192904000-00002; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; LEHMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J AM ACAD PSYCHIATRY, V26, P247; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Max JE, J AM ACAD C IN PRESS; Moos RH, 1994, LIFE STRESSORS SOCIA; OTTO U, 1960, Acta Paedopsychiatr, V27, P6; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rune V, 1970, ACTA PAEDIATR SC   S, V209, P3; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SHAFFER D, 1975, OUTCOME SEVERE DAMAG, P191; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Strecker EA, 1924, ARCH NEURO PSYCHIATR, V12, P443, DOI 10.1001/archneurpsyc.1924.02200040092006; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K.O., 2012, ARCH PEDIAT ADOLESC	55	43	43	0	20	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2012	24	4					427	436		10.1176/appi.neuropsych.12060149			10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	057WK	WOS:000312594700038	23224448				2022-02-06	
J	Wang, B; Sun, L; Tian, Y; Li, ZY; Wei, HJ; Wang, D; Yang, Z; Chen, JL; Zhang, JN; Jiang, RC				Wang, Bin; Sun, Lin; Tian, Ye; Li, Zhanying; Wei, Huijie; Wang, Dong; Yang, Zhuo; Chen, Jieli; Zhang, Jianning; Jiang, Rongcai			Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Endothelial progenitor cell; Traumatic brain injury; Atorvastatin; Angiogenesis; Rat	ENDOTHELIAL PROGENITOR CELLS; REDUCES NEUROLOGICAL DEFICIT; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; STATINS; STROKE; NEUROGENESIS; INCREASE; THERAPY; SYNAPTOGENESIS	Circulating endothelial progenitor cells (EPCs) play an important role in angiogenesis and vasculogenesis. Statins administered promote functional improvement in rats, independent of their capability to lower cholesterol. Whether statin treatment regulates circulating EPCs after traumatic brain injury (TBI) has not been investigated. We hypothesized that atorvastatin increases circulating EPCs and promotes angiogenesis in TBI rats. Wistar rats (20 months old) were subjected to TBI and treated with or without atorvastatin (orally administered, 1 mg/kg/day) starting 1 h after TBI and then daily for 14 consecutive days. Long term potentiation (LTP) in the cornu ammonis1 of the hippocampus as well as the Modified Neurological Severity Score (mNSS) and the Morris Water Maze (MWM) functional tests were performed. Blood circulating EPCs were identified by flow cytometry. Rats were sacrificed 25 days after TBI. vWF and CD31 immunostaining was performed. We found that atorvastatin administration significantly induced angiogenesis and increased circulating EPC levels as well as improved functional recovery when compared with non-treatment TBI-control rats (P<0.05). The circulating EPC level is correlated with vascular density (r = 0.878, P < 0.05) and CD31 positive cell number in the injured brain (r = 0.921, P < 0.05). The results suggest that increasing circulating EPCs with atorvastatin treatment may contribute to the observed increase in angiogenesis and improved functional outcome after TBI. (C) 2012 Elsevier B.V. All rights reserved.	[Wang, Bin; Sun, Lin; Tian, Ye; Li, Zhanying; Wei, Huijie; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Wang, Bin; Sun, Lin; Tian, Ye; Li, Zhanying; Wei, Huijie; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin, Peoples R China; [Wang, Bin; Sun, Lin; Tian, Ye; Li, Zhanying; Wei, Huijie; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Wang, Bin; Sun, Lin; Tian, Ye; Li, Zhanying; Wei, Huijie; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Li, Zhanying] Kailuan Hosp, N China Coal Med Sch, Dept Neurosurg, Tangshan, Peoples R China; [Yang, Zhuo] Nankai Univ, Coll Life Sci, Minist Educ, Sch Med,Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com; jianghope@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100920]; Tianjin Research Program of Application Foundation and Advanced Technology [11JCZDJC18100]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]	We acknowledge Weiyun Cui, Fanglian Chen, and Lei Zhou for their assistance with the technical aspects of experiments and data interpretation. The work is supported by the National Natural Science Foundation of China (grant 81100920), Tianjin Research Program of Application Foundation and Advanced Technology (grant 11JCZDJC18100) and Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430).	Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Ladhoff J, 2010, CARDIOVASC RES, V88, P121, DOI 10.1093/cvr/cvq109; Lam CF, 2008, ANESTH ANALG, V107, P686, DOI 10.1213/ane.0b013e31817e6719; Lara-Hernandez R, 2010, ANN VASC SURG, V24, P287, DOI 10.1016/j.avsg.2009.10.012; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mahooti S, 2000, AM J PATHOL, V157, P75, DOI 10.1016/S0002-9440(10)64519-1; Matsumura M, 2009, J ATHEROSCLER THROMB, V16, P319, DOI 10.5551/jat.No026; Murohara T, 2002, ANTIOXID REDOX SIGN, V4, P825, DOI 10.1089/152308602760598981; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhang L, 2005, CIRCULATION, V112, P3486, DOI 10.1161/CIRCULATIONAHA.104.516757	37	43	50	2	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	AUG 15	2012	319	1-2					117	123		10.1016/j.jns.2012.04.015			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	971ZS	WOS:000306246900023	22658532				2022-02-06	
J	Lange, RT; Brickell, TA; French, LM; Merritt, VC; Bhagwat, A; Pancholi, S; Iverson, GL				Lange, Rael T.; Brickell, Tracey A.; French, Louis M.; Merritt, Victoria C.; Bhagwat, Aditya; Pancholi, Sonal; Iverson, Grant L.			Neuropsychological Outcome from Uncomplicated Mild, Complicated Mild, and Moderate Traumatic Brain Injury in US Military Personnel	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Military service members; Personality Assessment Inventory	HEAD-INJURY; COGNITIVE PERFORMANCE; COMPUTED-TOMOGRAPHY; DIAGNOSIS THREAT; ABNORMALITIES; SYMPTOMS	This study compared the neuropsychological outcome in military personnel following mild-to-moderate traumatic brain injury (TBI). Participants were 83 service members divided into three injury severity groups: uncomplicated mild TBI (MTBI; n 24), complicated MTBI (n 17), and moderate TBI (n 42). Participants were evaluated within 6 months following injury (73 within 3 months) using neurocognitive testing and the Personality Assessment Inventory (PAI). There were no significant differences between the three groups on the majority of neurocognitive measures. Similarly, there were no significant differences between the three groups on the majority of PAI clinical scales (all p .05), with the exception of two scales. The uncomplicated MTBI group had significantly higher scores on the Anxiety-Related Disorders and Aggression scales compared with the complicated MTBI group, but not the moderate TBI group. Overall, these results suggest that within the first 6 months post injury, there were few detectable differences in the neuropsychological outcome following uncomplicated MTBI, complicated MTBI, or moderate TBI in this military sample.	[Lange, Rael T.; Brickell, Tracey A.; French, Louis M.; Bhagwat, Aditya; Pancholi, Sonal; Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD 20852 USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.; Bhagwat, Aditya] Walter Reed Natl Mil Med Ctr, Silver Spring, MD USA; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Merritt, Victoria C.] Penn State Univ, University Pk, PA 16802 USA; [Pancholi, Sonal] Ft Belvoir Community Hosp, Ft Belvoir, VA USA		Lange, RT (corresponding author), Def & Vet Brain Injury Ctr, 11300 Rockville Pike,Suite 1100, Bethesda, MD 20852 USA.	rlange@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Iverson, Grant/0000-0001-7348-9570; Merritt, Victoria/0000-0001-5683-4168			Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bigler ED, 2007, BRAIN INJURY MED PRI, P201; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Conners K., 2002, CONNERS CONTINUOUS P; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; FRENCH BN, 1977, SURG NEUROL, V7, P171; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Green P., 2003, GREENS WORD MEMORY T; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange RT, 2011, NATO SCI PEACE SEC, V86, P171, DOI 10.3233/978-1-60750-797-0-171; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Morey, 1991, PERSONALITY ASSESSME; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; *PSYCH CORP, 2001, WECHSL TEST AD READ; Reitan RM, 1992, TRAIL MAKING TEST MA; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tellier A, 1999, BRAIN INJURY, V13, P463; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson J. T. L, 1996, RECOVERY TRAUMATIC B, P29	51	43	43	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2012	27	5					480	494		10.1093/arclin/acs059			15	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	976UN	WOS:000306611300002	22766317	Bronze			2022-02-06	
J	Whyte, J; Barrett, AM				Whyte, John; Barrett, A. M.			Advancing the Evidence Base of Rehabilitation Treatments: A Developmental Approach	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Rehabilitation; Translational medical research	TRAUMATIC BRAIN-INJURY; ATTENTION RATING-SCALE; CLINICAL-RESEARCH; THERAPY; TRIALS; NEUROREHABILITATION; CONSCIOUSNESS; DISORDERS; AROUSAL; PATIENT	Translational research refers to the development of new scientific discoveries into evidence-based treatments for human diseases and conditions. This developmental process requires that a number of scientific, as well as social and psychological obstacles, be overcome during a sequence of research stages that address different goals. Rehabilitation, like other biomedical disciplines, requires this kind of developmental process. For a variety of reasons, however, development of rehabilitation treatments is less linear than the familiar phases of pharmaceutical research. In addition, research on treatments intended to address impairments (body structure/function, in terms of the International Classification of Functioning, Disability and Health), faces the challenge of determining the likely impact of an impairment-level treatment on the multifaceted activities and aspects of participation that are the typical goals of rehabilitation treatments. This article describes the application of treatment theory and enablement theory to the development of new impairment-based treatments, and examines similarities and differences between the developmental sequence needed for rehabilitation treatment research versus pharmaceutical research in other areas of medicine.	[Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Barrett, A. M.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Barrett, A. M.] Univ Med & Dent New Jersey, NJ Med Sch, Newark, NJ 07103 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	jwhyte@einstein.edu	Barrett, A.M./ABG-4475-2021	Barrett, A.M./0000-0002-0789-2887; Whyte, John/0000-0002-4381-1474	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD050836, HD062647]; National Institute on Disability and Rehabilitation Research [H133A080053]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD062647] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS047099, R01NS055808] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health (grant nos. HD050836 and HD062647) and National Institute on Disability and Rehabilitation Research (cooperative agreement no. H133A080053).	Barrett AM, 1999, ARCH PHYS MED REHAB, V80, P600, DOI 10.1016/S0003-9993(99)90205-8; BARRETT AM, 2004, PRINCIPLES PRACTICE, P409; Barrett AM, 2007, AM J PHYS MED REHAB, V86, P694, DOI 10.1097/PHM.0b013e31813e6280; Barrett AM, 2009, BEHAV NEUROL, V22, P17, DOI 10.3233/BEN-2009-0250; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Foundas A L, 1995, J Int Neuropsychol Soc, V1, P62; Franklin G., 2004, CLIN PRACTICE GUIDEL; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Gonzalez-Rothi LJ, 2006, J HEAD TRAUMA REHAB, V21, P194, DOI 10.1097/00001199-200603000-00011; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Kummar S, 2008, CANCER J, V14, P133, DOI 10.1097/PPO.0b013e318172d6f3; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Poeck K, 1985, ADV PSYCHOL, P99, DOI DOI 10.1016/S0166-4115(08)61138-3; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Robey RR, 1999, APHASIOLOGY, V13, P445, DOI 10.1080/026870399402028; Rosnow R.L., 2009, ARTIFACTS BEHAV RES, P138; Rothi LJG, 2006, J INT NEUROPSYCH SOC, V12, P812, DOI 10.1017/S1355617706060991; Rothi LJG, 1992, FLORIDA APRAXIA BATT; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P203, DOI 10.1016/j.apmr.2007.11.026; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146; Whyte J, 2009, ARCH PHYS MED REHAB, V90, pS3, DOI 10.1016/j.apmr.2009.07.008; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	41	43	44	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8		2			S101	S110		10.1016/j.apmr.2011.11.040			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XL	WOS:000307151900002	22683206	Green Accepted			2022-02-06	
J	Chen, CM; Yi, HY; Yoon, YH; Dong, CH				Chen, Chiung M.; Yi, Hsiao-Ye; Yoon, Young-Hee; Dong, Chuanhui			Alcohol Use at Time of Injury and Survival Following Traumatic Brain Injury: Results From the National Trauma Data Bank	JOURNAL OF STUDIES ON ALCOHOL AND DRUGS			English	Article							ACUTE ETHANOL INTOXICATION; HEAD-INJURY; PATIENT MORTALITY; OUTCOMES; ASSOCIATION; CONSUMPTION; SEVERITY; MODERATE; MECHANISM; CULTURES	Objective: Premised on biological evidence from animal research, recent clinical studies have, for the most part, concluded that elevated blood alcohol concentration levels are independently associated with higher survival or decreased mortality in patients with moderate to severe traumatic brain injury (TBI). This study aims to provide some counterevidence to this claim and to further future investigations. Method: Incident data were drawn from the largest U.S. trauma registry, the National Trauma Data Bank, for emergency department admission years 2002-2006. TBI was identified according to the National Trauma Data Bank's definition using international Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), codes. To eliminate confounding, the exact matching method was used to match alcohol-positive with alcohol-negative incidents on sex, age, race/ethnicity, and facility. Logistic regression compared in-hospital mortality between 44,043 alcohol-positive and 59,817 matched alcohol-negative TBI incidents, with and without causes and intents of TBI and Injury Severity Score as covariates. A sensitivity analysis was performed within a subsample of isolated moderate to severe TBI incidents. Results: Alcohol use at the time of injury was found to be significantly associated with an increased risk for TBI. Including varied causes and intents of TBI and Injury Severity Score as potential confounders in the regression model explained away the statistical significance of the seemingly protective effect of alcohol against TBI mortality for all TBIs and for isolated moderate to severe TBIs. Conclusions: The null finding shows that the purported reduction in TBI mortality attributed to positive blood alcohol likely is attributable to residual confounding. Accordingly, the risk of TBI associated with alcohol use should not be overlooked. (J. Stud. Alcohol Drugs, 73.531-541, 2012)	[Chen, Chiung M.; Yi, Hsiao-Ye; Yoon, Young-Hee; Dong, Chuanhui] CSR Inc, Alcohol Epidemiol Data Syst, Arlington, VA 22201 USA		Chen, CM (corresponding author), CSR Inc, Alcohol Epidemiol Data Syst, 2107 Wilson Blvd,Suite 1000, Arlington, VA 22201 USA.	cchen@csrincorporated.com			National Institute on Alcohol Abuse and Alcoholism, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [HH-SN267200800023C]	This article is based on a study conducted for the Alcohol Epidemiologic Data System project funded by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, through Contract No. HH-SN267200800023C to CSR, Incorporated. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the sponsoring agency or the federal government.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Cebere A, 2003, NEUROCHEM RES, V28, P1193, DOI 10.1023/A:1024228412198; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; CLARK D, 2007, NATL TRAUMA DATA BAN; Clark DE, 2009, ICDPIC STATA MODULE; Committee on Trauma American College of Surgeons, 2008, NAT TRAUM DAT BANK N; Cummings P, 2003, EPIDEMIOL REV, V25, P43, DOI 10.1093/epirev/mxg002; Fantus Richard J, 2008, Bull Am Coll Surg, V93, P48; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Morgan SL, 2006, SOCIOL METHOD RES, V35, P3, DOI 10.1177/0049124106289164; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, INT CLASS DIS 9 REV; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Royston P, 2008, MULTIVARIABLE MODEL MULTIVARIABLE MODEL; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Watt K, 2006, J STUD ALCOHOL, V67, P14, DOI 10.15288/jsa.2006.67.14; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Yaghoubian A, 2009, AM SURGEON, V75, P950; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	42	43	43	0	7	ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV	PISCATAWAY	C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA	1937-1888			J STUD ALCOHOL DRUGS	J. Stud. Alcohol Drugs	JUL	2012	73	4					531	541		10.15288/jsad.2012.73.531			11	Substance Abuse; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychology	971KJ	WOS:000306202500003	22630791	Green Published			2022-02-06	
J	Cannon, RL; Baldwin, DR; Shaw, TL; Diloreto, DJ; Phillips, SM; Scruggs, AM; Riehl, TC				Cannon, Rex L.; Baldwin, Debora R.; Shaw, Tiffany L.; Diloreto, Dominic J.; Phillips, Sherman M.; Scruggs, Annie M.; Riehl, Timothy C.			Reliability of quantitative EEG (qEEG) measures and LORETA current source density at 30 days	NEUROSCIENCE LETTERS			English	Article						EEG reliability; LORETA; Current source density; Neuroimaging reliability	RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; TRAUMATIC BRAIN INJURY; ANTERIOR CINGULATE; PSYCHIATRY; ELECTROENCEPHALOGRAPHY; NEUROFEEDBACK; SYMPTOMS; SPIKES; INDEX; POWER	There is a growing interest for using quantitative EEG and LORETA current source density in clinical and research settings. Importantly, if these indices are to be employed in clinical settings then the reliability of these measures is of great concern. Neuroguide (Applied Neurosciences) is sophisticated software developed for the analyses of power, and connectivity measures of the EEG as well as LORETA current source density. To date there are relatively few data evaluating topographical EEG reliability contrasts for all 19 channels and no studies have evaluated reliability for LORETA calculations. We obtained 4 min eyes-closed and eyes-opened EEG recordings at 30-day intervals. The EEG was analyzed in Neuroguide and FFT power, coherence and phase was computed for traditional frequency bands (delta, theta, alpha and beta) and LORETA current source density was calculated in 1 Hz increments and summed for total power in eight regions of interest (ROI). In order to obtain a robust measure of reliability we utilized a random effects model with an absolute agreement definition. The results show very good reproducibility for total absolute power and coherence. Phase shows lower reliability coefficients. LORETA current source density shows very good reliability with an average 0.81 for ECB and 0.82 for EOB. Similarly, the eight regions of interest show good to very good agreement across time. Implications for future directions and use of gEEG and LORETA in clinical populations are discussed. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Cannon, Rex L.; Baldwin, Debora R.; Shaw, Tiffany L.; Diloreto, Dominic J.; Phillips, Sherman M.; Scruggs, Annie M.; Riehl, Timothy C.] Univ Tennessee, Dept Psychol, Clin Neurosci Self Regulat & Biol Psychol Lab, Knoxville, TN 37996 USA; [Cannon, Rex L.; Shaw, Tiffany L.] Univ Tennessee, Cole Neurosci Ctr, Med Ctr, Knoxville, TN 37920 USA		Cannon, RL (corresponding author), Univ Tennessee, Dept Psychol, Clin Neurosci Self Regulat & Biol Psychol Lab, Knoxville, TN 37996 USA.	rcannon2@utk.edu					Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Bjork MH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-89; Brown GG, 2011, NEUROIMAGE, V54, P2163, DOI 10.1016/j.neuroimage.2010.09.076; Campbell PD., 2011, J NEUROTHERAPY, V15, P3, DOI [10.1080/10874208.2011.545752, DOI 10.1080/108]; Cannon R., 2011, J NEUROTHERAPY, V15, P358, DOI [10.1080/10874208.2011.623093, DOI 10.1080/10874208.2011.623093]; Cannon R, 2008, APPL PSYCHOPHYS BIOF, V33, P223, DOI 10.1007/s10484-008-9067-9; Cannon R, 2007, INT J NEUROSCI, V117, P337, DOI 10.1080/00207450500514003; Cannon R, 2009, INT J NEUROSCI, V119, P404, DOI 10.1080/00207450802480325; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Corsi-Cabrera M, 2007, CLIN NEUROPHYSIOL, V118, P9, DOI 10.1016/j.clinph.2006.08.013; Coutin-Churchman P, 2003, CLIN NEUROPHYSIOL, V114, P2294, DOI 10.1016/S1388-2457(03)00228-1; Grossberg S, 2008, BRAIN RES, V1218, P278, DOI 10.1016/j.brainres.2008.04.024; Hu SQ, 2010, IEEE T SYST MAN CY B, V40, P1294, DOI 10.1109/TSMCB.2009.2037237; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Oakes TR, 2004, HUM BRAIN MAPP, V21, P257, DOI 10.1002/hbm.20004; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pizzagalli DA, 2003, PSYCHOPHYSIOLOGY, V40, P939, DOI 10.1111/1469-8986.00112; Prichep LS, 2002, CLIN ELECTROENCEPHAL, V33, P8, DOI 10.1177/155005940203300104; Saletu B, 1997, NEUROPSYCHOBIOLOGY, V36, P130, DOI 10.1159/000119374; Sanei S., 2007, EEG SIGNAL PROCESSIN; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P116, DOI 10.1177/155005940503600211; Thatcher RW, 2003, CLIN ELECTROENCEPHAL, V34, P39, DOI 10.1177/155005940303400203; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Zuidema SU, 2011, INT J GERIATR PSYCH, V26, P127, DOI 10.1002/gps.2499; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1380, DOI 10.1016/j.clinph.2006.02.019	28	43	43	1	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 14	2012	518	1					27	31		10.1016/j.neulet.2012.04.035			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	964RR	WOS:000305714900007	22575610				2022-02-06	
J	Busch, DJ; Morgan, JR				Busch, David J.; Morgan, Jennifer R.			Synuclein accumulation is associated with cell-specific neuronal death after spinal cord injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						axotomy; Fluoro-Jade; C; lamprey; Nissl; Parkinson's disease; reticulospinal; ubiquitin	AXOTOMIZED RUBROSPINAL NEURONS; TRAUMATIC BRAIN-INJURY; HUMAN ALPHA-SYNUCLEIN; FLUORO-JADE-C; PARKINSONS-DISEASE; RETICULOSPINAL NEURONS; NEUROFILAMENT EXPRESSION; NERVOUS-SYSTEM; MOTOR-NEURONS; LAMPREY BRAIN	Spinal cord injury axotomizes neurons and induces many of them to die, whereas others survive. Therefore, it is important to identify factors that lead to neuronal death after injury as a first step toward developing better strategies for increasing neuronal survival and functional recovery. However, the intrinsic molecular pathways that govern whether an injured neuron lives or dies remain surprisingly unclear. To address this question, we took advantage of the large size of giant reticulospinal (RS) neurons in the brain of the lamprey, Petromyzon marinus. We report that axotomy of giant RS neurons induces a select subset of them to accumulate high levels of synuclein, a synaptic vesicle-associated protein whose abnormal accumulation is linked to Parkinson's disease. Injury-induced synuclein accumulation occurred only in neurons that were classified as poor survivors by both histological and Fluoro-Jade C staining. In contrast, post-injury synuclein immunofluorescence remained at control levels in neurons that were identified as good survivors. Synuclein accumulation appeared in the form of aggregated intracellular inclusions. Cells that accumulated synuclein also exhibited more ubiquitin-containing inclusions, similar to what occurs during disease states. When synuclein levels and cell vitality were measured in the same neurons, it became clear that synuclein accumulation preceded and strongly correlated with subsequent neuronal death. Thus, synuclein accumulation is identified as a marker and potential risk factor for forthcoming neuronal death after axotomy, expanding its implications beyond the neurodegenerative diseases. J. Comp. Neurol. 520:17511771, 2012. (C) 2011 Wiley Periodicals, Inc.	[Busch, David J.; Morgan, Jennifer R.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Inst Neurosci, Austin, TX 78712 USA		Morgan, JR (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Inst Neurosci, 2401 Speedway, Austin, TX 78712 USA.	jmorgan@mail.utexas.edu			Morton Cure Paralysis Fund; University of Texas at Austin; Dorothea Bennett graduate fellowship	Grant sponsor: Morton Cure Paralysis Fund; and The University of Texas at Austin start-up funds (to J.R.M.), and a Dorothea Bennett graduate fellowship (to D.J.B.).	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bloom OE, 2011, MOL CELL NEUROSCI, V48, P339, DOI 10.1016/j.mcn.2011.04.003; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P853, DOI 10.1152/jn.2000.83.2.853; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Giovanni S, 2009, EXPERT OPIN THER TAR, V13, P1387, DOI 10.1517/14728220903307517; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Ehara A, 2009, ACTA HISTOCHEM CYTOC, V42, P171, DOI 10.1267/ahc.09018; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Flann S, 1997, NEUROSCIENCE, V81, P173, DOI 10.1016/S0306-4522(97)00196-6; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Houle JD, 1999, NEUROSCIENCE, V94, P929, DOI 10.1016/S0306-4522(99)00359-0; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; KASICKI S, 1986, NEUROSCI LETT, V69, P239, DOI 10.1016/0304-3940(86)90486-6; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; Lee BH, 2004, BRAIN RES, V1020, P37, DOI 10.1016/j.brainres.2004.05.113; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matz Mikhail V, 2003, Methods Mol Biol, V221, P41; Matz Mikhail V, 2002, Methods Mol Biol, V183, P3; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Mori F, 1997, EXP NEUROL, V143, P45, DOI 10.1006/exnr.1996.6318; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nielson JL, 2010, J NEUROSCI, V30, P11516, DOI 10.1523/JNEUROSCI.1433-10.2010; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Oliphint PA, 2010, J COMP NEUROL, V518, P2854, DOI 10.1002/cne.22368; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pfefferkorn CM, 2011, BIOCH BIOPHYS ACTA; Pijak DS, 1996, J COMP NEUROL, V368, P569; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1000, DOI 10.1152/jn.1967.30.5.1000; Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004; Sakurai M, 2009, J CEREBR BLOOD F MET, V29, P752, DOI 10.1038/jcbfm.2008.167; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SELZER ME, 1979, BRAIN RES, V163, P181, DOI 10.1016/0006-8993(79)90348-2; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; Shifman MI, 2000, NEUROREHAB NEURAL RE, V14, P49, DOI 10.1177/154596830001400106; Shifman MI, 2009, EXP NEUROL, V217, P242, DOI 10.1016/j.expneurol.2009.02.011; Smith J, 2011, BIOL BULL-US, V221, P18, DOI 10.1086/BBLv221n1p18; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Sun ZH, 2008, DEV DYNAM, V237, P2490, DOI 10.1002/dvdy.21569; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; SWAIN GP, 1994, EXP NEUROL, V126, P256, DOI 10.1006/exnr.1994.1063; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Yamaguchi Y, 2010, J MOL BIOL, V395, P445, DOI 10.1016/j.jmb.2009.10.068; Yasuda T, 2010, APOPTOSIS, V15, P1312, DOI 10.1007/s10495-010-0486-8; Yoshida H, 2006, BIOCHEMISTRY-US, V45, P2599, DOI 10.1021/bi051993m; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	76	43	43	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	JUN 1	2012	520	8					1751	1771		10.1002/cne.23011			21	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	918FU	WOS:000302235500010	22120153				2022-02-06	
J	Hoh, BL; Neal, DW; Kleinhenz, DT; Hoh, DJ; Mocco, J; Barker, FG				Hoh, Brian L.; Neal, Daniel W.; Kleinhenz, Dominic T.; Hoh, Daniel J.; Mocco, J.; Barker, Fred G., II			Higher Complications and No Improvement in Mortality in the ACGME Resident Duty-Hour Restriction Era: An Analysis of More Than 107000 Neurosurgical Trauma Patients in the Nationwide Inpatient Sample Database	NEUROSURGERY			English	Article						Complications; Medical errors; Mortality; Neurosurgery; Residency; Training; Trauma	STAFF WORKING HOURS; ACCREDITATION-COUNCIL; SLEEP-DEPRIVATION; INTERNAL-MEDICINE; SURGICAL RESIDENTS; HOURS REGULATIONS; IMPACT; CARE; EDUCATION; REFORM	BACKGROUND: The Accreditation Council for Graduate Medical Education resident duty-hour restrictions were implemented in July 2003 based on the supposition that resident fatigue contributes to medical errors. OBJECTIVE: To examine the effect of duty-hour restrictions on outcome in neurotrauma patients. METHODS: The Nationwide Inpatient Sample database was analyzed for a time period with no restrictions (years 1999-2002) compared with a period with restrictions (years 2005-2008) for (1) mortality and (2) complications. We analyzed both teaching and nonteaching hospitals to account for potential differences attributed to nonresident-related factors. RESULTS: There were 107 006 teaching hospital and 115 604 nonteaching hospital admissions for neurotrauma. Multivariate logistic regression demonstrated significantly more complications in the time period with restrictions in teaching hospitals. In nonteaching hospitals, there was no difference in complications. In both teaching and nonteaching hospitals, there was no difference in mortality between the 2 time periods. For teaching and nonteaching hospitals, there was no difference in hospital length of stay, but hospital charges were significantly higher in the period with restrictions. The occurrence of a complication was significantly associated with longer hospital length of stay and higher hospital charges in both time periods in both teaching and nonteaching hospitals. CONCLUSION: The implementation of the Accreditation Council for Graduate Medical Education resident duty-hour restrictions was associated with increased complications and no change in mortality for neurotrauma patients in teaching hospitals. In nonteaching hospitals, there was no change in complications and mortality. The occurrence of a complication was associated with longer length of stay and higher hospital charges in both time periods in both teaching and nonteaching hospitals.	[Hoh, Brian L.; Kleinhenz, Dominic T.; Hoh, Daniel J.; Mocco, J.] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; [Neal, Daniel W.] Univ Florida, Dept Biostat, Gainesville, FL 32610 USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA		Hoh, BL (corresponding author), Univ Florida, Dept Neurosurg, POB 100265, Gainesville, FL 32610 USA.	brian.hoh@neurosurgery.ufl.edu			Codman Neurovascular	Dr Mocco received an unrestricted educational grant from Codman Neurovascular and is a consultant to Actelion Pharmaceuticals, Nfocus, and Lazarus Effect. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	ACGME, 2003, REP ACGME WORK GROUP; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Basu CB, 2004, PLAST RECONSTR SURG, V114, P1878, DOI 10.1097/01.PRS.0000142768.07468.64; Browne JA, 2009, J BONE JOINT SURG AM, V91A, P2079, DOI 10.2106/JBJS.H.01240; Cohen-Gadol AA, 2005, NEUROSURGERY, V56, P398, DOI 10.1227/01.NEU.0000147999.64356.57; Damadi Amir, 2007, J Surg Educ, V64, P256, DOI 10.1016/j.jsurg.2007.07.008; Denisco R A, 1987, J Clin Monit, V3, P22, DOI 10.1007/BF00770879; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Friedman WA, 2004, NEUROSURGERY, V54, P925, DOI 10.1227/01.NEU.0000115153.30283.F5; Gopaldas RR, 2009, J SURG RES, V157, P268, DOI 10.1016/j.jss.2009.03.042; Grady MS, 2009, J NEUROSURG, V110, P828, DOI 10.3171/2009.2.JNS081583; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Howard DL, 2004, J GEN INTERN MED, V19, P1, DOI 10.1111/j.1525-1497.2004.30336.x; Hutter MM, 2006, ANN SURG, V243, P864, DOI 10.1097/01.sla.0000220042.48310.66; Irani JL, 2005, SURGERY, V138, P246, DOI 10.1016/j.surg.2005.06.010; JACQUES CHM, 1990, J FAM PRACTICE, V30, P223; Jagannathan J, 2009, J NEUROSURG, V110, P820, DOI 10.3171/2009.2.JNS081446; Kaafarani HMA, 2005, J SURG RES, V126, P167, DOI 10.1016/j.jss.2004.12.024; Kort KC, 2004, SURGERY, V136, P861, DOI 10.1016/j.surg.2004.07.005; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Landrigan CP, 2008, PEDIATRICS, V122, P250, DOI 10.1542/peds.2007-2306; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Morrison CA, 2009, J SURG RES, V154, P157, DOI 10.1016/j.jss.2008.06.004; Mycyk MB, 2005, AM J HEALTH-SYST PH, V62, P1592, DOI 10.2146/ajhp040527; Myers JS, 2006, ACAD MED, V81, P1052, DOI 10.1097/01.ACM.0000246687.03462.59; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Prasad M, 2009, CRIT CARE MED, V37, P2564, DOI 10.1097/CCM.0b013e3181a93468; Privette AR, 2009, ANN SURG, V250, P316, DOI 10.1097/SLA.0b013e3181ae332a; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; Schenarts P, 2005, AM J SURG, V190, P147, DOI 10.1016/j.amjsurg.2005.03.026; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Shonka DC, 2009, LARYNGOSCOPE, V119, P635, DOI 10.1002/lary.20144; Stamp Thomas, 2005, Curr Surg, V62, P117, DOI 10.1016/j.cursur.2004.09.013; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z; Watson JC, 2005, NEUROLOGY, V64, pE11, DOI 10.1212/01.WNL.0000152728.17155.41; Yaghoubian A, 2008, ARCH SURG-CHICAGO, V143, P847, DOI 10.1001/archsurg.143.9.847	45	43	43	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2012	70	6					1369	1381		10.1227/NEU.0b013e3182486a75			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	946RV	WOS:000304372600020	22227483				2022-02-06	
J	Kelly, MP; Coldren, RL; Parish, RV; Dretsch, MN; Russell, ML				Kelly, Mark P.; Coldren, Rodney L.; Parish, Robert V.; Dretsch, Michael N.; Russell, Michael L.			Assessment of Acute Concussion in the Combat Environment	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Military; Neuropsychological testing; Combat; Automated Neuropsychological Assessment Metrics	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; NEUROPSYCHOLOGICAL ASSESSMENT; SPORTS; MILITARY; RECOVERY; IMPACT; SENSITIVITY; PERFORMANCE; VALIDATION	Despite the prevalence of concussion in soldiers deployed to Iraq and Afghanistan, neuropsychological tests used to assist in concussion management have not been validated on the battlefield. This study evaluated the validity of the Automated Neuropsychological Assessment Metrics (ANAM) in the combat environment. Cases meeting criteria for concussion, healthy controls, and injured controls were assessed. Soldiers were administered the ANAM, traditional neuropsychological tests, and a background questionnaire. Cases were enrolled within 72 h of concussion. Cases exhibited poorer performance than controls on all ANAM subtests, with significant differences on simple reaction time (SRT), procedural reaction time (PRT), code substitution, and matching to sample (p .001). Discriminant ability of scores on SRT and PRT subtests was 71, which improved to 76 when pre-deployment baseline scores were available. An exploratory clinical decision tool incorporating ANAM scores and symptoms improved discriminant ability to 81. Results provide initial validation of the ANAM for detecting acute effects of battlefield concussion.	[Kelly, Mark P.; Parish, Robert V.] Walter Reed Army Med Ctr, Dept Psychol, Washington, DC 20307 USA; [Coldren, Rodney L.] USA, Publ Hlth Command, Directorate Epidemiol & Dis Surveillance, Aberdeen Proving Ground, MD USA; [Dretsch, Michael N.] USA, Aeromed Res Lab, Warfighter & Hlth Div, Ft Rucker, AL USA; [Russell, Michael L.] USA, Med Command Headquarters, Behav Hlth Div, Ft Sam Houston, TX USA		Kelly, MP (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Psychol, Bldg 10,7th Floor,7NE, Bethesda, MD 20889 USA.	mark.kelly1@us.army.mil			U.S. Army Medical Research Acquisition Activity [W81XWIH-09-2-0057]	This work was supported in part by the U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, Maryland 21702- 5014, Project W81XWIH-09-2-0057.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr W., 2008, TXB CLIN NEUROPSYCHO, P660; Barth J., 2010, MILITARY NEUROPSYCHO, P127; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Coldren RL, 2011, MIL MED, V176, pIV; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Defense and Veterans Brain Injury Center, 2011, DOD WORLDWIDE NUMB T; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Defense, 2007, 07030 DEP DEF; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greiffenstein M. F., 2010, MILITARY NEUROPSYCHO, P81; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heaton R., 1997, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McNeil J., 2010, MILITARY NEUROPSYCHO, P361; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; PETERSON LS, 2008, ANN M SW ED RES ASS; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; RIEGELMAN RK, 2004, STUDYING STUDY TESTI; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2010, MILITARY NEUROPSYCHO, P321; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wesensten N., 2010, MILITARY NEUROPSYCHO, P297; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	65	43	44	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2012	27	4					375	388		10.1093/arclin/acs036			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	944JX	WOS:000304198300001	22491730	Bronze			2022-02-06	
J	O'Connor, SS; Zatzick, DF; Wang, J; Temkin, N; Koepsell, TD; Jaffe, KM; Durbin, D; Vavilala, MS; Dorsch, A; Rivara, FP				O'Connor, Stephen S.; Zatzick, Douglas F.; Wang, Jin; Temkin, Nancy; Koepsell, Thomas D.; Jaffe, Kenneth M.; Durbin, Dennis; Vavilala, Monica S.; Dorsch, Andrea; Rivara, Frederick P.			Association between posttraumatic stress, depression, and functional impairments in adolescents 24 months after traumatic brain injury	JOURNAL OF TRAUMATIC STRESS			English	Article							QUALITY-OF-LIFE; PATIENT HEALTH QUESTIONNAIRE-9; PSYCHIATRIC-DISORDERS; SYMPTOMS; CHILDREN; VALIDITY; OUTCOMES; RELIABILITY; TERM; CARE	The degree to which postinjury posttraumatic stress disorder (PTSD) and/or depressive symptoms in adolescents are associated with cognitive and functional impairments at 12 and 24 months after traumatic brain injury (TBI) is not yet known. The current study used a prospective cohort design, with baseline assessment and 3-, 12-, and 24-month followup, and recruited a cohort of 228 adolescents ages 1417 years who sustained either a TBI (n = 189) or an isolated arm injury (n = 39). Linear mixed-effects regression was used to assess differences in depressive and PTSD symptoms between TBI and arm-injured patients and to assess the association between 3-month PTSD and depressive symptoms and cognitive and functional outcomes. Results indicated that patients who sustained a mild TBI without intracranial hemorrhage reported significantly worse PTSD (Hedges g = 0.49, p = .01; Model R2 = .38) symptoms across time as compared to the arm injured control group. Greater levels of PTSD symptoms were associated with poorer school (?2 = .07, p = .03; Model R2 = .36) and physical (?2 = .11, p = .01; Model R2 = .23) functioning, whereas greater depressive symptoms were associated with poorer school (?2 = .06, p = .05; Model R2 = .39) functioning.	[O'Connor, Stephen S.; Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Dept Biostat, Seattle, WA 98104 USA; [Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Dorsch, Andrea] Seattle Childrens Hosp, Div Rehabil Psychol, Seattle, WA USA		O'Connor, SS (corresponding author), Univ Washington, Dept Psychiat, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA.	oconnor7@u.washington.edu	Durbin, Dennis/AAD-7829-2022		AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32/HS013835] Funding Source: Medline		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hedeker D., 2006, LONGITUDINAL DATA AN; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marr A., 2004, CENTRAL NERVOUS SYST; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2; Ramchand R, 2008, J CONSULT CLIN PSYCH, V76, P668, DOI 10.1037/0022-006X.76.4.668; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara FP, 2011, HEALTH SERV RES, V46, P964, DOI 10.1111/j.1475-6773.2010.01236.x; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; StataCorp, 2013, STATA STAT SOFTWARE; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2011, QUAL LIFE RES, V20, P913, DOI 10.1007/s11136-010-9823-1; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2011, PSYCHIAT SERV, V62, P264, DOI 10.1176/ps.62.3.pss6203_0264	34	43	43	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	JUN	2012	25	3					264	271		10.1002/jts.21704			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	962VV	WOS:000305576500009	22729979				2022-02-06	
J	Ettenhofer, ML; Barry, DM				Ettenhofer, Mark L.; Barry, David M.			A Comparison of Long-Term Postconcussive Symptoms between University Students with and without a History of Mild Traumatic Brain Injury or Orthopedic Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Concussion; Postconcussive symptoms; Post-Concussion Syndrome; Chronic; Orthopedic injury; Postconcussional Disorder	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; QUESTIONNAIRE; COMPLAINTS	Mild traumatic brain injury (mild TBI) is often associated with postconcussive symptoms such as headache, memory problems, and irritability. However, high rates of similar symptoms in groups without a history of TBI raise questions about the clinical validity of the postconcussive syndrome. This study was conducted to address these issues through systematic examination of symptoms reported by those with and without a history of mild TBI or orthopedic injury. Responses to the Postconcussion Syndrome Checklist (PCSC), demographic information, and medical history were collected via online questionnaire from 3027 non-referred university students (2280 without a history of mild TBI or orthopedic injury, 491 with a history of orthopedic injury, and 256 with post-acute mild TBI). Although the mild TBI group reported higher mean levels of symptoms, confirmatory factor analyses demonstrated that symptoms clustered into parallel cognitive, somatic, affective, and sensory factors in all three groups. Despite modestly higher mean symptoms among those with a history of mild TBI, symptom clusters did not differ from non-TBI groups. These findings cast doubts about the clinical validity of the "postconcussive syndrome" and raise questions about pathways by which mild TBI and other factors may influence the expression of chronic symptoms. (JINS, 2012, 18, 451-460)	[Ettenhofer, Mark L.; Barry, David M.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA		Ettenhofer, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mark.ettenhofer@usuhs.mil	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; BOHNEN NJ, 1995, J NEUROL REHABIL, V9, P33; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCrea M., 2008, MILD TRAUMATIC BRAIN; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 2004, ICD 10 INT STAT CLAS	37	43	43	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2012	18	3					451	460		10.1017/S1355617711001895			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	937VG	WOS:000303690500007	22321647				2022-02-06	
J	Kasahara, K; Hashimoto, K; Abo, M; Senoo, A				Kasahara, Kazumi; Hashimoto, Keiji; Abo, Masahiro; Senoo, Atsushi			Voxel- and atlas-based analysis of diffusion tensor imaging may reveal focal axonal injuries in mild traumatic brain injury - comparison with diffuse axonal injury	MAGNETIC RESONANCE IMAGING			English	Article						Mild traumatic brain injury; Diffusion tensor imaging; Voxel-based analysis; Atlas-based analysis; Focal axonal injury; DARTEL	WHITE-MATTER INJURY; HEAD-INJURY; POSTCONCUSSION SYNDROME; EXECUTIVE DYSFUNCTION; CORPUS-CALLOSUM; MODERATE; ABNORMALITIES; DEGENERATION; IMPAIRMENT; INTEGRITY	Background: The diagnosis and management of mild traumatic brain injury (MTBI) continue to be subjects of debate, with varying opinions regarding the extent to which tissue-based impairments versus the impacts of other stressors cause ongoing disability. Detecting areas of the brain with abnormalities that can explain symptoms and behavior in patients with MTBI is important in order to confirm the diagnosis of MTBI. Methods: In this study, we calculated diffusion maps from results of diffusion tensor imaging (DTI) performed in an apparently healthy control group. We then compared these maps with those of patients with MTBI (MTBI group) or diffuse axonal injury (DAI group). All diffusion maps were normalized to the International Consortium for Brain Mapping atlas for atlas-based analysis and were segmented and normalized by the Diffeomorphic Anatomical Registration Through Exponentiated Lie tool in SPM8 to reduce misregistration. Results: All diffusion measures in the DAI group were lower than in the control group. There were significant differences in the body and splenium of the corpus callosum, fornix and right cerebral peduncle in the DAI group compared with the control group (P<.001). The MTBI group had higher axial diffusivity than the control group in the right corticospinal tract, left medial lemniscus, left inferior cerebellar peduncle, bilateral anterior limb of the internal capsule, right anterior corona radiata, bilateral cingulum (cingulate gyrus) and left superior frontooccipital fasciculus (P<.05). Conclusions: Voxel- and atlas-based analysis of DTI might suggest that patients with MTBI have focal axonal injury and that the pathophysiology is significantly different from that of DAI. These findings will help in the diagnosis of patients with MTBI. (C) 2012 Elsevier Inc. All rights reserved.	[Kasahara, Kazumi; Senoo, Atsushi] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo 1168551, Japan; [Kasahara, Kazumi] Japan Soc Promot Sci, Saitama, Japan; [Hashimoto, Keiji; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo 1578535, Japan		Hashimoto, K (corresponding author), Natl Ctr Child Hlth & Dev, Div Rehabil, Tokyo 1578535, Japan.	hashimoto-k@ncchd.go.jp		Kasahara, Kazumi/0000-0002-1306-3989; Abo, Masahiro/0000-0001-6701-4974	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [10J06361] Funding Source: KAKEN		Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Friston K, 1999, HUM BRAIN MAPP, V8, P92, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<92::AID-HBM4>3.3.CO;2-R; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	54	43	43	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X			MAGN RESON IMAGING	Magn. Reson. Imaging	MAY	2012	30	4					496	505		10.1016/j.mri.2011.12.018			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	929ST	WOS:000303086700004	22285880				2022-02-06	
J	Lange, RT; Pancholi, S; Brickell, TA; Sakura, S; Bhagwat, A; Merritt, V; French, LM				Lange, Rael T.; Pancholi, Sonal; Brickell, Tracey A.; Sakura, Sara; Bhagwat, Aditya; Merritt, Victoria; French, Louis M.			Neuropsychological Outcome from Blast versus Non-blast: Mild Traumatic Brain Injury in US Military Service Members	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Blast injury; Military; Service members; Neurocognitive; Psychological outcome	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; WAR; OVERPRESSURE; MECHANISMS; DIAGNOSIS; MODEL; IRAQ; TBI	The purpose of this study was to compare the neuropsychological outcome from blast-related versus non-blast related mild traumatic brain injury (MTBI). Participants were 56 U.S. military service members who sustained an MTBI, divided into two groups based on mechanism of injury: (a) non-blast related (Non-blast; n = 21), and (b) blast plus secondary blunt trauma (Blast Plus; n = 35). All participants had sustained their injury in theatre whilst deployed during Operation Iraqi Freedom or Operation Enduring Freedom. Patients had been seen for neuropsychological evaluation at Walter Reed Army Medical Center on average 4.4 months (SD = 4.1) post-injury. Measures included 14 clinical scales from the Personality Assessment Inventory (PAL) and 12 common neurocognitive measures. For the PAI, there were no significant differences between groups on all scales (p > .05). However, medium effect sizes were found for the Depression (d = .49) and Stress (d = .47) scales (i.e., Blast Plus > Non-blast). On the neurocognitive measures, after controlling for the influence of psychological distress (i.e., Depression, Stress), there were no differences between the Non-blast and Blast Plus groups on all measures. These findings provide little evidence to suggest that blast exposure plus secondary blunt trauma results in worse cognitive or psychological recovery than blunt trauma alone. (JINS, 2012, 18, 595-605)	[Lange, Rael T.; Pancholi, Sonal; Brickell, Tracey A.; Sakura, Sara; Bhagwat, Aditya; French, Louis M.] Def & Vet Brain Injury Ctr, Dept Res, Bethesda, MD 20852 USA; [Lange, Rael T.; Brickell, Tracey A.; Sakura, Sara; Bhagwat, Aditya; French, Louis M.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed & Rehabil, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Pancholi, Sonal] Ft Belvoir Community Hosp, Ft Belvoir, VA USA; [Bhagwat, Aditya] US PHS, Bethesda, MD USA; [Merritt, Victoria] Penn State Univ, Dept Psychol, State Coll, PA USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Lange, RT (corresponding author), Def & Vet Brain Injury Ctr, Dept Res, 11300 Rockville Pike,Suite 1100, Bethesda, MD 20852 USA.	rlange@dvbic.org	french, louis/AAB-2083-2020	Merritt, Victoria/0000-0001-5683-4168; french, louis/0000-0002-9451-0604			Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Anderson-Barnes VC, 2011, CLIN NEUROPSYCHOL, V25, P517; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bochicchio GV, 2008, AM SURGEON, V74, P267; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cohen J., 2013, STAT POWER ANAL BEHA; Conners K., 2002, CONNERS CONTINUOUS P; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Green P., 2003, GREENS WORD MEMORY T; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Managment of Concussion/nTBI Working Group, 2009, VA DOD CLIN PRACT GU; Mayorga M., 2010, NEUROIMAGE S1, V54, pS83; Morey, 1991, PERSONALITY ASSESSME; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; *PSYCH CORP, 2001, WECHSL TEST AD READ; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reitan RM, 1992, TRAIL MAKING TEST MA; Salijo A., 2010, J NEUROTRAUM, V27, P283; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014	46	43	44	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2012	18	3					595	605		10.1017/S1355617712000239			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	937VG	WOS:000303690500021	22459022				2022-02-06	
J	Marco, EJ; Harrell, KM; Brown, WS; Hill, SS; Jeremy, RJ; Kramer, JH; Sherr, EH; Paul, LK				Marco, Elysa J.; Harrell, Kathryn M.; Brown, Warren S.; Hill, Susanna S.; Jeremy, Rita J.; Kramer, Joel H.; Sherr, Elliott H.; Paul, Lynn K.			Processing Speed Delays Contribute to Executive Function Deficits in Individuals with Agenesis of the Corpus Callosum	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Absence of the corpus callosum; Human information processing; Inhibition; Stroop Paradigm; Trail Making Test; Cognition	TRAUMATIC BRAIN-INJURY; METHYLPHENIDATE; ABNORMALITIES; COGNITION	Corpus callosum malformation and dysfunction are increasingly recognized causes of cognitive and behavioral disability. Individuals with agenesis of the corpus callosum (AgCC) offer unique insights regarding the cognitive skills that depend specifically upon callosal connectivity. We examined the impact of AgCC on cognitive inhibition, flexibility, and processing speed using the Color-Word Interference Test (CWIT) and Trail Making Test (TMT) from the Delis-Kaplan Executive Function System. We compared 36 individuals with AgCC and IQs within the normal range to 56 matched controls. The AgCC cohort was impaired on timed measures of inhibition and flexibility; however, group differences on CWIT inhibition, CWIT Inhibition/Switching and TMT Number-Letter Switching appear to be largely explained by slow performance in basic operations such as color naming and letter sequencing. On CWIT Inhibition/Switching, the AgCC group was found to commit significantly more errors which suggests that slow performance is not secondary to a cautious strategy. Therefore, while individuals with agenesis of the corpus callosum show real deficits on tasks of executive function, this impairment appears to be primarily a consequence of slow cognitive processing. Additional studies are needed to investigate the impact of AgCC on other aspects of higher order cortical function. (JINS, 2012, 18, 521-529)	[Paul, Lynn K.] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Marco, Elysa J.; Hill, Susanna S.; Kramer, Joel H.; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Marco, Elysa J.; Kramer, Joel H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Marco, Elysa J.; Sherr, Elliott H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Harrell, Kathryn M.; Brown, Warren S.; Jeremy, Rita J.; Paul, Lynn K.] Fuller Grad Sch Psychol, Travis Res Inst, Pasadena, CA USA; Univ Calif San Francisco, Clin & Translat Sci Inst, Pediat Clin Res Ctr, San Francisco, CA 94143 USA		Paul, LK (corresponding author), CALTECH, Div Humanities & Social Sci, 1200 E Calif Blvd,HSS 228-77, Pasadena, CA 91125 USA.	lkpaul@hss.caltech.edu		Hill, Susanna/0000-0001-5376-1872; Paul, Lynn/0000-0002-3128-8313	Simons Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K-02 NS052192, R01 NS058721, K12 NS01692, 1K23MH083890-01, KL2 R12024130]; UCSF; NIH/NCRR UCSF-CTSIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024130, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH094258, K23MH083890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K12NS001692, K02NS052192, R01NS058721] Funding Source: NIH RePORTER	We thank the participants and their families for making this study possible and the D-KEFS team for the generous contribution of their data. Portions of this study served as the Master's Thesis of the co-first author, Kathryn Harrell, at the Fuller Graduate School of Psychology. This work was supported by the Simons Foundation (L.K.P. on grant held by Ralph Adolphs at Caltech), National Institutes of Health (E.H.S., K-02 NS052192, R01 NS058721; E.J.M., K12 NS01692, 1K23MH083890-01; EMS, E.J.M. and R.J.J., KL2 R12024130), and the UCSF Program for Breakthrough Biomedical Research (E.H.S.); and R.J.J., NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. No conflicts of interest exist. Drs. Marco and Harrell contributed equally to this manuscript.	Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; Brown WS, 2005, NEUROPSYCHOLOGIA, V43, P906, DOI 10.1016/j.neuropsychologia.2004.09.008; DAVID AS, 1992, NEUROPSYCHOLOGIA, V30, P161, DOI 10.1016/0028-3932(92)90025-H; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fisher M, 2010, SCHIZOPHRENIA BULL, V36, P869, DOI 10.1093/schbul/sbn170; Glass HC, 2008, AM J MED GENET A, V146A, P2495, DOI 10.1002/ajmg.a.32418; Grynszpan O, 2011, PSYCHOL MED, V41, P163, DOI 10.1017/S0033291710000607; Imamura T, 1994, Behav Neurol, V7, P43, DOI 10.3233/BEN-1994-7201; Jeeves M, 2001, CORTEX, V37, P643, DOI 10.1016/S0010-9452(08)70611-7; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mueller KLO, 2009, BEHAV NEUROSCI, V123, P1000, DOI 10.1037/a0016868; Nakata Y, 2009, AM J NEURORADIOL, V30, P1142, DOI 10.3174/ajnr.A1527; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Parry AMM, 2003, BRAIN, V126, P2750, DOI 10.1093/brain/awg284; Paul L.K., 2000, COGNITIVE NEUROPSYCH, V5, P135, DOI [10.1080/135468000395781, DOI 10.1080/135468000395781]; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schieffer B.M., 1999, DISS ABSTR INT B, V62; SOLURSH LP, 1965, J NERV MENT DIS, V141, P180, DOI 10.1097/00005053-196508000-00005; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Tang PH, 2009, AM J NEURORADIOL, V30, P257, DOI 10.3174/ajnr.A1331; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Turk AA, 2010, NEUROPSYCHOLOGIA, V48, P43, DOI 10.1016/j.neuropsychologia.2009.08.009; Voineskos AN, 2012, NEUROBIOL AGING, V33, P21, DOI 10.1016/j.neurobiolaging.2010.02.009; Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wolinsky FD, 2010, INT PSYCHOGERIATR, V22, P470, DOI 10.1017/S1041610209991281	35	43	45	1	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2012	18	3					521	529		10.1017/S1355617712000045			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	937VG	WOS:000303690500014	22390821	Green Accepted			2022-02-06	
J	Chen, T; Zhang, L; Qu, Y; Huo, K; Jiang, XF; Fei, Z				Chen, Tao; Zhang, Lei; Qu, Yan; Huo, Kai; Jiang, Xiaofan; Fei, Zhou			The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						apoptosis; neuroprotective effect; traumatic brain injury; extracellular signal-regulated kinase; Akt	METABOTROPIC GLUTAMATE ANTAGONIST; SIGNAL-REGULATED KINASE; ELEMENT-BINDING PROTEIN; EXCITATORY AMINO-ACIDS; INDUCED CELL-DEATH; NEURONAL INJURY; BEHAVIORAL DEFICITS; RAT HIPPOCAMPUS; NMDA RECEPTORS; CYTOCHROME-C	Group I metabotropic glutamate receptors (mGluRs) have been implicated in the pathophysiology of central nervous system injury, but the role of mGluR5 in traumatic brain injury (TB!) remains unclear. In the present study, we investigated the neuroprotective potency of (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG), a selective mGluR5 agonist, for protecting against TBI in both in vitro and in vivo models. Primary cortical neurons were treated with 1 mM CHPG in an in vitro preparation 30 min before TBI, and 250 nM CHPG was injected into the right lateral ventricle of rats 30 min before TBI was induced in in vivo studies. The results showed that CHPG significantly attenuated lactate dehydrogenase (LDH) release and neuronal apoptosis and reduced lesion volume. Compared to the control or vehicle group, the phosphorylation levels of extracellular signal-regulated kinase (ERK) and Akt were increased in the presence of CHPG, even following the induction of TBI. Furthermore, treatment with either the ERK inhibitor PD98059 or Akt inhibitor LY294002 partially reversed the CHPG's neuroprotective effects. These data suggest that CHPG minimizes brain damage after induction of TBI both in vitro and in vivo, and that these protective effects were possibly mediated by activation of the ERK and Akt signaling pathways. Thus, potentiating mGluR5 activity with selective agonists such as CHPG may be useful for the treatment of traumatic brain injury.	[Chen, Tao; Zhang, Lei; Qu, Yan; Huo, Kai; Jiang, Xiaofan; Fei, Zhou] Fourth Mil Med Univ, Xijing Inst Clin Neurosci, Dept Neurosurg, Xijing Hosp, Xian 710032, Shannxi, Peoples R China; [Chen, Tao] 123th Hosp PLA, Dept Surg, Bengbu 233000, Anhui, Peoples R China		Jiang, XF (corresponding author), Fourth Mil Med Univ, Xijing Inst Clin Neurosci, Dept Neurosurg, Xijing Hosp, Xian 710032, Shannxi, Peoples R China.	fmmujiangxiaofan@163.com; muzhoufei@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670796, 30930093, 81071034]	This study was financially supported by the National Natural Science Foundation of China (nos. 30670796, 30930093 and 81071034).	Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Choe ES, 2001, MOL BRAIN RES, V94, P75, DOI 10.1016/S0169-328X(01)00217-0; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; COPANI A, 1995, MOL PHARMACOL, V47, P890; Copani A, 1998, EUR J NEUROSCI, V10, P2173, DOI 10.1046/j.1460-9568.1998.00230.x; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Guerra B, 2004, J NEUROCHEM, V91, P99, DOI 10.1111/j.1471-4159.2004.02695.x; Homayoun H, 2010, EUR J PHARMACOL, V639, P33, DOI 10.1016/j.ejphar.2009.12.042; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Kuroki Y, 2001, EUR J NEUROSCI, V13, P472, DOI 10.1046/j.0953-816x.2000.01409.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Liu F, 2005, J NEUROCHEM, V95, P1363, DOI 10.1111/j.1471-4159.2005.03474.x; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MAJNO G, 1995, AM J PATHOL, V146, P3; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Movsesyan VA, 2001, J PHARMACOL EXP THER, V296, P41; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	48	43	43	1	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	APR	2012	29	4					630	636		10.3892/ijmm.2011.870			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	911XI	WOS:000301757300017	22211238	Bronze, Green Published, Green Submitted			2022-02-06	
J	Plantman, S; Ng, KC; Lu, J; Davidsson, J; Risling, M				Plantman, Stefan; Ng, Kian Chye; Lu, Jia; Davidsson, Johan; Risling, Marten			Characterization of a Novel Rat Model of Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; models of injury; penetrating ballistic-like brain injury; traumatic brain injury	CONTROLLED CORTICAL IMPACT; WOUND BALLISTICS; GUNSHOT WOUNDS; CELL-DEATH; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; LESIONS; HEAD; MECHANISMS; EDEMA	A penetrating traumatic brain injury (pTBI) occurs when an object impacts the head with sufficient force to penetrate the skin, skull, and meninges, and inflict injury directly to the brain parenchyma. This type of injury has been notoriously difficult to model in small laboratory animals such as rats or mice. To this end, we have established a novel non-fatal model for pTBI based on a modified air rifle that accelerates a pellet, which in turn impacts a small probe that then causes the injury to the experimental animal's brain. In the present study, we have focused on the acute phase and characterized the tissue destruction, including increasing cavity formation, white matter degeneration, hemorrhage, edema, and gliosis. We also used a battery of behavioral models to examine the neurological outcome, with the most noteworthy finding being impairment of reference memory function. In conclusion, we have described a number of events taking place after pTBI in our model. We expect this model will prove useful in our efforts to unravel the biological events underlying injury and regeneration after pTBI and possibly serve as a useful animal model in the development of novel therapeutic and diagnostic approaches.	[Plantman, Stefan; Risling, Marten] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Ng, Kian Chye; Lu, Jia] Def Med & Environm Res Inst, DSO Natl Labs, Combat Care Lab, Singapore, Singapore; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety, S-41296 Gothenburg, Sweden		Plantman, S (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	Stefan.Plantman@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514; plantman, stefan/0000-0003-2236-4238			Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Asher RA, 2000, J NEUROSCI, V20, P2427; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Carey ME, 1990, J NEUROTRAUM, V7, P13, DOI 10.1089/neu.1990.7.13; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Davalos A, 2000, NEUROLOGY, V54, P1568, DOI 10.1212/WNL.54.8.1568; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fackler ML, 1998, EMERG MED CLIN N AM, V16, P17, DOI 10.1016/S0733-8627(05)70346-1; FAWCETT J, 1994, J NEUROL, V242, pS25, DOI 10.1007/BF00939237; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1987, NEUROSURGERY, V20, P254, DOI 10.1227/00006123-198702000-00010; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lee D, 1997, OTOLARYNG HEAD NECK, V116, P372, DOI 10.1016/S0194-5998(97)70276-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maddux JM, 2007, BEHAV NEUROSCI, V121, P63, DOI 10.1037/0735-7044.121.1.63; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maiden N, 2009, FORENSIC SCI MED PAT, V5, P204, DOI 10.1007/s12024-009-9096-6; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEYER K, 2008, J TRAUMA NURS, V15, P190; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Oehmichen M, 2004, FORENSIC SCI INT, V146, P111, DOI 10.1016/j.forsciint.2004.06.023; ORDOG GJ, 1984, ANN EMERG MED, V13, P1113, DOI 10.1016/S0196-0644(84)80336-4; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Patradoon-Ho P, 2005, Pediatr Rehabil, V8, P303, DOI 10.1080/13638490500049578; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solmaz I, 2009, TURK NEUROSURG, V19, P216; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	76	43	43	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1219	1232		10.1089/neu.2011.2182			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100022	22181060				2022-02-06	
J	Prevedello, LM; Raja, AS; Zane, RD; Sodickson, A; Lipsitz, S; Schneider, L; Hanson, R; Mukundan, S; Khorasani, R				Prevedello, Luciano M.; Raja, Ali S.; Zane, Richard D.; Sodickson, Aaron; Lipsitz, Stuart; Schneider, Louise; Hanson, Richard; Mukundan, Srinivasan; Khorasani, Ramin			Variation in Use of Head Computed Tomography by Emergency Physicians	AMERICAN JOURNAL OF MEDICINE			English	Article						Computed tomography; Emergency department; Head; Ordering; Variation	TRAUMATIC BRAIN-INJURY; SEVERITY INDEX; STROKE CARE; EXPERIENCE; DISPARITIES; RISK; PAIN	OBJECTIVE: Variation in emergency department head computed tomography (CT) use in patients with atraumatic headaches between hospitals is being measured nationwide. However, the magnitude of interphysician variation within a hospital is currently unknown. We hypothesized that there was significant variation in the rates of physician head CT use, both overall and for patients diagnosed with atraumatic headaches. METHODS: This cross-sectional study was conducted in the emergency department of a large urban academic hospital, and institutional review board approval was obtained. All emergency department visits from 2009 were analyzed, and the primary outcome measure was whether or not head CT was performed. Logistic regression was used to control for patient, physician, and visit characteristics potentially associated with head CT ordering. The degree of interphysician variability was tested, both before and after controlling for these variables. RESULTS: Of 55,286 emergency department patient encounters, 4919 (8.9%) involved head CT examinations. Unadjusted head CT ordering rates per physician ranged from 4.4% to 16.9% overall and from 15.2% to 61.7% in patients diagnosed with atraumatic headaches, with both rates varying significantly between physicians. Two-fold variation in head CT ordering overall (6.5%-13.5%) and approximately 3-fold variation in head CT ordering for atraumatic headaches (21.2%-60.1%) persisted even after controlling for pertinent variables. CONCLUSION: Emergency physicians vary significantly in their use of head CT both overall and in patients with atraumatic headaches. Further studies are needed to identify strategies to reduce interphysician variation in head CT use. (C) 2012 Elsevier Inc. All rights reserved. The American Journal of Medicine (2012) 125, 356-364	[Prevedello, Luciano M.; Sodickson, Aaron; Hanson, Richard; Mukundan, Srinivasan; Khorasani, Ramin] Brigham & Womens Hosp, Dept Radiol, Brookline, MA 02445 USA; [Raja, Ali S.; Zane, Richard D.; Schneider, Louise] Brigham & Womens Hosp, Dept Emergency Med, Brookline, MA 02445 USA; [Lipsitz, Stuart] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Brookline, MA 02445 USA; [Prevedello, Luciano M.; Raja, Ali S.; Zane, Richard D.; Sodickson, Aaron; Lipsitz, Stuart; Mukundan, Srinivasan; Khorasani, Ramin] Harvard Univ, Sch Med, Boston, MA USA; [Prevedello, Luciano M.; Raja, Ali S.; Zane, Richard D.; Sodickson, Aaron; Schneider, Louise; Hanson, Richard; Mukundan, Srinivasan; Khorasani, Ramin] Brigham & Womens Hosp, Ctr Evidence Based Imaging, Brookline, MA 02445 USA		Prevedello, LM (corresponding author), Brigham & Womens Hosp, Dept Radiol, 20 Kent St, Brookline, MA 02445 USA.	lprevedello@partners.org	Khorasani, Ramin/AAM-8526-2021; Raja, Ali S./AAE-5103-2019; Prevedello, Luciano/G-8650-2014	Sodickson, Aaron/0000-0003-1275-681X; Prevedello, Luciano/0000-0002-6768-6452	Marval Biosciences	Dr Sodickson is a consultant for Siemens and Toshiba CT. Dr Mukundan is the recipient of corporate-sponsored research grants on advanced visualization of CT scans and advanced magnetic resonance technique development, and a scientific consultant for Marval Biosciences (preclinical contrast agent). None of the other authors have any conflicts of interest associated with the work presented in this manuscript.	[Anonymous], QUALITYNET MEAS; Bhalla A, 2004, AGE AGEING, V33, P618, DOI 10.1093/ageing/afh219; Charlson ME, 2005, J GEN INTERN MED, V20, P497, DOI 10.1111/j.1525-1497.2005.0085.x; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Chisolm DJ, 2006, PEDIAT ALLERG IMM-UK, V17, P199, DOI 10.1111/j.1399-3038.2005.00362.x; Couchman GR, 2004, ACAD RADIOL, V11, P735, DOI 10.1016/j.acra.2004.03.050; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Harris B, 2009, AM J EMERG MED, V27, P333, DOI 10.1016/j.ajem.2008.03.041; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Kee YYK, 2009, POSTGRAD MED J, V85, P115, DOI 10.1136/pgmj.2008.070607; Khorasani R, 2001, RADIOGRAPHICS, V21, P1015, DOI 10.1148/radiographics.21.4.g01jl371015; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Pezzin LE, 2007, ACAD EMERG MED, V14, P149, DOI 10.1197/j.aem.2006.08.020; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Rosen MP, 1997, J GEN INTERN MED, V12, P407, DOI 10.1046/j.1525-1497.1997.00071.x; Rothschild J M, 2000, Diagn Imaging (San Franc), V22, P95; Rothschild JM, 2000, DIAGN IMAGING, V22, P101; Rothschild JM, 2000, DIAGNOSTIC IMAGING, V22, P99; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; TANDBERG D, 1994, ANN EMERG MED, V23, P299, DOI 10.1016/S0196-0644(94)70044-3; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van der Wulp I, 2009, EMERG MED J, V26, P506, DOI 10.1136/emj.2008.063768; van der Wulp I, 2010, EMERG MED J     1115; Verstappen WH, 2004, FAM PRACT, V21, P387, DOI 10.1093/fampra/cmh408; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	28	43	43	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	APR	2012	125	4					356	364		10.1016/j.amjmed.2011.06.023			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916RH	WOS:000302120400019	22325235				2022-02-06	
J	Noe, E; Olaya, J; Navarro, MD; Noguera, P; Colomer, C; Garcia-Panach, J; Rivero, S; Moliner, B; Ferri, J				Noe, Enrique; Olaya, Jose; Dolores Navarro, M.; Noguera, Paloma; Colomer, Carolina; Garcia-Panach, Javier; Rivero, Sandra; Moliner, Belen; Ferri, Joan			Behavioral Recovery in Disorders of Consciousness: A Prospective Study With the Spanish Version of the Coma Recovery Scale-Revised	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Consciousness; Rehabilitation; Treatment outcome; Vegetative state	PERSISTENT VEGETATIVE STATE; BRAIN-INJURY; FOLLOW-UP; RECOMMENDATIONS; REHABILITATION; PREDICTORS; ACCURACY	Noe E, Olaya J, Navarro MD, Noguera P, Colomer C, Garcia-Panach J, Rivero S, Moliner B, Ferri J. Behavioral recovery in disorders of consciousness: a prospective study with the Spanish version of the Coma Recovery Scale Revised. Arch Phys Med Rehabil 2012;93:428-33. Objective: To describe the clinical characteristics and short-term pattern of evolution of a sample of patients within I year after acquiring a brain injury that led to a vegetative state (VS) or a minimally conscious state (MCS). Design: Cohort study. Setting: Inpatient brain injury rehabilitation program. Participants: Patients with acquired brain injury (N=32; 47% traumatic, 37.5% hemorrhagic, 15.5% anoxic) who were in a VS or an MCS according to Coma Recovery Scale Revised (CRS-R) scores. Intervention: Integrative multisensory program comprising daily physical rehabilitation procedures and multimodal sensory stimulation. Main Outcome Measure: All patients were assessed with a Spanish version of the CRS-R at admission and then monthly for at least 6 months or until emergence from MCS. Results: At the time of admission, 12 patients were diagnosed as being in a VS and 20 as being in an MCS. Eight patients were able to emerge from their MCS during follow-up. Seven of these 8 patients were diagnosed as being in an MCS at inclusion, and only 1 was diagnosed as being in a VS. Emergence from an MCS was mostly associated with improvement in both the communication and motor function scales (n=4). Lesser chronicity (P=.01) and the presence of more than visual behavioral responses at admission (P=.05) were both significant predictors of emergence from an MCS. Conclusions: The CRS-R seems appropriate for establishing an immediate prognosis in this population. A quick referral of these patients for specialized assessment and rehabilitation facilities is recommended.	Hosp NISA, Serv NeuroRehabil & Dano Cerebral, Valencia, Spain; Fdn Hosp NISA, Valencia, Spain		Noe, E (corresponding author), Hosp NISAValencia Mar, Serv NeuroRehabil & Dano Cerebral, C Rio Tajo 1, Valencia 46011, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Dolce G, 2011, J NEUROTRAUM, V28, P1149, DOI 10.1089/neu.2010.1405; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino J, 1995, J HEAD TRAUMA REHAB, V10, P44; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; JENNETT B, 1972, LANCET, V1, P734; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	26	43	45	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2012	93	3					428	433		10.1016/j.apmr.2011.08.048			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	902GW	WOS:000301027600008	22277244				2022-02-06	
J	Walter, KH; Kiefer, SL; Chard, KM				Walter, Kristen H.; Kiefer, Sarah L.; Chard, Kathleen M.			Relationship Between Posttraumatic Stress Disorder and Postconcussive Symptom Improvement After Completion of a Posttraumatic Stress Disorder/Traumatic Brain Injury Residential Treatment Program	REHABILITATION PSYCHOLOGY			English	Article						posttraumatic stress disorder; traumatic brain injury; postconcussive symptoms	MILITARY TBI; REHABILITATION; COMPLAINTS; VETERANS; IMPACT; PTSD	Objective: Research has demonstrated that veterans with a history of traumatic brain injury (TB!) may experience persistent symptoms following injury. These symptoms are frequently maintained or exacerbated by psychiatric symptoms, including posttraumatic stress disorder (PTSD). Studies suggest that decreasing PTSD symptoms may also reduce postconcussive symptoms. This study examined whether (a) PTSD and postconcussive symptoms decreased over the course of residential PTSD/TBI treatment and (b) a reduction in PTSD symptoms was associated with a reduction in postconcussive symptoms. Method: Twenty-eight veterans who met diagnostic criteria for PTSD and had a history of TBI were included in the study. Veterans received 8 weeks of treatment in a residential PTSD/TBI program and completed self-report measures of PTSD and postconcussive symptoms at pre- and posttreatment. Results: Results indicated that PTSD and postconcussive symptoms significantly decreased over the course of treatment. Furthermore, the decreases in PTSD and postconcussive symptoms were significantly positively related. Conclusions: The reduction in PTSD symptoms is positively associated with a reduction in postconcussive symptoms following residential treatment in a PTSD/TBI program. These findings suggest that PTSD and postconcussive symptoms are interdependent and mutually influence one another.	[Walter, Kristen H.; Chard, Kathleen M.] Cincinnati Vet Affairs Med Ctr, PTSD, Ft Thomas, KY 41075 USA; [Chard, Kathleen M.] Univ Cincinnati, Sch Med, Cincinnati, OH 45221 USA; [Walter, Kristen H.; Chard, Kathleen M.] Cincinnati Vet Affairs Med Ctr, Anxiety Disorders Div, Ft Thomas, KY 41075 USA		Chard, KM (corresponding author), Cincinnati Vet Affairs Med Ctr, PTSD, 1000 S Ft Thomas Ave, Ft Thomas, KY 41075 USA.	kathleen.chard@va.gov	Walter, Kristen H/S-1827-2019	Sautter, Frederic/0000-0001-6440-6358			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Linehan MM., 1993, COGNITIVE BEHAV TREA; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Monson C. M., 2007, COGNITIVE PROCESSING; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weathers F. W., 1991, PCL S DSM 4	31	43	43	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2012	57	1					13	17		10.1037/a0026254			5	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	901JX	WOS:000300964300003	22121935				2022-02-06	
J	Ozdemir, D; Baykara, B; Aksu, I; Kiray, M; Sisman, AR; Cetin, F; Dayi, A; Gurpinar, T; Uysal, N; Arda, MN				Ozdemir, Durgul; Baykara, Basak; Aksu, Ilkay; Kiray, Muge; Sisman, Ali Riza; Cetin, Ferihan; Dayi, Ayfer; Gurpinar, Tugba; Uysal, Nazan; Arda, M. Nuri			Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats	NEUROSCIENCE LETTERS			English	Article						Hippocampus; Immature rat; Insulin-like growth factor (IGF)-1; Spatial memory; Traumatic brain injury	GROWTH-FACTOR-I; HEAD-INJURY; MOUSE-BRAIN; CHILDREN; MEMORY; APOPTOSIS; ADOLESCENTS; INVOLVEMENT; EXPRESSION; CORTEX	It is well known that traumatic brain injury (TBI) induces the cognitive dysfunction resulting from hippocampal damage. In the present study, we aimed to assess whether the circulating IGF-I levels are associated with cognition and hippocampal damage in 7-day-old rat pups subjected to contusion injury. Hippocampal damage was examined by cresyl violet staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. Spatial memory performance was assessed in the Morris water maze. Serum IGF-1 levels decreased in both early and late period of TBI. Decreased levels of serum IGF-1 were correlated with hippocampal neuron loss and spatial memory deficits. Circulating IGF-1 levels may be predictive of cognitive dysfunction resulted from hippocampal damage following traumatic injury in developing brain. Therapy strategies that increase circulating IGF-1 may be highly promising for preventing the unfavorable outcomes of traumatic damage in young children. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Ozdemir, Durgul] Dokuz Eylul Univ, Fac Med, Dept Pediat, Izmir, Turkey; [Baykara, Basak] Dokuz Eylul Univ, High Sch Phys Therapy & Rehabil, Izmir, Turkey; [Aksu, Ilkay; Kiray, Muge; Cetin, Ferihan; Dayi, Ayfer; Uysal, Nazan] Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey; [Sisman, Ali Riza] Dokuz Eylul Univ, Fac Med, Dept Biochem, Izmir, Turkey; [Gurpinar, Tugba] Celal Bayar Univ, Fac Med, Dept Pharmacol, Izmir, Turkey; [Arda, M. Nuri] Dokuz Eylul Univ, Fac Med, Dept Neurosurg, Izmir, Turkey		Ozdemir, D (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Pediat, Izmir, Turkey.	durgul.ozdemir@deu.edu.tr	dayi, ayfer/O-9503-2019; Baykara, Basak/AAC-6504-2019	dayi, ayfer/0000-0002-4102-1399; Baykara, Basak/0000-0002-4178-2235; Uysal, Nazan/0000-0002-2348-7427			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Amaral David G., 1995, P443; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P416, DOI 10.1016/j.ghir.2005.09.001; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Carro E, 2000, J NEUROSCI, V20, P2926; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Felderhoff-Mueser Ursula, 2000, Current Opinion in Neurology, V13, P141, DOI 10.1097/00019052-200004000-00005; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gunnell D, 2005, PEDIATRICS, V116, pE681, DOI 10.1542/peds.2004-2390; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Jo YS, 2007, J NEUROSCI, V27, P13567, DOI 10.1523/JNEUROSCI.3589-07.2007; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Rendeiro C, 2009, GENES NUTR, V4, P251, DOI 10.1007/s12263-009-0137-2; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Sanus GZ, 2007, ULUS TRAVMA ACIL CER, V13, P281; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Tamatani M, 1998, CELL DEATH DIFFER, V5, P911, DOI 10.1038/sj.cdd.4400439; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200	37	43	47	0	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 17	2012	507	1					84	89		10.1016/j.neulet.2011.11.059			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	WOS:000300274800017	22172933				2022-02-06	
J	de Sousa, A; McDonald, S; Rushby, J				de Sousa, Arielle; McDonald, Skye; Rushby, Jacqueline			Changes in emotional empathy, affective responsivity, and behavior following severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Emotional empathy; Emotional contagion; Emotional responsivity; Loss of emotional control; Loss of drive	ANXIETY STRESS SCALES; BLUNT HEAD-INJURY; CONSECUTIVE SERIES; FACIAL EXPRESSION; MIMICRY REACTIONS; SEX-DIFFERENCES; STATES; RECOGNITION; DYSFUNCTION; IMPAIRMENT	This study was designed to examine the relationship between deficits in empathy, emotional responsivity, and social behavior in adults with severe traumatic brain injury (TBI). A total of 21 patients with severe TBI and 25 control participants viewed six film clips containing pleasant, unpleasant, and neutral content whilst facial muscle responses, skin conductance, and valence and arousal ratings were measured. Emotional empathy (the Balanced Emotional Empathy Scale, BEES: self-report) and changes in drive and control in social situations (The Current Behaviour Scale, CBS: relative report) were also assessed. In comparison to control participants, those in the TBI group reported less ability to empathize emotionally and had reduced facial responding to both pleasant and unpleasant films. They also exhibited lowered autonomic arousal, as well as abnormal ratings of valence and arousal, particularly to unpleasant films. Relative reported loss of emotional control was significantly associated with heightened empathy, while there was a trend to suggest that impaired drive (or motivation) may be related to lower levels of emotional empathy. The results represent the first to suggest that level of emotional empathy post traumatic brain injury may be associated with behavioral manifestations of disorders of drive and control.	[de Sousa, Arielle; McDonald, Skye; Rushby, Jacqueline] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		de Sousa, A (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	aydesous@bigpond.net.au	McDonald, Skye/G-4118-2014; Rushby, Jacqueline/D-1820-2010	McDonald, Skye/0000-0003-0723-6094; Rushby, Jacqueline/0000-0002-5018-638X			[Anonymous], 1996, BRIT MED J, V313, P1448; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Birkin J., 1992, MERRY CHRISTMAS BEAN; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bruggemann JM, 2002, PERS INDIV DIFFER, V32, P1029, DOI 10.1016/S0191-8869(01)00108-8; Burgess P.W., 1997, HAYLING BRIXTON TEST; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Darwin C, 1872, EXPRESSION EMOTION M; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Devlin D. (, 1980, MY BODYGUARD MOTION; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Elliot A., 1994, EMOTION CONTAGION; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Gomez P, 2005, BIOL PSYCHOL, V68, P223, DOI 10.1016/j.biopsycho.2004.06.003; Grattan, 1996, J INT NEUROPSYCH SOC, V2, P15; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; HSEE CK, 1990, COGNITION EMOTION, V4, P327, DOI 10.1080/02699939008408081; HUBERT W, 1991, INT J PSYCHOPHYSIOL, V11, P131, DOI 10.1016/0167-8760(91)90005-I; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kemp D., 2008, EXTREME ALASKA DENAL; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lang P. J., 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P. J., 1999, A4 U FLOR CTR RES PS; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McDonald S, 1999, J HEAD TRAUMA REHAB, V16, P612; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; McHugo G. J., 1982, MOTIV EMOTION, V6, P365, DOI DOI 10.1007/BF00998191; Mehrabian A., 2000, MANUAL BALANCED EMOT; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Pandya DN, 1987, FRONTAL LOBES REVISI, P41; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Reiner R., 1989, HARRY MET SALLY MOTI; Reitan RM, 1992, TRAIL MAKING TEST; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Spencer N., 1987, CRY FREEDOM MOTION P; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; WechslerD, 2001, WECHSLER TEST ADULT; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; [No title captured]	71	43	45	3	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	6					606	623		10.1080/13803395.2012.667067			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970YM	WOS:000306168400006	22435955				2022-02-06	
J	Ocwieja, KE; Mihalik, JP; Marshall, SW; Schmidt, JD; Trulock, SC; Guskiewicz, KM				Ocwieja, Karen E.; Mihalik, Jason P.; Marshall, Stephen W.; Schmidt, Julianne D.; Trulock, Scott C.; Guskiewicz, Kevin M.			The Effect of Play Type and Collision Closing Distance on Head Impact Biomechanics	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Concussion; Helmet; Injury threshold; Mild traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; NCAA CONCUSSION; GAME IMPACTS; EPIDEMIOLOGY; PERFORMANCE; RISK	Football accounts for 55% of concussions to collegiate athletes. In the National Football League, players are at a greater risk for concussion during kickoffs and punts compared to rushing and passing plays. The two primary purposes of this study were to determine if game-related special teams head impacts were greater in magnitude than head impacts sustained during offensive and defensive plays, and to better understand the effect closing distance between players (short vs. long) had on head impact magnitude. Collegiate football players were enrolled in a prospective cohort study assessing head impact biomechanics during special teams, offensive, and defensive collisions; long closing distance (>= 10 yards) and short closing distance (<10 yards) impacts were also studied. Data were analyzed using random intercepts general linear mixed models. Long closing distance collisions generated more severe head impacts than short closing distances. Collisions occurring on special teams plays over long closing distances were most severe while collisions occurring on special teams and defensive plays over short closing distances resulted in the least severe impacts. Decreasing the impact severity of collisions in collegiate football may be accomplished by reducing the closing distance prior to impact.	[Ocwieja, Karen E.; Mihalik, Jason P.; Schmidt, Julianne D.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Ocwieja, Karen E.] US Olymp Comm, Lake Placid, NY USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Trulock, Scott C.] Univ N Carolina, Campus Hlth Serv, Chapel Hill, NC 27599 USA		Mihalik, JP (corresponding author), Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Complex,Campus Bo, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Mihalik, Jason/0000-0001-6085-8322; Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Athletic Trainers' Association Research & Education Foundation; National Operating Committee on Standards for Athletic Equipment	This study was supported in part by the Centers for Disease Control and Prevention, National Athletic Trainers' Association Research & Education Foundation, and the National Operating Committee on Standards for Athletic Equipment.	Broglio S. P., 2010, MED SCI SPORTS EXERC; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mueller F. O., 2010, ANN SURVEY FOOTBALL, P30; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	29	43	43	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		90	96		10.1007/s10439-011-0401-7			7	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700008	21994061	Green Published			2022-02-06	
J	White, MD; Mulvey, P; Fox, AM; Choate, D				White, Michael D.; Mulvey, Philip; Fox, Andrew M.; Choate, David			A Hero's Welcome? Exploring the Prevalence and Problems of Military Veterans in the Arrestee Population	JUSTICE QUARTERLY			English	Article						veterans and crime; military and crime; combat-related problems and crime	POSTTRAUMATIC-STRESS-DISORDER; VIETNAM COMBAT VETERANS; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; SUBSTANCE-ABUSE; WAR-ZONE; IRAQ; PTSD; ILL; VIOLENCE	The potential for veterans to end up in the criminal justice system as a result of physical and psychological problems that may be combat-related has generated much interest, illustrated most recently by the development of specialized veterans' courts. However, little is known about how often veterans are arrested and incarcerated, the nature of their problems, or the extent to which their military service has contributed to their criminality. Using interview data from 2,102 arrestees booked in Maricopa County (AZ) during 2009, this paper examines the problems and prior experiences of arrested military veterans and compares veteran and non-veteran arrestees along a range of measures. Results indicate that veterans comprise 6.3% of the arrestee population, and that more than 50% of veterans report suffering from at least one combat-related problem including physical injury, post-traumatic stress disorder (PTSD), other mental health problems, and substance abuse. Multivariate analysis indicates that veteran arrestees differ from non-veterans on a number of key measures, most notably more frequent arrests for violent offenses and greater use of crack cocaine and opiates. The paper concludes with a discussion of implications for the potential link between military service and criminality as well as for criminal justice policy and practice.	[White, Michael D.; Mulvey, Philip; Fox, Andrew M.] Arizona State Univ, Sch Criminol & Criminal Justice, Phoenix, AZ 85004 USA; [Mulvey, Philip] Arizona State Univ, Ctr Appl Behav Hlth Policy, Phoenix, AZ 85004 USA; [Fox, Andrew M.; Choate, David] Arizona State Univ, Ctr Violence Prevent & Community Safety, Phoenix, AZ 85004 USA		White, MD (corresponding author), Arizona State Univ, Sch Criminol & Criminal Justice, 411 N Cent Ave, Phoenix, AZ 85004 USA.	mdwhite1@asu.edu		Fox, Andrew/0000-0001-5919-1735			ABRAMSON MF, 1972, HOSP COMMUNITY PSYCH, V23, P101; Alemagno S. A., 2004, CHARACTERISTICS ARRE; ARCHER D, 1976, AM SOCIOL REV, V41, P937, DOI 10.2307/2094796; Associated Press, 2004, ASSOCIATED PRESS; Beckham JC, 1998, J TRAUMA STRESS, V11, P777, DOI 10.1023/A:1024453618638; Belenko S, 2001, RES DRUG COURTS CRIT; Bennett JamesV., 1954, FED PROBAT, V18, P40; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Byrne C A, 1996, Violence Vict, V11, P213; Cunningham M., 2007, VITAL MISSION ENDING; Daly R., 2006, PSYCHIAT NEWS, V41, P8; DARROW C, 1922, CRIME ITS CAUSES TRE; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Ditton P., 1999, MENTAL HLTH TREATMEN; Dupont R, 2000, J AM ACAD PSYCHIATRY, V28, P338; Erickson SK, 2008, PSYCHIAT SERV, V59, P178, DOI 10.1176/ps.2008.59.2.178; Fontana A, 2005, J NERV MENT DIS, V193, P203, DOI 10.1097/01.nmd.0000154835.92962.e5; Freeman TW, 2001, J NERV MENT DIS, V189, P317, DOI 10.1097/00005053-200105000-00008; Gearan A., 2010, ARIZONA REPUBLI 0630, P1; Goldkamp JS, 2001, J DRUG ISSUES, V31, P27, DOI 10.1177/002204260103100104; GREEN BL, 1990, AM J PSYCHIAT, V147, P729; Greenburg DL, 2007, J GEN INTERN MED, V22, P888, DOI 10.1007/s11606-007-0172-x; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Hendin H, 1984, Psychohist Rev, V12, P25; Higgins S. Anthony, 1991, LAW PSYCHOL REV, V15, P259; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; KARDINER A, 1941, PSYCHOSOMATIC MED MO, V2; Katz CM, 1997, J CRIM JUST, V25, P31, DOI 10.1016/S0047-2352(96)00049-9; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lamb HR, 1998, PSYCHIATR SERV, V49, P483, DOI 10.1176/ps.49.4.483; LASKO NB, 1994, COMPR PSYCHIAT, V35, P373, DOI 10.1016/0010-440X(94)90278-X; Lewis L., 2008, NATL PUBLIC RAD 0404; Maricopa County Arizona, 2010, MARICOPA COUNTY JUST; MCFALL ME, 1991, J NERV MENT DIS, V179, P33, DOI 10.1097/00005053-199101000-00007; McGuire J, 2003, PSYCHIAT SERV, V54, P201, DOI 10.1176/appi.ps.54.2.201; Menzies R., 2006, CRIMINOLOGY, V25, P429; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mumola C. J., 2000, VETERANS PRISONS JAI; Mumola CJ., 2007, VETERANS STATE FEDER; National Council on Disability, 2009, INV WOUNDS SERV SERV; National Survey on Drug Use and Health, 2005, SUBST US DEP TREATM; O'Bryant J., 2007, US FORCES IRAQ; O'Bryant J., 2008, US FORCES AFGHANISTA; O'Hanlon M. E., 2008, IRAQ INDEX TRACKING; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; Riccardi N., 2009, LOS ANGELES TIM 1003; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; SHAW DM, 1987, COMPR PSYCHIAT, V28, P403, DOI 10.1016/0010-440X(87)90057-5; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; SPEED N, 1989, J NERV MENT DIS, V177, P147, DOI 10.1097/00005053-198903000-00004; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steadman H.J., 1997, PROVIDING SERVICES J; Teller JLS, 2006, PSYCHIAT SERV, V57, P232, DOI 10.1176/appi.ps.57.2.232; TEPLIN LA, 1983, PSYCHOL BULL, V94, P54, DOI 10.1037/0033-2909.94.1.54; TEPLIN LA, 1992, INT J LAW PSYCHIAT, V15, P139, DOI 10.1016/0160-2527(92)90010-X; TEPLIN LA, 1994, AM J PUBLIC HEALTH, V84, P290, DOI 10.2105/AJPH.84.2.290; TEPLIN LA, 1984, AM PSYCHOL, V39, P794, DOI 10.1037/0003-066X.39.7.794; TEPLIN LA, 1985, AM J PSYCHIAT, V142, P593; Troops risk undetected brain injury, 2006, US TODAY         MAY; True W. R., 1988, AM J EPIDEMIOL, V177, P154; Visher CA, 1991, COMP URINALYSIS TECH; White M. D., 2009, ARIZONA ARRESTEE REP; White M. D., 2010, ARIZONA ARRESTEE REP; Willbach H, 1948, J CRIM LAW CRIM, V38, P501, DOI 10.2307/1138926; Wilson D. B., 2006, J EXP CRIMINOL, P459, DOI [10.1007/s11292-006-9019-4, DOI 10.1007/S11292-006-9019-4]; YAGER T, 1984, ARCH GEN PSYCHIAT, V41, P327	74	43	43	0	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0741-8825	1745-9109		JUSTICE Q	Justice Q.		2012	29	2					258	286		10.1080/07418825.2011.560890			29	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	920LS	WOS:000302406600004					2022-02-06	
J	Lepore, AC; O'Donnell, J; Kim, AS; Yang, EJ; Tuteja, A; Haidet-Phillips, A; O'Banion, CP; Maragakis, NJ				Lepore, Angelo C.; O'Donnell, John; Kim, Andrew S.; Yang, Eun Ju; Tuteja, Alisha; Haidet-Phillips, Amanda; O'Banion, Colin P.; Maragakis, Nicholas J.			Reduction in Expression of the Astrocyte Glutamate Transporter, GLT1, Worsens Functional and Histological Outcomes Following Traumatic Spinal Cord Injury	GLIA			English	Article						secondary injury; GLT1+/- mice; crush injury; glutamate uptake; excitotoxicity	MICE LACKING; BRAIN-INJURY; AMINO-ACIDS; MECHANISMS; DISEASE; NMDA; TRANSPLANTATION; CONTRIBUTES; ANTAGONIST; PATHOLOGY	The astrocyte glutamate transporter, GLT1, is responsible for the vast majority of glutamate uptake in the adult central nervous system (CNS), thereby regulating extracellular glutamate homeostasis and preventing excitotoxicity. Glutamate dysregulation plays a central role in outcome following traumatic spinal cord injury (SCI). To determine the role of GLT1 in secondary cell loss following SCI, mice heterozygous for the GLT1 astrocyte glutamate transporter (GLT1(+/-)) and wild-type mice received thoracic crush SCI. Compared with wild-type controls, GLT1(+/-) mice had an attenuated recovery in hindlimb motor function, increased lesion size, and decreased tissue sparing. GLT1(+/-) mice showed a decrease in intraspinal GLT1 protein and functional glutamate uptake compared with wild-type mice, accompanied by increased apoptosis and neuronal loss following crush injury. These results suggest that astrocyte GLT1 plays a role in limiting secondary cell death following SCI, and also show that compromise of key astrocyte functions has significant effects on outcome following traumatic CNS injury. These findings also suggest that increasing intraspinal GLT1 expression may represent a therapeutically relevant target for SCI treatment. (C) 2011 Wiley-Liss, Inc.	[O'Donnell, John; Kim, Andrew S.; Yang, Eun Ju; Tuteja, Alisha; Haidet-Phillips, Amanda; O'Banion, Colin P.; Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lepore, Angelo C.] Thomas Jefferson Univ, Coll Med, Dept Neurosci, Jefferson Hosp Neurosci, Philadelphia, PA 19107 USA		Maragakis, NJ (corresponding author), Johns Hopkins Sch Med, Dept Neurol, 855 N Wolfe St,Rangos 250, Baltimore, MD 21205 USA.	nmaragak@jhmi.edu		O'Donnell, John/0000-0002-0774-9028	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32-NS059155]; Paralyzed Veterans of America [160837]; Craig H. Neilsen Foundation [190140]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS059155] Funding Source: NIH RePORTER	Grant sponsor: NIH; Grant number: F32-NS059155; Grant sponsor: Paralyzed Veterans of America; Grant number: 160837; Grant sponsor: Craig H. Neilsen Foundation; Grant number: 190140;	Agrawal SK, 1997, J NEUROSCI, V17, P1055; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gaviria M, 2000, BRAIN RES, V874, P200, DOI 10.1016/S0006-8993(00)02581-6; HOLTZ A, 1991, ACTA NEUROL SCAND, V84, P334, DOI 10.1111/j.1600-0404.1991.tb04964.x; Hulsebosch CE, 2008, EXP NEUROL, V214, P6, DOI 10.1016/j.expneurol.2008.07.016; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2011, J NEUROSCI RES, V89, P1001, DOI 10.1002/jnr.22624; Li S, 1999, J Neurosci, V19, pRC16; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; McAdoo DJ, 2000, BRAIN RES, V865, P283, DOI 10.1016/S0006-8993(00)02296-4; McDonald JW, 2003, AM J PHYS MED REHAB, V82, pS38, DOI 10.1097/01.PHM.0000086994.53716.17; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Rosenberg LJ, 1999, J NEUROSCI, V19, P464, DOI 10.1523/JNEUROSCI.19-01-00464.1999; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; Xu GY, 2005, NEUROSCI LETT, V384, P271, DOI 10.1016/j.neulet.2005.04.100; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	36	43	44	1	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0894-1491			GLIA	Glia	DEC	2011	59	12					1996	2005		10.1002/glia.21241			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833KY	WOS:000295885500017	21882244	Green Accepted			2022-02-06	
J	Ehrenreich, H; Kastner, A; Weissenborn, K; Streeter, J; Sperling, S; Wang, KK; Worthmann, H; Hayes, RL; von Ahsen, N; Kastrup, A; Jeromin, A; Herrmann, M				Ehrenreich, Hannelore; Kaestner, Anne; Weissenborn, Karin; Streeter, Jackson; Sperling, Swetlana; Wang, Kevin K.; Worthmann, Hans; Hayes, Ronald L.; von Ahsen, Nico; Kastrup, Andreas; Jeromin, Andreas; Herrmann, Manfred			Circulating Damage Marker Profiles Support a Neuroprotective Effect of Erythropoietin in Ischemic Stroke Patients	MOLECULAR MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; TISSUE-PLASMINOGEN ACTIVATOR; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; C-TERMINAL HYDROLASE; NEUROBIOCHEMICAL MARKERS; OUTCOME PREDICTION; BIOMARKER; COMBINATION; HEMORRHAGE	The German Multicenter EPO Stroke Trial, which investigated safety and efficacy of erythropoietin (EPO) treatment in ischemic stroke, was formally declared a negative study. Exploratory subgroup analysis, however, revealed that patients not receiving thrombolysis most likely benefited from EPO during clinical recovery, a result demonstrated in the findings of the Gottingen EPO Stroke Study The present work investigated whether the positive signal on clinical outcome in this patient subgroup was mirrored by respective poststroke biomarker profiles. All patients of the German Multicenter EPO Stroke Trial nonqualifying for thrombolysis were included if they (a) were treated per protocol and (b) had at least two of the five follow-up blood samples for circulating damage markers drawn (n = 163). The glial markers S100B and glial fibrillary acid protein (GFAP) and the neuronal marker ubiquitin C-terminal hydrolase (UCH-L1) were measured by enzyme-linked immunosorbent assay in serum on d 1, 2, 3, 4 and 7 poststroke. All biomarkers increased poststroke. Overall, EPO-treated patients had significantly lower concentrations (area under the curve) over 7 d of observation, as reflected by the composite score of all three markers (Cronbach alpha = 0.811) and by UCH-L1. S100B and GFAP showed a similar tendency. To conclude, serum biomarker profiles, as an outcome measure of brain damage, corroborate an advantageous effect of EPO in ischemic stroke. In particular, reduction in the neuronal damage marker UCH-L1 may reflect neuroprotection by EPO. (C) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2011.00259	[Ehrenreich, Hannelore] Max Planck Inst Expt Med, Div Clin Neurosci, D-37075 Gottingen, Germany; [Weissenborn, Karin; Worthmann, Hans] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Streeter, Jackson; Hayes, Ronald L.; Jeromin, Andreas] Banyan Biomarkers Inc, Alachua, FL USA; [von Ahsen, Nico] Univ Gottingen, Dept Clin Chem, Gottingen, Germany; [Kastrup, Andreas] Klinikum Bremen Ost & Bremen Mitte, Dept Neurol, Bremen, Germany; [Herrmann, Manfred] Univ Bremen, Dept Neuropsychol & Behav Neurobiol, D-28359 Bremen, Germany		Ehrenreich, H (corresponding author), Max Planck Inst Expt Med, Div Clin Neurosci, Hermann Rein Str 3, D-37075 Gottingen, Germany.	ehrenreich@em.mpg.de; ajeromin@banyanbio.com	Herrmann, Manfred/H-3931-2011	Herrmann, Manfred/0000-0003-1872-8406; Ehrenreich, Hannelore/0000-0001-8371-5711; Wang, Kevin/0000-0002-9343-6473	Max Planck Society and Banyan Biomarkers, Inc.	This study was supported by the Max Planck Society and Banyan Biomarkers, Inc.	Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Jia LF, 2010, STROKE, V41, P2071, DOI 10.1161/STROKEAHA.110.586198; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; Zechariah A, 2010, STROKE, V41, P1008, DOI 10.1161/STROKEAHA.109.574418	19	43	45	0	7	FEINSTEIN INST MED RES	MANHASSET	350 COMMUNITY DR, MANHASSET, NY 11030 USA	1076-1551			MOL MED	Mol. Med.	NOV-DEC	2011	17	11-12					1306	1310		10.2119/molmed.2011.00259			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860OY	WOS:000297958800021	21912808	Green Published, gold			2022-02-06	
J	Krajewska, M; You, ZR; Rong, J; Kress, C; Huang, XS; Yang, JS; Kyoda, T; Leyva, R; Banares, S; Hu, Y; Sze, CH; Whalen, MJ; Salmena, L; Hakem, R; Head, BP; Reed, JC; Krajewski, S				Krajewska, Maryla; You, Zerong; Rong, Juan; Kress, Christina; Huang, Xianshu; Yang, Jinsheng; Kyoda, Tiffany; Leyva, Ricardo; Banares, Steven; Hu, Yue; Sze, Chia-Hung; Whalen, Michael J.; Salmena, Leonardo; Hakem, Razqallah; Head, Brian P.; Reed, John C.; Krajewski, Stan			Neuronal Deletion of Caspase 8 Protects against Brain Injury in Mouse Models of Controlled Cortical Impact and Kainic Acid-Induced Excitotoxicity	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; FOCAL CEREBRAL-ISCHEMIA; C-JUN; HEAD-INJURY; IN-VITRO; ORGANOTYPIC CULTURES; NERVOUS-SYSTEM; JNK ACTIVATION; APOPTOSIS; MICE	Background: Acute brain injury is an important health problem. Given the critical position of caspase 8 at the crossroads of cell death pathways, we generated a new viable mouse line (Ncasp8(-/-)), in which the gene encoding caspase 8 was selectively deleted in neurons by cre-lox system. Methodology/Principal Findings: Caspase 8 deletion reduced rates of neuronal cell death in primary neuronal cultures and in whole brain organotypic coronal slice cultures prepared from 4 and 8 month old mice and cultivated up to 14 days in vitro. Treatments of cultures with recombinant murine TNF alpha (100 ng/ml) or TRAIL (250 ng/mL) plus cyclohexamide significantly protected neurons against cell death induced by these apoptosis-inducing ligands. A protective role of caspase 8 deletion in vivo was also demonstrated using a controlled cortical impact (CCI) model of traumatic brain injury (TBI) and seizure-induced brain injury caused by kainic acid (KA). Morphometric analyses were performed using digital imaging in conjunction with image analysis algorithms. By employing virtual images of hundreds of brain sections, we were able to perform quantitative morphometry of histological and immunohistochemical staining data in an unbiased manner. In the TBI model, homozygous deletion of caspase 8 resulted in reduced lesion volumes, improved post-injury motor performance, superior learning and memory retention, decreased apoptosis, diminished proteolytic processing of caspases and caspase substrates, and less neuronal degeneration, compared to wild type, homozygous cre, and caspase 8-floxed control mice. In the KA model, Ncasp8(-/-) mice demonstrated superior survival, reduced seizure severity, less apoptosis, and reduced caspase 3 processing. Uninjured aged knockout mice showed improved learning and memory, implicating a possible role for caspase 8 in cognitive decline with aging. Conclusions: Neuron-specific deletion of caspase 8 reduces brain damage and improves post-traumatic functional outcomes, suggesting an important role for this caspase in pathophysiology of acute brain trauma.	[Krajewska, Maryla; Rong, Juan; Kress, Christina; Huang, Xianshu; Kyoda, Tiffany; Leyva, Ricardo; Banares, Steven; Sze, Chia-Hung; Reed, John C.; Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [You, Zerong; Yang, Jinsheng; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA USA; [Hu, Yue; Head, Brian P.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hu, Yue] VA San Diego Healthcare Syst, San Diego, CA USA; [Salmena, Leonardo; Hakem, Razqallah] Ontario Canc Inst, Dept Med Biophys, Toronto, ON M4X 1K9, Canada		Krajewska, M (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	jreed@sanfordburnham.org; stan@sanfordburnham.org		Hakem, Razq/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36821, CA69381]; DoDUnited States Department of Defense [W81XWH-08-2-0067, W81XWH-07-1-0569]; VA CDA-2; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064545, R01NS036821] Funding Source: NIH RePORTER	Supported by the NIH grants (NS36821 [SK]; CA69381 [JCR]) and DoD grants (W81XWH-08-2-0067 [SK]; W81XWH-07-1-0569 [JCR]); VA CDA-2 [BPH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2005, J NEUROSCI METH, V149, P110, DOI 10.1016/j.jneumeth.2005.05.022; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Banares S, 2005, GENESIS, V42, P6, DOI 10.1002/gene.20117; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Ben Moshe T, 2008, CYTOKINE GROWTH F R, V19, P209, DOI 10.1016/j.cytogfr.2008.04.012; Bermpohl D, 2007, J CEREB BLOOD FLOW M; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Feng YZ, 2003, EUR J PHARMACOL, V481, P169, DOI 10.1016/j.ejphar.2003.09.016; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harrison DC, 2001, MOL BRAIN RES, V89, P133, DOI 10.1016/S0169-328X(01)00058-4; Henshall DC, 2001, P NATL ACAD SCI USA, V98, P15318; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Johnson V. E., 2010, NAT REV NEUROSCI; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim YE, 2010, NAT PROTOC, V5, P1396, DOI 10.1038/nprot.2010.101; Krajewska M, 2008, AM J PATHOL, V172, P1312, DOI 10.2353/ajpath.2008.070594; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Krajewski S, 2009, METHODS MOL BIOL, V536, P473, DOI 10.1007/978-1-59745-542-8_48; Kumar S, 1997, INT J BIOCHEM CELL B, V29, P393, DOI 10.1016/S1357-2725(96)00146-X; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; Li TF, 2006, BRAIN RES, V1098, P204, DOI 10.1016/j.brainres.2006.04.131; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.ne.11.030188.000333; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Qiu JH, 2002, J NEUROSCI, V22, P3504; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xiang ZM, 2000, J NEUROSCI METH, V98, P145, DOI 10.1016/S0165-0270(00)00197-7; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yoon JJ, 2010, BRAIN RES, V1353, P194, DOI 10.1016/j.brainres.2010.07.005; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang JH, 2001, BIOCHEM BIOPH RES CO, V285, P1143, DOI 10.1006/bbrc.2001.5313; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	89	43	46	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24341	10.1371/journal.pone.0024341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	WOS:000295173800020	21957448	gold, Green Published, Green Submitted			2022-02-06	
J	Garcia-Panach, J; Lull, N; Lull, JJ; Ferri, J; Martinez, C; Sopena, P; Robles, M; Chirivella, J; Noe, E				Garcia-Panach, Javier; Lull, Nuria; Jose Lull, Juan; Ferri, Joan; Martinez, Carlos; Sopena, Pablo; Robles, Montserrat; Chirivella, Javier; Noe, Enrique			A Voxel-Based Analysis of FDG-PET in Traumatic Brain Injury: Regional Metabolism and Relationship between the Thalamus and Cortical Areas	JOURNAL OF NEUROTRAUMA			English	Article						cerebral metabolism; consciousness; functional imaging; head injury; image analysis; positron emission tomography	DIFFUSE AXONAL INJURY; CEREBRAL GLUCOSE-METABOLISM; MINIMALLY CONSCIOUS STATES; VEGETATIVE STATE; POSTTRAUMATIC AMNESIA; DEFAULT MODE; HEAD-INJURY; RECOVERY; LESIONS; CONNECTIVITY	The objective was to study the correlations and the differences in glucose metabolism between the thalamus and cortical structures in a sample of severe traumatic brain injury (TBI) patients with different neurological outcomes. We studied 49 patients who had suffered a severe TBI and 10 healthy control subjects using 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET). The patients were divided into three groups: a vegetative or minimally-conscious state (MCS&VS) group (n=17), which included patients who were in a vegetative or a minimally conscious state; an In-post-traumatic amnesia (In-PTA) group (n=12), which included patients in PTA; and an Out-PTA group (n=20), which included patients who had recovered from PTA. SPM5 software was used to determine the metabolic differences between the groups. FDG-PET images were normalized and four regions of interest were generated around the thalamus, precuneus, and the frontal and temporal lobes. The groups were parameterized using Student's t-test. Principal component analysis was used to obtain an intensity-estimated-value per subject to correlate the function between the structures. Differences in glucose metabolism in all structures were related to the neurological outcome, and the most severe patients showed the most severe hypometabolism. We also found a significant correlation between the cortico-thalamocortical metabolism in all groups. Voxel-based analysis suggests a functional correlation between these four areas, and decreased metabolism was associated with less favorable outcomes. Higher levels of activation of the cortico-cortical connections appear to be related to better neurological condition. Differences in the thalamocortical correlations between patients and controls may be related to traumatic dysfunction due to focal or diffuse lesions.	[Garcia-Panach, Javier; Lull, Nuria; Jose Lull, Juan; Robles, Montserrat] Univ Politecn Valencia, Inst Aplicac Tecnol Informac & Comunicac Avanzada, Grp Informat Biomed, E-46071 Valencia, Spain; [Garcia-Panach, Javier; Ferri, Joan; Chirivella, Javier; Noe, Enrique] Fdn Hosp NISA, Serv Dano Cerebral Hosp NISA, Valencia, Spain; [Lull, Nuria] Univ CEU Cardenal Herrera, Valencia, Spain; [Martinez, Carlos; Sopena, Pablo] Hosp 9 Octubre, Serv PET Med Nucl, Valencia, Spain		Noe, E (corresponding author), Hosp NISA Valencia Mar, Serv Neurorehabil, C Rio Tajo 1, Valencia 46011, Spain.	enoe@comv.es	Lull, Juan Jose/AAB-5154-2019; Sopena-Novales, Pablo/AAA-4427-2019; Robles, Montserrat/A-6722-2016	Lull, Juan Jose/0000-0002-4399-950X; Sopena-Novales, Pablo/0000-0002-0560-0051; Robles, Montserrat/0000-0002-7705-1389; Noe Sebastian, Enrique/0000-0002-2547-8727	Official College of Physicians of Valladolid	A preliminary version of the manuscript presented here has obtained the 2nd award of IV Convocatoria de los Premios de Investigacion en Medicina del Colegio de Medicos de Valladolid (IV edition of the Medical Research Award of the Official College of Physicians of Valladolid).	Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Cruse D, 2010, CURR OPIN NEUROL, V23, P656, DOI 10.1097/WCO.0b013e32833fd4e7; EVANS AC, 1993, IEEE NUCL SCI S MED, P1813; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hattori N, 2003, J NUCL MED, V44, P1709; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitelman SA, 2006, BRAIN RES, V1114, P125, DOI 10.1016/j.brainres.2006.07.043; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Phillips CL, 2011, NEUROIMAGE, V56, P797, DOI 10.1016/j.neuroimage.2010.05.083; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008	43	43	44	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1707	1717		10.1089/neu.2011.1851			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000004	21770759	Green Published			2022-02-06	
J	Lustenberger, T; Inaba, K; Barmparas, G; Talving, P; Plurad, D; Lam, L; Konstantinidis, A; Demetriades, D				Lustenberger, Thomas; Inaba, Kenji; Barmparas, Galinos; Talving, Peep; Plurad, David; Lam, Lydia; Konstantinidis, Agathoklis; Demetriades, Demetrios			Ethanol Intoxication Is Associated with a Lower Incidence of Admission Coagulopathy in Severe Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						adrenergic response; alcohol; coagulopathy; morbidity; mortality; severe traumatic brain injury	MOTOR-VEHICLE CRASHES; ALCOHOL-CONSUMPTION; PENTOBARBITAL COMA; HEAD TRAUMA; OUTCOMES; MORTALITY; FIBRINOLYSIS; RISK; PREVALENCE; FIBRINOGEN	The aim of this study was to determine the impact of ethanol (ETOH) on the incidence of severe traumatic brain injury (sTBI)-associated coagulopathy and to examine the effect of ETOH on in-hospital outcomes in patients sustaining sTBI. Patients admitted to the surgical intensive care unit from June 2005 through December 2008 following sTBI, defined as a head Abbreviated Injury Scale (AIS) score >= 3, were retrospectively identified. Patients with a chest, abdomen, or extremity AIS score > 3 were excluded to minimize the impact of extracranial injuries. Criteria for sTBI-associated coagulopathy included thrombocytopenia and/or elevated International Normalized Ratio (INR) and/or prolonged activated partial thromboplastin time (aPTT). The incidence of admission coagulopathy, in-hospital complications, and mortality were compared between patients who were ETOH positive [ETOH (+)] and ETOH negative [ETOH (-)]. During the study period, there were 439 patients with ETOH levels available for analysis. Overall, 46.5% (n = 204) of these patients were ETOH (+), while 53.5% (n = 235) were ETOH (-). Coagulopathy was significantly less frequent in the ETOH (+) patients compared to their ETOH (-) counterparts (5.4% versus 15.3%; adjusted p < 0.001). In the forward logistic regression analysis, a positive ETOH level proved to be an independent protective factor for admission coagulopathy [OR (95% CI) = 0.24 (0.10,0.54; p = 0.001]. ETOH (+) patients had a significantly lower in-hospital mortality rate than ETOH (-) patients [9.8% versus 16.6%; adjusted p = 0.011; adjusted OR (95% CI) = 0.39 (0.19,0.81)]. For brain-injured patients arriving alive to the hospital, ETOH intoxication is associated with a significantly lower incidence of early coagulopathy and in-hospital mortality. Further research to establish the pathophysiologic mechanisms underlying any potential beneficial effect of ETOH on the coagulation system following sTBI is warranted.	[Lustenberger, Thomas; Inaba, Kenji; Barmparas, Galinos; Talving, Peep; Plurad, David; Lam, Lydia; Konstantinidis, Agathoklis; Demetriades, Demetrios] Univ So Calif, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, Los Angeles, CA 90033 USA		Inaba, K (corresponding author), Univ So Calif, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, Los Angeles Cty Gen Hosp LAC USC, 1200 N State St,IPT,C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	INABA, KENJI/AAC-8532-2020; Talving, Peep/G-8621-2015; Barmparas, Galinos/L-6530-2019; Talving, Peep/E-6015-2013	Talving, Peep/0000-0002-9741-2073; 			Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; de Lange DW, 2004, ALCOHOL CLIN EXP RES, V28, P1562, DOI 10.1097/01.ALC.0000141808.62230.75; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; El-Sayed MS, 2000, BLOOD COAGUL FIBRIN, V11, P359, DOI 10.1097/00001721-200006000-00007; Engstrom M, 2006, BLOOD COAGUL FIBRIN, V17, P661, DOI 10.1097/MBC.0b013e32801010b7; Erstad B L, 1999, Am J Ther, V6, P299; ERSTAD BL, 1993, ANN PHARMACOTHER, V27, P889, DOI 10.1177/106002809302700716; Field CA, 2001, J TRAUMA, V50, P13, DOI 10.1097/00005373-200101000-00002; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Grenett HE, 2000, THROMB RES, V97, P247, DOI 10.1016/S0049-3848(99)00172-3; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kiviniemi TO, 2009, EUR J CARDIOV PREV R, V16, P161, DOI 10.1097/HJR.0b013e328320ad1b; Lacoste L, 2001, AM J CARDIOL, V87, P82, DOI 10.1016/S0002-9149(00)01277-7; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Plurad D, 2006, J AM COLL SURGEONS, V202, P919, DOI 10.1016/j.jamcollsurg.2006.02.024; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Tabengwa EM, 2002, ALCOHOL CLIN EXP RES, V26, P1121, DOI 10.1097/01.ALC.0000024358.83124.6B; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; van de Wiel A, 2001, EUR J CLIN INVEST, V31, P164, DOI 10.1046/j.1365-2362.2001.00773.x; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; WOOLF PD, 1991, J TRAUMA, V31, P1271, DOI 10.1097/00005373-199109000-00012; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x	41	43	45	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1699	1706		10.1089/neu.2011.1866			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000003	21902539				2022-02-06	
J	Brenner, LA; Betthauser, LM; Homaifar, BY; Villarreal, E; Harwood, JEF; Staves, PJ; Huggins, JA				Brenner, Lisa A.; Betthauser, Lisa M.; Homaifar, Beeta Y.; Villarreal, Edgar; Harwood, Jeri E. F.; Staves, Pamela J.; Huggins, Joseph A.			Posttraumatic Stress Disorder, Traumatic Brain Injury, and Suicide Attempt History among Veterans Receiving Mental Health Services	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							EMOTIONAL RISK-FACTORS; CUMULATIVE DISADVANTAGE; IRAQ; AFGHANISTAN; ASSOCIATION; PREVALENCE; ADVERSITY; BURDEN	History of posttraumatic stress disorder (PTSD) or traumatic brain injury (TBI) has been found to increase risk of suicidal behavior. The association between suicide attempt history among veterans with PTSD and/or TBI was explored. Cases (N = 81) and 2: 1 matched controls (N = 160) were randomly selected from a Veterans Affairs Medical Center clinical database. PTSD history was associated with an increased risk for a suicide attempt (OR = 2.8; 95% CI: 1.5, 5.1). This increased risk was present for those with and without a history of TBI. Results support incorporating PTSD history when assessing suicide risk among veterans with and without TBI.	[Brenner, Lisa A.; Betthauser, Lisa M.; Homaifar, Beeta Y.; Staves, Pamela J.; Huggins, Joseph A.] VA VISN 19 Mental Illness Res Educ & Clin Ctr MIR, Denver, CO 80220 USA; [Brenner, Lisa A.; Homaifar, Beeta Y.; Harwood, Jeri E. F.] Univ Colorado Denver, Sch Med, Denver, CO USA; [Villarreal, Edgar] Texas A&M Univ, Dept Counseling Psychol, College Stn, TX USA		Brenner, LA (corresponding author), VA VISN 19 Mental Illness Res Educ & Clin Ctr MIR, 1055 Clermont St,4E-135, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019	Huggins, Joe/0000-0001-8151-5062			Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; *DEP VET AFF, 2004, TRAUM BRAIN INJ CONT; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Ferraro KF, 2003, AM SOCIOL REV, V68, P707, DOI 10.2307/1519759; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; ORand AM, 1996, GERONTOLOGIST, V36, P230, DOI 10.1093/geront/36.2.230; Preston SH, 1998, SOC SCI MED, V47, P1231, DOI 10.1016/S0277-9536(98)00180-4; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; VanCott AC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-4; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50	30	43	43	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	AUG	2011	41	4					416	423		10.1111/j.1943-278X.2011.00041.x			8	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	810VX	WOS:000294157200006	21599727				2022-02-06	
J	Murnane, OD; Akin, FW; Kelly, JK; Byrd, S				Murnane, Owen D.; Akin, Faith W.; Kelly, J. Kip; Byrd, Stephanie			Effects of Stimulus and Recording Parameters on the Air Conduction Ocular Vestibular Evoked Myogenic Potential	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						Ocular reflexes; ocular vestibular evoked myogenic potentials; otoliths; saccule; utricle; vestibular evoked myogenic potentials	SUPERIOR CANAL DEHISCENCE; VESTIBULOOCULAR REFLEXES; EXTRAOCULAR POTENTIALS; ENDOLYMPHATIC HYDROPS; MENIERES-DISEASE; SOUND; BONE; FREQUENCY; VIBRATION; MUSCLES	Background: Vestibular evoked myogenic potentials (VEMPs) have been recorded from the sternocleidomastoid muscle (cervical VEMP or cVEMP) and more recently from the eye muscles (ocular VEMP or oVEMP) in response to air conduction and bone conduction stimuli. Both cVEMPs and oVEMPs are mediated by the otoliths and thereby provide diagnostic information that is complementary to videonystagmography and rotational chair tests. In contrast to the air conduction cVEMP, which originates from the saccule/inferior vestibular nerve, recent evidence suggests the possibility that the air conduction oVEMP may be. mediated by the utricle/superior vestibular nerve. The oVEMP, therefore, may provide complementary diagnostic information relative to the cVEMP. There are relatively few studies, however, that have quantified the effects of stimulus and recording parameters on the air conduction oVEMP, and there is a paucity of normative data. Purpose: To evaluate the effects of several stimulus and recording parameters on the air conduction oVEMP and to establish normative data for clinical use. Research Design: A prospective repeated measures design was utilized. Study Sample: Forty-seven young adults with no history of neurologic disease, hearing loss, middle ear pathology, open or closed head injury, cervical injury, or audiovestibular disorder participated in the study. Data Collection and Analysis: The effects of stimulus frequency, stimulus level, gaze elevation, and recording electrode location on the amplitude and latency of the oVEMP for monaural air conduction stimuli were assessed using repeated measures analyses of variance in an initial group of 17 participants. The optimal stimulus and recording parameters obtained in the initial group were used subsequently to obtain oVEMPs from 30 additional participants. Results: The effects of stimulus frequency, stimulus level, gaze elevation, and electrode location on the response prevalence, amplitude, and latency of the oVEMP for monaural air conduction stimuli were significant. The maximum N1-P1 amplitude and response prevalence were obtained for contralateral oVEMPs using a 500 Hz tone burst presented at 125 dB (peak) SPL during upward gaze at an elevation of 30 degrees. Conclusions: The optimal stimulus and recording parameters quantified in this study were used to establish normative data that may be useful for the clinical application of the air conduction oVEMP.	[Murnane, Owen D.; Akin, Faith W.; Kelly, J. Kip; Byrd, Stephanie] James H Quillen VAMC, Mountain Home, TN 37684 USA; [Murnane, Owen D.; Akin, Faith W.] E Tennessee State Univ, Dept Speech Pathol & Audiol, Johnson City, TN 37614 USA		Murnane, OD (corresponding author), James H Quillen VAMC, Mountain Home, TN 37684 USA.	owen.murnane@va.gov			Auditory and Vestibular Dysfunction Research Enhancement Award Program; Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.US Department of Veterans Affairs;  [C6065R]	This work was supported by a Merit Review (C6065R) and the Auditory and Vestibular Dysfunction Research Enhancement Award Program sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C.	Akin F W, 2001, J Am Acad Audiol, V12, P445; American National Standards Institute, 2004, S362004 ANSI; Cheng PW, 2009, CLIN NEUROPHYSIOL, V120, P1841, DOI 10.1016/j.clinph.2009.08.002; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; Chihara Y, 2009, NEUROREPORT, V20, P1491, DOI 10.1097/WNR.0b013e3283329b4a; Chihara Y, 2009, CLIN NEUROPHYSIOL, V120, P581, DOI 10.1016/j.clinph.2008.12.030; Colebatch JG, 2010, CLIN NEUROPHYSIOL, V121, P124, DOI 10.1016/j.clinph.2009.09.026; Curthoys IS, 2011, CLIN NEUROPHYSIOL, V122, P611, DOI 10.1016/j.clinph.2010.07.018; Curthoys IS, 2011, EXP BRAIN RES, V210, P347, DOI 10.1007/s00221-010-2499-5; Curthoys IS, 2010, CLIN NEUROPHYSIOL, V121, P977, DOI 10.1016/j.clinph.2010.01.025; Curthoys IS, 2010, CLIN NEUROPHYSIOL, V121, P132, DOI 10.1016/j.clinph.2009.09.027; de Waele C, 2001, EXP BRAIN RES, V141, P541, DOI 10.1007/s00221-001-0894-7; Govender S, 2009, CLIN NEUROPHYSIOL, V120, P1386, DOI 10.1016/j.clinph.2009.04.017; Halmagyi GM, 2010, CLIN NEUROPHYSIOL, V121, P631, DOI 10.1016/j.clinph.2010.01.035; Iwasaki S, 2007, NEUROLOGY, V68, P1227, DOI 10.1212/01.wnl.0000259064.80564.21; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Leigh RJ, 1999, NEUROLOGY EYE MOVEME, P3; Lewis A, 2010, J OTOLARYNGOL-HEAD N, V39, P491, DOI 10.2310/7070.2010.090205; Manzari L, 2010, OTOLARYNG HEAD NECK, V143, P274, DOI 10.1016/j.otohns.2010.03.020; Manzari L, 2010, EUR ARCH OTO-RHINO-L, V267, P1487, DOI 10.1007/s00405-010-1317-9; Murnane Owen D., 2009, Seminars in Hearing, V30, P267, DOI 10.1055/s-0029-1241127; Murofushi T, 2010, EUR ARCH OTO-RHINO-L, V267, P995, DOI 10.1007/s00405-010-1246-7; OKUNO T, 1987, ANN OTO RHINOL LARYN, V96, P438, DOI 10.1177/000348948709600418; PAPARELLA MM, 1985, ACTA OTO-LARYNGOL, V99, P445, DOI 10.3109/00016488509108936; Park HJ, 2010, CLIN NEUROPHYSIOL, V121, P85, DOI 10.1016/j.clinph.2009.10.003; PORTER JD, 2003, ADLERS PHYSL EYE CLI, P787; Rodionov V, 1996, ANN OTO RHINOL LARYN, V105, P43, DOI 10.1177/000348949610500107; Rodionov V, 1996, EVOKED POTENTIAL, V100, P354, DOI 10.1016/0168-5597(96)95515-X; Rosengren SM, 2008, J NEUROL NEUROSUR PS, V79, P559, DOI 10.1136/jnnp.2007.126730; Rosengren SM, 2010, CLIN NEUROPHYSIOL, V121, P636, DOI 10.1016/j.clinph.2009.10.016; Rosengren SM, 2009, CLIN NEUROPHYSIOL, V120, P569, DOI 10.1016/j.clinph.2008.12.001; Rosengren SM, 2005, CLIN NEUROPHYSIOL, V116, P1938, DOI 10.1016/j.clinph.2005.03.019; ROSENHALL U, 1972, ANN OTO RHINOL LARYN, V81, P339, DOI 10.1177/000348947208100305; SCHUKNECHT HF, 1986, ANN OTO RHINOL LARYN, V95, P36, DOI 10.1177/000348948609500108; Smulders YE, 2009, CLIN NEUROPHYSIOL, V120, P1567, DOI 10.1016/j.clinph.2009.06.008; Sohmer H, 1999, EEG CL N SU, V50, P226; Su HC, 2004, OTOL NEUROTOL, V25, P977, DOI 10.1097/00129492-200411000-00019; Taylor RL, CLIN NEUROP IN PRESS; Todd NPM, 2008, CLIN NEUROPHYSIOL, V119, P1638, DOI 10.1016/j.clinph.2008.03.009; Todd NPM, 2009, NEUROSCI LETT, V451, P175, DOI 10.1016/j.neulet.2008.12.055; Todd NPM, 2007, CLIN NEUROPHYSIOL, V118, P381, DOI 10.1016/j.clinph.2006.09.025; Todd NPM, 2010, CLIN NEUROPHYSIOL, V121, P978, DOI 10.1016/j.clinph.2010.01.026; Uzun-Coruhlu H, 2007, HEARING RES, V233, P77, DOI 10.1016/j.heares.2007.07.008; Wang SJ, 2009, CLIN NEUROPHYSIOL, V120, P420, DOI 10.1016/j.clinph.2008.10.157; Welgampola MS, 2008, NEUROLOGY, V70, P464, DOI 10.1212/01.wnl.0000299084.76250.4a; Welgampola MS, 2010, OTOLARYNG HEAD NECK, V143, P281, DOI 10.1016/j.otohns.2010.05.024; Welgampola MS, 2009, CLIN NEUROPHYSIOL, V120, P158, DOI 10.1016/j.clinph.2008.06.020; Welgampola MS, 2001, OTOL NEUROTOL, V22, P796, DOI 10.1097/00129492-200111000-00014; Welgampola MS, 2001, CLIN NEUROPHYSIOL, V112, P1971, DOI 10.1016/S1388-2457(01)00645-9; WRIGHT CG, 1979, ANN OTO RHINOL LARYN, V88, P267, DOI 10.1177/000348947908800220; Zhou W, 2004, EXP BRAIN RES, V156, P129, DOI 10.1007/s00221-003-1778-9	51	43	48	0	13	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545			J AM ACAD AUDIOL	J. Am. Acad. Audiol.	JUL-AUG	2011	22	7			SI		469	480		10.3766/jaaa.22.7.7			12	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	831DD	WOS:000295708000007	21993052				2022-02-06	
J	Arun, P; Spadaro, J; John, J; Gharavi, RB; Bentley, TB; Nambiar, MP				Arun, Peethambaran; Spadaro, John; John, Jennifer; Gharavi, Robert B.; Bentley, Timothy B.; Nambiar, Madhusoodana P.			Studies on blast traumatic brain injury using in-vitro model with shock tube	NEUROREPORT			English	Article						biochemical analysis; blast injury; cellular effects; cellular injury; in-vitro model; neurobiological effects; neuropathology; shock tube; traumatic brain injury	ADULT-RAT BRAIN; LASTING IMPULSE NOISE; CYCLOPHILIN-A; INTRACRANIAL-PRESSURE; INDUCED NEUROTRAUMA; COGNITIVE FUNCTION; CELL-CULTURES; EXPOSURE; OVERPRESSURE; EXPRESSION	One of the major limitations in studying the mechanisms of blast-induced traumatic brain injury (bTBI) or screening therapeutics for protection is the lack of suitable laboratory model systems that can closely mimic the complex blast exposure. Although animal models of bTBI that use shock tubes to mimic blast exposure are available, no high throughput shock tube-based in-vitro models have been reported. Here, we report an in-vitro bTBI model using a compressed air-driven shock tube and mouse neuroblastoma/rat glioblastoma hybrid cells (NG108-15) or SH-SY5Y human neuroblastoma cells in tissue culture plates. Our data showed significant neurobiological effects with decreased adenosine triphosphate levels, increased cellular injury, lactate dehydrogenase release, and reactive oxygen species formation after blast exposure. NeuroReport 22:379-384 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Arun, Peethambaran; Spadaro, John; John, Jennifer; Gharavi, Robert B.; Bentley, Timothy B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Nambiar, MP (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	Madhusoodana.nambiar@us.army.mil					Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Guy R J, 2000, J R Nav Med Serv, V86, P27; Kim SH, 2004, AM J PATHOL, V164, P1567, DOI 10.1016/S0002-9440(10)63715-7; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Monnet-Tschudi F, 2007, HUM EXP TOXICOL, V26, P339, DOI 10.1177/0960327107074589; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Redell JB, 2007, J NEUROSCI RES, V85, P1980, DOI 10.1002/jnr.21324; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Sinha R, 2010, CANCER EPIDEM BIOMAR, V19, P2332, DOI 10.1158/1055-9965.EPI-10-0253; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Yang H, 2005, J SURG RES, V123, P312, DOI 10.1016/j.jss.2004.08.026	25	43	43	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	JUN 11	2011	22	8					379	384		10.1097/WNR.0b013e328346b138			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756SY	WOS:000290036200004	21532394				2022-02-06	
J	Marion, DW; Curley, KC; Schwab, K; Hicks, RR				Marion, Donald W.; Curley, Kenneth C.; Schwab, Karen; Hicks, Ramona R.		mTBI Diagnostics Workgrp	Proceedings of the Military mTBI Diagnostics Workshop, St. Pete Beach, August 2010	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diagnosis; mild traumatic brain injury; Neurocognitive Assessment Tool (NCAT); Military Acute Concussion Evaluation (MACE); Operation Iraqi Freedom (OIF); Operation Enduring Freedom (OEF); military mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; BIOCHEMICAL MARKERS; HEAD-INJURY; CONCUSSION; SERUM; S-100B; DAMAGE; S100B; BIOMARKERS	Approximately 28,000 service members (SMs) sustain a traumatic brain injury (TBI) each year in the U. S. military. The majority of the injuries result either in a brief or no loss of consciousness, and are classified as a mild TBI (mTBI or concussion). Current evaluation guidelines of SMs suspected of having a mTBI rely heavily on self-reports. However, there is concern that SMs typically minimize or do not report their symptoms of mTBI for fear that doing so will result in being removed from the battlefield. Because mTBI often results in headaches, cognitive dysfunction, attention difficulties, and balance problems, returning to the battlefield before resolution of their symptoms can be dangerous for the SM and for their unit. Sustaining a second concussion before resolution of a previous mTBI also may make long-term neuronal injury more likely. The mTBI Diagnostics Workshop was designed as a forum where civilian and military experts from a variety of TBI-related clinical and basic science disciplines could meet to define the diagnostic tools, alone or in combination, that were most likely to result in an acute, objective diagnosis of mTBI. The premise of the meeting was that a small number of well-focused research projects conducted over the next 2-3 years could be done to validate the optimal test, or more likely combination of tests, that would be practical and reliable for the acute diagnosis of mTBI within 2-3 h of injury in theater. The recommendations of the Workshop are provided in this report.	[Marion, Donald W.; Schwab, Karen] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Curley, Kenneth C.] USA, Combat Casualty Care Directorate, Med Res & Mat Command, Ft Detrick, MD USA; [Hicks, Ramona R.] NINDS, Bethesda, MD 20892 USA		Marion, DW (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Bldg 1,Room B209 6900 Georgia Ave NW, Washington, DC 20307 USA.	Donald.Marion@us.army.mil	Marion, Donald/AAR-5749-2021		mTBI Diagnostics Workshop	Support for the mTBI Diagnostics Workshop was provided by Col. Dallas Hack, Director of the Combat Casualty Care Directorate, U.S. Army Medical Research and Materiel Command, and by Col. Jamie Grimes, National Director of the Defense and Veterans Brain Injury Center. Marithea Goberville, Ph.D., provided a transcript of the report-out session of the conference.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Holtkamp K, 2008, J NEURAL TRANSM, V115, P937, DOI 10.1007/s00702-008-0041-8; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Mao Q, 1995, Hua Xi Yi Ke Da Xue Xue Bao, V26, P135; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; *MTBI WORK GROUP, 2009, VA DOD CLIN PRACT GU; Mussack T, 2000, ACT NEUR S, V76, P393; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Parsons TD, 2008, STUD HEALTH TECHNOL, V132, P351; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Tanielian T., 2008, INVISIBLE WOUNDS MEN; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x	36	43	45	2	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					517	526		10.1089/neu.2010.1638			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200003	21265587				2022-02-06	
J	Donkin, JJ; Cernak, I; Blumbergs, PC; Vink, R				Donkin, James J.; Cernak, Ibolja; Blumbergs, Peter C.; Vink, Robert			A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered Up to 12 Hours after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neurogenic inflammation; neuropeptides; neurotrauma; neurokinin 1 (NK1) antagonist	AMYLOID PRECURSOR PROTEIN; NEUROGENIC INFLAMMATION; FUNCTIONAL DEFICITS; THERAPEUTIC WINDOW; HEAD-INJURY; RATS; EDEMA; MEMORY; RECEPTOR; MODEL	Previous studies have demonstrated that the compound N-acetyl-L-tryptophan (NAT) reduces brain edema and improves functional outcome following traumatic brain injury (TBI). In this study we examined whether this effect was mediated via the neurokinin-1 receptor, and whether there was an effect on axonal injury. We also explored whether the compound was effective, even when administered at delayed time points. Male Sprague-Dawley rats were subject to acceleration-induced, diffuse TBI and administered NAT, its inactive D-enantiomer, or saline vehicle. In contrast to NAT (2.5 mg/kg), the inactive D-enantiomer was ineffective at improving rotarod motor performance after TBI. NAT also improved cognitive outcome as assessed by the Morris water maze and novel object recognition tests, and reduced axonal injury at 5 and 24 h after TBI as assessed by amyloid precursor protein immunohistochemistry. However, efficacy of the membrane-impermeable NAT was limited to administration within 5 h, whereas administration of a form of NAT, L-732,138 (47 mg/kg), in which a trifluoromethyl benzyl ester group has been added, making it highly lipid soluble and able to cross the intact blood-brain barrier, significantly improved motor outcome, even when administration was delayed by as much as 12 h. We conclude that the neuroprotective effects of NAT are receptor-mediated, and that administration of the membrane-permeable form of the compound can be effective even up to 12 h after TBI.	[Donkin, James J.; Blumbergs, Peter C.; Vink, Robert] Univ Adelaide, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; [Blumbergs, Peter C.; Vink, Robert] Hanson Inst Ctr Neurol Dis, Adelaide, SA, Australia; [Cernak, Ibolja] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA		Vink, R (corresponding author), Univ Adelaide, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X	Neurosurgical Research Foundation (Adelaide); Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This work was supported in part by the Neurosurgical Research Foundation (Adelaide), and by a grant from the Australian National Health and Medical Research Council.	Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Bellgowan PSF, 2009, LEARN MEMORY, V16, P433, DOI 10.1101/lm.1357309; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bracci-Laudiero L, 1999, NEUROSCI LETT, V275, P57, DOI 10.1016/S0304-3940(99)00737-5; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CASCIERI MA, 1994, J BIOL CHEM, V269, P6587; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; HUSTON JP, 1995, BEHAV BRAIN RES, V66, P117, DOI 10.1016/0166-4328(94)00132-Y; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; MACLEOD M, 1994, J MED CHEM, V37, P1269, DOI 10.1021/jm00035a006; Marmarou A, 2003, ACT NEUR S, V86, P7; Mauler F, 2003, CNS DRUG REV, V9, P343; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NEWBOLD P, 1995, BRIT J PHARMACOL, V114, P570, DOI 10.1111/j.1476-5381.1995.tb17177.x; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Schable S, 2010, PEPTIDES, V31, P108, DOI 10.1016/j.peptides.2009.10.009; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	42	43	43	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					217	224		10.1089/neu.2010.1632			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700005	21175297				2022-02-06	
J	Shin, SS; Bray, ER; Zhang, CQ; Dixon, CE				Shin, Samuel S.; Bray, Eric R.; Zhang, Cathy Q.; Dixon, C. Edward			Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats	BRAIN RESEARCH			English	Article						Dopamine; Traumatic; Microdialysis; Tyrosine; Hydroxylase; Phosphorylation	CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; CATECHOLAMINE SYNTHESIS; AMANTADINE; PHOSPHORYLATION; RECOVERY; AMPHETAMINE; MICRODIALYSIS; ACETYLCHOLINE; DYSFUNCTION	There is increasing evidence that traumatic brain injury (TBI) induces hypofunction of the striatal dopaminergic system, the mechanisms of which are unknown. In this study, we analyzed the activity of striatal tyrosine hydroxylase (TH) in rats at 1 day, 1 week, and 4 weeks after TBI using the controlled cortical impact model. There were no changes in the level of TH phosphorylated at serine 40 site (pser40TH) at 1 day or 4 weeks. At 1 week, injured animals showed decreased pser40TH to 73.9 +/- 7.3% (p <= 0.05) of sham injured rats. The in vivo TH activity assay showed no significant difference between injured and sham rats at 1 day. However, there was a decreased activity in injured rats to 62.1 +/- 8.2% (p <= 0.05) and 68.8 +/- 6.2% (p <= 0.05) of sham injured rats at 1 and 4 weeks, respectively. Also, the activity of protein kinase A, which activates TH, decreased at 1 week (injured: 87.8 +/- 2.8%, sham: 100.0 +/- 4.2%, p <= 0.05). To study the release activity of dopamine after injury, potassium (80 mM)-evoked dopamine release was measured by microdialysis in awake, freely moving rats. Dialysates were collected and analyzed by high-performance liquid chromatography. There were no significant differences in dopamine release at 1 day and 4 weeks between sham and injured groups. At 1 week, there was a significant decrease (injured: 0.067 +/- 0.015 mu M, sham: 0.127 +/- 0.027 mu M, p <= 0.05). These results suggest that TBI-induced dopamine neurotransmission deficits are, at least in part, attributable to deficits in TH activity. (C) 2010 Published by Elsevier B.V.	[Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F30NS067731-01, 5R01NS060672-02]; Pittsburgh Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS067731, R01NS060672] Funding Source: NIH RePORTER	We would like to thank Ruth Perez and Teresa Hastings for insightful comments and suggestions. This project is supported by NIH grant 1F30NS067731-01, NIH grant 5R01NS060672-02, and the Copeland Fund of the Pittsburgh Foundation.	Agut J, 2000, ANN NY ACAD SCI, V920, P332; ANDEN NE, 1964, LIFE SCI, V3, P523, DOI 10.1016/0024-3205(64)90161-4; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; BAK IJ, 1972, J NEURAL TRANSM, V33, P45, DOI 10.1007/BF01244727; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barbay S, 2009, NEUROREHABILITATION, V25, P5, DOI 10.3233/NRE-2009-0495; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FAIRBROTHER IS, 1990, J NEUROCHEM, V54, P1844, DOI 10.1111/j.1471-4159.1990.tb04881.x; FEENEY DM, 1981, P W PHARMACOL SOC, V24, P15; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Harada K, 1996, J NEUROCHEM, V67, P629; HOKFELT T, 1977, MED BIOL, V55, P21; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lindgren N, 2000, J NEUROCHEM, V74, P2470, DOI 10.1046/j.1471-4159.2000.0742470.x; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Shui HA, 1998, NEUROSCI LETT, V257, P1, DOI 10.1016/S0304-3940(98)00801-5; Stanford JA, 2000, INT J DEV NEUROSCI, V18, P411, DOI 10.1016/S0736-5748(00)00009-5; Urbanavicius J, 2007, J NEUROCHEM, V102, P723, DOI 10.1111/j.1471-4159.2007.04560.x; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wang L, 2005, J MOL NEUROSCI, V27, P137, DOI 10.1385/JMN:27:1:137; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; WAYMIRE JC, 1988, J BIOL CHEM, V263, P12439; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087	39	43	43	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 19	2011	1369						208	215		10.1016/j.brainres.2010.10.096			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714GE	WOS:000286794700022	21047500	Green Accepted			2022-02-06	
J	Giza, CC; DiFiori, JP				Giza, Christopher C.; DiFiori, John P.			Pathophysiology of Sports-Related Concussion: An Update on Basic Science and Translational Research	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; sports; pathology	TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; COLLEGIATE FOOTBALL PLAYERS; USE-DEPENDENT EXAGGERATION; MILD HEAD-INJURY; TEMPORAL WINDOW; HIGH-SCHOOL; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; CEREBRAL CONCUSSION	Context: Concussions that occur during participation in athletic events affect millions of individuals each year. Although our understanding of the pathophysiology of concussion has grown considerably in recent years, much remains to be elucidated. This article reviews basic science and relevant translational clinical research regarding several aspects of concussion. Evidence Acquisition: A literature search was conducted using PubMed from 1966 to 2010, with an emphasis on work published within the past 10 years. Additional articles were identified from the bibliography of recent reviews. Results: Basic science and clinical data both indicate that there is a period of increased vulnerability to repeated injury following a concussion and that its duration is variable. Growing evidence indicates that postinjury activity is likely to affect recovery from brain injury. Data suggest that long-term sequelae may result from prior concussion-particularly, repeated injuries. The unique aspects of cerebral development may account for differences in the effects of concussion in children and adolescents when compared with adults. Conclusions: The available pathophysiologic data from basic science and clinical studies have increased the evidence base for concussion management strategies-the approaches to which may differ between young athletes and adults.	[Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA USA; [DiFiori, John P.] Univ Calif Los Angeles, Div Sports Med, Los Angeles, CA USA		Giza, CC (corresponding author), UCLA, David Geffen Sch Med, Brain Injury Res Ctr, Room 18-218B Semel Inst,10833 Conte Blvd, Los Angeles, CA 90095 USA.	cgiza@mednet.ucla.edu			National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544, NS057420]; University of California, Los AngelesUniversity of California System; Brain Injury Research Center and Faculty Grants Program; Winokur Family Foundation/Child Neurology Foundation; Thrasher Research Fund	Supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke NS27544 and NS057420; the University of California, Los Angeles, Brain Injury Research Center and Faculty Grants Program; the Winokur Family Foundation/Child Neurology Foundation; and the Thrasher Research Fund.	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hartman RE, 2002, J NEUROSCI, V22, P10083; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hovda D. A, 1996, METABOLIC DYSFUNCTIO, P1459; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly JP, 1997, NEUROLOGY, V48, P581; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pearce JMS, 2008, EUR NEUROL, V59, P332, DOI 10.1159/000121428; Pierce JES, 1996, J NEUROSCI, V16, P1083; Prins M, 2009, J NEUROTRAUM, V26, pA84; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	92	43	43	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2011	3	1					46	51		10.1177/1941738110391732			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19RT	WOS:000214836800007	23015990	Green Published			2022-02-06	
J	Morton, N; Barker, L				Morton, Nicholas; Barker, Lynne			The contribution of injury seventy, executive and implicit functions to awareness of deficits after traumatic brain injury (TBI)	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Tacit; Conscious; Control processes; Impairment; Neuropathology	CLOSED-HEAD-INJURY; IMPAIRED SELF-AWARENESS; COGNITION; INSIGHT; DISEASE; ADULTS; PERFORMANCE; ADJUSTMENT; KNOWLEDGE; LESIONS	Deficits in self-awareness are commonly seen after Traumatic Brain Injury (TBI) and adversely affect rehabilitative efforts, independence and quality of life (Ponsford, 2004) Awareness models predict that executive and implicit functions are important cognitive components of awareness though the putative relationship between implicit and awareness processes has not been subject to empirical investigation (Crosson et al, 1989, Ownsworth, Clare & Morris 2006 Toglia & Kirk, 2000) Severity of injury, also thought to be a crucial determinant of awareness outcome post insult is under-explored in awareness studies (Sherer Boake Levin Silver Ringholz & Walter 1998) The present study measured the contribution of injury seventy, IQ, mood state executive and implicit functions to awareness in head-injured patients assigned to moderate/severe head-injured groups using several awareness executive, and implicit measures Severe injuries resulted in greater impairments across most awareness executive and implicit measures compared with moderate injuries although deficits were still seen in the moderate group Hierarchical regression results showed that severity of injury, IQ, mood state executive and implicit functions made significant unique contributions to selective aspects of awareness Future models of awareness should account for both implicit and executive contributions to awareness and the possibility that both are vulnerable to disruption after neuropathology (JINS 2010 16 1089-1098)	[Morton, Nicholas] Rotherham Doncaster & S Humber Mental Hlth NHS Tr, Tickhill Rd Hosp, Neurorehabil Serv, Doncaster DN4 8QL, S Yorkshire, England; [Barker, Lynne] Sheffield Hallam Univ, Dept Psychol, Sheffield S1 1WB, S Yorkshire, England		Morton, N (corresponding author), Rotherham Doncaster & S Humber Mental Hlth NHS Tr, Tickhill Rd Hosp, Neurorehabil Serv, Doncaster DN4 8QL, S Yorkshire, England.		Morton, NICHOLAS/ABF-3774-2020				ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Andres P, 2002, NEUROPSYCHOLOGIA, V40, P835, DOI 10.1016/S0028-3932(01)00182-8; Banks SJ, 2009, J NEUROPSYCH CLIN N, V21, P299, DOI 10.1176/appi.neuropsych.21.3.299; Barker LA, 2006, NEUROPSYCHOLOGIA, V44, P1413, DOI 10.1016/j.neuropsychologia.2005.12.005; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Beldarrain MG, 2002, EXP BRAIN RES, V142, P529, DOI 10.1007/s00221-001-0935-2; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Delis DC., 2001, DELIS KAPLAN EXECUTI; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037/0022-3514.75.2.318; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hamsher K., 1989, MULTILINGUAL APHASIA; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; HART T, 1999, NEUROPSYCHOL REHABIL, V19, P161; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS RG, 2004, COGNITIVE NEUROPSYCH; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P263; Ponsford J, 2004, COGNITIVE BEHAV REHA; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 2010, ADV STUDY ANOSOGNOSI; *PSYCH CORP, 2001, WECHSL TEST AD READ; REBER AS, 2002, IMPLICIT LEARNING CO; Rich JB, 1996, NEUROPSY NEUROPSY BE, V9, P99; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Seger CA, 1997, CONSCIOUS COGN, V6, P108, DOI 10.1006/ccog.1996.0285; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Wechsler D., 2011, WECHSLER ABBREVIATED; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wong PS, 1997, CONSCIOUS COGN, V6, P519, DOI 10.1006/ccog.1997.0322; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	62	43	44	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2010	16	6					1089	1098		10.1017/S1355617710000925			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	690RL	WOS:000285023200016	20735889	Green Accepted			2022-02-06	
J	Defrin, R; Gruener, H; Schreiber, S; Pick, CG				Defrin, Ruth; Gruener, Hila; Schreiber, Shaul; Pick, Chaim G.			Quantitative somatosensory testing of subjects with chronic post-traumatic headache: Implications on its mechanisms	EUROPEAN JOURNAL OF PAIN			English	Article						Chronic pain; Traumatic head injury; Quantitative somatosensory testing (QST)	TRAUMATIC BRAIN-INJURY; TENSION-TYPE HEADACHE; CHRONIC PAIN; WHIPLASH INJURY; STRESS-DISORDER; MIGRAINE; PTSD; NECK; EXCITOTOXICITY; SENSITIZATION	Background: Chronic headache is one of the most prominent symptoms among subjects with traumatic head injury (THI). Despite the relatively high prevalence of chronic post-traumatic headache (CPTHA) and its enormous effect on the already poor quality of life of subjects with THI, its mechanisms has not been studied in depth. Objective: To conducted quantitative somatosensory testing in THI subjects with and without chronic post-traumatic headache (CPTHA) in order to shed light on the yet, unknown pathophysiology of CPTHA. Methods: THI subjects with and without CPTHA and healthy controls underwent thermal and mechanical threshold measurements in painful and pain-free regions in the head and in their hands (a remote pain-free region) and filled out and the post-traumatic stress disorder (PTSD) inventory. In addition, the THI and CPTHA filled out the Mc'Gill pain questionnaire (MPQ). Results: THI subjects with CPTHA had significantly higher thermal thresholds in both the head and hand indicating central damage to the pain and temperature system and in addition, a significantly lower pressure- pain threshold in the head as well as more severe PTSD symptomatology than the pain-free THI subjects and healthy controls. Conclusions: The sensory profile of subjects with CPTHA suggests that CPTHA may be a form of central pain. The cranial mechanical hyperalgesia may originate from peripheral tissue damage accompanying the THI. Psychological factors may contribute to the development, and maintenance of CPTHA in susceptible individuals. (C) 2010 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.	[Defrin, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Sch Allied Hlth Profess, IL-69978 Tel Aviv, Israel; [Gruener, Hila; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Dept Psychiat, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel		Defrin, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Sch Allied Hlth Profess, IL-69978 Tel Aviv, Israel.	rutidef@post.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; Ashina M, 2000, CEPHALALGIA, V20, P919, DOI 10.1046/j.1468-2982.2000.00150.x; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Barcellos Sue, 1996, P139; Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166; Bendtsen L, 2000, CEPHALALGIA, V20, P486, DOI 10.1046/j.1468-2982.2000.00070.x; BOVIM G, 1992, PAIN, V51, P169, DOI 10.1016/0304-3959(92)90258-D; Bowsher D, 1999, Am J Hosp Palliat Care, V16, P593, DOI 10.1177/104990919901600408; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Buchgreitz L, 2006, PAIN, V123, P19, DOI 10.1016/j.pain.2006.01.040; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; DE TOMMASO M, 2003, PAIN, V104, P111; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; *DSM 4 TR, 1994, DIAGN STAT MAN MENT; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fernandez-De-Las-Penas C, 2007, CEPHALALGIA, V27, P383, DOI 10.1111/j.1468-2982.2007.01295.x; Finnerup NB, 2003, BRAIN, V126, P57, DOI 10.1093/brain/awg007; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; GOBEL H, 1992, CEPHALALGIA, V12, P142, DOI 10.1046/j.1468-2982.1992.1203142.x; Hansson P, 2004, EUR J NEUROL, V11, P22, DOI 10.1111/j.1471-0552.2004.00793.x; Hao JX, 1998, EXP BRAIN RES, V118, P259, DOI 10.1007/s002210050280; Jensen R, 1999, CEPHALALGIA, V19, P602, DOI 10.1046/j.1468-2982.1999.019006602.x; JENSEN R, 1993, PAIN, V52, P193, DOI 10.1016/0304-3959(93)90131-8; Johansen MK, 1999, PAIN, V83, P229, DOI 10.1016/S0304-3959(99)00106-2; Kasch H, 2001, CEPHALALGIA, V21, P189, DOI 10.1046/j.1468-2982.2001.00179.x; Keidel M, 2001, PAIN, V92, P319, DOI 10.1016/S0304-3959(01)00272-X; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; McMahon S B, 1993, Curr Opin Neurobiol, V3, P602, DOI 10.1016/0959-4388(93)90062-4; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Merskey H, 1994, CLASSIFICATION CHRON; NICOLODI M, 1994, HEADACHE, V34, P12, DOI 10.1111/j.1526-4610.1994.hed3401012.x; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PACKARD RC, 1993, HEADACHE, V33, P133, DOI 10.1111/j.1526-4610.1993.hed3303133.x; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Packard Russell C, 2002, Curr Pain Headache Rep, V6, P301, DOI 10.1007/s11916-002-0051-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Radanov BP, 2001, EUR SPINE J, V10, P403, DOI 10.1007/s005860000227; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Sandrini G, 2002, NEUROSCI LETT, V317, P135, DOI 10.1016/S0304-3940(01)02447-8; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Sheftell FD, 2007, NEUROL SCI, V28, pS203, DOI 10.1007/s10072-007-0777-1; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Solomon S, 2005, HEADACHE, V45, P53, DOI 10.1111/j.1526-4610.2005.05011.x; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; VOGELBAUM MA, 1998, CLIN NEUROL, V3, P1; WALKER R, 2004, 200401 CDAR KENT DEP; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Weissman-Fogel I, 2003, PAIN, V104, P693, DOI 10.1016/S0304-3959(03)00159-3; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; [No title captured]	70	43	43	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain	OCT	2010	14	9					924	931		10.1016/j.ejpain.2010.03.004			8	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	651ZH	WOS:000281967400006	20363652				2022-02-06	
J	Rich, NJ; VanLandingham, JW; Figueiroa, S; Seth, R; Corniola, RS; Levenson, CW				Rich, Nicholas J.; VanLandingham, Jacob W.; Figueiroa, Silvia; Seth, Rohit; Corniola, Rikki S.; Levenson, Cathy W.			Chronic Caloric Restriction Reduces Tissue Damage and Improves Spatial Memory in a Rat Model of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						TBI; morris water maze; p53; BDNF	DIETARY RESTRICTION; FOOD RESTRICTION; NEUROTROPHIC FACTOR; BEHAVIORAL DEFICITS; ALZHEIMERS-DISEASE; MOUSE MODEL; BDNF LEVELS; EXPRESSION; EXERCISE; ISCHEMIA	Although it has been known for some time that chronic caloric or dietary restriction reduces the risk of neurodegenerative disorders and injury following ischemia, the possible role of chronic restriction in improving outcomes after traumatic brain injury (TBI) has not been previously studied. Therefore, 2-month-old male Sprague-Dawley rats were divided into two dietary groups, an ad libitum fed group (AL) and a caloricrestriction group (CR) that was provided with 70% of the food intake of AL rats (n = 10/group). After 4 months, a weight-drop device (300 g) was used to produce a 2-mm bilateral medial frontal cortex contusion following craniotomy. Additional animals in each dietary group (n = 10) were used as sham-operated controls. The CR diet resulted in body weights that were reduced by 30% compared with AL controls. Not only did CR decrease the size of the cortical lesion after injury, there were marked improvements in spatial memory as measured by Morris water maze that included an increase in the number of animals successfully finding the platform as well as significantly reduced time to finding the hidden platform. Western analysis, used to examine the expression of proteins that play a role in neuronal survival, revealed significant increases in brain-derived neurotrophic factor (BDNF) in the cortical region around the site of injury and in the hippocampus in CR rats after injury. These findings suggest that molecular mechanisms involved in cell survival may play a role in reducing tissue damage and improving cognition after TBI and that these mechanisms can be regulated by dietary interventions. (C) 2010 Wiley-Liss, Inc.	[Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Tallahassee, FL 32306 USA; Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA		Levenson, CW (corresponding author), Florida State Univ, Coll Med, Program Neurosci, 1115 W Call St, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu		Levenson, Cathy W/0000-0003-4463-3136	Florida State University Council for Research and Creativity	Contract grant sponsor: Florida State University Council for Research and Creativity, Multidisciplinary Grants Program.	Andrade JP, 2006, NEUROSCI LETT, V399, P135, DOI 10.1016/j.neulet.2006.01.043; Araya AV, 2008, ENDOCRINE, V33, P300, DOI 10.1007/s12020-008-9090-x; Bellush LL, 1996, PHYSIOL BEHAV, V60, P541, DOI 10.1016/S0031-9384(96)80029-1; Burgener SC, 2008, J NUTR HEALTH AGING, V12, P18, DOI 10.1007/BF02982159; Chase HW, 2008, NEUROPSYCHOLOGIA, V46, P2650, DOI 10.1016/j.neuropsychologia.2008.04.021; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Guimaraes LR, 2008, PROG NEURO-PSYCHOPH, V32, P1595, DOI 10.1016/j.pnpbp.2008.06.004; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hansalik M, 2006, EXP GERONTOL, V41, P169, DOI 10.1016/j.exger.2005.11.002; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jacobs WB, 2006, J NEUROCHEM, V97, P1571, DOI 10.1111/j.1471-4159.2006.03980.x; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lefevre M, 2009, ATHEROSCLEROSIS, V203, P206, DOI 10.1016/j.atherosclerosis.2008.05.036; Madeddu F, 2004, NEUROREPORT, V15, P2045, DOI 10.1097/00001756-200409150-00010; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; Overton JM, 1997, J NUTR, V127, P655, DOI 10.1093/jn/127.4.655; Pasinetti Giulio Maria, 2007, V35, P159; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2	35	43	45	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2010	88	13					2933	2939		10.1002/jnr.22443			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	642OK	WOS:000281225100016	20544832				2022-02-06	
J	Zhang, YL; Xiong, Y; Mahmood, A; Meng, YL; Liu, ZW; Qu, CS; Chopp, M				Zhang, Yanlu; Xiong, Ye; Mahmood, Asim; Meng, Yuling; Liu, Zhongwu; Qu, Changsheng; Chopp, Michael			Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment	BRAIN RESEARCH			English	Article						Axonal plasticity; Erythropoietin; Functional recovery; Rat; Traumatic brain injury	MARROW STROMAL CELL; ENHANCES NEUROGENESIS; STROKE; MODEL; NEUROPROTECTION; TRANSPLANTATION; REGENERATION; PLASTICITY; SYSTEM; VOLUME	Erythropoietin (EPO) promotes functional recovery after traumatic brain injury (TBI). This study was designed to investigate whether EPO treatment promotes contralateral corticospinal tract (CST) plasticity in the spinal cord in rats after TBI. Biotinylated dextran amine (BDA) was injected into the right sensorimotor cortex to anterogradely label the CST. TBI was induced by controlled cortical impact over the left parietal cortex immediately after BDA injections. EPO (5000 U/kg) or saline was administered intraperitoneally at Days 1, 2, and 3 post-injury. Neurological function was assessed using a modified neurological severity score (mNSS) and footfault tests. Animals were sacrificed 35 days after injury and brain sections stained for histological analysis. Compared to the saline treatment, 1:PO treatment significantly improved sensorimotor functional outcome (lower mNSS and reduced footfaults) from Days 7 to 35 post-injury. TBI alone significantly stimulated contralateral CST axon sprouting toward the denervated gray matter of the cervical and lumbar spinal cord; however, EPO treatment further significantly increased the axon sprouting in TBI rats although EPO treatment did not significantly affect axon sprouting in sham animals. The contralesional CST sprouting was highly and positively correlated with sensorimotor recovery after TBI. These data demonstrate that CST fibers originating from the contralesional intact cerebral hemisphere are capable of sprouting into the denervated spinal cord after TB! and EPO treatment, which may at least partially contribute to functional recovery. (C) 2010 Elsevier B.V. All rights reserved.	[Zhang, Yanlu; Xiong, Ye; Mahmood, Asim; Meng, Yuling; Qu, Changsheng] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Liu, Zhongwu; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA		Xiong, Y (corresponding author), Henry Ford Hosp, Dept Neurosurg, E&R Bldg,Room 3096,2799 W Grand Blvd, Detroit, MI 48202 USA.	nsxye@neuro.hfh.edu	Zhang, Yanlu/H-1275-2011	Xiong, Ye/0000-0001-9770-6031	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS 62002, PO1 NS42345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS062002] Funding Source: NIH RePORTER	This work was supported by NIH grants RO1 NS 62002 (YX) and PO1 NS42345 (MA and MC). Special thanks to Ms. Susan MacPhee-Gray for editorial assistance.	Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chen Q, 2005, J NEUROSCI, V25, P281, DOI 10.1523/JNEUROSCI.3692-04.2005; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Daniels CML, 2009, NEUROSCI LETT, V450, P191, DOI 10.1016/j.neulet.2008.11.017; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Ramic M, 2006, BRAIN RES, V1111, P176, DOI 10.1016/j.brainres.2006.06.063; Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; STANFIELD BB, 1992, PROG NEUROBIOL, V38, P169, DOI 10.1016/0301-0082(92)90039-H; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yin ZS, 2010, AM J NEURORADIOL, V31, P509, DOI 10.3174/ajnr.A1820; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	44	43	45	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 24	2010	1353						249	257		10.1016/j.brainres.2010.07.046			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	657NN	WOS:000282419500026	20654589	Green Accepted			2022-02-06	
J	Brazinova, A; Mauritz, W; Leitgeb, J; Wilbacher, I; Majdan, M; Janciak, I; Rusnak, M				Brazinova, Alexandra; Mauritz, Walter; Leitgeb, Johannes; Wilbacher, Ingrid; Majdan, Marek; Janciak, Ivan; Rusnak, Martin			Outcomes of Patients with Severe Traumatic Brain Injury Who Have Glasgow Coma Scale Scores of 3 or 4 and Are Over 65 Years Old	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Coma Scale; Glasgow Outcome Scale; old age; traumatic brain injury	SEVERE HEAD-INJURY; PROSPECTIVE MULTICENTER; DATA-BANK; MANAGEMENT; IMPACT; EPIDEMIOLOGY; MORTALITY; DESIGN; GENDER; TRIAL	The goal of this study was to investigate the outcomes of patients with traumatic brain injury (TBI) who had Glasgow Coma Scale (GCS) scores of 3 or 4, and were aged 66 years or older. Between January 2001 and December 2005, 13 European centers enrolled patients with severe brain trauma. Data sets of all patients who had a GCS score of 3 or 4 and were 66 years of age or older were analyzed. Outcomes were classified according to the Glasgow Outcome Scale (GOS) 12 months post-trauma as "favorable" (GOS score of 4 or 5), or "unfavorable" (GOS score of 1-3); relevant data for patients of the two groups were compared. Variables were analyzed by univariate analyses (chi-square, Wilcoxon-Mann-Whitney, and Fisher's exact tests), and a p value of <0.05 was considered significant. We analyzed 100 patients identified from the database as having GCS scores of 3 or 4 and age over 65 years. Factors having significant effects on outcomes were worse results of the Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), and Abbreviated Injury Scale (AIS) for the head. Closed or partially closed basal cisterns and/or midline shift >15mm were also associated with unfavorable outcomes, as was subarachnoid hemorrhage (SAH). Patients with GCS scores of 3 or 4 who are older than 65 years have a poor, but not hopeless, prognosis. Confirmed factors predicting poor prognosis for this group of patients were closed basal cisterns and midline shift >15mm on the first CT scan. Factors possibly related to favorable outcomes were female gender, lower trauma severity, open or partially open basal cisterns, and no midline shift on the first CT scan.	[Brazinova, Alexandra; Janciak, Ivan] Int Neurotrauma Res Org, Data & IT, A-1080 Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Dept Publ Hlth, Fac Hlth & Social Serv, Trnava, Slovakia; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Wilbacher, Ingrid] Social Insurance Co, Vienna, Austria		Brazinova, A (corresponding author), Int Neurotrauma Res Org, Data & IT, Molkergasse 4-3, A-1080 Vienna, Austria.	abrazinova@igeh.org	Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Mauritz, Walter/0000-0001-9043-3712	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; "Jubilaumsfonds" of the Austrian National Bank [8987]; INRO	The data used for this study were collected for a project funded by a European Union grant (Project "Research-Treat-TBI"; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number : ICA2-CT-2002-100), and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/2003), and by the "Jubilaumsfonds" of the Austrian National Bank (project number 8987). INRO was supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various other sources.	Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; DE LA PLATA CAM, 2008, ARCH PHYS MED REHAB, V89, P896; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pascrell B Jr, 2001, N J Med, V98, P47; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; STEIN SC, 2009, J NEUROSURG     0911; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	34	43	44	0	15	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1549	1555		10.1089/neu.2010.1315			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500001	20597653				2022-02-06	
J	Fedor, M; Berman, RF; Muizelaar, JP; Lyeth, BG				Fedor, Mark; Berman, Robert F.; Muizelaar, J. Paul; Lyeth, Bruce G.			Hippocampal Theta Dysfunction after Lateral Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						electroencephalogram; fluid percussion injury; memory; rat; theta rhythm; traumatic brain injury	LONG-TERM POTENTIATION; TRAUMATIC BRAIN-INJURY; OSCILLATIONS; MEMORY; RHYTHM; STIMULATION; WORKING; RATS; FREQUENCY; DEFICITS	Chronic memory deficits are a major cause of morbidity following traumatic brain injury (TBI). In the rat, the hippocampal theta rhythm is a well-studied correlate of memory function. This study sought to investigate disturbances in hippocampal theta rhythm following lateral fluid percussion injury in the rat. A total of 13 control rats and 12 TBI rats were used. Electrodes were implanted in bilateral hippocampi and an electroencephalogram (EEG) was recorded while the rats explored a new environment, and also while navigating a modified version of the Barnes maze. Theta power and peak theta frequency were significantly attenuated in the injured animals. Further, injured rats were less likely to develop a spatial strategy for Barnes maze navigation compared to control rats. In conclusion, rats sustaining lateral fluid percussion injury demonstrated deficits in hippocampal theta activity. These deficits may contribute to the underlying memory problems seen in chronic TBI.	[Fedor, Mark; Berman, Robert F.; Muizelaar, J. Paul; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95618 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95618 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER	Expert technical assistance was provided by Christina Kopriva, Maria Dynin, Damoon Rejaei, and Ken Van. This research was supported in part by National Institutes of Health grant NS29995.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Basar-Eroglu C, 2001, INT J PSYCHOPHYSIOL, V39, P167, DOI 10.1016/S0167-8760(00)00140-9; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Brazhnik ES, 1999, EXP BRAIN RES, V127, P244, DOI 10.1007/s002210050794; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DIAMOND DM, 1988, J NEUROSCI, V8, P4079; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GIVENS B, 1994, J NEUROSCI, V14, P3578; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GREEN KF, 1979, ELECTROEN CLIN NEURO, V47, P420, DOI 10.1016/0013-4694(79)90158-5; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hyman JM, 2003, J NEUROSCI, V23, P11725; Jiang F, 1997, PHYSIOL BEHAV, V62, P1279, DOI 10.1016/S0031-9384(97)00306-5; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KRAUS JF, 2005, NEUROPSYCHIATRY TRAU, P3; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li CY, 2005, J NEUROPHYSIOL, V93, P3001, DOI 10.1152/jn.00546.2004; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Lyeth BG, 2001, HEAD TRAUMA, P115; Manns JR, 2007, NEUROBIOL LEARN MEM, V87, P9, DOI 10.1016/j.nlm.2006.05.007; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; OLTON DS, 1994, NEUROTOXICOLOGY, V15, P439; Olvera-Cortes E, 2004, BRAIN RES BULL, V62, P379, DOI 10.1016/j.brainresbull.2003.10.003; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Pan WX, 1997, BRAIN RES, V764, P101, DOI 10.1016/S0006-8993(97)00431-9; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; VERTES RP, 1982, PROG NEUROBIOL, V19, P159, DOI 10.1016/0301-0082(82)90005-3; Villarreal DM, 2007, J NEUROSCI, V27, P13457, DOI 10.1523/JNEUROSCI.3702-07.2007; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073.abs; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WIENER SI, 1989, J NEUROSCI, V9, P2737; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0; Woldeit ML, 2010, NEUROSCIENCE, V165, P642, DOI 10.1016/j.neuroscience.2009.11.002; Wu M, 2000, J NEUROSCI, V20, P3900, DOI 10.1523/JNEUROSCI.20-10-03900.2000	57	43	43	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1605	1615		10.1089/neu.2010.1370			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500007	20597686	Green Published			2022-02-06	
J	Matousek, SB; Hein, AM; Shaftel, SS; Olschowka, JA; Kyrkanides, S; O'Banion, MK				Matousek, Sarah B.; Hein, Amy M.; Shaftel, Solomon S.; Olschowka, John A.; Kyrkanides, Stephanos; O'Banion, M. Kerry			Cyclooxygenase-1 mediates prostaglandin E-2 elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1 beta expression	JOURNAL OF NEUROCHEMISTRY			English	Article						cyclooxygenase-1; hippocampus; interleukin-1; neuroinflammation; prostaglandin E-2	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMER-DISEASE; MOUSE-BRAIN; CEREBRAL-ISCHEMIA; COX-2; NEUROINFLAMMATION; INHIBITION; ACCUMULATION	P>Interleukin (IL)-1 beta is a proinflammatory cytokine implicated in several neurodegenerative disorders. Downstream actions of IL-1 beta include production of prostaglandin (PG) E-2 by increasing expression of cyclooxygenase (COX) enzymes and prostaglandin E synthase (PGES) isoforms. We recently developed a transgenic mouse carrying a dormant human IL-1 beta eXcisional Activation Transgene (XAT) for conditional and chronic up-regulation of IL-1 beta in selected brain regions. This model is characterized by regionally specific glial activation, immune cell recruitment, and induction of cytokines and chemokines. Here, we aimed to elucidate the effects of long-term IL-1 beta expression on the PGE(2) synthetic pathway and to determine the effects of PGs on inflammation and memory in our model. As expected, PGE(2) levels were significantly elevated after IL-1 beta up-regulation. Quantitative real-time PCR analysis indicated significant induction of mRNAs for COX-1 and membranous PGES-1, but not COX-2 or other PGES isoforms. Immunohistochemistry revealed elevation of COX-1 but no change in COX-2 following sustained IL-1 beta production. Furthermore, pharmacological inhibition of COX-1 and use of COX-1 knockout mice abrogated IL-1 beta-mediated PGE(2) increases. Although COX-1 deficient mice did not present a dramatically altered neuroinflammatory phenotype, they did exhibit improved contextual fear memory. This data suggests a unique role for COX-1 in mediating chronic neuroinflammatory effects through PGE(2) production.	[O'Banion, M. Kerry] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Sch Med & Dent, Rochester, NY 14642 USA; [Kyrkanides, Stephanos] SUNY Stony Brook, Med Ctr, Dept Orthodont & Pediat Dent, Stony Brook, NY 11794 USA		O'Banion, MK (corresponding author), Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Sch Med & Dent, 601 Elmwood Ave,Box 603, Rochester, NY 14642 USA.	kerry_obanion@urmc.rochester.edu		O'Banion, M. Kerry/0000-0003-1246-3363	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS33553, R21 NS048522, RO1 AG030149, F31 AG031667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033553, R21NS048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG030149, F31AG031667] Funding Source: NIH RePORTER	This work was supported by NIH RO1 NS33553, R21 NS048522 and RO1 AG030149 to MKO, and F31 AG031667 to SBM. The authors would like to thank Jen-nie Miller for FIV packaging, Jack Walter and Mallory Olschowka for animal colony maintenance and aid with experiments, Renee Johnson for ELISA expertise, and Linda Callahan for assistance with confocal microscopy.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Cakala M, 2007, PHARMACOL REP, V59, P164; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Candelario-Jalil E, 2006, J NEUROIMMUNOL, V174, P39, DOI 10.1016/j.jneuroim.2006.01.003; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2006, J NEUROCHEM, V98, P801, DOI 10.1111/j.1471-4159.2006.03926.x; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Deininger MH, 2000, J NEUROIMMUNOL, V106, P198, DOI 10.1016/S0165-5728(00)00187-9; Dore S, 2003, ANN NEUROL, V54, P155, DOI 10.1002/ana.10612; Hauss-Wegrzyniak B, 1999, NEUROBIOL AGING, V20, P305, DOI 10.1016/S0197-4580(99)00028-7; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hoozemans JJM, 2005, CNS NEUROL DISORD-DR, V4, P307, DOI 10.2174/1568007054038201; Jin DQ, 2008, PHARMACOL BIOCHEM BE, V89, P404, DOI 10.1016/j.pbb.2008.01.016; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Lai YC, 2006, ARTHRITIS RHEUM-US, V54, P1184, DOI 10.1002/art.21771; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Matsumoto Y, 2004, NEUROPHARMACOLOGY, V46, P1195, DOI 10.1016/j.neuropharm.2004.02.012; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Moore AH, 2004, RADIAT RES, V161, P153, DOI 10.1667/RR3116; Moore AH, 2005, INT J RADIAT ONCOL, V62, P267, DOI 10.1016/j.ijrobp.2005.01.035; Moore AH, 2004, J NEUROIMMUNOL, V148, P32, DOI 10.1016/j.jneuroim.2003.11.001; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; O'Banion MK, 2010, PROSTAG OTH LIPID M, V91, P113, DOI 10.1016/j.prostaglandins.2009.04.008; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; OBanion MK, 1996, J NEUROCHEM, V66, P2532; OITZL MS, 1993, BRAIN RES, V613, P160, DOI 10.1016/0006-8993(93)90468-3; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Schwab JM, 2000, ACTA NEUROPATHOL, V99, P609, DOI 10.1007/s004010051170; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shaw KN, 2005, BRAIN RES, V1038, P231, DOI 10.1016/j.brainres.2005.01.035; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Takemiya T, 2007, NEUROCHEM INT, V51, P112, DOI 10.1016/j.neuint.2007.05.009; Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Yermakova AV, 2001, NEUROBIOL AGING, V22, P823, DOI 10.1016/S0197-4580(01)00303-7; Zhang D, 2009, TOXICOL APPL PHARM, V238, P64, DOI 10.1016/j.taap.2009.04.015	54	43	44	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUL	2010	114	1					247	258		10.1111/j.1471-4159.2010.06759.x			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	608FA	WOS:000278567100023	20412387	Green Accepted, Bronze			2022-02-06	
J	Dahlin, AP; Wetterhall, M; Caldwell, KD; Larsson, A; Bergquist, J; Hillered, L; Hjort, K				Dahlin, Andreas P.; Wetterhall, Magnus; Caldwell, Karin D.; Larsson, Anders; Bergquist, Jonas; Hillered, Lars; Hjort, Klas			Methodological Aspects on Microdialysis Protein Sampling and Quantification in Biological Fluids: An In Vitro Study on Human Ventricular CSF	ANALYTICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; HUMAN SKELETAL-MUSCLE; SURFACE INTERACTIONS; CEREBRAL MICRODIALYSIS; CEREBROSPINAL-FLUID; POLYETHYLENE OXIDE; RELATIVE RECOVERY; HUMAN SKIN; MEMBRANE; MACROMOLECULES	There is growing interest in sampling of protein biomarkers from the interstitial compartment of the brain and other organs using high molecular cutoff membrane microdialysis (MD) catheters. However, recent data suggest that protein sampling across such MD membranes is a highly complex process that needs to be further studied. Here, we report three major improvements for microdialysis sampling of proteins in complex biological matrixes. The improvements in this in vitro study using human ventricular cerebrospinal fluid as the sample matrix include increased fluid recovery control, decreased protein adsorption on the microdialysis membrane and materials, and novel quantitative mass spectrometry analysis. Dextrans in different concentrations and sizes were added to the perfusion fluid. It was found that dextrans with molecular mass 250 and 500 kDa provided a fluid recovery close to 100%. An improved fluid recovery precision could be obtained by self-assembly triblock polymer surface modification of the MD catheters. The modified catheters also delivered a significantly increased extraction efficiency for some of the investigated proteins. The final improvement was to analyze the dialysates with isobaric tagged (iTRAQ) proteomics, followed by tandem mass spectrometric analysis. By using this technique, 48 proteins could be quantified and analyzed with respect to their extraction efficiencies. The novel aspects of microdialysis protein sampling, detection, and quantification in biological fluids presented in this study should be considered as a first step toward better understanding and handling of the challenges associated with microdialysis sampling of proteins. The next step is to optimize the developed methodology in vivo.	[Dahlin, Andreas P.; Hjort, Klas] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden; [Wetterhall, Magnus; Caldwell, Karin D.; Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, SE-75124 Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Hillered, Lars] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden		Dahlin, AP (corresponding author), Uppsala Univ, Dept Engn Sci, Box 534, SE-75121 Uppsala, Sweden.	andreas.dahlin@angstrom.uu.se	Bergquist, Jonas/C-5894-2015; Dahlin, Andreas P/F-7210-2010	Hillered, Lars/0000-0002-2808-9292; Bergquist, Jonas/0000-0002-4597-041X; Dahlin, Andreas/0000-0002-0041-0902	Uppsala Berzelii Technology Centre for Neurodiagnostics [P29797-1]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Uppsala University Hospital; Selander Foundation; Ahlen Foundation	We acknowledge Inger Stahl Myllyaho for collecting vCSF sample material and Uppsala Berzelii Technology Centre for Neurodiagnostics P29797-1 for financial and expertise support. We also acknowledge CMA Microdialysis and Pharmacosmos AC for sharing their knowledge and for material support. Additional sources of financial support were the Swedish Research Council, Uppsala University Hospital, the Selander Foundation, and the Ahlen Foundation.	ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bungay PM, 2010, J MEMBRANE SCI, V348, P131, DOI 10.1016/j.memsci.2009.10.050; Buttler T, 1996, J CHROMATOGR A, V725, P41, DOI 10.1016/0021-9673(95)01120-X; Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Clough GF, 2007, J INVEST DERMATOL, V127, P2799, DOI 10.1038/sj.jid.5700930; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Helmy A, 2007, CURR MED CHEM, V14, P1525, DOI 10.2174/092986707780831113; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9; JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8; KAZUHIKO I, 2002, BIOMEDICAL DIAGNOSTI, P367; Kjellstrom S, 1999, CHROMATOGRAPHIA, V50, P539, DOI 10.1007/BF02493658; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Li JT, 1996, ADV CHEM SER, V248, P61; Li ZH, 2008, J MEMBRANE SCI, V310, P237, DOI 10.1016/j.memsci.2007.10.051; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Maurer Martin H, 2003, Proteome Sci, V1, P7, DOI 10.1186/1477-5956-1-7; McAdoo DJ, 2008, PHARMACOL BIOCHEM BE, V90, P282, DOI 10.1016/j.pbb.2008.03.001; Nejadnik MR, 2009, LANGMUIR, V25, P6245, DOI 10.1021/la9001169; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Roche S, 2008, PROTEOM CLIN APPL, V2, P428, DOI 10.1002/prca.200780040; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Rosdahl H, 2000, INT J BIOL MACROMOL, V28, P69, DOI 10.1016/S0141-8130(00)00148-3; Rosenbloom AJ, 2006, J IMMUNOL METHODS, V309, P55, DOI 10.1016/j.jim.2005.11.013; Rosenbloom AJ, 2005, J NEUROSCI METH, V148, P147, DOI 10.1016/j.jneumeth.2005.04.018; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; Stenken JA, 2010, AAPS J, V12, P73, DOI 10.1208/s12248-009-9163-7; Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2; Torto N, 1998, J CHROMATOGR A, V806, P265, DOI 10.1016/S0021-9673(98)00063-6; Torto N, 2004, PURE APPL CHEM, V76, P879, DOI 10.1351/pac200476040879; Torto N, 1997, J MEMBRANE SCI, V130, P239, DOI 10.1016/S0376-7388(97)00030-6; Trickler W, 2003, J PHARM SCI-US, V92, P1419, DOI 10.1002/jps.10410; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Wang XD, 2007, ANAL CHEM, V79, P1816, DOI 10.1021/ac061503b; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E	48	43	43	1	34	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	JUN 1	2010	82	11					4376	4385		10.1021/ac1007706			10	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	601MD	WOS:000278062800014	20465223				2022-02-06	
J	Hillary, FG; Genova, HM; Medaglia, JD; Fitzpatrick, NM; Chiou, KS; Wardecker, BM; Franklin, RG; Wang, JL; DeLuca, J				Hillary, Frank G.; Genova, Helen M.; Medaglia, John D.; Fitzpatrick, Neal M.; Chiou, Kathy S.; Wardecker, Britney M.; Franklin, Robert G., Jr.; Wang, Jianli; DeLuca, John			The Nature of Processing Speed Deficits in Traumatic Brain Injury: is Less Brain More?	BRAIN IMAGING AND BEHAVIOR			English	Article						TBI; fMRI; Reorganization; Working memory; Processing speed	DIFFUSE AXONAL INJURY; PREFRONTAL CORTICAL ACTIVITY; ADULT AGE-DIFFERENCES; WORKING-MEMORY LOAD; MULTIPLE-SCLEROSIS; FUNCTIONAL MRI; NEUROPSYCHOLOGICAL DEFICITS; COGNITIVE-CONTROL; QUANTIFIED MRI; MS PATIENTS	The cognitive constructs working memory (WM) and processing speed are fundamental components to general intellectual functioning in humans and highly susceptible to disruption following neurological insult. Much of the work to date examining speeded working memory deficits in clinical samples using functional imaging has demonstrated recruitment of network areas including prefrontal cortex (PFC) and anterior cingulate cortex (ACC). What remains unclear is the nature of this neural recruitment. The goal of this study was to isolate the neural networks distinct from those evident in healthy adults and to determine if reaction time (RT) reliably predicts observable between-group differences. The current data indicate that much of the neural recruitment in TBI during a speeded visual scanning task is positively correlated with RT. These data indicate that recruitment in PFC during tasks of rapid information processing are at least partially attributable to normal recruitment of PFC support resources during slowed task processing.	[Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Fitzpatrick, Neal M.; Wang, Jianli] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Genova, Helen M.; DeLuca, John] Kessler Fdn Res Ctr, W Orange, NJ USA; [Hillary, Frank G.] Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Hillary, Frank G.; Medaglia, John D.; Chiou, Kathy S.; Wardecker, Britney M.; Franklin, Robert G., Jr.] Penn State Univ, Dept Psychol, State Coll, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Wardecker, Britney/0000-0003-2168-538X			Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BRADLEY VA, 1989, J NEUROL NEUROSUR PS, V52, P1228, DOI 10.1136/jnnp.52.11.1228; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Ernst T, 2003, NEUROIMAGE, V19, P1686, DOI 10.1016/S1053-8119(03)00232-5; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Forn C, 2006, NEUROIMAGE, V31, P686, DOI 10.1016/j.neuroimage.2005.12.030; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; GENOVA HM, 2009, J INT NEUROPSYCHOLOG; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P965, DOI 10.1076/jcen.25.7.965.16490; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; [刘建兴 Liu Jianxing], 2005, [资源科学, Resources Science], V27, P33; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P699, DOI 10.1080/01688638908400926; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2001, PSYCHOL AGING, V16, P371, DOI 10.1037//0882-7974.16.3.371; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; SALTHOUSE TA, 1992, MEM COGNITION, V20, P413, DOI 10.3758/BF03210925; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1993, J GERONTOL, V48, pP245, DOI 10.1093/geronj/48.5.P245; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Smith, 1973, SYMBOL DIGIT MODALIT; SMITH A, 1997, SYMBOL DIGIT MODALIT; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; TEASDALE G, 1974, LANCET, V2, P81; Trenerry MR, 1990, VISUAL SEARCH ATTENT; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42	71	43	43	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2010	4	2					141	154		10.1007/s11682-010-9094-z			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606HJ	WOS:000278413200003	20502993				2022-02-06	
J	Stephens, R; Rutherford, A; Potter, D; Fernie, G				Stephens, Richard; Rutherford, Andrew; Potter, Douglas; Fernie, Gordon			Neuropsychological Consequence of Soccer Play in Adolescent UK School Team Soccer Players	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							HEAD-INJURY; FOOTBALL SOCCER	To assess mild head injury effects in adolescent soccer players, neuropsychological performance across school team soccer players, rugby players and noncontact sport players was assessed in a quasi-experimental cross-sectional design. One hundred eighty-five males were tested (ages 13-16; response rate 55%) and 86 contributed data to the analyses after exclusion for recent concussion and overlapping sports participation. Soccer players showed lower premorbid intellectual functioning, but neither soccer players nor rugby players showed neuropsychological decrement compared with noncontact sport players. Cumulative heading did not predict neuropsychological performance. While no specific attribute of soccer was linked with neuropsychological impairment, head injury predicted reduced attention for all participants. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22:295-303)	[Stephens, Richard; Rutherford, Andrew] Univ Keele, Sch Psychol, Keele ST5 5BG, Staffs, England; [Potter, Douglas] Univ Dundee, Sch Psychol, Dundee, Scotland; [Fernie, Gordon] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England		Stephens, R (corresponding author), Univ Keele, Sch Psychol, Keele ST5 5BG, Staffs, England.	r.stephens@psy.keele.ac.uk	Stephens, Richard/C-4062-2009	Stephens, Richard/0000-0002-5851-8975	Wellcome TrustWellcome TrustEuropean Commission [054248]	Funded by the Wellcome Trust, grant reference 054248. This research was approved by the Keele University Department of Psychology Research Ethics Committee.	Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Barth J T, 2000, Dent Clin North Am, V44, P67; Barth JT, 1989, MILD HEAD INJURY, P257; BODEN B, 1988, AM J SPORTS MED, V26, P238; CHRISTENSEN PR, 1960, ALTERNATE USES FORM; Cohen J., 1988, STAT POWER BEHAV SCI; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fox K, 2004, SPORT LEISURE RESULT; Golden CJ, 1978, STROOP COLOR WORD TE; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HOCHBERG Y, 1995, J STAT PLAN INFER, V48, P141, DOI 10.1016/0378-3758(95)00005-T; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Iverson G L, 2000, Appl Neuropsychol, V7, P247, DOI 10.1207/S15324826AN0704_7; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; KOVACS M, 1982, CHILDHOOD DEPRESSION; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; RUTHERFORD A, 1992, BRIT J MATH STAT PSY, V45, P197, DOI 10.1111/j.2044-8317.1992.tb00988.x; Rutherford A, 2001, INTRO ANOVA ANCOVA G; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; *SOCC ASS FED INT, 2007, FIFA BIG COUNT 2006; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tysvaer A, 1981, Br J Sports Med, V15, P163; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1974, WECHSLER INTELLIGENC; West S. G., 1991, MULTIPLE REGRESSION; Westfall P.H., 1993, RESAMPLING BASED MUL; WITHERS R T, 1982, Journal of Human Movement Studies, V8, P159; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; ZIMMERMAN P, 1995, ATTENTIONAL PERFORMA	45	43	43	1	15	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2010	22	3					295	303		10.1176/appi.neuropsych.22.3.295			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	635IM	WOS:000280648800006	20686136				2022-02-06	
J	O'Donnell, ML; Creamer, M; McFarlane, AC; Silove, D; Bryant, RA				O'Donnell, Meaghan L.; Creamer, Mark; McFarlane, Alexander C.; Silove, Derrick; Bryant, Richard A.			Should A2 be a diagnostic requirement for posttraumatic stress disorder in DSM-V?	PSYCHIATRY RESEARCH			English	Article						Traumatic injury; Criterion A	BRAIN INJURY; CRITERION; PTSD; IV; CONTROVERSIES	The requirement that trauma survivors experience fear, helplessness or horror (Criterion A2) as a part of their posttraumatic stress disorder (PTSD) diagnosis was introduced into DSM-IV. The imminent re-definition of PTSD in DSM-V highlights the need for empirical studies to validate the utility of the A2 requirement. We aimed to identify (i) how often A2 was associated with PTSD (B-F criteria) at 3 months after trauma and (ii) what was the peritraumatic emotional experience for those who met PTSD criteria but were A2 negative. In a prospective design cohort study we assessed the peritraumatic emotional experience of 535 injury patients in four Australian hospitals. These patients were followed up 3 months later and assessed for PTSD using a structured clinical interview. The majority of those who developed PTSD (B-F criterion) at 3 months met A2 criteria. A substantial minority, however (23%), did not meet A2 criteria. Those PTSD patients who were A2 negative fell into three groups: (i) those who experienced subthreshold levels of A2; (ii) those who experienced intense peritrauma emotional responses other than fear, helplessness or horror; and (iii) those who were amnesic to their peritrauma emotional experience. These findings do not support the inclusion of A2 as diagnostic requirement for DSM-V. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[O'Donnell, Meaghan L.; Creamer, Mark] Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic 3002, Australia; [O'Donnell, Meaghan L.; Creamer, Mark] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [O'Donnell, Meaghan L.] Natl Trauma Res Inst, Prahran, Vic, Australia; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Silove, Derrick] Univ New S Wales, Dept Psychiat, Sydney, NSW, Australia; [Silove, Derrick] Mental Hlth Ctr, Psychiat Res & Teaching Unit, Liverpool, NSW, Australia; [McFarlane, Alexander C.] Univ Adelaide, Dept Psychiat, Adelaide, SA 5005, Australia		O'Donnell, ML (corresponding author), Australian Ctr Posttraumat Mental Hlth, Level 1,340 Albert St, Melbourne, Vic 3002, Australia.	mod@unimelb.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022	NHMRCNational Health and Medical Research Council of Australia [300304, 359284]; Victorian Trauma Foundation [V-11]	This study was supported by an NHMRC Program Grant (300304), a Victorian Trauma Foundation grant (#V-11), and a National Health and Medical Research Council Australian Clinical Research Fellowship (359284).	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Brewin CR, 2000, J TRAUMA STRESS, V13, P499, DOI 10.1023/A:1007741526169; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; DAVIDSON JRT, 1991, J ABNORM PSYCHOL, V100, P346, DOI 10.1037/0021-843X.100.3.346; Elhai JD, 2005, BRIT J PSYCHIAT, V187, P189, DOI 10.1192/bjp.187.2.189-a; Harvey AG, 2000, J NERV MENT DIS, V188, P602, DOI 10.1097/00005053-200009000-00007; KILPATRICK DG, 1997, DSM 4 SOURCEBOOK, V4; Long ME, 2009, PSYCHOL INJ LAW, V2, P167, DOI 10.1007/s12207-009-9043-6; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; ODONNELL ML, CLIN GUIDE SCI POSTT; Schnurr P. P., 2002, J CLIN GEROPSYCHOLOG, V8, P175, DOI DOI 10.1023/A:1015992110544; Weathers FW, 2007, J TRAUMA STRESS, V20, P107, DOI 10.1002/jts.20210	20	43	45	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	APR 30	2010	176	2-3					257	260		10.1016/j.psychres.2009.05.012			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	585MP	WOS:000276830000030	20207009				2022-02-06	
J	Rollnik, JD; Janosch, U				Rollnik, Jens D.; Janosch, Uwe			Current Trends in the Length of Stay in Neurological Early Rehabilitation	DEUTSCHES ARZTEBLATT INTERNATIONAL			English	Article							GERMANY; INJURY	Background: Neurological early rehabilitation (phase B) is an integral component of the phase model of the German Federal Rehabilitation Council (Bundesarbeits-gemeinschaft fur Rehabilitation, BAR). We studied the current trend in patients' length of stay. Methods: This study included 2060 cases of the BDH-Klinik Hessisch Oldendorf (a neurological rehabilitation clinic) from 2005 to 2008 that fulfilled the structural characteristics of item 8-552 of the German coding system for operations and procedures (Operationenund Prozedurenschlussel, OPS), which codes for neurological and neurosurgical early rehabilitation. We studied the parameters age, sex, length of stay, type of discharge, diagnoses, and morbidity. 75.7% of the collective carried a diagnosis of cerebral ischemia, traumatic brain injury, or intracerebral hemorrhage. Results: The mean length of stay over the entire period of the study was 44.6 days. A successive reduction of the mean length of stay from 2005 to 2008 was evident, from 46.8 days in 2005 to 37.5 in 2008 (p< 0.001). The morbidity, too, declined over the period of the study. 76.4% of the cases analyzed stayed in hospital for at least the minimum of 8 weeks proposed by the BAR. 39.5% of the patients improved to such an extent in phase B that they were able to be transferred to a further rehabilitation facility, while about one patient in five was transferred from early rehabilitation to a nursing facility. The mortality was 0.9%. Although the early rehabilitation procedure was correctly coded, a total of 60 different diagnosis-related groups (DRGs) were applied. Conclusion: These data support the BAR's recommendation for a minimum length of stay of 8 weeks in phase B. The observed shortening of the length of stay was found to be primarily the result of a reduction in morbidity during early rehabilitation. This, in turn, may well be due to a selection effect of the early rehabilitation procedure code 8-552.	[Rollnik, Jens D.] Hannover Med Sch, Akad Lehrkrankenhaus, BDH Klin Hessisch Oldendorf, D-31840 Hessisch Oldendorf, Germany		Rollnik, JD (corresponding author), Hannover Med Sch, Akad Lehrkrankenhaus, BDH Klin Hessisch Oldendorf, Greitstr 18-28, D-31840 Hessisch Oldendorf, Germany.						Bundesarbeitsgemeinschaft fur Rehabilitation, 1995, EMPF NEUR REH PAT SC; *G DRG, FALLP KAT G DRG VERS; Rollnik JD, 2009, AKTUEL NEUROL, V36, P368, DOI 10.1055/s-0029-1220390; Rollnilk JD, 2009, REHABILITATION, V48, P91, DOI 10.1055/s-0029-1202294; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Schonle PV, 1996, NERVENHEILKUNDE, V15, P220; Shen Q, 2006, ACTA NEUROL SCAND, V113, P114, DOI 10.1111/j.1600-0404.2005.00542.x; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Stier-Jarmer M, 2002, PHYS MED REHAB KUROR, V12, P260, DOI 10.1055/s-2002-35154; Wallesch CW, 2009, AKTUEL NEUROL, V36, P93, DOI 10.1055/s-0028-1090182; [No title captured]	11	43	44	0	2	DEUTSCHER AERZTE-VERLAG GMBH	COLOGNE	DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY	1866-0452			DTSCH ARZTEBL INT	Dtsch. Arztebl. Int.	APR 23	2010	107	16					286	292		10.3238/arztebl.2010.0286			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592NW	WOS:000277387300003	20467554	Green Published			2022-02-06	
J	Ekeh, AP; Dominguez, KM; Markert, RJ; McCarthy, MC				Ekeh, Akpofure Peter; Dominguez, Kathleen M.; Markert, Ronald J.; McCarthy, Mary C.			Incidence and Risk Factors for Deep Venous Thrombosis After Moderate and Severe Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Brain injury; Deep venous thrombosis; Incidence; Risk factors; Prophylaxis	MOLECULAR-WEIGHT HEPARIN; VEIN THROMBOSIS; TRAUMA PATIENTS; SURVEILLANCE BIAS; THROMBOEMBOLISM; PROPHYLAXIS; PREVENTION; EXTREMITY; CARE; DVT	Background: Patients with traumatic injuries possess a high risk of developing deep venous thrombosis (DVT), thus the need for appropriate prophylaxis. Patients with head injuries pose a unique challenge due to contraindication to the use of anticoagulation. We sought to determine the incidence of DVT and identify specific risk factors for its development in patients with head injuries. Methods: All head injury admissions between January 1, 2000, and July 31, 2006, with a length of stay >= 7 days were identified. Patient data including age, sex, injuries, Glasgow Coma Scale, Injury Severity Score (ISS), and venous duplex scan results were collected. Mechanical methods were routinely used for prophylaxis; heparin was not used in this population. Weekly duplex screening was commenced at 7 days to 10 days after admission. Results: There were 939 patients who met criteria for review, however, duplex scans were performed in only 677, which was the population studied. Overall, DVT was present in 31.6%. There were fewer DVTs in patients with isolated head injuries (25.8%) compared with patients with those with head and extracranial injuries (34.3%)-p = 0.026. Independent predictors for DVT identified included male gender (p = 0.04), age >= 55 (p < 0.001), ISS >= 15 (p = 0.014), subarachnoid hemorrhage (p = 0.006), and lower extremity injury (p = 0.001). Conclusions: DVT occurs in one third of moderately to severely brain injured patients. Isolated head injuries have a lower incidence. Older age, male gender, higher ISS, and the presence of a lower extremity injury are strong predictors for developing DVT. Regular screening and the use of prophylactic inferior vena cava filters in patients with risk factors should be strongly considered.	[Ekeh, Akpofure Peter; Dominguez, Kathleen M.; Markert, Ronald J.; McCarthy, Mary C.] Wright State Univ, Div Trauma Crit Care & Emergency Gen Surg, Dept Surg, Dayton, OH 45435 USA		Ekeh, AP (corresponding author), Miami Valley Hosp, CHE 7000,1 Wyoming St, Dayton, OH 45409 USA.	peter.ekeh@wright.edu					Brandt MM, 2007, AM J SURG, V193, P383; Britt LD, 1996, AM J SURG, V172, P13, DOI 10.1016/S0002-9610(96)00079-7; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Crowther MA, 2005, J CRIT CARE, V20, P334, DOI 10.1016/j.jcrc.2005.09.011; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts William H, 2006, Hematology Am Soc Hematol Educ Program, P462; GERSIN K, 1994, J TRAUMA, V37, P205, DOI 10.1097/00005373-199408000-00009; GIANNOUKAS AD, 1995, EUR J VASC ENDOVASC, V10, P398, DOI 10.1016/S1078-5884(05)80161-3; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Hingorani A, 1997, AM J SURG, V174, P214, DOI 10.1016/S0002-9610(97)00088-3; Keller, 2000, Curr Surg, V57, P456, DOI 10.1016/S0149-7944(00)00314-7; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Labropoulos N, 1999, J VASC SURG, V30, P787, DOI 10.1016/S0741-5214(99)70002-9; Murakami M, 2003, J VASC SURG, V38, P923, DOI 10.1016/S0741-5214(03)00792-4; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Shackford SR, 2004, ANN SURG, V240, P496; Sharma OP, 2007, AM SURGEON, V73, P1173; Sing R, 2007, J TRAUMA, V63, P1135; Stawicki SP, 2005, AM SURGEON, V71, P387; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Velmahos GC, 2006, WORLD J SURG, V30, P483, DOI 10.1007/s00268-005-0427-9; Wagner RH, 1999, J HEAD TRAUMA REHAB, V14, P558, DOI 10.1097/00001199-199912000-00004	29	43	47	6	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2010	68	4					912	915		10.1097/TA.0b013e3181b21cad			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	583GY	WOS:000276663100031	19996795				2022-02-06	
J	Pardini, M; Krueger, F; Raymont, V; Grafman, J				Pardini, Matteo; Krueger, Frank; Raymont, Vanessa; Grafman, Jordan			Ventromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury	NEUROLOGY			English	Article							MULTIPLE-SCLEROSIS; MACAQUE MONKEYS; HEAD-INJURY; DISORDERS; DEPRESSION; REGIONS; SCALE; RAT; MRI	Background: Fatigue is a common and disabling symptom in neurologic disorders including traumatic penetrating brain injury (PBI). Despite fatigue's prevalence and impact on quality of life, its pathophysiology is not understood. Studies on effort perception in healthy subjects, animal behavioral paradigms, and recent evidence in different clinical populations suggest that ventromedial prefrontal cortex could play a significant role in fatigue pathophysiology in neurologic conditions. Methods: We enrolled 97 PBI patients and 37 control subjects drawn from the Vietnam Head Injury Study registry. Fatigue was assessed with a self-report questionnaire and a clinician-rated instrument; lesion location and volume were evaluated on CT scans. PBI patients were divided in 3 groups according to lesion location: a nonfrontal lesion group, a ventromedial prefrontal cortex lesion (vmPFC) group, and a dorso/lateral prefrontal cortex (d/lPFC) group. Fatigue scores were compared among the 3 PBI groups and the healthy controls. Results: Individuals with vmPFC lesions were significantly more fatigued than individuals with d/lPFC lesions, individuals with nonfrontal lesions, and healthy controls, while these 3 latter groups were equally fatigued. VmPFC volume was correlated with fatigue scores, showing that the larger the lesion volume, the higher the fatigue scores. Conclusions: We demonstrated that ventromedial prefrontal cortex lesion (vmPFC) plays a critical role in penetrating brain injury-related fatigue, providing a rationale to link fatigue to different vmPFC functions such as effort and reward perception. The identification of the anatomic and cognitive basis of fatigue can contribute to developing pathophysiology-based treatments for this disabling symptom. Neurology (R) 2010; 74: 749-754	[Pardini, Matteo; Krueger, Frank; Raymont, Vanessa; Grafman, Jordan] NINCDS, Cognit Neurosci Sect, NIH, Bethesda, MD 20892 USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Krueger, Frank] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Raymont, Vanessa] Natl Naval Med Ctr, Vietnam Head Injury Study, Henry M Jackson Fdn, Bethesda, MD USA		Grafman, J (corresponding author), NINCDS, Cognit Neurosci Sect, NIH, Bldg 10,Room 7D43,MSC 1440, Bethesda, MD 20892 USA.	GrafmanJ@ninds.nih.gov	Pardini, Matteo/F-8414-2010	Pardini, Matteo/0000-0002-4740-1982; Grafman, Jordan H./0000-0001-8645-4457	NIH/National Institute of Neurological Disorders and Stroke/CNSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation [DAMD17-01-1-0675]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003024, ZIANS002792] Funding Source: NIH RePORTER	Supported by the Intramural Research Program of the NIH/National Institute of Neurological Disorders and Stroke/CNS and project grant from the United States Army Medical Research and Material Command and administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: A 30 Year Post-Injury Follow-Up Study: Grant number: DAMD17-01-1-0675).; Dr. Pardini, Dr. Krueger, and Dr. Raymont report no disclosures. Dr. Grafman serves as Coeditor of Cortex and receives research support from the Intramural Research Program NIH/NINDS and the Henry M. Jackson Foundation.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; BRUNO RL, 1994, ARCH PHYS MED REHAB, V75, P498; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Cornuz J, 2006, CAN MED ASSOC J, V174, P765, DOI 10.1503/cmaj.1031153; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; First M.B., 1994, STRUCTURED CLIN INTE; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Ketter TA, 1999, NEUROLOGY, V53, pS53; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Merkelbach S, 2001, MULT SCLER, V7, P320, DOI 10.1177/135245850100700508; Ongur D, 1998, J COMP NEUROL, V401, P480; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Romani A, 2008, NEUROL SCI, V29, pS247, DOI 10.1007/s10072-008-0952-z; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Walton ME, 2002, J NEUROSCI, V22, P10996	31	43	43	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 2	2010	74	9					749	754		10.1212/WNL.0b013e3181d25b6b			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	562GG	WOS:000275037300009	20194914	Green Published			2022-02-06	
J	Gu, Y; Wang, J; Ding, F; Hu, N; Wang, YX; Gu, XS				Gu, Yun; Wang, Jie; Ding, Fei; Hu, Nan; Wang, Yaxian; Gu, Xiaosong			Neurotrophic Actions of Bone Marrow Stromal Cells on Primary Culture of Dorsal Root Ganglion Tissues and Neurons	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Bone marrow stromal cells; Dorsal root ganglion; Coculture; Neurotrophic factor; Peripheral nerve regeneration	TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION; ADULT RATS; FUNCTIONAL RECOVERY; GROWTH-FACTOR; SPINAL-CORD; CEREBRAL-ISCHEMIA; TRANSPLANTATION; DIFFERENTIATION	Application of adult bone marrow stromal cells (BMSCs) provides therapeutic benefits to the treatment of neurological insults. The aim of this study was to explore the potential of nonhematopoietic BMSCs to produce soluble factors and stimulate signaling pathways in neurons that mediate trophic effects. A combination of enzyme-linked immunosorbent assay and two-dimensional gel electrophoresis coupled with mass spectrometry showed that the BMSCs released into the culture medium an array of soluble factors such as nerve growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, and ciliary neurotrophic factor, which have been shown to exhibit potent neurotrophic effects on neural cells. Immunochemistry, cell viability assay, and quantitative real-time RT-PCR collectively showed that neurite outgrowth and neurogenesis in cultured rat dorsal root ganglion (DRG) explants and neurons were enhanced after they were cocultured with rat BMSCs. Western blot analysis revealed that BMSC-conditioned medium activated phosphorylation of mitogen-activated protein kinase/extracellular signal-regulated protein kinase and/or phosphoinositide 3-kinase/serine/threonine kinase (PI3K/Akt) in primary culture of rat DRG neurons, which suggested that BMSCs trigger endogenous survival signaling pathways in neurons through their secreted soluble factors. Our data help to elucidate the mechanisms by which BMSCs function as a cell therapy agent in peripheral nerve regeneration.	[Gu, Yun; Wang, Jie; Ding, Fei; Hu, Nan; Wang, Yaxian; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China		Gu, XS (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	neurongu@public.nt.js.cn			Hi-Tech Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2006AA02A128]; Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670667]	The financial supports of the Hi-Tech Research and Development Program of China (863 Program, grant number 2006AA02A128) and the Nature Science Foundation of China (grant number 30670667) are gratefully acknowledged. We thank Professor Jie Liu for assistance in manuscript preparation.	ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chen Y, 2006, CELL MOL LIFE SCI, V63, P1649, DOI 10.1007/s00018-006-6019-5; Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4; Chen ZY, 2001, BRAIN RES, V902, P272, DOI 10.1016/S0006-8993(01)02395-2; Cheng YY, 2006, SOLID STATE PHENOMEN, V111, P115, DOI 10.4028/www.scientific.net/SSP.111.115; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cuevas P, 2002, NEUROL RES, V24, P634, DOI 10.1179/016164102101200564; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hou SY, 2006, NEUROSCIENCE, V140, P101, DOI 10.1016/j.neuroscience.2006.01.066; Kocsis JD, 2002, J REHABIL RES DEV, V39, P287; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Marcol W, 2003, J NEUROSCI RES, V72, P417, DOI 10.1002/jnr.10560; Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Sun HL, 2006, J MUSCLE RES CELL M, V27, P241, DOI 10.1007/s10974-006-9067-4; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098; Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	46	43	46	0	15	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2010	40	3					332	341		10.1007/s12031-009-9304-6			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	557ZN	WOS:000274709700007	19894026				2022-02-06	
J	Lin, MR; Chiu, WT; Chen, YJ; Yu, WY; Huang, SJ; Tsai, MD				Lin, Mau-Roung; Chiu, Wen-Ta; Chen, Yi-Ju; Yu, Wen-Yu; Huang, Sheng-Jean; Tsai, Ming-Dar			Longitudinal Changes in the Health-Related Quality of Life During the First Year After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Depression; Quality of life; Rehabilitation; Social support; Taiwan	SOCIAL SUPPORT; RESPONSE-SHIFT; WHOQOL-BREF; SATISFACTION	Lin M-R, Chiu W-T, Chen Y-J, Yu W-Y, Huang S-J, Tsai M-D. Longitudinal changes in the health-related quality of life during the first year after traumatic brain injury. Arch Phys Med Rehabil 2010;91:474-80. Objective: To track the health-related quality of life (HRQL) at discharge and at 6 and 12 months after a traumatic brain injury (TBI) and examine factors associated with changes in each HRQL domain. Design: Longitudinal cohort study. Setting: Using codes of the International Classification of Diseases, eligible participants who had a newly diagnosed TBI were identified from discharge records of 4 hospitals in northern Taiwan. Information on the HRQL and injury-related characteristics at the initial and 2 follow-up assessments was collected by extracting medical records and conducting telephone interviews. Participants: Subjects (N=158) participated in the initial assessment, and 147 and 146, respectively, completed the follow-up assessments at 6 and 12 months after injury. Interventions: Not applicable. Main Outcome Measure: The brief version of the World Health Organization Quality of Life (WHOQOL-BREF) with 4 domains of physical capacity, psychologic well being, social relationships, and environment. Results: Scores on all WHOQOL-BREF domains except social relationships greatly improved over the first 6 months and showed continued improvement at 12 months after injury. The domain scores of the WHOQOL-BREF at discharge were significantly associated with the preinjury HRQL level, marital status, alcohol consumption at the time of injury, Glasgow Outcome Scale (GOS) level, cognition, activities of daily living, social support, and depressive status. However, after adjusting for these baseline differences, only the GOS level and depressive status significantly influenced longitudinal changes in the psychologic and social domains over the 12-month period. Changes in the physical and environmental domains were not significantly associated with any characteristics of the study. Conclusions: During the first year after a TBI, the magnitude of HRQL recovery differed across different HRQL domains. Many factors may have significant associations with the initial domain scores of HRQL after TBI; however, only a few factors can significantly influence longitudinal changes in the HRQL.	[Lin, Mau-Roung; Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, Shuang Ho Hosp, Taipei 11031, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei 11031, Taiwan; [Chen, Yi-Ju] Cathay Gen Hosp, Dept Nursing, Taipei, Taiwan; [Yu, Wen-Yu] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Ming-Dar] Shin Kong Wu Ho Su Mem Hosp, Dept Neurosurg, Taipei, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan.	wtchiu@tmu.edu.tw			National Science CouncilMinistry of Science and Technology, Taiwan [NSC97-2314-B-038-012-MY3]; National Health Research Institute, Taiwan, ROCNational Health Research Institutes - Taiwan [98TMU-SHH-07]	Supported by the National Science Council (grant no. NSC97-2314-B-038-012-MY3) and the National Health Research Institute (grant no. 98TMU-SHH-07), Taiwan, ROC.	Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHESNUT RM, 1999, 2 AG HLTH CAR POL RE; Chiu W. T., 1996, NEUROTRAUMA, P905; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dawson DR, 2000, BRAIN COGNITION, V44, P35; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; JENNETT B, 1975, LANCET, V1, P480; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MacKenzie E, 2001, INJURY CONTROL GUIDE; MAHONEY F I, 1965, Md State Med J, V14, P61; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; O'Shanick G J, 1986, Adv Psychosom Med, V16, P173; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sprangers MAG, 1996, CANCER TREAT REV, V22, P55, DOI 10.1016/S0305-7372(96)90064-X; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TENNSTEDT SL, 1992, AM J PUBLIC HEALTH, V82, P1541; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; World Health Organization, 1980, INT CLASS IMP DIS HA; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	39	43	44	1	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2010	91	3					474	480		10.1016/j.apmr.2009.10.031			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	592YM	WOS:000277417900023	20298842				2022-02-06	
J	Yasuda, H; Kuroda, S; Shichinohe, H; Kamei, S; Kawamura, R; Iwasaki, Y				Yasuda, Hiroshi; Kuroda, Satoshi; Shichinohe, Hideo; Kamei, Shintaro; Kawamura, Ryoichi; Iwasaki, Yoshinobu			Effect of biodegradable fibrin scaffold on survival, migration, and differentiation of transplanted bone marrow stromal cells after cortical injury in rats Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						bone marrow stromal cell; transplantation; fibrin; scaffold; brain injury	TRAUMATIC BRAIN-INJURY; MICE CEREBRAL INFARCT; SPINAL-CORD-INJURY; STEM-CELLS; ACID RECEPTOR; HEART-TISSUE; ADULT; TRACKING; REPAIR; REGENERATION	Object. In this study the authors' aim was to assess whether fibrin matrix could act as an injectable, valuable scaffold in bone marrow stromal cell (BMSC) transplantation for injured CNS tissue. Methods. Both clotting time and 31) structure of fibrin matrix were analyzed with various concentrations of fibrinogen and CaCl2. The BMSCs were harvested from green fluorescent protein-transgenic mice and cultured. A cortical lesion was produced in rats by application of a very cold rod to the right cerebral hemisphere. The BMSCs, fibrin matrix, or BMSC-fibrin matrix complex was transplanted into the lesion though a small bur hole 7 days after the insult. Using immunohistochemical analysis, the authors evaluated the survival, migration, and differentiation of the transplanted cells 4 weeks after transplantation. Results. Based on in vitro observations, the concentrations of fibrinogen and CaCl2 were fixed at 2.5 mg/ml and 2 mu M in animal experiments, respectively. Fibrin matrix almost completely disappeared 4 weeks after transplantation. However, immunohistochemical analysis revealed that fibrin matrix exclusively enhanced the retention of the transplanted cells within the lesion. migration toward the lesion boundary zone, and differentiation into the neurons and perivascular cells. Conclusions. Injectable fibrin matrix enhanced the Survival, migration, and differentiation of the BMSCs transplanted into the cortical lesion in rats. The authors believe that it is one of the promising candidates for a potential, minimally invasive scaffold for CNS disorders. The present findings strongly suggest that such a strategy of tissue engineering could be a therapeutic option for CNS regeneration in patients with CNS injuries. (DOI: 10.3171/10.3171/2009.2.JNS08495)	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kamei, Shintaro; Kawamura, Ryoichi] Chemo Sero Therapeut Res Inst, Kumamoto, Japan		Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Shichinohe, Hideo/G-5367-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [14370424, 15390426, 17390389, 18390387, 19390371]	This study was supported by Grants-in-Aid from the Ministry of Education, Science and Culture of Japan (Grant Nos. 14370424, 15390426, 17390389, 18390387, and 19390371). The authors report no other conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P330, DOI 10.3171/spi.2004.1.3.0330; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392; de Haro J, 2005, NEUROSCI LETT, V377, P7, DOI 10.1016/j.neulet.2004.11.060; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Lacza Z, 2003, BRAIN RES PROTOC, V11, P145, DOI 10.1016/S1385-299X(03)00039-4; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Leor J, 2000, CIRCULATION, V102, P56; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; LI RK, 1999, CIRCULATION S, V100, P1163; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058; Sawamura Y, 1999, NEUROSURGERY, V44, P332, DOI 10.1097/00006123-199902000-00048; Shi EY, 2006, ANN THORAC SURG, V81, P2227, DOI 10.1016/j.athoracsur.2005.12.056; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Terasaka S, 2006, NEUROSURGERY, V58, P134, DOI 10.1227/01.NEU.0000193515.95039.49; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182(02)00143-9; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0; Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10	39	43	45	0	16	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2010	112	2					336	344		10.3171/2009.2.JNS08495			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	550CX	WOS:000274107000020	19267524				2022-02-06	
J	Butler, TR; Self, RL; Smith, KJ; Sharrett-Field, LJ; Berry, JN; Littleton, JM; Pauly, JR; Mulholland, PJ; Prendergast, MA				Butler, T. R.; Self, R. L.; Smith, K. J.; Sharrett-Field, L. J.; Berry, J. N.; Littleton, J. M.; Pauly, J. R.; Mulholland, P. J.; Prendergast, M. A.			SELECTIVE VULNERABILITY OF HIPPOCAMPAL CORNU AMMONIS 1 PYRAMIDAL CELLS TO EXCITOTOXIC INSULT IS ASSOCIATED WITH THE EXPRESSION OF POLYAMINE-SENSITIVE N-METHYL-D-ASPARATE-TYPE GLUTAMATE RECEPTORS	NEUROSCIENCE			English	Article						glutamate; calcium; head injury; amino acid; spermidine	CEREBELLAR GRANULE CELLS; D-ASPARTATE RECEPTOR; EXTRASYNAPTIC NMDA RECEPTORS; TRAUMATIC BRAIN-INJURY; SLICE CULTURES; ETHANOL WITHDRAWAL; RAT-BRAIN; CEREBRAL-ISCHEMIA; CALCIUM-CHANNELS; NEURONAL DEATH	Excess glutamate release and stimulation of postsynaptic glutamatergic receptors have been implicated in the pathophysiology of many neurological diseases. The hippocampus, and the pyramidal cell layer of the cornu ammonus 1 (CA1) region in particular, has been noted for its selective sensitivity to excitotoxic insults. The current studies examined the role of N-methyl-D-aspartate (NMDA) receptor subunit composition and sensitivity to stimulatory effects of the polyamine spermidine, an allosteric modulator of NMDA NR2 subunit activity, in hippocampal CA1 region sensitivity to excitotoxic insult. Organotypic hippocampal slice cultures of 8 day-old neonatal rat were obtained and maintained in vitro for 5 days. At this time, immunohistochemical analysis of mature neuron density (NeuN); microtubule associated protein-2(a,b) density (MAP-2); and NMDA receptor NR1 and NR2B subunit density in the primary cell layers of the dentate gyrus (DG), CA3, and CA1 regions, was conducted. Further, autoradiographic analysis of NMDA receptor distribution and density (i.e. [I-121]MK-801 binding) and spermidine (100 mu M)-potentiated [I-125]MK-801 binding in the primary cell layers of these regions was examined. A final series of studies examined effects of prolonged exposure to NMDA (0.1-10 mu M) on neurodegeneration in the primary cell layers of the DG, CA3, and CA1 regions, in the absence and presence of spermidine (100 mu M) or ifenprodil (100 mu M), an allosteric inhibitor of NR2B polypeptide subunit activity. The pyramidal cell layer of the CA1 region demonstrated significantly greater density of mature neurons, MAP-2, NR1 and NR2B subunits, and [I-125]MK-801 binding than the CA3 region or DG. Twenty-four hour NMDA (10 mu M) exposure produced marked neurodegeneration (similar to 350% of control cultures) in the CA1 pyramidal cell region that was significantly reduced by co-exposure to ifenprodil or DL-2-Amino-5-phosphonopentanoic acid (APV). The addition of spermidine significantly potentiated [I-125] MK-801 binding and neurodegeneration induced by exposure to a non-toxic concentration of NMDA, exclusively in the CA1 region. This neurodegeneration was markedly reduced with co-exposure to ifenprodil. These data suggest that selective sensitivity of the CA1 region to excitotoxic stimuli may be attributable to the density of mature neurons expressing polyamine-sensitive NR2B polypeptide subunits. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Prendergast, M. A.] Univ Kentucky, Dept Psychol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Littleton, J. M.; Pauly, J. R.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA		Prendergast, MA (corresponding author), Univ Kentucky, Dept Psychol, Spinal Cord & Brain Injury Res Ctr, B449 Biomed & Biol Sci Res Bldg,741 S Limestone S, Lexington, KY 40536 USA.	prender@uky.edu	Mulholland, Patrick J/L-9353-2017	Butler, Tracy/0000-0002-3849-7951	 [AA103561];  [AA013388];  [AA015676];  [AA014771]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA015676, F31AA014771, R56AA013388, R01AA013388] Funding Source: NIH RePORTER	The authors acknowledge the support of AA 103561, AA013388, AA015676, and AA014771.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Atlante A, 1997, J NEUROCHEM, V68, P2038, DOI 10.1046/j.1471-4159.1997.68052038.x; Baskys A, 2005, NEUROPHARMACOLOGY, V49, P146, DOI 10.1016/j.neuropharm.2005.04.029; Bonde C, 2005, NEUROSCIENCE, V136, P779, DOI 10.1016/j.neuroscience.2005.07.020; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; CASACCIABONNEFIL P, 1993, NEUROSCI LETT, V154, P5, DOI 10.1016/0304-3940(93)90157-G; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Chizh BA, 2005, CURR PHARM DESIGN, V11, P2977, DOI 10.2174/1381612054865082; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Gibson DA, 2003, ALCOHOL CLIN EXP RES, V27, P1099, DOI 10.1097/01.ALC.0000075824.10502.DD; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Halpain S, 1998, J NEUROSCI, V18, P9835; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HERMAN MD, 1993, J PHYSIOL-LONDON, V462, P645, DOI 10.1113/jphysiol.1993.sp019574; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holopainen IE, 2004, NEUROCHEM INT, V45, P1, DOI 10.1016/j.neuint.2004.01.005; Ikegaya Y, 2002, NEUROSCIENCE, V113, P253, DOI 10.1016/S0306-4522(02)00217-8; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Kim GH, 2009, CAN J NEUROL SCI, V36, P14, DOI 10.1017/S0317167100006247; Kristensen BW, 2003, BRAIN RES, V964, P264, DOI 10.1016/S0006-8993(02)04080-5; Lahtinen H, 2001, NEUROSCIENCE, V105, P131, DOI 10.1016/S0306-4522(01)00168-3; Laschet J, 1999, EPILEPSY RES, V35, P161, DOI 10.1016/S0920-1211(99)00009-1; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Martens U, 2001, ANAT EMBRYOL, V203, P491, DOI 10.1007/s004290100174; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MATTSON MP, 1991, BRAIN RES, V565, P94, DOI 10.1016/0006-8993(91)91740-R; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mulholland PJ, 2003, NEUROSCI RES, V46, P369, DOI 10.1016/S0168-0102(03)00102-0; NADLER JV, 1980, BRAIN RES, V195, P47; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Pelletier MR, 1999, J NEUROPHYSIOL, V81, P3054, DOI 10.1152/jn.1999.81.6.3054; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; Prendergast MA, 2007, NEUROSCIENCE, V146, P330, DOI 10.1016/j.neuroscience.2007.01.023; Prendergast MA, 2004, NEUROSCIENCE, V124, P869, DOI 10.1016/j.neuroscience.2003.12.013; Prendergast MA, 2000, ALCOHOL CLIN EXP RES, V24, P1855, DOI 10.1111/j.1530-0277.2000.tb01990.x; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Scartabelli T, 2008, NEUROPHARMACOLOGY, V55, P509, DOI 10.1016/j.neuropharm.2008.06.019; Schuh RA, 2008, J NEUROSCI RES, V86, P3306, DOI 10.1002/jnr.21772; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; SILVERSTEIN FS, 1991, PEDIATR RES, V30, P587, DOI 10.1203/00006450-199112000-00021; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Stoll L, 2007, BIOPHYS J, V92, P1343, DOI 10.1529/biophysj.106.089896; STOLTENBURGDIDINGER G, 1994, NEUROTOXICOLOGY, V15, P445; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; WALSH TJ, 1988, TOXICOLOGY, V49, P137, DOI 10.1016/0300-483X(88)90185-0; Wilkins LH, 2006, ALCOHOL CLIN EXP RES, V30, P1768, DOI 10.1111/j.1530-0277.2006.00210.x; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Yamakura T, 1999, PROG NEUROBIOL, V59, P279, DOI 10.1016/S0301-0082(99)00007-6; Yan DH, 2005, J PHYSIOL-LONDON, V563, P713, DOI 10.1113/jphysiol.2004.077677; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	64	43	44	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 20	2010	165	2					525	534		10.1016/j.neuroscience.2009.10.018			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545IC	WOS:000273724700023	19837138	Green Accepted			2022-02-06	
J	LaPlaca, MC; Prado, GR				LaPlaca, Michelle C.; Prado, Gustavo R.			Neural mechanobiology and neuronal vulnerability to traumatic loading	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Traumatic spinal cord injury; Injury biomechanics; Cellular models; Mechanoporation; Plasma membrane permeability	IN-VITRO MODEL; EXPERIMENTAL BRAIN-INJURY; NERVOUS-SYSTEM INJURY; SPINAL-CORD-INJURY; AXONAL INJURY; PLASMA-MEMBRANE; MECHANICAL STRETCH; WHITE-MATTER; CEREBRAL CONCUSSION; CORTICAL-NEURONS	In order to understand the physical tolerance of neurons to traumatic insults, engineers and neuroscientists have attempted to reproduce the biomechanical environment during a traumatic event using in vitro injury systems with isolated components of the nervous system. This approach allows one to begin to unravel the underlying molecular and biochemical mechanisms that lead to cell dysfunction and death as a function of mechanical inputs. Excess mechanical force and deformation causes structural and functional breakdown, including several key deleterious cellular processes, such as membrane damage, an upset of calcium homeostasis, glutamate release, cell death, and caspase-mediated proteolysis. Understanding of the mechanotransduction events, however, that lead to cellular failure and dysfunction, are not well understood. Mechanically characterized cellular models of traumatic loading are critical to the improved understanding of mechanotransduction in the context of neural injury, the improvement of protective systems, and to provide a controlled setting for testing therapeutic interventions. In this review of the cellular mechanics of traumatic neural loading. we focus on the backdrop and motivation for studying mechanical thresholds in neurons and glial cells and discuss some of the acute responses that may help elucidate improved tolerance criteria and illuminate future research directions. (C) 2009 Elsevier Ltd. All rights reserved.	[LaPlaca, Michelle C.; Prado, Gustavo R.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Neural Injury Biomech & Repair Lab, Georgia Inst Technol,Inst Bioengn & Biosci, Atlanta, GA 30322 USA		LaPlaca, MC (corresponding author), Emory Univ, Wallace H Coulter Dept Biomed Engn, Neural Injury Biomech & Repair Lab, Georgia Inst Technol,Inst Bioengn & Biosci, 313 Ferst Dr, Atlanta, GA 30322 USA.	michelle.laplaca@bme.gatech.edu			Whitaker Foundation; Institute for Bioengineering and Bioscience; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB000786]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000786] Funding Source: NIH RePORTER	The authors acknowledge Dr. Mark R. Prausnitz and Dr. Donna M. Geddes-Klein for technical advice, Dr. Robert P. Apkarian (deceased) for generous electron microscopy assistance, and the Whitaker Foundation, the Institute for Bioengineering and Bioscience, and the NIH (EB000786) for funding.	Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BALENTINE JD, 1988, LAB INVEST, V58, P93; Barbee KA, 2005, ANN NY ACAD SCI, V1066, P67, DOI 10.1196/annals.1363.006; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; CULLEN DK, 2007, BRAIN RES; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Galle B, 2007, J BIOMECH, V40, P3029, DOI 10.1016/j.jbiomech.2007.03.014; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; HAYES RL, 1995, J NEUROTRAUM, V12, P933, DOI 10.1089/neu.1995.12.933; Holbourn AHS, 1943, LANCET, V2, P438; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; KING AI, 2003, P 2003 IRCOBI C LISB; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McNeil PL, 2002, J CELL SCI, V115, P873; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; POVISHLOK J, 1996, ACTA NEUROCHIR SUPP, V66, P81; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; RINK A, 1995, AM J PATHOL, V147, P1575; RZIGALINSKI BA, 1996, J NEUROTRAUM, V13, P609; SAHAY KB, 1992, J BIOMECH, V25, P319, DOI 10.1016/0021-9290(92)90029-Z; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 2004, J NEUROCYTOL, V33, P203, DOI 10.1023/B:NEUR.0000030695.76840.19; SHIELDS M, 1987, BIOCHIM BIOPHYS ACTA, V905, P181, DOI 10.1016/0005-2736(87)90022-8; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 1999, J CELL SCI, V112, P719; Tymianski M, 1996, NEUROSURGERY, V38, P1176; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WHALEN MJ, 2007, J CEREB BLOOD FLOW M; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	86	43	44	0	32	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 5	2010	43	1			SI		71	78		10.1016/j.jbiomech.2009.09.011			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	547SL	WOS:000273909400011	19811784				2022-02-06	
J	Culley, C; Evans, JJ				Culley, Campbell; Evans, Jonathan J.			SMS text messaging as a means of increasing recall of therapy goals in brain injury rehabilitation: A single-blind within-subjects trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Goal-setting; Traumatic brain injury; Memory rehabilitation; External memory aid	MEMORY AID; PERFORMANCE	A single-blind within-subjects trial was used to test the efficacy of sending SMS text messages to patients with a traumatic brain injury as a means of improving their recall of rehabilitation goals. Eleven participants were recruited from two community-based rehabilitation centres and were sent text messages relating to three randomly selected goals from a selection of six current goals three times per day for 14 days. Participants' recall of their rehabilitation goals was assessed at baseline, seven days, and 14 days via free recall and cued recall procedures. Results showed that goals in the otexto condition were recalled better than goals in the ono texto condition. Practical applications and extensions are discussed.	[Culley, Campbell; Evans, Jonathan J.] Univ Glasgow, Fac Med, Sect Psychol Med, Glasgow G12 0XH, Lanark, Scotland		Evans, JJ (corresponding author), Univ Glasgow, Fac Med, Sect Psychol Med, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	Jonathan.evans@clinmed.gla.ac.uk			NHS Education for Scotland; Sackler Foundation	We are grateful to all of the participants who took part in this study and to staff at the Community Treatment Centre for Brain Injury, Glasgow and the Central Scotland Brain Injury Rehabilitation Centre, Wishaw for their assistance with this study. We are also grateful to two anonymous reviewers for their helpful suggestions for improvements to the manuscript, and to NHS Education for Scotland and the Sackler Foundation for financial support.	BARRACLOUGH C, 1986, BEHAV PHYSCHOTHERAPY, V14, P183; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Bryman Alan., 1990, QUANTITATIVE DATA AN; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Field A., 2003, DESIGN REPORT EXPT; FUCHS LS, 1986, EXCEPT CHILDREN, V53, P199, DOI 10.1177/001440298605300301; Gauggel S., 1998, NEUROPSYCHOLOGICAL R; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; HOUTS PS, 1975, GOAL ATTAINMENT REV, V2, P33; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; KENNEDY P, 1991, PARAPLEGIA, V29, P197, DOI 10.1038/sc.1991.28; LAPORTE RE, 1976, J EDUC PSYCHOL, V68, P260, DOI 10.1037/0022-0663.68.3.260; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; LOCKE EA, 1981, PSYCHOL BULL, V90, P125, DOI 10.1037/0033-2909.90.1.125; McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P241, DOI 10.1080/096020199389356; *MOB DAT ASS, 2008, Q1 2008 UK MOB TREND; Pijnenborg GHM, 2007, REHABIL PSYCHOL, V52, P236, DOI 10.1037/0090-5550.52.2.236; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Theodorakis Y, 1997, J SPORT REHABIL, V6, P355, DOI 10.1123/jsr.6.4.355; Wade DT, 1998, CLIN REHABIL, V12, P273, DOI 10.1191/026921598678166365; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; WARD C, 1993, NEUROLOGICAL REHABIL, P13; WechslerD, 2001, WECHSLER TEST ADULT; WILSON B, 1989, MODELS BRAIN INJURY, P117; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874	29	43	43	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	1					103	119	PII 911703432	10.1080/09602010902906926			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	530SB	WOS:000272611500006	19468962				2022-02-06	
J	Sandhir, R; Berman, NEJ				Sandhir, Rajat; Berman, Nancy E. J.			Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Inflammation; CCAAT enhancer binding proteins; Transcription factors; C/EBP alpha; C/EBP beta; C/EBP delta; CHOP; Aging	ENDOPLASMIC-RETICULUM STRESS; C/EBP TRANSCRIPTION FACTORS; CONTROLLED CORTICAL IMPACT; GENE-EXPRESSION; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; BETA; INFLAMMATION; CYTOKINES; CELLS	Exacerbated inflammatory responses have been reported following traumatic injury to the aged brain. The present study was designed to investigate the involvement of the transcription factors belonging to the CCAAT/enhancer binding protein (C/EBP) family that regulate expression of many of the pro-inflammatory genes which show increased expression following injury to the aged brain. Controlled cortical impact injury was induced in adult (5-6 months) and aged (22-24 months) C57/BL6 mice. C/EBP mRNA and protein expression were analyzed in injured cortex at 1, 3, and 7 days post-injury. Expression of C/EBP alpha was reduced relative to baseline at day 1 in both adult and aged mice, whereas, it increased at days 3 and 7 post-injury. No significant differences were observed between adult and aged brain. Upregulation of C/EBP beta was observed I day following injury in both the adult and aged brain, but there were no major age-related differences in mRNA levels. However, there was higher C/EBP beta protein in the aged brain. C/EBP delta expression increased beginning 1 day post-injury in both adult and aged brain. In this case, the increase in C/EBP delta expression was higher in the aged brain than in the adult at all time points studied. Expression of CCAAT/enhancer binding protein homologous protein (CHOP), a transcription factor involved in ER stress and protein unfolding responses, was also up-regulated in response to injury, but CHOP levels were significantly lower in the aged than the adult brain. Based on these results, we conclude that differential expression of C/EBP P, 8 and CHOP might contribute to the hyper-inflammatory response and poor prognosis following traumatic brain injury in the elderly patients. In addition elevated C/EBP delta levels following TBI in the aged brain may play a role in the link between TBI and Alzheimer's disease. (C) 2009 Elsevier Ltd. All rights reserved.	[Sandhir, Rajat; Berman, Nancy E. J.] Univ Kansas, Med Ctr, Steve Palermo Nerve Regenerat Lab, Kansas City, KS 66160 USA; [Sandhir, Rajat; Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Berman, NEJ (corresponding author), Univ Kansas, Med Ctr, Steve Palermo Nerve Regenerat Lab, Mail Stop 3038,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	nberman@kumc.edu			Steve Palermo Endowment; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG031140, P30 HD02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031140] Funding Source: NIH RePORTER	The authors acknowledge the assistance of Eugene Gregory in carrying out the work and Dr. Y.Y. He for his help with controlled cortical impact injury. The study was supported in part by the Steve Palermo Endowment and the National Institute of Health (R01 AG031140 and research core support P30 HD02528).	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ANDERSON J, 2009, J NEUROTRAUMA; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.3.CO;2-9; Choi BK, 2009, EXP BRAIN RES, V193, P581, DOI 10.1007/s00221-008-1660-x; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hwang IK, 2007, NEUROCHEM RES, V32, P1530, DOI 10.1007/s11064-007-9345-6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rabek JP, 1998, BBA-GENE STRUCT EXPR, V1398, P137, DOI 10.1016/S0167-4781(98)00038-4; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tanaka R, 2002, J CEREBR BLOOD F MET, V22, P280, DOI 10.1097/00004647-200203000-00005; TANSEY MG, 2009, ENCY NEUROSCIENCE, P131; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Walton M, 1998, MOL BRAIN RES, V61, P11, DOI 10.1016/S0169-328X(98)00169-7; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Won JS, 2003, J NEUROSCI, V23, P7470; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Yiangou M, 2001, BBA-GENE STRUCT EXPR, V1518, P47, DOI 10.1016/S0167-4781(01)00165-8	53	43	45	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2010	56	1					188	193		10.1016/j.neuint.2009.10.002			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	569JZ	WOS:000275593700025	19833158	Green Accepted			2022-02-06	
J	Scheibel, RS; Newsome, MR; Troyanskaya, M; Steinberg, JL; Goldstein, FC; Mao, H; Levin, HS				Scheibel, Randall S.; Newsome, Mary R.; Troyanskaya, Maya; Steinberg, Joel L.; Goldstein, Felicia C.; Mao, Hui; Levin, Harvey S.			Effects of Severity of Traumatic Brain Injury and Brain Reserve on Cognitive-Control Related Brain Activation	JOURNAL OF NEUROTRAUMA			English	Article						brain reserve; cognitive control; functional MRI; Glasgow Coma Scale; traumatic brain injury	WORKING-MEMORY LOAD; SEVERE HEAD-INJURY; SPATIAL ATTENTION; POSTERIOR CINGULATE; PRACTICAL SCALE; MOTOR SCORE; VALIDATION; PREDICTION; CLASSIFICATION; FMRI	Functional magnetic resonance imaging (fMRI) has revealed more extensive cognitive-control related brain activation following traumatic brain injury (TBI), but little is known about how activation varies with TBI severity. Thirty patients with moderate to severe TBI and 10 with orthopedic injury (OI) underwent fMRI at 3 months post-injury using a stimulus response compatibility task. Regression analyses indicated that lower total Glasgow Coma Scale (GCS) and GCS verbal component scores were associated with higher levels of brain activation. Brain-injured patients were also divided into three groups based upon their total GCS score (3-4, 5-8, or 9-15), and patients with a total GCS score of 8 or less produced increased, diffuse activation that included structures thought to mediate visual attention and cognitive control. The cingulate gyrus and thalamus were among the areas showing greatest increases, and this is consistent with vulnerability of these midline structures in severe, diffuse TBI. Better task performance was associated with higher activation, and there were differences in the over-activation pattern that varied with TBI severity, including greater reliance upon left-lateralized brain structures in patients with the most severe injuries. These findings suggest that over-activation is at least partially effective for improving performance and may be compensatory.	[Scheibel, Randall S.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Steinberg, Joel L.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Mao, Hui] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA		Scheibel, RS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	scheibel@bcm.tmc.edu			 [NS-21889];  [NS-42772]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889, R01NS042772] Funding Source: NIH RePORTER	We thank Dr. Ronald A. Rauch for coding the anatomical image data, Xiaoqi Li for assisting with statistical analysis, and Candace Howell, Meghan Mitchell, and Tara Ravichandran for assisting with data acquisition. This research was supported by grants NS-21889 and NS-42772 awarded to Harvey S. Levin. The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) in Houston, TX, and the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) provided access to equipment and facilities used for the acquisition and analysis of the image data.	Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Bryant RA, 2005, BIOL PSYCHIAT, V58, P111, DOI 10.1016/j.biopsych.2005.03.021; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 2005, REHABILITATION TRAUM, P338; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Nielson KA, 2002, PSYCHOL AGING, V17, P56, DOI 10.1037//0882-7974.17.1.56; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; PRICE CJ, 2001, HDB FUNCTIONAL NEURO, P379; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Shibata H, 2003, EUR J NEUROSCI, V18, P1615, DOI 10.1046/j.1460-9568.2003.02868.x; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; SOLEPADULLES C, 2009, NEUROBIOL A IN PRESS; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	44	43	44	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2009	26	9					1447	1461		10.1089/neu.2008.0736			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	489NG	WOS:000269426200002	19645622	Green Published			2022-02-06	
J	Kasturi, BS; Stein, DG				Kasturi, Badrinarayanan S.; Stein, Donald G.			Traumatic Brain Injury Causes Long-Term Reduction in Serum Growth Hormone and Persistent Astrocytosis in the Cortico-Hypothalamo-Pituitary Axis of Adult Male Rats	JOURNAL OF NEUROTRAUMA			English	Article						anterior pituitary; growth hormone; hypopituitarism; hypothalamus; TBI	SPINAL-CORD-INJURY; GH DEFICIENCY; IGF-I; SUBARACHNOID HEMORRHAGE; INFLAMMATORY RESPONSE; PROGRESSIVE ATROPHY; HIGH-RISK; HYPOPITUITARISM; DYSFUNCTION; PROGESTERONE	In humans, traumatic brain injury (TBI) causes pathological changes in the hypothalamus (HT) and the pituitary. One consequence of TBI is hypopituitarism, with deficiency of single or multiple hormones of the anterior pituitary (AP), including growth hormone (GH). At present no animal model of TBI with ensuing hypopituitarism has been demonstrated. The main objective of this study was to investigate whether cortical contusion injury (CCI) could induce long-term reduction of serum GH in rats. We also tested the hypothesis that TBI to the medial frontal cortex (MFC) would induce inflammatory changes in the HT and AP. Methods: Nine young adult male rats were given sham surgery (n =4) or controlled impact contusions (n = 5) of the MFC. Two months post-injury they were killed, trunk blood collected and their brains and AP harvested. GH was measured in serum and AP using ELISA and Western blot respectively. Interleukin-1 beta (IL-1 beta) and glial fibrillary acidic protein (GFAP) were measured in the cortex (Cx), HT, and AP by Western blot. Results: Lesion rats had significantly (p< 0.05) lower levels of GH in the AP and serum, unaltered serum IGF-1, and significantly (p< 0.05) higher levels of IL-1 beta in the Cx and HT and GFAP in the Cx, HT, and AP compared to that of shams. Conclusion: CCI leads to a long-term depletion of serum GH in male rats. This chronic change in GH post-TBI is probably the result of systemic and persistent inflammatory changes observed at the level of HT and AP, the mechanism of which is not yet known.	[Kasturi, Badrinarayanan S.; Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA		Kasturi, BS (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	bkastur@emory.edu	Stein, Donald/AAJ-5139-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS048451]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048451] Funding Source: NIH RePORTER	We gratefully acknowledge the assistance provided by Sneha Kemkar and Priya Gandhi in this study. This study was partly supported by funding from the NIH (grant no. 5R01NS048451).	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 1998, J ENDOCRINOL INVEST, V21, P506, DOI 10.1007/BF03347336; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Bechmann I, 1997, HISTOCHEM CELL BIOL, V107, P391, DOI 10.1007/s004180050125; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; BLUM WF, 1993, J CLIN ENDOCR METAB, V76, P1610, DOI 10.1210/jc.76.6.1610; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Ceballos R, 1966, Ala J Med Sci, V3, P185; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Francis J, 2004, AM J PHYSIOL-HEART C, V286, pH2264, DOI 10.1152/ajpheart.01072.2003; Gasco V, 2008, PITUITARY, V11, P121, DOI 10.1007/s11102-008-0110-x; GRANADA UL, 2000, EUROPEAN J ENDOCRINO, P243; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Horie H, 1997, NEUROREPORT, V8, P1955, DOI 10.1097/00001756-199705260-00032; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KASTURI BS, 2008, NAT NEUR SOC ANN M O; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KITA H, 1994, ACTA NEUROCHIR WIEN, V60, pS452; Koliatsos VE, 2004, P NATL ACAD SCI USA, V101, P14264, DOI 10.1073/pnas.0404364101; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIVI GP, 1991, J BIOL CHEM, V266, P15348; Lu G, 1997, NEUROCHEM INT, V30, P401, DOI 10.1016/S0197-0186(96)00075-7; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; PAPADAKIS MA, 1995, J AM GERIATR SOC, V43, P1350, DOI 10.1111/j.1532-5415.1995.tb06613.x; PATEL HC, 2003, ANN NY ACAD SCI, V992, P1; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SARTORIO A, 1995, HORM RES, V44, P6, DOI 10.1159/000184582; Sartorio A, 1996, HORM RES, V45, P23, DOI 10.1159/000184754; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soares CDN, 1999, ARQ NEURO-PSIQUIAT, V57, P182; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Sonntag WE, 2000, J ANAT, V197, P575, DOI 10.1017/S002187829900713X; Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515; Sonntag WE, 2006, AM J PHYSIOL-ENDOC M, V291, pE604, DOI 10.1152/ajpendo.00012.2006; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; WARNER SJC, 1987, J IMMUNOL, V139, P1911	75	43	43	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1315	1324		10.1089/neu.2008.0751			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900014	19317601	Green Published			2022-02-06	
J	Kim, KS; Brophy, GM				Kim, Keri S.; Brophy, Gretchen M.			Symptomatic Venous Thromboembolism: Incidence and Risk Factors in Patients with Spontaneous or Traumatic Intracranial Hemorrhage	NEUROCRITICAL CARE			English	Article						Enoxaparin; Heparin; Neurosurgery; Risk factors; Venous thromboembolism	MOLECULAR-WEIGHT HEPARIN; NEUROSURGICAL PATIENTS; COMPRESSION STOCKINGS; PROPHYLAXIS; THROMBOSIS; PREVENTION; COMPLICATIONS; CRANIOTOMY; SURGERY	The objectives of this study are to determine the incidence of symptomatic venous thromboembolism (VTE) in neurosurgery intensive care unit (NSICU) patients with spontaneous or traumatic intracranial hemorrhage and to identify the common VTE risk factors by injury type. This retrospective, single-center cohort study included adult patients admitted to the NSICU between January 2001 and July 2004 with a primary diagnosis of subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), or traumatic brain injury (TBI). Patients and VTE events were identified using ICD-9 codes. All patients received low-dose unfractionated heparin or enoxaparin and intermittent pneumatic compression device. Descriptive statistics were used to describe patient characteristics. The overall incidence of symptomatic VTE was 3.8% (n = 1195). The incidence of VTE was 6.7% in SAH patients (n = 179), 2.9% in ICH patients (n = 516), and 3.8% in TBI patients (n = 500). The most commonly identified risk factors in the three groups were: greater than 40 years of age, immobility due to paresis or restrictions for mechanical ventilation, presumed infection, and presence of indwelling central venous catheter. There was no objective evidence of intracranial bleeding associated with pharmacologic VTE prophylaxis in VTE patients. This is the first study to determine symptomatic VTE incidence and to identify common risk factors by injury type in nontumor patients who are not routinely screened with venous duplex ultrasonography but receiving early IPC and LDUH. Further studies are needed to determine the overall incident of symptomatic and nonsymptomatic VTE and independent risk factors for VTE events in NSICU patients.	[Brophy, Gretchen M.] Virginia Commonwealth Univ, Dept Pharm & Neurosurg, Richmond, VA 23298 USA; [Kim, Keri S.] Univ Illinois, Med Ctr Chicago, Dept Pharm Practice, Chicago, IL USA		Brophy, GM (corresponding author), Virginia Commonwealth Univ, Dept Pharm & Neurosurg, Med Coll Virginia Campus,410 N 12th St,Room 336,P, Richmond, VA 23298 USA.	gbrophy@vcu.edu		Brophy, Gretchen/0000-0002-4749-2693; Kim, Keri S./0000-0002-8480-4801			Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; *BRAIN TRAUM FDN A, 2007, J NEUROTRAUMA S1, V24, pS32, DOI DOI 10.1089/NEU.2007.9991; CMACDONALD RL, 1999, NEUROSURGERY, V45, P245, DOI DOI 10.1097/00006123-199908000-00008; Epstein NE, 2005, SURG NEUROL, V64, P295, DOI 10.1016/j.surneu.2005.04.039; FRIM DM, 1992, NEUROSURGERY, V30, P830, DOI 10.1227/00006123-199206000-00002; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerlach R, 2003, NEUROSURGERY, V53, P1028, DOI 10.1227/01.NEU.0000088565.15719.22; Gnanalingham KK, 2003, J CLIN NEUROSCI, V10, P467, DOI 10.1016/S0967-5868(03)00060-2; Goldhaber SZ, 2002, CHEST, V122, P1933, DOI 10.1378/chest.122.6.1933; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Macdonald RL, 2003, SURG NEUROL, V59, P363, DOI 10.1016/S0090-3019(03)00111-3; Mack WJ, 2008, NEUROL RES, V30, P889, DOI 10.1179/174313208X327946; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Ogata T, 2008, J NEUROL SCI, V272, P83, DOI 10.1016/j.jns.2008.04.032; Raabe A, 2001, ACTA NEUROCHIR, V143, P1, DOI 10.1007/s007010170131; Wen DY, 1998, SURG NEUROL, V50, P521, DOI 10.1016/S0090-3019(98)00083-4; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F	19	43	52	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2009	11	1					28	33		10.1007/s12028-009-9201-4			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	468AU	WOS:000267786400006	19238588				2022-02-06	
J	Mahmood, A; Goussev, A; Kazmi, H; Qu, CS; Lu, DY; Chopp, M				Mahmood, Asim; Goussev, Anton; Kazmi, Humaira; Qu, Changsheng; Lu, Dunyue; Chopp, Michael			LONG-TERM BENEFITS AFTER TREATMENT OF TRAUMATIC BRAIN INJURY WITH SIMVASTATIN IN RATS	NEUROSURGERY			English	Article						Long term; Newly generated cells; Simvastatin; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; ENDOTHELIAL NITRIC-OXIDE; COA REDUCTASE INHIBITORS; PLASMINOGEN-ACTIVATOR; INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; NERVOUS-SYSTEM; HEAD-INJURY; STATINS; ATORVASTATIN	OBJECTIVE: This study was designed to investigate the long-term effects of simvastatin treatment after traumatic brain injury (TBI) in rats. METHODS: Adult female Wistar rats (n = 24) were injured with controlled cortical impact and divided into 3 groups. The first 2 groups were treated with simvastatin (0.5 or 1.0 mg/kg) administered orally for 14 days starting 1 day after TBI. The third group (control) received phosphate-buffered saline orally for 14 days. Neurological functional outcome was measured with modified neurological severity scores performed I day before TBI; on days 1, 4, 7, 14 after TBI; and biweekly thereafter. All animals were sacrificed 3 months after TBI. Brain tissues of half of the animals were processed for preparation of paraffin-embedded sections for immunohistological studies. The remaining half were frozen for enzyme-linked immunosorbent assay studies for quantification of brain-derived neurotrophic factor (BDNF) in the hippocampus and cortex. RESULTS: The results showed that both doses of simvastatin significantly improved functional outcome compared with the control, with no difference between the 2 doses. Simvastatin treatment of 1.0 mg/kg increased the number of morphologically intact neurons in the hippocampus, but treatment of 0.5 mg/kg had no significant effect. Enzyme-linked immunosorbent assay studies showed that 0.5 mg/kg simvastatin significantly increased BDNF levels within the hippocampus, but 1.0 mg/kg had no significant effect. Neither dose had any effect on BDNF levels within the cortex. CONCLUSION: Simvastatin treatment provides long-lasting functional improvement after TBI in rats. It also enhances neuronal survival in the hippocampus and increases BDNF levels in the hippocampus secondary to simvastatin treatment.	[Mahmood, Asim; Goussev, Anton; Kazmi, Humaira; Qu, Changsheng] Henry Ford Hosp, Dept Neurosurg, Henry Ford Hlth Syst, Detroit, MI 48202 USA; [Lu, Dunyue] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA; [Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, Henry Ford Hlth Syst, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5RO1 NS052280-04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052280] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant 5RO1 NS052280-04. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Amin-Hanjani S, 2001, STROKE, V32, P980, DOI 10.1161/01.STR.32.4.980; Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Bang OY, 2007, NEUROLOGY, V68, P737, DOI 10.1212/01.wnl.0000252799.64165.d5; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bocan Thomas M A, 2002, Curr Opin Investig Drugs, V3, P1312; Bourcier T, 2000, ARTERIOSCL THROM VAS, V20, P556, DOI 10.1161/01.ATV.20.2.556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dujovne CA, 2000, AM J CARDIOL, V85, P350, DOI 10.1016/S0002-9149(99)00745-6; Essig M, 1998, J AM SOC NEPHROL, V9, P1377; Eto M, 2003, ENDOTHELIUM-J ENDOTH, V10, P35, DOI 10.1080/10623320303359; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hoglund K, 2005, DEMENT GERIATR COGN, V19, P256, DOI 10.1159/000084550; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Joukhadar C, 2001, THROMB HAEMOSTASIS, V85, P47, DOI 10.1055/s-0037-1612902; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Laufs U, 2003, EUR J CLIN PHARMACOL, V58, P719, DOI 10.1007/s00228-002-0556-0; Laufs U, 2003, ARTERIOSCL THROM VAS, V23, P156, DOI 10.1161/01.ATV.0000051360.79309.4E; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Miida T, 2007, PHARMACOL THERAPEUT, V113, P378, DOI 10.1016/j.pharmthera.2006.09.003; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Naval NS, 2008, NEUROCRIT CARE, V8, P6, DOI 10.1007/s12028-007-0080-2; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; POSTMANTUR R, 1997, NEUROSCIENCE, V77, P875; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Shi JM, 2003, BLOOD COAGUL FIBRIN, V14, P575, DOI 10.1097/00001721-200309000-00010; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; White CM, 1999, J CLIN PHARMACOL, V39, P111, DOI 10.1177/00912709922007642; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zhang L, 2005, CIRCULATION, V112, P3486, DOI 10.1161/CIRCULATIONAHA.104.516757	46	43	44	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2009	65	1					187	192		10.1227/01.NEU.0000343540.24780.D6			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	474EP	WOS:000268265600023	19574841	Green Accepted			2022-02-06	
J	Snaphaan, L; Rijpkema, M; van Uden, I; Fernandez, G; de Leeuw, FE				Snaphaan, Liselore; Rijpkema, Mark; van Uden, Inge; Fernandez, Guillen; de Leeuw, Frank-Erik			Reduced medial temporal lobe functionality in stroke patients: a functional magnetic resonance imaging study	BRAIN			English	Article						stroke; fMRI; MTL; imaging; n-back task	TRAUMATIC BRAIN-INJURY; MEMORY FUNCTION; WORKING-MEMORY; COGNITIVE DYSFUNCTION; HIPPOCAMPAL ATROPHY; CORTISOL-LEVELS; SCHIZOPHRENIA; DEPRESSION; FMRI; DEFICITS	Stroke is a leading cause of disability, not only because of motor limitations, but also because of the frequent occurrence of post-stroke cognitive impairment. This is illustrated by the fact that the risk of post-stroke dementia is reportedly higher than a recurrent stroke. The loss of subcortical and cortical functions in the post-stroke cognitive dysfunction spectrum is usually well explained by the size and location of the infarction. However, this does not apply for post-stroke memory dysfunction (especially episodic memory dysfunction), as there is almost never an infarction in the medial temporal lobe. Involvement of the medial temporal lobe in post-stroke memory dysfunction seems likely since this structure is essential for memory encoding and retrieval. For a proper episodic memory function, the medial temporal lobe depends on intact connections with virtually the whole brain. Disconnection from other brain areas due to the infarction could lead to a reduced medial temporal lobe function and the attendant reduced episodic memory function. We investigated medial temporal lobe functionality in 28 'first-ever' stroke patients and 22 healthy controls with the aid of functional magnetic resonance imaging. Stroke patients with a reduced episodic memory function 6-8 weeks after infarction had reduced medial temporal lobe functionality. Post-stroke reduced medial temporal lobe functionality may be responsible for the frequent observation of impaired post-stroke episodic memory function. Insight into this mechanism could be helpful in identifying which stroke patients may be at increased risk for developing post-stroke dementia and those who could benefit from early cognitive rehabilitation.	[Snaphaan, Liselore; van Uden, Inge; Fernandez, Guillen; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Dept Neurol, Donders Inst Brain Cognit & Behav, Med Ctr,Ctr Neurosci, NL-6500 HB Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands		de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Dept Neurol, Donders Inst Brain Cognit & Behav, Med Ctr,Ctr Neurosci, POB 9101,HP 935, NL-6500 HB Nijmegen, Netherlands.	H.deLeeuw@neuro.umcn.nl	van Uden, Inge/E-2396-2016; Fernandez, Guillen/B-3771-2009; Rijpkema, Mark/D-1974-2010; de Leeuw, H.F./L-4479-2015; Grootjen, Franc/B-3915-2010; de Leeuw, Frank-Erik/E-4795-2012	Fernandez, Guillen/0000-0002-5522-0604; Rijpkema, Mark/0000-0002-8495-4703; 			Brierley B, 2002, BRAIN RES REV, V39, P84, DOI 10.1016/S0165-0173(02)00160-1; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; de Jonghe J F, 1997, Tijdschr Gerontol Geriatr, V28, P224; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; Delis DC, 1987, CALIFORNIA VERBAL LE; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; FOLSTEIN M, 1973, BIOL PSYCHIAT, V7, P147; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; HERMANN BP, 1987, EPILEPSIA, V28, P547, DOI 10.1111/j.1528-1157.1987.tb03687.x; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Ibrahimagic Omer C, 2005, Med Arh, V59, P79; Johnson SC, 2001, J INT NEUROPSYCH SOC, V7, P55, DOI 10.1017/S135561770171106X; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Kimberley TJ, 2008, EXP BRAIN RES, V186, P183, DOI 10.1007/s00221-007-1221-8; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Loewenstein DA, 2004, AM J GERIAT PSYCHIAT, V12, P395, DOI 10.1176/appi.ajgp.12.4.395; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; MAHONEY F I, 1965, Md State Med J, V14, P61; Marklund N, 2004, J INTERN MED, V256, P15, DOI 10.1111/j.1365-2796.2004.01334.x; Meisenzahl EM, 2006, EUR ARCH PSY CLIN N, V256, P522, DOI 10.1007/s00406-006-0687-x; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; MUNGAS D, 1985, EPILEPSIA, V26, P340, DOI 10.1111/j.1528-1157.1985.tb05660.x; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Sullivan EV, 1996, BIOL PSYCHIAT, V39, P234, DOI 10.1016/0006-3223(95)00135-2; Suzuki WA, 2007, HIPPOCAMPUS, V17, P842, DOI 10.1002/hipo.20321; Szczudlik A, 2004, J ENDOCRINOL INVEST, V27, P37, DOI 10.1007/BF03350908; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VERHAGE F, 1964, INTELIGENCE AGE; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weinberger DR, 1996, NEUROIMAGE, V4, pS118, DOI 10.1006/nimg.1996.0062; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yokota C, 2004, CEREBROVASC DIS, V18, P111, DOI 10.1159/000079258; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	43	52	1	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2009	132		7				1882	1888		10.1093/brain/awp133			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	463OE	WOS:000267440700024	19482967	Bronze			2022-02-06	
J	Harris, OA; Muh, CR; Surles, MC; Pan, Y; Rozycki, G; Macleod, J; Easley, K				Harris, Odette A.; Muh, Carrie R.; Surles, Monique C.; Pan, Yi; Rozycki, Grace; Macleod, Jana; Easley, Kirk			Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial Clinical article	JOURNAL OF NEUROSURGERY			English	Article						cooling helmet; hypothermia; trauma; traumatic brain injury	SEVERE HEAD-INJURIES; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA	Object. Hypothermia has been extensively evaluated in the management of traumatic brain injury (TBI), but no consensus as to its effectiveness has yet been reached. Explanatory hypotheses include a possible confounding effect of the neuroprotective benefits by adverse systemic effects. To minimize the systemic effects, the authors evaluated a selective cerebral cooling system, the CoolSystem Discrete Cerebral Hypothermia System (a "cooling cap"), in the management of TBI. Methods. A prospective randomized controlled clinical trial was conducted at Grady Memorial Hospital, a Level I trauma center. Adults admitted with severe TBI (Glasgow Coma Scale [GCS] score <= 8) were eligible. Patients assigned to the treatment group received the cooling cap, while those in the control group did not. Patients in the treatment group were treated with selective cerebral hypothermia for 24 hours, then rewarmed over 24 hours. Their intracranial and bladder temperatures. cranial-bladder temperature gradient, Glasgow Outcome Scale (GOS) and Functional Independence Measure (FIM) scores, and mortality rates were evaluated. The primary Outcome was to establish a cranial-bladder temperature gradient in those patients with the cooling cap. The secondary outcomes were mortality and morbidity per GOS and FIM scores. Results. The cohort comprised 25 patients (12 in the treatment group, 13 controls). There was no significant intergroup difference in demographic data or median GCS score at enrollment (treatment group 3.0, controls 3.0; p = 0.7). After the third hour of the study, the mean intracranial temperature of the treatment group was significantly lower than that of the controls at all time points except Hours 4 (p = 0.08) and 6 (p = 0.08). However, the target intracranial temperature of 33 degrees C was achieved in only 2 patients in the treatment group. The mean intracranial-bladder temperature gradient was not significant for the treatment group (p = 0.07) or the controls (p = 0.67). Six (50.0%) of 12 patients in the treatment group and 4 (30.8%) of 13 in the control group died (p = 0.43). The medians of the maximum change in GOS and FIM scores during the study period (28 days) for both groups were 0. There was no significant difference in complications between the groups (p value range 0.20-1.0). Conclusions. The cooling cap was not effective in establishing a statistically significant cranial-bladder temperature gradient or in reaching the target intracranial temperature in the majority of patients. No significant difference was achieved in mortality or morbidity between the 2 groups. As the technology Currently stands, the Discrete Cerebral Hypothermia System cooling cap is not beneficial for the management of TBI. Further refinement of the equipment available for the delivery of selective cranial cooling will be needed before any definite conclusions, regarding the efficacy of discrete cerebral hypothermia can be reached. (DOI: 10.3171/2009.1.JNS081320)	[Harris, Odette A.; Muh, Carrie R.; Surles, Monique C.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30303 USA; [Rozycki, Grace; Macleod, Jana] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30303 USA; [Pan, Yi; Easley, Kirk] Emory Univ, Dept Biostat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA		Harris, OA (corresponding author), Emory Univ, Sch Med, Grady Mem Hosp, Dept Neurosurg, 49 Jesse Hill Jr Dr SE,Fac Off Bldg,Room 339, Atlanta, GA 30303 USA.	oharris@emory.edu	Easley, Kirk/K-6910-2015	Easley, Kirk/0000-0003-4419-2617; Surles-Zeigler, Monique/0000-0002-2308-8813; Muh, Carrie/0000-0002-3764-4163; Macleod, Jana/0000-0003-3401-7575	NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007056] Funding Source: NIH RePORTER		Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell T E, 1998, J Cardiovasc Nurs, V13, P34; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; *CDC, 2006, MMWR-MORBID MORTAL W, V55, P201; *CDC, 2007, MMWR-MORBID MORTAL W, V56, P173; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; FAY T, 1940, NY STATE J MED, V40, P1351; Gabbe BJ, 2007, J TRAUMA, V63, P1374, DOI 10.1097/01.ta.0000240481.55341.38; Guido RC, 2006, DIGIT SIGNAL PROCESS, V16, P24, DOI 10.1016/j.dsp.2005.04.002; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; MAHER J, 1993, CEREBROVAS BRAIN MET, V5, P277; Maier C. M., 1995, Society for Neuroscience Abstracts, V21, P1030; MAIER CM, 1996, SOC NEUR ABS, V21, P1938; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MOURITZEN CV, 1966, J THORAC CARDIOV SUR, V51, P585, DOI 10.1016/S0022-5223(19)43326-6; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; ROSOMOFF HL, 1965, ARCH NEUROL-CHICAGO, V13, P337, DOI 10.1001/archneur.1965.00470040003001; ROSOMOFF HL, 1959, ANN NY ACAD SCI, V80, P475, DOI 10.1111/j.1749-6632.1959.tb49225.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Stein S. C., 1996, NEUROTRAUMA, P31; STEINBERG GK, 1995, DELIBERATE HYPOTHERM; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; YOON EJ, 1994, SOC NEUR ABS, V20, P224; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	43	43	47	1	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2009	110	6					1256	1264		10.3171/2009.1.JNS081320			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	451HH	WOS:000266460800023	19249933				2022-02-06	
J	Sullivan, SJ; Bourne, L; Choie, S; Eastwood, B; Isbister, S; McCrory, P; Gray, A				Sullivan, S. John; Bourne, Liam; Choie, Sharon; Eastwood, Brigitte; Isbister, Sarah; McCrory, Paul; Gray, Andrew			Understanding of Sport Concussion by the Parents of Young Rugby Players: A Pilot Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; parents; pediatrics; rugby; signs and symptoms		Objective: Establish the knowledge and beliefs of the parents of high school rugby players about concussion. Design: Descriptive cross-sectional intercept style face-to-face pilot survey. Setting: The survey was conducted during high school rugby games. Participants: Two hundred parents of male high school rugby players who were attending their teenagers' games. Main Outcome Measures: Exploratory analysis of the closed- and open-ended questionnaire. Concussion signs and symptoms were subsequently mapped onto the framework of the Sport Concussion Assessment Tool. Results: Most parents (83%; 165 of 198) reported that they were able to recognize a concussion in their teenager and provide a list of well-accepted signs and symptoms. Nearly all (96%; 188 of 196) were aware of the risks of continuing to play while concussed, and approximately half (51%; 99 of 196) were aware of return-to-play guidelines/recommendations after a concussion. Conclusions: Parents of male high school rugby players reported having basic knowledge of concussion symptoms and the seriousness of concussion. Parents are potentially key figures in the detection of a possible concussion in the postgame/practice home environment.	[Sullivan, S. John; Bourne, Liam; Choie, Sharon; Eastwood, Brigitte; Isbister, Sarah] Univ Otago, Ctr Physiotherapy Res, Sch Physiotherapy, Dunedin 9054, New Zealand; [McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Gray, Andrew] Univ Otago, Dept Prevent & Social Med, Dunedin Sch Med, Dunedin 9054, New Zealand		Sullivan, SJ (corresponding author), Univ Otago, Ctr Physiotherapy Res, Sch Physiotherapy, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Gray, Andrew Robert/L-9161-2015	Gray, Andrew Robert/0000-0003-4299-2194; McCrory, Paul/0000-0003-4850-0568			*ACC COMP CORP, ACC SPORTSSMART RES; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; MILNE C, 1999, NZ J SPORTS MED, P15; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511	10	43	44	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2009	19	3					228	230		10.1097/JSM.0b013e3181a41e43			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	443FN	WOS:000265895700006	19423976				2022-02-06	
J	Koopmans, GC; Deumens, R; Buss, A; Geoghegan, L; Myint, AM; Honig, WHH; Kern, N; Joosten, EA; Noth, J; Brook, GA				Koopmans, Guido C.; Deumens, Ronald; Buss, Armin; Geoghegan, Liam; Myint, Aye Mu; Honig, Wiel H. H.; Kern, Nadine; Joosten, Elbert A.; Noth, Johannes; Brook, Gary A.			Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Immunomodulation; Rolipram; Thalidomide; TNF-alpha; IL-1 beta; Cytokines; Functional recovery; Neuroprotection	TUMOR-NECROSIS-FACTOR; PHOSPHODIESTERASE INHIBITOR ROLIPRAM; ERYTHEMA-NODOSUM LEPROSUM; FUNCTIONAL RECOVERY; FACTOR-ALPHA; ADULT-RAT; SECONDARY INJURY; AXONAL REGENERATION; BRAIN-INJURY; TNF-ALPHA	Traumatic spinal cord injury (SCI) causes severe and permanent functional deficits due to the primary mechanical insult followed by secondary tissue degeneration. The cascade of secondary degenerative events constitutes a range of therapeutic targets which, if successfully treated, could significantly ameliorate functional loss after traumatic SCI. During the early hours after injury, potent pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) are synthesized and released, playing key roles in secondary tissue degeneration. In the present investigation, the ability of rolipram and thalidomide (FDA approved drugs) to reduce secondary tissue degeneration and improve motor function was assessed in an experimental model of spinal cord contusion injury. The combined acute single intraperitoneal administration of both drugs attenuated TNF-alpha and IL-1 beta production and improved white matter Sparing at the lesion epicenter. This was accompanied by a significant (2.6 point) improvement in the BBB locomotor score by 6 weeks. There is, at present, no widely accepted intervention strategy that is appropriate for the early treatment of human SCI. The present data suggest that clinical trials for the acute combined application of rolipram and thalidomide may be warranted. The use of such "established drugs" could facilitate the early initiation of trials. (C) 2009 Elsevier Inc. All rights reserved.	[Koopmans, Guido C.; Deumens, Ronald; Honig, Wiel H. H.; Joosten, Elbert A.] Acad Hosp Maastricht, Dept Anesthesiol, NL-6200 AZ Maastricht, Netherlands; [Buss, Armin; Kern, Nadine; Noth, Johannes; Brook, Gary A.] Aachen Univ Hosp, Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Geoghegan, Liam; Myint, Aye Mu] Univ Limburg, Acad Hosp Maastricht, Div Cellular Neurosci, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands; [Brook, Gary A.] Aachen Univ Hosp, Rhein Westfal TH Aachen, Dept Neuropathol, D-52074 Aachen, Germany		Koopmans, GC (corresponding author), Spinal Cord Therapeut GmbH, Max Planck Str 15A, D-40699 Erkrath, Germany.	guido.koopmans@sctpx.com			Institutional Institute for Research in Paraplegia [P80/04]	This work was supported by a grant from the Institutional Institute for Research in Paraplegia (P80/04) and forms part of the doctoral thesis of Nadine Kern (D82, Diss. RWTH Aachen). The authors have no conflicting financial interests.	ANKENY DP, NEUROSCIENC IN PRESS, DOI DOI 10.1016/J.NEUROSCIENCE.2008.07.001; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; BARIOL C, 2002, J GASTROEN HEPATOL, V17, P233; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Bonmann E, 1997, NEUROSCI LETT, V230, P109, DOI 10.1016/S0304-3940(97)00485-0; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; BUNGE RP, 1993, ADV NEUROL, V59, P75; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; Buttini M, 1997, BRIT J PHARMACOL, V122, P1483, DOI 10.1038/sj.bjp.0701502; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; EIDELBERG E, 1977, EXP NEUROL, V56, P312, DOI 10.1016/0014-4886(77)90350-8; Fitch MT, 1999, J NEUROSCI, V19, P8182; FLEISCHHACKER WW, 1992, NEUROPSYCHOBIOLOGY, V26, P59, DOI 10.1159/000118897; Fujimaki K, 2000, NEUROPSYCHOPHARMACOL, V22, P42, DOI 10.1016/S0893-133X(99)00084-6; Genovese T, 2007, NEUROSCIENCE, V150, P168, DOI 10.1016/j.neuroscience.2007.06.059; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Green B A, 1973, Surg Neurol, V1, P98; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Haslett PAJ, 2005, J INFECT DIS, V192, P2045, DOI 10.1086/498216; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hunt GS, 2003, ANN EMERG MED, V42, pS40; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; Kim YS, 2004, MOL CELLS, V17, P210; King VR, 2007, EUR J NEUROSCI, V26, P90, DOI 10.1111/j.1460-9568.2007.05635.x; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Laffitte Emmanuel, 2004, Expert Opin Drug Saf, V3, P47, DOI 10.1517/14740338.3.1.47; Lankhorst AJ, 1999, J NEUROTRAUM, V16, P323, DOI 10.1089/neu.1999.16.323; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Leskovar A, 2000, J EXP BIOL, V203, P1783; Loy DN, 2002, EXP NEUROL, V177, P575, DOI 10.1006/exnr.2002.7959; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Majumdar S, 2002, J IMMUNOL, V168, P2644, DOI 10.4049/jimmunol.168.6.2644; Meierhofer C, 2003, CURR OPIN DRUG DISC, V6, P92; Mulcahy NJ, 2003, BRIT J PHARMACOL, V140, P471, DOI 10.1038/sj.bjp.0705462; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Penkowa M, 1999, GLIA, V25, P343; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Ribeiro RA, 2000, EUR J PHARMACOL, V391, P97, DOI 10.1016/S0014-2999(99)00918-8; Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SCOTT AIF, 1991, EUR J CLIN PHARMACOL, V40, P127; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Settles B, 2001, CELL MOL BIOL, V47, P1105; Takami T, 2002, J NEUROTRAUM, V19, P653, DOI 10.1089/089771502753754118; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thome J, 2002, NERVENARZT, V73, P595, DOI 10.1007/s00115-002-1276-5; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Villahermosa LG, 2005, AM J TROP MED HYG, V72, P518, DOI 10.4269/ajtmh.2005.72.518; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Witkamp R, 2000, VET QUART, V22, P11, DOI 10.1080/01652176.2000.9695016; Wu JJ, 2005, BRIT J DERMATOL, V153, P254, DOI 10.1111/j.1365-2133.2005.06747.x; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yan P, 2001, J NEUROTRAUM, V18, P563, DOI 10.1089/089771501300227369; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yennurajalingam Sriram, 2004, Support Cancer Ther, V1, P97, DOI 10.3816/SCT.2004.n.003; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1191/135245899678847194; YOUNG W, 1993, J EMERGENCY MED, V11, pS13; Zhu J, 2001, CNS DRUG REV, V7, P387	86	43	46	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2009	216	2					490	498		10.1016/j.expneurol.2009.01.005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424ZK	WOS:000264606600031	19320007				2022-02-06	
J	Cavinato, M; Freo, U; Ori, C; Zorzi, M; Tonin, P; Piccione, F; Merico, A				Cavinato, Marianna; Freo, Ulderico; Ori, Carlo; Zorzi, Manuel; Tonin, Paolo; Piccione, Francesco; Merico, Antonio			Post-acute P300 predicts recovery of consciousness from traumatic vegetative state	BRAIN INJURY			English	Article						Brainstem auditory evoked potentials; Disability Rating Scale; electroencephalogram; P300; sensory evoked potentials; vegetative state	COGNITIVE EVOKED-POTENTIALS; SEVERE BRAIN-INJURY; POSTANOXIC COMA; DISORDERS; PROGNOSIS; RESPONSES; SCALE; EEG	Background: Evoked potentials allow one to assess functional integrity of sensory pathways projecting to primary sensory cortices and event-related potentials assess higher order cortical functions associated with stimulus detection and decision-making. Evoked and event-related potentials have been used to predict emergence from coma. This study aimed to determine whether they can help prediction of consciousness recovery in post-traumatic vegetative state (VS). Methods: Thirty-four patients in post-traumatic VS were assessed clinically and neurophysiologically at 2-3 months after injury and followed up to 1 year. Patients were assessed with the Disability Rating Scale (DRS) and with electroencephalogram (EEG), brainstem auditory (BAEP) and somatosensory evoked potentials (SEP) and P300. Demographic, clinical and neurophysiological measures were analysed by descriptive and logistic regression techniques. Results: At 1 year from injury, 26 patients (76%) had recovered consciousness and eight patients (24%) had not. In univariate analyses, a detectable P300, a reactive EEG and lower DRS scores were found at entry assessment more frequently (p<0.05) in patients who later recovered consciousness than in those who did not. Logistic regression analysis revealed that P300 was the only factor contributing to prediction of conscious recovery with an area under the ROC curve of 0.94 (95% CI, 0.80-0.99). Conclusions: P300 is a strong predictor of conscious recovery in VS.	[Freo, Ulderico] Univ Padua, Dipartimento Farmacol & Anestesiol, Ist Anestesia & Terapia Intens, I-35121 Padua, Italy; [Cavinato, Marianna; Tonin, Paolo; Piccione, Francesco; Merico, Antonio] Osped IRCCS, Ist Cura San Camillo, Venice, Lido, Italy; [Zorzi, Manuel] Ist Oncol Veneto, Padua, Italy		Freo, U (corresponding author), Univ Padua, Dipartimento Farmacol & Anestesiol, Ist Anestesia & Terapia Intens, Via C Battisti 267, I-35121 Padua, Italy.	ulderico.freo@unipd.it	Tonin, Paolo/K-7483-2016; Freo, Ulderico/V-8249-2017; Zorzi, Manuel/J-7029-2016; Piccione, Francesco/K-7214-2016	Tonin, Paolo/0000-0002-4867-1378; Freo, Ulderico/0000-0001-6183-2909; Zorzi, Manuel/0000-0001-6025-5214; Piccione, Francesco/0000-0002-0173-903X; merico, antonio/0000-0001-6783-1333; Cavinato, Marianna/0000-0003-4158-9766			Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2008, INT ANESTHESIOL CLIN, V46, P147, DOI 10.1097/AIA.0b013e318181adcc; de Beyl DZ, 2007, NEUROLOGY, V68, P877, DOI 10.1212/01.wnl.0000260053.80913.b6; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; HARRIS DP, 1990, EAR HEARING, V11, P340, DOI 10.1097/00003446-199010000-00004; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Horovitz SG, 2004, NEUROIMAGE, V22, P1587, DOI 10.1016/j.neuroimage.2004.04.018; JENNETT B, 1972, LANCET, V1, P734; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MEYER E, 1991, ANN NEUROL, V29, P440, DOI 10.1002/ana.410290418; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; *MULT TASK FORC, 1994, NEW ENGL J MED, V333, P1572; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ruytjens L, 2007, EUR J NUCL MED MOL I, V34, P2073, DOI 10.1007/s00259-007-0517-z; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Vanhaudenhuyse A, 2008, NEUROCRIT CARE, V8, P262, DOI 10.1007/s12028-007-9016-0; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	30	43	53	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	12					973	980		10.3109/02699050903373493			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	529YL	WOS:000272555200005	19831494				2022-02-06	
J	Chen, JWY; Ruff, RL; Eavey, R; Wasterlain, CG				Chen, James W. Y.; Ruff, Robert L.; Eavey, Roland; Wasterlain, Claude G.			Posttraumatic epilepsy and treatment	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						anticonvulsants; brain imaging; posttraumatic epilepsy; posttraumatic stress disorder; refractory seizures; rehabilitation; seizures; traumatic brain injury; unprovoked seizures; veterans	POST-TRAUMATIC EPILEPSY; HEAD-INJURY; SEIZURES; PROPHYLAXIS; PHENYTOIN; RISK; ANTICONVULSANT; AGENTS	Posttraumatic epilepsy (PTE) is a major long-term complication of traumatic brain injury (TBI). PTE usually develops within 5 years of head injury. The risk for developing PTE varies with TBI type. Both Korean and Vietnam war veterans with penetrating TBI had a 53% risk of developing PTE. The risk of developing PTE is between 10% and 25% in combat-associated closed-head trauma with positive brain imaging and about 5% in moderately severe closed-head injury without imaging finding. We do not know the risk of PTE among Operation Iraqi Freedom/Operation Enduring Freedom veterans with minimal TBI because of blast exposure. Partial seizures may manifest with subtle behavioral alterations that can be mistaken for manifestations of posttraumatic stress disorder and improperly treated. Accidents and medical complications commonly occur during seizures. Sudden unexpected death in epilepsy is most frequent among 20- to 40-year-olds. Seizures increase the likelihood of refractory seizures years after TBI. Seizures are also a social stigma that compromise veterans' reintegration into society. People with uncontrolled epilepsy are not allowed to drive and have difficulty obtaining or maintaining employment. Optimal seizure control is essential to the physical and emotional health of veterans with TBI and to their ability to lead productive lives.	[Chen, James W. Y.; Eavey, Roland; Wasterlain, Claude G.] VA Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA USA; [Chen, James W. Y.; Eavey, Roland; Wasterlain, Claude G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ruff, Robert L.] Louis Stokes Cleveland VA Med Ctr, Neurol Serv, Cleveland, OH USA; [Ruff, Robert L.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA		Chen, JWY (corresponding author), W Los Angeles VA Healthcare Ctr, Neurol MC 127,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	jwychen@ucla.edu	Ritter, Stefanie L/D-9312-2012	Chen, James/0000-0002-3220-138X	Veterans AffairsUS Department of Veterans Affairs [I01BX000273] Funding Source: NIH RePORTER; BLRD VA [I01 BX000273] Funding Source: Medline		Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1962, J NEUROSURG, V19, P122, DOI 10.3171/jns.1962.19.2.0122; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Jennett B, 1979, Adv Neurol, V22, P137; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; PRICE DJ, 1980, PLACE SODIUM VALPROA, P23; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TAYLOR DC, 1980, J NEUROL NEUROSUR PS, V43, P758, DOI 10.1136/jnnp.43.9.758; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x	21	43	46	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	6					685	695		10.1682/JRRD.2008.09.0130			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	531BQ	WOS:000272638100006	20104398	Bronze			2022-02-06	
J	Ley, EJ; Scehnet, J; Park, R; Schroff, S; Dagliyan, G; Conti, PS; Margulies, DR; Salim, A				Ley, Eric J.; Scehnet, Jeff; Park, Ryan; Schroff, Stu; Dagliyan, Grant; Conti, Peter S.; Margulies, Daniel R.; Salim, Ali			The In Vivo Effect of Propranolol on Cerebral Perfusion and Hypoxia After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Trauma; Traumatic brain injury; Beta blocker; Propranolol; Perfusion	BETA-BLOCKER EXPOSURE; HEAD-INJURY; IMPROVED OUTCOMES; IMPROVED SURVIVAL; STROMAL CELLS; IMPACT; TBI; PET	Background. Recent epidemiologic evidence has identified beta-blockade as independently associated with improved survival in patients with isolated traumatic brain injury (TBI). Reduced sympathetic discharge and catecholamine release may improve circulation in the injured areas and influence delayed demise. The purpose of this study was to investigate the cerebral effect of beta-blockade in a murine TBI model using immunohistochemical and microPET analysis. Methods: Balb/c mice underwent TBI as in a previously described model and were randomized to receive treatment with propranolol or placebo in a blinded fashion. Immunofluorescent images were obtained for vessel density (CD31), vessel perfusion (Ricinus communis agglutinin [RCA]-lectin), and cerebral hypoxia (hypoxyprobe-1) and compared by digital quantification. Perfusion measurements were acquired using positron emission tomography microPET scans with [Cu-64]-pyruvaldehyde bis(N-4-methylthiosemicarbazone) ([Cu-64]-PTSM) and converted into standardized uptake values (SUV) for analysis. Results: On immunobistochemical analysis, the normal mouse cerebral perfusion was a quantitated mean of 325 +/- 21), the cerebral perfusion after TBI and treatment with placebo was 113 +/- 25, and the cerebral perfusion after TBI treated with propranolol was 172 +/- 23. Immunohistochemical analysis demonstrated treatment with propranolol improved cerebral perfusion by 152% (p value <0.01) and reduced cerebral hypoxia by 24.2% (p value <0.01) compared with treatment with placebo. MicroPET imaging of the normal mouse brain after injection with placebo measured a SUV of 0.7075 +/- 0.02; the normal mouse brain after treatment with propranolol measured a SUV of 0.400 +/- 0.02. After TBI and treatment with placebo, the SUV reduced to 0395 +/- 0.01; after treatment with propranolol the SUV measured 0.515 +/- 0.04. MicroPET imaging demonstrated propranolol improved cerebral perfusion after TBI to 130% of placebo (p value <0.01). Conclusion: Propranolol in vivo increased cerebral perfusion and decreased cerebral hypoxia. This research demonstrates beta-blockade may prevent additional brain damage after traumatic insult and should be the focus of future clinical trials.	[Ley, Eric J.; Scehnet, Jeff; Park, Ryan; Schroff, Stu; Dagliyan, Grant; Conti, Peter S.; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org					Alauddin MM, 2007, NUCL MED BIOL, V34, P267, DOI 10.1016/j.nucmedbio.2006.12.009; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Chiu W, 2007, J TRAUMA, V63, P510; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Conti PS, 2008, NUCL MED BIOL, V35, P131, DOI 10.1016/j.nucmedbio.2007.09.003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; Enderson BL, 2007, J TRAUMA, V62, P33; GREEN MA, 1990, J NUCL MED, V31, P1989; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Lewis JS, 1999, J NUCL MED, V40, P177; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Pryor JP, 2007, J TRAUMA, V62, P61; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Young H, 1994, J Nucl Biol Med, V38, P89; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	22	43	44	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2009	66	1					154	161		10.1097/TA.0b013e31819388be			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	395SJ	WOS:000262543500020	19131818				2022-02-06	
S	Maiese, K; Chong, ZZ; Hou, JL; Shang, YC		Maiese, K		Maiese, Kenneth; Chong, Zhao Zhong; Hou, Jinling; Shang, Yan Chen			The "O" Class: Crafting Clinical Care with FoxO Transcription Factors	FORKHEAD TRANSCRIPTION FACTORS: VITAL ELEMENTS IN BIOLOGY AND MEDICINE	Advances in Experimental Medicine and Biology		English	Article; Book Chapter							INFLAMMATORY MICROGLIAL ACTIVATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROSTATE-CANCER CELLS; SMOOTH-MUSCLE-CELLS; NERVE GROWTH-FACTOR; REGULATORY T-CELLS; NF-KAPPA-B; OXIDATIVE-STRESS; PROTEIN-KINASE; LIFE-SPAN	Forkhead Transcription Factors: Vital Elements in Biology and Medicine provides a unique platform for the presentation of novel work and new insights into the vital role that fork-head transcription factors play in both cellular physiology as well as clinical medicine. Internationally recognized investigators provide their insights and perspectives for a number of forkhead genes and proteins that may have the greatest impact for the development of new strategies for a broad array of disorders that can involve aging, cancer, cardiac function, neurovascular integrity, fertility, stem cell differentiation, cellular metabolism, and immune system regulation. Yet, the work clearly sets a precedent for the necessity to understand the cellular and molecular function of forkhead proteins since this family of transcription factors can limit as wen as foster disease progression depending upon the cellular environment. With this in mind, our concluding chapter for Forkhead Transcription Factors: Vital Elements in Biology and Medicine offers to highlight both the diversity and complexity of the forkhead transcription family by focusing upon the mammalian forkhead transcription factors of the O class (FoxOs) that include FoxO1, FoxO3, FoxO4, and FoxO6. FoxO proteins are increasingly considered to represent unique cellular targets that can control numerous processes such as angiogenesis, cardiovascular development, vascular tone, oxidative stress, stem cell proliferation, fertility, and immune surveillance. Furthermore, FoxO transcription factors are exciting considerations for disorders such as cancer in light of their pro-apoptotic and inhibitory cell cycle effects as well as diabetes mellitus given the close association FoxOs hold with cellular metabolism. In addition, these transcription factors are closely integrated with several novel signal transduction pathways, such as erythropoietin and Writ proteins, that may influence the ability of FoxOs to lead to cell survival or cell injury. Further understanding of both the function and intricate nature of the forkhead transcription factor family, and in particular the FoxO proteins, should allow selective regulation of cellular development or cellular demise for the generation of successful future clinical strategies and patient well-being.	[Maiese, Kenneth] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA		Maiese, K (corresponding author), Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA.	kmaiese@med.wayne.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES006639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053946] Funding Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES06639, P30 ES006639] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS053946-05, R01 NS053946-03, R01 NS053946-04, R01 NS053946-03S1, R01 NS053946-06, R01 NS053946, R01 NS053946-01A2, R01 NS053946-05W1, R01 NS053946-02] Funding Source: Medline		Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Bosque A, 2007, BLOOD, V109, P1627, DOI 10.1182/blood-2006-05-022319; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Cariou A, 2008, RESUSCITATION, V76, P397, DOI 10.1016/j.resuscitation.2007.10.003; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; Chong ZZ, 2008, CURR NEUROVASC RES, V5, P159, DOI 10.2174/156720208785425666; Chong ZZ, 2007, CURR NEUROVASC RES, V4, P194; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Chong ZZ, 2007, INT J MOL MED, V19, P263; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P197, DOI 10.2174/1567202054368317; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; Chong ZZ, 2004, ANTIOXID REDOX SIGN, V6, P277, DOI 10.1089/152308604322899341; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chonga ZZ, 2004, EXP CELL RES, V296, P196, DOI 10.1016/j.yexcr.2004.01.021; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cools N, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89195; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Eddy SF, 2007, CANCER RES, V67, P9018, DOI 10.1158/0008-5472.CAN-07-1691; Emami KH, 2007, CANCER LETT, V253, P170, DOI 10.1016/j.canlet.2006.12.040; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Goettsch W, 2008, J CELL PHYSIOL, V214, P491, DOI 10.1002/jcp.21229; Gomez-Gutierrez JG, 2006, CANCER BIOL THER, V5, P875, DOI 10.4161/cbt.5.7.2911; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Han CY, 2008, CARCINOGENESIS, V29, P1837, DOI 10.1093/carcin/bgn092; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hellwinkel OJC, 2008, BJU INT, V101, P1454, DOI 10.1111/j.1464-410X.2008.07540.x; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Hockstra AV, 2008, GYNECOL ONCOL, V108, pS141; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Jin CW, 1998, BIOCHEMISTRY-US, V37, P6179, DOI 10.1021/bi980031v; Jin GS, 2004, ACTA MED OKAYAMA, V58, P197; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Kaestner KH, 2000, GENE DEV, V14, P142; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang JQ, 2003, J NEUROSCI RES, V74, P37, DOI 10.1002/jnr.10740; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kikuchi S, 2007, CANCER SCI, V98, P1949, DOI 10.1111/j.1349-7006.2007.00623.x; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4; Kim JR, 2006, OBESITY, V14, P188, DOI 10.1038/oby.2006.24; Kim JH, 2007, MODERN PATHOL, V20, P835, DOI 10.1038/modpathol.3800789; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Larson ET, 2007, VIROLOGY, V368, P249, DOI 10.1016/j.virol.2007.06.040; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Li F, 2006, HISTOL HISTOPATHOL, V21, P103, DOI 10.14670/HH-21.103; Li F, 2006, CURR NEUROVASC RES, V3, P187, DOI 10.2174/156720206778018758; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Li FQ, 2005, CURR NEUROVASC RES, V2, P331, DOI 10.2174/156720205774322557; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin SH, 2001, J CEREBR BLOOD F MET, V21, P262, DOI 10.1097/00004647-200103000-00010; Liu CM, 2007, CANCER GENE THER, V14, P945, DOI 10.1038/sj.cgt.7701091; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Ludikhuize J, 2007, ARTHRITIS RHEUM-US, V56, P2180, DOI 10.1002/art.22653; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; Maiese K, 2005, CURR NEUROVASC RES, V2, P425, DOI 10.2174/156720205774962692; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; MAIESE K, 2009, NEUROVASCULAR MED PU; Maiese Kenneth, 2008, Expert Rev Cardiovasc Ther, V6, P281, DOI 10.1586/14779072.6.3.281; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Maiese K, 2008, EXPERT OPIN THER TAR, V12, P905, DOI 10.1517/14728222.12.7.905 ; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Maiese K, 2008, BIOMED PHARMACOTHER, V62, P218, DOI 10.1016/j.biopha.2008.01.009; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Maiese K, 2007, CURR NEUROVASC RES, V4, P295, DOI 10.2174/156720207782446306; Maiese K, 2008, CYTOKINE GROWTH F R, V19, P145, DOI 10.1016/j.cytogfr.2008.01.004; Maiese K, 2007, CURR NEUROVASC RES, V4, P63, DOI 10.2174/156720207779940653; Maiese K, 2007, CURR MED CHEM, V14, P1729; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Maiese K, 2009, CLIN SCI, V116, P191, DOI 10.1042/CS20080113; Maiese K, 2008, CELL CYCLE, V7, P3829, DOI 10.4161/cc.7.24.7231; Marchetti V, 2006, DIABETES, V55, P2231, DOI 10.2337/db06-0369; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morris JB, 2005, ENDOCRINOLOGY, V146, P4370, DOI 10.1210/en.2005-0162; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Munoz-Fontela C, 2007, J VIROL, V81, P1511, DOI 10.1128/JVI.01816-06; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sauvageot CM, 2007, NEUROL CLIN, V25, P891, DOI 10.1016/j.ncl.2007.07.014; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Sela U, 2006, EUR J IMMUNOL, V36, P2971, DOI 10.1002/eji.200636137; Shang YC, 2009, CURR NEUROVASC RES, V6, P20, DOI 10.2174/156720209787466064; Slomka M, 2008, ACTA NEUROBIOL EXP, V68, P1; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Tajes M, 2009, MECH AGEING DEV, V130, P253, DOI 10.1016/j.mad.2008.12.006; Ticchioni M, 2007, ONCOGENE, V26, P7081, DOI 10.1038/sj.onc.1210519; Tomita H, 2007, CANCER RES, V67, P4079, DOI 10.1158/0008-5472.CAN-06-4025; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Watkins WJ, 2006, FERTIL STERIL, V86, P1518, DOI 10.1016/j.fertnstert.2006.03.054; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Won CK, 2006, NEUROSCI LETT, V398, P39, DOI 10.1016/j.neulet.2005.12.060; Xu HT, 2007, ANN SURG ONCOL, V14, P3251, DOI 10.1245/s10434-007-9555-9; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	175	43	43	0	8	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0065-2598	2214-8019	978-1-4419-1598-6	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2009	665						242	260			10.1007/978-1-4419-1599-3		19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	BMC36	WOS:000271833300018	20429429				2022-02-06	
J	Rossaint, J; Rossaint, R; Weis, J; Fries, M; Rex, S; Coburn, M				Rossaint, Jan; Rossaint, Rolf; Weis, Joachim; Fries, Michael; Rex, Steffen; Coburn, Mark			Propofol: neuroprotection in an in vitro model of traumatic brain injury	CRITICAL CARE			English	Article							ORGANOTYPIC HIPPOCAMPAL CULTURES; CEREBRAL-ISCHEMIA; CELL-DEATH; REGIONAL VULNERABILITY; OXIDATIVE STRESS; NEURONAL DEATH; SLICE CULTURES; INFARCT SIZE; GLUTAMATE; RAT	Introduction The anaesthetic agent propofol (2,6-diisopropylphenol) has been shown to be an effective neuroprotective agent in different in vitro models of brain injury induced by oxygen and glucose deprivation. We examined its neuroprotective properties in an in vitro model of traumatic brain injury. Methods In this controlled laboratory study organotypic hippocampal brain-slice cultures were gained from six-to eight-day-old mice pups. After 14 days in culture, hippocampal brain slices were subjected to a focal mechanical trauma and subsequently treated with different molar concentrations of propofol under both normo- and hypothermic conditions. After 72 hours of incubation, tissue injury assessment was performed using propidium iodide (PI), a staining agent that becomes fluorescent only when it enters damaged cells via perforated cell membranes. Inside the cell, PI forms a fluorescent complex with nuclear DNA. Results A dose-dependent reduction of both total and secondary tissue injury could be observed in the presence of propofol under both normo- and hypothermic conditions. This effect was further amplified when the slices were incubated at 32 degrees C after trauma. Conclusions When used in combination, the dose-dependent neuroprotective effect of propofol is additive to the neuroprotective effect of hypothermia in an in vitro model of traumatic brain injury.	[Rossaint, Jan; Rossaint, Rolf; Fries, Michael; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anesthesiol, D-52074 Aachen, Germany; [Weis, Joachim] Univ Hosp RWTH Aachen, Inst Neuropathol, D-52074 Aachen, Germany; [Rex, Steffen] Univ Hosp RWTH Aachen, Dept Surg Intens Care, D-52074 Aachen, Germany		Coburn, M (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773; Rex, Steffen/0000-0002-3536-9321; Coburn, Mark/0000-0002-7930-0270	START program of the Medical Faculty of the RWTH Aachen	This research was conducted with funding by the START program of the Medical Faculty of the RWTH Aachen. We would like to thank Rosemarie Blaumeiser-Debarry for help with data acquisition; the teams at the Departments of Neuropathology, Pathology and Animal Research at the University Hospital Aachen; Professor Nicholas P. Franks for expert laboratory advice, assistance and help; Christina Mutscher and Elfriede Arweiler for their statistical support; and Michelle Haager for helpful comments on the manuscript.	AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Adembri C, 2007, CNS DRUG REV, V13, P333, DOI 10.1111/j.1527-3458.2007.00015.x; Alkire MT, 2001, BRIT J ANAESTH, V86, P618, DOI 10.1093/bja/86.5.618; Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bayona NA, 2004, ANESTHESIOLOGY, V100, P1151, DOI 10.1097/00000542-200405000-00017; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Crain SM, 1998, METHODS, V16, P228, DOI 10.1006/meth.1998.0681; Daskalopoulos R, 2001, ANESTH ANALG, V93, P1199, DOI 10.1097/00000539-200111000-00030; De Riu PL, 2000, EUR J ANAESTH, V17, P18, DOI 10.1097/00003643-200001000-00004; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Engdahl O, 1998, BRIT J ANAESTH, V81, P957, DOI 10.1093/bja/81.6.957; Feiner JR, 2005, ANESTH ANALG, V100, P215, DOI 10.1213/01.ANE.0000142129.17005.73; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Fowler CJ, 2004, TRENDS PHARMACOL SCI, V25, P59, DOI 10.1016/j.tips.2003.12.001; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gelb AW, 2002, ANESTHESIOLOGY, V96, P1183, DOI 10.1097/00000542-200205000-00023; Gredell JA, 2004, BRIT J ANAESTH, V93, P810, DOI 10.1093/bja/aeh272; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Lahtinen H, 2001, NEUROSCIENCE, V105, P131, DOI 10.1016/S0306-4522(01)00168-3; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Ludbrook GL, 2002, ANESTHESIOLOGY, V97, P1363, DOI 10.1097/00000542-200212000-00006; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Patel S, 2003, BRIT J PHARMACOL, V139, P1005, DOI 10.1038/sj.bjp.0705334; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; Qi SH, 2002, ANESTH ANALG, V94, P655, DOI 10.1097/00000539-200203000-00032; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RIDENOUR TR, 1992, ANESTHESIOLOGY, V76, P807, DOI 10.1097/00000542-199205000-00020; SHYR MH, 1995, NEUROSCI LETT, V184, P212, DOI 10.1016/0304-3940(94)11209-2; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; TASKER RC, 1992, J NEUROSCI, V12, P4298; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Tsai Y C, 1994, Acta Anaesthesiol Sin, V32, P99; Tsuchiya M, 2002, ACTA ANAESTH SCAND, V46, P1068, DOI 10.1034/j.1399-6576.2002.460903.x; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Zhu HC, 1997, ANESTHESIOLOGY, V87, P944, DOI 10.1097/00000542-199710000-00030	56	43	46	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	2							R61	10.1186/cc7795			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453UN	WOS:000266638500033	19397790	gold, Green Published			2022-02-06	
J	Ramakrishna, R; Stiefel, M; Udoteuk, J; Spiotta, A; Levine, JM; Kofke, WA; Zager, E; Yang, W; LeRoux, P				Ramakrishna, Rohan; Stiefel, Michael; Udoteuk, Joshua; Spiotta, Alejandro; Levine, Joshua M.; Kofke, W. Andrew; Zager, Eric; Yang, Wei; LeRoux, Peter			Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						brain tissue oxygen; cerebral perfusion pressure; subarachnoid hemorrhage	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL ANEURYSM; ELDERLY PATIENTS; MENSTRUAL-CYCLE; SEX-DIFFERENCES; GRADE PATIENTS; HEALTHY WOMEN; TISSUE OXYGEN; NORMAL VALUES	Object Poor Outcome is common after aneurysmal subarachnoid hemorrhage (SAH). Clinical studies Suggest that cerebral hypoxia after traumatic brain injury is associated with poor Outcome. In this study we examined the relationship between brain oxygen tension (PbtO(2)) and death I after aneurysmal SAH. Methods. Forty-six patients, including 34 women and 12 men (Glasgow Coma Scale Score :5 8 and median age 8.5 bears) who underwent PbtO(2) monitoring were studied prospectively during a 2-year period in a neurosurgical intensive care unit at a University Level I Trauma Center. Brain oxygen tension, intracranial pressure (ICP), mean arterial pressure, cerebral perfusion pressure (CIPP), and brain temperature were continuously monitored. and treatment was directed toward ICP. CPR and PbtO(2) targets. The relationship between PbtO(2) and 1-month survival was examined. Results. Data were available from 5424 hours of PbtO(2) monitoring. For the entire cohort the mean ICP. CPR and PbtO(2) were 13.85 +/- 2.40, 84.05 +/- 3.41. and 30.79 +/- 1.91 mm Hg, respectively. Twenty-five patients died (54%). The mean daily PbtO(2) was higher in survivors than nonsurvivors (33.94 +/- 2.74 vs 28.14 +/- 2.59 mm Hg p = 0.05). In addition. survivors had significantly shorter episodes of compromised PbtO(2) (defined as 15-25 mm Hg) than nonsurvivors (125.85 +/- 15.44 vs 271.14 +/- 55.23 minutes; p < 0.01). Intracranial pressure was similar in survivors and nonsurvivors. In contrast, the average CPP was significantly lower in nonsurvivors than survivors (76.96 +/- 5.50 vs 92.49 +/- 2.75 mm Hg (p = 0.01). When PbtO(2) was stratified according to CPP level, Survivors had higher PbtO(2) levels. Following logistic regression, the number of episodes of compromised PbtO, (odds ratio 1.1, 95% confidence interval 1.003-1.2) and number of episodes of cerebral hypoxia (< 15 mm Hg: odds ratio 1.3. 95% confidence interval 1.0-1.7) were more frequent in those who died. Conclusions. Patient deaths after SAH may be associated with a lower mean PbtO, and longer periods of compromised cerebral oxygenation than ill Survivors. This knowledge may be used to help direct therapy. (DOI: 10.3171.JNS.2008.109.12.1075)	[Ramakrishna, Rohan; Stiefel, Michael; Udoteuk, Joshua; Spiotta, Alejandro; Levine, Joshua M.; Kofke, W. Andrew; Zager, Eric; LeRoux, Peter] Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA; [Levine, Joshua M.] Univ Penn, Dept Neurol, Philadelphia, PA 19107 USA; [Levine, Joshua M.; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19107 USA; [Yang, Wei] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19107 USA		LeRoux, P (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389			ABOUKHALIL B, 1994, CRIT CARE MED, V22, P633, DOI 10.1097/00003246-199404000-00020; Bardt TF, 1998, ACT NEUR S, V71, P153; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dings J, 1998, NEUROL RES, V20, pS71; FRIDRIKSSON SM, 1995, NEUROSURGERY, V37, P627, DOI 10.1227/00006123-199510000-00004; Geary GG, 2000, AM J PHYSIOL-HEART C, V279, pH511, DOI 10.1152/ajpheart.2000.279.2.H511; GUR RC, 1987, ARCH GEN PSYCHIAT, V44, P617; HUGOSSON R, 1973, ACTA NEUROCHIR, V28, P157, DOI 10.1007/BF01432227; INAGAWA T, 1993, J NEUROSURG, V78, P554, DOI 10.3171/jns.1993.78.4.0554; INAGAWA T, 1988, J NEUROSURG, V69, P332, DOI 10.3171/jns.1988.69.3.0332; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KETY S S, 1956, J Chronic Dis, V3, P478, DOI 10.1016/0021-9681(56)90146-1; Krejza J, 2005, AM J NEURORADIOL, V26, P730; Krejza J, 2003, ULTRASOUND OBST GYN, V22, P627, DOI 10.1002/uog.907; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; MALONEYWILENSKY E, 2007, NEUROCRIT CARE, V6, P216; MATHEW RJ, 1986, BIOL PSYCHIAT, V21, P907, DOI 10.1016/0006-3223(86)90264-7; MATSUDA H, 1984, STROKE, V15, P336, DOI 10.1161/01.STR.15.2.336; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; OHMAN J, 1991, J NEUROSURG, V74, P14, DOI 10.3171/jns.1991.74.1.0014; OSULLIVAN MG, 1994, BRIT J NEUROSURG, V8, P23, DOI 10.3109/02688699409002389; PANTANO P, 1984, STROKE, V15, P635, DOI 10.1161/01.STR.15.4.635; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; ROOTWELT K, 1986, SCAND J CLIN LAB INV, V46, P97; SAKAKI S, 1989, CLIN NEUROL NEUROSUR, V91, P21, DOI 10.1016/S0303-8467(89)80004-6; Schwertz DW, 2001, HEART LUNG, V30, P401, DOI 10.1067/mhl.2001.118764; SENGUPTA RP, 1978, BRIT MED J, V2, P246, DOI 10.1136/bmj.2.6132.246; SHAW TG, 1984, NEUROLOGY, V34, P855, DOI 10.1212/WNL.34.7.855; SHIRAHATA N, 1985, J COMPUT ASSIST TOMO, V9, P861, DOI 10.1097/00004728-198509000-00004; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; SOLERTE SB, 1988, BRIT J OBSTET GYNAEC, V95, P1305, DOI 10.1111/j.1471-0528.1988.tb06822.x; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vath A, 2002, ACT NEUR S, V81, P307; Waddell TK, 1999, J HYPERTENS, V17, P413, DOI 10.1097/00004872-199917030-00015; WANG S, 2004, MANAGEMENT CEREBRAL, P409; WHITE RE, 1995, CIRC RES, V77, P936, DOI 10.1161/01.RES.77.5.936; Yang SH, 2001, J CEREBR BLOOD F MET, V21, P174, DOI 10.1097/00004647-200102000-00009	45	43	43	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2008	109	6					1075	1082		10.3171/JNS.2008.109.12.1075			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	376SY	WOS:000261204500018	19035722				2022-02-06	
J	Wennberg, RA; Tator, CH				Wennberg, Richard A.; Tator, Charles H.			Concussion Incidence and Time Lost from Play in the NHL During the Past Ten Years	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							CONSENSUS INJURY DEFINITIONS; TEAM SPORTS; ICE HOCKEY; HEAD; DEBATE; FOCUS; SIZE	Background: The problem of concussions in professional hockey has attracted Much recent attention. To evaluate file current state of this injury in the National Hockey League (NHL), we analyzed the Concussion incidence and time lost from play Clue to Concussions during the past tell NHL seasons. Methods: Data were obtained from a complete review of injury reports in two different sports media sources covering the NFIL seasons 1997-98 through 2007-08. Time lost from play was measured in missed games per concussion. Results: The incidence of concussions reported in the regular season ranged from it high of 1.81/1000 athlete exposures in 1998-99 to a low of 1.04/1000 athlete exposures in 2005-06. There was if downward trend ill the number Of Concussions reported per season during the past tell years (p=0.01). However, average time lost from play per concussion increased over the same period (p < 0.0005). Forwards suffered a disproportionately high percentage of concussions (p < 0.0001). Conclusions: Possibly related to injury reduction efforts. the number of concussions reported per season in the NHL has trended downward in recent years. However. the incidence of concussion remains high and the average time lost from play per concussion has increased. This may reflect increased injury severity in recent years or, alternatively, increased adherence to modern management guidelines preventing premature return to play.	[Wennberg, Richard A.] Univ Toronto, Toronto Western Hosp, Div Neurol, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada; [Tator, Charles H.] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada; [Wennberg, Richard A.; Tator, Charles H.] ThinkFirst, Toronto, ON, Canada		Wennberg, RA (corresponding author), Univ Toronto, Toronto Western Hosp, Div Neurol, Krembil Neurosci Ctr, 399 Bathurst St,Suite 5W444, Toronto, ON M5T 2S8, Canada.						Agel J, 2007, J ATHL TRAINING, V42, P241; Carson J, 2006, CAN FAM PHYSICIAN, V52, P756; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MEEUWISSE W, 2001, BRIT J SPORT MED, V35, P375; MENDOZA M, 2006, COLUMBIAN       1206, pB1; MOORE M, 2006, SAVING GAME; Orchard J, 2002, BRIT J SPORT MED, V36, P16, DOI 10.1136/bjsm.36.1.16; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; REID SM, 2007, ORANGE COUNTY R 0923, P1; STARKMAN R, 2007, TORONTO STAR    1223, pS1; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; WENNBERG R, 2004, GLOBE MAIL      0826, pA17; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	19	43	43	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2008	35	5					647	651		10.1017/S031716710000946X			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	379JZ	WOS:000261393800017	19235451	Bronze			2022-02-06	
J	Schanke, AK; Rike, PO; Psychol, C; Molmen, A; Psychol, C; Osten, PE				Schanke, Anne-Kristine; Rike, Per-Ola; Psychol, Cand; Molmen, Anette; Psychol, Cand; Osten, Per Egil			DRIVING BEHAVIOUR AFTER BRAIN INJURY: A FOLLOW-UP OF ACCIDENT RATE AND DRIVING PATTERNS 6-9 YEARS POST-INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						driving; brain injury; accidents	SIMULATOR; STROKE	Objective: A follow-up of accident rate and driving patterns of patients 6-9 years after brain injury. Design: Postal questionnaire sent to patients with brain injury who were assessed consecutively in the period 1997-2000 and who were re-issued. Subjects: A total of 93 persons, 69 men and 24 women, mean age 57 years, average 9 years post-injury, 65 persons with brain injury after cerebrovascular accidents and 28 with traumatic brain injury. Methods: The questionnaire covered self-reported driving accidents pre- and post-injury, yearly distance driven, behaviour in traffic and self-reported care taken in driving. Results: The cerebrovascular accident group had reduced their driving significantly post-injury and had also changed their driving patterns. No significant changes were found in distance driven and driving patterns for the group with traumatic brain injury. Compared with normative data, reported accidents post-injury in the cerebrovascular accident group showed no increased accident rate, while the accident rate in the traumatic brain injury-group was more than 2 times higher. Conclusion: Patients with traumatic brain injury represent a risk group for accidents post-injury, while those with brain injury after cerebrovascular accidents do not. Possible causes for this difference are discussed.	[Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Res Unit, N-1450 Nesoddtangen, Norway		Schanke, AK (corresponding author), Sunnaas Rehabil Hosp, Res Unit, N-1450 Nesoddtangen, Norway.	Anne-kristine.schanke@sunnaas.no					Akinwuntan AE, 2006, NEUROREHAB NEURAL RE, V20, P417, DOI 10.1177/1545968306287157; Bieliauskas LA, 2005, BRAIN INJURY, V19, P221, DOI 10.1080/02699050400017213; BJORNSKAU T, 6942003 I TRANSP EC; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Goode KT, 1998, J CLIN PSYCHOL MED S, V5, P425, DOI 10.1023/A:1026206927686; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lundberg C, 1998, ACCIDENT ANAL PREV, V30, P371, DOI 10.1016/S0001-4575(97)00111-5; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; MOSBERG A, 2000, J  NORWEGIAN MED ASS, V120, P3392; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697	17	43	45	0	9	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	OCT	2008	40	9					733	736		10.2340/16501977-0256			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	363VP	WOS:000260295300008	18843425	gold			2022-02-06	
J	Reddy, CC; Collins, MW; Gioia, GA				Reddy, Cara Camiolo; Collins, Michael W.; Gioia, Gerald A.			Adolescent-Sports Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; GENDER-DIFFERENCES; RECOVERY; GUIDELINES; MANAGEMENT; SYMPTOMS; HEADACHE	Approximately 2 million sports and recreation concussive injuries occur per year in the United States, which may be an underestimate because of inconsistent data reporting. The field of concussion management has evolved rapidly over the last 10 years, and with these advances comes new understanding of the significant symptomatic and cognitive impairments of concussion. These sequelae are more fully realized and may last longer than previously thought. Data have emerged regarding pathophysiology of concussion, risk factors, outcome, effects of repetitive injury, subtypes of concussive injury, and treatment protocols. This evidence calls for more conservative management of concussion, particularly in younger athletes, and demonstrates the shortcomings of concussion guidelines.	[Reddy, Cara Camiolo] Univ Pittsburgh, Dept Phys Med & Rehabil, Med Ctr, Pittsburgh, PA 15213 USA; [Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, Med Ctr, Pittsburgh, PA 15203 USA; [Gioia, Gerald A.] George Washington Univ, Dept Pediat, Sch Med, Rockville, MD 20850 USA; [Gioia, Gerald A.] Childrens Natl Med Ctr, Rockville, MD 20850 USA; [Gioia, Gerald A.] George Washington Univ, Dept Psychiat, Sch Med, Rockville, MD 20850 USA		Reddy, CC (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Med Ctr, 3471 5th Ave,LKB Suite 201, Pittsburgh, PA 15213 USA.	camioloce1@upmc.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bergschneider M, 2003, J NEUROSURG, V86, P241; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; *C NEUR SURG COMM, 1996, CLIN NEUROSURG, V12, P386; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2001, J ATHL TRAINING, V36, P244; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; GUSKIEWICZ KM, 2000, AM J SPORTS MED, V28, P1; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MAJERSKE CW, J ATHL TRAI IN PRESS; MATSER E, 1998, JAMA-J AM MED ASSOC, V282, P971; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; PARNES LS, 1993, ANN OTO RHINOL LARYN, V102, P325, DOI 10.1177/000348949310200501; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WOJYTS ED, 1999, AM J SPORTS MED, V27, P676; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	60	43	43	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2008	19	2					247	+		10.1016/j.pmr.2007.12.002			24	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	437NB	WOS:000265493100006	18395647				2022-02-06	
J	Strangman, GE; O'Neil-Pirozzi, TM; Goldstein, R; Kelkar, K; Katz, DI; Burke, D; Rauch, SL; Savage, CR; Glenn, MB				Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Kelkar, Kalika; Katz, Douglas I.; Burke, David; Rauch, Scott L.; Savage, Cary. R.; Glenn, Mel B.			Prediction of memory rehabilitation outcomes in traumatic brain injury by using functional magnetic resonance imaging	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						magnetic resonance imaging; rehabilitation	COGNITIVE REHABILITATION; HEAD-INJURY; PREFRONTAL CORTEX; FOLLOW-UP; ACTIVATION; RECOVERY; MECHANISMS; RETRIEVAL; PERFORMANCE; FMRI	Objective: To evaluate the ability of functional magnetic resonance imaging (fMRI) measures collected from people with traumatic brain injury (TBI) to provide predictive value for rehabilitation outcomes over and above standard predictors. Design: Prospective study. Setting: Academic medical center. Participants: Persons (N=54) with TBI greater than I year postinjury. Intervention: A novel 12-session a up rehabilitation program focusing on internal strategies to improve memory, Main Outcome Measure: The Hopkins Verbal Learning Test-Revised (HVLT-R) delayed recall score. Results: fMRI measures were collected while participants performed a strategically directed word memorization task. Prediction models were multiple linear regressions with the following primary predictors of outcome: age, education, injury severity, preintervention HVLT-R, and task-related fMRI activation of the left dorsolateral and left ventrolateral prefrontal cortex (VLPFC). Baseline HVLT-R was a significant predictor of outcome (P = .007), as was injury severity (for severe vs mild. P = .049), We also found a significant quadratic (inverted-U) effect of fMRI in the VLPFC (P = .007). Conclusions: This Study Supports previous evidence that left prefrontal activity is related to strategic verbal learning, and the magnitude of this activation predicted success in response to cognitive memory rehabilitation strategies. Extreme under- or overactivation of VLPFC was associated with less successful learning after rehabilitation. Further study is necessary to clarify this relationship and to expand and optimize the possible uses of functional imaging to guide rehabilitation therapies.	[Strangman, Gary E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Charlestown, MA USA; [Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Kelkar, Kalika; Glenn, Mel B.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Burke, David] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Rauch, Scott L.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA; [Savage, Cary. R.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA		Strangman, GE (corresponding author), Neural Syst Grp, 149 13th St,Room 2651, Charlestown, MA 02129 USA.	strang@mmr.mgh.harvard.edu		Katz, Douglas/0000-0002-7502-8505; Strangman, Gary/0000-0001-8896-2164	National institute on Disability and Rehabilitation Research [H133A020513]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25-NS046554]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS046554] Funding Source: NIH RePORTER	Supported by National institute on Disability and Rehabilitation Research (grant no. H133A020513) and the National Institute of Neurological Disorders and Stroke (grant no. K25-NS046554).	Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hoeft F, 2007, BEHAV NEUROSCI, V121, P602, DOI 10.1037/0735-7044.121.3.602; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KENNEDY M, 2006, AHSA LEAD, V11, P8; Kennedy M, 2006, AHSA LEAD, V11, P34; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kirkby BS, 1996, NEUROPSYCHOLOGIA, V34, P689; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Little R. J., 2019, STAT ANAL MISSING DA, V793; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; Marchini JL, 2000, NEUROIMAGE, V12, P366, DOI 10.1006/nimg.2000.0628; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reber PJ, 2002, J NEUROSCI, V22, P9541; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; RYAN TV, 1986, THESIS CALIFORNIA SC; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schafer JL, 1997, ANAL INCOMPLETE MULT; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strauss E, 2006, COMPENDIUM NEUROSYCH; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON B, 2003, RIVERMEAD BEHAV ME S, V2; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; ZENCIUS A, 1991, Brain Injury, V5, P321, DOI 10.3109/02699059109008102	76	43	43	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					974	981		10.1016/j.apmr.2008.02.011			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900025	18452748				2022-02-06	
J	Howe, TJ				Howe, Tami J.			The ICF Contextual Factors related to speech-language pathology	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						ICF; World Health Organization; speech-language pathology; Contextual Factors; Environmental Factors; Personal Factors	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; COMMUNICATION DISORDERS; COMMUNITY INTEGRATION; ENVIRONMENTAL-FACTORS; STUTTERING TREATMENT; SPASMODIC DYSPHONIA; LATERAL-SCLEROSIS; CONTROLLED-TRIAL; VOICE PROBLEMS	The World Health Organization's International Classification of Functioning, Disability and Health (ICF) conceptualizes functioning and disability as a dynamic interaction between a person's health condition and their contextual factors. Contextual factors "represent the complete background of an individual's life and living" and comprise two components: Environmental Factors and Personal Factors. This review aims to: (1) discuss why contextual factors are important for speech-language pathologists to address in their clinical practice, (2) describe how, environmental factors are coded in the ICF, (3) identify environmental factors that are relevant for people with communication disorders, and (4) identify personal factors that are relevant for people with communication disorders. Research on environmental factors that can influence the functioning of individuals with various communication disorders is presented, in addition to studies on personal factors that are important for speech-language pathologists to consider. The paper concludes that speech-language pathologists need to address contextual factors routinely, in order to provide a holistic approach to intervention for their clients. Furthermore, although a number of contextual factors that are relevant for people with communication disorders have been reported in the literature, more research is needed in this area.	Univ Queensland, Sch Hlth & Rehabil Sci, Commun Disabil Ctr, Brisbane, Qld 4072, Australia		Howe, TJ (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Commun Disabil Ctr, Brisbane, Qld 4072, Australia.	t.howe@uq.edu.au					Adams S, 2006, J MED SPEECH-LANG PA, V14, P221; *AM SPEECH LANG HE, 2001, SCOP PRACT SPEECH LA; ASHTON C, APHASIOLOGY IN PRESS; Bailey RL, 2006, LANG SPEECH HEAR SER, V37, P50, DOI 10.1044/0161-1461(2006/006); Balandin S., 2004, AUGMENTATIVE ALTERNA, V20, P243, DOI DOI 10.1080/07434610400011646; Ball LJ, 2004, J COMMUN DISORD, V37, P197, DOI 10.1016/j.jcomdis.2003.09.002; Barr J, 2008, LANG SPEECH HEAR SER, V39, P21, DOI 10.1044/0161-1461(2008/003); Baylor CR, 2005, J COMMUN DISORD, V38, P395, DOI 10.1016/j.jcomdis.2005.03.003; Blood G. W., 2004, CONT ISSUES COMMUNIC, V31, P69, DOI DOI 10.1044/CICSD_31_S_69; Bornman J, 2004, DISABIL REHABIL, V26, P182, DOI 10.1080/09638280410001665218; Bothe AK, 2006, AM J SPEECH-LANG PAT, V15, P342, DOI 10.1044/1058-0360(2006/032); BOURGEOIS MS, 1992, J SPEECH HEAR RES, V35, P1344, DOI 10.1044/jshr.3506.1344; Brown K, 2006, APHASIOLOGY, V20, P595, DOI 10.1080/02687030600626256; Brundage SB, 2006, J FLUENCY DISORD, V31, P325, DOI 10.1016/j.jfludis.2006.08.003; Carr MM, 2000, OTOLARYNG HEAD NECK, V122, P39, DOI 10.1016/S0194-5998(00)70141-0; Cherney L. R., 2001, LANGUAGE INTERVENTIO, P148; CORRELL A, 2004, ACQUIRING KNOWLEDGE, V6, P93; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Cox R M, 1999, J Am Acad Audiol, V10, P1; Crowe LK, 2004, J COMMUN DISORD, V37, P177, DOI 10.1016/j.jcomdis.2003.09.001; de Graeff A, 2000, HEAD NECK-J SCI SPEC, V22, P398, DOI 10.1002/1097-0347(200007)22:4<398::AID-HED14>3.3.CO;2-M; DePaul R, 2000, AM J SPEECH-LANG PAT, V9, P230, DOI 10.1044/1058-0360.0903.230; Drager K. D. R., 2004, AUGMENTATIVE ALTERNA, V20, P103, DOI [DOI 10.1080/07434610410001699681, 10.1080/07434610410001699681]; Eadie TL, 2003, AM J SPEECH-LANG PAT, V12, P189, DOI 10.1044/1058-0360(2003/065); Ebert K. A., 1994, LANG SPEECH HEAR SER, V25, P211; Elman RJ, 2000, APHASIOLOGY, V14, P455, DOI 10.1080/026870300401234; Finn P, 2003, J COMMUN DISORD, V36, P153, DOI 10.1016/S0021-9924(03)00004-2; Fleming J, 1999, BRAIN INJURY, V13, P417; FLORANCE CL, 1980, CLIN APHASIOLOGY C P, V10, P285; Fox A, 2005, DISABIL REHABIL, V27, P1399, DOI 10.1080/09638280500052567; Garcia LJ, 2000, APHASIOLOGY, V14, P269, DOI 10.1080/026870300401478; Garcia LJ, 2002, J COMMUN DISORD, V35, P187, DOI 10.1016/S0021-9924(02)00064-3; GREENER J, 2001, COCHRANE DB SYST REV, V4; Gross J, 2004, ENVIRON BEHAV, V36, P424, DOI 10.1177/0013916503262536; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Guest CM, 2006, J DEAF STUD DEAF EDU, V11, P252, DOI 10.1093/deafed/enj028; HO K, 2005, AUGMENTATIVE ALTERNA, V21, P218; Howe T., 2006, THESIS U QUEENSLAND; Howe TJ, 2004, APHASIOLOGY, V18, P1015, DOI 10.1080/02687030444000499; HOWE TJ, APHASIOLOGY IN PRESS; HUGHES D, 1985, LANGUAGE TREATMENT G; Hurst R, 2003, DISABIL REHABIL, V25, P572, DOI 10.1080/0963828031000137072; Hustad KC, 2003, AM J SPEECH-LANG PAT, V12, P198, DOI 10.1044/1058-0360(2003/066); Joan Murphy, 2004, AUGMENT ALTERN COMM, V20, P259, DOI [10.1080/07434610400005663, DOI 10.1080/07434610400005663]; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Klasner ER, 2005, J MED SPEECH-LANG PA, V13, P127; Knox E, 2003, INT J LANG COMM DIS, V38, P1, DOI 10.1080/13682820304817; LaFrance C, 2007, J COMMUN DISORD, V40, P215, DOI 10.1016/j.jcomdis.2006.06.010; Lass N. J., 1992, LANG SPEECH HEAR SER, V23, P78, DOI [10.1044/0161-1461.2301.73, DOI 10.1044/0161-1461.2301.73]; LASSALETTA L, 2005, EUROPEAN ARCH OTO RH, V263, P267; Law J, 2005, DISABIL SOC, V20, P169, DOI 10.1080/09687590500059267; LeDorze G, 1996, DISABIL REHABIL, V18, P550; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; McConachie H, 2007, J EVAL CLIN PRACT, V13, P120, DOI 10.1111/j.1365-2753.2006.00674.x; MELIN L, 1981, J APPL BEHAV ANAL, V14, P47, DOI 10.1901/jaba.1981.14-47; Muo R, 2005, DISABIL REHABIL, V27, P1405, DOI 10.1080/09638280500052542; Murphy J, 2006, HEALTH EXPECT, V9, P49, DOI 10.1111/j.1369-7625.2006.00366.x; Murphy J., 2000, BRIT J THERAPY REHAB, V7, P454; Nordehn G, 2006, TOP STROKE REHABIL, V13, P68, DOI 10.1310/5K2W-P6CD-EFDF-8HG4; O'Halloran R, 2008, INT J SPEECH-LANG PA, V10, P18, DOI 10.1080/14417040701772620; Owens JS, 2006, AUGMENT ALTERN COMM, V22, P196, DOI 10.1080/07434610600649971; OWENS RE, 2007, INTRO COMMUNICATION; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Parr S., 1997, TALKING APHASIA LIVI; Plexico L, 2005, J FLUENCY DISORD, V30, P1, DOI 10.1016/j.jfludis.2004.12.001; RICHARDSON J L, 1989, Health and Social Work, V14, P283; Rose TA, 2003, APHASIOLOGY, V17, P947, DOI 10.1080/02687030344000319; Roth CR, 2000, J MED SPEECH-LANG PA, V8, P365; Roy N, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/050); Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Smith E, 1998, J VOICE, V12, P480, DOI 10.1016/S0892-1997(98)80057-X; *SPEECH PATH AUSTR, 2002, SCOP PRACT SPEECH PA; Stephens D, 2001, AUDIOLOGY, V40, P294; Sullivan M. D., 1993, J MED SPEECH-LANG PA, V1, P73; Terrell JE, 2004, ARCH OTOLARYNGOL, V130, P401, DOI 10.1001/archotol.130.4.401; Thomas G, 2006, FOLIA PHONIATR LOGO, V58, P305, DOI 10.1159/000094566; THREATS T, 2000, FOLIA PHONIATR LOGO, V8, pR13; Threats T, 2004, ADV SPEECH LANGUAGE, V6, P53, DOI DOI 10.1080/14417040410001669426; Threats T. T., 2003, SPEECH PATHOLOGY ONL; Threats T, 2007, APHASIOLOGY, V21, P67, DOI 10.1080/02687030600798303; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Townsend E.A., 2002, ENABLING OCCUPATION; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; VERDOLINIMARSTON K, 1994, J VOICE, V8, P30, DOI 10.1016/S0892-1997(05)80317-0; VOGEL D, 1995, EFFECTS DRUGS COMMUN; Vuorialho A, 2006, INT J AUDIOL, V45, P400, DOI 10.1080/14992020600625007; Waller A, 1998, INT J LANG COMM DIS, V33, P45, DOI 10.1080/136828298247929; Ward EC, 2003, FOLIA PHONIATR LOGO, V55, P39, DOI 10.1159/000068056; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall L. E., 2000, NEUROGENIC COMMUNICA, P162; Yaruss JS, 2002, J FLUENCY DISORD, V27, P115; Zimmerman S, 1997, J SPEECH LANG HEAR R, V40, P1130, DOI 10.1044/jslhr.4005.1130; ZWIRNER P, 1991, J VOICE, V5, P78, DOI 10.1016/S0892-1997(05)80167-5; [No title captured]	96	43	46	1	15	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1754-9507			INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	FEB-APR	2008	10	1-2					27	37		10.1080/14417040701774824			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	448JP	WOS:000266259200005					2022-02-06	
J	Katz-Leurer, M; Rotem, H; Lewitus, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Lewitus, Hana; Keren, Ofer; Meyer, Shirley			Relationship between balance abilities and gait characteristics in children with post-traumatic brain injury	BRAIN INJURY			English	Article						children; traumatic brain injury; gait; variability; balance	OLDER-ADULTS; ELECTRONIC WALKWAY; STEP WIDTH; VARIABILITY; PARAMETERS; VALIDITY; MOTOR; ADOLESCENTS; PERFORMANCE; RECOVERY	Objectives: To quantify the differences in gait variability and balance performance between typically developed (TD) children and children with post-traumatic brain injury (TBI) and to determine the association between gait variability and functional balance in both groups. Design: Cross-sectional study. Setting: Physical therapy department of a paediatric and adolescent rehabilitation hospital. Participants: A convenience sample of 24 children post-TBI and 24 TD age and sex matched controls. Intervention: Not applicable. Main outcome measure: Step length, step time and base width variability measured with an electronic walkway; timed up and go (TUG) test and functional reach test (FRT) as a functional balance test. Results: Base width and step time variability showed no significant difference between the groups. However, children post-TBI had significantly greater variability in step length in comparison to healthy controls. The functional balance abilities of children post-TBI were significantly limited compared to TD children. A significant linear inverse correlation was found between balance performance and step length variability only among children with a TBI. Conclusion: Ambulatory children post-severe TBI had decreased balance performance, decreased gait speed and increased step length variability as compared to age-matched healthy controls.	[Katz-Leurer, Michal] Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Sackler Fac Med, Ramat Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Lewitus, Hana; Keren, Ofer; Meyer, Shirley] Alyn Hosp, Pediat & Adolescent Rehabil Ctr, Jerusalem, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Sackler Fac Med, Ramat Aviv, Israel.	michalkz@post.tau.ac.il					Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Burton CL, 2002, CLIN NEUROPSYCHOL, V16, P264, DOI 10.1076/clin.16.3.264.13854; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Cutlip RG, 2000, GAIT POSTURE, V12, P134, DOI 10.1016/S0966-6362(00)00062-X; Donahoe B, 1994, PEDIAT PHYSICAL THER, V6, P189, DOI DOI 10.1097/00001577-199400640-00004; Dusing SC, 2007, GAIT POSTURE, V25, P135, DOI 10.1016/j.gaitpost.2006.06.003; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HEITMANN DK, 1989, PHYS THER, V69, P923, DOI 10.1093/ptj/69.11.923; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LEITNER Y, 2007, J NEUROLOGY     0402; Lowes LP, 1996, PEDIATR PHYS THER, V8, P176; LOWES LP, 1997, THESIS ALLEGHENY U H; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Niznik Theresa M., 1995, Physical and Occupational Therapy in Pediatrics, V15, P1; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Provost Beth, 2007, Pediatr Phys Ther, V19, P2, DOI 10.1097/01.pep.0000249418.25913.a3; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2	35	43	44	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	2					153	159		10.1080/02699050801895399			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	258DW	WOS:000252849600006	18240044				2022-02-06	
J	Zampolini, M; Todeschini, E; Guitart, MB; Hermens, H; Ilsbroukx, S; Macellari, V; Magni, R; Rogante, M; Marchese, SS; Vollenbroek, M; Giacomozzi, C				Zampolini, Mauro; Todeschini, Elisabetta; Bernabeu Guitart, Montserrat; Hermens, Hermie; Ilsbroukx, Stephan; Macellari, Velio; Magni, Riccardo; Rogante, Marco; Marchese, Sandro Scattareggia; Vollenbroek, Miriam; Giacomozzi, Claudia			Tele-rehabilitation: present and future	ANNALI DELL ISTITUTO SUPERIORE DI SANITA			English	Article						stroke; multiple sclerosis; traumatic brain injury; tele-rehabilitation; upper limb; home rehabilitation	INDUCED MOVEMENT THERAPY; RANDOMIZED CLINICAL-TRIAL; UPPER EXTREMITY FUNCTION; MIRROR NEURON SYSTEM; VIRTUAL-REALITY; STROKE REHABILITATION; TELEREHABILITATION SYSTEM; SELF-EFFICACY; SPECIAL NEEDS; BRAIN-INJURY	During the last decade we assisted to relevant progress in rehabilitation studies and in technological development. From the combination of these issues rises the tele-rehabilitation - a subfield of telemedicine consisting of a system to control rehabilitation "at distance" - as an actual possibility of application and a promising development in the future. The present paper offers a short review of the state of the art in the field of tele-rehabilitation, with a special focus on upper limb tele-rehabilitation. The experience is also briefly reported of the preliminary application of the H-CAD (home care activity desk) system and the HELLODOC (Healthcare service linking tele-rehabilitation to disabled people and clinicians) tele-rehabilitation service, conducted by the authors within two European projects in the period 2003-2005 and 2005-2007 respectively.	[Zampolini, Mauro; Todeschini, Elisabetta] ASL 3, Unita Organ Riabilitaz Intens Neuromotoria, Perugia, Italy; [Bernabeu Guitart, Montserrat] Fundacio Inst Guttmann, Barcelona, Spain; [Hermens, Hermie; Vollenbroek, Miriam] Roessingh Res & Dev BV, Enschede, Netherlands; [Ilsbroukx, Stephan] Natl Multiple Sclerosis Ctr, Melsbroek, Belgium; [Macellari, Velio; Rogante, Marco; Giacomozzi, Claudia] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy; [Magni, Riccardo] Pragma Engn Srl, Perugia, Italy; [Marchese, Sandro Scattareggia] Signo Motus Srl, Messina, Italy		Zampolini, M (corresponding author), Dipartimento Riabilitaz ASL3 Reg Umbria, Piazza Garibaldi 5, I-06039 Perugia, Italy.	marco.roganti@iss.it	Giacomozzi, Claudia/G-5018-2016; Giacomozzi, Claudia/AAH-1640-2021; Zampolini, Mauro/B-7749-2009	Giacomozzi, Claudia/0000-0001-6950-4934; Giacomozzi, Claudia/0000-0001-6950-4934; Vollenbroek-Hutten, Miriam/0000-0001-8730-1487; Sipahi, Busra/0000-0002-1859-0075			Baheux K, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-27; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Blanton S, 1999, PHYS THER, V79, P847, DOI 10.1093/ptj/79.9.847; Boniver R, 2006, B-ENT, V2, P147; Burdea G, 2000, IEEE T REHABIL ENG, V8, P430, DOI 10.1109/86.867886; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Burns RB, 1998, ASSIST TECHNOL, V10, P126, DOI 10.1080/10400435.1998.10131970; Carey JR, 2007, NEUROREHAB NEURAL RE, V21, P216, DOI 10.1177/1545968306292381; Carey LM, 2005, AM J PHYS MED REHAB, V84, P428, DOI 10.1097/01.PHM.0000159971.12096.7F; Carignan CR, 2006, J REHABIL RES DEV, V43, P695, DOI 10.1682/JRRD.2005.05.0085; Chumbler NR, 2004, TELEMED J E-HEALTH, V10, P129, DOI 10.1089/1530562041641200; Colombo R, 2005, IEEE T NEUR SYS REH, V13, P311, DOI 10.1109/TNSRE.2005.848352; DAWSON SJ, 1999, PHYSICAL THERAPY CAS, V3, P84; Dawson Steve, 2002, Telemed Today, V9, P8; DeChant H K, 1996, Telemed J, V2, P303, DOI 10.1089/tmj.1.1996.2.303; Diamond BJ, 2003, NEUROREHABILITATION, V18, P171; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; Galea M, 2006, TELEMED J E-HEALTH, V12, P160, DOI 10.1089/tmj.2006.12.160; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Girone M, 2000, Stud Health Technol Inform, V70, P89; Gourlay D, 2000, STUD HEALTH TECHNOL, V77, P1181; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Heuser A, 2007, IEEE T NEUR SYS REH, V15, P43, DOI 10.1109/TNSRE.2007.891393; Higgins J, 2006, CLIN REHABIL, V20, P296, DOI 10.1191/0269215505cr943oa; Hill AJ, 2006, AM J SPEECH-LANG PAT, V15, P45, DOI 10.1044/1058-0360(2006/006); Holden MK, 2007, IEEE T NEUR SYS REH, V15, P36, DOI 10.1109/TNSRE.2007.891388; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; JEROME L, 1993, HOSP COMMUNITY PSYCH, V44, P81; Johnson MJ, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-29; Kahn LE, 2006, J REHABIL RES DEV, V43, P619, DOI 10.1682/JRRD.2005.03.0056; Kalra L, 2007, J REHABIL MED, V39, P97, DOI 10.2340/16501977-0043; KETELAER P, 2001, INT MS J, V8, P10; Kuttuva M, 2006, CYBERPSYCHOL BEHAV, V9, P148, DOI 10.1089/cpb.2006.9.148; Kwakkel G, 2002, J NEUROL NEUROSUR PS, V72, P473; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Lum PS, 2006, J REHABIL RES DEV, V43, P391, DOI 10.1682/JRRD.2005.02.0042; Masiero S, 2006, AGING CLIN EXP RES, V18, P531; McClellan R, 2004, AUST J PHYSIOTHER, V50, P163, DOI 10.1016/S0004-9514(14)60154-9; Monger C, 2002, CLIN REHABIL, V16, P361, DOI 10.1191/0269215502cr506oa; Ozdemir F, 2001, ARCH PHYS MED REHAB, V82, P1375, DOI 10.1053/apmr.2001.25973; Page SJ, 2007, ARCH PHYS MED REHAB, V88, P922, DOI 10.1016/j.apmr.2007.03.038; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Piron L, 2004, MED INFORM INTERNET, V29, P119, DOI 10.1080/14639230410001723428; Piron L, 2001, ST HEAL T, V81, P386; PLACIDI G, 2006, COMPUT BIOL MED; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; Reinkensmeyer DJ, 2002, IEEE T NEUR SYS REH, V10, P102, DOI 10.1109/TNSRE.2002.1031978; Ricker JH, 2003, NEUROREHABILITATION, V18, P179; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Rintala DH, 2004, J REHABIL RES DEV, V41, P481, DOI 10.1682/JRRD.2004.03.0481; Rizzolatti G, 2005, CURR OPIN NEUROBIOL, V15, P623, DOI 10.1016/j.conb.2005.10.018; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Robinson SS, 2003, TELEMED J E-HEALTH, V9, P57, DOI 10.1089/153056203763317657; Rodriguez-Ascaso A, 2002, J TELEMED TELECARE, V8, P72, DOI 10.1258/135763302320302109; Romano DM, 2005, DEV MED CHILD NEUROL, V47, P580, DOI 10.1017/S0012162205001143; Russell TG, 2002, J TELEMED TELECARE, V8, P50, DOI 10.1258/13576330260440853; Salbach NM, 2005, J AM GERIATR SOC, V53, P576, DOI 10.1111/j.1532-5415.2005.53203.x; Sanford JA, 2004, ASSIST TECHNOL, V16, P43, DOI 10.1080/10400435.2004.10132073; Sanford JA, 2006, J AM GERIATR SOC, V54, P1641, DOI 10.1111/j.1532-5415.2006.00913.x; Savard L, 2003, NEUROREHABILITATION, V18, P93; Simon AM, 2007, J BIOMECH, V40, P1286, DOI 10.1016/j.jbiomech.2006.05.021; Stein J, 2004, AM J PHYS MED REHAB, V83, P720, DOI 10.1097/01.PHM.0000137313.14480.CE; Sugarman H, 2006, CYBERPSYCHOL BEHAV, V9, P178, DOI 10.1089/cpb.2006.9.178; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Vitali P, 2007, NEUROREHAB NEURAL RE, V21, P152, DOI 10.1177/1545968306294735; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; Wakeford Linn, 2005, Am J Occup Ther, V59, P656; Walker MF, 2007, J REHABIL MED, V39, P193, DOI 10.2340/16501977-0063; Walker MF, 2004, STROKE, V35, P2226, DOI 10.1161/01.STR.0000137766.17092.fb; Winters JM, 2004, P ANN INT IEEE EMBS, V26, P4777; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; YALONCHAMOVITZ S, 2007, RES DEV DISABIL	77	43	44	5	19	EDITRICE KURTIS S R L	MILAN	VIA LUIGI ZOJA 30, 20153 MILAN, ITALY	0021-2571			ANN I SUPER SANITA	Ann. Ist. Super. Sanita		2008	44	2					125	134					10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	V15PB	WOS:000207812800002	18660562				2022-02-06	
J	Zhang, ZY; Zhang, ZR; Fauser, U; Schluesener, HJ				Zhang, Zhi-Yuan; Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.			Global hypomethylation defines a sub-population of reactive microglia/macrophages in experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; hypomethylation; 5-methylcytosine; microglia/macrophages; dexamethasone	DNA METHYLATION; HEAD-INJURY; SPINAL-CORD; MICROGLIA; RATS; ACTIVATION; EXPRESSION; CHROMATIN; IMPACT; CELLS	Global alterations in gene expression have been observed indifferent traumatic brain injury (TBI) models and are considered of crucial importance to the development of subsequent tissue injury and repair. Cytosine methylation is a well-known process of endogenous DNA modification in mammals and the primary mechanism responsible for changes in epigenetic gene expression. Here we have investigated the early global spatio-temporal changes of the status of cellular DNA methylation in a rat TBI model by immunohistochemistry and analyzed the effects of dexamethasone on these changes. Global cellular hypomethylation was seen as early as day 1 in pannecrosis and day 2 in peripannecrosis following TBI. A subpopulation of reactive microglia/macrophages was identified as the major source of hypomethylated cells by double-staining experiments. Further, peripheral administration of dexamethasone suppressed this lesional hypomethylation at day 2 post-injury. In sum, our data suggest that lesional hypomethylation defines a sub-population of activated microglia/macrophages involved in the early processes following traumatic brain injury. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Zhang, Zhi-Yuan; Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.] Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany		Zhang, ZR (corresponding author), Univ Tubingen, Inst Brain Res, Calwer St 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Zhang, Zhi-Yuan/0000-0001-9067-0670			AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; De Capoa A, 1999, FASEB J, V13, P89; Drew PD, 2000, BRAIN RES BULL, V52, P391, DOI 10.1016/S0361-9230(00)00275-6; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; Gloria L, 1996, CANCER, V78, P2300, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2300::AID-CNCR5>3.0.CO;2-Q; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Seifert HH, 2007, EXP MOL PATHOL, V82, P292, DOI 10.1016/j.yexmp.2006.08.002; Sharma RP, 2005, J PSYCHIATR NEUROSCI, V30, P257; Smith SS, 2000, J MOL BIOL, V302, P1, DOI 10.1006/jmbi.2000.4046; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Woods AG, 1999, NEUROSCIENCE, V91, P1277, DOI 10.1016/S0306-4522(98)00685-X; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8	29	43	43	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	DEC 11	2007	429	1					1	6		10.1016/j.neulet.2007.09.061			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	245UP	WOS:000251964600001	17996371				2022-02-06	
J	Bourgeois, MS; Lenius, K; Turkstra, L; Camp, C				Bourgeois, Michelle S.; Lenius, Kerry; Turkstra, Lyn; Camp, Cameron			The effects of cognitive teletherapy on reported everyday memory behaviours of persons with chronic traumatic brain injury	BRAIN INJURY			English	Article						memory; cognition; treatment; teletherapy	EXTERNAL AIDS; ERRORLESS; DEMENTIA; TBI; REHABILITATION; INTERVENTION; INDIVIDUALS; RELIABILITY; ACQUISITION; STRATEGIES	Primary objective: The purpose of this study was to evaluate the effects of an errorless training approach, Spaced Retrieval (SR) training delivered over the telephone, on the reported everyday memory problems of adults with chronic traumatic brain injury (TBI). Research design: The study was a randomized controlled clinical trial. Methods: Thirty-eight participants received either SR training or didactic strategy instruction (SI). Participants in both groups identified three memory-related goals and were paired to receive the same total telephone contact time. The main outcome measures were frequency of reported memory problems and perceived quality of life. Results: Participants in the SR group reported significantly more treatment goal mastery/strategy use than those in the Sl group, immediately and at 1-month post-training. Caregivers reported similarly significant between-groups differences in everyday use of treatment behaviours at 1 month. Both groups reported some generalized strategy use to other non-targeted behaviours and decreased frequency of reported memory problems, but there were no significant between-groups differences in participant or caregiver reports of generalized strategy use or reported memory problems at either time-point. There was no change in perceived quality of life in either group. Conclusions: SR treatment delivered by phone produced significantly more treatment goal mastery/strategy use and maintenance than SI; however, both treatments improved reported everyday memory functioning for persons with TBI without significant group differences on measures of generalized strategy use or perceived quality of life.	[Bourgeois, Michelle S.; Lenius, Kerry] Florida State Univ, Dept Commun Disorders, Tallahassee, FL 32306 USA; [Turkstra, Lyn] Univ Wisconsin, Dept Commun Disorders, Neurosci Training Program, Madison, WI 53706 USA; [Turkstra, Lyn] Univ Wisconsin, Neurosci Training Program, Dept Neurol Surg, Madison, WI 53706 USA; [Camp, Cameron] Menorah Pk Ctr Senior Living, Myers Res Inst, Beachwood, OH USA		Bourgeois, MS (corresponding author), Florida State Univ, Dept Commun Disorders, Tallahassee, FL 32306 USA.	michelle.bourgeois@comm.fsu.edu	Bourgeois, Michelle/F-9397-2015; Turkstra, Lyn/ABC-5831-2021	Bourgeois, Michelle/0000-0003-1458-6842; Turkstra, Lyn/0000-0002-6948-6921	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD046583] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD046583] Funding Source: Medline		Abrahams Joel P., 1993, Clinical Gerontologist, V12, P57, DOI 10.1300/J018v12n03_06; Baddeley A., 1992, SPEED CAPACITY LANGU; BIRD M, 1995, INT J GERIATR PSYCH, V10, P305, DOI 10.1002/gps.930100407; Bjork R., 1988, PRACT ASP MEM, V2; BOURGEOIS M, 2003, AM SPEECH LANG HEAR; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; Brush JA, 1998, THERAPY TECHNIQUE IM; Camp C. J., 2006, GERIATRIC NEUROPSYCH, P275; Camp C.J, 2000, COGNITIVE REHABILITA, P224; Camp CJ, 1996, APPL COGNITIVE PSYCH, V10, P193, DOI 10.1002/(SICI)1099-0720(199606)10:3<193::AID-ACP374>3.0.CO;2-4; CAMP CJ, 1999, INNOVATIONS PRACTICE; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; Cherry K.E., 1999, J CLIN GEROPSYCHOLOG, V5, P159, DOI DOI 10.1023/A:1022983131186; COELHO C, 1996, J SPEECH HEAR RES, V39, P5; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Ebbinghaus, 1964, MEMORY CONTRIBUTION; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Fogler J., 1988, IMPROVING YOUR MEMOR; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Hayden Claudia M., 1995, Clinical Gerontologist, V16, P80; Helm-Estabrooks N, 1991, BRIEF TEST HEAD INJU; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Hopper T, 2005, J MED SPEECH-LANG PA, V13, pXXVII; Hunkin NM, 1998, NEUROPSYCHOL REHABIL, V8, P433, DOI 10.1080/713755581; MCKITRICK LA, 1992, J GERONTOL, V47, P337, DOI DOI 10.1093/GERONJ/47.5.P337; McMahon C.M., 2003, CLIN PSYCHOL, V7, P50, DOI [https://doi.org/10.1080/13284200410001707483, DOI 10.1080/13284200410001707483]; McNair D. M., 1983, ASSESSMENT GERIATRIC; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; NEUNDORFER MM, 2002, ANN M GER SOC AM BOS; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; SPSS Incorporation, 2005, SPSS 14 0 WIND; Squire Larry R., 1994, P203; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sterns HL, 1998, APPL PSYCHOL-INT REV, V47, P175, DOI 10.1111/j.1464-0597.1998.tb00020.x; Sykes, 1978, PRACTICAL ASPECTS ME, P625; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; VANHALLE C, 1998, NEUORPHYSIOLOGY NEUR, P17; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	51	43	43	0	20	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1245	1257		10.1080/02699050701727452			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200004	18236200				2022-02-06	
J	Atkins, CM; Oliva, AA; Alonso, OF; Chen, S; Bramlett, HM; Hu, BR; Dietrich, WD				Atkins, Coleen M.; Oliva, Anthony A., Jr.; Alonso, Ofelia F.; Chen, Shaoyi; Bramlett, Helen M.; Hu, Bing-Ren; Dietrich, W. Dalton			Hypothermia treatment potentiates ERK1/2 activation after traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						CREB; fluid-percussion; hypothermia; ERK1/2; traumatic brain injury	SIGNAL-REGULATED KINASE; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; MEK1 PROTEIN-KINASE; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CELL-DEATH; THERAPEUTIC HYPOTHERMIA; SYNAPTIC PLASTICITY; NEURONAL SURVIVAL	Traumatic brain injury (TBI) results in significant hippocampal pathology and hippocampal-dependent memory loss, both of which are alleviated by hypothermia treatment. To elucidate the molecular mechanisms regulated by hypothermia after TBI, rats underwent moderate parasagittal fluid-percussion brain injury. Brain temperature was maintained at normothermic or hypothermic temperatures for 30 min prior and up to 4 h after TBI. The ipsilateral hippocampus was assayed with Western blotting. We found that hypothermia potentiated extracellular signal-regulated kinase 1/2 (ERK1/2) activation and its downstream effectors, p90 ribosomal S6 kinase (p90RSK) and the transcription factor cAMP response element-binding protein. Phosphorylation of another p90RSK substrate, Bad, also increased with hypothermia after TBI. ERK1/2 regulates mRNA translation through phosphorylation of mitogen-activated protein kinase-interacting kinase 1 (Mnk1) and the translation factor eukaryotic initiation factor 4E (eIF4E). Hypothermia also potentiated the phosphorylation of both Mnk1 and eIF4E. Augmentation of ERK1/2 activation and its downstream signalling components may be one molecular mechanism that hypothermia treatment elicits to improve functional outcome after TBI.	Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33152 USA; Univ Miami, Miller Sch Med, Neurotrauma Res Ctr, Miami, FL 33152 USA; Univ Miami, Miller Sch Med, Dept Neurol, Neurochem Lab Brain Injury, Miami, FL 33152 USA		Dietrich, WD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, POB 016960 R-48, Miami, FL 33136 USA.	ddietrich@miami.edu		Atkins, Coleen/0000-0003-4718-7493	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291, NS42133] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS042133] Funding Source: NIH RePORTER		Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chan EYW, 1999, J CLIN INVEST, V103, P1337, DOI 10.1172/JCI5474; CHEN S, 2006, J CEREB BLOOD FLOW M, V27, P939; Choi JS, 2006, NEUROSCI LETT, V409, P187, DOI 10.1016/j.neulet.2006.09.053; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; D'Cruz BJ, 2005, BRAIN RES, V1064, P108, DOI 10.1016/j.brainres.2005.09.052; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, ADV NEUROL, V71, P177; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Eberspacher E, 2005, ACTA ANAESTH SCAND, V49, P477, DOI 10.1111/j.1399-6576.2005.00649.x; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Fritz HG, 2004, J NEUROSURG ANESTH, V16, P43, DOI 10.1097/00008506-200401000-00009; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568, DOI 10.1152/ajpheart.2001.281.6.H2568; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Haranishi Y, 2005, EUR J ANAESTH, V22, P140, DOI 10.1017/S0265021505000268; Harrington DK, 2007, ANN THORAC SURG, V83, pS799, DOI 10.1016/j.athoracsur.2006.11.018; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Hicks SD, 2000, NEUROSCIENCE, V98, P677, DOI 10.1016/S0306-4522(00)00169-X; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kinouchi T, 2002, BIOL GROW ANIM, V1, P203, DOI 10.1016/S1877-1823(09)70123-7; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kulich SM, 2003, J BIOSCIENCES, V28, P83, DOI 10.1007/BF02970136; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Langlois J.A., 2004, TRAUMATIC BRAIN INJU, P1; Lee KH, 2005, J BIOL CHEM, V280, P13179, DOI 10.1074/jbc.M410059200; Levati A, 2007, J NEUROSURG ANESTH, V19, P25, DOI 10.1097/01.ana.0000211022.96054.4d; LIN CA, 2001, MASS COMMUNICATION S, V4, P19, DOI DOI 10.1207/S15327825MCS0401_03; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Liu HQ, 2006, NEUROCHEM RES, V31, P967, DOI 10.1007/s11064-006-9102-2; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Rothoerl Ralf Dirk, 2006, Neurosurg Focus, V20, pE5; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu RX, 1998, NEUROSURGERY, V43, P107, DOI 10.1097/00006123-199807000-00070; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	100	43	45	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2007	26	4					810	819		10.1111/j.1460-9568.2007.05720.x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	203GP	WOS:000248963400002	17666079				2022-02-06	
J	Banks, ME				Banks, Martha E.			Overlooked but critical - Traumatic brain injury as a consequence of interpersonal violence	TRAUMA VIOLENCE & ABUSE			English	Article						traumatic brain injury; intimate partner violence; rehabilitation; prevention; neuropsychology; assessment; memory; emotions	DOMESTIC VIOLENCE; BATTERED WOMEN; HEAD-INJURY; ABUSE; IMPAIRMENT; VICTIMS	Despite evidence that more than 80% of female victims of intimate partner violence, seen for medical treatment of violence-related injuries, have sustained facial injuries, traumatic brain injury is often overlooked as a consequence of those injuries. This article reviews the scant literature available and examines research on equivalent injuries sustained by athletes. Practical domains of symptoms are described, as is a review of literature pertinent to culturally relevant rehabilitation for victims sustaining traumatic brain injuries.	Coll Wooster, Wooster, OH 44691 USA		Banks, ME (corresponding author), Abackans DCP, Akron, OH USA.		Banks, Martha/AAB-2391-2021	Banks, Martha/0000-0002-5367-2076			Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; ACKERMAN RJ, 2003, PROSTITUTION DISSOCI; ACKERMAN RJ, 2006, ACKERMAN BANKS NEURO; Ackerman Rosalie J, 2004, Phys Med Rehabil Clin N Am, V15, P919, DOI 10.1016/j.pmr.2004.04.001; Banks M. E., 2003, WOMEN VISIBLE INVISI, pxxi; Banks Martha E, 2003, Cultur Divers Ethnic Minor Psychol, V9, P367, DOI 10.1037/1099-9809.9.4.367; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; BANKS ME, 1997, POST ASSAULT TRAUMAT; BANKS ME, 2007, ENCY DOMESTIC VIOLEN; Belgrave FZ, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P585, DOI 10.1037/10361-028; BELL CC, 2000, VIOLENCE AGAINST WOM, V6, P515; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Browne Angela, 1999, VIOLENCE AGAINST WOM, V5, P393, DOI DOI 10.1177/10778019922181284; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Campbell JC, 1999, J INTERPERS VIOLENCE, V14, P21, DOI 10.1177/088626099014001002; CAMPBELL JC, 2005, HDB WOMEN STRESS TRA, P123; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; FARLEY M, 2003, WOMEN VISIBLE INVISB, P247; FERRARO FR, 2002, MINORITY CROSSCULTUR; Gagnon J, 2006, B MENNINGER CLIN, V70, P1, DOI 10.1521/bumc.2006.70.1.1; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Hassouneh-Phillips D, 2002, REHABIL COUNS BULL, V45, P96, DOI 10.1177/003435520204500204; Jackson H, 2004, AP PRA H PS, P233; Kozorovitskiy Y, 2003, J CLIN EXP NEUROPSYC, V25, P721, DOI 10.1076/jcen.25.5.721.14580; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Malec JF, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P417, DOI 10.1037/10361-020; Malec JF, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P15; Manetta AA, 1999, J BLACK STUD, V29, P510, DOI 10.1177/002193479902900403; Manly JJ, 2002, STUD NEUROPSYCHOL DE, P79; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; MORTON RL, 2004, TRAUMATIC BRAIN INJU, P183; Muelleman RL, 1998, AM J EMERG MED, V16, P128, DOI 10.1016/S0735-6757(98)90028-6; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; MUKHERJEE D, 2003, WOMEN VISIBLE INVISI, P3; Nosek MA, 2001, SEX DISABIL, V19, P177, DOI 10.1023/A:1013152530758; Ochs HA, 1996, J AM DENT ASSOC, V127, P757, DOI 10.14219/jada.archive.1996.0311; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; Schootman M, 2000, BRAIN INJURY, V14, P373; SHERR RL, 1992, NEUROPSYCHOLOGY, V6, P417, DOI DOI 10.1037/0894-4105.6.4.417; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; SIKORA E, 2003, DISS ABSTR INT, V63, pB3939; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tellier A, 1999, BRAIN INJURY, V13, P463; Thoennes, 2000, EXTENT NATURE CONSEQ; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tjaden P., 1998, PREVALENCE INCIDENCE; Uzzell BP, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P1; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; Wolkenstein BH, 1998, PROF PSYCHOL-RES PR, V29, P341, DOI 10.1037/0735-7028.29.4.341; Wuest J., 1999, VIOLENCE AGAINST WOM, V5, P110, DOI DOI 10.1177/1077801299005002002; ZEITLIN SB, 1993, AM J PSYCHIAT, V150, P661	61	43	43	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8380	1552-8324		TRAUMA VIOLENCE ABUS	Trauma Violence Abus.	JUL	2007	8	3					290	298		10.1177/1524838007303503			9	Criminology & Penology; Family Studies; Social Work	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Social Work	183QF	WOS:000247586600005	17596346				2022-02-06	
J	Ives, JC; Alderman, M; Stred, SE				Ives, Jeffrey C.; Alderman, Mark; Stred, Susan E.			Hypopituitarism after multiple concussions: A retrospective case study in an adolescent male	JOURNAL OF ATHLETIC TRAINING			English	Article						neuroendocrinology; mild traumatic brain injury; sports	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; POSTCONCUSSION SYNDROME; HEAD TRAUMA; HIGH-RISK; CHILDREN; DYSFUNCTION; PERFORMANCE	Objective: To describe the development of hypopituitarism in an adolescent athlete after multiple concussions and to raise awareness among sports medicine clinicians concerning the growing concern of hypopituitarism in concussion injury surveillance and management. Background: A 14-year-old, previously healthy male athlete suffered 4 head traumas over a 4-month period. The first 3 traumas were considered by the athlete to be minor and were not reported to medical personnel. The fourth trauma was a medically diagnosed concussion suffered during soccer play. Over the next year, the patient noted a decline in strength and conditioning and a failure to grow. Differential Diagnosis: After physical examination and a full battery of endocrine tests, the patient, then 16.5 years old, was diagnosed with hypopituitarism. Follow-up interviews provided evidence that at least 2 of the 3 head injuries suffered before the last concussion could also be considered concussions, which may have contributed to the severity of the last head injury. Treatment: The patient is currently being treated with physiologic replacement hormones (growth hormone, cortisol, and thyroxine), with resumption of linear growth and strength. He is progressing well. Uniqueness: In the past few years in the medical literature, increased attention has been drawn to the occult occurrence of hypopituitarism after traumatic brain injury in adults. Initial reports indicate that children are also at risk. To our knowledge, this is the first reported case of hypopituitarism after mild traumatic brain injury in the sports medicine literature. Conclusions: Symptoms of hypopituitarism are often masked by trauma and postconcussion symptoms and may not appear until months or years after the trauma incident, which can lead to significant delay in proper diagnosis and treatment. We urge greater vigilance by, and training of, sports medicine clinicians toward the goal of recognizing the possibility of pituitary disorders after sports concussion.	Ithaca Coll, Ithaca, NY 14850 USA; Upstate Med Univ, Syracuse, NY USA		Ives, JC (corresponding author), Ithaca Coll, Ithaca, NY 14850 USA.	jives@ithaca.edu					Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bruce JM, 2004, NEUROLOGY, V63, P1516; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLean JP, 2006, MED SCI SPORT EXER, V38, pS132, DOI 10.1249/00005768-200605001-01481; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Rosenfeld RG, 1997, J CLIN ENDOCR METAB, V82, P349, DOI 10.1210/jc.82.2.349; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Stewart PM, 2001, HORM RES, V56, P1, DOI 10.1159/000048126; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	51	43	43	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2007	42	3					431	439					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	220FG	WOS:000250141800017	18060001				2022-02-06	
J	Wilson, JTL; Slieker, FJA; Legrand, V; Murray, G; Stocchetti, N; Maas, AIR				Wilson, J. T. Lindsay; Slieker, Frans J. A.; Legrand, Valerie; Murray, Gordon; Stocchetti, Nino; Maas, Andrew I. R.			Observer variation in the assessment of outcome in traumatic brain injury: Experience from a multicenter, international randomized clinical trial	NEUROSURGERY			English	Article						clinical trials; observer variation; outcome; traumatic brain injury	EFFICACY	OBJECTIVE: Accurate and consistent outcome assessment is essential to randomized clinical trials. We aimed to explore observer variation in the assessment of outcome in a recently completed trial of dexanabinol in head injury and to consider steps to reduce such variation. METHODS: Eight hundred sixty-one patients with severe traumatic brain injury who were admitted to 86 centers were included in a multicenter, placebo-controlled, Phase III trial. Outcome was assessed at 3 and 6 months postinjury using the extended Glasgow Outcome Scale; standardized assessment was facilitated by the use of a structured interview. Before initiation of trial centers, outcome ratings were obtained for sample cases to establish initial levels of agreement. Training sessions in outcome assessment were held, and problems in assigning outcome were investigated. During the trial, a process of central review was established to monitor performance. Interobserver variation was analyzed using the K statistic. RESULTS: Substantial observer variation was found in the rating of sample cases (weighted K, 0.72; confidence interval, 0.68-0.75) and in assigning outcome based on completed structured interviews (weighted K, 0.61; confidence interval, 0.57-0.64). In the early stages of the trial, a relatively large number of discrepancies (29-3 7%) were identified on central review. This number declined as the trial progressed and coincided with investigator training and feedback from central review. Centers with higher enrollment rates showed better performance. CONCLUSION: Observer variation in outcome assessment is a significant problem for head injury trials. Consistency can be improved by standardizing procedures, training assessors, and monitoring the quality of assessments and providing feedback to interviewers.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; Quintiles, Paris, France; Univ Edinburgh, Sch Med, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Milan, IRCCS, Osped Policlin, Neurosci Intens Care Unit, I-20122 Milan, Italy		Wilson, JTL (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	J.T.L.Wilson@stir.ac.uk	Stocchetti, Nino/O-7444-2017; Wilson, Lindsay/A-3659-2009; Maas, Andrew IR/C-5584-2013; Wilson, Lindsay/O-8883-2019	Stocchetti, Nino/0000-0003-3250-6834; Wilson, Lindsay/0000-0003-4113-2328; Maas, Andrew IR/0000-0003-1612-1264; Wilson, Lindsay/0000-0003-4113-2328; Murray, Gordon/0000-0001-9866-4734			BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; BULLOCK MR, 2002, NEUROSURG FOCUS, V13; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; JENNETT B, 1975, LANCET, V1, P480; Kobak KA, 2004, J CLIN PSYCHOPHARM, V24, P113, DOI 10.1097/01.jcp.0000116651.91923.54; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	13	43	44	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2007	61	1					123	128		10.1227/01.neu.0000279732.21145.9e			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	185AF	WOS:000247683000027	17621027				2022-02-06	
J	Catala-Temprano, A; Teruel, GC; Lasaosa, FJC; Odena, MP; Julian, AN; Rico, A				Catala-Temprano, Albert; Claret Teruel, Gemma; Cambra Lasaosa, Francisco Jose; Pons Odena, Marti; Noguera Julian, Antoni; Palomeque Rico, Antonio			Intracranial pressure and cerebral perfusion pressure as risk factors in children with traumatic brain injuries	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial pressure; cerebral perfusion pressure; pediatric neurosurgery	SEVERE HEAD-INJURIES; BLOOD-PRESSURE; MANAGEMENT; CARE	Object. The authors evaluated the initial intracranial pressure (ICP) and cerebral perfusion pressure (CPP) as prognostic factors in severe head injury in children and tried to determine the optimal CPP range. Methods. The authors performed a 9-year retrospective review of all patients with severe traumatic brain injuries (TBIs) who required invasive ICP monitoring and were admitted to the pediatric intensive care unit at their institution between January 1995 and December 2003. These patients had Glasgow Coma Scale scores lower than 8 and/or required ICP monitoring due to worsening neurological status or neuroimaging results suggestive of cerebral hypertension. Clinical summaries and imaging studies were reviewed. Data for 156 pediatric patients who ranged in age from I to 18 years were obtained. Half of these patients presented with normal initial ICPs (< 20 mm Hg), and a good outcome was achieved in 80% of these children. An unfavorable outcome was observed in more than 60% of patients with an initial CPP lower than 40 min Hg. The proportion of patients with an unfavorable Outcome decreased to 10% with initial CPPs higher than 60 min Hg, but patients with initial CPPs higher than 70 min Hg did not improve. Conclusions. Initial ICP and CPP measurements were useful as prognostic factors in pediatric patients with severe TBIs: patients with initial CPPs between 40 and 70 nim Hg were found to have a better neurological prognosis than those with CPPs either higher or lower than that range.	Univ Barcelona, Hosp Univ Sant Joan Deu, Integrated Unit Sant Joan Deu Clin, Pediat Intens Care Unit,Pediat Dept, Barcelona 7, Spain		Catala-Temprano, A (corresponding author), Passeig Sant Joan Deu, Barcelona 208950, Spain.	acatala@hsjdbcn.org	Odena, Marti Pons/K-3054-2019; PONS-ODENA, MARTI/G-3982-2015	PONS-ODENA, MARTI/0000-0002-1181-3547; Noguera-Julian, Antoni/0000-0001-7485-0583; CATALA, ALBERT/0000-0003-0133-1752; Cambra Lasaosa, Francisco Jose/0000-0002-3818-8032			BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Daley ML, 2004, STROKE, V35, P1952, DOI 10.1161/01.STR.0000133690.94288.c9; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; JENNETT B, 1975, LANCET, V1, P480; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Maidaun MVC, 2002, ARQ NEURO-PSIQUIAT, V60, P967, DOI 10.1590/S0004-282X2002000600015; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; RODRIQUEZ JO, 2001, MED INTENSIVA, V25, P8; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Wagner BP, 2002, CRIT CARE MED, V30, P2014, DOI 10.1097/00003246-200209000-00010	19	43	46	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2007	106	6		S			463	466		10.3171/ped.2007.106.6.463			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	174WH	WOS:000246973000008	17566403				2022-02-06	
J	Cater, HL; Gitterman, D; Davis, SM; Benham, CD; Morrison, B; Sundstrom, LE				Cater, Heather L.; Gitterman, Daniel; Davis, Susan M.; Benham, Christopher D.; Morrison, Barclay, III; Sundstrom, Lars E.			Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels	JOURNAL OF NEUROCHEMISTRY			English	Article						calcium; electrophysiology; glutamate; immunohistochemistry; trauma; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; LATERAL FLUID PERCUSSION; LONG-TERM POTENTIATION; AXONAL INJURY; VITRO MODEL; MECHANICAL INJURY; CORTICAL-NEURONS; HEAD-INJURY; DELAYED DEPOLARIZATION	The relationship between an initial mechanical event causing brain tissue deformation and delayed neurodegeneration in vivo is complex because of the multiplicity of factors involved. We have used a simplified brain surrogate based on rat hippocampal slices grown on deformable silicone membranes to study stretch-induced traumatic brain injury. Traumatic injury was induced by stretching the culture substrate, and the biological response characterized after 4 days. Morphological abnormalities consistent with traumatic injury in humans were widely observed in injured cultures. Synaptic function was significantly reduced after a severe injury. The N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 attenuated neuronal damage, prevented loss of microtubule-associated protein 2 immunoreactivity and attenuated reduction of synaptic function. In contrast, the NMDA receptor antagonists 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP) and GYKI53655, were neuroprotective in a moderate but not a severe injury paradigm. Nifedipine, an L-type voltage-dependent calcium channel antagonist was protective only after a moderate injury, whereas omega-conotoxin attenuated damage following severe injury. These results indicate that the mechanism of damage following stretch injury is complex and varies depending on the severity of the insult. In conclusion, the pharmacological, morphological and electrophysiological responses of organotypic hippocampal slice cultures to stretch injury were similar to those observed in vivo. Our model provides an alternative to animal testing for understanding the mechanisms of post-traumatic delayed cell death and could be used as a high-content screen to discover neuroprotective compounds before advancing to in vivo models.	Univ Southampton, Div Clin Neurosci, Southampton, Hants, England; GlaxoSmithKline, Harlow, Essex, England; Columbia Univ, Dept Biomed Engn, New York, NY USA		Cater, HL (corresponding author), Capsant Neurotechnol Ltd, Biomed Sci Bldg,Bassett Crescent East, Southampton SO16 7PX, Hants, England.	hlcater@yahoo.co.uk	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Cater, Heather/0000-0002-8696-6070			Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Colak A, 2003, J NEUROSURG, V98, P275, DOI 10.3171/spi.2003.98.3.0275; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; Jennett B, 1979, Adv Neurol, V22, P137; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Koura SS, 1998, ACT NEUR S, V71, P244; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Leybaert L, 1996, EXP BRAIN RES, V112, P392, DOI 10.1007/BF00227945; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2004, J NEUROTRAUM, V21, P1273; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panizzon KL, 1998, NEUROREPORT, V9, P4131, DOI 10.1097/00001756-199812210-00024; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Pringle AK, 1996, STROKE, V27, P2124, DOI 10.1161/01.STR.27.11.2124; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 1999, J NEUROSCI, V19, P4263; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Toth Z, 1997, J NEUROSCI, V17, P8106; TROSSEILLE X, 1992, STAPP CAR CRASH J, V36, P235; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Winkler T, 2003, ACTA NEUROCHIR SUPPL, V86, P425; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	78	43	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2007	101	2					434	447		10.1111/j.1471-4159.2006.04379.x			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	151TD	WOS:000245312800013	17250683	Bronze			2022-02-06	
J	Swartz, KR; Fee, DB; Joy, KM; Roberts, KN; Sun, S; Scheff, NN; Wilson, ME; Scheff, SW				Swartz, Karin R.; Fee, Dominic B.; Joy, Kelly M.; Roberts, Kelly N.; Sun, Sophie; Scheff, Nicole N.; Wilson, Melinda E.; Scheff, Stephen W.			Gender differences in spinal cord injury are not estrogen-dependent	JOURNAL OF NEUROTRAUMA			English	Article						estrogen; gender; neuroprotection; neurotrauma; spinal cord injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; RATING-SCALE; RATS; OUTCOMES; LESION; MODEL; 17-BETA-ESTRADIOL; EPIDEMIOLOGY; RECEPTOR	Recent attention has been given to gender differences in neurotrauma, and the anecdotal suggestion is that females have better outcomes than males, suggesting that circulating levels of estrogen (ED may be neuroprotective. In order to address this issue, both young adult male and ovariectomized female rats were subjected to a T10 spinal cord injury (SCI), and E2 levels were maintained at chronic, constant circulating levels. Animals were clinically evaluated for locomotor changes using the Basso-Beattie-Bresnahan (BBB) scoring system. Morphologic differences were evaluated with unbiased stereology. Data analysis failed to reveal any significant benefit for the E2 therapy in either males or females. We did find a non-estrogen-dependent difference between male and female rats in length of injury, and percent of spared tissue, with female outcomes more favorable. These results suggest that E-2 does not provide a viable therapy following SCI.	Univ Kentucky, Med Ctr, Dept Surg, Div Neurosurg, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Neurol, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Physiol, Lexington, KY 40536 USA		Swartz, KR (corresponding author), Univ Kentucky, Med Ctr, Dept Surg, Div Neurosurg, 800 Rose St,MS108, Lexington, KY 40536 USA.	krswar2@email.uky.edu					Baker KA, 2005, J NEUROTRAUM, V22, P415, DOI 10.1089/neu.2005.22.415; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Greenwald BD, 2001, ARCH PHYS MED REHAB, V82, P1181, DOI 10.1053/apmr.2001.24891; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Johnson ME, 2000, MAYO CLIN PROC, V75, P921, DOI 10.4065/75.9.921; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Nobunaga AI, 1999, ARCH PHYS MED REHAB, V80, P1372, DOI 10.1016/S0003-9993(99)90247-2; Pleym H, 2003, ACTA ANAESTH SCAND, V47, P241, DOI 10.1034/j.1399-6576.2003.00036.x; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2003, J NEUROTRAUM, V20, P659, DOI 10.1089/089771503322144572; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; TATOR CH, 1993, SURG NEUROL, V40, P207, DOI 10.1016/0090-3019(93)90069-D; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Wilson ME, 2002, MECH AGEING DEV, V123, P593, DOI 10.1016/S0047-6374(01)00406-7; WISE PM, 1981, BIOL REPROD, V24, P820, DOI 10.1095/biolreprod24.4.820; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086	37	43	44	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2007	24	3					473	480		10.1089/neu.2006.0167			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	152RQ	WOS:000245379900004	17402853				2022-02-06	
J	Jacobs, ML; Donders, J				Jacobs, Monica L.; Donders, Jacobus			Criterion validity of the California Verbal Learning Test-Second Edition (CVLT-II) after traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						learning; memory; traumatic brain injury	PERFORMANCE; DIAGNOSIS; MEMORY; SCORES	The California Verbal Learning Test-Second Edition (CVLT-II) was performed by 200 participants, divided into moderate-severe traumatic brain injury (n = 43), mild traumatic brain injury (n = 57) and demographically matched control (n = 100) groups. Participants with complicating premorbid histories or who scored below 15/16 on the CVLT-II forced choice recognition trial were excluded. There were statistically significant (p <.0001) effects of group status on the CVLT-II total recall discrim inability and recognition discriminability indices. Logistic regression revealed that, in the classification of control versus moderate-severe traumatic brain injury, CVLT-II variables were accurate 66-71% overall, but false positive rates ranged from 49 to 54%. In conclusion, average scores on the CVLT-II differ meaningfully between patients with various degrees of severity of traumatic brain injury and controls, but this test should not be used in isolation to determine the presence or absence of acquired memory impairment. (c) 2006 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy,SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					*AM ED RES ASS AM, 1999, STAND ED PSYCH TEST; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1996, AM J PSYCHIAT, V153, P7; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CVLT 2 COMPREHENSIVE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; DONDERS J, IN PRESS J INT NEURO; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Larrabee, 2005, FORENSIC NEUROPSYCHO, P209; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	27	43	44	1	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2007	22	2					143	149		10.1016/j.acn.2006.12.002			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	154WT	WOS:000245539300002	17207963	Bronze			2022-02-06	
J	Deb, S; Burns, J				Deb, Shoumitro; Burns, James			Neuropsychiatric consequences of traumatic brain injury: A comparison between two age groups	BRAIN INJURY			English	Article						psychiatric disorders; neurobehavioural symptoms; traumatic brain injury; old age; young age	HEAD-INJURY; UNITED-STATES; OLDER-ADULTS; MILD; QUESTIONNAIRE; DISABILITY; DISORDERS; SYMPTOMS; SCALE	Background: Neurobehavioural symptoms and certain psychiatric disorders are common after a traumatic brain injury ( TBI). Relatively few studies have investigated the effect of age upon these outcomes. Aim: Our aim was to compare the rates of neurobehavioural symptoms and psychiatric disorders between 18 - 65 year old and over 65 year old patients with TBI. Method: 120 adults aged 18 to 65 years and 45 adults over 65 years of age who were admitted to a hospital following a TBI were assessed for neurobehavioural symptoms and psychiatric disorders one year after the injury. Results: Our estimate suggested that a higher proportion of 18 - 65 year old patients ( 32%) had ICD- 10 psychiatric disorders according to the Schedule for Clinical Assessment in Neuropsychiatry ( SCAN) interview compared with patients over 65 years of age ( 16%). Similarly, the ICD- 10 depressive disorder was more common among the younger patients ( 16%) than the older group of patients ( 11%). None of these differences were statistically significant. However, a multiple regression analysis revealed that among other risk factors, a younger age was significantly associated with the presence of a psychiatric disorder. Also, a significantly higher rate of psychiatric caseness was detected among the younger age group using screening instruments such as the General Health Questionniare- 28 ( GHQ- 28) ( p < 0.01) and the Clinical Interview Schedule- Revised ( CIS- R) ( p < 0.01). The rates of individual neurobehavioural symptoms varied significantly between the two age groups. The most prevalent symptoms in 18 - 65 year olds were irritability ( 37%) and sleep problems ( 37%). In the older group of patients the most prevalent symptoms were poor memory ( 40%), dependence ( 38%) and slowness in thinking ( 33%). Conclusion: 18 - 65 year old patients are likely to be at a greater risk of psychiatric morbidity following TBI than over 65 year olds whereas neurobehavioural symptoms are prevalent in both age groups.	Univ Birmingham, Queen Elizabeth Psychiat Hosp, Div Nueropsychiat, Birmingham B15 2QZ, W Midlands, England; Univ Birmingham, Sch Med, Birmingham, W Midlands, England		Deb, S (corresponding author), Univ Birmingham, Queen Elizabeth Psychiat Hosp, Div Nueropsychiat, Mindelsohn Way, Birmingham B15 2QZ, W Midlands, England.	s.deb@bham.ac.uk		Deb, Shoumitro/0000-0002-1300-8103			AFFLECK JW, 1988, LANCET, V1, P230; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Goldberg D., 1978, MANUAL GEN HLTH QUES; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MYERSON J, 1992, PSYCHOL AGING, V7, P57; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; REGIER DA, 1993, ACTA PSYCHIAT SCAND, V88, P35, DOI 10.1111/j.1600-0447.1993.tb03411.x; SINGLETON N, 2000, PSYCHIAT MORBIDITY A; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P586; World Health Organization, 1978, MENT DIS GLOSS GUID	29	43	44	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	3					301	307		10.1080/02699050701253137			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IW	WOS:000246518400005	17453758				2022-02-06	
J	Dhikav, V; Anand, KS				Dhikav, Vikas; Anand, Kujeet Singh			Is hippocampal atrophy a future drug target?	MEDICAL HYPOTHESES			English	Article							CA3 PYRAMIDAL NEURONS; ADULT-RAT HIPPOCAMPUS; ALZHEIMERS-DISEASE; MOOD STABILIZERS; CHRONIC STRESS; ANTIDEPRESSANT TREATMENT; CELL-PROLIFERATION; NEUROGENESIS; TIANEPTINE; PHENYTOIN	Hippocampus is the brain structure, vital for episodic and declarative memory. Atrophy of the human hippocampus is seen in a variety of psychiatric and neurological disorders e.g. recurrent depression, schizophrenia, bipolar disorder, post-traumatic stress disorder, epilepsy, head injury, and Alzheimer's disease (AD). Importantly, aging hippocampus also undergoes atrophy. In many instances, for example, AD, the atrophy precedes the development of symptoms while in others, there is a temporal relationship between atrophy and symptomatology. The presence of atrophied hippocampus is one of the most consistent features of many common psychiatric disorders. Several factors contribute to this atrophy. Stress is one of the most profound factors implicated and the mechanisms involve glucocorticoids, serotonin, excitatory amino acids etc. Hippocampal formation as a whole can undergo atrophy or its individual structural components e.g. apical dendrities can exhibit atrophy. Several drugs of unrelated classes have been shown to prevent atrophy indicating heterogenous manner in which hippocampal atrophy is produced. These include, tianeptine (affects structural plasticity in hippocampus and is an effective antidepressant); phenytoin (antiseizure and neuroprotective); fluoxetine (downregulates neurodegenerative enzyme and increases neuroprotective hippocampal S100beta); lithium (neu ro protective and antiapoptotic); tricyclic antidepressants (increase hippocampal. neurogenesis); antipsychotics (reduce hippocampal neuronal suppression); sodium valproate (increases neurogenesis) and mifepristone (antioxidant, neuroprotective and anti-glucocorticoid). Now the most important question is: to what extent does the hippocampal atrophy play a role in the genesis of symptoms of diseases or their progression? And if it does, can we achieve the same degree of prevention or reversal seen in experimental animals, in humans also. An even more important question is: whether the prevention of atrophy would be clinically useful in affecting disease, viz slowing its progression, reducing morbidity, complications or positively affecting the outcome of one or more of its clinically important aspects. If the answer to this is yes, we would have to know at what stage of the disease we use the drugs, dose, duration, follow-up and efficacy. The use of these drugs in the above mentioned conditions can not only test the potential of atrophy as a future drug target, but could also help in Learning more about the hippocampus in both health and diseases. 0 2006 Elsevier Ltd. All rights reserved.	All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India; GSS IP Univ, Dr RML Hosp, PGIMER, Dept Neurol, New Delhi 110001, India		Dhikav, V (corresponding author), All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India.	vikasdhikav@hotmail.com; Kutjeet_anand@rediffmail.com					Belanoff JK, 2002, J MOL NEUROSCI, V19, P201, DOI 10.1007/s12031-002-0033-3; Bremner JD, 2005, J PSYCHOPHARMACOL, V19, P159, DOI 10.1177/0269881105048996; BRODERICK PA, 1991, BRAIN RES BULL, V27, P689, DOI 10.1016/0361-9230(91)90046-M; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chuang DM, 2005, ANN NY ACAD SCI, V1053, P195, DOI 10.1196/annals.1344.018; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Dawirs RR, 1998, J NEURAL TRANSM, V105, P317, DOI 10.1007/s007020050061; de la Torre JC, 2003, NEUROL RES, V25, P635, DOI 10.1179/016164103101201931; DeBattista C, 2006, TRENDS ENDOCRIN MET, V17, P117, DOI 10.1016/j.tem.2006.02.006; Dhikav V, 2006, MED HYPOTHESES, V67, P725, DOI 10.1016/j.mehy.2006.04.038; DRAGUNOW M, 1990, NEUROSCI LETT, V109, P128, DOI 10.1016/0304-3940(90)90550-S; Eberling JL, 2003, NEUROBIOL AGING, V24, P725, DOI 10.1016/S0197-4580(02)00056-8; Fester L, 2006, J NEUROCHEM, V97, P1136, DOI 10.1111/j.1471-4159.2006.03809.x; Franklin TB, 2006, PSYCHONEUROENDOCRINO, V31, P38, DOI 10.1016/j.psyneuen.2005.05.008; GARCIAJIMENEZ A, 2002, BRAIN AGING, V2, P7; Halim ND, 2004, NEUROPSYCHOPHARMACOL, V29, P1063, DOI 10.1038/sj.npp.1300422; HALIM ND, EFFECTS CHRONIC HALO; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Hashimoto M, 2005, AM J PSYCHIAT, V162, P676, DOI 10.1176/appi.ajp.162.4.676; Henderson VW, 2006, NEUROSCIENCE, V138, P1031, DOI 10.1016/j.neuroscience.2005.06.017; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Liu XH, 1997, NEUROSCI LETT, V235, P93, DOI 10.1016/S0304-3940(97)00675-7; Luo L, 2001, ACTA PHARMACOL SIN, V22, P865; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev R, 2001, EUR J PHARMACOL, V420, pR1, DOI 10.1016/S0014-2999(01)00989-X; Manji HK, 2000, BIOL PSYCHIAT, V48, P740, DOI 10.1016/S0006-3223(00)00979-3; McEwen BS, 2005, MOL PSYCHIATR, V10, P525, DOI 10.1038/sj.mp.4001648; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; Pomara N, 2002, NEUROLOGY, V58, P1436, DOI 10.1212/WNL.58.9.1436; Pomara Nunzio, 2003, Psychopharmacol Bull, V37, P120; Reagan LP, 1999, NEUROSCIENCE, V91, P211, DOI 10.1016/S0306-4522(98)00615-0; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; RIEKKINEN P, 1995, NEUROREPORT, V6, P1297, DOI 10.1097/00001756-199506090-00017; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Wagstaff AJ, 2001, CNS DRUGS, V15, P231, DOI 10.2165/00023210-200115030-00006; Wang HD, 2004, NEUROPSYCHOPHARMACOL, V29, P1230, DOI 10.1038/sj.npp.1300449; Wang WP, 2006, BRAIN RES, V1084, P210, DOI 10.1016/j.brainres.2006.02.024; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101; Zhang YM, 2003, ACTA PHARMACOL SIN, V24, P403; Zhou R, 2005, J NEUROSCI, V25, P4493, DOI 10.1523/JNEUROSCI.4530-04.2005	48	43	45	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2007	68	6					1300	1306		10.1016/j.mehy.2006.09.040			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	168QV	WOS:000246540000020	17098374				2022-02-06	
J	Gao, WM; Chadha, MS; Berger, RP; Omenn, GS; Allen, DL; Pisano, M; Adelson, PD; Clark, RSB; Jenkins, LW; Kochanek, PM				Gao, Wei-Min; Chadha, Mandeep S.; Berger, Rachel P.; Omenn, Gilbert S.; Allen, David L.; Pisano, Michael; Adelson, P. David; Clark, Robert S. B.; Jenkins, Larry W.; Kochanek, Patrick M.			A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article							SHAKEN-BABY SYNDROME; PROSTAGLANDIN-D SYNTHASE; SEVERE HEAD-INJURY; YOUNG-CHILDREN; QUINOLINIC ACID; RAT-BRAIN; INFANTS; PROTEIN; EXPRESSION; APOPTOSIS	Traumatic brain injury (TBI) is the most common cause of traumatic death in infancy, and inflicted TBI (iTBI) is the predominant cause. Like other central nervous system pathologies, TBI changes the composition of cerebrospinal fluid (CSF), which may represent a unique clinical window on brain pathophysiology. Proteomic analysis, including two-dimensional (2-D) difference in gel electrophoresis (DIGE) combined with mass spectrometry (MS), was used to compare the CSF protein profile of two pooled samples from pediatric iTBI (n = 13) and non-inflicted TBI (nTBI; n = 13) patients with severe injury. CSF proteins from iTBI and nTBI were fluorescently labeled in triplicate using different fluorescent Cy dyes and separated by 2-D gel electrophoresis. Approximately 250 protein spots were found in CSF, with 90% between-gel reproducibility of the 2-D gel. Following in-gel digestion, the tryptic peptides were analyzed by MS for protein identification. The acute phase reactant, haptoglobin (HP) isoforms, showed an approximate fourfold increase in nTBI versus iTBI. In contrast, the levels of prostaglandin D-2 synthase (PGDS) and cystatin C (CC) were 12-fold and sevenfold higher in iTBI versus nTBI, respectively. The changes of HP, PGDS, and CC were confirmed by Western blot. These initial results with conventional gel-based proteomics show new protein changes that may ultimately help to understand pathophysiological differences between iTBI and nTBI.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Proteom Res Serv Inc, Ann Arbor, MI USA; Texas Tech Univ, Dept Environm Toxicol, Lubbock, TX 79409 USA; Texas Tech Univ, Inst Environm & Human Hlth, Lubbock, TX 79409 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 2323 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Omenn, Gilbert S./0000-0002-8976-6074	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000005] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 40686, K23 HD043843, K23 HD 043843-01, T32 HD040686] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [U54 DA021519, U54 DA 021519] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS030318, R01 NS042648, NS 42648, NS 38087, P50 NS030318, NS 30318, R01 NS042648-04, R01 NS038087] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS038087, P50NS030318, P20NS030318, R01NS042648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U54DA021519] Funding Source: NIH RePORTER		ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRED AR, 1995, COMP BIOCHEM PHYS B, V111, P1, DOI 10.1016/0305-0491(94)00229-N; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Berger RP, 2004, CHILD ABUSE NEGLECT, V28, P739, DOI 10.1016/j.chiabu.2004.01.007; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; CLAUSEN J, 1961, P SOC EXP BIOL MED, V107, P170; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; Freeman WM, 2004, NEUROCHEM RES, V29, P1065, DOI 10.1023/B:NERE.0000023594.21352.17; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Hochstrasser DF, 2002, PROTEOMICS, V2, P807, DOI 10.1002/1615-9861(200207)2:7<807::AID-PROT807>3.0.CO;2-4; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Odani N, 1996, J BIOL CHEM, V271, P16609, DOI 10.1074/jbc.271.28.16609; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Olsson T, 2004, NEUROSCIENCE, V128, P65, DOI 10.1016/j.neuroscience.2004.06.024; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Rohlff C, 2000, ELECTROPHORESIS, V21, P1227; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; SPAIDE RF, 1990, AM FAM PHYSICIAN, V41, P1145; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Urade Yoshihiro, 2004, Nihon Yakurigaku Zasshi, V123, P5; Vejda S, 2002, MOL CELL PROTEOMICS, V1, P387, DOI 10.1074/mcp.M200004-MCP200; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Zheng PP, 2003, J NEUROPATH EXP NEUR, V62, P855, DOI 10.1093/jnen/62.8.855	46	43	45	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					43	53		10.1089/neu.2006.0061			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100005	17263669	Green Submitted, Green Accepted			2022-02-06	
J	Jensen, T; Jensen, J; Norholt, SE; Dahl, M; Lenk-Hansen, L; Svensson, P				Jensen, Thomas; Jensen, John; Norholt, Sven Erik; Dahl, Martin; Lenk-Hansen, Lone; Svensson, Peter			Open reduction and rigid internal fixation of mandibular condylar fractures by an intraoral approach: A long-term follow-up study of 15 patients	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SUBCONDYLAR FRACTURES; NECK FRACTURES; CLOSED TREATMENT; BITE FORCES; OSTEOSYNTHESIS; MANAGEMENT; REPAIR	Purpose: To evaluate the long-term results obtained with open reduction and rigid internal fixation of mandibular condylar fractures by an intraoral approach. Patients and Methods: Fifteen patients with 24 mandibular condylar fractures were retrospectively examined with an average follow-up of 23 months (range, 6-63 months). Clinical and radiographic examination was conducted according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD), including an evaluation of maximum voluntary bite force measurements and facial nerve function. Statistical analysis was performed on maximum voluntary bite force measurements and maximum pressure pain threshold. Results: Two patients fulfilled the criteria for a RDC/TMD diagnosis. Myofacial pain (group 1) and bilateral arthralgia (group III), combined with a moderate nonspecific physical symptom score, was diagnosed in 1 patient and 1 patient received a diagnosis of disc displacement with reduction (group H). Satisfying radiographic fracture healing was seen in 12 joints. However, miniplate fracture occurred in 3 patients and severe bone resorption of the condylar head was seen in one patient. Minor adjustment of the postoperative occlusion was necessary in 6 patients. No significant difference between maximum voluntary isometric bite force measurements or maximum pressure pain threshold was found between the fracture side and the opposite side in unilateral cases or between the operated and nonoperated side in bilateral cases. None of the patients showed facial nerve injury or visible facial scars. Conclusion: Within the limitations of a retrospective study, the present study emphasized that optimal management of dislocated bilateral condylar injuries combined with other fractures of the facial skeleton constitute a challenging issue in maxillofacial trauma. Moreover, open reduction and rigid internal fixation of mandibular condylar fractures by an intraoral approach is a technically demanding surgical procedure associated with a high risk of postoperative complications in these injuries. (C) 2006 American Association of Oral and Maxillofacial Surgeons.	Aarhus Univ Hosp, Aalborg Hosp, Dept Oral & Maxillofacial Surg, DK-9000 Aalborg, Denmark; Univ Aarhus, Fac Hlth Sci, Sch Dent, Dept Clin Oral Physiol, DK-8000 Aarhus C, Denmark		Jensen, T (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Oral & Maxillofacial Surg, Hobrovej 18-22, DK-9000 Aalborg, Denmark.	u00250@aas.nja.dk	Svensson, Peter/H-6735-2012				Banks P, 1998, INT J ORAL MAX SURG, V27, P244, DOI 10.1016/S0901-5027(05)80504-1; Chen CT, 1999, PLAST RECONSTR SURG, V103, P60, DOI 10.1097/00006534-199901000-00011; Choi BH, 2001, INT J ORAL MAX SURG, V30, P296, DOI 10.1054/ijom.2001.0054; Choi BH, 1999, ORAL SURG ORAL MED O, V88, P292, DOI 10.1016/S1079-2104(99)70030-2; DAHLSTROM L, 1989, INT J ORAL MAX SURG, V18, P18, DOI 10.1016/S0901-5027(89)80009-8; Derogatis L., 1983, SCL90R CLIN PSYCH RE; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P586; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Hammer B, 1997, BRIT J ORAL MAX SURG, V35, P288, DOI 10.1016/S0266-4356(97)90050-4; Haug RH, 2002, J ORAL MAXIL SURG, V60, P73, DOI 10.1053/joms.2002.29078; Hovinga J, 1999, INT J ORAL MAX SURG, V28, P429, DOI 10.1034/j.1399-0020.1999.280606.x; IIZUKA T, 1991, ORAL SURG ORAL MED O, V72, P400, DOI 10.1016/0030-4220(91)90547-P; JETER TS, 1988, J ORAL MAXIL SURG, V46, P1113, DOI 10.1016/0278-2391(88)90462-4; Kellman Robert M, 2003, Arch Facial Plast Surg, V5, P244, DOI 10.1001/archfaci.5.3.244; KONSTANTINOVIC VS, 1992, J ORAL MAXIL SURG, V50, P349, DOI 10.1016/0278-2391(92)90395-G; LACHNER J, 1991, ORAL SURG ORAL MED O, V71, P257, DOI 10.1016/0030-4220(91)90295-N; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P195, DOI 10.1016/S0300-9785(77)80009-4; LINDSAY KW, 1997, NEUROLOGY NEUROSURGE; Miloro M, 2003, ORAL SURG ORAL MED O, V96, P387, DOI 10.1016/j.tripleo.2003.07.004; Mitchell DA, 1997, BRIT J PLAST SURG, V50, P67, DOI 10.1016/S0007-1226(97)91286-8; Motamedi MHK, 2003, J ORAL MAXIL SURG, V61, P61, DOI 10.1053/joms.2003.50049; Newman L, 1998, BRIT J ORAL MAX SURG, V36, P176, DOI 10.1016/S0266-4356(98)90492-2; Schon R, 2002, INT J ORAL MAX SURG, V31, P237, DOI 10.1054/ijom.2001.0213; Silvennoinen U, 1998, INT J ORAL MAX SURG, V27, P280, DOI 10.1016/S0901-5027(05)80615-0; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Suzuki T, 2004, J ORAL MAXIL SURG, V62, P919, DOI 10.1016/j.joms.2004.01.016; Svensson Peter, 1995, Journal of Orofacial Pain, V9, P347; TATE GS, 1994, J ORAL MAXIL SURG, V52, P734, DOI 10.1016/0278-2391(94)90489-8; Undt G, 1999, ORAL SURG ORAL MED O, V88, P534, DOI 10.1016/S1079-2104(99)70082-X; Widmark G, 1996, INT J ORAL MAX SURG, V25, P107, DOI 10.1016/S0901-5027(96)80052-X; WORSAAE N, 1994, J ORAL MAXIL SURG, V52, P353, DOI 10.1016/0278-2391(94)90436-7; Yang WG, 2002, J TRAUMA, V52, P498, DOI 10.1097/00005373-200203000-00014; Zou Z J, 1987, Dentomaxillofac Radiol, V16, P91	37	43	46	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	DEC	2006	64	12					1771	1779		10.1016/j.joms.2005.12.069			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	112ZV	WOS:000242567800011	17113444				2022-02-06	
J	Berger, RP; Kochanek, PM				Pardes Berger, Rachel; Kochanek, Patrick M.			Urinary S100B concentrations are increased after brain injury in children: A preliminary study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Society/Society-for-Pediatric-Research	MAY 14-17, 2005	Washington, DC	Pediat Acad Soc, Soc Pediat Res		S100B; urine; traumatic brain injury; hypoxemic brain injury; pediatrics	S-100 PROTEIN MEASUREMENTS; NEURON-SPECIFIC ENOLASE; INFLICTED HEAD-INJURY; FULL-TERM INFANTS; EARLY IDENTIFICATION; GESTATIONAL-AGE; CARDIAC-SURGERY; SERUM-LEVELS; DAMAGE; PRETERM	Objective: S100B is a renally excreted protein concentrated in glial cells of the nervous system. Increases in serum S100B concentrations reflect brain injury. However, increases in serum are rapid and transient and therefore may be of limited use in certain patients. Urinary S100B concentrations may be able to provide information about brain injury in this subgroup of patents. Design: Prospective, descriptive study. Setting: Level I trauma center. Patients: Fifteen children with acute traumatic or hypoxemic brain injury (subjects) and 14 healthy controls. Interventions: Urine and serum samples were collected from subjects and controls. Serial samples were collected in brain injury subjects up to every 12 hrs for 3 days. S100B concentrations were measured by enzyme-linked immunosorbent assay (Nanogen, San Diego CA). Outcome was assessed by Glasgow Outcome Scale score. Measurements and Main Results: Urinary S100B concentrations were detectable in 80% of subjects with increased serum S100B concentrations and 0% of controls. Peak urinary S100B concentrations occurred significantly later than peak serum S100B concentratons: 55.3 (29.8) (mean [SD]) vs. 14.6 (11.8) hrs after injury (p = .002). All subjects with an undetectable urinary S100B had a good outcome vs. only 20% of subjects with a detectable urinary S100B. Subjects with increased serum S100B were more likely to have a poor outcome than those with normal S100B (p = .01). Conclusions: Increases in urinary S100B are found in the majority of children with acute brain injury and an increased serum S100B. Urinary S100B concentrations peak later than serum concentrations, suggesting that measurement of urinary S100B may be helpful in subjects in whom early serum S100B is unavailable. Urinary and/or serum S100B concentrations may be useful to assist in the prediction of outcome after pediatric brain injury.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Child Advocacy Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15213 USA		Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15213 USA.		Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR00084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD43843-01] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR323155-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000084] Funding Source: NIH RePORTER		Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Gazzolo D, 2005, PEDIATR RES, V58, P1170, DOI 10.1203/01.pdr.0000185131.22985.30; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2001, CLIN CHEM, V47, P1132; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 2000, CLIN CHEM, V46, P998; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Portela LVC, 2002, CLIN CHEM, V48, P950; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rao P, 1999, CLIN RADIOL, V54, P495, DOI 10.1016/S0009-9260(99)90845-0; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	30	43	45	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2006	7	6					557	561		10.1097/01.PCC.0000244426.37793.23			5	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Pediatrics	103HY	WOS:000241877500007	17006387				2022-02-06	
J	Chibbaro, S; Tacconi, L				Chibbaro, S.; Tacconi, L.			Orbito-cranial injuries caused by penetrating non-missile foreign bodies. Experience with eighteen patients	ACTA NEUROCHIRURGICA			English	Article						non missile; orbito-facial; orbito-cranial; penetrating; angiography; cranio-cerebral	ANEURYSM SECONDARY; CRANIOCEREBRAL INJURIES; COMPUTED-TOMOGRAPHY; TRAUMATIC ANEURYSMS; INTRACRANIAL NAIL; BRAIN-ABSCESS; HEAD-INJURY; WOUNDS; PENCIL; WOOD	Background. Penetrating non-missile orbito-cranial injuries are uncommon civilian injuries which have some special features. Only limited case-reports are available in the international literature. Method. We present a retrospective review of 18 such in presumed trivial orbital injury. Early identification and removal of retained foreign body fragments was achieved within 36 hours. Findings. Patients were operated on and followed up for at least of 3 years. The final clinical outcome was excellent: 16 had a Glasgow Outcome Scale (GOS) of 5 while in the remaining 2 it was 4. Conclusion. The present report indicates that good results, in managing such injuries, can be achieved by a high index of suspicion and early diagnosis of intracranial injury in presumed trivial wounds and by the removal of every possible retained foreign body.	Univ Hosp Trieste, Dept Neurosurg, I-34100 Trieste, Italy		Chibbaro, S (corresponding author), Univ Hosp Trieste, Dept Neurosurg, Strada Fiume 447, I-34100 Trieste, Italy.	schibbaro@hotmail.com	Chibbaro, Salvatore/AAI-6368-2020	tacconi, leonello/0000-0003-3915-5635; chibbaro, salvatore/0000-0003-1318-1245			ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ASKENASY HM, 1961, J NEUROSURG, V18, P554, DOI 10.3171/jns.1961.18.4.0554; BAKAY L, 1977, ACTA NEUROCHIR, V39, P219, DOI 10.1007/BF01406732; BRAUN J, 1987, J COMPUT ASSIST TOMO, V11, P525, DOI 10.1097/00004728-198705000-00030; BURSICK DM, 1981, SURG NEUROL, V16, P427, DOI 10.1016/0090-3019(81)90235-4; Buxton N, 1997, J R Army Med Corps, V143, P112; CAROTHERS A, 1978, JAMA-J AM MED ASSOC, V239, P1151, DOI 10.1001/jama.239.12.1151; CHADDUCK WM, 1969, J NEUROSURG, V31, P77, DOI 10.3171/jns.1969.31.1.0077; CHAPMAN PH, 1985, CONCEPTS PEDIAT NEUR, V5, P1; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; CLARK EC, 1986, J NEUROSURG, V6, P9; DOOLING JA, 1967, J NEUROSURG, V26, P636, DOI 10.3171/jns.1967.26.6.0636; DOUCET TW, 1983, ANN OPHTHALMOL, V15, P325; DUFFY GP, 1969, BRIT J SURG, V56, P685, DOI 10.1002/bjs.1800560912; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FANNING WL, 1976, J TRAUMA, V16, P919, DOI 10.1097/00005373-197611000-00011; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FOX JL, 1971, ACTA NEUROCHIR, V24, P315, DOI 10.1007/BF01405415; FOY P, 1980, LANCET, V2, P662; GLATT HJ, 1990, OPHTHALMIC PLAST REC, V6, P108, DOI 10.1097/00002341-199006000-00005; GREEN BF, 1990, OPHTHALMOLOGY, V97, P608; GREENE KA, 1993, SURG NEUROL, V40, P499, DOI 10.1016/0090-3019(93)90054-5; GUTHKELCH AN, 1960, BMJ-BRIT MED J, V5202, P842; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; HORNER FA, 1964, NEW ENGL J MED, V271, P342, DOI 10.1056/NEJM196408132710703; IDE CH, 1971, AM J OPHTHALMOL, V71, P1037, DOI 10.1016/0002-9394(71)90571-X; Kahler RJ, 1998, NEUROSURGERY, V42, P1370, DOI 10.1097/00006123-199806000-00108; KAISER MC, 1983, NEURORADIOLOGY, V24, P229, DOI 10.1007/BF00399777; KICK CF, 1984, J NEUROSURG, V60, P42; MARKHAM JW, 1964, J NEUROSURG, V21, P1095, DOI 10.3171/jns.1964.21.12.1095; MILLER CF, 1977, SURG NEUROL, V7, P95; MOSDAL C, 1985, ACTA NEUROCHIR, V74, P31, DOI 10.1007/BF01413273; ONEILL OR, 1994, SURG NEUROL, V42, P494, DOI 10.1016/0090-3019(94)90079-5; Rahman NU, 1997, INT OPHTHALMOL, V21, P13, DOI 10.1023/A:1005834913614; Rao GP, 1998, BRIT J NEUROSURG, V12, P569; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; SOLOMON KD, 1993, J TRAUMA, V34, P285, DOI 10.1097/00005373-199302000-00020; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; Van der Heijden ECM, 1998, J ECON PSYCHOL, V19, P5, DOI 10.1016/S0167-4870(97)00035-4; WEISMAN RA, 1983, ARCH OTOLARYNGOL, V109, P265	43	43	48	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2006	148	9					937	942		10.1007/s00701-006-0794-5			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	081KK	WOS:000240316300003	16763734				2022-02-06	
J	Cragar, DE; Berry, DTR; Fakhoury, TA; Cibula, JE; Schmitt, FA				Cragar, Dona E.; Berry, David T. R.; Fakhoury, Toufic A.; Cibula, Jean E.; Schmitt, Frederick A.			Performance of patients with epilepsy or psychogenic non-epileptic seizures on four measures of effort	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	29th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 2001	CHICAGO, IL	Int Neuropsychol Soc			MEMORY; DEPRESSION; IMPAIRMENT; VALIDATION; DIAGNOSIS; INJURY; TOMM	Exaggeration of cognitive symptoms or poor effort on cognitive testing has been addressed primarily in the traumatic brain injury literature. The present investigation aims to extend the evaluation of effort to the epilepsy monitoring setting, where base rates of failure on effort testing remain unknown for patients with intractable epilepsy (ES), psychogenic nonepileptic seizures (PNES), or both conditions (ES+PNES). In addition, this investigation explores how well four measures of effort (DMT, LMT, TOMM, PDRT) distinguish between these diagnostic groups. Results show that 20% of the combined sample failed one or more effort measure. When examining failure rates for each diagnostic group, 22% of epilepsy patients, 24% of PNES patients, and 11% of ES+PNES patients performed suboptimally on one or more measure of effort. The utility of these effort measures to differentiate between these diagnostic groups appears limited. Further research is needed to clarify the base rate of poor effort in the epilepsy monitoring unit setting in general and in these three diagnostic groups specifically.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; Univ Kentucky, Dept Neurol, Lexington, KY 40506 USA; Univ Kentucky, Dept Psychiat, Lexington, KY 40506 USA; Univ Kentucky, Dept Behav Sci, Lexington, KY 40506 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA		Cragar, DE (corresponding author), Mayo Clin, Div Psychol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	locke.dona@mayo.edu		Locke, Dona/0000-0002-1966-7716			Allen L., 1997, CARB 97 MANUAL COMPU; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1994, J CLIN EXP NEUROPSYC, V16, P524, DOI 10.1080/01688639408402663; Binder LM, 1998, ARCH CLIN NEUROPSYCH, V13, P513, DOI 10.1016/S0887-6177(97)00042-5; BINDER LM, 2002, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Cragar DE, 2003, J CLIN EXP NEUROPSYC, V25, P793, DOI 10.1076/jcen.25.6.793.16471; Cragar DE, 2002, NEUROPSYCHOL REV, V12, DOI 10.1023/A:1015491123070; D'Arcy RCN, 2000, BRAIN COGNITION, V44, P54; DEVINSKY O, 1995, NEUROL CLIN, V13, P299, DOI 10.1016/S0733-8619(18)30047-1; Green P, 2003, ARCH CLIN NEUROPSYCH, V18, P625, DOI 10.1016/S0887-6177(03)00094-5; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 1996, WORD MEMORY TEST MAN; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Hill S. K., 2003, J FORENSIC NEUROPSYC, P1, DOI [10.1300/J151v03n03_01, DOI 10.1300/J151V03N03_01]; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Martin R, 2003, NEUROLOGY, V61, P1791, DOI 10.1212/01.WNL.0000098890.13946.F5; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reynolds CR, 1998, CRIT ISS NE, P261; SMIGIELSKI JS, 2004, 24 ANN NAT AC NEUR C; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Williamson David J., 2003, Epilepsia, V44, P13	33	43	43	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					552	566		10.1080/13854040590947380			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000015	16895866				2022-02-06	
J	Kim, E; Bijlani, M				Kim, Edward; Bijlani, Mona			A pilot study of quetiapine treatment of aggression due to traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							OVERT AGGRESSION; SCHIZOPHRENIA; RISPERIDONE; OLANZAPINE; REHABILITATION; HALOPERIDOL; CLOZAPINE; PSYCHOSIS; DISORDER	In a 6-week open-label, flexible dose pilot study of quetiapine for treatment of aggression secondary to traumatic brain injury (TBI) seven subjects who were at least 3-months post-injury were enrolled. The Overt Aggression Scale - Modified (OAS-M) and Clinical Global Impression (CGI) were primary outcome measures. Administration of quetiapine at doses of 25 to 300mg daily was efficacious and well-tolerated in reducing irritability and aggression resulting from TBI, with an associated improvement in cognitive functioning.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08855 USA; Bristol Myers Squibb Co, Plainsboro, NJ USA		Kim, E (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, 671 Hoes Lane, Piscataway, NJ 08855 USA.	edward.kim@bms.com					Akdede BBK, 2005, PROG NEURO-PSYCHOPH, V29, P233, DOI 10.1016/j.pnpbp.2004.11.005; Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; Corson AH, 2004, J CLIN PSYCHIAT, V65, P1531, DOI 10.4088/JCP.v65n1115; EYSENCK MW, 1991, PERSPECTIVES COGNITI; Harvey PD, 2004, SCHIZOPHR RES, V66, P101, DOI 10.1016/j.schres.2003.07.009; Kraus J. F., 1999, REHABILITATION ADULT, P3; Krieger D, 2003, NEUROREHABILITATION, V18, P205; KRUETZER J, 1999, NEUROBEHAVIORAL FUNC; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; MASSMAN PJ, 1992, J CLIN EXP NEUROPSYC, V14, P687, DOI 10.1080/01688639208402856; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Randolph C., 1998, RBANS REPEATABLE BAT; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; SANDEL ME, 1993, BRAIN INJURY, V7, P77, DOI 10.3109/02699059309008159; Scharre DW, 2002, ALZ DIS ASSOC DIS, V16, P128, DOI 10.1097/00002093-200204000-00011; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Temple M J, 2003, J R Army Med Corps, V149, P54; Volavka J, 2004, J CLIN PSYCHOPHARM, V24, P225, DOI 10.1097/01.jcp.0000117424.05703.29; Walker C, 2003, INT J OFFENDER THER, V47, P556, DOI 10.1177/0306624X03253027; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	24	43	43	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2006	18	4					547	549		10.1176/appi.neuropsych.18.4.547			3	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	103BX	WOS:000241861800012	17135382				2022-02-06	
J	Wilde, EA; Bigler, ED; Pedroza, C; Ryser, DK				Wilde, Elisabeth A.; Bigler, Erin D.; Pedroza, Claudia; Ryser, David K.			Post-traumatic amnesia predicts long-term cerebral atrophy in traumatic brain injury	BRAIN INJURY			English	Article						morphometry; neuroimaging; post-traumatic amnesia; traumatic brain injury; ventricle-to-brain ratio	CLOSED-HEAD-INJURY; PRACTICAL SCALE; REHABILITATION; SEVERITY; SEQUELAE; MILD; COMA; MRI	Primary objective: To examine post-traumatic amnesia (PTA) and its relation to long-term cerebral atrophy in persons with traumatic brain injury (TBI) using objective indicators of PTA duration and Quantitative Magnetic Resonance Imaging (QMRI). It was hypothesized that longer PTA would predict later generalized atrophy (increased ventricle-to-brain ratio (VBR)). As a guide in assessing patients with TBI, this study determined the probability of developing chronic cerebral atrophy based on PTA duration. Research design: Probability model using 60 adult patients with mild-to-severe TBI. Main outcomes and results: A logistic regression model with a cut-off determined by normative QMRI data confirmed that longer PTA duration predicts increased VBR. A probability model demonstrated a 6% increase in the odds of developing later atrophy on neuroimaging with each additional day of PTA. Conclusions: PTA has previously proven to be a good indicator of later cognitive recovery and functional outcome and also predicts long-term parenchymal change.	Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; Univ Texas, Sch Publ Hlth, Houston, TX USA; LDS Hosp, Neuro Special Rehabil Unit, Salt Lake City, UT USA		Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1709 Dryden Rd,Ste 725, Houston, TX 77030 USA.	ewilde@bcm.tmc.edu		Pedroza, Claudia/0000-0003-4235-1282			Ahmed S, 2000, BRAIN INJURY, V14, P765; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BIGLER ED, 2005, NEUROPSYCHIATRY TRAU, P79; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; GUISE E, 2005, BRAIN INJURY, V19, P1087; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; RYSER DK, 1996, INT PERSPECTIVES TRA, P79; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	29	43	43	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2006	20	7					695	699		10.1080/02699050600744079			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200003	16809201				2022-02-06	
J	Keenan, HT; Runyan, DK; Nocera, M				Keenan, HT; Runyan, DK; Nocera, M			Longitudinal follow-up of families and young children with traumatic brain injury	PEDIATRICS			English	Article						traumatic brain injury; outcomes; child abuse; shaken baby syndrome	PEDIATRIC INTENSIVE-CARE; SCORES	OBJECTIVES. To examine the stability of functional outcomes 2 years after injury among children who sustained a traumatic brain injury (TBI) before 2 years of age and to examine the characteristics of the families caring for these children. METHODS. All North Carolina-resident children who were hospitalized between January 2000 and December 2001 in any of the state's 9 PICUs and survived a TBI that occurred on or before their second birthday were eligible to participate in the prospective cohort study. Child health status, use of ancillary medical resources, and family characteristics were assessed through maternal caregiver interviews similar to 2 years after injury. Comparisons were made among injury types ( inflicted versus noninflicted). RESULTS. There were 112 children who survived a TBI during the 2-year study period. Fifty-seven (79%) of the 72 maternal caregivers who had completed an interview 1 year after the child's injury participated in the year 2 interview. Most children (67%) had an outcome of mild disability or better at year 2, with 45% functioning at an age-appropriate level. Children's outcomes did not differ significantly at year 2 according to the mechanism of injury. The majority ( 67%) of children retained their Pediatric Overall Performance Category scores from year 1 to year 2. Children who changed were as likely to show improvement as deterioration. Children differed very little across time, as measured with the Stein-Jessup Functional Status II ( Revised) scale. Families tended to have multiple environmental factors that could put their children at risk for poor developmental outcomes, including living below the poverty level (22%) and low social capital (39%). CONCLUSIONS. The children in this cohort had relatively stable functional outcomes from year 1 to year 2 after injury. This population of children remains very vulnerable to poor developmental outcomes secondary to the effects of their TBI and environmental factors.	Univ Utah, Intermt Control Res Ctr, Salt Lake City, UT 84158 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; Univ N Carolina, Dept Social Med, Chapel Hill, NC USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; Univ N Carolina, Univ N Carolina Canc Injury Prevent Res Ctr, Chapel Hill, NC USA		Keenan, HT (corresponding author), Univ Utah, Intermt Control Res Ctr, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD041040-04, K23 HD041040-01A2, K23 HD041040] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR402444] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD041040] Funding Source: NIH RePORTER		COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; POLITZ K, 2001, CONSUMERS GUIDE GETT; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; RUNYAN DK, 2001, WELL BEING CHILDREN; Sameroff A J, 1998, Pediatrics, V102, P1287; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110	17	43	44	1	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2006	117	4					1291	1297		10.1542/peds.2005-1883			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	029EA	WOS:000236540500062	16585326	Green Accepted, Green Submitted			2022-02-06	
J	Peleg, K; Rivkind, A; Aharonson-Damel, L				Peleg, K; Rivkind, A; Aharonson-Damel, L		Israeli Trauma Grp	Does body armor protect from firearm injuries?	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							PERSONAL ARMOR; BATTLEFIELD; CASUALTIES; WARFARE; WOUNDS; IRAQ	BACKGROUND: Bullet-p roof vests and helmets protect from harm in combat and military engagements. The use of armor against shrapnel has been studied, yet little has been documented as to how they protect from high velocity, gunshots. This study aims to describe the medical consequences of high velocity Firearm Injuries and to differentiate between patients injured while using protective wear and those injured unprotected. STUDY DESIGN: National trauma registry, data oil injury, characteristics, treatment and outcomes between October 1, 2000 and December 31, 2003 were retrieved and analyzed. RESULTS: There were 669 terror-related Firearm injuries recorded: 236 (37.8%) in soldiers (protected) and 433 (62.2%) In civilians (unprotected). Injury severity was notably, higher in civilian patients (31% versus 16% with Injury, Severity Score 16). Civilians had more ICU care (26% versus 20%, p = 0.06), and double the inpatient mortality (8.6% [n = 37] versus 3.4% (n = 81 patients). Protected body, regions Such as abdomen, chest, and brain, were injured less frequently Once a traumatic brain injury was sustained, no statistical differences were found ill severity distribution, ICU stay, or inpatient death between protected and unprotected patients. But injury, severity, in patients with chest Injuries was Much higher in those who were unprotected (Injury Severity Score >= 25, 41% versus 23%, respectively, p = 0.08). This increased severity could be attributed partly to more multiple injuries involving the chest. Abdominal injuries showed a similar pattern. CONCLUSIONS: Body armor has a protective effect on victims of high velocity, gunshot wounds; lower rates of head, brain, chest, and abdominal injuries are seen. In addition, armor reduces the severity of injuries to the chest and the abdomen. (J Am Coll Surg 2006;202:643-648. (c) 2006 by the American College of Surgeons).	Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Hashomer, Israel; Hadassah Hebrew Univ Hosp, Dept Gen Surg, Jerusalem, Israel; Hadassah Hebrew Univ Hosp, Shock Trauma Unit, Jerusalem, Israel		Peleg, K (corresponding author), Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Hashomer, Israel.		Aharonson-Daniel, Limor/F-1998-2012	Aharonson-Daniel, Limor/0000-0003-4585-6892			BELLAMY RF, 1984, MIL MED, V149, P55; Gofrit ON, 1996, INJURY, V27, P577, DOI 10.1016/S0020-1383(96)00072-1; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Kosashvili Y, 2005, J TRAUMA, V58, P1236, DOI 10.1097/01.TA.0000169804.17603.76; LEITH RA, 1997, ANAL CASUALTY RATES; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MAUGHON JS, 1970, MIL MED, V135, P8, DOI 10.1093/milmed/135.1.8; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; ZAJTCHUK BG, 1997, TXB MILITARY MED	9	43	46	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2006	202	4					643	648		10.1016/j.jamcollsurg.2005.12.019			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	028HE	WOS:000236476900014	16571436				2022-02-06	
J	Preusser, M; Strobel, T; Gelpi, E; Eiler, M; Broessner, G; Schmutzhard, E; Budka, H				Preusser, M; Strobel, T; Gelpi, E; Eiler, M; Broessner, G; Schmutzhard, E; Budka, H			Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HEAD-INJURY; AMYLOID PLAQUES; BETA-PROTEIN; BRAIN-INJURY; COEXISTENCE; INFECTIONS; DEPOSITION; PATHOLOGY; DEMENTIA; OVERLAP	We report the case of a 28 year old man who had received a cadaverous dura mater graft after a traumatic open skull fracture with tearing of the dura at the age of 5 years. A clinical suspicion of Creutzfeldt-Jakob disease (CJD) was confirmed by a brain biopsy 5 months prior to death and by autopsy, thus warranting the diagnosis of iatrogenic CJD (iCJD) according to WHO criteria. Immunohistochemistry showed widespread cortical depositions of disease associated prion protein (PrPsc) in a synaptic pattern, and western blot analysis identified PrPsc of type 2A according to Parchi et al. Surprisingly, we found Alzheimer-type senile plaques and cerebral amyloid angiopathy in widespread areas of the brain. Plaque-type and vascular amyloid was immunohistochemically identified as deposits of beta-A4 peptide. CERAD criteria for diagnosis of definite Alzheimer's disease ( AD) were met in the absence of neurofibrillar tangles or alpha-synuclein immunoreactive inclusions. There was no family history of AD, CJD, or any other neurological disease, and genetic analysis showed no disease specific mutations of the prion protein, presenilin 1 and 2, or amyloid precursor protein genes. This case represents (a) the iCJD case with the longest incubation time after dural grafting reported so far, (b) the youngest documented patient with concomitant CJD and Alzheimer-type neuropathology to date, (c) the first description of Alzheimer-type changes in iCJD, and (d) the second case of iCJD in Austria. Despite the young patient age, the Alzheimer-type changes may be an incidental finding, possibly related to the childhood trauma.	Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria; Gen Hosp Vienna, Austrian Reference Ctr Human Prion Dis, Vienna, Austria; LKH Rankweil, Dept Neurol, Rankweil, Austria; Med Univ Innbruck, Dept Neurol, Innsbruck, Austria		Budka, H (corresponding author), Med Univ Vienna, Inst Neurol, Waehringer Guertel 18-20,4J, A-1097 Vienna, Austria.	herbert.budka@kin.at	Budka, Herbert/I-3486-2019; Preusser, Matthias/C-8530-2011	Budka, Herbert/0000-0002-1933-1577; Schmutzhard, Erich/0000-0003-3295-7491; Preusser, Matthias/0000-0003-3541-2315			BARCIKOWSKA M, 1995, HISTOPATHOLOGY, V26, P445; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; BROWN P, 1990, NEUROLOGY, V40, P226, DOI 10.1212/WNL.40.2.226; BUGIANI O, 1993, J NEUROPATH EXP NEUR, V52, P64, DOI 10.1097/00005072-199301000-00008; Castellani RJ, 2004, ACTA NEUROBIOL EXP, V64, P11; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; DEARMOND SJ, 1993, CURR OPIN NEUROL, V6, P872, DOI 10.1097/00019052-199312000-00008; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GAJDUSEK DC, 1994, ANN NY ACAD SCI, V724, P173, DOI 10.1111/j.1749-6632.1994.tb38909.x; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GRAY F, 1994, ACTA NEUROPATHOL, V88, P106, DOI 10.1007/BF00294366; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kretzschmar HA, 2003, BRAIN PATHOL, V13, P245; LIBERSKI PP, 1987, ACTA NEUROL SCAND, V76, P428, DOI 10.1111/j.1600-0404.1987.tb03598.x; MASTERS CL, 1988, CIBA F SYMP, V135, P24; MASTERS CL, 1981, BRAIN, V104, P535, DOI 10.1093/brain/104.3.535; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MIYAZONO M, 1992, ACTA NEUROPATHOL, V83, P333, DOI 10.1007/BF00713522; MURAMOTO T, 1992, ACTA NEUROPATHOL, V84, P686; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; POWERS JM, 1991, ACTA NEUROPATHOL, V83, P95, DOI 10.1007/BF00294437; Radbauer C, 1998, WIEN KLIN WOCHENSCHR, V110, P496; Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885, DOI 10.1093/jnen/62.9.885; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; WATSON CP, 1979, ANN NEUROL, V6, P368, DOI 10.1002/ana.410060415; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	33	43	43	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2006	77	3					413	416		10.1136/jnnp.2005.070805			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	016WK	WOS:000235651900034	16484658	Green Published			2022-02-06	
J	Sinha, K; Karimi-Abdolrezaee, S; Velumian, AA; Fehlings, MG				Sinha, K; Karimi-Abdolrezaee, S; Velumian, AA; Fehlings, MG			Functional changes in genetically dysmyelinated spinal cord axons of shiverer mice: Role of juxtaparanodal Kv1 family K+ channels	JOURNAL OF NEUROPHYSIOLOGY			English	Article							MYELIN BASIC-PROTEIN; GATED POTASSIUM CHANNELS; CENTRAL-NERVOUS-SYSTEM; MAJOR DENSE LINE; MUTANT MOUSE; HYPOMYELINATED AXONS; PARANODAL JUNCTIONS; CONDUCTION-BLOCK; XENOPUS OOCYTES; SCHWANN-CELLS	Axonal dysfunction after spinal cord injury (SCI) and other types of neurotrauma is associated with demyelination and exposure of juxtaparanodal K+ channels. In this study, sucrose gap electrophysiology using selective and nonselective K+ channel blockers, confocal immunohistochemistry, and Western blotting were used to study the role of Kv1.1 and Kv1.2 K+ channel subunits in dysmyelination-induced spinal cord axonal dysfunction in shiverer mice, which lack the gene encoding myelin basic protein (MBP) and exhibit incomplete myelin sheath formation on CNS axons. The shiverer spinal cord axons exhibited smaller amplitude of compound action potentials (CAPs), reduced conduction velocity, reduced excitability, and greater degree of high-frequency conduction failure. The "fast" K+ channel blocker 4-aminopyridine, the toxin DTX-I, which targets the Kv1.1 and Kv1.2, but not DTX-K, which has higher selectivity for Kv1.1, increased the amplitude and area of CAPs of shiverer mice spinal cord axons but had insignificant effects in wild-type mice. Confocal immunohistochemistry showed that, unlike wild-type mice, which have a precise juxtaparanodal localization of the Kv1.l and Kv1.2 K+ channel subunits, shiverer mouse axons displayed a dispersed distribution of these subunits along the internodes. In contrast, the Kv1. l and Kv1.2 subunits, Na+ channels remained highly localized to the nodal regions. Western blotting showed an increased expression of Kv 1.1 and 1.2 in the shiverer mouse spinal cord. These results provide evidence that the neurological deficits associated with myelin deficiency reflect the altered distribution and expression of the K+ channel subunits Kv1. l and Kv1.2 along the internodes of spinal cord axons associated with the biophysical consequences caused by alterations in the myelin sheaths.	Univ Toronto, Toronto Western Hosp, Univ Hlth Network,Toronto Western Res Inst, Krembil Neurosci Ctr,Div Cell & Mol Biol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5T 2S8, Canada		Fehlings, MG (corresponding author), Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Div Neurosurg, Rm 4W-449,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.on.ca		Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663; Fehlings, Michael/0000-0002-5722-6364			Agrawal SK, 1996, J NEUROSCI, V16, P545; Arroyo EJ, 2002, J NEUROSCI, V22, P1726, DOI 10.1523/JNEUROSCI.22-05-01726.2002; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Chiu S Y, 1981, Adv Neurol, V31, P313; CHIU SY, 1980, NATURE, V284, P170, DOI 10.1038/284170a0; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Devaux JJ, 2005, J NEUROSCI, V25, P1470, DOI 10.1523/JNEUROSCI.3328-04.2005; Dodson PD, 2003, J PHYSIOL-LONDON, V550, P27, DOI 10.1113/jphysiol.2003.046250; DUBOIS JM, 1981, J PHYSIOL-LONDON, V318, P297; DUPOUEY P, 1979, NEUROSCI LETT, V12, P113, DOI 10.1016/0304-3940(79)91490-3; Eftekharpour E, 2005, EXP NEUROL, V193, P334, DOI 10.1016/j.expneurol.2005.01.019; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ERLANGER JGH, 1937, ELECT SIGNS NERVOUS, P1221; Fehlings MG, 1997, J NEUROSCI METH, V71, P215, DOI 10.1016/S0165-0270(96)00147-1; Fehlings MG, 1996, BRAIN RES, V736, P135, DOI 10.1016/S0006-8993(96)00667-1; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; HAYES KC, 1994, J NEUROTRAUM, V11, P433, DOI 10.1089/neu.1994.11.433; Honmou O, 1996, J NEUROSCI, V16, P3199; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; HUDSON LD, 1990, SEMIN NEUROSCI, V2, P483; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; MACKLIN WB, 1987, FEBS LETT, V223, P417, DOI 10.1016/0014-5793(87)80331-9; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; Marcus J, 2002, J CELL BIOL, V156, P567, DOI 10.1083/jcb.200111047; Mathis C, 2001, DEVELOPMENT, V128, P4881; McDonald JW, 2000, NAT MED, V6, P358, DOI 10.1038/74759; MEDIRATTA NK, 1983, J PHYSIOL-LONDON, V336, P545, DOI 10.1113/jphysiol.1983.sp014597; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; NADON NL, 1990, DEVELOPMENT, V110, P529; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570; NOEBELS JL, 1991, NATURE, V352, P431, DOI 10.1038/352431a0; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; READHEAD C, 1991, HUM REPROD, V6, P93, DOI 10.1093/oxfordjournals.humrep.a137265; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; ROACH A, 1985, CELL, V42, P1049; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; Rosenbluth J, 2003, GLIA, V41, P318, DOI 10.1002/glia.10179; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Sobko A, 1998, J NEUROSCI, V18, P10398; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TARG EF, 1985, BRAIN RES, V328, P358, DOI 10.1016/0006-8993(85)91049-2; TYTGAT J, 1995, J BIOL CHEM, V270, P24776, DOI 10.1074/jbc.270.42.24776; UTZSCHNEIDER DA, 1994, P NATL ACAD SCI USA, V91, P53, DOI 10.1073/pnas.91.1.53; VIGNAIS L, 1993, INT J DEV NEUROSCI, V11, P603, DOI 10.1016/0736-5748(93)90049-J; Vitry S, 2003, J NEUROSCI, V23, P10724; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992	73	43	43	0	10	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAR	2006	95	3					1683	1695		10.1152/jn.00899.2005			13	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	014KE	WOS:000235477900036	16319208				2022-02-06	
J	Fingerhut, LA; Warner, M				Fingerhut, LA; Warner, M			The ICD-10 injury mortality diagnosis matrix	INJURY PREVENTION			English	Article								Objective: To standardize the presentation of the more than 1200 ICD-10 "S'' and "T'' codes from Chapter XIX by cross classifying the body region of injury by the nature of injury using the ICD-10 injury mortality diagnosis matrix. This paper explains the rationale for decisions made when developing the matrix and presents mortality data using the matrix. Design: ICD-10 codes are organized by diagnosis groups and body regions of injury for the purpose of standardizing presentation. The categories can be collapsed to facilitate analysis at varying levels of detail. Findings from the United States 2002 injury mortality data are used as an example. Main outcome measures: All injury diagnoses mentioned in deaths with an underlying cause of injury. Results: There were a total of 247,195 injury diagnoses mentioned in the 161,269 deaths with an underlying cause of injury in 2002 in the United States. The matrix can be used to show that 30% of all injury diagnoses mentioned were to the head and neck region; 28% were system wide injuries, 17% were to the torso. Open wounds accounted for 17% of all injury diagnoses mentioned, and close to half of all open wounds were traumatic brain injuries. Twenty eight percent of injury diagnoses mentioned were unspecified as to their nature and 9.5% had no body region specified. Conclusions: Multiple cause of death data are a rich but underused source of injury data often due to the complexity of the data and of the ICD classification system. Analytic techniques will need to be refined to accommodate deaths with multiple contributing injury diagnoses. The injury mortality diagnosis matrix will facilitate analysis as it is a useful tool for summarizing diagnosis data associated with injury deaths.	Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA		Fingerhut, LA (corresponding author), Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	LFingerhut@cdc.gov					Aharonson-Daniel L, 2005, INJURY PREV, V11, P197, DOI 10.1136/ip.2005.008227; Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Anderson Robert N, 2004, Natl Vital Stat Rep, V52, P1; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; FINKELSTEIN EA, 2005, INCIDENCE EC BURDEN; Heinen M, 2005, NATL TRENDS INJURY H; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MARIETTA GA, 2003, STATE TERRITORIAL IN; MININO AM, 2006, IN PRESS NATL VITAL; *NCHS, COMP CAUS DEATH BETW; *NCHS, 2005, COMP ED MORT DAT INC; *US DEP HHS, 2004, US DHHS CDCP; World Health Organisation (WHO), 1977, MAN INT STAT CLASS D; World Health Organization, 2004, ICD 10 INT STAT CLAS	14	43	43	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047			INJURY PREV	Inj. Prev.	FEB	2006	12	1					24	29		10.1136/ip.2005.009076			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	009BK	WOS:000235085900008	16461416	Green Published			2022-02-06	
J	Kompanje, EJO; Bakker, J; Slieker, FJA; Ijzermans, JNM; Maas, AIR				Kompanje, EJO; Bakker, J; Slieker, FJA; Ijzermans, JNM; Maas, AIR			Organ donations and unused potential donations in traumatic brain injury, subarachnoid haemorrhage and intracerebral haemorrhage	INTENSIVE CARE MEDICINE			English	Article						brain death; ethics; potential organ donor; intracerebral haemorrhage; non-heart-beating organ donation; subarachnoid haemorrhage; traumatic brain injury	HIGH-RISK; DEATH; IDENTIFICATION; TRANSPLANTATION; DONORS; CARE	Objective:To obtain insight into the occurrence of brain death and the potential for brain dead and controlled non-heart-beating organ donors (CNHB) in patients with traumatic brain injury (TBI), subarachnoid haemorrhage (SAH) and intracerebral haemorrhage (ICH) in a large neurosurgical serving area (2.1 million inhabitants). Design:Retrospective analysis of data concerning patients with TBI, SAH and ICH who died during the course of ICU treatment during 1999-2003. Setting:A 16-bed neuro-intensive care unit. Patients: Patients with TBI, SAH or ICH who died during the course of ICU treatment. Measurements and results:The number of ICU deaths in patients with TBI, SAH and ICH declined from 111 in 1999 to 64 in 2003. In total, 476 deaths occurred. Of these, 177 patients were not included in the analysis. Two hundred ninety-nine (299) ventilated patients had two or more absent brainstem reflexes (ABSR) and a Glasgow Coma Score of 3-4 at the moment of treatment withdrawal and formed the potential for organ donation; 61 of these patients were treated until full brain death. Organs of 57 patients could be harvested. We analysed the reasons that organs were not procured in the 242 remaining patients. The most important reasons were family refusal (32%), medical contraindications (14%), and the treating physician not considering potential organ donation (20%). The missed potential is 162/299 (54%). Conclusion:The number of actual and potential organ donors is declining, but a considerable number of potential CNHB donors exists. Refusal by relatives is the most important reason for failure to procure organs.	Erasmus Univ, Med Ctr, Dept Intens Care, NL-3000 CA Rotterdam, Netherlands; Erasmus MC Univ, Med Ctr, Dept Intens Care, NL-3000 CA Rotterdam, Netherlands; Erasmus MC Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands		Kompanje, EJO (corresponding author), Erasmus Univ, Med Ctr, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009; Maas, Andrew IR/C-5584-2013	Bakker, Jan/0000-0003-2236-7391; Maas, Andrew IR/0000-0003-1612-1264			Altinors N, 1998, TRANSPLANT P, V30, P771, DOI 10.1016/S0041-1345(98)00041-4; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Chiara O, 2002, INJURY, V33, P553, DOI 10.1016/S0020-1383(02)00123-7; Cohen B, 2005, NEPHROL DIAL TRANSPL, V20, P34, DOI 10.1093/ndt/gfh506; Dominguez-Roldan JM, 1999, TRANSPL P, V31, P2595, DOI 10.1016/S0041-1345(99)00516-3; Dominguez-Roldan JM, 2002, TRANSPLANT P, V34, P9, DOI 10.1016/S0041-1345(01)02646-X; Dosemeci L, 2004, TRANSPL P, V36, P20, DOI 10.1016/j.transproceed.2003.11.050; FALTIN DL, 1992, TRANSPLANTATION, V54, P85, DOI 10.1097/00007890-199207000-00015; GORE SM, 1989, BRIT MED J, V299, P1193, DOI 10.1136/bmj.299.6709.1193; Kleindienst A, 1999, ACTA NEUROCHIR, V141, P641, DOI 10.1007/s007010050354; Matesanz R, 2002, J NEPHROL, V15, P22; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; Navarro A, 1996, TRANSPLANT P, V28, P103; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pratschke J, 2004, TRANSPLANTATION, V77, P43, DOI 10.1097/01.TP.0000092003.02115.95; Procaccio F, 2001, Minerva Anestesiol, V67, P71; Pugliese MR, 2003, TRANSPL INT, V16, P21, DOI 10.1111/j.1432-2277.2003.tb00218.x; SALIH MAM, 1991, BRIT MED J, V302, P1053, DOI 10.1136/bmj.302.6784.1053; Schaeffer M J, 1998, J Transpl Coord, V8, P9; Senouci K, 2004, INTENS CARE MED, V30, P38, DOI 10.1007/s00134-003-1923-8; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; SPRUNG CL, 2004, JAMA-J AM MED ASSOC, V290, P790; Tullius SG, 2001, TRANSPLANTATION, V72, P1341, DOI 10.1097/00007890-200110270-00001	25	43	44	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2006	32	2					217	222		10.1007/s00134-005-0001-9			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011EH	WOS:000235250300006	16432680				2022-02-06	
J	Ciuffreda, KJ; Han, Y; Kapoor, N; Ficarra, AP				Ciuffreda, Kenneth J.; Han, Ying; Kapoor, Neera; Ficarra, Anthony P.			Oculomotor rehabilitation for reading in acquired brain injury	NEUROREHABILITATION			English	Article						acquired brain injury; oculomotor feedback; oculomotor rehabilitation; reading; saccadic adaptation; visual attention		The purpose of this study was to assess reading-related oculomotor rehabilitation in individuals with acquired brain injury. Adults with either stroke ( n = 5) or traumatic brain injury ( n = 9) participated. Training paradigms included single-line and multiple-line simulated reading, as well as basic versional tracking ( fixation, saccade, and pursuit), twice per week over an 8 week period. Training modes included normal internal oculomotor visual feedback either in isolation ( 4 weeks) or concurrent with external oculomotor auditory feedback ( 4 weeks). Training effects were assessed objectively using infrared eye movement recording technology for simulated and actual reading, with the assessments occurring before, midway, and after training. In addition, the individuals were assessed subjectively using a reading rating-scale questionnaire. All reported considerably improved reading ability, and this was confirmed by several of the objective oculomotor measures. There was a trend for improvement to be better with the combined visual and auditory oculomotor feedback. Reading-related oculomotor rehabilitation produced significant gains in both the subjective and objective domains. It is believed that rapid saccadic oculomotor adaptation, as well as the training of rhythmicity and automaticity, were involved in modifying eye movement behavior to produce a more systematic approach and resultant improved reading profile.	SUNY, State Coll Optomet, Dept Vis Sci, New York, NY 10036 USA; Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, New York, NY 10036 USA; Cincinnati VA Med Ctr, Optometry Serv, Cincinnati, OH 45220 USA		Ciuffreda, KJ (corresponding author), SUNY, State Coll Optomet, Dept Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					ABRAMS SG, 1972, READ RES QUART, V8, P40, DOI 10.2307/746979; Carmichael L., 1947, READING VISUAL FATIG; CHEIMAN M, 1994, CLIN MANAGEMENT BINO; Ciuffreda K. J., 2001, DOWNEY DARLINGS PHYS, P241; Ciuffreda K. J., 1996, J BEHAV OPTOM, V7, P31; Ciuffreda K. J., 1994, EYE MOVEMENTS READIN, P163; Ciuffreda KJ, 2002, MODELS VISUAL SYSTEM, P741; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Desmurget M, 1998, NAT NEUROSCI, V1, P524, DOI 10.1038/2241; Fayos B, 1998, J BEHAV OPTOMETRY, V9, P143; FLETCHER J, 1993, J LEARN DISABIL, V26, P683, DOI 10.1177/002221949302601006; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; GUR S, 1992, ISRAEL J MED SCI, V28, P622; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; KAPOOR N, 2005, TXB TRAUMATIC BRAIN, P405; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Koenig G S, 1997, J Am Optom Assoc, V68, P155; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Rayner K., 1989, PSYCHOL READING; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; ROBINSON GM, 1977, J EXP PSYCHOL HUMAN, V3, P83; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Solan HA, 2001, J LEARN DISABIL-US, V34, P107, DOI 10.1177/002221940103400202; Suchoff IB, 2001, VISUAL VESTIBULAR CO; SUCHOFF IB, 2000, LIGHTHOUSE HDB VISIO, P517; Tannen B., 1995, EYE MOVEMENT BASICS; Taylor E. A., 1966, FUNDAMENTAL READING; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891; Zihl J, 2000, NEUROPSY REHABIL MOD; Zost MG, 2001, DIAGNOSIS MANAGEMENT, P75	35	43	43	1	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	1					9	21					13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045KY	WOS:000237742200003	16720933				2022-02-06	
J	Aimaretti, G; Ambrosio, MR; Di Somma, C; Gasperi, M; Cannavo, S; Scaroni, C; De Marinis, L; Baldelli, R; Bona, G; Giordano, G; Ghigo, E				Aimaretti, G; Ambrosio, MR; Di Somma, C; Gasperi, M; Cannavo, S; Scaroni, C; De Marinis, L; Baldelli, R; Bona, G; Giordano, G; Ghigo, E			Hypopituitarism induced by traumatic brain injury in the transition phase	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; hypopituitarism; adolescence; transition phase	GROWTH-HORMONE DEFICIENCY; GH DEFICIENCY; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; STIMULATION TEST; HEAD TRAUMA; ADULTS; DIAGNOSIS; PREVALENCE	Traumatic brain injury (TBI) has been associated with hypopituitarism in general and GH deficiency (GHD) in particular; the consequences of this on growth and development are likely to be critical in children and adolescents in the so-called "transition phase". In order to verify the consequences of TBI on pituitary function in the transition phase, we studied a population of adolescents and young adults 3 and 12 months after brain injury [no. = 23, 9 females, 14 males; age: 16-25 yr; body mass index (BMI): 21.9 +/- 0.6 kg/m(2)]. At 3 months, hypopituitarism was present in 34.6%. Total, multiple and isolated deficits were present in 8.6, 4.3 and 21.7%, respectively. Diabetes insipidus (DI) was present in 8.6% patients and mild hyperprolactinemia in 4.3%. At 12 months, hypopituitarism was present in 30.3%. Total, multiple and isolated deficits were present in 8.6, 4.3 and 17.4%, respectively. DI was present in 4.3% of patients and mild hyperprolactinemia in 4.3%. Total hypopituitarism was always confirmed at retesting. Multiple and isolated hypopituitarism were confirmed in 0/1 and 2/5, respectively. Two/23 patients showed isolated hypopituitarism at 12 months only; 1 patient with isolated at 3 months showed multiple hypopituitarism at retesting. GHD and secondary hypogonadism were the most common acquired pituitary deficits. These results show the high risk of TBI-induced hypopituitarism also in the transition age. Thus it is recommended that pediatric endocrinologists follow-up pituitary function of children and adolescents after brain injuries.	Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy; Univ Ferrara, Endocrinol Sect, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy; Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Naples, Italy; Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; Univ Messina, Dept Med & Pharmacol, Endocrinol Sect, Messina, Italy; Univ Padua, Div Endocrinol, Dept Surg & Med Sci, Padua, Italy; Catholic Univ, Div Endocrinol, Rome, Italy; Univ Piemonte Orientale, Div Paediat, Novara, Italy		Aimaretti, G (corresponding author), Univ Turin, Dipartimento Med Interna, Div Endocrinol & Malattie Metab, C Dogliotti,14, I-10126 Turin, Italy.	gianluca.aimaretti@unito.it	Scaroni, Carla/G-3853-2017; Cannavo, Salvatore/D-7608-2013; Di Somma, Carolina/K-7772-2016	Scaroni, Carla/0000-0001-9396-3815; Cannavo, Salvatore/0000-0001-8779-7283; ambrosio, maria rosaria/0000-0002-7911-9770; Di Somma, Carolina/0000-0002-5724-1951			*AG HLTH CAR POL R, 1998, REH TRAUM BRAIN INJ; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; AIMARETTI G, 2005, IN PRESS J CLIN ENDO; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Faglia G., 2001, ENDOCRINOL METAB, P73; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Pappert E.J., 1999, TXB CLIN NEUROLOGY; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; THORNER MO, 1998, WILLIAMS TXB ENDOCRI, P165	29	43	44	0	2	EDITRICE KURTIS S R L	MILAN	VIA LUIGI ZOJA 30, 20153 MILAN, ITALY	0391-4097			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	DEC	2005	28	11					984	989		10.1007/BF03345336			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	006BO	WOS:000234870300005	16483176				2022-02-06	
J	Boschen, KA; Tonack, M; Gargaro, J				Boschen, KA; Tonack, M; Gargaro, J			The impact of being a support provider to a person living in the community with a spinal cord injury	REHABILITATION PSYCHOLOGY			English	Article						support provider; caregivers; spinal cord injury; community integration; quality of life	SEVERE PHYSICAL-DISABILITIES; PROBLEM-SOLVING ABILITIES; TRAUMATIC BRAIN INJURY; SOCIAL SUPPORT; FAMILY CAREGIVERS; QUALITY; LIFE; ADJUSTMENT; REINTEGRATION; OUTCOMES	Objective: To examine the personal impact of being I support provider (SP) to a community-dwelling person with a spinal cord injury (SCI). Study Design: Quantitative phase (interview-completed questionnaire; n = 100), followed by qualitative phase (8 focus groups; n = 46). Participants: Convenience sample; self-selected subsample in focus groups. Main Outcome Measures: Productivity status, satisfaction with community integration, quality of life. Results: Supporting a person with SCI brings significant life change. Greater support provision was related to lower productivity and community integration of the SPs. They felt underserved and unprepared emotionally and cognitively for their new, unanticipated role. Conclusions: More attention, understanding, and service directed to SPs are required to reduce trial-and-error learning and emotional and physical burden. Enhanced injury resource materials, peer networks, and knowledge-building opportunities may ameliorate SP difficulties.	Toronto Rehabil Inst, Lyndhurst Ctr, Dept Res, Toronto, ON M4G 3V9, Canada; Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada		Boschen, KA (corresponding author), Toronto Rehabil Inst, Lyndhurst Ctr, Dept Res, 520 Sutherland Dr, Toronto, ON M4G 3V9, Canada.	boschen.kathy@torontorehab.on.ca					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BOSCHEN K, 1998, CAN J REHABIL, V11, P184; Boschen KA, 1998, INT J REHABIL RES, V21, P285, DOI 10.1097/00004356-199809000-00004; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; BOSCHEN KA, 1999, J REHABILITATION OUT, V3, P1; BOSCHEN KA, 1997, CANADIAN J REHABILIT, V10, P125; BROOKINGS JB, 1988, AM J COMMUN PSYCHOL, V16, P137, DOI 10.1007/BF00906076; Canam C, 1999, Rehabil Nurs, V24, P192; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Christy MA, 1999, PARAPLEGIA NEWS, V53, P8; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cresswell JW., 1998, QUALITATIVE INQUIRY; DEJONG G, 1982, ARCH PHYS MED REHAB, V63, P68; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Elliott T. R., 1998, J VOCATIONAL REHABIL, V10, P123, DOI DOI 10.1016/S1052-2263(98)00007-5; Elliott TR, 2002, J CLIN PSYCHOL MED S, V9, P65, DOI 10.1023/A:1014931924809; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Erlandson D. A., 1993, DOING NATURALISTIC I; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; Fougeyrollas P, 2002, TOPICS SPINAL CORD I, V7, P56, DOI DOI 10.1310/1UGA-EY2T-N6XP-1PHE; Fougeyrollas P., 2002, TOP SPINAL CORD INJ, V7, P1, DOI DOI 10.1310/QDNN-8FN0-NJMG-TVWB; FRIEDLAND J, 1987, ARCH PHYS MED REHAB, V68, P475; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Glaser B., 1967, DISCOVERY GROUNDED T; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kurylo MF, 2001, J COUNS DEV, V79, P275, DOI 10.1002/j.1556-6676.2001.tb01972.x; Levenson H, 1981, RES LOCUS CONTROL CO, V1, P15; MCCOLL MA, 1989, OCCUP THER J RES, V9, P218, DOI 10.1177/153944928900900403; McMillen JC, 2003, REHABIL PSYCHOL, V48, P77, DOI 10.1037/0090-5550.48.2.77; Meade MA, 2004, REHABIL PSYCHOL, V49, P150, DOI 10.1037/0090-5550.49.2.150; MINTZ S, 1997, PARAPLEGIA NEWS, V51, P14; MINTZ S, 1999, PARAPLEGIA NEWS, V53, P12; MINTZ S, 1996, PARAPLEGIA NEWS, V50, P79; NOSEK MA, 1992, REHABIL COUNS BULL, V36, P21; RIVERA PA, 2003, TOP SPINAL CORD INJ, V9, P53, DOI DOI 10.1310/G82F-BR2R-T69L-3QX8; Shewchuk RM, 2004, J CLIN PSYCHOL MED S, V11, P141, DOI 10.1023/B:JOCS.0000037608.55768.df; Shewchuk RM, 1998, HEALTH PSYCHOL, V17, P125, DOI 10.1037/0278-6133.17.2.125; *STAT CAN, 2004, LAB FORC EMPL UN MEM; Strauss A., 1990, BASICS QUALITATIVE R; Tashakkori A., 1998, MIXED METHODOLOGY CO; Taylor S. J., 1984, INTRO QUALITATIVE ME; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583	45	43	44	0	3	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2005	50	4					397	407		10.1037/0090-5550.50.4.397			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	990KL	WOS:000233741700010					2022-02-06	
J	Xiong, Y; Shie, FS; Zhang, J; Lee, CP; Ho, YS				Xiong, Y; Shie, FS; Zhang, J; Lee, CP; Ho, YS			Prevention of mitochondrial dysfunction in post-traumatic mouse brain by superoxide dismutase	JOURNAL OF NEUROCHEMISTRY			English	Article						controlled cortical impact; oxidative phosphorylation; reactive oxygen species; transgenic and knockout mice	CONTROLLED CORTICAL IMPACT; CYTOCHROME-C RELEASE; LIPID-PEROXIDATION; CASPASE ACTIVATION; AMINO-ACIDS; INJURY; MICE; DAMAGE; COPPER; RAT	Reactive oxygen species (ROS) are known to be involved in the pathogenesis of traumatic brain injury (TBI). Previous studies have shown that the susceptibility of mice to TBI-induced formation of cortical lesion is determined by the expression levels of copper-zinc and manganese superoxide dismutase (CuZnSOD and MnSOD, respectively). However, the underlying biochemical mechanisms are not understood. In this study, we measured the efficiency of mitochondrial respiration in mouse brains with altered expression of these two enzymes. While controlled cortical impact injury (CCII) with a deformation depth of 2 mm caused a drastic decrease in NAD-linked bioenergetic capacity in brain mitochondria of wild-type mice, the functional decrease was not observed in brains of littermate transgenic mice overexpressing CuZnSOD or MnSOD. In addition, a 1 mm CCII greatly compromised brain mitochondrial function in mice deficient in CuZnSOD or MnSOD, but not wild-type mice. Inclusion of the calcium-chelating agent, EGTA, in the assay solution could completely prevent dysfunction of oxidative phosphorylation in all mitochondrial samples, suggesting that the observed impairment of mitochondrial function was a result of calcium overloading. In conclusion, our results imply that mitochondrial dysfunction induced by superoxide anion radical contributes to lesion formation in mouse brain following physical trauma.	Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA; Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA		Ho, YS (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, 2727 2nd Ave,Room 4000, Detroit, MI 48201 USA.	yho@wayne.edu		Xiong, Ye/0000-0001-9770-6031	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL54321, HL63317] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES006639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL063317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES006639] Funding Source: NIH RePORTER		AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Boveris A, 1977, Adv Exp Med Biol, V78, P67; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Buki A, 2000, J NEUROSCI, V20, P2825; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Crapo J D, 1978, Methods Enzymol, V53, P382; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GELLER BL, 1982, J BIOL CHEM, V257, P8945; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goldberg D.M., 1965, METHODS ENZYMATIC AN, P875; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; HOVDA DA, 1994, ACTA NEUROCHIR, P521; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KUO CF, 1987, J BIOL CHEM, V262, P4724; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee C. P., 1993, V2, P41; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LITTLE C, 1970, J BIOL CHEM, V245, P3632; LYNCH RE, 1978, J BIOL CHEM, V253, P4697; Madsen K, 1996, ANAL BIOCHEM, V237, P37, DOI 10.1006/abio.1996.0197; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ookawara T, 1998, AM J PHYSIOL-CELL PH, V275, pC840, DOI 10.1152/ajpcell.1998.275.3.C840; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SLOT JW, 1986, LAB INVEST, V55, P363; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	66	43	45	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2005	95	3					732	744		10.1111/j.1471-4159.2005.03412.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	972ZZ	WOS:000232493900013	16248885	Bronze			2022-02-06	
J	Clausen, T; Khaldi, A; Zauner, A; Reinert, M; Doppenberg, E; Menzel, M; Soukup, J; Alves, OL; Bullock, MR				Clausen, T; Khaldi, A; Zauner, A; Reinert, M; Doppenberg, E; Menzel, M; Soukup, J; Alves, OL; Bullock, MR			Cerebral acid-base homeostasis after severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; cerebral acid-base homeostasis; carbon dioxide; lactate/ischemia; multimodal monitoring	TISSUE OXYGEN-TENSION; ISCHEMIC CELL-DAMAGE; HUMAN HEAD-INJURY; SUBSTRATE DELIVERY; BLOOD-FLOW; GLUCOSE-UTILIZATION; INITIAL-EXPERIENCE; PERFUSION-PRESSURE; LACTIC-ACIDOSIS; FELINE BRAIN	Object. Brain tissue acidosis is known to mediate neuronal death. Therefore the authors measured the main parameters of cerebral acid-base homeostasis, as well as their interrelations, shortly after severe traumatic brain injury (TBI) in humans. Methods. Brain tissue pH, PCO2, PO2, and/or lactate were measured in 151 patients with severe head injuries, by using a Neurotrend sensor and/or a microdialysis probe. Monitoring was started as soon as possible after the injury and continued for up to 4 days. During the 1st day following the trauma, the brain tissue pH was significantly lower, compared with later time points, in patients who died or remained in a persistent vegetative state. Six hours after the injury, brain tissue PCO2 was significantly higher in patients with a poor outcome compared with patients with a good outcome. Furthermore, significant elevations in cerebral concentrations of lactate were found during the 1st day after the injury, compared with later time points. These increases in lactate were typically more pronounced in patients with a poor outcome. Similar biochemical changes were observed during later hypoxic events. Conclusions. Severe human TBI profoundly disturbs cerebral acid-base homeostasis. The observed pH changes persist for the first 24 hours after the trauma. Brain tissue acidosis is associated with increased tissue PCO2 and lactate concentration; these pathobiochemical changes are more severe in patients who remain in a persistent vegetative state or die. Furthermore, increased brain tissue PCO2 (> 60 mm Hg) appears to be a useful clinical indicator of critical cerebral ischemia, especially when accompanied by increased lactate concentrations.	Virginia Commonwealth Univ, Div Neurosurg, Hlth Syst, Richmond, VA 23298 USA; Univ Halle Wittenberg, Dept Anesthesiol & Intens Care Med, Halle An Der Saale, Germany; Univ Miami, Lois Pope Life Ctr, Dept Neurosurg, Miami, FL 33152 USA; Inselspital Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; Univ Porto, Ctr Hosp Gaia, Fac Med, Serv Neurocirugia, P-4100 Oporto, Portugal		Bullock, MR (corresponding author), Virginia Commonwealth Univ, Div Neurosurg, Hlth Syst, POB 980631, Richmond, VA 23298 USA.	robulloc@mail2.vcu.edu	Reinert, Michael/AAA-3929-2019; Reinert, Michael/E-4964-2011	Reinert, Michael/0000-0002-0971-9543; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		Alessandri B, 1999, ACT NEUR S, V75, P25; ARTRU F, 1989, INTENS CARE MED, V15, P499, DOI 10.1007/BF00273560; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Charbel FT, 1997, SURG NEUROL, V48, P414, DOI 10.1016/S0090-3019(96)00473-9; Charbel FT, 2000, SURG NEUROL, V54, P432, DOI 10.1016/S0090-3019(00)00340-2; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chesnut R M, 1995, New Horiz, V3, P366; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; DESALLES AAF, 1987, NEUROSURGERY, V20, P297, DOI 10.1227/00006123-198702000-00017; Doppenberg EMR, 1997, J NEUROSURG, V87, P809, DOI 10.3171/jns.1997.87.6.0809; GENTLEMAN D, 1992, INT SURG, V77, P297; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Lang E W, 1995, New Horiz, V3, P400; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; REHNCRONA S, 1989, J CEREBR BLOOD F MET, V9, P65, DOI 10.1038/jcbfm.1989.9; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; WELSH FA, 1980, STROKE, V11, P355, DOI 10.1161/01.STR.11.4.355; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	49	43	43	1	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2005	103	4					597	607		10.3171/jns.2005.103.4.0597			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	971LG	WOS:000232385000005	16266040				2022-02-06	
J	Simpson, G; Tate, R				Simpson, G; Tate, R			Clinical features of suicide attempts after traumatic brain injury	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						suicide attempts; traumatic brain injury; suicide prevention	PREVENTION; LETHALITY; SCALE; RISK	This study documents demographic, clinical and temporal parameters for suicide attempts after traumatic brain injury (TBI). Clinical interviews and a medical file review were conducted with an outpatient sample (N = 172), identifying 45 clients (26.2%) who had collectively made a lifetime total of 80 suicide attempts. Data were collected on postinjury psychopathology, current hopelessness, and suicide ideation, as well as historical data about the attempts. The sample (N = 43, missing data N = 2) had a lifetime prevalence of 1.86 attempts, with 19 clients (44.2%) making repeat attempts. The majority (70%) of the attempts were made postinjury. Medical attention was provided in 60.7% of attempts. The odds ratio found that respondents with a comorbid postinjury history of psychiatric/emotional disturbance and substance abuse were 21 times more likely to have made an attempt post-TBI compared with respondents with no such history. The findings can inform suicide prevention initiatives among people with TBI.	Liverpool Hosp, Brain Injury Rehabil Unit, Liverpool BC, NSW 1871, Australia; Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Royal Rehabil Ctr Sydney, Sydney, NSW, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool BC, NSW 1871, Australia.		Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			ACHTE KA, 1971, ACTA PSYCHIAT SCAN S, V225, P1; Beck A.T., 1993, BECK HOPELESSNESS SC; Beck A.T., 1993, BECK SCALE SUICIDE I; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1975, AM J PSYCHIAT, V132, P285; BONGAR B, 1991, SUICIDAL PATIENT CLI; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; HAWTON K, 1982, BRIT J PSYCHIAT, V140, P118, DOI 10.1192/bjp.140.2.118; JACOBS D, 1989, SUICIDE UNDERSTANDIN, P363; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; MALONE KM, 1995, J AFFECT DISORDERS, V34, P173, DOI 10.1016/0165-0327(95)00015-F; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Maris R., 1981, PATHWAYS SUICIDE SUR; MORGAN HG, 1993, BRIT J PSYCHIAT, V163, P111, DOI 10.1192/bjp.163.1.111; MOSCICKI EK, 1995, SUICIDE PREVENTION Y, P22; MURPHY GE, 1987, PSYCHIATRY, V1, P1; ROBINSON RG, 2000, SYNOPSIS NEUROPSYCHI, P289; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shneidman E., 1985, DEFINITION SUICIDE; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SIMPSON GK, 2001, SUICIDE PREVENTION T; SMITH K, 1984, SUICIDE LIFE-THREAT, V14, P215; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436	27	43	44	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	OCT	2005	193	10					680	685		10.1097/01.nmd.0000180743.65943.c8			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	973VD	WOS:000232549800007	16208164				2022-02-06	
J	Guyton, MK; Wingrave, JM; Yallapragada, AV; Wilford, GG; Sribnick, EA; Matzelle, DD; Tyor, WR; Ray, SK; Banik, NL				Guyton, MK; Wingrave, JM; Yallapragada, AV; Wilford, GG; Sribnick, EA; Matzelle, DD; Tyor, WR; Ray, SK; Banik, NL			Upregulation of calpain correlates with increased neuro degeneration in acute experimental auto-immune encephalomyelitis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						EAE; MS; calpain; Ca2+ influx; neurodegeneration	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; OPTIC NEURITIS; AXONAL-INJURY; PUTATIVE ROLE; INFLAMMATORY CELLS; NERVOUS-SYSTEM; CROSS-TALK	Although calpain up-regulation is well established in experimental auto-immune encephalomyelitis (EAE); a link between increased calpain expression and activity and neurodegeneration has not been examined. Therefore, spinal cord tissue from Lewis rats with EAE was examined to test the hypothesis that increased calpain expression in neurons would correlate with increased cell death and axonal damage in a time-dependent manner following EAE induction. We found that increased calpain expression in EAE corresponded to increased TUNEL-positive neurons and to increased expression of dephosphorylated neurofilament protein, markers of cell death and axonal degeneration, respectively. An increase in internucleosomal DNA fragmentation in EAE spinal cord suggested that cell death was, at least partially, due to apoptosis. Axonal damage was further demonstrated in EAE spinal cord compared with control via morphological analysis, revealing granular degeneration of filament and microtubule integrity, loss of myelin, and mitochondrial damage. Calcium (Ca2+) influx, which is required for calpain activation, was also increased in EAE spinal cord. From these findings, we conclude that increases in Ca2+-induced calpain activity may play a crucial role in neurodegeneration in acute EAE. (c) 2005 Wiley-Liss, Inc.	Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA		Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurol, 96 Jonathan Lucus St, Charleston, SC 29425 USA.	baniknl@musc.edu	Sribnick, Eric/AAH-6693-2020				Ahmed Z, 2001, AM J PATHOL, V158, P2127, DOI 10.1016/S0002-9440(10)64684-6; Alcazar A, 1998, NEUROSCI LETT, V255, P75, DOI 10.1016/S0304-3940(98)00708-3; Banik N L, 1984, Prog Clin Biol Res, V146, P145; Banik NL, 2000, NEUROCHEM RES, V25, P1509, DOI 10.1023/A:1007684311023; Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; Banik NL, 1999, HISTOL HISTOPATHOL, V14, P649, DOI 10.14670/HH-14.649; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; CHAKRABARTI AK, 1989, NEUROCHEM RES, V14, P259, DOI 10.1007/BF00971321; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Gores GJ, 1998, BBA-BIOENERGETICS, V1366, P167, DOI 10.1016/S0005-2728(98)00111-X; GUYTON K, 2002, 33 ANN AM SOC NEUR M; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kornek B, 2001, BRAIN, V124, P1114, DOI 10.1093/brain/124.6.1114; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; MATTSON MP, 1993, ANN NY ACAD SCI, V679, P1, DOI 10.1111/j.1749-6632.1993.tb18285.x; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x; OGITA K, 1990, ADV SEC MESS PHOSPH, V24, P218; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Paschen W, 2000, BRAIN RES BULL, V53, P409, DOI 10.1016/S0361-9230(00)00369-5; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Piccoli F, 1979, Riv Neurol, V49, P253; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Ray SK, 2000, BRAIN RES PROTOC, V5, P305, DOI 10.1016/S1385-299X(00)00027-1; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; Ray SK, 2000, BRAIN RES, V867, P80, DOI 10.1016/S0006-8993(00)02260-5; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Schaecher K, 2002, J NEUROIMMUNOL, V129, P1, DOI 10.1016/S0165-5728(02)00142-X; Shields DC, 1998, EXP EYE RES, V67, P403, DOI 10.1006/exer.1998.0537; Shields DC, 1998, BRAIN RES, V794, P68, DOI 10.1016/S0006-8993(98)00193-0; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; Shields DC, 1998, P NATL ACAD SCI USA, V95, P5768, DOI 10.1073/pnas.95.10.5768; Shields DC, 1999, J NEUROIMMUNOL, V99, P1, DOI 10.1016/S0165-5728(99)00043-0; Shields DC, 1998, BRAIN RES, V784, P299, DOI 10.1016/S0006-8993(97)01381-4; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Varghese J, 2001, EUR J IMMUNOL, V31, P2035, DOI 10.1002/1521-4141(200107)31:7<2035::AID-IMMU2035>3.0.CO;2-Y; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	56	43	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL 1	2005	81	1					53	61		10.1002/jnr.20470			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	941LS	WOS:000230216900007	15952172				2022-02-06	
J	Rappaport, M				Rappaport, M			The Disability Rating and Coma/Near-Coma scales in evaluating severe head injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Conference of the International-Neuropsychological-Society	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc			TRAUMATIC BRAIN INJURY; EVOKED-POTENTIALS; RECOVERY; VALIDITY; STATES	The Disability Rating (DR) and Coma/Near-Coma (C/NC) scales for evaluating severe head injury are described. Scales are related to patient status, course and outcome and also underlying electroneurophysiological dysfunction. They lend themselves to high inter-rater reliability with brief training and can be completed in minutes, conserving staff time and energy.			Rappaport, M (corresponding author), 1185 McKendrie St, San Jose, CA 95126 USA.	rappapor@ix.netcom.com					ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GOODIN DS, 1983, NEUROLOGY, V33, P1215, DOI 10.1212/WNL.33.9.1215; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P258; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; RAPPAPORT M, 1985, CLIN ELECTROENCEPHAL, V16, P183, DOI 10.1177/155005948501600404; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; Rappaport M, 1996, MED REHABILITATION T, P271; RAPPAPORT M, 1994, J HEAD TRAUMA REHAB, V9, P94; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; SCRANTON J, 1970, Archives of Physical Medicine and Rehabilitation, V51, P1; TEASDALE G, 1974, LANCET, V2, P81	23	43	43	1	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					442	453		10.1080/09602010443000335			12	Neurosciences; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900029	16350985				2022-02-06	
J	Kerman, M; Cirak, B; Ozguner, MF; Dagtekin, A; Sutcu, R; Altuntas, I; Delibas, N				Kerman, M; Cirak, B; Ozguner, MF; Dagtekin, A; Sutcu, R; Altuntas, I; Delibas, N			Does melatonin protect or treat brain damage from traumatic oxidative stress?	EXPERIMENTAL BRAIN RESEARCH			English	Article						melatonin; antioxidant enzymes; lipid peroxidation; experimental brain damage	CENTRAL-NERVOUS-SYSTEM; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; ALPHA-TOCOPHEROL; FREE-RADICALS; INJURY; ANTIOXIDANTS	A variety of experimental studies have demonstrated the neuroprotective effects of melatonin, based on its antioxidant activity. In a prospective randomized study, the effects of melatonin were investigated in experimental head trauma-induced oxidative stress in rabbits. The experimental study was performed on 30 rabbits. The animals were divided into three groups. Group I (sham procedure): a right parietal craniotomy was performed on each animal, and the dura mater was left intact. Group II: experimental brain trauma (EBT) was performed on each animal using a 1 cm inner diameter x 10 cm long glass tube, through which a 20 g weight (0.5 cm diameter) was dropped onto the brain at the craniotomy site, causing a contusional head trauma. Group III: the same EBT model was performed, but 2.5 mg/kg melatonin was injected intraperitoneally four times (total dose 10 mg/kg); these injections were performed 20 min before the operation, during the trauma, 1 h later and 2 h later. The rabbits were sacrificed after the EBT at 24 h after the brain trauma. The activities of the three principal antioxidant enzymes-catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px)-were determined, and the levels of malondialdehyde (MDA), a product of lipid peroxidation, and glutathione (GSH) were measured in brain homogenates. MDA levels were found to be higher in the EBT group than in the EBT+melatonin group or the sham procedure group. The SOD activity was found to be higher in the EBT group than in the sham procedure group. Enzymatic parameters (except for SOD) were significantly higher in melatonin-treated animals than in EBT animals. GSH levels in melatonin-treated animals were decreased compared with EBT animals. In conclusion, the data indicate that melatonin protects against free radical-mediated oxidative changes in brain tissue by boosting antioxidant enzymes, and in particular lowering lipid peroxidation in rabbits with EBT.	S Demirel Univ, Sch Med, Dept Neurosurg, Isparta, Turkey; Pamukkale Univ, Dept Neurosurg, Denizli, Turkey; S Demirel Univ, Sch Med, Dept Physiol, Isparta, Turkey; S Demirel Univ, Sch Med, Dept Clin Biochem, Isparta, Turkey		Cirak, B (corresponding author), Pamukkale Univ, Tip Fak, Beyin Sinir Cerrahisi Klin, Kinikli Denizli, Turkey.	bayramcirak@yahoo.com	Dagtekin, Ahmet/AAE-2408-2020; DELIBAS, NAMIK/I-8378-2013; Dagtekin, Ahmet/E-7905-2016; Delibas, Namik/N-1695-2017	Dagtekin, Ahmet/0000-0001-7368-6937; DELIBAS, NAMIK/0000-0001-8014-6189; Delibas, Namik/0000-0002-1354-8927			AEBI H, 1984, METHOD ENZYMOL, V105, P121; BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BULLOCK R, 1993, SCHWEIZ MED WSCHR, V123, P449; CADET JL, 1988, INT J NEUROSCI, V40, P13, DOI 10.3109/00207458808985722; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Franceschini D, 1999, ADV EXP MED BIOL, V467, P207; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HARA H, 1990, BRAIN RES, V510, P335, DOI 10.1016/0006-8993(90)91386-U; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; IKEDA Y, 1989, Neurological Research, V11, P213; IKEDA Y, 1990, NEUROSURGERY, V27, P1; IKEDA Y, 1989, NEUROSURGERY, V24, P679, DOI 10.1227/00006123-198905000-00004; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Long DM, 1972, STEROIDS BRAIN EDEMA, P87; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; MEYDANI SN, 1990, AM J CLIN NUTR, V52, P557, DOI 10.1093/ajcn/52.3.557; NISHIBE M, 1989, Hokkaido Journal of Medical Science, V64, P301; Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1993, BRAZ J MED BIOL RES, V26, P1141; Reiter Russel J., 1994, Acta Neurobiologiae Experimentalis (Warsaw), V54, P31; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; SHIN SM, 1994, BRAIN RES, V653, P45, DOI 10.1016/0006-8993(94)90370-0; Vural H, 2001, J PINEAL RES, V31, P193, DOI 10.1034/j.1600-079X.2001.310301.x; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Zang LY, 1998, BBA-GEN SUBJECTS, V1425, P469, DOI 10.1016/S0304-4165(98)00099-3	35	43	44	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2005	163	3					406	410		10.1007/s00221-005-2338-2			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	933GV	WOS:000229617800015	15856200				2022-02-06	
J	Binder, S; Corrigan, JD; Langlois, JA				Binder, S; Corrigan, JD; Langlois, JA			The public health approach to traumatic brain injury - An overview of CDC's research and programs	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; craniocerebral trauma; public health		Every year, 50,000 people die with a traumatic brain injury (TBI). At least 5.3 million Americans live with long-term disabilities related to TBI. Through its TBI-associated research and programs, CDC's National Center for Injury Prevention and Control (NCIPC) seeks to reduce the adverse consequences of TBIs by ensuring that data, data systems, and public awareness about TBI are in place. The public health model provides a useful framework for identifying important efforts needed to reduce the impact of this potentially disabling injury.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Binder, S (corresponding author), 3958 Preston Court, Atlanta, GA 30319 USA.	scbinder@bellsouth.net	Corrigan, John D./E-2921-2011				Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P276; *CDCP NAT CTR INJ, 2003, MILD TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2002, CDC INJ RES AG; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; GILLESPIE LD, 2004, COCHRANE LIB; Krug, 2002, INJURY LEADING CAUSE; Langlois J, 2005, TRAUMATIC BRAIN INJU; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; PICKELSIMER E, 2002, BRIAN INJ SOURCE, V6, P18; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sleet DA, 1997, PRINCIPLES PUBLIC HL, P337; *STAT TERR INJ PRE, 2003, SAF STAT; Task Force on Community Preventive Services, GUID COMM PREV SERV; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA	23	43	44	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2005	20	3					189	195		10.1097/00001199-200505000-00002			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	926ZZ	WOS:000229163500002	15908819				2022-02-06	
J	Cohen, JE; Rajz, G; Itshayek, E; Shoshan, Y; Umansky, F; Gomori, JM				Cohen, JE; Rajz, G; Itshayek, E; Shoshan, Y; Umansky, F; Gomori, JM			Endovascular management of traumatic and iatrogenic aneurysms of the pericallosal artery - Report of two cases	JOURNAL OF NEUROSURGERY			English	Article						traumatic aneurysm; pericallosal artery; endovascular therapy; tumor; complication	MISSILE HEAD WOUNDS; INTRACRANIAL ANEURYSMS; CHILDHOOD; VESSELS	Traumatic intracranial aneurysms are rare complications of closed and penetrating head injuries and may also be related to a variety of neurosurgical procedures. The primary goals in the treatment of patients harboring these lesions are early identification and intervention to prevent bleeding. Traumatic aneurysms are fragile, prone to rupture, and represent a challenging subset of vascular lesions for either surgery or endovascular therapy. Surgical approaches to aneurysms located at the pericallosal arteries are associated with higher rates of morbidity and mortality than approaches to other supratentorial aneurysms. Current endovascular treatment most often involves occlusion of the parent artery with the potential of added morbidity. The authors present their experience in the endovascular management of traumatic and iatrogenic aneurysms of the pericallosal artery achieved by primary coil embolization with parent vessel preservation. For patients harboring traumatic pericallosal aneurysms with favorable anatomical characteristics, in which the morbidity caused by parent vessel occlusion is not acceptable, endosaccular coil placement may be a valuable option.	Hadassah Univ Hosp, Hadassah Stroke Ctr, Sect Endovasc Neurosurg & Intervent Neuroradiol, Dept Neurosurg, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Hadassah Stroke Ctr, Sect Endovasc Neurosurg & Intervent Neuroradiol, Dept Radiol, IL-91120 Jerusalem, Israel		Cohen, JE (corresponding author), Hadassah Univ Hosp, Hadassah Stroke Ctr, Sect Endovasc Neurosurg & Intervent Neuroradiol, Dept Neurosurg, IL-91120 Jerusalem, Israel.	jcohenns@yahoo.com					AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; de Sousa AA, 1999, SURG NEUROL, V52, P128, DOI 10.1016/S0090-3019(99)00066-X; HADDAD FS, 1991, NEUROSURGERY, V28, P1; Hentschel S, 2003, CAN J NEUROL SCI, V30, P63, DOI 10.1017/S0317167100002468; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; Menovsky T, 2002, NEUROSURGERY, V50, P11, DOI 10.1097/00006123-200201000-00003; Pierot L, 1996, NEUROL RES, V18, P49, DOI 10.1080/01616412.1996.11740377; SORIA ED, 1988, ANGIOLOGY, V39, P609, DOI 10.1177/000331978803900708; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125	17	43	50	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2005	102	3					555	557		10.3171/jns.2005.102.3.0555			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	911PR	WOS:000228017200026	15796396				2022-02-06	
J	Jones, NC; Constantin, D; Prior, MJW; Morris, PG; Marsden, CA; Murphy, S				Jones, NC; Constantin, D; Prior, MJW; Morris, PG; Marsden, CA; Murphy, S			The neuroprotective effect of progesterone after traumatic brain injury in male mice is independent of both the inflammatory response and growth factor expression	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						behaviour; cytokines; inflammation; oedema; trauma	CEREBRAL-ARTERY OCCLUSION; SPINAL-CORD; PREFRONTAL CORTEX; CELL-DEATH; MALE-RATS; G-CSF; GENDER; INTERLEUKIN-1-BETA; ESTROGEN; PROTECTS	Previous studies suggest that progesterone may possess neuroprotective properties after traumatic insult but, with the exception of reduced formation of cerebral oedema, limited experimental evidence has been presented to support this claim. In the present study we focused on the effect of progesterone treatment on structural and functional deficits in an experimental model of traumatic brain injury. Female mice exhibited significantly (P = 0.0445) reduced lesion volumes compared with males after aseptic cryogenic cerebral injury (ACI), suggesting that female sex steroids provide protection against this injury. In male mice, progesterone treatment after injury (three intraperitoneal doses of 8 mg/kg) reduced lesion volume (P = 0.0429) and improved performance in a spatial cognitive task (Morris water maze; P = 0.0014). However, progesterone had no demonstrable effect on the formation of oedema as measured using T-2-weighted magnetic resonance imaging, nor did it affect brain water content. The pro-inflammatory cytokines TNF-alpha and IL-1 beta, and growth factors BDNF and G-CSF, were all strongly transcriptionally activated after ACI. However, progesterone administration did not affect expression of these genes. This study provides strong evidence that progesterone possesses neuroprotective properties in a mouse model of traumatic brain injury, but suggests that the steroid achieves this effect through mechanism(s) independent of the inflammatory response or growth factor up-regulation.	Univ Nottingham, Inst Cell Signalling, Nottingham NG7 2UH, England; Univ Nottingham, Inst Neurosci, Nottingham NG7 2UH, England; Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2UH, England		Murphy, S (corresponding author), Univ Nottingham, Inst Cell Signalling, Clifton Blvd, Nottingham NG7 2UH, England.	sean.murphy@nottingham.ac.uk	Jones, Nigel C/K-7773-2012	Jones, Nigel/0000-0002-1080-8439			Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; AVITSUR R, 1995, BRAIN BEHAV IMMUN, V9, P234, DOI 10.1006/brbi.1995.1022; Bergeron R, 1996, J NEUROSCI, V16, P1193; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hermann DM, 2000, ACTA NEUROPATHOL, V99, P147, DOI 10.1007/PL00007418; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Jain SK, 2004, CYTOKINE, V26, P102, DOI 10.1016/j.cyto.2004.01.002; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kuebler JF, 2003, CRIT CARE MED, V31, P1786, DOI 10.1097/01.CCM.0000063441.41446.23; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Miller L, 1998, J IMMUNOL, V160, P5098; Mohammad S, 1998, EPILEPSY RES, V30, P195, DOI 10.1016/S0920-1211(98)00004-7; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; POLAN ML, 1989, J CLIN ENDOCR METAB, V69, P1200, DOI 10.1210/jcem-69-6-1200; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Sharma HS, 2003, ACT NEUR S, V86, P383; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Vegeto E, 1999, FASEB J, V13, P793, DOI 10.1096/fasebj.13.8.793; Wiedermann FJ, 2001, WIEN KLIN WOCHENSCHR, V113, P90; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	45	43	45	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAR	2005	21	6					1547	1554		10.1111/j.1460-9568.2005.03995.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	918PM	WOS:000228560100009	15845082				2022-02-06	
J	Zygun, DA; Laupland, KB; Hader, WJ; Kortbeek, JB; Findlay, C; Doig, CJ; Hameed, SM				Zygun, DA; Laupland, KB; Hader, WJ; Kortbeek, JB; Findlay, C; Doig, CJ; Hameed, SM			Severe traumatic brain injury in a large Canadian health region	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SEVERE HEAD-INJURY; EMERGENCY CARE; POPULATION; EPIDEMIOLOGY; TRENDS; MANAGEMENT; COMMUNITY; MORTALITY; OUTCOMES; COUNTY	Background: Although severe traumatic brain injury (sTBI) is a devastating condition with tremendous public health implications, the epidemiology of this disease has not previously been described in Canada. We Sought to define the incidence, risk factors and outcome of patients suffering sTBI in a large Canadian region. Methods: A population-based surveillance cohort design was utilized to identify all Calgary Heath Region residents who were victims of trauma with an injury severity score greater than or equal to12. Subsequent application of a specific sTBI case definition defined the final cohort. Results: The annual incidence of sTBI was 11.4 per 100,000 population. The incidence of sTBI was significantly higher for males as compared to females [17.1 vs. 5.9 per 100,000; relative risk (RR) = 2.91, 95% confidence interval; 2.17, 3.94; p<0.0001]. There was a striking increase in the annual age specific population incidence of sTBI observed among those older than 74 years of age. The relative risk among the highest risk group of elderly (>85 years) males as compared to the lowest risk female group (50-64 years) was 19.78 (95% CI; 6.27, 62.3; p<0.0001). One hundred and eight patients died prior to hospital discharge for a mortality rate of 5.1 per 100,000 per year. Conclusions: Severe traumatic brain injury is common among residents of the Calgary Health Region and is associated with a high mortality rate. Males and the elderly are at the highest risk for acquiring sTBI and may represent target groups for preventive efforts.	Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Surg, Calgary, AB, Canada; Calgary Hlth Res, Calgary, AB, Canada		Hameed, SM (corresponding author), Vancouver Gen Hosp, Trauma Serv, 855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.		Kortbeek, John B/AAO-5298-2020; Laupland, Kevin/AAG-3656-2020; Laupland, kevin/AAJ-6339-2020; Doig, Christopher/AAC-7949-2020	Laupland, kevin/0000-0002-1205-5354; Doig, Christopher/0000-0002-8576-9139			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULLOCK MR, 2000, J NEUROTRAUM, V17, P450; FOULKES MA, 1991, J NEUROSURG, V75, pS1, DOI 10.3171/sup.1991.75.1s.00s1; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lane PL, 2000, CAN J SURG, V43, P442; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PARKINSON D, 1985, CAN J SURG, V28, P79; Pickett W, 2001, CAN MED ASSOC J, V165, P288; SNOW WG, 1988, CAN J SURG, V31, P191; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; *STAT CAN, 2001, CAN NAT POP CENS; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	29	43	44	0	5	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	2005	32	1					87	92		10.1017/S0317167100016930			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	901DY	WOS:000227264400013	15825552	Bronze			2022-02-06	
J	Wong, LF; Ralph, GS; Walmsley, LE; Bienemann, AS; Parham, S; Kingsman, SM; Uney, JB; Mazarakis, ND				Wong, LF; Ralph, GS; Walmsley, LE; Bienemann, AS; Parham, S; Kingsman, SM; Uney, JB; Mazarakis, ND			Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus	MOLECULAR THERAPY			English	Article							ISCHEMIC BRAIN-INJURY; INDUCED NEURONAL DEATH; NEUROTROPHIC FACTOR; GENE-TRANSFER; IN-VIVO; TRANSGENE EXPRESSION; NERVOUS-SYSTEM; FLUORO-JADE; VECTOR; CALCIUM	Nutrient deprivation during ischemia leads to severe insult to neurons causing widespread excitotoxic damage in specific brain regions such as the hippocampus. One possible strategy for preventing neurodegeneration is to express therapeutic proteins in the brain to protect against excitotoxicity. We investigated the utility of equine infectious anemia virus (EIAV)-based vectors as genetic tools for delivery of therapeutic proteins in an in vivo excitotoxicity model. The efficacy of these vectors at preventing cellular loss in target brain areas following excitotoxic insult was also assessed. EIAV vectors generated to overexpress the human antiapoptotic Bcl-2 or growth factor glial-derived neurotrophic factor (GDNF) genes protected against glutamate-induced toxicity in cultured hippocampal neurons. In an in vivo excitotoxicity model, adult Wistar rats received a unilateral dose of the glutamate receptor agonist N-methyl-D-aspartate to the hippocampus that induced a large lesion in the CA1 region. Neuronal loss could not be protected by prior transduction of a control vector expressing beta-galactosidase. In contrast, EIAV-mediated expression of Bcl-2 and GDNF significantly reduced lesion size thus protecting the hippocampus from excitotoxic damage. These results demonstrate that EIAV vectors can be effectively used to deliver putative neuroprotective genes to target brain areas and prevent cellular loss in the event of a neurological insult. Therefore these lentiviral vectors provide potential therapeutic tools for use in cases of acute neurotrauma such as cerebral ischemia.	Oxford BioMed UK Ltd, Medawar Ctr, Oxford OX4 4GA, England; Univ Bristol, Henry Wellcome Labs Integrated Neurosci & Endocri, Bristol BS1 3NY, Avon, England		Wong, LF (corresponding author), Oxford BioMed UK Ltd, Medawar Ctr, Robert Robinson Ave,Oxford Sci Pk, Oxford OX4 4GA, England.	l.wong@oxfordbiomedica.co.uk			Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [GTH12528] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [069280] Funding Source: Medline		Azzouz M, 2002, J NEUROSCI, V22, P10302; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lawrence MS, 1996, J NEUROSCI, V16, P486; LINNIK MD, 1995, STROKE, V26, P1670, DOI 10.1161/01.STR.26.9.1670; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Martin-Rendon E, 2002, MOL THER, V5, P566, DOI 10.1006/mthe.2002.0576; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McMenamin MM, 1998, GENE THER, V5, P594, DOI 10.1038/sj.gt.3300639; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Ozawa CR, 2000, P NATL ACAD SCI USA, V97, P9270, DOI 10.1073/pnas.160503997; Perrelet D, 2002, NAT CELL BIOL, V4, P175, DOI 10.1038/ncb751; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Ralph GS, 2004, J CEREBR BLOOD F MET, V24, P245, DOI 10.1097/01.WCB.0000110532.48786.46; Rohll JB, 2002, METHOD ENZYMOL, V346, P466; Sarabi A, 2000, BRAIN RES, V877, P262, DOI 10.1016/S0006-8993(00)02682-2; Sawada H, 2000, J NEUROCHEM, V74, P1175; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SHIMAZAKI K, 1994, NEUROSCI RES, V20, P95, DOI 10.1016/0168-0102(94)90026-4; Shimazaki K, 2000, GENE THER, V7, P1244, DOI 10.1038/sj.gt.3301211; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Tsai TT, 2000, EXP NEUROL, V166, P266, DOI 10.1006/exnr.2000.7505; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Yang GY, 2001, J CEREBR BLOOD F MET, V21, P722, DOI 10.1097/00004647-200106000-00010; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403	41	43	46	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-0016			MOL THER	Mol. Ther.	JAN	2005	11	1					89	95		10.1016/j.ymthe.2004.08.026			7	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	906BI	WOS:000227615100010	15585409	hybrid			2022-02-06	
J	Han, Y; Ciuffreda, KJ; Kapoor, N				Han, Y; Ciuffreda, KJ; Kapoor, N			Reading-related oculomotor testing and training protocols for acquired brain injury in humans	BRAIN RESEARCH PROTOCOLS			English	Article						oculomotor rehabilitation; reading; traumatic brain injury (TBI); cerebral vascular accident (CVA, stroke); acquired brain injury (ABI); oculomotor adaptation; visual attention; visual feedback; auditory feedback	EYE-MOVEMENTS	Many individuals with acquired brain injury (ABI) report reading problems of oculomotor origin. These may include frequent loss of place, skipping of lines and difficulty shifting to the next line of print. We describe two protocols for the testing and training of reading-related eye movements in adult individuals with ABI (traumatic brain injury [7131] and stroke with hemianopia), who experience oculomotor-based symptoms when reading. These protocols use objective eye movement recording techniques and computer-based stimulus presentation and analysis. One protocol tests and the other trains basic horizontal and vertical versional eye movements (fixation, saccades and pursuit), as well as reading eye movements using simulated single and multiple line dynamic arrays. In addition, a reading rating-scale questionnaire is administered before and after completion of training to assess subjective reading improvement. In all paradigms, the target consists of a 0.5degrees luminous square, which is displayed on a computer monitor positioned 40 cm from the subject along the midline. All testing and training are conducted under binocular viewing conditions with optical correction in place. There are two modes of training: normal internal oculomotor visual feedback either alone (4 weeks) or in conjunction with external oculomotor auditory feedback (4 weeks) administered in a counterbalanced manner within each diagnostic group. Training is performed 1 h, twice weekly for the 8 weeks. Oculomotor testing is conducted before, midway and after training. Following training, reading-related eye movements and reading ability improved as assessed both subjectively and objectively. These protocols provide a systematic approach to the quantitative and comprehensive testing and training of reading-related eye movement skills and behaviors in the ABI population manifesting oculomotor-based reading dysfunctions. Furthermore, the training protocol results in the rapid remediation of the eye movement deficits, which appear to transfer to activities of daily living. (C) 2004 Elsevier B.V. All rights reserved.	SUNY Coll Optometry, Dept Vis Sci, Raymond J Greenwald Rehabil Ctr, New York, NY 10036 USA; SUNY Coll Optometry, Dept Clin Sci, Raymond J Greenwald Rehabil Ctr, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Vis Sci, Raymond J Greenwald Rehabil Ctr, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					Benjamin W. J., 1998, BORISHS CLIN REFRACT; Ciuffreda K., 1983, VERGENCE EYE MOVEMEN; Ciuffreda K. J., 1996, J BEHAV OPTOM, V7, P31; CIUFFREDA KJ, 1983, AM J OPTOM PHYS OPT, V60, P242; CIUFFREDA KJ, 1976, AM J OPTOM PHYS OPT, V53, P389; CIUFFREDA KJ, 1985, AM J OPTOM PHYS OPT, V62, P844; CIUFFREDA KJ, UNPUB OCULOMOTOR REH; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; CIUFFREDA KJ, UNPUB NEUROL REHABIL; COOPER J, 1995, NEURO-OPHTHALMOLOGY, V15, P249, DOI 10.3109/01658109509044610; Cooper J, 2000, J NEURO-OPHTHALMOL, V20, P5, DOI 10.1097/00041327-200020010-00003; Fayos B, 1998, J BEHAV OPTOMETRY, V9, P143; FLETCHER J, 1993, J LEARN DISABIL, V26, P683, DOI 10.1177/002221949302601006; GIANUTSOS R, 2001, VISUAL VESTIBULAR CO, P48; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; GUR S, 1992, ISRAEL J MED SCI, V28, P622; HUNG GK, 1986, IEEE T BIO-MED ENG, V33, P1021, DOI 10.1109/TBME.1986.325868; Kapoor N, 2002, CLIN J PAIN, V18, P93, DOI 10.1097/00002508-200203000-00004; KAPOOR N, IN PRESS NEUROPSYCHI; KATZ M, 1984, AM J OPTOM PHYS OPT, V61, P196; KENYON RV, 1980, INVEST OPHTH VIS SCI, V19, P60; Koenig G S, 1997, J Am Optom Assoc, V68, P155; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; ROBINSON GM, 1977, J EXP PSYCHOL HUMAN, V3, P83; Selenow A., 1991, AMBLYOPIA BASIC CLIN; SOLAN HA, 1985, AM J OPTOM PHYS OPT, V62, P812; STARK L, 1977, AM J OPTOM PHYS OPT, V54, P85; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Tannen B, 1989, J Am Optom Assoc, V60, P748; Tannen B., 1995, EYE MOVEMENT BASICS; Taylor E. A., 1966, FUNDAMENTAL READING; Zee D.S., 1999, NEUROLOGY EYE MOVEME, V3rd; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891; Zihl J, 2000, NEUROPSY REHABIL MOD; Zost MG, 2001, DIAGNOSIS MANAGEMENT, P75	35	43	43	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1385-299X			BRAIN RES PROTOC	Brain Res. Protoc.	NOV 1	2004	14	1					1	12		10.1016/j.brainresprot.2004.06.002			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	874KJ	WOS:000225349000001	15519946				2022-02-06	
J	Kapoor, N; Ciuffreda, KJ; Han, Y				Kapoor, N; Ciuffreda, KJ; Han, Y			Oculomotor rehabilitation in acquired brain injury: A case series	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology	MAY 04-09, 2003	FT LAUDERDALE, FL	Assoc Res Vis & Ophthalmol		attention; brain injuries; ocular motility disorder; reading; stroke; rehabilitation	DISORDERS	Objective: To investigate the effects of systematic, oculomotor rehabilitation on basic versional ocular motility, as well as reading eye movements, in subjects with acquired brain injury, using objective eye movement recording and subjective rating of reading ability. Design: Case series. Setting: Clinical research laboratory. Participants: Two men with acquired brain injury: one with traumatic brain injury and one with stroke. Interventions: Versional oculomotor training was performed for 1 hour, twice weekly for 8 weeks. There were 2 feedback modes of training: normal internal oculomotor visual feedback alone (4wk), or that feedback in conjunction with external oculomotor auditory feedback (4wk). Testing was conducted before and after training. Main Outcome Measures: Objective outcome measures included both basic eye movement parameters (fixational accuracy, saccadic gain and latency, pursuit gain, mean saccade frequency ratio for simulated reading), and reading eye movement parameters (words per minute, grade level equivalent, fixations per 100 words, regressions per 100 words, percentage of reading comprehension, duration of fixation in seconds). Subjective outcome measures included the subject's ability to read based on the responses to the reading rating-scale questionnaire. Results: Both subjects improved objectively in terms of basic versional oculomotor accuracy and reading ability. These findings concurred with their subjective impressions. Conclusions: This case series provides objective documentation of the positive effects of oculomotor rehabilitation on basic ocular motility and reading ability in selected cases with acquired brain injury, thus suggesting the need for a larger clinical trial in this area. (C) 2004 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	SUNY State Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, New York, NY 10036 USA; SUNY State Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Vis Sci, New York, NY 10036 USA		Kapoor, N (corresponding author), SUNY State Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, 33 W 42nd St, New York, NY 10036 USA.	nkapoor@sunyopt.edu					BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Benjamin W. J., 1998, BORISHS CLIN REFRACT; BERNETHY B, 1997, BIOPHYSICAL FDN HUMA; BYL NN, 2001, DOWNEY DARLINGS PHYS, P609; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; Ciuffreda K. J., 1996, J BEHAV OPTOM, V7, P31; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Ciuffreda KJ, 1999, CLIN EYE VIS CARE, V11, P41, DOI DOI 10.1016/S0953-4431(99)00010-7; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; DANGELO CM, 1994, J AM OPTOM ASSOC, V64, P60; Desmurget M, 1998, NAT NEUROSCI, V1, P524, DOI 10.1038/2241; Fayos B, 1998, J BEHAV OTPOM, V9, P1; Garzia R P, 1990, J Am Optom Assoc, V61, P124; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; GOTTLIEB GL, 1988, EXP BRAIN RES, V73, P436; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; GUR S, 1992, ISRAEL J MED SCI, V28, P622; HAN Y, IN PRESS BRAIN RES P; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hibbard M. R., 2001, VISUAL VESTIBULAR CO, P32; KEELE SW, 1986, HDB PERCEPTION HUMAN, V2, P1; KELLEY RE, 1989, NEUROLOGY NONNEUROLO, P52; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Koenig G S, 1997, J Am Optom Assoc, V68, P155; LEIGH RJ, 1909, NEUROLOGY EYE MOVEME; LEPORE FE, 1995, ARCH NEUROL-CHICAGO, V52, P924, DOI 10.1001/archneur.1995.00540330106022; LISBERGER SG, 1988, SCIENCE, V242, P728, DOI 10.1126/science.3055293; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MUELLER C, 1993, DEV MED CHILD NEUROL, V35, P163; Nag S, 1999, NEUROL INDIA, V47, P32; National Institutes of Health, 1999, NIH PUBL, V99-3674; OBINSON GM, 1977, J EXP PSYCHOL HUMAN, V3, P83; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quinn B, 2000, BRAIN INJURY, V14, P1063; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Richter E. F., 2001, VISUAL VESTIBULAR CO, P10; RON S, 1978, SCAND J REHABIL MED, V10, P39; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; SUCHOFF I, 2000, PHYS MED REHABILITAT, P608; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; SUCHOFF IB, 2000, LIGHTHOUSE HDB VISIO, P517; SUTER PS, 1995, TRAUMATIC BRAIN INJU, P198; Tannen B., 1995, EYE MOVEMENT BASICS; Taylor E. A., 1966, FUNDAMENTAL READING; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891; Zihl J, 2000, NEUROPSY REHABIL MOD; ZIUFFREDA KJ, 2003, 7K ANN M ASS RES VIS; ZOST MG, 1995, DIAGNOSIS MANAGEMENT, pCH4	57	43	43	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2004	85	10					1667	1678		10.1016/j.apmr.2003.12.044			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	861GS	WOS:000224404700017	15468029				2022-02-06	
J	Hart, T; Buchhofer, R; Vaccaro, M				Hart, T; Buchhofer, R; Vaccaro, M			Portable electronic devices as memory and organizational aids after traumatic brain injury: A consumer survey study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assistive technology; cognitive compensations; traumatic brain injury	POCKET-COMPUTER; PEOPLE; REHABILITATION; SYSTEM	Objective: To ascertain consumer experiences and attitudes regarding the use of portable electronic devices as memory and organizational aids after traumatic brain injury (TBI). Design: Survey study. Setting: Post-acute TBI rehabilitation programs, research registries. Participants: Eighty persons with moderate to severe TBI interviewed a median of 3.7 years postinjury. Outcome Measure: Survey administered in structured interview format, analyzed both quantitatively and qualitatively. Results: Two thirds of participants reported regular use of computers, but fewer than one third had experience with handheld computers or similar devices. Interest in using portable devices for everyday memory and organizational tasks was higher than the expressed need for improvement in participants' current strategies. Respondents expressed reliable preferences for key device features, including simplicity of use, technical support, and long-lasting battery power. Preferred functions included keeping track of money spent, remembering things to do, and remembering what other people say. Conclusion: Portable electronic devices are acceptable or desirable by consumers with moderate to severe TBI for use as compensatory aids.	Thomas Jefferson Univ, Med Coll, Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Med Coll, Dept Rehabil Med, Philadelphia, PA 19141 USA		Hart, T (corresponding author), Thomas Jefferson Univ, Med Coll, Rehabil Res Inst, 1200 W Tabor Rd,Korman Suite 213, Philadelphia, PA 19141 USA.	thart@einstein.edu					Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Davies DK, 2002, MENT RETARD, V40, P358, DOI 10.1352/0047-6765(2002)040<0358:EITMSO>2.0.CO;2; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; HART T, 2004, ARCH PHYS MED RE SEP, P85; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; KAYE HS, 2000, COOMPUTER INTERNET A; NELSON D, QUESTION APPRAISAL S; Oriani M, 2003, AGING MENT HEALTH, V7, P22, DOI 10.1080/1360786021000045863; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Scherer M.J., 2002, TECHNOL DISABIL, V14, P125, DOI [DOI 10.3233/TAD-2002-14308, 10.3233/tad-2002-14308]; van den Broek MD, 2000, BRAIN INJURY, V14, P455; WILSON BA, 1989, CORTEX, V25, P115, DOI 10.1016/S0010-9452(89)80011-5; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006	18	43	44	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					351	365		10.1097/00001199-200409000-00001			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300001	15597027				2022-02-06	
J	Roche, RAP; Dockree, PM; Garavan, H; Foxe, JJ; Robertson, IH; O'Mara, SM				Roche, RAP; Dockree, PM; Garavan, H; Foxe, JJ; Robertson, IH; O'Mara, SM			EEG alpha power changes reflect response inhibition deficits after traumatic brain injury (TBI) in humans	NEUROSCIENCE LETTERS			English	Article						event-related potentials; spectral power; desynchronisation; N2/P3 complex; inhibitory control	ATTENTION; SCHIZOPHRENIA; PERFORMANCE	Brain damage due to traumatic brain injury (TBI) has been associated with deficits in executive functions and the dynamic control of behaviour. Event-related brain potentials and spectral power data were recorded from eight TBI participants and eight matched controls while they completed a Go/NoGo response inhibition task. The TBI group was found to be significantly impaired at the task compared to controls, and exhibited abnormal N2 and P3 waveform components in response to NoGo stimuli relative to controls. Significant correlations were also found between alpha power, Go-trial RT and errors. We conclude that abnormal activity in the structures damaged in this group may render such patients less capable of maintaining a state of alpha desynchronisation compared to controls, resulting in poorer performance on the task. (C) 2004, Elsevier Ireland Ltd. All rights reserved.	Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA		Roche, RAP (corresponding author), Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland.	riroche@tcd.ie	Roche, Richard AP/C-4798-2009	Roche, Richard AP/0000-0001-6606-4187; Foxe, John/0000-0002-4300-3098; Robertson, Ian H/0000-0001-8637-561X; O'Mara, Shane/0000-0001-8087-8531	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA14100] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA014100] Funding Source: NIH RePORTER		Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Curtis CE, 2001, EXP BRAIN RES, V137, P228, DOI 10.1007/s002210000635; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Dias EC, 2003, CEREB CORTEX, V13, P701, DOI 10.1093/cercor/13.7.701; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Konrad KN, 2000, BRAIN INJURY, V14, P859; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROCHE RAP, UNPUB EXP BRAIN RES; Worden MS, 2000, J NEUROSCI, V20; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	16	43	47	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 13	2004	362	1					1	5		10.1016/j.neulet.2003.11.064			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	822HZ	WOS:000221531100001	15147767				2022-02-06	
J	Kline, AE; Massucci, JL; Dixon, CE; Zafonte, RD; Bolinger, BD				Kline, AE; Massucci, JL; Dixon, CE; Zafonte, RD; Bolinger, BD			The therapeutic efficacy conferred by the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia	JOURNAL OF NEUROTRAUMA			English	Article						8-OH-DPAT; controlled cortical impact (CCI); function; learning; memory; Morris water maze (MWM); recovery	BAY X 3702; VESICULAR ACETYLCHOLINE TRANSPORTER; WATER MAZE PERFORMANCE; MODERATE HYPOTHERMIA; COGNITIVE DEFICITS; GLUTAMATE RELEASE; RAT HIPPOCAMPUS; EVOKED RELEASE; IN-VITRO; MODEL	We recently reported that the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8OH-DPAT) attenuated traumatic brain injury (TBI)-induced cognitive deficits and histopathology. However, 8-OH-DPAT also produced mild hypothermia (Hypo), which may have contributed to the benefit. To clarify this issue, we conducted an experiment similar to the previous, but included an 8-OH-DPAT group that was maintained at 37 +/- 0.5degreesC (normothermia; Normo). Isoflurane-anesthetized rats received either a cortical impact (2.7-mm deformation at 4 m/sec) or sham injury and then were randomly assigned to two saline (Sham/Vehicle, n = 5; Injury/Vehicle, n = 10) or three 8-OH-DPAT (Sham/DPAT, n = 5; Injury/DPAT+Normo, n 10; Injury/DPAT+Hypo, n = 10) groups. 8-OH-DPAT (0.5 mg/kg) or a comparable volume of saline was administered intraperitoneally 15 min after cortical impact or sham injury. Core temperatures were taken prior to treatment and every 15 min thereafter for 2 h. Function was assessed by established motor and cognitive tasks on post-operative days 1-5 and 14-20, respectively. Hippocampal CA(1)/CA(3) cell survival and cortical lesion volume were quantified at 4 weeks. Both the Injury/DPAT+Normo and Injury/DPAT+Hypo groups exhibited enhanced cognitive performance (spatial acquisition and retention) and reduced histopathology (CA(3) cell loss and cortical lesion volume) versus the Injury/Vehicle group (P < 0.05), but did not differ from one another despite a rapid (15 min), mild (34.4-34.9degreesC), and transient (similar to1 h) hypothermic effect in the latter. These data confirm that a single systemic administration of 8-OH-DPAT confers neurological protection after TBI, and demonstrate that the beneficial effect is not mediated by concomitant hypothermia. The mechanisms for the protective effects of 8-OH-DPAT after TBI require further inquiry.	Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Kline, AE (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	klineae@upmc.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD043851] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS033150] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033150] Funding Source: NIH RePORTER		Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ANDRADE R, 1992, DRUG DEVELOP RES, V26, P275, DOI 10.1002/ddr.430260307; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cryan JF, 1999, J PSYCHOPHARMACOL, V13, P278, DOI 10.1177/026988119901300310; De Vry J, 1998, J PHARMACOL EXP THER, V284, P1082; De Vry J, 1998, EUR J PHARMACOL, V357, P1, DOI 10.1016/S0014-2999(98)00503-2; De Vry Jean, 1997, Drugs of the Future, V22, P341; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fujii T, 1997, BRAIN RES, V761, P244, DOI 10.1016/S0006-8993(97)00325-9; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HJORTH S, 1985, J NEURAL TRANSM, V61, P131, DOI 10.1007/BF01253058; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2001, HEAD TRAUMA, P65; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Koyama T, 1999, NEUROSCI LETT, V265, P33, DOI 10.1016/S0304-3940(99)00200-1; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsuyama S, 1996, BRAIN RES, V728, P175, DOI 10.1016/0006-8993(96)00395-2; Mauler F, 2001, BRAIN RES, V888, P150, DOI 10.1016/S0006-8993(00)03074-2; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Melena J, 2000, EUR J PHARMACOL, V406, P319, DOI 10.1016/S0014-2999(00)00688-9; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; MILLAN MJ, 1993, J PHARMACOL EXP THER, V264, P1364; Ohman J, 2001, J NEUROTRAUM, V18, P1313, DOI 10.1089/08977150152725614; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; PREHN JHM, 1993, BRAIN RES, V630, P10, DOI 10.1016/0006-8993(93)90636-2; PREHN JHM, 1991, EUR J PHARMACOL, V203, P213, DOI 10.1016/0014-2999(91)90717-5; RAITERI M, 1991, J PHARMACOL EXP THER, V257, P1184; Sakaue M, 2000, BRIT J PHARMACOL, V129, P1028, DOI 10.1038/sj.bjp.0703139; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SQUIRE LR, 1981, ANNU REV PHARMACOL, V21, P323, DOI 10.1146/annurev.pa.21.040181.001543; Torup L, 2000, EUR J PHARMACOL, V395, P137, DOI 10.1016/S0014-2999(00)00175-8; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X	56	43	45	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2004	21	2					175	185		10.1089/089771504322778631			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	774WB	WOS:000189008200005	15000758				2022-02-06	
J	Bruce, JM; Echemendia, RJ				Bruce, JM; Echemendia, RJ			Delayed-onset deficits in verbal encoding strategies among patients with mild traumatic brain injury	NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; SPORTS; ORGANIZATION; MEMORY	Knowledge obtained from longitudinal animal models was used to predict the course of verbal memory deficits in 19 concussed patients and 19 control patients who were given versions of the Hopkins Verbal Learning Test-Revised at 2 hr, 48 hr, and I week postconcussion. The physiological literature suggests that concussed patients should exhibit a decline in performance from 2 hr to 48 hr postconcussion on a measure of complex memory strategies. Consistent with this hypothesis, mixed-factor analysis of covariance revealed that concussed patients used less semantic clustering strategies than control patients at 48 hr postconcussion, whereas minimal differences were found at 2 hr postinjury. Furthermore, a chi-square analysis showed that a significant number of concussed patients experienced a decline in the number of semantic clusters they used from 2 hr to 48 hr. No differences were found between the groups at the 1-week testing session.	Penn State Univ, Coll Liberal Arts, Dept Psychol, University Pk, PA 16802 USA		Bruce, JM (corresponding author), Penn State Univ, Coll Liberal Arts, Dept Psychol, 429 Bruce V Moore Bldg, University Pk, PA 16802 USA.	jmb518@psu.edu	Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462			BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC, 1987, CALIFORNIA VERBAL LE; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; Gupta A, 1991, J PERS CLIN STUD, V7, P55; HALL S, 1991, PERCEPT MOTOR SKILL, V72, P1295, DOI 10.2466/PMS.72.4.1295-1298; HAYES RL, 1989, MILD HEAD INJURY, P54; HODVA DA, 1995, J NEUROTRAUM, V12, P903; Johnson M. K., 1991, PERSPECTIVES COGNITI, P197; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kelly JP, 1997, NEUROLOGY, V48, P581; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; SARTER M, 1994, PSYCHOPHARMACOLOGY, V114, P539, DOI 10.1007/BF02244983; SHUELL TJ, 1969, PSYCHOL BULL, V72, P353, DOI 10.1037/h0028141; STUSS DT, 1987, FRONTAL LOBES REVIS; Trennery M. R., 1989, STROOP NEUROPSYCHOLO; [No title captured]	32	43	43	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2003	17	4					622	629		10.1037/0894-4105.17.4.622			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	740AP	WOS:000186378900009	14599275				2022-02-06	
J	Hlatky, R; Lui, H; Cherian, L; Goodman, JC; O'Brien, WE; Contant, CF; Robertson, CS				Hlatky, R; Lui, H; Cherian, L; Goodman, JC; O'Brien, WE; Contant, CF; Robertson, CS			The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; endothelial NOS; nitric oxide; traumatic brain injury	TRAUMATIC BRAIN-INJURY; L-ARGININE; DEFICIENT; HYPERTENSION; RESPONSES; LACKING; GENE; RATS	Traumatic brain injury causes a reduction in cerebral blood flow, which may cause additional damage to the brain. The purpose of this study was to examine the role of nitric oxide produced by endothelial nitric oxide synthase (eNOS) in these vascular effects of trauma. To accomplish this, cerebral hemodynamics were monitored in mice deficient in eNOS and wild-type control mice that underwent lateral controlled cortical impact injury followed by administration of either L-arginine, 300 mg/kg, or saline at 5 min after the impact injury. The eNOS deficient mice had a greater reduction in laser Doppler flow (LDF) in the contused brain tissue at the impact site after injury, despite maintaining a higher blood pressure. L-Arginine administration increased LDF post-injury only in the wild-type mice. L-Arginine administration also resulted in a reduction in contusion volume, from 2.4 +/- 1.5 to 1.1 +/- 1.2 mm(3) in wild-type mice. Contusion volume in the eNOS deficient mice was not significantly altered by L-arginine administration. These differences in cerebral hemodynamics between the eNOS-deficient and the wild-type mice suggest an important role for nitric oxide produced by eNOS in the preservation of cerebral blood flow in contused brain following traumatic injury, and in the improvement in cerebral blood flow with L-arginine administration.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Genet & Mol Biol, Houston, TX 77030 USA; Charles Univ Prague, Univ Hosp, Dept Neurosurg, Hradec Kralove, Czech Republic; W China Univ Med Sci, Univ Hosp 1, Dept Surg, Chengdu 610041, Peoples R China		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St 944, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER		Champion HC, 2000, AM J PHYSIOL-HEART C, V278, pH8, DOI 10.1152/ajpheart.2000.278.1.H8; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; DALKARA T, 1995, J CEREBR BLOOD F MET, V15, P631, DOI 10.1038/jcbfm.1995.78; Goldstein H., 1995, MULTILEVEL STAT MODE; Gregg AR, 1998, AM J PHYSIOL-HEART C, V275, pH2319, DOI 10.1152/ajpheart.1998.275.6.H2319; Grima G, 2001, EUR J NEUROSCI, V14, P1762, DOI 10.1046/j.0953-816x.2001.01799.x; Hefler LA, 2001, BIOL REPROD, V64, P666, DOI 10.1095/biolreprod64.2.666; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Kurihara N, 1998, HYPERTENSION, V32, P856, DOI 10.1161/01.HYP.32.5.856; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Lo EH, 1996, STROKE, V27, P1381, DOI 10.1161/01.STR.27.8.1381; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; RASBASH J, 2002, MLWIN VERSION 1 20 M; Rehman A, 1997, BRIT J PHARMACOL, V122, P1702, DOI 10.1038/sj.bjp.0701556; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WADA K, 1997, J NEUROTRAUM, V14, P760; WU CC, 1995, BRIT J PHARMACOL, V114, P1666, DOI 10.1111/j.1476-5381.1995.tb14955.x; Yamada M, 2000, J CEREBR BLOOD F MET, V20, P709, DOI 10.1097/00004647-200004000-00008	26	43	45	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2003	20	10					995	1006		10.1089/089771503770195849			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734RX	WOS:000186072300008	14588116				2022-02-06	
J	Denslow, N; Michel, ME; Temple, MD; Hsu, CY; Saatman, K; Hayes, RL				Denslow, N; Michel, ME; Temple, MD; Hsu, CY; Saatman, K; Hayes, RL			Application of proteomics technology to the field of neurotrauma	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; mass spectroscopy; proteomics; spinal cord trauma	2-DIMENSIONAL GEL-ELECTROPHORESIS; HUMAN GENES; PROTEIN; NEUROSCIENCE; SEQUENCE; NETWORK; DEATH	Near-completion of the Human Genome Project has stimulated scientists to begin looking for the next step in unraveling normal and abnormal functions within biological systems. Consequently, there is new focus on the role of proteins in these processes. Proteomics is a burgeoning field that may provide a valuable approach to evaluate the post-traumatic central nervous system (CNS). Although we cannot provide a comprehensive assessment of all methods for protein analysis, this report summarizes some of the newer proteomic technologies that have propelled this field into the limelight and that are available to most researchers in neurotrauma. Three technical approaches (two-dimensional gel electrophoresis, direct analysis by mass spectrometry, including two-dimensional chromatography coupled to mass spectrometry and isotope coded affinity tags, and antibody technologies) are reviewed, and their advantages and disadvantages presented. A discussion of proteomic technology in the context of brain and spinal cord trauma follows, addressing current and future challenges. Proteomics will likely be very useful for developing diagnostic predictors after CNS injury and for mapping changes in proteins after injury in order to identify new therapeutic targets. Neurotrauma results in complex alterations to the biological systems within the nervous system, and these changes evolve over time. Exploration of the "new nervous system" that follows injury will require methods that can both fully assess and simplify this complexity.	NINDS, Repair & Plast Program, Bethesda, MD 20982 USA; Univ Florida, Biotechnol Program, Gainesville, FL USA; Natl Inst Biomed Imaging & Bioengn, Bethesda, MD USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA		Michel, ME (corresponding author), NINDS, Repair & Plast Program, 6001 Execut Blvd,Rm 2227, Bethesda, MD 20982 USA.			Hsu, Chung Y./0000-0002-5632-2733			AMESS B, 1995, ELECTROPHORESIS, V16, P1255, DOI 10.1002/elps.11501601207; Buonocore G, 1999, J NEUROCHEM, V73, P2139; CharriautMarlangue C, 1996, ELECTROPHORESIS, V17, P1781, DOI 10.1002/elps.1150171117; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Grant SGN, 2001, TRENDS BIOTECHNOL, V19, pS49, DOI 10.1016/S0167-7799(01)01799-1; Grant SGN, 2001, J NEUROSCI, V21, P8315, DOI 10.1523/JNEUROSCI.21-21-08315.2001; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; KIRSCHENBAUM B, 1990, BRAIN RES, V12, P21; Leski ML, 1996, NEUROCHEM RES, V21, P681, DOI 10.1007/BF02527725; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; PERSIDIS A, 2001, PROTEOMICS NAT BIO S, V18, pIT45; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Shouse B, 2002, SCIENCE, V295, P1457; Tonge R, 2001, PROTEOMICS, V1, P377; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weir M, 2001, TRENDS BIOTECHNOL, V19, pS61, DOI 10.1016/S0167-7799(01)01794-2; Wojcik J, 2000, Brief Bioinform, V1, P250, DOI 10.1093/bib/1.3.250	20	43	48	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2003	20	5					401	407		10.1089/089771503765355487			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	682MY	WOS:000183096900001	12803973				2022-02-06	
J	Zhang, XP; Graham, SH; Kochanek, PM; Marion, DW; Nathaniel, PD; Watkins, SC; Clark, RSB				Zhang, XP; Graham, SH; Kochanek, PM; Marion, DW; Nathaniel, PD; Watkins, SC; Clark, RSB			Caspase-8 expression and proteolysis in human brain after severe head injury	FASEB JOURNAL			English	Article						apoptosis; cysteine protease; Fas; programmed cell death; traumatic brain injury	TUMOR-NECROSIS-FACTOR; CEREBROSPINAL-FLUID; NEURONAL APOPTOSIS; FAS LIGAND; CELL-DEATH; SIGNALING COMPLEX; ACTIVATION; MICE; CONTUSIONS; INDUCTION	Programmed cell death involves a complex and interrelated cascade of cysteine proteases termed caspases that are synthesized as inactive zymogens, which are proteolytically processed to active enzymes. Caspase-8 is an initiator caspase that becomes activated when Fas death receptor-Fas ligand (FasL) coupling on the cell surface leads to coalescence of a "death complex" perpetuating the programmed cell death cascade. In this study, brain tissue samples removed from adult patients during the surgical management of severe intracranial hypertension after traumatic brain injury (TBI; n=17) were compared with postmortem control brain tissue samples (n=6). Caspase-8 mRNA was measured by semiquantitative reverse transcription and polymerase chain reaction, and caspase-8 protein was examined by Western blot and immunocytochemistry. Fas and FasL were also examined using Western blot. Caspase-8 mRNA and protein were increased in TBI patients vs. controls, and caspase-8 protein was predominately expressed in neurons. Proteolysis of caspase-8 to 20-kDa fragments was seen only in TBI patients. Fas was also increased after TBI vs. control and was associated with relative levels of caspase-8, supporting formation of a death complex. These data identify additional steps in the programmed cell death cascade involving Fas death receptors and caspase-8 after TBI in humans.	Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Safar Ctr Resuscitat Res, Dept Neurol, Pittsburgh, PA USA; Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA USA; Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA USA; Safar Ctr Resuscitat Res, Dept Cell Biol & Physiol, Pittsburgh, PA USA; Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA USA; VA Pittsburgh Hlth Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA		Clark, RSB (corresponding author), Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Watkins, Simon/ABG-2590-2021; Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Watkins, Simon/0000-0003-4092-1552; Kochanek, Patrick M/0000-0002-2627-913X			Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Buki A, 2000, J NEUROSCI, V20, P2825; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Henshall DC, 2001, NEUROBIOL DIS, V8, P568, DOI 10.1006/nbdi.2001.0415; HOLMIN S, 2000, J NEUROSURG, V92; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1411, DOI 10.1097/00004647-200112000-00005; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Qiu JH, 2002, J NEUROSCI, V22, P3504; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SEIDBERG N, 2002, IN PRESS J NEUROCHEM; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	33	43	49	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2003	17	8					1367	+		10.1096/fj.02-1067fje			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	683TE	WOS:000183165000027	12738800				2022-02-06	
J	Kuhtz-Buschbeck, JP; Stolze, H; Golge, M; Ritz, A				Kuhtz-Buschbeck, JP; Stolze, H; Golge, M; Ritz, A			Analyses of gait, reaching, and grasping in children after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting on Neurotraumatology and Neuropsychological Rehabailitation	OCT   30, 2001	MANNHEIM, GERMANY			brain injuries; children; gait; hand; rehabilitation	MOTOR COORDINATION; FOLLOW-UP; REHABILITATION; PERFORMANCE; RELIABILITY; RECOVERY; COHORT; IDENTIFICATION; ADOLESCENTS; AGREEMENT	Objective: To evaluate motor behavior in children after traumatic brain injury (TBI) with quantitative instrumented measures of gait and of functional hand movements (reaching, grasping) and with clinical assessments. Design: Case-control study. Setting: Tertiary pediatric trauma rehabilitation center in Germany. Participants: Twenty children (age range, 6-13y) with moderate or severe TBI were examined 1+/-1.2 years (mean+/-standard deviation) postinjury. Fifteen were reexamined 2 months later. Control data were obtained from 20 healthy children and matched for age, gender, and school grade. Interventions: Not applicable Main Outcome Measures: Quantitative measures included 10 spatiotemporal gait parameters and 6 variables describing reaching and grasping. Qualitative scores of gait and upper-limb movements were also obtained. Results: Gait velocity and step and stride lengths were significantly smaller in children after TBI than in control subjects (Mann-Whitney U test, P<.05). Reach-to-grasp movements of the TBI children were characterized by a significantly longer reaction time (Mann-Whitney U test, P<.05) and movement duration, reduced velocity, and coordination deficits. The instrumented measures did not change significantly in 2 months. Several significant correlations between clinical and instrumented measures were obtained. Conclusion: Functional motor behavior is affected in children after moderate or severe TBI. To supplement clinical assessments with objective data, impairments of gait, reaching, and grasping movements can be recorded with instrumented measures.	Univ Kiel, Dept Physiol, Inst Physiol, D-24098 Kiel, Germany; Neurol Rehabil Zentrum Kinder & Jugendliche Fried, Bremen, Germany		Kuhtz-Buschbeck, JP (corresponding author), Univ Kiel, Dept Physiol, Inst Physiol, Olshaussenstr 40, D-24098 Kiel, Germany.		Kuhtz-Buschbeck, Johann/F-7745-2010	Kuhtz-Buschbeck, Johann P/0000-0002-4603-7103			BEHBEHANI K, 1990, ARCH PHYS MED REHAB, V71, P106; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BRUININKS R, 1977, BRUININKSOSERETSKY T; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kuhtz-Buschbeck JP, 1999, GAIT POSTURE, V9, P184, DOI 10.1016/S0966-6362(99)00015-6; Kuhtz-Buschbeck JP, 1998, EXP BRAIN RES, V122, P424, DOI 10.1007/s002210050530; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Masanic CA, 1998, ARCH PHYS MED REHAB, V79, P811, DOI 10.1016/S0003-9993(98)90361-6; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Melchers P, 1999, RESTOR NEUROL NEUROS, V14, P153; MELCHERS P, 1991, KAUFMAN ASSESSMENT B; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Quinn B, 2000, BRAIN INJURY, V14, P1063; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; SULLIVAN SJ, 1994, BRAIN INJURY, V8, P613, DOI 10.3109/02699059409151014; Swaine BR, 1996, BRAIN INJURY, V10, P263, DOI 10.1080/026990596124449; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; WING AM, 1986, J MOTOR BEHAV, V18, P245	35	43	43	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2003	84	3					424	430		10.1053/apmr.2003.50017			7	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	653KL	WOS:000181434300016	12638112				2022-02-06	
J	Mohta, M; Sethi, AK; Tyagi, A; Mohta, A				Mohta, M; Sethi, AK; Tyagi, A; Mohta, A			Psychological care in trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; BRAIN INJURY; HEAD-INJURY; EMOTIONAL SEQUELAE; TRAFFIC ACCIDENTS; MAJOR TRAUMA; SCALE; VICTIMS; CHILDREN	The clinician manages trauma patients in the emergency room, operation theatre, intensive care unit and trauma ward with an endeavour to provide best possible treatment for physical injuries. At the same time, it is equally important to give adequate attention to behavioural and psychological aspects associated with the event. Knowledge of the predisposing factors and their management helps the clinician to prevent or manage these psychological problems. Various causes of psychological disturbances in trauma patients have been highlighted. These include pain, the sudden and unexpected nature of events and the procedures and interventions necessary to resuscitate and stabilise the patient. The ICU and trauma ward environment, sleep and sensory deprivation, impact of injury on CNS, medications and associated pre-morbid conditions are also significant factors. Specific problems that concern the traumatised patients are helplessness, humiliation, threat to body image and mental symptoms. The patients react to these stressors by various defence mechanisms like conservation withdrawal, denial, regression, anger, anxiety and depression. Some of them develop delirium or even more severe problems like acute stress disorder or post-traumatic stress disorder. Physical, pharmacological or psychological interventions can be performed to prevent or minimise these problems in trauma patients. These include adequate pain relief, prevention of sensory and sleep deprivation, providing familiar surroundings, careful explanations and reassurance to the patient, psychotherapy and pharmacological treatment whenever required. (C) 2002 Elsevier Science Ltd. All rights reserved.	Univ Coll Med Sci, Dept Anaesthesiol & Crit Care, Delhi 110095, India; GTB Hosp, Delhi 110095, India; Univ Coll Med Sci, Dept Surg, Delhi 110095, India		Mohta, M (corresponding author), 28-B,Pocket C,SFS Flats,Mayur Vihar Phase 3, Delhi 110096, India.		Mohta, Anup/AAE-1490-2020	TYAGI, ASHA/0000-0001-5331-6832; Mohta, Anup/0000-0003-1712-5750			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARCHER J, 1991, J ADV HLTH NURS CARE, V1, P9; Averill J.R., 1982, ANGER AGGRESSION ESS; Baker C F, 1984, CCQ, V6, P66; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; Blumenfield M., 1993, P 20 INT C AUT LANG, P1; BRACKETT TO, 1984, JAMA-J AM MED ASSOC, V252, P793; BRESLAU N, 1982, AM J DIS CHILD, V136, P682, DOI 10.1001/archpedi.1982.03970440026007; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brewer M J, 1985, Crit Care Nurse, V5, P35; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; BROM D, 1993, J CLIN PSYCHOL, V49, P131, DOI 10.1002/1097-4679(199303)49:2<131::AID-JCLP2270490202>3.0.CO;2-2; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CHRISTIE J, 2000, TRAUMA CARE TEAM APP, P3; CIVETTA JM, 1981, CRIT CARE MED, V9, P763, DOI 10.1097/00003246-198111000-00001; Davidson JRT, 1997, INT CLIN PSYCHOPHARM, V12, P41, DOI 10.1097/00004850-199701000-00006; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; DUBOVSKY SL, 1981, UNDERSTANDING HUMAN, P90; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; ENGEL GL, 1956, J AM PSYCHOANAL ASS, V4, P428; Fitzpatrick MC, 1999, CLIN ORTHOP RELAT R, P98; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; GREGORIO MAP, 1992, INTENS CARE MED, V18, P278; Harvey AG, 1999, J NERV MENT DIS, V187, P443, DOI 10.1097/00005053-199907000-00009; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 1999, J TRAUMA STRESS, V12, P673, DOI 10.1023/A:1024773202939; HICKLING EJ, 1992, J ANXIETY DISORD, V6, P285, DOI 10.1016/0887-6185(92)90040-E; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jamerson PA, 1996, HEART LUNG, V25, P467, DOI 10.1016/S0147-9563(96)80049-5; JENNETT B, 1975, LANCET, V1, P480; Kbler-Ross E., 1969, DEATH DYING; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kleck H G, 1984, CCQ, V6, P21; KORNFELD DS, 1969, BRIT MED J, V1, P108, DOI 10.1136/bmj.1.5636.108; KUCH K, 1985, CAN J PSYCHIAT, V30, P426, DOI 10.1177/070674378503000610; Leszcz M., 1995, THEORY PRACTICE GROU; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; Malt U F, 1992, Psychiatr Med, V10, P117; Malt U. F., 1993, European Psychiatry, V8, P227; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCCLELLAND P, 1987, TRAUMA CARE, V2, P198; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Mieszala P, 1978, CCQ, V1, P93; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUELLER AD, 1962, ARCH PHYSICAL MED RE, V43, P151; NAGLER B, 1950, AM J PSYCHIAT, V107, P49, DOI 10.1176/ajp.107.1.49; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARKES CM, 1975, BRIT J PSYCHIAT, V127, P204, DOI 10.1192/bjp.127.3.204; PETERSON KC, 1991, POSTTRAUMATIC STRESS, P171; RIBBERS G, 1989, INT J REHABIL RES, V12, P175, DOI 10.1097/00004356-198906000-00006; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SCHMIDT CW, 1985, MANAGEMENT TRAUMA, P807; SCHNAPER N, 1975, J TRAUMA, V15, P94, DOI 10.1097/00005373-197502000-00002; SCHNAPER N, 1976, AM J PSYCHIAT, V133, P883; Schnyder U, 2000, CRIT CARE MED, V28, P86, DOI 10.1097/00003246-200001000-00014; Schnyder U, 1998, J PSYCHOSOM RES, V45, P419, DOI 10.1016/S0022-3999(98)00008-7; SHERMAN RS, 1988, J REHABIL RES DEV, V25, P7; Spitzer R.L., 1994, STRUCTURED CLIN INTE; STEDEFORD A, 1984, FACING DEATH PATIENT, P154; STEIN DJ, 2000, POSTTRAUMATIC STRESS, P131; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Strain J.J., 1975, PSYCHOL CARE MED ILL; STRAIN JJ, 1978, PSYCHOL INTERVENTION; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H; VREVEN DL, 1995, J TRAUMA STRESS, V8, P91, DOI 10.1007/BF02105409; Wallace-Barnhill George L., 1997, P89; WALLACEBARNHILL GL, 1989, TXB CRITICAL CARE, P1414; Wolman R. L., 1988, CONTEMP SURG S20, V3, P33	74	43	47	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2003	34	1					17	25	PII S0020-1383(02)00377-7	10.1016/S0020-1383(02)00377-7			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	640XP	WOS:000180714300004	12531372				2022-02-06	
J	Dirette, D				Dirette, D			The development of awareness and the use of compensatory strategies for cognitive deficits	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; SELF-AWARENESS; ADULTS; REHABILITATION; INTERVENTION	Background: Cognitive rehabilitation often involves teaching individuals with acquired brain injuries (ABI) to use compensatory strategies for cognitive deficits. The use of compensatory strategies is frequently limited by reduced awareness of deficits. The process through which a person with ABI develops awareness and begins to use compensatory strategies is rarely explored from the clients' perspectives. Objective: To explore the development of awareness and the use of compensatory strategies by adults with ABI. Setting: A cognitive rehabilitation day treatment programme. Method: A critical incidents, qualitative inquiry was conducted with three clients who had made good recovery. The development of awareness and the use of compensatory strategies is examined from the clients' perspectives. Their perspectives are compared to the perspectives of the therapists with whom they worked during the cognitive rehabilitation process. Results: Clients described the development of deficit awareness as a slow process with occasional 'aha' moments. These moments involved a comparison of current performance to pre-morbid performance on functional tasks. There was agreement among clients and therapists on the cognitive deficits manifested and on the strategies used to compensate for those deficits. The description of the process of developing awareness, however, was different. Conclusion: In-depth qualitative exploration of the experiences of clients has the potential to provide guidance for more effective cognitive rehabilitation interventions.	Western Michigan Univ, Occupat Therapy Dept, Kalamazoo, MI 49008 USA		Dirette, D (corresponding author), Western Michigan Univ, Occupat Therapy Dept, 1903 W Michigan Ave, Kalamazoo, MI 49008 USA.						Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Birnboim S, 1995, BRIT J OCCUPATIONAL, V58, P61; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dirette DK, 1999, OCCUP THER J RES, V19, P223, DOI 10.1177/153944929901900401; Dirette DK, 1999, J HEAD TRAUMA REHAB, V14, P595, DOI 10.1097/00001199-199912000-00008; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; FLEMING J, 1997, BRIT J OCCUPATIONAL, V60, P295, DOI DOI 10.1177/030802269706000703; Fleming JM, 1996, BRAIN INJURY, V10, P1; Katz N., 1997, CANADIAN J OCCUPATIO, V64, P53, DOI DOI 10.1177/000841749706400201; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; LAATSCH L, 2001, J COGNITIVE REHA SPR, P10; Mosey A.C., 1996, APPL SCI INQUIRY HLT; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; PRIGATANO GP, 1986, AWARENESS DEFICIT BR, P1; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; TEHAN G, 1995, MEM COGNITION, V23, P181, DOI 10.3758/BF03197220; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505	23	43	43	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2002	16	10					861	871		10.1080/02699050210131902			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	599VG	WOS:000178355400003	12418999				2022-02-06	
J	Prakash, KRC; Tang, Y; Kozikowski, AP; Flippen-Anderson, JL; Knoblach, SM; Faden, AI				Prakash, KRC; Tang, Y; Kozikowski, AP; Flippen-Anderson, JL; Knoblach, SM; Faden, AI			Synthesis and biological activity of novel neuroprotective diketopiperazines	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; TRAUMATIC BRAIN INJURY; CELL-DEATH; TRH; CULTURES; GLYCINE; RAT; ALKYLATION; RECOVERY; CALCIUM	The cyclic dipeptide cyclo[His-Pro] (CHP) is synthesized endogenously de novo and as a breakdown product of thyrotropin-releasing hormone (TRH). a tripeptide with known neuroprotective activity. We synthesized two isomeric compounds based on the structure of CHP, in which the histidine residue was replaced by 3.5-di-tert-butyltyrosine (DBT), a phenolic amino acid that traps reactive oxygen species. These novel diketopiperazines prevented neuronal death in an in vitro model of traumatic injury. In addition, they dose-dependent prevented death caused by the direct induction of free radicals, and by calcium mobilization through an agent that evokes rapid. necrotic death. The drugs showed activity in the latter system at picomolar concentrations. The neuroprotective profile of these compounds suggests that they may be useful as treatments for neuronal degeneration in potentially through several different mechanisms. (C) 2002 Elsevier Science Ltd. All rights reserved.	Georgetown Univ, Ctr Med, Drug Discovery Program, Dept Neurol, Washington, DC 20007 USA; USN, Res Lab, Struct Matter Lab, Washington, DC 20375 USA; Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA		Kozikowski, AP (corresponding author), Georgetown Univ, Ctr Med, Drug Discovery Program, Dept Neurol, 3900 Reservoir Rd,NW, Washington, DC 20007 USA.	kozikowa@georgetown.edu					BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BREESE GR, 1975, J PHARMACOL EXP THER, V193, P11; DELAPENA P, 1992, BIOCHEM J, V284, P891, DOI 10.1042/bj2840891; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FADEN AI, 1993, J NEUROTRAUM, V10, P101, DOI 10.1089/neu.1993.10.101; FADEN AI, 1989, ANN NY ACAD SCI, V553, P380; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Koenig ML, 1996, BRAIN RES, V730, P143; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; KOLVASULO FI, 1979, ACTA PHYSL SCAND, V106, P83; LAHTI H, 1983, EXPERIENTIA, V39, P1338, DOI 10.1007/BF01990091; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; METCALF G, 1974, NATURE, V252, P310, DOI 10.1038/252310a0; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; ODONNELL MJ, 1988, J AM CHEM SOC, V110, P8520, DOI 10.1021/ja00233a031; ODONNELL MJ, 1994, TETRAHEDRON, V50, P4507, DOI 10.1016/S0040-4020(01)89382-0; PETERKOFSKY A, 1982, MOL CELL BIOCHEM, V42, P45; Prasad C, 1998, THYROID, V8, P969, DOI 10.1089/thy.1998.8.969; PRASAD C, 1987, NEUROCHEM RES, V12, P767, DOI 10.1007/BF00971513; PRASAD C, 1988, NEUROSCI BIOBEHAV R, V12, P19, DOI 10.1016/S0149-7634(88)80069-1; PRASAD C, 1989, ANN NY ACAD SCI, V553, P232; RAMARAO P, 1990, NEUROPEPTIDES, V15, P213, DOI 10.1016/0143-4179(90)90015-Q; Rauk A, 2000, J AM CHEM SOC, V122, P9761, DOI 10.1021/ja994436u; Shaikh ZA, 1999, TOXICOLOGY, V132, P139; STANISH C, 1989, AM ANTHROPOL, V91, P7, DOI 10.1525/aa.1989.91.1.02a00010; STANTON TL, 1980, BRAIN RES, V181, P470, DOI 10.1016/0006-8993(80)90632-0; TACHE Y, 1985, EUR J PHARMACOL, V107, P149, DOI 10.1016/0014-2999(85)90053-6; Tanaka K, 1997, REGUL PEPTIDES, V70, P173, DOI 10.1016/S0167-0115(97)01013-6; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351	35	43	46	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP	2002	10	9					3043	3048	PII S0968-0896(02)00132-3	10.1016/S0968-0896(02)00132-3			6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	584TL	WOS:000177484800026	12110327				2022-02-06	
J	Fujii, DE; Ahmed, I				Fujii, DE; Ahmed, I			Risk factors in psychosis secondary to traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SEX-DIFFERENCES; HEAD TRAUMA; SCHIZOPHRENIA; DISEASE; RECOVERY; APHASIA	Psychosis is a rare but devastating sequela of traumatic brain injury (TBI). This study examined risk factors for developing a psychosis secondary to TBI (PSTBI). Demographics of 25 inpatients with PSTBI were statistically analyzed for risk factors. Data from the PSTBI group were also compared with data from a control group of TBI patients without psychosis. Results indicate the PSTBI group was more likely to have had a previous congenital neurological disorder or to have sustained a head injury prior to adolescence. The PSTBI also had a higher proportion of males. Discussion focuses on potential models for developing PSTBI.	John A Burns Sch Med, Dept Psychiat, Honolulu, HI USA; Hawaii State Hosp, Dept Neuropsychol, Kaneohe, HI USA		Fujii, DE (corresponding author), Hawaii State Hosp, Dept Neuropsychol, 45-710 Keaahala Rd, Kaneohe, HI 96744 USA.						ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BASSO A, 1982, CORTEX, V18, P469, DOI 10.1016/S0010-9452(82)80044-0; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CUMMINGS JL, 1988, PSYCHOSOMATICS, V29, P16, DOI 10.1016/S0033-3182(88)72418-4; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; FEINSTEIN A, 1990, PSYCHOL MED, V20, P793, DOI 10.1017/S0033291700036485; Feinstein A, 1998, J NEUROPSYCH CLIN N, V10, P448, DOI 10.1176/jnp.10.4.448; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; Fujii DE, 1996, PROF PSYCHOL-RES PR, V27, P266; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; Gualtari CT, 1991, BRAIN INJURY, V5, P219; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.7089587; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; Harrington C R, 1997, Int Psychogeriatr, V9, P229, DOI 10.1017/S1041610297004390; Harwood DG, 1999, AM J GERIAT PSYCHIAT, V7, P119; HILIBOM E, 1960, ACTA PSYCHIAT NEUR S, V142, P1; Ingvar D., 1987, BIOL PERSPECTIVES SC, P201; Levy J., 1992, HDB BEHAVIORAL NEURO, P245; Lishman W. A., 1987, ORGANIC PSYCHIAT PSY; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; NASRALLAH HA, 1992, TXB NEUROPSYCHIATRY, P621; PIZZAMIGLIO L, 1985, BRAIN LANG, V25, P213, DOI 10.1016/0093-934X(85)90081-1; ROSSI A, 1990, BIOL PSYCHIAT, V27, P61, DOI 10.1016/0006-3223(90)90020-3; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SHAPIRO LB, 1939, ILLINOIS MED J, V76, P250; Smeltzer Donald J., 1994, P251; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; Waddington JL, 1998, PSYCHIAT CLIN N AM, V21, P123, DOI 10.1016/S0193-953X(05)70364-6; WEINBERGER DR, 1988, SCHIZOPHRENIA BULL, V14, P157, DOI 10.1093/schbul/14.2.157; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661; YATES WR, 1990, NEUROPSY NEUROPSY BE, V3, P98	38	43	45	0	4	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2001	13	1					61	69		10.1176/appi.neuropsych.13.1.61			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	401TR	WOS:000166944800008	11207331				2022-02-06	
J	Siegel, JH; Loo, G; Dischinger, PC; Burgess, AR; Wang, SC; Schneider, LW; Grossman, D; Rivara, F; Mock, C; Natarajan, GA; Hutchins, KD; Bents, FD; McCammon, L; Leibovich, E; Tenenbaum, N				Siegel, JH; Loo, G; Dischinger, PC; Burgess, AR; Wang, SC; Schneider, LW; Grossman, D; Rivara, F; Mock, C; Natarajan, GA; Hutchins, KD; Bents, FD; McCammon, L; Leibovich, E; Tenenbaum, N			Factors influencing the patterns of injuries and outcomes in car versus car crashes compared to sport utility, van, or pick-up truck versus car crashes: Crash injury research engineering network study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						motor vehicle crash (MVC); injury; trauma; airbags; MVC vehicle incompatibility; MVC vehicle mass ratio; MVC DELTA V; MVC side-impacts	MULTIPLE TRAUMA PATIENTS; MOTOR-VEHICLE CRASHES; IMPACT; DRIVERS; COSTS	Background. Data using crash dummies suggest that motor vehicle crashes (MVCs) involving passenger sedans (S) vs sport utility, vans, or light trucks (SUVTs) produce more severe injuries than those involving two sedans (SvS). However, no detailed data regarding pattern of injuries or force mechanisms involved have been presented in real patients. Methods: The relationship of injury patterns and severities with MVC reconstruction data were obtained in 412 MVC patients, drivers or front seat passengers. Crashes were examined with regard to impact direction, frontal (F) or lateral (L) crashes, vehicle mass ratio, ISS, DELTA V, seat belt use, and airbag deployment (AB). Results: In 309 F-MVC, AB reduced overall ISS (24.3 to 17.9) with a reduction in the mean severity of traumatic brain injury (TBI) GCS less than or equal to 12, from 48% to only 28%. This AB protection from TBI was preserved as DELTA V increased to > 30 mph even though non-AB protected body areas (thorax, lung, liver, and lower extremity injuries) all increased. When vehicles of incompatible size and mass (SUVT) had F-MVC with sedans the incidence of severe TBI rose as did face lacerations despite AB or belt use. In L-MVC between SUVT and sedans compared with SvS MVC, there was a cephalad shift in body injuries with increased thorax, but decreased lower extremity injuries. The incidence of TBI increased. Analysis of injury contact sites (hits) showed more hits and a wider distribution of contract sites in SUVT vs sedan MVC. These appeared due to the greater mass excess and larger mass ratio, hood height, and width in the F-SUVT vs S crashes. All of these factors plus the increased bumper height above the body frame side-door sill were injury causal factors in the L-SUVT vs S MVCs. Conclusion: Both F and L crashes between sedans and SUVT with a high mass ratio shift the pattern of injury cephalad with increased thorax and intrathoracic organ injuries, and more severe TBI. These data suggest that improved head and thorax side-impact buffering and design features which transmit MVC forces from the higher front end of the larger mass SUVT to the frame of the sedan may better protect sedan occupants from side-impacts.	UMDNJ, New Jersey Med Sch, Dept Anat Cell Biol & Injury Sci, Newark, NJ 07103 USA; UMDNJ, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA; Univ Maryland, Charles McC Mathias Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA; Univ Michigan, Trauma Burn Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA; Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Edwin H Albano Inst Forens Sci, Reg Med Examiner Off, Woodland Hills, CA USA; Dynam Sci Inc, Woodland Hills, CA USA		Siegel, JH (corresponding author), UMDNJ, New Jersey Med Sch, Dept Anat Cell Biol & Injury Sci, Med Sci Bldg G-609,185 S Orange Ave, Newark, NJ 07103 USA.			Mock, Charles/0000-0002-0564-568X			BLINCOE LJ, 1996, DOT PUBLICATION HS; CHIPMAN ML, 1993, P ASS ADV AUTOMOTIVE, V37, P329; DALMOTAS DJ, 1995, J TRAUMA, V38, P476, DOI 10.1097/00005373-199504000-00002; DISCHINGER PC, 1993, J TRAUMA, V35, P454, DOI 10.1097/00005373-199309000-00020; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; *DOT, 1998, DOT PUBL HS, P18; *DOT, 1997, DOT PUBL HS; EVANS L, 1993, ACCIDENT ANAL PREV, V25, P213, DOI 10.1016/0001-4575(93)90062-2; EVANS L, 1993, P ASS ADV AUT MED, V37, P313; *INS I HIGHW SAF, 1998, STATUS REPORT, V33, P1; JOLLY BT, 1996, P ASS ADV AUTOMOTIVE, V40, P519; Loo GT, 1996, J TRAUMA, V41, P935, DOI 10.1097/00005373-199612000-00001; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; MCDERMUTT FJF, 1982, BRIT J SURG, V66, P518; McLellan BA, 1996, J TRAUMA, V41, P708, DOI 10.1097/00005373-199610000-00019; MILLER TR, 1989, ACCIDENT ANAL PREV, V21, P303, DOI 10.1016/0001-4575(89)90022-5; REATH DB, 1989, J TRAUMA, V29, P1173, DOI 10.1097/00005373-198908000-00018; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; SIEGEL JH, 1993, J TRAUMA, V35, P920, DOI 10.1097/00005373-199312000-00019; SIEGEL JH, 1994, J TRAUMA, V37, P928, DOI 10.1097/00005373-199412000-00010; SIEGEL JH, 1992, DOT PUBLICATION, P51; SIEGEL JH, 1994, Patent No. 8358891; VIANO DC, 1990, ACCIDENT ANAL PREV, V22, P177, DOI 10.1016/0001-4575(90)90068-V	24	43	43	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2001	51	5					975	990		10.1097/00005373-200111000-00024			16	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	495QJ	WOS:000172351600030	11706349				2022-02-06	
J	Harris, LK; Black, RT; Golden, KM; Reeves, TM; Povlishock, JT; Phillips, LL				Harris, LK; Black, RT; Golden, KM; Reeves, TM; Povlishock, JT; Phillips, LL			Traumatic brain injury-induced changes in gene expression and functional activity of mitochondrial cytochrome c oxidase	JOURNAL OF NEUROTRAUMA			English	Article						cytochrome c oxidase; deafferentation; neuroexcitation; plasticity; traumatic brain injury	FLUID-PERCUSSION INJURY; MESSENGER-RNA; DIFFERENTIAL DISPLAY; RAT; METABOLISM; HIPPOCAMPUS; SUBUNIT; DISEASE; AMELIORATION; PROTEOLYSIS	Traumatic brain injury (TBI) is documented to have detrimental effects on CNS metabolism, including alterations in glucose utilization and the depression of mitochondrial oxidative phosphorylation. Studies on mitochondrial metabolism have also provided evidence for reduced activity of the cytochrome oxidase complex of the electron transport chain (complex IV) after TBI and an immediate (1hr) reduction in mitochondrial state 3 respiratory rate, which can persist for up to 14 days postinjury. Using differential display methods to screen for differences in gene expression, we have found that cytochrome c oxidase H (COII), a mitochondrial encoded subunit of complex IV, is upregulated following TBI. Since COH carries a binding site for cytochrome c in the respiratory chain, and since it is required for the passage of chain electrons to molecular oxygen, driving the production of ATP, we hypothesized that metabolic dysfunction resulting from TBI alters COII gene expression directly, perhaps influencing the synaptic plasticity that occurs during postinjury recovery processes. To test this hypothesis, we documented COII mRNA expression and complex IV (cytochrome c oxidase) functional activity at 7 days postinjury, focusing on the long-term postinjury period most closely associated with synaptic reorganization. Both central fluid percussion TBI and combined TBI and bilateral entorhinal cortical lesion were examined. At 7 days survival, differential display, RT-PCR, and Northern blot analysis of hippocampal RNA from both TBI and combined insult models showed a significant induction of COII mRNA. This long-term elevation in COII gene expression was supported by increases in COII immunobinding. By contrast, cytochrome oxidase histochemical activity within tissue sections from injured brains suggested a reduction of complex IV activity within the TBI cases, but not within animals subjected to the combined insult. These differences in cytochrome c oxidase activity were supported by in vitro assay of complex IV using cerebral cortical and hippocampal tissues. Our present results support the hypothesis that COH is selectively vulnerable to TBI and that COII differences may indicate the degree of metabolic dysfunction induced by different pathologies. Taken together, such data will better define the role of metabolic function in long-term recovery after TBI.	Virginia Commonwealth Univ, MCV Stn, Dept Anat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Div Neurosurg, Richmond, VA 23298 USA		Harris, LK (corresponding author), Virginia Commonwealth Univ, MCV Stn, Dept Anat, 1217 E Marshall St Rm 7-36,POB 980709, Richmond, VA 23298 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587, R01NS020193] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 20193, NS 12587] Funding Source: Medline		Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; BAUDRY M, 1982, SCIENCE, V216, P411, DOI 10.1126/science.7071588; BENNETT MC, 1992, BEHAV NEURAL BIOL, V58, P72, DOI 10.1016/0163-1047(92)90967-9; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; BOROWSKY IW, 1989, NEUROSCIENCE, V33, P253, DOI 10.1016/0306-4522(89)90204-2; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; CHAN PH, 1992, J NEUROTRAUM, V9, pS417; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; Chandrasekaran K, 1998, BRAIN RES, V796, P13, DOI 10.1016/S0006-8993(98)00248-0; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CHOI DW, 1987, J NEUROSCI, V7, P357; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; DUGAN LL, 1995, J NEUROSCI, V15, P6377; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FUKUHARA T, 1994, BRAIN RES, V657, P333, DOI 10.1016/0006-8993(94)90987-3; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Harris L. K., 1998, Society for Neuroscience Abstracts, V24, P739; HARRIS LK, 1997, J NEUROTRAUM, V14, P794; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEALES SJR, 1995, NEUROCHEM RES, V20, P31; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Inokuchi K, 1996, BIOCHEM BIOPH RES CO, V221, P430, DOI 10.1006/bbrc.1996.0612; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Jiang XB, 1999, NEUROL MED-CHIR, V39, P649, DOI 10.2176/nmc.39.649; KAGEYAMA GH, 1988, J COMP NEUROL, V278, P521, DOI 10.1002/cne.902780405; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Keppel G., 1991, DESIGN ANAL RES HDB; Kitahara T, 1996, NEUROL RES, V18, P329; LAND PW, 1987, J COMP NEUROL, V262, P78, DOI 10.1002/cne.902620107; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MELLGREN SI, 1967, Z ZELLFORSCH MIK ANA, V78, P167, DOI 10.1007/BF00334762; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MJAATVEDT AE, 1988, J COMP NEUROL, V277, P155, DOI 10.1002/cne.902770202; NELSON C, 1994, PEDIATR RES, V36, P12, DOI 10.1203/00006450-199407001-00003; Norusis, 1993, SPSS WINDOWS ADV STA; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; OKONKWO DO, 1999, J CEREB BLOOD FLOW M, V19, P332; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; STEWARD O, 1973, BRAIN RES, V54, P65, DOI 10.1016/0006-8993(73)90034-6; Tzagoloff, 1967, METHOD ENZYMOL, V10, P245; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WAGNER KR, 1990, J NEUROL SCI, V100, P142, DOI 10.1016/0022-510X(90)90025-I; WongRiley MTT, 1997, NEUROSCIENCE, V76, P1035, DOI 10.1016/S0306-4522(96)00410-1; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; [No title captured]	63	43	45	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2001	18	10					993	1009		10.1089/08977150152693692			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	484NG	WOS:000171696000003	11686499				2022-02-06	
J	Cristofori, L; Tavazzi, B; Gambin, R; Vagnozzi, R; Vivenza, C; Amorini, AM; Di Pierro, D; Fazzina, G; Lazzarino, G				Cristofori, L; Tavazzi, B; Gambin, R; Vagnozzi, R; Vivenza, C; Amorini, AM; Di Pierro, D; Fazzina, G; Lazzarino, G			Early onset of lipid peroxidation after human traumatic brain injury: A fatal limitation for the free radical scavenger pharmacological therapy?	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article						human traumatic brain injury; reactive oxygen species; lipid peroxidation; malondialdehyde; cerebrospinal fluid	SEVERE HEAD-INJURY; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID; ENERGY-METABOLISM; RATS; MALONDIALDEHYDE; MULTICENTER; ISCHEMIA; TRIAL	Background: On the basis of the contradiction between data on experimental head trauma showing oxidative stress-mediated cerebral tissue damage and failure of the majority of clinical trials using free radical scavenger drugs, we monitored the time-course changes of malondialdehyde (MDA, an index of cell lipid peroxidation), ascorbate, and dephosphorylated ATP catabolites in cerebrospinal fluid (CSF) of traumatic brain-injured patients. Methods: CSF samples were obtained from 20 consecutive patients suffering from severe brain injury. All patients were comatose, with a Glasgow Coma Scale on admission of 6 +/-1. The first CSF sample for each patient was collected within a mean value of 2.95 hours from trauma (SD=1.98), after the insertion of a ventriculostomy catheter for the continuous monitoring of intracranial pressure. During the next 48 hours, CSF was withdrawn from each patient once every 6 hours. All samples were analyzed by an ion-pairing high-performance liquid chromatographic method for the simultaneous determination of MDA, ascorbic acid, hypoxanthine, xanthine, uric acid, inosine, and adenosine. Results: In comparison with values recorded in 10 herniated-lumbar-disk, noncerebral control patients, data showed that all CSF samples of brain-injured patients had high values (0.226 mu moL/1,; SD=0.196) of MDA (undetectable in samples of control patients) and decreased ascorbate levels (96.25 mu mol/L; SD=31.74), already at the time of first withdrawal at the time of hospital admission. MDA was almost constant in the next two withdrawals and tended to decrease thereafter, although 48 hours after hospital admission, a mean level of 0.072 mu mol/L CSF (SD=0.026) was still recorded. The ascorbate level was normalized 42 hours after hospital admission. Changes in the CSF values of ATP degradation products (oxypurines and nucleosides) suggested a dramatic alteration of neuronal energy metabolism after traumatic brain injury. Conclusions: On the whole, these data demonstrate the early onset of oxygen radical-mediated oxidative stress, proposing a valid explanation for the failure of clinical trials based on the administration of oxygen free radical scavenger drugs and suggesting a possible rationale for testing the efficacy of lipid peroxidation "chain breakers" in future clinical trials.	Univ Catania, Biochem Lab, Dept Chem Sci, I-95125 Catania, Italy; Univ Roma Tor Vergata, Dept Neurosci, Chair Neurosurg, Rome, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy; Univ Hosp Verona, Dept Neurosurg, Verona, Italy		Lazzarino, G (corresponding author), Univ Catania, Biochem Lab, Dept Chem Sci, Viale A Doria 6, I-95125 Catania, Italy.		TAVAZZI, BARBARA/AAB-9830-2019; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; AMORINI, Angela Maria/0000-0003-3525-9955; lazzarino, giuseppe/0000-0002-5917-7279			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Ammar RF, 2000, CARDIOVASC RES, V47, P595, DOI 10.1016/S0008-6363(00)00094-8; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Calabrese V, 1998, DRUG EXP CLIN RES, V24, P125; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; GIARDINA B, 1993, AM J CARDIOL, V71, P788, DOI 10.1016/0002-9149(93)90825-W; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; HAMVAS A, 1992, J APPL PHYSIOL, V72, P621, DOI 10.1152/jappl.1992.72.2.621; JENNETT B, 1975, LANCET, V1, P480; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; LAZZARINO G, 1994, CIRCULATION, V90, P291, DOI 10.1161/01.CIR.90.1.291; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soto-Otero R, 2000, J NEUROCHEM, V74, P1605, DOI 10.1046/j.1471-4159.2000.0741605.x; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Tavazzi B, 1998, FREE RADICAL RES, V28, P25, DOI 10.3109/10715769809097873; Tavazzi B, 2000, EUR J BIOCHEM, V267, P684, DOI 10.1046/j.1432-1327.2000.01042.x; THOM SR, 1991, FREE RADICAL BIO MED, V10, P413, DOI 10.1016/0891-5849(91)90050-D; Treitinger A, 2000, EUR J CLIN INVEST, V30, P454; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Wang YX, 2000, NEUROBIOL AGING, V21, P525, DOI 10.1016/S0197-4580(00)00114-7; Watson BD, 1998, CELL MOL NEUROBIOL, V18, P581, DOI 10.1023/A:1020209616428; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	34	43	45	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1081-5589			J INVEST MED	J. Invest. Med.	SEP	2001	49	5					450	458		10.2310/6650.2001.33790			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	464QQ	WOS:000170543600010	11523701				2022-02-06	
J	Finnie, JW				Finnie, JW			Animal models of traumatic brain injury: a review	AUSTRALIAN VETERINARY JOURNAL			English	Article						animal models; traumatic brain injury; neuropathology	DIFFUSE AXONAL INJURY; HEAD-INJURY; CEREBRAL CONCUSSION; CHILDREN; IMPACT; LAMBS; SHEEP; AGE	Objective To review the main types of animal models of traumatic brain injury (TBI), their desirable characteristics and limitations, the major structural changes in the brain modelled, and special features of paediatric TBI modelling. Conclusion Animal models have contributed substantially to our understanding of the mechanisms of TBI in humans, but many aspects of closed head injury remain to be elucidated and effective neuroprotective agents are few. Many of the advances in the pathogenesis of human TBI also have application in veterinary medicine and there is ample opportunity for veterinarians to contribute to the selection, development and characterisation of potential animal models of neurotrauma and other disorders and ensure that animal welfare standards are maintained.	Inst Med & Vet Sci, Vet Serv Div, Gilles Plains, SA 5086, Australia		Finnie, JW (corresponding author), Inst Med & Vet Sci, Vet Serv Div, 101 Blacks Rd, Gilles Plains, SA 5086, Australia.						Adams J. H., 1982, HEAD INJURY BASIC CL, P141; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; ANDERSON TE, 1996, NEUROTRAUMA, P1357; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; DELAHUNTA A, 1983, VET NEUROANATOMY CLI, P356; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DOBBING J, 1981, SCI FDN PAEDIAT, P745; DUHAIME AC, 1999, TRAUMATIC BRAIN INJU, P257; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; FEARNSIDE MR, 1997, HEAD INJURY PATHOPHY, P3; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2001, J COMP PATHOL, V124, P159, DOI 10.1053/jcpa.2000.0446; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1985, CENTRAL NERVOUS SYST, P392; Graham D.I., 1996, NEUROTRAUMA, P43; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; Jubb KVF, 1993, PATHOLOGY DOMESTIC A, P267; Kochanek PM, 1999, TRAUMATIC BRAIN INJU, P233; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; MURPHY EJ, 1994, NEUROBIOLOGY CENTRAL, P216; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, HEAD INJURY C P, P3211; Povlishock J.T., 1994, NEUROBIOLOGY CENTRAL, P109; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT., 1996, NEUROTRAUMA, P1325; Rajtova V, 1976, Gegenbaurs Morphol Jahrb, V122, P927; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SHAPIRO K, 1993, HEAD INJURY, P427; SUMMERS BA, 1995, VET NEUROPATHOLOGY, P15; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; Ward JD, 1996, NEUROTRAUMA, P859	44	43	46	1	13	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0005-0423			AUST VET J	Aust. Vet. J.	SEP	2001	79	9					628	633		10.1111/j.1751-0813.2001.tb10785.x			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	475EB	WOS:000171148200036	11702936				2022-02-06	
J	Schwab, JM; Seid, K; Schluesener, HJ				Schwab, JM; Seid, K; Schluesener, HJ			Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats	JOURNAL OF NEUROTRAUMA			English	Article						bystander damage; inflammation; prostaglandin; tissue remodeling	SPINAL-CORD INJURY; CEREBRAL-ISCHEMIA; GENE DISRUPTION; EFFECTOR-CELLS; IN-VIVO; INFLAMMATION; COX-1; DIFFERENTIATION; DISEASE; GLIOMA	Inflammatory cellular responses to brain injury are promoted by proinflammatory messengers. Cyclooxygenases (prostaglandin endoperoxide H synthases [PGH]) are key enzymes in the conversion of arachidonic acid into prostanoids, which mediate immunomodulation, mitogenesis, apoptosis, blood flow, secondary injury (lipid peroxygenation), and inflammation. Here, we report COX-1 expression following brain injury. In control brains, COX-1 expression was localized rarely to brain microglia/macrophages. One to 5 days after injury, we observed a highly significant (P < 0.0001) increase in COX-1(+) microglia/macrophages at perilesional areas and in the developing core with a delayed culmination of cell accumulation at day 7, correlating with phagocytic activity. There, cell numbers remained persistently elevated up to 21 days following injury. Further, COX-1(+) cells were located in perivascular Virchow-Robin spaces also reaching maximal numbers at day 7. Lesion-confined COX-1(+) vessels increased in numbers from day 1, reaching the maximum at days 5-7. Double-labeling experiments confirmed coexpression of COX-1 by ED-1(+) and OX-42(+) microglia/ macrophages. Transiently after injury, most COX-1(+) microglia/macrophages coexpress the activation antigen OX-6 (MHC class II). However, the prolonged accumulation of COX-1(+), ED-1(+) microglia/macrophages in lesional areas enduring the acute postinjury inflammatory response points to a role of COX-1 in the pathophysiology of secondary injury. We have identified localized, accumulated COX-1 expression as a potential pharmacological target in the treatment of brain injury. Our results suggest that therapeutic approaches based on long-term blocking including COX-1, might be superior to selective COX-2 blocking to suppress the local synthesis of prostanoids.	Univ Tubingen, Sch Med, Inst Brain Res, D-72076 Tubingen, Germany		Schwab, JM (corresponding author), Univ Tubingen, Sch Med, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.			Schwab, Jan/0000-0001-6784-4919			Becher B, 1996, GLIA, V18, P1; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Deininger MH, 1999, J NEUROIMMUNOL, V95, P202, DOI 10.1016/S0165-5728(98)00257-4; Deininger MH, 1999, ACTA NEUROPATHOL, V98, P240, DOI 10.1007/s004010051075; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GUILIAN D, 1993, GLIA, V7, P102; HALL ED, 1996, NEUROTRAUMA, P1405; HOFF T, 1993, FEBS LETT, V320, P38, DOI 10.1016/0014-5793(93)81653-H; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Kaplan MD, 1997, J BIOL CHEM, V272, P18534, DOI 10.1074/jbc.272.30.18534; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; MATSUO M, 1995, BRAIN RES, V685, P201, DOI 10.1016/0006-8993(95)00490-H; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Nogawa S, 1997, J NEUROSCI, V17, P2746; Perry V H, 1992, Curr Opin Neurobiol, V2, P679, DOI 10.1016/0959-4388(92)90038-M; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Roller A, 1999, BIOCHEM BIOPH RES CO, V259, P600, DOI 10.1006/bbrc.1999.0825; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; SANDERS KM, 1978, AM J PHYSIOL, V234, pE209, DOI 10.1152/ajpendo.1978.234.2.E209; Schwab JM, 2000, ACTA NEUROPATHOL, V99, P609, DOI 10.1007/s004010051170; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shillabeer G, 1998, METABOLISM, V47, P461, DOI 10.1016/S0026-0495(98)90060-9; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; WILBERGER JE, 1996, NEUROTRAUMA, P1219; Williams CS, 1996, AM J PHYSIOL, V270, P393; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003	48	43	44	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2001	18	9					881	890		10.1089/089771501750451802			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	471TP	WOS:000170945000004	11565600				2022-02-06	
J	Server, A; Dullerud, R; Haakonsen, M; Nakstad, PH; Johnsen, ULH; Magnaes, B				Server, A; Dullerud, R; Haakonsen, M; Nakstad, PH; Johnsen, ULH; Magnaes, B			Post-traumatic cerebral infarction - Neuroimaging findings, etiology and outcome	ACTA RADIOLOGICA			English	Article						brain injuries; cerebral infarction; carotid artery dissection; CT; MR imaging; angiography; comparative investigation	CAROTID-ARTERY DISSECTION; ISCHEMIC BRAIN-DAMAGE; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; ANGIOGRAPHIC FINDINGS; EARLY DIAGNOSIS; CT; HERNIATION; THERAPY; BLOOD	Purpose. To assess the radiological characteristics of post-traumatic cerebral infarctions (PTCIs), the etiology and site of infarction, and to provide neuroimaging indicators of a poor clinical outcome. Material and Methods. A retrospective study of 16 patients with the neuroimaging-based diagnosis of PTCI was carried out. Ah CT, MR examinations, cerebral angiograms and medical records of the patients were reviewed. Results: Infarcts were diagnosed in the territory of the posterior cerebral artery in 9 patients, in the middle cerebral artery in 5, in the anterior cerebral artery in 3, lenticulostriate-thalamoperforating in 2, vertebrobasilar in 3, and cortical infarcts in 2 patients. Neuroimaging studies suggested focal mass effect and/or acquired intracranial herniations as the cause of infarction in 13/16 patients (81.2%). In 3/16 patients (18.8%), PTCI was due to vascular injury of which 2 were angiographically documented (carotid artery dissection). Eight of the 16 patients in this study died or were left in a persistent vegetative state. Patients with associated subdural hematoma, brain swelling/edema and traumatic subarachnoid hemorrhage (tSAH) exhibited the worst outcome. Conclusion. Gross mechanical shift of the brain and herniation across the fair and/or tentorium accounted for infarction in a majority of cases in our study. The overall death rate was 43.8% and this result suggests that PTCI is an indication of a poor clinical outcome, especially among patients with associated subdural hematoma, brain swelling/edema and tSAH.	Univ Oslo, Ulleval Hosp, Div Radiol, Dept Neuroradiol, N0-0407 Oslo, Norway; Aker Hosp, Dept Radiol, Oslo, Norway; Natl Hosp Oslo, Dept Neuroradiol, Oslo, Norway; Univ Oslo, Ulleval Hosp, Dept Neurosurg, N0-0407 Oslo, Norway		Server, A (corresponding author), Univ Oslo, Ulleval Hosp, Div Radiol, Dept Neuroradiol, N0-0407 Oslo, Norway.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERMAN SA, 1984, AM J ROENTGENOL, V142, P1035, DOI 10.2214/ajr.142.5.1035; BERMAN SA, 1980, AM J NEURORADIOL, V1, P259; BUI LN, 1993, STROKE, V24, P126, DOI 10.1161/01.STR.24.1.126; DANIEL W, 1995, BIOSTATISTICS FDN AN; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; FERNANDEZFRESNO LF, 1997, RADIOLOGIA, V39, P545; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gentry LR., 1996, MAGNETIC RESONANCE I, P611; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HART RG, 1983, NEUROL CLIN N AM, V1, P255; HOSOYA T, 1996, JAPAN RAD MED, V14, P241; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KEARNE JR, 1986, ANN NEUROL, V8, P186; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; Laitt RD, 1996, CLIN RADIOL, V51, P117, DOI 10.1016/S0009-9260(96)80268-6; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Macmillan CSA, 1999, NEUROSURGERY, V45, P188, DOI 10.1097/00006123-199907000-00047; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MIRVIS SE, 1990, AJNR, V11, P335; MORGAN MK, 1987, J NEUROSURG, V66, P192, DOI 10.3171/jns.1987.66.2.0192; Mulloy JP, 1998, RADIOLOGY, V207, P571, DOI 10.1148/radiology.207.3.9609876; Osborn AG, 1991, NEUORIMAGING CLIN N, V1, P461; OSBORN AG, 1996, HDB NEURORADIOLOGY B, P198; OSULLIVAN RM, 1990, AM J NEURORADIOL, V11, P1150; Ozdoba C, 1996, RADIOLOGY, V199, P191, DOI 10.1148/radiology.199.1.8633145; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; REICH JB, 1993, ANN NEUROL, V33, P159, DOI 10.1002/ana.410330205; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SALAMON G, 1976, RADIOLOGIC ANATOMY B, P48; SATO M, 1986, NEUROSURGERY, V18, P300, DOI 10.1227/00006123-198603000-00007; SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604; SMIRNIOTOPOULOS JG, 1992, IMAGING TRAUMA CRITI, P23; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TAVERAS JM, 1976, CEREBRAL ANGIOGRAPHY, V2, P543; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; WEISBERG LA, 1979, COMPUT TOMOGR, V3, P15, DOI 10.1016/0363-8235(75)90004-6	45	43	48	0	4	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0284-1851			ACTA RADIOL	Acta Radiol.	MAY	2001	42	3					254	260					7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	435WZ	WOS:000168906300002	11350282				2022-02-06	
J	Vibert, N; MacDougall, HG; de Waele, C; Gilchrist, DPD; Burgess, AM; Sidis, A; Migliaccio, A; Curthoys, IS; Vidal, PP				Vibert, N; MacDougall, HG; de Waele, C; Gilchrist, DPD; Burgess, AM; Sidis, A; Migliaccio, A; Curthoys, IS; Vidal, PP			Variability in the control of head movements in seated humans: a link with whiplash injuries?	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							RAPID POSTURAL RESPONSES; NECK MUSCLES; ACCIDENT MECHANISMS; RANDOM ROTATIONS; VERTICAL PLANE; STABILIZATION; PERTURBATIONS; PATTERNS; ACTIVATION; ORGANIZATION	1. The aim of this study was to determine how context and on-line sensory information are combined to control posture in seated subjects submitted to high-jerk, passive linear accelerations. Subjects were seated with eyes closed on a servo-controlled linear sled. They were asked to relax and received brief accelerations either sideways or in the fore-aft direction. The stimuli had an abrupt onset, comparable to the jerk experienced during a minor car collision. 2. notation and translation of the head and body were measured using an Optotrak system. In some of the subjects, surface electromyographic (EMG) responses of selected neck and/or back muscles were recorded simultaneously. For each subject, responses were highly stereotyped from the first trial, and showed little sign of habituation or sensitisation. 3. Comparable results were obtained with sideways and fore-aft accelerations. During each impulse, the head lagged behind the trunk for several tens of milliseconds. The subjects' head movement responses were distributed as a continuum in between two extreme categories. The 'stiff' subjects showed little rotation or translation of the head relative to the trunk for the whole duration of the impulse. In contrast, the 'floppy' subjects showed a large roll or pitch of the head relative to the trunk in the direction opposite to the sled movement. This response appeared as an exaggerated 'inertial' response to the impulse. 4. Surface EMG recordings showed that most of the stiff subjects were not contracting their superficial neck or back muscles. We think they relied on bilateral contractions of their deep, axial musculature to keep the head-neck ensemble in line with the trunk during the movement. 5. About half of the floppy subjects displayed reflex activation of the neck muscles on the side opposite to the direction of acceleration, which occurred before or during the head movement and tended to exaggerate it. The other floppy subjects seemed to rely on only the passive biomechanical properties of their head-neck ensemble to compensate for the perturbation. 6. In our study, proprioception was the sole source of sensory information as long as the head did not move. We therefore presume that the EMG responses and head movements we observed were mainly triggered by the activation of stretch receptors in the hips, trunk and/or neck. 7. The visualisation of an imaginary reference in space during sideways impulses significantly reduced the head roll exhibited by floppy subjects. This suggests that the adoption by the central nervous system of an extrinsic, 'allocentric' frame of reference instead of an intrinsic, 'egocentric' one may be instrumental for the selection of the stiff strategy. 8. The response of floppy subjects appeared to be maladaptive and likely to increase the risk of whiplash injury during motor vehicle accidents. Evolution of postural control may not have taken into account the implications of passive, high-acceleration perturbations affecting seated subjects.	CNRS, Lab Neurobiol Reseaux Sensorimoteurs, ESA 7060, F-75270 Paris 06, France; Univ Sydney, Dept Psychol, Vestibular Res Lab, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Eye & Ear Res Unit, Camperdown, NSW 2050, Australia		Vibert, N (corresponding author), CNRS, Lab Neurobiol Reseaux Sensorimoteurs, ESA 7060, 45 Rue St Peres, F-75270 Paris 06, France.		Migliaccio, Americo/A-5791-2013; Curthoys, Ian/ABE-6627-2021	MacDougall, Hamish/0000-0001-6201-1707; Curthoys, Ian/0000-0002-9416-5038; Migliaccio, Americo/0000-0001-8547-6590			ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Allum JHJ, 1998, EXP BRAIN RES, V121, P478, DOI 10.1007/s002210050484; Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; ALLUM JHJ, 1985, EXP BRAIN RES, V58, P82; ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; AZZENA GB, 1978, ARCH ITAL BIOL, V116, P120; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Burleigh A, 1996, J NEUROPHYSIOL, V75, P1619, DOI 10.1152/jn.1996.75.4.1619; Castro W H, 1997, Eur Spine J, V6, P366, DOI 10.1007/BF01834062; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Corna S, 1996, J PHYSIOL-LONDON, V496, P589, DOI 10.1113/jphysiol.1996.sp021710; CREMIEUX J, 1994, PERCEPT MOTOR SKILL, V78, P67, DOI 10.2466/pms.1994.78.1.67; Davis CG, 1998, J MANIP PHYSIOL THER, V21, P629; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; Freeman MD, 1999, SPINE, V24, P86, DOI 10.1097/00007632-199901010-00022; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Grauer JN, 1997, SPINE, V22, P2489, DOI 10.1097/00007632-199711010-00005; GRESTY M, 1989, MOVEMENT DISORD, V4, P233, DOI 10.1002/mds.870040305; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Harm D L, 1993, J Vestib Res, V3, P297; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HUELKE DF, 1981, J NEUROSURG, V54, P316, DOI 10.3171/jns.1981.54.3.0316; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Ito Y, 1997, EXP BRAIN RES, V117, P266, DOI 10.1007/s002210050221; Kanaya T, 1995, J PHYSIOL-LONDON, V489, P895, DOI 10.1113/jphysiol.1995.sp021102; Kaneoka K, 1999, SPINE, V24, P763, DOI 10.1097/00007632-199904150-00006; KESHNER EA, 1995, J NEUROPHYSIOL, V73, P2293, DOI 10.1152/jn.1995.73.6.2293; KESHNER EA, 1989, EXP BRAIN RES, V75, P335; KESHNER EA, 1995, J NEUROPHYSIOL, V73, P2302, DOI 10.1152/jn.1995.73.6.2302; Keshner EA, 2000, GAIT POSTURE, V11, P1, DOI 10.1016/S0966-6362(99)00046-6; KESHNER EA, 1988, EXP BRAIN RES, V71, P455, DOI 10.1007/BF00248739; KRAFFT M, 1998, P 16 INT TECHN C ENH; KULLGREN A, 1995, ACCIDENT ANAL PREV, V27, P717, DOI 10.1016/0001-4575(95)00025-U; Kuo AD, 1998, EXP BRAIN RES, V122, P185, DOI 10.1007/s002210050506; Luyat M, 1997, ACTA PSYCHOL, V95, P181, DOI 10.1016/S0001-6918(96)00015-7; Magnusson ML, 1999, EUR SPINE J, V8, P118, DOI 10.1007/s005860050140; MayouxBenhamou MA, 1997, EXP BRAIN RES, V113, P353, DOI 10.1007/BF02450333; MAZZINI L, 1992, ELECTROEN CLIN NEURO, V85, P183, DOI 10.1016/0168-5597(92)90131-T; MORRIS AP, 1996, P 40 STAPP CAR C; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; Richter M, 1999, ORTHOPADE, V28, P414, DOI 10.1007/PL00003625; Runge CF, 1998, EXP BRAIN RES, V122, P403, DOI 10.1007/s002210050528; RYAN GA, 1993, MED J AUSTRALIA, V159, P651, DOI 10.5694/j.1326-5377.1993.tb138078.x; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; STURZENEGGER M, 1995, J NEUROL, V242, P443, DOI 10.1007/BF00873547; Thomson DB, 1996, EXP BRAIN RES, V110, P392; Versteegen G J, 1998, Eur Spine J, V7, P195, DOI 10.1007/s005860050055; VIDAL PP, 1982, AVIAT SPACE ENVIR MD, V53, P166; VIDAL PP, 1999, P INT C VIS VERS VES; VIVIANI P, 1975, BIOL CYBERN, V19, P19, DOI 10.1007/BF00319778; Wilson VJ, 1999, EXP BRAIN RES, V129, P483, DOI 10.1007/s002210050918; WINTERS JM, 1990, MULTIPLE MUSCLE SYST, P00461	56	43	43	0	6	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	MAY 1	2001	532	3					851	868		10.1111/j.1469-7793.2001.0851e.x			18	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	432ED	WOS:000168678500023	11313451	Bronze, Green Published			2022-02-06	
J	Drescher, W; Schneider, T; Becker, C; Hobolth, J; Ruther, W; Hansen, ES; Bunger, C				Drescher, W; Schneider, T; Becker, C; Hobolth, J; Ruther, W; Hansen, ES; Bunger, C			Selective reduction of bone blood flow by short-term treatment with high-dose methylprednisolone - An experimental study in pigs	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							STEROID-RELATED COMPLICATIONS; FEMORAL-HEAD; CYCLOSPORINE ERA; OSTEONECROSIS; NECROSIS; RABBITS	Treatment with corticosteroids is a risk factor for non-traumatic avascular necrosis of the femoral head, but the pathological mechanism is poorly understood, Short-term treatment with high doses of methylprednisolone is used in severe neurotrauma and after kidney and heart transplantation. We investigated the effect of such treatment on the pattern of perfusion of the femoral head and of bone in general in the pig, We allocated 15 immature pigs to treatment with high-dose methylprednisolone (20 mg/kg per day intramuscularly for three days, followed by 10 mg/kg intramuscularly for a further II days) and 15 to a control group. Perfusion of the systematically subdivided femoral head, proximal femur, acetabulum, humerus, and soft tissues was determined by the microsphere technique, Blood flow in bone was severely reduced in the steroid-treated group. The reduction of flow affected all the segments and the entire epiphysis of the femoral head. No changes in flow were found in non-osseous tissue, Short-term treatment with high-dose methylprednisolone causes reduction of osseous blood flow which may be the pathogenetic Factor in the early stage of steroid-induced osteonecrosis.	Aarhus Univ Hosp, DK-8000 Aarhus, Denmark		Drescher, W (corresponding author), Aarhus Univ, Dept Orthopaed, DK-8000 Aarhus C, Denmark.						BRADBURY G, 1994, J BONE JOINT SURG AM, V76A, P1385, DOI 10.2106/00004623-199409000-00014; BUNGER C, 1989, T ORS, P422; COOPER RR, 1966, J BONE JOINT SURG AM, VA 48, P1239, DOI 10.2106/00004623-196648070-00001; Cui Q, 1997, J BONE JOINT SURG AM, V79A, P1054, DOI 10.2106/00004623-199707000-00012; FRYER JP, 1994, CLIN TRANSPLANT, V8, P224; FRYER JP, 1994, TRANSPL P, V26, P91; Glueck CJ, 1998, CLIN ORTHOP RELAT R, P159; Glueck CJ, 1997, CLIN ORTHOP RELAT R, P43; GLUECK CJ, 1994, AM J HEMATOL, V45, P156, DOI 10.1002/ajh.2830450212; HANSEN ES, 1991, ACTA ORTHOP SCAND, V62, P268, DOI 10.3109/17453679108993608; Hirano K, 1997, CLIN ORTHOP RELAT R, P192; LANDMANN J, 1987, J BONE JOINT SURG AM, V69A, P1226, DOI 10.2106/00004623-198769080-00017; LAUSTEN GS, 1993, ACTA ORTHOP SCAND, V64, P533, DOI 10.3109/17453679308993686; Liesner RJ, 1999, J BONE JOINT SURG BR, V81B, P565, DOI 10.1302/0301-620X.81B4.0810565a; Nishimura T, 1997, CLIN ORTHOP RELAT R, P37; REMAGEN W, 1990, ORTHOPADE, V19, P174; SPENCER JD, 1988, CLIN ORTHOP RELAT R, P127; STERN PJ, 1979, J BONE JOINT SURG AM, V61, P851, DOI 10.2106/00004623-197961060-00008; Thomas DP, 1999, J BONE JOINT SURG BR, V81B, P691, DOI 10.1302/0301-620X.81B4.9438; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; WANG GJ, 1981, CLIN ORTHOP RELAT R, P274; WANG GJ, 1985, J BONE JOINT SURG AM, V67A, P121, DOI 10.2106/00004623-198567010-00015; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119	24	43	46	0	3	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	MAR	2001	83B	2					274	277		10.1302/0301-620X.83B2.10323			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	415UM	WOS:000167742000025	11284580				2022-02-06	
J	Gutierrez, E; Huang, YL; Haglid, K; Bao, F; Hansson, HA; Hamberger, A; Viano, D				Gutierrez, E; Huang, YL; Haglid, K; Bao, F; Hansson, HA; Hamberger, A; Viano, D			A new model for diffuse brain injury by rotational acceleration: I model, gross appearance, and astrocytosis	JOURNAL OF NEUROTRAUMA			English	Article						astrocytosis; biomechanics; head impact; rotational acceleration; subarachnoid hemorrhage; traumatic brain injury	AXONAL INJURY; BIOMECHANICS; DAMAGE; RATS	Rapid head rotation is a major cause of brain damage in automobile crashes and falls, This report details a new model for rotational acceleration about the center of mass of the rabbit head. This allows the study of brain injury without translational acceleration of the head. Impact from a pneumatic cylinder was transferred to the skull surface to cause a half-sine peak acceleration of 2.1 x 10(5) rad/s(2) and 0.96-ms pulse duration. Extensive subarachnoid hemorrhages and small focal bleedings were observed in the brain tissue. A pronounced reactive astrogliosis was found 8-14 days after trauma, both as networks around the focal hemorrhages and more diffusely in several brain regions. Astrocytosis was prominent in the gray matter of the cerebral cortex, layers II-V, and in the granule cell layer and around the axons of the pyramidal neurons in the hippocampus. The nuclei of cranial nerves, such as the hypoglossal and facial nerves, also showed intense astrocytosis. The new model allows study of brain injuries from head rotation in the absence of translational influences.	Univ Gothenburg, Dept Anat & Cell Biol, SE-40530 Gothenburg, Sweden; Chalmers Univ Technol, Crash Safety Div, S-41296 Gothenburg, Sweden; Saab Automobile AB, Trollhattan, Sweden; China Med Univ, Brain Res Inst, Shenyang, Peoples R China		Hamberger, A (corresponding author), Univ Gothenburg, Dept Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.		Farewik, Elena M. Gutierrez/AAU-9832-2020; Gutierrez-Farewik, Elena/G-6945-2012; Farewik, Elena M Gutierrez/I-6842-2018	Farewik, Elena M. Gutierrez/0000-0001-5417-5939; Gutierrez-Farewik, Elena/0000-0001-5417-5939; Farewik, Elena M Gutierrez/0000-0001-5417-5939			Anderson R., 1997, P INT IRCOBI C BIOM, P181; CORETZ SC, 1989, BRAIN RES, V482, P271; Ding M, 2000, NEUROCHEM INT, V36, P313, DOI 10.1016/S0197-0186(99)00139-4; *ESTC, 1997, STRAT ROAD SAF PLAN; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Goldsmith W, 1984, BIOMECHANICS IMPACT, P149; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Holbourn AHS, 1943, LANCET, V2, P438; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; LIGTHLL JW, 1988, J NEUROTRAUM, V5, P1; LOWENHIELM P, 1978, J BIOENG, V2, P501; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1985, IRCOBI C GOT SWED; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Melvin J.W., 1993, ACCIDENTAL INJURY BI, P268; OMMAYA AK, 1984, BIOMECHANICS IMPACT, P117; OMMAYA AK, 1967, P 11 STAPP CAR CRASH, P73; PINCEMAILLE Y, 1989, STAPP CAR CRASH C, P177; POPESKI P, 1992, COLOUR ATLAS ANATOMY; ROSENGREN LE, 1986, BRIT J IND MED, V43, P291; SJOSTRAND J, 1965, Z ZELLFORSCH MIK ANA, V68, P481, DOI 10.1007/BF00347712; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; UNTERHARNSCHEIDT F, 1969, TEX REP BIOL MED, V27, P127; VIANO DC, 1997, THESIS KAROLINSKA I; VIANO DC, 1986, P 30 STAPP CAR CRASH, P269; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; YANG QN, 1995, BRAIN RES, V696, P49, DOI 10.1016/0006-8993(95)00755-F; 1971, FR, V36, P4600	32	43	46	2	7	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2001	18	3					247	257		10.1089/08977150151070874			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	414EM	WOS:000167653000003	11284546				2022-02-06	
J	Prueckner, S; Safar, P; Kentner, R; Stezoski, J; Tisherman, SA				Prueckner, S; Safar, P; Kentner, R; Stezoski, J; Tisherman, SA			Mild hypothermia increases survival from severe pressure-controlled hemorrhagic shock in rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	13th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 10-15, 2000	SANIBEL, FL	Eastern Assoc Surg Trauma		hypothermia; rat model; fluid resuscitation; hemorrhage; hemorrhagic shock; hypotension; outcome; survival	TRAUMATIC BRAIN INJURY; CARDIAC-ARREST; MODERATE HYPOTHERMIA; OUTCOME MODEL; POSTTRAUMATIC HYPOTHERMIA; PROLONGS SURVIVAL; BODY-TEMPERATURE; RESUSCITATION; DOGS; OXYGEN	Background: In previous studies, mild hypothermia (34 degreesC) during uncontrolled hemorrhagic shock (HS) increased survival. Hypothermia also increased mean arterial pressure (MAP), which may have contributed to its beneficial effect, We hypothesized that hypothermia would improve survival in a pressure-controlled HS model and that prolonged hypothermia would further Improve survival, Methods: Thirty rats were prepared under light nitrous oxide/halothane anesthesia with spontaneous breathing, The rats underwent HS with an initial blood withdrawal of 2 mL/100 g over 10 minutes and pressure-controlled IIS at a MAP of 40 mm Ng over 90 minutes (without anticoagulation), followed by return of shed blood and additional lactated Ringer's solution to achieve normotension, Hemodynamic monitoring and anesthesia were continued to 1 hour, temperature control to 12 hours, and observation without anesthesia to 72 hours. After HS of 15 minutes, 10 rats each were randomized to group 1, with normothermia (38 degreesC) throughout; group 2, with brief mild hypothermia (34 degreesC during HS 15-90 minutes plus 30 minutes after reperfusion); and group 3, with prolonged mild hypothermia (same as group 2, then 35 degreesC [possible without shivering] from 30 minutes after reperfusion to 12 hours). Results: MAP during HS and initial resuscitation was the same in all three groups, but was higher in the hypothermia groups 2 and 3, compared with the normothermia group 1, at 15 and 60 minutes after reperfusion, Group 1 required less blood withdrawal to maintain MAP 40 mm Hg during HS and more lactated Ringer's solution for resuscitation, At end of IIS, lactate levels were higher in group 1 than in groups 2 and 3 (p < 0.02). Temperatures were according to protocol. Survival to 72 hours was achieved in group 1 by 3 of 10 rats, in group 2 by 7 of 10 rats (p = 0.18 vs. group 1), and in group 3 by 9 of 10 rats (p = 0.02 vs. group I,p = 0.58 vs. group 2), Survival time was longer in group 2 (p = 0.09) and group 3 (p = 0.007) compared with group 1. Conclusion: Brief hypothermia had physiologic benefit and a trend toward improved survival, Prolonged mild hypothermia significantly increased survival after severe HS even with controlled MAP. Extending the duration of hypothermia beyond the acute phases of shock and resuscitation may be needed to ensure improved outcome after prolonged HS.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol CCM, Pittsburgh, PA 15260 USA		Tisherman, SA (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	tishermansa@msx.upmc.edu	Prueckner, Stephan/AAB-2280-2021; Tisherman, Samuel A./AAK-9377-2020	Prueckner, Stephan/0000-0002-5128-7625; Tisherman, Samuel A./0000-0003-3810-3729			Baiping Lei, 1994, Stroke, V25, P147; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BRADER E, 1985, Annals of Emergency Medicine, V14, P510, DOI 10.1016/S0196-0644(85)80398-X; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DRIPPS RD, 1956, PHYSL INDUCED HYPOTH; EDMEYER U, 1998, J NEUROTRAUM, V15, P323; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GISVOLD SE, 1984, STROKE, V15, P803, DOI 10.1161/01.STR.15.5.803; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; HALMAGYI DF, 1973, SURGERY, V74, P370; Holzer M, 1997, Acta Anaesthesiol Scand Suppl, V111, P55; JURKOVICH GJ, 1988, J SURG RES, V44, P514, DOI 10.1016/0022-4804(88)90156-4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; KRAMER RS, 1968, J THORAC CARDIOV SUR, V56, P699, DOI 10.1016/S0022-5223(19)42797-9; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LEONOV Y, 1990, STROKE, V21, P1600, DOI 10.1161/01.STR.21.11.1600; LEONOV Y, 1995, ACAD EMERG MED, V2, P401; LITTLE RA, 1981, BRIT J SURG, V68, P221, DOI 10.1002/bjs.1800680402; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MEDEN P, 1994, BRAIN RES, V647, P131, DOI 10.1016/0006-8993(94)91407-9; MEYER D M, 1987, Current Surgery, V44, P399; MEYER DM, 1990, J SURG RES, V48, P61, DOI 10.1016/0022-4804(90)90147-T; MEYER DM, 1988, ANN SURG, V207, P462, DOI 10.1097/00000658-198804000-00015; MICHENFELDER JD, 1970, ANESTHESIOLOGY, V33, P430, DOI 10.1097/00000542-197010000-00013; Mizushima Y, 2000, J TRAUMA, V48, P58, DOI 10.1097/00005373-200001000-00010; *NAT CTR HLTH STAT, 1992, MONTHL VIT STAT REP, V43, P1; PATT A, 1988, SURG CLIN N AM, V68, P775; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; POPE A, 1999, FLUID RESUSCITATION, P123; POSTEL AH, 1957, ANN SURG, V145, P311, DOI 10.1097/00000658-195703000-00003; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rozenfeld RA, 1996, J APPL PHYSIOL, V81, P1834, DOI 10.1152/jappl.1996.81.4.1834; SAFAR P, 1988, CRIT CARE MED, V16, P923, DOI 10.1097/00003246-198810000-00003; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; Schlichtig R, 1996, J CRIT CARE, V11, P51, DOI 10.1016/S0883-9441(96)90020-9; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SORI AJ, 1987, AM SURGEON, V53, P706; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Takasu A, 1999, CRIT CARE MED, V27, P1557, DOI 10.1097/00003246-199908000-00025; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Tanaka J, 1983, Adv Shock Res, V9, P219; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561	63	43	46	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2001	50	2					253	261		10.1097/00005373-200102000-00010			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	404WL	WOS:000167125000018	11242289				2022-02-06	
J	Victorov, IV; Prass, K; Dirnagl, U				Victorov, IV; Prass, K; Dirnagl, U			Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin	BRAIN RESEARCH PROTOCOLS			English	Article						acidophilia; brain pathology; neuron; vanadium acid fuchsin; toluidine blue; Gill's hematoxylin	HYPOGLYCEMIC BRAIN-DAMAGE; RAT-BRAIN; ISCHEMIA; DEGENERATION; OCCLUSION; NECROSIS; CORTEX; INJURY; TRAUMA	Acidophilia is one of the hallmarks of acute neuronal damage and death in brain ischemia, excitotoxic and traumatic lesions and epileptic seizures. We here describe a novel and simple method for visualizing acidophilic neurons on paraffin sections, using vanadium acid fuchsin (VAF) staining and toluidine blue or hematoxylin counterstaining. Paraffin sections of the brain fixed in ethanol-formalin-acetic acid mixture are stained in 0.1% acid fuchsin containing 0.125% of ammonium metavanadate and 1% of glacial acetic acid, differentiated if overstained in 0.01% of borax solution, and counterstained with 0.05-0.025% of toluidine blue in acetate buffer (pH 3.3) or Gill's II hematoxylin. The sections are dehydrated, cleared in xylene and mounted in Canada balsam or any synthetic mounting media for light microscopy. VAF combined with toluidine blue or hematoxylin results in highly selective and reproducible color contrast staining of acidophilic neurons as well as glial nuclei and hyperchromatic neurons. As a progressive method, acid fuchsin staining usually does not require differentiation. The red acidophilic neurons are clearly visible on the background of non-damaged cells, which significantly facilitates the identification, and localization of damaged neurons, even at low magnification under the light microscope. (C) 2000 Elsevier Science B.V. All rights reserved.	Brain Res Inst, Lab Expt Neurocytol, Moscow 103064, Russia; Humboldt Univ, Charite, D-10098 Berlin, Germany		Victorov, IV (corresponding author), Brain Res Inst, Lab Expt Neurocytol, Pereulok Obukha 5, Moscow 103064, Russia.		Victorov, Ilya/C-4680-2012	Dirnagl, Ulrich/0000-0003-0755-6119			AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; Brown A W, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P155; BROWN AW, 1972, J NEUROL SCI, V16, P59, DOI 10.1016/0022-510X(72)90102-5; BUCHAN AM, 1990, BRAIN RES, V512, P7, DOI 10.1016/0006-8993(90)91163-B; CAMMERMEYER J, 1978, HISTOCHEMISTRY, V56, P97, DOI 10.1007/BF00508437; CAMMERMEYER J, 1960, EXP NEUROL, V2, P379, DOI 10.1016/0014-4886(60)90022-4; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; CHANG D, 1994, DEV BRAIN RES, V77, P133, DOI 10.1016/0165-3806(94)90220-8; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; GARCIA JH, NEURONAL ISCHEMIC IN, P43; GARCIA JH, 1986, NATO ASI SERIES A, V115, P65; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; Kiernan JA, 1998, BIOTECH HISTOCHEM, V73, P244, DOI 10.3109/10520299809141118; KIRINO T, 1985, PROG BRAIN RES, V63, P39; LEES GJ, 1989, ACTA NEUROPATHOL, V77, P519, DOI 10.1007/BF00687254; Lillie RD, 1965, HISTOPATHOLOGIC TECH; ROBBINS SL, 1979, PATHOLOGIC BASIS DIS, P22; ROSENBLUM WI, 1997, J NEUROTRAUM, V14, P311; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SPIELMEYER W, 1922, HISTOPATHOLOGIC NERV, pS74; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; VICTOROV IV, 1993, PATHOL PHYSL EXP THE, V2, P53	27	43	53	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-299X			BRAIN RES PROTOC	Brain Res. Protoc.	APR	2000	5	2					135	139		10.1016/S1385-299X(00)00004-0			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	311VV	WOS:000086907300003	10775832				2022-02-06	
J	Read, SJ; Smith, MI; Hunter, AJ; Upton, N; Parsons, AA				Read, SJ; Smith, MI; Hunter, AJ; Upton, N; Parsons, AA			SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat	CEPHALALGIA			English	Article						migraine; novel therapeutics; nitric oxide; SB-220453	CEREBRAL BLOOD-FLOW; TRIGEMINAL NUCLEUS CAUDALIS; ANESTHETIZED CAT; MIGRAINE; METABOLISM; MECHANISMS; HEADACHE; EXPRESSION; RAT	Profound nitric oxide release associated with cortical spreading depression (SD), has been implicated in stroke, traumatic brain injury and migraine pathophysiology. SB-220453 represents a mechanistically novel, well-tolerated class of compounds which may have therapeutic potential in the treatment of conditions associated with neuronal hyperexcitability and inflammation. The aim of the present study was to investigate the effects of SB-220453 on the nitric oxide (NO) release associated with SD in the anaesthetized cat. In vehicle treated animals, KCl application for 6 min to the cortical surface produced repeated changes in extracellular direct current field potential with associated NO release. This activity was sustained for a median duration of 55 min (25-75% range, 32-59 min) and 59 min (25-75% range, 34-59 min), respectively. SB-220453 (1, 3 and 10 mg/kg i.p.) produced a dose-related inhibition of this activity and at the highest dose tested, the median duration of changes in extracellular field potential and NO release were reduced to 9 min (25-75% range, 4-5min) and 5 min (25-75% range, 5-5min), respectively. No effect was observed on basal systemic haemodynamic parameters or resting cerebral laser Doppler blood flux at any of the doses of SB-220453 tested. SB-220453 therefore represents a novel compound to assess the potential benefit of inhibiting SD associated nitric oxide release in neurological disease.	SmithKline Beecham Pharmaceut, Neurosci Res, Harlow CM19 5AD, Essex, England; SmithKline Beecham Pharmaceut, Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA		Read, SJ (corresponding author), SmithKline Beecham Pharmaceut, Neurosci Res, New Frontiers Sci Pk, Harlow CM19 5AD, Essex, England.						Andersson JLR, 1997, CEPHALALGIA, V17, P570, DOI 10.1046/j.1468-2982.1997.1705570.x; Aurora SK, 1998, CURR OPIN NEUROL, V11, P205, DOI 10.1097/00019052-199806000-00003; CAO Y, 1997, J CEREB BLOOD FLOW M, V17, pS176; Chan WN, 1999, BIOORG MED CHEM LETT, V9, P285, DOI 10.1016/S0960-894X(98)00728-8; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; GOADSBY PJ, 1992, BRAIN RES, V595, P167, DOI 10.1016/0006-8993(92)91470-Y; Ingvardsen BK, 1997, PAIN, V72, P407, DOI 10.1016/S0304-3959(97)00069-9; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Lambert GA, 1999, CEPHALALGIA, V19, P631, DOI 10.1046/j.1468-2982.1999.019007631.x; Lassen LH, 1997, LANCET, V349, P401, DOI 10.1016/S0140-6736(97)80021-9; LAURITZEN M, 1987, TRENDS NEUROSCI, V10, P8, DOI 10.1016/0166-2236(87)90115-9; LAURITZEN M, 1984, BRAIN, V107, P447, DOI 10.1093/brain/107.2.447; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; MOSKOWITZ MA, 1993, CEREBROVAS BRAIN MET, V5, P159; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; OLESEN J, 1993, NEUROREPORT, V4, P1027, DOI 10.1097/00001756-199308000-00008; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Read SJ, 1999, BRAIN RES, V847, P1, DOI 10.1016/S0006-8993(99)01985-X; Read SJ, 1997, CEPHALALGIA, V17, P826, DOI 10.1046/j.1468-2982.1997.1708826.x; Read SJ, 1999, CEPHALALGIA, V19, P403; Read SJ, 1997, NEUROSCI LETT, V232, P127, DOI 10.1016/S0304-3940(97)00604-6; Read SJ, 1998, NEUROSCI LETT, V250, P115, DOI 10.1016/S0304-3940(98)00442-X; READ SJ, EXP HEADACHE MODELS, P81; READ SJ, 1997, HEADACHE PATHOGENESI; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; Welch KMA, 1998, CURR OPIN NEUROL, V11, P193, DOI 10.1097/00019052-199806000-00001; WELCH KMA, 1995, J NEUROL SCI, V134, P9, DOI 10.1016/0022-510X(95)00196-1; WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; WOOLF CJ, 1996, MIGRAINE 2000 DEV NE, V12, P173; ZHANG ZG, 1994, J CEREBR BLOOD F MET, V14, P939, DOI 10.1038/jcbfm.1994.125	33	43	46	0	0	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0333-1024			CEPHALALGIA	Cephalalgia	MAR	2000	20	2					92	99		10.1046/j.1468-2982.2000.00022.x			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347BD	WOS:000088905600004	10961764				2022-02-06	
J	Brown, M; Gordon, WA; Haddad, L				Brown, M; Gordon, WA; Haddad, L			Models for predicting subjective quality of life in individuals with traumatic brain injury	BRAIN INJURY			English	Article							SPINAL-CORD INJURY; OF-LIFE; REHABILITATION OUTCOMES; SATISFACTION; DISABLEMENT; COMMUNITY; HANDICAP	The objective of this study was to compare the utility of ICIDH-based models and needs-based models for predicting subjective quality of life in individuals with traumatic brain injury (TBI). Using an existing data base of individuals with TBI living in the community, seven predictive models were tested using multiple regression analyses. In comparing adjusted R-2 associated With each of seven models, ic was concluded that needs-based models using subjective indicators clearly predict more variance in measures of life satisfaction, or subjective well-bring, than do either type of model relying on objective measures. It is suggested that, in documenting 'outcomes' of rehabilitation, the degree to which the focal individual's important needs are met defines more directly his/her Well-being than do measures of impairment, disability or handicap.	CUNY Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Community & Prevent Med, New York, NY 10029 USA		Gordon, WA (corresponding author), CUNY Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1425 Madison Ave, New York, NY 10029 USA.		; Carneiro D'Albuquerque, Luiz Augusto/A-8812-2013	Haddad, Lisa/0000-0002-7631-6760; Carneiro D'Albuquerque, Luiz Augusto/0000-0001-7607-7168			ABBEY A, 1985, SOC INDIC RES, V16, P1, DOI 10.1007/BF00317657; ANDERSON TP, 1982, ARCH PHYSICAL MED RE, V63; Andrews F. M., 1976, SOCIAL INDICATORS WE; BECK A, 1987, BECK DEPRESSIONI INV; BIGELOW DA, 1990, PSYCHOSOC REHABIL, V14, P94; Brown M, 1999, MT SINAI J MED, V66, P160; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; BROWN M, 1999, UNPUB SUBJECTIVE QUA; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Campbell A.-Ph. E. Converse-W. L., 1976, QUALITY AM LIFE PERC; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CREWE NM, 1980, MINN MED, V63, P586; deLateur BJ, 1997, ARCH PHYS MED REHAB, V78, P237, DOI 10.1016/S0003-9993(97)90026-5; DEMBO T, 1964, REHABIL LIT, V25, P231; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fayers PM, 1997, QUAL LIFE RES, V6, P393, DOI 10.1023/A:1018491512095; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; GORDON WA, IN PRESS BRAIN INJUR; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; HEUBNER RA, 1998, J REHABILITATION OUT, V2, P8; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Krause JS, 1998, REHABIL PSYCHOL, V43, P282, DOI 10.1037/0090-5550.43.4.282; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; LARSEN RJ, 1985, SOC INDIC RES, V17, P1, DOI 10.1007/BF00354108; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; LINDENBERG S, 1993, ACTA SOCIOL, V36, P191, DOI 10.1177/000169939303600304; Lindenberg S., 1986, PARADOXICAL EFFECTS; LUNDQVIST C, 1991, SPINE, V16, P78, DOI 10.1097/00007632-199101000-00014; Maslow A.H., 1970, MOTIVATION PERSONALI, V2nd ed.; *MED OUTC TRUST, 1992, SF36 HLTH SURV; Murray H.A., 1938, EXPLOR PERS; Ormel J, 1997, SOC SCI MED, V45, P1051, DOI 10.1016/S0277-9536(97)00032-4; Pieters L, 1995, PHYTOMEDICINE, V2, P17, DOI 10.1016/S0944-7113(11)80043-7; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; STIGLER GJ, 1977, AM ECON REV, V67, P76; TENNANT A, 1995, ANN RHEUM DIS, V54, P439, DOI 10.1136/ard.54.6.439; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WHITENECK GG, 1992, UNPUB COMMUNITY REEN; *WHO, 1997, ICIDH2 INT CLASS IMP; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization, 1980, INT CLASS IMP DIS HA; 1995, QUALITY LIFE INTERVI	54	43	44	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2000	14	1					5	19		10.1080/026990500120899			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CY	WOS:000084747200003	10670658				2022-02-06	
J	Shi, R; Pryor, JD				Shi, R; Pryor, JD			Temperature dependence of membrane sealing following transection in mammalian spinal cord axons	NEUROSCIENCE			English	Article						axon; temperature; membrane scaling; spinal cord injury; neurotrauma; nerve repair	CULTURED APLYSIA NEURONS; NERVE MYELINATED AXONS; CNS WHITE MATTER; MODERATE HYPOTHERMIA; IN-VITRO; NA+-CA2+ EXCHANGER; BRAIN INJURY; POSTTRAUMATIC HYPOTHERMIA; DENDRITE TRANSECTION; NEURITE TRANSECTION	Using an in vitro sucrose-gap recording chamber, sealing of cut axone in isolated strips of white matter from guinea pig spinal cord was measured by recording the "compound membrane potential". This functional sealing was found to correlate well with anatomical resealing, measured by a horseradish peroxidase uptake assay. Near-complete functional and anatomical recovery of the axonal membrane occurred routinely within 60 min following transection at 37 degrees C in regular Krebs' solution. The rate of membrane potential recovery is exponential, with a time-constant of 20 +/- 5 min. The sealing process at 31 degrees C was similar to that at 37 degrees C, acid was effectively blocked at 25 degrees C, under which condition most axons continued to take up horseradish peroxidase for more than 1 h, and failed to substantially recover their membrane potential. Seventy-five percent of the cords transected at 40 degrees C had similar sealing behavior to those at 37 degrees C and 31 degrees C. The balance failed to seal the cut end. Two-dimensional morphometric analysis has shown that raising the temperature from 25 degrees C to above 31 degrees C significantly decreases axonal permeabilization to horseradish peroxidase (increases the sealing of transected ends) across all areas of a transverse section of spinal cord. Moreover, this enhancement of sealing exists across all axon calibers. Since severe cooling compromises membrane resealing, caution needs to be taken when hypothermic treatment (below 25 degrees C) is applied within the first 60 min following mechanical injury. In summary, we have found that at normal temperature (37 degrees C), nerve fibers repair their damaged membrane following physical injury with an hour. This is similar at mildly lower (31 degrees C) and relatively higher (40 degrees C) temperature, although some fibers tend to collapse under this febrile temperature. Moreover, severely low temperature (25 degrees C) hindered the repair of damaged membranes. Based on our study, caution is needed in treating spinal cord injury with low temperatures. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Shi, R (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA.						Agrawal SK, 1996, J NEUROSCI, V16, P545; AGUAYO AJ, 1983, BIRTH DEFECTS-ORIG, V19, P327; BENBASSAT D, 1994, EUR J NEUROSCI, V6, P1605, DOI 10.1111/j.1460-9568.1994.tb00551.x; Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; BOENING JA, 1989, NEUROSCIENCE, V33, P263, DOI 10.1016/0306-4522(89)90205-4; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; BORGENS RB, 1986, J COMP NEUROL, V250, P157, DOI 10.1002/cne.902500203; BORGENS RB, 1981, SCIENCE, V213, P611, DOI 10.1126/science.7256258; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; Borgens RB, 1989, ELECT FIELDS VERTEBR; Bray GM, 1987, PROG BRAIN RES <D>, V71, P373; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; CAMPBELL G, 1992, J NEUROCYTOL, V21, P755, DOI 10.1007/BF01237903; CARLSTEDT T, 1985, BRAIN RES, V347, P188, DOI 10.1016/0006-8993(85)90911-4; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; DIETRICH WD, 1992, J NEUROTRAUMA, V9, P475; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Ebmeyer U, 1998, J NEUROTRAUM, V15, P323, DOI 10.1089/neu.1998.15.323; GALLANT PE, 1988, J NEUROSCI, V8, P1479; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; GOLDBERG WJ, 1986, J NEUROSCI, V6, P3144; GROSS GW, 1983, J NEUROSCI, V3, P1979; HANSEBOUT RR, 1984, SPINE, V9, P508, DOI 10.1097/00007632-198407000-00020; HAYES KC, 1993, PARAPLEGIA, V31, P730, DOI 10.1038/sc.1993.115; Howard MJ, 1999, NEUROSCIENCE, V93, P807, DOI 10.1016/S0306-4522(99)00195-5; KEIRSTEAD HS, 1995, J NEUROSCI, V15, P6963; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; LAMPERT P, 1964, LAB INVEST, V13, P825; Lehning EJ, 1996, J NEUROCHEM, V66, P493; LOPACHIN RM, 1995, J NEUROSCI, V15, P6735; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; LUCAS JH, 1994, J NEUROTRAUM, V11, P35, DOI 10.1089/neu.1994.11.35; LUCAS JH, 1987, BRAIN RES, V425, P384, DOI 10.1016/0006-8993(87)90526-9; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MEIRI H, 1981, SCIENCE, V211, P709, DOI 10.1126/science.7455707; NIGGLI V, 1987, J MEMBRANE BIOL, V100, P97, DOI 10.1007/BF02209144; Rosenberg LJ, 1996, BRAIN RES, V734, P349; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; SANGER JW, 1980, P NATL ACAD SCI-BIOL, V77, P5268, DOI 10.1073/pnas.77.9.5268; Shi R., 1996, Society for Neuroscience Abstracts, V22, P1185; Shi R., 1997, Society for Neuroscience Abstracts, V23, P270; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; SHI R, 1995, J NEUROTRAUM, V12, P996; Shi RY, 1989, J NEUROTRAUM, V6, P261, DOI 10.1089/neu.1989.6.261; SIMS TJ, 1994, EXP BRAIN RES, V99, P25; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; STYS PK, 1992, J NEUROSCI, V12, P430; Teng YD, 1997, J NEUROSCI, V17, P4359; Trescher WH, 1997, BRAIN DEV-JPN, V19, P326, DOI 10.1016/S0387-7604(97)00027-2; VINCENT C, 1990, MOL REPROD DEV, V26, P227, DOI 10.1002/mrd.1080260306; WANG OL, 1993, BIOCHEM J, V291, P803, DOI 10.1042/bj2910803; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; XIE XY, 1991, J NEUROSCI, V11, P3257; YAWO H, 1983, SCIENCE, V222, P1351, DOI 10.1126/science.6658457; YAWO H, 1985, J NEUROSCI, V5, P1626; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x	64	43	44	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2000	98	1					157	166		10.1016/S0306-4522(00)00096-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	326NA	WOS:000087740600017	10858622				2022-02-06	
J	Pruneau, D; Chorny, I; Benkovitz, V; Artru, A; Roitblat, L; Shapira, Y				Pruneau, D; Chorny, I; Benkovitz, V; Artru, A; Roitblat, L; Shapira, Y			Effect of LF 16-0687MS, a new nonpeptide bradykinin B-2 receptor antagonist, in a rat model of closed head trauma	JOURNAL OF NEUROTRAUMA			English	Article						B-2 receptors; bradykinin; brain edema; closed head trauma; neurological status; nonpeptide antagonists; rat	VASOGENIC BRAIN EDEMA; KALLIKREIN-KININ SYSTEM; CEREBRAL ARTERIOLES; NEUROPEPTIDE-Y; SPINAL-CORD; ASTROCYTES; INJURY; PERMEABILITY; MEDIATOR; VESSELS	Bradykinin is an endogenous nonapeptide which potently dilates the cerebral vasculature and markedly increases vascular permeability. These effects are mediated by B-2 receptors located on the vascular endothelium. Previous experimental studies have shown that blockade of the kallikrein-kinin system, which mediates the formation of bradykinin, afforded a reduction of the brain edema that developed following a cryogenic cortical lesion. In the present study, we investigated the effect of LF 16-0687MS, a novel nonpeptide B-2 receptor antagonist, on cerebral edema and neurological severity score (NSS) after closed head injury to rats. LF 16-0687MS or its vehicle (NaCl 0.9%) was continuously infused at 10, 30, and 100 mu g/kg/min over 23 h starting 1 h after a focal trauma to the left hemisphere was induced using a weight-drop device. The extent of edema formation was evaluated 24 h after trauma from left and right hemispheres samples by measurement of specific gravity and water content. In a separate study, a neurological severity score based on scoring of behavioural and motor functions was evaluated 1 h and over 1 week after trauma. LF 16-0687MS at 100 mu g/kg/min markedly reduced the development of brain edema as indicated by a 68% increase in specific gravity (p < 0.05) and a 64% decrease of water content (p < 0.05) in the left hemisphere. In addition the recovery of neurological function was significantly improved by 100 mu g/kg/min LF 16-0687MS from day 3 to day 7 after CHT. In a separate experiment, we also showed that LF 16-0687MS at 100 mu g/kg/min given either 1 h before or 30 min after CHT did not affect mean arterial blood pressure. These results show that blockade of bradykinin B-2 receptors is an effective approach to reduce cerebral edema and to improve neurological outcome after a focal contusion to the cranium.	Fournier Labs, Res Ctr, F-21121 Daix, France; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Beer Sheva, Israel; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA		Pruneau, D (corresponding author), Fournier Labs, Res Ctr, 50 Rue Dijon, F-21121 Daix, France.	d.pruneau@fournier.fr					BHOOLA KD, 1992, PHARMACOL REV, V44, P1; DODEY P, 1998, 13 FRENCH JAP S MED; DODEY P, 1998, Patent No. 24783; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; ELLIS EF, 1989, J NEUROSURG, V61, P97; FELETOU M, 1994, BRIT J PHARMACOL, V112, P683, DOI 10.1111/j.1476-5381.1994.tb13130.x; Gecse A, 1989, Adv Exp Med Biol, V247A, P249; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; HOSLI E, 1993, NEUROREPORT, V4, P159; HOSLI L, 1992, NEUROSCI LETT, V148, P114, DOI 10.1016/0304-3940(92)90817-Q; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; KATUSIC ZS, 1993, STROKE, V24, P392, DOI 10.1161/01.STR.24.3.392; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Mayhan WG, 1996, BRAIN RES, V738, P337, DOI 10.1016/S0006-8993(96)01000-1; MENKE JG, 1994, J BIOL CHEM, V269, P21583; NAROTAM PK, 1995, J NEUROSURG, V82, pA350; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pruneau D, 1999, FUND CLIN PHARMACOL, V13, P75, DOI 10.1111/j.1472-8206.1999.tb00323.x; Pruneau D, 1998, BRIT J PHARMACOL, V125, P365, DOI 10.1038/sj.bjp.0702083; PRUNEAU D, 1999, IN PRESS IMMUNOPHARM; Raidoo DM, 1997, J NEUROIMMUNOL, V77, P39, DOI 10.1016/S0165-5728(97)00048-9; REGOLI D, 1980, PHARMACOL REV, V32, P1; ROSENBLUM WI, 1987, CIRC RES, V61, P601, DOI 10.1161/01.RES.61.4.601; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; ROSOMOFF HL, 1959, ANN NY ACAD SCI, V80, P475, DOI 10.1111/j.1749-6632.1959.tb49225.x; SCHILLING L, 1997, KIDNEY INT S59, V51, pS69; SCHULZ J, 1999, 11 INT S BRAIN OED M; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1989, PROSTAG LEUKOTR ESS, V36, P49, DOI 10.1016/0952-3278(89)90162-2; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; STEPHENS GJ, 1993, NEUROSCI LETT, V153, P223, DOI 10.1016/0304-3940(93)90327-H; STOVER J, 1999, 11 INT S BRAIN OED M; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; WAHL M, 1983, J CEREBR BLOOD F MET, V3, P231, DOI 10.1038/jcbfm.1983.31; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; WHITTLE IR, 1992, ACTA NEUROCHIR, V115, P53, DOI 10.1007/BF01400591; XU J, 1991, J NEUROCHEM, V57, P975, DOI 10.1111/j.1471-4159.1991.tb08246.x	47	43	43	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	1999	16	11					1057	1065		10.1089/neu.1999.16.1057			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	260MM	WOS:000083954500004	10595822				2022-02-06	
J	Carter, BG; Taylor, A; Butt, W				Carter, BG; Taylor, A; Butt, W			Severe brain injury in children: long-term outcome and its prediction using somatosensory evoked potentials (SEPs)	INTENSIVE CARE MEDICINE			English	Article						somatosensory evoked potentials; brain injury; outcome; outcome prediction; health state measure	SEVERE HEAD-INJURY; HYPOXIC-ISCHEMIC COMA; FOLLOW-UP; PROGNOSTIC UTILITY; TRAUMATIC COMA; CONDUCTION; SURVIVAL; DAMAGE; TIME	Objective: To evaluate the outcome of children 1 and 5 years after severe brain injury (Glasgow Coma Score < 8) using a functional measure [Glasgow Outcome Scale (GOS)] and a health status measure (the Torrance Health State (HUI:1)) and to determine the ability of somatosensory evoked potentials (SEPs) to predict these longterm outcomes. Design: Prospective study. Setting: A 16-bed paediatric intensive care unit in a tertiary children's hospital. Patients ann participants: 105 children with severe brain injury: Interventions: SEPs were recorded once in the first week after admission. Outcome was assessed 1 and 5 years after injury using the GOS and at 5 years after injury using HUI:1. Measurements and results: At 5 years, using the GOS, 46 (43.8%) children had a good outcome, 10 (9.5 %) were moderately disabled, 2 (1.9 %) severely disabled, 3 (2.9 %) vegetative and 44 (41.9 %) had died. At 5 years, 17 of 40 (42.5 %) survivors from 1 year had changed outcomes: 12 had improved, 3 had worsened and 2 had died. For a normal SEP, positive predictive power was 85.4 %, sensitivity 62.5 %, specificity 87.8 %, negative predictive power 67.2 % and the positive likelihood ratio was 5.1. For bilaterally absent responses, positive predictive power was 90.9 %, sensitivity 61.2 %, specificity 94.6 %, negative predictive Fewer 73.6 % and the positive likelihood ratio was 11.4. Outcomes using HUI:1 were: 30 (28.6 %) had a good quality of life, 21 (20.0 %) had a moderate quality of life, 7 (6.7 %) a poor quality, 44 died (41.9 %) and 3 (2.9 %) survived in a state deemed worse than death. For a normal SEP, positive predictive power was 85.4 %, sensitivity 68.6 %, specificity 88.9 %, negative predictive power 75.0 % and the positive likelihood ratio was 6.2. For bilaterally absent responses, positive predictive power was 93.9 %, sensitivity 57.4 %, specificity 96.1 %, negative predictive power 68.1 % and the positive likelihood ratio was 14.6. Conclusions: The outcome for children with severe brain injury should be assessed 5 years after injury because important changes occur between 1 year and 5 years. Differences exist between outcomes assessed using the GOS and HUI:1 as they measure slightly different aspects of function. Consideration should therefore be given to using both measures. SEPs are excellent predictors of long-term outcome measured by either the GOS or the HUI:1.	Royal Childrens Hosp, Paediat Intens Care Unit, Parkville, Vic 3052, Australia		Carter, BG (corresponding author), Royal Childrens Hosp, Paediat Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.						ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; DEMEIRLEIR LJ, 1987, PEDIATR NEUROL, V3, P78, DOI 10.1016/0887-8994(87)90031-2; FACCO E, 1991, Brain Topography, V3, P447, DOI 10.1007/BF01129004; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRIEGER D, 1995, CRIT CARE MED, V23, P1123, DOI 10.1097/00003246-199506000-00020; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MCPHERSON RW, 1986, ANESTHESIOLOGY, V65, P584, DOI 10.1097/00000542-198612000-00004; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NEWLON PG, 1983, NEUROSURGERY, V12, P613, DOI 10.1227/00006123-198306000-00003; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; SACKETT DL, 1997, EVIDENCE BASED MED P, P118; SBORDONE RJ, 1995, BREAIN INJ, V9, P255; SLOAN TB, 1990, BRIT J ANAESTH, V64, P590, DOI 10.1093/bja/64.5.590; SUTTON LN, 1982, J NEUROSURG, V57, P178, DOI 10.3171/jns.1982.57.2.0178; SWAN PK, 1987, CRIT CARE MED, V15, P355, DOI 10.1097/00003246-198704000-00034; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; TORRANCE GW, 1992, PROVISIONAL HLTH STA; YING Z, 1992, J NEUROL NEUROSUR PS, V55, P470, DOI 10.1136/jnnp.55.6.470	49	43	45	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUL	1999	25	7					722	728		10.1007/s001340050936			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223TL	WOS:000081856900013	10470577				2022-02-06	
J	Dietrich, WD; Truettner, J; Zhao, WZ; Alonso, OF; Busto, R; Ginsberg, MD				Dietrich, WD; Truettner, J; Zhao, WZ; Alonso, OF; Busto, R; Ginsberg, MD			Sequential changes in glial fibrillary acidic protein and gene expression following parasagittal fluid-percussion brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; glial fibrillary acidic protein (GFAP); gene expression; traumatic injury	GFAP-MESSENGER-RNA; MILD CORTICAL CONTUSION; NERVE GROWTH-FACTOR; HEAD-INJURY; POSTTRAUMATIC HYPOTHERMIA; SPREADING DEPRESSION; CEREBRAL CONTUSION; ASTROCYTOMA-CELLS; NEURONAL-ACTIVITY; ASTROGLIAL CELLS	This study documents the regional and temporal patterns of glial fibrillary acidic protein (GFAP) RNA and protein expression after parasagittal fluid-percussion (F-P) brain injury (1.7 to 2.2 atm) in male Sprague-Dawley rats. In situ hybridization was conducted in 28 rats with a S-35-labeled antisense riboprobe to GFAP at 0.5, 2, and 6 hours and 1, 3, and 30 days after traumatic brain injury (TBI) or sham procedures. Immunocytochemical staining of GFAP was conducted in 20 rats at 1, 3, 7, and 30 days after TBI or sham procedures. At 0.5 and 2 hours after TBI, increased GFAP mRNA was restricted to superficial cortical areas underlying the impact site. At 24 hours, increased GFAP mRNA was observed throughout the traumatized hemisphere except within the histopathologically vulnerable lateral parietal cortex and external capsule. Contralateral expression within the hippocampus and cingulate and lateral cortices was also observed. Three days after TBI, GFAP mRNA expression was prominent overlying pial surfaces, in cortical regions surrounding the contusion, and within the hippocampus and lateral thalamus. Immunocytochemical visualization of GFAP at 1 and 3 days demonstrated reactive astrocytes overlying the pial surface, surrounding the cortical contusion, and within ipsilateral white matter tracts, hippocampus, and lateral thalamus. At 30 days, GFAP mRNA and protein expression were present within the deeper cortical layers of the lateral somatosensory cortex and lateral thalamus and throughout ipsilateral white matter tracts. These data demonstrate a complex pattern of GFAP mRNA and protein expression within gray and white matter tracts following F-P brain injury. Patterns of GFAP gene expression may be a sensitive molecular marker for evaluating the global response of the brain to focal injury in terms of progressive neurodegenerative as well as regenerative processes.	Univ Miami, Sch Med, Dept Neurol D4 5, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33101 USA		Dietrich, WD (corresponding author), Univ Miami, Sch Med, Dept Neurol D4 5, POB 016960, Miami, FL 33101 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; Antanitus DS, 1998, NEUROSCIENTIST, V4, P154, DOI 10.1177/107385849800400310; AQUINO DA, 1990, J NEUROCHEM, V54, P1398, DOI 10.1111/j.1471-4159.1990.tb01975.x; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Baldwin SA, 1996, GLIA, V16, P266; Baldwin SA, 1997, NEUROSCI RES COMMUN, V20, P157, DOI 10.1002/(SICI)1520-6769(199705)20:3<157::AID-NRC197>3.3.CO;2-Z; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; Bodjarian N, 1997, NEUROREPORT, V8, P3951, DOI 10.1097/00001756-199712220-00020; BOLOVENTA P, 1996, NEUROANALASTROCYTIC, P367; BONTHIUS DJ, 1993, BRAIN RES, V618, P83, DOI 10.1016/0006-8993(93)90432-M; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; CHEN H, 1993, J NEUROL SCI, V118, P109, DOI 10.1016/0022-510X(93)90099-K; CHEN WJ, 1994, J CELL BIOL, V127, P813, DOI 10.1083/jcb.127.3.813; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1992, CAN J PHYSIOL PHARM, V70, pS206, DOI 10.1139/y92-264; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, J CEREBR BLOOD F MET, V14, P20, DOI 10.1038/jcbfm.1994.4; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ENG LF, 1988, CURRENT ISSUES NEURA, P247; FURUKAWA S, 1986, BIOCHEM BIOPH RES CO, V136, P57, DOI 10.1016/0006-291X(86)90876-4; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Ginsberg MD, 1996, J NEUROSCI METH, V68, P225; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOMEZPINILLA F, 1994, NEUROREPORT, V1, P211; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAJOS F, 1990, GLIA, V3, P301, DOI 10.1002/glia.440030410; HANSEN A, 1991, J NEUROCHEM, V57, P1716, DOI 10.1111/j.1471-4159.1991.tb06372.x; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KRAIG RP, 1990, STROKE, V21, P184; KRAIG RP, 1991, J NEUROSCI, V11, P2187; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MAXWELL DS, 1965, J CELL BIOL, V25, P141, DOI 10.1083/jcb.25.2.141; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MUCKE L, 1991, NEW BIOL, V3, P465; MURPHY S, 1987, NEUROSCIENCE, V22, P381, DOI 10.1016/0306-4522(87)90342-3; Nathaniel EJ., 1981, ADV CELLULAR NEUROBI, P249, DOI [10.1016/B978-0-12-008302-2.50012-2, DOI 10.1016/B978-0-12-008302-2.50012-2]; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.3.CO;2-E; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; PETITO CK, 1982, ANN NEUROL, V11, P510, DOI 10.1002/ana.410110511; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; Porter JT, 1996, J NEUROSCI, V16, P5073; PORTER T, 1995, IEEE MULTIMEDIA, V2, P101; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Rudge J. S., 1993, ASTROCYTES PHARM FUN, P267; RUTKA JT, 1993, CANCER RES, V53, P3624; SCHMIDTKASTNER R, 1993, INT J DEV NEUROSCI, V11, P157, DOI 10.1016/0736-5748(93)90076-P; SCHMIDTKASTNER R, 1990, NEUROSCIENCE, V38, P527, DOI 10.1016/0306-4522(90)90048-9; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STEWARD O, 1990, NEUROL NEUR, V60, P71; STEWARD O, 1990, J NEUROSCI, V10, P2373; STEWARD O, 1991, P NATL ACAD SCI USA, V88, P6819, DOI 10.1073/pnas.88.15.6819; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; SUGAYA E, 1975, J NEUROPHYSIOL, V38, P822, DOI 10.1152/jn.1975.38.4.822; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; Tannock GW, 1992, LACTIC ACID BACTERIA, V1, P21; TORRE ER, 1993, BRAIN RES, V631, P256, DOI 10.1016/0006-8993(93)91543-2; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZHAO WZ, 1993, IEEE T MED IMAGING, V12, P782, DOI 10.1109/42.251130; ZILLES L, 1985, CORTEX RAT STEREOTAX	95	43	45	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	1999	16	7					567	581		10.1089/neu.1999.16.567			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	220EN	WOS:000081651700002	10447069				2022-02-06	
J	McKinley, WO; Kolakowsky, SA; Kreutzer, JS				McKinley, WO; Kolakowsky, SA; Kreutzer, JS			Substance abuse, violence, and outcome after traumatic spinal cord injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						spinal cord injury; violence; substance abuse; outcome	BRAIN INJURY; ALCOHOL; MODEL	Alcohol and drug use have been shown to contribute to the onset of traumatic spinal cord injury and to be a marker for later onset substance abuse issues. Admission toxicology (drug and alcohol) screens were collected from 87 consecutive rehabilitation medicine patients with a diagnosis of acute traumatic spinal cord injury. Forty-six patients (53%) presented with positive screens (44% alcohol only, 30% drug only, 26% both). Seventy-five percent of those with positive alcohol screens met state criteria for alcohol intoxication (blood alcohol level, greater than or equal to 0.08 mg/dl). Compared with individuals with negative screens, those with positive screens were significantly (P < 0.05) younger and unmarried. Compared with nonviolence-related spinal cord injury, patients with violence-related spinal cores injury (gunshot wound and assault) were significantly (P < 0.01) more likely to have positive admission toxicology screens (76% v 41%), drug screens (62% v 14%), and intoxication screens (72% v 34%). Rehabilitation outcome comparisons between those with positive and negative screens revealed similar length of stay, admission and discharge Functional independence Measure (FIM(TM)) scores, FIM change scores, and FIM efficiency scores. This study has important implications with regard to substance abuse issues and their impact on traumatic spinal cord injury outcome, which may assist in better targeting prevention.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		McKinley, WO (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, POB 980661, Richmond, VA 23298 USA.						BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DeVivo MJ, 1997, SPINAL CORD, V35, P509, DOI 10.1038/sj.sc.3100430; DEVIVO MJ, 1980, ARCH NEUROL-CHICAGO, V37, P707, DOI 10.1001/archneur.1980.00500600055011; Ditunnio John F. Jr., 1995, P170; Dunnegan SW, 1997, J PSYCHOACTIVE DRUGS, V29, P345, DOI 10.1080/02791072.1997.10400561; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; FULLERTON DT, 1981, ARCH GEN PSYCHIAT, V38, P1369; GO BK, 1995, SPINAL CORD INJURY C; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALLKM, 1994, ARCH PHYS MED RE S12, V75, pSC10; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hawkins DA, 1998, REHABIL PSYCHOL, V43, P219, DOI 10.1037/0090-5550.43.3.219; HEINEMANN AW, 1995, REHABIL PSYCHOL, V40, P125; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HEINEMANN AW, 1988, ALCOHOL CLIN EXP RES, V12, P815, DOI 10.1111/j.1530-0277.1988.tb01352.x; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; HICKMAN JK, 1993, SPINAL CORD INJURY V; Higgins JP, 1996, AM J EMERG MED, V14, P265, DOI 10.1016/S0735-6757(96)90172-2; International standards for neurological and functional classifications of spinal cord injury, 1982, INT STAND NEUR FUNCT; JOHNSON DC, 1985, ALCOHOL USE PERSONS; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; MEYERS JK, 1984, ARCH GEN PSYCHIAT, V41, P959; *NAT I ALC AB ALC, 1981, DHHS PUBL ADM; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Soderstrom CA, 1997, J TRAUMA, V42, P67, DOI 10.1097/00005373-199701000-00012; Spain DA, 1997, J TRAUMA, V43, P423, DOI 10.1097/00005373-199709000-00006; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Stein DJ, 1997, S AFR MED J, V87, P996; STOVER SL, 1986, SPINAL CORD INJURY F; WOODRUFF BA, 1994, AM J PREV MED, V10, P10, DOI 10.1016/S0749-3797(18)30640-8	33	43	44	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1999	78	4					306	312		10.1097/00002060-199907000-00002			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	216AP	WOS:000081418600002	10418834				2022-02-06	
J	Abu-Judeh, HH; Parker, R; Singh, M; El-Zeftawy, H; Atay, S; Kumar, M; Naddaf, S; Aleksic, S; Abdel-Dayem, HM				Abu-Judeh, HH; Parker, R; Singh, M; El-Zeftawy, H; Atay, S; Kumar, M; Naddaf, S; Aleksic, S; Abdel-Dayem, HM			SPET brain perfusion imaging in mild traumatic brain injury without loss of consciousness and normal computed tomography	NUCLEAR MEDICINE COMMUNICATIONS			English	Article							CEREBRAL BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; MINOR HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; ARTERIAL SPASM; TC-99(M)-HMPAO; HISTORY	We present SPET brain perfusion findings in 32 patients who suffered mild traumatic brain injury without loss of consciousness and normal computed tomography. None of the patients had previous traumatic brain injury, CVA, HIV, psychiatric disorders or a history of alcohol or drug abuse. Their ages ranged from 11 to 61 years (mean = 42). The study was performed in 20 patients (62%) within 3 months of the date of injury and in 12 (38%) patients more than 3 months post-injury. Nineteen patients (60%) were involved in a motor vehicle accident, 10 patients (31%) sustained a fall and three patients (9%) received a blow to the head. The most common complaints were headaches in 26 patients (81%), memory deficits in 15 (47%), dizziness in 13 (41%) and sleep disorders in eight (25%). The studies were acquired approximately 2 h after an intravenous injection of 740 MBq (20.0 mCi) of Tc-99(m)-HMPAO. All images were acquired on a triple-headed gamma camera. The data were displayed on a 10-grade colour scale, with 2-pixel thickness (7.4 mm), and were reviewed blind to the patient's history of symptoms. The cerebellum was used as the reference site (100% maximum value). Any decrease in cerebral perfusion in the cortex or basal ganglia less than 70%, or less than 50% in the medial temporal lobe, compared to the cerebellar reference was considered abnormal. The results show that 13 (41%) had normal studies and 19 (59%) were abnormal (13 studies performed within 3 months of the date of injury and six studies performed more than 3 months post-injury). Analysis of the abnormal studies revealed that 17 showed 48 focal lesions and two showed diffuse supratentorial hypoperfusion (one from each of the early and delayed imaging groups). The 12 abnormal studies performed early had 37 focal lesions and averaged 3.1 lesions per patient, whereas there was a reduction to an average of 2.2 lesions per patient in the five studies (total 11 lesions) performed more than 3 months post-injury. In the 17 abnormal studies with focal lesions, the following regions were involved in descending frequency: frontal lobes 58%, basal ganglia and thalami 47%, temporal lobes 26% and parietal lobes 16%. We conclude that: (1) SPET brain perfusion imaging is valuable and sensitive for the evaluation of cerebral perfusion changes following mild traumatic brain injury; (2) these changes fan occur without loss of consciousness; (3) SPET brain perfusion imaging is more sensitive than computed tomography in detecting brain lesions; and (4) the changes may explain a neurological component of the patient's symptoms in the absence of morphological abnormalities using other imaging modalities. ((C) 1999 Lippincott Williams & Wilkins).	New York Med Coll, Dept Radiol, Nucl Med Sect, St Vincent Hosp & Med Ctr, New York, NY 10011 USA		Abdel-Dayem, HM (corresponding author), New York Med Coll, Dept Radiol, Nucl Med Sect, St Vincent Hosp & Med Ctr, 153 W 11th St, New York, NY 10011 USA.						ABDELDAYEM HM, 1997, CLIN NUCL MED, V122, P345; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; BANDAK FA, 1996, J NEUROTRAUM, V12, P635; Chandler W. F., 1990, NEUROLOGICAL SURG, V4, P2367; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; COTE L, 1991, PRINCIPLES NEUROSCIE, P646; CROSSAON B, 1992, SUBCORTICAL FUNCTION, P78; DHARKER SR, 1993, NEUROSURGERY, V33, P863; FUMEYA H, 1990, ACT NEUR S, V51, P283; GOLDSTEIN J, 1991, MED CLIN N AM, V75, P641, DOI 10.1016/S0025-7125(16)30439-4; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; GRAY BG, 1992, J NUCL MED, V33, P52; Heilman K.M., 1993, CLIN NEUROPSYCHOLOGY, P141; HEILMAN KM, 1983, CLIN NEUROPSYCHOLOGY, P661; Jacobs A, 1996, J NUCL MED, V37, P1605; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KELLY JP, 1991, PRINCIPLES NEURAL SC, P283; KESTER N, 1993, BRAIN INJURY, V7, P469; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MASDEU CJ, 1995, J NEUROIMAGING, V5, pS53; Masdeu J C, 1994, J Neuroimaging, V4, P177; Miller J. D., 1986, CEREBRAL ARTERIAL SP, P476; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; *NAT I NEUR DIS ST, 1995, INT HEAD INJ TASK FO; Nordhoff L. S., 1996, MOTOR VEHICLE COLLIS, P1; PARKER R, 1995, J NEUROL ORTH MED S, V16, P118; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; PARKER RS, 1994, J NEUROL ORTH MED S, V15, P123; Reis D. J., 1996, PRIMER AUTONOMIC NER, P56; Robertson C. S., 1996, NEUROTRAUMA, P487; Robinson Robert G., 1994, P219; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; Tikofsky Ronald S., 1995, P171; Zasler Nathan D., 1994, P443; Zigmond Michael J., 1995, P45	41	43	44	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0143-3636			NUCL MED COMMUN	Nucl. Med. Commun.	JUN	1999	20	6					505	510		10.1097/00006231-199906000-00003			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	219UZ	WOS:000081626700003	10451861				2022-02-06	
J	Andersson, S; Gundersen, PM; Finset, A				Andersson, S; Gundersen, PM; Finset, A			Emotional activation during therapeutic interaction in traumatic brain injury: effect of apathy, self-awareness and implications for rehabilitation	BRAIN INJURY			English	Article							HEAD-INJURY; DISEASE; PERCEPTIONS; RELIABILITY; VALIDITY; LESIONS; SCALE	Apathy and reduced self-awareness are frequent occurring neurobehavioural sequelae following traumatic brain injury (TBI). Apathy, in terms of reduced goal directed activity and lowered motivation, and reduced self-awareness have a negative impact on the rehabilitation process. In this study, 30 patients suffering severe TBI were clinically rated for apathy and monitored for cardiovascular and electrodermal reactivity during baseline, neutral speech and therapeutic interaction. Applying a cut-off score criterion, two thirds of the TBI sample were classified as apathetic. The apathetic patients showed less psychophysiological reactivity from neutral speech to therapeutic interaction, compared to non-apathetic patients. They also reported less perceived emotional discomfort in the therapeutic situation measured with a visual analogue scale. Moreover, reduced self-awareness was associated with low autonomic reactivity. The results suggest that the reduced psychophysiological reactivity in apathetic patients may be a correlate to the lack of emotional responsivity, disengagement, lack of insight and concern about their own situation. Clinically, these results may have implications for psychotherapeutic intervention aimed at improving self-awareness. Recording psychophysiological responses during therapeutic interaction may serve as a method for monitoring emotional involvement during psychotherapy with TBI patients.	Sunnaas Rehabil Hosp, Neuropsychol Lab, Oslo, Norway; Univ Oslo, Dept Behav Sci Med, Oslo, Norway		Andersson, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.						Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BOGUSSLAVSKY J, 1991, ACTA NEUROL SCAND, V83, P309; BURNS A, 1990, J NERV MENT DIS, V178, P20, DOI 10.1097/00005053-199001000-00004; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; DELIS D, 1987, CALIFORNIA VERBAL LE; DOODY RS, 1995, J NEUROPSYCH CLIN N, V7, P54; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Galynker I, 1997, J NERV MENT DIS, V185, P616, DOI 10.1097/00005053-199710000-00004; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Herbert CM, 1989, CLIN REHABIL, V3, P125; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HUGHES CF, 1994, J PERS, V62, P565, DOI 10.1111/j.1467-6494.1994.tb00309.x; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; LACEY JI, 1959, RES PSYCHOTHER, V1, P160; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lang P. J., 1971, HDB PSYCHOTHERAPY BE; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1997, REV PSYCHIAT, V15, P205; MATTHEW CG, 1964, INSTRUCTION MANUAL A; NOTARIUS CI, 1989, HDB SOCIAL PSYCHOPHY, P393; PENNEBAKER JW, 1987, J PERS SOC PSYCHOL, V52, P781, DOI 10.1037/0022-3514.52.4.781; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; WATANABE MD, 1995, J NEUROPSYCH CLIN N, V7, P502; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WECHSLER D, 1955, WECHSTER ADULT INTEL; WILLIAMS RB, 1972, PSYCHOSOM MED, V34, P194, DOI 10.1097/00006842-197205000-00002; [No title captured]	46	43	44	0	9	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1999	13	6					393	404		10.1080/026990599121458			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204DA	WOS:000080746600001	10401541				2022-02-06	
J	Hicks, RR; Li, CY; Zhang, LX; Dhillon, HS; Prasad, MR; Seroogy, KB				Hicks, RR; Li, CY; Zhang, LX; Dhillon, HS; Prasad, MR; Seroogy, KB			Alterations in BDNF and trkB mRNA levels in the cerebral cortex following experimental brain trauma in rats	JOURNAL OF NEUROTRAUMA			English	Article						head injury; neurotrophic factors; traumatic brain injury	NERVE GROWTH-FACTOR; NEUROTROPHIN-3 MESSENGER-RNAS; TRANSIENT FOREBRAIN ISCHEMIA; RETINAL GANGLION-CELLS; DOPAMINERGIC-NEURONS; INCREASED EXPRESSION; HIPPOCAMPAL-NEURONS; FULL-LENGTH; IN-VIVO; INJURY	Recent studies have suggested that brain-derived neurotrophic factor (BNDF) and its receptor, trkB, may provide neuroprotection following injury to the central nervous system. Conversely, other studies have implicated BDNF as a contributing factor to neurodegenerative events that occur following injury. In order to further investigate the role of BDNF in neuroprotection, we subjected adult rats to a lateral fluid percussion (FP) injury of moderate severity (2.0-2.1 atm) or sham injury. After survival periods of 1, 3, 6, 24, or 72 h, the brains were processed for the in situ hybridization localization of BDNF and trkB mRNAs using S-35-labeled cRNA probes. Hybridization levels were compared between injured and sham animals for regions of the cortex that were located within, adjacent to, and remote from the site of the cortical contusion. BDNF mRNA levels were significantly decreased in the injured cortex at 72 h, increased in adjacent cortical areas at 3 h, and increased bilaterally in the piriform cortex from 3 to 24 h post-FP injury. Expression of trkB mRNA was significantly decreased at all postinjury time-points in the injured cortex and at 24 h in the adjacent cortex. These results demonstrate that, following lateral FP injury, BDNF and trkB mRNA levels are decreased in cortical regions that contain degenerating neurons, generally unchanged in adjacent regions, and increased in remote areas. Thus, injury-induced decreases in the expression of BDNF and trkB may confer vulnerability to neurons within the cortical contusion.	Univ Kentucky, Div Phys Therapy, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Surg, Lexington, KY 40536 USA		Hicks, RR (corresponding author), Univ Kentucky, Div Phys Therapy, Lexington, KY 40536 USA.	rrhick00@pop.uky.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS31816, NS35164] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031816, R55NS031816, R01NS035164] Funding Source: NIH RePORTER		ADAMS JH, 1992, GREENFIELDS NEUROPAT, P110; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BARNEOUD P, 1991, BEHAV BRAIN RES, V44, P87, DOI 10.1016/S0166-4328(05)80242-6; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cheng Y, 1997, ANN NEUROL, V41, P521, DOI 10.1002/ana.410410416; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; Dietrich W. D., 1987, CEREBROVASC DIS, P285; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; GALL CM, 1992, MOL CELL NEUROSCI, V3, P56, DOI 10.1016/1044-7431(92)90009-Q; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; Goodness TP, 1997, EUR J NEUROSCI, V9, P1574, DOI 10.1111/j.1460-9568.1997.tb01515.x; Hagg T, 1998, EXP NEUROL, V149, P183, DOI 10.1006/exnr.1997.6684; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; HUNTLEY CW, 1994, TRENDS NEUROSCI, V17, P536; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KINDY MS, 1993, J CEREBR BLOOD F MET, V13, P372, DOI 10.1038/jcbfm.1993.50; Klocker N, 1998, J NEUROSCI, V18, P1038; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Kokaia Z, 1996, NEUROSCIENCE, V75, P197, DOI 10.1016/0306-4522(96)00257-6; Kokaia Z, 1996, MOL BRAIN RES, V38, P139, DOI 10.1016/0169-328X(96)00002-2; KOLB B, 1990, CEREBRAL CORTEX RAT, P25; KUBO T, 1995, DEV BRAIN RES, V85, P249, DOI 10.1016/0165-3806(94)00220-T; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Litaudon P, 1997, EUR J NEUROSCI, V9, P1593, DOI 10.1111/j.1460-9568.1997.tb01517.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MUDO G, 1993, NEUROSCIENCE, V57, P901, DOI 10.1016/0306-4522(93)90036-F; Mudo G, 1996, EPILEPSIA, V37, P198, DOI 10.1111/j.1528-1157.1996.tb00012.x; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Seroogy K., 1997, NEUROCHEMISTRY PRACT, P121; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; SKAPER SD, 1993, J NEUROSCI RES, V34, P478, DOI 10.1002/jnr.490340413; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Tanaka K, 1996, BRAIN RES, V737, P59, DOI 10.1016/0006-8993(96)00658-0; Tsukahara T, 1998, NEUROCHEM INT, V33, P201, DOI 10.1016/S0197-0186(97)00112-5; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011	60	43	44	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	1999	16	6					501	510		10.1089/neu.1999.16.501			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	206LD	WOS:000080879800006	10391366				2022-02-06	
J	Kim, SH; Manes, F; Kosier, T; Baruah, S; Robinson, RG				Kim, SH; Manes, F; Kosier, T; Baruah, S; Robinson, RG			Irritability following traumatic brain injury	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							HEAD-INJURY; STROKE PATIENTS; POSTCONCUSSION SYNDROME; LESION LOCATION; MOOD DISORDERS; DEPRESSION; SEQUELAE; MILD	This study was undertaken to identify the clinical and pathoanatomical correlates of irritability in patients with closed head injuries. A consecutive series of 66 patients was assessed in hospital and at 3, 6, 9, and 12-month follow-ups. Patients fulfilling criteria for irritability were divided into 2 groups based on the immediate or delayed onset of their irritability and compared with patients without irritability for background characteristics, impairment variables, and lesion characteristics. There were IZ patients (18.2%) with acute onset irritability and 10 (15.1%) with delayed onset irritability. Acute onset irritability patients had a higher frequency of left cortical lesions. Delayed onset irritability patients showed a strong association with poor social functioning and greater impairment in activities of daily Living. The findings suggest that post-brain injury irritability may have different causes and treatment in the acute and chronic stages.	Univ Iowa, Dept Psychiat, Coll Med, Iowa City, IA 52242 USA; Chosun Univ, Coll Med, Dept Psychiat, Kwangju 501759, South Korea		Robinson, RG (corresponding author), Univ Iowa, Dept Psychiat, Coll Med, 200 Hawkins Dr,2887 JPP, Iowa City, IA 52242 USA.		Robinson, Robert/AAF-6191-2021		NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 52879, MH 53592] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH053592, R01MH052879] Funding Source: NIH RePORTER		BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Caine T. M., 1967, MANUAL HOSTILITY DIR; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALBRAITH S, 1985, BRIT MED J, V291, P1668, DOI 10.1136/bmj.291.6510.1668; GUALTIERI CT, 1991, NEUROPSYCHIAT BEHAV; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, V1st; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; LIDVALL HF, 1974, ACTA NEUROL SCAND, V50, P133; LONG CJ, 1995, NEUROPSYCHOLOGICAL A, P35; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCGINNIS GS, 1988, TRAUMA NURSING RESUS, P364; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NOVACO RW, 1985, ANGER HOSTILITY CARD; Novaco RW., 1975, ANGER CONTROL DEV EV; Paradiso S, 1996, J NERV MENT DIS, V184, P746, DOI 10.1097/00005053-199612000-00005; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; ROBINSON RG, 1985, AM J PSYCHIAT, V142, P1424; ROHRBAUGH RM, 1988, J AM GERIATR SOC, V36, P736, DOI 10.1111/j.1532-5415.1988.tb07177.x; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SPITZER RL, 1979, SCHEDULE AFFECTIVE D; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; TAYLOR CA, 1994, NEUROPSYCHIATRY TRAU, P87; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wing J. K., 1974, MEASUREMENT CLASSIFI	40	43	45	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	JUN	1999	187	6					327	335		10.1097/00005053-199906000-00001			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	205KN	WOS:000080820000001	10379719				2022-02-06	
J	Vaquero, J; Zurita, M; de Oya, S; Coca, S				Vaquero, J; Zurita, M; de Oya, S; Coca, S			Vascular endothelial growth permeability factor in spinal cord injury	JOURNAL OF NEUROSURGERY			English	Article						spinal cord injury; vascular endothelial growth factor; vascular permeability factor	VASOGENIC BRAIN EDEMA; TUMOR ANGIOGENESIS; FACTOR EXPRESSION; MENINGIOMAS; BREAKDOWN; BARRIER	Object. Predicated on the hypothesis that this cytokine can contribute to the development of vascular hyperpermeability, leading to tissue edema after trauma, the purpose of this study was to determine the presence in tissue of vascular endothelial growth/permeability factor (VEG/PF) after experimental spinal cord injury. Methods. The presence of VEG/PF was studied at 8 hours and 2, 8, and 14 days after a traumatic injury in adult Wistar rats. Studies were conducted in which a monoclonal antibody to the VEG/PF was used. Strong VEG/PF immunoreactivity was detected in the walls of pial and intramedullary vessels and in reactive astrocytes 8 hours posttrauma and was unchanged on Days 2 and 8. By Day 14, immunoreactivity decreased, and most of the arterioles from the pia and gray matter showed no mural VEG/PF. Conclusions. The authors' present findings suggest a role for this cytokine in the development of tissue edema after spinal cord trauma and point to the possible usefulness of a therapeutic approach to spinal cord injury based on blocking the cell expression of VEG/PF or its physiological effects.	Autonomous Univ Madrid, Neurosurg Serv, Puerta De Hierro Clin, E-28049 Madrid, Spain; Autonomous Univ Madrid, Neurosci Res Unit, Mapfre Med Fdn, E-28049 Madrid, Spain		Vaquero, J (corresponding author), Univ Madrid, Hosp Clin Puerta Hierro, Serv Neurocirugia, San Martin de Porres 4, Madrid, Spain.						BREIER G, 1992, DEVELOPMENT, V114, P521; DVORAK HF, 1995, INT ARCH ALLERGY IMM, V107, P233, DOI 10.1159/000236988; Goldman CK, 1997, NEUROSURGERY, V40, P1269, DOI 10.1097/00006123-199706000-00029; HAGG T, 1994, NEUROBIOLOGY CENTRAL, P245; KALARIA RN, 1995, J CEREB BLOOD FLOW M, V15, pS599; Kalkanis SN, 1996, J NEUROSURG, V85, P1095, DOI 10.3171/jns.1996.85.6.1095; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Murata T, 1996, LAB INVEST, V74, P819; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Provias J, 1997, NEUROSURGERY, V40, P1016, DOI 10.1097/00006123-199705000-00027; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STRUGAR J, 1994, J NEUROSURG, V81, P560, DOI 10.3171/jns.1994.81.4.0560; STRUGAR JG, 1995, J NEUROSURG, V83, P682, DOI 10.3171/jns.1995.83.4.0682; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; TISCHER E, 1991, J BIOL CHEM, V266, P11947; VAQUEROCRESPO J, 1976, INVEST CLIN, V17, P115; VAQUEROCRESPO J, 1976, INVEST CLIN, V17, P150	19	43	45	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	APR	1999	90	4		S			220	223		10.3171/spi.1999.90.2.0220			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	181YT	WOS:000079471600008	10199251				2022-02-06	
J	Triyoso, DH; Good, TA				Triyoso, DH; Good, TA			Pulsatile shear stress leads to DNA fragmentation in human SH-SU5Y neuroblastoma cell line	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							FINITE-ELEMENT ANALYSIS; NITRIC-OXIDE PRODUCTION; TRAUMATIC BRAIN INJURY; ENDOTHELIAL-CELLS; G-PROTEINS; EXPERIMENTAL GLAUCOMA; OXIDATIVE STRESS; MESSENGER-RNA; PC12 CELLS; C-FOS	1. Using an in vitro model of shear stress-induced cell injury we demonstrate that application of shear to differentiated human SH-SY5Y cells leads to cell death characterized by DNA fragmentation. Controlled shear stress was applied to cells via a modified cone and plate viscometer. 2. We show that pulsatile shear stress leads to DNA fragmentation, as determined via flow cytometry of fluorescein-12-dUTP nick-end labelled cells, in 45 +/- 4% of cells. No lactate dehydrogenase (LDH) release was observed immediately after injury; however, 24 h after injury significant LDH release was observed. 3. Nitric oxide production by cells subjected tu pulsatile shear increased two- to threefold over that in unsheared control cells. 4. Inhibition of protein synthesis, nitric oxide production, Ca(2+) entry into cells, and pertussis toxin-sensitive G protein activation attenuated the shear stress-induced cell injury. 5. Our results show for the first time that application of pulsatile shear stress to a neuron-like cell in vitro leads to nitric oxide-dependent cell death.	Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA		Good, TA (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	tgood@tamu.edu					ALEVRIADOU BR, 1993, ANN BIOMED ENG, V21, P1, DOI 10.1007/BF02368159; BERTHIAUME F, 1992, FEBS LETT, V308, P277, DOI 10.1016/0014-5793(92)81292-T; Bird R.B., 2006, TRANSPORT PHENOMENA, V2nd; Brubaker RF, 1996, AM J OPHTHALMOL, V121, P473, DOI 10.1016/S0002-9394(14)75421-2; CAHANE M, 1992, OPHTHALMIC RES, V24, P280, DOI 10.1159/000267179; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Chen S.S., 1987, J FLUIDS STRUCT, V1, P35, DOI [10.1016/s0889-9746(87)90170-8, DOI 10.1016/S0889-9746(87)90170-8]; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Desole MS, 1997, NEUROCHEM INT, V31, P169, DOI 10.1016/S0197-0186(96)00146-5; Ehrich M, 1998, J TOXICOL ENV HEAL A, V53, P385, DOI 10.1080/009841098159240; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Frangos JA, 1996, BIOCHEM BIOPH RES CO, V224, P660, DOI 10.1006/bbrc.1996.1081; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; HILL JO, 1993, REV INORG CHEM, V13, P183; HONG MS, 1997, THESIS TEXAS A M U; HSIEH HJ, 1993, J CELL PHYSIOL, V154, P143, DOI 10.1002/jcp.1041540118; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Kruman I, 1997, J NEUROSCI, V17, P5089; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; LAN QX, 1994, BIOCHEM BIOPH RES CO, V201, P950, DOI 10.1006/bbrc.1994.1794; Lee HF, 1997, TELECOMMUN SYST, V7, P355, DOI 10.1023/A:1019188715963; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; Mackrill JJ, 1997, BIOCHEM J, V327, P251, DOI 10.1042/bj3270251; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MATTSON MP, 1992, ANN NY ACAD SCI, V679, P1; McConkey DJ, 1996, MOL ASPECTS MED, V17, P1, DOI 10.1016/0098-2997(95)00006-2; MIKAWA S, 1995, MOL BRAIN RES, V33, P288, DOI 10.1016/0169-328X(95)00146-J; Miller SW, 1996, J NEUROCHEM, V67, P1897; Nikonorov IM, 1998, ANESTH ANALG, V86, P885, DOI 10.1097/00000539-199804000-00038; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Papadaki M, 1997, BIOTECHNOL PROGR, V13, P209, DOI 10.1021/bp970029f; Prince JA, 1997, BRAIN RES BULL, V43, P515, DOI 10.1016/S0361-9230(97)00328-6; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Reich KM, 1997, ENDOCRINOLOGY, V138, P1014, DOI 10.1210/en.138.3.1014; Ridge J, 1996, IN VITRO CELL DEV-AN, V32, P238; Satoh T, 1996, J BIOCHEM-TOKYO, V120, P540; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; YAN DB, 1994, BRIT J OPHTHALMOL, V78, P643, DOI 10.1136/bjo.78.8.643; YAN GM, 1995, J NEUROCHEM, V65, P2425	45	43	43	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	MAR 1	1999	515	2					355	365		10.1111/j.1469-7793.1999.355ac.x			11	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	182VQ	WOS:000079519200004	10050003	Green Published, Bronze			2022-02-06	
J	Bicik, I; Radanov, BP; Schafer, N; Dvorak, J; Blum, B; Weber, B; Burger, C; von Schulthess, GK; Buck, A				Bicik, I; Radanov, BP; Schafer, N; Dvorak, J; Blum, B; Weber, B; Burger, C; von Schulthess, GK; Buck, A			PET with (18)fluorodeoxyglucose and hexamethylpropylene amine oxime SPECT in late whiplash syndrome	NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; TECHNETIUM-99M-HMPAO SPECT; CEREBRAL SYMPTOMS; COMMON WHIPLASH; DYSFUNCTION; DEPRESSION; VALIDATION; DEFICITS; MRI	Background: Many patients have cognitive abnormalities and psychological problems after whiplash injury to the cervical spine. To our knowledge, neuroradiologic imaging has not depicted brain damage that explains the symptoms. Parietotemporo-occipital perfusion deficits on hexamethylpropylene amine oxime (HMPAO) SPECT studies have been described among patients who have sustained whiplash injury. Methods: Mie examined 13 patients with typical late whiplash syndrome (study group) using HMPAO SPECT, (18)fluorodeoxyglucose (FDG) PET, and MRI of the brain and compared the findings with those for 16 control subjects who underwent FDG PET. Results: In the study group, statistical parametric mapping revealed significantly decreased FDG uptake in the frontopolar and lateral temporal cortex and in the putamen. The frontopolar hypometabolism correlated significantly with scores of the Beck Depression Inventory. However, in individual cases, reliability in the depiction of hypometabolic areas was relatively low. No alterations were found in the parietotemporo-occipital area. In these areas, decreased uptake of HMPAO and FDG correlated with cortical mass. Conclusion: FDG PET did not allow reliable diagnosis of metabolic disturbances for individual patients. Therefore, we do not recommend FDG PET or HMPAO SPECT as a diagnostic tool in routine examinations of patients with late whiplash syndrome.	Univ Zurich, Dept Med Radiol, Div Nucl Med, CH-8006 Zurich, Switzerland; Univ Bern, Inselspital, Dept Psychiat, CH-3010 Berne, Switzerland; Schulthess Clin, Spine Unit, Dept Neurol, Zurich, Switzerland; Univ Zurich, Dept Neurol, CH-8006 Zurich, Switzerland		Buck, A (corresponding author), Univ Zurich Hosp, Dept Med Radiol, Div Nucl Med, Ramistr 100, CH-8091 Zurich, Switzerland.		Weber, Bruno/E-4400-2013	Schaefer, Niklaus/0000-0002-9732-7696			Beck AT, 1987, BECK DEPRESSION INVE; BERSTAD JR, 1975, ACTA NEUROL SCAND, V51, P268; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; HARRIS GJ, 1994, AM J NEURORADIOL, V15, P225; HAUTZINGER M, 1992, DEPRESSIONS INVENTAR; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; KEIDEL M, 1992, NERVENARZT, V63, P731; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; KOHN MI, 1991, RADIOLOGY, V178, P115, DOI 10.1148/radiology.178.1.1984289; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; OMMAYA K, 1975, HDB CLIN NEUROLOGY, V24, P67; Otte A, 1996, EUR J NUCL MED, V23, P72, DOI 10.1007/BF01736993; Otte A, 1997, J NUCL MED, V38, P1002; OTTE A, 1995, LANCET, V345, P8963; PIETRZYK U, 1994, J NUCL MED, V35, P2011; RADANOV BP, 1994, J NEUROL NEUROSUR PS, V57, P486, DOI 10.1136/jnnp.57.4.486; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Radanov BP, 1996, PAIN, V64, P429, DOI 10.1016/0304-3959(95)00148-4; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SPITZER WO, 1995, SPINE, V20, pS1; Talairach J., 1988, COPLANAR STEREOTAXIC; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Zimmermann P., 1993, DEV ASSESSMENT REHAB, P3	28	43	43	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0028-3878			NEUROLOGY	Neurology	AUG	1998	51	2					345	350		10.1212/WNL.51.2.345			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110NN	WOS:000075387400009	9710001				2022-02-06	
J	Dutcher, SA; Underwood, BD; Walker, PD; Diaz, FG; Michael, DB				Dutcher, SA; Underwood, BD; Walker, PD; Diaz, FG; Michael, DB			Patterns of heat-shock protein 70 biosynthesis following human traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral cortex; gene expression; hsp70; human brain injury	FOCAL CEREBRAL-ISCHEMIA; RAT-BRAIN; GENE-EXPRESSION; C-FOS; TRANSIENT ISCHEMIA; HYPOXIA-ISCHEMIA; KAINIC ACID; INDUCTION; HIPPOCAMPUS; CELLS	Heat-shock protein 70 (hsp70) is activated upon cellular stress/injury and participates in the folding and intracellular transport of damaged proteins, The expression of hsp70 following CNS trauma has been speculated to be part of a cellular response which is involved in the repair of damaged proteins, In this study, we measured hsp70 mRNA and protein levels within human cerebral cortex subjected to traumatic brain injury. Specimens were obtained during routine neurosurgery for trauma and processed for Northern mRNA and Western protein analysis, The largest increase in hsp70 mRNA levels was detected in trauma tissue obtained 4-6 h following injury. By 24 h, hsp70 mRNA levels were similar to nontrauma comparison tissues, hsp70 protein expression exhibited its greatest increases at 12-20 h post-injury, Immunocytological techniques revealed hsp70 protein expression in cells with neuronal-like morphology at 12 h after injury, These results suggest a role for hsp70 in human cortex following TBI, Moreover, since the temporal induction pattern of hsp70 biosynthesis is similar to that reported in the rodent, our observations validate the importance of rodent brain injury models in providing useful information directly applicable to human brain injury.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Dutcher, SA (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030550] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30550] Funding Source: Medline		Amin V, 1996, NEUROSCI LETT, V206, P45, DOI 10.1016/0304-3940(96)12421-6; Bellmann K, 1996, FEBS LETT, V391, P185, DOI 10.1016/0014-5793(96)00730-2; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRIE RW, 1981, SCIENCE, V214, P72, DOI 10.1126/science.7280681; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1994, MOL BRAIN RES, V25, P19, DOI 10.1016/0169-328X(94)90274-7; DWYER BE, 1989, EXP NEUROL, V104, P28, DOI 10.1016/0014-4886(89)90005-8; FERRIERO DM, 1990, DEV BRAIN RES, V53, P145, DOI 10.1016/0165-3806(90)90136-M; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; JACEWICZ M, 1986, J CEREBR BLOOD F MET, V6, P263, DOI 10.1038/jcbfm.1986.48; KASOF GM, 1995, J NEUROSCI, V15, P4238; KONOPKA D, 1995, NEUROSCI LETT, V185, P167, DOI 10.1016/0304-3940(95)11252-R; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; SATOH J, 1992, BRAIN RES, V573, P37, DOI 10.1016/0006-8993(92)90111-L; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; UNEY JB, 1988, FEBS LETT, V235, P215, DOI 10.1016/0014-5793(88)81265-1; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; WALKER PD, 1993, J NEUROSCI RES, V36, P588, DOI 10.1002/jnr.490360511; WALKER PD, 1993, NEUROREPORT, V4, P699, DOI 10.1097/00001756-199306000-00024	28	43	47	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	1998	15	6					411	420		10.1089/neu.1998.15.411			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZR931	WOS:000074030700003	9624626				2022-02-06	
J	Lin, VWH; Singh, H; Chitkara, RK; Perkash, I				Lin, VWH; Singh, H; Chitkara, RK; Perkash, I			Functional magnetic stimulation for restoring cough in patients with tetraplegia	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							TRAUMATIC QUADRIPLEGIA; CORD INJURY; DIAPHRAGM; NERVE; BRAIN	Objective: To evaluate the usefulness of functional magnetic stimulation (FMS) as a noninvasive method for assisting cough in patients with tetraplegia. Design: A prospective before-after trial. Setting: The functional magnetic stimulation laboratory of a spinal cord injury (SCI) service. Participants: Thirteen male SCI patients, with injury levels between C4 and C7. Intervention: A commercially available magnetic stimulator with a round magnetic coil (MC) was used. Expiratory muscle activation was achieved by placing the MC along the lower thoracic spine. Main Outcome Measure: The planned major outcome measures were the maximal expired pressure (MEP), expiratory reserve volume (ERV), and forced expiratory flow rate (FEF) by FMS compared with voluntary maximal efforts. Another outcome was the optimal MC placement and stimulation intensity that would result in highest expired pressure. Results: The mean (+/-SEM) MEP, ERV, and FEF generated by FMS were 66.40 +/- 6.69cmH(2)O, .77 +/- .14L, and 5.28 +/- .42L/sec, respectively. They were 118%, 169%, and 110% of voluntary maximum efforts. MC placement at the T10 to T11 spinous process and stimulation intensity at 80% produced the highest MEP and FEF. Conclusion: FMS of the expiratory muscles produced significant expired pressures, volumes, and flow rates when compared with voluntary maximum efforts; therefore, FMS can be used as an effective method to restore cough in tetraplegic patients. (C) 1998 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Vet Adm Palo Alto Hlth Care Syst, Spinal Cord Injury Serv, Funct Magnet Simulat Lab, Stanford, CA 94305 USA; Vet Adm Palo Alto Hlth Care Syst, Pulm Dis Sect, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Funct Restorat, Div Phys Med & Rehabil, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA		Lin, VWH (corresponding author), Vet Adm Palo Alto Hlth Care Syst, Spinal Cord Injury Serv, Funct Magnet Simulat Lab, 3801 Miranda Ave, Stanford, CA 94305 USA.			Lin, Vernon/0000-0002-8078-0275			BARKER AT, 1987, NEUROSURGERY, V20, P100; BELLAMY R, 1973, J NEUROSURG, V39, P596, DOI 10.3171/jns.1973.39.5.0596; BRAUN SR, 1984, AM J PHYS MED REHAB, V63, P1; CADWELL J, 1989, MAGNETIC STIMULATION, P16; CHOKROVERTY S, 1995, MUSCLE NERVE, V18, P987, DOI 10.1002/mus.880180910; DIMARCO AF, 1995, AM J RESP CRIT CARE, V151, P1466, DOI 10.1164/ajrccm.151.5.7735601; FISHBURN MJ, 1990, ARCH PHYS MED REHAB, V71, P197; FUGL-MEYER A R, 1971, Scandinavian Journal of Rehabilitation Medicine, V3, P141; JAEGER RJ, 1993, ARCH PHYS MED REHAB, V74, P1358, DOI 10.1016/0003-9993(93)90093-P; Kirby N A, 1966, Arch Phys Med Rehabil, V47, P705; LEDSOME JR, 1981, AM REV RESPIR DIS, V124, P41; Lin V W, 1997, J Spinal Cord Med, V20, P218; LIN VWH, 1997, AM J RESP CRIT CARE, V155, pA917; LIN VWH, 1993, ARCH PHYS MED REHAB, V74, P1237; LINDER SH, 1993, CHEST, V103, P166, DOI 10.1378/chest.103.1.166; LISSENS MA, 1994, J NEUROL SCI, V124, P204, DOI 10.1016/0022-510X(94)90327-1; MACABEE PJ, 1991, ELECTROEN CLIN NEURO, V81, P224; MCMICHAN JC, 1980, JAMA-J AM MED ASSOC, V243, P528, DOI 10.1001/jama.243.6.528; SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P1311, DOI 10.1152/jappl.1989.67.4.1311; STONE DJ, 1963, AM REV RESPIR DIS, V88, P621; WRAGG S, 1994, EUR RESPIR J, V7, P1778; Zifko U, 1996, MUSCLE NERVE, V19, P614, DOI 10.1002/(SICI)1097-4598(199605)19:5<614::AID-MUS9>3.3.CO;2-6	22	43	51	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	1998	79	5					517	522		10.1016/S0003-9993(98)90065-X			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZM198	WOS:000073514500007	9596391				2022-02-06	
J	Drummond, JC; Patel, PM; Cole, DJ; Kelly, PJ				Drummond, JC; Patel, PM; Cole, DJ; Kelly, PJ			The Effect of the reduction of colloid oncotic pressure, with and without reduction of osmolality, on post-traumatic cerebral edema	ANESTHESIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Anesthesiologists	OCT 17-25, 1996	NEW ORLEANS, LOUISIANA	Amer Soc Anesthesiologists		cerebral edema; fluid percussion injury; fluid resuscitation; head injury; osmolality; trauma	BRAIN-BARRIER PERMEABILITY; PLASMA OSMOLALITY; CRYOGENIC INJURY; PENTASTARCH; ISCHEMIA; RESUSCITATION; HEMODILUTION; REPERFUSION; SALINE; RATS	Background: It has been asserted that reduction of colloid oncotic pressure (COP) can aggravate traumatic brain edema. To explore this issue, the authors measured the effect of COP reduction, with and without a simultaneous decrease in osmolality, on the development of brain edema after fluid percussion injury (FPI). Methods: Isoflurane-anesthetized Wistar rats received a 2.7-atm right parasagittal FPI followed by isovolemic exchange with (1) normal saline (NS); (2) half-normal saline (0.5 NS); (3) whole blood (WB); or (4) hetastarch (Hespan, Dupont). Shed blood (16 mi) was replaced with donor erythrocytes suspended in the study fluid. The WB group received heparinized fresh donor WB. Central venous pressure was maintained with additional study fluid as required. The specific gravity (SG) of the cortex and subcortex near the impact site was determined 4.5 h after FPI. The water content of the hemispheres was also determined using the wet-dry method. To define the status of the blood-brain barrier in the non-FPI hemisphere, two additional groups (FPI, non-FPI) were studied. Both groups received 30 mg/kg Evans' blue and NS at 4 ml/kg(-1)/h(-1). Four hours after FPI, the concentration of Evans' blue in the hemispheres was determined. Results: After exchange, COP (mmHg +/- SD) decreased in the NS (9.6 +/- 2.1) and 0.5 NS (8.5 +/- 0.5) groups and was unchanged in the WB (16.7 +/- 3.3) and hetastarch (18.9 +/- 1.1) groups. Osmolality was unchanged in the WB group (295 +/- 5 mOsm/kg), increased in the NS (304 +/- 3 mOsm/kg) and hetastarch (306 +/- 2 mOsm/kg) groups, and was decreased in the 0.5 NS group (261 +/- 6 mOsm/kg). The Evans' blue data indicated that FPI resulted in blood-brain barrier damage in both hemispheres. In all four exchange groups, the SG of both cortical and subcortical tissue was less (indicating greater water content) in the impact hemisphere than in the nonimpact hemisphere. The SG was less in both hemispheres, although it was less in both hemispheres in the NS and 0.5 NS groups than in the WB and hetastarch groups. The lowest SG values were observed in the 0.5 NS group. The wet-dry water content determinations yielded a similar pattern of edema formation. Conclusions: These data, while confirming the important edematogenic effect of decreased osmolality, indicate that COP reduction per se can also aggravate brain edema after a mild to moderate mechanical head injury.	Univ Calif San Diego, Dept Anesthesia, San Diego, CA 92103 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA USA		Drummond, JC (corresponding author), Univ Calif San Diego, Med Ctr, Dept Anesthesiol, 200 W Arbor Dr, San Diego, CA 92103 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R29-GMS2098-01A1] Funding Source: Medline		COLE DJ, 1990, CAN J NEUROL SCI, V17, P372, DOI 10.1017/S0317167100030900; GO KG, 1972, J NEUROL SCI, V16, P209, DOI 10.1016/0022-510X(72)90090-1; GOULIN GD, 1994, ANESTH ANALG, V79, P1036; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P554, DOI 10.1097/00000542-198910000-00013; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KOROSUE K, 1990, J NEUROSURG, V73, P576, DOI 10.3171/jns.1990.73.4.0576; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; NAGY KK, 1993, CIRC SHOCK, V40, P289; PROUGH DS, 1994, ANESTH ANALG, V79, P1034; RACKOW EC, 1977, CHEST, V72, P709, DOI 10.1378/chest.72.6.709; SCHELL RM, 1992, ANESTHESIOLOGY, V77, P86, DOI 10.1097/00000542-199207000-00013; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; TRANMER BI, 1989, NEUROSURGERY, V25, P173, DOI 10.1227/00006123-198908000-00004; VIRGILIO RW, 1979, SURGERY, V85, P129; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; ZIKRIA BA, 1989, SURGERY, V105, P625; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	19	43	45	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-3022			ANESTHESIOLOGY	Anesthesiology	APR	1998	88	4					993	1002		10.1097/00000542-199804000-00020			10	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ZG645	WOS:000073024700020	9579509				2022-02-06	
J	Lancon, JA; Haines, DE; Parent, AD				Lancon, JA; Haines, DE; Parent, AD			Anatomy of the shaken baby syndrome	ANATOMICAL RECORD			English	Article						shaken baby syndrome; traumatic injuries; child abuse	PERMANENT BRAIN-DAMAGE; MENTAL-RETARDATION; INFANTS; INJURIES; SHAKING; FALLS	Shaken baby syndrome refers to the constellation of nonaccidental injuries occurring in infants and young children as a consequence of violent shaking, The typical victim of shaken baby syndrome is a male infant younger than six months of age who is alone with the perpetrator at the time of injury, Occurrence of the syndrome is unrelated to race, gender, socioeconomic status, or education, The characteristic injuries observed in shaken baby syndrome include subdural hemorrhages, retinal hemorrhages, and fractures of the ribs or long bones. Although each of these injuries may result from violent shaking of the victim, the most severe brain injuries result from the addition of a forceful impact of the infant's or child's head against a firm surface, The unique anatomic features of the infant's head and skeletal system, which account for the type and pattern of injuries observed in shaken baby syndrome, are emphasized in this article. (C) 1998 Wiley-Liss, Inc.	Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Anat, Jackson, MS 39216 USA		Lancon, JA (corresponding author), Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA.						BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Giardino A.P., 1997, PRACTICAL GUIDE EVAL; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; HELFER RE, 1977, PEDIATRICS, V60, P533; KLEINMAN PK, 1986, AM J ROENTGENOL, V146, P895, DOI 10.2214/ajr.146.5.895; KLEINMAN PK, 1989, NEW ENGL J MED, V320, P507, DOI 10.1056/NEJM198902233200807; Levin AV, 1990, OPHTHALMOL CLIN N AM, V3, P249; MONTELEONE JA, 1994, CHILD MALTREATMENT C; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; WILSON EF, 1977, PEDIATRICS, V60, P751	14	43	44	0	6	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0003-276X			ANAT REC	Anat. Rec.	FEB	1998	253	1					13	18		10.1002/(SICI)1097-0185(199802)253:1<13::AID-AR8>3.0.CO;2-F			6	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	ZF467	WOS:000072900400008	9556020				2022-02-06	
J	McCrory, PR; Berkovic, SF				McCrory, PR; Berkovic, SF			Concussive convulsions - Incidence in sport and treatment recommendations	SPORTS MEDICINE			English	Article							CEREBRAL CONCUSSION; SYNCOPE; GUIDELINES; EPISODES	Concussive convulsions (CC) are nonepileptic phenomena which are an immediate sequelae of concussive brain injury. Although uncommon, occurring with an approximate incidence of 1 case per 70 concussions, these episodes are often confused with post-traumatic epilepsy which may occur with more severe structural brain injury. The pathophysiological mechanism of CC remains speculative, but may involve a transient traumatic functional decerebration with loss of cortical inhibition and release of brainstem activity. The phenomenology of the CC is somewhat akin to convulsive syncope, with an initial tonic phase occurring within 2 seconds of impact, followed by a clonic or myoclonic phase which may last several minutes. Lateralising features are common during the convulsions. There is no evidence of structural or permanent brain injury on clinical assessment, neuropsychological testing or neuroimaging studies. Long term outcome is universally good with no evidence of long term epilepsy and athletes are usually able to return to sport within 2 weeks. The correct management of these episodes centres on the appropriate management of the associated concussive injury and the exclusion of other cerebral injury by medical assessment. The CC requires no specific management beyond immediate onfield first aid measures such protection of the airway. Antiepileptic therapy is not indicated and prolonged absence from spc,rt is unwarranted. These episodes, although dramatic, are relatively straightforward to manage and all team physicians and those involved in athlete care need to be aware of this condition.	Olymp Pk Sports Med Ctr, Melbourne, Vic 3004, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic, Australia		McCrory, PR (corresponding author), Olymp Pk Sports Med Ctr, Swan St, Melbourne, Vic 3004, Australia.	pmccrory@compuserve.com	McCrory, Paul/Q-8688-2019				AMINOFF MJ, 1988, ANN INTERN MED, V108, P791, DOI 10.7326/0003-4819-108-6-791; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BOVE AA, 1973, AEROSPACE MED, V44, P245; BRUKNER P, 1993, CLIN SPORTS MED, P608; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Chadwick D, 1997, BRIT MED J, V314, P1283; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DUVOISIN RC, 1962, ARCH NEUROL-CHICAGO, V7, P219, DOI 10.1001/archneur.1962.04210030057008; GASTAUT H, 1957, LANCET, V2, P1018; GASTAUT H, 1974, HDB CLIN NEUROLOGY; GASTAUT H, 1972, EPILEPTIC SEIZURES C, P186; GOWERS WR, 1907, BORDERLAND EPILEPSY, P45; GOWERS WR, 1881, EPILEPSY CHRONIC CON, P24; HOWARD P, 1951, BRIT MED J, V2, P382, DOI 10.1136/bmj.2.4728.382; JENNETT B, 1975, EPILEPSY NONMISSILE, P13; KHURANA RK, 1980, ANN NEUROL, V7, P144, DOI 10.1002/ana.410070209; Lempert T, 1996, J ROY SOC MED, V89, P372, DOI 10.1177/014107689608900705; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; ORCHARD J, 1995, AFL 1995 INJURY REPO; ORCHARD J, 1995, AFL VSFL INJURIES 19; PHILLIPS G, 1954, J NEUROL NEUROSUR PS, V17, P1, DOI 10.1136/jnnp.17.1.1; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; Roos R, 1996, PHYSICIAN SPORTSMED, V24, P67, DOI 10.3810/psm.1996.10.1327; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; STEPHENSON JBP, 1990, FITS FAINTS, P112; TORG JF, 1991, ATHLETIC INJURIES HE, P270; WESTPHAL CFO, 1871, BERLINER FKLIN WOCHE, V1, P39; WESTPHAL CFO, 1872, BRIT MED J, V1, P399; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012; WLAKER AE, 1969, LATE EFFECTS HEAD IN, P23	38	43	45	1	9	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.	FEB	1998	25	2					131	136		10.2165/00007256-199825020-00005			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YZ634	WOS:000072273900007	9519401				2022-02-06	
J	Nast-Kolb, D; Trupka, A; Ruchholtz, S; Schweiberer, L				Nast-Kolb, D; Trupka, A; Ruchholtz, S; Schweiberer, L			Abdominal trauma	UNFALLCHIRURG			German	Article						multitrauma; emergency therapy; abdominal diagnosis; laparoscopy; laparotomy	SEVERE HEPATIC-TRAUMA; SEVERE LIVER TRAUMA; STAB WOUNDS; NONOPERATIVE MANAGEMENT; BLUNT TRAUMA; INJURIES; TRANSPLANTATION; RESUSCITATION; LAPAROSCOPY; HEMORRHAGE	While a great part of the Anglo-American medical literature addresses the topic of penetrating trauma the German spreaking countries rather publish on blunt abdominal injury. The presented paper discusses the strategic principles of acute clinical management of abdominal trauma on the combined basis of own research results and a comprehensive review of the literature. Blunt abdominal injuries in most cases from a part in the pattern of multiple trauma. The early, first-hours mortality is most often caused by severe traumatic brain injury or abdominal trauma with massive hemorrhage. The prehospital management of penetrating injuries is characterized rather by the concept of 'load and go', whereas the on-scene stabilization of the patient with blunt abdominal injury should precede transport to the adequate hospital. On arrival in the accident and emergency room an immediate blood transfusion is recommended far hemodynamically unstable patients. If then a stabilization is not achieved, an emergency laparotomy should follow. Abdominal stab injuries should be explored by laparoscopy if an intraperitoneal lesion is suspected. If then the possibility of an intestinal lesion is present a laparotomy should be performed directly thereafter. Firearm injuries require open revision in almost all cases. The standard diagnostic technique in blunt abdominal trauma is sonography, assisted by computed tomography and, if indicated, angiography in hemodynamically stable patients. Isolated abdominal injuries without hemodynamic or coagulation disorders allow conservative treatment in the intensive care setting. In severe multiple trauma as well as in manifest shock even the smallest fluid detection should lead to laparotomy. The surgical treatment of splenic rupture is still a matter of discussion. Splenectomy is indicated in patients with severe concomitating injuries or shock whereas in the remainder of cases the total or partial preservation of the spleen should be pursued. Hepatic injuries offer a broad spectrum of operative interventions, ranging from superficial hemostatic measures over compression techniques like 'packing' and 'mesh-wrapping' to atypical and anatomical resections and to liver transplantation in exceptional cases. Lesions of tubular organs and the pancreas pose especially difficult diagnostical problems but regularly allow a rather easy operative treatment.	Univ Munich, Klinikum Innenstadt, Chirurg Klin & Poliklin, D-8000 Munich, Germany		Nast-Kolb, D (corresponding author), Chirurg Klin, Nussbaumstr 20, D-80336 Munich, Germany.						ANDERSSON R, 1986, ACTA CHIR SCAND, V152, P739; ANGSTADT J, 1989, J TRAUMA, V29, P606, DOI 10.1097/00005373-198905000-00012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARDENHEUER M, 1995, UNFALLCHIRURG, V268, P269; BEAL SL, 1990, J TRAUMA, V30, P163, DOI 10.1097/00005373-199002000-00005; BEGER H, 1992, CHIRG OPERATIONSLEHR, V3, P75; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Branney SW, 1997, J TRAUMA, V42, P1086, DOI 10.1097/00005373-199706000-00017; BRUNET C, 1994, J TRAUMA, V37, P200, DOI 10.1097/00005373-199408000-00008; COGBILL TH, 1988, J TRAUMA, V28, P1433, DOI 10.1097/00005373-198810000-00004; CROCE MA, 1991, J TRAUMA, V31, P806, DOI 10.1097/00005373-199106000-00011; CUE JI, 1990, J TRAUMA, V30, P1007, DOI 10.1097/00005373-199008000-00010; DEMETRIADES D, 1986, BRIT J SURG, V73, P736, DOI 10.1002/bjs.1800730919; DEMETRIADES D, 1987, ANN SURG, V205, P129, DOI 10.1097/00000658-198702000-00005; DOCK W, 1988, UNFALLCHIRURG, V91, P185; DURHAM RM, 1992, AM J SURG, V164, P477, DOI 10.1016/S0002-9610(05)81184-5; ENDERSON BL, 1991, SURG CLIN N AM, V71, P399; Ertel W, 1996, UNFALLCHIRURG, V99, P288; ESQUIVEL CO, 1987, J TRAUMA, V27, P800, DOI 10.1097/00005373-198707000-00020; FABIAN TC, 1993, ANN SURG, V217, P557, DOI 10.1097/00000658-199305010-00017; FARNELL MB, 1988, SURGERY, V104, P748; FELICIANO DV, 1986, ANN SURG, V204, P438, DOI 10.1097/00000658-198610000-00012; FELICIANO DV, 1988, ANN SURG, V208, P362, DOI 10.1097/00000658-198809000-00014; FELICIANO PD, 1992, J TRAUMA, V33, P340, DOI 10.1097/00005373-199209000-00002; GOLDBERGER JH, 1982, J TRAUMA, V22, P476, DOI 10.1097/00005373-198206000-00006; HALLFELDT KKJ, 1998, IN PRESS SURG ENDOSC; HOLLANDS MJ, 1991, BRIT J SURG, V78, P968, DOI 10.1002/bjs.1800780824; IVATURY RR, 1993, J TRAUMA, V34, P822, DOI 10.1097/00005373-199306000-00013; KIRSCHNER P, 1974, THERAPIEWOCHE, V24, P4268; Kohlberger E J, 1989, Fortschr Med, V107, P244; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; KUDSK K, 1982, ABDOMINAL TRAUMA TRA; KUNIN JR, 1993, AM J ROENTGENOL, V160, P1221, DOI 10.2214/ajr.160.6.8498221; Matsuoka T, 1996, J TRAUMA, V41, P439, DOI 10.1097/00005373-199609000-00009; MCHENRY CR, 1994, AM J SURG, V168, P280, DOI 10.1016/S0002-9610(05)80202-8; MCINTYRE R, 1989, INJURY, V20, P355, DOI 10.1016/0020-1383(89)90013-2; MCKENNEY M, 1994, J TRAUMA, V37, P439, DOI 10.1097/00005373-199409000-00018; MEREDITH JW, 1994, J TRAUMA, V36, P529, DOI 10.1097/00005373-199404000-00012; MOORE EE, 1984, AM J SURG, V148, P712, DOI 10.1016/0002-9610(84)90422-7; NAGEL M, 1992, ZBL CHIR, V117, P453; NAGEL M, 1991, UNFALLCHIRURG, V94, P105; NASTKOLB D, 1994, UNFALLCHIRURG, V97, P292; NASTKOLB D, 1997, LANGENBECKS ARCH C S, V2, P330; NASTKOLB D, 1993, CHIRURG, V64; OLDHAFER KJ, 1993, UNFALLCHIRURG, V96, P497; Patton JH, 1997, J TRAUMA, V43, P234, DOI 10.1097/00005373-199708000-00005; PEIPER HJ, 1987, CHIRURG, V58, P189; REED R, 1992, ANN SURG, V26, P524; RINGE B, 1991, SURGERY, V109, P792; ROSS SE, 1995, INJURY, V26, P393, DOI 10.1016/0020-1383(95)00058-H; ROSSI P, 1993, AM J SURG, V166, P707, DOI 10.1016/S0002-9610(05)80684-1; SCHMIDT U, 1994, UNFALLCHIRURG, V97, P54; SCHWEIBERER L, 1991, JB CHIRURG 1991, P19; SEUFERT R, 1992, CHIRURG ABDOMENS, V3, P127; SMITH JS, 1992, J TRAUMA, V33, P363, DOI 10.1097/00005373-199209000-00005	55	43	44	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	FEB	1998	101	2					82	91		10.1007/s001130050239			16	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	ZB289	WOS:000072456100002	9553475				2022-02-06	
J	Abe, K; Setoguchi, Y; Hayashi, T; Itoyama, Y				Abe, K; Setoguchi, Y; Hayashi, T; Itoyama, Y			In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain	BRAIN RESEARCH			English	Article						gene transfer; lacZ gene; ischemia; brain	CENTRAL-NERVOUS-SYSTEM; FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; NEURONAL DEATH; THERAPY; INVIVO; VECTORS; INDUCTION; DISEASE; CELLS	In an attempt to study whether ischemic brain could express a foreign gene in vivo, a replication-defective adenoviral vector containing the Escherichia coli lacZ gene was directly injected into the ischemic or reperfused cerebral cortex of rat, and temporal and spatial profiles of the exogenous gene expression were compared with that of the control brain. Right middle cerebral artery (MCA) of rat was continuously occluded by an insertion of nylon thread for 2 days, or only transiently occluded for 90 min and then the blood flow was restored for 21 days. The adenoviral vector was administered just after the MCA occlusion or reperfusion in the case of continuous ischemia and reperfusion, respectively. Adenoviral vector was transferred into the continuous ischemic brain, and the lacZ gene was expressed until 2 days of the occlusion in the cerebral cortex of the occluded MCA territory with the number of expressing cells smaller and the staining just weaker than that of the control brain. In contrast, expression of the lacZ gene was not or only minimally observed in the reperfused brain until 2 days. However, the expression dramatically exploded at 7 days of reperfusion at a level similar to that of the control, and the expression diminished by 21 days. A few neurons in the ipsilateral thalamus, hypothalamus, and basal ganglia, and in the contralateral cerebral cortex expressed the lacZ gene at 7 days after reperfusion, a phenomenon similar to the case of the control. The majority of brain cells that expressed the lacZ gene were neurons, and a part (5-10%) were astroglial cells. Traumatic injury and immunological response in the brain were minimal both in the cases of control and ischemia/reperfusion. The present study shows an effective gene transfer and the expression in neural cells of ischemic and reperfused brains in vivo, and suggests a great potential of the gene therapy for ischemic stroke patients in the future. (C) 1997 Elsevier Science B.V.	JUNTENDO UNIV,SCH MED,DEPT RESP MED,TOKYO 113,JAPAN		Abe, K (corresponding author), TOHOKU UNIV,SCH MED,DEPT NEUROL,AOBA KU,1-1 SEIRYO MACHI,SENDAI,MIYAGI 98077,JAPAN.		Setoguchi, Yasuhiro/AAE-1448-2021	Setoguchi, Yasuhiro/0000-0002-0892-6364			ABE K, 1991, NEUROSCI LETT, V123, P248, DOI 10.1016/0304-3940(91)90942-M; ABE K, 1995, NEUROSCI LETT, V199, P152, DOI 10.1016/0304-3940(95)12039-7; ABE K, 1987, BRAIN RES, V423, P221, DOI 10.1016/0006-8993(87)90843-2; ABE K, 1991, NEUROSCI LETT, V125, P166, DOI 10.1016/0304-3940(91)90018-O; ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; ABE K, 1988, J NEUROCHEM, V51, P1470, DOI 10.1111/j.1471-4159.1988.tb01113.x; ABE K, 1993, PROG BRAIN RES, V96, P221; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BAUTERS C, 1994, AM J PHYSIOL-HEART C, V267, pH1263, DOI 10.1152/ajpheart.1994.267.4.H1263; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; BREAKEFIELD XO, 1993, NAT GENET, V3, P187, DOI 10.1038/ng0393-187; CULOTTA E, 1993, SCIENCE, V260, P914, DOI 10.1126/science.8493527; DANKO I, 1993, HUM MOL GENET, V2, P2055, DOI 10.1093/hmg/2.12.2055; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DECONINCK N, 1996, P NATL ACAD SCI USA, V93, P350; FELDMAN LJ, 1995, J AM COLL CARDIOL, V26, P826, DOI 10.1016/0735-1097(95)00235-V; FINK DJ, 1992, HUM GENE THER, V3, P11, DOI 10.1089/hum.1992.3.1-11; FINKEL T, 1995, FASEB J, V9, P843, DOI 10.1096/fasebj.9.10.7615154; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Heistad DD, 1996, STROKE, V27, P1688, DOI 10.1161/01.STR.27.9.1688; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Karpati G, 1996, TRENDS NEUROSCI, V19, P49; LINNIK MD, 1995, STROKE, V26, P1670, DOI 10.1161/01.STR.26.9.1670; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NABEL EG, 1995, CIRCULATION, V91, P541, DOI 10.1161/01.CIR.91.2.541; NEVE RL, 1993, TRENDS NEUROSCI, V16, P251, DOI 10.1016/0166-2236(93)90174-K; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Okada Y, 1996, AM J PATHOL, V149, P37; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; OOBOSHI H, 1995, CIRC RES, V77, P7, DOI 10.1161/01.RES.77.1.7; PALLELA TD, 1989, GENE, V80, P137; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SALLE GL, 1993, SCIENCE, V259, P988; SETOGUCHI Y, 1994, AM J RESP CELL MOL, V10, P369, DOI 10.1165/ajrcmb.10.4.8136153; SETOGUCHI Y, 1994, BLOOD, V84, P2946; SETOGUCHI Y, 1994, J INVEST DERMATOL, V102, P415, DOI 10.1111/1523-1747.ep12372181; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WILLIAMS RS, 1993, AM J MED SCI, V306, P129, DOI 10.1097/00000441-199308000-00013; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379; Yang YP, 1996, HUM MOL GENET, V5, P1703, DOI 10.1093/hmg/5.11.1703	46	43	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 25	1997	763	2					191	201		10.1016/S0006-8993(97)00389-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT038	WOS:A1997XT03800005	9296559				2022-02-06	
J	Max, JE; Lindgren, SD; Robin, DA; Smith, WL; Sato, Y; Mattheis, PJ; Castillo, CS; Stierwalt, JAG				Max, JE; Lindgren, SD; Robin, DA; Smith, WL; Sato, Y; Mattheis, PJ; Castillo, CS; Stierwalt, JAG			Traumatic brain injury in children and adolescents: Psychiatric disorders in the second three months	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							RELIABILITY; SCALE	Psychiatric disorders may be common after traumatic brain injury (TBI) in children, yet there is a dearth of prospective studies examining this problem. Fifty children aged 6 to 14, hospitalized after TBI, were assessed soon after TBI regarding preinjury psychiatric, behavioral, adaptive, and family functioning, family psychiatric history status and injury severity. The outcome measure was the presence of a ''novel'' psychiatric disorder (not present before the injury) during the second 3 months after the injury. Forty-two subjects were reassessed at 6 months. Severity of injury, family psychiatric history, and family function predicted a novel psychiatric disorder. Among children suffering a mild/moderate injury, those with preinjury lifetime psychiatric disorders were no longer (as they had been in the first 3 months) at higher risk than those without such a lifetime history. Thus, there appeared to be children, identifiable through clinical assessment, at increased risk for novel psychiatric disorders after TBI.	CEDAR CTR,CEDAR RAPIDS,IA		Max, JE (corresponding author), UNIV IOWA HOSP & CLIN,DEPT PSYCHIAT,1876 JPP,IOWA CITY,IA 52242, USA.		Mohamadifard, Mahtab/AAH-3843-2021; Robin, Donald/F-2109-2010	Sato, Yutaka/0000-0002-5245-232X			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Ciccetti D., 1984, VINELAND ADAPTIVE BE; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hoover H.D., 1986, MANUAL SCH ADM IOWA; KRAUS JF, 1987, PEDIATRICS, V79, P501; Lindgren S.D., 1987, ADV BEHAVIORAL ASSES, V3, P57; MARSHALL LD, 1991, J NEUROSURG, V75, P514; Max J. E., 1992, NEUROPSYCHIATRIC RAT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; *SPSS INC, 1993, SPSS WIND PROF STAT; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD	21	43	43	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	JUN	1997	185	6					394	401		10.1097/00005053-199706000-00006			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	XE747	WOS:A1997XE74700006	9205426				2022-02-06	
J	Peace, KA; Orme, SM; Sebastian, JP; Thompson, AR; Barnes, S; Ellis, A; Belchetz, PE				Peace, KA; Orme, SM; Sebastian, JP; Thompson, AR; Barnes, S; Ellis, A; Belchetz, PE			The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; HEAD-INJURY; SELF-REPORT	OBJECTIVE Studies of mood in hypopituitary adults have yielded inconsistent results. This investigation was carried out to investigate whether treatment characteristics may be responsible for the inconsistent results. DESIGN AND MEASUREMENTS We compared three groups of patients with a group of matched healthy controls on self-report measures of mood and social adjustment (Beck depression inventory, State-trait anxiety inventory, Social adjustment scale (modified)) and a measure of quality of life (Nottingham health profile, NHP). PATIENTS The patient groups were those treated with transfrontal surgery (n = 23), transsphenoidal surgery (n = 23) or medication only (n = 23), in addition, a close informant of each subject was asked to complete a social adjustment measure about the subject's lever of adjustment. RESULTS On the self-report mood and social adjustment measures and the emotion sub-scale of the NHP, the transsphenoidal and medication patient groups rated themselves as being more depressed, anxious and having poorer social adjustment than the transfrontal or control groups. The close informants, however, rated all three patient groups as having poorer social adjustment than the controls. Patients treated with surgery and without radiotherapy reported fewer symptoms of depression than those treated with radiotherapy. Realistic self-appraisal of social adjustment in surgical patients was found only in those treated with transsphenoidal surgery without radiotherapy. CONCLUSIONS Patients treated for pituitary tumour, excepting those treated with transfrontal surgery and to a lesser extent those treated with radiotherapy, suffer from mild mood disturbance and self-perceived decreased social adjustment. All patient groups are seen by others as having decreased social adjustment, raising the possibility that the transfrontal patients and possibly those who have had radiotherapy, lack insight. This may explain some of the discrepancies in the previous literature and needs to be taken into account when using self-report measures with these patients.	GEN INFIRM, DEPT ENDOCRINOL, LEEDS LS1 3EX, W YORKSHIRE, ENGLAND; ST JAMES UNIV HOSP, DEPT CLIN PSYCHOL, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND; YORK UNIV, DEPT PSYCHOL, YORK, N YORKSHIRE, ENGLAND				Padayatty, Sebastian J/A-8581-2012	Padayatty, Sebastian J/0000-0001-8758-3170; Thompson, Andrew/0000-0001-6788-7222			BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; COOPER P, 1982, BRIT J PSYCHIAT, V141, P68, DOI 10.1192/bjp.141.1.68; DEGERBLAD M, 1990, ACTA ENDOCRINOL-COP, V123, P185, DOI 10.1530/acta.0.1230185; DEPUY HJ, 1984, ASSESSMENT QUALITY L; DEYO RA, 1986, J CHRON DIS, V39, P897, DOI 10.1016/0021-9681(86)90038-X; FAHY TJ, 1967, LANCET, V2, P475; FAZZIO AF, 1977, VITAL HLTH STAT, V2; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; JORGENSEN JOL, 1989, LANCET, V1, P1221; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; MCGAULEY GA, 1989, ACTA PAEDIATR SCAND, P70; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MELMED S, 1990, NEW ENGL J MED, V323, P612; Peace KA, 1997, J CLIN EXP NEUROPSYC, V19, P1, DOI 10.1080/01688639708403831; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; *SPSS INC, 1994, SPSS WIND VERS 6 1; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; WHITE JC, 1955, ARCH NEURO PSYCHIATR, V74, P383, DOI 10.1001/archneurpsyc.1955.02330160033006; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x	23	43	45	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	APR	1997	46	4					445	450		10.1046/j.1365-2265.1997.1600971.x			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	XA806	WOS:A1997XA80600011	9196607				2022-02-06	
J	Warren, L; Wrigley, JM; Yoels, WC; Fine, PR				Warren, L; Wrigley, JM; Yoels, WC; Fine, PR			Factors associated with life satisfaction among a sample of persons with neurotrauma	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						life satisfaction; rehabilitation; spinal cord injury; traumatic brain injury	SPINAL-CORD INJURY; HEAD-INJURY; REHABILITATION; HANDICAP; OUTCOMES	Factors were examined that are associated with life satisfaction one year post-discharge for persons with a spinal cord (SCI) or traumatic brain injury (TBI). Findings show persons with SCI or TBI should be considered as two distinct groups with regard to factors affecting life satisfaction. Different strategies might be considered to affect either group. Three psychosocial variables significantly increased life satisfaction for persons with SCI: closeness to family, the level of family activities, and blaming oneself for the injury. For persons with TBI, total family satisfaction, blaming oneself for the injury, being employed, being married, and having memory and bowel independence significantly increased life satisfaction, For persons with TBI, there was a difference in the number of factors affecting life satisfaction dependent on whether the persons blamed themselves or not. Those who do not blame themselves show a greater number of functional activities as indicators for their self-satisfaction.	UNIV ALABAMA, INJURY CONTROL RES CTR, BIRMINGHAM, AL 35294 USA; ALABAMA DEPT ENVIRONM MANAGEMENT, MONTGOMERY, AL 36130 USA				Warren, Lorraine/P-3967-2017	Warren, Lorraine/0000-0001-7459-0136			BACH JR, 1994, ARCH PHYS MED REHAB, V75, P626, DOI 10.1016/0003-9993(94)90183-X; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; Chase B W, 1990, Int J Rehabil Res, V13, P325, DOI 10.1097/00004356-199012000-00006; CRISP R, 1992, PARAPLEGIA, V30, P420, DOI 10.1038/sc.1992.92; DEVIVO MJ, 1987, ARCH PHYS MED REHAB, V68, P494; Drewes A M, 1989, Int Disabil Stud, V11, P178; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; KANELLOS MC, 1985, AM J OCCUP THER, V39, P726, DOI 10.5014/ajot.39.11.726; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Koehler M L, 1989, Rehabil Nurs, V14, P9; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; MCGOWAN MB, 1987, PARAPLEGIA, V25, P357, DOI 10.1038/sc.1987.64; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; NAKAJIMA A, 1988, PARAPLEGIA, V26, P165, DOI 10.1038/sc.1988.27; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Nieves C C, 1991, Rehabil Nurs, V16, P129; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OLSON DH, 1979, FAM PROCESS, V18, P3, DOI 10.1111/j.1545-5300.1979.00003.x; SHOLOMSKAS DE, 1990, J APPL SOC PSYCHOL, V20, P548, DOI 10.1111/j.1559-1816.1990.tb00427.x; STAMBROOK M, 1991, PARAPLEGIA, V29, P318, DOI 10.1038/sc.1991.46; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149; YARKONY G, AM J PHSY MED REHABI, V67, P73	25	43	43	0	0	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	OCT	1996	33	4					404	408					5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	VL572	WOS:A1996VL57200007	8895135				2022-02-06	
J	Hamm, RJ; Temple, MD; Pike, BR; Ellis, EF				Hamm, RJ; Temple, MD; Pike, BR; Ellis, EF			The effect of postinjury administration of polyethylene glycol-conjugated superoxide dismutase (Pegorgotein, Dismutec(R)) or lidocaine on behavioral function following fluid-percussion brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; motor; memory; PEG-SOD; lidocaine; rat; free radicals	CEREBRAL BLOOD-FLOW; RADICAL SCAVENGER; SCOPOLAMINE; IMPAIRMENT; MODEL; CATS	Previous studies in our laboratory have shown that polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) or lidocaine treatment before experimental fluid-percussion brain injury in rats reduces the cortical hypoperfusion normally found in the early posttraumatic period, The purpose of the current study was to determine if posttreatment with PEG-SOD or lidocaine is also associated with changes in the trauma-induced suppression of motor and cognitive function that occurs following traumatic brain injury (TBI), Twenty-four hours after surgical preparation, rats were randomly assigned to a saline or drug posttreatment group, PEG-SOD (pegorgotein, Dismutec(R), 10,000 IU/kg) or lidocaine (2 mg/kg), which was injected iv 30 min after moderate injury, PEG-SOD completely prevented beam walk latency deficits on days 1-5 postinjury while lidocaine similarly prevented beam walk deficits on days 2 through 5 postinjury. Both drugs produced a statistically insignificant trend for a decrease in beam balance duration deficits on days 1-5 postinjury and had no effect on cognitive function, as assessed by the Morris water maze, on days 11 through 15 postinjury, The mechanism by which PEG-SOD and lidocaine reduce posttraumatic motor deficits may be related to their free radical scavenging effect or previously reported effects on posttraumatic cerebral blood flow, To our knowledge, this is the first report of the effectiveness of these two agents in laboratory animals when administered after traumatic injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298						PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [05274, 27214] Funding Source: Medline		BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DAS KC, 1992, MOL CELL BIOCHEM, V115, P179; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KONTOS HA, 1984, CIRC RES, V55, P295, DOI 10.1161/01.RES.55.3.295; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; MUIR JK, 1992, J NEUROTRAUM, V9, P394; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; MURI JK, 1995, AM J PHYSIOL, V37, pH68; RASOOL N, 1990, STROKE, V21, P929, DOI 10.1161/01.STR.21.6.929; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	29	43	43	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	1996	13	6					325	332		10.1089/neu.1996.13.325			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UZ052	WOS:A1996UZ05200005	8835800				2022-02-06	
J	Stablum, F; Mogentale, C; Umilta, C				Stablum, F; Mogentale, C; Umilta, C			Executive functioning following mild closed head injury	CORTEX			English	Article							REACTION-TIME; CONCUSSION; ATTENTION; SYMPTOMS; RECOVERY; LESIONS; BRAIN; CONSCIOUSNESS; ORGANIZATION; DISABILITY	This study was aimed to identify impaired attentional components in mild CHI patients. The CHI features taken into account were age (less than or equal to 30 vs. >30 years), loss of consciousness (yes vs. no), and time after injury (few days vs. some months). The groups tested were composed of 26 patients and 26 controls (matched for age, sex and education). Experiment 1 used a dual-task paradigm (Umilta et al., 1992), which taps executive functions. The double task-single task difference was greater for the CHI group, but only for patients older than 30 years and/or with consciousness loss. Two years after injury, some of these patients were retested: The results showed that this deficit was still present. Experiment 2 studied visual selective attention using the Navon (1977) paradigm. In this case, there were no differences between patients and controls. The results are discussed with reference to the anterior/posterior attention systems.			Stablum, F (corresponding author), UNIV PADUA,DIPARTIMENTO PSICOL GEN,VIA VENEZIA 8,I-35131 PADUA,ITALY.			Stablum, Franca/0000-0003-0123-5090			Allport A., 1989, FDN COGNITIVE SCI, P631; ALVISADOS B, 1982, CORTEX, V18, P5; BENYISHAY Y, 1983, REHABILITATION HEAD; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BIRREN JE, 1974, AM PSYCHOL, V29, P808, DOI 10.1037/h0037433; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BOOKS N, 1987, BRAIN INJURY, V1, P5; CERELLA J, 1991, J EXP PSYCHOL GEN, V120, P215, DOI 10.1037/0096-3445.120.2.215; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; DIKMEN SS, 1989, MILD HEAD INJURY, P229; DOYON J, 1991, NEUROPSYCHOLOGIA, V29, P343, DOI 10.1016/0028-3932(91)90024-3; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOLDBERG E, 1989, CORTEX, V25, P687, DOI 10.1016/S0010-9452(89)80029-2; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HICKS L, 1970, PSYCHOL BULL, V74, P281; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LAMB MR, 1990, J EXP PSYCHOL LEARN, V16, P471, DOI 10.1037/0278-7393.16.3.471; LAMB MR, 1989, NEUROPSYCHOLOGIA, V27, P471, DOI 10.1016/0028-3932(89)90052-3; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARKER R, 1990, TRAUMATIC BRAIN INJU; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; POLICH J, 1990, ACTA PSYCHOL, V74, P47, DOI 10.1016/0001-6918(90)90034-D; POLSTER MR, 1994, CORTEX, V30, P487, DOI 10.1016/S0010-9452(13)80344-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Prigatano GP, 1985, NEUROPSYCHOLOGICAL R; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; ROBERTSON LC, 1986, NEUROPSYCHOLOGIA, V24, P363, DOI 10.1016/0028-3932(86)90021-7; ROBERTSON LC, 1991, NEUROPSYCHOLOGIA, V29, P959, DOI 10.1016/0028-3932(91)90060-L; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Salthouse TA, 1985, THEORY COGNITIVE AGI, V28th; SHALLICE T, 1994, ATTENTION PERFORM, V15, P395; Shallice T., 1988, NEUROPSYCHOLOGY MENT; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STRUGAR J, 1993, J TRAUMA, V34, P555, DOI 10.1097/00005373-199304000-00012; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; UMILTA C, 1992, EUR J COGN PSYCHOL, V4, P21, DOI 10.1080/09541449208406241; Umilta C, 1988, HDB NEUROPSYCHOLOGY, P175; Umilta C., 1988, CONSCIOUSNESS CONT S, P334; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P, P75; Wechsler D., 1974, WECHSLER ADULT INTEL; Welford A.T., 1958, AGING HUMAN SKILL; WELFORD AT, 1981, HUM FACTORS, V23, P97, DOI 10.1177/001872088102300109; WELFORD AT, 1962, LANCET, V1, P335; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; ZANASI A, 1988, S FUNCTIONAL NEUROLO, V2, P185	77	43	43	0	8	MASSON DIVISIONE PERIODICI	MILAN	VIA STATUTO 2/4, 20121 MILAN, ITALY	0010-9452			CORTEX	Cortex	JUN	1996	32	2					261	278		10.1016/S0010-9452(96)80050-5			18	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	UT070	WOS:A1996UT07000004	8800614				2022-02-06	
J	Parker, RS				Parker, RS			The spectrum of emotional distress and personality changes after minor head injury incurred in a motor vehicle accident	BRAIN INJURY			English	Article								This is a systematic presentation of the emotional and personality disorders of 33 patients who incurred minor traumatic brain injury (MTBI) in a vehicular accident. A wide spectrum of disorders was observed: cerebral personality disorder, persistent altered consciousness, post-traumatic stress, psychodynamic reactions to impairment, and complex reactions expressing neurological, somatic, and psychological dysfunctions (sexuality and somatization). Examples of each category are offered to aid identification. A total of 31/33 patients suffered an additional psychiatric disorder. Unreported head trauma and loss of consciousness (LOC) elicited by detailed interviews helped to explain the extent of impairment. Emotional disorders, added to persistent cognitive loss and other neuropsychological symptoms, greatly impair the capacity to adapt after traumatic brain injury (TBI). Clinical procedures (interview; Rorschach; observation; figure drawings; checklists) are recommended to obtain detailed personality information needed for diagnosis, prognosis, and treatment. Behavioural outcome after TBI reflects disturbance in the processing of internal and external stimulation, and disturbance of pre-existing physiological and psychological processes. Emotional distress consistent with the accident and impairment adds to the credibility of patient complaints. There is an interaction between lesion effects and various emotional disturbances, which impacts employment, social relationships, and the enjoyment of life. Prompt and sympathetic treatment will contribute to more effective treatment, and may be anticipated to reduce or prevent some persistent symptoms after minor head injury.	NYU,MED CTR,NEW YORK,NY 10016								ADAMS JH, 1987, HEAD INJURY, P72; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; APPLEBY L, 1989, BRIT MED J, V298, P977; BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; Bar-On D., 1990, J TRAUMA STRESS, V3, P415; BECKER ME, 1993, BRAIN INJURY, V7, P515, DOI 10.3109/02699059309008179; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; COVELLI V, 1994, NEUROIMMUNOMODULAT, P212; Cummings J, 1985, CLIN NEUROPSYCHIATRY; DAVIDOFF RA, 1995, MIGRAIN; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; DEVINSKY O, 1993, NEUROL CLIN, V11, P127, DOI 10.1016/S0733-8619(18)30173-7; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; FEYEREISON P, 1991, HDB NEUROPSYCHOLOGY, V3, P271; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; GAINOTTI G, 1991, HDB NEUROPSYCHOLOGY, V3, P343; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GASS CS, 1991, J CLIN PSYCHOL, V47, P100, DOI 10.1002/1097-4679(199101)47:1<100::AID-JCLP2270470116>3.0.CO;2-H; Gean AD, 1994, IMAGING HEAD TRAUMA; GRIGSBY J, 1991, PSYCHIATRY, V54, P39; GRIGSBY JP, 1989, PSYCHOL REP, V64, P527, DOI 10.2466/pr0.1989.64.2.527; HEILMAN KM, 1991, HDB NEUROPSYCHOLOGY, V3, P403; HENDLER N, 1990, NEUROLOGICAL SURG, V4, P3813; HIRSCH AD, 1968, 287 DEP NAV NAV SHIP, V19, P252; Janoff-Bulman R, 1985, TRAUMAAND ITS WAKE S, P15; JORJE RE, 1993, J NERV MENT DIS, V181, P91; KAPP B S, 1992, P229; KERR DS, 1991, J NEUROSCI, V11, P1316; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; Kroening R. J., 1990, NEUROLOGICAL SURG, P3803; Kupfermann I, 1991, PRINCIPLES NEURAL SC, P735; LEDOUX J E, 1992, P339; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; MCEWEN B, 1994, SEMIN NEUROSCI, V6, P195, DOI 10.1006/smns.1994.1025; MCLAURIN RL, 1990, NEUROLOGICAL SURG, V4, P2175; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; MIKAIL SF, 1994, CLIN PSYCHOL REV, V14, P1, DOI 10.1016/0272-7358(94)90045-0; MILLER L, 1993, J COGNITIVE REHABILI, V11, P18; Miller L., 1994, PSYCHOBIOLOGY AGGRES, V21, P91, DOI DOI 10.1300/J076; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ommaya A. K., 1990, NEUROLOGICAL SURG, V3, P1877; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Pansky B., 1988, REV NEUROSCIENCE; PARKER R, 1990, TRAUMATIC BRAIN INJU; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PARKER RS, 1983, SELF IMAGE PSYCHODYN; PARKER RS, IN PRESS J NEUROLOGI; PARKER RS, 1994, GUIDE ANAL UNDERSTAN, P79; PARKER RS, 1994, J NEUROL ORTH MED S, V15, P123; PARKER RS, 1968, J PROJECTIVE TECHNIQ, V32, P32; PARKER RS, 1994, GUIDE ANAL UNDERSTAN, P309; PARKER RS, IN PRESS J CLIN PSYC; PILOWSKY I, 1985, BRIT J PSYCHIAT, V147, P310, DOI 10.1192/bjp.147.3.310; PIOTROWSKI ZA, 1965, PERCEPTANALYSIS; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RADANOV BP, 1994, BRIT J RHEUMATOL, V33, P442; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; ROBERTSON E, 1994, CLIN NEUROPSYCHOL, V8, P69; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; RON MA, 1994, J NEUROL NEUROSUR PS, V57, P1161, DOI 10.1136/jnnp.57.10.1161; ROSS ED, 1993, NEUROL CLIN, V11, P9, DOI 10.1016/S0733-8619(18)30168-3; RYAN JJ, 1991, J CLIN PSYCHOL, V47, P104, DOI 10.1002/1097-4679(199101)47:1<104::AID-JCLP2270470117>3.0.CO;2-2; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Spiers P. A., 1985, PRINCIPLES BEHAVIORA, P289; STRAUSS E, 1992, ARCH NEUROL-CHICAGO, V49, P391, DOI 10.1001/archneur.1992.00530280079026; TRIMBLE MR, 1995, NEUROLOGY GENERAL ME, P473; URSIN H, 1994, NEUROIMMUNOMODULAT, P204; Wechsler, 1997, WECHSLER ADULT INTEL	69	43	44	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1996	10	4					287	302		10.1080/026990596124467			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100006	9044694				2022-02-06	
J	Leathem, J; Heath, E; Woolley, C				Leathem, J; Heath, E; Woolley, C			Relatives' perceptions of role change, social support and stress after traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; PATIENT; IMPACT; VIEW; MOOD	There is general agreement between researchers and clinicians alike that relatives of people with head injuries experience heightened stress as a result of the injury and its consequences. In the present study a single structured interview, including both verbally administered and written response questionnaires, was completed by 1.8 parents and 11 partners. Measures included the Daily Hassles and Uplifts Scale, the Arizona Social Support Interview Schedule and questions regarding role change and health problems. The combined parents and partners group indicated that they experienced moderate levels of stress and role change. A relatively small proportion of participants reported experiencing health problems. Partners indicated a slightly higher degree of stress and a greater degree of role change than parents, and a larger proportion of partners indicated the presence of health problems. Qualitative differences between the two groups were found in terms of sources of stress. There was little quantitative or qualitative difference between the two groups in sources, utilization of and satisfaction with social support. Positive correlations were found between stress and role change and stress and health problems.	OPT COMMUNITY LIVING, PALMERSTON NORTH, NEW ZEALAND		Leathem, J (corresponding author), MASSEY UNIV, DEPT PSYCHOL, PALMERSTON NORTH, NEW ZEALAND.						Barrera Jr M, 1981, SOCIAL NETWORKS SOCI, P69; BIGLER ED, 1988, BRAIN INJURY, V3, P73; BLYTH B, 1981, NEW ZEAL MED J, V93, P267; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BOND MR, 1983, REHABILITATION HEAD, P209; Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, HEAD INJURY PSYCHOL, P123; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CRAWFORD C, 1983, NEW ZEAL MED J, V96, P972; DELONGIS A, 1988, J PERS SOC PSYCHOL, V54, P486, DOI 10.1037/0022-3514.54.3.486; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KANNER AD, J BEHAV MED, V4, P1; KANTER AD, 1981, J BEHAV MED, V4, P1; Kaplan B H, 1977, Med Care, V15, P47, DOI 10.1097/00005650-197705001-00006; LEFCOURT HM, 1985, SOCIAL SUPPORT THEOR, P155; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LONG CJ, 1984, J REHABIL, V50, P39; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PANTING A, 1982, REHABILITATION, V38, P33; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; RIMEL RW, 1983, REHABILITATION HEAD, P9; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; ZEIGLER EA, 1987, J REHABIL, V53, P50; [No title captured]	34	43	47	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	1996	10	1					27	38					12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TY049	WOS:A1996TY04900003	8680390				2022-02-06	
J	Berry, DTR; Wetter, MW; Baer, RA; Youngjohn, JR; Gass, CS; Lamb, DG; Franzen, MD; MacInnes, WD; Buchholz, D				Berry, DTR; Wetter, MW; Baer, RA; Youngjohn, JR; Gass, CS; Lamb, DG; Franzen, MD; MacInnes, WD; Buchholz, D			Overreporting of closed-head injury symptoms on the MMPI-2	PSYCHOLOGICAL ASSESSMENT			English	Article							TRAUMATIC BRAIN INJURY; DEFICITS	Minnesota Multiphasic Personality Inventory( MMPI-2) validity scales were compared in 4 groups: nonclinical participants answering under standard instructions (n = 20), nonclinical participants instructed to fake closed-head injury (CHI) symptoms (n = 18), non-compensation-seeking CHI patients (n = 31), and compensation-seeking CHI patients (n = 30). The highest scores on MMPI-2 overreporting scales were obtained by nonclinical participants faking CHI, and significantly higher scores on these scales were obtained by compensation-seeking relative to non-compensation-seeking CHI patients. These results suggest that MMPI-2 overreporting scales are sensitive to fabrication of CHI complaints, and possibly to exaggeration of CHI complaints, although further research is necessary to evaluate the latter hypothesis fully.	VET AFFAIRS MED CTR, PSYCHOL SERV, MIAMI, FL 33125 USA; BARROW NEUROL INST, DEPT NEUROPSYCHOL, PHOENIX, AZ 85013 USA; ALLEGHENY NEUROPSYCHIAT INST, DEPT NEUROPSYCHOL, PITTSBURGH, PA USA; MIDMICHIGAN NEUROPSYCHOL ASSOCIATES PLC, MIDLAND, MI USA; VET AFFAIRS MED CTR, PSYCHOL SERV, LOUISVILLE, KY USA		Berry, DTR (corresponding author), UNIV KENTUCKY, DEPT PSYCHOL, KASTLE HALL, LEXINGTON, KY 40506 USA.		Gass, Carlton/AAO-5906-2020				Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ARBISI P, 1993, 28TH ANN S REC DEV M; Berry DT., 1992, PSYCHOL ASSESSMENT, V4, P340, DOI [10.1037/1040-3590.4.3.340, DOI 10.1037/1040-3590.4.3.340]; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BERRY DTR, 1991, PSYCHOL ASSESSMENT J, V3, P418, DOI DOI 10.1037/1040-3590.3.3.418; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BUCHHOLZ D, 1984, CLIN PSYCHOL REV, V4, P693, DOI 10.1016/0272-7358(84)90012-6; Butcher J, 1989, MANUAL ADM SCORING M; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; EISENBERG HM, 1987, NEUROBEHAVIORAL RECO, P13; FAUST D, 1991, BRAIN DAMAGE CLAIMS; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GOUGH HG, 1954, J CONSULT PSYCHOL, V18, P287; GOUGH HG, 1950, J CONSULT PSYCHOL, V14, P408; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hathaway S.R., 1951, MINNESOTA MULTIPHASI; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; KRAUS J, 1994, NEUROPSYCHAITRY TRAU; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEESHALEY P, IN PRESS ARCH CLIN N; LEESHALEY P, 1992, AM J FORENSIC PSYCHO, V0010, P00025; LOVELL M, 1994, NEUROPSYCHIATRY TRAU; MILLIS S, 1995, 30TH ANN S REC DEV U; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Pope K.S., 1993, MMPI MMPI 2 MMPI A C; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; ROGERS R, 1988, CLIN ASSESSMENT MALI; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; TAYLOR C, 1994, NEUROPSYCHIATRY TRAU; WETTER MW, 1992, PSYCHOL ASSESSMENT, V4, P369, DOI DOI 10.1037/1040-3590.4.3.369; WETTER MW, 1993, PSYCHOL ASSESSMENT, V5, P317, DOI DOI 10.1037/1040-3590.5.3.317; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	45	43	43	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	1995	7	4					517	523					7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TL180	WOS:A1995TL18000013					2022-02-06	
J	SIEGEL, JH				SIEGEL, JH			THE EFFECT OF ASSOCIATED INJURIES, BLOOD-LOSS, AND OXYGEN DEBT ON DEATH AND DISABILITY IN BLUNT TRAUMATIC BRAIN INJURY - THE NEED FOR EARLY PHYSIOLOGICAL PREDICTORS OF SEVERITY	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		TRAUMATIC BRAIN INJURY; SECONDARY INSULT; HYPOVOLEMIA; MORBIDITY	MORTALITY; VOLUME; SHOCK	Studies of 4590 patients with blunt trauma injuries admitted to a Level I Trauma Center, have shown that 37% had a blunt traumatic brain injury (BTBI). Of these brain injured patients 60% has an associated other injury, Examination of mortality has shown that those with an isolated brain injury had an 11% mortality compared with 21.8% in those with an associated systemic injury, Further investigation demonstrated that the cause of the increased mortality was related to the blood loss associated with the injuries and that when hypovolemic shock resulted, mortality rose from 12.8 to 62%. The severity of the associated injuries effect on the brain injured patient could be estimated by a parameter of oxygen debt, the base deficit and this allowed for a quantitative estimate of the probability of death as an index of severity, A combined linear logistic model using the admission Glasgow Coma Score (GCS) as a measure of brain injury and the base deficit as a measure of physiologic injury provides such a predictive score, The effect of associated injuries in patients with moderate brain injury (AIS 2,3) was to increase the average total cost of medical care in the first year of injury by three-fold ($12,489 to $36,177) and for severe brain injury (AIS 4,5) to increase average cost from $59,000 in isolated BTBI to $90,000 in BTBI with associated injury, The high incidence of brain injuries in motor vehicle crashes (MVC) caused by lateral impacts and their association with other side-impact injuries (lungs, spleen, kidney, and pelvic fractures) in which large blood volume losses are common, focuses attention on the need for side impact protection standards that simultaneously protect brain, thoracoabdominal viscera, and pelvis as a means of reducing the severity and cost of lateral impact MVCs.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT ANAT CELL BIOL & INJURY SCI,NEWARK,NJ 07103		SIEGEL, JH (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEW JERSEY TRAUMA CTR,DEPT SURG,185 S ORANGE AVE,NEWARK,NJ 07103, USA.						ADDIS MD, 1994, UNPUB J TRAUMA; COOPER PJ, 1987, HEAD INJURY, P1; CROWELL JW, 1991, AM J PHYSIOL, V206, P313; DUNHAM CM, 1991, CRIT CARE MED, V19, P231, DOI 10.1097/00003246-199102000-00020; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LAWLESS JF, 1992, STATISTICAL MODELS M; RIVKIND AI, 1989, ANN SURG, V210, P355, DOI 10.1097/00000658-198909000-00012; SACHS L, 1992, APPLIED STATISTICS H; SCHMOKER JD, 1993, J TRAUMA, V35, P627; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; SIEGEL JH, 1993, J TRAUMA, V35, P920, DOI 10.1097/00005373-199312000-00019; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SIEGEL JH, 1993, PATHOPHYSIOLOGY SHOC, P626; SIEGEL JH, 1987, TRAUMA EMERGENCY SUR, P201; SOSIN DM, 1986, JAMA-J AM MED ASSOC, V262, P2251; TEASDALE G, 1974, LANCET, V2, P81	18	43	44	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					579	590		10.1089/neu.1995.12.579			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000009	8683609				2022-02-06	
J	HAYES, RL; DIXON, CE				HAYES, RL; DIXON, CE			NEUROCHEMICAL CHANGES IN MILD HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; EXTRACELLULAR POTASSIUM; HORSERADISH-PEROXIDASE; SPINAL-INJURY; AMINO-ACIDS; NALOXONE; RAT; RESPONSES; HYPERTENSION; CONCUSSION	In this article, we review the present understanding of neurochemical changes associated with experimental mild head injury. The majority of these data are derived from recent laboratory studies primarily conducted in rodents. They indicate that excessive release of excitatory neurotransmitters, including acetylcholine (ACh) and excitatory amino acids (EAA), can importantly contribute to acute pathobiologic cascades that ultimately produce enduring neurologic deficits even at relatively low levels of traumatic brain injury (TBI). An ultimate loss of calcium homeostasis may be an important mediator of this acute excitotoxic cascade. Some studies have indicated that early changes in endogenous opiates may also mediate pathologic responses to mild head injury. Important findings from our own and other laboratories suggest that certain endogenous opiates can reduce neurologic deficits following mild TBI. Other data suggest that low levels of TBI may produce diffuse reductions in cerebral metabolic activity. The ultimate significance of these generalized depressions in energy metabolism is not completely understood. Mild TBI can also produce significant disruptions of the blood-brain barrier (BBB), which may have important consequences for acute responses to trauma. For example, excitatory neurotransmitters normally excluded from the brain can gain entry, thereby exacerbating acute, harmful, excitotoxic effects.	UNIV TEXAS,HLTH SCI CTR,HLTH SCI CTR,DEPT NEUROL,HOUSTON,TX 77225								BASKIN DS, 1982, LIFE SCI, V31, P2201, DOI 10.1016/0024-3205(82)90118-7; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEWITT D S, 1988, Society for Neuroscience Abstracts, V14, P621; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; EISENBERG HM, 1989, MILD MODERATE HEAD I, P95; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; ELLISON MD, 1986, J CEREBR BLOOD F MET, V6, P471, DOI 10.1038/jcbfm.1986.81; FADEN A I, 1983, Current Concepts of Cerebrovascular Disease and Stroke, V18, P27; FADEN AI, 1981, SCIENCE, V211, P493, DOI 10.1126/science.7455690; FADEN AI, 1983, STROKE, V14, P169, DOI 10.1161/01.STR.14.2.169; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GRAHAM DI, 1989, MILD MODERATE HEAD I, P63; HABER B, 1980, NEUROBIOLOGY CEREBRO, P345; HAYES R, 1987, IEEE T SOFTWARE ENG, V13, P1254, DOI 10.1109/TSE.1987.232879; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1991, J NEUROTRAUM, V9, P173; HAYES RL, 1990, UNPUB NMDA RECEPTOR; HAYES RL, 1988, J NEUROTRAUM, V5, P287; HAYES RL, 1989, MILD HEAD INJURY, P54; Holaday JW, 1984, CENTRAL PERIPHERAL E, P237; HOSOBUCHI Y, 1982, SCIENCE, V215, P69, DOI 10.1126/science.6274019; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; JANE JA, 1989, MILD MODERATE HEAD I, P3; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; JENKINS LW, 1989, MICHIGAN S SERIES TR, V1, P47; JIANG JY, 1991, P SATELLITE S BRAIN, V91, P89; JOHANSSON B, 1970, ACTA NEUROPATHOL, V16, P117, DOI 10.1007/BF00687666; JULIAN FJ, 1962, J GEN PHYSIOL, V46, P297, DOI 10.1085/jgp.46.2.297; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1984, BRAIN RES, V296, P241, DOI 10.1016/0006-8993(84)90062-3; KAWAMATA T, 1990, Society for Neuroscience Abstracts, V16, P778; KAWAMATA T, 1990, 8TH P ANN M SOC NEUR; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P559, DOI 10.1038/jcbfm.1986.102; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Long J B, 1986, Cent Nerv Syst Trauma, V3, P295; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH B G, 1991, Society for Neuroscience Abstracts, V17, P165; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1989, SOC NEUR ABS, V15, P113; LYETH BG, IN PRESS NEUROTRAUMA; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NAGY Z, 1979, J COMP NEUROL, V185, P579, DOI 10.1002/cne.901850308; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; RAPPORT SI, 1976, EXP NEUROL, V52, P467; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; RUGE D, 1954, J NEUROSURG, V11, P77, DOI 10.3171/jns.1954.11.1.0077; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SMITH D H, 1990, Society for Neuroscience Abstracts, V16, P779; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; THOMPSON SM, 1985, J NEUROSCI, V5, P817; TORTELLA FC, 1987, INACTIVATION HYPERSE, P3; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; YOUNG W, 1981, J NEUROSURG, V55, P209, DOI 10.3171/jns.1981.55.2.0209; ZIMMERMAN R S, 1989, Society for Neuroscience Abstracts, V15, P131	75	43	43	0	2	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					25	31		10.1055/s-2008-1041055			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE151	WOS:A1994NE15100006	7913245				2022-02-06	
J	PARK, CK; CHOI, KH; KIM, MC; KANG, JK; CHOI, CR				PARK, CK; CHOI, KH; KIM, MC; KANG, JK; CHOI, CR			SPONTANEOUS EVOLUTION OF POSTTRAUMATIC SUBDURAL HYGROMA INTO CHRONIC SUBDURAL-HEMATOMA	ACTA NEUROCHIRURGICA			English	Article						POSTTRAUMATIC SUBDURAL HYGROMA; CHRONIC SUBDURAL HEMATOMA; PATHOGENESIS; EVOLUTION	COMPUTERIZED TOMOGRAPHY; HEMATOMAS	Thirteen of 145 patients with Post-traumatic subdural hygroma (SDHy) developed chronic subdural haematoma (CSDH) at the involved site over a period of 6 years. CSDHs were found at the site of SDHys with no history of further head injury at a mean interval of 56 days. It appeared that these 13 patients did not have any distinguishing clinical features early on. Old age and brain atrophy on CT scans do not seem to be reasonable causative factors in the evolution of SDHy into CSDH. Initial enlargement of subdural accumulations at an early stage of SDHy and a subsequent increase in density at a later stage may point to the development of CSDH from SDHy in some instances. Ten of these 13 CSDH cases underwent surgical drainage, and the remaining 3 cases received no specific management. All resolved completely. The prognosis was good in all patients. The possible mechanism for the evolution of SDHy into CSDH is discussed.	CATHOLIC UNIV,COLL MED,DEPT NEUROSURG,SEOUL,SOUTH KOREA; CATHOLIC UNIV,COLL MED,DEPT RADIOL,SEOUL,SOUTH KOREA								DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; ECKLIN FA, 1956, JAMA-J AM MED ASSOC, V161, P1345; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457; FRENCH BN, 1978, SURG NEUROL, V9, P145; FRENCH BN, 1977, SURG NEUROL, V7, P171; GUTIERREZ FA, 1974, AM J DIS CHILD, V128, P327, DOI 10.1001/archpedi.1974.02110280057007; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; HOFF J, 1973, J TRAUMA, V13, P870, DOI 10.1097/00005373-197313100-00005; ITO H, 1976, J NEUROSURG, V45, P26, DOI 10.3171/jns.1976.45.1.0026; ITO H, 1978, J NEUROSURG, V48, P197, DOI 10.3171/jns.1978.48.2.0197; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; MCLAURIN RL, 1961, J NEUROSURG, V18, P61, DOI 10.3171/jns.1961.18.1.0061; NAFFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; NAKAMURA H, 1981, NEUROL MED CHIR, V21, P491; OKA H, 1972, ACTA NEUROCHIR, V26, P265, DOI 10.1007/BF01407072; Payr E, 1916, MED KLIN, V12, P841; ROSENBLUTH PR, 1962, JAMA-J AM MED ASSOC, V179, P759, DOI 10.1001/jama.1962.03050100013003; SCHNEIDER RC, 1969, CORRELATIVE NEUROSUR, P533; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; TAGUCHI Y, 1982, Neurologia Medico-Chirurgica, V22, P276, DOI 10.2176/nmc.22.276; TAKAHASHI Y, 1982, NEUROSURGERY, V10, P281; THOMAS LM, 1973, NEUROLOGICAL SURGERY, V2, P960; WETTERLING T, 1988, ACTA NEUROCHIR, V91, P79, DOI 10.1007/BF01400533; WINESTOCK DP, 1975, RADIOLOGY, V115, P373, DOI 10.1148/115.2.373; YAMADA H, 1980, SURG NEUROL, V13, P441	29	43	49	0	2	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1994	127	1-2					41	47		10.1007/BF01808545			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NC941	WOS:A1994NC94100009	7942180				2022-02-06	
J	LYETH, BG; LIU, SL; HAMM, RJ				LYETH, BG; LIU, SL; HAMM, RJ			COMBINED SCOPOLAMINE AND MORPHINE TREATMENT OF TRAUMATIC BRAIN INJURY IN THE RAT	BRAIN RESEARCH			English	Article						OPIOID; SCOPOLAMINE; MORPHINE; TRAUMATIC BRAIN INJURY; FLUID PERCUSSION	ENDOGENOUS OPIOIDS; RESPONSES; BEHAVIOR; NEURONS; FLUID	Previous studies have indicated that either scopolamine (1.0 mg/kg) or morphine (10.0 mg/kg) administered to rats prior to or soon after moderate fluid percussion traumatic brain injury (TBI) reduces behavioral deficits associated with injury. In this study, a series of experiments examined the effects of a combination of these drugs, as well as each drug individually, on behavioral outcome, brain temperature, and systemic physiological responses to TBI. Experiment I: a single systemic bolus injection of scopolamine (n = 10), morphine (n = 11), scopolamine plus morphine (n = 11), or saline (n = 10) was administered to rats 15 min prior to TBI. Animals were assessed on beam-walking behavioral performance for 5 days after injury. Scopolamine alone or morphine alone significantly reduced (P < 0.05) deficits produced by injury. Treatment with a combination of scopolamine and morphine provided greater protection on beam-walking behavioral measures than either drug alone. Experiment II: morphine raised brain temperature in uninjured rats (n = 5) to a mean of 39.3-degrees-C +/- 0.3 by 60 min post-injection. Neither scopolamine (n = 5) nor scopolamine plus morphine (n = 5) altered brain temperature. Experiment III: scopolamine (n = 7) significantly raised heart rate for 5 min after injury. Saline (n = 8), morphine (n = 9) and scopolamine plus morphine (n = 7) significantly lowered heart rate after injury. All four groups had similar hypertensive responses to TBI which peaked at 10 s after injury. The results confirm that pharmacological blockade of muscarinic receptors or stimulation of A opioid receptors reduces functional deficits associated with TBI. The greater protection observed with the combined drug treatment indicates that a cocktail of pharmacological treatments has the potential for providing greater benefit than single drug strategies.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,DIV NEUROSURG,RICHMOND,VA 23298		LYETH, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,BOX 693,MCV STN,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587, NS 29995] Funding Source: Medline		BRADLEY PB, 1984, BRIT J PHARMACOL, V83, P763, DOI 10.1111/j.1476-5381.1984.tb16231.x; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HAYES RL, 1988, J NEUROTRAUM, V5, P287; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LAPCHAK P A, 1987, Society for Neuroscience Abstracts, V13, P1192; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, 8TH ANN NEUR S; MCINTOSH T K, 1988, Society for Neuroscience Abstracts, V14, P1152; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NICOLL RA, 1977, P NATL ACAD SCI USA, V74, P2584, DOI 10.1073/pnas.74.6.2584; NORTH RA, 1979, LIFE SCI, V24, P1527, DOI 10.1016/0024-3205(79)90014-6; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; ROBINSON S E, 1991, Society for Neuroscience Abstracts, V17, P721; ROBINSON SE, 1989, BRAIN RES, V503, P32, DOI 10.1016/0006-8993(89)91699-5; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SIMONDS WF, 1988, ENDOCR REV, V9, P200, DOI 10.1210/edrv-9-2-200; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; YAO JJ, 1988, NEUROPEPTIDES, V12, P177, DOI 10.1016/0143-4179(88)90051-0; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	34	43	43	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 16	1993	617	1					69	75		10.1016/0006-8993(93)90614-S			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LL526	WOS:A1993LL52600010	8374747				2022-02-06	
J	WU, AHB; WANG, XM; GORNET, TG; ORDONEZLLANOS, J				WU, AHB; WANG, XM; GORNET, TG; ORDONEZLLANOS, J			CREATINE-KINASE MB ISOFORMS IN PATIENTS WITH SKELETAL-MUSCLE INJURY - RAMIFICATIONS FOR EARLY DETECTION OF ACUTE MYOCARDIAL-INFARCTION	CLINICAL CHEMISTRY			English	Article						THROMBOLYTIC THERAPY; EXERCISE, EFFECTS OF; STROKE; CLOSED HEAD INJURY; SCLERODERMA; ISOENZYMES	ISOENZYME-MB; EARLY DIAGNOSIS; TROPONIN-T; SERUM; MASS; MM; MYOGLOBIN; SUBFORMS; DAMAGE; ASSAY	We measured total creatine kinase (CK), CK-MB isoenzyme, and the MB isoforms in 202 serum and plasma samples from nine groups of patients and normal individuals: 39 with acute myocardial infarction (MI), divided according to time between the onset of chest pain and blood collection (1-6 h, 7-12 h, and 13-48 h); 26 with chest pain for whom an MI was ruled out, sampled at admission; 17 undergoing bypass surgery or cardiac catheterization, sampled within 6 h after either procedure; 17 with acute skeletal muscle injury, sampled within 8 h after injury; 30 marathon runners immediately after a race; 17 runners and other athletes >12 h after training or a race; 12 with cerebral injury or seizures, sampled at admission; 8 with closed head injury, sampled at admission; and 38 normal subjects. CK-MB (relative index) and MB isoforms (MB2/MB1) were respectively increased in 15% and 75% of MI patients 1-6 h after onset, 94% and 94% after 7-12 h, and 88% and 8% after 12 h, and in 87% and 82% of cardiac surgery patients. MB isoforms were increased in most patients with acute skeletal muscle trauma and in subjects examined after exercise, but were within normal limits in patients for whom MI was ruled out, patients with cerebral trauma, and normal individuals. The relative index of MB/total CK was normal in essentially all individuals in the last groups, including those with acute skeletal muscle trauma. We concluded that the CK-MB isoform ratio is increased in both acute skeletal muscle injury and MI. The isoform ratio is most useful for distinguishing recent from old (>12 h) injury.	UNIV TEXAS,SCH MED,DEPT PATHOL,HOUSTON,TX 77030; HUNAN MED UNIV,DEPT BIOCHEM,CHANGSHA,PEOPLES R CHINA; HOSP ST CRUE & ST PAU,SERVEI BIOQUIM,BARCELONA,SPAIN				Ordonez-Llanos, Jordi/B-4961-2011; Ordonez-Llanos, Jorge/A-9335-2010; Ordonez-Llanos, Jorge/N-1126-2019; Ordonez-Llanos, Jorge/AAE-3088-2020	Ordonez-Llanos, Jordi/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832			ANNESLEY TM, 1985, CLIN CHEM, V31, P402; BODOR G, 1990, CLIN CHEM, V36, P1103; BRUNS DE, 1989, CLIN CHEM, V35, P705; CHAPELLE JP, 1981, CLIN CHIM ACTA, V115, P255, DOI 10.1016/0009-8981(81)90239-4; ELALLAF M, 1986, CLIN CHEM, V32, P291; GERHARDT W, 1991, CLIN CHEM, V37, P1405; GIBLER WB, 1987, ANN EMERG MED, V16, P851; GRAEBER GM, 1985, SURG CLIN N AM, V65, P539; GULBIS B, 1990, CLIN CHEM, V36, P1784; HARKER CC, 1990, CLIN CHEM, V36, P1128; JACKOWSKI G, 1989, CIRCULATION, V30, P854; KESHGEGIAN AA, 1988, CLIN CHEM, V34, P1067; KOCH TR, 1986, CLIN CHEM, V32, P186; KONNIGS CH, 1989, ANN CLIN BIOCHEM, V26, P254; LIU N, 1992, Clinical Chemistry, V38, P984; MAIR J, 1991, CLIN CHEM, V37, P845; NEUIER D, 1981, CREATINE KINASE ISOE, P85; PANTEGHINI M, 1986, CLIN CHIM ACTA, V155, P1, DOI 10.1016/0009-8981(86)90093-8; PULEO P R, 1992, Journal of the American College of Cardiology, V19, p303A; PULEO PR, 1990, CIRCULATION, V82, P759, DOI 10.1161/01.CIR.82.3.759; PULEO PR, 1989, CLIN CHEM, V35, P1452; SCHULTZ A, 1986, AM HEART J, V112, P609, DOI 10.1016/0002-8703(86)90529-6; SCHWARTZ JG, 1989, CLIN CHEM, V35, P651; SCHWARZ F, 1982, AM J CARDIOL, V50, P933, DOI 10.1016/0002-9149(82)90398-8; SIEGEL AJ, 1981, JAMA-J AM MED ASSOC, V246, P2049, DOI 10.1001/jama.246.18.2049; THOMPSON WG, 1988, CLIN CHEM, V34, P2208; WANG J, 1989, CLIN CHIM ACTA, V181, P325, DOI 10.1016/0009-8981(89)90238-6; WU AHB, 1989, CLIN CHEM, V35, P1752; WU AHB, 1987, CLIN CHEM, V33, P359; 1985, NEW ENGL J MED, V312, P923	30	43	43	0	1	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526	0009-9147			CLIN CHEM	Clin. Chem.	DEC	1992	38	12					2396	2400					5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	KD011	WOS:A1992KD01100007	1458574				2022-02-06	
J	INGERSOLL, CD; ARMSTRONG, CW				INGERSOLL, CD; ARMSTRONG, CW			THE EFFECTS OF CLOSED-HEAD INJURY ON POSTURAL SWAY	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						HEAD INJURY; HEAD INJURY OUTCOME; POSTURE; POSTURAL SWAY; SENSORY INTEGRATION	COMPUTED-TOMOGRAPHY; FOOTBALL; BALANCE	The purpose of this study was to determine the effects of closed-head injury upon postural sway. Forty-eight subjects (26 males and 22 females) between the ages of 18 and 45 were equally divided into four groups corresponding to their level of head injury. Group 1 had not incurred a head injury, group 2 members incurred head injuries but did not lose consciousness, group 3 lost consciousness for less than 6 h, and group 4 lost consciousness for greater than 6 h. All subjects were at least 1 yr postinjury. Each subject performed three trials of six variations of the Romberg test. The center of pressure transmitted through the bottom of the feet was monitored during each 30-s trial. Total, anterior-posterior (AP), and medial-lateral (ML) sway was calculated from center of pressure data. The severely head-injured group generally evidenced greater AP sway than the other three experimental groups for all but one test condition. It was concluded that closed-head injury, particularly when associated with relatively long periods of unconsciousness, results in postural instability.	UNIV TOLEDO, DEPT HLTH PROMOT & HUMAN PERFORMANCE, APPL BIOMECH LAB, TOLEDO, OH 43606 USA		INGERSOLL, CD (corresponding author), INDIANA STATE UNIV, DEPT PHYS EDUC, SPORTS INJURY RES LAB, TERRE HAUTE, IN 47809 USA.		Ingersoll, Christopher/H-6474-2015	Ingersoll, Christopher/0000-0001-9157-6846			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; ARCAN M, 1977, SCAND J REHABIL MED, V9, P165; BOHANNON RW, 1984, PHYS THER, V64, P1067, DOI 10.1093/ptj/64.7.1067; CHASON JL, 1958, J NEUROSURG, V15, P135, DOI 10.3171/jns.1958.15.2.0135; DICHGANS J, 1976, AGRESSOLOGIE, V17, P15; FREDRICKSON JM, 1966, EXP BRAIN RES, V2, P318; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; HAYES KC, 1983, SOC NEUR ABSTR, V13, P2115; Henriksson NG, 1967, ACTA OTO-LARYNGOL, V63, P272, DOI [10.3109/00016486709123592, DOI 10.3109/00016486709123592]; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JANSEN EC, 1982, ACTA NEUROL SCAND, V66, P93; KELLY CR, 1981, ARCH PHYS MED REHAB, V62, P324; MITCHELL DE, 1973, LANCET, V2, P215; Mueller Frederick O, 1982, Phys Sportsmed, V10, P135, DOI 10.1080/00913847.1982.11947346; NASHNER LM, 1983, EXP BRAIN RES, V49, P393; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NJIOKIKTJIEN C, 1972, AGRESSOLOGIE, V13, P1; NJIOKIKTJIEN CJ, 1976, AGRESSOLOGIE, V17, P19; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; ROY S, 1983, SPORTS MED PREVENTIO, P141; SAHLSTRAND T, 1978, ACTA ORTHOP SCAND, V49, P354, DOI 10.3109/17453677809050088; SCHNEIDER RC, 1969, MED SCI SPORTS, V1, P115; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; SILFVERSKIOLD BP, 1969, ACTA NEUROL SCAND, V45, P292; STARR A, 1981, BRAIN, V104, P149, DOI 10.1093/brain/104.1.149; STRICH SJ, 1961, LANCET, V2, P443; TORG JC, 1982, ATHLETIC INJURIES HE, P15; VANPARYS JAP, 1976, AGRESSOLOGIE, V17, P95; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; [No title captured]	35	43	43	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	1992	24	7					739	743					5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JC413	WOS:A1992JC41300001	1501556				2022-02-06	
J	CITTAPIETROLUNGO, TJ; ALEXANDER, MA; STEG, NL				CITTAPIETROLUNGO, TJ; ALEXANDER, MA; STEG, NL			EARLY DETECTION OF HETEROTOPIC OSSIFICATION IN YOUNG-PATIENTS WITH TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BONE SCANS; HETEROTOPIC OSSIFICATION; TRAUMATIC BRAIN INJURY	DISODIUM ETIDRONATE; HEAD-INJURY; THERAPY	Heterotopic ossification (HO) is frequently a complication in patients with severe head injury, impeding the rehabilitation process. Detection of HO is often delayed until the appearance of clinical manifestations. To better characterize the frequency and distribution of HO, a three-year prospective study at a pediatric brain injury rehabilitation unit was done. Triple-phase bone scans were performed routinely on all patients. Early intervention followed, with intensive physical therapy and indomethacin. We report an incidence of HO in 25 of 111 cases (22.5%). Of 55 sites identified, the hip was most commonly affected. Clinically significant heterotopic bone impeded the rehabilitation process in five patients (20%), although none of these patients required surgical intervention. Bone scanning identified HO in patients whose symptoms were clinically silent, as well as in those who were symptomatic. In addition, multiple sites of involvement were found in areas not clinically suspect. This study suggests that HO may be more prevalent in young, traumatically brain injured patients than previously suspected.	ALFRED I DUPONT INST,DIV REHABIL,1600 ROCKLAND RD,WILMINGTON,DE 19899; ALFRED I DUPONT INST,DIV PEDIAT REHABIL,WILMINGTON,DE 19899								CHIODO AE, 1987, ARCH PHYS MED REHAB, V68, P645; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; Hagen C, 1979, LEVELS COGNITIVE FUN; HARCKE HT, 1986, DIAGNOSTIC RADIOLOGY, P2197; HOFFER MM, 1975, CLIN ORTHOPAEDICS, V110, P244; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; MITAL MA, 1987, J PEDIATR ORTHOPED, V7, P83, DOI 10.1097/01241398-198701000-00017; RITTER MA, 1985, CLIN ORTHOP RELAT R, V196, P217; ROBERTS P H, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P70; ROGERS JG, 1977, J PEDIATR-US, V91, P1011, DOI 10.1016/S0022-3476(77)80918-9; Rogers R C, 1988, Brain Inj, V2, P169, DOI 10.3109/02699058809150941; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; Stover S L, 1976, Paraplegia, V14, P146; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199	16	43	46	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1992	73	3					258	262					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HH123	WOS:A1992HH12300010	1543430				2022-02-06	
J	ZWIMPFER, TJ; BERNSTEIN, M				ZWIMPFER, TJ; BERNSTEIN, M			SPINAL-CORD CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article									UNIV TORONTO,DIV NEUROSURG,25 LEONARD AVE,SUITE 211,TORONTO M5T 2R2,ONTARIO,CANADA								[Anonymous], 1966, CLIN NEUROSURG, V12, P386; BARR ML, 1979, HUMAN NERVOUS SYSTEM, P106; BELL HS, 1970, J NEUROSURG, V33, P376, DOI 10.3171/jns.1970.33.4.0376; Countee R W, 1979, J Natl Med Assoc, V71, P257; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOLDSWORTH F, 1970, J BONE JOINT SURG AM, VA 52, P1534, DOI 10.2106/00004623-197052080-00002; Holmes G, 1915, Br Med J, V2, P769; JANE JA, 1982, HEAD INJURY BASIC CL, P229; Kobrine A I, 1975, Surg Neurol, V3, P261; KOBRINE AI, 1979, J NEUROSURG, V50, P639, DOI 10.3171/jns.1979.50.5.0639; MARBURG O, 1936, HDB NEUROLOGIE; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OBERSTEINER H, 1879, WEIN MED JB, V34, P531; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; RICHARDSON PM, 1979, J NEUROSURG, V51, P178, DOI 10.3171/jns.1979.51.2.0178; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; Schneider R C, 1973, Clin Neurosurg, V20, P424; Shetter A G, 1979, Adv Neurol, V22, P5; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	28	43	49	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	1990	72	6					894	900		10.3171/jns.1990.72.6.0894			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DF001	WOS:A1990DF00100010	2338574				2022-02-06	
J	YASHON, D; JOHNSON, AB; JANE, JA				YASHON, D; JOHNSON, AB; JANE, JA			BILATERAL INTERNAL CAROTID ARTERY OCCLUSION SECONDARY TO CLOSED HEAD INJURIES	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article																	AMELI NO, 1949, LANCET, V257, P1078; Andrell PO, 1943, ACTA MED SCAND, V114, P336; Andreyev LA, 1935, ARCH NEURO PSYCHIATR, V34, P481, DOI 10.1001/archneurpsyc.1935.02250210002001; Blackwood W., 1963, GREENFIELDS NEUROPAT; BOYD RJ, 1962, ARCH SURG-CHICAGO, V84, P434, DOI 10.1001/archsurg.1962.01300220058009; BRASS K, 1957, Frankf Z Pathol, V68, P254; BULL JWD, 1962, BRIT J RADIOL, V35, P801, DOI 10.1259/0007-1285-35-420-801; CALDWELL HW, 1948, ANN INTERN MED, V28, P1132, DOI 10.7326/0003-4819-28-6-1132; Cooper A, 1836, GUYS HOSP REP, V1, P457; DONALD DE, 1961, NEUROLOGY, V11, P836, DOI 10.1212/WNL.11.9.836; DONIGER DE, 1963, NEUROLOGY, V13, P673, DOI 10.1212/WNL.13.8.673; ECKER AD, 1945, J NEUROSURG, V2, P479, DOI 10.3171/jns.1945.2.6.0479; ELVIDGE AR, 1951, AMA ARCH NEUROL PSY, V66, P752, DOI 10.1001/archneurpsyc.1951.02320120085011; FIELDS WS, 1961, ARCH NEUROL-CHICAGO, V4, P369, DOI 10.1001/archneur.1961.00450100017004; FOTOPULOS D, 1962, Zentralbl Neurochir, V22, P216; FROVIG AG, 1946, ACTA PSYCHIAT KBH  S, V39; Gardner MD, 1935, P SOC EXP BIOL MED, V32, P1034; GOSS CM, 1954, ANATOMY HUMAN BODY, P637; GRAY H, 1954, ANATOMY HUMAN BODY, P637; GRECO T, 1935, ARCH ITAL CHIR, V39, P757; GROCH SN, 1960, ARCH NEUROL-CHICAGO, V2, P130, DOI 10.1001/archneur.1960.03840080016003; HIGAZI I, 1963, J NEUROSURG, V20, P354, DOI 10.3171/jns.1963.20.4.0354; HOCKADAY TDR, 1959, J NEUROL NEUROSUR PS, V22, P229, DOI 10.1136/jnnp.22.3.229; HOUCK WS, 1964, ANN SURG, V159, P219, DOI 10.1097/00000658-196402000-00006; HUMPHREY JG, 1960, BRAIN, V83, P565, DOI 10.1093/brain/83.4.565; JOHNSON HC, 1951, J NEUROSURG, V8, P631, DOI 10.3171/jns.1951.8.6.0631; KECHT B, 1937, ARCH OHR NAS KEHLKHE, V143, P3; LINZELL JL, 1957, J PHYSIOL-LONDON, V138, pP20; LOHR W, 1936, ZENTRALBLATT CHIR, V63, P2593; MURPHEY F, 1959, J NEUROSURG, V16, P24, DOI 10.3171/jns.1959.16.1.0024; MURRAY DS, 1957, BRIT J SURG, V44, P556, DOI 10.1002/bjs.18004418803; Northcroft GB, 1944, BRIT J SURG, V32, P105, DOI 10.1002/bjs.18003212518; SCHNEIDER RC, 1952, J NEUROSURG, V9, P495, DOI 10.3171/jns.1952.9.5.0495; SEDZIMIR CB, 1955, J NEUROL NEUROSUR PS, V18, P293, DOI 10.1136/jnnp.18.4.293; SILVERSTEIN A, 1963, NEUROLOGY, V13, P679, DOI 10.1212/WNL.13.8.679; SMITH MC, 1963, J NEUROSURG, V20, P46, DOI 10.3171/jns.1963.20.1.0046; VERBIEST H, 1959, Folia Psychiatr Neurol Neurochir Neerl, V62, P371; VERNEUIL, 1872, B ACAD MED PARIS, V1, P46; [No title captured]	39	43	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1964	27	6					547	+		10.1136/jnnp.27.6.547			1	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	60255	WOS:A19646025500011	14249397	Green Published, Bronze			2022-02-06	
J	Jefferson, G				Jefferson, G			The nature of concussion	BRITISH MEDICAL JOURNAL			English	Article																	BRESLAUER J, 1914, ARCH KLIN CHIR, V103, P478; BROWN DD, 1941, BRAIN, V64, P93; Cairns H, 1941, BRAIN, V64, P273, DOI 10.1093/brain/64.4.273; FISCHER H, 1870, SAMM KLIN VORTR, P119; Fulton JF, 1929, J NERV MENT DIS, V69, P1, DOI 10.1097/00005053-192901000-00001; Globus JH, 1940, ARCH NEURO PSYCHIATR, V43, P125, DOI 10.1001/archneurpsyc.1940.02280010133010; Greenfield J G, 1938, Proc R Soc Med, V32, P43; HARRISON J, 1940, HYPOTHALAMUS, V20, P635; Jefferson G, 1938, ARCH NEURO PSYCHIATR, V40, P857, DOI 10.1001/archneurpsyc.1938.02270110011001; Jefferson Geoffrey, 1942, Glasgow Med J, V138, P77; Kleitman N., 1939, SLEEP WAKEFULNESS; KNAUER A, 1922, J PSYCHOL NEUROL, V29, P1; KOCHER T, 1901, HIRNERCHUTTERUNG; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; PENFIELD W, 1941, EPILEPSY CEREBRAL LO, P143; RANSON S. W., 1939, ERGEBN PHYSIOL, V41, P56, DOI 10.1007/BF02322411; SYMONDS CP, 1940, INJURIES SKULL BRAIN; TROTTER W, 1932, CHOYCES SYSTEM SURG, V3, P363; von EC0N0M0 C., 1930, JOUR NERV & MENT DIS, V71, P249; VONECONOMO C, 1926, HDB NORMALEN PATHOLO, V17, P591; WHITE JC, 1940, HYPOTHALAMUS, V20, P855; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; WITKOWSKI L, 1877, VIRCHOWS ARCH, V69, P498	23	43	43	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN-JUN	1944	1944		1				1	5					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07XP	WOS:000200534500001	20785201				2022-02-06	
J	Kaseda, ET; Levine, AJ				Kaseda, Erin T.; Levine, Andrew J.			Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors	CLINICAL NEUROPSYCHOLOGIST			English	Article						COVID-19; medical trauma; PTSD differential diagnoses	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; MILD HEAD-INJURY; QUALITY-OF-LIFE; MENTAL-HEALTH; RISK-FACTORS; CRITICAL ILLNESS; POSTCONCUSSIVE SYMPTOMS; POSTOPERATIVE DELIRIUM	Objective: SARS-CoV-2 infection and its oft-associated illness COVID-19 may lead to neuropsychological deficits, either through direct mechanisms (i.e., neurovirulance) or indirect mechanisms, most notably complications caused by the virus (e.g., stroke) or medical procedures (e.g., intubation). The history of past human coronavirus outbreaks resulting in similar health emergencies suggests there will be a substantial prevalence of post-traumatic stress disorder (PTSD) among COVID-19 survivors. To prepare neuropsychologists for the difficult task of differentiating PTSD-related from neuropathology-related deficits in the oncoming wave of COVID-19 survivors, we integrate research across a spectrum of related areas. Methods: Several areas of literature were reviewed: psychiatric, neurologic, and neuropathological outcomes of SARS and MERS patients; neurological outcomes in COVID-19 survivors; PTSD associated with procedures common to COVID-19 patients; and differentiating neuropsychological deficits due to PTSD from those due to acquired brain injuries in other patient groups. Conclusions: Heightened risk of PTSD occurred in MERS and SARS survivors. While data concerning COVID-19 is lacking, PTSD is known to occur in patient groups who undergo similar hospital courses, including ICU survivors, patients who are intubated and mechanically ventilated, and those that experience delirium. Research with patients who develop PTSD in the context of mild traumatic brain injury further suggests that PTSD may account for some or all of a patient's subjective cognitive complaints and neuropsychological test performance. Recommendations are provided for assessing PTSD in the context of COVID-19.	[Kaseda, Erin T.] Rosalind Franklin Univ Med & Sci, Dept Psychol, 3333 Green Bay Rd, N Chicago, IL 60064 USA; [Levine, Andrew J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Kaseda, ET (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Psychol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	erin.kaseda@my.rfums.org	Levine, Andrew/ABD-7628-2021	Kaseda, Erin/0000-0001-8845-7459			Ahles TA, 2018, ANNU REV CLIN PSYCHO, V14, P425, DOI [10.1146/annurev-clinpsy-050817-084903, 10.1146/annurev-clinpsy-050817084903]; Altman MT, 2017, ANN AM THORAC SOC, V14, P1457, DOI 10.1513/AnnalsATS.201702-148SR; Arbour N, 1999, J VIROL, V73, P3326, DOI 10.1128/JVI.73.4.3326-3337.1999; Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832; Ashrafi F, 2020, NEUROL SCI, V41, P1985, DOI 10.1007/s10072-020-04521-3; Asimakopoulou E, 2014, ISSUES MENT HEALTH N, V35, P954, DOI 10.3109/01612840.2014.924609; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bashar FR, 2018, J CRIT CARE, V43, P88, DOI 10.1016/j.jcrc.2017.08.034; Bennett Susan J, 2003, J Cardiovasc Nurs, V18, P219; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brodsky R., 2020, NEWSDAY         0412; Buxbaum S., 2020, UTAH PUBLIC RAD 0629; Cristallo A, 1997, MICROBIOLOGICA, V20, P105; Cuthbertson BH, 2004, INTENS CARE MED, V30, P450, DOI 10.1007/s00134-003-2004-8; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Davydow DS, 2009, GEN HOSP PSYCHIAT, V31, P428, DOI 10.1016/j.genhosppsych.2009.05.007; Dhooria S, 2016, INDIAN J CRIT CARE M, V20, P323, DOI 10.4103/0972-5229.183908; DiGangi JA, 2017, PROG NEURO-PSYCHOPH, V75, P63, DOI 10.1016/j.pnpbp.2017.01.004; DiMartini A, 2007, PSYCHOSOMATICS, V48, P436, DOI 10.1176/appi.psy.48.5.436; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dreher M, 2020, DTSCH ARZTEBL INT, V117, P271, DOI 10.3238/arztebl.2020.0271; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fan SY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00806; FAZZINI E, 1992, MOVEMENT DISORD, V7, P153, DOI 10.1002/mds.870070210; Friese RS, 2007, J TRAUMA, V63, P1210, DOI 10.1097/TA.0b013e31815b83d7; Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Girard TD, 2007, CRIT CARE, V11, DOI 10.1186/cc5708; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Gosselin E., 2018, SCI NURS HLTH PRACT, V1, P1019, DOI [DOI 10.31770/2561-7516.1019, 10.31770/2561-7516.1019]; Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z; Hatch R, 2011, CRIT CARE, V15, DOI 10.1186/cc10054; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Janelsins MC, 2018, J CLIN ONCOL, V36, P3231, DOI 10.1200/JCO.2018.78.6624; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnson-Lussenburg C M, 1987, Adv Exp Med Biol, V218, P421; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Jones C, 2010, J INTENSIVE CARE SOC, V11, P12, DOI DOI 10.1177/17511437100112S105; Jones C, 2010, CRIT CARE, V14, DOI 10.1186/cc9260; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Kotfis K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02882-x; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P595, DOI 10.1017/S1355617707070749; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Lee C, 2009, INTENS CARE MED, V35, P314, DOI 10.1007/s00134-008-1277-3; Lee SH, 2019, PSYCHIAT INVEST, V16, P59, DOI 10.30773/pi.2018.10.22.3; Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499; Litton E, 2016, CRIT CARE MED, V44, P992, DOI 10.1097/CCM.0000000000001557; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; Mak IWC, 2010, GEN HOSP PSYCHIAT, V32, P590, DOI 10.1016/j.genhosppsych.2010.07.007; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Malarbi S, 2017, NEUROSCI BIOBEHAV R, V72, P68, DOI 10.1016/j.neubiorev.2016.11.004; Marelli S, 2021, J NEUROL, V268, P8, DOI 10.1007/s00415-020-10056-6; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Meeker J, 2019, AM J RESP CRIT CARE, V199; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458; MURRAY RS, 1992, ANN NEUROL, V31, P525, DOI 10.1002/ana.410310511; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; O'Hanlon S, 2020, AGE AGEING, V49, P497, DOI 10.1093/ageing/afaa094; Park JS, 2018, ARCH PSYCHIAT NURS, V32, P2, DOI 10.1016/j.apnu.2017.09.006; Patel MB, 2016, AM J RESP CRIT CARE, V193, P1373, DOI 10.1164/rccm.201506-1158OC; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Presser L., 2020, MEDICAL WORKER DESCR; Qian GQ, 2020, CLIN INFECT DIS, V71, P861, DOI 10.1093/cid/ciaa316; Reijmer YD, 2011, DIABETES-METAB RES, V27, P195, DOI 10.1002/dmrr.1163; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Samuelson KW, 2017, PSYCHOL TRAUMA-US, V9, P537, DOI 10.1037/tra0000210; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schou L, 2012, RESP MED, V106, P1071, DOI 10.1016/j.rmed.2012.03.013; Schultz IZ, 2018, PSYCHOL INJ LAW, V11, P153, DOI 10.1007/s12207-018-9319-9; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shaw RJ, 2009, PSYCHOSOMATICS, V50, P586, DOI 10.1176/appi.psy.50.6.586; Shaw RJ, 2001, PSYCHOSOMATICS, V42, P35, DOI 10.1176/appi.psy.42.1.35; Spadaro S, 2020, CHEST, V158, P848, DOI 10.1016/j.chest.2020.05.521; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Sprung J, 2017, BRIT J ANAESTH, V119, P316, DOI 10.1093/bja/aex130; STEWART JN, 1992, VIROLOGY, V191, P502, DOI 10.1016/0042-6822(92)90220-J; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Svenningsen H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/876947; TALBOT PJ, 1993, ADV EXP MED BIOL, V342, P339; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taylor AK, 2019, BRIT J GEN PRACT, V69, P154, DOI 10.3399/bjgp19X701765; Tobe Edward, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-02-2012-5945; Twigg E, 2008, ACTA ANAESTH SCAND, V52, P202, DOI 10.1111/j.1399-6576.2007.01531.x; van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9; Varela V. S., 2011, PSYCHO-ONCOLOGY, V22, P434, DOI [10.1002/pon, DOI 10.1002/P0N.2109]; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Wade D, 2013, MINERVA ANESTESIOL, V79, P944; Waldron-Perrine B, 2015, BRAIN INJURY, V29, P1051, DOI 10.3109/02699052.2015.1004742; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Westphal M, 2011, DEPRESS ANXIETY, V28, P686, DOI 10.1002/da.20842; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Wolters AE, 2016, CRIT CARE MED, V44, P1808, DOI 10.1097/CCM.0000000000001861; Wu KK, 2005, EMERG INFECT DIS, V11, P1297, DOI 10.3201/eid1108.041083; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921; Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7; Yeh EA, 2004, PEDIATRICS, V113, pE73, DOI 10.1542/peds.113.1.e73; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575	119	42	42	7	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 16	2020	34	7-8			SI		1498	1514		10.1080/13854046.2020.1811894		AUG 2020	17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OB1RG	WOS:000565424300001	32847484	Bronze			2022-02-06	
J	Ritzel, RM; Doran, SJ; Glaser, EP; Meadows, VE; Faden, AI; Stoica, BA; Loane, DJ				Ritzel, Rodney M.; Doran, Sarah J.; Glaser, Ethan P.; Meadows, Victoria E.; Faden, Alan, I; Stoica, Bogdan A.; Loane, David J.			Old age increases microglial senescence, exacerbates secondary neuroinflammation, and worsens neurological outcomes after acute traumatic brain injury in mice	NEUROBIOLOGY OF AGING			English	Article						Aging; Traumatic brain injury; Neuroinflammation; Microglia; Behavior	ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ELDERLY-PATIENTS; YOUNG ADULTHOOD; NEURODEGENERATION; INFLAMMATION; ACTIVATION; DAMAGE; CELLS; DEGRADATION	After traumatic brain injury (TBI), individuals aged over 65 years show increased mortality and worse functional outcomes compared with younger persons. As neuroinflammation is a key pathobiological mechanism of secondary injury after TBI, we examined how aging affects post-traumatic microglial responses and functional outcomes. Young (3-month-old) and aged (18-month-old) male C57BL/6 mice were subjected to moderate-level controlled cortical impact or sham surgery, and neurological function was evaluated. At 72 hours after injury, brain, blood, and spleen leukocyte counts were assessed ex vivo using flow cytometry. Aged mice demonstrated more severe deficits in forelimb grip strength, balance and motor coordination, spontaneous locomotor activity, and anxiety-like behavior. These animals also exhibited more robust microglial proliferation and significantly higher numbers of brain-infiltrating leukocytes. Microglia in aged mice showed impairments in phagocytic activity and higher production of interleukin-1 beta (IL-1 beta). Infiltrating myeloid cells in aged TBI mice also had deficits in phagocytosis but showed diminished proinflammatory cytokine production and greater reactive oxygen species production. Expression of several senescence markers (Bcl-2, p16(ink4a), p21(cip1a), lipofuscin, and H2AX [pS139]) was increased with age and/or TBI in both microglia and injured cortex. Although there was no difference in the number of circulating blood neutrophils as a function of age, young mice exhibited more pronounced TBI-induced splenomegaly and splenic myeloid cell expansion. Thus, worse post-traumatic behavioral outcomes in aged animals are associated with exaggerated microglial responses, increased leukocyte invasion, and upregulation of senescence markers. (C) 2019 Elsevier Inc. All rights reserved.	[Ritzel, Rodney M.; Doran, Sarah J.; Glaser, Ethan P.; Meadows, Victoria E.; Faden, Alan, I; Stoica, Bogdan A.; Loane, David J.] Univ Maryland, Dept Anesthesiol, Sch Med, 655 West Baltimore St,6-011, Baltimore, MD 21201 USA; [Ritzel, Rodney M.; Doran, Sarah J.; Glaser, Ethan P.; Meadows, Victoria E.; Faden, Alan, I; Stoica, Bogdan A.; Loane, David J.] Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Sch Med, Baltimore, MD 21201 USA		Loane, DJ (corresponding author), Univ Maryland, Dept Anesthesiol, Sch Med, 655 West Baltimore St,6-011, Baltimore, MD 21201 USA.	dloane@som.umaryland.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Ritzel, Rodney/0000-0002-0160-2930	National Institutes of Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308, R01NS037313, F32NS105355, T32AI095190]; National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center [P30-AG028747]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI095190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS105355, R01NS037313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028747] Funding Source: NIH RePORTER	The authors would like to acknowledge Nicholas Braganca, BSc, and Wesley Shoap, BSc, for their technical assistance. The authors thank Xiaoxuan Fan, PhD, and Karen Underwood, BSc, of the University of Maryland Greenebaum Comprehensive Cancer Center Flow Cytometry Facility for support with flow cytometry studies. This work was supported by the National Institutes of Health, United States grants R01NS082308 (DJL), R01NS037313 (AIF), F32NS105355 (RMR), and T32AI095190 (SJD) and the National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center P30-AG028747 (DJL).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Al-Mashhadi S, 2015, BRAIN PATHOL, V25, P565, DOI 10.1111/bpa.12216; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chaturvedi M, 2014, MOL NEUROBIOL, V49, P563, DOI 10.1007/s12035-013-8538-z; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Chen NC, 2018, J GERONTOL A-BIOL, V73, P1187, DOI 10.1093/gerona/gly022; Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Clausen BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29291; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Filer William, 2015, N C Med J, V76, P111; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; Foster KA, 2008, NEUROBIOL AGING, V29, P598, DOI 10.1016/j.neurobiolaging.2006.11.006; Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Ge X, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.32981; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Hall BM, 2016, AGING-US, V8, P1294, DOI 10.18632/aging.100991; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Hornsby PJ, 2010, CELLULAR SENESCENCE AND TUMOR SUPPRESSION, P85, DOI 10.1007/978-1-4419-1075-2_4; Itoh T, 2013, BRAIN STRUCT FUNCT, V218, P209, DOI 10.1007/s00429-012-0394-5; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lopes KO, 2008, GLIA, V56, P1048, DOI 10.1002/glia.20678; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marshall JL, 2017, HIST BIOL, P1; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moreno-Garcia A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00464; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Musi N., 2018, BIORXIV, V17; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Prattichizzo F, 2016, AGING-US, V8, P3159, DOI 10.18632/aging.101133; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Ritzel RM, 2018, ACTA NEUROPATHOL, V136, P89, DOI 10.1007/s00401-018-1859-2; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosenzweig S, 2013, STROKE, V44, P2579, DOI 10.1161/STROKEAHA.113.001796; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; SAMORAJSKI T, 1976, J AM GERIATR SOC, V24, P4, DOI 10.1111/j.1532-5415.1976.tb03246.x; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sharaf A, 2013, CELL TISSUE RES, V351, P373, DOI 10.1007/s00441-012-1537-y; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stojiljkovic MR, 2019, NEUROBIOL AGING, V74, P56, DOI 10.1016/j.neurobiolaging.2018.10.007; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2014, CURR OPIN IMMUNOL, V29, P93, DOI 10.1016/j.coi.2014.05.005; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Venna VR, 2012, ACTA NEUROPATHOL, V124, P425, DOI 10.1007/s00401-012-0990-8; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wei Z, 2016, CHINESE MED J-PEKING, V129, P1835, DOI 10.4103/0366-6999.186646; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Xu K, 2007, ADV EXP MED BIOL, V599, P199; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zoller T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030706	99	42	43	3	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2019	77						194	206		10.1016/j.neurobiolaging.2019.02.010			13	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	HU5FQ	WOS:000465302200020	30904769	Green Accepted			2022-02-06	
J	Hill, CE; Blank, LJ; Thibault, D; Davis, KA; Dahodwala, N; Litt, B; Willis, AW				Hill, Chloe E.; Blank, Leah J.; Thibault, Dylan; Davis, Kathryn A.; Dahodwala, Nabila; Litt, Brian; Willis, Allison W.			Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS; ELECTROGRAPHIC SEIZURES; VALIDATION; CHILDREN	Objective To characterize continuous EEG (cEEG) use patterns in the critically ill and to determine the association with hospitalization outcomes for specific diagnoses. Methods We performed a retrospective cross-sectional study with National Inpatient Sample data from 2004 to 2013. We sampled hospitalized adult patients who received intensive care and then compared patients who underwent cEEG to those who did not. We considered diagnostic subgroups of seizure/status epilepticus, subarachnoid or intracerebral hemorrhage, and altered consciousness. Outcomes were in-hospital mortality, hospitalization cost, and length of stay. Results In total, 7,102,399 critically ill patients were identified, of whom 22,728 received cEEG. From 2004 to 2013, the proportion of patients who received cEEG increased from 0.06% (95% confidence interval [CI] 0.03%-0.09%) to 0.80% (95% CI 0.62%-0.98%). While the cEEG cohort appeared more ill, cEEG use was associated with reduced in-hospital mortality after adjustment for patient and hospital characteristics (odds ratio [OR] 0.83, 95% CI 0.75-0.93, p < 0.001). This finding held for the diagnoses of subarachnoid or intracerebral hemorrhage and for altered consciousness but not for the seizure/status epilepticus subgroup. Cost and length of hospitalization were increased for the cEEG cohort (OR 1.17 and OR 1.11, respectively, p < 0.001). Conclusions There was a >10-fold increase in cEEG use from 2004 to 2013. However, this procedure may still be underused; cEEG was associated with lower in-hospital mortality but used for only 0.3% of the critically ill population. While administrative claims analysis supports the utility of cEEG for critically ill patients, our findings suggest variable benefit by diagnosis, and investigation with greater clinical detail is warranted.	[Hill, Chloe E.; Blank, Leah J.; Thibault, Dylan; Davis, Kathryn A.; Dahodwala, Nabila; Litt, Brian; Willis, Allison W.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Hill, Chloe E.; Dahodwala, Nabila; Willis, Allison W.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Thibault, Dylan; Willis, Allison W.] Univ Penn, Dept Neurol, Translat Ctr Excellence Neurol Outcomes Res, Philadelphia, PA 19104 USA; [Willis, Allison W.] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA		Hill, CE (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.; Hill, CE (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.	chloehi@med.umich.edu	Willis, Allison/ABC-9010-2020	Willis, Allison/0000-0001-5724-7192; Dahodwala, Nabila/0000-0003-3659-0244; Blank, Leah J/0000-0001-8719-6752	Mirowski Family Fund; Family of Johnathan Rothberg; American Epilepsy Society/Epilepsy Foundation Research and Training Fellowship for Clinicians; Neurologic Clinical Epidemiology Training Grant [T32-NS-061779]; University of Pennsylvania Department of Neurology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS092973, T32NS061779] Funding Source: NIH RePORTER	The first authors were supported by the Mirowski Family Fund and the Family of Johnathan Rothberg (C.H.) and by the American Epilepsy Society/Epilepsy Foundation Research and Training Fellowship for Clinicians, as well as the Neurologic Clinical Epidemiology Training Grant (T32-NS-061779) (L.B.). Additional funding for this study came from the University of Pennsylvania Department of Neurology.	Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Alvarez V, 2017, CLIN NEUROPHYSIOL, V128, P570, DOI 10.1016/j.clinph.2017.01.001; Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Committee on the Learning Health Care System in America, 2013, BEST CARE LOWER COST; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Gorelick PB, 2016, LANCET NEUROL, V15, P444, DOI 10.1016/S1474-4422(16)00020-X; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2015, EPILEPSY CURR, V15, P313, DOI 10.5698/1535-7511-15.6.313; Kerlin MP, 2016, AM J RESP CRIT CARE, V194, P1548; Khawaja AM, 2017, MED SCI MONITOR, V23, P649, DOI 10.12659/MSM.900826; Kilbride RD, 2009, ARCH NEUROL-CHICAGO, V66, P723, DOI 10.1001/archneurol.2009.100; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schmitt SE, 2017, J CLIN NEUROPHYSIOL, V34, P158, DOI 10.1097/WNP.0000000000000335; Sutter R, 2013, NAT REV NEUROL, V9, P525, DOI 10.1038/nrneurol.2013.154; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001	30	42	45	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 1	2019	92	1					E9	E18		10.1212/WNL.0000000000006689			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ3TZ	WOS:000462334700002	30504428	Green Published			2022-02-06	
J	Ledoux, AA; Tang, K; Yeates, KO; Pusic, MV; Boutis, K; Craig, WR; Gravel, J; Freedman, SB; Gagnon, I; Gioia, GA; Osmond, MH; Zemek, RL; McGahern, C; Sangha, G; Beer, D; Burns, E; Farion, KJ; Mikrogianakis, A; Barlow, K; Dubrovsky, AS; Meeuwisse, W; Meehan, WP; Kamil, Y; Beauchamps, MH; Hoshizaki, B; Anderson, P; Brooks, BL; Vassilyadi, M; Klassen, T; Keightley, M; Richer, L; DeMatteo, C				Ledoux, Andree-Anne; Tang, Ken; Yeates, Keith O.; Pusic, Martin, V; Boutis, Kathy; Craig, William R.; Gravel, Jocelyn; Freedman, Stephen B.; Gagnon, Isabelle; Gioia, Gerard A.; Osmond, Martin H.; Zemek, Roger L.; McGahern, Candice; Sangha, Gurinder; Beer, Darcy; Burns, Emma; Farion, Ken J.; Mikrogianakis, Angelo; Barlow, Karen; Dubrovsky, Alexander S.; Meeuwisse, Willem; Meehan, William P., III; Kamil, Yael; Beauchamps, Miriam H.; Hoshizaki, Blaine; Anderson, Peter; Brooks, Brian L.; Vassilyadi, Michael; Klassen, Terry; Keightley, Michelle; Richer, Lawrence; DeMatteo, Carol		Pediat Emergency Res Canada PERC	Natural Progression of Symptom Change and Recovery From Concussion in a Pediatric Population	JAMA PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; PROLONGED RECOVERY; CHILDREN; HEAD; PREDICTORS; GENDER; SEVERITY; VISITS	IMPORTANCE The natural progression of symptom change and recovery remains poorly defined in children after concussion. OBJECTIVES To describe the natural progression of symptom change by age group (5-7, 8-12, and 13-18 years) and sex, as well as to develop centile curves to inform families about children after injury recovery. DESIGN, SETTING, AND PARTICIPANTS Planned secondary analysis of a prospective multicenter cohort study (Predicting Persistent Postconcussive Problems in Pediatrics). The setting was 9 pediatric emergency departments within the Pediatric Emergency Research Canada (PERC) network. Participants were aged 5 to 18 years with acute concussion, enrolled from August 1, 2013, to May 31, 2015, and data analyses were performed between January 2018 and March 2018. EXPOSURES Participants had a concussion consistent with the Zurich Consensus Statement on Concussion in Sport diagnostic criteria and 85% completeness of the Postconcussion Symptom Inventory (PCSI) at each time point. MAIN OUTCOMES AND MEASURES The primary outcome was symptom change, defined as current rating minus preinjury rating (delta score), at presentation and 1, 2, 4, 8, and 12 weeks after injury, measured using the PCSI. Symptoms were self-rated for ages 8 to 18 years and rated by the child and parent for ages 5 to 7 years. The secondary outcome was recovery, defined as no change in symptoms relative to current preinjury PCSI ratings (delta score = 0). Mixed-effects models incorporated the total score, adjusting for random effects (site and participant variability), fixed-effects indicators (age, sex, time, age by time interaction, and sex by time interaction), and variables associated with recovery. Recovery centile curves by age and sex were computed. RESULTS A total of 3063 children (median age, 12.0 years [interquartile range, 9.2-14.6 years]; 60.7% male) completed the primary outcome; 2716 were included in the primary outcome analysis. For the group aged 5 to 7 years, symptom change primarily occurred the first week after injury; by 2 weeks, 75.6% of symptoms had improved (PCSI change between 0 and 2 weeks, -5.3; 95% CI, -5.5 to -5.0). For the groups aged 8 to 12 years and 13 to 18 years, symptom change was prominent the first 2 weeks but flattened between 2 and 4 weeks. By 4 weeks, 83.6% and 86.2% of symptoms, respectively, had improved for the groups aged 8 to 12 years (PCSI change between 0 and 4 weeks, -9.0; 95% CI, -9.6 to -8.4) and 13 to 18 years (PCSI change between 0 and 4 weeks, -28.6; 95% CI, -30.8 to -.26.3). Sex by time interaction was significant only for the adolescent group (beta = 0.32; 95% CI, 0.21-0.43; P < .001). Most adolescent girls had not recovered by week 12. CONCLUSIONS AND RELEVANCE Symptom improvement primarily occurs in the first 2 weeks after concussion in children and in the first 4 weeks after concussion in preadolescents and male adolescents. Female adolescents appear to have protracted recovery. The derived recovery curves may be useful for evidence-based anticipatory guidance.	[Ledoux, Andree-Anne; Tang, Ken; Osmond, Martin H.; Zemek, Roger L.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith O.; Freedman, Stephen B.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Pusic, Martin, V] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Craig, William R.] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Dept Pediat, Montreal Childrens Hosp, Montreal, PQ, Canada; [Gioia, Gerard A.] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Rockville, MD USA; [Osmond, Martin H.; Zemek, Roger L.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [McGahern, Candice; Kamil, Yael] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Sangha, Gurinder] London Childrens Hosp, Dept Pediat, London, ON, Canada; [Beer, Darcy; Klassen, Terry] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Farion, Ken J.] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen] Albertas Childrens Hosp, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Dubrovsky, Alexander S.] Montreal Childrens Hosp, Dept Pediat, Montreal, PQ, Canada; [Meeuwisse, Willem] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Beauchamps, Miriam H.] Univ Montreal, Ste Justine Res Ctr, Montreal, PQ, Canada; [Hoshizaki, Blaine] Univ Ottawa, Dept Kinesiol, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Dept Psychol, Ottawa, ON, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neurosurg, Ottawa, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Richer, Lawrence] Stollery Childrens Hosp, Dept Neurol, Edmonton, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Zemek, RL (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Yeates, Keith/AAJ-4223-2020; Mikrogianakis, Angelo/AAW-5929-2021; Richer, Lawrence/D-3622-2009; Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014; Freedman, Stephen/H-9102-2012	Mikrogianakis, Angelo/0000-0002-8854-0620; Richer, Lawrence/0000-0002-6897-8668; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Osmond, Martin/0000-0001-8275-8381; Freedman, Stephen/0000-0003-2319-6192; Craig, William/0000-0002-4804-194X; Yeates, Keith/0000-0001-7680-2892; Gagnon, Isabelle/0000-0003-2043-1644; Pusic, Martin/0000-0001-5236-6598	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team grant [TM1 127047]; CIHR planning grantCanadian Institutes of Health Research (CIHR) [MRP 119829]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness; University of Ottawa Clinical Research Chair in pediatric concussion	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197), a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team grant (TM1 127047), and a CIHR planning grant (MRP 119829). Dr Freedman is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness. Dr Zemek is supported by a University of Ottawa Clinical Research Chair in pediatric concussion.	Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; BOX G. E. P., 1994, TIME SERIES ANAL FOR, V3rd; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Faes C, 2009, AM STAT, V63, P389, DOI 10.1198/tast.2009.08196; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jones, 1993, LONGITUDINAL DATA SE, DOI [10.1007/978-1-4899-4489-4, DOI 10.1007/978-1-4899-4489-4]; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Verbeke G, 2009, SPRINGER SER STAT, P375; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P2624, DOI 10.1001/jama.2016.7407; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	52	42	42	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JAN	2019	173	1							e183820	10.1001/jamapediatrics.2018.3820			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HG8OF	WOS:000455261300002	30398522	Green Published, Bronze			2022-02-06	
J	Giacino, JT; Katz, DI; Schiff, ND; Whyte, J; Ashman, EJ; Ashwal, S; Barbano, R; Hammond, FM; Laureys, S; Ling, GSF; Nakase-Richardson, R; Seel, RT; Yablon, S; Getchius, TSD; Gronseth, GS; Armstrong, MJ				Giacino, Joseph T.; Katz, Douglas, I; Schiff, Nicholas D.; Whyte, John; Ashman, Eric J.; Ashwal, Stephen; Barbano, Richard; Hammond, Flora M.; Laureys, Steven; Ling, Geoffrey S. F.; Nakase-Richardson, Risa; Seel, Ronald T.; Yablon, Stuart; Getchius, Thomas S. D.; Gronseth, Gary S.; Armstrong, Melissa J.			Practice Guideline Update Recommendations Summary: Disorders of Consciousness Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							PERSISTENT VEGETATIVE STATE; BRAIN-INJURED PATIENTS; LOCKED-IN SYNDROME; INPATIENT REHABILITATION; RECOVERY; SCALE; OUTCOMES; COMA; RESPONSIVENESS; COMORBIDITIES	Objective: To update the 1995 American Academy of Neurology (AAN) practice parameter on persistent vegetative state and the 2002 case definition on minimally conscious state (MCS) and provide care recommendations for patients with prolonged disorders of consciousness (DoC). Methods: Recommendations were based on systematic review evidence, related evidence, care principles, and inferences using a modified Delphi consensus process according to the AAN 2011 process manual, as amended. Recommendations: Clinicians should identify and treat confounding conditions, optimize arousal, and perform serial standardized assessments to improve diagnostic accuracy in adults and children with prolonged DoC (Level B). Clinicians should counsel families that for adults, MCS (vs vegetative state [VS]/ unresponsive wakefulness syndrome [UWS]) and traumatic (vs nontraumatic) etiology are associated with more favorable outcomes (Level B). When prognosis is poor, long-term care must be discussed (Level A), acknowledging that prognosis is not universally poor (Level B). Structural MRI, SPECT, and the Coma Recovery Scale-Revised can assist prognostication in adults (Level B); no tests are shown to improve prognostic accuracy in children. Pain always should be assessed and treated (Level B) and evidence supporting treatment approaches discussed (Level B). Clinicians should prescribe amantadine (100-200 mg bid) for adults with traumatic VS/UWS or MCS (4-16 weeks post injury) to hasten functional recovery and reduce disability early in recovery (Level B). Family counseling concerning children should acknowledge that natural history of recovery, prognosis, and treatment are not established (Level B). Recent evidence indicates that the term chronic VS/UWS should replace permanent VS, with duration specified (Level B). Additional recommendations are included. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Giacino, Joseph T.] Harvard Med Sch, Boston, MA 02115 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Katz, Douglas, I] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Katz, Douglas, I] Braintree Rehabil Hosp, Boston, MA USA; [Schiff, Nicholas D.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Ashman, Eric J.] Bronson Methodist Hosp, Bronson Neurosci Ctr, Kalamazoo, MI USA; [Ashwal, Stephen] Loma Linda Univ, Sch Med, Div Child Neurol, Dept Pediat, Loma Linda, CA 92350 USA; [Barbano, Richard] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14627 USA; [Hammond, Flora M.] Univ Indiana, Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Laureys, Steven] Sart Tillman Liege Univ, Coma Sci Grp GIGA Res, Liege, Belgium; [Laureys, Steven] Sart Tillman Liege Univ, Dept Neurol, Liege, Belgium; [Laureys, Steven] Univ Hosp, Liege, Belgium; [Ling, Geoffrey S. F.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Ling, Geoffrey S. F.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Nakase-Richardson, Risa] US Dept Vet Affairs, James A Haley Vet Hosp, Tampa, FL USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Seel, Ronald T.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Ctr Rehabil Sci & Engn, Richmond, VA 23284 USA; [Yablon, Stuart] Univ Mississippi, Sch Med, Div Phys Med & Rehabil, University, MS 38677 USA; [Yablon, Stuart] Methodist Rehabil Ctr, Brain Injury Program, Jackson, MS USA; [Getchius, Thomas S. D.] Heart Rhythm Soc, Washington, DC USA; [Gronseth, Gary S.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, MO USA; [Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA		Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA.; Giacino, JT (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Giacino, JT (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	guidelines@aan.com	Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Giacino, Joseph/AAF-1952-2021	Laureys, Steven/0000-0002-3096-3807; Giacino, Joseph/0000-0002-7916-9698; Armstrong, Melissa/0000-0002-2163-1907	American Academy of Neurology (AAN); American Congress of Rehabilitation Medicine; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services	This practice guideline was funded by the American Academy of Neurology (AAN), the American Congress of Rehabilitation Medicine, and the National Institute on Disability, Independent Living, and Rehabilitation Research. Authors who serve or served as AAN subcommittee members (E.J.A., S.A., R.B., G.S.G.) or as methodologists (M.J.A., G.S.G.), or who were AAN staff members (T.S.D.G.), were reimbursed by the AAN for expenses related to travel to subcommittee meetings where drafts of manuscripts were reviewed.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, NEUROLOGY; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kotchoubey B, 2014, CURR PHARM DESIGN, V20, P4239; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; Riganello F, 2015, J NEUROTRAUM, V32, P1071, DOI 10.1089/neu.2014.3539; Schnakers C, 2015, PM&R, V7, pS270, DOI 10.1016/j.pmrj.2015.09.016; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Smart CM, 2008, NAT CLIN PRACT NEURO, V4, P448, DOI 10.1038/ncpneuro0823; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	40	42	44	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2018	99	9					1699	1709		10.1016/j.apmr.2018.07.001			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GT2YK	WOS:000444366000001	30098791				2022-02-06	
J	Zanier, ER; Bertani, I; Sammali, E; Pischiutta, F; Chiaravalloti, MA; Vegliante, G; Masone, A; Corbelli, A; Smith, DH; Menon, DK; Stocchetti, N; Fiordaliso, F; De Simoni, MG; Stewart, W; Chiesa, R				Zanier, Elisa R.; Bertani, Ilaria; Sammali, Eliana; Pischiutta, Francesca; Chiaravalloti, Maria Antonietta; Vegliante, Gloria; Masone, Antonio; Corbelli, Alessandro; Smith, Douglas H.; Menon, David K.; Stocchetti, Nino; Fiordaliso, Fabio; De Simoni, Maria-Grazia; Stewart, William; Chiesa, Roberto			Induction of a transmissible tau pathology by traumatic brain injury	BRAIN			English	Article						traumatic brain injury; tau pathology; prion; neurological dysfunction; neurodegeneration	CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; MOUSE-BRAIN; NEUROFIBRILLARY TANGLES; IN-VIVO; MODEL; MICE; ENCEPHALOPATHY; TAUOPATHIES; PROPAGATION	Traumatic brain injury is a risk factor for subsequent neurodegenerative disease, including chronic traumatic encephalopathy, a tauopathy mostly associated with repetitive concussion and blast, but not well recognized as a consequence of severe traumatic brain injury. Here we show that a single severe brain trauma is associated with the emergence of widespread hyperphosphorylated tau pathology in a proportion of humans surviving late after injury. In parallel experimental studies, in a model of severe traumatic brain injury in wild-type mice, we found progressive and widespread tau pathology, replicating the findings in humans. Brain homogenates from these mice, when inoculated into the hippocampus and overlying cerebral cortex of naive mice, induced widespread tau pathology, synaptic loss, and persistent memory deficits. These data provide evidence that experimental brain trauma induces a self-propagating tau pathology, which can be transmitted between mice, and call for future studies aimed at investigating the potential transmissibility of trauma associated tau pathology in humans.	[Zanier, Elisa R.; Bertani, Ilaria; Sammali, Eliana; Pischiutta, Francesca; Chiaravalloti, Maria Antonietta; Vegliante, Gloria; Masone, Antonio; De Simoni, Maria-Grazia; Chiesa, Roberto] IRCCS, Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy; [Sammali, Eliana] Fdn IRCCS, Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy; [Corbelli, Alessandro; Fiordaliso, Fabio] IRCCS, Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, I-20156 Milan, Italy; [Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge CB2 2QQ, England; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, I-20122 Milan, Italy; [Stocchetti, Nino] Osped Maggiore, Policlin Milano, Fdn IRCCS Ca Granda, I-20122 Milan, Italy; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TE, Lanark, Scotland		Zanier, ER; Chiesa, R (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy.	elisa.zanier@marionegri.it; roberto.chiesa@marionegri.it	Fiordaliso, Fabio/AAA-7161-2020; Pischiutta, Francesca/AAA-7927-2020; De Simoni, Maria Grazia/I-6021-2012; Chiaravalloti, Maria Antonietta/ABI-5305-2020; Zanier, Elisa/AAA-8095-2020; Masone, Antonio/ABF-7042-2021; Chiesa, Roberto/Q-4295-2019; Sammali, Eliana/AAA-2464-2019; Vegliante, Gloria/ABF-9054-2021; Corbelli, Alessandro/ABG-3900-2020	Fiordaliso, Fabio/0000-0002-0172-4030; Pischiutta, Francesca/0000-0002-7151-0812; De Simoni, Maria Grazia/0000-0001-6695-5297; Chiaravalloti, Maria Antonietta/0000-0002-5355-1346; Zanier, Elisa/0000-0002-3011-8718; Masone, Antonio/0000-0001-8357-5931; Chiesa, Roberto/0000-0002-3842-3733; Vegliante, Gloria/0000-0002-7563-0889; Corbelli, Alessandro/0000-0001-8545-8050; Bertani, Ilaria/0000-0003-3175-8677; Stewart, William/0000-0003-2199-2582	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH NS094003, NS038104]; NHS Research Scotland Career-Researcher Fellowship; Alzheimer's AssociationAlzheimer's Association [AARG-18532633]; National Institute for Health Research (UK)National Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1100578, MR/N004272/1, G0701018] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS038104] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (NIH NS094003 and NS038104) (D.H.S., W.S.); by NHS Research Scotland Career-Researcher Fellowship (W.S.); and the Alzheimer's Association (AARG-18532633) (E.R.Z., R.C.); D.K.M. was supported by a Senior Investigator award from the National Institute for Health Research (UK).	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Bouybayoune I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004796; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Chiesa R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004745; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0298-7; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Heise C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00106; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sekino Y, 2017, ADV EXP MED BIOL, V1006, P183, DOI 10.1007/978-4-431-56550-5_11; Senatore A, 2012, NEURON, V74, P300, DOI 10.1016/j.neuron.2012.02.027; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041	51	42	43	3	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	SEP	2018	141		9				2685	2699		10.1093/brain/awy193			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW0IX	WOS:000446548100023	30084913	Green Accepted, Green Published, Bronze, Green Submitted			2022-02-06	
J	Kerr, ZY; Comstock, RD; Dompier, TP; Marshall, SW				Kerr, Zachary Y.; Comstock, R. Dawn; Dompier, Thomas P.; Marshall, Stephen W.			The First Decade of Web-Based Sports Injury Surveillance (2004-2005 Through 2013-2014): Methods of the National Collegiate Athletic Association Injury Surveillance Program and High School Reporting Information Online	JOURNAL OF ATHLETIC TRAINING			English	Article							UNITED-STATES; CONSENSUS STATEMENT; SOCCER INJURIES; DATA-COLLECTION; FOOTBALL DATA; RISK-FACTORS; EPIDEMIOLOGY; SYSTEM; CONCUSSION; PREVENTION	Objective: To describe the methods of the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) and High School Reporting Information Online (HS RIO) system as a complement to the sport-specific manuscripts that will follow. Background: The NCAA-ISP and HS RIO collect injury and exposure data from samples of collegiate and high school sports programs, respectively. The NCAA-ISP, which the NCAA has maintained since 1982, was relaunched as a Web-based platform at the beginning of the 2004-2005 academic year. In 2005, the HS RIO was introduced to capture data on high school athletes and modeled after the NCAA-ISP. Relevant data are shared with the NCAA and high school sport and policy committees to develop evidence-based rules and programs that help protect the health and safety of student-athletes. Description: The NCAA-ISP and HS RIO monitor participation in school-sanctioned competitions and practices that occur from the first preseason practice to the final postseason contest for more than 25 sports. For this series of publications in the Journal of Athletic Training, injury information on 13 sports at the collegiate level during the 2004-2005 through 2013-2014 academic years and the high school level during the 2005-2006 through 2013-2014 academic years was evaluated. Conclusions: Athletic trainers have been a vital source of data collection over the past decade to help produce the largest datasets of collegiate and high school sports injuries. Such data have helped various sport and policy committees advance protocols that aim to increase sports safety. This series of publications will aid by continuing to provide data to stakeholders in the sports community.	[Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Program Injury Prevent Educ & Res, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The Injury Surveillance Program was funded by the NCAA. Funding for HS RIO was provided in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P736; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Cross KM, 2013, AM J SPORT MED, V41, P742, DOI 10.1177/0363546513475342; Dick R, 2007, J ATHL TRAINING, V42, P173; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dragoo JL, 2013, KNEE, V20, P191, DOI 10.1016/j.knee.2012.07.006; Dragoo JL, 2012, AM J SPORT MED, V40, P2066, DOI 10.1177/0363546512454653; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Howard AF, 2014, J ADOLESCENT HEALTH, V55, P627, DOI 10.1016/j.jadohealth.2014.05.013; Hunt KJ, 2013, CLIN J SPORT MED, V23, P278, DOI 10.1097/JSM.0b013e31827ee829; Kerr ZY, 2017, NEUROL CLIN, V35, P409, DOI 10.1016/j.ncl.2017.03.001; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kerr ZY, 2011, CLIN J SPORT MED, V21, P101, DOI 10.1097/JSM.0b013e31820bd1b6; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Last J. M., 2001, DICT EPIDEMIOLOGY, VFourth; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Collegiate Athletic Association, STUD ATHL PART 1981; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Robinson TW, 2014, PEDIATRICS, V133, P272, DOI 10.1542/peds.2013-2279; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	42	42	1	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					729	737		10.4085/1062-6050-143-17			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GW7OJ	WOS:000447157700004	30024769	gold, Green Published			2022-02-06	
J	Cnossen, MC; van der Naalt, J; Spikman, JM; Nieboer, D; Yue, JK; Winkler, EA; Manley, GT; von Steinbuechel, N; Polinder, S; Steyerberg, EW; Lingsma, HF				Cnossen, Maryse C.; van der Naalt, Joukje; Spikman, Joke M.; Nieboer, Daan; Yue, John K.; Winkler, Ethan A.; Manley, Geoffrey T.; von Steinbuechel, Nicole; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.			Prediction of Persistent Post-Concussion Symptoms after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						external validation; mild traumatic brain injury; post-concussion symptoms; prediction model	POSTCONCUSSION SYNDROME; EXTERNAL VALIDATION; PROGNOSTIC MODELS; EVENT SCALE; QUESTIONNAIRE; DIAGNOSIS; IMPACT	Persistent post-concussion symptoms (PPCS) occur frequently after mild traumatic brain injury (mTBI). The identification of patients at risk for poor outcome remains challenging because valid prediction models are missing. The objectives of the current study were to assess the quality and clinical value of prediction models for PPCS and to develop a new model based on the synthesis of existing models and addition of complaints at the emergency department (ED). Patients with mTBI (Glasgow Coma Scale score 13-15) were recruited prospectively from three Dutch level I trauma centers between 2013 and 2015 in the UPFRONT study. PPCS were assessed using the Head Injury Severity Checklist at six months post-injury. Two prediction models (Stulemeijer 2008; Cnossen 2017) were examined for calibration and discrimination. The final model comprised variables of existing models with the addition of headache, nausea/vomiting, and neck pain at ED, using logistic regression and bootstrap validation. Overall, 591 patients (mean age 51years, 41% female) were included; PPCS developed in 241 (41%). Existing models performed poorly at external validation (area under the curve [AUC]: 0.57-0.64). The newly developed model included female sex (odds ratio [OR] 1.48, 95% confidence interval [CI] [1.01-2.18]), neck pain (OR 2.58, [1.39-4.78]), two-week post-concussion symptoms (OR 4.89, [3.19-7.49]) and two-week post-traumatic stress (OR 2.98, [1.88-4.73]) as significant predictors. Discrimination of this model was adequate (AUC after bootstrap validation: 0.75). Existing prediction models for PPCS perform poorly. A new model performs reasonably with predictive factors already discernible at ED warranting further external validation. Prediction research in mTBI should be improved by standardizing definitions and data collection and by using sound methodology.	[Cnossen, Maryse C.; Nieboer, Daan; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [van der Naalt, Joukje; Spikman, Joke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Spikman, Joke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Yue, John K.; Winkler, Ethan A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Winkler, Ethan A.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands		Cnossen, MC (corresponding author), Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps-2012-06]; European Union FP 7th Framework program [602150]	The UPFRONT study was funded by the Dutch Brain Foundation (Ps-2012-06). The authors M.C. Cnossen, S. Polinder, H.F. Lingsma, S. Polinder, D. Nieboer, and E.W. Steyerberg were funded by the European Union FP 7th Framework program (grant 602150).	Akaike H, 1973, 2 INT S INF THEOR; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2017, J NEUROTRAUMA; Collins G.S., 2014, BMJ-BRIT MED J, P350; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Foks K.A., 2017, J NEUROTRAUMA; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King NS, 2013, BRAIN IMPAIR, V14, P235, DOI 10.1017/BrImp.2013.17; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman V, 2014, BRAIN INJURY, V28, P817; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steyerberg, 2019, CLIN PREDICTION MODE; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Warren AM, 2015, J TRAUMA ACUTE CARE, V79, P1062, DOI 10.1097/TA.0000000000000875	42	42	42	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2691	2698		10.1089/neu.2017.5486		JUL 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439664000001	29690799	Green Submitted			2022-02-06	
J	Haarbauer-Krupa, J; Arbogast, KB; Metzger, KB; Greenspan, AI; Kessler, R; Curr, AE; Bell, JM; DePadilla, L; Pfeiffer, MR; Zonfrillo, MR; Master, CL				Haarbauer-Krupa, Juliet; Arbogast, Kristy B.; Metzger, Kristina B.; Greenspan, Arlene, I; Kessler, Ronni; Curr, Allison E.; Bell, Jeneita M.; DePadilla, Lara; Pfeiffer, Melissa R.; Zonfrillo, Mark R.; Master, Christina L.			Variations in Mechanisms of Injury for Children with Concussion	JOURNAL OF PEDIATRICS			English	Article							EMERGENCY-DEPARTMENT VISITS; TRAUMATIC BRAIN-INJURY; SPORTS; RISK; BIOMECHANICS; SYMPTOMS; FOOTBALL; TRENDS	Objectives To assess the distribution of injury mechanisms and activities among children with concussions in a large pediatric healthcare system. Study design All patients, age 0-17 years, who had at least 1 clinical encounter with an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis of concussion in the Children's Hospital of Philadelphia's electronic health record system from July 1,2012 to June 30, 2014, were selected (N = 8233) and their initial concussion-related visit identified. Approximately, 20% of the patients (n = 1625) were randomly selected for manual record review to examine injury mechanisms and activities. Results Overall, 70% of concussions were sports related; however, this proportion varied by age. Only 18% of concussions sustained by children aged 0-4 were sports related, compared with greater proportions for older children (67% for age 5-11,77% for age 12-14, and 73% for age 15-17). When the concussion was not sports related, the primary mechanisms of injury were struck by an object (30%) and falls (30%). Conclusions Sports-related injuries in children older than 6 years of age contributed to the majority of concussions in this cohort; however, it is important to note that approximately one-third of concussions were from non-sports-related activities. Although there is increased participation in community and organized sports activities among children, a focus on prevention efforts in other activities where concussions occur is needed.	[Haarbauer-Krupa, Juliet; Greenspan, Arlene, I; Bell, Jeneita M.; DePadilla, Lara] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Arbogast, Kristy B.; Metzger, Kristina B.; Kessler, Ronni; Curr, Allison E.; Pfeiffer, Melissa R.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Curr, Allison E.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA		Haarbauer-Krupa, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Highway NE,MS-F62, Atlanta, GA 30341 USA.	JHaarbauerKrupa@cdc.gov	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563; Master, Christina/0000-0002-6717-4270; Arbogast, Kristy/0000-0002-1694-4562; Curry, Allison/0000-0001-7076-3538	US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Children's Hospital of Philadelphia	Supported by an intergovernmental personnel act agreement between the US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and the Children's Hospital of Philadelphia. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. The authors declare no conflicts of interest.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC. Centers for Disease Control and Prevention, 2011, YOUTH RISK BEH SURV; Centers for Medicare and Medicaid Services & the National Center for Health Statistics (NCHS), 2011, ICD 9 CM OFF GUID CO; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Comstock D, HIGH SCH RIO REPORTI; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; DURANT RH, 1991, AM J DIS CHILD, V145, P1119, DOI 10.1001/archpedi.1991.02160100051022; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Howard Ivory, 2005, Ethn Dis, V15, pS5; Institute of Medicine (IOM) and National Research Council (NRC), 2013, SPORTS RELATED CONCU; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marin JR, 2014, JAMA-J AM MED ASSOC, P311; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; National Council of Youth Sports, REP TRENDS PART ORG; Schwebel DC, 2014, J ATHL TRAINING, V49, P780, DOI 10.4085/1062-6050-49.3.41; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theisen D, 2013, J SCI MED SPORT, V16, P200, DOI 10.1016/j.jsams.2012.07.007; Turner Robert W, 2015, Glob Pediatr Health, V2, p2333794X15577944, DOI 10.1177/2333794X15577944; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Washington RL, 2001, PEDIATRICS, V107, P1205; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	35	42	42	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUN	2018	197						241	+		10.1016/j.jpeds.2018.01.075			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GG9UR	WOS:000433047100043	29627189	Green Accepted			2022-02-06	
J	Howell, DR; Buckley, TA; Lynall, RC; Meehan, WP				Howell, David R.; Buckley, Thomas A.; Lynall, Robert C.; Meehan, William P., III			Worsening Dual-Task Gait Costs after Concussion and their Association with Subsequent Sport-Related Injury	JOURNAL OF NEUROTRAUMA			English	Article						head injury; injury risk; mild traumatic brain injury; pediatric sports medicine	EXTREMITY MUSCULOSKELETAL INJURY; 4TH INTERNATIONAL-CONFERENCE; TRAUMATIC BRAIN-INJURY; CONSENSUS STATEMENT; BALANCE CONTROL; ADOLESCENTS; RISK; PERFORMANCE; RECOVERY; INCREASE	Prior studies suggest that concussion may lead to an increased risk of a subsequent time-loss sport-related injury, but the mechanisms responsible are unknown. We measured the symptom and dual-task gait outcomes for athletes initially post-concussion and after clinical recovery. Participants then self-reported any additional injuries incurred in the year after their concussion. Forty-two athletes (52% female, mean age=16.8 +/- 3.2 years) completed the study. They underwent a dual-task gait evaluation and symptom inventory within 21 days post-concussion, and again after they were deemed clinically recovered. Approximately one year later, participants documented if they had sustained any subsequent sport-related injuries. The repeated measures analysis of variance (ANOVA) was used to evaluate changes in dual-task gait and symptoms across time and between groups. A significant group*time interaction (p=0.02) indicated that the group that went on to sustain a subsequent time-loss injury after returning to sports (n=15) demonstrated significant average walking speed dual-task cost worsening across time (-17.9 +/- 9.1% vs. -25.1 +/- 12.5%; p=0.007). In contrast, the group that did not sustain an additional injury walked with consistent dual-task cost values across time (-25.2 +/- 9.2% vs. -24.6 +/- 8.4%; p=0.76). Symptoms improved for all participants (main effect of time, p<0.001; Post-Concussion Symptom Scale [PCSS]=25.0 +/- 16.9 vs. 2.8 +/- 7.5; p<0.001), but did not differ between groups (p=0.77). Significant dual-task gait cost worsening throughout concussion recovery was associated with time-loss injuries during sports in the year after a concussion. These findings indicate that worsening ability to execute a concurrent gait and cognitive task may relate to the risk of incurring an injury during sports after clinical concussion recovery.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sc, Newark, DE USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg & Pediat, Boston, MA USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Buckley, Thomas A/B-7525-2016; Lynall, Robert/M-2888-2014	Buckley, Thomas A/0000-0002-0515-0150; Lynall, Robert/0000-0002-0785-6640			Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Fino P.C., 2017, CLIN J SPORT MED; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guy J.A., 2016, PRIM CARE COMPANION, P18; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Howell D R, 2017, CLIN J SPORT MED; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Read PJ, 2016, SPORTS MED, V46, P1059, DOI 10.1007/s40279-016-0479-z; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	36	42	42	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1630	1636		10.1089/neu.2017.5570		MAY 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000431462900001	29490564				2022-02-06	
J	Anderson, EN; Gochenaur, L; Singh, A; Grant, R; Patel, K; Watkins, S; Wu, JY; Pandey, UB				Anderson, Eric N.; Gochenaur, Lauren; Singh, Aditi; Grant, Rogan; Patel, Krishani; Watkins, Simon; Wu, Jane Y.; Pandey, Udai Bhan			Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models	HUMAN MOLECULAR GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; BRAIN-INJURY; HEAD-INJURY; DROSOPHILA MODEL; AXONAL INJURY; CYTOPLASMIC MISLOCALIZATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE	Traumatic brain injury (TBI) has been predicted to be a predisposing factor for amyotrophic lateral sclerosis (ALS) and other neurological disorders. Despite the importance of TBI in ALS progression, the underlying cellular and molecular mechanisms are still an enigma. Here, we examined the contribution of TBI as an extrinsic factor and investigated whether TBI influences the susceptibility of developing neurodegenerative symptoms. To evaluate the effects of TBI in vivo, we applied mild to severe trauma to Drosophila and found that TBI leads to the induction of stress granules (SGs) in the brain. The degree of SGs induction directly correlates with the level of trauma. Furthermore, we observed that the level of mortality is directly proportional to the number of traumatic hits. Interestingly, trauma-induced SGs are ubiquitin, p62 and TDP-43 positive, and persistently remain over time suggesting that SGs might be aggregates and exert toxicity in our fly models. Intriguingly, TBI on animals expressing ALS-linked genes increased mortality and locomotion dysfunction suggesting that mild trauma might aggravate neurodegenerative symptoms associated with ALS. Furthermore, we found elevated levels of high molecular weight ubiquitinated proteins and p62 in animals expressing ALS-causing genes with TBI, suggesting that TBI may lead to the defects in protein degradation pathways. Finally, we observed that genetic and pharmacological induction of autophagy enhanced the clearance of SGs and promoted survival of flies in vivo. Together, our study demonstrates that trauma can induce SG formation in vivo and might enhance neurodegenerative phenotypes in the fly models of ALS.	[Anderson, Eric N.; Singh, Aditi; Grant, Rogan; Patel, Krishani; Pandey, Udai Bhan] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Child Neurol,Dept Pediat, Pittsburgh, PA 15224 USA; [Gochenaur, Lauren; Pandey, Udai Bhan] Univ Pittsburgh, Dept Neurosci, Dietrich Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Watkins, Simon] Univ Pittsburgh, Med Ctr, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; [Watkins, Simon] Univ Pittsburgh, Med Ctr, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Pandey, Udai Bhan] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Pandey, Udai Bhan] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA		Pandey, UB (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Child Neurol,Dept Pediat, Pittsburgh, PA 15224 USA.; Pandey, UB (corresponding author), Univ Pittsburgh, Dept Neurosci, Dietrich Sch Arts & Sci, Pittsburgh, PA 15260 USA.; Pandey, UB (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.; Pandey, UB (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA.	udai@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Grant, Rogan/0000-0003-0655-0882	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081303, NS094921, NS100055, NS101661, NS098379]; Muscular Dystrophy Association (MDA)Muscular Dystrophy Association; Robert Packard Center for ALS at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098379, R21NS101661, R21NS094921, R01NS081303, R21NS100055] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health R01 (NS081303), R21 grants (NS094921, NS100055, NS101661 and NS098379), Muscular Dystrophy Association (MDA) and the Robert Packard Center for ALS at Johns Hopkins to UBP.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00423, 10.3389/fncel.2015.00423]; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Baron DM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-30; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bellou V, 2016, PARKINSONISM RELAT D, V23, P1, DOI 10.1016/j.parkreldis.2015.12.008; Belly A, 2005, NEUROSCI LETT, V379, P152, DOI 10.1016/j.neulet.2004.12.071; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bozzoni V, 2016, FUNCT NEUROL, V31, P7, DOI 10.11138/fneur/2016.31.1.007; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen Pan, 2016, F1000Res, V5, DOI 10.12688/f1000research.7431.1; Chen YB, 2011, PROTEIN CELL, V2, P477, DOI 10.1007/s13238-011-1065-7; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DeVorkin Lindsay, 2014, Cold Spring Harb Protoc, V2014, P959, DOI 10.1101/pdb.prot080333; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; Feddermann-Demont N, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.630; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hand CK, 2002, MUSCLE NERVE, V25, P135; Hasegawa M, 2017, PHARMACOL THERAPEUT, V172, P22, DOI 10.1016/j.pharmthera.2016.11.010; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Johnson FO, 2011, J PHARMACOL EXP THER, V338, P518, DOI 10.1124/jpet.110.174466; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kasarskis EJ, 2009, AMYOTROPH LATERAL SC, V10, P35, DOI 10.1080/17482960802351029; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Keller BA, 2012, ACTA NEUROPATHOL, V124, P733, DOI 10.1007/s00401-012-1035-z; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; King A, 2013, ACTA NEUROPATHOL, V125, P303, DOI 10.1007/s00401-012-1050-0; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; KURLAND LT, 1992, J NEUROL SCI, V113, P133, DOI 10.1016/0022-510X(92)90241-C; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Kwee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032768; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lanson NA, 2012, BRAIN RES, V1462, P44, DOI 10.1016/j.brainres.2012.01.039; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; LEIGH PN, 1988, NEUROSCI LETT, V93, P197, DOI 10.1016/0304-3940(88)90081-X; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liang C, 2010, CELL DEATH DIFFER, V17, P1807, DOI 10.1038/cdd.2010.115; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Matsuoka T, 2011, NEUROPATHOLOGY, V31, P71, DOI 10.1111/j.1440-1789.2010.01129.x; Matus S, 2014, NEUROBIOL AGING, V35, P2832, DOI 10.1016/j.neurobiolaging.2014.08.019; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; McKee AC, 2017, JAMA-J AM MED ASSOC, V318, P2353, DOI 10.1001/jama.2017.16687; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meisl G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18728; Mo C, 2015, NEUROSCI BIOBEHAV R, V52, P178, DOI 10.1016/j.neubiorev.2015.03.003; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nichols C. D., 2012, J VIS EXP IN PRESS; Nomura T, 2014, J BIOL CHEM, V289, P1192, DOI 10.1074/jbc.M113.516492; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pazman C, 2000, DEVELOPMENT, V127, P1715; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Qiu HY, 2014, J CLIN INVEST, V124, P981, DOI 10.1172/JCI72723; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Riggs JE, 1996, ARCH NEUROL-CHICAGO, V53, P225, DOI 10.1001/archneur.1996.00550030031019; Riggs JE, 2001, MIL MED, V166, P731, DOI 10.1093/milmed/166.8.731; RIGGS JE, 1985, ARCH NEUROL-CHICAGO, V42, P205, DOI 10.1001/archneur.1985.04060030015004; RIGGS JE, 1995, CLIN NEUROPHARMACOL, V18, P273, DOI 10.1097/00002826-199506000-00008; Riggs JE, 2003, MIL MED, V168, P143, DOI 10.1093/milmed/168.2.143; Ryu HH, 2014, NEUROBIOL AGING, V35, P2822, DOI 10.1016/j.neurobiolaging.2014.07.026; Saini A, 2014, LANGMUIR, V30, P3845, DOI 10.1021/la404710w; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Smethurst P, 2016, NEUROBIOL DIS, V96, P236, DOI 10.1016/j.nbd.2016.08.007; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Terni B, 2007, ACTA NEUROPATHOL, V113, P403, DOI 10.1007/s00401-006-0192-3; Thomsen GM, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0059-14.2015; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanderweyde T, 2013, GERONTOLOGY, V59, P524, DOI 10.1159/000354170; Villar-Pique A, 2016, P NATL ACAD SCI USA, V113, pE6506, DOI 10.1073/pnas.1606791113; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Williams K. L., 2012, NEUROBIOL AGING, V33, pe3; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wolozin B, 2014, DISCOV MED, V17, P47; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110	132	42	42	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	APR 15	2018	27	8					1366	1381		10.1093/hmg/ddy047			16	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	GC0TM	WOS:000429490700005	29432563	Green Published, Bronze			2022-02-06	
J	Servadei, F; Rossini, Z; Nicolosi, F; Morselli, C; Park, KB				Servadei, Franco; Rossini, Zefferino; Nicolosi, Federico; Morselli, Carlotta; Park, Kee B.			The Role of Neurosurgery in Countries with Limited Facilities: Facts and Challenges	WORLD NEUROSURGERY			English	Article						Education; Global surgery; Lancet Commission; LMICs; Neurosurgical care; Training; WFNS	TRAUMATIC BRAIN-INJURY; EMERGENCY NEUROSURGERY; DEVELOPING-WORLD; EPIDEMIOLOGY; MANAGEMENT; RESOURCE; TUMORS; CARE; HYDROCEPHALUS; TELEMEDICINE	The Lancet Commission on Global Surgery has recently focused its attention on the lack of surgical care worldwide. Like other surgical subspecialties, neurosurgical care needs to be better distributed around the world, with a major focus on low- to middle-income countries. Neurosurgical diseases like hydrocephalus, traumatic brain injury, and brain tumors have a high impact on families, individual quality of life, and cost for the society. Implementation of neurosurgical care in poor settings is not easy. More than other surgeries, neurosurgery requires great amounts of human resources, dedicated environments, and specialized postoperative care. It is responsibility of the neurosurgical community to identify major areas of current gaps and outline strategies for intervention.	[Servadei, Franco] Humanitas Univ, Dept Neurosurg, Pieve Emanuele, MI, Italy; [Servadei, Franco; Rossini, Zefferino; Nicolosi, Federico; Morselli, Carlotta] Humanitas Clin & Res Ctr, Dept Neurosurg, Rozzano, MI, Italy; [Servadei, Franco] World Federat Neurosurg Soc, Nyon, Switzerland; [Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, Boston, MA USA		Servadei, F (corresponding author), Humanitas Univ, Dept Neurosurg, Pieve Emanuele, MI, Italy.; Servadei, F (corresponding author), Humanitas Clin & Res Ctr, Dept Neurosurg, Rozzano, MI, Italy.	franco.servadei@hunimed.eu	Rossini, Zefferino/AAW-5420-2021	Morselli, Carlotta/0000-0003-1031-4874			Adams LP, 1998, PHOTOGRAMM REC, V16, P259, DOI 10.1111/0031-868X.00125; Adeleye AO, 2016, J NEUROL SURG PART A, V77, P167, DOI 10.1055/s-0035-1566115; Adeleye AO, 2012, WORLD NEUROSURG, V78, DOI [10.1016/j.wneu.2011.07.015, 10.1016/J.WNEU.2011.07.015]; Adeloye A, 1997, E AFR MED J, V74, P263; Azad TD, 2015, WORLD NEUROSURG, V84, P1832, DOI 10.1016/j.wneu.2015.07.074; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Dadlani R, 2014, WORLD NEUROSURG, V82, P270, DOI 10.1016/j.wneu.2014.05.027; Dewan MC, 2017, PEDIATR NEUROSURG, V52, P401, DOI 10.1159/000452809; Ellegala DB, 2014, J NEUROSURG, V121, P1526, DOI 10.3171/2014.7.JNS122153; Ezzat S, 2016, J NEURO-ONCOL, V126, P371, DOI 10.1007/s11060-015-1979-7; Ganapathy K, 2002, SURG NEUROL, V58, P388, DOI 10.1016/S0090-3019(02)00924-2; Griswold D, 2016, WORLD NEUROSURG, V93, P474, DOI 10.1016/j.wneu.2016.06.044; Gupta S, 2017, WORLD NEUROSURG, V100, P267, DOI 10.1016/j.wneu.2016.12.104; Howe KL, 2013, WORLD NEUROSURG, V80, pE171, DOI [10.1016/j.wneu.2013.07.003, 10.1016/j.wneu.2013.02.087]; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Mainthia R, 2009, J NEUROSURG-PEDIATR, V4, P4, DOI 10.3171/2009.1.PEDS08193; Meara JG, 2014, LANCET, V383, P12, DOI 10.1016/S0140-6736(13)62345-4; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Muir RT, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16273; Ng-Kamstra JS, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000011; Ojo O A, 2015, Niger Postgrad Med J, V22, P45; Okazaki T, 2016, WORLD NEUROSURG, V93, P336, DOI 10.1016/j.wneu.2016.06.070; Owler BK, 2015, J NEUROSURG-PEDIATR, V16, P340, DOI 10.3171/2015.2.PEDS14310; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Piquer J, 2015, J NEUROSURG-PEDIATR, V15, P552, DOI 10.3171/2014.10.PEDS14318; Rasul FT, 2012, BRIT J NEUROSURG, V26, P736, DOI 10.3109/02688697.2012.690909; Ravindra VM, 2015, WORLD NEUROSURG, V84, P1458, DOI 10.1016/j.wneu.2015.06.046; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2015, ANZ J SURG, V85, P600, DOI 10.1111/ans.13207; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Srivastava PV, 2014, INT J STROKE, V9, P133, DOI 10.1111/ijs.12326; Stagno V, 2014, CHILD NERV SYST, V30, P137, DOI 10.1007/s00381-013-2297-z; Stahl I, 2017, SPINE J, V17, P161, DOI 10.1016/j.spinee.2016.08.021; Thapa A, 2016, WORLD NEUROSURG, V95, P270, DOI 10.1016/j.wneu.2016.08.001; UN, 2015, MILL DEV GOAL 8 TAK; Warf BC, 2005, J NEUROSURG, V102, P358, DOI 10.3171/ped.2005.102.4.0358; Warf BC, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2010.09.021; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12179; World Health Organization, 2015, GLOB STAT REP ROAD S	43	42	43	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						315	321		10.1016/j.wneu.2018.01.047			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700172	29366998				2022-02-06	
J	Makinde, HM; Cuda, CM; Just, TB; Perlman, HR; Schwulst, SJ				Makinde, Hadijat M.; Cuda, Carla M.; Just, Talia B.; Perlman, Harris R.; Schwulst, Steven J.			Nonclassical Monocytes Mediate Secondary Injury, Neurocognitive Outcome, and Neutrophil Infiltration after Traumatic Brain Injury	JOURNAL OF IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MACROPHAGE INFILTRATION; ISCHEMIC-STROKE; BLOOD; MICROGLIA; RECRUITMENT; MOUSE; CELLS; CCR2; NEUROTOXICITY	Traumatic brain injury (TBI) results in rapid recruitment of leukocytes into the injured brain. Monocytes constitute a significant proportion of the initial infiltrate and have the potential to propagate secondary brain injury or generate an environment of repair and regeneration. Monocytes are a diverse population of cells (classical, intermediate, and nonclassical) with distinct functions, however, the recruitment order of these subpopulations to the injured brain largely remains unknown. Thus, we examined which monocyte subpopulations are required for the generation of early inflammatory infiltrate within the injured brain, and whether their depletion attenuates secondary injury or neurocognitive outcome. Global monocyte depletion correlated with significant improvements in brain edema, motor coordination, and working memory, and abrogated neutrophil infiltration into the injured brain. However, targeted depletion of classical monocytes alone had no effect on neutrophil recruitment to the site of injury, implicating the nonclassical monocyte in this process. In contrast, mice that have markedly reduced numbers of nonclassical monocytes (CX3CR1(-/-)) exhibited a significant reduction in neutrophil infiltration into the brain after TBI as compared with control mice. Our data suggest a critical role for nonclassical monocytes in the pathology of TBI in mice, including important clinical outcomes associated with mortality in this injury process.	[Makinde, Hadijat M.; Just, Talia B.; Schwulst, Steven J.] Northwestern Univ, Div Trauma & Crit Care, Dept Surg, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA; [Cuda, Carla M.; Perlman, Harris R.] Northwestern Univ, Div Rheumatol, Dept Med, Chicago, IL 60611 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Div Trauma & Crit Care, Dept Surg, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA.	s-schwulst@northwestem.edu		Makinde, Hadijat-Kubura/0000-0001-8492-4187; Cuda, Carla/0000-0002-2022-8171; Schwulst, Steven/0000-0003-4248-8545; Just, Talia/0000-0002-6372-7974	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM117341, AR064313, AR064546, HL134375, AG049665, UH2AR067687]; American College of Surgeons C. James Carrico Research Fellowship; United States-Israel Binational Science FoundationUS-Israel Binational Science Foundation [2013247]; Rheumatology Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL134375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32AR007611, K01AR064313, R01AR064546, UH2AR067687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM117341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG049665] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant GM117341 and The American College of Surgeons C. James Carrico Research Fellowship to S.J.S.; National Institutes of Health Grant AR064313 to C.M.C.; National Institutes of Health Grants AR064546, HL134375, AG049665, and UH2AR067687, the United States-Israel Binational Science Foundation (Award 2013247), and the Rheumatology Research Foundation (Agreement 05/06/14) to H.R.P. H.R.P. is also the Mabel Greene Myers Professor of Medicine.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Christophi GP, 2009, J VIROL, V83, P522, DOI 10.1128/JVI.01210-08; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Collins CE, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.005.2010; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Faul M, 2010, TRAUMATIC BRAIN INJU; FORD AL, 1995, J IMMUNOL, V154, P4309; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; Price CJS, 2004, STROKE, V35, P1659, DOI 10.1161/01.STR.0000130592.71028.92; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Soares HD, 1995, J NEUROSCI, V15, P8223; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Tran EH, 1998, J IMMUNOL, V161, P3767; Weiss C, 1998, NEUROSCI RES COMMUN, V23, P77, DOI 10.1002/(SICI)1520-6769(199809/10)23:2<77::AID-NRC2>3.0.CO;2-Y; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	51	42	42	0	10	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 15	2017	199	10					3583	3591		10.4049/jimmunol.1700896			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM0MK	WOS:000414660600018	28993515	Bronze, Green Accepted			2022-02-06	
J	Hicks, SD; Johnson, J; Carney, MC; Bramley, H; Olympia, RP; Loeffert, AC; Thomas, NJ				Hicks, Steven D.; Johnson, Jeremiah; Carney, Molly C.; Bramley, Harry; Olympia, Robert P.; Loeffert, Andrea C.; Thomas, Neal J.			Overlapping MicroRNA Expression in Saliva and Cerebrospinal Fluid Accurately Identifies Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; concussion; microRNA; pediatrics; saliva	BIOMARKERS; CONCUSSION; DIAGNOSIS; SPECTRUM; SPORT; RNAS	To assess the accuracy and physiological relevance of circulating microRNA (miRNA) as a biomarker of pediatric concussion, we compared changes in salivary miRNA and cerebrospinal fluid (CSF) miRNA concentrations after childhood traumatic brain injury (TBI). A case-cohort design was used to compare longitudinal miRNA concentrations in CSF of seven children with severe TBI against three controls without TBI. The miRNAs "altered" in CSF were interrogated in saliva of 60 children with mild TBI and compared with 18 age- and sex-matched controls. The miRNAs with parallel changes (Wilcoxon rank sum test) in CSF and saliva were interrogated for predictive accuracy of TBI status using a multivariate regression technique. Spearman rank correlation identified relationships between miRNAs of interest and clinical features. Functional analysis with DIANA mirPath identified related mRNA pathways. There were 214 miRNAs detected in CSF, and 135 (63%) were also present in saliva. Six miRNAs had parallel changes in both CSF and saliva (miR-182-5p, miR-221-3p, mir-26b-5p, miR-320c, miR-29c-3p, miR-30e-5p). These miRNAs demonstrated an area under the curve of 0.852 for identifying mild TBI status. Three of the miRNAs exhibited longitudinal trends in CSF and/or saliva after TBI, and all three targeted mRNAs related to neuronal development. Concentrations of miR-320c were directly correlated with child and parent reports of attention difficulty. Salivary miRNA represents an easily measured, physiologically relevant, and accurate potential biomarker for TBI. Further studies assessing the influence of orthopedic injury and exercise on peripheral miRNA patterns are needed.	[Hicks, Steven D.; Johnson, Jeremiah; Carney, Molly C.; Bramley, Harry; Olympia, Robert P.; Loeffert, Andrea C.; Thomas, Neal J.] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Olympia, Robert P.] Penn State Coll Med, Dept Emergency Med, Hershey, PA USA; [Thomas, Neal J.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA		Hicks, SD (corresponding author), Penn State Coll Med, Mail Code HS83,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	shicks1@hmc.psu.edu		Hicks, Steven/0000-0002-9579-6798	Children's Miracle Network [417-51HY-4BFB]; Quadrant Biosciences Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002015, UL1TR002014] Funding Source: NIH RePORTER	Supported by the Children's Miracle Network (Grant# 417-51HY-4BFB to SDH) and Quadrant Biosciences Inc. (Research agreement with AL and SDH).	Bahn JH, 2015, CLIN CHEM, V61, P221, DOI 10.1373/clinchem.2014.230433; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hicks SD, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0586-x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lopez JP, 2014, INT J NEUROPSYCHOPH, V17, P23, DOI 10.1017/S1461145713000941; Majem B, 2015, INT J MOL SCI, V16, P8676, DOI 10.3390/ijms16048676; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rogelj B, 2004, REV NEUROSCIENCE, V15, P185; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xia J., 2016, CURR PROTOC BIOINFOR, V55, P1014; Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	28	42	43	3	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					64	72		10.1089/neu.2017.5111		OCT 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414454100001	28762893	Green Published			2022-02-06	
J	Caeyenberghs, K; Verhelst, H; Clemente, A; Wilson, PH				Caeyenberghs, Karen; Verhelst, Helena; Clemente, Adam; Wilson, Peter H.			Mapping the functional connectome in traumatic brain injury: What can graph metrics tell us?	NEUROIMAGE			English	Article						Traumatic brain injury; Connectome; Functional MRI; Graph theory; Network	SMALL-WORLD; MODULAR ORGANIZATION; COGNITIVE CONTROL; CONTROL NETWORKS; CORPUS-CALLOSUM; AXONAL INJURY; HEAD-INJURY; CONNECTIVITY; MILD; REORGANIZATION	Objective: Traumatic brain injury (TBI) is associated with cognitive and motor deficits, and poses a significant personal, societal, and economic burden. One mechanism by which TBI is thought to affect cognition and behavior is through changes in functional connectivity. Graph theory is a powerful framework for quantifying topological features of neuroimaging-derived functional networks. The objective of this paper is to review studies examining functional connectivity in TBI with an emphasis on graph theoretical analysis that is proving to be valuable in uncovering network abnormalities in this condition. Methods: We review studies that have examined TBI-related alterations in different properties of the functional brain network, including global integration, segregation, centrality and resilience. We focus on functional data using task-related fMRI or resting-state fMRI in patients with TBI of different severity and recovery phase, and consider how graph metrics may inform rehabilitation and enhance efficacy. Moreover, we outline some methodological challenges associated with the examination of functional connectivity in patients with brain injury, including the sample size, parcellation scheme used, node definition and subgroup analyses. Results: The findings suggest that TBI is associated with hyperconnectivity and a suboptimal global integration, characterized by increased connectivity degree and strength and reduced efficiency of functional networks. This altered functional connectivity, also evident in other clinical populations, is attributable to diffuse white matter pathology and reductions in gray and white matter volume. These functional alterations are implicated in postconcussional symptoms, posttraumatic stress and neurocognitive dysfunction after TBI. Finally, the effects of focal lesions have been found to depend critically on topological position and their role in the network. Conclusion: Graph theory is a unique and powerful tool for exploring functional connectivity in brain-injured patients. One limitation is that its results do not provide specific measures about the biophysical mechanism underlying TBI. Continued work in this field will hopefully see graph metrics used as biomarkers to provide more accurate diagnosis and help guide treatment at the individual patient level.	[Caeyenberghs, Karen; Clemente, Adam; Wilson, Peter H.] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, 115 Victoria Pde, Melbourne, Vic 3065, Australia; [Verhelst, Helena] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium		Caeyenberghs, K (corresponding author), Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, 115 Victoria Pde, Melbourne, Vic 3065, Australia.	Karen.Caeyenberghs@acu.edu.au	Wilson, Peter H./E-2881-2018	Wilson, Peter H./0000-0003-3747-0287; Clemente, Adam/0000-0002-4742-7015; Caeyenberghs, Karen/0000-0001-7009-6843; Verhelst, Helena/0000-0002-6861-0249			Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Balanc B, 2016, J NEUROSCI RES, V94, P39, DOI 10.1002/jnr.23676; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bosma I, 2008, J NEURO-ONCOL, V88, P77, DOI 10.1007/s11060-008-9535-3; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Delvaux V, 2003, CLIN NEUROPHYSIOL, V114, P1217, DOI 10.1016/S1388-2457(03)00070-1; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Drijkoningen D, 2015, HUM BRAIN MAPP, V36, P4897, DOI 10.1002/hbm.22958; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gooijers J, 2016, BRAIN, V139, P2469, DOI 10.1093/brain/aww177; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kuceyeski A, 2016, NEUROIMAGE-CLIN, V11, P635, DOI 10.1016/j.nicl.2016.04.006; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Papo D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0525; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rincon S, 2016, HAND CLINIC, V135, P447, DOI 10.1016/B978-0-444-53485-9.00022-2; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Serbruyns L, 2015, BRAIN STRUCT FUNCT, V220, P273, DOI 10.1007/s00429-013-0654-z; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Soto-Ares G, 2001, NEUROPEDIATRICS, V32, P153, DOI 10.1055/s-2001-16615; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Ruitenbeek P., 2016, BRAIN STRUCT FUNCT, V221; Vargas ER, 2016, MED BIOL ENG COMPUT, V54, P235, DOI 10.1007/s11517-015-1396-2; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373	103	42	42	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 15	2017	160				SI		113	123		10.1016/j.neuroimage.2016.12.003			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FL5DV	WOS:000414252800010	27919750				2022-02-06	
J	Bennett, TD; DeWitt, PE; Greene, TH; Srivastava, R; Riva-Cambrin, J; Nance, ML; Bratton, SL; Runyan, DK; Dean, JM; Keenan, HT				Bennett, Tellen D.; DeWitt, Peter E.; Greene, Tom H.; Srivastava, Rajendu; Riva-Cambrin, Jay; Nance, Michael L.; Bratton, Susan L.; Runyan, Desmond K.; Dean, J. Michael; Keenan, Heather T.			Functional Outcome After Intracranial Pressure Monitoring for Children With Severe Traumatic Brain Injury	JAMA PEDIATRICS			English	Article							PROPENSITY SCORE; TRIAL; BIAS; CARE	IMPORTANCE Intracranial pressure (ICP) monitoring is a mainstay of therapy for children with traumatic brain injury (TBI), but its overall association with patient outcome is unclear. OBJECTIVE To test the hypothesis that ICP monitoring is associated with improved functional survival of children with severe TBI. DESIGN, SETTING, AND PARTICIPANTS A propensity-weighted effectiveness analysis was conducted using 2 linked national databases with data from 30 US children's hospitals from January 1, 2007, to December 31, 2012, on 3084 children with severe TBI. Clinical events including neurosurgical procedures were identified using validated computable phenotypes. Data analysis was conducted from September 1, 2016, to March 1, 2017. EXPOSURE Placement of an ICP monitor. MAIN OUTCOMES AND MEASURES A composite of hospital mortality, discharge to hospice, or survival with placement of new tracheostomy and gastrostomy tubes. RESULTS Of the 3084 children in the study (1128 girls and 1956 boys; mean [SD] age, 7.03 [5.44] years), 1002 (32.4%) underwent ICP monitoring, with substantial hospital variation (6% to 50% by hospital). Overall, 484 children (15.7%) experienced the primary composite outcome. A propensity approach using matching weights generated good covariate balance between those who did and those who did not undergo ICP monitoring. Using a propensity-weighted logistic regression model clustered by hospital, no statistically significant difference was found in functional survival between monitored and unmonitored patients (odds ratio of poor outcome among those who underwent ICP monitoring, 1.31; 95% CI, 0.99-1.74). In a prespecified secondary analysis, no difference in mortality was found (odds ratio, 1.16; 95% CI, 0.89-1.50). Prespecified subgroup analyses of children younger and older than 2 years of age and among those with unintentional and inflicted (intentional) injuries also showed no difference in outcome with ICP monitoring. CONCLUSIONS AND RELEVANCE With the use of linked national data and validated computable phenotypes, no evidence was found of a benefit from ICP monitoring on functional survival of children with severe TBI. Intracranial pressure monitoring is a widely but inconsistently used technology with incompletely demonstrated effectiveness. A large prospective cohort study or randomized trial is needed.	[Bennett, Tellen D.] Univ Colorado, Sch Med, Pediat Crit Care, 13199 E Montview Blvd,Ste 300,Campus Mail F443, Aurora, CO 80045 USA; [Bennett, Tellen D.] Childrens Hosp Colorado, Aurora, CO USA; [Bennett, Tellen D.] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA; [DeWitt, Peter E.] Colorado Sch Publ Hlth, Bioinformat & Biostat, Aurora, CO USA; [Greene, Tom H.] Univ Utah, Sch Med, Div Biostat, Salt Lake City, UT USA; [Srivastava, Rajendu] Univ Utah, Sch Med, Pediat Inpatient Med, Salt Lake City, UT USA; [Srivastava, Rajendu] Intermt Healthcare, Res Off, Salt Lake City, UT USA; [Riva-Cambrin, Jay] Univ Calgary, Dept Clin Neurosci, Div Pediat Neurosurg, Calgary, AB, Canada; [Riva-Cambrin, Jay] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Nance, Michael L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat Surg, Philadelphia, PA 19104 USA; [Bratton, Susan L.; Dean, J. Michael; Keenan, Heather T.] Univ Utah, Sch Med, Pediat Crit Care, Salt Lake City, UT USA; [Runyan, Desmond K.] Univ Colorado, Sch Med, Kempe Ctr, Dept Pediat, Aurora, CO 80045 USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Pediat Crit Care, 13199 E Montview Blvd,Ste 300,Campus Mail F443, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu	Bratton, Susan L./O-2353-2013; Runyan, Desmond/S-3974-2016	Bratton, Susan L./0000-0002-4605-8078; Runyan, Desmond/0000-0001-5571-9029; Bennett, Tellen/0000-0003-1483-4236; Greene, Tom/0000-0002-3706-7570	Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620]; Colorado Clinical and Translational Science Institute from the National Center for Research Resources [UL1 TR001082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	This work was supported by grant K23HD074620 from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (Dr Bennett) and Colorado Clinical and Translational Science Institute grant UL1 TR001082 from the National Center for Research Resources.	Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Allaire JJ, RMARKDOWN DYNAMIC DO; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bennett TD, 2017, PEDIATR CRIT CARE ME, V18, P442, DOI 10.1097/PCC.0000000000001120; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Faul M, 2010, TRAUMATIC BRAIN INJU; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; Frieden T., 2014, REPORT C TRAUMATIC B; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kozar RA, 2014, J TRAUMA ACUTE CARE, V76, P634, DOI 10.1097/TA.0000000000000130; Li L, 2013, INT J BIOSTAT, V9, P215, DOI 10.1515/ijb-2012-0030; Lumley T, SURVEY; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; R Core Team, 2016, R LANG ENV STAT COMP; Ridgeway G, TWANG TOOLKIT WEIGHT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Van Cleve W, 2014, NEUROSURGERY, V74, pE156; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; VanderWeele, 2015, EXPLANATION CAUSAL I; Wickham H., ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics (3.3.5) [Computer software]; Xie Y., KNITR GEN PURPOSE PA; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	37	42	44	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	OCT	2017	171	10					965	971		10.1001/jamapediatrics.2017.2127			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FI7PV	WOS:000412190300014	28846763	Green Published			2022-02-06	
J	Neuberger, EJ; Swietek, B; Corrubia, L; Prasanna, A; Santhakumar, V				Neuberger, Eric J.; Swietek, Bogumila; Corrubia, Lucas; Prasanna, Anagha; Santhakumar, Vijayalakshmi			Enhanced Dentate Neurogenesis after Brain Injury Undermines Long-Term Neurogenic Potential and Promotes Seizure Susceptibility	STEM CELL REPORTS			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEURAL STEM-CELLS; POSTTRAUMATIC EPILEPSY; COGNITIVE RECOVERY; PROGENITOR CELLS; INHIBITION; HIPPOCAMPUS; CONTRIBUTES; GYRUS; HYPEREXCITABILITY	Hippocampal dentate gyrus is a focus of enhanced neurogenesis and excitability after traumatic brain injury. Increased neurogenesis has been proposed to aid repair of the injured network. Our data show that an early increase in neurogenesis after fluid percussion concussive brain injury is transient and is followed by a persistent decrease compared with age-matched controls. Post-injury changes in neurogenesis paralleled changes in neural precursor cell proliferation and resulted in a long-term decline in neurogenic capacity. Targeted pharmacology to restore post-injury neurogenesis to control levels reversed the long-term decline in neurogenic capacity. Limiting post-injury neurogenesis reduced early increases in dentate excitability and seizure susceptibility. Our results challenge the assumption that increased neurogenesis after brain injury is beneficial and show that early post-traumatic increases in neurogenesis adversely affect long-term outcomes by exhausting neurogenic potential and enhancing epileptogenesis. Treatments aimed at limiting excessive neurogenesis can potentially restore neuroproliferative capacity and limit epilepsy after brain injury.	[Neuberger, Eric J.; Swietek, Bogumila; Corrubia, Lucas; Prasanna, Anagha; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Pharmacol Physiol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA		Santhakumar, V (corresponding author), Rutgers New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Pharmacol Physiol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA.	santhavi@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097750, R01NS069861]; NJCBIR [CBIR16IRG017, CBIR11PJT003]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861, R01NS097750] Funding Source: NIH RePORTER	We thank Jenieve Guevarra, Dipika Sekhar, and Ying Li for their helpful comments and technical assistance and Dr. Steve Levison for helpful discussions. We extend a special thanks to Dr. Deepak Subramanian for original artwork and design of schematics and graphical representations. The project was supported by NIH R01NS097750 and R01NS069861, and NJCBIR CBIR16IRG017 and CBIR11PJT003 to V.S.	Artegiani B, 2012, AGING-US, V4, P176, DOI 10.18632/aging.100446; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cha BH, 2004, BRAIN DEV-JPN, V26, P394, DOI 10.1016/j.braindev.2003.12.006; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Connor B., 2012, COMPENSATORY NEUROGE; Danzer SC, 2008, NEUROSCIENTIST, V14, P446, DOI 10.1177/1073858408317008; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jacob B, 2009, J CELL BIOCHEM, V107, P393, DOI 10.1002/jcb.22150; Kempermann G., 2015, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPE; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Parent JM, 1997, J NEUROSCI, V17, P3727; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Rosen LS, 2001, CANCER J, V7, pS120; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun GC, 2013, BIOL PHARM BULL, V36, P548; Toth Z, 1997, J NEUROSCI, V17, P8106; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Whiting M. D., 2006, ANIMAL MODELS COGNIT; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Yu JD, 2016, CEREB CORTEX, V26, P4299, DOI 10.1093/cercor/bhv199; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	51	42	42	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	SEP 12	2017	9	3					972	984		10.1016/j.stemcr.2017.07.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FG4WO	WOS:000410279200020	28826852	Green Published, gold			2022-02-06	
J	Bogner, JA; Whiteneck, GG; MacDonald, J; Juengst, SB; Brown, AW; Philippus, AM; Marwitz, JH; Lengenfelder, J; Mellick, D; Arenth, P; Corrigan, JD				Bogner, Jennifer A.; Whiteneck, Gale G.; MacDonald, Jessica; Juengst, Shannon B.; Brown, Allen W.; Philippus, Angela M.; Marwitz, Jennifer H.; Lengenfelder, Jeannie; Mellick, Dave; Arenth, Patricia; Corrigan, John D.			Test-Retest Reliability of Traumatic Brain Injury Outcome Measures: A Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; psychometrics; test-retest reliability	FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; INTRACLASS CORRELATION-COEFFICIENT; FACTOR SURVEILLANCE SYSTEM; TBI IDENTIFICATION METHOD; SAMPLE-SIZE REQUIREMENTS; LIFE SCALE; STRUCTURED INTERVIEWS; VALIDITY; KAPPA	Objective: Evaluate the test-retest reliability of measures that comprise the Traumatic Brain Injury Model Systems follow-up data set. Participants: A total of 224 persons with a moderate-severe traumatic brain injury (TBI) enrolled in the Traumatic Brain Injury Model Systems National Database. Design: Following standard administration of the follow-up interview, a second interview was administered 14 to 28 days later using the same interviewer and the same mode of administration. Main Measures: Traumatic Brain Injury Model Systems follow-up interview that includes 66 variables comprised (a) single item measures of demographics; employment; general health as well as specific health conditions; rehospitalization; tobacco, alcohol, and other drug use; transportation; and mental health and (b) multi-item instruments: FIM; Participation Assessment With Recombined Tools-Objective; Disability Rating Scale; Glasgow Outcome Scale-Extended; Supervision Rating Scale; Satisfaction With Life Scale; TBI Quality of Life Anxiety and Depression items; and The Ohio State University TBI Identification Method. Results: Intraclass correlation coefficient values ranged from 0.65 to 0.99, weighted kappa values ranged from 0.54 to 0.99, and kappa values ranged from 0.43 to 1.00. Four kappa/weighted kappa estimates fell below 0.60: arrested, psychiatric hospitalization, number of days not in good physical health, and rating of general emotional health. Conclusions: With few exceptions, good to excellent test-retest reliability estimates were obtained. The findings support the use of these measures in prior and future studies and indicate that persons with moderate-severe TBI can provide reliable self-report.	[Bogner, Jennifer A.; MacDonald, Jessica; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Whiteneck, Gale G.; Philippus, Angela M.; Mellick, Dave] Craig Hosp Res Dept, Englewood, CO USA; [Juengst, Shannon B.; Arenth, Patricia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Lengenfelder, Jeannie] Kessler Fdn, E Hanover, NJ USA; [Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA		Bogner, JA (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Div Rehabil Psychol, Med Ctr 480, Columbus, OH 43210 USA.	bogner.1@osu.edu	Corrigan, John D./E-2921-2011; Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Philippus, Angela/0000-0001-7427-8660; Brown, Allen W./0000-0001-7228-3351	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0084, 90DP0040, 90DP0034, 90DP0041, 90DP0033, 90DP0030, 90DP0032]	The contents of this report were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DP0084, 90DP0040, 90DP0034, 90DP0041, 90DP0033, 90DP0030, 90DP0032). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this report do not necessarily represent the policy of NIDILRR, ACL, HHS, and endorsement by the Federal Government should not be assumed.	Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bonevski B, 2010, ADDICT BEHAV, V35, P492, DOI 10.1016/j.addbeh.2009.12.030; BROWNSON RC, 1994, EPIDEMIOLOGY, V5, P545; Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150; Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS; Cham PMH, 2007, BRIT J DERMATOL, V156, P922, DOI 10.1111/j.1365-2133.2006.07740.x; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dal Grande E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-108; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Green J, 2001, DISABIL REHABIL, V23, P670, DOI 10.1080/09638280110045382; Hadzi-Pavlovic D, 2010, ACTA NEUROPSYCHIATR, V22, P199, DOI 10.1111/j.1601-5215.2010.00479.x; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; Masedo AI, 2005, AM J PHYS MED REHAB, V84, P167, DOI 10.1097/01.PHM.0000154898.25609.4A; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Petrunoff NA, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/423035; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rasinski, 2000, PSYCHOL SURVEY RESPO; Rosengren L, 2015, ACTA NEUROL SCAND, V132, P164, DOI 10.1111/ane.12380; Sim J, 2005, PHYS THER, V85, P257; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; Substance Abuse and Mental Health Services Administration, 2010, OFFICE APPL STUDIE M; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001; Zou GY, 2012, STAT MED, V31, P3972, DOI 10.1002/sim.5466	45	42	42	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E1	E16		10.1097/HTR.0000000000000291			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800001	28195954				2022-02-06	
J	Godin, JA; Chahla, J; Moatshe, G; Kruckeberg, BM; Muckenhirn, KJ; Vap, AR; Geeslin, AG; LaPrade, RF				Godin, Jonathan A.; Chahla, Jorge; Moatshe, Gilbert; Kruckeberg, Bradley M.; Muckenhirn, Kyle J.; Vap, Alexander R.; Geeslin, Andrew G.; LaPrade, Robert F.			A Comprehensive Reanalysis of the Distal Iliotibial Band Quantitative Anatomy, Radiographic Markers, and Biomechanical Properties	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						knee; iliotibial band; Kaplan fibers; quantitative anatomy	ANTEROLATERAL LIGAMENT; SEGOND FRACTURE; POSTEROLATERAL KNEE; TRACT; RECONSTRUCTION; IDENTIFICATION; LANDMARKS; INJURIES; PATTERNS; TRAUMA	Background: The qualitative anatomy of the distal iliotibial band (ITB) has previously been described. However, a comprehensive characterization of the quantitative anatomic, radiographic, and biomechanical properties of the Kaplan fibers of the deep distal ITB has not yet been established. It is paramount to delineate these characteristics to fully understand the distal ITB's contribution to rotational knee stability. Purpose/Hypothesis: There were 2 distinct purposes for this study: (1) to perform a quantitative anatomic and radiographic evaluation of the distal ITB's attachment sites and their relationships to pertinent osseous and soft tissue landmarks, and (2) to quantify the biomechanical properties of the deep (Kaplan) fibers of the distal ITB. It was hypothesized that the distal ITB has definable parameters concerning its anatomic attachments and consistent relationships to surgically pertinent landmarks with correlating plain radiographic findings. In addition, it was hypothesized that the biomechanical properties of the Kaplan fibers would support their role as important restraints against internal rotation. Study Design: Descriptive laboratory study. Methods: Ten nonpaired, fresh-frozen human cadaveric knees (mean age, 61.1 years; range, 54-65 years) were dissected for anatomic and radiographic purposes. A coordinate measuring device quantified the attachment areas of the distal ITB to the distal femur, patella, and proximal tibia and their relationships to pertinent bony landmarks. A radiographic analysis was performed by inserting pins into the attachment sites of relevant anatomic structures to assess their location relative to pertinent bony landmarks with fluoroscopic guidance. A further biomechanical assessment of 10 cadaveric knees quantified the load to failure and stiffness of the Kaplan fibers' insertion on the distal femur after a preconditioning protocol. Results: Two separate deep (Kaplan) fiber bundles were identified with attachments to 2 newly identified femoral bony prominences (ridges). The proximal and distal bundles inserted on the distal femur 53.6 mm (95% CI, 50.7-56.6 mm) and 31.4 mm (95% CI, 27.3-35.5 mm) proximal to the lateral epicondyle, respectively. The centers of the bundle insertions were 22.5 mm (95% CI, 19.1-25.9 mm) apart. The total insertion area of the distal ITB on the proximal tibia was 429.1 mm(2) (95% CI, 349.2-509.1 mm(2)). A distinct capsulo-osseous layer of the distal ITB was also identified that was intimately related to the lateral knee capsule. Its origin was in close proximity to the lateral gastrocnemius tubercle, and it inserted on the proximal tibia at the lateral tibial tubercle between the fibular head and the Gerdy tubercle. Radiographic analysis supported the quantitative anatomic findings. The mean maximum load during pull-to-failure testing was 71.3 N (95% CI, 41.2-101.4 N) and 170.2 N (95% CI, 123.6-216.8 N) for the proximal and distal Kaplan bundles, respectively. Conclusion: The most important finding of this study was that 2 distinct deep bundles (Kaplan fibers) of the distal ITB were identified. Each bundle of the deep layer of the ITB was associated with a newly identified distinct bony ridge. Radiographic analysis confirmed the measurements previously recorded and established reproducible landmarks for the newly described structures. Biomechanical testing revealed that the Kaplan fibers had a strong attachment to the distal femur, thereby supporting a role in rotational knee stability.	[Godin, Jonathan A.; Chahla, Jorge; Moatshe, Gilbert; Kruckeberg, Bradley M.; Muckenhirn, Kyle J.; Vap, Alexander R.; Geeslin, Andrew G.; LaPrade, Robert F.] Steadman Philippon Res Inst, Dept Biomed Engn, Vail, CO USA; [Godin, Jonathan A.; Chahla, Jorge; Moatshe, Gilbert; Vap, Alexander R.; Geeslin, Andrew G.; LaPrade, Robert F.] Steadman Clin, 181 West Meadow Dr,Suite 400, Vail, CO 81657 USA; [Godin, Jonathan A.; Kruckeberg, Bradley M.; Muckenhirn, Kyle J.; Vap, Alexander R.; Geeslin, Andrew G.; LaPrade, Robert F.] Steadman Philippon Res Inst, Vail, CO USA; [Moatshe, Gilbert] Oslo Univ Hosp, Oslo, Norway; [Moatshe, Gilbert] Univ Oslo, Oslo, Norway; [Moatshe, Gilbert; LaPrade, Robert F.] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway		LaPrade, RF (corresponding author), Steadman Clin, 181 West Meadow Dr,Suite 400, Vail, CO 81657 USA.	drlaprade@sprivail.org	Geeslin, Andrew/AAL-8969-2020		Arthrex; Ossur; Smith Nephew; Linvatec; South-Eastern Norway Regional Health Authorities	One or more of the authors has declared the following potential conflict of interest or source of funding: R.F.L. receives royalties from Arthrex and Smith & Nephew; is a paid consultant for Arthrex, Ossur, and Smith & Nephew; and receives research support from Arthrex, Smith & Nephew, Ossur, and Linvatec. G.M. receives research support from South-Eastern Norway Regional Health Authorities and Arthrex.	Cerminara AJ, 2014, AM J SPORT MED, V42, P2988, DOI 10.1177/0363546514549447; Claes S, 2013, J ANAT, V223, P321, DOI 10.1111/joa.12087; Vieira ELC, 2007, ARTHROSCOPY, V23, P269, DOI 10.1016/j.arthro.2006.11.019; De Maeseneer M, 2015, SKELETAL RADIOL, V44, P413, DOI 10.1007/s00256-014-2044-x; Dodds AL, 2014, BONE JOINT J, V96B, P325, DOI [10.1302/0301620X.96B3.33033, 10.1302/0301-620X.96B3.33033]; Flores DV, 2016, SKELETAL RADIOL, V45, P1635, DOI 10.1007/s00256-016-2479-3; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Helito CP, 2014, AM J SPORT MED, V42, P2356, DOI 10.1177/0363546514543770; KAPLAN EB, 1958, J BONE JOINT SURG AM, V40, P817, DOI 10.2106/00004623-195840040-00006; Kennedy MI, 2015, AM J SPORT MED, V43, P1606, DOI 10.1177/0363546515578253; KITTL C, 2016, AM J SPORT MED, V44; Kittl C, 2015, AM J SPORT MED, V43, P354, DOI 10.1177/0363546514560993; LaPrade RF, 2000, AM J SPORT MED, V28, P191, DOI 10.1177/03635465000280020901; LaPrade RE, 2007, J BONE JOINT SURG AM, V89A, P2000, DOI 10.2106/JBJS.F.01176; LOBENHOFFER P, 1987, ARCH ORTHOP TRAUM SU, V106, P285, DOI 10.1007/BF00454335; Mansour R, 2014, SKELETAL RADIOL, V43, P1369, DOI 10.1007/s00256-014-1918-2; Mazzuca SA, 2001, ARTHRITIS RHEUM, V44, P1786, DOI 10.1002/1529-0131(200108)44:8<1786::AID-ART315>3.0.CO;2-L; Parsons EM, 2015, AM J SPORT MED, V43, pNP22, DOI 10.1177/0363546515597218; Pietrini SD, 2009, AM J SPORT MED, V37, P542, DOI 10.1177/0363546508328117; Rahnemai-Azar AA, 2016, AM J SPORT MED, V44, P892, DOI 10.1177/0363546515623500; Schottle PB, 2007, AM J SPORT MED, V35, P801, DOI 10.1177/0363546506296415; Sonnery-Cottet B, 2016, AM J SPORT MED, V44, P1209, DOI 10.1177/0363546515625282; Spencer L, 2015, AM J SPORT MED, V43, P2189, DOI 10.1177/0363546515589166; TERRY GC, 1993, AM J SPORT MED, V21, P55, DOI 10.1177/036354659302100110; TERRY GC, 1986, AM J SPORT MED, V14, P39, DOI 10.1177/036354658601400108; Terry GC, 1996, AM J SPORT MED, V24, P732, DOI 10.1177/036354659602400606; Wijdicks CA, 2009, J BONE JOINT SURG AM, V91A, P521, DOI 10.2106/JBJS.H.00909; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Wytrykowski K, 2016, ARTHROSCOPY, V16, P241	29	42	42	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2017	45	11					2595	2603		10.1177/0363546517707961			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FF3NP	WOS:000408809800019	28609131				2022-02-06	
J	Wright, DK; Liu, SJ; van der Poel, C; McDonald, SJ; Brady, RD; Taylor, L; Yang, L; Gardner, AJ; Ordidge, R; O'Brien, TJ; Johnston, LA; Shultz, SR				Wright, David K.; Liu, Shijie; van der Poel, Chris; McDonald, Stuart J.; Brady, Rhys D.; Taylor, Lily; Yang, Li; Gardner, Andrew J.; Ordidge, Roger; O'Brien, Terence J.; Johnston, Leigh A.; Shultz, Sandy R.			Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease	CEREBRAL CORTEX			English	Article						amyotrophic lateral sclerosis; MRI; animal model; TDP-43; neurodegeneration	AMYOTROPHIC-LATERAL-SCLEROSIS; VOXEL-BASED MORPHOMETRY; TRANSGENIC MOUSE MODEL; WHITE-MATTER INTEGRITY; CORTICOSPINAL TRACT; HEAD-INJURY; MUSCLE-FIBERS; DIFFUSION MRI; ALS; TDP-43	Traumatic brain injury (TBI) has been suggested to increase the risk of amyotrophic lateral sclerosis (ALS). However, this link remains controversial and as such, here we performed experimental moderate TBI in rats and assessed for the presence of ALS-like pathological and functional abnormalities at both 1 and 12 weeks post-injury. Serial in-vivo magnetic resonance imaging (MRI) demonstrated that rats given a TBI had progressive atrophy of the motor cortices and degeneration of the corticospinal tracts compared with sham-injured rats. Immunofluorescence analyses revealed a progressive reduction in neurons, as well as increased phosphorylated transactive response DNA-binding protein 43 (TDP-43) and cytoplasmic TDP-43, in the motor cortex of rats given a TBI. Rats given a TBI also had fewer spinal cord motor neurons, increased expression of muscle atrophy markers, and altered muscle fiber contractile properties compared with sham-injured rats at 12 weeks, but not 1 week, post-injury. All of these changes occurred in the presence of persisting motor deficits. These findings resemble some of the pathological and functional abnormalities common in ALS and support the notion that TBI can result in a progressive neurodegenerative disease process pathologically bearing similarities to a motor neuron disease.	[Wright, David K.; Ordidge, Roger] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Wright, David K.; Johnston, Leigh A.] Florey Inst Neurosci & Mental Hlth, Anim Imaging Facil, Parkville, Vic 3052, Australia; [Liu, Shijie; Taylor, Lily; Yang, Li; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [van der Poel, Chris; McDonald, Stuart J.; Brady, Rhys D.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Yang, Li] Kunming Med Univ, Dept Histol & Embryol, Kunming 650000, Yunnan, Peoples R China; [Gardner, Andrew J.] Univ Newcastle, Dept Med & Publ Hlth, Ctr Translat Neurosci & Mental Hlth, Callaghan, NSW 2308, Australia; [Johnston, Leigh A.] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia		Shultz, SR (corresponding author), Univ Melbourne, Dept Med, Off 1-02,Kenneth Myer Bldg, Parkville, Vic 3052, Australia.	sshultz@unimelb.edu.au	Johnston, Leigh A/D-7102-2014; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Johnston, Leigh A/0000-0002-5032-4674; Wright, David/0000-0002-7535-8651; Ordidge, Roger/0000-0002-1005-3654; O'Brien, Terence/0000-0002-7198-8621; Gardner, Andrew/0000-0001-5031-5586; McDonald, Stuart/0000-0001-5190-3179	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1062653, 1006077]; Victorian Neurotrauma Initiative project [DNP13]; Motor Neurone Disease Research Institute of Australia	This work was supported by a fellowship to SS from the Canadian Institute of Health Research, and grants to SS and TOB from the Australian National Health and Medical Research Council (grant numbers 1062653, 1006077), the Victorian Neurotrauma Initiative project (grant number DNP13), and Motor Neurone Disease Research Institute of Australia.	Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Agosta F, 2009, AMYOTROPH LATERAL SC, V10, P168, DOI 10.1080/17482960802603841; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Canu E, 2011, AM J NEURORADIOL, V32, P1307, DOI 10.3174/ajnr.A2469; Chang JL, 2005, NEUROLOGY, V65, P75, DOI 10.1212/01.wnl.0000167602.38643.29; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Cirillo M, 2012, AM J NEURORADIOL, V33, P1102, DOI 10.3174/ajnr.A2918; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Cosottini M, 2010, J COMPUT ASSIST TOMO, V34, P746, DOI 10.1097/RCT.0b013e3181e35129; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hong YH, 2008, J NEUROIMAGING, V18, P282, DOI 10.1111/j.1552-6569.2007.00153.x; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lynch GS, 2000, AM J PHYSIOL-CELL PH, V279, pC1290, DOI 10.1152/ajpcell.2000.279.4.C1290; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prudlo J, 2012, J NEUROL, V259, P1848, DOI 10.1007/s00415-012-6420-y; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Seals RM, 2016, AM J EPIDEMIOL, V183, P294, DOI 10.1093/aje/kwv169; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2014, NEUROTHERAPEUTICS, V11, P347, DOI 10.1007/s13311-014-0258-1; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Turner MR, 2007, AMYOTROPH LATERAL SC, V8, P343, DOI 10.1080/17482960701538734; Ueyama H, 1998, J NEUROL SCI, V155, P163, DOI 10.1016/S0022-510X(97)00309-2; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang MD, 2016, NEUROTOXICOLOGY; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; WILLIAMS DA, 1993, J PHYSIOL-LONDON, V460, P51, DOI 10.1113/jphysiol.1993.sp019458; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zang DW, 2002, NEUROSCI LETT, V332, P99, DOI 10.1016/S0304-3940(02)00944-8; Zhang JQ, 2014, J NEUROL, V261, P412, DOI 10.1007/s00415-013-7215-5	82	42	42	1	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2017	27	9					4503	4515		10.1093/cercor/bhw254			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD9MY	WOS:000407847800017	27566977	Bronze			2022-02-06	
J	Koerte, IK; Nichols, E; Tripodis, Y; Schultz, V; Lehner, S; Igbinoba, R; Chuang, AZ; Mayinger, M; Klier, EM; Muehlmann, M; Kaufmann, D; Lepage, C; Heinen, F; Schulte-Koerne, G; Zafonte, R; Shenton, ME; Sereno, AB				Koerte, Inga K.; Nichols, Elizabeth; Tripodis, Yorghos; Schultz, Vivian; Lehner, Stefan; Igbinoba, Randy; Chuang, Alice Z.; Mayinger, Michael; Klier, Eliana M.; Muehlmann, Marc; Kaufmann, David; Lepage, Christian; Heinen, Florian; Schulte-Koerne, Gerd; Zafonte, Ross; Shenton, Martha E.; Sereno, Anne B.			Impaired Cognitive Performance in Youth Athletes Exposed to Repetitive Head Impacts	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; cognitive improvement; heading; repetitive head impact; soccer; sports-related brain trauma	PROFESSIONAL SOCCER PLAYERS; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; EXERCISE; CONCUSSION; SWIMMERS; SPORTS; HUMANS; TIME	Worldwide, more than 22 million children and adolescents are exposed to repetitive head impacts (RHI) in soccer. Evidence indicates cumulative effects on brain structure, but it is not known whether exposure to RHI affects cognitive improvement in adolescents. The aim of the study was to determine whether exposure to RHI while heading the ball in soccer affects improvement in cognitive performance in adolescents over time. The study group consisted of a convenience sample of 16 male soccer players (mean age 15.7 - 0.7 years). A comparison cohort of 14 male non-contact sports athletes (mean age 14.9 - 1.1 years) was recruited from competitive athletic clubs and group-matched in age. Using the ProPoint and AntiPoint tasks, sensorimotor and cognitive functions were measured over both immediate (pre- vs. post-training) as well as across multiple time points within a play season. The number and type of head impacts that occurred during the training were counted. The main outcome measure was the change in response time (RT) in the ProPoint and AntiPoint tasks. The immediate (pre-vs. post-training) and longer-term (across a play season) change in RT was analyzed, and the effect of the number and type of head impacts was tested. Thirty athletes with and without exposure to RHI demonstrated a decrease in RT in both tasks immediately after training. Over the play season, both groups showed improvement in sensorimotor function. While the control group also improved in cognitive performance, the soccer players did not, however. Further, the more long headers performed, the slower the improvement in RT over the season. Youth athletes experience an immediate cognitive improvement after training most likely because of physical exercise. Results of this study also suggest an association between exposure to specific RHI (long headers) and lack of improvement in cognitive performance in youth athletes over time.	[Koerte, Inga K.; Nichols, Elizabeth; Schultz, Vivian; Mayinger, Michael; Schulte-Koerne, Gerd] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Koerte, Inga K.; Schultz, Vivian; Mayinger, Michael; Lepage, Christian; Shenton, Martha E.] Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Koerte, Inga K.; Schultz, Vivian; Mayinger, Michael; Lepage, Christian; Shenton, Martha E.] Harvard Med Sch, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lehner, Stefan] Univ Appl Sci, Dept Appl Sci & Mechatron, Munich, Germany; [Igbinoba, Randy; Klier, Eliana M.; Sereno, Anne B.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Chuang, Alice Z.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Muehlmann, Marc] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Munich, Germany; [Kaufmann, David] Charite, Dept Radiol, Berlin, Germany; [Heinen, Florian] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat Neurol, Munich, Germany; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Boston, MA USA		Koerte, IK (corresponding author), Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Shenton, Martha/V-8780-2019; Koerte, Inga Katharina/AAW-3031-2021; Schulte-Korne, Gerd/AAI-4828-2021; Heinen, Florian/B-6594-2015	Schulte-Korne, Gerd/0000-0002-9960-1572; Heinen, Florian/0000-0002-3872-6136; Lepage, Chris/0000-0001-5719-0982; Tripodis, Yorghos/0000-0003-2190-7608	Else Kroner-Fresenius-Stiftung, Germany; U.S. Department of State Fulbright Scholarship; Mission Connect, a program of TIRR Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30-EY010608]; VA Merit AwardUS Department of Veterans Affairs; German Academic Exchange ServiceDeutscher Akademischer Austausch Dienst (DAAD); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	We thank all study participants. This study was in part supported by the Else Kroner-Fresenius-Stiftung, Germany (IK), the U.S. Department of State Fulbright Scholarship, 2014-2015 (EN), Mission Connect, a program of TIRR Foundation (AS), NIH P30-EY010608 (AC), a VA Merit Award (MES), and the German Academic Exchange Service PROMOS Award (VS).	Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Billat V, 1996, ERGONOMICS, V39, P267, DOI 10.1080/00140139608964457; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Budde H, 2008, NEUROSCI LETT, V441, P219, DOI 10.1016/j.neulet.2008.06.024; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Clery J, 2015, J NEUROSCI, V35, P4179, DOI 10.1523/JNEUROSCI.3031-14.2015; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Hogervorst E, 1996, PERCEPT MOTOR SKILL, V83, P479, DOI 10.2466/pms.1996.83.2.479; HOLMER I, 1974, J APPL PHYSIOL, V36, P711, DOI 10.1152/jappl.1974.36.6.711; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; Kirchgessner MA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00453; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Pang EW, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00170; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Sereno A. B., United States patent application, Patent No. [US 2014/ 0249447 A1, 20140249447]; Suchomel A., 2010, INT J TABLE TENNIS S, V6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tonnessen E, 2013, INT J SPORT PHYSIOL, V8, P323, DOI 10.1123/ijspp.8.3.323; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; WARREN JB, 1984, CLIN SCI, V66, P87, DOI 10.1042/cs0660087; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	35	42	42	1	38	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2389	2395		10.1089/neu.2016.4960			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400002	28381107	Green Published, Green Submitted			2022-02-06	
J	Truettner, JS; Bramlett, HM; Dietrich, WD				Truettner, Jessie S.; Bramlett, Helen M.; Dietrich, W. Dalton			Posttraumatic therapeutic hypothermia alters microglial and macrophage polarization toward a beneficial phenotype	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cytokines; inflammation; macrophages; microglial; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; BARRIER PERMEABILITY; MODERATE HYPOTHERMIA; WHITE-MATTER; RAT; NEUROINFLAMMATION; ACTIVATION; NEURODEGENERATION; NEUROPROTECTION	Posttraumatic inflammatory processes contribute to pathological and reparative processes observed after traumatic brain injury (TBI). Recent findings have emphasized that these divergent effects result from subsets of proinflammatory (M1) or anti-inflammatory (M2) microglia and macrophages. Therapeutic hypothermia has been tested in preclinical and clinical models of TBI to limit secondary injury mechanisms including proinflammatory processes. This study evaluated the effects of posttraumatic hypothermia (PTH) on phenotype patterns of microglia/ macrophages. Sprague-Dawley rats underwent moderate fluid percussion brain injury with normothermia (37 degrees C) or hypothermia (33 degrees C). Cortical and hippocampal regions were analyzed using flow cytometry and reverse transcription-polymerase chain reaction (RT-PCR) at several periods after injury. Compared to normothermia, PTH attenuated infiltrating cortical macrophages positive for CD11b(+) and CD45 high. At 24 h, the ratio of iNOS(+) (M1) to arginase(+) (M2) cells after hypothermia showed a decrease compared to normothermia. RT-PCR of M1-associated genes including iNOS and IL-1 beta was significantly reduced with hypothermia while M2-associated genes including arginase and CD163 were significantly increased compared to normothermic conditions. The injury-induced increased expression of the chemokine Ccl2 was also reduced with PTH. These studies provide a link between temperature-sensitive alterations in macrophage/microglia activation and polarization toward a M2 phenotype that could be permissive for cell survival and repair.	[Truettner, Jessie S.; Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Dietrich, WD (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace,Suite 2-30, Miami, FL 33136 USA.	ddietrich@miami.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS089443, R01 NS042133]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089443, R01NS042133] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by R01 NS089443 and R01 NS042133 from NIH/NINDS.	Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, TRAUMATIC BRAIN INJU; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Saigal S, 2015, INDIAN J CRIT CARE M, V19, P537, DOI 10.4103/0972-5229.164806; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Yenari MA, 2013, FRONT NEUROL NEUROSC, V32, P122, DOI 10.1159/000346428; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0440-3; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	42	44	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2017	37	8					2952	2962		10.1177/0271678X16680003			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FC0FO	WOS:000406514300025	27864465	Green Published, Bronze			2022-02-06	
J	Chhor, V; Moretti, R; Le Charpentier, T; Sigaut, S; Lebon, S; Schwendimann, L; Ore, MV; Zuiani, C; Milan, V; Josserand, J; Vontell, R; Pansiot, J; Degos, V; Ikonomidou, C; Titomanlio, L; Hagberg, H; Gressens, P; Fleiss, B				Chhor, Vibol; Moretti, Raffaella; Le Charpentier, Tifenn; Sigaut, Stephanie; Lebon, Sophie; Schwendimann, Leslie; Ore, Marie-Virginie; Zuiani, Chiara; Milan, Valentina; Josserand, Julien; Vontell, Regina; Pansiot, Julien; Degos, Vincent; Ikonomidou, Chrysanthy; Titomanlio, Luigi; Hagberg, Henrik; Gressens, Pierre; Fleiss, Bobbi			Role of microglia in a mouse model of paediatric traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Phenotype; Cytokine; Chemokine; Apoptosis; Neuron; Immature; Cerebral; Macrophage; Inflammation; Minocycline	WHITE-MATTER INJURY; CELL-DEATH; MICROGLIA/MACROPHAGE ACTIVATION; CEREBRAL-ISCHEMIA; RAT-BRAIN; MINOCYCLINE; EXPRESSION; PROTECTS; AGE; NEUROPROTECTION	The cognitive and behavioural deficits caused by traumatic brain injury (TBI) to the immature brain are more severe and persistent than TBI in the mature brain. Understanding this developmental sensitivity is critical as children under four years of age sustain TBI more frequently than any other age group. Microglia (MG), resident immune cells of the brain that mediate neuroinflammation, are activated following TBI in the immature brain. However, the type and temporal profile of this activation and the consequences of altering it are still largely unknown. In a mouse model of closed head weight drop paediatric brain trauma, we characterized i) the temporal course of total cortical neuroinflammation and the phenotype of ex vivo isolated CD11B-positive microglia/macrophage (MG/M Phi) using a battery of 32 markers, and ii) neuropathological outcome 1 and 5 days post-injury. We also assessed the effects of targeting MG/M Phi activation directly, using minocycline a prototypical microglial activation antagonist, on these processes and outcome. TBI induced a moderate increase in both pro- and anti-inflammatory cytokines/chemokines in the ipsilateral hemisphere. Isolated cortical MG/M Phi expressed increased levels of markers of endogenous reparatory/regenerative and immunomodulatory phenotypes compared with shams. Blocking MG/M Phi activation with minocycline at the time of injury and 1 and 2 days post-injury had only transient protective effects, reducing ventricular dilatation and cell death 1 day post-injury but having no effect on injury severity at 5 days. This study demonstrates that, unlike in adults, the role of MG/M Phi in injury mechanisms following TBI in the immature brain may not be negative. An improved understanding of MG/M Phi function in paediatric TBI could support translational efforts to design therapeutic interventions. (C) 2016 The Author(s). Published by Elsevier Inc.	[Chhor, Vibol; Moretti, Raffaella; Le Charpentier, Tifenn; Sigaut, Stephanie; Lebon, Sophie; Schwendimann, Leslie; Ore, Marie-Virginie; Zuiani, Chiara; Milan, Valentina; Josserand, Julien; Pansiot, Julien; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] Unversite Paris Diderot, PROTECT, INSERM, Sorbonne Paris Cite, Paris, France; [Chhor, Vibol; Moretti, Raffaella; Le Charpentier, Tifenn; Sigaut, Stephanie; Lebon, Sophie; Schwendimann, Leslie; Ore, Marie-Virginie; Zuiani, Chiara; Milan, Valentina; Josserand, Julien; Pansiot, Julien; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] PremUP, Paris, France; [Chhor, Vibol] Georges Pompidou European Hosp, Dept Anesthesia & Intens Care, Paris, France; [Moretti, Raffaella] Univ Udine, Udine, Italy; [Vontell, Regina; Hagberg, Henrik; Gressens, Pierre; Fleiss, Bobbi] Kings Coll London, St Thomas Hosp, Dept Perinatal Imaging & Hlth, Dept Div Imaging Sci & Biomed Engn, London SE1 7EH, England; [Hagberg, Henrik] Hop La Pitie Salpetriere, Dept Anesthesia & Intens Care, F-75013 Paris, France; [Ikonomidou, Chrysanthy] Univ Wisconsin, Dept Neurol, Madison, WI USA; [Degos, Vincent] Gothenburg Univ, Sahlgrenska Acad E Hosp, Dept Clin Sci, S-41685 Gothenburg, Sweden; [Zuiani, Chiara] Univ Trieste, Trieste, Italy		Fleiss, B (corresponding author), Inserm U1141, Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France.	Bobbi.Fleiss@inserm.fr	Fleiss, Bobbi/F-9899-2011; gressens, pierre/M-7557-2017	Fleiss, Bobbi/0000-0001-7828-673X; gressens, pierre/0000-0002-0909-4221; Sigaut, Stephanie/0000-0002-4888-7769; Lebon, Sophie/0000-0003-0039-5519; Hagberg, Henrik/0000-0003-3962-1448	InsermInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Universite Paris Diderot; Universite Sorbonne-Paris-Cite; Investissement d'AvenirFrench National Research Agency (ANR) [ANR-11-INBS-0011]; ERA-NET Neuron (Micromet); DHU PROTECT; PremUP; Fondation de FranceFondation de France; Fondation pour la Recherche sur le Cerveau; Fondation des Gueules Cassees; Institut Servier; Roger de Spoelberch Foundation; Grace de Monaco Foundation; Leducq FoundationLeducq Foundation; Cerebral Palsy Alliance Research Foundation Australia; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [VR 2015-02493]; Hjarnfonden (Brain Foundation) [2015-0004]; Swedish Governmental [ALFGBG-426401]; Wellcome TrustWellcome TrustEuropean Commission [WSCR P32674]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's College London and King's College Hospital NHS Foundation Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802853] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0802853] Funding Source: researchfish; Action Medical Research [2485] Funding Source: researchfish	This study was supported by grants from Inserm, Universite Paris Diderot, Universite Sorbonne-Paris-Cite, Investissement d'Avenir (ANR-11-INBS-0011, NeurATRIS), ERA-NET Neuron (Micromet), DHU PROTECT, PremUP, Fondation de France, Fondation pour la Recherche sur le Cerveau, Fondation des Gueules Cassees, Institut Servier, Roger de Spoelberch Foundation, Grace de Monaco Foundation, Leducq Foundation, Cerebral Palsy Alliance Research Foundation Australia, The Swedish Medical Research Council (VR 2015-02493), Hjarnfonden (Brain Foundation 2015-0004), Swedish Governmental Grant to Researchers at University Hospitals (ALFGBG-426401), and the Wellcome Trust (WSCR P32674). In addition, the authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The supporting bodies played no role in any aspect of study design, analysis, interpretation or decision to publish these data.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Bennet L., 2013, CLIN EXP PHARM PHYSL; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cai Z, 2006, NEUROSCIENCE, V137, P425, DOI 10.1016/j.neuroscience.2005.09.023; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Fernandez-Gomez FJ, 2005, NEUROBIOL DIS, V20, P384, DOI 10.1016/j.nbd.2005.03.019; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gonzalez JC, 2007, EUR J NEUROSCI, V26, P2481, DOI 10.1111/j.1460-9568.2007.05873.x; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Hart AD, 2012, BRAIN BEHAV IMMUN, V26, P754, DOI 10.1016/j.bbi.2011.11.006; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Kaindl AM, 2007, PROTEOM CLIN APPL, V1, P640, DOI 10.1002/prca.200600696; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kernt M, 2010, CLIN OPHTHALMOL, V4, P591; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Koistinaho M, 2005, J CEREBR BLOOD F MET, V25, P460, DOI 10.1038/sj.jcbfm.9600040; Kumar A., 2015, J NEUROTRAUMA; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lechpammer M, 2008, NEUROPATH APPL NEURO, V34, P379, DOI 10.1111/j.1365-2990.2007.00925.x; Li ZL, 2014, BRAIN BEHAV IMMUN, V38, P237, DOI 10.1016/j.bbi.2014.02.008; Lingwood BE, 2008, J NEUROSCI METH, V171, P140, DOI 10.1016/j.jneumeth.2008.02.011; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00054; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Moretti R., 2016, J NEUROSCI RES; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Nijboer CH, 2010, BRAIN BEHAV IMMUN, V24, P420, DOI 10.1016/j.bbi.2009.11.009; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Schang AL, 2014, BRAIN BEHAV IMMUN, V37, P95, DOI 10.1016/j.bbi.2013.11.005; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0431-4; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wang G., 2013, J CEREB BLOOD FLOW M; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yoon SY, 2012, NEUROSCIENCE, V221, P214, DOI 10.1016/j.neuroscience.2012.06.024; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	87	42	44	1	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2017	63				SI		197	209		10.1016/j.bbi.2016.11.001			13	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EW0ZG	WOS:000402219100019	27818218	Green Published, Green Submitted, hybrid			2022-02-06	
J	Kirkpatrick, B; Mucci, A; Galderisi, S				Kirkpatrick, Brian; Mucci, Armida; Galderisi, Silvana			Primary, Enduring Negative Symptoms: An Update on Research	SCHIZOPHRENIA BULLETIN			English	Article						deficit schizophrenia; nosology; negative symptoms; psychopathology; schizophrenia	NON-DEFICIT SCHIZOPHRENIA; WHITE-MATTER ALTERATIONS; TRAUMATIC BRAIN-INJURY; NAIVE PATIENTS; DIMINISHED EXPRESSION; NEUROIMAGING EVIDENCE; INTERSTITIAL-CELLS; APATHY; IMPAIRMENTS; PSYCHOSIS	We previously proposed that people with schizophrenia who have primary, enduring negative symptoms have a disease-deficit schizophrenia (DS)-that is separate from that affecting people with schizophrenia without these features. Additional evidence consistent with the separate disease hypothesis has accumulated in recent years. White matter changes may be widespread in deficit compared to nondeficit patients and may relate to problems in early brain migration. These 2 patient groups also appear to differ on metabolic measures prior to antipsychotic treatment. Studies of reward and defeatist beliefs provide the basis for future treatment trials. The 2 factors or groups within negative symptoms broadly defined (both primary and secondary) have also been found in DS, and recent evidence suggests these 2 symptom groups have different correlates and reflect the existence of 2 groups with in DS. Negative symptoms are found in disorders other than schizophrenia, and excess summer birth, a deficit risk factor, has been found in a non-patient group with deficit-like features. It may be useful in future research to determine whether findings in DS extend to patients with other neuropsychiatric disorders who also have negative symptoms.	[Kirkpatrick, Brian] Univ Nevada, Reno Sch Med, Dept Psychiat & Behav Sci, 1664 North Virginia St,Mail Stop 0354, Reno, NV 89557 USA; [Mucci, Armida] Univ Naples SUN, Dept Psychiat, Naples, Italy; [Galderisi, Silvana] Univ Campania Luigi Vanvitelli SUN, Dept Psychiat, Naples, Italy; [Galderisi, Silvana] Univ Hosp SUN, Naples, Italy		Kirkpatrick, B (corresponding author), Univ Nevada, Reno Sch Med, Dept Psychiat & Behav Sci, 1664 North Virginia St,Mail Stop 0354, Reno, NV 89557 USA.	bkirkpatrick2@aol.com	Mucci, Armida/ABF-2121-2021	Mucci, Armida/0000-0002-6195-9456	Genentech/RocheRoche HoldingGenentech; Minerva Neurosciences; ProPhase LLC; Decision Resources, Inc; Walsh Medical Media; Physicians Postgraduate Press, Inc.; LundbeckLundbeck Corporation; Janssen PharmaceuticalsJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; Hoffman-La Roche; Angelini-Acraf; OtsukaOtsuka Pharmaceutical; Pierre Fabre; Gedeon-Richter; PfizerPfizer	B.K. has received licensing royalties from ProPhase LLC for use of the Brief Negative Symptom Scale (BNSS) by for-profit groups; these fees are donated to the Brain and Behavior Research Foundation. B.K. has also received consulting fees and travel support from Genentech/Roche, Minerva Neurosciences, and ProPhase LLC, some of the fees for teaching the BNSS to pharmaceutical company raters; he has also received consulting fees from anonymized pharmaceutical companies through Decision Resources, Inc. and L.E.K. Consulting, and from an investment capital company through Guideposts. B.K. also receives fees from Walsh Medical Media for editorial services, and received fees for editorial services from Physicians Postgraduate Press, Inc. S.G. received honoraria or advisory board/consulting fees from the following companies: Lundbeck, Janssen Pharmaceuticals, Hoffman-La Roche, Angelini-Acraf, Otsuka, Pierre Fabre and Gedeon-Richter. A.M. received honoraria or advisory board/consulting fees from the following companies: Janssen Pharmaceuticals, Otsuka, Pfizer and Pierre Fabre.	Ahmed AO, 2015, SCHIZOPHRENIA BULL, V41, P879, DOI 10.1093/schbul/sbu163; Arango C, 1999, AM J PSYCHIAT, V156, P1097; Arango C, 2011, EUR NEUROPSYCHOPHARM, V21, P867, DOI 10.1016/j.euroneuro.2011.03.005; Beck AT, 2013, SCHIZOPHRENIA BULL, V39, P43, DOI 10.1093/schbul/sbr040; Blanchard JJ, 2005, SCHIZOPHR RES, V77, P151, DOI 10.1016/j.schres.2005.03.022; Blanchard JJ, 2006, SCHIZOPHRENIA BULL, V32, P238, DOI 10.1093/schbul/sbj013; Blanchard JJ, SCHIZOPHR RES; Bucci P, 2016, SCHIZOPHR RES, V174, P172, DOI 10.1016/j.schres.2016.01.032; Campellone TR, 2016, SCHIZOPHRENIA BULL, V42, P1343, DOI 10.1093/schbul/sbw026; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Cohen AS, 2007, SCHIZOPHRENIA BULL, V33, P1201, DOI 10.1093/schbul/sbl066; Dantas CR, 2011, SCHIZOPHR RES, V128, P124, DOI 10.1016/j.schres.2011.01.023; De Rossi P, 2016, PSYCHIAT RES-NEUROIM, V254, P48, DOI 10.1016/j.pscychresns.2016.06.004; Fernandez-Egea E, 2012, PSYCHIAT RES-NEUROIM, V203, P109, DOI 10.1016/j.pscychresns.2011.09.016; Fervaha G, 2015, SCHIZOPHR RES, V168, P483, DOI 10.1016/j.schres.2015.07.023; Fischer BA, 2012, SCHIZOPHR RES, V136, P51, DOI 10.1016/j.schres.2012.01.030; Galderisi S, 2002, AM J PSYCHIAT, V159, P983, DOI 10.1176/appi.ajp.159.6.983; Galderisi S, 2015, EUR ARCH PSY CLIN N, V265, P543, DOI 10.1007/s00406-015-0590-4; Galderisi S, 2014, WORLD PSYCHIATRY, V13, P275, DOI 10.1002/wps.20167; Galderisi S, 2013, SCHIZOPHR RES, V147, P157, DOI 10.1016/j.schres.2013.03.020; Garcia-Rizo C, 2012, PSYCHIAT RES, V198, P212, DOI 10.1016/j.psychres.2011.08.014; Grant PM, 2009, SCHIZOPHRENIA BULL, V35, P798, DOI 10.1093/schbul/sbn008; Hong LE, 2003, SCHIZOPHR RES, V63, P39, DOI 10.1016/S0920-9964(02)00388-2; Kimhy D, 2006, SCHIZOPHRENIA BULL, V32, P274, DOI 10.1093/schbul/sbi064; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; KIRKPATRICK B, 1993, PSYCHIAT RES, V47, P47, DOI 10.1016/0165-1781(93)90054-K; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Kirkpatrick B, 2003, J NERV MENT DIS, V191, P563, DOI 10.1097/01.nmd.0000087181.61164.e1; Kirkpatrick B, 1999, SYNAPSE, V34, P95, DOI 10.1002/(SICI)1098-2396(199911)34:2<95::AID-SYN2>3.0.CO;2-I; Kirkpatrick B, 2008, WORLD PSYCHIATRY, V7, P143; Kirkpatrick B, 2008, SCHIZOPHR RES, V103, P151, DOI 10.1016/j.schres.2007.12.479; Kirkpatrick B, 2009, SCHIZOPHR RES, V107, P122, DOI 10.1016/j.schres.2008.09.023; Kirschner M, 2016, J PSYCHIATR NEUROSCI, V41, P152, DOI 10.1503/jpn.140383; Kranz TM, 2016, EBIOMEDICINE, V6, P206, DOI 10.1016/j.ebiom.2016.03.008; Lei W, 2015, PSYCHIAT RES-NEUROIM, V234, P219, DOI 10.1016/j.pscychresns.2015.09.015; Lei W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12994; Li Z, 2013, ASIA-PAC PSYCHIAT, V5, P69, DOI 10.1111/appy.12030; Santos JL, 2010, SCHIZOPHR RES, V119, P183, DOI 10.1016/j.schres.2010.01.010; Marder SR, 2017, WORLD PSYCHIATRY, V16, P14, DOI 10.1002/wps.20385; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Mucci A, 2015, EUR PSYCHIAT, V30, P641, DOI 10.1016/j.eurpsy.2015.01.014; Mucci A, 2015, PSYCHOL MED, V45, P1765, DOI 10.1017/S0033291714002943; Nakaya M, 2008, PSYCHIAT RES, V158, P256, DOI 10.1016/j.psychres.2007.10.008; Nemeth G, 2017, LANCET, V389, P1103, DOI [10.1016/S0140-6736(17)30060-0, 10.1016/s0140-6736(17)30060-0]; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; Pegoraro LFL, 2013, SCHIZOPHR RES, V147, P91, DOI 10.1016/j.schres.2013.02.041; Peralta V, 2014, SCHIZOPHRENIA BULL, V40, P214, DOI 10.1093/schbul/sbs152; Pillny M, 2016, PSYCHIAT RES, V244, P117, DOI 10.1016/j.psychres.2016.07.018; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Rethelyi JM, 2012, EUR ARCH PSY CLIN N, V262, P107, DOI 10.1007/s00406-011-0224-4; Rowland LM, 2009, NEUROPSYCHOPHARMACOL, V34, P1514, DOI 10.1038/npp.2008.207; Spalletta G, 2015, PSYCHIAT RES-NEUROIM, V231, P252, DOI 10.1016/j.pscychresns.2014.12.006; Strauss GP, 2008, SCHIZOPHR RES, V102, P76, DOI 10.1016/j.schres.2008.01.014; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Strauss GP, 2012, SCHIZOPHR RES, V142, P96, DOI 10.1016/j.schres.2012.09.007; Strauss GP, 2012, SCHIZOPHR RES, V135, P134, DOI 10.1016/j.schres.2011.11.007; Strauss GP, 2010, SCHIZOPHRENIA BULL, V36, P860, DOI 10.1093/schbul/sbn178; Strauss GP, 2010, SCHIZOPHRENIA BULL, V36, P788, DOI 10.1093/schbul/sbn167; Takayanagi M, 2013, SCHIZOPHR RES, V150, P484, DOI 10.1016/j.schres.2013.07.036; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; Telfer S, 2011, ACTA PSYCHIAT SCAND, V124, P357, DOI 10.1111/j.1600-0447.2011.01751.x; Trotman HD, 2011, SCHIZOPHR RES, V126, P252, DOI 10.1016/j.schres.2010.08.024; Vaskinn A, 2015, PSYCHIAT RES, V228, P803, DOI 10.1016/j.psychres.2015.05.019; Vogel SJ, 2013, SCHIZOPHR RES, V151, P97, DOI 10.1016/j.schres.2013.07.052; Voineskos AN, 2013, JAMA PSYCHIAT, V70, P472, DOI 10.1001/jamapsychiatry.2013.786; Wheeler AL, 2015, JAMA PSYCHIAT, V72, P446, DOI 10.1001/jamapsychiatry.2014.3020; Yu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138357	68	42	44	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0586-7614	1745-1701		SCHIZOPHRENIA BULL	Schizophr. Bull.	JUL	2017	43	4					730	736		10.1093/schbul/sbx064			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EX6HU	WOS:000403344200011	28575513	Green Published, Bronze			2022-02-06	
J	Swan, AA; Nelson, JT; Swiger, B; Jaramillo, CA; Eapen, BC; Packer, M; Pugh, MJ				Swan, A. A.; Nelson, J. T.; Swiger, B.; Jaramillo, C. A.; Eapen, B. C.; Packer, M.; Pugh, M. J.			Prevalence of hearing loss and tinnitus in Iraq and Afghanistan Veterans: A Chronic Effects of Neurotrauma Consortium study	HEARING RESEARCH			English	Article						Head injury; Hearing loss; Tinnitus; Prevalence; Comorbidities; Veterans	TRAUMATIC BRAIN-INJURY; POLYTRAUMA-CLINICAL-TRIAD; UNITED-STATES; IMPAIRMENT; BLAST; DEPRESSION; ASSOCIATION; HEALTH; COHORT; ADULTS	The purpose of this study was to describe the prevalence of hearing loss and tinnitus in a cohort of Iraq and Afghanistan Veterans (IAV) with common post-deployment conditions, including traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and other typical post-concussive conditions such as headaches and vertigo/dizziness. This retrospective observational study used data from the national Veterans Health Administration (VA) data repository from fiscal years 2001-2014. Veteran data was included if there were at least three years of VA care, with one or more years of care in 2007 or after. We identified comorbidities that may be associated with post-deployment hearing loss or tinnitus including TBI, PTSD, depression, and common post-concussive symptoms using International Classification of Diseases, 9th Revision, Clinical Modification codes. A multinomial logistic regression analysis was used to examine conditions associated with hearing loss or tinnitus. Among IAV, 570,332 were included in the final analysis. Of these, 7.78% of these were diagnosed with hearing loss alone, 6.54% with tinnitus alone, and 6.24% with both hearing loss and tinnitus. Comorbid TBI, PTSD, and depression were significantly associated with increased rates of hearing loss, tinnitus, or both conditions together. Older individuals, males, and those with TBI, PTSD, or vertigo/dizziness were significantly more likely to have hearing loss, tinnitus, or both. In order to provide more holistic post-deployment support, this myriad of conditions should be carefully considered in the planning of clinical care and beyond. (C) 2017 Elsevier B.V. All rights reserved.	[Swan, A. A.; Jaramillo, C. A.; Eapen, B. C.; Pugh, M. J.] South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Swan, A. A.; Nelson, J. T.; Pugh, M. J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Nelson, J. T.; Packer, M.] Dept Def Hearing Ctr Excellence, Washington, DC USA; [Swiger, B.] Brooke Army Med Ctr, Ctr Nursing Sci & Clin Inquiry, Ft Sam Houston, TX 78234 USA		Swan, AA (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	swana3@uthscsa.edu	Swan, Alicia A/O-3536-2018; Pugh, Mary Jo/K-5336-2019	Swan, Alicia A/0000-0003-2412-0499; Pugh, Mary Jo/0000-0003-4196-7763; Nelson, Jeremy/0000-0003-4428-8694			Abrams TE, 2006, J AM GERIATR SOC, V54, P1475, DOI 10.1111/j.1532-5415.2006.00875.x; Armed Forces Health Surveillance Branch, 2015, SURV CAS DEF 13 0 NE; AXELSSON A, 1985, ACTA OTO-LARYNGOL, V100, P379, DOI 10.3109/00016488509126561; Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BRUINS WR, 1991, J LARYNGOL OTOL, V105, P890, DOI 10.1017/S002221510011775X; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Casale M, 2012, SLEEP BREATH, V16, P413, DOI 10.1007/s11325-011-0517-x; Chandler D W, 1997, J Am Acad Audiol, V8, P81; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Cruickshanks KJ, 2015, J AM GERIATR SOC, V63, P918, DOI 10.1111/jgs.13401; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; de Graaf R, 2002, PSYCHOSOM MED, V64, P61, DOI 10.1097/00006842-200201000-00009; Fausti SA, 2005, J REHABIL RES DEV, V42, P45, DOI 10.1682/JRRD.2005.02.0039; Figueiredo RR, 2015, EUR ARCH OTO-RHINO-L, V272, P3089, DOI 10.1007/s00405-014-3277-y; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Geocze L, 2013, BRAZ J OTORHINOLAR, V79, P106, DOI 10.5935/1808-8694.20130018; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Helfer Thomas M, 2005, Am J Audiol, V14, P161, DOI 10.1044/1059-0889(2005/018); Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P253, DOI 10.1007/s10654-011-9563-8; Langguth B, 2011, OTOLARYNG HEAD NECK, V145, P519, DOI 10.1177/0194599811411851; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Office of Public Health, 2015, AN VA HLTH CAR UT OP; Office of the Deputy Assistant Secretary of Defense, 2015, 2014 DEM REP PROF MI; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Udupi Venkataraja Aithal, 2013, Int Tinnitus J, V18, P29, DOI 10.5935/0946-5448.20130005; Veterans Benefits Administration, 2016, COMP SERV CONN DIS D; WICKENS T. D., 1989, MULTIWAY CONTINGENCY; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; YETISER S, 1993, MIL MED, V158, P803, DOI 10.1093/milmed/158.12.803	48	42	42	2	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUN	2017	349				SI		4	12		10.1016/j.heares.2017.01.013			9	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	EW2SB	WOS:000402345200002	28153668	hybrid			2022-02-06	
J	Yang, B; Hamilton, JA; Valenzuela, KS; Bogaerts, A; Xi, XP; Aronowski, J; Mays, RW; Savitz, SI				Yang, Bing; Hamilton, Jason A.; Valenzuela, Krystal S.; Bogaerts, Annelies; Xi, XiaoPei; Aronowski, Jaroslaw; Mays, Robert W.; Savitz, Sean I.			Multipotent Adult Progenitor Cells Enhance Recovery After Stroke by Modulating the Immune Response from the Spleen	STEM CELLS			English	Article						Rat model; Adult human bone marrow; Bone marrow stromal cells; Cellular therapy	REGULATORY T-CELLS; MARROW MONONUCLEAR-CELLS; HYPOXIC-ISCHEMIC INJURY; TRAUMATIC BRAIN-INJURY; INTERFERON-GAMMA; RAT-BRAIN; INFLAMMATION; THERAPY; SIZE; TRANSPLANTATION	Stem cell therapy modulates not only the local microenvironment of the brain but also the systemic immune responses. We explored the impact of human multipotent adult progenitor cells (MAPC) modulating splenic activation and peripheral immune responses after ischemic stroke. Hundred twenty-six Long-Evans adult male rats underwent middle cerebral artery occlusion. Twenty-four hours later, they received IV MAPC or saline treatment. At 3 days after infusion, RNA was isolated from the injured cortex and spleen for microarray analysis. Spleen mass, splenocyte phenotype, and releasing cytokines were measured. Serum cytokines, MAPC biodistribution, brain lesion sizes and neurofunctional deficits were compared in rats treated with MAPC or saline with and without spleens. Stroked animals treated with MAPC exhibited genes that more closely resembled animals with sham surgery. Gene categories downregulated by MAPC included leukocyte activation, antigen presentation, and immune effector processing, associated with the signaling pathways regulated by TNF-, IL-1, IL-6, and IFN- within the brain. MAPC treatment restored spleen mass reduction caused by stroke, elevated Treg cells within the spleen, increased IL-10 and decreased IL-1 released by splenocytes. MAPC reduced IL-6 and IL-1 and upregulated IL-10 serum levels. Compared with saline, MAPC enhance stroke recovery in rats with intact spleens but had no effects in rats without spleens. MAPC restores expression of multiple genes and pathways involved in immune and inflammatory responses after stroke. Immunomodulation of the splenic response by the intravenous administration of MAPC may create a more favorable environment for brain repair after stroke. Stem Cells2017;35:1290-1302	[Yang, Bing; Valenzuela, Krystal S.; Xi, XiaoPei; Aronowski, Jaroslaw; Savitz, Sean I.] UT Hlth Houston, McGovern Med Sch, Stroke Program, 6431 Fannin St, Houston, TX 77030 USA; [Hamilton, Jason A.; Mays, Robert W.] Athersys, Cleveland, OH USA; [Hamilton, Jason A.] Novartis Pharmaceut, E Hanover, NJ USA; [Bogaerts, Annelies] ReGenesys, Leuven, Belgium		Savitz, SI (corresponding author), UT Hlth Houston, McGovern Med Sch, Stroke Program, 6431 Fannin St, Houston, TX 77030 USA.	sean.i.savitz@uth.tmc.edu			Athersys Inc.	This work was supported by a grant sponsored by Athersys Inc.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Becker KJ, 2010, STROKE, V41, pS75, DOI 10.1161/STROKEAHA.110.592881; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Burrows GG, 2013, STEM CELL TRANSL MED, V2, P745, DOI 10.5966/sctm.2013-0031; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; de Bilbao F, 2009, J NEUROCHEM, V110, P12, DOI 10.1111/j.1471-4159.2009.06098.x; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; DePaul MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16795; Gao L, 2014, INT J MOL SCI, V15, P4431, DOI 10.3390/ijms15034431; Golden JE, 2012, TRANSL STROKE RES, V3, P491, DOI 10.1007/s12975-012-0208-3; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Illoh K, 2006, J CEREBR BLOOD F MET, V26, P1538, DOI 10.1038/sj.jcbfm.9600308; Jacobs SA, 2013, CELL TRANSPLANT, V22, P1915, DOI 10.3727/096368912X657369; Jellema RK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0459-5; Kasam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032793; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu ZJ, 2015, CNS NEUROSCI THER, V21, P320, DOI 10.1111/cns.12361; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Ostrowski RP, 2012, TRANSL STROKE RES, V3, P473, DOI 10.1007/s12975-012-0206-5; Pennypacker KR, 2015, J CEREBR BLOOD F MET, V35, P186, DOI 10.1038/jcbfm.2014.212; Reading JL, 2015, MOL THER, V23, P1783, DOI 10.1038/mt.2015.131; Reading JL, 2013, J IMMUNOL, V190, P4542, DOI 10.4049/jimmunol.1202710; Robert W, 2010, J EXP STROKE TRANSL, V3, P3; Ross Amy Miner, 2007, J Stroke Cerebrovasc Dis, V16, P203, DOI 10.1016/j.jstrokecerebrovasdis.2007.05.002; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Seifert HA, 2012, METAB BRAIN DIS, V27, P131, DOI 10.1007/s11011-012-9283-0; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Yan J, 2012, J NEUROIMMUNOL, V243, P89, DOI 10.1016/j.jneuroim.2011.12.019; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Yasuhara T, 2006, REV NEUROSCIENCE, V17, P215; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zeng LL, 2013, NEUROSCI LETT, V548, P4, DOI 10.1016/j.neulet.2013.04.037	50	42	43	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2017	35	5					1290	1302		10.1002/stem.2600			13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	ET1HC	WOS:000400017200015	28263009	Bronze			2022-02-06	
J	DeKosky, ST; Asken, BM				DeKosky, Steven T.; Asken, Breton M.			Injury cascades in TBI-related neurodegeneration	BRAIN INJURY			English	Article						Traumatic brain injury; TBI; Concussion; Neurodegeneration; Chronic traumatic encephalopathy; CTE; Repetitive brain trauma; Dementia	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEINS; HIGH-SCHOOL FOOTBALL; ALZHEIMERS-DISEASE; HEAD-INJURY; BETA ACCUMULATION; RISK-FACTOR; ENCEPHALOPATHY; DEMENTIA; HUMANS	Traumatic brain injury (TBI) is a widely recognized risk factor for neurodegenerative disease. The purpose Of this review is to provide an update on the state Of the science related to injury cascades in TBI-related neurodegeneration.;Acute and chronic pathological outcomes of TBI are,similar to those seen in several neurodegenerative conditions, suggesting common linking pathways. Initial research described severe TBI patients with post-mortem identification of abnormal proteins, such as amyloid deposits. History of mild TBI (mTBI) is less consistently associated with heightened risk of neurodegenerative outcomes, but specific populations with complicated medical histories and comorbidities may be more susceptible. Our understanding of a pathological signature associated with repetitive nnTBI and/or sobclincial brain trauma advanced significantly over the past decade, and is now commonly referred to as chronic traumatic encephalopathy. We discuss hypotheses linking TBI to neurodegenerative disease, and the importance of considering factors like injury severity, timing of injury (early life versus older age), injury frequency, and repetitive subclinical brain trauma when extrapolating results from current literature to certain populations. We describe the challenges to obtaining the data necessary for accurate epidemiological research and determination of true risk magnitude, and note the importance of developing treatment-based approaches to risk mitigation.	[DeKosky, Steven T.] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL USA; [DeKosky, Steven T.] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL USA; [Asken, Breton M.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Neuropsychol, Gainesville, FL USA		DeKosky, ST (corresponding author), McKnight Brain Inst, Dept Neurol & Neurosci, POB 100236, Gainesville, FL 32610 USA.	DeKosky@UFL.edu		Asken, Breton/0000-0001-8419-142X; DeKosky, Steven/0000-0003-3743-2758	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG047266]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG047266] Funding Source: NIH RePORTER	This work was supported by NIA AG047266 (STDeK). Dr DeKosky reports consulting for Acumen, Inc., Amgen, Biogen, Cognition Therapeutics, Lilly Pharmaceuticals and Novartis Pharmaceuticals.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dickstein D, 2016, NEUROLOGY, V86; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gandy S, 2014, F1000RESEARCH, P3229; Gandy S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004274; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	42	42	5	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1177	1182		10.1080/02699052.2017.1312528			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600003	28981345	hybrid, Green Accepted			2022-02-06	
J	Griffin, JM; Lee, MK; Bangerter, LR; Van Houtven, CH; Friedemann-Sanchez, G; Phelan, SM; Carlson, KF; Meis, LA				Griffin, Joan M.; Lee, Minji K.; Bangerter, Lauren R.; Van Houtven, Courtney Harold; Friedemann-Sanchez, Greta; Phelan, Sean M.; Carlson, Kathleen F.; Meis, Laura A.			Burden and Mental Health Among Caregivers of Veterans With Traumatic Brain Injury/Polytrauma	AMERICAN JOURNAL OF ORTHOPSYCHIATRY			English	Article						caregiving; traumatic brain injury; veterans; mental health; social support	SOCIAL SUPPORT; INJURY TBI; STRESS; REHABILITATION; DEPRESSION; INTERVIEW; FAMILIES; VERSION; SYSTEM; INDEX	Veterans who survive multiple traumatic injuries, including traumatic brain injuries (TBI), must often rely on family caregivers for ongoing care and support with reintegration. Understanding factors associated with caregiving that help or harm caregivers' health is critical for identifying appropriate and effective interventions that support caregiver health and promote the provision of quality care to veterans. This study utilized cross-sectional data from the Family and Caregiver Experiences Study, a survey of 564 caregivers caring for veterans who served after September 11, 2001, survived TBI/polytrauma during service, and received inpatient rehabilitation care in a Veterans Affairs Polytrauma Rehabilitation Center. Structural equation modeling was used to examine the relationship between caregiver stress (i.e., veterans' neurobehavioral problems and intensity of care required), and caregiver well-being (i.e., caregiver burden and mental health). Analyses also examined how intrapersonal, family or social, and financial resources mediate and moderate the relationship between caregiver stress and well-being. Results indicate that veterans' neurobehavioral problems and intensity of required care were associated with more caregiver burden, and more burden was associated with poor mental health. Intrapersonal and family or social resources mediated the relationship between veteran functioning and mental health. Family or social resources also moderated the relationship between care intensity and burden. The model explained a moderate amount of variability in burden (59%) and a substantial amount in mental health (75%). We conclude that caregivers of veterans with neurobehavioral problems who require intense care are at risk for burden and poor mental health. Increasing resources to bolster family or social resources may reduce risks.	[Griffin, Joan M.] Mayo Clin, Div Hlth Care Policy & Res HCPR, 200 First St Southwest, Rochester, MN 55905 USA; [Griffin, Joan M.] Minneapolis VA Healthcare Syst, Minneapolis, MN USA; [Lee, Minji K.; Phelan, Sean M.] Mayo Clin, Rochester, MN USA; [Bangerter, Lauren R.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Van Houtven, Courtney Harold] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Van Houtven, Courtney Harold] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Veteran Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Meis, Laura A.] Minneapolis VA Healthcare Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Meis, Laura A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA		Griffin, JM (corresponding author), Mayo Clin, Div Hlth Care Policy & Res HCPR, 200 First St Southwest, Rochester, MN 55905 USA.	griffin.joan@mayo.edu		Friedemann-Sanchez, Greta/0000-0002-0493-7218; Griffin, Joan/0000-0001-8120-3229; Van Houtven, Courtney/0000-0002-0783-1611	Department of Veterans AffairsUS Department of Veterans Affairs; VA Health Services Research and Development (HSRD) serviceUS Department of Veterans Affairs [SDR-07-044]	This research was supported by the Department of Veterans Affairs and a grant from VA Health Services Research and Development (HSR&D) service (SDR-07-044). The findings and conclusions are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or HSR&D.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 2010, S C; Balducci C, 2008, GERONTOLOGIST, V48, P276, DOI 10.1093/geront/48.3.276; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chin WW, 1998, QUANT METH SER, P295; Christian L.M., 2014, INTERNET PHONE MAIL, P4; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cribbie RA, 2007, STRUCT EQU MODELING, V14, P98, DOI 10.1207/s15328007sem1401_5; Crowley SL, 1997, J PERS ASSESS, V68, P508, DOI 10.1207/s15327752jpa6803_4; DEGENEFFE CE, 2015, FAMILIES REHABILITAT, P213; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Folkman S., 1984, STRESS; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hancock G. R., 2001, STRUCTURAL EQUATION, P195; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HOLM S, 1979, SCAND J STAT, V6, P65; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Jamshidian M, 2010, PSYCHOMETRIKA, V75, P649, DOI 10.1007/s11336-010-9175-3; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KESSLER RC, 1988, J SOC ISSUES, V44, P69, DOI 10.1111/j.1540-4560.1988.tb02092.x; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mueller R. O., 2008, BEST PRACTICES QUANT, P488, DOI DOI 10.4135/9781412995627.D38; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205, DOI 10.1177/002214650504600206; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Pornprasertmanit S., 2015, USEFUL TOOLS FOR STR; Ramchand R., 2014, HIDDEN HEROES AMERIC; Rosenberg M., 1979, BASIC BOOKS; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Urbach N., 2010, J INFORM TECHNOLOGY, V11, P5, DOI DOI 10.1037/0021-9010.90.4.710; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; VINOKUR A, 1987, J APPL SOC PSYCHOL, V17, P1007, DOI 10.1111/j.1559-1816.1987.tb02345.x; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	52	42	42	2	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0002-9432	1939-0025		AM J ORTHOPSYCHIAT	Am. J. Orthopsychiatr.		2017	87	2			SI		139	148		10.1037/ort0000207			10	Psychiatry; Social Work	Social Science Citation Index (SSCI)	Psychiatry; Social Work	EN2SD	WOS:000395859400004	28206801	Bronze			2022-02-06	
J	Feeney, JM; Santone, E; DiFiori, M; Kis, L; Jayaraman, V; Montgomery, SC				Feeney, James M.; Santone, Elizabeth; DiFiori, Monica; Kis, Lilla; Jayaraman, Vijay; Montgomery, Stephanie C.			Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: A TQIP study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic intracranial hemorrhage; direct oral anticoagulants; traumatic brain injury; anticoagulants	ATRIAL-FIBRILLATION PATIENTS; RIVAROXABAN; METAANALYSIS; PREVENTION; DABIGATRAN; EFFICACY; SAFETY; STROKE; TRIAL	BACKGROUND Falls represent the leading cause of traumatic brain injury in adults older than 65, with nearly one third experiencing a fall each year. Evidence suggests that up to 0.5% of anticoagulated patients suffer from intracranial hemorrhage (ICH) annually. Direct oral anticoagulants (DOACs) have become an increasingly popular alternative to warfarin for anticoagulation; however, there is a dearth of research regarding the safety of DOACs, in particular on the outcome of traumatic ICH while taking DOACs. METHODS We queried our Trauma Quality Improvement Project registry for patients who presented with traumatic intracranial hemorrhage during anticoagulant use. Patients were grouped into those prescribed warfarin and patients prescribed DOAC medications. The groups were compared with respect to age, gender, Glasgow Coma Score (GCS) on arrival, Abbreviated Injury Scale (AIS) (head), Injury Severity Score (ISS), mortality, need for operative intervention, hospital and ICU lengths of stay, proportion of patients transfused (and their transfusion requirements), and rates of discharge to skilled nursing facility. Poisson regression was conducted to determine the relationship between mortality and treatment group while controlling for covariates (comorbidities, ISS). RESULTS There were no differences between DOAC and warfarin groups in terms of age, gender, median ISS, median AIS head, or median admission GCS. Mechanisms of injury, median hospital and ICU lengths of stay, ICU free days, and transfusion requirements were also not significantly different. DOAC use was associated with significantly lower mortality (4.9% vs. 20.8%; p < 0.008) and a lower rate of operative intervention (8.2% vs. 26.7%; p = 0.023) when compared with warfarin. Excluding patients who died, the observed rate of discharge to skilled nursing facility was lower in the DOAC group (28.8% compared with 39.7%; p = 0.03). Multivariate Poisson regression analysis demonstrated that warfarin use was associated with an increased mortality when controlling for injury severity, and comorbidities. CONCLUSIONS We report improved mortality and reduced rates of operative intervention in patients with traumatic ICH associated with DOACs compared with a similar group taking warfarin. We also noted an association with decreased rate of discharge to SNF in patients taking DOACs compared with warfarin. LEVEL OF EVIDENCE Therapeutic study, level IV.	[Feeney, James M.; Jayaraman, Vijay; Montgomery, Stephanie C.] St Francis Hosp & Med Ctr, Dept Surg, Hartford, CT USA; [Feeney, James M.; Santone, Elizabeth; Jayaraman, Vijay; Montgomery, Stephanie C.] Univ Connecticut, Sch Med, Farmington, CT USA; [DiFiori, Monica; Kis, Lilla] Trinity Coll, Hartford, CT 06106 USA		Feeney, JM (corresponding author), St Francis Hosp & Med Ctr, 114 Woodland St, Hartford, CT 06103 USA.	feeneymd@yahoo.com					Alonso A, 2014, STROKE, V45, P2286, DOI 10.1161/STROKEAHA.114.006016; Beynon C, 2015, THROMB RES, V136, P560, DOI 10.1016/j.thromres.2015.07.001; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Caldeira D, 2015, J NEUROL, V262, P516, DOI 10.1007/s00415-014-7462-0; Dempfle CE, 2014, SEMIN HEMATOL, V51, P89, DOI 10.1053/j.seminhematol.2014.03.005; Gordon JL, 2013, J TRAUMA ACUTE CARE, V75, P475, DOI 10.1097/TA.0b013e3182a07391; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Miller SL, 2008, ANN EMERG MED, V52, P483, DOI 10.1016/j.annemergmed.2008.03.021; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sardar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077694	14	42	42	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2016	81	5					843	848		10.1097/TA.0000000000001245			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EC0IG	WOS:000387782800006	27602897				2022-02-06	
J	Gilbert, FC; Burdette, GT; Joyner, AB; Llewellyn, TA; Buckley, TA				Gilbert, Frances C.; Burdette, G. Trey; Joyner, A. Barry; Llewellyn, Tracy A.; Buckley, Thomas A.			Association Between Concussion and Lower Extremity Injuries in Collegiate Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						injury risk; ankle sprain; anterior cruciate ligament injury; muscle strain; mild traumatic brain injury	PROFESSIONAL FOOTBALL PLAYERS; MANAGEMENT PRACTICE PATTERNS; SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; RECURRENT CONCUSSION; MUSCULOSKELETAL INJURY; POSTURAL CONTROL; NCAA CONCUSSION; BALANCE; RECOVERY	Background: Concussions have been associated with elevated musculoskeletal injury risk; however, the influence of unreported and unrecognized concussions has not been investigated. Hypothesis: The purpose of this study was to examine the association between concussion and lower extremity musculoskeletal injury rates across a diverse array of sports among collegiate student-athletes at the conclusion of their athletic career. The hypothesis was that there will be a positive association between athletes who reported a history of concussions and higher rates of lower extremity injuries. Study Design: Cross-sectional study. Level of Evidence: Level 3. Methods: Student-athletes (N = 335; 62.1% women; mean age, 21.2 +/- 1.4 years) from 13 sports completed a reliable injury history questionnaire. Respondents indicated the total number of reported, unreported, and potentially unrecognized concussions as well as lower extremity injuries including ankle sprains, knee injuries, and muscle strains. Chi-square analyses were performed to identify the association between concussion and lower extremity injuries. Results: There were significant associations between concussion and lateral ankle sprain (P = 0.012), knee injury (P = 0.002), and lower extremity muscle strain (P = 0.031). There were also significant associations between reported concussions and knee injury (P = 0.003), unreported concussions and knee injury (P = 0.002), and unrecognized concussions and lateral ankle sprain (P = 0.001) and lower extremity muscle strains (P = 0.006), with odds ratios ranging from 1.6 to 2.9. Conclusion: There was a positive association between concussion history and lower extremity injuries (odds ratios, 1.6-2.9 elevated risk) among student-athletes at the conclusion of their intercollegiate athletic careers. Clinical Relevance: Clinicians should be aware of these elevated risks when making return-to-participation decisions and should incorporate injury prevention protocols.	[Gilbert, Frances C.] Univ North Georgia, Dept Intercollegiate Athlet, Dahlonega, GA USA; [Burdette, G. Trey] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA USA; [Joyner, A. Barry] Georgia Southern Univ, Coll Hlth & Human Sci, Statesboro, GA USA; [Llewellyn, Tracy A.] Carolinas Healthcare Syst, Charlotte, NC USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave, Newark, DE 19716 USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Llewellyn, Tracy/0000-0002-6483-2776			Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2015, CURR RES CONCUSSION, V2, P59; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hewett TE, 2012, CLIN ORTHOP RELAT R, V470, P2930, DOI 10.1007/s11999-012-2440-2; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Onate JA, 2016, CLIN J SPORT MED, V26, P435, DOI 10.1097/JSM.0000000000000284; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Pietrosimone BG, 2015, J ATHL TRAINING, V50, P665, DOI 10.4085/1062-6050-50.1.11; Pietrosimone BG, 2012, J ATHL TRAINING, V47, P621, DOI 10.4085/1062-6050-47.6.11; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	48	42	42	1	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV-DEC	2016	8	6					661	667		10.1177/1941738116666509			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8DN	WOS:000391286000011	27587598	Green Published			2022-02-06	
J	Meizoso, JP; Ray, JJ; Karcutskie, CA; Allen, CJ; Zakrison, TL; Pust, GD; Koru-Sengul, T; Ginzburg, E; Pizano, LR; Schulman, CI; Livingstone, AS; Proctor, KG; Namias, N				Meizoso, Jonathan P.; Ray, Juliet J.; Karcutskie, Charles A.; Allen, Casey J.; Zakrison, Tanya L.; Pust, Gerd D.; Koru-Sengul, Tulay; Ginzburg, Enrique; Pizano, Louis R.; Schulman, Carl I.; Livingstone, Alan S.; Proctor, Kenneth G.; Namias, Nicholas			Effect of time to operation on mortality for hypotensive patients with gunshot wounds to the torso: The golden 10 minutes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						GSW; laparotomy; penetrating trauma; time to operation	ENDOVASCULAR BALLOON OCCLUSION; SYSTOLIC BLOOD-PRESSURE; ROOM RESUSCITATION; TRAUMA PATIENTS; 110 MMHG; MULTICENTER; TRANSFUSION; ACTIVATION; SURVIVAL; DEATHS	INTRODUCTION Timely hemorrhage control is paramount in trauma; however, a critical time interval from emergency department arrival to operation for hypotensive gunshot wound (GSW) victims is not established. We hypothesize that delaying surgery for more than 10 minutes from arrival increases all-cause mortality in hypotensive patients with GSW. METHODS Data of adults (n = 309) with hypotension and GSW to the torso requiring immediate operation from January 2004 to September 2013 were retrospectively reviewed. Patients with resuscitative thoracotomies, traumatic brain injury, transfer from outside institutions, and operations occurring more than 1 hour after arrival were excluded. Survival analysis using multivariate Cox regression models was used for comparison. Hazard ratios (HRs) and 95% confidence intervals (CIs) are reported. Statistical significance was considered at p 0.05. RESULTS The study population was aged 32 12 years, 92% were male, Injury Severity Score was 24 15, systolic blood pressure was 81 +/- 29 mm Hg, Glasgow Coma Scale score was 13 +/- 4. Overall mortality was 27%. Mean time to operation was 19 +/- 13 minutes. After controlling for organ injury, patients who arrived to the operating room after 10 minutes had a higher likelihood of mortality compared with those who arrived in 10 minutes or less (HR, 1.89; 95% CI, 1.10-3.26; p = 0.02); this was also true in the severely hypotensive patients with systolic blood pressure of 70 mm Hg or less (HR, 2.67; 95% CI, 0.97-7.34; p = 0.05). The time associated with a 50% cumulative mortality was 16 minutes. CONCLUSIONS Delay to the operating room of more than 10 minutes increases the risk of mortality by almost threefold in hypotensive patients with GSW. Protocols should be designed to shorten time in the emergency department. Further prospective observational studies are required to validate these findings. LEVEL OF EVIDENCE Therapeutic study, level IV.	[Meizoso, Jonathan P.; Ray, Juliet J.; Karcutskie, Charles A.; Allen, Casey J.; Zakrison, Tanya L.; Pust, Gerd D.; Ginzburg, Enrique; Pizano, Louis R.; Schulman, Carl I.; Livingstone, Alan S.; Proctor, Kenneth G.; Namias, Nicholas] Univ Miami, Miller Sch Med, Ryder Trauma Ctr, DeWitt Daughtry Family Dept Surg, 1800 NW 10th Ave,Suite T-215 D40, Miami, FL 33136 USA; [Meizoso, Jonathan P.; Ray, Juliet J.; Koru-Sengul, Tulay] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA		Namias, N (corresponding author), Univ Miami, Miller Sch Med, Ryder Trauma Ctr, DeWitt Daughtry Family Dept Surg, 1800 NW 10th Ave,Suite T-215 D40, Miami, FL 33136 USA.	nnamias@miami.edu	Proctor, Kenneth/AAA-2199-2022; Meizoso, Jonathan/AAF-5777-2019; Schulman, Carl/AAE-7448-2021; Livingstone, Alan/AAA-4026-2019	Proctor, Kenneth/0000-0003-1326-6628; Meizoso, Jonathan/0000-0002-6616-6682; Namias, Nicholas/0000-0001-7021-2250; Schulman, Carl/0000-0001-8899-4350; Koru-Sengul, Tulay/0000-0003-0974-8405	Office of Naval Research, Naval Medical Research Center; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Supported in part by grants from the Office of Naval Research, Naval Medical Research Center, and the US Army Medical Research and Materiel Command.	Allen CJ, 2015, J SURG RES, V197, P240, DOI 10.1016/j.jss.2015.03.005; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Deree J, 2007, J VASC SURG, V45, P493, DOI 10.1016/j.jvs.2006.11.018; FISCHER RP, 1978, JAMA-J AM MED ASSOC, V240, P1731, DOI 10.1001/jama.240.16.1731; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; HOYT DB, 1989, ARCH SURG-CHICAGO, V124, P906; Khetarpal S, 1999, J TRAUMA, V47, P576, DOI 10.1097/00005373-199909000-00028; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Martin M, 2012, AM J SURG, V204, P187, DOI 10.1016/j.amjsurg.2012.06.001; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Mesar T, 2015, J TRAUMA ACUTE CARE, V79, P39, DOI 10.1097/TA.0000000000000696; Morrison JJ, 2012, J SURG RES, V177, P341, DOI 10.1016/j.jss.2012.04.035; Mowery NT, 2011, J TRAUMA, V70, P1317, DOI 10.1097/TA.0b013e3182175199; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Porter JM, 2001, AM SURGEON, V67, P611; Remick KN, 2014, J TRAUMA ACUTE CARE, V76, P1251, DOI 10.1097/TA.0000000000000218; RHODES M, 1989, J TRAUMA, V29, P907, DOI 10.1097/00005373-198907000-00002; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Steele JT, 1997, AM J SURG, V174, P683, DOI 10.1016/S0002-9610(97)00194-3; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	33	42	43	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2016	81	4					685	691		10.1097/TA.0000000000001198			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DZ2FX	WOS:000385658800009	27488491				2022-02-06	
J	Miller, LE; Urban, JE; Stitzel, JD				Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.			Development and validation of an atlas-based finite element brain model	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain atlas; Head injury; Validation; Optimization; Finite element model; CORA	MAXIMUM PRINCIPAL STRAIN; VISCOELASTIC PROPERTIES; PROBABILISTIC ATLAS; HEAD; INJURY; BIOMECHANICS; METHODOLOGY; RESPONSES; IMPACTS; SPORTS	Traumatic brain injury is a leading cause of disability and injury-related death. To enhance our ability to prevent such injuries, brain response can be studied using validated finite element (FE) models. In the current study, a high-resolution, anatomically accurate FE model was developed from the International Consortium for Brain Mapping brain atlas. Due to wide variation in published brain material parameters, optimal brain properties were identified using a technique called Latin hypercube sampling, which optimized material properties against three experimental cadaver tests to achieve ideal biomechanics. Additionally, falx pretension and thickness were varied in a lateral impact variation. The atlas-based brain model (ABM) was subjected to the boundary conditions from three high-rate experimental cadaver tests with different material parameter combinations. Local displacements, determined experimentally using neutral density targets, were compared to displacements predicted by the ABM at the same locations. Error between the observed and predicted displacements was quantified using CORrelation and Analysis (CORA), an objective signal rating method that evaluates the correlation of two curves. An average CORA score was computed for each variation and maximized to identify the optimal combination of parameters. The strongest relationships between CORA and material parameters were observed for the shear parameters. Using properties obtained through the described multiobjective optimization, the ABM was validated in three impact configurations and shows good agreement with experimental data. The final model developed in this study consists of optimized brain material properties and was validated in three cadaver impacts against local brain displacement data.	[Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Ctr Injury Biomech, 575 Patterson Ave,Suite 120, Winston Salem, NC 27101 USA		Miller, LE (corresponding author), Wake Forest Ctr Injury Biomech, 575 Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	logmille@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Miller, Logan/0000-0002-6348-7536	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS082453]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082453] Funding Source: NIH RePORTER	Funding for this project is provided by the National Institutes of Health (R01 NS082453). All simulations were run on the DEAC Cluster at Wake Forest University. The authors would like to thank the ANSIR Lab for providing the ICBM label maps and Elizabeth Lillie for her work on the MATLAB code to produce the ABM from the label maps.	Abel J, 1978, SAE TECHNICAL PAPERS; Al-Bsharat A. S., 1999, STAPP CAR CRASH J, V43, P321; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chan HS, 1974, SAE TECHNICAL PAPER; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Faul M, 2010, TRAUMATIC BRAIN INJU; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gehre C, 2009, 21 ESV C JUN 15 18 2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Golman A., 2013, P 41 INT WORKSH; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W, 2007, THESIS; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Jirousek O, 2005, SOLID MECH APPL, V124, P459; Kangarlou K, 2013, NATLPARK FORSCH SCHW, V102, P1571; KENNER VH, 1972, INT J MECH SCI, V14, P557, DOI 10.1016/0020-7403(72)90056-2; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King AI, 2003, P IRCOBI C LISB; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pinnoji PK, 2010, INT J IMPACT ENG, V37, P274, DOI 10.1016/j.ijimpeng.2009.05.013; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Stalnaker RL, 1977, VALIDATION STUDIES H; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Urban Jillian E, 2012, Biomed Sci Instrum, V48, P447; Vavalle NA, 2013, TRAFFIC INJ PREV, V14, pS87, DOI 10.1080/15389588.2013.802777; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yu H, 2004, INT J CRASHWORTHINES, V9, P175, DOI 10.1533/ijcr.2004.0276; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	55	42	43	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2016	15	5					1201	1214		10.1007/s10237-015-0754-1			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DW4KM	WOS:000383611800014	26762217	Green Accepted			2022-02-06	
J	Multani, N; Goswami, R; Khodadadi, M; Ebraheem, A; Davis, KD; Tator, CH; Wennberg, R; Mikulis, DJ; Ezerins, L; Tartaglia, MC				Multani, Namita; Goswami, Ruma; Khodadadi, Mozhgan; Ebraheem, Ahmed; Davis, Karen D.; Tator, Charles H.; Wennberg, Richard; Mikulis, David J.; Ezerins, Leo; Tartaglia, Maria Carmela			The association between white-matter tract abnormalities, and neuropsychiatric and cognitive symptoms in retired professional football players with multiple concussions	JOURNAL OF NEUROLOGY			English	Article						Sport-related concussion; Repetitive mild traumatic brain injury; Diffusion tensor imaging; Superior longitudinal fasciculus; Visuospatial function	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; MEMORY COMPLAINTS; AXONAL INJURY; HEAD-INJURY; DIFFUSION; MRI; IMPAIRMENT; SPORTS; TRACTOGRAPHY	Retired professional athletes, who have suffered repetitive concussions, report symptoms of depression, anxiety, and memory impairment over time. Moreover, recent imaging data suggest chronic white-matter tract deterioration in sport-related concussion. The aim of this study is to evaluate the impact of repetitive concussions in retired professional football players on white-matter tracts, and relate these changes to neuropsychological function. All subjects (18 retired professional football players and 17 healthy controls) underwent imaging, neuropsychological assessment, and reported on concussion-related symptoms. Whole brain tract-based spatial statistics analysis revealed increased axial diffusivity in the right hemisphere of retired players in the (1) superior longitudinal fasciculus (SLF), (2) corticospinal tract, and (3) anterior thalamic radiations, suggesting chronic axonal degeneration in these tracts. Moreover, retired players report significantly higher neuropsychiatric and cognitive symptoms than healthy controls, and worsening of these symptoms since their last concussion. Loss of integrity in the right SLF significantly correlated with participants' visual learning ability. In sum, these results suggest that repetitive concussions in retired professional football players are associated with focal white-matter tract abnormalities that could explain some of the neuropsychiatric symptoms and cognitive deficits experienced by these retired athletes.	[Multani, Namita; Goswami, Ruma; Khodadadi, Mozhgan; Ebraheem, Ahmed; Davis, Karen D.; Tator, Charles H.; Wennberg, Richard; Mikulis, David J.; Ezerins, Leo; Tartaglia, Maria Carmela] Toronto Western Hosp, Tanz Ctr Res Neurodegenerat Dis, Memory Clin, Canadian Sports Concuss Project, 399 Bathurst St,West Wing 5-449, Toronto, ON M5T 2S8, Canada; [Multani, Namita; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Goswami, Ruma; Davis, Karen D.; Tator, Charles H.; Mikulis, David J.] Univ Hlth Network, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Hosp, Toronto Western Res Inst, 399 Bathurst St, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.; Tator, Charles H.; Mikulis, David J.] Univ Toronto, Inst Med Sci, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Davis, Karen D.; Tator, Charles H.] Univ Toronto, Dept Surg, 149 Coll St, Toronto, ON M5T 1P5, Canada; [Tator, Charles H.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Krembil Neurosci Ctr, 399 Bathurst St, Toronto, ON M5T 2S8, Canada; [Multani, Namita; Wennberg, Richard; Tartaglia, Maria Carmela] Univ Hlth Network, Toronto Western Hosp, Div Neurol, Krembil Neurosci Ctr, 399 Bathurst St, Toronto, ON M5T 2S8, Canada; [Mikulis, David J.] Univ Hlth Network, Toronto Western Hosp, Dept Med Imaging, 399 Bathurst St, Toronto, ON M5T 2S8, Canada		Tartaglia, MC (corresponding author), Toronto Western Hosp, Tanz Ctr Res Neurodegenerat Dis, Memory Clin, Canadian Sports Concuss Project, 399 Bathurst St,West Wing 5-449, Toronto, ON M5T 2S8, Canada.; Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada.; Tartaglia, MC (corresponding author), Univ Hlth Network, Toronto Western Hosp, Div Neurol, Krembil Neurosci Ctr, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	carmela.tartaglia@uhn.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892	PSI Foundation; Canadian Sports Concussion Project, Krembil Neuroscience Centre, Toronto Western Hospital (Toronto General & Western Hospital Foundation)	PSI Foundation and the Canadian Sports Concussion Project, Krembil Neuroscience Centre, Toronto Western Hospital (Toronto General & Western Hospital Foundation).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chechlacz M, 2015, J NEUROSCI, V35, P10647, DOI 10.1523/JNEUROSCI.0210-15.2015; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Holdnack H.A., 2001, WECHSLER TEST ADULT; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kryscio RJ, 2014, NEUROLOGY, V83, P1359, DOI 10.1212/WNL.0000000000000856; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Mori S, 2005, MRI ATLAS HUMAN WHIT; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; van der Flier WM, 2004, J NEUROL, V251, P671, DOI 10.1007/s00415-004-0390-7; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	57	42	43	1	37	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUL	2016	263	7					1332	1341		10.1007/s00415-016-8141-0			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ4PH	WOS:000379185300010	27142715				2022-02-06	
J	Winter, CC; Katiyar, KS; Hernandez, NS; Song, YJ; Struzyna, LA; Harris, JP; Cullen, DK				Winter, Carla C.; Katiyar, Kritika S.; Hernandez, Nicole S.; Song, Yeri J.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy			Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration	ACTA BIOMATERIALIA			English	Article						Tissue engineering; Living scaffold; Glial cell transplant; Biomaterials; Regeneration; Neurotrauma; Neurodegeneration; Traumatic brain injury; Cell migration; Axon pathfinding; Neural stem cells	ROSTRAL MIGRATORY STREAM; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; NEURITE OUTGROWTH; IN-VITRO; SUBSTRATE CURVATURE; TRACT AXONS; GLIAL SCAR; BRAIN; ALIGNMENT	Neurotrauma, stroke, and neurodegenerative disease may result in widespread loss of neural cells as well as the complex interconnectivity necessary for proper central nervous system function, generally resulting in permanent functional deficits. Potential regenerative strategies involve the recruitment of endogenous neural stem cells and/or directed axonal regeneration through the use of tissue engineered "living scaffolds" built to mimic features of three-dimensional (3-D) in vivo migratory or guidance pathways. Accordingly, we devised a novel biomaterial encasement scheme using tubular hydrogel-collagen micro-columns that facilitated the self-assembly of seeded astrocytes into 3-D living scaffolds consisting of long, cable-like aligned astrocytic networks. Here, robust astrocyte alignment was achieved within a micro-column inner diameter (ID) of 180 mu m or 300-350 mu m but not 1.0 mm, suggesting that radius of curvature dictated the extent of alignment. Moreover, within small ID micro-columns, >70% of the astrocytes assumed a bi-polar morphology, versus similar to 10% in larger micro-columns or planar surfaces. Cell-cell interactions also influenced the aligned architecture, as extensive astrocyte-collagen contraction was achieved at high (9-12 x 10(5) cells/mL) but not lower (2-6 x 10(5) cells/mL) seeding densities. This high density micro-column seeding led to the formation of ultra-dense 3-D "bundles" of aligned bi-polar astrocytes within collagen measuring up to 150 mu m in diameter yet extending to a remarkable length of over 2.5 cm. Importantly, co-seeded neurons extended neurites directly along the aligned astrocytic bundles, demonstrating permissive cues for neurite extension. These transplantable cable-like astrocytic networks structurally mimic the glial tube that guides neuronal progenitor migration in vivo along the rostral migratory stream, and therefore may be useful to guide progenitor cells to repopulate sites of widespread neurodegeneration. Statement of Significance This manuscript details our development of novel micro-tissue engineering techniques to generate robust networks of longitudinally aligned astrocytes within transplantable micro-column hydrogels. We report a novel biomaterial encasement scheme that facilitated the self-assembly of seeded astrocytes into long, aligned regenerative pathways. These miniature "living scaffold" constructs physically emulate the glial tube - a pathway in the brain consisting of aligned astrocytes that guide the migration of neuronal progenitor cells - and therefore may facilitate directed neuronal migration for central nervous system repair. The small size and self-contained design of these aligned astrocyte constructs will permit minimally invasive transplantation in models of central nervous system injury in future studies. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Winter, Carla C.; Katiyar, Kritika S.; Hernandez, Nicole S.; Song, Yeri J.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Winter, Carla C.; Struzyna, Laura A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Winter, Carla C.; Katiyar, Kritika S.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Hernandez, Nicole S.; Song, Yeri J.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu		Harris, James/0000-0002-8458-5434	Penn Medicine Neuroscience Center; National Science FoundationNational Science Foundation (NSF) [DGE-1321851]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-NS043126, F31-NS090746]; Michael J. Fox Foundation (Therapeutic Pipeline Program) [9998]; Department of Veterans Affairs (RRD Merit Review)US Department of Veterans Affairs [B1097-I]; U.S. Army Medical Research and Materiel Command through the Joint Warfighter Medical Research Program [W81XWH-13-207004]; Penn's Center for Undergraduate Research Fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS090746, T32NS043126, U01NS094340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA028874] Funding Source: NIH RePORTER	Financial support was provided by the Penn Medicine Neuroscience Center, National Science Foundation (Graduate Research Fellowship DGE-1321851), National Institutes of Health (T32-NS043126; F31-NS090746), Michael J. Fox Foundation (Therapeutic Pipeline Program #9998), Department of Veterans Affairs (RR&D Merit Review #B1097-I), U.S. Army Medical Research and Materiel Command through the Joint Warfighter Medical Research Program (#W81XWH-13-207004), and Penn's Center for Undergraduate Research & Fellowships. We thank Patricia Murphy for technical assistance in these studies.	Abematsu M., 2012, J CLIN INVEST, P3255; Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Arellano JI, 2011, NATURE, V478, P333, DOI 10.1038/478333a; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Barry DS, 2013, J ANAT, V222, P203, DOI 10.1111/joa.12006; Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hsiao TW, 2015, BIOMATERIALS, V39, P124, DOI 10.1016/j.biomaterials.2014.10.062; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2; Katiyar K. S., 2016, J TISSUE EN IN PRESS; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X; Ladewig J, 2014, NAT NEUROSCI, V17, P24, DOI 10.1038/nn.3583; LaPlaca MC, 2010, ARTECH HSE METH BIOE, P187; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4; Rivet Christopher J, 2015, Biomatter, V5, pe1005527, DOI 10.1080/21592535.2015.1005527; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Thompson LH, 2015, NEUROBIOL DIS, V79, P28, DOI 10.1016/j.nbd.2015.04.003; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	56	42	42	0	60	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 1	2016	38						44	58		10.1016/j.actbio.2016.04.021			15	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	DQ1LZ	WOS:000378963800005	27090594	Green Accepted			2022-02-06	
J	Israel, I; Ohsiek, A; Al-Momani, E; Albert-Weissenberger, C; Stetter, C; Mencl, S; Buck, AK; Kleinschnitz, C; Samnick, S; Siren, AL				Israel, Ina; Ohsiek, Andrea; Al-Momani, Ehab; Albert-Weissenberger, Christiane; Stetter, Christian; Mencl, Stine; Buck, Andreas K.; Kleinschnitz, Christoph; Samnick, Samuel; Siren, Anna-Leena			Combined [F-18]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Neuroinflammation; TBI; IBA-1; Immunohistochemistry; Focal; Diffuse; Weight drop; TSPO; PET; Autoradiography	TRAUMATIC BRAIN-INJURY; TRANSLOCATOR PROTEIN; RAT MODEL; MOUSE MODEL; BENZODIAZEPINE-RECEPTORS; 18 KDA; PET; NEUROINFLAMMATION; TSPO; LIGAND	Background: Traumatic brain injury (TBI) is a major cause of death and disability. Neuroinflammation contributes to acute damage after TBI and modulates long-term evolution of degenerative and regenerative responses to injury. The aim of the present study was to evaluate the relationship of microglia activation to trauma severity, brain energy metabolism, and cellular reactions to injury in a mouse closed head injury model using combined in vivo PET imaging, ex vivo autoradiography, and immunohistochemistry. Methods: A weight-drop closed head injury model was used to produce a mixed diffuse and focal TBI or a purely diffuse mild TBI (mTBI) in C57BL6 mice. Lesion severity was determined by evaluating histological damage and functional outcome using a standardized neuroscore (NSS), gliosis, and axonal injury by immunohistochemistry. Repeated intra-individual in vivo mu PET imaging with the specific 18-kDa translocator protein (TSPO) radioligand [F-18]DPA-714 was performed on day 1, 7, and 16 and [F-18]FDG-mu PET imaging for energy metabolism on days 2-5 after trauma using freshly synthesized radiotracers. Immediately after [F-18]DPA-714-mu PET imaging on days 7 and 16, cellular identity of the [F-18]DPA-714 uptake was confirmed by exposing freshly cut cryosections to film autoradiography and successive immunostaining with antibodies against the microglia/macrophage marker IBA-1. Results: Functional outcome correlated with focal brain lesions, gliosis, and axonal injury. [F-18]DPA-714-mu PET showed increased radiotracer uptake in focal brain lesions on days 7 and 16 after TBI and correlated with reduced cerebral [F-18]FDG uptake on days 2-5, with functional outcome and number of IBA-1 positive cells on day 7. In autoradiography, [F-18]DPA-714 uptake co-localized with areas of IBA1-positive staining and correlated strongly with both NSS and the number of IBA1-positive cells, gliosis, and axonal injury. After mTBI, numbers of IBA-1 positive cells with microglial morphology increased in both brain hemispheres; however, uptake of [F-18]DPA-714 was not increased in autoradiography or in mu PET imaging. Conclusions: [F-18]DPA-714 uptake in mu PET/autoradiography correlates with trauma severity, brain metabolic deficits, and microglia activation after closed head TBI.	[Israel, Ina; Al-Momani, Ehab; Buck, Andreas K.; Samnick, Samuel] Univ Hosp Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany; [Ohsiek, Andrea; Albert-Weissenberger, Christiane; Stetter, Christian; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, Expt Neurosurg, D-97080 Wurzburg, Germany; [Albert-Weissenberger, Christiane; Mencl, Stine; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Kleinschnitz, Christoph] Univ Hosp Essen, Dept Neurol, D-45147 Essen, Germany		Siren, AL (corresponding author), Univ Hosp Wurzburg, Dept Neurosurg, Expt Neurosurg, D-97080 Wurzburg, Germany.	siren.a@nch.uni-wuerzburg.de	Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081; Buck, Andreas/0000-0002-6447-0613; Kleinschnitz, Christoph/0000-0002-1650-8875	Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A226]; German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame [BMBF 01EW1502B]; German Research FoundationGerman Research Foundation (DFG) [SFB 688, TP Z02]	This project was financially supported by the Interdisciplinary Center for Clinical Research (IZKF) Wurzburg (Project A226), the German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame (BMBF 01EW1502B), and the German Research Foundation (SFB 688, TP Z02, A13).	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Bennett RE, 2015, J NEUROSCI METH, V245, P25, DOI 10.1016/j.jneumeth.2015.02.005; Boutin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056441; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Greuter HNJM, 2005, NUCL MED BIOL, V32, P307, DOI 10.1016/j.nucmedbio.2004.12.005; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harhausen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069529; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lyoo CH, 2015, J NUCL MED, V56, P701, DOI 10.2967/jnumed.114.146027; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Ory D, 2015, NUCL MED BIOL, V42, P753, DOI 10.1016/j.nucmedbio.2015.06.010; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vallez Garcia D, 2016, J NEUROTRAUMA; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Venneti S, 2007, J NEUROCHEM, V102, P2118, DOI 10.1111/j.1471-4159.2007.04690.x; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2014, MOL PHARMACEUT, V11, P3463, DOI 10.1021/mp500234d; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Yu AS, 2009, J NUCL MED, V50, P966, DOI 10.2967/jnumed.108.060533; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zinnhardt B, 2015, J CEREBR BLOOD F MET, V35, P1711, DOI 10.1038/jcbfm.2015.149	45	42	42	1	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUN 7	2016	13								140	10.1186/s12974-016-0604-9			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DN7VV	WOS:000377289200002	27266706	Green Published, gold			2022-02-06	
J	Myer, GD; Yuan, WH; Foss, KDB; Smith, D; Altaye, M; Reches, A; Leach, J; Kiefer, AW; Khoury, JC; Weiss, M; Thomas, S; Dicesare, C; Adams, J; Gubanich, PJ; Geva, A; Clark, JF; Meehan, WP; Mihalik, JP; Krueger, D				Myer, Gregory D.; Yuan, Weihong; Foss, Kim D. Barber; Smith, David; Altaye, Mekibib; Reches, Amit; Leach, James; Kiefer, Adam W.; Khoury, Jane C.; Weiss, Michal; Thomas, Staci; Dicesare, Chris; Adams, Janet; Gubanich, Paul J.; Geva, Amir; Clark, Joseph F.; Meehan, William P., III; Mihalik, Jason P.; Krueger, Darcy			The Effects of External Jugular Compression Applied during Head Impact Exposure on Longitudinal Changes in Brain Neuroanatomical and Neurophysiological Biomarkers: a Preliminary Investigation	FRONTIERS IN NEUROLOGY			English	Article						head injury; pediatric traumatic brain injury; traumatic brain injury; EEG	WHITE-MATTER INTEGRITY; COLLEGIATE FOOTBALL PLAYERS; DIFFUSION TENSOR; CORPUS-CALLOSUM; WORKING-MEMORY; AXONAL INJURY; UNITED-STATES; MILD; CONNECTIVITY; MODERATE	Objectives: Utilize a prospective in vivo clinical trial to evaluate the potential for mild neck compression applied during head impact exposure to reduce anatomical and physiological biomarkers of brain injury. Methods: This project utilized a prospective randomized controlled trial to evaluate effects of mild jugular vein (neck) compression (collar) relative to controls (no collar) during a competitive hockey season (males; 16.3 +/- 1.2 years). The collar was designed to mildly compress the jugular vein bilaterally with the goal to increase intracranial blood volume to reduce risk of brain slosh injury during head impact exposure. Helmet sensors were used to collect daily impact data in excess of 20 g (games and practices) and the primary outcome measures, which included changes in white matter (WM) microstructure, were assessed by diffusion tensor imaging (DTI). Specifically, four DTI measures: fractional anisotropy, mean diffusivity (MD), axial diffusivity, and radial diffusivity (RD) were used in the study. These metrics were analyzed using the tract-based Spatial Statistics (TBSS) approach - a voxel-based analysis. In addition, electroencephalography-derived event-related potentials were used to assess changes in brain network activation (BNA) between study groups. Results: For athletes not wearing the collar, DTI measures corresponding to a disruption of WM microstructure, including MD and RD, increased significantly from pre-season to mid-season (p < 0.05). Athletes wearing the collar did not show a significant change in either MD or RD despite similar accumulated linear accelerations from head impacts (p > 0.05). In addition to these anatomical findings, electrophysiological network analysis of the degree of congruence in the network electrophysiological activation pattern demonstrated concomitant changes in brain network dynamics in the non-collar group only (p < 0.05). Similar to the DTI findings, the increased change in BNA score in the non-collar relative to the collar group was statistically significant (p < 0.01). Changes in DTI outcomes were also directly correlated with altered brain network dynamics (r = 0.76; p < 0.05) as measured by BNA. Conclusion: Group differences in the longitudinal changes in both neuroanatomical and electrophysiological measures, as well as the correlation between the measures, provide initial evidence indicating that mild jugular vein compression may have reduced alterations in the WM response to head impacts during a competitive hockey season. The data indicate sport-related alterations in WM microstructure were ameliorated by application of jugular compression during head impact exposure. These results may lead to a novel line of research inquiry to evaluate the effects of protecting the brain from sports-related head impacts via optimized intracranial fluid dynamics.	[Myer, Gregory D.; Foss, Kim D. Barber; Smith, David; Kiefer, Adam W.; Thomas, Staci; Dicesare, Chris; Gubanich, Paul J.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Myer, Gregory D.; Foss, Kim D. Barber; Kiefer, Adam W.; Thomas, Staci; Dicesare, Chris] Cincinnati Childrens Hosp Med Ctr, Human Performance Lab, Cincinnati, OH 45229 USA; [Myer, Gregory D.; Kiefer, Adam W.; Gubanich, Paul J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA; [Myer, Gregory D.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber] Mt St Joseph Univ, Div Hlth Sci, Dept Athlet Training, Cincinnati, OH USA; [Smith, David] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Altaye, Mekibib; Khoury, Jane C.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Reches, Amit; Weiss, Michal; Geva, Amir] ElMindA Ltd, Herzliyya, Israel; [Leach, James; Adams, Janet] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Kiefer, Adam W.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Geva, Amir] Ben Gurion Univ Negev, Dept Elect & Comp Engn, POB 653, IL-84105 Beer Sheva, Israel; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Univ, Sch Med, Dept Pediat & Orthoped, Boston, MA USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Krueger, Darcy] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA.; Myer, GD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Human Performance Lab, Cincinnati, OH 45229 USA.; Myer, GD (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.; Myer, GD (corresponding author), Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA.; Myer, GD (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA USA.; Myer, GD (corresponding author), Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA.	greg.myer@cchmc.org	Kiefer, Adam/F-1756-2018; DiCesare, Christopher/AAA-3327-2021; Meijer, Anna/K-5118-2016; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Geva, Amir/0000-0003-3159-3673; Krueger, Darcy/0000-0002-7250-7391	Heidt Family Foundation; Q30 Innovations, LLC; Q30 Sports Innovations	The authors would like to thank Adam Tramonte and Jason Kamp, John Sullivan, Michael Gordon, and Ken Rushford for their support and assistance to conduct this study. Thanks to the hockey parents and players. We appreciate their patience with the testing scheduling, follow-ups, and equipment additions. The authors would like to thank Lacey Haas, Brynne Williams, and Matt Lanier in the Imaging Research Center. Their support made this study possible. The authors would like to acknowledge the support of ElMindA for providing the EEG equipment and supportive analyses. Funding for this study was provided by The Heidt Family Foundation and Q30 Innovations, LLC. Q30 Sports Innovations has financial interests in the development of the Q-Collar.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barth JT, 2001, J ATHL TRAINING, V36, P253; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BOUYSSOU M, 1985, J DENT RES, V64, P721; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brooks MA, 2013, AM AC PED ANN C SESS; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Courtney M., 2007, ARXIV07113804; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fisher JA, 2013, EFFECT JUGULAR VEIN; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; GILLAND O, 1969, AMER J ROENTGENOL RA, V106, P369, DOI 10.2214/ajr.106.2.369; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hatt A, 2015, AM J NEURORADIOL, V36, P1971, DOI 10.3174/ajnr.A4361; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Leach JL, 2013, AM SOC NEUR ANN M SA; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mongan P, 2013, PRACTICAL APPROACH N; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Reches A, 2016, EUR J PAIN, V20, P250, DOI 10.1002/ejp.716; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Sui J, 2014, NEUROIMAGE, V102, P11, DOI 10.1016/j.neuroimage.2013.09.044; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Wallerson R, 2014, WALL ST J ONLINE; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	64	42	43	0	20	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2016	7								74	10.3389/fneur.2016.00074			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN5BG	WOS:000377080400001	27375546	Green Published, gold			2022-02-06	
J	Loring, DW; Goldstein, FC; Chen, CQ; Drane, DL; Lah, JJ; Zhao, LP; Larrabee, GJ				Loring, David W.; Goldstein, Felicia C.; Chen, Chuqing; Drane, Daniel L.; Lah, James J.; Zhao, Liping; Larrabee, Glenn J.		Alzheimer's Dis Neuroimaging	False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity test; False-positive rate; Test specificity; Reliable Digit Span; AVLT	MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; DETECTING POOR EFFORT; IQ-ADJUSTED NORMS; SYMPTOM VALIDITY; CLASSIFICATION ACCURACY; EFFORT INDICATORS; AGES 56; DEMENTIA; VALIDATION	Objective: The objective is to examine failure on three embedded performance validity tests [Reliable Digit Span (RDS), Auditory Verbal Learning Test (AVLT) logistic regression, and AVLT recognition memory] in early Alzheimer disease (AD; n = 178), amnestic mild cognitive impairment (MCI; n = 365), and cognitively intact age-matched controls (n = 206). Method: Neuropsychological tests scores were obtained from subjects participating in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Results: RDS failure using a a parts per thousand currency sign7 RDS threshold was 60/178 (34%) for early AD, 52/365 (14%) for MCI, and 17/206 (8%) for controls. A a parts per thousand currency sign6 RDS criterion reduced this rate to 24/178 (13%) for early AD, 15/365 (4%) for MCI, and 7/206 (3%) for controls. AVLT logistic regression probability of a parts per thousand yen.76 yielded unacceptably high false-positive rates in both clinical groups [early AD = 149/178 (79%); MCI = 159/365 (44%)] but not cognitively intact controls (13/206, 6%). AVLT recognition criterion of a parts per thousand currency sign9/15 classified 125/178 (70%) of early AD, 155/365 (42%) of MCI, and 18/206 (9%) of control scores as invalid, which decreased to 66/178 (37%) for early AD, 46/365 (13%) for MCI, and 10/206 (5%) for controls when applying a a parts per thousand currency sign5/15 criterion. Despite high false-positive rates across individual measures and thresholds, combining RDS a parts per thousand currency sign 6 and AVLT recognition a parts per thousand currency sign9/15 classified only 9/178 (5%) of early AD and 4/365 (1%) of MCI patients as invalid performers. Conclusions: Embedded validity cutoffs derived from mixed clinical groups produce unacceptably high false-positive rates in MCI and early AD. Combining embedded PVT indicators lowers the false-positive rate.	[Loring, David W.; Goldstein, Felicia C.; Drane, Daniel L.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Loring, David W.; Drane, Daniel L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Chen, Chuqing] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Zhao, Liping] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA		Loring, DW (corresponding author), Emory Univ, Brain Hlth Ctr, 12 Execut Pk, Atlanta, GA 30329 USA.	dloring@emory.edu		Loring, David/0000-0003-2497-1074	Emory Alzheimer's Disease Research Center [NIH-NIA 5 P50 AG025688]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904, P50AG025688] Funding Source: NIH RePORTER	This work was also supported by the Emory Alzheimer's Disease Research Center (NIH-NIA 5 P50 AG025688).	Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Army Individual Test Battery, 1944, MAN DIR SCOR; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; Bondi MW, 2014, J INT NEUROPSYCH SOC, V20, P129, DOI 10.1017/S1355617714000010; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Kaplan E, 1983, BOSTON NAMING TEST; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Loring DW, 2014, CLIN NEUROPSYCHOL, V28, P556, DOI 10.1080/13854046.2012.762552; Martinson BC, 2010, J PHYS ACT HEALTH, V7, P127, DOI 10.1123/jpah.7.1.127; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Schmidt M., 1996, REY AUDITORY VERBAL; Silverberg N, 2005, J CLIN EXP NEUROPSYC, V27, P907, DOI 10.1080/13803390490919326; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P280, DOI 10.1080/13854040590945229; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Straus S. E., 2010, EVIDENCE BASED MED P; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Tierney M, 1994, PSYCHOL ASSESSMENT, V6, P129, DOI DOI 10.1037/1040-3590.6.2.129; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Whitney KA, 2015, ARCH CLIN NEUROPSYCH, V30, P130, DOI 10.1093/arclin/acu094; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	45	42	42	1	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2016	31	4					313	331		10.1093/arclin/acw014			19	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DN9RG	WOS:000377417200004	27084732	Green Published, Bronze			2022-02-06	
J	Shen, X; Ma, L; Dong, WW; Wu, Q; Gao, Y; Luo, CL; Zhang, MY; Chen, XP; Tao, LY				Shen, Xi; Ma, Lu; Dong, Wenwen; Wu, Qiong; Gao, Yuan; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Autophagy regulates intracerebral hemorrhage induced neural damage via apoptosis and NF-kappa B pathway	NEUROCHEMISTRY INTERNATIONAL			English	Article						Intracerebral hemorrhage; Neuron; Autophagy; Apoptosis; Inflammation	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; CELL-DEATH; PLASMALEMMA PERMEABILITY; RAT MODEL; RECEPTOR; ACTIVATION; NEUROPROTECTION; INHIBITION; EXPRESSION	Autophagy can be a pro-survival or a pro-death mechanism depending on the context. The role of autophagy in intracerebral hemorrhage (ICH) remains elusive. In this study, in vivo and in vitro experiments have been carried out to investigate the role of autophagy after ICH. Collagenase-induced ICH model in mouse was made for in vivo experiments. Primary cortical neurons cultures were exposed to hemin to mimic ICH in vitro. 3-Methyladenine (3-MA) and rapamycin (RAP) were administrated both in vivo and in vitro. We first measured brain water content and cell death after ICH in model. Expression of LC3, p62/SQSTM1 (p62), Beclin1, Caspase3 and Bcl-2, which have been found related to autophagy and apoptosis, were assessed both in vivo and in vitro. Furthermore, NF-kappa B was detected to explore the potential mechanisms. We found brain edema in ICH model in mouse and the number of Propidium Iodide (PI)-positive cells both in vivo and in vitro were decreased by 3-MA pretreated. Simultaneously, both in vivo and in vitro, 3-MA significantly decreased the expression of LC3-II and Beclin-1, and maintained p62 at high level after ICH. Furthermore, pretreatment with 3-MA downregulated the level of cleaved caspase-3 but upregulated the Bcl-2 level. Conversely, RAP pretreatment reversed all these results above. These data indicated that autophagy activation may deprave ICH induced brain injury in ICH model and neuro-damage may be related to regulating of NF-kappa B pathway and thereby promote inflammation and apoptosis, thus might provide novel therapeutic interventions for ICH. (C) 2016 Elsevier Ltd. All rights reserved.	[Shen, Xi; Ma, Lu; Wu, Qiong; Gao, Yuan; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Sch Med, Dept Forens Sci, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China; [Dong, Wenwen] China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang 110122, Peoples R China		Tao, LY (corresponding author), Soochow Univ, Sch Med, Dept Forens Sci, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China.	luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763; Shen, Xi/0000-0001-7568-7335	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81271379, 81373251, 81301039, 81400999]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants 81530062, 81271379, 81373251, 81301039 and 81400999 from the National Natural Science Foundation of China, National High Technology Research and Development Program of China (863 Program, No.2015AA020503), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adeoye O, 2011, TRANSL STROKE RES, V2, P17, DOI 10.1007/s12975-010-0037-1; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Chang P, 2014, J MOL NEUROSCI, V52, P242, DOI 10.1007/s12031-013-0132-3; Chen CW, 2012, AUTOPHAGY, V8, P1510, DOI 10.4161/auto.21289; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Colleran A, 2011, J BIOL CHEM, V286, P22886, DOI 10.1074/jbc.M110.199950; Criollo A, 2012, CELL CYCLE, V11, P194, DOI 10.4161/cc.11.1.18669; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gao C., 2015, PLOS ONE, V10; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Gleixner A. M., 2015, MOL NEUROBIOL; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Hu SK, 2011, BRAIN RES, V1424, P60, DOI 10.1016/j.brainres.2011.09.062; Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Jing CH, 2012, NEUROSCIENCE, V213, P144, DOI 10.1016/j.neuroscience.2012.03.055; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lee IN, 2015, J NEUROSCI RES, V93, P178, DOI 10.1002/jnr.23454; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Mohan S, 2015, NEUROTOXICOLOGY, V46, P53, DOI 10.1016/j.neuro.2014.10.012; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang L. F., 2015, PLOS ONE, V10; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006; Yan JH, 2008, EXP NEUROL, V214, P37, DOI 10.1016/j.expneurol.2008.07.006; Yang Y, 2014, J RECEPT SIG TRANSD, V22, P1; Yang Z, 2015, J NEUROIMMUNOL, V278, P232, DOI 10.1016/j.jneuroim.2014.11.010; Yuan DM, 2014, CELL MOL NEUROBIOL, V34, P951, DOI 10.1007/s10571-014-0081-6; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974; Zhou QB, 2014, INFLAMMATION, V37, P107, DOI 10.1007/s10753-013-9717-9; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672	67	42	45	2	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2016	96						100	112		10.1016/j.neuint.2016.03.004			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DN1DO	WOS:000376806700011	26964766				2022-02-06	
J	Bragin, A; Li, L; Almajano, J; Alvarado-Rojas, C; Reid, AY; Staba, RJ; Engel, J				Bragin, Anatol; Li, Lin; Almajano, Joyel; Alvarado-Rojas, Catalina; Reid, Aylin Y.; Staba, Richard J.; Engel, Jerome, Jr.			Pathologic electrographic changes after experimental traumatic brain injury	EPILEPSIA			English	Article						Traumatic brain injury; Epileptogenesis; Pathologic high frequency oscillations; Seizure; Electroencephalography; Spindles; Repetitive HFOs and spikes	HIGH-FREQUENCY OSCILLATIONS; FLUID PERCUSSION INJURY; SPIKE-WAVE DISCHARGES; SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; SLEEP SPINDLES; STATUS EPILEPTICUS; ENTORHINAL CORTEX; ABSENCE EPILEPSY; SEIZURES	Objective: To investigate possible electroencephalography (EEG) correlates of epileptogenesis after traumatic brain injury (TBI) using the fluid percussion model. Methods: Experiments were conducted on adult 2- to 4-month-old male Sprague-Dawley rats. Two groups of animals were studied: (1) the TBI group with depth and screw electrodes implanted immediately after the fluid percussion injury (FPI) procedure, and (2) a naive age-matched control group with the same electrode implantation montage. Pairs of tungsten microelectrodes (50 lm outer diameter) and screw electrodes were implanted in neocortex inside the TBI core, areas adjacent to TBI, and remote areas. EEG activity, recorded on the day of FPI, and continuously for 2 weeks, was analyzed for possible electrographic biomarkers of epileptogenesis. Video-EEG monitoring was also performed continuously in the TBI group to capture electrographic and behavioral seizures until the caps came off (28-189 days), and for 1 week, at 2, 3, and 6 months of age, in the control group. Results: Pathologic high-frequency oscillations (pHFOs) with a central frequency between 100 and 600 Hz, were recorded from microelectrodes, beginning during the first two post-FPI weeks, in 7 of 12 animals in the TBI group (58%) and never in the controls. pHFOs only occurred in cortical areas within or adjacent to the TBI core. These were associated with synchronous multiunit discharges and popSpikes, duration 1540 msec. Repetitive pHFOs and EEG spikes (rHFOSs) formed paroxysmal activity, with a unique arcuate pattern, in the frequency band 10-16 Hz in the same areas as isolated pHFOs, and these events were also recorded by screw electrodes. Although loss of caps prevented long-term recordings from all rats, pHFOs and rHFOSs occurred during the first 2 weeks in all four animals that later developed seizures, and none of the rats without these events developed late seizures. Significance: pHFOs, similar to those associated with epileptogenesis in the status rat model of epilepsy, may also reflect epileptogenesis after FPI. rHFOSs could be noninvasive biomarkers of epileptogenesis.	[Bragin, Anatol; Li, Lin; Almajano, Joyel; Alvarado-Rojas, Catalina; Reid, Aylin Y.; Staba, Richard J.; Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurol, 710 Wetwood Plaza, Los Angeles, CA 90095 USA; [Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Med, Los Angeles, CA USA		Bragin, A; Engel, J (corresponding author), Univ Calif Los Angeles, Dept Neurol, 710 Wetwood Plaza, Los Angeles, CA 90095 USA.	abragin@mednet.ucla.edu; engel@ucla.edu	Alvarado-Rojas, Catalina/AAR-8761-2021; Li, Lin/V-4460-2019; Staba, Richard/AAN-3149-2021	Bragin, Anatol/0000-0003-1207-8481; Reid, Aylin Yasmin/0000-0001-6855-9669; Alvarado-Rojas, Catalina/0000-0002-2315-5692; LI, LIN/0000-0002-9996-9377	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065877, NS071048]; Citizens United for Research in Epilepsy [NS033310, NS080181]; Alberta Innovates-Health Solutions; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS033310, R01NS065877, R01NS033310, R01NS071048, P20NS080181] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) grants NS065877 (AB); NS071048 and Citizens United for Research in Epilepsy (RS); NS033310 and NS080181 (JE). AYR was supported by a Clinical Fellowship award from Alberta Innovates-Health Solutions.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 2004, EPILEPSIA, V45, P1017, DOI 10.1111/j.0013-9580.2004.17004.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Bragin A, 2007, EPILEPSIA, V48, P35, DOI 10.1111/j.1528-1167.2007.01287.x; Bragin A, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2010.02896.x; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Giza CC, 2010, EPILEPSY MECH MODELS, P181; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Kandel A, 1997, J NEUROSCI, V17, P6783; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Mazarati A, 2002, EPILEPSIA, V43, P74, DOI 10.1046/j.1528-1157.43.s.5.25.x; Molle M, 2009, EUR J NEUROSCI, V29, P1071, DOI 10.1111/j.1460-9568.2009.06654.x; Moeller F, 2013, EPILEPSIA, V54, pE103, DOI 10.1111/epi.12243; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pinault D, 2006, J PHYSIOL-LONDON, V574, P209, DOI 10.1113/jphysiol.2006.108498; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sitnikova E, 2014, BRAIN RES, V1543, P290, DOI 10.1016/j.brainres.2013.11.001; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; vanLuijtelaar ELJM, 1997, ACTA NEUROBIOL EXP, V57, P113; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WILLOUGHBY JO, 1992, LAB ANIM SCI, V42, P551	38	42	43	2	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAY	2016	57	5					735	745		10.1111/epi.13359			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR8ID	WOS:000380140700010	27012461	Green Accepted, Green Published			2022-02-06	
J	Quintard, H; Patet, C; Zerlauth, JB; Suys, T; Bouzat, P; Pellerin, L; Meuli, R; Magistretti, PJ; Oddo, M				Quintard, Herve; Patet, Camille; Zerlauth, Jean-Baptiste; Suys, Tamarah; Bouzat, Pierre; Pellerin, Luc; Meuli, Reto; Magistretti, Pierre J.; Oddo, Mauro			Improvement of Neuroenergetics by Hypertonic Lactate Therapy in Patients with Traumatic Brain Injury Is Dependent on Baseline Cerebral Lactate/Pyruvate Ratio	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cerebral microdialysis; hypertonic; lactate; traumatic brain injury	INTRACRANIAL HYPERTENSIVE EPISODES; POSITRON-EMISSION-TOMOGRAPHY; NUCLEAR-MAGNETIC-RESONANCE; NEUROPROTECTIVE ROLE; ENERGY-METABOLISM; SODIUM LACTATE; BLOOD LACTATE; PERFUSION CT; GLUCOSE; MICRODIALYSIS	Energy dysfunction is associated with worse prognosis after traumatic brain injury (TBI). Recent data suggest that hypertonic sodium lactate infusion (HL) improves energy metabolism after TBI. Here, we specifically examined whether the efficacy of HL (3h infusion, 30-40 mu mol/kg/min) in improving brain energetics (using cerebral microdialysis [CMD] glucose as a main therapeutic end-point) was dependent on baseline cerebral metabolic state (assessed by CMD lactate/pyruvate ratio [LPR]) and cerebral blood flow (CBF, measured with perfusion computed tomography [PCT]). Using a prospective cohort of 24 severe TBI patients, we found CMD glucose increase during HL was significant only in the subgroup of patients with elevated CMD LPR >25 (n = 13; +0.13 [95% confidence interval (CI) 0.08-0.19] mmol/L, p < 0.001; vs. +0.04 [-0.05-0.13] in those with normal LPR, p = 0.33, mixed-effects model). In contrast, CMD glucose increase was independent from baseline CBF (coefficient +0.13 [0.04-0.21] mmol/L when global CBF was <32.5 mL/100 g/min vs. +0.09 [0.04-0.14] mmol/L at normal CBF, both p < 0.005) and systemic glucose. Our data suggest that improvement of brain energetics upon HL seems predominantly dependent on baseline cerebral metabolic state and support the concept that CMD LPR - rather than CBF - could be used as a diagnostic indication for systemic lactate supplementation following TBI.	[Quintard, Herve; Patet, Camille; Suys, Tamarah; Bouzat, Pierre; Oddo, Mauro] Univ Lausanne Hosp, Neurosci Crit Care Res Grp, Dept Intens Care Med, CHU Vaudois, Lausanne, Switzerland; [Zerlauth, Jean-Baptiste; Meuli, Reto] Univ Lausanne Hosp, CHU Vaudois, Dept Med Radiol, Lausanne, Switzerland; [Magistretti, Pierre J.] Univ Lausanne Hosp, CHU Vaudois, Dept Psychiat, Ctr Neurosci Psychiat, Lausanne, Switzerland; [Quintard, Herve] Nice Univ Hosp, Dept Anesthesia & Intens Care, Nice, France; [Bouzat, Pierre] Grenoble Univ Hosp, Dept Anesthesia & Intens Care, Grenoble, France; [Pellerin, Luc] Univ Lausanne, Inst Physiol, Lausanne, Switzerland; [Magistretti, Pierre J.] KAUST, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neuroenerget & Cellular Dynam, Lausanne, Switzerland		Oddo, M (corresponding author), CHUV Univ Hosp, Dept Intens Care Med, Rue Bugnon 46,BH 08-623, CH-1011 Lausanne, Switzerland.	mauro.oddo@chuv.ch	Oddo, Mauro/R-3370-2016; Pellerin, Luc/A-8912-2017; Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014	Oddo, Mauro/0000-0002-6155-2525; Pellerin, Luc/0000-0002-1016-1970; Bouzat, Pierre/0000-0003-4667-6738; Magistretti, Pierre Julius/0000-0002-6678-320X			Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Herzog RI, 2013, J CLIN INVEST, V123, P1988, DOI 10.1172/JCI65105; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maran A, 2000, DIABETOLOGIA, V43, P733, DOI 10.1007/s001250051371; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schurr A, 1997, J NEUROCHEM, V69, P423; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Sotelo-Hitschfeld T, 2012, GLIA, V60, P674, DOI 10.1002/glia.22304; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111	43	42	44	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					681	687		10.1089/neu.2015.4057			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700007	26421521	Green Submitted, Green Published, hybrid			2022-02-06	
J	Zhao, HL; Zhang, X; Dai, ZQ; Feng, Y; Li, Q; Zhang, JH; Liu, X; Chen, YJ; Feng, H				Zhao, Hengli; Zhang, Xuan; Dai, Zhiqiang; Feng, Yang; Li, Qiang; Zhang, John H.; Liu, Xin; Chen, Yujie; Feng, Hua			P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats	SCIENTIFIC REPORTS			English	Article							CENTRAL-NERVOUS-SYSTEM; P2X(7) RECEPTORS; SUBARACHNOID HEMORRHAGE; INTRAVENTRICULAR HEMORRHAGE; HEMATOMA VOLUME; KINASE; MICE; INTEGRITY; STROKE; INJURY	Blockading P2X7 receptor(P2X7R) provides neuroprotection toward various neurological disorders, including stroke, traumatic brain injury, and subarachnoid hemorrhage. However, whether and how P2X7 receptor suppression protects blood-brain barrier(BBB) after intracerebral hemorrhage(ICH) remains unexplored. In present study, intrastriatal autologous-blood injection was used to mimic ICH in rats. Selective P2X7R inhibitor A438079, P2X7R agonist BzATP, and P2X7R siRNA were administrated to evaluate the effects of P2X7R suppression. Selective RhoA inhibitor C3 transferase was administered to clarify the involvement of RhoA. Post-assessments, including neurological deficits, Fluoro-Jade C staining, brain edema, Evans blue extravasation and fluorescence, western blot, RhoA activity assay and immunohistochemistry were performed. Then the key results were verified in collagenase induced ICH model. We found that endogenous P2X7R increased at 3 hrs after ICH with peak at 24 hrs, then returned to normal at 72 hrs after ICH. Enhanced immunoreactivity was observed on the neurovascular structure around hematoma at 24 hrs after ICH, along with perivascular astrocytes and endothelial cells. Both A438079 and P2X7R siRNA alleviated neurological deficits, brain edema, and BBB disruption after ICH, in association with RhoA activation and down-regulated endothelial junction proteins. However, BzATP abolished those effects. In addition, C3 transferase reduced brain injury and increased endothelial junction proteins' expression after ICH. These data indicated P2X7R suppression could preserve BBB integrity after ICH through inhibiting RhoA activation.	[Zhao, Hengli; Zhang, Xuan; Dai, Zhiqiang; Feng, Yang; Li, Qiang; Liu, Xin; Chen, Yujie; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Zhang, John H.] Loma Linda Univ, Dept Anesthesiol Neurosurg & Physiol, Loma Linda, CA 92350 USA		Chen, YJ; Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.	yujiechen6886@foxmail.com; fenghua8888@vip.163.com	Chen, Yujie/AAS-6995-2021; Feng, Hua/AAX-4121-2021	Chen, Yujie/0000-0002-9905-9138; Feng, Hua/0000-0003-4489-9217	National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB541600]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501002, 81220108009]	This study was supported by the National Basic Research Program of China (973 Program, No. 2014CB541600) and the National Natural Science Foundation of China (Grant No. 81501002, 81220108009).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Allen C, 2010, STROKE, V41, P2056, DOI 10.1161/STROKEAHA.109.574939; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chen YJ, 2015, NEUROSCI LETT, V588, P131, DOI 10.1016/j.neulet.2015.01.005; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Chen Z, 2014, NEUROREPORT, V25, P635, DOI 10.1097/WNR.0000000000000050; Chrovian CC, 2014, PROGR MED CHEM, V53, P65, DOI 10.1016/B978-0-444-63380-4.00002-0; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Fang JQ, 2015, CANCER BIOL THER, V16, P498, DOI 10.1080/15384047.2015.1016663; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Fu ZH, 2014, INT J CLIN EXP PATHO, V7, P7844; Fujita Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00338; Henriquez M, 2011, J CELL SCI, V124, P1581, DOI 10.1242/jcs.073171; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Kang SS, 2013, TRANSL STROKE RES, V4, P533, DOI 10.1007/s12975-013-0265-2; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11357; LoPresti MA, 2014, J NEUROL SCI, V345, P3, DOI 10.1016/j.jns.2014.06.057; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Marzal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097321; Mendelow A. D., 1993, STROKE S, V24, pI118; Mendelow A. D., 1993, STROKE S1, V24, pI115; Murthy SB, 2015, STROKE, V46, P3088, DOI 10.1161/STROKEAHA.115.010054; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubio-Araiz A, 2014, INT J NEUROPSYCHOPH, V17, P1243, DOI 10.1017/S1461145714000145; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sathanoori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125111; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Vose LR, 2013, J NEUROSCI, V33, P17232, DOI 10.1523/JNEUROSCI.2713-13.2013; Wang LX, 2013, ANN NEUROL, V73, P189, DOI 10.1002/ana.23762; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Xi GH, 2014, PROG NEUROBIOL, V115, P45, DOI 10.1016/j.pneurobio.2013.09.007; Yang F., 2015, STROKE J CEREBRAL CI, DOI [10.1161/STROKEAHA.114.008336, DOI 10.1161/STROKEAHA.114.008336]; Yu Y, 2014, INT J MOL MED, V33, P661, DOI 10.3892/ijmm.2014.1618; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792; Zheng Y, 2015, STROKE, V46, P485, DOI 10.1161/STROKEAHA.114.006372; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	51	42	45	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 16	2016	6								23286	10.1038/srep23286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4QB	WOS:000372055700002	26980524	gold, Green Published			2022-02-06	
J	Kochanek, PM; Bramlett, HM; Shear, DA; Dixon, CE; Mondello, S; Dietrich, WD; Hayes, RL; Wang, KKW; Poloyac, SM; Empey, PE; Povlishock, JT; Mountney, A; Browning, M; Deng-Bryant, Y; Yan, HQ; Jackson, TC; Catania, M; Glushakova, O; Richieri, SP; Tortella, FC				Kochanek, Patrick M.; Bramlett, Helen M.; Shear, Deborah A.; Dixon, C. Edward; Mondello, Stefania; Dietrich, W. Dalton; Hayes, Ronald L.; Wang, Kevin K. W.; Poloyac, Samuel M.; Empey, Philip E.; Povlishock, John T.; Mountney, Andrea; Browning, Megan; Deng-Bryant, Ying; Yan, Hong Q.; Jackson, Travis C.; Catania, Michael; Glushakova, Olena; Richieri, Steven P.; Tortella, Frank C.			Synthesis of Findings, Current Investigations, and Future Directions: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; therapy; rat; biomarker; controlled cortical impact; pre-clinical modeling; micropig; penetrating ballistic-like brain injury; reproducibility; fluid percussion; drug	CONTROLLED CORTICAL IMPACT; MICROGLIAL ACTIVATION; HEMORRHAGIC-SHOCK; RAT MODEL; INJURY; AMANTADINE; DEFICITS; MICE; NEUROPROTECTION; PERFORMANCE	Operation Brain Trauma Therapy (OBTT) is a fully operational, rigorous, and productive multicenter, pre-clinical drug and circulating biomarker screening consortium for the field of traumatic brain injury (TBI). In this article, we synthesize the findings from the first five therapies tested by OBTT and discuss both the current work that is ongoing and potential future directions. Based on the results generated from the first five therapies tested within the exacting approach used by OBTT, four (nicotinamide, erythropoietin, cyclosporine A, and simvastatin) performed below or well below what was expected based on the published literature. OBTT has identified, however, the early post-TBI administration of levetiracetam as a promising agent and has advanced it to a gyrencephalic large animal model-fluid percussion injury in micropigs. The sixth and seventh therapies have just completed testing (glibenclamide and Kollidon VA 64), and an eighth drug (AER 271) is in testing. Incorporation of circulating brain injury biomarker assessments into these pre-clinical studies suggests considerable potential for diagnostic and theranostic utility of glial fibrillary acidic protein in pre-clinical studies. Given the failures in clinical translation of therapies in TBI, rigorous multicenter, pre-clinical approaches to therapeutic screening such as OBTT may be important for the ultimate translation of therapies to the human condition.	[Kochanek, Patrick M.; Browning, Megan; Jackson, Travis C.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Vet Affairs Med Ctr, Bruce W Carter Dept, Miami, FL 33125 USA; [Shear, Deborah A.; Mountney, Andrea; Deng-Bryant, Ying; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Neurorestorat, Silver Spring, MD USA; [Dixon, C. Edward; Yan, Hong Q.] Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Neuroprote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Poloyac, Samuel M.; Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Ctr Pharmaceut Sci, Pittsburgh, PA 15260 USA; [Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Catania, Michael; Glushakova, Olena; Richieri, Steven P.] Banyan Biomarkers, Alachua, FL USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Mondello, Stefania/A-1813-2012; Empey, Philip/L-9604-2019; Glushakova, Olena/AAY-1130-2021	Mondello, Stefania/0000-0002-8587-3614; Empey, Philip/0000-0001-7474-2339; Glushakova, Olena/0000-0002-2109-3651; Wang, Kevin/0000-0002-9343-6473			Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bigler ED, 2014, NEUROLOGY, V82, P1641, DOI 10.1212/WNL.0000000000000395; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Kernie SG, 2015, PEDIATR CRIT CARE ME, V16, P294, DOI 10.1097/PCC.0000000000000347; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Reier Paul J, 2012, Handb Clin Neurol, V109, P411, DOI 10.1016/B978-0-444-52137-8.00026-7; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917; Warner DS, 2014, JAMA NEUROL, V71, P1311, DOI 10.1001/jamaneurol.2014.1238; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	52	42	42	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2016	33	6					606	614		10.1089/neu.2015.4133			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DG6HN	WOS:000372184800009	26671284	Green Submitted			2022-02-06	
J	Ibrahim, S; Hu, WP; Wang, XT; Gao, X; He, CY; Chen, JH				Ibrahim, Sara; Hu, Weipeng; Wang, Xiaoting; Gao, Xiang; He, Chunyan; Chen, Jinhui			Traumatic Brain Injury Causes Aberrant Migration of Adult-Born Neurons in the Hippocampus	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; INDUCED CELL-PROLIFERATION; MODERATE HEAD-INJURY; DENTATE GYRUS; ENHANCED NEUROGENESIS; COGNITIVE RECOVERY; MOUSE MODEL; DIFFERENTIATION; PROTEIN; DEATH	Traumatic brain injury (TBI) promotes neural stem/progenitor cell (NSC) proliferation in an attempt to initiate innate repair mechanisms. However, all immature neurons in the CNS are required to migrate from their birthplace to their final destination to develop into functional neurons. Here we assessed the destination of adult-born neurons following TBI. We found that a large percentage of immature neurons migrated past their normal stopping site at the inner granular cell layer (GCL), and became misplaced in the outer GCL of the hippocampal dentate gyrus. The aberrant migration of adult-born neurons in the hippocampus occurred 48 hours after TBI, and lasted for 8 weeks, resulting in a great number of newly generated neurons misplaced in the outer GCL in the hippocampus. Those misplaced neurons were able to become mature and differentiate into granular neurons, but located ectopically in the outer GCL with reduced dendritic complexity after TBI. The adult-born neurons at the misplaced position may make wrong connections with inappropriate nearby targets in the pre-existing neural network. These results suggest that although stimulation of endogenous NSCs following TBI might offer new avenues for cell-based therapy, additional intervention is required to further enhance successful neurogenesis for repairing the damaged brain.	[Ibrahim, Sara; Wang, Xiaoting; Gao, Xiang; Chen, Jinhui] Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN USA; [Hu, Weipeng] Fujian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Quanzhou 362000, Peoples R China; [He, Chunyan] Huaqiao Univ, Sch Biomed Sci, Quanzhou 362000, Peoples R China		Chen, JH (corresponding author), Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN USA.	chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research Grants; Ralph W. and Grace M. Showalter Research Award; Indiana University Biological Research Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS075733, 1R21NS072631-01A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072631, R21NS075733] Funding Source: NIH RePORTER	This work was supported through funding from the Indiana Spinal Cord & Brain Injury Research Grants, the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, and NIH grants R21NS075733 and 1R21NS072631-01A.	BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Chen JH, 2000, NEUROSCIENCE, V96, P231, DOI 10.1016/S0306-4522(99)00408-X; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Prigatano GP, 2005, ACT NEUR S, V93, P39; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; SHOLL D A, 1956, Prog Neurobiol, P324; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P127, DOI 10.1016/0165-0270(86)90116-0; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; ZIMMER J, 1971, J COMP NEUROL, V142, P393, DOI 10.1002/cne.901420402	64	42	42	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 22	2016	6								21793	10.1038/srep21793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE3GF	WOS:000370514800001	26898165	Green Published, gold			2022-02-06	
J	Lettieri, CJ; Williams, SG; Collen, JF				Lettieri, Christopher J.; Williams, Scott G.; Collen, Jacob F.			OSA Syndrome and Posttraumatic Stress Disorder Clinical Outcomes and Impact of Positive Airway Pressure Therapy	CHEST			English	Article						continuous positive airway pressure; CPAP adherence; obstructive sleep apnea; posttraumatic stress disorder; quality of life	OBSTRUCTIVE SLEEP-APNEA; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; CPAP USE; DAYTIME SLEEPINESS; MILITARY PERSONNEL; FUNCTIONAL STATUS; ADHERENCE; INSOMNIA; NIGHTMARES	BACKGROUND: We sought to determine the impact of OSA syndrome (OSAS) on symptoms and quality of life (QoL) among patients with posttraumatic stress disorder (PTSD). In addition, we assessed adherence and response to positive airway pressure (PAP) therapy in this population. METHODS: This was a case-controlled observational cohort study at the Sleep Disorders Center of an academic military medical center. Two hundred consecutive patients with PTSD underwent sleep evaluations. Patients with PTSD with and without OSAS were compared with 50 consecutive age-matched patients with OSAS without PTSD and 50 age-matched normal control subjects. Polysomnographic data, sleep-related symptoms and QoL measures, and objective PAP usage were obtained. RESULTS: Among patients with PTSD, more than one-half (56.6%) received a diagnosis of OSAS. Patients with PTSD and OSAS had lower QoL and more somnolence compared with the other groups. Patients with PTSD demonstrated significantly lower adherence and response to PAP therapy. Resolution of sleepiness occurred in 82% of patients with OSAS alone, compared with 62.5% of PAP-adherent and 21.4% of nonadherent patients with PTSD and OSAS (P < .001). Similarly, posttreatment Functional Outcomes of Sleep Questionnaire >= 17.9 was achieved in 72% of patients with OSAS, compared with only 56.3% of patients with PTSD and OSA who were PAP adherent and 26.2% who were nonadherent (P < .03). CONCLUSIONS: In patients with PTSD, comorbid OSAS is associated with worsened symptoms, QoL, and adherence and response to PAP. Given the negative impact on outcomes, the possibility of OSAS should be considered carefully in patients with PTSD. Close follow-up is needed to optimize PAP adherence and efficacy in this at-risk population.	[Lettieri, Christopher J.; Williams, Scott G.; Collen, Jacob F.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD USA; [Lettieri, Christopher J.] Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, Bethesda, MD USA; [Williams, Scott G.] Womack Army Med Ctr, Dept Pulm Crit Care & Sleep Med, Ft Bragg, NC USA; [Collen, Jacob F.] Brooke Army Med Ctr, Dept Pulm Crit Care & Sleep Med, Ft Sam Houston, TX 78234 USA		Collen, JF (corresponding author), Brooke Army Med Ctr, Pulm Crit Care & Sleep Med, San Antonio Mil Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	jacob.f.collen.mil@mail.mil		Lettieri, Christopher/0000-0001-7950-2908			Aloia Mark S, 2007, Behav Sleep Med, V5, P229; Aloia MS, 2013, SLEEP, V36, P1655; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Nguyen ATD, 2006, J CLIN SLEEP MED, V2, P170; [Anonymous], 2012, RAND CROSS TRIAL 2 T; [Anonymous], STANF FAT VIS NUM SC; [Anonymous], 2013, EFF CPAP THER PTSD S; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Arnetz BB, 2012, PSYCHOSOM MED, V74, P824, DOI 10.1097/PSY.0b013e31826bf1ec; Bartlett D, 2013, SLEEP, V36, P1647, DOI 10.5665/sleep.3118; Budhiraja R, 2007, SLEEP, V30, P320; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Crawford MR, 2014, SLEEP MED REV, V18, P123, DOI 10.1016/j.smrv.2013.03.002; Damiani MF, 2013, CHEST, V143, P1569, DOI 10.1378/chest.12-2174; Dickerson SS, 2013, HEART LUNG, V42, P346, DOI 10.1016/j.hrtlng.2013.07.011; El-Solh AA, 2010, SLEEP, V33, P1495, DOI 10.1093/sleep/33.11.1495; Iber C., 2007, AASM MANUAL SCORING, P7; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; Kline CE, 2012, J CLIN SLEEP MED, V8, P357, DOI 10.5664/jcsm.2022; Kline CE, 2011, SLEEP, V34, P1631, DOI 10.5665/sleep.1422; Krakow B, 2004, J TRAUMA STRESS, V17, P257, DOI 10.1023/B:JOTS.0000029269.29098.67; Krakow B, 2002, J NERV MENT DIS, V190, P442, DOI 10.1097/00005053-200207000-00004; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Krakow B, 2006, J NERV MENT DIS, V194, P433, DOI 10.1097/01.nmd.0000221286.65021.e0; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Lewis KE, 2004, SLEEP, V27, P134, DOI 10.1093/sleep/27.1.134; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Moyer CA, 2001, SLEEP MED, V2, P477, DOI 10.1016/S1389-9457(01)00072-7; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, CHEST, V143, P582, DOI 10.1378/chest.12-2269; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Pepin JL, 1999, AM J RESP CRIT CARE, V160, P1124, DOI 10.1164/ajrccm.160.4.9802027; Reimer MA, 2003, SLEEP MED REV, V7, P335, DOI 10.1053/smrv.2001.0220; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stepnowsky Carl J Jr, 2002, Sleep Med, V3, P239, DOI 10.1016/S1389-9457(01)00162-9; Tamanna S, 2014, J CLIN SLEEP MED, V10, P631, DOI 10.5664/jcsm.3786; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weaver TE, 2001, SLEEP MED REV, V5, P103, DOI 10.1053/smrv.2001.0152; Weaver TE, 1997, SLEEP, V20, P835; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Youakim JM, 1998, PSYCHOSOMATICS, V39, P168, DOI 10.1016/S0033-3182(98)71365-9; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	57	42	44	0	6	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	FEB	2016	149	2					483	490		10.1378/chest.15-0693			8	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	DD1DC	WOS:000369660400031	26291560	Bronze			2022-02-06	
J	Gardner, RC; Hess, CP; Brus-Ramer, M; Possin, KL; Cohn-Sheehy, BI; Kramer, JH; Berger, MS; Yaffe, K; Miller, B; Rabinovici, GD				Gardner, Raquel C.; Hess, Christopher P.; Brus-Ramer, Marcel; Possin, Katherine L.; Cohn-Sheehy, Brendan I.; Kramer, Joel H.; Berger, Mitchel S.; Yaffe, Kristine; Miller, Bruce; Rabinovici, Gil D.			Cavum Septum Pellucidum in Retired American Pro-Football Players	JOURNAL OF NEUROTRAUMA			English	Article						concussion; magnetic resonance imaging; septum pellucidum; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ENCEPHALOPATHY; DEMENTIA; DISEASE; BOXERS; MRI	Previous studies report that cavum septum pellucidum (CSP) is frequent among athletes with a history of repeated traumatic brain injury (TBI), such as boxers. Few studies of CSP in athletes, however, have assessed detailed features of the septum pellucidum in a case-control fashion. This is important because prevalence of CSP in the general population varies widely (2% to 85%) between studies. Further, rates of CSP among American pro-football players have not been described previously. We sought to characterize MRI features of the septum pellucidum in a series of retired pro-football players with a history of repeated concussive/subconcussive head traumas compared with controls. We retrospectively assessed retired American pro-football players presenting to our memory clinic with cognitive/behavioral symptoms in whom structural MRI was available with slice thickness 2mm (n=17). Each player was matched to a memory clinic control patient with no history of TBI. Scans were interpreted by raters blinded to clinical information and TBI/football history, who measured CSP grade (0-absent, 1-equivocal, 2-mild, 3-moderate, 4-severe) and length according to a standard protocol. Sixteen of 17 (94%) players had a CSP graded 2 compared with 3 of 17 (18%) controls. CSP was significantly higher grade (p<0.001) and longer in players than controls (mean length +/- standard deviation: 10.6mm +/- 5.4 vs. 1.1mm +/- 1.3, p<0.001). Among patients presenting to a memory clinic, long high-grade CSP was more frequent in retired pro-football players compared with patients without a history of TBI.	[Gardner, Raquel C.; Possin, Katherine L.; Cohn-Sheehy, Brendan I.; Kramer, Joel H.; Miller, Bruce; Rabinovici, Gil D.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94121 USA; [Gardner, Raquel C.; Yaffe, Kristine] San Francisco VA Med Ctr, Dept Vet Affairs, San Francisco, CA USA; [Hess, Christopher P.; Brus-Ramer, Marcel] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94121 USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA		Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St,Neurol Box 127, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu	Rabinovici, Gil/AAA-2495-2020; Brus-Ramer, Marcel/AAQ-8858-2020	Gardner, Raquel C./0000-0003-4028-440X	Department of Veterans Affairs Advanced Fellowship in Mental Illness Research/Treatment; UCSF Pepper Center Research Career Development Core; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24-AG031155, R01-AG045611, K23-AG037566]; Alzheimer's AssociationAlzheimer's Association; Avid Radiopharmaceuticals; John Douglas French Alzheimer's Foundation; Hellman Family Foundation; Tau Consortium; UCSF ADRC [P50 AG023501]; State Center grants; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG045611, K24AG031155, P01AG019724, P30AG044281, K23AG037566, P50AG023501] Funding Source: NIH RePORTER	We thank our patients and their families for contributing to research on TBI. We acknowledge administrative and technical support from Trishna Subas and Shirley Reeder. Funding: Department of Veterans Affairs Advanced Fellowship in Mental Illness Research/Treatment (RCG); UCSF Pepper Center Research Career Development Core (RCG); NIA K24-AG031155 (KY), NIA R01-AG045611 (GDR), Alzheimer's Association (GDR), Avid Radiopharmaceuticals (GDR), John Douglas French Alzheimer's Foundation (GDR), Hellman Family Foundation (GDR), Tau Consortium (GDR), UCSF ADRC (P50 AG023501) (GDR, BM), and State Center grants (BM), NIA K23-AG037566 (KP).	Bodensteiner JB, 1997, SPORTS MED, V24, P361, DOI 10.2165/00007256-199724060-00002; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Born CM, 2004, EUR ARCH PSY CLIN N, V254, P295, DOI 10.1007/s00406-004-0496-z; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Hwang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078590; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Raybaud C, 2010, NEURORADIOLOGY, V52, P447, DOI 10.1007/s00234-010-0696-3; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Zimmerman RD, 1993, MED ASPECTS BOXING, P188	15	42	42	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					157	161		10.1089/neu.2014.3805			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200018	25970145	Green Published			2022-02-06	
J	Kober, SE; Schweiger, D; Witte, M; Reichert, JL; Grieshofer, P; Neuper, C; Wood, G				Kober, Silvia Erika; Schweiger, Daniela; Witte, Matthias; Reichert, Johanna Louise; Grieshofer, Peter; Neuper, Christa; Wood, Guilherme			Specific effects of EEG based neurofeedback training on memory functions in post-stroke victims	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Cognitive rehabilitation; EEG; Neurofeedback; Memory; Stroke recovery	TRAUMATIC BRAIN-INJURY; STROKE REHABILITATION; COGNITIVE IMPAIRMENT; ALPHA; PERFORMANCE; RHYTHM; SLEEP; HYPERACTIVITY; OSCILLATIONS; BIOFEEDBACK	Background: Using EEG based neurofeedback (NF), the activity of the brain is modulated directly and, therefore, the cortical substrates of cognitive functions themselves. In the present study, we investigated the ability of stroke patients to control their own brain activity via NF and evaluated specific effects of different NF protocols on cognition, in particular recovery of memory. Methods: N = 17 stroke patients received up to ten sessions of either SMR (N = 11, 12-15 Hz) or Upper Alpha (N = 6, e.g. 10-12 Hz) NF training. N = 7 stroke patients received treatment as usual as control condition. Furthermore, N = 40 healthy controls performed NF training as well. To evaluate the NF training outcome, a test battery assessing different cognitive functions was performed before and after NF training. Results: About 70 % of both patients and controls achieved distinct gains in NF performance leading to improvements in verbal short- and long-term memory, independent of the used NF protocol. The SMR patient group showed specific improvements in visuo-spatial short-term memory performance, whereas the Upper Alpha patient group specifically improved their working memory performance. NF training effects were even stronger than effects of traditional cognitive training methods in stroke patients. NF training showed no effects on other cognitive functions than memory. Conclusions: Post-stroke victims with memory deficits could benefit from NF training as much as healthy controls. The used NF training protocols (SMR, Upper Alpha) had specific as well as unspecific effects on memory. Hence, NF might offer an effective cognitive rehabilitation tool improving memory deficits of stroke survivors.	[Kober, Silvia Erika; Schweiger, Daniela; Witte, Matthias; Reichert, Johanna Louise; Neuper, Christa; Wood, Guilherme] Graz Univ, Dept Psychol, A-8010 Graz, Austria; [Kober, Silvia Erika; Neuper, Christa; Wood, Guilherme] BioTechMed Graz, Graz, Austria; [Grieshofer, Peter] Klin Judendorf Strassengel, Gratwein Strassengel, Austria; [Neuper, Christa] Graz Univ Technol, Inst Knowledge Discovery, Lab Brain Comp Interfaces, A-8010 Graz, Austria		Kober, SE (corresponding author), Graz Univ, Dept Psychol, Univ Pl 2-3, A-8010 Graz, Austria.	silvia.kober@uni-graz.at		Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336	European Community's Seventh-Framework-Programme FP7, CONTRAST project [287320]	This work was partially supported by the European Community's Seventh-Framework-Programme FP7/2007-2013, CONTRAST project, under grant agreement nr. 287320. Possible inaccuracies of information are under the responsibility of the project team. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of the information contained therein. The authors are grateful to Alexandra Pongratz, Aida Mujkanovic, Margit Krenn, Katharina Farveleder, Julia Schobel and Jasmin Wiesler for data acquisition.	Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Angelakis E, 2007, CLIN NEUROPSYCHOL, V21, P110, DOI 10.1080/13854040600744839; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Bearden TS, 2003, APPL PSYCHOPHYS BIOF, V28, P241, DOI 10.1023/A:1024689315563; Benjamini Y, 2001, ANN STAT, V29, P1165; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Bortz J., 2005, STAT HUMAN SOZIALWIS; Bounias M., 2001, Journal of Neurotherapy, V5, P23, DOI 10.1300/J184v05n04_03; Brain Products GmbH, 2009, BRAINVISION AN 2 0 1; Cannon KB., 2010, J NEUROTHER, V14, P107, DOI [10.1080/10874201003772155, DOI 10.1080/10874201003772155]; Dempster T, 2009, APPL PSYCHOPHYS BIOF, V34, P309, DOI 10.1007/s10484-009-9112-3; Doppelmayr M., 2011, J NEUROTHER, V15, P115, DOI [10.1080/10874208.2011.570689, DOI 10.1080/10874208.2011.570689]; Doppelmayr M., 2007, BIOFEEDBACK, V35, P126; Draganova R, 1999, PHYSIOL RES, V48, P157; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Escolano C, 2013, IEEE ENG MED BIO, P6293, DOI 10.1109/EMBC.2013.6610992; Escolano C, 2012, IEEE ENG MED BIO, P4643, DOI 10.1109/EMBC.2012.6347002; Escolano C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00296; Escolano C, 2011, IEEE ENG MED BIO, P2327, DOI 10.1109/IEMBS.2011.6090651; Fimm B, 2007, TESTBATTERIE AUFMERK; Fox DJ, 2005, APPL PSYCHOPHYS BIOF, V30, P365, DOI 10.1007/s10484-005-8422-3; Gruzelier JH, 2014, NEUROSCI BIOBEHAV R, V44, P124, DOI 10.1016/j.neubiorev.2013.09.015; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; Harting C., 2000, WECHSLER GEDACHTNIST; Hoedlmoser K, 2008, SLEEP, V31, P1401; Hofer D, 2014, LERNEN LERNSTORUNGEN, V3, P1; Hoffmann T, 2010, TOP STROKE REHABIL, V17, P99, DOI 10.1310/tsr1702-99; HOLM S, 1979, SCAND J STAT, V6, P65; Huber H. P., 1973, PSYCHOMETRISCHE EINZ; Huber H. P., 1977, BEHAV ANAL MODIFICAT, V2, P1; Kessler J, 1990, MINI MENTAL STATUS E; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kober SE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00695; Kober SE, 2015, CLIN NEUROPHYSIOL, V126, P82, DOI 10.1016/j.clinph.2014.03.031; Kropotov JD, 2009, QUANTITATIVE EEG, EVENT-RELATED POTENTIALS AND NEUROTHERAPY, P1; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; Melkas S, 2014, DEGENER NEUROL NEURO, V4, P21, DOI 10.2147/DNND.S37353; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Nan WY, 2012, INT J PSYCHOPHYSIOL, V86, P83, DOI 10.1016/j.ijpsycho.2012.07.182; Nelson LA, 2007, TOP STROKE REHABIL, V14, P59, DOI 10.1310/tsr1404-59; Niemann H, 2003, DTSCH NORMIERUNG; Ninaus M, 2015, BIOL PSYCHOL, V110, P126, DOI 10.1016/j.biopsycho.2015.07.009; Ninaus M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00914; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Putman J.A., 2002, J NEUROTHER, V5, P27, DOI DOI 10.1300/J184V05N03_; ROZELLE GR, 1995, BIOFEEDBACK SELF-REG, V20, P211, DOI 10.1007/BF01474514; Schabus M, 2014, BIOL PSYCHOL, V95, P126, DOI 10.1016/j.biopsycho.2013.02.020; Schelling D., 2001, VVM VISUELLER VERBAL; STERMAN MB, 1970, SCIENCE, V167, P1146, DOI 10.1126/science.167.3921.1146; Sterman MB, 1996, BIOFEEDBACK SELF-REG, V21, P3, DOI 10.1007/BF02214147; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vernon D, 2003, INT J PSYCHOPHYSIOL, V47, P75, DOI 10.1016/S0167-8760(02)00091-0; Vernon DJ, 2005, APPL PSYCHOPHYS BIOF, V30, P347, DOI 10.1007/s10484-005-8421-4; Weber E, 2011, APPL PSYCHOPHYS BIOF, V36, P37, DOI 10.1007/s10484-010-9142-x; Witte M, 2013, FRONT HUM NEUROSCI, V7, P1; Wood G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00171	61	42	44	2	32	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	DEC 1	2015	12								107	10.1186/s12984-015-0105-6			13	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	CX6EI	WOS:000365793600001	26625906	Green Published, gold			2022-02-06	
J	Fride, Y; Adamit, T; Maeir, A; Ben Assayag, E; Bornstein, NM; Korczyn, AD; Katz, N				Fride, Y.; Adamit, T.; Maeir, A.; Ben Assayag, E.; Bornstein, N. M.; Korczyn, A. D.; Katz, N.			What are the correlates of cognition and participation to return to work after first ever mild stroke?	TOPICS IN STROKE REHABILITATION			English	Article						Mild stroke; work; RTW; Cognition; Executive function; Participation; Quality of life	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; TO-MODERATE STROKE; IMPACT SCALE; HEALTH; REHABILITATION; VALIDITY; CONSEQUENCES; DETERMINANTS; RELIABILITY	Background: The percentage of working age people with mild stroke has risen. Evidence indicates that even mild stroke impact cognition, executive functioning, and daily functioning, consequently affecting participation, quality of life (QoL) and return to work (RTW). Objectives: (1) Compare cognition, participation and QoL between people 3 months post-mild stroke who RTW and those who did not; and (2) To determine the correlates of these variables to RTW of participants 3 months post-stroke. Methods: We visited at home 163 stroke survivors (117 men, 46 women) 3 months post-mild stroke ranging from 50 to 89 years. Participants who returned to work (n=114) and those who did not (n=49). Data collection at home included measures for cognitive status (MoCA), executive functions (EFPT, DEX), depression (GDS), participation (RNL), and QoL (SIS recovery). Results: Significant differences were found between RTW participants and those who did not RTW in measures of cognition, depression, participation and QoL (t=2.36 to -5.62, P<0.022-0.001). No difference was found on age or gender. Stepwise regression showed that significant correlates of RTW were participation (RNL), executive functions (EFPT), and QoL (SIS recovery). Conclusions: To enable RTW after mild stroke, participation, executive functions and QoL must be considered in planning interventions.	[Fride, Y.; Adamit, T.; Maeir, A.] Hebrew Univ Jerusalem, Sch Occupat Therapy, IL-91905 Jerusalem, Israel; [Ben Assayag, E.; Bornstein, N. M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Korczyn, A. D.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Katz, N.] Ono Acad Coll, Res Inst Hlth & Med Profess, Qiryat Ono, Israel		Katz, N (corresponding author), Ono Acad Coll, Res Inst Hlth & Med Profess, Qiryat Ono, Israel.	Noomi.katz@ono.ac.il	Korczyn, Amos D/C-3461-2017	Korczyn, Amos D/0000-0003-0125-2579; Maeir, Adina/0000-0002-3356-5847			Adamit T, 2015, DISABIL REHABIL, V37, P667, DOI 10.3109/09638288.2014.923523; Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Ben Assayag E, 2012, INT J STROKE, V7, P341, DOI 10.1111/j.1747-4949.2011.00652.x; Brenner MH., 2002, UNEMPLOYMENT EMPLOYM; Burton A.K., 2006, IS WORK GOOD YOUR HL; Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295; Carlsson GE, 2004, DISABIL REHABIL, V26, P1373, DOI 10.1080/09638280400000211; Carlsson GE, 2009, DISABIL REHABIL, V31, P773, DOI 10.1080/09638280802638857; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Frey B.S., 2002, HAPPINESS EC EC I AF; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hommel M, 2009, J NEUROL NEUROSUR PS, V80, P876, DOI 10.1136/jnnp.2008.169672; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Jaillard A, 2010, CEREBROVASC DIS, V29, P415, DOI 10.1159/000289344; Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; Johansson Ann, 2007, Occup Ther Int, V14, P170, DOI 10.1002/oti.232; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Lai SM, 2003, STROKE, V34, P488, DOI 10.1161/01.STR.0000054162.94998.C0; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Lindstrom M, 2005, OCCUP MED-OXFORD, V55, P568, DOI 10.1093/occmed/kqi122; Mansueti L, 2008, AGING NEUROPSYCHOL C, V15, P545, DOI 10.1080/13825580701858216; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Medin J, 2006, DISABIL REHABIL, V28, P1051, DOI 10.1080/09638280500494819; Mendis S, 2013, INT J STROKE, V8, P3, DOI 10.1111/j.1747-4949.2012.00969.x; Muren MA, 2008, TOP STROKE REHABIL, V15, P51, DOI 10.1310/tsr1501-51; Muus I, 2010, SCAND J CARING SCI, V24, P211, DOI 10.1111/j.1471-6712.2009.00705.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Brien AN, 2010, WORK, V36, P441, DOI 10.3233/WOR-2010-1047; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; RANKIN J, 1957, Scott Med J, V2, P200; Rochette A, 2007, TOP STROKE REHABIL, V14, P59, DOI 10.1310/tsr1403-59; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Roth EJ, 2014, TOP STROKE REHABIL, V21, pS75, DOI 10.1310/tsr21S1-S75; Saeki S, 2010, J REHABIL MED, V42, P254, DOI 10.2340/16501977-0503; Schmidt WP, 2004, J AM GERIATR SOC, V52, P1045, DOI 10.1111/j.1532-5415.2004.52300.x; Shopin L, 2013, DEMENT GERIATR COGN, V36, P36, DOI 10.1159/000350035; SMITH NR, 1986, AM J OCCUP THER, V40, P278, DOI 10.5014/ajot.40.4.278; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Srikanth VK, 2003, STROKE, V34, P1136, DOI 10.1161/01.STR.0000069161.35736.39; Stark SL, 2005, ARCH PHYS MED REHAB, V86, P344, DOI 10.1016/j.apmr.2004.03.020; Tanaka H, 2011, ARCH PHYS MED REHAB, V92, P743, DOI 10.1016/j.apmr.2010.12.009; Tellier M, 2009, TOP STROKE REHABIL, V16, P454, DOI 10.1310/tsr1606-454; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Wilson AB, 1997, METHODOLOGY FRONTAL, P239; Wolf TJ, 2009, AM J OCCUP THER, V63, P621, DOI 10.5014/ajot.63.5.621; WOLFE CDA, 1991, STROKE, V22, P1242, DOI 10.1161/01.STR.22.10.1242; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 2007, INT CLASS FUNCT DIS; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568; Wright J., FUNCTIONAL INDEPENDE; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	63	42	46	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.	OCT	2015	22	5					317	325		10.1179/1074935714Z.0000000013			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CT5HA	WOS:000362838400001	26461878				2022-02-06	
J	Ellis, MJ; Leiter, J; Hall, T; McDonald, PJ; Sawyer, S; Silver, N; Bunge, M; Essig, M				Ellis, Michael J.; Leiter, Jeff; Hall, Thomas; McDonald, Patrick J.; Sawyer, Scott; Silver, Norm; Bunge, Martin; Essig, Marco			Neuroimaging findings in pediatric sports-related concussion	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						neuroimaging; sports-related concussion; pediatric patients; computed tomography; magnetic resonance imaging; trauma	CRANIAL COMPUTED-TOMOGRAPHY; DIFFUSE AXONAL INJURY; DECISION RULE; HEAD-INJURY; INTERNATIONAL-CONFERENCE; ARACHNOID CYSTS; CHILDREN; RISK; STATEMENT; RETURN	OBJECT The goal in this review was to summarize the results of clinical neuroimaging studies performed in patients with sports-related concussion (SRC) who were referred to a multidisciplinary pediatric concussion program. METHODS The authors conducted a retrospective review of medical records and neuroimaging findings for all patients referred to a multidisciplinary pediatric concussion program between September 2013 and July 2014. Inclusion criteria were as follows: 1) age 19 years; and 2) physician-diagnosed SRC. All patients underwent evaluation and follow-up by the same neurosurgeon. The 2 outcomes examined in this review were the frequency of neuroimaging studies performed in this population (including CT and MRI) and the findings of those studies. Clinical indications for neuroimaging and the impact of neuroimaging findings on clinical decision making were summarized where available. This investigation was approved by the local institutional ethics review board. RESULTS A total of 151 patients (mean age 14 years, 59% female) were included this study. Overall, 36 patients (24%) underwent neuroimaging studies, the results of which were normal in 78% of cases. Sixteen percent of patients underwent CT imaging; results were normal in 79% of cases. Abnormal CT findings included the following: arachnoid cyst (1 patient), skull fracture (2 patients), suspected intracranial hemorrhage (1 patient), and suspected hemorrhage into an arachnoid cyst (1 patient). Eleven percent of patients underwent MRI; results were normal in 75% of cases. Abnormal MRI findings included the following: intraparenchymal hemorrhage and sylvian fissure arachnoid cyst (1 patient); nonhemorrhagic contusion (1 patient); demyelinating disease (1 patient); and posterior fossa arachnoid cyst, cerebellar volume loss, and nonspecific white matter changes (1 patient). CONCLUSIONS Results of clinical neuroimaging studies are normal in the majority of pediatric patients with SRC. However, in selected cases neuroimaging can provide information that impacts decision making about return to play and retirement from the sport.	[Ellis, Michael J.; Leiter, Jeff; McDonald, Patrick J.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Sawyer, Scott; Silver, Norm] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Bunge, Martin; Essig, Marco] Univ Manitoba, Dept Diagnost Imaging, Winnipeg, MB, Canada; [Leiter, Jeff; McDonald, Patrick J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Sawyer, Scott; Silver, Norm] Hlth Sci Ctr Childrens Hosp, Winnipeg, MB, Canada; [Ellis, Michael J.; Leiter, Jeff; Hall, Thomas; McDonald, Patrick J.] Pan Am Clin, Winnipeg, MB R3M 3E4, Canada; [Ellis, Michael J.; McDonald, Patrick J.] Canada North Concuss Network, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		essig, marco/0000-0002-7964-2297	Pan Am Clinic Foundation	We thank the Pan Am Clinic Foundation for their financial support of this study.	Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cress M, 2013, NEUROSURGERY, V72, P716, DOI 10.1227/NEU.0b013e318285b3a4; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395	43	42	42	0	15	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2015	16	3					241	247		10.3171/2015.1.PEDS14510			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CP6VY	WOS:000360027500001	26031620	Bronze			2022-02-06	
J	Johnson, B; Zhang, K; Hallett, M; Slobounov, S				Johnson, Brian; Zhang, Kai; Hallett, Mark; Slobounov, Semyon			Functional neuroimaging of acute oculomotor deficits in concussed athletes	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Oculomotor; Mild traumatic brain injury; Eye-Tracking	TRAUMATIC BRAIN-INJURY; MEMORY-GUIDED SACCADES; SMOOTH-PURSUIT; EYE-MOVEMENT; VOLITIONAL SACCADES; PREFRONTAL CORTEX; NEUROPHYSIOLOGY; ABNORMALITIES; NEUROANATOMY; PERFORMANCE	In the pursuit to better understand the neural underpinnings of oculomotor deficits following concussion we performed a battery of oculomotor tests while performing simultaneous functional magnetic resonance imaging (fMRI). Based on the increasing evidence that concussion can disrupt multiple brain functional networks, including the oculomotor control networks, a series of classic saccadic and smooth pursuit tasks were implemented. Nine concussed athletes were tested within seven days of injury along with nine age and sex matched healthy normal volunteers. Both behavioral and fMRI data revealed differential results between the concussed and normal volunteer groups. Concussed subjects displayed longer latency time in the saccadic tasks, worse position errors, and fewer numbers of self-paced saccades compared to normal volunteer subjects. Furthermore, the concussed group showed recruitment of additional brain regions and larger activation sites as evidenced by fMRI. As a potential diagnostic and management tool for concussion, oculomotor testing shows promise, and here we try to understand the reasons for this disrupted performance with the aide of advanced neuroimaging tools.	[Johnson, Brian; Zhang, Kai; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Slobounov, Semyon] Penn State Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Hallett, Mark; Slobounov, Semyon] NINDS, NIH, Bethesda, MD 20892 USA		Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, Penn 276 Recreat Bldg, University Pk, PA 16802 USA.	sms18@psu.edu	Zhang, Kai/F-3261-2015	Zhang, Kai/0000-0002-5460-6150	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002667] Funding Source: NIH RePORTER		Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; BodisWollner I, 1997, NEUROLOGY, V49, P416, DOI 10.1212/WNL.49.2.416; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; Dieterich M, 2009, ANN NY ACAD SCI, V1164, P282, DOI 10.1111/j.1749-6632.2008.03718.x; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Kaufman LD, 2010, J ALZHEIMERS DIS, V19, P781, DOI 10.3233/JAD-2010-1275; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Nitschke MF, 2004, HUM BRAIN MAPP, V22, P155, DOI 10.1002/hbm.20025; Ozyurt J, 2006, NEUROREPORT, V17, P1005; PIERROTDESEILLIGNY C, 1993, EXP BRAIN RES, V95, P166; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Schraa-Tam CKL, 2009, EXP BRAIN RES, V192, P175, DOI 10.1007/s00221-008-1569-4; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sweeney JA, 2007, NEUROIMAGE, V36, pT54, DOI 10.1016/j.neuroimage.2007.03.018; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Toepper M, 2010, BRAIN RES, V1354, P91, DOI 10.1016/j.brainres.2010.07.065; Van der Stappen A, 2000, ACTA OTO-LARYNGOL, V120, P724, DOI 10.1080/000164800750000243; Wade NJ, 2010, PERCEPTION, V39, P1150; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3	44	42	42	0	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					564	573		10.1007/s11682-014-9316-x			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR8LQ	WOS:000361604300016	25179246				2022-02-06	
J	Hammond, FM; Sherer, M; Malec, JF; Zafonte, RD; Whitney, M; Bell, K; Dikmen, S; Bogner, J; Mysiw, J; Pershad, R				Hammond, Flora M.; Sherer, Mark; Malec, James F.; Zafonte, Ross D.; Whitney, Marybeth; Bell, Kathleen; Dikmen, Sureyya; Bogner, Jennifer; Mysiw, Jerry; Pershad, Rashmi		Amantadine Irritability Multisite	Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study	JOURNAL OF NEUROTRAUMA			English	Article						agitation; aggression; amantadine; brain injuries; irritability	NEUROPSYCHIATRIC INVENTORY; BEHAVIOR-CHANGE; ALLIANCE; DISEASE; TRIALS; SCALE	This study examines the effect of amantadine on irritability in persons in the post-acute period after traumatic brain injury (TBI). There were 168 persons 6 months post-TBI with irritability who were enrolled in a parallel-group, randomized, double-blind, placebo-controlled trial receiving either amantadine 100mg twice daily or equivalent placebo for 60 days. Subjects were assessed at baseline and days 28 (primary end-point) and 60 of treatment using observer-rated and participant-rated Neuropsychiatric Inventory (NPI-I) Most Problematic item (primary outcome), NPI Most Aberrant item, and NPI-I Distress Scores, as well as physician-rated Clinical Global Impressions (CGI) scale. Observer ratings between the two groups were not statistically significantly different at day 28 or 60; however, observers rated the majority in both groups as having improved at both intervals. Participant ratings for day 60 demonstrated improvements in both groups with greater improvement in the amantadine group on NPI-I Most Problematic (p<0.04) and NPI-I Distress (p<0.04). These results were not significant with correction for multiple comparisons. CGI demonstrated greater improvement for amantadine than the placebo group (p<0.04). Adverse event occurrence did not differ between the two groups. While observers in both groups reported large improvements, significant group differences were not found for the primary outcome (observer ratings) at either day 28 or 60. This large placebo or nonspecific effect may have masked detection of a treatment effect. The result of this study of amantadine 100mg every morning and noon to reduce irritability was not positive from the observer perspective, although there are indications of improvement at day 60 from the perspective of persons with TBI and clinicians that may warrant further investigation.	[Hammond, Flora M.; Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Hammond, Flora M.; Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hammond, Flora M.; Whitney, Marybeth; Pershad, Rashmi] Carolinas HealthCare Syst, Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Zafonte, Ross D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bell, Kathleen; Dikmen, Sureyya] Univ Washington, Seattle, WA 98195 USA; [Bogner, Jennifer; Mysiw, Jerry] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bell, Kathleen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Carolinas Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com		Bell, Kathleen/0000-0002-0928-2046	US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133A080035]	The research reported in this article was supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability and Rehabilitation Research grant H133A080035. This support included the funds to purchase amantadine. The study sponsor had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; or the preparation review, or approval of the manuscript.	Berry DA, 1996, J NATL CANCER I, V88, P1606, DOI 10.1093/jnci/88.22.1606; Bird EL, 2013, HEALTH PSYCHOL, V32, P829, DOI 10.1037/a0032078; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ehde D., 2014, 42 ANN S INT NEUR SO; Eknoyan D, 2013, J NEUROPSYCH CLIN N, V25, P250; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Fava M, 2003, PSYCHOTHER PSYCHOSOM, V72, P115, DOI 10.1159/000069738; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; HOLM S, 1979, SCAND J STAT, V6, P65; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; Peeters M, 2003, NEUROSCI LETT, V343, P205, DOI 10.1016/S0304-3940(03)00398-7; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Rief W, 2009, J AFFECT DISORDERS, V118, P1, DOI 10.1016/j.jad.2009.01.029; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Spahn JM, 2010, J AM DIET ASSOC, V110, P879, DOI 10.1016/j.jada.2010.03.021; Wampold, 2001, GREAT PSYCHOTHERAPY; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	26	42	42	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1230	1238		10.1089/neu.2014.3803			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400007	25774566	Green Published, Bronze			2022-02-06	
J	Blixt, J; Svensson, M; Gunnarson, E; Wanecek, M				Blixt, Jonas; Svensson, Mikael; Gunnarson, Eli; Wanecek, Michael			Aquaporins and blood-brain barrier permeability in early edema development after traumatic brain injury	BRAIN RESEARCH			English	Article						Aquaporin; Blood-brain barrier; Brain injury; Brain edema; Rat; Brain trauma	CEREBRAL-ISCHEMIA; HEAD-INJURY; CELLULAR EDEMA; WATER CHANNELS; RAT MODEL; MICE; DISRUPTION; EXPRESSION; HYPOXIA; VOLUME	Traumatic brain injury (TB!) is a major contributor to mortality and morbidity. The pathophysiology involves development of brain edema. Therapeutic options are limited as the mechanisms are not fully understood. Changes in the function of the blood-brain barrier (BBB), as well as variations in aquaporin expression, have been proposed to be involved in the development of the edema but the contribution of each factor has not been fully elucidated. In order to evaluate these mechanisms, in a potential window of opportunity, the early dynamic response was studied using an animal model causing a moderate TBI. Sprague-Dawley rats were subjected to blunt controlled head trauma and followed for up to four days by magnetic-resonance-imaging, immunohistofluorescence, immunohistochemistry, and quantitative protein analysis. Non-traumatized animals served as controls. TBI resulted in a midline shift and a decrease in Apparent Diffusion Coefficient indicating a hemispheric enlargement due to cytotoxic edema. The tight junction protein Zona Occludens-1 was decreased (-25%) and associated with an increased IgG permeability (+20%) in the perilesional brain tissue in accordance with a BBB breakdown. The total amount of AQP4 protein decreased (-20%). The disruption of the BBB lasted for 4 days while the impact on AQP4 levels disappeared between day 1 and 4. Our findings shows that blunt focal brain injury results in an early development of brain edema involving both cytotoxic and vasogenic components, a persistent BBB breakdown and a temporaxy decrease in AQP4, and indicates that both types of edemas and mechanisms should be targeted in TBI treatment. (C) 2015 Elsevier B.V. All rights reserved.	[Blixt, Jonas] Karolinska Inst, Karolinska Univ Hosp, Dept Anesthesiol & Intens Care, SE-17177 Stockholm, Sweden; [Blixt, Jonas; Wanecek, Michael] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Svensson, Mikael] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Gunnarson, Eli] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden		Blixt, J (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	Jonas.blixt@karolinska.se; Mikael.svensson@ki.se; Eli.gunnarson@ki.se; Michael.wanecek@ki.se	Wanecek, Michael/AAE-7998-2021; Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003	Swedish Medical Research FoundationSwedish Medical Research Council (SMRC); Swedish Society of Medicine [C330132013]; Magn. Bergvalls Foundation; Karolinska InstitutetKarolinska Institutet [C330132023]; Sallskapet Barnavard; Stockholm County CouncilStockholm County Council; Karolinska InstitutetKarolinska Institutet	The authors would like to thank Tim Baker for proof reading and language help, Britt Meijer and Anette Ebberyd for excellent technical assistance. This Study was supported by the Swedish Medical Research Foundation, the Swedish Society of Medicine (C330132013), Magn. Bergvalls Foundation, Funds from the Karolinska Institutet (C330132023), Sallskapet Barnavard and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Broman T, 1955, ACTA PSYCH NEUROL, V30, P115, DOI 10.1111/j.1600-0447.1955.tb06051.x; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Castejon OJ, 1998, J SUBMICR CYTOL PATH, V30, P145; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Honeybul S, 2011, J NEUROSURG SCI, V55, P343; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jou IM, 2000, J APPL PHYSIOL, V89, P1766, DOI 10.1152/jappl.2000.89.5.1766; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; KEMPSKI O, 1987, STROKE, V18, P623, DOI 10.1161/01.STR.18.3.623; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Koyama Junji, 2007, Kobe J Med Sci, V53, P199; Lythgoe MF, 1997, MAGN RESON MED, V38, P662, DOI 10.1002/mrm.1910380421; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Nielsen S, 1997, J NEUROSCI, V17, P171; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rao KVR, 2007, METAB BRAIN DIS, V22, P265, DOI 10.1007/s11011-007-9063-4; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818	64	42	45	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 22	2015	1611						18	28		10.1016/j.brainres.2015.03.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK3PD	WOS:000356127100003	25770057				2022-02-06	
J	Villiger, M; Grabher, P; Hepp-Reymond, MC; Kiper, D; Curt, A; Bolliger, M; Hotz-Boendermaker, S; Kollias, S; Eng, K; Freund, P				Villiger, Michael; Grabher, Patrick; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Curt, Armin; Bolliger, Marc; Hotz-Boendermaker, Sabina; Kollias, Spyros; Eng, Kynan; Freund, Patrick			Relationship between structural brainstem and brain plasticity and lower-limb training in spinal cord injury: a longitudinal pilot study	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						spinal cord injury; structural plasticity; lower limb; virtual reality-augmented neurorehabilitation; tensor-based morphometry; voxel-based morphometry	VOXEL-BASED MORPHOMETRY; TENSOR-BASED MORPHOMETRY; VIRTUAL-REALITY; CEREBELLAR DEGENERATION; CORTICAL THICKNESS; RAPID PLASTICITY; NEUROPATHIC PAIN; MOTOR CORTEX; GRAY; MRI	Rehabilitative training has shown to improve significantly motor outcomes and functional walking capacity in patients with incomplete spinal cord injury (iSCI). However, whether performance improvements during rehabilitation relate to brain plasticity or whether it is based on functional adaptation of movement strategies remain uncertain. This study assessed training improvement-induced structural brain plasticity in chronic iSCI patients using longitudinal MRI. We used tensor-based morphometry (TBM) to analyze longitudinal brain volume changes associated with intensive virtual reality (VR)-augmented lower limb training in nine traumatic iSCI patients. The MRI data was acquired before and after a 4-week training period (16-20 training sessions). Before training, voxel-based morphometry (VBM) and voxel-based cortical thickness (VBCT) assessed baseline morphometric differences in nine iSCI patients compared to 14 healthy controls. The intense VR-augmented training of limb control improved significantly balance, walking speed, ambulation, and muscle strength in patients. Retention of clinical improvements was confirmed by the 3-4 months follow-up. In patients relative to controls, VBM revealed reductions of white matter volume within the brainstem and cerebellum and VBCT showed cortical thinning in the primary motor cortex. Over time, TBM revealed significant improvement-induced volume increases in the left middle temporal and occipital gyrus, left temporal pole and fusiform gyrus, both hippocampi, cerebellum, corpus callosum, and brainstem in iSCI patients. This study demonstrates structural plasticity at the cortical and brainstem level as a consequence of VR-augmented training in iSCI patients. These structural changes may serve as neuroimaging biomarkers of VR-augmented lower limb neurorehabilitation in addition to performance measures to detect improvements in rehabilitative training.	[Villiger, Michael; Grabher, Patrick; Curt, Armin; Bolliger, Marc; Hotz-Boendermaker, Sabina; Freund, Patrick] Univ Zurich, Spinal Cord Injury Ctr Balgrist, CH-8008 Zurich, Switzerland; [Villiger, Michael] Univ Coll Physiotherapy Thim van der Laan, Landquart, Switzerland; [Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] ETH, Zurich, Switzerland; [Kollias, Spyros] Univ Zurich, Univ Zurich Hosp, Inst Neuroradiol, Zurich, Switzerland; [Freund, Patrick] UCL, Dept Brain Repair & Rehabil, UCL Inst Neurol, London, England; [Freund, Patrick] UCL, Wellcome Trust Ctr Neuroimaging, UCL Inst Neurol, London, England		Villiger, M (corresponding author), Univ Zurich, Spinal Cord Injury Ctr Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	michael.villiger@gmail.com; pfreund@paralab.balgrist.ch	Freund, Patrick/D-4193-2013; Hotz, S/AAL-7043-2020; Bolliger, Marc/AAC-8076-2020	Freund, Patrick/0000-0002-4851-2246; Hotz, S/0000-0001-9455-6074; Bolliger, Marc/0000-0001-9059-0304; Eng, Kynan/0000-0002-1434-8767; Grabher, Patrick/0000-0002-5420-6114	International Foundation for Research in Paraplegia (IRP); Clinical Research Priority Program (CRPP); Neuro-Rehab UZH; Swiss National Science Foundation (SNP)Swiss National Science Foundation (SNSF) [51NF40-144619/PMPDP3-124282]; OPO Foundation Zurich; Neuroscience Center Zurich (ZNZ); Wings for Life [WFL-CH-007/14]	Thanks to Pawel Pyk, Jeremy Spillmann and Bruno Meilick for their technical support, to Chris Schmidt for his critical review of a former version of this manuscript and to all participants for their generous help. There is a commercial interest of two authors (Kiper and Eng) relevant to the subject of the manuscript. All other authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. This research was supported by the International Foundation for Research in Paraplegia (IRP), Clinical Research Priority Program (CRPP), Neuro-Rehab UZH, Swiss National Science Foundation (SNP; Grant Number 51NF40-144619/PMPDP3-124282), OPO Foundation Zurich, the Neuroscience Center Zurich (ZNZ) and Wings for Life (WFL-CH-007/14).	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Bryce TN, 2012, SPINAL CORD, V50, P404, DOI 10.1038/sc.2012.2; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Catz A, 2007, SPINAL CORD, V45, P275, DOI 10.1038/sj.sc.3101960; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Deliagina TG, 2008, BRAIN RES REV, V57, P212, DOI 10.1016/j.brainresrev.2007.06.017; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051729; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Hassanpour K, 2012, J NEUROL, V259, P1142, DOI 10.1007/s00415-011-6316-2; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Houk JC, 1996, BEHAV BRAIN SCI, V19, P368, DOI 10.1017/S0140525X00081474; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kantak SS, 2013, NEUROSCIENCE, V247, P55, DOI 10.1016/j.neuroscience.2013.05.001; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; Landi SM, 2011, J NEUROSCI, V31, P11808, DOI 10.1523/JNEUROSCI.2253-11.2011; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Moseley GL, 2007, PAIN, V130, P294, DOI 10.1016/j.pain.2007.01.007; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sampaio-Baptista C, 2015, NEUROIMAGE, V106, P15, DOI 10.1016/j.neuroimage.2014.11.032; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Tao GZ, 2009, J NEUROL SCI, V282, P39, DOI 10.1016/j.jns.2008.12.035; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; van Hedel H, 2006, SPINAL CORD, V44, P352, DOI 10.1038/sj.sc.3101853; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Villiger M., 2011, INT C VIRT REH ICVR; Villiger M, 2013, NEUROREHAB NEURAL RE, V27, P675, DOI 10.1177/1545968313490999; Walz AD, 2015, BEHAV BRAIN RES, V278, P393, DOI 10.1016/j.bbr.2014.08.044; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078	55	42	45	3	26	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 6	2015	9								254	10.3389/fnhum.2015.00254			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CK2AL	WOS:000356011600001	25999842	Green Published, gold, Green Accepted			2022-02-06	
J	Ponsford, JL; Spitz, G				Ponsford, Jennie L.; Spitz, Gershon			Stability of Employment Over the First 3 Years Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						employment; productivity; return to work; traumatic brain injury	POSTTRAUMATIC AMNESIA; COMMUNITY INTEGRATION; ACUTE PREDICTORS; RETURN; WORK; PRODUCTIVITY; MULTICENTER; MODERATE; OUTCOMES; LIFE	Objective: To examine the stability of employment between 1 and 3 years following traumatic brain injury (TBI) and to identify the variables associated with continued employment throughout this time span. Participants: This study included 236 individuals with predominantly moderate to very severe TBI, who had received rehabilitation in the context of a no-fault accident compensation system. Participants were eligible for the current study if they were employed before injury and reported their employment status at 1, 2, and 3 years following their injury as part of a longitudinal head injury outcome study. Results: Only 44% of participants remained employed at each of the 3 years following TBI. There was also substantial transition into and out of employment across the 3 years. Significantly greater instability in employment was reported by individuals who were machinery operators or laborers before injury, had a longer duration of posttraumatic amnesia, reported more cognitive difficulties, and were less mobile 1 year following their injury. Conclusion: A number of important factors determine the likelihood of achieving stability in employment following TBI. Findings from the current study support the continued need to identify ways in which physical as well as cognitive changes contribute to employment following TBI. Further examination is needed to identify possible compensatory strategies or job modifications to maximize the likelihood of job retention.	[Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia; Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17,Clayton Campus,Wellington Rd, Melbourne, Vic 3800, Australia.	Jennie.Ponsford@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480			Access Economics, 2009, EC COST SPINAL CORD; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Australian Bureau of Statistics, 2013, LAB FORC AUSTR CAT 6; Australian Bureau of Statistics, 2006, ANZC AUSTR NZ STAND; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Erez ABH, 2009, AM J OCCUP THER, V63, P634; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Goran DA, 1997, ARCH CLIN NEUROPSYCH, V12, P691, DOI 10.1016/S0887-6177(97)00004-8; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; O'Neill L J, 1998, Br J Nurs, V7, P842; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Possl O, 2001, BRAIN INJURY, V15, P15; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	44	42	42	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E1	E11		10.1097/HTR.0000000000000033			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100001	24816157				2022-02-06	
J	Rassovsky, Y; Levi, Y; Agranov, E; Sela-Kaufman, M; Sverdlik, A; Vakil, E				Rassovsky, Yuri; Levi, Yifat; Agranov, Eugenia; Sela-Kaufman, Michal; Sverdlik, Anna; Vakil, Eli			Predicting long-term outcome following traumatic brain injury (TBI)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Functional outcome; Rehabilitation; Head injury; Traumatic brain injury; Cognitive reserve; Injury severity	INFORMATION-PROCESSING SPEED; SEVERE HEAD-INJURY; COGNITIVE RESERVE; INCOG RECOMMENDATIONS; LIFE-STYLE; ENVIRONMENTAL ENRICHMENT; UNITED-STATES; SEVERITY; DEMENTIA; MEMORY	Objective: Traumatic brain injury (TBI) is the most common cause of brain damage, resulting in long-term disability. The ever increasing life expectancies among TBI patients necessitate a critical examination of the factors that influence long-term outcome. Our objective was to evaluate the contribution of premorbid factors (which were identified in our previous work) and acute injury indices to long-term functioning following TBI. Method: Eighty-nine participants with moderate-to-severe TBI were evaluated at an average of 14.2 years postinjury (range: 1-53 years) with neuropsychological battery, medical examination, clinical interviews, and questionnaires. Results: TBI severity predicted cognitive, social, and daily functioning outcomes. After controlling for injury severity, preinjury intellectual functioning predicted cognitive status, as well as occupational, social, emotional, and daily functioning. Preinjury leisure activity also predicted cognitive, emotional, and daily functioning, whereas socioeconomic status failed to predict any of these variables. Conclusion: Findings offer further support for the cognitive reserve construct in explaining significant variance in TBI outcome, over and above the variance explained by injury severity.	[Rassovsky, Yuri; Levi, Yifat; Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri; Vakil, Eli] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Agranov, Eugenia; Sverdlik, Anna] Chaim Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel; [Agranov, Eugenia; Sverdlik, Anna] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel; [Sela-Kaufman, Michal] Acad Coll Tel Aviv Yaffo, Dept Behav Sci, Tel Aviv, Israel		Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	yurir@biu.ac.il		Rassovsky, Yuri/0000-0002-6362-9944	Israeli Ministry of Defense, Rehabilitation Department; National Institute for the Rehabilitation of the Brain Injured	This work was supported by the Israeli Ministry of Defense, Rehabilitation Department, and the National Institute for the Rehabilitation of the Brain Injured.	Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bigler E. D, 2006, COGNITIVE RESERVE TH; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chamberlain M. A., 1995, TRAUMATIC BRAIN INJU, P3; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Derogatis L.R., 1975, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fritsch T, 2007, GERONTOLOGIST, V47, P307, DOI 10.1093/geront/47.3.307; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Grafman J., 1989, PREOPERATIVE EVENTS, P277; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Heaton SK, 1993, WISCONSIN CARD SORTI; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; MELAMED S, 1985, SCAND J REHABIL MED, P129; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Qiu CX, 2001, ARCH NEUROL-CHICAGO, V58, P2034, DOI 10.1001/archneur.58.12.2034; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rey A., 1964, EXAMEN CLIN PSYCHOL; Roe A., 1956, PSYCHOL OCCUPATIONS, P76; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Sherer M, 1999, BRAIN INJURY, V13, P973; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Silver J. M., 2005, TXB TRAUMATIC BRAIN; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	42	43	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 21	2015	37	4					354	366		10.1080/13803395.2015.1015498			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CI7GP	WOS:000354931400002	25832742				2022-02-06	
J	Muradashvili, N; Benton, RL; Saatman, KE; Tyagi, SC; Lominadze, D				Muradashvili, Nino; Benton, Richard L.; Saatman, Kathryn E.; Tyagi, Suresh C.; Lominadze, David			Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice	METABOLIC BRAIN DISEASE			English	Article						Caveolae; Cellular prion protein (PrPC); Cerebrovascular permeability; Fibrinogen; Macromolecular leakage; Memory loss	OBJECT RECOGNITION; PRION PROTEIN; IN-VIVO; BLOOD; DISEASE; BINDING; MECHANISMS; EXPRESSION; EDEMA; MODEL	Traumatic brain injury (TBI) is accompanied with enhanced matrix metalloproteinase-9 (MMP-9) activity and elevated levels of plasma fibrinogen (Fg), which is a known inflammatory agent. Activation of MMP-9 and increase in blood content of Fg (i.e. hyperfibrinogenemia, HFg) both contribute to cerebrovascular disorders leading to blood brain barrier disruption. It is well-known that activation of MMP-9 contributes to vascular permeability. It has been shown that at an elevated level (i.e. HFg) Fg disrupts blood brain barrier. However, mechanisms of their actions during TBI are not known. Mild TBI was induced in wild type (WT, C57BL/6 J) and MMP-9 gene knockout (Mmp9(-/-)) homozygous, mice. Pial venular permeability to fluorescein isothiocyanate-conjugated bovine serum albumin in pericontusional area was observed 14 days after injury. Mice memory was tested with a novel object recognition test. Increased expression of Fg endothelial receptor intercellular adhesion protein-1 and formation of caveolae were associated with enhanced activity of MMP-9 causing an increase in pial venular permeability. As a result, an enhanced deposition of Fg and cellular prion protein (PrPC) were found in pericontusional area. These changes were attenuated in Mmp9(-/-) mice and were associated with lesser loss of short-term memory in these mice than in WT mice. Our data suggest that mild TBI-induced increased cerebrovascular permeability enhances deposition of Fg-PrPC and loss of memory, which is ameliorated in the absence of MMP-9 activity. Thus, targeting MMP-9 activity and blood level of Fg can be a possible therapeutic remedy to diminish vasculo-neuronal damage after TBI.	[Muradashvili, Nino; Tyagi, Suresh C.; Lominadze, David] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40202 USA; [Benton, Richard L.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Benton, Richard L.] Univ Louisville, Sch Med, KSCIRC, Louisville, KY 40202 USA; [Saatman, Kathryn E.] Univ Kentucky, Dept Physiol & Neurosurg & Spinal Cord, Lexington, KY USA; [Saatman, Kathryn E.] Univ Kentucky, Brain Injury Res Ctr SCoBIRC, Lexington, KY USA		Lominadze, D (corresponding author), Univ Louisville, Sch Med, Dept Physiol & Biophys, Bldg A,Room 1115,500 South Preston St, Louisville, KY 40202 USA.	dglomi01@louisville.edu		Lominadze, David/0000-0002-9911-4539	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 GM-103507, NS-084823, NS-051568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071010, R01HL108621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051568, R01NS084823] Funding Source: NIH RePORTER	Supported in part by NIH grants P30 GM-103507 (Pilot Project to D.L.), NS-084823 (to D.L. and S.C.T.), and NS-051568 (to S.C.T.)	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chhabra G, 2010, NEUROL INDIA, V58, P756, DOI 10.4103/0028-3886.72175; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; del Zoppo GJ, 2009, STROKE, V40, P1687, DOI 10.1161/STROKEAHA.108.527804; DERASMO E, 1993, J MED, V24, P185; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Fernandez-Patron C, 2001, FASEB J, V15, P2230, DOI 10.1096/fj.01-0178com; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Granger DN, 2010, C SERIES INTEGRATED; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hnasko R, 2002, J ENDOCRINOL, V175, P649, DOI 10.1677/joe.0.1750649; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LETCHER RL, 1981, AM J MED, V70, P1195, DOI 10.1016/0002-9343(81)90827-5; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; Lominadze D, 2005, AM J PHYSIOL-HEART C, V288, pH1257, DOI 10.1152/ajpheart.00856.2004; Lominadze D, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02037.x; Lominadze D, 1998, AM J HYPERTENS, V11, P784, DOI 10.1016/S0895-7061(98)00056-9; Lyon L, 2012, PSYCHOPHARMACOLOGY, V220, P647, DOI 10.1007/s00213-011-2536-5; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mozer AB, 2010, CURR NEUROVASC RES, V7, P238; Muradashvili N, 2013, CELL BIOCH BIOPHYSIC; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Muradashvili N, 2011, BIOCHEM BIOPH RES CO, V413, P509, DOI 10.1016/j.bbrc.2011.07.133; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Phillips PG, 2004, AM J PHYSIOL-LUNG C, V286, pL1055, DOI 10.1152/ajplung.00262.2003; Pleasant J, 2011, J NEUROTRAUMA; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rosell A, 2005, STROKE, V36, P1415, DOI 10.1161/01.STR.0000170641.01047.cc; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sen U, 2009, AM J PHYSIOL-CELL PH, V296, pC840, DOI 10.1152/ajpcell.00515.2008; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhang RF, 2012, ANAL BIOCHEM, V427, P116, DOI 10.1016/j.ab.2012.05.008; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	73	42	42	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	APR	2015	30	2					411	426		10.1007/s11011-014-9550-3			16	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	CD2HA	WOS:000350894800007	24771110	Green Accepted			2022-02-06	
J	Peltz, ED; D'Alessandro, A; Moore, EE; Chin, T; Silliman, CC; Sauaia, A; Hansen, KC; Banerjee, A				Peltz, Erik D.; D'Alessandro, Angelo; Moore, Ernest E.; Chin, Theresa; Silliman, Christopher C.; Sauaia, Angela; Hansen, Kirk C.; Banerjee, Anirban			Pathologic metabolism: An exploratory study of the plasma metabolome of critical injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Metabolomics; trauma; energy metabolism; proteolysis; lipolysis; ketoacidosis	TRAUMATIC BRAIN-INJURY; MULTIPLE ORGAN FAILURE; LUNG INJURY; HEMORRHAGIC-SHOCK; ROUTINE STORAGE; BASE DEFICIT; IN-VITRO; ACID; LACTATE; CARE	BACKGROUND: Severe trauma is associated with massive alterations in metabolism. Thus far, investigations have relied on traditional bioanalytic approaches including calorimetry or nuclear magnetic resonance. However, recent strides in mass spectrometry (MS)-based metabolomics present enhanced analytic opportunities to characterize a wide range of metabolites in the critical care setting. METHODS: MS-based metabolomics analyses were performed on plasma samples from severely injured patients' trauma activation field blood and plasma samples obtained during emergency department thoracotomy. These were compared against the metabolic profiles of healthy controls. RESULTS: Few significant alterations were observed between trauma activation field blood and emergency department thoracotomy patients. In contrast, we identified trauma-dependent metabolic signatures, which support a state of hypercatabolism, driven by sugar consumption, lipolysis and fatty acid use, accumulation of ketone bodies, proteolysis and nucleoside breakdown, which provides carbon and nitrogen sources to compensate for trauma-induced energy consumption and negative nitrogen balance. Unexpectedly, metabolites of bacterial origin (including tricarballylate and citramalate) were detected in plasma from trauma patients. CONCLUSION: In the future, the correlation between metabolomics adaptation and recovery outcomes could be studied by MS-based approaches, and this work can provide a method for assessing the efficacy of alternative resuscitation strategies. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Peltz, Erik D.; Moore, Ernest E.; Chin, Theresa; Silliman, Christopher C.; Sauaia, Angela] Univ Colorado Denver, Sch Med, Dept Surg, Trauma Res Ctr, Aurora, CO USA; [D'Alessandro, Angelo; Hansen, Kirk C.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Sauaia, Angela] Univ Colorado Denver, Sch Med, Dept Hlth Care Policy & Res, Aurora, CO USA; [Silliman, Christopher C.] Univ Colorado Denver, Sch Med, Dept Pediat Haematol Oncol, Anschutz Med Campus Childrens Hosp Colorado, Aurora, CO USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Aurora, CO USA; [Silliman, Christopher C.] Belle Bonfils Blood Ctr, Denver, CO USA		Peltz, ED (corresponding author), Univ Colorado Anschutz Med Campus, Dept Surg, 12631 E 17th Ave,Room 6001, Aurora, CO 80045 USA.	Erik.Peltz@ucdenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM008315, P50-GM049222]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008315, P50GM049222] Funding Source: NIH RePORTER	This study was supported in part by National Institute of General Medical Sciences grants T32-GM008315 and P50-GM049222. E.D.P., A.D., E.E.M., T.C., C.C.S., A.S., K.C.H., and A.B. have no reported biomedical financial interests or potential conflicts of interest.	Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Beloborodova N, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-89; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Bruegger D, 2007, CRIT CARE, V11, DOI 10.1186/cc6200; Chaleckis R, 2014, MOL BIOSYST, V10, P2538, DOI 10.1039/c4mb00346b; CLOWES GHA, 1985, ANN SURG, V202, P446, DOI 10.1097/00000658-198510000-00006; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; D'Alessandro A, 2015, VOX SANG, V108, P131, DOI 10.1111/vox.12193; D'Alessandro A, 2015, TRANSFUSION, V55, P205, DOI 10.1111/trf.12804; D'Alessandro A, 2012, HAEMATOL-HEMATOL J, V97, P107, DOI 10.3324/haematol.2011.051789; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dieterle F, 2011, METHODS MOL BIOL, V691, P385, DOI 10.1007/978-1-60761-849-2_24; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; FORSE RA, 1987, ANN SURG, V206, P744, DOI 10.1097/00000658-198712000-00010; Franconi F, 2001, THROMB RES, V102, P255, DOI 10.1016/S0049-3848(01)00249-3; FRANKENFIELD DC, 1994, CRIT CARE MED, V22, P1796; Hasenboehler Erik, 2006, World J Emerg Surg, V1, P29, DOI 10.1186/1749-7922-1-29; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3; KOIKE K, 1994, CRIT CARE MED, V22, P1438, DOI 10.1097/00003246-199409000-00014; Lee SJ, 2006, NEPHROL DIAL TRANSPL, V21, P3; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Mao HL, 2009, J PROTEOME RES, V8, P5423, DOI 10.1021/pr900576y; Martin M, 2005, J TRAUMA, V58, P238, DOI 10.1097/01.TA.0000152535.97968.4E; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; MOORE FA, 1992, J TRAUMA, V33, P58, DOI 10.1097/00005373-199207000-00012; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Moviat M, 2008, CRIT CARE MED, V36, P752, DOI 10.1097/CCM.0B013E31816443CB; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peltz ED, 2009, SURGERY, V146, P347, DOI 10.1016/j.surg.2009.02.022; PIEK J, 1985, INTENS CARE MED, V11, P192, DOI 10.1007/BF00272402; Pitt J, 2002, J INHERIT METAB DIS, V25, P83, DOI 10.1023/A:1015654608166; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; SCHUMER W, 1986, J TRAUMA, V26, P1009, DOI 10.1097/00005373-198611000-00009; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; SEYDEWITZ HH, 1984, THROMB RES, V33, P487, DOI 10.1016/0049-3848(84)90014-8; Silliman CC, 2011, TRANSFUSION, V51, P2549, DOI 10.1111/j.1537-2995.2011.03186.x; Spath B, 2012, PLATELETS, V23, P60, DOI 10.3109/09537104.2011.590255; VANDERMEER C, 1981, CIRC SHOCK, V8, P375; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020; Wischmeyer PE, 2014, CRIT CARE, V18, DOI 10.1186/cc13836; Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569	50	42	43	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2015	78	4					742	751		10.1097/TA.0000000000000589			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CE8EJ	WOS:000352074000013	25807403	Green Accepted			2022-02-06	
J	Walker, WC; Cifu, DX; Hudak, AM; Goldberg, G; Kunz, RD; Sima, AP				Walker, William C.; Cifu, David X.; Hudak, Anne M.; Goldberg, Gary; Kunz, Richard D.; Sima, Adam P.			Structured Interview for Mild Traumatic Brain Injury after Military Blast: Inter-Rater Agreement and Development of Diagnostic Algorithm	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; epidemiology; adult brain injury; traumatic brain injury; concussion; military injury	OPERATION ENDURING FREEDOM; IRAQI FREEDOM; TBI IDENTIFICATION; STRESS-DISORDER; UNITED-STATES; VETERANS; CONCUSSION; VALIDITY; RELIABILITY; DEPLOYMENT	The existing gold standard for diagnosing a suspected previous mild traumatic brain injury (mTBI) is clinical interview. But it is prone to bias, especially for parsing the physical versus psychological effects of traumatic combat events, and its inter-rater reliability is unknown. Several standardized TBI interview instruments have been developed for research use but have similar limitations. Therefore, we developed the Virginia Commonwealth University (VCU) retrospective concussion diagnostic interview, blast version (VCU rCDI-B), and undertook this cross-sectional study aiming to 1) measure agreement among clinicians' mTBI diagnosis ratings, 2) using clinician consensus develop a fully structured diagnostic algorithm, and 3) assess accuracy of this algorithm in a separate sample. Two samples (n=66; n=37) of individuals within 2 years of experiencing blast effects during military deployment underwent semistructured interview regarding their worst blast experience. Five highly trained TBI physicians independently reviewed and interpreted the interview content and gave blinded ratings of whether or not the experience was probably an mTBI. Paired inter-rater reliability was extremely variable, with kappa ranging from 0.194 to 0.825. In sample 1, the physician consensus prevalence of probable mTBI was 84%. Using these diagnosis ratings, an algorithm was developed and refined from the fully structured portion of the VCU rCDI-B. The final algorithm considered certain symptom patterns more specific for mTBI than others. For example, an isolated symptom of "saw stars" was deemed sufficient to indicate mTBI, whereas an isolated symptom of "dazed" was not. The accuracy of this algorithm, when applied against the actual physician consensus in sample 2, was almost perfect (correctly classified=97%; Cohen's kappa=0.91). In conclusion, we found that highly trained clinicians often disagree on historical blast-related mTBI determinations. A fully structured interview algorithm was developed from their consensus diagnosis that may serve to enhance diagnostic standardization for clinical research in this population.	[Walker, William C.; Cifu, David X.; Hudak, Anne M.; Goldberg, Gary; Kunz, Richard D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Walker, William C.; Cifu, David X.; Hudak, Anne M.; Goldberg, Gary] HH McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu		Cifu, David/0000-0003-1600-9387; Sima, Adam/0000-0001-8426-9987	US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) [W91ZSQ8118N6200001]; Epidemiological Study of Mild Traumatic Brain Injury Sequelae Caused by Blast Exposure during Operations Iraq Freedom and Enduring Freedom	This study was supported by a grant from US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP; grant no.: W91ZSQ8118N6200001); Epidemiological Study of Mild Traumatic Brain Injury Sequelae Caused by Blast Exposure during Operations Iraq Freedom and Enduring Freedom.	Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Crewson PE, 2005, AM J ROENTGENOL, V184, P1391, DOI 10.2214/ajr.184.5.01841391; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0	37	42	42	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2015	32	7					464	473		10.1089/neu.2014.3433			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CE4YV	WOS:000351837400006	25264909				2022-02-06	
J	Yuan, HJ; Myers, SJ; Wells, G; Nicholson, KL; Swanger, SA; Lyuboslavsky, P; Tahirovic, YA; Menaldino, DS; Ganesh, T; Wilson, LJ; Liotta, DC; Snyder, JP; Traynelis, SF				Yuan, Hongjie; Myers, Scott J.; Wells, Gordon; Nicholson, Katherine L.; Swanger, Sharon A.; Lyuboslavsky, Polina; Tahirovic, Yesim A.; Menaldino, David S.; Ganesh, Thota; Wilson, Lawrence J.; Liotta, Dennis C.; Snyder, James P.; Traynelis, Stephen F.			Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects	NEURON			English	Article							RANDOMIZED CONTROLLED-TRIAL; D-ASPARTATE ANTAGONIST; ACUTE ISCHEMIC STROKE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; AMINO-TERMINAL DOMAIN; CLINICAL-TRIALS; NR2B SUBUNIT; INTRACELLULAR PH; EXTRACELLULAR PH	Stroke remains a significant problem despite decades of work on neuroprotective strategies. NMDA receptor ( NMDAR) antagonists are neuroprotective in preclinical models, but have been clinically unsuccessful, in part due to side effects. Here we describe a prototypical GluN2B-selective antagonist with an IC50 value that is 10-fold more potent at acidic pH 6.9 associated with ischemic tissue compared to pH 7.6, a value close to the pH in healthy brain tissue. This should maximize neuroprotection in ischemic tissue while minimizing on-target side effects associated with NMDAR blockade in noninjured brain regions. We have determined the mechanism underlying pH-dependent inhibition and demonstrate the utility of this approach in vivo. We also identify dicarboxylate dimers as a novel proton sensor in proteins. These results provide insight into the molecular basis of pH-dependent neuroprotective NMDAR block, which could be beneficial in a wide range of neurological insults associated with tissue acidification.	[Yuan, Hongjie; Myers, Scott J.; Swanger, Sharon A.; Lyuboslavsky, Polina; Ganesh, Thota; Traynelis, Stephen F.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Wells, Gordon; Tahirovic, Yesim A.; Menaldino, David S.; Wilson, Lawrence J.; Liotta, Dennis C.; Snyder, James P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Nicholson, Katherine L.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Nicholson, Katherine L.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23298 USA		Traynelis, SF (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.	strayne@emory.edu	Swanger, Sharon A/ABA-4018-2021	Swanger, Sharon/0000-0003-0615-6244	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS036654]; ATDC; EmTech Bio; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS036654, R01NS065371, R01NS036604, R01NS036654] Funding Source: NIH RePORTER	This work was supported by NINDS (NS036654 ST), by ATDC (ST), EmTech Bio (RD). We thank Hiro Furukawa for critical comments on the manuscript, and Phuong Le, Jing Zhang, and Anel Tankovic for excellent technical assistance. We thank Ray Dingledine (NS36604) for early contributions and discussion. Several of the authors (Y.A.T., J.P.S., S.J.M., S.F.T., L.J.W., and D.C.L.) are coinventors of patented and patent-pending technology related to glutamate receptors, have an equity position (J.P.S., D.C.L., and S.F.T.), are board members (D.C.L.), paid consultants (S.F.T.), current employees (S.J.M.), or former employees (P.L.,Y.A.T., and L.J.W.) for a company (NeurOp Inc) that has licensed this technology.	Albers GV, 2001, JAMA-J AM MED ASSOC, V286, P2673, DOI 10.1001/jama.286.21.2673; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Balster R L, 1988, Psychopharmacol Ser, V4, P122; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; BENVENISTE M, 1992, MOL PHARMACOL, V42, P679; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Blagrove M, 2009, PSYCHOPHARMACOLOGY, V203, P109, DOI 10.1007/s00213-008-1377-3; Bombarda E, 2010, J PHYS CHEM B, V114, P1994, DOI 10.1021/jp908926w; Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chang YQ, 2014, SCIENCE, V344, P1131, DOI 10.1126/science.1252043; Chaperon F, 2003, BEHAV PHARMACOL, V14, P477, DOI 10.1097/01.fbp.0000091471.79060.ed; CHOI DW, 1988, J NEUROSCI, V8, P185; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; De Vry J, 2003, BEHAV PHARMACOL, V14, P229, DOI 10.1097/00008877-200305000-00007; Diener HC, 2002, J NEUROL, V249, P561, DOI 10.1007/s004150200065; ELLREN K, 1989, NEUROSCIENCE, V32, P371, DOI 10.1016/0306-4522(89)90085-7; Farin A, 2004, ACT NEUR S, V89, P101; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hamill CE, 2009, EXP NEUROL, V217, P136, DOI 10.1016/j.expneurol.2009.01.023; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HATFIELD RH, 1992, EUR J PHARMACOL, V216, P1, DOI 10.1016/0014-2999(92)90201-E; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; KAPLAN J, 1987, RESUSCITATION, V15, P149, DOI 10.1016/0300-9572(87)90012-8; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; Katsura K., 1998, P563; Kidwell CS, 2001, STROKE, V32, P1349, DOI 10.1161/01.STR.32.6.1349; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI 10.1107/S0021 88980600731X; MATSUMOTO T, 1990, STROKE, V21, P1192, DOI 10.1161/01.STR.21.8.1192; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Mosley CA, 2009, BIOORGAN MED CHEM, V17, P6463, DOI 10.1016/j.bmc.2009.05.085; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nicholson KL, 2007, BEHAV PHARMACOL, V18, P731, DOI 10.1097/FBP.0b013e3282f14ed6; Nutt JG, 2008, MOVEMENT DISORD, V23, P1860, DOI 10.1002/mds.22169; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pahk AJ, 1997, NEUROSCI LETT, V225, P29, DOI 10.1016/S0304-3940(97)00176-6; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Ritschel T, 2009, CHEMBIOCHEM, V10, P716, DOI 10.1002/cbic.200800782; Rowland LM, 2005, AVIAT SPACE ENVIR MD, V76, pC52; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; Saver JL, 2013, STROKE, V44, P270, DOI 10.1161/STROKEAHA.112.671354; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shipman ST, 2007, PHYS CHEM CHEM PHYS, V9, P4572, DOI 10.1039/b704900e; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Sussman F, 2013, CURR PHARM DESIGN, V19, P4257, DOI 10.2174/1381612811319230009; Tahirovic YA, 2008, J MED CHEM, V51, P5506, DOI 10.1021/jm8002153; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Tzeli D, 2011, J AM CHEM SOC, V133, P16977, DOI 10.1021/ja206555d; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Vasileiou C, 2009, PROTEINS, V76, P281, DOI 10.1002/prot.22334; Wang HC, 2014, NEUROCRIT CARE, V20, P119, DOI 10.1007/s12028-013-9944-9; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xiao F, 2004, RESUSCITATION, V61, P209, DOI 10.1016/j.resuscitation.2003.12.022; Yang Y, 2003, J NEUROSURG, V98, P397, DOI 10.3171/jns.2003.98.2.0397; Young D., 2001, COMPUTATIONAL CHEM, P330; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428	71	42	43	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 18	2015	85	6					1305	1318		10.1016/j.neuron.2015.02.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD8BA	WOS:000351319000016	25728572	Green Accepted, Bronze			2022-02-06	
J	Bao, HJ; Zhang, L; Han, WC; Dai, DK				Bao, Hai-Jun; Zhang, Lin; Han, Wen-Can; Dai, Ding-Kun			Apelin-13 Attenuates Traumatic Brain Injury-Induced Damage by Suppressing Autophagy	NEUROCHEMICAL RESEARCH			English	Article						Apelin-13; Traumatic brain injury (TBI); Autophagy	CONTROLLED CORTICAL IMPACT; TRANSCRIPTION FACTOR NRF2; SELECTIVE AUTOPHAGY; TISSUE DISTRIBUTION; CELL-DEATH; P62/SQSTM1; RECEPTOR; PEPTIDE; APJ; P62	The adipocytokine apelin is a peptide, Apelin and its receptor are abundantly expressed in the nervous and cardiovascular systems. Previous studies had found apelin-13 reduces brain injuries and postischemic cerebral edema through blocking programmed cell death, Apelin-13 is also able to inhibit glucose deprivation induced cardiomyocyte autophagy in a concentration dependent fashion. To observe the effect of Apelin-13 on the brain injury induced by traumatic brain injury (TBI), and explore the effect of Apelin-13 on autophagy in TBI, We performed The neurological test, and the numbers of TBI-induced neural cell death were also counted by propidium iodide labeling. At last, the autophagy associated proteins LC3, Beclin-1, Bcl-2, p62 were also assessed with western-blotting. Compared with saline vehicle groups, the neural cell death, lesion volume, and neural dysfunction were attenuated by apelin-13 after TBI. In additionally, Apelin-13 also reversed TBI induced downregulation of LC3, Beclin-1, Bcl-2, p62 expression, compared with saline vehicle groups, at 24 and 48 h post TBI. Apelin-13 attenuates TBI induced brain damage by suppressing autophagy. All these results revealed that Apelin-13 suppressed autophagy. The autophagy may be involved in the mechanism of Apelin-13 rescue the subsequent damaged neuron in TBI.	[Bao, Hai-Jun; Zhang, Lin; Han, Wen-Can] Xuzhou Med Coll, Dept Pathol, 209 Tongshan Rd,Xuzhou Yunlong Town, Xuzhou, Peoples R China; [Dai, Ding-Kun] Peoples Hosp Subei, Dept Forens Identificat, Yangzhou, Peoples R China		Bao, HJ (corresponding author), Xuzhou Med Coll, Dept Pathol, 209 Tongshan Rd,Xuzhou Yunlong Town, Xuzhou, Peoples R China.	bahajun@163.com			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81302612]	The work was supported by the National Science Foundation of China (No 81302612).	Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Choe W, 2000, J NEUROVIROL, V6, pS61; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiao H, 2013, EXP THER MED, V5, P797, DOI 10.3892/etm.2013.902; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Khaksari M, 2012, J MOL NEUROSCI, V48, P201, DOI 10.1007/s12031-012-9808-3; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; O'Donnell LA, 2007, J NEUROCHEM, V102, P1905, DOI 10.1111/j.1471-4159.2007.04645.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pozuelo RM, 2011, AUTOPHAGY, V7, P240; Puyal J, 2009, AUTOPHAGY, V5, P1060, DOI 10.4161/auto.5.7.9728; Qin ZH, 1999, J NEUROSCI, V19, P4023; Shankar S, 2008, BIOCHEM BIOPH RES CO, V373, P478; Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Susaki E, 2005, REGUL PEPTIDES, V129, P37, DOI 10.1016/j.regpep.2005.01.013; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	41	42	44	2	20	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2015	40	1					89	97		10.1007/s11064-014-1469-x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AZ7DH	WOS:000348378100010	25362565				2022-02-06	
J	Amenta, PS; Jallo, JI; Tuma, RF; Hooper, DC; Elliott, MB				Amenta, Peter S.; Jallo, Jack I.; Tuma, Ronald F.; Hooper, D. Craig; Elliott, Melanie B.			Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Controlled cortical impact; Traumatic brain injury; Cannabinoid; Inflammation; Intracellular adhesion molecule	BARRIER PERMEABILITY CHANGES; CENTRAL-NERVOUS-SYSTEM; CB2 RECEPTOR; MOUSE-BRAIN; RAT MODEL; ACTIVATION; AGONIST; MICROGLIA; CLEARANCE; MIGRATION	Background: Immunomodulatory therapies have been identified as interventions for secondary injury after traumatic brain injury (TBI). The cannabinoid receptor type-2 (CB2R) is proposed to play an important, endogenous role in regulating inflammation. The effects of CB2R stimulation, blockade, and deletion on the neurovascular inflammatory responses to TBI were assessed. Methods: Wild-type C57BL/6 or CB2R knockout mice were randomly assigned to controlled cortical impact (CCI) injury or to craniotomy control groups. The effects of treatment with synthetic, selective CB2R agonists (0-1966 and JWH-133), a selective CB2R antagonist, or vehicle solution administered to CCI groups were assessed at 1-day after injury. Changes in TNF-alpha, intracellular adhesion molecule (ICAM-1), inducible nitric oxide synthase (iNOS), macrophage/microglial ionized calcium-binding adaptor molecule, and blood-brain-barrier (BBB) permeability were assessed using ELISA, quantitative RT-PCR, immunohistochemistry, and fluorometric analysis of sodium fluorescein uptake. CB2R knockouts and wild-type mice with CCI injury were treated with a CB2R agonist or vehicle treatment. Results: TNF-alpha mRNA increased at 6 hours and 1 to 3 days after CCI; a CB2R antagonist and genetic knockout of the CB2R exacerbated TNF-alpha mRNA expression. Treatment with a CB2R agonist attenuated TNF-alpha protein levels indicating post-transcriptional mechanisms. Intracellular adhesion molecule (ICAM-1) mRNA was increased at 6 hours, and at 1 to 2 days after CCI, reduced in mice treated with a CB2R agonist, and increased in CB2R knockout mice with CCI. Sodium fluorescein uptake was increased in CB2R knockouts after CCI, with and without a CB2R agonist. iNOS mRNA expression peaked early (6 hours) and remained increased from 1 to 3 days after injury. Treatment with a CB2R agonist attenuated increases in iNOS mRNA expression, while genetic deletion of the CB2R resulted in substantial increases in iNOS expression. Double label immunohistochemistry confirmed that iNOS was expressed by macrophage/microglia in the injured cortex. Conclusion: Findings demonstrate that the endogenous cannabinoid system and CB2R play an important role in regulating inflammation and neurovascular responses in the traumatically injured brain. CB2R stimulation with two agonists (0-1966 and JWH-133) dampened post-traumatic inflammation, while blockade or deletion of the CB2R worsened inflammation. Findings support previous evidence that modulating the CB2R alters infiltrating macrophages and activated resident microglia. Further investigation into the role of the CB2R on specific immune cell populations in the injured brain is warranted.	[Amenta, Peter S.; Jallo, Jack I.; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurol Surg, Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Hooper, D. Craig] Thomas Jefferson Univ, Dept Canc Biol, Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Tuma, Ronald F.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA		Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurol Surg, Thomas Jefferson Univ Hosp, 1020 Locust St, Philadelphia, PA 19107 USA.	Melanie.elliott@jefferson.edu		Jallo, Jack/0000-0002-5512-1729	DODUnited States Department of Defense [W81XWH-12-1-0326]	Research support by DOD Award W81XWH-12-1-0326 to Dr. Elliott. We would also like to thank Rhonda Kean (Dr. Hooper's laboratory) for help with RT-PCR and members from Dr. Elliott's laboratory including Brittany Diautolo, Ashley Tyburski, and Christine Macolino for making RT-PCR, immunohisto-chemistry, and surgical contributions.	Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Ashton JC, 2012, HIPPOCAMPUS, V22, P643, DOI 10.1002/hipo.20946; Ashton JC, 2011, BRIT J PHARMACOL, V163, P1113, DOI 10.1111/j.1476-5381.2010.01139.x; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Fabis MJ, 2008, P NATL ACAD SCI USA, V105, P15511, DOI 10.1073/pnas.0807656105; Fishbein-Kaminietsky M, 2014, J NEUROSCI RES, V92, P1669, DOI 10.1002/jnr.23452; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giambelluca M, 2013, OA INFLAMMATION, V1, P3; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Landry RP, 2012, J PAIN, V13, P836, DOI 10.1016/j.jpain.2012.05.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nag Sukriti, 2003, Methods Mol Med, V89, P97; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Phares TW, 2007, J IMMUNOL, V178, P7334, DOI 10.4049/jimmunol.178.11.7334; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Sacerdote P, 2000, J NEUROIMMUNOL, V109, P155, DOI 10.1016/S0165-5728(00)00307-6; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Wiley JL, 2002, J PHARMACOL EXP THER, V301, P679, DOI 10.1124/jpet.301.2.679; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang M, 2009, MICROVASC RES, V78, P86, DOI 10.1016/j.mvr.2009.03.005; Zhang M, 2009, J NEUROIMMUNE PHARM, V4, P249, DOI 10.1007/s11481-009-9148-4	63	42	43	3	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	NOV 22	2014	11								191	10.1186/s12974-014-0191-6			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AW6KW	WOS:000346379400001	25416141	Green Published, gold			2022-02-06	
J	Sharma, A; Chandran, R; Barry, ES; Bhomia, M; Hutchison, MA; Balakathiresan, NS; Grunberg, NE; Maheshwari, RK				Sharma, Anuj; Chandran, Raghavendar; Barry, Erin S.; Bhomia, Manish; Hutchison, Mary Anne; Balakathiresan, Nagaraja S.; Grunberg, Neil E.; Maheshwari, Radha K.			Identification of Serum MicroRNA Signatures for Diagnosis of Mild Traumatic Brain Injury in a Closed Head Injury Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ACOUSTIC STARTLE REFLEX; C-TERMINAL HYDROLASE; RAT CEREBRAL-CORTEX; FEMALE RATS; ADULT RATS; NEUROSURGICAL INTERVENTION; INTRACRANIAL LESIONS; PHYSICAL-ACTIVITY; BODY-WEIGHT	Wars in Iraq and Afghanistan have highlighted the problems of diagnosis and treatment of mild traumatic brain injury (mTBI). MTBI is a heterogeneous injury that may lead to the development of neurological and behavioral disorders. In the absence of specific diagnostic markers, mTBI is often unnoticed or misdiagnosed. In this study, mice were induced with increasing levels of mTBI and microRNA (miRNA) changes in the serum were determined. MTBI was induced by varying weight and fall height of the impactor rod resulting in four different severity grades of the mTBI. Injuries were characterized as mild by assessing with the neurobehavioral severity scale-revised (NSS-R) at day 1 post injury. Open field locomotion and acoustic startle response showed behavioral and sensory motor deficits in 3 of the 4 injury groups at day 1 post injury. All of the animals recovered after day 1 with no significant neurobehavioral alteration by day 30 post injury. Serum microRNA (miRNA) profiles clearly differentiated injured from uninjured animals. Overall, the number of miRNAs that were significantly modulated in injured animals over the sham controls increased with the severity of the injury. Thirteen miRNAs were found to identify mTBI regardless of its severity within the mild spectrum of injury. Bioinformatics analyses revealed that the more severe brain injuries were associated with a greater number of miRNAs involved in brain related functions. The evaluation of serum miRNA may help to identify the severity of brain injury and the risk of developing adverse effects after TBI.	[Sharma, Anuj; Chandran, Raghavendar; Bhomia, Manish; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Chandran, Raghavendar] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India; [Barry, Erin S.; Hutchison, Mary Anne; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA		Maheshwari, RK (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	radha.maheshwari@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Chandran, Raghavendar/AAB-9402-2019; Bhomia, Manish/C-7683-2015	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Chandran, Raghavendar/0000-0002-7915-2810; Bhomia, Manish/0000-0003-2808-9927; Barry, Erin/0000-0003-0788-7153; Sharma, Anuj/0000-0001-6906-190X	Congressionally Directed Medical Research Programs (CDMRP)United States Department of Defense [D10_I_AR_J6_855]	This study was supported by funding from Congressionally Directed Medical Research Programs (CDMRP), Project# D10_I_AR_J6_855 (PI: Radha K Maheshwari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRI JB, 1994, PSYCHOPHARMACOLOGY, V114, P369, DOI 10.1007/BF02244861; ACRI JB, 1991, PSYCHOPHARMACOLOGY, V104, P244, DOI 10.1007/BF02244186; Alain C, 2008, J COGNITIVE NEUROSCI, V20, P285, DOI 10.1162/jocn.2008.20014; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Allison P. D., 1990, SOCIOLOGICAL METHODO, V20, P93, DOI [10.2307/271083, DOI 10.2307/271083]; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCIENCE M; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BOWEN DJ, 1986, PHARMACOL BIOCHEM BE, V25, P1131, DOI 10.1016/0091-3057(86)90099-7; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Elliott BM, 2004, PHARMACOL BIOCHEM BE, V77, P21, DOI 10.1016/j.pbb.2003.09.016; Faraday MM, 1998, PHARMACOL BIOCHEM BE, V61, P281, DOI 10.1016/S0091-3057(98)00094-X; Faraday MM, 2003, PHARMACOL BIOCHEM BE, V74, P325, DOI 10.1016/S0091-3057(02)00999-1; Fischer H., 2013, CRS REP C, P1; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Freund Hans-Joachim, 2003, Adv Neurol, V93, P179; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goh CP, 2014, EXP NEUROL, V252, P37, DOI 10.1016/j.expneurol.2013.11.017; Goossens K, 2013, STEM CELLS DEV; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GRUNBERG NE, 1985, PHARMACOL BIOCHEM BE, V23, P851, DOI 10.1016/0091-3057(85)90081-4; Grunberg NE, 2011, ANN M SOC NEUR WASH; Hamilton KR, 2012, EXP CLIN PSYCHOPHARM, V20, P345, DOI 10.1037/a0029088; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lee YL, 1996, J NEUROSCI, V16, P3775; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leung AWS, 2011, NEUROIMAGE, V55, P1260, DOI 10.1016/j.neuroimage.2010.12.055; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; Mayr M, 2013, ARTERIOSCL THROM VAS, V33, P206, DOI 10.1161/ATVBAHA.112.300141; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Morse DE, 1997, PHARMACOL BIOCHEM BE, V56, P221, DOI 10.1016/S0091-3057(96)00214-6; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sharma Pushpa, 2012, Int J Crit Illn Inj Sci, V2, P172, DOI 10.4103/2229-5151.100931; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; SWERDLOW NR, 1992, J PSYCHOPHARMACOL, V6, P176, DOI 10.1177/026988119200600210; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yarnell AM, 2013, BLAST TRAUMATIC BRAI, P9; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	98	42	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112019	10.1371/journal.pone.0112019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	WOS:000344863100050	25379886	gold, Green Published, Green Submitted			2022-02-06	
J	Vergales, BD; Zanelli, SA; Matsumoto, JA; Goodkin, HP; Lake, DE; Moorman, JR; Fairchild, KD				Vergales, Brooke D.; Zanelli, Santina A.; Matsumoto, Julie A.; Goodkin, Howard P.; Lake, Douglas E.; Moorman, J. Randall; Fairchild, Karen D.			Depressed Heart Rate Variability is Associated with Abnormal EEG, MRI, and Death in Neonates with Hypoxic Ischemic Encephalopathy	AMERICAN JOURNAL OF PERINATOLOGY			English	Article						hypoxic ischemic encephalopathy; heart rate variability; neonate; asphyxia; electroen-cephalogram	TRAUMATIC BRAIN-INJURY; SEPSIS-LIKE ILLNESS; THERAPEUTIC HYPOTHERMIA; PREMATURE-INFANTS; CARDIAC-ARREST; FETAL SHEEP; CHILDREN; ASPHYXIA; PHYSIOMARKERS; MORTALITY	Objective Asphyxia can lead to autonomic nervous system dysfunction, including depressed heart rate variability (HRV). We tested the hypothesis that low HRV is associated with adverse short-term outcomes of abnormalities on electroencephalogram (EEG) and brain magnetic resonance imaging (MRI) and death in neonates with hypoxic ischemic encephalopathy (HIE). Study Design Neonates undergoing hypothermia therapy for HIE underwent monitoring of HRV. HRV in the first day after birth and after hypothermia and rewarming (days 4-7) were analyzed in relation to death and severity of abnormal findings on EEG and MRI. Results A total of 37 neonates had data available in the first 24 hour after birth and 67 had data days 2 to 7. Depressed HRV was significantly associated with adverse outcomes of death or moderate-to-severe abnormalities on EEG or MRI. In the first 24 hours, the odds ratio (OR) of one or more adverse outcomes for every 10-millisecond decrease in HRV was 3.19 (95% CI, 1.3-7.8; p = 0.01). HRV improved over time but low HRV remained significantly associated with adverse outcomes days 4 to 7 (OR, 2.72; CI, 1.32-5.61; p < 0.01). Conclusions Monitoring HRV, which is reflected in the heart rate characteristic index, may provide useful adjunct information on the severity of brain injury in infants with HIE.	[Vergales, Brooke D.; Zanelli, Santina A.; Fairchild, Karen D.] Univ Virginia, Dept Pediat, Div Neonatol, Charlottesville, VA USA; [Matsumoto, Julie A.] Univ Virginia, Dept Radiol & Med Imaging, Div Neuroradiol, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia, Dept Neurol, Div Pediat Neurol, Charlottesville, VA USA; [Lake, Douglas E.; Moorman, J. Randall] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA USA; [Lake, Douglas E.] Univ Virginia, Dept Stat, Charlottesville, VA USA		Fairchild, KD (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Div Neonatol, POB 800386, Charlottesville, VA 22908 USA.	kdf2n@virginia.edu	Moorman, J Randall/ABG-9946-2020	Goodkin, Howard/0000-0003-0528-4949	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [051609]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [064640]; University of Virginia Children's Hospital	This work was supported by the following funding sources: NICHD 051609 (KDF), NIGMS 064640 (JRM), and the University of Virginia Children's Hospital.	Addison K, 2009, J PERINATOL, V29, P750, DOI 10.1038/jp.2009.81; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Aliefendioglu D, 2012, INDIAN J PEDIATR, V79, P1468, DOI 10.1007/s12098-012-0703-2; [Anonymous], 2006, J CLIN NEUROPHYSIOL, V23, P92; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Beuchee A, 2009, NEONATOLOGY, V96, P109, DOI 10.1159/000208792; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Burnsed J, 2011, J CLIN NEUROPHYSIOL, V28, P10, DOI 10.1097/WNP.0b013e318205134b; Cao HQ, 2004, ANN BIOMED ENG, V32, P233, DOI 10.1023/B:ABME.0000012743.81754.0b; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fairchild K, 2010, J PERINATOL, V30, P324, DOI 10.1038/jp.2009.168; Fairchild KD, 2013, CURR OPIN PEDIATR, V25, P172, DOI 10.1097/MOP.0b013e32835e8fe6; Fairchild KD, 2010, CLIN PERINATOL, V37, P581, DOI 10.1016/j.clp.2010.06.002; Fairchild KD, 2009, AM J PHYSIOL-REG I, V297, pR1019, DOI 10.1152/ajpregu.00132.2009; Fleisher LA, 1996, CLIN SCI, V90, P97, DOI 10.1042/cs0900097; Flower AA, 2010, EXP BIOL MED, V235, P531, DOI 10.1258/ebm.2010.009336; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; Frasch MG, 2009, REPROD SCI, V16, P509, DOI 10.1177/1933719108327597; George S, 2004, AM J PHYSIOL-REG I, V287, pR925, DOI 10.1152/ajpregu.00263.2004; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Gonzalez FF, 2009, CLIN PERINATOL, V36, P859, DOI 10.1016/j.clp.2009.07.013; Griffin MP, 2007, PEDIATR RES, V61, P222, DOI 10.1203/01.pdr.0000252438.65759.af; Griffin MP, 2005, PEDIATRICS, V115, P937, DOI 10.1542/peds.2004-1393; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Griffin MP, 2004, PEDIATR RES, V55, P782, DOI 10.1203/01.PDR.0000119366.21770.9E; Griffin MP, 2003, PEDIATR RES, V53, P920, DOI 10.1203/01.PDR.0000064904.05313.D2; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; GRIFFIN MP, 1994, J CARDIOVASC ELECTR, V5, P112, DOI 10.1111/j.1540-8167.1994.tb01151.x; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hallioglu O, 2008, EPILEPSY RES, V79, P49, DOI 10.1016/j.eplepsyres.2007.12.020; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kovatchev BP, 2003, PEDIATR RES, V54, P892, DOI 10.1203/01.PDR.0000088074.97781.4F; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lasky RE, 2009, NEONATOLOGY, V96, P93, DOI 10.1159/000205385; LOWENSOHN RI, 1977, LANCET, V1, P626; Massaro AN, 2012, J PEDIATR-US, V161, P434, DOI 10.1016/j.jpeds.2012.02.047; Mercuri E, 2000, PEDIATRICS, V106, P235, DOI 10.1542/peds.106.2.235; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Moorman JR, 2006, IEEE T BIO-MED ENG, V53, P126, DOI 10.1109/TBME.2005.859810; Norman GJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00131; Pin TW, 2009, EUR J PAEDIATR NEURO, V13, P224, DOI 10.1016/j.ejpn.2008.05.001; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Richman JS, 2004, METHOD ENZYMOL, V384, P172; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shellhaas RA, 2008, J PEDIATR-US, V153, P369, DOI 10.1016/j.jpeds.2008.03.004; Tiainen M, 2009, CRIT CARE MED, V37, P403, DOI 10.1097/CCM.0b013e31819572c4; Westgate JA, 1999, BRIT J OBSTET GYNAEC, V106, P664, DOI 10.1111/j.1471-0528.1999.tb08365.x; Zanelli S, 2008, J PERINATOL, V28, P171, DOI 10.1038/sj.jp.7211896	52	42	43	0	11	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0735-1631	1098-8785		AM J PERINAT	Am. J. Perinatol.	NOV	2014	31	10					855	861		10.1055/s-0033-1361937			7	Obstetrics & Gynecology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Pediatrics	AP3FS	WOS:000341961600005	24347263				2022-02-06	
J	McDonald, S; Gowland, A; Randall, R; Fisher, A; Osborne-Crowley, K; Honan, C				McDonald, Skye; Gowland, Alison; Randall, Rebekah; Fisher, Alana; Osborne-Crowley, Katie; Honan, Cynthia			Cognitive Factors Underpinning Poor Expressive Communication Skills After Traumatic Brain Injury: Theory of Mind or Executive Function?	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; communication; theory of mind; executive function	CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; MEDIAL PREFRONTAL CORTEX; SOCIAL COGNITION; FOLLOW-UP; EMOTION RECOGNITION; PERSPECTIVE-TAKING; VERBAL IMPAIRMENT; ECOLOGICAL VALIDITY; CLINICAL TOOL	Objective: The ability to see things from another's perspective, that is, have a theory of mind (ToM), is essential to effective communication. So too is the ability to regulate verbal output, that is, to exercise executive control. People with traumatic brain injuries (TBIs) have impaired communication abilities, but the extent to which this reflects ToM versus executive dysfunction is unclear. This study explored the relative contributions of executive abilities, specifically flexibility and inhibition and ToM abilities in language production post-TBI. Method: Twenty-five adults (18 males: mean age of 48.2 years, SD = 12.0 years) with moderate to severe TBI (posttraumatic amnesia = 69.2, SD = 54.6 days) and 28 noninjured adults (19 males: mean age 49.0, SD = 12.2 years) completed three sets of communication tasks with low executive demands, high flexibility, and high inhibition demands. Within each, parallel versions had low or high ToM requirements. Results: For low executive and high flexibility tasks, scores on the high ToM versions were predicted by scores on the low ToM versions, suggesting that poor performance was explained by the executive demands the parallel tasks had in common. The exception was the high inhibition task. In this case, speakers with TBI had differential difficulty with the high ToM version, that is, they had specific difficulty inhibiting self-referential thoughts in order to cater for another's perspective. Conclusion: We found problems with inhibiting the self-perspective accords with descriptive accounts of the egocentric nature of some communication patterns following TBI, which points to potential targets for remediation.	[McDonald, Skye; Gowland, Alison; Randall, Rebekah; Fisher, Alana; Osborne-Crowley, Katie; Honan, Cynthia] Univ New S Wales, Sch Psychol, Kensington Campus, Sydney, NSW 2052, Australia; [McDonald, Skye; Fisher, Alana; Osborne-Crowley, Katie; Honan, Cynthia] Moving Ahead Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Kensington Campus, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Fisher, Alana/T-1869-2019; McDonald, Skye/G-4118-2014; Honan, Cynthia/O-6332-2017	McDonald, Skye/0000-0003-0723-6094; Gowland, Alison/0000-0002-6578-4112; Honan, Cynthia/0000-0001-5735-4270; Osborne-Crowley, Katherine/0000-0003-0295-1849; Fisher, Alana/0000-0002-6027-659X	Australian Research CouncilAustralian Research Council	This study was supported by a research grant from the Australian Research Council. We thank all the people with traumatic brain injuries and community controls who willingly donated their time to participate in this research. The authors have no competing or conflicts of interest to report.	Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Benton AL, 1994, MULTILINGUAL APHASIA; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Body R, 1998, BRAIN INJURY, V12, P963, DOI 10.1080/026990598122016; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Burgess P.W., 1997, HAYLING BRIXTON TEST; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Prince S, 2002, J MED SPEECH-LANG PA, V10, P19; Reitan RM, 1992, TRAIL MAKING TEST; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1988, SCAND J REHABIL MED, P55; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257, DOI 10.1111/j.2044-835X.1991.tb00875.x; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	83	42	43	0	54	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2014	28	5					801	811		10.1037/neu0000089			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AO4FO	WOS:000341291800014	24819067				2022-02-06	
J	Hoffman, K; Cole, E; Playford, ED; Grill, E; Soberg, HL; Brohi, K				Hoffman, Karen; Cole, Elaine; Playford, E. Diane; Grill, Eva; Soberg, Helene L.; Brohi, Karim			Health Outcome after Major Trauma: What Are We Measuring?	PLOS ONE			English	Article							QUALITY-OF-LIFE; SEVERE MULTIPLE INJURIES; INTERNATIONAL CLASSIFICATION; REHABILITATION OUTCOMES; FUNCTIONAL OUTCOMES; BRAIN-INJURY; MULTIDISCIPLINARY REHABILITATION; PHYSICAL RECOVERY; GENERAL HEALTH; GLOBAL BURDEN	Importance: Trauma is a global disease and is among the leading causes of disability in the world. The importance of outcome beyond trauma survival has been recognised over the last decade. Despite this there is no internationally agreed approach for assessment of health outcome and rehabilitation of trauma patients. Objective: To systematically examine to what extent outcomes measures evaluate health outcomes in patients with major trauma. Data Sources: MEDLINE, EMBASE, and CINAHL (from 2006-2012) were searched for studies evaluating health outcome after traumatic injuries. Study selection and data extraction: Studies of adult patients with injuries involving at least two body areas or organ systems were included. Information on study design, outcome measures used, sample size and outcomes were extracted. The World Health Organisation International Classification of Function, Disability and Health (ICF) were used to evaluate to what extent outcome measures captured health impacts. Results: 34 studies from 755 studies were included in the review. 38 outcome measures were identified. 21 outcome measures were used only once and only five were used in three or more studies. Only 6% of all possible health impacts were captured. Concepts related to activity and participation were the most represented but still only captured 12% of all possible concepts in this domain. Measures performed very poorly in capturing concepts related to body function (5%), functional activities (11%) and environmental factors (2%). Conclusion: Outcome measures used in major trauma capture only a small proportion of health impacts. There is no inclusive classification for measuring disability or health outcome following trauma. The ICF may provide a useful framework for the development of a comprehensive health outcome measure for trauma care.	[Hoffman, Karen; Cole, Elaine; Brohi, Karim] Queen Mary Univ London, Ctr Trauma Sci, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Playford, E. Diane] UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Grill, Eva] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway		Hoffman, K (corresponding author), Queen Mary Univ London, Ctr Trauma Sci, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England.	K.hoffman@qmul.ac.uk; karim@trauma.org	Grill, Eva/D-1875-2010; Grill, Eva/AAF-8104-2020	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Cole, Elaine/0000-0002-3642-3537; Playford, E Diane/0000-0001-7314-787X	National Institute for Health Research University College London Hospitals Biomedical Research CentreGeneral Electric	We would like to thank Melissa Selb, MSc, Coordinator, ICF Research Branch, a cooperation partner of the WHO Family of International Classifications in Germany who assisted in coordinating authors for the review. Diane Playford was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Ashley J, 1990, Health Trends, V22, P135; Attenberger C, 2012, INJURY, V43, P1566, DOI 10.1016/j.injury.2011.01.002; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ballabeni P, 2011, J OCCUP REHABIL, V21, P43, DOI 10.1007/s10926-010-9255-3; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Christensen MC, 2011, J TRAUMA, V70, P1524, DOI 10.1097/TA.0b013e3181f053c2; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Derrett S, 2010, NEW ZEAL MED J, V123, P66; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Franzen C, 2009, J CLIN NURS, V18, P108, DOI 10.1111/j.1365-2702.2008.02436.x; Gabbe BJ, 2006, J TRAUMA, V61, P1393, DOI 10.1097/01.ta.0000225926.34180.47; Gabbe BJ, 2013, SURG-J R COLL SURG E, V11, P114, DOI 10.1016/j.surge.2012.11.002; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gradinger F, 2011, SLEEP MED REV, V15, P33, DOI 10.1016/j.smrv.2010.07.001; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Horwitz DA, 2008, CURR OPIN CRIT CARE, V14, P445, DOI 10.1097/MCC.0b013e328307f25f; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; JENKINSON C, 1993, BRIT MED J, V307, P449, DOI 10.1136/bmj.307.6901.449; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Khan F, 2007, DISABIL REHABIL, V29, P205, DOI 10.1080/09638280600756141; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Neugebauer E, 2006, EUR J TRAUMA, V32, P44, DOI 10.1007/s00068-006-0150-8; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pirente N, 2007, LANGENBECK ARCH SURG, V392, P739, DOI 10.1007/s00423-007-0171-8; Posl M, 2007, QUAL LIFE RES, V16, P1521, DOI 10.1007/s11136-007-9259-4; Polinder S, 2008, ACCIDENT ANAL PREV, V40, P182, DOI 10.1016/j.aap.2007.05.001; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Probst C, 2010, J TRAUMA, V68, P706, DOI 10.1097/TA.0b013e3181a8b21c; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Rommers, 2006, EUROPEAN J TRAUMA, V32, P365, DOI [DOI 10.1007/S00068-006-5112-7, 10.1007/s00068-006-5112-7]; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Siddharthan K, 2008, REHABIL NURS, V33, P221, DOI 10.1002/j.2048-7940.2008.tb00231.x; Sleat GKJ, 2011, EMERG MED J, V28, P1008, DOI 10.1136/emermed-2011-200326; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Soberg HL, 2010, ARCH PHYS MED REHAB, V91, P481, DOI 10.1016/j.apmr.2009.11.007; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Soberg HL, 2007, J TRAUMA, V62, P471, DOI 10.1097/TA.0b013e31802e95f4; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Stelfox HT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-31; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Sutherland AG, 2006, J TRAUMA, V61, P1408, DOI 10.1097/01.ta.0000197562.34651.df; Sutherland AG, 2011, J ORTHOP TRAUMA, V25, P228, DOI 10.1097/BOT.0b013e3181ee40a9; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Valent F, 2004, LANCET, V363, P2032, DOI 10.1016/S0140-6736(04)16452-0; van Aswegen H, 2011, EUR J TRAUMA EMERG S, V37, P419, DOI 10.1007/s00068-010-0071-4; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; Velstra IM, 2011, PM&R, V3, P846, DOI 10.1016/j.pmrj.2011.03.014; Weninger P, 2008, J TRAUMA, V65, P799, DOI 10.1097/TA.0b013e3181820dae; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organisation, 2001, WHO INT CLASS FUNCT; Zeckey C, 2011, BRAIN INJURY, V25, P551, DOI 10.3109/02699052.2011.568036; Zelle B, 2003, CHIRURG, V74, P361, DOI 10.1007/s00104-003-0621-y	76	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103082	10.1371/journal.pone.0103082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	WOS:000339551100085	25051353	Green Submitted, Green Published, gold			2022-02-06	
J	Lee, S; Kim, J; Seo, SG; Choi, BR; Han, JS; Lee, KW; Kim, J				Lee, Siyoung; Kim, Jisung; Seo, Sang Gwon; Choi, Bo-Ryoung; Han, Jung-Soo; Lee, Ki Won; Kim, Jiyoung			Sulforaphane alleviates scopolamine-induced memory impairment in mice	PHARMACOLOGICAL RESEARCH			English	Article						Sulforaphane; Memory; Acetylcholine; Acetylcholinesterase; Choline acetyltransferase	CHOLINE-ACETYLTRANSFERASE ACTIVITY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; GENE-EXPRESSION; RAT-BRAIN; ACETYLCHOLINE; NEURONS; DIFFERENTIATION; MODEL	Sulforaphane, an organosulfur compound present in cruciferous vegetables, has been shown to exert neuroprotective effects in experimental in vitro and in vivo models of neurodegeneration. To determine whether sulforaphane can preserve cognitive function, we examined its effects on scopolamine-induced memory impairment in mice using the Morris water maze test. Sulforaphane (10 or 50 mg/kg) was administered to C57BL/6 mice by oral gavage for 14 days (days 1-14), and memory impairment was induced by intraperitoneal injection of scopolamine (1 mg/kg) for 7 days (days 8-14). Mice that received scopolamine alone showed impaired learning and memory retention and considerably decreased cholinergic system reactivity in the hippocampus and frontal cortex, as indicated by a decreased acetylcholine (ACh) level and an increased acetylcholinesterase (AChE) activity. Sulforaphane significantly attenuated the scopolamine-induced memory impairment and improved cholinergic system reactivity, as indicated by an increased ACh level, decreased AChE activity, and increased choline acetyltransferase (ChAT) expression in the hippocampus and frontal cortex. These effects of sulforaphane on cholinergic system reactivity were confirmed in vitro. Sulforaphane (10 or 20 mu M) increased the ACh level, decreased the AChE activity, and increased ChAT expression in scopolamine-treated primary cortical neurons. These observations suggest that sulforaphane might exert a significant neuroprotective effect on cholinergic deficit and cognitive impairment. (C) 2014 Published by Elsevier Ltd.	[Lee, Siyoung; Kim, Jisung; Seo, Sang Gwon; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul 151742, South Korea; [Choi, Bo-Ryoung; Han, Jung-Soo] Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea; [Lee, Ki Won; Kim, Jiyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151921, South Korea; [Seo, Sang Gwon; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang 232916, South Korea; [Kim, Jiyoung] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Toxicol Lab, Seoul 151742, South Korea		Kim, J (corresponding author), Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Toxicol Lab, Seoul 151742, South Korea.	kiwon@snu.ac.kr; jiyoungkim1107@snu.ac.kr	Lee, Ki Won/M-4114-2018; Kim, Jiyoung/A-9934-2014	Kim, Jiyoung/0000-0002-2999-3320; Han, Jung-Soo/0000-0001-8447-4518	Basic Science Research Program, the National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea [2012R1A1A3011954]	This project was funded by the Basic Science Research Program (2012R1A1A3011954), the National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea.	ABE E, 1991, PSYCHOPHARMACOLOGY, V105, P310, DOI 10.1007/BF02244423; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Burgess A, 2006, J NEUROCHEM, V99, P797, DOI 10.1111/j.1471-4159.2006.04110.x; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; DAWSON GR, 1992, BEHAV PHARMACOL, V3, P285; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Dong ZH, 2012, EUR J PHARMACOL, V683, P174, DOI 10.1016/j.ejphar.2012.03.009; Eichenbaum H, 1997, SCIENCE, V277, P330, DOI 10.1126/science.277.5324.330; Fu AL, 2005, BIOCHEM BIOPH RES CO, V336, P268, DOI 10.1016/j.bbrc.2005.07.199; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Giacobini E, 2004, PHARMACOL RES, V50, P433, DOI 10.1016/j.phrs.2003.11.017; GIOVANNINI MG, 1991, PHARMACOL RES, V24, P395, DOI 10.1016/1043-6618(91)90044-X; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hirokawa S, 1996, J ETHNOPHARMACOL, V50, P77, DOI 10.1016/0378-8741(95)01332-6; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Huang L, 2013, CURR TOP MED CHEM, V13, P1864, DOI 10.2174/15680266113139990142; Iversen SD, 1997, LIFE SCI, V60, P1145, DOI 10.1016/S0024-3205(97)00059-3; JOHNSON JA, 1994, J BIOL CHEM, V269, P18856; Kim HV, 2013, AMYLOID, V20, P7, DOI 10.3109/13506129.2012.751367; Kitiyanant N, 2012, NEUROCHEM RES, V37, P143, DOI 10.1007/s11064-011-0592-1; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; MOLCHAN SE, 1992, BRAIN RES REV, V17, P215, DOI 10.1016/0165-0173(92)90017-G; Morroni F, 2013, NEUROTOXICOLOGY, V36, P63, DOI 10.1016/j.neuro.2013.03.004; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Park HM, 2009, ARCH PHARM RES, V32, P109, DOI 10.1007/s12272-009-1124-2; Pepeu G, 2004, LEARN MEMORY, V11, P21, DOI 10.1101/lm.68104; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Vauzour D, 2010, MOL NUTR FOOD RES, V54, P532, DOI 10.1002/mnfr.200900197; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; Zambrzycka A, 2002, NEUROCHEM RES, V27, P277, DOI 10.1023/A:1014951010834; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	38	42	43	1	23	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	JUL	2014	85						23	32		10.1016/j.phrs.2014.05.003			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AK4QS	WOS:000338409800005	24836869				2022-02-06	
J	Torrente, D; Avila, MF; Cabezas, R; Morales, L; Gonzalez, J; Samudio, I; Barreto, GE				Torrente, D.; Avila, M. F.; Cabezas, R.; Morales, L.; Gonzalez, J.; Samudio, I.; Barreto, G. E.			Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Traumatic brain injury; mesenchymal stem cells; wound closure; reactive oxygen species	NEONATAL ISCHEMIC BRAIN; LOW-DENSITY-LIPOPROTEIN; BONE-MARROW; GLUCOSE DEPRIVATION; STROMAL CELLS; NERVOUS-SYSTEM; ADIPOSE-TISSUE; ASTROCYTES; MIGRATION; RAT	Traumatic brain injury (TBI) consists of a primary and a secondary insult characterized by a biochemical cascade that plays a crucial role in cell death in the brain. Despite the major improvements in the acute care of head injury victims, no effective strategies exist for preventing the secondary injury cascade. This lack of success might be due to that most treatments are aimed at targeting neuronal population, even if studies show that astrocytes play a key role after a brain damage. In this work, we propose a new model of in vitro traumatic brain-like injury and use paracrine factors released by human mesenchymal stem cells (hMSCs) as a neuroprotective strategy. Our results demonstrate that hMSC-conditioned medium increased wound closure and proliferation at 12 h and reduced superoxide production to control conditions. This was accompanied by changes in cell morphology and polarity index, as both parameters reflect the ability of cells to migrate toward the wound. These findings indicate that hMSC is an important regulator of oxidative stress production, enhances cells migration, and shall be considered as a useful neuroprotective approach for brain recovery following injury.	[Torrente, D.; Avila, M. F.; Cabezas, R.; Morales, L.; Gonzalez, J.; Samudio, I.; Barreto, G. E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Bogota, Colombia.	gsampaio@javeriana.edu.co	Barreto, George E./B-5747-2014; GONZALEZ, JANNETH/AAB-9948-2020; Morales, Ludis/AAZ-7053-2020; Barreto, George E./AAD-7420-2020; Samudio, Ismael/D-3581-2013	Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-2009-3374; Barreto, George E./0000-0002-6644-1971; Gonzalez, Janneth/0000-0003-4482-256X; Samudio, Ismael/0000-0001-8676-1035	PUJ [4327, 4367]	This work was supported in part by grants PUJ IDs 4327 and 4367 to GEB.	Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Bonmati-Carrion MA, 2013, INT J MOL SCI, V14, P3901, DOI 10.3390/ijms14023901; AOKI H, 1993, NEUROSCIENCE, V56, P345, DOI 10.1016/0306-4522(93)90336-E; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caraballo-Miralles V, 2012, MOL CELL NEUROSCI, V49, P282, DOI 10.1016/j.mcn.2011.12.003; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; de Joannon AC, 2000, NEUROSCI LETT, V285, P218, DOI 10.1016/S0304-3940(00)01051-X; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Gasque P, 1996, J IMMUNOL, V156, P2247; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; Hawker KM, 1998, AM J PHYSIOL-LUNG C, V275, pL469, DOI 10.1152/ajplung.1998.275.3.L469; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jo I, 2002, BIOCHEM BIOPH RES CO, V299, P102, DOI 10.1016/S0006-291X(02)02599-8; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee SH, 2012, ANN DERMATOL, V24, P136, DOI 10.5021/ad.2012.24.2.136; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lin Q, 2010, EXP LUNG RES, V36, P120, DOI 10.3109/01902140903214659; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Milusheva EA, 1996, NEUROCHEM INT, V28, P501, DOI 10.1016/0197-0186(95)00129-8; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; National Center for Injury Prevention and Control (CDC), 1999, EP TRAUM BRAIN INJ U; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Ouyang YB, 2006, CELL STRESS CHAPERON, V11, P180, DOI 10.1379/CSC-182R.1; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rosado JA, 2002, CELL SIGNAL, V14, P547, DOI 10.1016/S0898-6568(01)00273-X; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Seo SY, 1999, J NEUROSCI, V19, P8849, DOI 10.1523/JNEUROSCI.19-20-08849.1999; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; van Aalst JA, 2004, J VASC SURG, V40, P1208, DOI 10.1016/j.jvs.2004.09.020; van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64; van Velthoven CTJ, 2011, BRAIN BEHAV IMMUN, V25, P1342, DOI 10.1016/j.bbi.2011.03.021; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	56	42	43	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	JUL	2014	33	7					673	684		10.1177/0960327113509659			12	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	AJ9GL	WOS:000338015700001	24178889				2022-02-06	
J	Meyers, JE; Miller, RM; Thompson, LM; Scalese, AM; Allred, BC; Rupp, ZW; Dupaix, ZP; Lee, AJ				Meyers, John E.; Miller, Ronald M.; Thompson, Lisa M.; Scalese, Adam M.; Allred, Bonnie C.; Rupp, Zachary W.; Dupaix, Zacharias P.; Lee, Amy Junghyun			Using Likelihood Ratios to Detect Invalid Performance with Performance Validity Measures	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Malingering; symptom validity testing; Mild cognitive; Impairment; Test construction	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; VALIDATION; TESTS; INDICATORS	Larrabee (2008) applied chained likelihood ratios to selected performance validity measures (PVMs) to identify non-valid performances on neuropsychological tests. He presented a method of combining different PVMs with different sensitivities and specificities into an overall probability of non-validity. We applied his methodology to a set of 11 PVMs using a sample of 255 subjects. The results of the study show that in various combinations of two or three PVMs, a high reliability of invalidity can be determined using the chained likelihood ratio method. This study advances the ability of clinicians to chain various PVMs together and calculate the probability that a set of data is invalid.	[Meyers, John E.] Meyers Neuropsychol Serv, Mililani, HI 96857 USA; [Miller, Ronald M.; Thompson, Lisa M.; Scalese, Adam M.; Allred, Bonnie C.; Rupp, Zachary W.; Dupaix, Zacharias P.; Lee, Amy Junghyun] Brigham Young Univ Hawaii, Dept Psychol, Laie, HI USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, Mililani, HI 96857 USA.	jmeyersneuro@yahoo.com		Lee, Amy Junghyun/0000-0001-7745-7058			BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Boone K., 2007, ASSESSMENT FEIGNED C; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; Green, 2003, WORD MEMORY TEST; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hamberger MJ, 1999, EPILEPSY RES, V35, P229, DOI 10.1016/S0920-1211(99)00023-6; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers J E, 1996, Appl Neuropsychol, V3, P89, DOI 10.1207/s15324826an0302_8; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers J. E, 2013, ELECT MANUAL MEYERS; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P148, DOI 10.1080/09084282.2013.780173; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Reitan R, 1985, HALSTEAD REITAN NEUR; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M	42	42	42	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2014	29	3					224	235		10.1093/arclin/acu001			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AG9WC	WOS:000335769700002	24499725	Bronze			2022-02-06	
J	Knight, SJ; Anderson, VA; Spencer-Smith, MM; Da Costa, AC				Knight, Sarah J.; Anderson, Vicki A.; Spencer-Smith, Megan M.; Da Costa, Annette C.			Neurodevelopmental Outcomes in Infants and Children With Single-Suture Craniosynostosis: A Systematic Review	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							POSTOPERATIVE DEVELOPMENTAL ATTAINMENT; TRAUMATIC BRAIN INJURY; LONG-TERM; COGNITIVE-DEVELOPMENT; SAGITTAL CRANIOSYNOSTOSIS; METOPIC SYNOSTOSIS; MENTAL-DEVELOPMENT; YOUNG-CHILDREN; SPINA-BIFIDA; LANGUAGE	Children with single-suture craniosynostosis (SSC) are increasingly considered to be at high risk of adverse neurodevelopmental outcomes. This systematic review aimed to synthesise and critically appraise the existing literature on the neurodevelopmental features of SSC, with particular attention to methodological quality. A total of 33 articles based on 27 cohorts met inclusion criteria. In the context of variable methodological design and quality, most neurodevelopmental studies indicated that children with SSC are at increased risk for difficulties in cognitive, language, and motor domains during infancy (both pre- and post-surgery) and childhood. Limited information exists on factors influencing outcome.	[Knight, Sarah J.; Anderson, Vicki A.; Spencer-Smith, Megan M.; Da Costa, Annette C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Knight, Sarah J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Knight, Sarah J.; Anderson, Vicki A.; Da Costa, Annette C.] Univ Melbourne, Melbourne, Vic, Australia; [Knight, Sarah J.; Anderson, Vicki A.] Monash Childrens, Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia; [Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Spencer-Smith, Megan M.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Da Costa, Annette C.] Royal Childrens Hosp, Dept Plast & Maxillofacial Surg, Melbourne, Vic, Australia		Knight, SJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	sarah.knight@mcri.edu.au	Knight, Sarah/AAZ-8515-2020	Knight, Sarah/0000-0002-9908-2231; Spencer-Smith, Megan/0000-0002-1047-0829			Abbas Nejad E, 2010, IRAN J CHILD NEUROL, V3, P45; Aldridge K, 2005, ANAT REC PART A, V285A, P690, DOI 10.1002/ar.a.20201; Aldridge K, 2002, J ANAT, V201, P31, DOI 10.1046/j.1469-7580.2002.00074.x; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Arnaud E, 2002, PLAST RECONSTR SURG, V110, P6, DOI 10.1097/00006534-200207000-00002; Ballantyne AO, 2007, CHILD NEUROPSYCHOL, V13, P494, DOI 10.1080/09297040601114878; Becker DB, 2005, PLAST RECONSTR SURG, V116, P400, DOI 10.1097/01.prs.0000172763.71043.b8; Bellew M, 2005, ARCH DIS CHILD, V90, P346, DOI 10.1136/adc.2003.035824; Bellew M, 2011, J NEUROSURG-PEDIATR, V7, P121, DOI 10.3171/2010.11.PEDS10216; Boltshauser E, 2003, NEUROPEDIATRICS, V34, P293; Bottero L, 1998, PLAST RECONSTR SURG, V102, P952, DOI 10.1097/00006534-199809040-00002; Chieffo D, 2010, J NEUROS-PEDIATR, V5, P232, DOI 10.3171/2009.10.PEDS09231; Cohen Jr MM, 2000, CRANIOSYNOSTOSIS DIA; Cohen SR, 2004, PLAST RECONSTR SURG, V114, P841, DOI 10.1097/01.PRS.0000132854.14237.A8; Da Costa AC, 2006, PLAST RECONSTR SURG, V118, P175, DOI 10.1097/01.prs.0000221009.93022.50; Da Costa AC, 2012, CHILD NERV SYST, V28, P869, DOI 10.1007/s00381-011-1660-1; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; DENNIS M, 2007, COGNITIVE RESERVE TH, P53; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Gewalli F, 2001, ANN PLAS SURG, V46, P415, DOI 10.1097/00000637-200104000-00011; Kapp-Simon KA, 2005, CLEFT PALATE-CRAN J, V42, P377, DOI 10.1597/04-044.1; Kapp-Simon KA, 1998, CLEFT PALATE-CRAN J, V35, P197, DOI 10.1597/1545-1569(1998)035<0197:MDALDI>2.3.CO;2; Kapp-Simon KA, 2007, CHILD NERV SYST, V23, P269, DOI 10.1007/s00381-006-0251-z; KAPPSIMON KA, 1993, PLAST RECONSTR SURG, V92, P831, DOI 10.1097/00006534-199392050-00008; Kelleher MO, 2006, J NEUROSURG, V105, P382, DOI 10.3171/ped.2006.105.5.382; Korpilahti P, 2012, CHILD NERV SYST, V28, P419, DOI 10.1007/s00381-011-1623-6; Lajeunie E, 1998, AM J MED GENET, V75, P211, DOI 10.1002/(SICI)1096-8628(19980113)75:2<211::AID-AJMG19>3.0.CO;2-S; Lattanzi W, 2012, CHILD NERV SYST, V28, P1301, DOI 10.1007/s00381-012-1781-1; Limperopoulos C, 2002, J PEDIATR-US, V141, P51, DOI 10.1067/mpd.2002.125227; Loddenkemper T, 2007, PEDIATRICS, V119, P930, DOI 10.1542/peds.2006-2530; Lomax-Bream LE, 2007, DEV NEUROPSYCHOL, V31, P1, DOI 10.1207/s15326942dn3101_1; Magge SN, 2002, J CRANIOFAC SURG, V13, P99, DOI 10.1097/00001665-200201000-00023; Mathijssen I, 2006, J NEUROSURG, V105, P16, DOI 10.3171/ped.2006.105.1.16; Mendonca DA, 2009, J CRANIOFAC SURG, V20, P85, DOI 10.1097/SCS.0b013e3181955244; Panchal J, 2001, PLAST RECONSTR SURG, V108, P1492, DOI 10.1097/00006534-200111000-00007; Richtsmeier JT, 2006, J EXP ZOOL PART B, V306B, P360, DOI 10.1002/jez.b.21092; Ruiz-Correa S, 2007, CLEFT PALATE-CRAN J, V44, P548, DOI 10.1597/06-190.1; Shipster C, 2003, DEV MED CHILD NEUROL, V45, P34, DOI 10.1017/S0012162203000070; Sidoti EJ, 1996, PLAST RECONSTR SURG, V97, P276, DOI 10.1097/00006534-199602000-00002; Singer S, 1999, AM J MED GENET, V83, P382, DOI 10.1002/(SICI)1096-8628(19990423)83:5<382::AID-AJMG8>3.0.CO;2-A; Speltz ML, 2007, PLAST RECONSTR SURG, V119, P1874, DOI 10.1097/01.prs.0000259184.88265.3f; Speltz ML, 2004, J PEDIATR PSYCHOL, V29, P651, DOI 10.1093/jpepsy/jsh068; Speltz ML, 1997, CLEFT PALATE-CRAN J, V34, P374, DOI 10.1597/1545-1569(1997)034<0374:PAPMAP>2.3.CO;2; Starr JR, 2007, J NEUROSURG, V107, P103, DOI 10.3171/PED-07/08/103; Starr JR, 2010, NEUROSURGERY, V67, P408, DOI 10.1227/01.NEU.0000371992.72539.8B; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Toth K, 2008, CHILD NEUROPSYCHOL, V14, P339, DOI 10.1080/09297040701594888; Treyvaud K, 2009, PEDIATRICS, V123, P555, DOI 10.1542/peds.2008-0477; Virtanen R, 1999, PEDIATRICS, V103, P791, DOI 10.1542/peds.103.4.791; Warschausky S, 2005, PLAST RECONSTR SURG, V115, P1518, DOI 10.1097/01.PRS.0000160270.27558.64; Westmacott R, 2009, STROKE, V40, P2012, DOI 10.1161/STROKEAHA.108.533976; ZEITSER I, 2008, J THORACIC CARDIOVAS, V135, P91, DOI DOI 10.1016/J.JTCVS.2007.04.074	56	42	43	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	APR 3	2014	39	3					159	186		10.1080/87565641.2014.886690			28	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AF1PX	WOS:000334486900001	24742309				2022-02-06	
J	Ayton, S; Zhang, M; Roberts, BR; Lam, LQ; Lind, M; McLean, C; Bush, AI; Frugier, T; Crack, PJ; Duce, JA				Ayton, Scott; Zhang, Moses; Roberts, Blaine R.; Lam, Linh Q.; Lind, Monica; McLean, Catriona; Bush, Ashley I.; Frugier, Tony; Crack, Peter J.; Duce, James A.			Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Traumatic brain injury; Iron; Mouse models; Amyloid precursor protein; Ceruloplasmin; Free radicals	OXIDATIVE STRESS; FERROXIDASE ACTIVITY; CEREBRAL-ISCHEMIA; SYNAPTIC PROTEINS; FERROUS IRON; SPINAL-CORD; RAT MODEL; ACCUMULATION; MICE; EXPRESSION	Traumatic brain injury (TBI) is in part complicated by pro-oxidant iron elevation independent of brain hemorrhage. Ceruloplasmin (CP) and beta-amyloid protein precursor (APP) are known neuroprotective proteins that reduce oxidative damage through iron regulation. We surveyed iron, CP, and APP in brain tissue from control and TBI-affected patients who were stratified according to time of death following injury. We observed CP and APP induction after TBI accompanying iron accumulation. Elevated APP and CP expression was also observed in a mouse model of focal cortical contusion injury concomitant with iron elevation. To determine if changes in APP or CP were neuroprotective we employed the same TBI model on APP(-/-) and CP-/- mice and found that both exhibited exaggerated infarct volume and iron accumulation postinjury. Evidence supports a regulatory role of both proteins in defence against iron-induced oxidative damage after TBI, which presents as a tractable therapeutic target. (C) 2014 Elsevier Inc. All rights reserved.	[Ayton, Scott; Roberts, Blaine R.; Lam, Linh Q.; Lind, Monica; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Zhang, Moses; Crack, Peter J.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [McLean, Catriona; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Frugier, Tony] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3010, Australia; [Duce, James A.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, N Yorkshire, England		Duce, JA (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, N Yorkshire, England.	james.duce@florey.edu.au	Bush, Ashley I/A-1186-2007; Crack, Peter/ABE-2065-2020; Ayton, Scott/J-8000-2015; Bush, Ashley/Y-2457-2019; Ayton, Scott/AAJ-3414-2021	Bush, Ashley I/0000-0001-8259-9069; Crack, Peter/0000-0002-5030-0330; Ayton, Scott/0000-0002-3479-2427; Bush, Ashley/0000-0001-8259-9069; Frugier, Tony/0000-0002-1275-5158; Roberts, Blaine/0000-0001-5466-0053; Duce, James/0000-0002-8762-2245	Australian Research CouncilAustralian Research Council; Australian National Health AMP; Medical Research Council; University of MelbourneUniversity of Melbourne; Florey Institute of Neuroscience and Mental Health; Alfred Hospital; Victorian Forensic Institute of Medicine; Alzheimers Research UKAlzheimer&apos;s Research UK (ARUK) [ART-SRF2011-1] Funding Source: researchfish	This work was supported by funds from the Australian Research Council, the Australian National Health & Medical Research Council, and Operational Infrastructure Support from the Victorian State Government. The Victorian Brain Bank Network is supported by The University of Melbourne, The Florey Institute of Neuroscience and Mental Health, The Alfred Hospital and the Victorian Forensic Institute of Medicine. Dr. Bush is a shareholder in Prana Biotechnology Pty Ltd., Eucalyptus Pty Ltd., and Mesoblast Pty Ltd. and a paid consultant for Collaborative Medicinal Developments LLC.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Asano Y, 2012, J HISTOCHEM CYTOCHEM, V60, P229, DOI 10.1369/0022155411431734; Auriat AM, 2012, EXP NEUROL, V234, P136, DOI 10.1016/j.expneurol.2011.12.030; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Caliaperumal J, 2012, EXP NEUROL, V237, P363, DOI 10.1016/j.expneurol.2012.07.001; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Justicia C, 2008, STROKE, V39, P1541, DOI 10.1161/STROKEAHA.107.503565; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; McNeill A, 2008, EUR NEUROL, V60, P200, DOI 10.1159/000148691; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Millerot-Serrurot E, 2008, NEUROCHEM INT, V52, P1442, DOI 10.1016/j.neuint.2008.04.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Patel BN, 2002, J NEUROSCI, V22, P6578; Pierce JES, 1996, J NEUROSCI, V16, P1083; Ramos P, 2014, J TRACE ELEM MED BIO, V28, P13, DOI 10.1016/j.jtemb.2013.08.001; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Sauerbeck A, 2013, EXP NEUROL, V248, P53, DOI 10.1016/j.expneurol.2013.05.011; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	57	42	42	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	APR	2014	69						331	337		10.1016/j.freeradbiomed.2014.01.041			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AD8BC	WOS:000333490500035	24509156				2022-02-06	
J	Fuller, G; Hasler, RM; Mealing, N; Lawrence, T; Woodford, M; Juni, P; Lecky, F				Fuller, Gordon; Hasler, Rebecca M.; Mealing, Nicole; Lawrence, Thomas; Woodford, Maralyn; Juni, Peter; Lecky, Fiona			The association between admission systolic blood pressure and mortality in significant traumatic brain injury: A multi-centre cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Craniocerebral trauma; Hypotension; Systolic blood pressure; Resuscitation	PROGNOSTIC VALUE; MULTIPLE IMPUTATION; SECONDARY INSULTS; HEAD-INJURY; HYPOTENSION; REGRESSION; PREDICTORS; ACCURATE	Introduction: Low systolic blood pressure (SBP) is an important secondary insult following traumatic brain injury (TBI), but its exact relationship with outcome is not well characterised. Although a SBP of <90 mmHg represents the threshold for hypotension in consensus TBI treatment guidelines, recent studies suggest redefining hypotension at higher levels. This study therefore aimed to fully characterise the association between admission SBP and mortality to further inform resuscitation endpoints. Methods: We conducted a multicentre cohort study using data from the largest European trauma registry. Consecutive adult patients with AIS head scores >2 admitted directly to specialist neuroscience centres between 2005 and July 2012 were studied. Multilevel logistic regression models were developed to examine the association between admission SBP and 30 day inpatient mortality. Models were adjusted for confounders including age, severity of injury, and to account for differential quality of hospital care. Results: 5057 patients were included in complete case analyses. Admission SBP demonstrated a smooth u-shaped association with outcome in a bivariate analysis, with increasing mortality at both lower and higher values, and no evidence of any threshold effect. Adjusting for confounding slightly attenuated the association between mortality and SBP at levels <120 mmHg, and abolished the relationship for higher SBP values. Case-mix adjusted odds of death were 1.5 times greater at <120 mmHg, doubled at <100 mmHg, tripled at <90 mmHg, and six times greater at SBP <70 mmHg, p <0.01. Conclusions: These findings indicate that TBI studies should model SBP as a continuous variable and may suggest that current TBI treatment guidelines, using a cut-off for hypotension at SBP <90 mmHg, should be reconsidered. (C) 2013 Elsevier Ltd. All rights reserved.	[Fuller, Gordon; Lawrence, Thomas; Woodford, Maralyn] Salford Royal Hosp, Trauma Audit & Res Network, Hlth Sci Res Grp, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Hasler, Rebecca M.] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Mealing, Nicole; Juni, Peter] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England		Fuller, G (corresponding author), Salford Royal Hosp, Trauma Audit & Res Network, Hlth Sci Res Grp, Manchester Acad Hlth Sci Ctr, Mayo Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	gordonwfuller@doctors.net.uk	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Lawrence, Thomas/0000-0003-3648-7634; Fuller, Gordon Ward/0000-0001-8532-3500	Department of HealthEuropean Commission [DRF-2011-04-050] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [DRF-2011-04-050] Funding Source: researchfish		Allison PD, 2001, MISSING DATA; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bur A, 2000, CRIT CARE MED, V28, P371, DOI 10.1097/00003246-200002000-00014; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; *COMM INJ SCAL, 1998, ABBR INJ SCAL 1998 R; Davis JW, 2003, J TRAUMA, V55, P860, DOI 10.1097/01.TA.0000092686.91877.DE; Department of Health, HOSP EP STAT; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Hosmer D, 1989, APPL LOGISTIC REGRES; Kleinbaum D.G., 1994, LOGISTIC REGRESSION; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pater C, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-6; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; [No title captured]	42	42	43	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2014	45	3					612	617		10.1016/j.injury.2013.09.008			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	302BH	WOS:000330575800027	24206920				2022-02-06	
J	Kabadi, SV; Stoica, BA; Loane, DJ; Luo, T; Faden, AI				Kabadi, Shruti V.; Stoica, Bogdan A.; Loane, David J.; Luo, Tao; Faden, Alan I.			CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cell cycle; CR8; cyclin-dependent kinases; neurodegeneration; neuroinflammation; traumatic brain injury	CELL-CYCLE ACTIVATION; ADULT NEUROGENESIS; NEUROINFLAMMATION; NEUROPROTECTION; DEATH; RAT; NEURODEGENERATION; PROLIFERATION; CONTRIBUTES; EXPRESSION	Central nervous system injury causes a marked increase in the expression of cell cycle-related proteins. In this study, we show that cell cycle activation (CCA) is detected in mature neurons at 24 hours after rat lateral fluid percussion (LFP)-induced traumatic brain injury (TBI), as reflected by increased expression of cyclin G1, phosphorylated retinoblastoma (phospho-Rb), E2F1 and proliferating cell nuclear antigen (PCNA). These changes were associated with progressive cortical, hippocampal, and thalamic neuronal loss and microglial and astrocyte activation. Notably, we detected 5-bromo-2'-deoxyuridine (BrdU)-positive neurons, microglia, and astrocytes at 7 days, but not at 24 hours, suggesting that cell cycle reaches the S phase in these cell types at the latter time point. A delayed systemic post-LFP administration at 3 hours of CR8 a potent second-generation cyclin-dependent kinase (CDK) inhibitor reduced CCA; cortical, hippocampal, and thalamic neuronal loss; and cortical microglial and astrocyte activation, Furthermore, CR8 treatment attenuated sensorimotor and cognitive deficits, alleviated depressive-like symptoms, and decreased lesion volume. These findings underscore the contribution of CCA to progressive neurodegeneration and chronic rieuroinflamrnation following TBI, and demonstrate the neuroprotective potential of cell cycle inhibition in a clinically relevant experimental TBI model.	[Kabadi, Shruti V.; Stoica, Bogdan A.; Loane, David J.; Luo, Tao; Faden, Alan I.] Univ Maryland, Ctr Shock Trauma & Anesthesiol STAR ORC, Natl Ctr Trauma & EMS, Dept Anesthesiol,Sch Med, Baltimore, MD 21201 USA		Kabadi, SV (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol STAR ORC, Natl Ctr Trauma & EMS, Dept Anesthesiol,Sch Med, Bressler Res Bldg BRB,655 W Baltimore St, Baltimore, MD 21201 USA.	skabadi@anes.umm.edu	STOICA, BOGDAN/H-9782-2013; Loane, David/ABD-5177-2021	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Faden, Alan I./0000-0003-0128-2348	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS052568]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052568] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institutes of Health, R01 NS052568.	Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kanaan NM, 2010, NEUROBIOL AGING, V31, P937, DOI 10.1016/j.neurobiolaging.2008.07.006; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; Nauta WJH, 1986, FUNDAMENTAL NEUROANA; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044027, 10.1371/journal.pone.0046393]; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	37	42	43	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2014	34	3					502	513		10.1038/jcbfm.2013.228			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AC2QD	WOS:000332348100018	24398934	Bronze, Green Published			2022-02-06	
J	Leunissen, I; Coxon, JP; Caeyenberghs, K; Michiels, K; Sunaert, S; Swinnen, SP				Leunissen, Inge; Coxon, James P.; Caeyenberghs, Karen; Michiels, Karla; Sunaert, Stefan; Swinnen, Stephan P.			Subcortical volume analysis in traumatic brain injury: The importance of the fronto-striato-thalamic circuit in task switching	CORTEX			English	Article						Traumatic brain injury; Task switching; Basal ganglia; Thalamus; Shape analysis; Diffusion tensor imaging	WHITE-MATTER INTEGRITY; HUMAN BASAL GANGLIA; COGNITIVE CONTROL; PREFRONTAL CORTEX; DIFFUSION-TENSOR; LONGITUDINAL CHANGES; RESPONSE-INHIBITION; FUNCTIONAL-ROLE; CONNECTIVITY; MODERATE	Traumatic brain injury (TBI) is associated with neuronal loss, diffuse axonal injury and executive dysfunction. Whereas executive dysfunction has traditionally been associated with prefrontal lesions, ample evidence suggests that those functions requiring behavioral flexibility critically depend on the interaction between frontal cortex, basal ganglia and thalamus. To test whether structural integrity of this fronto-striato-thalamic circuit can account for executive impairments in TBI we automatically segmented the thalamus, putamen and caudate of 25 patients and 21 healthy controls and obtained diffusion weighted images. We assessed components of executive function using the local-global task, which requires inhibition, updating and switching between actions. Shape analysis revealed localized atrophy of the limbic, executive and rostral-motor zones of the basal ganglia, whereas atrophy of the thalami was more global in TBI. This subcortical atrophy was related to white matter microstructural organization in TBI, suggesting that axonal injuries possibly contribute to subcortical volume loss. Global volume of the nuclei showed no clear relationship with task performance. However, the shape analysis revealed that participants with smaller volume of those subregions that have connections with the prefrontal cortex and rostral motor areas showed higher switch costs and mixing costs, and made more errors while switching. These results support the idea that flexible cognitive control over action depends on interactions within the fronto-striato-thalamic circuit. (C) 2013 Elsevier Ltd. All rights reserved.	[Leunissen, Inge; Caeyenberghs, Karen; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Louvain, Belgium; [Coxon, James P.] Univ Auckland, Movement Neurosci Lab, Auckland 1, New Zealand; [Caeyenberghs, Karen] Univ Ghent, Dept Phys Therapy & Motor Rehabil, B-9000 Ghent, Belgium; [Michiels, Karla] Univ Hosp, Dept Phys Med & Rehabil, Louvain, Belgium; [Sunaert, Stefan] Katholieke Univ Leuven, Grp Biomed Sci, Med Imaging Res Ctr, Louvain, Belgium; [Swinnen, Stephan P.] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium		Leunissen, I (corresponding author), Tervuursevest 101, B-3001 Heverlee, Belgium.	inge.leunissen@faber.kuleuven.be	Coxon, James/S-1286-2019	Coxon, James/0000-0003-2351-8489; Caeyenberghs, Karen/0000-0001-7009-6843; Leunissen, Inge/0000-0002-3977-3620	Research Program of the Research Foundation - Flanders (FWO)FWO [G.0483.10, G.0482.10, G.A114.11]; Interuniversity Attraction Poles program of the Belgian Federal GovernmentBelgian Federal Science Policy Office [P7/11]; Research Foundation - Flanders (FWO)FWO	The authors thank Monique Geurts from the Movement Control and Neuroplasticity Research Group of the KU Leuven for assistance with data collection. This work was supported by the Research Program of the Research Foundation - Flanders (FWO) [G.0483.10 & Levenslijn G.0482.10 & G.A114.11] and the Interuniversity Attraction Poles program of the Belgian Federal Government [P7/11]. I.L. is funded by a PhD fellowship of the Research Foundation - Flanders (FWO). The computational resources and services used in this work were provided by the Hercules Foundation and the Flemish Government Department EWI.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BRANDT J, 1996, NEUROPSYCHOLOGICAL A, P312; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Krause M, 2012, CORTEX, V48, P97, DOI 10.1016/j.cortex.2011.03.014; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKeown MJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-8; Mecklinger A, 1999, J CLIN EXP NEUROPSYC, V21, P606, DOI 10.1076/jcen.21.5.606.873; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rubin O, 2005, J EXP PSYCHOL LEARN, V31, P1477, DOI 10.1037/0278-7393.31.6.1477; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TAYLOR AE, 1995, BRAIN COGNITION, V28, P281, DOI 10.1006/brcg.1995.1258; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; van Schouwenburg MR, 2010, J NEUROSCI, V30, P9910, DOI 10.1523/JNEUROSCI.1111-10.2010; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001	77	42	42	0	8	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	FEB	2014	51						67	81		10.1016/j.cortex.2013.10.009			15	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	AB5WC	WOS:000331858400007	24290948				2022-02-06	
J	Robin, NC; Agoston, Z; Biechele, TL; James, RG; Berndt, JD; Moon, RT				Robin, Nicholas C.; Agoston, Zsuzsa; Biechele, Travis L.; James, Richard G.; Berndt, Jason D.; Moon, Randall T.			Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/beta-Catenin Signaling	STEM CELL REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; STEM-CELLS; ISOPRENOIDS FARNESYL; PROTEIN PRENYLATION; ALZHEIMERS-DISEASE; STATINS; MICE; ACTIVATION; PATHWAY; MODULATION	Statins improve recovery from traumatic brain injury and show promise in preventing Alzheimer disease. However, the mechanisms by which statins may be therapeutic for neurological conditions are not fully understood. In this study, we present the initial evidence that oral administration of simvastatin in mice enhances Wnt signaling in vivo. Concomitantly, simvastatin enhances neurogenesis in cultured adult neural progenitor cells as well as in the dentate gyrus of adult mice. Finally, we find that statins enhance Wnt signaling through regulation of isoprenoid synthesis and not through cholesterol. These findings provide direct evidence that Wnt signaling is enhanced in vivo by simvastatin and that this elevation of Wnt signaling is required for the neurogenic effects of simvastatin. Collectively, these data add to the growing body of evidence that statins may have therapeutic value for treating certain neurological disorders.	[Robin, Nicholas C.; Biechele, Travis L.; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Robin, Nicholas C.; Agoston, Zsuzsa; Biechele, Travis L.; James, Richard G.; Berndt, Jason D.; Moon, Randall T.] Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Robin, Nicholas C.; Agoston, Zsuzsa; Biechele, Travis L.; James, Richard G.; Berndt, Jason D.; Moon, Randall T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Robin, Nicholas C.; Agoston, Zsuzsa; Biechele, Travis L.; James, Richard G.; Berndt, Jason D.; Moon, Randall T.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [James, Richard G.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA		Moon, RT (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; james, richard/0000-0002-2302-7367	Howard Hughes Medical InstituteHoward Hughes Medical Institute; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 GM01619, U01 HL100395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL100395, R00HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007507] Funding Source: NIH RePORTER	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health grants P01 GM01619 and U01 HL100395.	Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; ENDO A, 1992, J LIPID RES, V33, P1569; FEARS R, 1981, BIOCHEM J, V199, P1; Garbe DS, 2012, CELL MOL NEUROBIOL, V32, P1159, DOI 10.1007/s10571-012-9841-3; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Hooff GP, 2012, MOL NEUROBIOL, V46, P179, DOI 10.1007/s12035-012-8285-6; Hughes AD, 1996, J HUM HYPERTENS, V10, P387; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin CL, 2008, AM J NEPHROL, V28, P290, DOI 10.1159/000111142; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Mahmood A., 2009, NEUROSURGERY, V65, P191, DOI DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Palmer TD, 1999, J NEUROSCI, V19, P8487; Qiao LJ, 2011, MOL CELLS, V32, P437, DOI 10.1007/s10059-011-0107-6; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Tamai I, 2000, J PHARM SCI-US, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2009, NEUROBIOL DIS, V35, P406, DOI 10.1016/j.nbd.2009.06.003; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wong WB, 2013, PHARMACOEPIDEM DR S, V22, P345, DOI 10.1002/pds.3381; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zimmerman Z.F., 2012, COLD SPRING HARB PER, V4, P4	37	42	45	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	JAN 14	2014	2	1					9	17		10.1016/j.stemcr.2013.11.002			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI1XA	WOS:000336647300002	24511465	Green Published, gold			2022-02-06	
J	Sumowski, JF; Chiaravalloti, N; Krch, D; Paxton, J; DeLuca, J				Sumowski, James F.; Chiaravalloti, Nancy; Krch, Denise; Paxton, Jessica; DeLuca, John			Education Attenuates the Negative Impact of Traumatic Brain Injury on Cognitive Status	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognitive disorders; Cognitive reserve; Neuropsychology; Rehabilitation	OLDER PERSONS; RESERVE; MEMORY	Objective: To investigate whether the cognitive reserve hypothesis helps to explain differential cognitive impairment among survivors of traumatic brain injury (TBI), whereby survivors with greater intellectual enrichment (estimated with education) are less vulnerable to cognitive impairment. Design: Cross-sectional study. Setting: Medical rehabilitation research center. Participants: Survivors of moderate or severe TBI (n=44) and healthy controls (n=36). Interventions: Not applicable. Main Outcome Measures: Intellectual enrichment was estimated with educational attainment. Group was defined as TBI or healthy control. Current cognitive status (processing speed, working memory, episodic memory) was evaluated with neuropsychological tasks. Results: TBI survivors exhibited worse cognitive status than healthy persons (P<.001), and education was positively correlated with cognitive status in TBI survivors (r=.54, P<.001). Most importantly, regression analysis revealed an interaction between group and education (R-2 change=.036, P=.004), whereas higher education attenuated the negative impact of TBI on cognitive status. TBI survivors with lower education performed much worse than matched healthy persons, but this TBI-related performance discrepancy was attenuated at higher levels of education. Conclusions: Higher intellectual enrichment (estimated with education) reduces the negative effect of TBI on cognitive outcomes, thereby supporting the cognitive reserve hypothesis in persons with TBI. Future work is necessary to investigate whether intellectual enrichment can build cognitive reserve as a rehabilitative intervention in survivors of TBI.	[Sumowski, James F.; Chiaravalloti, Nancy; Paxton, Jessica; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Sumowski, James F.; Chiaravalloti, Nancy; Krch, Denise; Paxton, Jessica; DeLuca, John] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Chiaravalloti, Nancy; Krch, Denise] Kessler Fdn, Traumat Brain Injury Lab, W Orange, NJ USA; [DeLuca, John] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA		Sumowski, JF (corresponding author), Kessler Fdn Res Ctr, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	jsumowski@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [CBIR11PJT020]; National Institute on Disability and Rehabilitation Research [H133A070037]; Department of Education, National Institute on Disability and Rehabilitation Research [H133P090009]	Supported by the New Jersey Commission on Brain Injury Research (grant no. CBIR11PJT020); the National Institute on Disability and Rehabilitation Research (grant no. H133A070037); and a fellowship training grant from the Department of Education, National Institute on Disability and Rehabilitation Research (grant no. H133P090009).	Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be	13	42	43	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2013	94	12					2562	2564		10.1016/j.apmr.2013.07.023			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	264UD	WOS:000327905600034	23932968				2022-02-06	
J	Schonnop, R; Yang, YJ; Feldman, F; Robinson, E; Loughin, M; Robinovitch, SN				Schonnop, Rebecca; Yang, Yijian; Feldman, Fabio; Robinson, Erin; Loughin, Marie; Robinovitch, Stephen N.			Prevalence of and factors associated with head impact during falls in older adults in long-term care	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; RISK-FACTORS; UPPER EXTREMITY; SERIOUS INJURY; HIP FRACTURE; PEOPLE; EPIDEMIOLOGY; PROGNOSIS; SEVERITY; YOUNG	Background: Falls cause more than 60% of head injuries in older adults. Lack of objective evidence on the circumstances of these events is a barrier to prevention. We analyzed video footage to determine the frequency of and risk factors for head impact during falls in older adults in 2 long-term care facilities. Methods: Over 39 months, we captured on video 227 falls involving 133 residents. We used a validated questionnaire to analyze the mechanisms of each fall. We then examined whether the probability for head impact was associated with upper-limb protective responses (hand impact) and fall direction. Results: Head impact occurred in 37% of falls, usually onto a vinyl or linoleum floor. Hand impact occurred in 74% of falls but had no significant effect on the probability of head impact (p = 0.3). An increased probability of head impact was associated with a forward initial fall direction, compared with backward falls (odds ratio [OR] 2.7, 95% confidence interval [CI] 1.3-5.9) or sideways falls (OR 2.8, 95% CI 1.2-6.3). In 36% of sideways falls, residents rotated to land backwards, which reduced the probability of head impact (OR 0.2, 95% CI 0.04-0.8). Interpretation: Head impact was common in observed falls in older adults living in long-term care facilities, particularly in forward falls. Backward rotation during descent appeared to be protective, but hand impact was not. Attention to upper-limb strength and teaching rotational falling techniques (as in martial arts training) may reduce fall-related head injuries in older adults.	[Schonnop, Rebecca; Yang, Yijian; Feldman, Fabio; Robinson, Erin; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Injury Prevent & Mobil Lab, Burnaby, BC V5A 1S6, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada; [Feldman, Fabio] Fraser Hlth Author, Older Adult Program, Surrey, BC, Canada; [Loughin, Marie] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada		Robinovitch, SN (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Injury Prevent & Mobil Lab, Burnaby, BC V5A 1S6, Canada.	stever@sfu.ca	Yang, Yijian/G-1580-2016	Yang, Yijian/0000-0002-5831-186X; Schonnop, Rebecca/0000-0003-0236-6711; Robinovitch, Stephen/0000-0003-3881-6227	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [AMG-100487, TIR-103945]; Canada Research Chairs ProgramCanada Research Chairs; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was funded by team grants from the Canadian Institutes of Health Research (grant nos. AMG-100487 and TIR-103945). Stephen Robinovitch also received support from the Canada Research Chairs Program, and Rebecca Schonnop received fellowship support from the Canadian Institutes of Health Research. The funding agencies had no direct role in the design and conduct of this study; the collection, management, analysis or interpretation of the data; or the preparation, review or approval of the manuscript.	Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bowers B, 2008, REHABIL NURS, V33, P253, DOI 10.1002/j.2048-7940.2008.tb00237.x; DeGoede KM, 2003, J BIOMECH, V36, P413, DOI 10.1016/S0021-9290(02)00396-2; DIETZ V, 1978, BRAIN RES, V142, P576, DOI 10.1016/0006-8993(78)90921-6; Drahota A, 2011, INJURY PREV, V17, P1, DOI 10.1136/injuryprev-2011-040154; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Hsiao ET, 1998, J BIOMECH, V31, P1; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Mackey DM, 2012, FLOORING INJURY PREV; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Raymond DE, 2011, REHABIL NURS, V36, P248, DOI 10.1002/j.2048-7940.2011.tb00090.x; Robinovitch SN, 2005, J GERONTOL A-BIOL, V60, P1553, DOI 10.1093/gerona/60.12.1553; Robinovitch SN, 2003, J BONE MINER RES, V18, P1267, DOI 10.1359/jbmr.2003.18.7.1267; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Saari P, 2007, ARCH GERONTOL GERIAT, V45, P207, DOI 10.1016/j.archger.2006.10.012; Sran MA, 2010, J GERONTOL A-BIOL, V65, P312, DOI 10.1093/gerona/glp153; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TIRET L, 1989, AM J PUBLIC HEALTH, V79, P316, DOI 10.2105/AJPH.79.3.316; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Weerdesteyn V, 2008, J ELECTROMYOGR KINES, V18, P235, DOI 10.1016/j.jelekin.2007.06.010; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; WILD D, 1981, J EPIDEMIOL COMMUN H, V35, P200, DOI 10.1136/jech.35.3.200; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yang YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-40	36	42	42	1	10	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	NOV 19	2013	185	17					E803	E810		10.1503/cmaj.130498			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	292SY	WOS:000329923900012	24101612	Green Published, gold			2022-02-06	
J	Lynall, RC; Laudner, KG; Mihalik, JP; Stanek, JM				Lynall, Robert C.; Laudner, Kevin G.; Mihalik, Jason P.; Stanek, Justin M.			Concussion-Assessment and -Management Techniques Used by Athletic Trainers	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; return-to-play guidelines; evaluation	SPORT-RELATED CONCUSSION; POSTURAL STABILITY; STATEMENT; SYMPTOMS	Context: Understanding concussion-assessmment and -management practices that athletic trainers (ATs) currently use will allow clinicians to identify potential strategies for enhancing the quality of care provided to patients. Objective: To assess current clinical concussion diagnostic and return-to-participation practices among ATs. Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: A link to the survey was sent randomly to a convenience sample of 3222 members of the National Athletic Trainers' Association. A total of 1053 (32.7%) certified ATs (experience as an AT = 11.2 +/- 9.1 years) responded to the survey. Intervention(s): Prospective participants received electronic correspondence informing them of the purpose of the study and providing a link to the Web-based survey instrument. A reminder e-mail was sent approximately 6 weeks later, and the survey remained online for a total of 8 weeks. Main Outcome Measure(s): We collected information on the annual number of concussions assessed and tools employed to diagnose, manage, and safely return an athlete to participation. Descriptive statistics were computed for each variable. Results: Participants reported observing 10.7 +/- 11.0 concussions per year. Clinical examination (n = 743, 70.6%) was the most commonly reported means for evaluating and diagnosing concussion. Less than half of our respondents employed the Standardized Assessment of Concussion (n = 467, 44.3%), any variation of the Romberg test (n = 461, 43.8%), and computerized neuropsychological testing (n = 459, 43.6%). Clinical examination (n = 773, 73.4%), return-to-participation guidelines (n = 713, 67.7%), physician recommendation (n = 660, 62.7%), or player self-report (n = 447, 42.5%) contributed to the return-to-participation decisions of ATs. Only 20.8% (n = 219) of ATs reported using all 3 recommended domains of the concussion battery. Conclusions: Our study demonstrated a growth in the number of ATs incorporating objective clinical measures of concussion as a part of their concussion management. Conversely, fewer ATs reported using a standard clinical examination in their concussion assessment. These findings suggest ATs must continue to increase their use of both objective concussion assessment tools and the standard clinical examination.	[Lynall, Robert C.; Laudner, Kevin G.; Stanek, Justin M.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Lynall, RC (corresponding author), Univ N Carolina, Stallings Evans Sports Med Ctr 2207, Campus Box 8700, Chapel Hill, NC 27599 USA.	rlynall@live.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Mihalik, Jason/0000-0001-6085-8322			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Brasfield K., 2010, LEGISLATIVE REQUIREM; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Ferrara Michael S., 2001, J Athl Train, V36, P145; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006	23	42	42	0	15	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2013	48	6					844	850		10.4085/1062-6050-48.6.04			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	268AW	WOS:000328141200015	24143906	Green Submitted, Green Published			2022-02-06	
J	Kim, JY; Kim, N; Zheng, Z; Lee, JE; Yenari, MA				Kim, Jong Youl; Kim, Nuri; Zheng, Zhen; Lee, Jong Eun; Yenari, Midori A.			The 70 kDa heat shock protein protects against experimental traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Brain injury; Heat shock protein; Cerebral hemorrhage	OXYGEN-GLUCOSE DEPRIVATION; MATRIX METALLOPROTEINASES; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; INFLAMMATORY RESPONSE; BARRIER DISRUPTION; STRESS-RESPONSE; OVEREXPRESSION; BLOOD; MATRIX-METALLOPROTEINASE-9	Traumatic brain injury (TBI) causes disruption of the blood brain barrier (BBB) leading to hemorrhage which can complicate an already catastrophic illness. Matrix metalloproteinases (MMPs) involved in the breakdown of the extracellular matrix may lead to brain hemorrhage. We explore the contribution of the 70 kDa heat shock protein (Hsp70) to outcome and brain hemorrhage in a model of TBI. Male, wildtype (Wt), Hsp70 knockout (Ko) and transgenic (Tg) mice were subjected to TBI using controlled cortical impact (CCI). Motor function, brain hemorrhage and lesion size were assessed at 3, 7 and 14 days. Brains were evaluated for the effects of Hsp70 on MMPs. In Hsp70 Tg mice, CCI led to smaller brain lesions, decreased hemorrhage and reduced expression and activation of MMPs compared to Wt. CCI also significantly decreased right-biased swings and corner turns in the Hsp70 Tg mice. Conversely, Hsp70 Ko mice had significantly increased lesion size, worsened brain hemorrhage and increased expression and activation of MMPs with worsened behavioral outcomes compared to Wt. Hsp70 is protective in experimental TBI. To our knowledge, this is the direct demonstration of brain protection by Hsp70 in a TBI model. Our data demonstrate a new mechanism linking TBI-induced hemorrhage and neuronal injury to the suppression of MMPs by Hsp70, and support the development of Hsp70 enhancing strategies for the treatment of TBI. Published by Elsevier Inc.	[Kim, Jong Youl; Kim, Nuri; Zheng, Zhen; Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Kim, Jong Youl; Kim, Nuri; Zheng, Zhen; Yenari, Midori A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Lee, Jong Eun] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Lee, Jong Eun] Yonsei Univ, Coll Med, BK Project Med Sci 21, Seoul, South Korea		Yenari, MA (corresponding author), VAMC 4150 Clement St, San Francisco, CA 94121 USA.	yenari@alum.mit.edu		Hegelmeyer, Nuri/0000-0003-3606-0155; Lee, Jong Eun/0000-0001-6203-7413	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS40516]; Veteran's Merit Award; American Heart Association Western States Affiliate Postdoctoral FellowshipAmerican Heart Association [13POST14810019]; NRF of KOREA; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012-0005827]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040516] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (NS40516) and the Veteran's Merit Award to MY, an American Heart Association Western States Affiliate Postdoctoral Fellowship (13POST14810019) to JYK and Basic Science Research Program through the NRF of KOREA funded by the Ministry of Education, Science and Technology (2012-0005827) to JEL. Grants to MY and JYK were administered by the Northern California Institute for Research and Education, and supported by resources of the Veterans Affairs Medical Center, San Francisco, California. The authors wish to thank Dr. Linda Noble-Haeusslein for helpful discussion and advice.	Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chang EF, 2003, J NEUROSCI, V23, P3689; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Grossetete M, 2008, J CEREBR BLOOD F MET, V28, P752, DOI 10.1038/sj.jcbfm.9600572; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoehn B, 2001, J CEREBR BLOOD F MET, V21, P1303, DOI 10.1097/00004647-200111000-00006; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kelly S, 2002, ANN NEUROL, V52, P160, DOI 10.1002/ana.10264; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kwon HM, 2008, NEUROL RES, V30, P740, DOI 10.1179/174313208X289615; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Lee JE, 2004, NEUROREPORT, V15, P499, DOI 10.1097/00001756-200403010-00023; Lee JE, 2001, EXP NEUROL, V170, P129, DOI 10.1006/exnr.2000.7614; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P161, DOI 10.1007/978-3-7091-0693-8_27; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Noble LJ, 2002, J NEUROSCI, V22, P7526; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Ouyang YB, 2005, NEUROSCI LETT, V380, P229, DOI 10.1016/j.neulet.2005.01.055; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.3.CO;2-V; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vilalta A, 2008, ACTA NEUROCHIR SUPPL, V102, P415, DOI 10.1007/978-3-211-85578-2_81; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang Q, 2009, NEUROBIOL DIS, V36, P223, DOI 10.1016/j.nbd.2009.07.018; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xu LJ, 2003, NEUROL RES, V25, P697, DOI 10.1179/016164103101202183; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	56	42	45	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	OCT	2013	58						289	295		10.1016/j.nbd.2013.06.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GC	WOS:000323585900033	23816752	Green Accepted, Green Published			2022-02-06	
J	Lim, SW; Wang, CC; Wang, YH; Chio, CC; Niu, KC; Kuo, JR				Lim, Sher-Wei; Wang, Che-Chuan; Wang, Yun-Han; Chio, Chung-Ching; Niu, Ko-Chi; Kuo, Jinn-Rung			Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Hyperbaric oxygen therapy; Microglia; Tumor necrosis factor-alpha; Anti-inflammation	LATERAL FLUID-PERCUSSION; MITOCHONDRIAL-FUNCTION; CEREBRAL OXYGENATION; RAT MODEL; INFLAMMATION; MECHANISMS; PHYSIOLOGY; NEUROTRAUMA; EXPRESSION; CONTUSIONS	Background: The mechanisms underlying the protective effects of hyperbaric oxygen (HBO) therapy on traumatic brain injury (TBI) are unclear. TBI initiates a neuroinflammatory cascade characterized by activation of microglia and increased production of proinflammatory cytokines. In this study, we attempted to ascertain whether the occurrence of neuroinflammation exhibited during TBI can be reduced by HBO. Methods: TBI was produced by the fluid percussion technique in rats. HBO (100% O-2 at 2.0 absolute atmospheres) was then used at 1 h (HBO I) or 8 h (HBO II) after TBI. Neurobehavior was evaluated by the inclined plane test on the 72 h after TBI and then the rats were killed. The infarction area was evaluated by Triphenyltetrazolium chloride. Immunofluorescence staining was used to evaluate neuronal apoptosis (TUNEL + NeuN), microglial cell aggregation count (OX42 + DAPI), and tumor necrosis factor-alpha (TNF-alpha) expression in microglia cell (OX42 + TNF-alpha). Results: The maximum grasp angle in the inclined plane test and cerebral infarction of the rats after TBI were significantly attenuated by HBO therapy regardless of whether the rats were treated with HBO 1 or 8 h after TBI compared with the controls. TBI-induced microglial activation, TNF-alpha expression, and neuronal apoptosis were also significantly reduced by HBO therapy. Conclusions: Our results demonstrate that treatment of TBI during the acute phase of injury can attenuate microgliosis and proinflammatory cytokine TNF-alpha expression resulting in a neuroprotective effect. Even treating TBI with HBO after 8 h had a therapeutic effect. (C) 2013 Elsevier Inc. All rights reserved.	[Lim, Sher-Wei; Wang, Che-Chuan; Wang, Yun-Han; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan 710, Taiwan; [Niu, Ko-Chi] Chi Mei Med Ctr, Dept Hyperbar Oxygen, Tainan 710, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Lim, SW (corresponding author), Chi Mei Med Ctr, Traumat Brain Ctr, Dept Neurosurg, 901 Jong Hwa Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com		Swanson, Raymond/0000-0002-3664-5359	 [NSC100-2314-B-384-005];  [CMNSC10010]	The project was supported by grants NSC100-2314-B-384-005 and CMNSC10010.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hanisch UK, 2004, GLIA, V14, P97; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Lin MT, 1997, AM J PHYSIOL-HEART C, V273, pH2072, DOI 10.1152/ajpheart.1997.273.4.H2072; LIN MT, 1994, NEUROSCI LETT, V174, P17, DOI 10.1016/0304-3940(94)90108-2; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Nemoto EM, 2007, NEUROL RES, V29, P116, DOI 10.1179/016164107X174138; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Niu KC, 2007, EUR J PHARMACOL, V570, P229, DOI 10.1016/j.ejphar.2007.05.056; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Sukoff MH, 2001, J NEUROSURG, V95, P544; Sukoff MH, 1984, HYPERB OXYGEN REV, V5, P35; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	43	42	51	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2013	184	2					1076	1084		10.1016/j.jss.2013.04.070			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	215XE	WOS:000324243500058	23726237				2022-02-06	
J	Shakeri, M; Boustani, MR; Pak, N; Panahi, F; Salehpour, F; Lotfinia, I; Meshkini, A; Daghighi, S; Vahedi, P; Khani, M; Taghiloo, D				Shakeri, Moslem; Boustani, Mohammad Reza; Pak, Neda; Panahi, Farid; Salehpour, Firouz; Lotfinia, Iraj; Meshkini, Ali; Daghighi, Shadi; Vahedi, Payman; Khani, Mehdi; Taghiloo, Dariush			Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Glasgow coma scale; Traumatic brain injury; Progesterone; Diffuse axonal injury; Neuro-protective agent	BRAIN-INJURY; CEREBRAL-ISCHEMIA; CONTUSION INJURY; RATS; PROTECTS; DAMAGE; TRIAL; DEATH	Objective: Severe traumatic brain injury (TBI) has a major role in mortality rate among the other types of trauma. The aim of this clinical study was to assess the effect of progesterone on the improvement of neurologic outcome in patients with acute severe TBI. Methods: A total of 76 patients who had arrived within 8 h of injury with a Glasgow Coma Score <= 8 were enrolled in the study. In a randomized style 38 received progesterone (1 mg/kg per 12 h for 5 days) and 38 did not. Results: There was a better recovery rate and GOS score for the patients who were given progesterone than for those in the control group in a 3-months follow-up period (50% vs. 21%); subgroup analysis showed a significant difference in the percentage of favorable outcome between the two groups with GCS of 5-8 (p = 0.03). Conclusion: The use of progesterone may significantly improve neurologic outcome of patients suffering severe TBI up to 3 months after injury, especially those with 5 <= GCS <= 8, providing a potential benefit to the treatment of acute severe TBI patients. Considering this drug had no significant side effects, so progesterone could be used in patients with severe TBI as a neuro-protective drug. (C) 2013 Elsevier B.V. All rights reserved.	[Shakeri, Moslem; Boustani, Mohammad Reza; Salehpour, Firouz; Lotfinia, Iraj; Meshkini, Ali] Tabriz Univ Med Sci, Sch Med, Imam Reza Teaching Hosp, Dept Neurosurg, Tabriz, Iran; [Pak, Neda] Univ Tehran Med Sci, Childrens Hosp, Med Ctr, Dept Radiol, Tehran, Iran; [Panahi, Farid] Tabriz Univ Med Sci, Sch Med, Imam Reza Teaching Hosp, Neurosci Res Ctr, Tabriz, Iran; [Daghighi, Shadi; Khani, Mehdi] Tabriz Univ Med Sci, Sch Med, Tabriz, Iran; [Vahedi, Payman] Mashhad Univ Med Sci, Nishabour Fac Med, Dept Neurosurg, Mashhad, Iran; [Panahi, Farid] Tabriz Univ Med Sci, Sch Med, Student Div, Res Dev & Coordinat Ctr, Tabriz, Iran; [Taghiloo, Dariush] Tabriz Univ Med Sci, Sch Med, Imam Reza Teaching Hosp, Dept Emergency Med, Tabriz, Iran		Panahi, F (corresponding author), Tabriz Univ Med Sci, Sch Med, Imam Reza Teaching Hosp, Neurosci Res Ctr, Golgasht Ave,POB 5166859188, Tabriz, Iran.	mb_np_dr@yahoo.com; Farid.Panahi@gmail.com	MESHKINI, ALI -/M-1009-2017; Panahi, Farid/K-3021-2012; Taghiloo, Dariush/N-8244-2016; salehpour, firooz/L-8833-2017	MESHKINI, ALI -/0000-0001-6996-5028; Panahi, Farid/0000-0002-8237-6989; Taghiloo, Dariush/0000-0002-1101-2627; Vahedi, Payman/0000-0002-0950-6476; Mahdkhah, Atta/0000-0001-9185-3997; salehpour, firooz/0000-0003-0693-6400	Tabriz University of Medical Sciences	Source of Support: Research Deputy of Tabriz University of Medical Sciences.	Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; JENNETT B, 1975, LANCET, V1, P480; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; XIAO GM, 2007, ZHONGHUA WAI KE ZA Z, V4, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	20	42	45	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2019	2022		10.1016/j.clineuro.2013.06.013			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200016	23871679				2022-02-06	
J	Franke, H; Parravicini, C; Lecca, D; Zanier, ER; Heine, C; Bremicker, K; Fumagalli, M; Rosa, P; Longhi, L; Stocchetti, N; De Simoni, MG; Weber, M; Abbracchio, MP				Franke, Heike; Parravicini, Chiara; Lecca, Davide; Zanier, Elisa R.; Heine, Claudia; Bremicker, Kristina; Fumagalli, Marta; Rosa, Patrizia; Longhi, Luca; Stocchetti, Nino; De Simoni, Maria-Grazia; Weber, Marco; Abbracchio, Maria P.			Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury	PURINERGIC SIGNALLING			English	Article						Activated microglia; Adult neural precursors; Human brain injury; Lesion repair; Reactive astrocytes	LEUKOTRIENE; ANTAGONIST; EXPRESSION; BINDING	Unveiling the mechanisms participating in the damage and repair of traumatic brain injury (TBI) is fundamental to develop new therapies. The P2Y-like GPR17 receptor has recently emerged as a sensor of damage and a key actor in lesion remodeling/repair in the rodent brain, but its role in humans is totally unknown. Here, we characterized GPR17 expression in brain specimens from seven intensive care unit TBI patients undergoing neurosurgery for contusion removal and from 28 autoptic TBI cases (and 10 control subjects of matched age and gender) of two university hospitals. In both neurosurgery and autoptic samples, GPR17 expression was strong inside the contused core and progressively declined distally according to a spatio-temporal gradient. Inside and around the core, GPR17 labeled dying neurons, reactive astrocytes, and activated microglia/macrophages. In peri-contused parenchyma, GPR17 decorated oligodendrocyte precursor cells (OPCs) some of which had proliferated, indicating re-myelination attempts. In autoptic cases, GPR17 expression positively correlated with death for intracranial complications and negatively correlated with patients' post-traumatic survival. Data indicate lesion-specific sequential involvement of GPR17 in the (a) death of irreversibly damaged neurons, (b) activation of microglia/macrophages remodeling the lesion, and (c) activation/proliferation of multipotent parenchymal progenitors (both reactive astrocytes and OPCs) starting repair processes. Data validate GPR17 as a target for neurorepair and are particularly relevant to setting up new therapies for TBI patients.	[Franke, Heike; Heine, Claudia; Bremicker, Kristina] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany; [Parravicini, Chiara; Lecca, Davide; Fumagalli, Marta; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol & Biomol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, I-20133 Milan, Italy; [Zanier, Elisa R.; De Simoni, Maria-Grazia] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy; [Heine, Claudia] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Rosa, Patrizia] CNR, Dept Med Pharmacol, Inst Neurosci, Milan, Italy; [Longhi, Luca; Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Longhi, Luca; Stocchetti, Nino] IRCCS Ca Granda Osped Maggiore Policlin, Neurosurg Care Unit, I-20122 Milan, Italy; [Weber, Marco] Univ Halle, Inst Legal Med, Halle, Saale, Germany		Abbracchio, MP (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, Via Balzaretti 9, I-20133 Milan, Italy.	mariapia.abbracchio@unimi.it	Longhi, Luca/AAF-9903-2021; Zanier, Elisa/AAA-8095-2020; Weber, Marco/Z-4601-2019; De Simoni, Maria Grazia/I-6021-2012; Weber, Marco/J-9620-2012; Stocchetti, Nino/O-7444-2017; Abbracchio, Maria Pia/B-9342-2014; Lecca, Davide/A-8850-2010	Longhi, Luca/0000-0001-9894-8788; Zanier, Elisa/0000-0002-3011-8718; Weber, Marco/0000-0002-6666-0592; De Simoni, Maria Grazia/0000-0001-6695-5297; Stocchetti, Nino/0000-0003-3250-6834; Abbracchio, Maria Pia/0000-0002-7833-3388; Lecca, Davide/0000-0002-3258-363X; Rosa, Patrizia/0000-0002-2590-6955; Fumagalli, Marta/0000-0002-0158-842X	Italian PRIN-COFIN [2006059022, 2008XFMEA3]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [FR 1253/3-2]; Fondazione Cariplo fellowship [2008.2907]; Fondazione Italiana Sclerosi MultiplaFondazione Italiana Sclerosi Multipla (FISM) [2010/R/2]; German Federal Ministry of Education and Research (BMBF, PtJ-Bio)Federal Ministry of Education & Research (BMBF) [0313909]; European Fund for Regional Development (EFRE)European Commission; Free State of Saxony [SAB12525]	The authors thank Prof. Enzo Wanke, University of Bicocca-Milan and Dr. Annalisa Buffo, University of Turin for useful discussion. The authors are also grateful to Prof. J. Dressler and Benjamin Ondruschka (Institute for Legal Medicine, Medical Faculty University of Leipzig) for providing autoptic samples, to Dr. Mauro Pluderi, MD, and Dr. Marco Locatelli, MD, from the Department of Neurosurgery of the Ospedale Maggiore Policlinico di Milano for assistance in resection of contusions and collection of neurosurgical brain samples, and to Mrs. Katrin Becker (RBI of Pharmacology and Toxicology, Leipzig) for expert technical assistance. This work was partially supported by the Italian PRIN-COFIN (Project Prot. 2006059022 and 2008XFMEA3 to M.P.A) and by Deutsche Forschungsgemeinschaft (FR 1253/3-2); C.P. was supported by a Fondazione Cariplo fellowship (project number 2008.2907); M.F. is supported by a fellowship from Fondazione Italiana Sclerosi Multipla (grant N. 2010/R/2); C.H. was supported by a funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0313909), the European Fund for Regional Development (EFRE), and the Free State of Saxony (grant no. SAB12525).	Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Boda E, 2010, ARCH ITAL BIOL, V148, P119; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Buccioni M, 2011, PURINERG SIGNAL, V7, P463, DOI 10.1007/s11302-011-9245-8; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Daniele S, 2011, J PHARMACOL EXP THER, V338, P559, DOI 10.1124/jpet.110.178715; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Eberini I, 2011, J COMPUT AID MOL DES, V25, P743, DOI 10.1007/s10822-011-9455-8; Fumagalli M, 2011, FRONT BIOSCI-LANDMRK, V16, P2326, DOI 10.2741/3856; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lecca D, 2008, BIOCHEM PHARMACOL, V75, P1869, DOI 10.1016/j.bcp.2007.12.009; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155	30	42	43	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1573-9538	1573-9546		PURINERG SIGNAL	Purinergic Signal.	SEP	2013	9	3					451	462		10.1007/s11302-013-9366-3			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	209HQ	WOS:000323746700013	23801362	Green Published			2022-02-06	
J	Pearl, PL; McCarter, R; McGavin, CL; Yu, YZ; Sandoval, F; Trzcinski, S; Atabaki, SM; Tsuchida, T; van den Anker, J; He, JP; Klein, P				Pearl, Phillip L.; McCarter, Robert; McGavin, Colleen L.; Yu, Yuezhou; Sandoval, Fabian; Trzcinski, Stacey; Atabaki, Shireen M.; Tsuchida, Tammy; van den Anker, John; He, Jianping; Klein, Pavel			Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy	EPILEPSIA			English	Article						Posttraumatic epilepsy; Levetiracetam; Pediatric	TRAUMATIC BRAIN-INJURY; SEIZURES; ADULTS	Posttraumatic seizures develop in up to 20% of children following severe traumatic brain injury (TBI). Children ages 6-17 years with one or more risk factors for the development of posttraumatic epilepsy, including presence of intracranial hemorrhage, depressed skull fracture, penetrating injury, or occurrence of posttraumatic seizure were recruited into this phase II study. Treatment subjects received levetiracetam 55 mg/kg/day, b. i. d., for 30 days, starting within 8 h postinjury. The recruitment goal was 20 treated patients. Twenty patients who presented within 8-24 h post-TBI and otherwise met eligibility criteria were recruited for observation. Follow-up was for 2 years. Forty-five patients screened within 8 h of head injury met eligibility criteria and 20 were recruited into the treatment arm. The most common risk factor present for pediatric inclusion following TBI was an imme-diate seizure. Medication compliance was 95%. No patients died; 19 of 20 treatment patients were retained and one observation patient was lost to follow-up. The most common severe adverse events in treatment subjects were headache, fatigue, drowsiness, and irritability. There was no higher incidence of infection, mood changes, or behavior problems among treatment subjects compared to observation subjects. Only 1 (2.5%) of 40 subjects developed posttraumatic epilepsy (defined as seizures > 7 days after trauma). This study demonstrates the feasibility of a pediatric posttraumatic epilepsy prevention study in an at-risk traumatic brain injury population. Levetiracetam was safe and well tolerated in this population. This study sets the stage for implementation of a prospective study to prevent posttraumatic epilepsy in an at-risk population.	[Pearl, Phillip L.; McGavin, Colleen L.; Yu, Yuezhou; Sandoval, Fabian; Trzcinski, Stacey; Tsuchida, Tammy] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [McCarter, Robert; He, Jianping] Childrens Natl Med Ctr, Dept Biostat, Washington, DC 20010 USA; [Atabaki, Shireen M.] Childrens Natl Med Ctr, Dept Emergency Med, Washington, DC 20010 USA; [van den Anker, John] Childrens Natl Med Ctr, Dept Pharmacol, Washington, DC 20010 USA; [Klein, Pavel] Midatlantic Epilepsy & Sleep Ctr, Bethesda, MD USA		Pearl, PL (corresponding author), Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA.	ppearl@childrensnational.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 NS45656]; GCRC of Children's National Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045656] Funding Source: NIH RePORTER	The study was supported by the NIH, Grant 1 R01 NS45656, and the GCRC of Children's National Medical Center. Levetiracetam was provided by UCB Pharma, Inc.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Klein P., 2012, ARCH NEUROL-CHICAGO, V9, P1; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; YOUNG B, 1983, CHILD BRAIN, V10, P185	9	42	45	1	19	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2013	54	9					e135	e137		10.1111/epi.12326			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	213BW	WOS:000324029400005	23876024	Green Accepted			2022-02-06	
J	Brooks, BR; Crumpacker, D; Fellus, J; Kantor, D; Kaye, RE				Brooks, Benjamin Rix; Crumpacker, David; Fellus, Jonathan; Kantor, Daniel; Kaye, Randall E.			PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions	PLOS ONE			English	Article							EMOTIONAL EXPRESSION DISORDER; PATHOLOGICAL LAUGHTER; POSTSTROKE DEPRESSION; INCONTINENCE; EPIDEMIOLOGY; SCLEROSIS; DISEASE; STROKE; ALS; PATHOPHYSIOLOGY	Background: Pseudobulbar affect (PBA) is a neurological condition characterized by involuntary, sudden, and frequent episodes of laughing and/or crying, which can be socially disabling. Although PBA occurs secondary to many neurological conditions, with an estimated United States (US) prevalence of up to 2 million persons, it is thought to be under-recognized and undertreated. The PBA Registry Series (PRISM) was established to provide additional PBA symptom prevalence data in a large, representative US sample of patients with neurological conditions known to be associated with PBA. Methods: Participating clinicians were asked to enroll >= 20 consenting patients with any of 6 conditions: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease (PD), stroke, or traumatic brain injury (TBI). Patients (or their caregivers) completed the Center for Neurologic Study-Lability Scale (CNS-LS) and an 11-point scale measuring impact of the neurological condition on the patient's quality of life (QOL). Presence of PBA symptoms was defined as a CNS-LS score >= 13. Demographic data and current use of antidepressant or antipsychotic medications were also recorded. Results: PRISM enrolled 5290 patients. More than one third of patients (n = 1944; 36.7%) had a CNS-LS score >= 13, suggesting PBA symptoms. The mean (SD) score measuring impact of neurological condition on QOL was significantly higher (worse) in patients with CNS-LS >= 13 vs,13 (6.7 [2.5] vs. 4.7 [3.1], respectively; P<0.0001 two-sample t-test). A greater percentage of patients with CNS-LS >= 13 versus <13 were using antidepressant/antipsychotic medications (53.0% vs 35.4%, respectively; P<0.0001, chi-square test). Conclusions: Data from PRISM, the largest clinic-based study to assess PBA symptom prevalence, showed that PBA symptoms were common among patients with diverse neurological conditions. Higher CNS-LS scores were associated with impaired QOL and greater use of antipsychotic/antidepressant medications. These data underscore a need for greater awareness, recognition, and diagnosis of PBA.	[Brooks, Benjamin Rix] Univ N Carolina, Sch Med, Carolinas Med Ctr, Charlotte, NC 28223 USA; [Crumpacker, David] Baylor Univ, Med Ctr, Dallas, TX USA; [Fellus, Jonathan] Int Brain Res Fdn, Flanders, NJ USA; [Kantor, Daniel] Neurologique, Ponte Vedra Beach, FL USA; [Kaye, Randall E.] Avanir Pharmaceut Inc, Aliso Viejo, CA USA		Kaye, RE (corresponding author), Avanir Pharmaceut Inc, Aliso Viejo, CA USA.	RKaye@avanir.com			Avanir Pharmaceuticals, Inc.	Funding for the PRISM study and editorial support for manuscript preparation were provided by Avanir Pharmaceuticals, Inc. RK is an employee of Avanir and participated in study design, data analysis and contributed as an author. The data were gathered by the individual investigators and were analyzed by MMS Holdings. The decision to publish was that of the authors.	Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Choi-Kwon S, 2012, NEUROLOGY, V78, P1130, DOI 10.1212/WNL.0b013e31824f8090; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cottrell SS, 1926, J NEUROL PSYCHOPATHO, V7, P1; Cummings JL, 2007, CNS SPECTRUMS, V12, P11; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Darwin C., 1965, EXPRESS EMOT MAN; Davison C, 1939, ARCH NEURO PSYCHIATR, V42, P595, DOI 10.1001/archneurpsyc.1939.02270220011001; Di Poggio MB, 2013, AMYOTROPH LAT SCL FR, V14, P52, DOI 10.3109/17482968.2012.729062; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HASTRUP JL, 1986, GERONTOLOGIST, V26, P91, DOI 10.1093/geront/26.1.91; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Hurwitz BJ, 2009, NEUROLOGY S1, pS3; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Langworthy OR, 1941, AM J PSYCHIAT, V98, P243, DOI 10.1176/ajp.98.2.243; Lopez OL, 1996, NEUROPSY NEUROPSY BE, V9, P154; McElvaney NG, 1997, CHEST, V111, P394, DOI 10.1378/chest.111.2.394; Miller A, 2011, EXPERT REV NEUROTHER, V11, P1077, DOI [10.1586/ERN.11.68, 10.1586/ern.11.68]; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; MULLER R, 1952, ACTA PSYCH NEUROL, V27, P137; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Nieuwenhuis-Mark RE, 2008, COGN BEHAV NEUROL, V21, P111, DOI 10.1097/WNN.0b013e31816be8f8; Oppenheim H., 1911, TXB NERVOUS DIS PHYS; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Parvizi J, 2007, MOVEMENT DISORD, V22, P798, DOI 10.1002/mds.21348; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Petracca GM, 2009, J NEUROPSYCH CLIN N, V21, P406, DOI 10.1176/appi.neuropsych.21.4.406; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; PRATT RTC, 1951, J NEUROL NEUROSUR PS, V14, P326, DOI 10.1136/jnnp.14.4.326; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; Rottenberg J, 2002, J ABNORM PSYCHOL, V111, P302, DOI 10.1037//0021-843X.111.2.302; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Siddiqui MS, 2009, WORLD J BIOL PSYCHIA, V10, P234, DOI 10.1080/15622970701639445; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Smith RA, 2004, MULT SCLER, V10, P1; Smith RA, 2006, EXPERT OPIN PHARMACO, V7, P2581, DOI 10.1517/14656566.7.18.2581; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Tang WK, 2009, J NEUROL NEUROSUR PS, V80, P1082, DOI 10.1136/jnnp.2009.175372; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tang WK, 2004, J NEUROL, V251, P865, DOI 10.1007/s00415-004-0450-z; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Vinceti M, 2012, Ann Ig, V24, P407; Vingerhoets AJJM, 2007, ACTA PSYCHIAT SCAND, V115, P340, DOI 10.1111/j.1600-0447.2006.00948.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wicks P, 2007, EUR J NEUROL, V14, P993, DOI 10.1111/j.1468-1331.2007.01843.x; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	60	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72232	10.1371/journal.pone.0072232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	WOS:000324470100088	23991068	Green Published, Green Submitted, gold			2022-02-06	
J	De Bonis, P; Sturiale, CL; Anile, C; Gaudino, S; Mangiola, A; Martucci, M; Colosimo, C; Rigante, L; Pompucci, A				De Bonis, Pasquale; Sturiale, Carmelo Lucio; Anile, Carmelo; Gaudino, Simona; Mangiola, Annunziato; Martucci, Matia; Colosimo, Cesare; Rigante, Luigi; Pompucci, Angelo			Decompressive craniectomy, interhemispheric hygroma and hydrocephalus: A timeline of events?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive craniectomy; Hydrocephalus; Interhemispheric hygroma; Subdural hygroma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; RISK-FACTORS; HEAD-INJURY; HEMICRANIECTOMY; EVACUATION; SECONDARY; DYNAMICS	Background: Decompressive craniectomy (DC) is a known risk factor for the development of post-traumatic hydrocephalus. The occurrence of subdural hygroma (SH) was also reported in 23-56% of patients after DC and it seemed to precede hydrocephalus in more than 80% of cases. We analyzed the relationship among DC, SH and hydrocephalus. Methods: From 2007 to 2011, 64 patients underwent DC after head trauma. Variables we analyzed were: intaventricular hemorrhage, age, GCS, distance of craniectomy from-the midline, evacuation of a hemorrhagic contusion (HC) and infection. Logistic regression was used to assess the independent contribution of the predictive factors to the development of hydrocephalus. Results: Nineteen patients (29.7%) developed hydrocephalus. Interhemispheric SH was present in 8/19 patients with hydrocephalus and temporally preceded the occurrence of ventricular enlargement. Moreover, most patients who developed a interhemispheric SH had been undergone DC whose superior margin was close to the midline. Logistic regression analysis showed that craniectomy closer than 25 mm to the midline was the only factor independently associated with the development of hydrocephalus. Conclusion: Craniectomy close to the midline can predispose patients to the development of hydrocephalus. SH could be generated with the same mechanism, and these three events could be correlated on a timeline. (C) 2012 Elsevier B.V. All rights reserved.	[De Bonis, Pasquale; Sturiale, Carmelo Lucio; Anile, Carmelo; Mangiola, Annunziato; Rigante, Luigi; Pompucci, Angelo] Catholic Univ, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Gaudino, Simona; Martucci, Matia; Colosimo, Cesare] Catholic Univ, Sch Med, Dept Bio Imaging, I-00168 Rome, Italy		Sturiale, CL (corresponding author), Catholic Univ, Sch Med, Inst Neurosurg, Lgo A Gemelli 8, I-00168 Rome, Italy.	cropcircle.2000@virgilio.it	Sturiale, Carmelo Lucio/K-6412-2016; de bonis, pasquale/K-8200-2016; Rigante, Luigi/K-7260-2016; Martucci, Matia/E-6703-2011	Sturiale, Carmelo Lucio/0000-0002-4080-2492; de bonis, pasquale/0000-0002-9879-8940; Gaudino, Simona/0000-0003-1681-4343; Rigante, Luigi/0000-0003-0539-526X; Colosimo, Cesare/0000-0003-3800-3648			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Anile C, 2009, CHILD NERV SYST, V25, P325, DOI 10.1007/s00381-008-0749-7; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Dandy WE, 1932, PRACTICE SURG, P306; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Relkin Norman, 2005, Neurosurgery, V57, pS4; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; Takeuchi S, 2012, CLIN NEUROLOGY NEURO; Takeuchi S, 2011, J NEUROSURG, V115, P194, DOI 10.3171/2011.2.JNS11122; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	31	42	43	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2013	115	8					1308	1312		10.1016/j.clineuro.2012.12.011			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	198NJ	WOS:000322929300020	23290122				2022-02-06	
J	Kirov, II; Tal, A; Babb, JS; Reaume, J; Bushnik, T; Ashman, TA; Flanagan, S; Grossman, RI; Gonen, O				Kirov, Ivan I.; Tal, Assaf; Babb, James S.; Reaume, Joseph; Bushnik, Tamara; Ashman, Teresa A.; Flanagan, Steven; Grossman, Robert I.; Gonen, Oded			Proton MR Spectroscopy Correlates Diffuse Axonal Abnormalities with Post-Concussive Symptoms in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; magnetic resonance spectroscopy; mild traumatic brain injury; N-acetyl-aspartate; post-concussive symptoms	HEAD-INJURY; RECOVERY	There are no established biomarkers for mild traumatic brain injury (mTBI), in part because post-concussive symptoms (PCS) are subjective and conventional imaging is typically unremarkable. To test whether diffuse axonal abnormalities quantified with three-dimensional (3D) proton magnetic resonance spectroscopic imaging (H-1-MRSI) correlated with patients' PCS, we retrospectively studied 26 mTBI patients (mean Glasgow Coma Scale [GCS] score of 14.7), 18- to 56-year-olds and 13 controls three to 55 days post-injury. All were scanned at 3 Tesla with T1- and T2-weighted MRI and 3D H-1-MRSI (480 voxels over 360 cm(3), similar to 30% of the brain). On scan day, patients completed a symptom questionnaire, and those who indicated at least one of the most common subacute mTBI symptoms (headache, dizziness, sleep disturbance, memory deficits, blurred vision) were grouped as PCS-positive. Global gray matter and white matter (GM/WM) absolute concentrations of N-acetylaspartate (NAA), choline (Cho), creatine (Cr) and myo-inositol (mI) in PCS-positive and PCS-negative patients were compared to age-and gender-matched controls using two-way analysis of variance. The results showed that the PCS-negative group (n = 11) and controls (n = 8) did not differ in any GM or WM metabolite level. The PCS-positive patients (n = 15) had lower WM NAA than the controls (n = 12; 7.0 +/- 0.6 versus 7.9 +/- 0.5mM; p = 0.0007). Global WM NAA, therefore, showed sensitivity to the TBI sequelae associated with common PCS in patients with mostly normal neuroimaging, as well as GCS scores. This suggests a potential biomarker role in a patient population in which objective measures of injury and symptomatology are currently lacking.	[Kirov, Ivan I.; Tal, Assaf; Babb, James S.; Reaume, Joseph; Grossman, Robert I.; Gonen, Oded] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; [Bushnik, Tamara; Ashman, Teresa A.; Flanagan, Steven] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY 10016 USA		Gonen, O (corresponding author), NYU, Sch Med, Dept Radiol, 660 1st Ave,4th Floor, New York, NY 10016 USA.	oded.gonen@med.nyu.edu	Kirov, Ivan/I-2792-2019	Kirov, Ivan/0000-0001-5641-8578; Bushnik, Tamara/0000-0003-3328-257X; Gonen, Oded/0000-0002-3148-2028; Tal, Assaf/0000-0001-6718-6522; Flanagan, Steven/0000-0001-9005-5897; Babb, James/0000-0003-1798-1186	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB01015, NS39135, NS29029, NS0050520]; Human Frontiers Science Project; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB001015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029029, R56NS050520, R01NS039135, R01NS050520, R37NS029029] Funding Source: NIH RePORTER	This work was supported by NIH Grants EB01015, NS39135, NS29029 and NS0050520. Dr. Tal acknowledges the support of the Human Frontiers Science Project.	Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; Grossman RI, 2012, NMR BIOMED; Johnson VE, 2012, EXP NEUROL; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kirov II, 2012, MAGN RESON MED, V67, P27, DOI 10.1002/mrm.23001; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Paling D, 2011, J NEUROL, V258, P2113, DOI 10.1007/s00415-011-6117-7; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5	20	42	45	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1200	1204		10.1089/neu.2012.2696			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400011	23339670	Green Published			2022-02-06	
J	Vagnozzi, R; Signoretti, S; Floris, R; Marziali, S; Manara, M; Amorini, AM; Belli, A; Di Pietro, V; D'Urso, S; Pastore, FS; Lazzarino, G; Tavazzi, B				Vagnozzi, Roberto; Signoretti, Stefano; Floris, Roberto; Marziali, Simone; Manara, Massimo; Amorini, Angela M.; Belli, Antonio; Di Pietro, Valentina; D'Urso, Serafina; Pastore, Francesco S.; Lazzarino, Giuseppe; Tavazzi, Barbara			Decrease in N-Acetylaspartate Following Concussion May Be Coupled to Decrease in Creatine	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain vulnerability; concussion; creatine; H-1 magnetic resonance spectroscopy; mild traumatic brain injury; N-acetylaspartate; sports-related concussion	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; METABOLIC ACETATE THERAPY; MITOCHONDRIAL DYSFUNCTION; TEMPORAL WINDOW; VULNERABILITY; GUANIDINOACETATE; PATHOPHYSIOLOGY; IMPAIRMENT; DEFICIENCY	Objectives: To assess the time course changes in N-acetylaspartate (NAA) and creatine (Cr) levels in the brain of athletes who suffered a sport-related concussion. Participants: Eleven nonconsecutive athletes with concussive head injury and 11 sex-and age-matched control volunteers Main outcome measures: At 3, 15, 30, and 45 days postinjury, athletes were examined by proton magnetic resonance spectroscopy for the determination of NAA, Cr, and choline (Cho) levels. Proton magnetic resonance spectroscopic data recorded for the control group were used for comparison. Results: Compared with controls (2.18 +/- 0.19), athletes showed an increase in the NAA/Cr ratio at 3 (2.71 +/- 0.16; P <.01) and 15 (2.54 +/- 0.21; P <.01) days postconcussion, followed by a decrease and subsequent normalization at 30 (1.95 +/- 0.16, P <.05) and 45 (2.17 +/- 0.20; P < .05) days postconcussion. The NAA/Cho ratio decreased at 3, 15, and 30 days postinjury (P < .01 compared with controls), with no differences observed in controls at 45 days postconcussion. Compared with controls, significant increase in the Cho/Cr ratio after 3 (+ 33%, P < .01) and 15 (+ 31.5%, P < .01) days postinjury was observed whereas no differences were recorded at 30 and 45 days postinjury. Conclusions: This cohort of athletes indicates that concussion may cause concomitant decrease in cerebral NAA and Cr levels. This provokes longer time for normalization of metabolism, as well as longer time for resolution of concussion-associated clinical symptoms.	[Vagnozzi, Roberto; Floris, Roberto; Marziali, Simone; D'Urso, Serafina; Pastore, Francesco S.] Univ Roma Tor Vergata, Dept Biomed & Prevent, Div Neurotraumatol & Neuroradiol, Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Div Neurosurg, Dept Neurosci Head & Neck Surg, Rome, Italy; [Manara, Massimo] Assoc Sports Phys Parma, FMSI, Parma, Italy; [Amorini, Angela M.; Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Div Biochem & Mol Biol, Dept Biol Geol & Environm Sci, Catania, Italy; [Belli, Antonio; Di Pietro, Valentina] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England; [Belli, Antonio; Di Pietro, Valentina] Univ Hosp Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England		Lazzarino, G (corresponding author), Dept Biol Geol & Environm Sci, Div Biochem & Mol Biol, Viale A Doria 6, I-95125 Catania, Italy.	lazzarig@unict.it	Floris, Roberto/AAC-4594-2022; Belli, Antonio/I-3799-2015; Signoretti, stefano/AAL-5631-2020; floris, roberto/AAC-2396-2019; pastore, francesco saverio/D-3827-2012; TAVAZZI, BARBARA/AAB-9830-2019; lazzarino, giuseppe/K-2277-2015	Floris, Roberto/0000-0002-6098-2232; Belli, Antonio/0000-0002-3211-9933; Signoretti, stefano/0000-0002-8086-1622; pastore, francesco saverio/0000-0002-2041-5161; TAVAZZI, BARBARA/0000-0001-8743-0895; Di Pietro, Valentina/0000-0001-9430-4723; Marziali, Simone/0000-0002-5805-5501; AMORINI, Angela Maria/0000-0003-3525-9955; lazzarino, giuseppe/0000-0002-5917-7279	University of Rome	This work has been supported in part by research funds of University of Rome "Tor Vergata," Catholic University of Rome, and University of Catania. The authors thank Mr Salvatore Meo for his technical assistance in preparing the artwork for the manuscript.	Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baslow MH, 2003, J MOL NEUROSCI, V21, P185, DOI 10.1385/JMN:21:3:185; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Royes LF, 2008, NEUROCHEM INT, V53, P33, DOI 10.1016/j.neuint.2008.04.008; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gruber S, 2008, EUR J RADIOL, V68, P320, DOI 10.1016/j.ejrad.2007.08.038; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; HOVDA DA, 1983, INTRACRANIAL PRESSUR, V8, P469; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Senaratne R, 2009, PSYCHIAT RES-NEUROIM, V172, P205, DOI 10.1016/j.pscychresns.2008.07.007; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Stockler S, 1996, AM J HUM GENET, V58, P914; Stockler Sylvia, 2007, V46, P149; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Tachikawa M, 2008, J NEUROCHEM, V107, P768, DOI 10.1111/j.1471-4159.2008.05652.x; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	50	42	43	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2013	28	4					284	292		10.1097/HTR.0b013e3182795045			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZO	WOS:000330363900006	23249772	Green Published			2022-02-06	
J	Redell, JB; Moore, AN; Grill, RJ; Johnson, D; Zhao, J; Liu, Y; Dash, PK				Redell, John B.; Moore, Anthony N.; Grill, Raymond J.; Johnson, Daniel; Zhao, Jing; Liu, Yin; Dash, Pramod K.			Analysis of Functional Pathways Altered after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bioinformatics; GFAP; IL-1 beta; MIP-1 alpha; neuroinflammation; UCHL1	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC-STRESS-DISORDER; LATERAL FLUID PERCUSSION; HEAD-INJURY; BEHAVIORAL DEFICITS; ENDOTHELIAL-CELLS; AXONAL PATHOLOGY; MESSENGER-RNAS; MOUSE MODEL; C-FOS	Concussive injury (or mild traumatic brain injury; mTBI) can exhibit features of focal or diffuse injury patterns. We compared and contrasted the cellular and molecular responses after mild controlled cortical impact (mCCI; a focal injury) or fluid percussion injury (FPI; a diffuse injury) in rats. The rationale for this comparative analysis was to investigate the brain's response to mild diffuse versus mild focal injury to identify common molecular changes triggered by these injury modalities and to determine the functional pathways altered after injury that may provide novel targets for therapeutic intervention. Microarrays containing probes against 21,792 unique messenger RNAs (mRNAs) were used to investigate the changes in cortical mRNA expression levels at 3 and 24 h postinjury. Of the 354 mRNAs with significantly altered expression levels after mCCI, over 89% (316 mRNAs) were also contained within the mild FPI (mFPI) data set. However, mFPI initiated a more widespread molecular response, with over 2300 mRNAs differentially expressed. Bioinformatic analysis of annotated Gene Ontology molecular function and biological pathway terms showed a significant overrepresentation of genes belonging to inflammation, stress, and signaling categories in both data sets. We therefore examined changes in the protein levels of a panel of 23 cytokines and chemokines in cortical extracts using a Luminex-based bead immunoassay and detected significant increases in macrophage inflammatory protein (MIP)-1 alpha (CCL3), GRO-KC (CXCL1), interleukin (IL)-1 alpha, IL-1 beta, and IL-6. Immunohistochemical localization of MIP-1 alpha and IL-1 beta showed marked increases at 3 h postinjury in the cortical vasculature and microglia, respectively, that were largely resolved by 24 h postinjury. Our findings demonstrate that both focal and diffuse mTBI trigger many shared pathobiological processes (e.g., inflammatory responses) that could be targeted for mechanism-based therapeutic interventions.	[Redell, John B.; Moore, Anthony N.; Johnson, Daniel; Zhao, Jing; Liu, Yin; Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, POB 20036, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	Department of Defense (DoD)United States Department of Defense [W81XWH-08-2-0134]; Institute for Rehabilitation and Research/Mission Connect; National Center for Research Resources (NCRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR027359]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR027359] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010022] Funding Source: NIH RePORTER	This work was supported by grants from the Department of Defense (DoD; W81XWH-08-2-0134), The Institute for Rehabilitation and Research/Mission Connect, and award number S10RR027359 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors, and does not necessarily represent the official views of the DoD, the NCRR, or the National Institutes of Health.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; d'Hemecourt P, 2011, CLIN SPORTS MED, V30, pviii; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	59	42	42	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		752	764		10.1089/neu.2012.2437			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600007	22913729	Green Published			2022-02-06	
J	Olivecrona, Z; Dahlqvist, P; Koskinen, LOD				Olivecrona, Zandra; Dahlqvist, Per; Koskinen, Lars-Owe D.			Acute neuro-endocrine profile and prediction of outcome after severe brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Severe traumatic brain injury; Hypopituitarism; Outcome; ICP targeted therapy; Hypothalamic-pituitary dysfunction; Prostacyclin	GROWTH-HORMONE; CRITICAL ILLNESS; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; THYROID-FUNCTION; CRITICALLY-ILL; PROSTACYCLIN; NEUROPROTECTION; HYPOPITUITARISM	Object: The aim of the study was to evaluate the early changes in pituitary hormone levels after severe traumatic brain injury (sTBI) and compare hormone levels to basic neuro-intensive care data, a systematic scoring of the CT-findings and to evaluate whether hormone changes are related to outcome. Methods: Prospective study, including consecutive patients, 15-70 years, with sTBI, Glasgow Coma Scale (GCS) score <= 8, initial cerebral perfusion pressure > 10 mm Hg, and arrival to our level one trauma university hospital within 24 hours after head trauma (n = 48). Serum samples were collected in the morning (08-10 am) day 1 and day 4 after sTBI for analysis of cortisol, growth hormone (GH), prolactin, insulin-like growth factor 1 (IGF-1), thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), follicular stimulating hormone (FSH), luteinizing hormone (LH), testosterone and sex hormone-binding globulin (SHBG) (men). Serum for cortisol and GH was also obtained in the evening (17-19 pm) at day 1 and day 4. The first CT of the brain was classified according to Marshall. Independent staff evaluated outcome at 3 months using GOS-E. Results: Profound changes were found for most pituitary-dependent hormones in the acute phase after sTBI, i.e. low levels of thyroid hormones, strong suppression of the pituitary-gonadal axis and increased levels of prolactin. The main findings of this study were: 1) A large proportion (54% day 1 and 70% day 4) of the patients showed morning s-cortisol levels below the proposed cut-off levels for critical illness related corticosteroid insufficiency (CIRCI), i.e. < 276 nmol/L (= 10 ug/dL), 2) Low s-cortisol was not associated with higher mortality or worse outcome at 3 months, 3) There was a significant association between early (day 1) and strong suppression of the pituitary-gonadal axis and improved survival and favorable functional outcome 3 months after sTBI, 4) Significantly lower levels of fT3 and TSH at day 4 in patients with a poor outcome at 3 months. 5) A higher Marshall CT score was associated with higher day 1 LH/FSH-and lower day 4 TSH levels 6) In general no significant correlation between GCS, ICP or CPP and hormone levels were detected. Only ICPmax and LH day 1 in men was significantly correlated. Conclusion: Profound dynamic changes in hormone levels are found in the acute phase of sTBI. This is consistent with previous findings in different groups of critically ill patients, most of which are likely to be attributed to physiological adaptation to acute illness. Low cortisol levels were a common finding, and not associated with unfavorable outcome. A retained ability to a dynamic hormonal response, i.e. fast and strong suppression of the pituitary-gonadal axis (day 1) and ability to restore activity in the pituitary-thyroid axis (day 4) was associated with less severe injury according to CT-findings and favorable outcome.	[Olivecrona, Zandra; Koskinen, Lars-Owe D.] Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden; [Dahlqvist, Per] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden		Olivecrona, Z (corresponding author), Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden.	zandra.olivecrona@gmail.com	Viani, Rafael/V-1196-2018; Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Clinical Neuroscience; Kempe Foundation; Pfizer, SwedenPfizer	We wish to express our gratitude to Pedram Tabatabai, MD, Lukas Bobinski, MD, Magnus Olivecrona, MD, PhD, Marie Rodling-Wahlstrom, MD, PhD, Silvana Naredi, MD, PhD and our research nurses Kristin Nyman and Anna-Lena Ostlund for help with the study. The Department of Clinical Neuroscience, Kempe Foundation and Pfizer, Sweden financially supported this study.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; ALLOLIO B, 1980, BRIT J CLIN PHARMACO, V10, P626, DOI 10.1111/j.1365-2125.1980.tb00524.x; Annane D, 2010, CRIT CARE MED, V38, P721, DOI 10.1097/CCM.0b013e3181c54620; [Anonymous], 1914, DEUT MED WOCHENSCHR, V40, P322; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Brorsson C, 2011, ACTA ANAESTH SCAND, V55, P944, DOI 10.1111/j.1399-6576.2011.02451.x; CHIOLERO RL, 1988, ACTA ENDOCRINOL-COP, V117, P80, DOI 10.1530/acta.0.1170080; Chisu V, 2006, ARCH ITAL BIOL, V144, P63; Christ-Crain M, 2007, AM J RESP CRIT CARE, V176, P913, DOI 10.1164/rccm.200702-307OC; CLAUSENSJOBOM N, 1987, ACTA MED SCAND, V222, P57; De Jongh FE, 2001, EUR J ENDOCRINOL, V144, P221, DOI 10.1530/eje.0.1440221; Debudaj Anna, 2010, Pol Merkur Lekarski, V28, P478; Della Corte F, 1998, CRIT CARE MED, V26, P1419; EDWARDS OM, 1986, MEDICINE, V65, P281; Escamilla R F, 1938, Cal West Med, V48, P343; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grill E, 2013, J SURG RES, V179, P132, DOI 10.1016/j.jss.2012.09.008; GRIMEE R, 1995, LIFE SCI, V57, P69, DOI 10.1016/0024-3205(95)00244-Z; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hassan-Smith Z, 2011, BEST PRACT RES CL EN, V25, P705, DOI 10.1016/j.beem.2011.04.002; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; LECKMAN JF, 1984, J AM ACAD CHILD PSY, V23, P174, DOI 10.1097/00004583-198403000-00008; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MATSUURA H, 1985, NEUROSURGERY, V16, P791, DOI 10.1227/00006123-198506000-00009; MOORE RA, 1985, ANAESTHESIA, V40, P124; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Murakawa T, 1998, Masui, V47, P1350; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Napoli R, 2003, J CLIN ENDOCR METAB, V88, P2817, DOI 10.1210/jc.2003-030144; Nordstrom CH, 2007, INTENS CARE MED, V33, P558, DOI 10.1007/s00134-006-0521-y; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Polo-Garvin A, 1993, Rev Esp Anestesiol Reanim, V40, P344; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Silha JV, 2005, CLIN ENDOCRINOL, V63, P79, DOI 10.1111/j.1365-2265.2005.02303.x; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; TAGAWA M, 1989, JPN J VET SCI, V51, P278; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Van den Berghe G, 2003, ENDOCRIN METAB CLIN, V32, P385, DOI 10.1016/S0889-8529(03)00005-7; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Van den Berghe G, 2000, NEW ENGL J MED, V342, P135; Venkatesh B, 2011, BEST PRACT RES CL EN, V25, P719, DOI 10.1016/j.beem.2011.04.007; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7	58	42	48	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 20	2013	21								33	10.1186/1757-7241-21-33			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	139PX	WOS:000318597100002	23601250	Green Published, gold			2022-02-06	
J	Armstrong, CM; Reger, GM; Edwards, J; Rizzo, AA; Courtney, CG; Parsons, TD				Armstrong, Christina M.; Reger, Greg M.; Edwards, Joseph; Rizzo, Albert A.; Courtney, Christopher G.; Parsons, Thomas D.			Validity of the Virtual Reality Stroop Task (VRST) in active duty military	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Stroop test; Executive functioning; Virtual reality; Validity; Active duty military	TRAUMATIC BRAIN-INJURY; SERIAL-ADDITION TASK; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERFORMANCE ASSESSMENT TEST; OUTCOMES; PASAT; CONCUSSION; NORMS; IRAQ	Virtual environments provide the ability to systematically deliver test stimuli in simulated contexts relevant to real world behavior. The current study evaluated the validity of the Virtual Reality Stroop Task (VRST), which presents test stimuli during a virtual reality military convoy with simulated combat threats. Active duty Army personnel (N=49) took the VRST, a customized version of the Automated Neuropsychological Assessment Metrics (ANAM)Fourth Edition TBI Battery (2007) that included the addition of the ANAM Stroop and Tower tests, and traditional neuropsychological measures, including the Delis-Kaplan Executive Function System version of the ColorWord Interference Test. Preliminary convergent and discriminant validity was established, and performance on the VRST was significantly associated with computerized and traditional tests of attention and executive functioning. Valid virtual reality cognitive assessments open new lines of inquiry into the impact of environmental stimuli on performance and offer promise for the future of neuropsychological assessments used with military personnel.	[Armstrong, Christina M.; Reger, Greg M.; Edwards, Joseph] Def Ctr Excellence DCoE Psychol Hlth & Traumat Br, Natl Ctr Telehlth & Technol T2, Tacoma, WA 98431 USA; [Rizzo, Albert A.; Courtney, Christopher G.; Parsons, Thomas D.] Univ So Calif, Inst Creat Technol, Los Angeles, CA USA		Armstrong, CM (corresponding author), Def Ctr Excellence DCoE Psychol Hlth & Traumat Br, Natl Ctr Telehlth & Technol T2, Old Madigan Army Med Ctr Bldg 9933A, Tacoma, WA 98431 USA.	drchristinaarmstrong@gmail.com	Armstrong, Christina M./AAU-4242-2020	Armstrong, Christina M./0000-0002-2942-6553; Edwards, Joe/0000-0003-4451-8103; Parsons, Thomas/0000-0003-0331-5019	Telemedicine and Advanced Technology Research Center (TATRC)	We would like to thank Lisa Thomas and Emily Fantelli for their support in this project. We would also like to acknowledge Telemedicine and Advanced Technology Research Center (TATRC), which funded a portion of this research. Thomas D. Parsons changed positions and is now at Clinical Neuropsychology and Simulation Lab, University of North Texas, Denton, TX, USA. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2007, AUT NEUR ASS METR VE; Armed Forces Health Surveillance Center, 2011, TBI NUMB SEV ALL ARM; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binet A., 1905, ANN PSYCHOL, V12, P191, DOI [10.3406/psy.1904.3675, DOI 10.3406/PSY.1904.3675]; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cohen J., 2013, STAT POWER ANAL BEHA; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; Deb S, 1999, AM J PSYCHIAT, V156, P374; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Defense, 2009, DEM 2009 PROF MIL CO; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Elkind JS, 2001, CYBERPSYCHOL BEHAV, V4, P489, DOI 10.1089/109493101750527042; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kolasinski E. M., 1995, 1027 US ARM RES I SI; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Long, 1996, ECOLOGICAL VALIDITY, P15; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Parsons TD, 2004, J CLIN EXP NEUROPSYC, V26, P95, DOI 10.1076/jcen.26.1.95.23932; Parsons TD, 2007, ANN REV CYBERTHERAPY, V5, P164; Parsons Thomas D, 2012, Stud Health Technol Inform, V173, P331; Parsons TD, 2011, STUD COMPUT INTELL, V337, P271; Parsons TD, 2011, STUD HEALTH TECHNOL, V163, P433, DOI 10.3233/978-1-60750-706-2-433; Parsons TD, 2009, LECT NOTES ARTIF INT, V5639, P243, DOI 10.1007/978-3-642-02728-4_26; Parsons TD, 2008, STUD HEALTH TECHNOL, V132, P351; Parsons TD, 2008, ANN REV CYBERTHERAPY, V6, P23; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SPIRDUSO WW, 1980, J GERONTOL, V35, P850, DOI 10.1093/geronj/35.6.850; Spreen O, 2006, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wechsler D., 1939, MEASUREMENT ADULT IN	46	42	43	4	35	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 1	2013	35	2					113	123		10.1080/13803395.2012.740002			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	092HM	WOS:000315111000001	23157431	Green Published			2022-02-06	
J	Doherty, A				Doherty, Alison			"It Takes a Village:" Interdisciplinary Research for Sport Management	JOURNAL OF SPORT MANAGEMENT			English	Article							PSYCHOLOGY; CONCUSSION; BAD	This paper, from the Dr. Earle F. Zeigler Award Lecture presented at the NASSM 2012 Conference in Seattle, outlines the merits and challenges of interdisciplinary research for the field of sport management. This alternative approach involves relating, integrating, and relocating disciplinary thinking to arrive at a mutually-determined research problem that represents new ways of conceptualizing phenomena. It enables moving away from the monodisciplinary research that characterizes much of our field to examine phenomena from different angles, and perhaps more effectively close the research-practice gap with knowledge derived from multiple perspectives. The author argues that it is time to engage in interdisciplinary research in sport management as no one discipline has all the answers; rather, "it takes a village" to solve the complex problems in our world.	Univ Western Ontario, Sch Kinesiol, London, ON, Canada		Doherty, A (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.						Aboelela SW, 2007, HEALTH SERV RES, V42, P329, DOI 10.1111/j.1475-6773.2006.00621.x; Amis J, 2005, J SPORT MANAGE, V19, P355, DOI 10.1123/jsm.19.4.355; Andrew D.P.S., 2009, INT J SPORT MANAGEME, V5, P73, DOI 10.1504/IJSMM.2009.021751; Bruhn JG, 1995, INTEGR PHYS BEH SCI, V30, P331, DOI 10.1007/BF02691605; Bruhn JG, 2000, INTEGR PHYS BEH SCI, V35, P58, DOI 10.1007/BF02911166; Buller H, 2009, AREA, V41, P395, DOI 10.1111/j.1475-4762.2008.00856.x; Chalip L, 2006, J SPORT MANAGE, V20, P1, DOI 10.1123/jsm.20.1.1; Chelladurai, 2009, MANAGING ORG SPORT P; Choi BCK, 2006, CLIN INVEST MED, V29, P351; Clinton HR., 1996, IT TAKES VILLAGE OTH; Costa CA, 2005, J SPORT MANAGE, V19, P117, DOI 10.1123/jsm.19.2.117; CROW GM, 1992, AM EDUC RES J, V29, P737, DOI 10.3102/00028312029004737; Culverhouse Gay, 2011, THROWAWAY PLAYERS CO; Cuneen J, 2004, J SPORT MANAGE, V18, P1, DOI 10.1123/jsm.18.1.1; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; DeNeui D. L., 1996, Journal of Sport and Social Issues, V20, P69, DOI 10.1177/019372396020001006; Doherty A., 2012, SPORT MANAGEMENT REV, DOI [10.1016/j.smr.2011.112.006, DOI 10.1016/J.SMR.2011.112.006]; Doherty A. J., 1998, Sport Management Review, V1, P1, DOI 10.1016/S1441-3523(98)70097-X; Eitzen D. S., 2012, FAIR FOUL MYTHS PARA; Frisby W, 2005, J SPORT MANAGE, V19, P1, DOI 10.1123/jsm.19.1.1; Giulianotti R, 2010, J SPORT SOC ISSUES, V34, P49, DOI 10.1177/0193723509354042; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Greenhow A., 2011, SPORTS LAW EJOURNAL; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hecht AN, 2002, SENTON HALL J SPORTS, V12, P17; Hokowhitu B., MAI REV, V1; Hoye R., 2009, SPORT MANAGEMENT PRI; Inglis S, 2007, J SPORT MANAGE, V21, P1, DOI 10.1123/jsm.21.1.1; Kidd B, 2008, SPORT SOC, V11, P370, DOI 10.1080/17430430802019268; Kim S. M., 2008, Sport Marketing Quarterly, V17, P109; Love A, 2012, SPORT MANAG REV, V15, P244, DOI 10.1016/j.smr.2011.08.001; Mahony DF, 2008, J SPORT MANAGE, V22, P1, DOI 10.1123/jsm.22.1.1; Mair H, 2006, LEISURE SCI, V28, P197, DOI 10.1080/01490400500484099; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maton KI, 2006, AM J COMMUN PSYCHOL, V38, P9, DOI 10.1007/s10464-006-9062-3; McGrath RG, 2007, ACAD MANAGE J, V50, P1365; National Academy of Sciences, 2005, FAC INT RES; Osborne B., 2012, ANN C N AM SOC SPORT; Oughton E, 2009, AREA, V41, P385, DOI 10.1111/j.1475-4762.2009.00903.x; Pedersen P.M., 2005, THE SPORT MANAGEMENT, V2, P33; Pederson P.M., 2011, CONT SPORT MANAGEMEN; PEETZ TB, 2011, SPORT MARKET Q, V20, P209; Pitts BG, 2001, J SPORT MANAGE, V15, P1, DOI 10.1123/jsm.15.1.1; Popper K.R., 1963, CONJECTURES REFUTATT; Porter AL, 2006, RES EVALUAT, V15, P187, DOI 10.3152/147154406781775841; Reich SM, 2006, AM J COMMUN PSYCHOL, V38, P51, DOI 10.1007/s10464-006-9064-1; Rhoten D., 2004, ITEMS ISSUES, V5, P6; Sa CM, 2008, HIGH EDUC, V55, P537, DOI 10.1007/s10734-007-9073-5; Sandberg J, 2011, ACAD MANAGE REV, V36, P338; Schwarz E. C., 2011, International Journal of Sport Management and Marketing, V7, P33, DOI 10.1504/IJSMM.2010.029710; Spence G. B., 2012, INT COACHING PSYCHOL, V7, P122; Thibault L, 2009, J SPORT MANAGE, V23, P1, DOI 10.1123/jsm.23.1.1; van Knippenberg D, 2011, ORGAN PSYCHOL REV, V1, P3, DOI 10.1177/2041386610386427; Watson T.J., 1994, SEARCH MANAGEMENT; WATSON TJ, 1997, BRIT J MANAGEMENT, V0005, P00003; Weingart P., 2000, PRACTISING INTERDISC, P23; Weiss MR, 2008, QUEST, V60, P63, DOI 10.1080/00336297.2008.10483569; Zeigler E.R, 2011, ANN C N AM SOC SPORT; Zeigler EF, 2007, J SPORT MANAGE, V21, P297, DOI 10.1123/jsm.21.3.297; Zeigler EF, 2003, QUEST, V55, P285, DOI 10.1080/00336297.2003.10491805; ZEIGLER EF, 1975, ADM THEORY PRACTICE	62	42	42	2	25	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0888-4773	1543-270X		J SPORT MANAGE	J.Sport Manage.	JAN	2013	27	1					1	10		10.1123/jsm.27.1.1			10	Hospitality, Leisure, Sport & Tourism; Management; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Business & Economics; Sport Sciences	075VR	WOS:000313915800001					2022-02-06	
J	Falahati, S; Breu, M; Waickman, AT; Phillips, AW; Arauz, EJ; Snyder, S; Porambo, M; Goeral, K; Comi, AM; Wilson, MA; Johnston, MV; Fatemi, A				Falahati, Sina; Breu, Markus; Waickman, Adam T.; Phillips, Andre W.; Arauz, Edwin J.; Snyder, Sophie; Porambo, Michael; Goeral, Katharina; Comi, Anne M.; Wilson, Mary Ann; Johnston, Michael V.; Fatemi, Ali			Ischemia-Induced Neuroinflammation Is Associated with Disrupted Development of Oligodendrocyte Progenitors in a Model of Periventricular Leukomalacia	DEVELOPMENTAL NEUROSCIENCE			English	Article						Infants; Inflammation; Ischemia; Microglia; Neonatal ischemic periventricular leukomalacia; Oligodendrocyte progenitor; White matter	WHITE-MATTER INJURY; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; PROTEIN 18 KDA; ACTIVATED MICROGLIA; PRETERM INFANTS; PRECURSOR CELLS; CEREBRAL-PALSY; NITRIC-OXIDE; NEONATAL-RATS	Microglial activation in crossing white matter tracts is a hallmark of noncystic periventricular leukomalacia (PVL), the leading pathology underlying cerebral palsy in prematurely born infants. Recent studies indicate that neuroinflammation within an early time window can produce long-lasting defects in oligodendroglial maturation, myelination deficit, as well as disruption of transcription factors important in oligodendroglial maturation. We recently reported an ischemic mouse model of PVL, induced by unilateral neonatal carotid artery ligation, leading to selective long-lasting bilateral myelination deficits, ipsilateral thinning of the corpus callosum, ventriculomegaly, as well as evidence of axonopathy. Here, we report that permanent unilateral carotid ligation on postnatal day 5 in CD-1 mice induces an inflammatory response, as defined by microglial activation and recruitment, as well as significant changes in cytokine expression (increased IL-1 beta, IL-6, TGF-beta(1), and TNF-alpha) following ischemia. Transient reduction in counts of oligodendrocyte progenitor cells (OPCs) at 24 and 48 h after ischemia, a shift in OPC cell size and morphology towards the more immature form, as well as likely migration of OPCs were found. These OPC changes were topographically associated with areas showing microglial activation, and OPC counts negatively correlated with increased microglial staining. The presented data show a striking neuroinflammatory response in an ischemia-induced model of PVL, associated with oligodendroglial injury. Future studies modulating the neuroinflammatory response in this model may contribute to a better understanding of the interaction between microglia and OPCs in PVL and open opportunities for future therapies. Copyright (C) 2013 S. Karger AG, Basel	[Falahati, Sina; Breu, Markus; Phillips, Andre W.; Arauz, Edwin J.; Snyder, Sophie; Porambo, Michael; Goeral, Katharina; Comi, Anne M.; Wilson, Mary Ann; Johnston, Michael V.; Fatemi, Ali] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Falahati, Sina; Breu, Markus; Phillips, Andre W.; Goeral, Katharina; Comi, Anne M.; Wilson, Mary Ann; Johnston, Michael V.; Fatemi, Ali] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Comi, Anne M.; Johnston, Michael V.; Fatemi, Ali] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Wilson, Mary Ann] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Waickman, Adam T.] Johns Hopkins Univ, Grad Program Immunol, Baltimore, MD USA; [Falahati, Sina; Breu, Markus; Goeral, Katharina] Med Univ Vienna, Vienna, Austria		Fatemi, A (corresponding author), Kennedy Krieger Inst, 707 N Broadway,500I, Baltimore, MD 21205 USA.	fatemi@kennedykrieger.org		Breu, Markus/0000-0003-3825-5749; Goeral, Katharina/0000-0002-5209-6169; Waickman, Adam/0000-0002-4536-6714	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS063956, R01NS028208, R01NS061969]; Child Neurology Foundation; Miracle for Megan Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS063956, R01NS028208, R01NS061969] Funding Source: NIH RePORTER	The authors would like to thank Ms. Patrice Carr and Ms. Karen Connor for their kind assistance with the immunohistochemial studies. This study was funded by the National Institute of Health (K08NS063956 to A. F., R01NS028208 to M.V.J., R01NS061969 to A. C.), Child Neurology Foundation (to A. F.), and the Miracle for Megan Foundation (to A.F.).	Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baud O, 2004, BRAIN PATHOL, V14, P1; Bechmann I, 2007, BLOOD BRAIN BARRIERS, P167; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dammann O, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00097.x; Deng WB, 2010, NAT REV NEUROL, V6, P328, DOI 10.1038/nrneurol.2010.53; Derugin N, 2000, STROKE, V31, P1752, DOI 10.1161/01.STR.31.7.1752; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Fatemi A, 2011, J CEREBR BLOOD F MET, V31, P2009, DOI 10.1038/jcbfm.2011.68; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Filipovic R, 2005, ANN NY ACAD SCI, V1048, P166, DOI 10.1196/annals.1342.015; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042; Haynes RL, 2005, J COMP NEUROL, V484, P156, DOI 10.1002/cne.20453; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Judas M, 2005, AM J NEURORADIOL, V26, P2671; Kadhim H, 2002, NEUROLOGY, V58, P1125, DOI 10.1212/WNL.58.7.1125; Kadhim H, 2001, NEUROLOGY, V56, P1278, DOI 10.1212/WNL.56.10.1278; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Leviton A, 2005, ANN NEUROL, V58, P821, DOI 10.1002/ana.20662; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Lin CY, 2010, ANN NEUROL, V68, P204, DOI 10.1002/ana.22049; Lipton SA, 1996, BRAIN PATHOL, V6, P507, DOI 10.1111/j.1750-3639.1996.tb00879.x; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Mallard C, 2003, NEUROCHEM RES, V28, P215, DOI 10.1023/A:1022368915400; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Miller BA, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-28; Monier A, 2007, J NEUROPATH EXP NEUR, V66, P372, DOI 10.1097/nen.0b013e3180517b46; Monier A, 2006, J COMP NEUROL, V499, P565, DOI 10.1002/cne.21123; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; National Center for Health Statistics, FIN NAT DAT; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Olivier P, 2005, J NEUROPATH EXP NEUR, V64, P998, DOI 10.1097/01.jnen.0000187052.81889.57; Palacios N, 2005, J NEUROCHEM, V95, P1091, DOI 10.1111/j.1471-4159.2005.03419.x; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sent E, 2006, MENT RETARD DEV D R, V12, P97, DOI 10.1002/mrdd.20106; Siebert JR, 2011, J NEUROCHEM, V119, P176, DOI 10.1111/j.1471-4159.2011.07370.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Talbott JF, 2007, EXP NEUROL, V204, P485, DOI 10.1016/j.expneurol.2006.12.013; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Verney C, 2012, J NEUROPATH EXP NEUR, V71, P251, DOI 10.1097/NEN.0b013e3182496429; Verney C, 2010, J ANAT, V217, P436, DOI 10.1111/j.1469-7580.2010.01245.x; Volpe JJ, 2011, ANN NEUROL, V70, P525, DOI 10.1002/ana.22533; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P406, DOI 10.1016/S0002-9378(97)70206-0	64	42	46	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2013	35	2-3					182	196		10.1159/000346682			15	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	178JX	WOS:000321445100008	23445614	Bronze, Green Accepted			2022-02-06	
J	Hooft, A; Ronda, J; Schaeffer, P; Asnes, AG; Leventhal, JM				Hooft, Anneka; Ronda, Jocelyn; Schaeffer, Paula; Asnes, Andrea G.; Leventhal, John M.			Identification of Physical Abuse Cases in Hospitalized Children: Accuracy of International Classification of Diseases Codes	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; MALTREATMENT; FRACTURES; SURVEILLANCE; DATABASE; RECORDS	Objective Hospital discharge databases are being increasingly used to track the incidence of child physical abuse in the United States. These databases use International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes to categorize illnesses and injuries in hospitalized patients. We assessed the accuracy of the assignment of these codes for cases of child physical abuse. Study design Participants were all children (N = 133) evaluated by a child abuse pediatrician (CAP) for suspicion of abuse at Yale-New Haven Children's Hospital from January 1, 2007-December 31, 2010. These children included both those judged to have injuries from abuse and those judged to have injuries accidental/medical in nature. We compared the ICD-9-CM codes entered in the hospital discharge database for each child with the decisions made by the CAPs, as documented in their child abuse registry. The CAPs' decisions were considered to be the gold standard. Sensitivity and specificity were calculated. Medical records were reviewed for cases in which the ICD-9-CM codes disagreed with the CAP's decision. Results In 133 cases of suspected child physical abuse, the sensitivity and specificity of ICD-9-CM codes for abuse were 76.7% (CI 61.4%, 88.2%) and 100% (CI 96.0%, 100%), respectively. Analysis of the 10 cases of abuse not receiving ICD-9-CM codes for abuse revealed that errors in physician documentation (n = 5) and in coding (n = 5) contributed to the reduction in sensitivity. Conclusions Despite high specificity in identifying child physical abuse, the sensitivity of ICD-9-CM codes is 77%, indicating that these codes underestimate the occurrence of abuse. (J Pediatr 2013;162:80-5).	[Hooft, Anneka; Schaeffer, Paula; Asnes, Andrea G.; Leventhal, John M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Ronda, Jocelyn] Johns Hopkins Sch Med, Dept Internal Med Pediat, Baltimore, MD USA		Leventhal, JM (corresponding author), Yale Univ, Sch Med, Dept Pediat, POB 208064,333 Cedar St, New Haven, CT 06520 USA.	john.leventhal@yale.edu			Child Abuse Funds, Department of Pediatrics; Office of Student Research, Yale School of Medicine; Doris Duke Foundation for Clinical Research for Child Abuse Prevention	Supported by the Child Abuse Funds, Department of Pediatrics and the Office of Student Research, Yale School of Medicine, and a grant from the Doris Duke Foundation for Clinical Research for Child Abuse Prevention. The authors declare no conflicts of interest.	Abellera J, 2005, STATES ARE COLLECTIN; American Hospital Association (AHA), AHA COD CLIN ICD 9 C; Coben J, 2005, HCUP METHODS SERIES; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Feng JY, 2011, CHILD ABUSE NEGLECT, V35, P655, DOI 10.1016/j.chiabu.2011.04.002; Gonzalez-Izquierdo A, 2010, ARCH DIS CHILD, V95, P918, DOI 10.1136/adc.2009.180216; Lane WG, 2011, PEDIATRICS, V127, pE1400, DOI 10.1542/peds.2010-2096; LANGLOIS JA, 1995, AM J PUBLIC HEALTH, V85, P1261, DOI 10.2105/AJPH.85.9.1261; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; National Center for Health Statistics, 2010, 2010 REL ICD 10 CM; National Center for Health Statistics, 2011, INT CLASS DIS, V1; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; THOMAS SA, 1991, PEDIATRICS, V88, P471; [U.S. Department of Health and Human Services Administration for Children and Families Administration on ChildrenYouth and Families Children's Bureau], 2011, CHILD MALTR 2010; US Department of Health and Human Services (USDHHS), 2010, ICD 9 CM OFF GUID CO; US Healthcare Cost and Utilization Project (HCUP), 2008, INTR HCUP KIDS INP D; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277; Wirtz SJ, 2008, AM J PREV MED, V34, pS134, DOI 10.1016/j.amepre.2007.11.004; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	23	42	42	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476			J PEDIATR-US	J. Pediatr.	JAN	2013	162	1					80	85		10.1016/j.jpeds.2012.06.037			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	062JK	WOS:000312915900019	22854329				2022-02-06	
B	Iverson, GL; Silverberg, N; Lange, RT; Zasler, ND		Zasler, ND; Katz, DI; Zafonte, RD		Iverson, Grant L.; Silverberg, Noah; Lange, Rael T.; Zasler, Nathan D.			Conceptualizing Outcome From Mild Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; WHITE-MATTER HYPERINTENSITIES; COGNITIVE-BEHAVIORAL THERAPY; CHRONIC-FATIGUE-SYNDROME; MINOR HEAD-INJURY; GOOD-OLD-DAYS; PERSISTENT POSTCONCUSSION SYNDROME; SOCIAL ANXIETY DISORDER		[Iverson, Grant L.; Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah] Univ British Columbia, Dept Acquired Brain Injury, GF Strong Rehab Ctr, Vancouver, BC, Canada; [Silverberg, Noah] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.						Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; ALQURAINY IA, 1995, BRIT J ORAL MAX SURG, V33, P71, DOI 10.1016/0266-4356(95)90203-1; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andersson G, 2008, INT J AUDIOL, V47, pS106, DOI 10.1080/14992020802301670; Antepohl W, 2003, NEUROREHABILITATION, V18, P307; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bachar E, 2005, J NERV MENT DIS, V193, P762, DOI 10.1097/01.nmd.0000185874.31672.a5; Balla JI, 1988, HEADACHE CERVICAL DI, P256; Barbour KA, 2007, J CARDIOPULM REHABIL, V27, P359, DOI 10.1097/01.HCR.0000300262.69645.95; Barker MJ, 2005, J INT NEUROPSYCH SOC, V11, P281, DOI 10.1017/S1355617705050332; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2005, J COGN REHABIL, V23, P8, DOI DOI 10.1080/0963828031000090489; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675; Benedetti F, 2003, J NEUROSCI, V23, P4315; BENOIT G, 1992, CAN J PSYCHOL, V46, P41, DOI 10.1037/h0084314; Benson H, 1997, PREV MED, V26, P612, DOI 10.1006/pmed.1997.0228; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2010, PSYCHOL INJ LAW, V3, P36, DOI 10.1007/s12207-010-9064-1; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; BLACK FO, 1990, NEUROL CLIN, V8, P361, DOI 10.1016/S0733-8619(18)30361-X; Blackledge JT, 2006, CHILD FAM BEHAV THER, V28, P1, DOI 10.1300/J019v28n01_01; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bond F W, 2000, J Occup Health Psychol, V5, P156, DOI 10.1037/1076-8998.5.1.156; Bond FW, 2003, J APPL PSYCHOL, V88, P1057, DOI 10.1037/0021-9010.88.6.1057; Boniver Raymond, 2002, Int Tinnitus J, V8, P129; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Bootzin RR, 2005, J CLIN PSYCHOL, V61, P871, DOI 10.1002/jclp.20131; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bortolotti B, 2008, GEN HOSP PSYCHIAT, V30, P293, DOI 10.1016/j.genhosppsych.2008.04.001; Bourgeois B, 2005, Ann Otolaryngol Chir Cervicofac, V122, P181, DOI 10.1016/S0003-438X(05)82346-1; Brady KT, 2005, SUBST USE MISUSE, V40, P2021, DOI 10.1080/10826080500294924; Brandt T., 1991, VERTIGO ITS MULTISEN; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Breslau N, 2000, NEUROLOGY, V54, P308, DOI 10.1212/WNL.54.2.308; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carter J E, 1983, Child Abuse Negl, V7, P279, DOI 10.1016/0145-2134(83)90005-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Channon S, 1999, J NEUROL NEUROSUR PS, V66, P162, DOI 10.1136/jnnp.66.2.162; Channon S, 1996, J AFFECT DISORDERS, V39, P107, DOI 10.1016/0165-0327(96)00027-4; CHAOULOFF F, 1989, ACTA PHYSIOL SCAND, V137, P1, DOI 10.1111/j.1748-1716.1989.tb08715.x; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Cote P, 2011, SPINE, V36, pS275, DOI 10.1097/BRS.0b013e3182388d32; Croft AC, 2002, WHIPLASH INJURIES CE, P335; Cytowic R, 1988, NEUROPSYCHOLOGICAL S, P226; Dahl J, 2004, BEHAV THER, V35, P785, DOI 10.1016/S0005-7894(04)80020-0; DAILY L, 1979, ARCH OPHTHALMOL-CHIC, V97, P360; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; Dalrymple KL, 2007, BEHAV MODIF, V31, P543, DOI 10.1177/0145445507302037; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Ekeland E., 2004, COCHRANE DATABASE SY; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; ELLIS HC, 1991, J EXP PSYCHOL GEN, V120, P310, DOI 10.1037/0096-3445.120.3.310; Ericsson M, 2002, DISABIL REHABIL, V24, P334, DOI 10.1080/09638280110096241; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Evans RW, 2003, HEADACHE, V43, P1113, DOI 10.1046/j.1526-4610.2003.03216.x; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; Ferrari R, 2001, MED HYPOTHESES, V56, P372, DOI 10.1054/mehy.2000.1215; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Festinger L., 1957, THEORY COGNITIVE DIS; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; FLOR H, 1987, J PSYCHOSOM RES, V31, P251, DOI 10.1016/0022-3999(87)90082-1; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Forman EM, 2007, BEHAV MODIF, V31, P772, DOI 10.1177/0145445507302202; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; Frisher M, 2005, J EPIDEMIOL COMMUN H, V59, P847, DOI 10.1136/jech.2004.030833; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; Grothues J, 2005, ALCOHOL ALCOHOLISM, V40, P394, DOI 10.1093/alcalc/agh182; Guez M, 2005, J CLIN EXP NEUROPSYC, V27, P151, DOI 10.1080/13803390490515487; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Gutierrez O, 2004, BEHAV THER, V35, P767, DOI 10.1016/S0005-7894(04)80019-4; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Hayes S.C., 2005, CLIN CASE STUD, V4, P246, DOI [10.1177/1534650103259689, DOI 10.1177/1534650103259689]; Hayes SC, 2004, BEHAV THER, V35, P35, DOI 10.1016/S0005-7894(04)80003-0; Hayes SC., 1999, ACCEPTANCE COMMITMEN; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heinrichs M, 2005, AM J PSYCHIAT, V162, P2276, DOI 10.1176/appi.ajp.162.12.2276; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hesser H, 2009, BEHAV RES THER, V47, P523, DOI 10.1016/j.brat.2009.02.002; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; Hill O., 1970, MODERN TRENDS PSYCHO, P26; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; HIRSCHFELD RMA, 1983, ARCH GEN PSYCHIAT, V40, P993; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hung CI, 2006, CEPHALALGIA, V26, P26, DOI 10.1111/j.1468-2982.2005.00985.x; Hunot V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001848; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JAMISON RN, 1988, INT J PSYCHIAT MED, V18, P183; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Johnston M, 2010, CLIN J PAIN, V26, P393, DOI 10.1097/AJP.0b013e3181cf59ce; Jolliffe CD, 2004, PAIN, V107, P167, DOI 10.1016/j.pain.2003.10.015; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendrick D, ACQUIRED BR IN PRESS; KENNEDY W P, 1961, Med World, V95, P203; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kouyanou K, 1998, PAIN, V76, P417, DOI 10.1016/S0304-3959(98)00074-8; Kowacs F, 2003, CEPHALALGIA, V23, P79, DOI 10.1046/j.1468-2982.2003.00461.x; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; LANCMAN ME, 1994, ANN NEUROL, V35, P359, DOI 10.1002/ana.410350319; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, J HEAD TRAUMA REHABI; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lemelin S, 1997, J NERV MENT DIS, V185, P542, DOI 10.1097/00005053-199709000-00002; Leonard KN, 2004, INT NEUR SOC M FEBR; Leventhal H, 2003, SELF REGULATION HLTH; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Magnusson JE, 2003, HEADACHE, V43, P1049, DOI 10.1046/j.1526-4610.2003.03206.x; MAIER W, 1992, J AFFECT DISORDERS, V24, P153, DOI 10.1016/0165-0327(92)90063-C; Maitland C G, 2001, Curr Neurol Neurosci Rep, V1, P486, DOI 10.1007/s11910-001-0111-x; Malouff JA, 2008, CLIN PSYCHOL REV, V28, P736, DOI 10.1016/j.cpr.2007.10.004; Malouff JM, 2011, CURR PSYCHIAT REP, V13, P31, DOI 10.1007/s11920-010-0163-1; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCracken LA, 2003, PAIN, V105, P197, DOI 10.1016/S0304-3959(03)00202-1; McCracken LM, 2005, BEHAV RES THER, V43, P1335, DOI 10.1016/j.brat.2004.10.003; McCracken LM, 1998, PAIN, V74, P21, DOI 10.1016/S0304-3959(97)00146-2; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McLean SA, 2004, MED HYPOTHESES, V63, P653, DOI 10.1016/j.mehy.2004.03.022; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; McNally RJ, 2003, BIOL PSYCHIAT, V53, P779, DOI 10.1016/S0006-3223(02)01663-3; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merom D, 2008, J ANXIETY DISORD, V22, P959, DOI 10.1016/j.janxdis.2007.09.010; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Michelini LC, 2009, EXP PHYSIOL, V94, P947, DOI 10.1113/expphysiol.2009.047449; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Munoz M, 2005, CLIN J PAIN, V21, P287; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Nijs J, 2008, J REHABIL MED, V40, P241, DOI 10.2340/16501977-0185; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Ontario Neurotrauma Foundation, 2011, GUID MILD TRAUM BRAI; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Panayiotou A, 2011, AUST PSYCHOL, P1; PARMELEE PA, 1993, J AM GERIATR SOC, V41, P517, DOI 10.1111/j.1532-5415.1993.tb01888.x; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P1329, DOI 10.1136/jnnp.52.12.1329; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Petersen CL, 2009, PSYCHOL REC, V59, P521, DOI 10.1007/BF03395679; Pine DS, 1996, J CHILD ADOL PSYCHOP, V6, P153, DOI 10.1089/cap.1996.6.153; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Price JR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001027.pub2; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; RUBIN W, 1990, NEUROL CLIN, V8, P225, DOI 10.1016/S0733-8619(18)30352-9; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruff RM, 1999, BRAIN INJURY, V13, P943; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SCHNURR RF, 1995, CLIN J PAIN, V11, P103, DOI 10.1097/00002508-199506000-00004; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SCHWEIGER A, 1981, PAVLOVIAN J BIOL SCI, V16, P140; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheftell FD, 2002, HEADACHE, V42, P934, DOI 10.1046/j.1526-4610.2002.02217.x; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Slattery EL, 2011, NEUROREHABILITATION, V29, P143, DOI 10.3233/NRE-2011-0688; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits JAJ, 2008, DEPRESS ANXIETY, V25, P689, DOI 10.1002/da.20411; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Spiegel H, 1997, PREV MED, V26, P616, DOI 10.1006/pmed.1997.0229; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; STERNBERG DE, 1976, ARCH GEN PSYCHIAT, V33, P219; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Strosahl KD, 2004, PRACTICAL GUIDE TO ACCEPTANCE AND COMMITMENT THERAPY, P31; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Symonds Charles, 1937, GUYS HOSP GAZ, V51, P461; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; TOLLISON CD, 1992, PAINFUL CERVICAL TRA; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Van Damme S, 2006, J PSYCHOSOM RES, V61, P595, DOI 10.1016/j.jpsychores.2006.04.015; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Van Os J, 1999, PSYCHOL MED, V29, P1055, DOI 10.1017/S0033291799001026; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; van Straten A, 2010, J PSYCHOSOM RES, V69, P23, DOI 10.1016/j.jpsychores.2010.01.019; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; van Wilgen CP, 2010, DISABIL REHABIL, V32, P1576, DOI 10.3109/09638281003596857; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Veale D., 2008, ADV PSYCHIAT TREAT, V14, P29, DOI [10.1192/apt.bp.107.004051, DOI 10.1192/APT.BP.107.004051]; Venable VL, 2001, HEADACHE, V41, P21, DOI 10.1046/j.1526-4610.2001.111006021.x; Vowels KE, 2008, COGN BEHAV PRACT, V16, P49; Wacogne C, 2003, CEPHALALGIA, V23, P451, DOI 10.1046/j.1468-2982.2003.00550.x; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; Weissman H. N., 1990, BEHAVIORAL SCI LAW, V8, P67; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Westin V, 2008, BEHAV RES THER, V46, P1259, DOI 10.1016/j.brat.2008.08.008; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wicksell RK, 2009, PAIN, V141, P248, DOI 10.1016/j.pain.2008.11.006; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williams GH, 1989, TXB HEAD INJURY, P367; Wilson KG, 2002, CLIN J PAIN, V18, P77, DOI 10.1097/00002508-200203000-00002; WOLFE J, 1987, J AFFECT DISORDERS, V13, P83, DOI 10.1016/0165-0327(87)90077-2; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; WOOLEY SC, 1978, PSYCHOSOM MED, V40, P379, DOI 10.1097/00006842-197808000-00003; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 2004, ICD 10 INT STAT CLAS; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yardley L, 2001, J ANXIETY DISORD, V15, P107, DOI 10.1016/S0887-6185(00)00045-1; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003; YOUNGSTEDT SD, 2005, CLIN SPORTS MED, V24, pR11; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8; Zasler ND, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P125; Zasler Nathan D., 1992, Archives of Physical Medicine and Rehabilitation, V73, P963; Zasler ND, 1991, J HEAD TRAUMA REHAB, V6, P78; Zasler ND, 1996, MED REHABILITATION T, P133; Zasler ND, CLIN MANUAL IN PRESS; Zeitzer JM, 2008, SLEEP DISORDERS CONT; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	407	42	42	0	16	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							470	497					28	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100030					2022-02-06	
J	Plach, HL; Sells, CH				Plach, Heidi Lynn; Sells, Carol Haertlein			Occupational Performance Needs of Young Veterans	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						adaptation, psychological; independent living; motivation; occupational therapy; social participation; veterans health	POSTTRAUMATIC-STRESS-DISORDER; IRAQ; AFGHANISTAN	OBJECTIVE. We examined the occupational performance issues facing young U.S. veterans (aged 20-29 yr) who served in Iraq and Afghanistan. Perceived challenges in occupational performance, the most common mental health and brain injuries of war, and motivations for participation in daily occupations upon return to civilian life were identified. METHOD. Thirty young veterans from Operation Iraqi Freedom and Operation Enduring Freedom were interviewed using the Canadian Occupational Performance Measure (Law et al., 2005). They were also screened for posttraumatic stress disorder, traumatic brain injury, major depression, and alcohol abuse or dependency. RESULTS. The top five occupational performance challenges were engagement in relationships, school, physical health, sleeping, and driving. The health conditions screened positive for 23%-77% of respondents. CONCLUSION. This study identified challenges faced by today's young veterans when reintegrating into the community and daily life. Strategies for occupational therapy practitioners to aid veterans in community reintegration are discussed. Plach, H. L., & Sells, C. H. (2013). Occupational performance needs of young veterans. American Journal of Occupational Therapy, 67, 73-81. http://dx.dotorg/10.5014/ajot.2013.003871	[Plach, Heidi Lynn; Sells, Carol Haertlein] Univ Wisconsin, Dept Occupat Sci & Technol, Milwaukee, WI 53201 USA		Plach, HL (corresponding author), Univ Wisconsin, Dept Occupat Sci & Technol, POB 413, Milwaukee, WI 53201 USA.	bertrahl@uwm.edu					Babor T.F., 1992, AUDIT ALCOHOL USE DI, P1; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Briere J., 2006, PRINCIPLES TRAUMA TH; Burman ML, 2004, J STUD ALCOHOL, V65, P621, DOI 10.15288/jsa.2004.65.621; Cahill Shawn P, 2005, Psychiatry (Edgmont), V2, P34; Centers for Disease Control and Prevention (CDC), 2009, SUIC FACTS GLANC; Creamer M, 2004, PSYCHOTHERAPY, V41, P388, DOI 10.1037/0033-3204.41.4.388; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Defense and Veterans Brain Injury Center, 2011, TBI FACTS; Defense and Veterans Brain Injury Center, 2007, 3 QUEST DVBIC TBI SC; Defense Manpower Data Center, 2011, CAS SUMM REAS; Dum M, 2008, ADDICT BEHAV, V33, P381, DOI 10.1016/j.addbeh.2007.09.017; Ebell MH, 2008, AM FAM PHYSICIAN, V78, P244; Eibner C., 2008, INVISIBLE WOUNDS WAR, P169, DOI 10.7249/mg720ccf; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hasselkus B. R., 2002, MEANING EVERYDAY OCC, P41; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaycox, 2008, INVISIBLE WOUNDS WAR, P3; Merriam S. B., 2002, QUALITATIVE RES PRAC; Munoz JP, 2006, OCCUP THER HEALTH CA, V20, P135, DOI [10.1300/J003v20n03_09, 10.1080/J003v20n03_09]; Office of the Surgeon Multi-National Force-Iraq & Office of the Surgeon General U.S. Army Medical Command, 2009, 6 MHAT USA MED COMM; Office of the Surgeon Multi-National Force-Iraq & Office of the Surgeon General U.S. Army Medical Command, 2008, 5 MHAT USA MED COMM; Pollock N., 2005, CANADIAN OCCUPATIONA; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Reger GM, 2006, MIL PSYCHOL, V18, P297, DOI 10.1207/s15327876mp1804_4; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; SOLLINGER JM, 2008, INVISIBLE WOUNDS WAR, P19; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tompkins TL, 2009, J PRIM PREV, V30, P131, DOI 10.1007/s10935-009-0171-2; Tryssenaar J, 1999, Can J Occup Ther, V66, P188; U.S. Department of Defense, 2012, OP IR FREED OP END F; Vogel E. E., 1961, EVENTS LEADING FORMA; Wyman PA, 2008, J CONSULT CLIN PSYCH, V76, P104, DOI 10.1037/0022-006X.76.1.104; Young JE., 2001, CLIN HDB PSYCHOL DIS, V3, P264	36	42	42	1	19	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2013	67	1					73	81		10.5014/ajot.2013.003871			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	073UO	WOS:000313768800009	23245785				2022-02-06	
J	Roquilly, A; Loutrel, O; Cinotti, R; Rosenczweig, E; Flet, L; Mahe, PJ; Dumont, R; Chupin, AM; Peneau, C; Lejus, C; Blanloeil, Y; Volteau, C; Asehnoune, K				Roquilly, Antoine; Loutrel, Olivier; Cinotti, Raphael; Rosenczweig, Elise; Flet, Laurent; Mahe, Pierre Joachim; Dumont, Romain; Chupin, Anne Marie; Peneau, Catherine; Lejus, Corinne; Blanloeil, Yvonnick; Volteau, Christelle; Asehnoune, Karim			Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study	CRITICAL CARE			English	Article							LACTATED RINGERS SOLUTION; SALINE-BASED HETASTARCH; ACID-BASE; METABOLIC-ACIDOSIS; HEAD-INJURY; MANAGEMENT; MORTALITY; STATEMENT; CONSENSUS; INFUSION	Introduction: We sought to investigate whether the use of balanced solutions reduces the incidence of hyperchloraemic acidosis without increasing the risk for intracranial hypertension in patients with severe brain injury. Methods: We conducted a single-centre, two-arm, randomised, double-blind, pilot controlled trial in Nantes, France. Patients with severe traumatic brain injury (Glasgow Coma Scale score <= 8) or subarachnoid haemorrhage (World Federation of Neurosurgical Society grade III or higher) who were mechanically ventilated were randomised within the first 12 hours after brain injury to receive either isotonic balanced solutions (crystalloid and hydroxyethyl starch; balanced group) or isotonic sodium chloride solutions (crystalloid and hydroxyethyl starch; saline group) for 48 hours. The primary endpoint was the occurrence of hyperchloraemic metabolic acidosis within 48 hours. Results: Forty-two patients were included, of whom one patient in each group was excluded (one consent withdrawn and one use of forbidden therapy). Nineteen patients (95%) in the saline group and thirteen (65%) in the balanced group presented with hyperchloraemic acidosis within the first 48 hours (hazard ratio = 0.28, 95% confidence interval [CI] = 0.11 to 0.70; P = 0.006). In the saline group, pH (P = .004) and strong ion deficit (P = 0.047) were lower and chloraemia was higher (P = 0.002) than in the balanced group. Intracranial pressure was not different between the study groups (mean difference 4 mmHg [-1;8]; P = 0.088). Seven patients (35%) in the saline group and eight (40%) in the balanced group developed intracranial hypertension (P = 0.744). Three patients (14%) in the saline group and five (25%) in the balanced group died (P = 0.387). Conclusions: This study provides evidence that balanced solutions reduce the incidence of hyperchloraemic acidosis in brain-injured patients compared to saline solutions. Even if the study was not powered sufficiently for this endpoint, intracranial pressure did not appear different between groups.	[Roquilly, Antoine; Loutrel, Olivier; Mahe, Pierre Joachim; Dumont, Romain; Chupin, Anne Marie; Peneau, Catherine; Lejus, Corinne; Blanloeil, Yvonnick] CHU Nantes, Hotel Dieu, Serv Anesthesie Reanimat, F-44000 Nantes, France; [Cinotti, Raphael; Blanloeil, Yvonnick] CHU Nantes, Hop Laennec, Serv Anesthesie Reanimat, F-44000 Nantes, France; [Rosenczweig, Elise] CHU Nantes, Serv Reanimat Med Polyvalente, F-44000 Nantes, France; [Flet, Laurent] CHU Nantes, DIEU Essais Clin, Serv HOTEL, F-44000 Nantes, France; [Volteau, Christelle] CHU Nantes, Cellule Biostat Cellule Promot Rech Clin, F-44000 Nantes, France		Asehnoune, K (corresponding author), CHU Nantes, Hotel Dieu, Serv Anesthesie Reanimat, F-44000 Nantes, France.	karim.asehnoune@chu-nantes.fr	FLET, Laurent/X-1192-2019; Roquilly, Antoine/P-9826-2017; Deriche, Mohamed/A-9871-2008	FLET, Laurent/0000-0001-8305-7085; Deriche, Mohamed/0000-0002-5287-1874	B-BRAUN MEDICAL; University Hospital of Nantes (UHN)	We gratefully acknowledge Delphine Flattres for her critical help with the study and the nurses and medical team of the Surgical Intensive Care Units of Nantes University Hospital for technical assistance. This work was supported by B-BRAUN MEDICAL. B-BRAUN MEDICAL provided the solutions but was not involved in the study design, patient recruitment, data collection and analysis, report writing and publication. The University Hospital of Nantes (UHN) sponsored the study. UHN stored the data, ensured the monitoring of the study. The biostatistics unit (Christelle Volteau) of UHN performed the statistical analysis. The local pharmacist (Laurent Flet) blinded the solutions. The results were presented (abstract) at the 53th congress of the French Congress of Anaesthesia and Critical Care Medicine (SFAR 2011).	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Audibert G, 2012, Ann Fr Anesth Reanim, V31, pe109, DOI 10.1016/j.annfar.2012.04.014; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Blanloeil Y, 2002, ANN FR ANESTH, V21, P211, DOI 10.1016/S0750-7658(02)00572-5; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kellum JA, 2005, CRIT CARE, V9, P500, DOI 10.1186/cc3789; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Martin G, 2002, J CARDIOTHOR VASC AN, V16, P441, DOI 10.1053/jcan.2002.125146; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MCFARLANE C, 1994, ANAESTHESIA, V49, P779; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Roche AM, 2006, ANESTH ANALG, V102, P1274, DOI 10.1213/01.ane.0000197694.48429.94; Roche AM, 2002, ANAESTHESIA, V57, P950, DOI 10.1046/j.1365-2044.2002.02707.x; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; WAKIM KG, 1970, J AMER MED ASSOC, V214, P1710, DOI 10.1001/jama.1970.03180090074027; Waters JH, 1999, CRIT CARE MED, V27, P2142, DOI 10.1097/00003246-199910000-00011; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Wilkes NJ, 2002, ANESTH ANALG, V94, P538, DOI 10.1097/00000539-200203000-00011; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Yunos NM, 2011, CRIT CARE MED, V39, P2419, DOI 10.1097/CCM.0b013e31822571e5; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	38	42	45	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	2							R77	10.1186/cc12686			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264OG	WOS:000327887300042	23601796	Green Published, gold			2022-02-06	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Effect of oculomotor rehabilitation on vergence responsivity in mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						acquired brain injury; mild traumatic brain injury; nearwork symptoms; neuroplasticity; oculomotor dysfunction; oculomotor learning; oculomotor rehabilitation; traumatic brain injury; vergence; vergence dysfunction; visual attention	EYE-MOVEMENTS; CONVERGENCE INSUFFICIENCY; VISUAL DYSFUNCTION; NEURAL PLASTICITY; DISPARITY; AREA; MILITARY; NEURONS; ACCOMMODATION; ADAPTATION	A range of dynamic and static vergence responses were evaluated in 12 individuals with mild traumatic brain injury (age: 29 +/ 3 yr) having near vision symptoms. All measures were performed in a crossover design before and after oculomotor training (OMT) and placebo (P) training. Following OMT, peak velocity for both convergence and divergence increased significantly. Increased peak velocity was significantly correlated with increased clinically based vergence prism flipper rate. Steady-state response variability for convergence reduced significantly following OMT. The maximum amplitude of convergence, relative fusional amplitudes, and near stereoacuity improved significantly. In addition, symptoms reduced significantly, and visual attention improved markedly. None of the measures were found to change significantly following P training. The significant improvement in most aspects of vergence eye movements following OMT demonstrates considerable residual brain plasticity via oculomotor learning. The improved vergence affected positively on nearwork-related symptoms and visual attention.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Thiagarajan, P (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	pthiagarajan@sunyopt.edu			U.S. Army; Department of Defense (Telemedicine and Advanced Technology Research Center)United States Department of Defense [W81XWH-10-1-1041, W81XWH-12-1-0240]; College of Optometrists in Vision Development; SUNY College of Optometry Graduate Program	This material was based on work supported by the U.S. Army, Department of Defense (Telemedicine and Advanced Technology Research Center awards W81XWH-10-1-1041 and W81XWH-12-1-0240), College of Optometrists in Vision Development, and SUNY College of Optometry Graduate Program.	Abernethy B, 2005, BIOPHYSICAL FDN HUMA, P51; ALQURAINY IA, 1995, BRIT J ORAL MAX SURG, V33, P71, DOI 10.1016/0266-4356(95)90203-1; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Arlinghaus K, 2011, TXB TRAUMATIC BRAIN, P55; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benjamin WT.., 2006, BORISHS CLIN REFRACT; BERNE SA, 1990, J OPTOM VIS DEV, V21, P13; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brautaset RL, 2006, INVEST OPHTH VIS SCI, V47, P2876, DOI 10.1167/iovs.04-1372; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Candler R., 1944, BR ORTHOPTIC J, V2, P56; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; CIUFFREDA K. J., 1992, J BEHAV OPTOM, V3, P3; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Cohen A H, 1992, J Am Optom Assoc, V63, P569; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; CROSS AG, 1948, ANN ROY COLL SURG, V2, P233; Cross AG, 1945, T OPHTHAL SOC UK, V65, P20; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; FISHER SK, 1990, PERCEPTION, V19, P171, DOI 10.1068/p190171; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; HELLERSTEIN LF, 1994, J BEHAV OPTOMETRY, V5, P143; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hung GK, 1997, VISION RES, V37, P1197, DOI 10.1016/S0042-6989(97)00271-X; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; KELLER EL, 1974, J NEUROPHYSIOL, V37, P316, DOI 10.1152/jn.1974.37.2.316; KERKHOFF G, 1994, BRAIN INJURY, V8, P15, DOI 10.3109/02699059409150955; Khan A. A., 2005, DIGITAL SIGNAL PROCE; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Leigh J.R., 2006, NEUROLOGY EYE MOVEME; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Ludlam WM, 1996, NEUROREHABILITATION, V6, P183, DOI 10.3233/NRE-1996-6304; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MANAS L, 1958, Am J Optom Arch Am Acad Optom, V35, P428; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; NORTH R, 1981, AM J OPTOM PHYS OPT, V58, P746; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Rambold H, 2005, ANN NY ACAD SCI, V1039, P567, DOI 10.1196/annals.1325.069; Rambold H, 2004, NEUROLOGY, V62, P1850, DOI 10.1212/01.WNL.0000125331.95849.62; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P339, DOI 10.1113/jphysiol.1961.sp006812; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; RON S, 1978, SCAND J REHABIL MED, V10, P39; Rosenfield M, 1997, OPTOMETRY VISION SCI, V74, P303, DOI 10.1097/00006324-199705000-00027; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2001, VISUAL VESTIBULAR CO; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Schor CM., 1983, VERGENCE EYE MOVEMEN, P484; Semmlow JL, 2002, IEEE T BIO-MED ENG, V49, P805, DOI 10.1109/TBME.2002.800758; SEMMLOW JL, 1993, OPHTHAL PHYSL OPT, V13, P48, DOI 10.1111/j.1475-1313.1993.tb00426.x; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Tannen B., 1995, EYE MOVEMENT BASICS; Thiagarajan P., 2012, THESIS STATE U NEW Y; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Thiagarajan P, 2010, OPTOMETRY VISION SCI, V87, P487, DOI 10.1097/OPX.0b013e3181e19ec2; Trenerry MR, 1990, VISUAL SEARCH ATTENT; VAEGAN, 1979, AM J OPTOM PHYS OPT, V56, P23; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; WESTHEIMER G, 1973, INVEST OPHTH VISUAL, V12, P618; Wick B., 2008, CLIN MANAGEMENT BINO; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495	87	42	42	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	9					1223	1239		10.1682/JRRD.2012.12.0235			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	287IE	WOS:000329534500009	24458963	Bronze			2022-02-06	
J	Verfaellie, M; Lafleche, G; Spiro, A; Tun, C; Bousquet, K				Verfaellie, Mieke; Lafleche, Ginette; Spiro, Avron, III; Tun, Carlos; Bousquet, Kathryn			Chronic Postconcussion Symptoms and Functional Outcomes in OEF/OIF Veterans with Self-Report of Blast Exposure	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Blast-injuries; PTSD; Depression; Postconcussion symptoms; Quality of life	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; SOCIAL SUPPORT; CONCUSSION; DEPLOYMENT; IRAQ; QUESTIONNAIRE; MISDIAGNOSIS	Postconcussion symptoms (PCS) and functional outcomes were evaluated in 91 OEF/OIF outpatient veterans with reported histories of blast-exposure, with the goal of evaluating (1) the association between these outcomes and a clinical diagnosis of mild traumatic brain injury (mTBI) with or without loss of consciousness (LOC); and (2) the influence of post-traumatic stress disorder (PTSD) and depression on PCS reporting and perceived functional limitations. Individuals who reported mTBI with LOC had greater PCS complaints than individuals who reported mTBI without LOC or individuals without mTBI. However, after adjusting for severity of PTSD and depression symptoms, this group difference disappeared. Functional limitations were particularly prominent in the psychosocial domain. Again, PTSD was significantly associated with functional outcomes, but the mTBI with LOC group had greater psychosocial limitations than the other two groups, even when PTSD and depression symptoms were taken into account. These findings highlight the role of mental health in both outcomes, but additionally point to the impact of mTBI with LOC on long-term psychosocial adjustment. (JINS, 2013, 19, 1-10)	[Verfaellie, Mieke; Lafleche, Ginette; Bousquet, Kathryn] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA 02130 USA; [Verfaellie, Mieke; Lafleche, Ginette; Spiro, Avron, III; Bousquet, Kathryn] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spiro, Avron, III] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA 02130 USA; [Spiro, Avron, III] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Tun, Carlos] VA Boston Healthcare Syst, Polytrauma Network Site, Boston, MA 02130 USA; [Tun, Carlos] Harvard Univ, Sch Med, Boston, MA USA		Verfaellie, M (corresponding author), VA Boston Healthcare Syst, Memory Disorders Res Ctr 151A, 150 S Huntington Ave, Boston, MA 02130 USA.	verf@bu.edu		Verfaellie, Mieke/0000-0001-5535-4584; Spiro III, Avron/0000-0003-4080-8621	Clinical Science Research and Development; Rehabilitation Research and Development Services of the Department of Veterans AffairsUS Department of Veterans Affairs	This research was supported by the Clinical Science Research and Development and the Rehabilitation Research and Development Services of the Department of Veterans Affairs. The authors thank Laura Grande, Ph.D. and Susan McGlynn, Ph.D. for facilitating participant recruitment. The authors have no conflict of interest affecting this manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler E. D., 2012, PTSD MILD TRAUMATIC, P15; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant R.A., 2012, PTSD TRAUMATIC BRAIN, P235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caplain S., 2008, J REHABILITATION M S, V22, P528; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrae M., 2008, MILD TRAUMATIC BRAIN; McDowell I., 1996, MEASURING HLTH OUTCO; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P82; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	60	42	43	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2013	19	1					1	U32		10.1017/S1355617712000902			21	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	063NB	WOS:000313005400001	23095177				2022-02-06	
J	Watts, LT; Sprague, S; Zheng, W; Garling, RJ; Jimenez, D; Digicaylioglu, M; Lechleiter, J				Watts, Lora Talley; Sprague, Shane; Zheng, Wei; Garling, R. Justin; Jimenez, David; Digicaylioglu, Murat; Lechleiter, James			Purinergic 2Y(1) Receptor Stimulation Decreases Cerebral Edema and Reactive Gliosis in a Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin 4; edema; mitochondria; purinergic receptor; reactive gliosis; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; MITOCHONDRIAL DYSFUNCTION; CELLULAR EDEMA; BARRIER PERMEABILITY; ENERGY-METABOLISM; WATER CHANNELS; GLIAL-CELLS; AQUAPORIN-4; ASTROCYTES; DIFFUSION	Traumatic brain injury (TBI) is the leading cause of death and disability in children and young adults. Neuroprotective agents that may promote repair or counteract damage after injury do not currently exist. We recently reported that stimulation of the purinergic receptor subtype P2Y(1)R using 2-methylthioladenosine 5' diphosphate (2MeSADP) significantly reduced cytotoxic edema induced by photothrombosis. Here, we tested whether P2Y(1)R stimulation was neuroprotective after TBI. A controlled closed head injury model was established for mice using a pneumatic impact device. Brains were harvested at 1, 3, or 7 days post-injury and assayed for morphological changes by immunocytochemistry, Western blot analysis, and wet/dry weight. Cerebral edema and expression of both aquaporin type 4 and glial fibrillary acidic protein were increased at all time points examined. Immunocytochemical measurements in both cortical and hippocampal slices also revealed significant neuronal swelling and reactive gliosis. Treatment of mice with 2MeSADP (100 mu M) or MRS2365 (100 mu M) 30 min after trauma significantly reduced all post-injury symptoms of TBI including edema, neuronal swelling, reactive gliosis, and AQ4 expression. The neuroprotective effect was lost in IP(3)R2-/- mice treated with 2MeSADP. Immunocytochemical labeling of brain slices confirmed that P2Y(1)R expression was defined to cortical and hippocampal astrocytes, but not neurons. Taken together, the data show that stimulation of astrocytic P2Y(1)Rs significantly reduces brain injury after acute trauma and is mediated by the IP3-signaling pathway. We suggest that enhancing astrocyte mitochondrial metabolism offers a promising neuroprotective strategy for a broad range of brain injuries.	[Lechleiter, James] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, STRF Neurosci Program MC8253, Sch Med, San Antonio, TX 78229 USA; [Sprague, Shane; Garling, R. Justin; Jimenez, David; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, Sch Med, San Antonio, TX 78229 USA		Lechleiter, J (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, STRF Neurosci Program MC8253, Sch Med, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	lechleiter@uthscsa.edu					Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adelson PD, 1998, ACT NEUR S, V71, P104; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; BETZ AL, 1994, J CEREBR BLOOD F MET, V14, P29, DOI 10.1038/jcbfm.1994.5; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cherniak C, 1990, J Cogn Neurosci, V2, P58, DOI 10.1162/jocn.1990.2.1.58; Chu XF, 2007, BRAIN RES, V1149, P157, DOI 10.1016/j.brainres.2007.02.061; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; DeWitt D S, 1995, New Horiz, V3, P376; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; ERISKAT J, 1994, ACTA NEUROCHIR, P425; Faul M, 2010, TRAUMATIC BRAIN INJU; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hajnoczky G, 2000, J BIOENERG BIOMEMBR, V32, P15, DOI 10.1023/A:1005504210587; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Patro A, 2009, INDIAN J NEUROTRAUM, V6, P11, DOI 10.1016/S0973-0508(09)80021-X; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Venero JL, 2004, CURR PHARM DESIGN, V10, P2153, DOI 10.2174/1381612043384150; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Verkman AS, 2002, J ANAT, V200, P617, DOI 10.1046/j.1469-7580.2002.00058.x; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VIJAYAN VK, 1990, MOL CHEM NEUROPATHOL, V13, P107, DOI 10.1007/BF03159912; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woitzik J, 2008, FRONT BIOSCI-LANDMRK, V13, P1500, DOI 10.2741/2776; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zheng W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014401	77	42	44	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	1					55	66		10.1089/neu.2012.2488			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	061GU	WOS:000312837300009	23046422				2022-02-06	
J	Hall, ED; Wang, JA; Miller, DM				Hall, Edward D.; Wang, Juan A.; Miller, Darren M.			Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Peroxynitrite; Oxidative damage; 3-Nitrotyrosine; Nitric oxide synthase	TYROSINE NITRATION; DEFICIENT MICE; MOUSE MODEL; SUPEROXIDE; NEURODEGENERATION; ANTIOXIDANT; EXPRESSION; REDUCTION; CONTUSION; TEMPOL	We have previously shown the pathophysiological importance of the reactive nitrogen species peroxynitrite (PN) formed from the reaction of nitric oxide (center dot NO) and superoxide (O-2(center dot-)) radicals and its involvement in lipid peroxidation (LP) and protein nitration damage in brain tissue following traumatic brain injury (TBI). Nitric oxide is produced by at least three isoforms of the enzyme nitric oxide synthase (NOS) including: endothelial NOS (eNOS) in the CNS vasculature, neuronal NOS (nNOS), and inducible NOS (iNOS) in macrophages/microglia. In view of the requirement of center dot NO synthesis for PN formation, we sought to address the time course of NOS expression (mRNA by real time quantitative PCR and protein by western blot) after TBI in comparison with the time course of PN-mediated protein nitration (3-nitrotyrosine, 3-NT) in ipsilateral cortex (CTX) and hippocampus (HIPP) between 3 hours and 1 week post-injury using a controlled cortical impact (CCI) mouse model of TBI in young adult CF-1 mice. Protein nitration showed a progressive posttraumatic increase that became significant in CTX at 24 hours and then peaked at 72 hours in both CTX and HIPP. During the increase in PN-derived 3-NT, there was no increase in either CTX or HIPP eNOS mRNA levels, whereas eNOS protein levels were significantly (p<0.05) increased at 48 and 72 hours in both brain regions. There was a significant decrease in HIPP, but not CTX nNOS mRNA; however, nNOS protein did not change except for a significant increase in CTX at 1 week. There was significantly increased CTX and HIPP iNOS mRNA levels at 24, 48, and 72 hours (p<.05) post-injury. In contrast, no change was seen in CTX or HIPP iNOS protein at any timepoint. Taken together, eNOS protein expression and iNOS mRNA appear to bear a coincident temporal relationship to the time course of PN-mediated protein nitrative damage after CCI-TBI suggesting that both constitutive and inducible NOS isoforms contribute center dot NO for PN formation and 3-NT protein modification after TBI. (C) 2012 Elsevier Inc. All rights reserved.	[Hall, Edward D.] Univ Kentucky, Med Ctr, SCoBIRC, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Med Ctr, SCoBIRC, Room B483,Biomed & Biol Sci Res Bldg,741 S Limest, Lexington, KY 40536 USA.	edhall@uky.edu; jawang@uky.edu; darren.miller@uky.edu	Hall, Edward D/F-8930-2013		Kentucky Spinal Cord and Head Injury Research Trust; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1T32 DA022738];  [1R01 NSO46566];  [2P01 NS058484];  [5P30 NS051220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046566, P01NS058484, P30NS051220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA022738] Funding Source: NIH RePORTER	This work was supported by 1R01 NSO46566, 2P01 NS058484, 5P30 NS051220 and the Kentucky Spinal Cord and Head Injury Research Trust. Darren M. Miller was supported by fellowship funds from the NIH Blueprint Translational Neuroscience Training Grant 1T32 DA022738.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hummel SG, 2006, FREE RADICAL BIO MED, V40, P501, DOI 10.1016/j.freeradbiomed.2005.08.047; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Radi R, 1998, CHEM RES TOXICOL, V11, P720, DOI 10.1021/tx980096z; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807	29	42	45	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	DEC	2012	238	2					176	182		10.1016/j.expneurol.2012.08.024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	046KE	WOS:000311763100014	22960186	Green Accepted			2022-02-06	
J	Whiteneck, G; Gassaway, J; Dijkers, MP; Heinemann, AW; Kreider, SED				Whiteneck, Gale; Gassaway, Julie; Dijkers, Marcel P.; Heinemann, Allen W.; Kreider, Scott E. D.			Relationship of patient characteristics and rehabilitation services to outcomes following spinal cord injury: The SCIRehab Project	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Tetraplegia; Paraplegia; Rehabilitation; Physical; Social participation; Quality of life; Activities of daily living; Spinal cord injury model system; Practice-based evidence	CLINICAL-PRACTICE IMPROVEMENT; THERAPY TREATMENT TIME; TRAUMATIC BRAIN; INPATIENT REHABILITATION; SEVERITY; STAY; CARE; COMPLICATIONS; RECOVERY; ILLNESS	Background/objective: To examine associations of patient characteristics along with treatment quantity delivered by seven clinical disciplines during inpatient spinal cord injury (SCI) rehabilitation with outcomes at rehabilitation discharge and 1-year post-injury. Methods: Six inpatient SCI rehabilitation centers enrolled 1376 patients during the 5-year SCIRehab study. Clinicians delivering standard care documented details of treatment. Outcome data were derived from SCI Model Systems Form I and II and a project-specific interview conducted at approximately 1-year post-injury. Regression modeling was used to predict outcomes; models were cross-validated by examining relative shrinkage of the original model R-2 using 75% of the dataset to the R-2 for the same outcome using a validation subsample. Results: Patient characteristics are strong predictors of outcome; treatment duration adds slightly more predictive power. More time in physical therapy was associated positively with motor Functional Independence Measure at discharge and the 1-year anniversary, CHART Physical Independence, Social Integration, and Mobility dimensions, and smaller likelihood of rehospitalization after discharge and reporting of pressure ulcer at the interview. More time in therapeutic recreation also had multiple similar positive associations. Time spent in other disciplines had fewer and mixed relationships. Seven models validated well, two validated moderately well, and four validated poorly. Conclusion: Patient characteristics explain a large proportion of variation in multiple outcomes after inpatient rehabilitation. The total amount of treatment received during rehabilitation from each of seven disciplines explains little additional variance. Reasons for this and the phenomenon that sometimes more hours of service predict poorer outcome, need additional study.	[Whiteneck, Gale; Kreider, Scott E. D.] Craig Hosp, Dept Res, Englewood, CO 80113 USA; [Gassaway, Julie] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Dijkers, Marcel P.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA		Whiteneck, G (corresponding author), Craig Hosp, Dept Res, 3425 S Clarkson St, Englewood, CO 80113 USA.	gale@craig-hospital.org	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, Office of Rehabilitative Services, US Department of EducationUS Department of Education [H133A060103, H133N060005, H133N060027, H133N060014]	The contents of this paper were developed under grants from the National Institute on Disability and Rehabilitation Research, Office of Rehabilitative Services, US Department of Education, to Craig Hospital (grant numbers H133A060103 and H133N060005) and to The Mount Sinai School of Medicine (grant number H133N060027), and Rehabilitation Institute of Chicago (grant number H133N060014). The opinions contained in this publication are those of the grantees and do not necessarily reflect those of the US Department of Education.	Abeyta N, 2009, J SPINAL CORD MED, V32, P336, DOI 10.1080/10790268.2009.11760787; AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Berns S, 1957, REHABILITATION MONOG; Brougham R, 2011, J SPINAL CORD MED, V34, P186, DOI 10.1179/107902611X12971826988174; Burnett DM, 2002, NEUROREHABILITATION, V17, P187; Cahow C, 2009, J SPINAL CORD MED, V32, P298, DOI 10.1080/10790268.2009.11760783; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P733, DOI 10.1016/S0003-9993(99)90219-8; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1284, DOI 10.1016/j.apmr.2009.02.009; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MPJM, 2002, SPINAL CORD, V40, P351, DOI 10.1038/sj.sc.3101310; Fiedler R., 1996, FUNCTIONAL ELEVATION, P75; Fiedler RC, 2000, AM J PHYS MED REHAB, V79, P184, DOI 10.1097/00002060-200003000-00012; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Gassaway J, 2011, J SPINAL CORD MED, V34, P176, DOI 10.1179/107902611X12971826988138; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Hammond FM, 2011, J SPINAL CORD MED, V34, P216, DOI 10.1179/107902611X12971826988291; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Horn S D, 1995, Med Interface, V8, P60; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 1996, NUTRITION, V12, P384; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; HORN SD, 1997, CLIN PRACTICE IMPROV; Horn SD., 1995, MED INTERFACE, V8, P70; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Huston T, 2011, J SPINAL CORD MED, V34, P196, DOI 10.1179/107902611X12971826988219; Jette AM, 2005, ARCH PHYS MED REHAB, V86, pS124, DOI 10.1016/j.apmr.2005.09.015; Johnson K, 2009, J SPINAL CORD MED, V32, P329, DOI 10.1080/10790268.2009.11760786; Kalpakjian CZ, 2011, ARCH PHYS MED REHAB, V92, P433, DOI 10.1016/j.apmr.2010.07.239; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mallinson, 2011, RASCH MEAS T, V251, P1317; Marino R., 2003, REFERENCE MANUAL INT; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Nair KPS, 2005, SPINAL CORD, V43, P558, DOI 10.1038/sj.sc.3101752; Natale A, 2009, J SPINAL CORD MED, V32, P270, DOI 10.1080/10790268.2009.11760781; National Spinal Cord Injury Statistical Center, 2011, DAT COLL SYLL NAT SP; Nizam A, 1998, APPL REGRESSION ANAL; Ottenbacher KJ, 2005, ARCH PHYS MED REHAB, V86, pS121; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; Parent S, 2011, J NEUROTRAUM, V28, P1363, DOI 10.1089/neu.2009.1151; ROACH MJ, 2002, TOP SPINAL CORD INJ, V7, P101; Rundquist J, 2011, J SPINAL CORD MED, V34, P205, DOI 10.1179/107902611X12971826988255; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Seel R T, 2001, J Spinal Cord Med, V24, P241; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Taylor-Schroeder S, 2011, J SPINAL CORD MED, V34, P149, DOI 10.1179/107902611X12971826988057; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whiteneck G, 2009, J SPINAL CORD MED, V32, P249; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P361, DOI 10.1016/j.apmr.2010.07.241; Whiteneck GG, 1992, GUIDE USE CHART CRAI; Willson D F, 2000, Pediatr Crit Care Med, V1, P127, DOI 10.1097/00130478-200010000-00007; Wilson C, 2009, J SPINAL CORD MED, V32, P319, DOI 10.1080/10790268.2009.11760785	63	42	42	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	NOV	2012	35	6					484	502		10.1179/2045772312Y.0000000057			19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	058YF	WOS:000312670400003	23318033	Green Published			2022-02-06	
J	Chiang, LC; Chen, WC; Dai, YT; Ho, YL				Chiang, Li-Chi; Chen, Wan-Chou; Dai, Yu-Tzu; Ho, Yi-Lwun			The effectiveness of telehealth care on caregiver burden, mastery of stress, and family function among family caregivers of heart failure patients: A quasi-experimental study	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Telehealth; Telenursing; Discharge planning; Family caregiver; Heart failure	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; CHINESE VERSION; HEALTH-CARE; INTERVENTION; MANAGEMENT; HOME; METAANALYSIS; INVENTORY; RELIABILITY	Background: Telehealth care was developed to provide home-based monitoring and support for patients with chronic disease. The positive effects on physical outcome have been reported; however, more evidence is required concerning the effects on family caregivers and family function for heart failure patients transitioning from the hospital to home. Objective: To evaluate the effectiveness of nursing-led transitional care combining discharge plans and telehealth care on family caregiver burden, stress mastery and family function in family caregivers of heart failure patients compared to those receiving traditional discharge planning only. Design: This is a quasi-experimental study design. Methods: Sixty-three patients with heart failure were assessed for eligibility and invited to participate in either telehealth care or standard care in a medical centre from May to October 2010. Three families refused to participate in data collection. Thirty families who chose telehealth care after discharge from the hospital to home comprised the experimental group: the others families receiving discharge planning only comprised the comparison group. Telenursing specialist provided the necessary family nursing interventions by 24-h remote monitoring of patients' health condition and counselling by telephone, helping the family caregivers successfully transition from hospital to home. Data on caregiver burden, stress mastery and family function were collected before discharge from the hospital and one month later at home. Effects of group, time, and group x time interaction were analysed using Mixed Model in SPSS (17.0). Results: Family caregivers in both groups had significantly lower burden, higher stress mastery, and better family function at one-month follow-up compared to before discharge. The total score of caregiver burden, stress mastery and family function was significantly improved for the family caregivers in the experimental group compared to the comparison group at posttest. Two subscales of family function-Relationships between family and subsystems and Relationships between family and society were improved in the experimental group compared to the comparison group, but Relationships between family and family members was not different. Conclusions: The results provide evidence that telehealth care combined with discharge planning could reduce family caregiver burden, improve stress mastery, and improve family function during the first 30 days at home after heart failure patients are discharged from the hospital. Telenursing specialists cared caregivers with the concepts of providing transitional care to help them successful cross the critical transition stage. (C) 2012 Elsevier Ltd. All rights reserved.	[Chiang, Li-Chi] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Chiang, Li-Chi] China Med Univ, Taipei, Taiwan; [Chiang, Li-Chi] Natl Def Med Ctr, Sch Nursing, Taichung, Taiwan; [Chiang, Li-Chi] China Med Univ, Taichung, Taiwan; [Chen, Wan-Chou; Dai, Yu-Tzu] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; [Dai, Yu-Tzu] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Div Cardiol, Taipei 10764, Taiwan		Ho, YL (corresponding author), NTU Telehlth Ctr, NTUH E Wing B Block,3rd Floor,7 Chung Shan S Rd, Taipei 100, Taiwan.	abundantia0909@gmail.com; yutzu@ntu.edu.tw; ylho@ntu.edu.tw	Chiang, Li-Chi/AAW-9661-2020	HO, YI-LWUN/0000-0002-8936-9570; Chiang, Li-Chi/0000-0002-6383-7495; DAI, YU-TZU/0000-0002-3803-3516	Tele-Health Center in National Taiwan University Hospital; National Science CouncilMinistry of Science and Technology, Taiwan [NSC97-2314-B-039-034-MY3]	This is supported the Tele-Health Center in National Taiwan University Hospital. This study has some supported by grants from the National Science Council (no. NSC97-2314-B-039-034-MY3).	*ACC AHA, 2005, J AM COLL CARDIOL, V46, pE1; American Heart Association, 2008, HEAT DIS STROK STAT; American Nurses Association, 1997, NURS TRENDS ISS ANA; Anker SD, 2011, LANCET, V378, P731, DOI 10.1016/S0140-6736(11)61229-4; Armola R R, 2001, Lippincotts Case Manag, V6, P246, DOI 10.1097/00129234-200111000-00005; Bakas T, 2006, NURS RES, V55, P180, DOI 10.1097/00006199-200605000-00004; Brislin R.W., 1973, CROSS CULTURAL RES M; Carelock J, 2001, AM J NURS, V101, P26, DOI 10.1097/00000446-200112000-00017; Caserta MS, 1996, INT J AGING HUM DEV, V43, P21, DOI 10.2190/2DKF-292P-A53W-W0A8; Chan Y H, 2004, Singapore Med J, V45, P354; Chaudhry SI, 2007, J CARD FAIL, V13, P56, DOI 10.1016/j.cardfail.2006.09.001; Chick N., 1986, NURSING RES METHODOL, P237; Chou KR, 2002, NURS RES, V51, P324, DOI 10.1097/00006199-200209000-00009; Clarke M, 2011, J TELEMED TELECARE, V17, P7, DOI 10.1258/jtt.2010.100113; Cleland John G F, 2002, Heart Fail Rev, V7, P229, DOI 10.1023/A:1020024122726; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins LG, 2011, AM FAM PHYSICIAN, V83, P1309; Davidson PM, 2007, J CARDIOVASC NURS, V22, P58, DOI 10.1097/00005082-200701000-00009; Dias VP, 2009, ST HEAL T, V146, P202, DOI 10.3233/978-1-60750-024-7-202; Duvall EM, 1985, MARRIAGE FAMILY DEV; Finkel S, 2007, AM J GERIAT PSYCHIAT, V15, P443, DOI 10.1097/JGP.0b013e3180437d87; Hagan Natalie, 2007, Aust Crit Care, V20, P113, DOI 10.1016/j.aucc.2007.05.004; Harkness KI, 2007, J CARD FAIL, V13, P577, DOI 10.1016/j.cardfail.2007.03.013; Ho YL, 2007, J FORMOS MED ASSOC, V106, P313, DOI 10.1016/S0929-6646(09)60258-8; Hoglund AT, 2008, J CLIN NURS, V17, P2979, DOI 10.1111/j.1365-2702.2008.02345.x; Hohashi N, 2008, J FAM NURS, V14, P201, DOI 10.1177/1074840708315967; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Huang C.R., 2008, 6 C INT SOC GER ISG0, P1; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; International Council of Nurses, 2001, NURS MATT TEL; Jerant Anthony F, 2003, Home Health Care Serv Q, V22, P1, DOI 10.1300/J027v22n01_01; Jonsson AM, 2008, TELEMED J E-HEALTH, V14, P1057, DOI 10.1089/tmj.2008.0022; Kang XF, 2011, J CARDIOVASC NURS, V26, P386, DOI 10.1097/JCN.0b013e3182076a69; Klersy C, 2009, J AM COLL CARDIOL, V54, P1683, DOI 10.1016/j.jacc.2009.08.017; Koehler F., 2011, J AM HEART ASS; Lorentz Madeline M, 2008, Home Healthc Nurse, V26, P237, DOI 10.1097/01.NHH.0000316702.22633.30; Luttik ML, 2007, J CARDIOVASC NURS, V22, P131, DOI 10.1097/00005082-200703000-00010; Manning S, 2011, J CARDIOVASC NURS, V26, P368, DOI 10.1097/JCN.0b013e318202b15c; Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006; Meleis AI, 2010, TRANSITIONS THEORY M; Molloy GJ, 2006, EUR J CARDIOV PREV R, V13, P381, DOI 10.1097/00149831-200606000-00014; Naditz A, 2009, TELEMED J E-HEALTH, V15, P825, DOI 10.1089/tmj.2009.9938; Natanzon A, 2009, AM J MED SCI, V338, P211, DOI 10.1097/MAJ.0b013e3181a3936f; National Taiwan University Hospital-TeleCare, 2011, INTR FRAM TEL CAR; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pattenden J F, 2007, Eur J Cardiovasc Nurs, V6, P273, DOI 10.1016/j.ejcnurse.2007.01.097; Pressler SJ, 2009, AM J CRIT CARE, V18, P149, DOI 10.4037/ajcc2009300; Radhakrishnan K., 2011, J CARDIOVASCULAR NUR, P1; Riegel B., 2010, TRANSITIONS THEORY M; ROBERTS CS, 1982, NURS RES, V31, P231; Schumacher K L, 1994, Image J Nurs Sch, V26, P119; Schwartz Kim A, 2011, N C Med J, V72, P216; Snooks HA, 2008, J ADV NURS, V61, P631, DOI 10.1111/j.1365-2648.2007.04546.x; Stewart S, 2005, EUR J HEART FAIL, V7, P590, DOI 10.1016/j.ejheart.2004.07.021; Tung HH, 2012, J CARDIOVASC NURS, V27, P16, DOI 10.1097/JCN.0b013e318211284b; Vreeland DG, 2011, CRIT CARE NURS Q, V34, P235, DOI 10.1097/CNQ.0b013e31821ffe5d; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Winkler S, 2010, J AM COLL CARDIOL, V55, P1505, DOI 10.1016/j.jacc.2009.12.028; YOUNGER JB, 1993, NURS RES, V42, P68; YOUNGER JB, 1991, ADV NURS SCI, V14, P76, DOI 10.1097/00012272-199109000-00009	66	42	50	0	80	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	OCT	2012	49	10					1230	1242		10.1016/j.ijnurstu.2012.04.013			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	028HA	WOS:000310412200005	22633448				2022-02-06	
J	Colamonico, J; Formella, A; Bradley, W				Colamonico, Jennifer; Formella, Andrea; Bradley, Walter			Pseudobulbar Affect: Burden of Illness in the USA	ADVANCES IN THERAPY			English	Article						Burden of illness; Health status; Occupational function; Pseudobulbar affect; Quality of life; Social function	AMYOTROPHIC-LATERAL-SCLEROSIS; HEALTH SURVEY SF-36; MULTIPLE-SCLEROSIS; SHORT-FORM; EMOTIONAL INCONTINENCE; PARKINSONS-DISEASE; DEXTROMETHORPHAN/QUINIDINE; PRODUCTIVITY; PREVALENCE; EMPLOYMENT	Pseudobulbar affect (PBA) is characterized by involuntary and uncontrollable laughing and/or crying episodes, occurring secondary to neurological disease or injury. The impact of PBA on social and occupational function, health status, quality of life (QOL), and quality of relationships (QOR) is not well studied. This US survey conducted by Harris Interactive compared health status and daily function of patients with and without PBA. Eligible respondents were Harris Panel Online registrants previously diagnosed with stroke, multiple sclerosis, Parkinson's disease, Alzheimer's disease, traumatic brain injury, or amyotrophic lateral sclerosis, or primary, nonpaid caregivers for such patients who were too debilitated to participate. PBA was identified by a Center for Neurologic Study lability scale score of 13 or greater. Measures included the 36-item short form health survey (SF-36), the work productivity and impairment (WPAI) questionnaire, visual analog scales (VAS) for impact of PBA symptoms on QOL and QOR, and customized questions related to burden and impact of involuntary laughing/crying episodes on patients' lives. Survey responses were weighted to adjust for the relative proportion of the primary neurological conditions in the overall population and between group differences in patient age and gender. PBA and non-PBA group responses were compared using two-tailed t tests adjusted for severity of the primary neurological conditions. The 1,052 respondents included 399 PBA group participants and 653 controls. The PBA group showed significantly worse scores versus non-PBA controls on component and summary SF-36 scores (P < 0.05 for all), VAS scores (P < 0.05 for both), and WPAI scores (P < 0.05). Among PBA group respondents, PBA contributed a great deal to or was the main cause of patients becoming housebound for 24% and being moved to supervised living placement for 9% of respondents. PBA is associated with considerable burden incremental to that of the underlying neurological conditions, affecting QOL, QOR, health status, and social and occupational functioning.	[Formella, Andrea] Avanir Pharmaceut Inc, Aliso Viejo, CA 92656 USA; [Colamonico, Jennifer] Harris Interact Inc, New York, NY USA; [Bradley, Walter] Univ Miami, Miller Sch Med, Miami, FL 33136 USA		Formella, A (corresponding author), Avanir Pharmaceut Inc, 20 Enterprise,Suite 200, Aliso Viejo, CA 92656 USA.	aformella@avanir.com	Formella, Andrea/AAE-4073-2020	Formella, Andrea/0000-0003-2737-7898	Avanir Pharmaceuticals, Inc.	J. Colamonico has nothing to disclose. A. Formella has received personal compensation for activities with Avanir Pharmaceuticals, Inc., as an employee. W. Bradley has received research grants from Avanir Pharmaceuticals, Inc.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Brooks BR, 2004, NEUROLOGY, V63, P1364; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Choi-Kwon S, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000047743; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Davison C, 1939, ARCH NEURO PSYCHIATR, V42, P595, DOI 10.1001/archneurpsyc.1939.02270220011001; Edgley K, 1991, CANADIAN J REHABILIT, V4, P127; Faul M, 2010, TRAUMATIC BRAIN INJU, P13, DOI DOI 10.3171/2009.10.JNS091500; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; Feinstein A, 1999, MULT SCLER, V5, P69, DOI 10.1177/135245859900500201; Guajardo VD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-826; Hagell P, 2007, J NEUROL NEUROSUR PS, V78, P1191, DOI 10.1136/jnnp.2006.111161; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; JENKINSON C, 1995, AGE AGEING, V24, P505, DOI 10.1093/ageing/24.6.505; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Lantz MS, 2005, CLIN GERIATR MED, V13, P14; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Morrow SA, 2010, CLIN NEUROPSYCHOL, V24, P1131, DOI 10.1080/13854046.2010.511272; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Petracca GM, 2009, J NEUROPSYCH CLIN N, V21, P406, DOI 10.1176/appi.neuropsych.21.4.406; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SCHWAB R, 1969, 3 S PARK DIS MAY 20; Siddiqui MS, 2009, WORLD J BIOL PSYCHIA, V10, P234, DOI 10.1080/15622970701639445; Smith RA, 2004, MULT SCLER, V10, P1; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; VITALIANO PP, 1991, GERONTOLOGIST, V31, P76, DOI 10.1093/geront/31.1.76; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001	42	42	42	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0741-238X	1865-8652		ADV THER	Adv. Ther.	SEP	2012	29	9					775	798		10.1007/s12325-012-0043-7			24	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	006KL	WOS:000308818000005	22941524	Bronze			2022-02-06	
J	Quirk, BJ; Torbey, M; Buchmann, E; Verma, S; Whelan, HT				Quirk, Brendan J.; Torbey, Michel; Buchmann, Ellen; Verma, Sumit; Whelan, Harry T.			Near-Infrared Photobiomodulation in an Animal Model of Traumatic Brain Injury: Improvements at the Behavioral and Biochemical Levels	PHOTOMEDICINE AND LASER SURGERY			English	Article							EMITTING DIODE IRRADIATION; CONTROLLED CORTICAL IMPACT; MITOCHONDRIAL DYSFUNCTION; BAX; APOPTOSIS; TRANSLOCATION; MEMBRANE; ACTIN; BCL-2; CELLS	Objective: The purpose of this was to evaluate the neuroprotective effects of near-infrared (NIR) light using an in-vivo rodent model of traumatic brain injury (TBI), controlled cortical impact (CCI), and to characterize changes at the behavioral and biochemical levels. Background data: NIR upregulates mitochondrial function, and decreases oxidative stress. Mitochondrial oxidative stress and apoptosis are important in TBI. NIR enhanced cell viability and mitochondrial function in previous in-vitro TBI models, supporting potential NIR in-vivo benefits. Methods: Sprague-Dawley rats were divided into three groups: severe TBI, sham surgery, and anesthetization only (behavioral response only). Cohorts in each group were administered either no NIR or NIR. They received two 670 nm LED treatments (5 min, 50 mW/cm(2), 15J/cm(2)) per day for 72 h (chemical analysis) or 10 days (behavioral). During the recovery period, animals were tested for locomotor and behavioral activities using a TruScan device. Frozen brain tissue was obtained at 72 h and evaluated for apoptotic markers and reduced glutathione (GSH) levels. Results: Significant differences were seen in the TBI plus and minus NIR (TBI+/-) and sham plus and minus NIR (S+/-) comparisons for some of the TruScan nose poke parameters. A statistically significant decrease was found in the Bax pro-apoptotic marker attributable to NIR exposure, along with lesser increases in Bcl-2 anti-apoptotic marker and GSH levels. Conclusions: These results show statistically significant, preclinical outcomes that support the use of NIR treatment after TBI in effecting changes at the behavioral, cellular, and chemical levels.	[Whelan, Harry T.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Torbey, Michel] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA		Whelan, HT (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	hwhelan@mcw.edu			Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W911NF-09-0117, 56482LSDRP09267]; Bleser Endowed Chair in Neurology; Baumann Research Endowment	This work was supported by the Defense Advanced Research Projects Agency (DARPA) Grant # W911NF-09-0117, Project # 56482LSDRP09267 (to Dr. Whelan), and the Bleser Endowed Chair in Neurology (to Dr. Whelan), as well as the Baumann Research Endowment (to Dr. Whelan). We gratefully acknowledge Brandi Jones and Joeylynn Nawrocki for technical assistance as well as Debbie Dye for administrative support in preparation of the manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu T. I., 2003, LOW POWER LASER THER; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MANVELYAN H, 2006, GEORGIAN MED NEWS, V140, P1306; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Monks TJ, 1999, TOXICOL SCI, V51, P161, DOI 10.1093/toxsci/51.2.161; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Quirk Brendan J, 2012, Front Biosci (Elite Ed), V4, P818; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Tang HL, 2006, BIOCHEM J, V396, P1, DOI 10.1042/BJ20060241; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	22	42	43	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418			PHOTOMED LASER SURG	Photomed. Laser Surg.	SEP	2012	30	9					523	529		10.1089/pho.2012.3261			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	996JM	WOS:000308081600004	22793787	Green Published			2022-02-06	
J	Warren, KM; Reeves, TM; Phillips, LL				Warren, Kelly M.; Reeves, Thomas M.; Phillips, Linda L.			MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						a distintegrin and metalloproteinase-10 (ADAM-10); brain injury; membrane type 5-matrix metalloproteinase (MT5-MMP); N-cadherin; synaptic plasticity	LONG-TERM POTENTIATION; AMYLOID PRECURSOR PROTEIN; MATRIX-METALLOPROTEINASE EXPRESSION; AMPA RECEPTOR TRAFFICKING; COMBINED FLUID PERCUSSION; CULTURED RAT ASTROCYTES; OLFACTORY NERVE INJURY; GFAP MESSENGER-RNA; DENTATE-GYRUS; CEREBRAL-ISCHEMIA	Matrix metalloproteinases (MMPs) influence synaptic recovery following traumatic brain injury (TBI). Membrane type 5-matrix metalloproteinase (MT5-MMP) and a distintegrin and metalloproteinase-10 (ADAM-10) are membrane-bound MMPs that cleave N-cadherin, a protein critical to synapse stabilization. This study examined protein and mRNA expression of MT5-MMP, ADAM-10, and N-cadherin after TBI, contrasting adaptive and maladaptive synaptogenesis. The effect of MMP inhibition on MT5-MMP, ADAM-10, and N-cadherin was assessed during maladaptive plasticity and correlated with synaptic function. Rats were subjected to adaptive unilateral entorhinal cortical lesion (UEC) or maladaptive fluid percussion TBI + bilateral entorhinal cortical lesion (TBI + BEC). Hippocampal MT5-MMP and ADAM-10 protein was significantly elevated 2 and 7 days post-injury. At 15 days after UEC, each MMP returned to control level, while TBI + BEC ADAM-10 remained elevated. At 2 and 7 days, N-cadherin protein was below control. By the 15-day synapse stabilization phase, UEC N-cadherin rose above control, a shift not seen for TBI + BEC. At 7 days, increased TBI + BEC ADAM-10 transcript correlated with protein elevation. UEC ADAM-10 mRNA did not change, and no differences in MT5-MMP or N-cadherin mRNA were detected. Confocal imaging showed MT5-MMP, ADAM-10, and N-cadherin localization within reactive astrocytes. MMP inhibition attenuated ADAM-10 protein 15 days after TBI + BEC and increased N-cadherin. This inhibition partially restored long-term potentiation induction, but did not affect paired-pulse facilitation. Our results confirm time-and injury-dependent expression of MT5-MMP, ADAM-10, and N-cadherin during reactive synaptogenesis. Persistent ADAM-10 expression was correlated with attenuated N-cadherin level and reduced functional recovery. MMP inhibition shifted ADAM-10 and N-cadherin toward adaptive expression and improved synaptic function.	[Warren, Kelly M.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	llphilli@vcu.edu			NIH/NINDS Center Core Grant [NS047463]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS057758, NS056247, NS044372]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS044372, R01NS056247, P30NS047463, R01NS057758, R01NS044372] Funding Source: NIH RePORTER	The authors wish to thank Lesley K. Harris, Raiford T. Black, and Nancy N. Lee for their excellent technical assistance. Quantitative RT-PCR was conducted through the VCU Molecular Diagnostics Laboratory, Department of Pathology, in collaboration with Dr. Cathy I. Dumur and Tana L. Blevins. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, which is funded in part by NIH/NINDS Center Core Grant NS047463. These studies were supported by NIH/NINDS grants NS057758, NS056247, and NS044372.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bandyopadhyay S, 2006, J NEUROSCI RES, V84, P106, DOI 10.1002/jnr.20864; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; CHANG HS, 1989, BRAIN RES, V505, P220, DOI 10.1016/0006-8993(89)91446-7; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Conant K, 2005, MATRIX METALLOPROTEINASES IN THE CENTRAL NERVOUS SYSTEM, P1, DOI 10.1142/9781860947179; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dong JH, 2004, GLIA, V47, P102, DOI 10.1002/glia.10355; Dumur CI, 2009, LARYNGOSCOPE, V119, P91, DOI 10.1002/lary.20005; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Harris JL, 2011, HIPPOCAMPUS, V21, P81, DOI 10.1002/hipo.20725; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huntley GW, 2012, HIPPOCAMPUS, V22, P17, DOI 10.1002/hipo.20859; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jangouk P, 2009, GLIA, V57, P1765, DOI 10.1002/glia.20889; Jaworski DM, 2000, BRAIN RES, V860, P174, DOI 10.1016/S0006-8993(00)02035-7; KAMPHUIS W, 1992, NEUROSCI LETT, V141, P101, DOI 10.1016/0304-3940(92)90344-7; KEPPEL G, 1991, DESIGN ANAL RESEARCH; Kieseier BC, 2003, GLIA, V42, P398, DOI 10.1002/glia.10226; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Komori K, 2004, FEBS LETT, V557, P125, DOI 10.1016/S0014-5793(03)01458-3; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; LEUNG LS, 1994, BRAIN RES, V650, P75; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Llano E, 1999, CANCER RES, V59, P2570; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; LOMO T, 1971, EXP BRAIN RES, V12, P46; Maarouf CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-20; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Marrs GS, 2009, MOL CELL NEUROSCI, V40, P390, DOI 10.1016/j.mcn.2008.12.007; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; McCusker Catherine D, 2009, Commun Integr Biol, V2, P155; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okonkwo David O., 2003, P263; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ortiz RM, 2005, MOL BRAIN RES, V137, P272, DOI 10.1016/j.molbrainres.2005.03.008; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Plumb J, 2005, J NEUROIMMUNOL, V164, P1, DOI 10.1016/j.jneuroim.2005.02.021; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Reeves TM, 2003, J NEUROSCI, V23, P10182; REEVES TM, 1986, EXP BRAIN RES, V65, P167; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 2001, STROKE, V32, P1162, DOI 10.1161/01.STR.32.5.1162; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Schlomann U, 2000, J NEUROSCI, V20, P7964; SCHULTZ GS, 1992, INVEST OPHTH VIS SCI, V33, P3325; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STEWARD O, 1988, J COMP NEUROL, V267, P203, DOI 10.1002/cne.902670205; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang WY, 2005, NEUROSCIENCE, V134, P1167, DOI 10.1016/j.neuroscience.2005.04.064; Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wells GMA, 1996, GLIA, V18, P332, DOI 10.1002/(SICI)1098-1136(199612)18:4<332::AID-GLIA7>3.0.CO;2-Z; Wojtowicz T, 2010, HIPPOCAMPUS, V20, P917, DOI 10.1002/hipo.20787; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0; Zalewska T, 2003, BRAIN RES, V977, P62, DOI 10.1016/S0006-8993(03)02742-2; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305; [No title captured]	114	42	44	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1922	1940		10.1089/neu.2012.2383			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400396	22489706	Green Published			2022-02-06	
J	Ng, SY; Semple, BD; Morganti-Kossmann, MC; Bye, N				Ng, Si Yun; Semple, Bridgette D.; Morganti-Kossmann, M. Cristina; Bye, Nicole			Attenuation of Microglial Activation with Minocycline Is Not Associated with Changes in Neurogenesis after Focal Traumatic Brain Injury in Adult Mice	JOURNAL OF NEUROTRAUMA			English	Article						adult neurogenesis; closed head injury; microglia; minocycline; traumatic brain injury	SPINAL-CORD-INJURY; CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; INTRACEREBRAL HEMORRHAGE; CELLULAR PROLIFERATION; CORTICAL NEUROGENESIS; GLIAL PROLIFERATION	Neurogenesis is stimulated following injury to the adult brain and could potentially contribute to tissue repair. However, evidence suggests that microglia activated in response to injury are detrimental to the survival of new neurons, thus limiting the neurogenic response. The aim of this study was to determine the effect of the anti-inflammatory drug minocycline on neurogenesis and functional recovery after a closed head injury model of focal traumatic brain injury (TBI). Beginning 30 min after trauma, minocycline was administered for up to 2 weeks and bromodeoxyuridine was given on days 1-4 to label proliferating cells. Neurological outcome and motor function were evaluated over 6 weeks using the Neurological Severity Score (NSS) and ledged beam task. Microglial activation was assessed in the pericontusional cortex and hippocampus at 1 week post-trauma, using immunohistochemistry to detect F4/80. Following immunolabeling of bromodeoxyuridine, double-cortin, and NeuN, cells undergoing distinct stages of neurogenesis, including proliferation, neuronal differentiation, neuroblast migration, and long-term survival, were quantified at 1 and 6 weeks in the hippocampal dentate gyrus, as well as in the subventricular zone of the lateral ventricles and the pericontusional cortex. Our results show that minocycline successfully reduced microglial activation and promoted early neurological recovery that was sustained over 6 weeks. We also show for the first time in the closed head injury model, that early stages of neurogenesis were stimulated in the hippocampus and subventricular zone; however, no increase in new mature neurons occurred. Contrary to our hypothesis, despite the attenuation of activated microglia, minocycline did not support neurogenesis in the hippocampus, lateral ventricles, or pericontusional cortex, with none of the neurogenic stages being affected by treatment. These data provide evidence that a general suppression of microglial activation is insufficient to enhance neuronal production, suggesting that further work is required to elucidate the relationship between microglia and neurogenesis after TBI.	[Ng, Si Yun; Semple, Bridgette D.; Morganti-Kossmann, M. Cristina; Bye, Nicole] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Ng, Si Yun; Semple, Bridgette D.; Morganti-Kossmann, M. Cristina; Bye, Nicole] Monash Univ, Dept Surg, Clayton, Vic 3800, Australia		Bye, N (corresponding author), Alfred Hosp, Natl Trauma Res Inst, 4th Floor,Burnet Tower,89 Commercial Rd, Melbourne, Vic 3004, Australia.	nicole.bye@monash.edu		Morganti-Kossmann, Cristina/0000-0002-0807-2063	Victorian Neurotrauma Initiative (VNI); Transport Accident Commission (TAC); Alfred Research Trust; Australian GovernmentAustralian GovernmentCGIAR	This research was supported by the Victorian Neurotrauma Initiative (VNI), Transport Accident Commission (TAC), and Alfred Research Trust, through research grants and fellowships to C. M. K. and N.B., and by the Australian Government through an Australian Postgraduate Award to B. D. S. The authors would like to thank Dr. Iska Carmichael of Monash Micro Imaging (AMREP), for training and assistance with confocal microscopy.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Craig CG, 1996, J NEUROSCI, V16, P2649; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Das S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017225; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Wasserman JK, 2007, BRAIN RES, V1136, P208, DOI 10.1016/j.brainres.2006.12.035; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu JM, 2009, NEUROL RES, V31, P183, DOI 10.1179/174313209X385680; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	66	42	43	0	14	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1410	1425		10.1089/neu.2011.2188			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600015	22260446				2022-02-06	
J	Yeh, DD; Schecter, WP				Yeh, Daniel Dante; Schecter, William P.			Primary Blast Injuries-An Updated Concise Review	WORLD JOURNAL OF SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; TYMPANIC-MEMBRANE PERFORATION; LUNG INJURY; EXPLOSIVE BLAST; CIVILIAN BUS; SURVIVORS; MANAGEMENT; DIAGNOSIS; PATHOLOGY; BOMBINGS	Blast injuries have been increasing in the civilian setting and clinicians need to understand the spectrum of injury and management strategies. Multisystem trauma associated with combined blunt and penetrating injuries is the rule. Explosions in closed spaces increase the likelihood of primary blast injury. Rupture of tympanic membranes is an inaccurate marker for severe primary blast injury. Blast lung injury manifests early and should be managed with lung-protective ventilation. Blast brain injury is more common than previously appreciated.	[Yeh, Daniel Dante] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA; [Schecter, William P.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Surg, San Francisco, CA 94143 USA		Yeh, DD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, 165 Cambridge St 810, Boston, MA 02114 USA.	dyeh2@partners.org					Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; Almogy G, 2005, ARCH SURG-CHICAGO, V140, P390, DOI 10.1001/archsurg.140.4.390; American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bochicchio GV, 2008, AM SURGEON, V74, P267; Braverman I, 2002, ISRAEL MED ASSOC J, V4, P528; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Covey CDC, 2002, J BONE JOINT SURG AM, V84A, P1221, DOI 10.2106/00004623-200207000-00022; Eshkol Z, 2005, INJURY, V36, P271, DOI 10.1016/j.injury.2004.06.016; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; Harrison CD, 2009, J TRAUMA, V67, P210, DOI 10.1097/TA.0b013e3181a5f1db; Hirshberg B, 1999, CHEST, V116, P1683, DOI 10.1378/chest.116.6.1683; Ho AMH, 2002, MED HYPOTHESES, V59, P611, DOI 10.1016/S0306-9877(02)00153-6; HULL JB, 1992, BRIT J SURG, V79, P1303, DOI 10.1002/bjs.1800791220; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Kapur GB, 2005, J TRAUMA, V59, P1436, DOI 10.1097/01.ta.0000197853.49084.3c; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Krohn PL, 1942, LANCET, V1, P252; Leibovici D, 1999, ANN EMERG MED, V34, P168, DOI 10.1016/S0196-0644(99)70225-8; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; MELINEK M, 1976, ISRAEL J MED SCI, V12, P560; Phillips YR, 1991, TXB MILITARY MED 1, P235; Pizov R, 1999, CHEST, V115, P165, DOI 10.1378/chest.115.1.165; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; Sorkine P, 1998, J TRAUMA, V45, P35, DOI 10.1097/00005373-199807000-00006; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tatic V, 1996, J TRAUMA, V40, pS94, DOI 10.1097/00005373-199603001-00022; Weiss YG, 1999, J CLIN ANESTH, V11, P132, DOI 10.1016/S0952-8180(99)00006-9; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	38	42	50	4	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAY	2012	36	5					966	972		10.1007/s00268-012-1500-9			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	943BZ	WOS:000304096700006	22411082				2022-02-06	
J	Farrer, TJ; Frost, RB; Hedges, DW				Farrer, Thomas J.; Frost, R. Brock; Hedges, Dawson W.			Prevalence of Traumatic Brain Injury in Intimate Partner Violence Offenders Compared to the General Population: A Meta-Analysis	TRAUMA VIOLENCE & ABUSE			English	Article						traumatic brain injury; domestic violence; intimate partner violence	BLUNT HEAD-INJURY; DOMESTIC VIOLENCE; AGGRESSIVE-BEHAVIOR; ASSOCIATION; ADJUSTMENT; RELATIVES; SYMPTOMS; COUPLES; CRIME; ABUSE	Intimate partner violence (IPV) is widespread. Several risk factors are associated with IPV perpetuation, including alcohol use and educational level. The aggression and violence associated with traumatic brain injury (TBI) suggest that brain trauma may also be a risk factor for IPV. To examine the association between TBI and IPV, the authors conducted a meta-analysis of peer-reviewed published studies reporting the prevalence of TBI in IPV perpetrators. The authors compared the frequency of TBI among IPV perpetuators to estimates of TBI in the general population using a single-sample test of proportions. Six studies containing a total of 222 subjects met inclusion criteria. Fifty-three percent (119) of the IPV perpetuators had a history of TBI, a prevalence significantly higher (p < .0001) than estimates of TBI in the general population. The prevalence of TBI among perpetuators of IPV appears significantly higher than the prevalence of TBI in the general population. To the extent that this association is causal, TBI may be a risk factor for interpersonal violence, although comparatively few source studies, lack of standardized information about TBI severity, and the inability to investigate potential confounding variables necessarily limit this conclusion.	[Farrer, Thomas J.; Frost, R. Brock; Hedges, Dawson W.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hedges, Dawson W.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA		Farrer, TJ (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT,POB 25543, Provo, UT 84602 USA.	thomasfarrer@yahoo.com		Farrer, Thomas J./0000-0001-8092-6214			Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ellison CG, 1999, J FAM ISSUES, V20, P87, DOI 10.1177/019251399020001005; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Felson RB, 2002, CRIMINOLOGY, V40, P617, DOI 10.1111/j.1745-9125.2002.tb00968.x; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; STRAUS MA, 1986, J MARRIAGE FAM, V48, P465, DOI 10.2307/352033; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Tjaden P, 2000, FULL REPORT PREVALEN; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122	37	42	42	1	28	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8380	1552-8324		TRAUMA VIOLENCE ABUS	Trauma Violence Abus.	APR	2012	13	2					77	82		10.1177/1524838012440338			6	Criminology & Penology; Family Studies; Social Work	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Social Work	951DW	WOS:000304702000002	22467643				2022-02-06	
J	McCranor, BJ; Bozym, RA; Vitolo, MI; Fierke, CA; Bambrick, L; Polster, BM; Fiskum, G; Thompson, RB				McCranor, Bryan J.; Bozym, Rebecca A.; Vitolo, Michele I.; Fierke, Carol A.; Bambrick, Linda; Polster, Brian M.; Fiskum, Gary; Thompson, Richard B.			Quantitative imaging of mitochondrial and cytosolic free zinc levels in an in vitro model of ischemia/reperfusion	JOURNAL OF BIOENERGETICS AND BIOMEMBRANES			English	Article						Zinc; Oxidative stress; Mitochondria; Ischemia; Stroke; Fluorescence biosensor; Ratiometric; Carbonic anhydrase II	CARBONIC-ANHYDRASE; INTRACELLULAR ZINC; CELL-DEATH; ISCHEMIA; APOPTOSIS; OXYGEN; ZN2+; HIPPOCAMPUS; ION; NEURODEGENERATION	The role of zinc ion in cytotoxicity following ischemic stroke, prolonged status epilepticus, and traumatic brain injury remains controversial, but likely is the result of mitochondrial dysfunction. We describe an excitation ratiometric fluorescence biosensor based on human carbonic anhydrase II variants expressed in the mitochondrial matrix, permitting free zinc levels to be quantitatively imaged therein. We observed an average mitochondrial matrix free zinc concentration of 0.2 pM in the PC12 rat pheochromacytoma cell culture line. Cytoplasmic and mitochondrial free zinc levels were imaged in a cellular oxygen glucose deprivation (OGD) model of ischemia/reperfusion. We observed a significant increase in mitochondrial zinc 1 h following 3 h OGD, at a time point when cytosolic zinc levels were depressed. Following the increase, mitochondrial zinc levels returned to physiological levels, while cytosolic zinc increased gradually over a 24 h time period in viable cells. The increase in intramitochondrial zinc observed during reoxygenation after OGD may contribute to bioenergetic dysfunction and cell death that occurs with both in vitro and in vivo models of reperfusion.	[McCranor, Bryan J.; Bozym, Rebecca A.; Vitolo, Michele I.; Thompson, Richard B.] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Vitolo, Michele I.] Univ Maryland, Univ Maryland Marlene & Stewart Greenebaum NIH Ca, Baltimore, MD 21201 USA; [Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Bambrick, Linda; Polster, Brian M.; Fiskum, Gary] Univ Maryland Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Bambrick, Linda; Polster, Brian M.; Fiskum, Gary] Univ Maryland Sch Med, Ctr Shock Trauma & Anesthesiol Res, Baltimore, MD 21201 USA		Thompson, RB (corresponding author), Univ Maryland Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	rthompso@umaryland.edu		Polster, Brian/0000-0003-2571-7510; Vitolo, Michele/0000-0001-8055-9645; McCranor, Bryan/0000-0002-1573-5793	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIBIB RO1 EB03924, NINDS RO1 NS064978]; Susan G. Komen Breast Cancer FoundationSusan G. Komen Breast Cancer Foundation [PDF 0601045]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB003924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064978] Funding Source: NIH RePORTER	The authors gratefully acknowledge the National Institutes of Health (NIBIB RO1 EB03924 (R. B. T., B.J.M., R. A. B., C. A. F.); PO1 HD16596-25 (G. F., L. H.); NINDS RO1 NS064978 (B. M. P.) and the Susan G. Komen Breast Cancer Foundation (PDF 0601045 (M. I. V.) for their support. The fluorescence sensing technology was originally developed with support from the Office of Naval Research.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Ayaz M, 2006, AM J PHYSIOL-HEART C, V290, pH1071, DOI 10.1152/ajpheart.00754.2005; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Bozym R, 2008, METHOD ENZYMOL, V450, P287, DOI 10.1016/S0076-6879(08)03414-9; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Caporale T, 2009, EXP NEUROL, V218, P228, DOI 10.1016/j.expneurol.2009.04.003; Danilov CA, 2008, GLIA, V56, P801, DOI 10.1002/glia.20655; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Fierke CA, 2001, BIOMETALS, V14, P205, DOI 10.1023/A:1012980628412; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Galasso SL, 2007, MOL MED, V13, P380, DOI 10.2119/2007-00044.Galasso; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Gazaryan IG, 2007, J BIOL CHEM, V282, P24373, DOI 10.1074/jbc.M611376200; Haase H, 2011, ZINC HUMAN HLTH; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Huang CC, 1996, BIOCHEMISTRY-US, V35, P3439, DOI 10.1021/bi9526692; Hunt JA, 1999, BIOCHEMISTRY-US, V38, P9054, DOI 10.1021/bi9900166; Hurst TK, 2010, BBA-PROTEINS PROTEOM, V1804, P393, DOI 10.1016/j.bbapap.2009.09.031; Hyun HJ, 2001, INVEST OPHTH VIS SCI, V42, P460; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Jiang ZG, 2006, P NATL ACAD SCI USA, V103, P1581, DOI 10.1073/pnas.0510573103; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; LINDSKOG S, 1971, ENZYMES, V5, P587; Masanta G, 2011, J AM CHEM SOC, V133, P5698, DOI 10.1021/ja200444t; McCall KA, 2004, BIOCHEMISTRY-US, V43, P3979, DOI 10.1021/bi0498914; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; PECK EJ, 1971, J BIOL CHEM, V246, P1160; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; PRASAD AS, 1968, J LAB CLIN MED, V72, P1006; Qin Y, 2011, P NATL ACAD SCI USA, DOI [10.1037/pnas.1015686108, DOI 10.1037/PNAS.1015686108]; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Rudolf E, 2010, BIOMETALS, V23, P339, DOI 10.1007/s10534-010-9302-8; Sensi SL, 2003, CELL CALCIUM, V34, P281, DOI 10.1016/S0143-4160(03)00122-2; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Soane L, 2010, APOPTOSIS PHYSL PATH; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Stumm W., 1996, AQUATIC CHEM CHEM EQ, V3rd; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TELFORD WG, 1995, J CELL PHYSIOL, V164, P259, DOI 10.1002/jcp.1041640206; Thompson RB, 2000, J NEUROSCI METH, V96, P35, DOI 10.1016/S0165-0270(99)00183-1; Thompson RB, 2002, J NEUROSCI METH, V118, P63, DOI 10.1016/S0165-0270(02)00144-9; Thompson RB, 2002, J BIOMED OPT, V7, P555, DOI 10.1117/1.1501886; Thompson RB, 2012, METAL IONS STROKE, DOI [10.1007/978-1-4419-9663-3_9, DOI 10.1007/978-1-4419-9663-3_9]; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; van Dongen EMWM, 2007, J AM CHEM SOC, V129, P3494, DOI 10.1021/ja069105d; Wang D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3613926; WARING P, 1990, INT J IMMUNOPHARMACO, V12, P445, DOI 10.1016/0192-0561(90)90028-L; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; ZALEWSKI PD, 1991, BIOCHEM INT, V24, P1093; Zeng HH, 2005, PROC SPIE, V5692, P51, DOI 10.1117/12.614168	64	42	43	0	23	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0145-479X	1573-6881		J BIOENERG BIOMEMBR	J. Bioenerg. Biomembr.	APR	2012	44	2					253	263		10.1007/s10863-012-9427-2			11	Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Cell Biology	920NG	WOS:000302411200002	22430627	Green Accepted			2022-02-06	
J	Singh, P; Doshi, S; Spaethling, JM; Hockenberry, AJ; Patel, TP; Geddes-Klein, DM; Lynch, DR; Meaney, DF				Singh, Pallab; Doshi, Shachee; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Lynch, David R.; Meaney, David F.			N-Methyl-D-aspartate Receptor Mechanosensitivity Is Governed by C Terminus of NR2B Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NR2B-CONTAINING NMDA RECEPTORS; EXCITATORY AMINO-ACIDS; IN-VITRO; DIFFERENTIAL ROLES; SIGNALING PATHWAYS; DISTINCT ROLES; NEURONAL DEATH; NR1 SUBUNIT; CELL-DEATH	N-Methyl-D-aspartate receptors (NMDARs), critical mediators of both physiologic and pathologic neurological signaling, have previously been shown to be sensitive to mechanical stretch through the loss of its native Mg2+ block. However, the regulation of this mechanosensitivity has yet to be further explored. Furthermore, as it has become apparent that NMDAR-mediated signaling is dependent on specific NMDAR subtypes, as governed by the identity of the NR2 subunit, a crucial unanswered question is the role of subunit composition in observed NMDAR mechanosensitivity. Here, we used a recombinant system to assess the mechanosensitivity of specific subtypes and demonstrate that the mechanosensitive property is uniquely governed by the NR2B subunit. NR1/NR2B NMDARs displayed significant stretch sensitivity, whereas NR1/NR2A NMDARs did not respond to stretch. Furthermore, NR2B mechanosensitivity was regulated by PKC activity, because PKC inhibition reduced stretch responses in transfected HEK 293 cells and primary cortical neurons. Finally, using NR2B point mutations, we identified a PKC phosphorylation site, Ser-1323 on NR2B, as a unique critical regulator of stretch sensitivity. These data suggest that the selective mechanosensitivity of NR2B can significantly impact neuronal response to traumatic brain injury and illustrate that the mechanical tone of the neuron can be dynamically regulated by PKC activity.	[Doshi, Shachee; Lynch, David R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19194 USA; [Lynch, David R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Singh, Pallab; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Patel, Tapan/0000-0001-8959-6645; Meaney, David/0000-0002-0954-4122; Hockenberry, Adam/0000-0001-9476-0104	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD41699, NS35712, NS015212]; U.S. Department of DefenseUnited States Department of Defense [W911NF-10-1-0526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035712, R01NS015212] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants HD41699, NS35712, and NS015212. This work was also supported by a U.S. Department of Defense Grant W911NF-10-1-0526.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BOECKMAN FA, 1994, NEUROSCI LETT, V173, P189, DOI 10.1016/0304-3940(94)90180-5; Boeckman FA, 1996, J PHARMACOL EXP THER, V279, P515; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 1998, J NEUROSCI, V18, P720; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Grant ER, 1998, J NEUROCHEM, V71, P1471; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kohr G, 2003, J NEUROSCI, V23, P10791; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuda S, 1999, NEUROSCI RES, V34, P157, DOI 10.1016/S0168-0102(99)00046-2; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Rao VLR, 2001, BRAIN RES, V911, P96; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tovar KR, 1999, J NEUROSCI, V19, P4180; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	75	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4348	4359		10.1074/jbc.M111.253740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	WOS:000300410900065	22179603	Green Published, hybrid			2022-02-06	
J	Heather, NL; Jefferies, C; Hofman, PL; Derraik, JGB; Brennan, C; Kelly, P; Hamill, JKM; Jones, RG; Rowe, DL; Cutfield, WS				Heather, Natasha L.; Jefferies, Craig; Hofman, Paul L.; Derraik, Jose G. B.; Brennan, Christine; Kelly, Patrick; Hamill, James K. M.; Jones, Rhys G.; Rowe, Deborah L.; Cutfield, Wayne S.			Permanent Hypopituitarism Is Rare after Structural Traumatic Brain Injury in Early Childhood	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE RESPONSE; BODY-MASS INDEX; PITUITARY-FUNCTION; YOUNG-CHILDREN; HEAD-INJURIES; COMA SCALE; CONSENSUS GUIDELINES; DYSFUNCTION; ADOLESCENTS	Background: Wesought to determine the incidence of permanent hypopituitarism in a potentially high-risk group: young children after structural traumatic brain injury (TBI). Methods: We conducted a cross-sectional study with longitudinal follow-up. Dynamic tests of pituitary function (GH and ACTH) were performed in all subjects and potential abnormalities critically evaluated. Puberty was clinically staged; baseline thyroid function, prolactin, IGF-I, serum sodium, and osmolality were compared with age-matched data. Diagnosis of GH deficiency was based on an integrated assessment of stimulated GH peak (<5 mu g/liter suggestive of deficiency), IGF-I, and growth pattern. ACTH deficiency was diagnosed based on a subnormal response to two serial Synacthen tests (peak cortisol <500 nmol/liter) and a metyrapone test. Results: We studied 198 survivors of structural TBI sustained in early childhood (112 male, age at injury 1.7 +/- 1.5 yr) 6.5 +/- 3.2 yr after injury. Sixty-four of the injuries (33%) were inflicted and 134 (68%) accidental. Two participants had developed precocious puberty, which is within the expected background population rate. Peak stimulated GH was subnormal in 16 participants (8%), in the context of normal IGF-I and normal growth. Stimulated peak cortisol was low in 17 (8%), but all had normal ACTH function on follow-up. One participant had a transient low serum T-4. Therefore, no cases of hypopituitarism were recorded. Conclusion: Permanenthypopituitarism is rare after both inflicted and accidental structural TBI in early childhood. Precocious puberty was the only pituitary hormone abnormality found, but the prevalence did not exceed that of the normal population. (J Clin Endocrinol Metab 97: 599-604, 2012)	[Heather, Natasha L.; Hofman, Paul L.; Derraik, Jose G. B.; Brennan, Christine; Rowe, Deborah L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Jones, Rhys G.] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1020, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1020, New Zealand; [Jefferies, Craig; Kelly, Patrick; Hamill, James K. M.] Starship Childrens Hosp, Auckland Dist Hlth Board, Auckland 1142, New Zealand		Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland, New Zealand.	w.cutfield@auckland.ac.nz	Jefferies, craig/ABA-1921-2021; Derraik, Jose Guilherme Behrensdorf/A-1925-2008; Heather, Natasha/AAV-8425-2020	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094	Health Research Council of New ZealandHealth Research Council of New Zealand; Australasian Pediatric Endocrine Group; Starship Fellowship Foundation	The study was supported by grants from the Health Research Council of New Zealand and the Australasian Pediatric Endocrine Group. N.L.H. was supported by the Starship Fellowship Foundation.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Association for the Advancement of Automatic Medicine, 2001, ABBR INJ SCAL; Barth JH, 2008, ANN CLIN BIOCHEM, V45, P598, DOI 10.1258/acb.2008.008074; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Berneis K, 2002, J CLIN ENDOCR METAB, V87, P5470, DOI 10.1210/jc.2001-011959; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dusick JR, 2008, PITUITARY       0515, DOI [10.1007/s11102-008-0130-6, DOI 10.1007/S11102-008-0130-6]; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Loche S, 2011, CLIN ENDOCRINOL, V74, P726, DOI 10.1111/j.1365-2265.2011.03988.x; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; TASSONI P, 1990, J CLIN ENDOCR METAB, V71, P230, DOI 10.1210/jcem-71-1-230; TEASDALE G, 1974, LANCET, V2, P81; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012	35	42	44	0	4	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	FEB	2012	97	2					599	604		10.1210/jc.2011-2284			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	904VP	WOS:000301226800057	22090267	Bronze			2022-02-06	
J	Campbell, JN; Register, D; Churn, SB				Campbell, John N.; Register, David; Churn, Severn B.			Traumatic Brain Injury Causes an FK506-Sensitive Loss and an Overgrowth of Dendritic Spines in Rat Forebrain	JOURNAL OF NEUROTRAUMA			English	Article						calcineurin; cofilin; epilepsy; epileptogenesis; traumatic brain injury	LONG-TERM DEPRESSION; IN-VIVO; AREA CA1; GLUTAMATE; SYNAPTOGENESIS; NEURONS; MODEL; POLO-LIKE-KINASE-2; DEPHOSPHORYLATION; HYPEREXCITABILITY	Traumatic brain injury (TBI) causes both an acute loss of tissue and a progressive injury through reactive processes such as excitotoxicity and inflammation. These processes may worsen neural dysfunction by altering neuronal circuitry beyond the focally-damaged tissue. One means of circuit alteration may involve dendritic spines, micron-sized protuberances of dendritic membrane that support most of the excitatory synapses in the brain. This study used a modified Golgi-Cox technique to track changes in spine density on the proximal dendrites of principal cells in rat forebrain regions. Spine density was assessed at 1 h, 24h, and 1 week after a lateral fluid percussion TBI of moderate severity. At 1 h after TBI, no changes in spine density were observed in any of the brain regions examined. By 24h after TBI, however, spine density had decreased in ipsilateral neocortex in layer and III and dorsal dentate gyrus (dDG). This apparent loss of spines was prevented by a single, post-injury administration of the calcineurin inhibitor FK506. These results; together with those of a companion study, indicate an FK506-sensitive mechanism of dendritic spine loss in the TBI model. Furthermore, by 1 week after TBI, spine density had increased substantially above control levels, bilaterally in CA1 and CA3 and ipsilaterally in dDG. The apparent overgrowth of spines in CA1 is of particular interest, as it may explain previous reports of abnormal and potentially epileptogenic activity in this brain region.	[Campbell, John N.; Churn, Severn B.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Register, David; Churn, Severn B.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; [Churn, Severn B.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Churn, SB (corresponding author), Virginia Commonwealth Univ, Dept Anat, POB 980599, Richmond, VA 23298 USA.	schurn@vcu.edu			Commonwealth Neurotrauma Initiative [07-302E]	This research was funded by a grant from the Commonwealth Neurotrauma Initiative (#07-302E) to S.B.C. The authors gratefully acknowledge Dr. Robert Hamm for the use of the fluid percussion injury device, Dr. M. Alex Meredith for the use of the microscope and Neurolucida system, and Dr. John Povlishock for the use of the vibratome.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; ANDERSON KJ, 1986, J COMP NEUROL, V252, P374, DOI 10.1002/cne.902520306; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Campbell J.N., 2011, J NEUROTRAUMA; Campbell JN, 2009, DENDRITIC SPINES: BIOCHEMISTRY, MODELING AND PROPERTIES, P45; Cesa R, 2005, EUR J NEUROSCI, V22, P579, DOI 10.1111/j.1460-9568.2005.04244.x; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Corbett D, 2006, EXP NEUROL, V202, P133, DOI 10.1016/j.expneurol.2006.05.020; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Halpain S, 1998, J NEUROSCI, V18, P9835; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hausser, 2008, DENDRITES, P1, DOI 10.1093/acprof:oso/9780198566564.003.0001; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Isokawa M, 2000, EPILEPSIA, V41, pS14, DOI 10.1111/j.1528-1157.2000.tb01550.x; JONES EG, 1969, J CELL SCI, V5, P509; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Monfils MH, 2004, SYNAPSE, V53, P114, DOI 10.1002/syn.20039; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shao LR, 2005, J NEUROPHYSIOL, V93, P3007, DOI 10.1152/jn.00877.2004; Spires-Jones TL, 2011, NEUROSCI LETT, V487, P260, DOI 10.1016/j.neulet.2010.10.033; Spruston N., 2007, HIPPOCAMPUS BOOK, P133; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu LX, 2007, BRAIN RES, V1168, P38, DOI 10.1016/j.brainres.2007.06.082; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	56	42	42	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					201	217		10.1089/neu.2011.1761			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300002	21517673				2022-02-06	
J	Menon, K; Ward, RE; Gaboury, I; Thomas, M; Joffe, A; Burns, K; Cook, D				Menon, Kusum; Ward, Roxanne E.; Gaboury, Isabelle; Thomas, Margot; Joffe, Ari; Burns, Karen; Cook, Deborah			Factors affecting consent in pediatric critical care research	INTENSIVE CARE MEDICINE			English	Article						Ethics; Consent; Informed consent; Pediatric critical care	TRAUMATIC BRAIN-INJURY; INFORMED-CONSENT; CLINICAL-RESEARCH; CHALLENGES; EMERGENCY; HEPARIN; INFANTS; TRIALS	Consent for research is a difficult and unpredictable process in pediatric critical care populations. The objectives of this study were to describe consent rates in pediatric critical care research and their association with patient, legal guardian, consent process, and study design-related factors. A prospective, cohort study was conducted from 2009 to 2010 in six tertiary care pediatric intensive care units (PICU) in Canada with legal guardians of patients who were approached for consent for any ongoing PICU research study. Data were recorded on details of the consent process for all consent encounters. We recorded 271 consent encounters. The overall consent rate was 80.1% (217/271). We observed higher consent rates when the research assistant was introduced by a member of the clinical team prior to approaching the family (89.7 vs. 77.7%; P = 0.04). Legal guardians of cardiac surgery patients were less likely to provide consent than those of all other patients (75.3 vs. 86.0%; P = 0.03). There was no difference in consent rates between therapeutic (117/145, 80.7%) versus non-therapeutic studies (100/126, 79.4%; P = 0.88). This study provides future researchers with consent data for determination of recruitment rates, sample sizes, budget estimations, and study timelines. Future pediatric critical care studies should consider incorporating the lower consent rates in cardiac surgery patients and routine introduction of the research assistant to the family by a member of the patient's care team into their study designs. The potential influence of parental factors on consent rates in pediatric critical care studies requires further research.	[Menon, Kusum] Childrens Hosp Eastern Ontario, Pediat Intens Care Unit, Ottawa, ON K1S 3H2, Canada; [Menon, Kusum] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Menon, Kusum; Ward, Roxanne E.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1S 3H2, Canada; [Gaboury, Isabelle] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Joffe, Ari] Univ Alberta, Stollery Childrens Hosp, John Dossetor Hlth Eth Ctr, Edmonton, AB, Canada; [Burns, Karen] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Cook, Deborah] McMaster Univ Hlth Sci, Hamilton, ON, Canada		Menon, K (corresponding author), Childrens Hosp Eastern Ontario, Pediat Intens Care Unit, 401 Smyth Rd, Ottawa, ON K1S 3H2, Canada.	menon@cheo.on.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This study was funded by the Canadian Institutes of Health Research (CIHR).	Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Breslow N E, 1987, IARC Sci Publ, P1; Choong K, 2009, AM J RESP CRIT CARE, V180, P632, DOI 10.1164/rccm.200902-0221OC; Flagel D C, 2000, IRB, V22, P1, DOI 10.2307/3564220; Glickman SW, 2008, ANN EMERG MED, V51, P775, DOI 10.1016/j.annemergmed.2007.11.002; Gruenwald CE, 2010, J AM COLL CARDIOL, V56, P1794, DOI 10.1016/j.jacc.2010.06.046; Hoehn KS, 2005, ARCH DIS CHILD-FETAL, V90, P267, DOI 10.1136/adc.2004.065078; Huckabay L M, 1999, Dimens Crit Care Nurs, V18, P36, DOI 10.1097/00003465-199903000-00009; Hulst JM, 2005, INTENS CARE MED, V31, P880, DOI 10.1007/s00134-005-2647-8; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; LaMontagne L L, 1994, Clin Nurs Res, V3, P104, DOI 10.1177/105477389400300204; Menon K, 2010, AM J RESP CRIT CARE, V182, P246, DOI 10.1164/rccm.200911-1738OC; Morris MC, 2007, J PEDIATR-US, V151, P532, DOI 10.1016/j.jpeds.2007.04.032; Morris MC, 2006, CRIT CARE MED, V34, P2567, DOI 10.1097/01.CCM.0000239115.76603.55; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Pierro A, 1997, LANCET, V349, P1703, DOI 10.1016/S0140-6736(05)62681-5; Sammons Helen M, 2007, BMC Pediatr, V7, P12, DOI 10.1186/1471-2431-7-12; Schroeder AR, 2010, PEDIATR CRIT CARE ME, V11, P489, DOI 10.1097/PCC.0b013e3181ce6e29; Simon CM, 2004, J CLIN ONCOL, V22, P2708, DOI 10.1200/JCO.2004.10.034; Singhal Nalini, 2002, J Perinatol, V22, P57, DOI 10.1038/sj.jp.7210608; Sturdivant L, 2009, CRIT CARE NURS Q, V32, P149, DOI 10.1097/CNQ.0b013e3181a27f6d; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; WALTERSPIEL JN, 1990, PEDIATRICS, V85, P119; Zupancic JAF, 1997, PEDIATRICS, V99, pE61	27	42	42	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JAN	2012	38	1					153	159		10.1007/s00134-011-2412-0			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858YM	WOS:000297839600022	22120768	Bronze			2022-02-06	
J	Robinson, RJ; Bhuta, S				Robinson, Richard J.; Bhuta, Sandeep			Susceptibility-Weighted Imaging of the Brain: Current Utility and Potential Applications	JOURNAL OF NEUROIMAGING			English	Article						Susceptibility-Weighted Imaging; Cerebrovascular disease; Traumatic brain injury; Venous Sinus Thrombosis; Minimum Intensity Projection; Cerebrospinal fluid; Fluid attenuated inversion recovery; Magnetic Resonance Imaging; Diffuse axonal injury; Computed Tomography; Subdural Hematoma; Subarachnoid Hemorrhage; Cerebral amyloid angiopathy; Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; Developmental Venous Anomalies; Neurodegeneration with brain iron accumulation; Pantothenate kinase associated neurodegeneration; Multiple Sclerosis; Glioblastoma Multiforme; World Health Organization	CEREBRAL AMYLOID ANGIOPATHY; DIFFUSE AXONAL INJURY; MRI; CHILDREN; LESIONS	BACKGROUND AND PURPOSE Susceptibility-Weighted Imaging (SWI) is a relatively new magnetic resonance imaging (MRI) sequence relying on susceptibility differences between adjacent tissues to produce an image. It is extremely sensitive for detection of blood products (hemosiderin, ferritin), deoxygenated blood, calcium, iron, and small vein depiction. Little information is available in the literature to describe common findings seen using this imaging sequence. This article is an comprehensive review of appearances across the spectrum of brain pathology encountered in routine clinical practice. MATERIALS AND METHODS A retrospective review of 400 MRI Brain examinations was performed by one fellowship trained Neuroradiologist with 5 years experience (SB) and one general radiologist (RR). Agreement was by consensus observing normal and pathological imaging features seen in SWI sequences. RESULTS Results are presented as a comprehensive pictorial review highlighting the key imaging findings observed and new directions using SWI. CONCLUSION SWI is an extremely useful adjunct to current MRI sequences of the brain and is advocated for inclusion into routine Neuroimaging protocols.	[Robinson, Richard J.; Bhuta, Sandeep] Griffith Univ, Sch Med, Gold Coast Hosp, Dept Med Imaging, Gold Coast, Qld 4215, Australia		Bhuta, S (corresponding author), Griffith Univ, Sch Med, Gold Coast Hosp, Dept Med Imaging, 108 Nerang St, Gold Coast, Qld 4215, Australia.	sandeepbhuta@gmail.com	S, Bhuta/H-5454-2019	S, Bhuta/0000-0002-7292-9658			Adachi M, 1999, AM J NEURORADIOL, V20, P1500; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Boukobza M, 2009, AM J NEURORADIOL, V30, P344, DOI 10.3174/ajnr.A1332; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cooper AD, 2008, NEUROLOGY, V71, P382, DOI 10.1212/01.wnl.0000319659.86629.c8; de Souza JM, 2008, AM J NEURORADIOL, V29, P154, DOI 10.3174/ajnr.A0748; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Duncan IC, 2005, AM J ROENTGENOL, V184, P1317, DOI 10.2214/ajr.184.4.01841317; Erdag N, 2001, AM J ROENTGENOL, V176, P1319, DOI 10.2214/ajr.176.5.1761319; Fushimi Y, 2010, J NEUROIMAGING, V20, P255, DOI 10.1111/j.1552-6569.2008.00348.x; Gao TL, 2008, NEUROL RES, V30, P272, DOI 10.1179/016164107X251556; Ghostine S, 2009, NEUROPATH APPL NEURO, V35, P116, DOI 10.1111/j.1365-2990.2008.00976.x; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; HAIMES AB, 1989, AM J ROENTGENOL, V152, P1073, DOI 10.2214/ajr.152.5.1073; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Kesavadas C, 2008, AJNR Am J Neuroradiol, V29, pe71, DOI 10.3174/ajnr.A1083; Kim HS, 2009, AJNR AM J NEURORADIO; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Pinker K, 2007, AM J NEURORADIOL, V28, P1280, DOI 10.3174/ajnr.A0540; Rauscher A, 2005, AM J NEURORADIOL, V26, P736; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617	26	42	48	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	OCT	2011	21	4					E189	E204		10.1111/j.1552-6569.2010.00516.x			16	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	834OF	WOS:000295970700001	21281380				2022-02-06	
J	Catroppa, C; Anderson, V; Godfrey, C; Rosenfeld, JV				Catroppa, Cathy; Anderson, Vicki; Godfrey, Celia; Rosenfeld, Jeffrey V.			Attentional skills 10 years post-paediatric traumatic brain injury (TBI)	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; attentional outcome	HEAD-INJURY; SUSTAINED ATTENTION; SELF-REGULATION; FRONTAL LOBES; CHILDREN; CHILDHOOD; TERM; RECOVERY; SEVERITY; DEFICITS	Objective: To date no study has reported findings regarding attentional deficits following pre-school paediatric traumatic brain injury (TBI), as long as 10 years post-injury. It was predicted that more severe TBI would be associated with generalized deficits at 10 years post-TBI, particularly for skills not mastered at time of injury. Research design: The sample comprised 40 prospectively-recruited children (42%% of the original sample) who had sustained a mild, moderate or severe traumatic brain injury (TBI) between the ages of 1--7 years and 19 non-injured control participants. Children were assessed 10 years post-TBI, with a focus on measures of attentional ability. Outcomes/results: While attentional deficits were not evident across all components of attentional ability, both early- and later-established attention skills were compromised, particularly following severe TBI. Environmental predictors were generally not successful predictors of attentional outcome at 10 years post-TBI. Age at injury and acute IQ were identified as contributing to attention at 10 years. Conclusions/implications: The present study shows that attentional deficits do occur and persist to 10 years following serious TBI. Clinicians may be able to screen for such deficits and so intervene in order to prevent or lessen the consequences of such difficulties.	[Catroppa, Cathy] Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; [Catroppa, Cathy; Anderson, Vicki; Godfrey, Celia] Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic 3010, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Melbourne, Vic 3004, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021; Rosenfeld, Jeffrey V/B-7249-2011	Catroppa, Cathy/0000-0002-9750-0436; 			Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 2013, STAT POWER ANAL BEHA; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Daniel A., 1983, POWER PRIVILEGE PRES; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 1995, TRAUMATIC HEAD INJUR; Dennis M, 1989, CLIN NEUOROPSYCHOLOG; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Goldstein FC, 1992, COGNITIVE DISORDERS; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; KAIL R, 1986, CHILD DEV, V57, P969, DOI 10.1111/j.1467-8624.1986.tb00259.x; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Lachar D., 1992, PERSONALITY INVENTOR; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Manly T., 1999, TEST EVERYDAY ATTENT; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Noller P, 1988, ICPS FAMILY FU UNPUB; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Rebok GW, 1997, CHILD NEUROPSYCHOL, V3, P28, DOI 10.1080/09297049708401366; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Stuss DT, 1995, STRUCTURE FUNCTION H; Taylor GH, 1992, ADV CLIN NEUROPSYCHO, V1, P50; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Van Heughten CM, 2008, BRAIN INJURY, V20, P895; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	68	42	42	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					858	869		10.3109/02699052.2011.589794			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300006	21714623				2022-02-06	
J	Marfia, G; Madaschi, L; Marra, F; Menarini, M; Bottai, D; Formenti, A; Bellardita, C; Di Giulio, AM; Carelli, S; Gorio, A				Marfia, Giovanni; Madaschi, Laura; Marra, Francesca; Menarini, Mauro; Bottai, Daniele; Formenti, Alessandro; Bellardita, Carmelo; Di Giulio, Anna Maria; Carelli, Stephana; Gorio, Alfredo			Adult neural precursors isolated from post mortem brain yield mostly neurons: An erythropoietin-dependent process	NEUROBIOLOGY OF DISEASE			English	Article						Adult neural progenitors; Erythropoietin; Gene regulation; Hypoxia- inducible factor-1 (HIF-1); mTOR; Neural plasticity	HYPOXIA-INDUCIBLE FACTOR; SPINAL-CORD-INJURY; GATED CALCIUM-CHANNELS; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; SUBVENTRICULAR ZONE; NEUROLOGICAL FUNCTION; ISCHEMIC TOLERANCE; PROGENITOR CELLS; GROWTH-FACTOR	This study was aimed at the isolation of neural precursor cells (NPCs) capable of resisting to a prolonged ischemic insult as this may occur at the site of traumatic and ischemic CNS injuries. Adult mice were anesthetized and then killed by cervical dislocation. The cadavers were maintained at room temperature or at 4 degrees C for different time periods. Post mortem neural precursors (PM-NPCs) were isolated, grown in vitro and their differentiation capability was investigated by evaluating the expression of different neuronal markers. PM-NPCs differentiate mostly in neurons, show activation of hypoxia-inducible factor-1 and MAPK, and express both erythropoietin (EPO) and its receptor ( EPO-R). The exposure of PM-NPCs to neutralizing antibodies to EPO or EPO-R dramatically reduced the extent of neuronal differentiation to about 11% of total PM-NPCs. The functionality of mTOR and MAPK is also required for the expression of the neuronal phenotype by PM-NPCs. These results suggest that PM-NPCs can be isolated from animal cadaver even several hours after death and their self-renewable capability is comparable to normal neural precursors. Differently, their ability to achieve a neural phenotype is superior to that of NPCs, and this is mediated by the activation of hypoxia-induced factor 1 and EPO signaling. PM-NPCs may represent good candidates for transplantation studies in animal models of neurodegenerative diseases. (C) 2011 Elsevier Inc. All rights reserved.	[Marfia, Giovanni; Madaschi, Laura; Marra, Francesca; Bottai, Daniele; Di Giulio, Anna Maria; Carelli, Stephana; Gorio, Alfredo] Univ Milan, Dept Med Surg & Dent, Pharmacol Lab, Milan, Italy; [Menarini, Mauro] Osped Montecatone, Bologna, Italy; [Formenti, Alessandro; Bellardita, Carmelo] Univ Milan, Sch Med, Dept Human Physiol, I-20122 Milan, Italy; [Carelli, Stephana; Gorio, Alfredo] IRCCS Humanitas, Clin Pharmacol, Milan, Italy		Gorio, A (corresponding author), Univ Milan, Dept Med Surg & Dent, Pharmacol Lab, Via A di Rudini 8, Milan, Italy.	alfredo.gorio@unimi.it	Bottai, Daniele/O-2586-2017; Formenti, Alessandro/F-7013-2011; Marfia, Giovanni/N-4650-2014; Bellardita, Carmelo/N-5467-2019; Carelli, Stephana/AAB-2365-2021; Marfia, Giovanni/AAB-8702-2020	Bottai, Daniele/0000-0002-7951-9512; Marfia, Giovanni/0000-0002-5849-7000; Bellardita, Carmelo/0000-0001-6198-243X; Carelli, Stephana/0000-0003-4603-396X; Marfia, Giovanni/0000-0002-5849-7000; Di Giulio, Anna Maria/0000-0002-5702-4623	Fondazione Montecatone; PRINMinistry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)	This work was supported in part by a grant from Fondazione Montecatone and PRIN 2005 to Alfredo Gorio.	Adelman D M, 2002, Methods Mol Biol, V185, P55; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Arnhold S, 2000, INT J DEV NEUROSCI, V18, P201, DOI 10.1016/S0736-5748(99)00089-1; Baer K, 2007, EXP NEUROL, V204, P828, DOI 10.1016/j.expneurol.2006.12.008; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Bottai D, 2008, MOL MED, V14, P634, DOI 10.2119/2008-00077.Bottai; Bottai D, 2010, EXP NEUROL, V223, P452, DOI 10.1016/j.expneurol.2010.01.010; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Carelli S, 2007, MOL MED, V13, P166, DOI 10.2119/2006-00091.Carelli; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Cino I, 2008, BBA-BIOMEMBRANES, V1778, P2437, DOI 10.1016/j.bbamem.2008.07.006; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Fricker-Gates RA, 2006, NEUROREPORT, V17, P1081, DOI 10.1097/01.wnr.0000230505.32726.65; Goetz M, 1998, TRENDS NEUROSCI, V21, P135, DOI 10.1016/S0166-2236(98)01228-4; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hoge RD, 2001, J CHEM NEUROANAT, V22, P43, DOI 10.1016/S0891-0618(01)00114-4; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Lesma E, 2005, AM J PATHOL, V167, P1093, DOI 10.1016/S0002-9440(10)61198-4; Lesma E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003558; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Mottet D, 2002, ANN NY ACAD SCI, V973, P448, DOI 10.1111/j.1749-6632.2002.tb04681.x; Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Park MH, 2006, BIOCHEM BIOPH RES CO, V339, P1021, DOI 10.1016/j.bbrc.2005.10.218; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Pong K, 2004, EXPERT OPIN THER TAR, V8, P125, DOI 10.1517/eott.8.2.125.30244; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Studer L, 2000, J NEUROSCI, V20, P7377; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Verdier F, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wu LY, 2008, NEUROCHEM RES, V33, P2118, DOI 10.1007/s11064-008-9728-3; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	60	42	44	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	JUL	2011	43	1			SI		86	98		10.1016/j.nbd.2011.02.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	771RZ	WOS:000291179700012	21324364				2022-02-06	
J	Phelan, SM; Griffin, JM; Hellerstedt, WL; Sayer, NA; Jensen, AC; Burgess, DJ; van Ryn, M				Phelan, Sean M.; Griffin, Joan M.; Hellerstedt, Wendy L.; Sayer, Nina A.; Jensen, Agnes C.; Burgess, Diana J.; van Ryn, Michelle			Perceived stigma, strain, and mental health among caregivers of veterans with traumatic brain injury	DISABILITY AND HEALTH JOURNAL			English	Article						Social stigma; Brain injuries; Caregivers; Mental health; Social isolation; Veterans	SOCIAL SUPPORT; FAMILY CAREGIVERS; PSYCHOLOGICAL DISTRESS; LIFE SATISFACTION; BURDEN; ILLNESS; STRESS; DISCRIMINATION; INDIVIDUALS; DEPRESSION	Background: Family caregivers of individuals with stigmatized conditions can experience stigma-by-association and discrimination. Moderate-to-severe traumatic brain injury (TB!) may elicit a stigma response if there are visible physical or neurobehavioral effects of the injury. Stigma is a considerable source of stress and may contribute to caregiver strain and stress-related mental health outcomes. We measured the frequency of perceived stigma and discrimination among caregivers of veterans with TBI and examined whether perceived stigma and discrimination are associated with caregiver strain, social isolation, depression, and anxiety. Methods: Seventy caregivers of veterans with TBI completed a mailed survey that assessed perceptions of discrimination toward themselves or their care recipient, stigma associated with caregiving, and whether they felt the need to cover up or provide an explanation for their care recipient's injury. Caregiver strain, social isolation, depression, and anxiety were also assessed via the questionnaire. Multivariate linear regression was used to test the associations between stigma and discrimination measures and outcomes, controlling for potential confounders and other caregiver or care recipient characteristics. Results: Both perceptions of caregiver discrimination and stigma associated with caregiving were significantly associated with caregiver strain, social isolation, depression, and anxiety. Perceived discrimination against the individual with TBI was associated with caregiver strain and social isolation. Conclusions: Our findings suggest that perceived discrimination and stigma experienced by caregivers of individuals with TBI are stressors that may lead to poor caregiver mental health outcomes. In order to promote both caregiver and care recipient health, we suggest that mental health support services consider these important stressors. (C) 2011 Elsevier Inc. All rights reserved.	[Phelan, Sean M.; van Ryn, Michelle] Univ Minnesota, Dept Family Med & Community Hlth, Minneapolis, MN 55414 USA; [Phelan, Sean M.; Griffin, Joan M.; Sayer, Nina A.; Jensen, Agnes C.; Burgess, Diana J.] Minneapolis VA Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55414 USA; [Hellerstedt, Wendy L.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55414 USA		Phelan, SM (corresponding author), 925 Delaware St SE,Suite 220, Minneapolis, MN 55414 USA.	phel0085@umn.edu	Burgess, Diana/A-1946-2016; Sayer, Nina/E-3249-2016		Veterans Affairs Predoctoral Associated Health Rehabilitation Research Fellowship	This research was supported by a Veterans Affairs Predoctoral Associated Health Rehabilitation Research Fellowship.	Alspaugh MEL, 1999, PSYCHOL AGING, V14, P34, DOI 10.1037/0882-7974.14.1.34; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Angermeyer MC, 2003, SOC PSYCH PSYCH EPID, V38, P593, DOI 10.1007/s00127-003-0680-x; As I.F., 2009, FED REGISTER, V74, P4199; Baronet AM, 1999, CLIN PSYCHOL REV, V19, P819, DOI 10.1016/S0272-7358(98)00076-2; Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037/0003-066X.54.10.805; Corrigan PW, 2006, J FAM PSYCHOL, V20, P239, DOI 10.1037/0893-3200.20.2.239; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Edwards AB, 2002, AGING MENT HEALTH, V6, P55, DOI 10.1080/13607860120101149; Edwards Nancy E, 2002, J Neurosci Nurs, V34, P184; Folkman S., 1984, STRESS; Gaugler JE, 2003, INT J AGING HUM DEV, V57, P91, DOI 10.2190/8MNF-QMA3-A5TX-6QQ3; Gaugler JE, 2004, AGING MENT HEALTH, V8, P65, DOI 10.1080/13607860310001613356; Glanz K., 2002, HLTH BEHAV HLTH ED T, V3rd ed; Goldstein NE, 2004, J PALLIAT CARE, V20, P38, DOI 10.1177/082585970402000108; Gonzalez J, 2007, PSCHIATRIC SERV, V58; Green SE, 2007, SOC SCI MED, V64, P150, DOI 10.1016/j.socscimed.2006.08.025; Green SE, 2003, SOC SCI MED, V57, P1361, DOI 10.1016/S0277-9536(02)00511-7; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Grunfeld E, 2004, CAN MED ASSOC J, V170, P1795, DOI 10.1503/cmaj.1031205; Halter MJ, 2008, ARCH PSYCHIAT NURS, V22, P20, DOI 10.1016/j.apnu.2007.03.003; Hebl MR, 2003, PERS SOC PSYCHOL B, V29, P28, DOI 10.1177/0146167202238369; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Kang E, 2006, AIDS PATIENT CARE ST, V20, P712, DOI 10.1089/apc.2006.20.712; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Kittikorn N, 2006, QUAL HEALTH RES, V16, P1286, DOI 10.1177/1049732306293992; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Larson JE, 2008, ACAD PSYCHIATR, V32, P87, DOI 10.1176/appi.ap.32.2.87; LaVeist TA, 2003, INT J HEALTH SERV, V33, P331, DOI 10.2190/TCAC-P90F-ATM5-B5U0; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; Magana SM, 2007, PSYCHIAT SERV, V58, P378, DOI 10.1176/appi.ps.58.3.378; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735; MALONEBEACH EE, 1991, INT J AGING HUM DEV, V32, P103, DOI 10.2190/WKAL-WKPU-FJMT-6Y8U; Markowitz FE, 1998, J HEALTH SOC BEHAV, V39, P335, DOI 10.2307/2676342; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martens L, 2001, SOC PSYCH PSYCH EPID, V36, P128, DOI 10.1007/s001270050301; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Mickelson KD, 2001, PERS SOC PSYCHOL B, V27, P1046, DOI 10.1177/0146167201278011; Myers A, 1999, INT J OBESITY, V23, P221, DOI 10.1038/sj.ijo.0800765; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; PEEBLESKLEIGER MJ, 1994, J TRAUMA STRESS, V7, P173, DOI 10.1007/BF02102943; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perlick DA, 2001, PSYCHIAT SERV, V52, P1627, DOI 10.1176/appi.ps.52.12.1627; Perlick DA, 2004, PSYCHIAT SERV, V55, P1029, DOI 10.1176/appi.ps.55.9.1029; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reynolds M, 1998, BEHAV RES THER, V36, P135, DOI 10.1016/S0005-7967(98)00013-8; Rosenberg M., 1979, CONCEIVING SELF; SCAMBLER G, 1986, SOCIOL HEALTH ILL, V8, P26, DOI 10.1111/1467-9566.ep11346455; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sherbourne C D, 1992, Qual Life Res, V1, P235, DOI 10.1007/BF00435632; SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941; SHERBOURNE CD, 1995, J CONSULT CLIN PSYCH, V63, P345, DOI 10.1037/0022-006X.63.3.345; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SHERBOURNE CD, 1990, J HEALTH SOC BEHAV, V31, P328, DOI 10.2307/2136817; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; Szmukler GI, 1996, SOC PSYCH PSYCH EPID, V31, P137, DOI 10.1007/BF00785760; TOSELAND RW, 1995, SOC SCI MED, V40, P517, DOI 10.1016/0277-9536(94)E0093-8; TOSELAND RW, 1990, SOC WORK, V35, P209; Treasure J, 2001, SOC PSYCH PSYCH EPID, V36, P343, DOI 10.1007/s001270170039; Turner HA, 1998, J HEALTH SOC BEHAV, V39, P137, DOI 10.2307/2676396; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Werner P, 2008, AGING MENT HEALTH, V12, P92, DOI 10.1080/13607860701616325; Werner P, 2008, INT PSYCHOGERIATR, V20, P174, DOI 10.1017/S1041610207005340; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS29, DOI 10.2105/AJPH.98.Supplement_1.S29; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	71	42	43	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JUL	2011	4	3					177	184		10.1016/j.dhjo.2011.03.003			8	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	792XU	WOS:000292784500005	21723524				2022-02-06	
J	Windelov, NA; Welling, KL; Ostrowski, SR; Johansson, PI				Windelov, Nis A.; Welling, Karen-Lise; Ostrowski, Sisse R.; Johansson, Par I.			The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis	BLOOD COAGULATION & FIBRINOLYSIS			English	Article							TRAUMATIC INTRACRANIAL HEMORRHAGE; COAGULOPATHY; PROGRESSION	Coagulopathy in patients with intracranial haemorrhage or traumatic brain injury (TBI) is associated with clinical deterioration and worse outcome. Whole blood viscoelastic haemostatic assays, like thrombelastography (TEG), might aid conventional coagulation assays in identification of patients with worse prognosis. We performed a review of patients (totalling 78 patients) with primary acute intracranial haemorrhage or isolated TBI admitted to a neurointensive care unit (NICU) for more than 24 h during a period of 9 months, who had TEG analysis performed at admission. Primary outcome was all-cause 30-day mortality, whereas decline in Glasgow Coma Scale (GCS) score at 24 h after admission or death due to cerebral incarceration were secondary outcomes. Patients were defined as hypocoaguable if TEG reaction time was more than 8 min, angle less than 55 degrees and/or maximal amplitude less than 51 mm. Patients were defined hypocoaguable according to conventional coagulation assays if international normalized ratio was more than 1.3, platelet counts less than 100 X 10(9)/l and/or activated partial thromboplastine time more than 35s. Eight patients were hypocoaguable by TEG on admission to NICU and had higher 30-day mortality (63% vs. 16%, P=0.008), more often declined in GCS (57% vs. 16%, P=0.02) and expired due to cerebral incarceration (50% vs. 6%, P=0.02). Hypocoagulability by TEG, lower admission GCS and subarachnoid haemorrhage were independently associated with higher 30-day mortality [TEG: odds ratio (OR) 14.8 (2.2-100.1), P=0.006; GCS: OR 1.3 (1.1-1.5), P=0.006; subarachnoid haemorrhage: OR: 5.3 (1.3-22.3), P=0.02]. Only two patients were hypocoaguable by both conventional coagulation assays and TEG. The current data indicate that hypocoagulability by TEG at admission to NICU predicts worse prognosis. Low concordance with conventional coagulation assays indicates that TEG might be valuable in identifying patients with clinically relevant coagulopathy. Blood Coagul Fibrinolysis 22:416-419 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Windelov, Nis A.; Ostrowski, Sisse R.; Johansson, Par I.] Copenhagen Univ Hosp, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, DK-2100 Copenhagen, Denmark; [Windelov, Nis A.] Copenhagen Univ Hosp, Rigshosp, Dept Anaesthesia, Ctr Head & Orthoped, DK-2100 Copenhagen, Denmark; [Welling, Karen-Lise] Copenhagen Univ Hosp, Rigshosp, Dept Neurointens Care, DK-2100 Copenhagen, Denmark		Windelov, NA (corresponding author), Copenhagen Univ Hosp, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	nis.windelov@gmail.com	Ostrowski, Sisse R/E-7423-2011; Johansson, Par I/P-9283-2015	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par I/0000-0001-9778-5964			Aguilar MI, 2010, CURR TREAT OPTION NE, V12, P113, DOI 10.1007/s11940-010-0061-1; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Kung WM, 2010, INJURY; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	9	42	47	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235			BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	JUL	2011	22	5					416	419		10.1097/MBC.0b013e3283464f53			4	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	789HP	WOS:000292506600010	21467918				2022-02-06	
J	Turner, RJ; Helps, SC; Thornton, E; Vink, R				Turner, Renee J.; Helps, Stephen C.; Thornton, Emma; Vink, Robert			A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke	BRAIN RESEARCH			English	Article						Ischaemic stroke; NK1 tachykinin receptor antagonist; Oedema; Neuropeptides; Neurogenic inflammation	MIDDLE CEREBRAL-ARTERY; SPINAL-CORD ASTROCYTES; NEUROGENIC INFLAMMATION; RECEPTOR ANTAGONIST; FUNCTIONAL DEFICITS; EDEMA FORMATION; BRAIN EDEMA; OCCLUSION; INJURY; TACHYKININ	Previous studies have suggested that substance P (SP) plays a critical role in the development of brain oedema and functional deficits following traumatic brain injury and that SP receptor antagonism may improve outcome. No studies have described such a role in ischemic stroke. The present study characterized the effects of the NK1 tachykinin receptor antagonist, n-acetyl-L-tryptophan (NAT), on blood-brain barrier (BBB) breakdown, oedema formation, infarct volume and functional outcome following reversible ischemic stroke in rats. Ischemia was induced using a reversible thread model of middle cerebral artery occlusion where occlusion was maintained for 2 h before reperfusion. Animals received either NAT or equal volume saline vehicle intravenously at 2 h post-reperfusion. Ischaemic stroke resulted in increased perivascular SP immunoreactivity at 24 h. Administration of NAT significantly reduced oedema formation and BBB permeability at 24 h post-ischemia and significantly improved functional outcome as assessed over 7 days. There was no effect on infarct volume. We conclude that inhibition of SP activity with a NK1 tachykinin receptor antagonist is effective in reducing cerebral oedema, BBB permeability and functional deficits following reversible ischemia and may therefore represent a novel therapeutic approach to the treatment of ischaemic stroke. (C) 2011 Elsevier B.V. All rights reserved.	[Turner, Renee J.] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia		Turner, RJ (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	Renee.Turner@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Supported, in part, by the National Health and Medical Research Council of Australia.	Alves RV, 1999, PEPTIDES, V20, P921, DOI 10.1016/S0196-9781(99)00082-0; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Bakhai A, 2004, PHARMACOECONOMICS, V22, P11, DOI 10.2165/00019053-200422004-00004; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Bondy B, 2003, BIOL PSYCHIAT, V53, P538, DOI 10.1016/S0006-3223(02)01544-5; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476, DOI 10.1152/ajpregu.1999.277.2.R476; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Fu D, 2004, NEUROSCIENCE, V125, P819, DOI 10.1016/j.neuroscience.2004.02.012; GROTTA JC, 1990, ANN NEUROL, V27, P612, DOI 10.1002/ana.410270605; HAFSTROM I, 1989, J RHEUMATOL, V16, P1033; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Kaya M, 2001, CAN J PHYSIOL PHARM, V79, P793, DOI 10.1139/cjpp-79-9-793; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; Lecrux C, 2008, STROKE, V39, P448, DOI 10.1161/STROKEAHA.107.492934; Li FH, 1997, J CEREBR BLOOD F MET, V17, P1132, DOI 10.1097/00004647-199710000-00016; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512290-00074; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046/j.1460-9568.2000.00946.x; MARRIOTT D, 1991, ADV PROSTAG THROMB L, V21, P739; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NIMMO AJ, 2004, RECENT PAT CNS DRUG, V4, P86; Palma C, 1997, GLIA, V21, P183, DOI 10.1002/(SICI)1098-1136(199710)21:2<183::AID-GLIA2>3.0.CO;2-8; PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B; PRESTON E, 1993, NEUROSCI LETT, V149, P75, DOI 10.1016/0304-3940(93)90351-K; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner R, 2007, DRUG NEWS PERSPECT, V20, P221, DOI 10.1358/dnp.2007.20.4.1103527; vanderStaay FJ, 1996, BRAIN RES, V735, P271; Vink R, 2003, ACT NEUR S, V86, P257; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006	38	42	45	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 1	2011	1393						84	90		10.1016/j.brainres.2011.03.066			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774JA	WOS:000291380300009	21466790				2022-02-06	
J	Mar, J; Arrospide, A; Begiristain, JM; Larranaga, I; Elosegui, E; Oliva-Moreno, J				Mar, Javier; Arrospide, Arantzazu; Maria Begiristain, Jose; Larranaga, Isabel; Elosegui, Elena; Oliva-Moreno, Juan			The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life	BMC NEUROLOGY			English	Article							MENTAL-ILLNESS; CANARY-ISLANDS; INFORMAL CARE; HEALTH SURVEY; COSTS; STROKE; BURDEN; DISEASE; INJURY; SF-36	Background: Patients with acquired brain damage (ABD) have suffered a brain lesion that interrupts vital development in the physical, psychological and social spheres. Stroke and traumatic brain injury (TBI) are the two main causes. The objectives of this study were to estimate the incidence and prevalence of ABD in the population of the Basque Country and Navarre in 2008, to calculate the associated cost of the care required and finally to assess the loss in health-related quality of life. Methods: On the one hand, a cross-sectional survey was carried out, in order to estimate the incidence of ABD and its consequences in terms of costs and loss in quality of life from the evolution of a sample of patients diagnosed with stroke and TBI. On the other hand, a discrete event simulation model was built that enabled the prevalence of ABD to be estimated. Finally, a calculation was made of the formal and informal costs of ABD in the population of the Basque Country and Navarre (2,750,000 people). Results: The cross-sectional study showed that the incidences of ABD caused by stroke and TBI were 61.8 and 12.5 cases per 100,000 per year respectively, while the overall prevalence was 657 cases per 100,000 people. The SF-36 physical and mental component scores were 28.9 and 44.5 respectively. The total economic burden was calculated to be 382.14 million euro per year, distributed between 215.27 and 166.87 of formal and informal burden respectively. The average cost per individual was 21,040 (sic) per year. Conclusions: The main conclusion of this study is that ABD has a high impact in both epidemiological and economic terms as well as loss in quality of life. The overall prevalence obtained is equivalent to 0.7% of the total population. The substantial economic burden is distributed nearly evenly between formal and informal costs. Specifically, it was found that the physical dimensions of quality of life are the most severely affected. The prevalence-based approach showed adequate to estimate the population impact of ABD and the resources needed to compensate the disability.	[Mar, Javier] Alto Deba Hosp, Clin Management Serv, Arrasate Mondragon, Spain; [Mar, Javier; Arrospide, Arantzazu] Alto Deba Hosp, Hlth Res Unit W Gipuzkoa, Arrasate Mondragon, Spain; [Maria Begiristain, Jose; Larranaga, Isabel; Elosegui, Elena] Govt Basque Country, Gipuzkoa Reg Off Hlth, Donostia San Sebastian, Spain; [Oliva-Moreno, Juan] Univ Castilla La Mancha, Toledo Fac Legal & Social Sci, Toledo, Spain		Mar, J (corresponding author), Alto Deba Hosp, Clin Management Serv, Arrasate Mondragon, Spain.	javier.marmedina@osakidetza.net	Oliva, Juan/A-1299-2011	Oliva, Juan/0000-0002-8997-0307; Arrospide, Arantzazu/0000-0003-3537-6588; Larranaga, Isabel/0000-0003-2231-6447			ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arrazola A, 2005, REV NEUROLOGIA, V40, P326, DOI 10.33588/rn.4006.2004435; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Cohen J, 1977, STAT POWER ANAL BEHA, P8; Comas M, 2008, VALUE HEALTH, V11, P1203, DOI 10.1111/j.1524-4733.2008.00322.x; Comas-Herrera A, 2006, AGEING SOC, V26, P285, DOI 10.1017/S0144686X05004289; *CONS INT SIST NAC, 2009, ESTR ICT SIST NAC SA; *DEP SAN, ENC SAL PAIS VASC ES; DRUMMOND MF, 1997, METHODS EC EVALUATIO, V2, P52; Evers SMAA, 2004, STROKE, V35, P1209, DOI 10.1161/01.STR.0000125860.48180.48; Greenland S, 1998, MODERN EPIDEMIOLOGY, P29; Hankey GJ, 2005, STROKE TREATMENT PRE, P1, DOI [10.1017/CBO9780511526893, DOI 10.1017/CBO9780511526893]; Hervas A, 2007, GAC SANIT, V21, P444, DOI 10.1157/13112236; Hewer RL, 2003, HDB NEUROLOGICAL REH, P5; Hilden J, 2008, MED DECIS MAKING, V28, P460, DOI 10.1177/0272989X08321903; Hu TW, 2006, J MENT HEALTH POLICY, V9, P3; *I NAC EST, ENC ESP ENC TRIM COS; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kelton W. D., 2007, SIMULATION ARENA; Knapp M., 2007, DEMENTIA UK FULL REP; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lopez-Bastida J, 2008, MOVEMENT DISORD, V23, P212, DOI 10.1002/mds.21798; Lopez-Bastida J, 2006, NEUROLOGY, V67, P2186, DOI 10.1212/01.wnl.0000249311.80411.93; Lopez-Bastida J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-55; MAHONEY F I, 1965, Md State Med J, V14, P61; Mar J, 2008, NEUROEPIDEMIOLOGY, V31, P57, DOI 10.1159/000140096; Mar J, 2010, VALUE HEALTH, V13, P69, DOI 10.1111/j.1524-4733.2009.00655.x; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Oliva-Moreno J, 2009, EUR J HEALTH ECON, V10, P361, DOI 10.1007/s10198-008-0135-0; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Youman P, 2003, PHARMACOECONOMICS, V21, P43, DOI 10.2165/00019053-200321001-00005	37	42	45	0	17	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	APR 18	2011	11								46	10.1186/1471-2377-11-46			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	766VD	WOS:000290813700001	21496356	Green Published, gold			2022-02-06	
J	Dore-Duffy, P; Wang, S; Mehedi, A; Katyshev, V; Cleary, K; Tapper, A; Reynolds, C; Ding, YC; Zhan, P; Rafols, J; Kreipke, CW				Dore-Duffy, Paula; Wang, Sherry; Mehedi, Afroza; Katyshev, Vladamir; Cleary, Kristen; Tapper, Alexander; Reynolds, Christian; Ding, Yuchuan; Zhan, Pang; Rafols, Jose; Kreipke, Christian W.			Pericyte-mediated vasoconstriction underlies TBI-induced hypoperfusion	NEUROLOGICAL RESEARCH			English	Article						Pericyte; Endothelin; Receptors	SMOOTH-MUSCLE; ENDOTHELIN RECEPTORS; CONTRACTILE PROTEINS; SCANNING-ELECTRON; BRAIN-INJURY; BLOOD-BRAIN; RAT MODEL; EXPRESSION; ACTIN; CELLS	Objectives: Endothelin-1 is a 21-amino acid peptide that together with specific receptors, A (ETrA) and B (ETrB) is induced following traumatic brain injury (TBI) and has been closely linked to regulation of cerebral vasospasm, oxidative stress, and hypoperfusion. Specific endothelin receptor antagonists have been shown to ameliorate early evidence of neuronal cell injury, activation of microglial cells, and hypoperfusion following TBI. The exact mechanism involved in TBI-induced hypoperfusion is still unclear; however, it is thought that endothelin-1 engagement of ETrA is primarily responsible for changes in blood flow. In this study we question the role of the microvascular pericyte in endothelin-1-mediated pathophysiology in TBI. Methods: Pericyte expression of endothelin-1, ETrA, and ETrB was examined in primary culture and in sham and impacted rat brain. Adult male rats were also given intracerebroventricular injections of ETrA (BQ-123) before being subjected to TBI using a closed head acceleration impact model. Results: Primary pericytes express both endothelin-1 and its receptors ETrA and ETrB. Following TBI, the number of alpha-smooth muscle actin (SMA) positive pericytes located in microvessels is significantly increased by 4 hours post-traumatic impact. Increases in pericyte expression of alpha-SMA correlated with evidence of a reduction in both arteriolar and capillary diameter. Capillary endothelin-1, ETrA, and ETrB transcript and protein was also increased. Increased endothelin-1 expression was seen by 2-4 hours post-impact. Upregulation of receptors was observed by 4-8 hours and maximum by 24 hours. ETrA antagonists decreased the number of alpha-SMA(+) pericytes as well as changes in microvascular diameter. Conclusion: These results suggest that decreased vasoconstriction following TBI may be due to an endothelin-1-induced pericyte-mediated regulation of microvessel blood flow following TBI. Furthermore, results suggest that ETrA antagonists ameliorate trauma induced hypoperfusion, in part, by inhibiting endothelin-1-mediated upregulation of alpha-SMA in pericytes.	[Dore-Duffy, Paula; Wang, Sherry; Mehedi, Afroza; Katyshev, Vladamir; Cleary, Kristen; Tapper, Alexander] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Reynolds, Christian; Rafols, Jose; Kreipke, Christian W.] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; [Ding, Yuchuan; Zhan, Pang] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Rafols, Jose; Kreipke, Christian W.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA		Dore-Duffy, P (corresponding author), Wayne State Univ, Sch Med, Dept Neurol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	pdduffy@med.wayne.edu					ALI SS, 1984, CELL TISSUE RES, V235, P675; Andrawis NS, 1996, LIFE SCI, V59, P523, DOI 10.1016/0024-3205(96)00332-3; BALDI E, 1991, J PHARMACOL EXP THER, V256, P581; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; Carloni V, 2000, HEPATOLOGY, V31, P131, DOI 10.1002/hep.510310121; CHAKRAVARTHY U, 1992, MICROVASC RES, V43, P241, DOI 10.1016/0026-2862(92)90022-H; Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007; Dehouck MP, 1997, J CEREBR BLOOD F MET, V17, P464, DOI 10.1097/00004647-199704000-00012; DEHOUCK MP, 2001, J CEREB BLOOD FLOW M, V17, P464; DELARUBIA G, 1992, DIABETES, V41, P1533, DOI 10.2337/diabetes.41.12.1533; Dore SE, 1923, BRIT J DERMATOL SYPH, V35, P398, DOI 10.1111/j.1365-2133.1923.tb09069.x; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Dore-Duffy Paula, 2003, Methods Mol Med, V89, P375; GAUDIO E, 1985, ANGIOLOGY, V36, P458, DOI 10.1177/000331978503600708; HAHN AWA, 1993, J VASC RES, V30, P192, DOI 10.1159/000158994; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; Jones R, 1999, AM J RESP CELL MOL, V20, P582, DOI 10.1165/ajrcmb.20.4.3357; JOYCE NC, 1985, J CELL BIOL, V100, P1379, DOI 10.1083/jcb.100.5.1379; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; KARIM OMA, 1992, J CELL BIOCHEM, V48, P373, DOI 10.1002/jcb.240480406; Kawamura H, 2002, INVEST OPHTH VIS SCI, V43, P882; Kreipke CW, 2010, NEUROL RES, V32, P209, DOI 10.1179/174313209X414515; Kreipke CW, 2009, J CELL MOL MED, V13, P262, DOI 10.1111/j.1582-4934.2008.00508.x; Kutcher ME, 2009, MICROVASC RES, V77, P235, DOI 10.1016/j.mvr.2009.01.007; Lam Hing-Chung, 2003, Current Vascular Pharmacology, V1, P243, DOI 10.2174/1570161033476600; Leung JWC, 2004, J CARDIOVASC PHARM, V44, pS293, DOI 10.1097/01.fjc.0000166277.70538.b0; Li Q, 2001, BRAIN RES, V907, P93, DOI 10.1016/S0006-8993(01)02607-5; Liu SQ, 1998, ATHEROSCLEROSIS, V140, P365, DOI 10.1016/S0021-9150(98)00143-9; LUNDBERG MS, 1995, IN VITRO CELL DEV-AN, V31, P595; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD DM, 1995, INVEST OPHTH VIS SCI, V36, P1088; McDonald DM, 1996, INVEST OPHTH VIS SCI, V37, P1067; NEHLS V, 1991, J CELL BIOL, V113, P147, DOI 10.1083/jcb.113.1.147; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; RAMACHANDRAN E, 1993, INVEST OPHTH VIS SCI, V34, P586; ROCKEY DC, 1995, BIOCHEM BIOPH RES CO, V207, P725, DOI 10.1006/bbrc.1995.1247; SIMONSON MS, 1990, J CLIN INVEST, V85, P790, DOI 10.1172/JCI114505; SPATZ M, 1993, PROSTAG LEUKOTR ESS, V49, P789, DOI 10.1016/0952-3278(93)90027-T; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; THOMAS CP, 1991, J CARDIOVASC PHARM, V17, pS79, DOI 10.1097/00005344-199100177-00022; Toribatake Y, 1997, SPINAL CORD, V35, P26, DOI 10.1038/sj.sc.3100348; WALLOW IHL, 1993, INVEST OPHTH VIS SCI, V34, P420; Yahiaoui L, 2006, CELL PHYSIOL BIOCHEM, V17, P37, DOI 10.1159/000091462; Yakubu MA, 1999, AM J PHYSIOL-CELL PH, V276, pC300; Yokota T, 2003, DIABETES, V52, P838, DOI 10.2337/diabetes.52.3.838	54	42	45	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					176	184		10.1179/016164111X12881719352372			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600009	21801592				2022-02-06	
J	Inness, EL; Howe, JA; Niechwiej-Szwedo, E; Jaglal, SB; McIlroy, WE; Verrier, MC				Inness, Elizabeth L.; Howe, Jo-Anne; Niechwiej-Szwedo, Ewa; Jaglal, Susan B.; McIlroy, William E.; Verrier, Molly C.			Measuring Balance and Mobility after Traumatic Brain Injury: Validation of the Community Balance and Mobility Scale (CB&M)	PHYSIOTHERAPY CANADA			English	Article						balance; brain injuries; posture; mobility limitations; outcome assessment	ASSESSMENT-TOOL HIMAT; GAIT VARIABILITY; OLDER ADULTS; PARAMETERS; AMBULATION; RECOVERY; VALIDITY; STROKE	Purpose: To further investigate the construct validity of the Community Balance and Mobility Scale (CB&M), developed for ambulatory individuals with traumatic brain injury (TBI). Methods: A convenience sample of 35 patients with TBI (13 in-patients, 22 outpatients) was recruited. Analyses included a comparison of CB&M and Berg Balance Scale (BBS) admission and change scores and associations between the CB&M and measures of postural sway, gait, and dynamic stability; the Community Integration Questionnaire (CIQ); and the Activities-specific Balance Confidence (ABC) Scale. Results: Mean admission scores on the BBS and the CB&M were 53.6/56 (SD = 4.3) and 57.8/96 (SD = 23.3) respectively. Significant correlations were demonstrated between the CB&M and spatiotemporal measures of gait, including walking velocity, step length, step width, and step time; measures of dynamic stability, including variability in step length and step time; and the ABC (p < 0.05). Significant correlations between the CB&M and CIQ were revealed with a larger data set (n = 47 outpatients) combined from previous phases of research. Conclusions: In patients with TBI, the CB&M is less susceptible to a ceiling effect than the BBS. The construct validity of the CB&M was supported, demonstrating associations with laboratory measures of dynamic stability, measures of community integration, and balance confidence.	[Inness, Elizabeth L.] Toronto Rehabil Inst, Mobil & Falls Clin, Toronto, ON M5G 2A2, Canada; [Inness, Elizabeth L.; Howe, Jo-Anne; Jaglal, Susan B.; Verrier, Molly C.] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON, Canada; [Niechwiej-Szwedo, Ewa] Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; [Jaglal, Susan B.; McIlroy, William E.; Verrier, Molly C.] Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON, Canada; [McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Fac Sci Appl, Waterloo, ON N2L 3G1, Canada		Inness, EL (corresponding author), Toronto Rehabil Inst, Mobil & Falls Clin, 550 Univ Ave 11015, Toronto, ON M5G 2A2, Canada.	inness.liz@torontorehab.on.ca		Jaglal, Susan/0000-0002-2930-1443; Inness, Elizabeth L./0000-0002-9217-4619	Ontario Neurotrauma Foundation [ONBO-00020]; Toronto Rehabilitation Institute under Ontario Ministry of Health and Long-Term Care; Toronto Rehabilitation Institute Chair at the University of Toronto	This research was funded by the Ontario Neurotrauma Foundation (grant #ONBO-00020). We also acknowledge the support of the Toronto Rehabilitation Institute, which receives funding under the Provincial Rehabilitation Research Program from the Ontario Ministry of Health and Long-Term Care. Dr. Jaglal is supported by the Toronto Rehabilitation Institute Chair at the University of Toronto.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Colton T, 1974, STAT MED; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; *HAM BRAIN INJ ASS, BRAIN INJ FACTS; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hillier SL, 1997, BRAIN INJURY, V11, P661; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; LERNERFRANKIEL MB, 1986, CLIN MANAG PHYS THER, V6, P12; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; OBERG T, 1993, J REHABIL RES DEV, V30, P210; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; ROBINETT CS, 1988, PHYS THER, V68, P1371, DOI 10.1093/ptj/68.9.1371; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WEINSTEIN C, 1989, ARCH PHYS MED REHAB, V70, P755; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wright JG, 1997, J CLIN EPIDEMIOL, V50, P239, DOI 10.1016/S0895-4356(96)00373-3; Zar J.H., 1999, BIOSTAT ANAL, V4th	29	42	42	2	16	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508			PHYSIOTHER CAN	Physiother. Can.	SPR	2011	63	2					199	208		10.3138/ptc.2009-45			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	843MZ	WOS:000296677300011	22379260	Green Published			2022-02-06	
J	Reeves, RR; Panguluri, RL				Reeves, Roy R.; Panguluri, Rajeev L.			Neuropsychiatric Complications of Traumatic Brain Injury	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; HEAD-INJURIES; SEQUELAE; SUICIDE; INDIVIDUALS; MANAGEMENT; MORTALITY; SECONDARY	Traumatic brain injury (TBI) may be defined as any extracranial mechanical force to the brain that results in any period of loss of consciousness, any loss of memory for events immediately before or after the event, or any alteration in mental status at the time of the event. The major causes are automobile accidents, falls, sporting injuries, and assaults. Many soldiers returning from combat in Afghanistan and Iraq have also experienced TBI. This article provides an overview of the neuropsychiatric complications of TBI, including impairment of consciousness, posttraumatic amnesia, cognitive disorders and dementia, posttraumatic epilepsy, aphasia, depression, mania, psychosis, anxiety disorders, personality changes, aggression, behavioral dyscontrol, fatigue/apathy, and increased risk of suicide. Discussion will focus primarily on issues affecting mental health clinicians. Because mental health providers are more involved in care of chronic issues related to TBI, these issues will be discussed in more detail, although acute neuropsychiatric complications of TBI will be briefly explained.	[Reeves, Roy R.; Panguluri, Rajeev L.] GV Sonny Montgomery VA Med Ctr, Jackson, MS 39216 USA; [Reeves, Roy R.; Panguluri, Rajeev L.] Univ Mississippi, Sch Med, Jackson, MS 39216 USA		Reeves, RR (corresponding author), GV Sonny Montgomery VA Med Ctr, 11M,1500 E Woodrow Wilson Dr, Jackson, MS 39216 USA.	roy.reeves@va.gov					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Deb S, 1999, AM J PSYCHIAT, V156, P374; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Epstein Richard S., 1994, P285; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Flanagan S, 1999, MT SINAI J MED, V66, P152; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kavanagh DO, 2010, CASE REP MED, V2010, DOI 10.1155/2010/678060; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Reeves RR, 2009, TERROR HOT SPOTS CON, P105; Ropper AH, 2008, HARRISONS PRINCIPLES, P2596; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver J. M., 2008, AM PSYCHIAT PUBLISHI, P595; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; Suchy Y, 2007, BRAIN INJURY, V21, P69, DOI 10.1080/02699050601149088; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wilgus J, 2009, J HIST NEUROSCI, V18, P340, DOI 10.1080/09647040903018402; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	56	42	45	0	43	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695			J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	MAR	2011	49	3					42	50		10.3928/02793695-20110201-03			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	742UA	WOS:000288969300016	21323264				2022-02-06	
J	Ahn, SK; Jeon, SY; Kim, JP; Park, JJ; Hur, DG; Kim, DW; Woo, SH; Kwon, OJ; Kim, JY				Ahn, Seong-Ki; Jeon, Sea-Yuong; Kim, Jin-Pyeong; Park, Jung Je; Hur, Dong Gu; Kim, Dae-Woo; Woo, Seung-Hoon; Kwon, Oh-Jin; Kim, Jin-Yong			Clinical Characteristics and Treatment of Benign Paroxysmal Positional Vertigo After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Benign paroxysmal positional vertigo; Therapy	MANAGEMENT; DIAGNOSIS; DIZZINESS; MANEUVER; BPPV	Background: Traumatic brain injury (TBI) has been reported to be a common cause of benign paroxysmal positional vertigo (BPPV). However, only a few studies have investigated BPPV after TBI. The aim of this study was to identify the clinical characteristics of BPPV after TBI and to determine whether there are clinical differences between BPPV after TBI and idiopathic BPPV. Methods: The authors reviewed the medical records of 192 consecutive patients with positional vertigo after head injury during the period 2003 to 2009 and investigated 112 patients with idiopathic BPPV treated over the same period. The clinical characteristics of BPPV after TBI and the clinical differences between the traumatic BPPV and idiopathic BPPV groups were investigated. Results: A total of 32 patients with BPPV after TBI fulfilled the inclusion criteria. Twenty-four patients in the traumatic BPPV group had posterior semicircular canal-BPPV and 11 patients lateral semicircular canal-BPPV. A total of 58 repositioning maneuver sessions were performed in these 32 patients. Members of the traumatic BPPV group required more treatment sessions than members of the idiopathic group (p < 0.05), but no tendency to recur was observed in the traumatic group (p > 0.05). Recurrence rates in the traumatic and idiopathic BPPV groups were 15.6% and 18.8%, respectively (p > 0.05). Conclusions: It is likely that BPPV after TBI is more difficult to treat than idiopathic BPPV, but no tendency to recur was observed in patients who developed BPPV after TBI compared with idiopathic BPPV. Further prospective clinical meta-analytic studies are needed to investigate the outcome of BPPV after TBI.	[Ahn, Seong-Ki; Jeon, Sea-Yuong; Kim, Jin-Pyeong; Park, Jung Je; Hur, Dong Gu; Kim, Dae-Woo; Woo, Seung-Hoon; Kwon, Oh-Jin; Kim, Jin-Yong] Gyeongsang Natl Univ, Sch Med, Dept Otolaryngol, Jinju 660702, South Korea		Ahn, SK (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Otolaryngol, Jinju 660702, South Korea.	skahn@gnu.ac.kr					BALOH RW, 1993, NEUROLOGY, V43, P2542, DOI 10.1212/WNL.43.12.2542; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Casani AP, 2002, LARYNGOSCOPE, V112, P172, DOI 10.1097/00005537-200201000-00030; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Escher A, 2007, EUR ARCH OTO-RHINO-L, V264, P1239, DOI 10.1007/s00405-007-0337-6; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Fung K, 1996, J OTOLARYNGOL, V25, P243; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Hilton M, 2002, CLIN OTOLARYNGOL, V27, P440, DOI 10.1046/j.1365-2273.2002.00613.x; Hughes CA, 1997, LARYNGOSCOPE, V107, P607, DOI 10.1097/00005537-199705000-00010; KATSARKAS A, 1978, J OTOLARYNGOL, V7, P320; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Lempert T, 1996, LARYNGOSCOPE, V106, P476, DOI 10.1097/00005537-199604000-00015; LONGRIDGE NS, 1978, J OTOLARYNGOL, V7, P395; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nunez RA, 2000, OTOLARYNG HEAD NECK, V122, P647, DOI 10.1067/mhn.2000.105185; Nuti D, 1998, ACTA OTO-LARYNGOL, V118, P455, DOI 10.1080/00016489850154559; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Vannucchi P, 1997, J VESTIBUL RES-EQUIL, V7, P1; White JA, 2005, OTOLARYNG HEAD NECK, V133, P278, DOI 10.1016/j.otohns.2005.03.080; 2001, J ORAL MAXILLOFAC SU, V59, P106	25	42	43	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					442	446		10.1097/TA.0b013e3181d0c3d9			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	719FV	WOS:000287187700041	20489667				2022-02-06	
J	Riggio, S				Riggio, Silvana			Traumatic Brain Injury and Its Neurobehavioral Sequelae	NEUROLOGIC CLINICS			English	Article						Traumatic brain injury; Postconcussive syndrome; Neuropsychiatric disorders; Frontal lobe seizures	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; CHRONIC PAIN; PSYCHIATRIC-DISORDERS; SYMPTOMS; FATIGUE; ASSOCIATION; PREVALENCE; CONCUSSION; DISABILITY	The neurobehavioral sequelae of TBI consist of a spectrum of somatic, neurologic, and psychiatric symptoms. The challenge for clinicians lies in understanding the interface of the various symptoms and how they interrelate with other entities. Specifically, the challenge is differentiating post-TBI-related symptoms from preexisting or de novo psychiatric, neurologic, and/or systemic disorders. A comprehensive evaluation and a multidisciplinary approach to evaluating patients are essential to be able to develop the differential diagnosis needed to design a management plan that maximizes recovery.	[Riggio, Silvana] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Riggio, Silvana] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Riggio, Silvana] James J Peters VA Med Ctr, Bronx, NY USA		Riggio, S (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA.	silvana.riggio@mssm.edu					Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Greve KW, 2001, BRAIN INJURY, V15, P255; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Quesney LF, 1986, RECENT ADV EPILEPSY, V3, P81; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; RIGGIO S, 1995, ADV NEUROL, V66, P153; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 1996, BRAIN INJURY, V8, P61; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316	46	42	43	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2011	29	1					35	+		10.1016/j.ncl.2010.10.008			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	714BA	WOS:000286780700004	21172569				2022-02-06	
J	Alley, MD; Schimizze, BR; Son, SF				Alley, Matthew D.; Schimizze, Benjamin R.; Son, Steven F.			Experimental modeling of explosive blast-related traumatic brain injuries	NEUROIMAGE			English	Article							HEAD IMPACT; BIOMECHANICS; MECHANISM; WAVES	This study aims to characterize the interaction of explosive blast waves through simulated anatomical systems. We have developed physical models and a systematic approach for testing traumatic brain injury (TBI) mechanisms and occurrences. A simplified series of models consisting of spherical poly(methyl methacrylate) (PMMA) shells housing synthetic gelatins as brain simulants have been utilized. A series of experiments was conducted to compare the sensitivity of the system response to mechanical properties of the simulants under high strain-rate explosive blasts. Small explosive charges were directed at the models to produce a realistic blast wave in a scaled laboratory setting. Blast profiles were measured and analyzed to compare system response severity. High-speed shadowgraph imaging captured blast wave interaction with the head model while particle tracking captured internal response for displacement and strain correlation. The results suggest amplification of shock waves inside the head near material interfaces due to impedance mismatches. In addition, significant relative displacement was observed between the interacting materials suggesting large strain values of nearly 5%. Further quantitative results were obtained through shadowgraph imaging of the blasts confirming a separation of time scales between blast interaction and bulk movement. These results lead to a conclusion that primary blast effects may potentially contribute significantly to the occurrence of military associated TBI. Published by Elsevier Inc.	[Alley, Matthew D.; Schimizze, Benjamin R.; Son, Steven F.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA		Alley, MD (corresponding author), 325 S Windstone CT, Bloomington, IN 47403 USA.	mdalley.purdue.me@gmail.com; bschimiz@purdue.edu; sson@purdue.edu		Son, Steven/0000-0001-7498-2922	JIEDDO/ARO [W911NF-07-1-0035]	The authors would also like to acknowledge and thank the collaborations of Professor Raul Radovitzky and supportive students of the Massachusetts Institute of Technology as well as the support from JIEDDO/ARO ("Mechanical Properties Measurements and Blast Loading Experiments on Brains for Model Calibration and Validation," Contract #: W911NF-07-1-0035) through research funding. Data collection and documentation was completed by the listed authors however, monetary and intellectual resources were provided through the referenced sponsorship.	ALLEN RM, 2003, EXPT NUMERICAL STUDY; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BOUAMOUL A, 2007, 23 INT S BALL TARR S; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cooper PW., 1996, EXPLOSIVES ENG; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; FOURNIER E, 2007, BLAST HEADFORM DEV D, P56; Fox R.W., 2004, INTRO FLUID MECH; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; *MIT, 2008, MIT TBI SEL HEAD MAT; PRABHU R, 2008, LOW STRAIN RATE MECH; RADOVITZKY R, 2007, MECH PROPERTIES MEAS; Richmond DR., 1968, ESTIMATE MANS TOLERA; Roberts JC, 2005, J HOPKINS APL TECH D, V26, P84; Settles G. S., 2006, SCHLIEREN SHADOWGRAP; Settles GS, 2006, AM SCI, V94, P22, DOI 10.1511/2006.1.22; Simmonds K., 2004, NRL REV, P156; SOCRATE S, 2008, LOW STRAIN RATE MECH; STEWART C, 2006, BLAST INJURIES, P88; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TAYLOR PA, 2007, BRAIN INJURY, P7; Wang ZL, 2003, MIL MED, V168, P330, DOI 10.1093/milmed/168.4.330; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilson C., 2007, IMPROVISED EXPLOSIVE; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Ziejewski M., 2007, BRAIN INJ PROF, V4, P10	32	42	43	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	JAN	2011	54			1			S45	S54		10.1016/j.neuroimage.2010.05.030			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600007	20580931				2022-02-06	
J	Green, P				Green, Paul			Comparison Between the Test of Memory Malingering (TOMM) and the Nonverbal Medical Symptom Validity Test (NV-MSVT) in Adults With Disability Claims	APPLIED NEUROPSYCHOLOGY			English	Article						effort; malingering; NV-MSVT; SVT; TOMM	TEST-PERFORMANCE; CHILDREN; DAMAGE	In this study, the Nonverbal Medical Symptom Validity Test (NV-MSVT; Green, 2008) and the Test of Memory Malingering (TOMM; Tombaugh, 1996) were given to a consecutive series of outpatients undergoing disability assessment. No cases of moderate to severe traumatic brain injury (TBI) failed the easy NV-MSVT subtests or the TOMM. However, 26% of the mild TBI group failed the NV-MSVT and 10% failed the TOMM. More than 10% of the whole sample passed the TOMM but failed the NV-MSVT. Using profile analysis, the NV-MSVT has been shown to have a zero false-positive rate in three independent groups of patients with severe cognitive impairment arising from dementia. The more severe the actual cognitive impairment, the more likely it is that false positives for poor effort will occur. Therefore, using the same criteria, we would also expect zero false positives in people with much less severe impairment, such as mild TBI. Those in the current study who passed the TOMM and failed the NV-MSVT had profiles that were not characteristic of people with actual severe impairment. Instead, they were of the paradoxical type seen in simulators. The results suggest that the NV-MSVT is considerably more sensitive to poor effort than the TOMM, if the conventional cutoff is used to define TOMM failure.			Green, P (corresponding author), 17010 103 Ave, Edmonton, AB T5S 1K7, Canada.	paulgreen@shaw.ca					Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2005, MANUAL WORD MEMORY T; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 2010, ADV INTERPRETATION P; Green P., DETECTION M IN PRESS; Green P, 1995, MANUAL ORAL WORD MEM; Green P.J.E., 2008, MANUAL NONVERBAL MED; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Tombaugh T.N., 1996, TEST MEMORY MALINGER	17	42	42	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	1					18	26	PII 934413787	10.1080/09084282.2010.523365			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	733MC	WOS:000288265800003	21390896				2022-02-06	
J	Mozeiko, J; Le, K; Coelho, C; Krueger, F; Grafman, J				Mozeiko, Jennifer; Le, Karen; Coelho, Carl; Krueger, Frank; Grafman, Jordan			The relationship of story grammar and executive function following TBI	APHASIOLOGY			English	Article; Proceedings Paper	40th Clinical Aphasiology Conference (CAC)	MAY 23-27, 2010	Isle of Palms, SC			Traumatic brain injury; penetrating head injury; Discourse analysis; narrative discourse; Story grammar; Executive function	TRAUMATIC BRAIN-INJURY; DEFICITS; ADULTS	Background: Story grammar is a super-structural measure of discourse performance that has shown to be sensitive to the deficits seen following traumatic brain injury (TBI). Narrative organisation and identification of logical relationships between events and characters are key components of story grammar. Reports of significant correlations for measures of story grammar and scores from various tests of executive functioning for individuals with TBI are thought to reflect executive control of cognitive and linguistic organisational processes. Aims: The purpose of the present study was to re-examine the relationship between story grammar and executive functions (EF) in a large group of participants with severe TBI secondary to diverse penetrating head wounds. It was hypothesised that participants with TBI would have significantly lower story grammar scores than a comparison group without TBI, and that story grammar performance of the group with TBI would be significantly correlated with their EF scores. Methods Procedures: A total of 167 participants with TBI and a comparison group of 46 adults without TBI were asked to retell a 16-frame story. Transcripts of each story retelling were broken into T-units and were analysed for story grammar. Outcomes Results: Results of MANOVA showed significant effect of group on the discourse measures. Univariate tests showed significant differences between the group with TBI and the comparison group for each of the story grammar measures. Story grammar measures were significantly correlated with executive function (EF) scores. Conclusions: Results indicated that the participants with TBI demonstrated significantly poorer performance on measures of story grammar abilities, lending support to earlier reports of story grammar impairments resulting from closed head injury (CHI). The present study also found significant correlations for measures of story grammar and the Sorting Test. Cognitive skills such as mental flexibility, required for successful performance on this card sorting task are likely the same as those required for episode generation. These findings have clinical implications for the management of cognitive-communication disorders in individuals with TBI. First, story grammar warrants inclusion in analyses of discourse. Second, discourse deficits following brain injury do not resolve spontaneously and persist as social barriers.	[Mozeiko, Jennifer; Le, Karen; Coelho, Carl] Univ Connecticut, Dept Commun Disorders, Storrs, CT USA; [Krueger, Frank; Grafman, Jordan] NINDS, Cognit Neurosci Sect, Bethesda, MD 20892 USA		Grafman, J (corresponding author), Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jgrafman@kesslerfoundation.org		Grafman, Jordan H./0000-0001-8645-4457			Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1998, ANAL DISCOURSE COMMU, P115; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; DELIS DC, 2001, DELISKAPLAN EXECUTIV; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dunbar K, 1995, ANN NY ACAD SCI, V769, P289, DOI 10.1111/j.1749-6632.1995.tb38146.x; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hunt K., 1965, 3 NCTE; Kaplan E, 1983, BOSTON NAMING TEST; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P611; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; PLAG JA, 1967, PERS PSYCHOL, V20, P323, DOI 10.1111/j.1744-6570.1967.tb01527.x; ROBBINS TW, 1997, METHODOLOGY FRONTAL, V10, P215; Stein N. L., 1979, ADV DISCOURSE PROCES, V2, P53; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	28	42	42	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2011	25	6-7					826	835	PII 934165989	10.1080/02687038.2010.543983			10	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	775XO	WOS:000291497000014					2022-02-06	
J	O'Rourke, JJF; Beglinger, LJ; Smith, MM; Mills, J; Moser, DJ; Rowe, KC; Langbehn, DR; Duff, K; Stout, JC; Harrington, DL; Carlozzi, N; Paulsen, JS				O'Rourke, Justin J. F.; Beglinger, Leigh J.; Smith, Megan M.; Mills, James; Moser, David J.; Rowe, Kelly C.; Langbehn, Douglas R.; Duff, Kevin; Stout, Julie C.; Harrington, Deborah L.; Carlozzi, Noelle; Paulsen, Jane S.		PREDICT-HD Investigators	The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Huntington disease; Cognition; Motor; Psychiatric; Neurodegenerative	TRAUMATIC BRAIN-INJURY; AGE-OF-ONSET; TEST INDEXES; COGNITIVE IMPAIRMENT; CONSTRUCT-VALIDITY; WORKING-MEMORY; DOUBLE-BLIND; PREDICT-HD; DEPRESSION; CARRIERS	We examined the Trail Making Test (TMT) in a sample of 767 participants with prodromal Huntington disease (prodromal HD) and 217 healthy comparisons to determine the contributions of motor, psychiatric, and cognitive changes to TMT scores. Eight traditional and derived TMT scores were also evaluated for their ability to differentiate prodromal participants closer to estimated age of diagnosis from those farther away and prodromal individuals from healthy comparisons. Results indicate that motor signs only mildly affected Part A, and psychiatric symptoms did not affect either part. Tests of perceptual processing, visual scanning, and attention were primarily associated with Part A, and executive functioning (response inhibition, set-shifting), processing speed, and working memory were associated with Part B. Additionally, TMT scores differentiated between healthy comparisons and prodromal HD individuals as far as 9-15 years before estimated diagnosis. In participants manifesting prodromal motor signs and psychiatric symptoms, the TMT primarily measures cognition and is able to discriminate between groups based on health status and estimated time to diagnosis.	[O'Rourke, Justin J. F.; Beglinger, Leigh J.; Smith, Megan M.; Mills, James; Moser, David J.; Rowe, Kelly C.; Langbehn, Douglas R.; Duff, Kevin; Paulsen, Jane S.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [O'Rourke, Justin J. F.] Univ Iowa, Dept Counseling Psychol, Iowa City, IA 52242 USA; [Rowe, Kelly C.] Univ Iowa, Dept Neurosci, Iowa City, IA 52242 USA; [Stout, Julie C.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Melbourne, Vic 3004, Australia; [Harrington, Deborah L.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Carlozzi, Noelle] Kessler Fdn Res Ctr, W Orange, NJ USA; [Paulsen, Jane S.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Paulsen, Jane S.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA		Paulsen, JS (corresponding author), Univ Iowa, Dept Psychiat, 1-305 Med Educ Bldg, Iowa City, IA 52242 USA.	jane-paulsen@uiowa.edu	Warner, Thomas T/A-1454-2013; Leavitt, Blair R/G-1934-2012; Schultz, Susan K./M-3516-2019; Paulsen, Jane/AAQ-2932-2020	Warner, Thomas T/0000-0001-6195-6995; Stout, Julie/0000-0001-9637-8590; Langbehn, Douglas/0000-0002-7803-4679; Moser, David/0000-0003-4102-5266; Bijanki, Kelly/0000-0003-1624-8767; Paulsen, Jane/0000-0002-0983-228X	National Institutes for HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40068]; CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040068] Funding Source: NIH RePORTER	This research is supported by the National Institutes for Health, National Institute of Neurological Disorders and Stroke (NS40068), and CHDI Foundation, Inc. We thank the PREDICT-HD sites, the study participants, and the National Research Roster for Huntington Disease Patients and Families.	Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Bigal M, 2008, HEADACHE, V48, P1337, DOI 10.1111/j.1526-4610.2008.01083.x; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Brandt J, 2002, J INT NEUROPSYCH SOC, V8, P918, DOI 10.1017/S1355617702870060; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; Coffey CE, 2001, J NEUROPSYCH CLIN N, V13, P471, DOI 10.1176/appi.neuropsych.13.4.471; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Decruyenaere M., 1995, Genetic Counseling, V6, P1; DEROGATIS LR, 1994, SCL R SYMPTOM CHECKL; Dichgans M, 2008, LANCET NEUROL, V7, P310, DOI 10.1016/S1474-4422(08)70046-2; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Fagerlund B, 2007, CLIN NEUROPHARMACOL, V30, P3, DOI 10.1097/01.WNF.0000240940.67241.F6; FOROUD T, 1995, ANN NEUROL, V37, P657, DOI 10.1002/ana.410370516; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; Horton AM, 2003, ARCH CLIN NEUROPSYCH, V18, P49, DOI 10.1016/S0887-6177(01)00183-4; Horton AM, 2001, INT J NEUROSCI, V111, P123, DOI 10.3109/00207450108986557; Horton AM, 2001, INT J NEUROSCI, V108, P281, DOI 10.3109/00207450108986518; Hoth KF, 2007, J CLIN EXP NEUROPSYC, V29, P365, DOI 10.1080/13803390600718958; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Langbehn DR, 2007, NEUROLOGY, V68, P1710, DOI 10.1212/01.wnl.0000261918.90053.96; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; LANGE H W, 1981, Verhandlungen der Anatomischen Gesellschaft, V75, P923; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larsson MU, 2008, NEUROPSYCHOLOGY, V22, P596, DOI 10.1037/0894-4105.22.5.596; Mahant N, 2003, NEUROLOGY, V61, P1085, DOI 10.1212/01.WNL.0000086373.32347.16; Misdraji EL, 2010, J CLIN EXP NEUROPSYC, V32, P159, DOI 10.1080/13803390902881942; OROURKE JJF, 2009, NEUROTHERAPEUTICS, V7, P147; Paulsen J, 1999, UNDERSTANDING BEHAV; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Saxton J, 2000, NEUROEPIDEMIOLOGY, V19, P312, DOI 10.1159/000026270; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tremont G, 1998, CLIN NEUROPSYCHOL, V12, P560, DOI 10.1076/clin.12.4.560.7238; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425	57	42	42	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	5					567	579	PII 933217830	10.1080/13803395.2010.541228			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	773AQ	WOS:000291279800008	21302170	Green Accepted			2022-02-06	
J	Stock, SE; Davies, DK; Wehmeyer, ML; Lachapelle, Y				Stock, Steven E.; Davies, Daniel K.; Wehmeyer, Michael L.; Lachapelle, Yves			Emerging new practices in technology to support independent community access for people with intellectual and cognitive disabilities	NEUROREHABILITATION			English	Article						Intellectual and cognitive disabilities; technology; community access	PARTICIPATION; ADULTS	The concept of community access is a multidimensional term, which may involve issues related to physical access, knowledge and information, power and control, relationships and communications, advocacy, participation and quality of life [21]. This paper discusses historical and emerging practices and interventions related to physical access to community and community based information for individuals with cognitive disabilities such as intellectual disability, autism or traumatic brain injury. While much societal attention has been paid to features of independent community access for populations such as individuals with hearing, vision or physical disabilities, less attention has focused on independent community access for people with intellectual and other significant cognitive disabilities. Attitudes and actions by families and professional service communities are often mixed for some individuals in this population. The somewhat limited research base in these areas is explored, including a case study review and results from several promising feasibility studies. The paper concludes with comments concerning future prospects and recommendations for improving independent community access for persons with significant cognitive disabilities.	[Stock, Steven E.; Davies, Daniel K.] AbleLink Technol Inc, Colorado Springs, CO USA; [Wehmeyer, Michael L.] Univ Kansas, Lawrence, KS 66045 USA; [Lachapelle, Yves] Univ Quebec, Trois Rivieres, PQ GA9 5H7, Canada		Stock, SE (corresponding author), 618 N Nevada Ave, Colorado Springs, CO 80903 USA.	steve@ablelinktech.com					AGRAN M, 1994, SKILLS INDEPENDENT L, P221; BOURLAND E, 1996, NICHCY TRANSITION SU, V9; DAVIES DK, 2008, WAYFINDER COGN UNPUB; DAVIES DK, 2010, INTELLECTUA IN PRESS; DAVIES DK, 2009, DEV EVALUATION UNPUB; Demers L., 2002, TECHNOL DISABIL, V14, P101, DOI [10.3233/TAD-2002-14304, 10.13072/midss.298, DOI 10.3233/TAD-2002-14304]; *DIR, COMM TRANSP SHOPM; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; GLAUSIER SR, 2000, CATALYST, V34, P11; GOLD MW, 1972, ADAPTIVE BEHAV PHILO; HALPERN A S, 1986, Australia and New Zealand Journal of Developmental Disabilities, V12, P147; *HUMANWARE, HUMANWARE PROD; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Kugel R. B., 1969, PRESIDENTS COMMITTEE; LEE M, 1990, PARENTS ALLIANCE EMP; Mechling L, 2010, EDUC TRAIN AUTISM DE, V45, P230; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; NIHIRA L, 1975, AM J MENT DEF, V79, P538; Nind M, 2009, DISABIL SOC, V24, P273, DOI 10.1080/09687590902789446; PORTAL ADA, ADA TRANSPORTATION S; REARDON MJ, 1993, GETTING BOARD REV TR; Stankiewicz BJ, 2007, J EXP PSYCHOL HUMAN, V33, P378, DOI 10.1037/0096-1523.33.2.378; SULLIVAN J, MOBILITY FOR ALL COM; Temple VA, 2009, INT J REHABIL RES, V32, P89, DOI 10.1097/MRR.0b013e328307f5a0; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P303, DOI 10.1111/j.1365-2788.2008.01144.x; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P54, DOI 10.1111/j.1365-2788.2008.01128.x; WEHMEYER ML, 2001, SELF DETERMINATION S	27	42	43	2	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2011	28	3					261	269		10.3233/NRE-2011-0654			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	783MF	WOS:000292086600009	21558631	Green Published			2022-02-06	
J	Doig, E; Fleming, J; Kuipers, P; Cornwell, PL				Doig, Emmah; Fleming, Jennifer; Kuipers, Pim; Cornwell, Petrea L.			Clinical Utility of the Combined Use of the Canadian Occupational Performance Measure and Goal Attainment Scaling	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; goals; occupational therapy; outcome assessment (health care); patient-centered care	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; REHABILITATION; THERAPY; CLIENT; ADULTS; SATISFACTION; DEFICITS; OUTCOMES; COMA	OBJECTIVE. We investigated the clinical utility of combined use of Goal Attainment Scaling (GAS) and the Canadian Occupational Performance Measure (COPM) to plan goals and measure progress in a community rehabilitation setting. METHOD. Fourteen participants with traumatic brain injury completed an outpatient, goal-directed 12-wk occupational therapy program; 53 goals were generated. Performance and satisfaction self-ratings and GAS ratings were collected before and after intervention. Self-awareness, motivation to change, and perceived client-centeredness measures were taken before intervention. RESULTS. Sensitivity to change was demonstrated by significant improvements after intervention for total performance self-ratings on the COPM and GAS T scores. CONCLUSION. Combined use of these tools, although time consuming, resulted in goals that were perceived almost unanimously as client centered, despite most participants' having moderate or severe impairment in self-awareness. The process also enabled subjective and objective demonstration of goal achievement, thereby supporting the clinical utility and treatment validity of the combined use of these tools.	[Doig, Emmah] Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia; [Kuipers, Pim] Princess Alexandra Hosp, Ctr Functioning Disabil & Hlth Res, Brisbane, Qld 4102, Australia; [Kuipers, Pim] Griffith Univ, Griffith Hlth Inst, Meadowbrook, Qld 4131, Australia; [Cornwell, Petrea L.] Queensland Hlth, Metro N Hlth Serv Dist, Brisbane, Qld, Australia; [Cornwell, Petrea L.] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia.	emmah.doig@optusnet.com.au	Cornwell, Petrea/AAE-5547-2019; Fleming, Jennifer M/B-4436-2011; Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286			Barnes M. D., 2000, TXB REHABILITATION M; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Chiu T, 2002, AM J OCCUP THER, V56, P217, DOI 10.5014/ajot.56.2.217; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; EAMES J, 1999, BRIT J OCCUPATIONAL, V62, P257; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming JM, 1996, BRAIN INJURY, V10, P1; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Haynes S. N., 2000, APPL CLIN P, DOI 10.1007/978-0-306-47469-9_12; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Kuipers P., 2004, BRAIN IMPAIR, V5, P30, DOI DOI 10.1375/BRIM.5.1.30.35404; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lannin Natasha, 2003, Occup Ther Health Care, V17, P43, DOI 10.1080/J003v17n01_04; Law M., 1994, CANADIAN OCCUPATIONA, V2; Law M., 1990, CANADIAN OCCUPATIONA; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; MacLeod GM, 1996, SPINAL CORD, V34, P525, DOI 10.1038/sc.1996.95; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; MIRANTI VS, 2004, HDB MOTIVATIONAL COU; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; OTTENBACHER KJ, 1993, AM J OCCUP THER, V47, P349, DOI 10.5014/ajot.47.4.349; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; PEDRETTI LW, 1996, OCCUPATIONAL THERAPY, P293; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Playford ED, 2000, CLIN REHABIL, V14, P491, DOI 10.1191/0269215500cr343oa; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rockwood K, 2003, J CLIN EPIDEMIOL, V56, P736, DOI 10.1016/S0895-4356(03)00132-X; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SHORDONE RJ, 1996, ECOLOGICAL VALIDITY; STEIN R, 2000, CLIN RES OCCUPATIONA; TEASDALE G, 1974, LANCET, V2, P81; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; WILSON BA, 2003, BRAIN IMPAIR, V4, P25, DOI DOI 10.1375/BRIM.4.1.25.27030; World Health Organization, 2007, INT CLASS FUNCT DIS; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	41	42	42	1	16	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	2010	64	6					904	914		10.5014/ajot.2010.08156			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	692SN	WOS:000285175500010	21218681	Green Published			2022-02-06	
J	Herrera, JJ; Sundberg, LM; Zentilin, L; Giacca, M; Narayana, PA				Herrera, Juan J.; Sundberg, Laura M.; Zentilin, Lorena; Giacca, Mauro; Narayana, Ponnada A.			Sustained Expression of Vascular Endothelial Growth Factor and Angiopoietin-1 Improves Blood-Spinal Cord Barrier Integrity and Functional Recovery after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						angiopoietin-1; magnetic resonance imaging; traumatic spinal cord injury; vascular endothelial growth factor; viral mediated transfection	RECOMBINANT ADENOASSOCIATED VIRUS; GENE-TRANSFER; BRAIN-BARRIER; TIE2 RECEPTOR; RATING-SCALE; VEGF; PERMEABILITY; ANGIOGENESIS; ISCHEMIA; NEOVASCULARIZATION	Spinal cord injury (SCI) results in immediate disruption of the spinal vascular network, triggering an ischemic environment and initiating secondary degeneration. Promoting angiogenesis and vascular stability through the induction of vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1), respectively, provides a possible therapeutic approach in treating SCI. We examined whether supplementing the injured environment with these two factors, which are significantly reduced following injury, has an effect on lesion size and functional outcome. Sustained delivery of both VEGF(165) and Ang-1 was realized using viral vectors based on the adeno-associated virus (AAV), which were injected directly into the lesion epicenter immediately after injury. Our results indicate that the combined treatment with VEGF and Ang-1 resulted in both reduced hyperintense lesion volume and vascular stabilization, as determined by magnetic resonance imaging (MRI). Western blot analysis indicated that the viral vector expression was maintained into the chronic phase of injury, and that the use of the AAV vectors did not exacerbate infiltration of microglia into the lesion epicenter. The combined treatment with AAV-VEGF and AAV-Ang-1 improved locomotor recovery in the chronic phase of injury. These results indicate that combining angiogenesis with vascular stabilization may have potential therapeutic applications following SCI.	[Herrera, Juan J.; Sundberg, Laura M.; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Zentilin, Lorena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy; [Giacca, Mauro] Univ Trieste, Fac Med, Dept Biomed, Trieste, Italy		Herrera, JJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, 6431 Fannin,MSE R102F, Houston, TX 77030 USA.	Juan.Herrera@uth.tmc.edu	Giacca, Mauro/J-9287-2016	Giacca, Mauro/0000-0003-2927-7225	NIH/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045624]; NIH/National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10 RR17205-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR017205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045624] Funding Source: NIH RePORTER	This work is supported by NIH/National Institute of Neurological Disorders and Stroke (NINDS) grant NS045624 to P.A.N. The 7-T MRI scanner was funded by the NIH/National Center for Research Resources under the High End Instrumentation Program (grant S10 RR17205-01 to P.A.N.). The NIH is not responsible for the contents of this manuscript.	Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940; Bilgen M, 2001, MAGNET RESON MED, V45, P614, DOI 10.1002/mrm.1083; Bitto A, 2008, CLIN SCI, V114, P707, DOI 10.1042/CS20070250; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen F, 2007, EUR J PHARMACOL, V568, P222, DOI 10.1016/j.ejphar.2007.04.047; Chen F, 2007, ACTA PHARMACOL SIN, V28, P493, DOI 10.1111/j.1745-7254.2007.00527.x; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Croll SD, 2001, MOL NEUROBIOL, V23, P121, DOI 10.1385/MN:23:2-3:121; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fenyes DA, 1998, MAGN RESON IMAGING, V16, P1249, DOI 10.1016/S0730-725X(98)00093-9; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hermens WTJMC, 1998, PROG NEUROBIOL, V55, P399, DOI 10.1016/S0301-0082(98)00007-0; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; HOLTZ A, 1990, NEUROSURGERY, V26, P952, DOI 10.1227/00006123-199006000-00005; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; Mills CD, 2001, J NEUROTRAUM, V18, P1091, DOI 10.1089/08977150152693773; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Peng XM, 2006, ANN NEUROL, V59, P843, DOI 10.1002/ana.20855; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Suidan GL, 2010, J IMMUNOL, V184, P1031, DOI 10.4049/jimmunol.0902773; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Svensson EC, 1999, CIRCULATION, V99, P201, DOI 10.1161/01.CIR.99.2.201; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; WEIRICH SD, 1990, SPINE, V15, P630, DOI 10.1097/00007632-199007000-00004; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Zacchigna S, 2007, HUM GENE THER, V18, P515, DOI 10.1089/hum.2006.162; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6; Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562	62	42	46	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2010	27	11					2067	2076		10.1089/neu.2010.1403			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	682BZ	WOS:000284375500013	20799882	Green Published, Green Submitted			2022-02-06	
J	Strangman, GE; O'Neil-Pirozzi, TM; Supelana, C; Goldstein, R; Katz, DI; Glenn, MB				Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Supelana, Christina; Goldstein, Richard; Katz, Douglas I.; Glenn, Mel B.			Regional brain morphometry predicts memory rehabilitation outcome after traumatic brain injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						cognitive rehabilitation; memory; structural neuroimaging; behavioral neurology; morphometrics; semantic clustering; brain trauma	HUMAN CEREBRAL-CORTEX; COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; WORKING-MEMORY; PREFRONTAL CORTEX; HEAD TRAUMA; MODERATE; MILD; MRI; RECOVERY	Cognitive deficits following traumatic brain injury (TBI) commonly include difficulties with memory, attention, and executive dysfunction. These deficits are amenable to cognitive rehabilitation, but optimally selecting rehabilitation programs for individual patients remains a challenge. Recent methods for quantifying regional brain morphometry allow for automated quantification of tissue volumes in numerous distinct brain structures. We hypothesized that such quantitative structural information could help identify individuals more or less likely to benefit from memory rehabilitation. Fifty individuals with TBI of all severities who reported having memory difficulties first underwent structural MRI scanning. They then participated in a 12 session memory rehabilitation program emphasizing internal memory strategies (I-MEMS). Primary outcome measures (HVLT, RBMT) were collected at the time of the MRI scan, immediately following therapy, and again at 1-month post-therapy. Regional brain volumes were used to predict outcome, adjusting for standard predictors (e. g., injury severity, age, education, pretest scores). We identified several brain regions that provided significant predictions of rehabilitation outcome, including the volume of the hippocampus, the lateral prefrontal cortex, the thalamus, and several subregions of the cingulate cortex. The prediction range of regional brain volumes were in some cases nearly equal in magnitude to prediction ranges provided by pretest scores on the outcome variable. We conclude that specific cerebral networks including these regions may contribute to learning during I-MEMS rehabilitation, and suggest that morphometric measures may provide substantial predictive value for rehabilitation outcome in other cognitive interventions as well.	[Strangman, Gary E.; Supelana, Christina] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Strangman, Gary E.; O'Neil-Pirozzi, Therese M.; Supelana, Christina; Goldstein, Richard; Glenn, Mel B.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Glenn, Mel B.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA		Strangman, GE (corresponding author), Dept Psychiat, Neural Syst Grp, 149 13th St,Suite 2651, Charlestown, MA 02129 USA.	strang@nmr.mgh.harvard.edu		Strangman, Gary/0000-0001-8896-2164; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research, Department of Education [H133A020513]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS: K25-NS046554]; National Institute on Disability and Rehabilitation Research [H133A020513]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25-NS046554]	We would like to thank Dana Christina, Kalika Kelkar, the Statewide Head Injury Program, and Community Rehabilitation Care for their help and support. The contents of this publication were developed under a grant from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A020513). However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. Funding for this project also came from the NIH (NINDS: K25-NS046554). Supported by National Institute on Disability and Rehabilitation Research (grant no. H133A020513), and the National Institute of Neurological Disorders and Stroke (grant no. K25-NS046554).	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chen KW, 2004, NEUROIMAGE, V22, P134, DOI 10.1016/j.neuroimage.2004.01.002; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cramer SC, 2004, STROKE, V35, P2695, DOI 10.1161/01.STR.0000143326.36847.b0; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper N.R., 1998, APPL REGRESSION ANAL; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Giles GM, 2001, BRAIN DAM B, P231; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KENNEDY DN, 1989, IEEE T MED IMAGING, V8, P1, DOI 10.1109/42.20356; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Mega MS, 2005, NEUROIMAGE, V26, P1009, DOI 10.1016/j.neuroimage.2005.03.031; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Messinger A, 2009, J NEUROSCI, V29, P5640, DOI 10.1523/JNEUROSCI.3857-08.2009; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; SCHMANSKY N, 2010, DESTRIEUX ATLAS CHAN; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412	61	42	43	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 14	2010	4								182	10.3389/fnhum.2010.00182			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	747GR	WOS:000289308800001	21048895	gold, Green Published			2022-02-06	
J	Sady, MD; Sander, AM; Clark, AN; Sherer, M; Nakase-Richardson, R; Malec, JF				Sady, Maegan D.; Sander, Angelle M.; Clark, Allison N.; Sherer, Mark; Nakase-Richardson, Risa; Malec, James F.			Relationship of Preinjury Caregiver and Family Functioning to Community Integration in Adults With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Family; Caregivers; Rehabilitation	SOCIAL SUPPORT; HEAD-INJURY; PREDICTING RETURN; WORK; RELIABILITY; PARTICIPATION; QUESTIONNAIRE; DISABILITY; SURVIVORS; OUTCOMES	Sady MD, Sander AM, Clark AN, Sherer M, Nakase-Richardson R, Malec JF. Relationship of preinjury caregiver and family functioning to community integration in adults with traumatic brain injury. Arch Phys Med Rehabil 2010;91:1542-50. Objective: To investigate the relationship of preinjury caregiver and family functioning to community integration outcomes in persons with traumatic brain injury (TBI). Design: Inception cohort. Setting: Three TBI Model Systems inpatient rehabilitation facilities. Participants: Persons with TBI (N=141) and their caregivers admitted to inpatient rehabilitation and followed up at 1 to 2 years after injury. Interventions: Not applicable. Main Outcome Measures: Community Integration Questionnaire and the Social and Occupation scales of the Craig Handicap Assessment and Reporting Technique. Results: There were significant interactions of several preinjury caregiver and family variables with injury severity. For persons with complicated mild/moderate injury, better family functioning was associated with greater home integration, and less caregiver distress was associated with better social integration. For persons with severe injuries, greater caregiver perceived social support was associated with better outcomes in productivity and social integration. Conclusions: Preinjury caregiver and family characteristics interact with injury severity to affect outcomes in persons with injury. Research on outcomes should include measures of caregiver and family functioning. Early interventions targeted toward decreasing caregiver distress, increasing support, and improving family functioning may have a positive impact on later outcomes.	[Sady, Maegan D.; Sander, Angelle M.; Clark, Allison N.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX 77019 USA; [Sady, Maegan D.] Univ Houston, Dept Psychol, Houston, TX USA; [Sander, Angelle M.; Clark, Allison N.; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Psychol Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA		Sander, AM (corresponding author), TIRR Mem Hermann, Brain Injury Res Ctr, 2323 S Shepherd Dr,Ste 907, Houston, TX 77019 USA.	asander@bcm.edu		Sady, Maegan/0000-0002-1438-4477			Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Brandt EN, 1997, ENABLING AM ASSESSIN; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1995, J INT NEUROPSYCH SOC, V1, P66; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; GRAVETTER FJ, 2007, STAT BEHAV SCI, P291; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAZARIAN SS, 1991, J COMMUNITY PSYCHOL, V19, P150, DOI 10.1002/1520-6629(199104)19:2<150::AID-JCOP2290190206>3.0.CO;2-J; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Oddy M, 2008, PSYCHOL APPROACHES R, P431; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; WEST M, 1990, VOCATIONAL REHABILIT, P201; WHITENECK G, 1988, GUIDE USE CHART CRAI; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1980, INT CLASS IMP DIS HA; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	60	42	42	1	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2010	91	10					1542	1550		10.1016/j.apmr.2010.07.012			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	661IT	WOS:000282720300009	20875512				2022-02-06	
J	Armstead, WM; Kiessling, JW; Kofke, WA; Vavilala, MS				Armstead, William M.; Kiessling, J. Willis; Kofke, W. Andrew; Vavilala, Monica S.			Impaired cerebral blood flow autoregulation during posttraumatic arterial hypotension after fluid percussion brain injury is prevented by phenylephrine in female but exacerbated in male piglets by extracellular signal-related kinase mitogen-activated protein kinase upregulation	CRITICAL CARE MEDICINE			English	Article						cerebral circulation; pediatric; traumatic brain injury; signal transduction; autoregulation	INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ISCHEMIC BRAIN; ADRENOMEDULLIN; GENDER; CHILDREN; AGE; NEWBORN; OCCLUSION; MEMORY	Objective: Traumatic brain injury contributes to morbidity and mortality in children and boys are disproportionately represented. Hypotension is common and worsens outcome after traumatic brain injury. Extracellular signal-related kinase mitogen-activated protein kinase is upregulated and reduces cerebral blood flow after fluid percussion brain injury in piglets. We hypothesized that increased cerebral perfusion pressure through phenylephrine sex dependently reduces impairment of cerebral autoregulation during hypotension after fluid percussion brain injury through modulation of extracellular signal-related kinase mitogen-activated protein kinase. Design: Prospective, randomized animal study. Setting: University laboratory. Subjects: Newborn (1-to 5-day-old) pigs. Interventions: Cerebral blood flow, pial artery diameter, intracranial pressure, and autoregulatory index were determined before and after fluid percussion brain injury in untreated, preinjury, and postinjury phenylephrine (1 mu g/kg/min intravenously) treated male and female pigs during normotension and hemorrhagic hypotension. Cerebrospinal fluid extracellular signal-related kinase mitogen-activated protein kinase was determined by enzyme-linked immunosorbent assay. Measurements and Main Results: Reductions in pial artery diameter, cerebral blood flow, cerebral perfusion pressure, and elevated intracranial pressure after fluid percussion brain injury were greater in males, which were blunted by phenylephrine pre- or postfluid percussion brain injury. During hypotension and fluid percussion brain injury, pial artery dilation was impaired more in males. Phenylephrine decreased impairment of hypotensive pial artery dilation after fluid percussion brain injury in females, but paradoxically caused vasoconstriction after fluid percussion brain injury in males. Papaverine-induced pial artery vasodilation was unchanged by fluid percussion brain injury and phenylephrine. Cerebral blood flow, cerebral perfusion pressure, and autoregulatory index decreased markedly during hypotension and fluid percussion brain injury in males but less in females. Phenylephrine prevented reductions in cerebral blood flow, cerebral perfusion pressure, and autoregulatory index during hypotension in females but increased reductions in males. Cerebrospinal fluid extracellular signal-related kinase mitogen-activated protein kinase was increased more in males than females after fluid percussion brain injury. Phenylephrine blunted extracellular signal-related kinase mitogen-activated protein kinase upregulation in females but increased extracellular signal-related kinase mitogen-activated protein kinase upregulation in males after fluid percussion brain injury. Conclusions: These data indicate that elevation of cerebral perfusion pressure with phenylephrine sex dependently prevents impairment of cerebral autoregulation during hypotension after fluid percussion brain injury through modulation of extracellular signal-related kinase mitogen-activated protein kinase. These data suggest the potential role for sex-dependent mechanisms in cerebral autoregulation after pediatric traumatic brain injury. (Crit Care Med 2010; 38:1868-1874)	[Armstead, William M.; Kiessling, J. Willis; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	Supported by grant HD57355 from the National Institutes of Health.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS5; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; DOBBING J, 1974, PEDIATRICS, V53, P2; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Juhl L, 2006, EUR J PHARMACOL, V538, P101, DOI 10.1016/j.ejphar.2006.03.005; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Miyashita K, 2006, ENDOCRINOLOGY, V147, P1642, DOI 10.1210/en.2005-1038; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480	36	42	42	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2010	38	9					1868	1874		10.1097/CCM.0b013e3181e8ac1a			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RK	WOS:000281559500014	20562700	Green Accepted			2022-02-06	
J	Williams, G; Galna, B; Morris, ME; Olver, J				Williams, Gavin; Galna, Brook; Morris, Meg E.; Olver, John			Spatiotemporal Deficits and Kinematic Classification of Gait Following a Traumatic Brain Injury: A Systematic Review	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain trauma; gait disorders/ataxia; rehabilitation; review literature	BOTULINUM-TOXIN-A; INTRATHECAL BACLOFEN; SPASTIC HEMIPLEGIA; HEAD-INJURY; RECOVERY; REHABILITATION; PATTERNS; BALANCE; PERFORMANCE; AMBULATION	Objective: To identify the key biomechanical gait abnormalities resulting from traumatic brain injury (TBI) and determine whether the abnormalities support a system for the classification of gait disorders. Design: Systematic review with data from quantitative studies synthesized in a narrative format. Participants: Adults with TBI. Outcome measures: Spatiotemporal, kinematic, and kinetic parameters of classification systems. Results: The search identified 38 articles that reported on various methods for gait assessment in TBI. Three-dimensional gait analysis (3DGA) was used in 15 studies, primarily to quantify spatiotemporal parameters. Results revealed that people with a TBI walked more slowly with shorter steps and greater mediolateral sway following TBI. Stepping over obstacles, walking with eyes closed, or performing dual tasks accentuated gait deficits. Only one small study reported kinematic data for the major lower limb joints in 8 well recovered patients. One further study used 3DGA to classify the gait patterns of people with TBI but this classification was based on methods developed for stroke and cerebral palsy. No studies attempted to develop a classification system on the basis of the gait disorders of people with TBI. Conclusion: Although the studies were generally of high quality, little is known about the nature of gait disorders following TBI. Classification based on systematic description of gait disorders following TBI has not been attempted.	[Williams, Gavin] Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic 3121, Australia; [Williams, Gavin; Galna, Brook; Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au		Olver, John/0000-0001-7069-1191; Galna, Brook/0000-0002-5890-1894; Morris, Meg/0000-0002-0114-4175; Williams, Gavin/0000-0003-2758-7473			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; BOGATAJ U, 1989, PHYS THER, V69, P319, DOI 10.1093/ptj/69.5.319; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Chang FM, 2006, J PEDIATR ORTHOPED, V26, P612, DOI 10.1097/01.bpo.0000229970.55694.5c; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chua KSG, 2000, ARCH PHYS MED REHAB, V81, P1432, DOI 10.1053/apmr.2000.9395; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; de Morais MC, 2008, GAIT POSTURE, V28, P316, DOI 10.1016/j.gaitpost.2008.01.013; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Freivogel S, 2008, BRAIN INJURY, V22, P625, DOI 10.1080/02699050801941771; Gradenigo B, 2002, EURA MEDICOPHYS, V38, P215; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Horn TS, 2005, ARCH PHYS MED REHAB, V86, P1127, DOI 10.1016/j.apmr.2004.11.013; Hosalkar H, 2008, CLIN ORTHOP RELAT R, V466, P2500, DOI 10.1007/s11999-008-0395-0; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kerrigan DC, 1996, ARCH PHYS MED REHAB, V77, P645, DOI 10.1016/S0003-9993(96)90002-7; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Law M, 2002, EVIDENCE BASED REHAB; LEE EH, 1992, ARCH PHYS MED REHAB, V73, P642; Lee LW, 1997, AM J PHYS MED REHAB, V76, P502, DOI 10.1097/00002060-199711000-00013; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MALEZIC M, 1992, J REHABIL RES DEV, V29, P41, DOI 10.1682/JRRD.1992.10.0041; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Molteni F, 1995, EUR J NEUROL, V2, P61; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Pohl M, 2006, CLIN REHABIL, V20, P324, DOI 10.1191/0269215506cr951oa; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Remy-Neris O, 2003, ARCH PHYS MED REHAB, V84, P643, DOI 10.1016/S0003-9993(02)04906-7; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; SWEENEY JK, 1983, PHYS THER, V63, P2018, DOI 10.1093/ptj/63.12.2018; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Toro B, 2003, ARCH PHYS MED REHAB, V84, P1878, DOI 10.1016/S0003-9993(03)00482-9; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Watson MJ, 2007, DISABIL REHABIL, V29, P231, DOI 10.1080/09638280600756299; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437	57	42	43	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					366	374		10.1097/HTR.0b013e3181cd3600			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400010	20142759				2022-02-06	
J	Ariyannur, PS; Moffett, JR; Madhavarao, CN; Arun, P; Vishnu, N; Jacobowitz, DM; Hallows, WC; Denu, JM; Namboodiri, AMA				Ariyannur, Prasanth S.; Moffett, John R.; Madhavarao, Chikkathur N.; Arun, Peethambaran; Vishnu, Nisha; Jacobowitz, David M.; Hallows, William C.; Denu, John M.; Namboodiri, Aryan M. A.			Nuclear-Cytoplasmic Localization of Acetyl Coenzyme A Synthetase-1 in the Rat Brain	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						immunohistochemistry; acetate; histone acetylation; gene expression; lipid synthesis; traumatic brain injury; N-acetylaspartate; oligodendrocytes; neurons	L-ASPARTIC ACID; N-ACETYLASPARTATE SYNTHESIS; ATP-CITRATE LYASE; COA SYNTHETASE; HISTONE ACETYLATION; A SYNTHETASE; ACETATE; ENZYME; ASPARTOACYLASE; ACETYLCHOLINE	Acetyl coenzyme A synthetase-1 (AceCS1) catalyzes the synthesis of acetyl coenzyme A from acetate and coenzyme A and is thought to play diverse roles ranging from fatty acid synthesis to gene regulation. By using an affinity-purified antibody generated against an 18-mer peptide sequence of AceCS1 and a polyclonal antibody directed against recombinant AceCS1 protein, we examined the expression of AceCS1 in the rat brain. AceCS1 immunoreactivity in the adult rat brain was present predominantly in cell nuclei, with only light to moderate cytoplasmic staining in some neurons, axons, and oligodendrocytes. Some nonneuronal cell nuclei were very strongly immunoreactive, including those of some oligodendrocytes, whereas neuronal nuclei ranged from unstained to moderately stained. Both antibodies stained some neuronal cell bodies and axons, especially in the hindbrain. AceCS1 immunoreactivity was stronger and more widespread in the brains of 18-day-old rats than in adults, with increased expression in oligodendrocytes and neurons, including cortical pyramidal cells. Expression of AceCS1 was substantially up-regulated in neurons throughout the brain after controlled cortical impact injury. The strong AceCS1 expression observed in the nuclei of CNS cells during brain development and after injury is consistent with a role in nuclear histone acetylation and therefore the regulation of chromatin structure and gene expression. The cytoplasmic staining observed in some oligodendrocytes, especially during postnatal brain development, suggests an additional role in CNS lipid synthesis and myelination. Neuronal and axonal localization implicates AceCS1 in cytoplasmic acetylation reactions in some neurons. J. Comp. Neurol. 518:2952-2977, 2010. (C) 2010 Wiley-Liss, Inc.	[Ariyannur, Prasanth S.; Moffett, John R.; Madhavarao, Chikkathur N.; Arun, Peethambaran; Vishnu, Nisha; Jacobowitz, David M.; Namboodiri, Aryan M. A.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Mol & Cell Biol Program, Bethesda, MD 20814 USA; [Ariyannur, Prasanth S.; Moffett, John R.; Madhavarao, Chikkathur N.; Arun, Peethambaran; Vishnu, Nisha; Jacobowitz, David M.; Namboodiri, Aryan M. A.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Hallows, William C.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA		Namboodiri, AMA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Mol & Cell Biol Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	anamboodiri@usuhs.mil	Ariyannur, Prasanth S./C-1280-2008	Ariyannur, Prasanth S./0000-0003-0888-8094; Madhavarao, Chikkathur/0000-0003-3392-1159	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS39387]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZO-1-MH-00388-31 LCS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM065386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01MH000388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039387] Funding Source: NIH RePORTER	Grant sponsor: National Institutes of Health; Grant number: RO1 NS39387 (to A.M.A.N.); Grant sponsor: National Institute of Mental Health; Grant number: ZO-1-MH-00388-31 LCS (to D.M.J.).	Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Baurle J, 1999, NEUROREPORT, V10, P3517; BENJAMIN AM, 1981, SCIENCE, V213, P1495, DOI 10.1126/science.7280667; Blum S, 1999, J MAGN RESON, V136, P219, DOI 10.1006/jmre.1998.1618; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Carroll PT, 1997, BRAIN RES, V753, P47, DOI 10.1016/S0006-8993(96)01485-0; Falcon AA, 2010, MOL CELL BIOCHEM, V333, P99, DOI 10.1007/s11010-009-0209-z; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Goldberg R P, 1980, Adv Exp Med Biol, V132, P413; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hershfield JR, 2006, FASEB J, V20, P2139, DOI 10.1096/fj.05-5358fje; IMESCH E, 1984, INT J BIOCHEM, V16, P875, DOI 10.1016/0020-711X(84)90146-0; Ingram-Smith Cheryl, 2007, Archaea, V2, P95; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; Kirmani BF, 2003, DEV BRAIN RES, V140, P105, DOI 10.1016/S0165-3806(02)00592-8; Kirmani BF, 2002, MOL BRAIN RES, V107, P176, DOI 10.1016/S0169-328X(02)00490-4; Klugmann M, 2003, NEUROREPORT, V14, P1837, DOI 10.1097/00001756-200310060-00016; KORNACKER MS, 1965, BIOCHEM J, V94, P209, DOI 10.1042/bj0940209; Kuang Y, 2007, J BIOCHEM BIOPH METH, V70, P649, DOI 10.1016/j.jbbm.2007.02.008; KWOK YN, 1982, J NEUROCHEM, V39, P16, DOI 10.1111/j.1471-4159.1982.tb04696.x; Loikkanen D, 2002, MECH DEVELOP, V115, P139, DOI 10.1016/S0925-4773(02)00097-7; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; MASSA PT, 1982, NEUROSCIENCE, V7, P523; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Namboodiri MAA, 2000, MOL BRAIN RES, V77, P285, DOI 10.1016/S0169-328X(00)00068-1; Papay R, 2006, J COMP NEUROL, V497, P209, DOI 10.1002/cne.20992; POW DV, 1993, J NEUROSCI METH, V48, P51, DOI 10.1016/S0165-0270(05)80007-X; Sakakibara I, 2009, CELL METAB, V9, P191, DOI 10.1016/j.cmet.2008.12.008; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Suematsu N, 2002, ACTA BIOCHIM POL, V49, P937; SZUTOWICZ A, 1980, J NEUROCHEM, V35, P775, DOI 10.1111/j.1471-4159.1980.tb07073.x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TALLAN HH, 1957, J BIOL CHEM, V224, P41; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WOODNUTT G, 1978, BIOCHEM J, V175, P757, DOI 10.1042/bj1750757	48	42	42	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	AUG 1	2010	518	15					2952	2977		10.1002/cne.22373			26	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	615EO	WOS:000279116500004	20533355	Green Accepted			2022-02-06	
J	Mihalik, JP; Greenwald, RM; Blackburn, JT; Cantu, RC; Marshall, SW; Guskiewicz, KM				Mihalik, Jason P.; Greenwald, Richard M.; Blackburn, J. Troy; Cantu, Robert C.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Effect of Infraction Type on Head Impact Severity in Youth Ice Hockey	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						ADOLESCENT ATHLETE; BIOMECHANICS; CONCUSSION; HELMETS; TRAUMATIC BRAIN INJURY	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; SPINAL-INJURIES; CONCUSSION; ACCELERATION; SPORTS; BIOMECHANICS; MAGNITUDE	MIHALIK, J. P., R. M. GREENWALD, J. T. BLACKBURN, R. C. CANTU, S. W. MARSHALL, and K. M. GUSKIEWICZ. Effect of Infraction Type on Head Impact Severity in Youth Ice Hockey. Med. Sci. Sports Exerc., Vol. 42, No. 8, pp. 1431-1438, 2010. Purpose: To identify the effects of infractions sustained during participation in youth ice hockey on biomechanical measures of head impact severity. Methods: Sixteen adolescent Bantam-aged male ice hockey players (age = 14.0 +/- 0.5 yr, height = 171.3 +/- 4.5 cm, mass = 63.7 +/- 6.6 kg) were equipped with accelerometer-instrumented helmets to collect biomechanical measures relating to head impacts (linear acceleration, rotational acceleration, and Head Impact Technology severity profile (HITsp)) sustained while participating in ice hockey. Single-camera video footage from 54 games was synchronized with the head impact data, and all viewable collisions (n = 665) were evaluated as resulting from a legal collision or an infraction. Infractions were further categorized into boarding or charging, checking from behind, and elbowing or intentional head contact. Statistical analyses included random-intercepts general linear mixed models. Results: Infractions were observed in 17.3% (115/665) of all body collisions. Overall, collisions involving infractions had higher linear accelerations (P = 0.012) and HITsp (P = 0.021) than collisions with no infraction. Specifically, elbowing, head contact, and high sticking infractions resulted in greater linear acceleration (P = 0.005) and HITsp (P = 0.010) than collisions with no infraction. A strong trend for higher rotational accelerations in this infraction type compared with legal collisions was also present (P = 0.059). Conclusions: Infractions result in higher measures of head impact severity than noninfraction collisions. Athletes and coaches should conform to playing rules, and officials should enforce more stringently existing rules and assess more severe penalties to participants who purposefully attempt to foul an opponent at the youth ice hockey level.	[Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Mihalik, Jason P.; Blackburn, J. Troy; Guskiewicz, Kevin M.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Neuromuscular Res Lab, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Dept Sport Med, Concord, MA USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA		Mihalik, JP (corresponding author), 209 Fetzer Gymnasium,South Rd,Campus Box 8700, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233	Ontario Neurotrauma Foundation (Toronto, Ontario, Canada) [2005-PREV-BANT-387]; USA Hockey Foundation (Colorado Springs, CO); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); engineering team at Simbex (Lebanon, NH); HIT System technology	This study was supported in part by a grant from the Ontario Neurotrauma Foundation (Toronto, Ontario, Canada) to the University of North Carolina at Chapel Hill Injury Prevention Research Center (grant No. 2005-PREV-BANT-387). The USA Hockey Foundation (Colorado Springs, CO) and the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS) also provided financial support.; The authors also thank the engineering team at Simbex (Lebanon, NH) for their continued support of this project.; Dr. Greenwald has a financial interest in the HIT System technology used to collect data for this study.	ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chu JJ, 2006, J BIOMECH S1, V39, pS534; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gwin J. T., 2009, J ASTM INT, V6, P1; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LANGLOIS JA, 2004, TRAUMATIC BRAIN INJU, P70; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MARCOTTE G, 1993, ASTM STP, V1212, P103, DOI DOI 10.1520/STP13128S; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARAYRE R, 1989, ASTM STP, V1050, P37; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Sutherland G W, 1976, Am J Sports Med, V4, P264, DOI 10.1177/036354657600400605; Tator CH, 1997, CLIN J SPORT MED, V7, P17, DOI 10.1097/00042752-199701000-00004; Tator CH, 2009, CLIN J SPORT MED, V19, P451, DOI 10.1097/JSM.0b013e3181bd0db6; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	31	42	42	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2010	42	8					1431	1438		10.1249/MSS.0b013e3181d2521a			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	626PH	WOS:000279977500001	20139779				2022-02-06	
J	Smith, JS; Anderson, R; Pham, T; Bhatia, N; Steward, O; Gupta, R				Smith, Jeremy S.; Anderson, Ryan; Pham, Thu; Bhatia, Nitin; Steward, Oswald; Gupta, Ranjan			Role of Early Surgical Decompression of the Intradural Space After Cervical Spinal Cord Injury in an Animal Model	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							FORELIMB MOTOR FUNCTION; QUANTITATIVE ASSESSMENT; RATS; RECOVERY; PATHOPHYSIOLOGY; COMPRESSION; SURGERY; TRAUMA; BRAIN; MICE	Background: The role of decompressing the intradural space through a durotomy as a treatment option for acute traumatic cervical spinal cord injury has not been explored in an animal model, to our knowledge. We sought to determine the role of durotomy and duraplasty in the treatment of acute cervical spinal cord injury and its effects on inflammation, scar formation, and functional recovery. Methods: Seventy-two adult female Sprague-Dawley rats were assigned to three groups: contusion injury alone, contusion injury with a decompressive durotomy, and contusion injury with a decompressive durotomy followed by placement of a dural allograft. A mild (200-kdyn [2-N]) contusive injury was delivered to the exposed spinal cord at C5. The injured segment was reexposed four hours after injury, and a durotomy with decompression was performed. When a dural allograft was used it was affixed to the surrounding intact dura with use of a fibrin sealant. The Grip Strength Meter was used to assess forelimb function. Animals were killed at two and four weeks, and immunohistochemical analysis was performed to assess scar formation, inflammatory cell infiltration, and lesional volume. Results: Immunohistochemical analysis revealed increased scar formation, cavitation, and inflammatory response in the animals treated only with a decompressive durotomy. Relative to the group with a contusion injury alone, the animals treated with a durotomy followed by a dural allograft had decreased cavitation and scar formation. Lesional volume measurements showed a significantly increased cavitation size at four weeks in both the contusion-only (mean and standard deviation, 12.6 +/- 0.5 mm(3)) and durotomy-only (15.1 +/- 1 mm(3)) groups relative to the animals that had received a dural allograft following durotomy (6.8 +/- 1.4 mm(3)). Conclusions: Functional recovery after acute cervical spinal cord injury was better in animals treated with decompression of the intradural space and placement of a dural allograft than it was in animals treated with decompression alone. These functional data correlated directly with histological evidence of a decrease in spinal cord cavitation, inflammation, and scar formation.	[Smith, Jeremy S.; Anderson, Ryan; Pham, Thu; Bhatia, Nitin; Steward, Oswald; Gupta, Ranjan] Univ Calif Irvine, Irvine, CA USA		Smith, JS (corresponding author), Univ Calif, Dept Orthopaed Surg, Irvine Med Ctr, 101 City Dr S, Orange, CA 92868 USA.	jssmith@uci.edu		Steward, Oswald/0000-0001-7069-8756	NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Roman Reed Foundation	In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants in excess of $10,000 from the NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke) and the Roman Reed Foundation. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity.	Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Anderson KD, 2004, EXP NEUROL, V190, P184, DOI 10.1016/j.expneurol.2004.06.029; Anderson KD, 2007, EXP NEUROL, V206, P318, DOI 10.1016/j.expneurol.2007.05.024; Anderson KD, 2009, EXP NEUROL, V220, P23, DOI 10.1016/j.expneurol.2009.08.020; Anderson KD, 2009, EXP NEUROL, V220, P9, DOI 10.1016/j.expneurol.2009.06.012; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f; FERNANDEZ E, 1985, ACTA NEUROCHIR, V76, P145, DOI 10.1007/BF01418478; Flanders AE, 1999, AM J NEURORADIOL, V20, P926; FUJII H, 1993, SPINE, V18, P2030, DOI 10.1097/00007632-199310001-00017; Horn TS, 2005, ARCH PHYS MED REHAB, V86, P1127, DOI 10.1016/j.apmr.2004.11.013; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Klekamp J, 2001, NEUROSURGERY, V48, P174, DOI 10.1097/00006123-200101000-00031; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; LEVI L, 1991, NEUROSURGERY, V29, P216, DOI 10.1227/00006123-199108000-00008; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; PERKINS PG, 1988, INJURY, V19, P397, DOI 10.1016/0020-1383(88)90132-5; Rasband W.S., IMAGEJ IMAGE PROCESS; Rosenfeld RA, 1998, SOC SCI RES, V27, P23, DOI 10.1006/ssre.1997.0609; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006	28	42	48	0	5	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192 USA	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	MAY	2010	92A	5					1206	1214		10.2106/JBJS.I.00740			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	591WH	WOS:000277335400018	20439667	Green Published			2022-02-06	
J	Padayachy, LC; Figaji, AA; Bullock, MR				Padayachy, Llewellyn C.; Figaji, Anthony A.; Bullock, M. R.			Intracranial pressure monitoring for traumatic brain injury in the modern era	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Intracranial pressure; Brain monitoring; Children; Neurocritical care	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; AGGRESSIVE TREATMENT; CLINICAL-EVALUATION; CRITICAL THRESHOLDS; OXYGEN-CONSUMPTION; INTENSIVE-CARE; BLOOD-PRESSURE; TISSUE OXYGEN	Intracranial pressure (ICP) has become a cornerstone of care in adult and pediatric patients with traumatic brain injury (TBI). Despite the fact that continuous monitoring of ICP in TBI was described almost 60 years ago, there are no randomized trials confirming the benefit of ICP monitoring and treatment in TBI. There is, however, a large body of clinical evidence showing that ICP monitoring influences treatment and leads to better outcomes if part of protocol-driven therapy. However, treatment of ICP has adverse effects, and there are several questions about ICP management that have yet to be definitively answered, particularly in pediatric TBI. This review examines the history and evolution of ICP monitoring, pathophysiological concepts that influence ICP interpretation, ongoing controversies, and the place of ICP monitoring in modern neurocritical care.	[Figaji, Anthony A.] Red Cross Childrens Hosp, ZA-7700 Cape Town, South Africa; [Bullock, M. R.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Padayachy, Llewellyn C.; Figaji, Anthony A.] Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, ZA-7925 Cape Town, South Africa		Figaji, AA (corresponding author), Red Cross Childrens Hosp, 617 ICH Bldg,Klipfontein Rd, ZA-7700 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Padayachy, Llewellyn/AAD-3821-2019	Figaji, Anthony/0000-0002-3357-6490	National Research Foundation [GUN 2072790]	This work was supported in part by a grant from the South Africa-Swedish Links Program/National Research Foundation (GUN 2072790).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Akopian G, 2007, AM SURGEON, V73, P447; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut RM, 2008, J TRAUMA, V65, P500, DOI 10.1097/TA.0b013e31818020b3; Chesnut RM, 2006, CRIT CARE MED, V34, P2262, DOI 10.1097/01.CCM.0000229885.76483.F7; Citerio G, 2008, NEUROSURGERY, V63, P1152, DOI 10.1227/01.NEU.0000335148.87042.D7; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E4; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Figaji AA, 2009, AM SURGEON, V75, P441; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Fog M, 1938, J NEUROL PSYCHIATRY, V1, P187, DOI 10.1136/jnnp.1.3.187; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; GUILLAUME J, 1951, REV NEUROL, V84, P131; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kohta M, 2007, J CLIN NEUROSCI, V14, P167, DOI 10.1016/j.jocn.2006.01.042; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; LUNDBERG N, 1965, ACTA NEUROL SCAND, VS 41, P115; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AI, 2008, J TRAUMA, V65, P966, DOI 10.1097/TA.0b013e318184ee7b; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou A, 1997, ACT NEUR S, V70, P68; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Monro A., 1823, OBSERVATIONS STRUCTU; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nordstrom Carl-Henrik, 2006, Neurosurgery, V58, pE590; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pietrini D, 2004, Minerva Anestesiol, V70, P549; Plotz FB, 2007, INTENS CARE MED, V33, P1675, DOI 10.1007/s00134-007-0643-x; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rossi S, 1998, ACT NEUR S, V71, P91; RYDER HW, 1953, J LAB CLIN MED, V41, P428; Salim A, 2008, AM SURGEON, V74, P1088; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Yau YH, 2005, ACT NEUR S, V95, P289; Young Jeffrey S, 2003, Neurosurg Focus, V15, pE2; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	98	42	43	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2010	26	4					441	452		10.1007/s00381-009-1034-0			12	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	568QI	WOS:000275537100006	19937249				2022-02-06	
J	Harhausen, D; Khojasteh, U; Stahel, PF; Morgan, BP; Nietfeld, W; Dirnagl, U; Trendelenburg, G				Harhausen, Denise; Khojasteh, Uldus; Stahel, Philip F.; Morgan, B. Paul; Nietfeld, Wilfried; Dirnagl, Ulrich; Trendelenburg, George			Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice	JOURNAL OF NEUROINFLAMMATION			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; HUMAN NT2-N NEURONS; PROGESTERONE PROTECTS; REPERFUSION INJURY; INFARCTION VOLUME; STROKE; INFLAMMATION; EXPRESSION	Background: The complement system is a crucial mediator of inflammation and cell lysis after cerebral ischemia. However, there is little information about the exact contribution of the membrane attack complex (MAC) and its inhibitor-protein CD59. Methods: Transient focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in young male and female CD59a knockout and wild-type mice. Two models of MCAO were applied: 60 min MCAO and 48 h reperfusion, as well as 30 min MCAO and 72 h reperfusion. CD59a knockout animals were compared to wild-type animals in terms of infarct size, edema, neurological deficit, and cell death. Results and Discussion: CD59a-deficiency in male mice caused significantly increased infarct volumes and brain swelling when compared to wild-type mice at 72 h after 30 min-occlusion time, whereas no significant difference was observed after 1 h-MCAO. Moreover, CD59a-deficient mice had impaired neurological function when compared to wild-type mice after 30 min MCAO. Conclusion: We conclude that CD59a protects against ischemic brain damage, but depending on the gender and the stroke model used.	[Harhausen, Denise; Khojasteh, Uldus; Dirnagl, Ulrich; Trendelenburg, George] Charite, CCM, D-10117 Berlin, Germany; [Stahel, Philip F.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Orthopaed Surg, Denver, CO 80204 USA; [Stahel, Philip F.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Neurosurg, Denver, CO 80204 USA; [Morgan, B. Paul] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Nietfeld, Wilfried] Max Planck Inst Mol Genet, D-14195 Berlin, Germany		Trendelenburg, G (corresponding author), Charite, CCM, D-10117 Berlin, Germany.	george.trendelenburg@charite.de		Morgan, Paul/0000-0003-4075-7676; Dirnagl, Ulrich/0000-0003-0755-6119	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [Tr742/1-1,2]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG grant Tr742/1-1,2)	Arumugam TV, 2009, NEUROSCIENCE, V158, P1074, DOI 10.1016/j.neuroscience.2008.07.015; Arumugam TV, 2006, CLIN CHIM ACTA, V374, P33, DOI 10.1016/j.cca.2006.06.010; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; Baalasubramanian S, 2004, J IMMUNOL, V173, P3684, DOI 10.4049/jimmunol.173.6.3684; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Buerke M, 1998, J PHARMACOL EXP THER, V286, P429; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Chen CH, 2005, STROKE, V36, P1557, DOI 10.1161/01.STR.0000169928.76321.3d; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cowell RM, 2003, J NEUROSCI, V23, P9459; del Zoppo GJ, 1999, NAT MED, V5, P995, DOI 10.1038/12431; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIRNAGL U, 2009, NATURE PRECEDINGS; Ducruet AF, 2009, EXP NEUROL, V219, P398, DOI 10.1016/j.expneurol.2009.07.018; Figueroa E, 2005, NEUROSCI LETT, V380, P48, DOI 10.1016/j.neulet.2005.01.027; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Imm MD, 2002, NEUROSCI LETT, V325, P175, DOI 10.1016/S0304-3940(02)00271-9; Katchanov J, 2003, BRAIN PATHOL, V13, P452; Kilgore KS, 1996, AM J PATHOL, V149, P953; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kolev MV, 2010, PHARMACOGENOMICS J, V10, P12, DOI 10.1038/tpj.2009.52; Komotar RJ, 2009, CURR VASC PHARMACOL, V7, P287, DOI 10.2174/157016109788340677; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MERI S, 1990, IMMUNOLOGY, V71, P1; MORGAN BP, 1999, BIOCHEM J, V264, P1; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; Palmon SC, 1998, J CEREBR BLOOD F MET, V18, P1248, DOI 10.1097/00004647-199811000-00011; Pedersen ED, 2007, SCAND J IMMUNOL, V66, P345, DOI 10.1111/j.1365-3083.2007.01959.x; Pedersen ED, 2009, SCAND J IMMUNOL, V69, P555, DOI 10.1111/j.1365-3083.2009.02253.x; Pedersen ED, 2007, MOL IMMUNOL, V44, P2459, DOI 10.1016/j.molimm.2006.10.022; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Sugita Y, 1995, IMMUNOTECHNOLOGY, V1, P157, DOI 10.1016/1380-2933(95)00018-6; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Tramontini NL, 2002, INFLAMMATION, V26, P311, DOI 10.1023/A:1021420903355; Trendelenburg G, 2008, J CEREBR BLOOD F MET, V28, P867, DOI 10.1038/sj.jcbfm.9600609; Trendelenburg M, 2007, SWISS MED WKLY, V137, P413; Turnberg D, 2004, AM J PATHOL, V165, P825, DOI 10.1016/S0002-9440(10)63345-7; Uitenbroek, 1997, SISA BINOMIAL; van Beek J, 2005, J IMMUNOL, V174, P2353, DOI 10.4049/jimmunol.174.4.2353; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869	61	42	44	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 4	2010	7								15	10.1186/1742-2094-7-15			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	571BJ	WOS:000275723600001	20202211	Green Published, gold, Green Accepted			2022-02-06	
J	Babikian, T; Prins, ML; Cai, Y; Barkhoudarian, G; Hartonian, I; Hovda, DA; Giza, CC				Babikian, Talin; Prins, Mayumi L.; Cai, Yan; Barkhoudarian, Garni; Hartonian, Ivet; Hovda, David A.; Giza, Christopher C.			Molecular and Physiological Responses to Juvenile Traumatic Brain Injury: Focus on Growth and Metabolism	DEVELOPMENTAL NEUROSCIENCE			English	Article						Growth; Metabolism; Traumatic brain injury, experimental; Traumatic brain injury, juvenile; Oxidative stress; Gene expression; Growth factor	CEREBRAL GLUCOSE-UTILIZATION; CONTROLLED CORTICAL IMPACT; ATTENUATES EDEMA FORMATION; KETONE-BODY UTILIZATION; RAT-BRAIN; DIETARY RESTRICTION; OXIDATIVE DAMAGE; GENE-EXPRESSION; KETOGENIC DIET; GLUTATHIONE-PEROXIDASE	Traumatic brain injury (TBI), one of the most frequent causes of neurologic and neurobehavioral morbidity in the pediatric population, can result in lifelong challenges not only for patients, but also for their families. Survivors of a brain injury experienced during childhood - when the brain is undergoing a period of rapid development - frequently experience unique challenges as the consequences of their injuries are overlaid on normal developmental changes. Experimental studies have significantly advanced our understanding of the mechanisms and underlying molecular underpinnings of the injury response and recovery process following a TBI in the developing brain. In this paper, normal and TBI-related alterations in growth, development and metabolism are comprehensively reviewed in the postweanling/juvenile age range in the rat (postnatal days 21-60). As part of this review, TBI-related changes in gene expression are presented, with a focus on the injury-induced alterations related to cerebral growth and metabolism, and discussed in the context of existing literature related to physiological and behavioral responses to experimental TBI. Increasing evidence from the existing literature and from our own gene microarray data indicates that molecular responses related to growth, development and metabolism may play a particularly important role in the injury response and the recovery trajectory following developmental TBI. While gene expression analysis shows many of these changes occur at the level of transcription, a comprehensive review of other studies suggests that the control of metabolic substrates may preferentially be regulated through changes in transporters and enzymatic activity. The interrelation between cellular metabolism and activity-dependent neuroplasticity shows great promise as an area for future study for an optimal translation of experimental data to clinical TBI, with the ultimate goal of guiding therapeutic interventions. Copyright (C) 2010 S. Karger AG, Basel	[Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg,Semel Inst, Los Angeles, CA 90095 USA; [Babikian, Talin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Hartonian, Ivet; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Hartonian, Ivet; Giza, Christopher C.] Mattel Childrens Hosp UCLA, Div Pediat Neurol, Los Angeles, CA USA		Giza, CC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg,Semel Inst, 10833 Le Conte Blvd,Room 18-218B, Los Angeles, CA 90095 USA.	cgiza@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	Child Neurology Foundation/Winokur Family Foundation;  [NS27544];  [NS02197];  [NS057420];  [NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS002197, K02NS057420, P01NS058489, R01NS027544] Funding Source: NIH RePORTER	This study was supported by the NS27544, NS02197, NS057420, NS058489 and the Child Neurology Foundation/Winokur Family Foundation.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; ASPBERG A, 1992, DEV BRAIN RES, V66, P55, DOI 10.1016/0165-3806(92)90139-N; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BEAR MF, 1990, J NEUROSCI, V10, P909; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Cherian L, 2004, J NEUROTRAUM, V21, P1196; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chugani HT, 1999, NEUROSCIENTIST, V5, P29, DOI 10.1177/107385849900500105; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; CHUGANI HT, 1991, J CEREBR BLOOD F MET, V11, P35, DOI 10.1038/jcbfm.1991.4; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; CRANE SC, 1983, J NUTR, V113, P1063, DOI 10.1093/jn/113.5.1063; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DENGBRYANT Y, J NEUROTRAUMA UNPUB; Dreiem A, 2005, TOXICOL SCI, V87, P156, DOI 10.1093/toxsci/kfi224; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; HAWKINS RA, 1979, SCIENCE, V205, P325, DOI 10.1126/science.451608; HAWKINS RA, 1986, AM J PHYSIOL, V250, pE169, DOI 10.1152/ajpendo.1986.250.2.E169; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kawamata T, 1997, ACT NEUR S, V70, P191; KENNEDY C, 1982, ANN NEUROL, V12, P333, DOI 10.1002/ana.410120404; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lomax J, 2005, BRIEF BIOINFORM, V6, P298, DOI 10.1093/bib/6.3.298; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Magistretti Pierre J., 1995, P657; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; MAVELLI I, 1982, BIOCHEM J, V204, P535, DOI 10.1042/bj2040535; McCall AL, 1996, J CEREBR BLOOD F MET, V16, P69, DOI 10.1097/00004647-199601000-00008; MILLER AL, 1981, INT REV NEUROBIOL, P47; Mori T, 1998, ACT NEUR S, V71, P120; NEHLIG A, 1991, NEUROSCIENCE, V40, P871, DOI 10.1016/0306-4522(91)90018-J; OHATA M, 1981, BRAIN, V104, P319, DOI 10.1093/brain/104.2.319; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924, DOI 10.1152/ajpheart.2000.279.3.H924; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; RAUSCHECKER JP, 1987, IMPRINTING CORTICAL, P193; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Sakurai T, 2002, DIABETES, V51, P430, DOI 10.2337/diabetes.51.2.430; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SPREEN O, 1995, DEV NEUROPSYCHOLOGY; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Urabe T, 1996, J NEUROCHEM, V67, P265; Vannucci SJ, 1998, DEV BRAIN RES, V107, P255, DOI 10.1016/S0165-3806(98)00021-2; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; WIGGINS RC, 1986, NEUROTOXICOLOGY, V7, P103; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang F, 2005, J NEUROSCI RES, V79, P139, DOI 10.1002/jnr.20312	90	42	42	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					431	441		10.1159/000320667			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900011	21071915	Green Published, Bronze			2022-02-06	
J	Braden, C; Hawley, L; Newman, J; Morey, C; Gerber, D; Harrison-Felix, C				Braden, Cynthia; Hawley, Lenore; Newman, Jody; Morey, Clare; Gerber, Don; Harrison-Felix, Cynthia			Social communication skills group treatment: A feasibility study for persons with traumatic brain injury and comorbid conditions	BRAIN INJURY			English	Article						Traumatic brain injury; communication; group treatment; cognitive rehabilitation	CLOSED-HEAD INJURY; CONTROLLED-TRIAL; SELF-EFFICACY; UNITED-STATES; REHABILITATION; DEFICITS; AWARENESS; VALIDITY; QUESTIONNAIRE; ABILITY	Objectives: To evaluate the feasibility of improving impaired social communication skills in persons with traumatic brain injury (TBI) and concomitant neurological or psychiatric conditions, using an intervention with evidence of efficacy in a TBI cohort without such complications. Research design: Cohort study with pre-post intervention and follow-up assessments. Methods: Thirty individuals with TBI >= 1 year post-injury and identified social communication problems participated in a group intervention to improve social communication skills. Interventions: Group Interactive Structured Treatment (GIST) for Social Competence; 13 week, 1.5 hour manualized intervention. Outcome measures: Profile of Pragmatic Impairment in Communication (PPIC); Social Communication Skills Questionnaire-Adapted (SCSQ-A); LaTrobe Communication Questionnaire (LCQ); Goal Attainment Scale (GAS), Awareness Questionnaire (AQ), Satisfaction with Life Scale (SWLS); Participation Assessment with Recombined Tools (PART). Main outcomes and results: Participants made statistically significant gains on the SCSQ-A, GAS and SWLS post-treatment and at 6 months follow-up, using self and other ratings. Gains on the PPIC did not reach statistical significance but trended toward improvement. Treatment effects were not noted in analyses of the AQ or the PART. The LCQ showed statistically significant gains post-treatment and at follow-up. Conclusions: Participants showed improvement on subjective social communication skills measures post-treatment and at follow-up, demonstrating potential efficacy of the intervention in a broader population of persons with TBI, worthy of further investigation.	[Braden, Cynthia; Hawley, Lenore; Newman, Jody; Morey, Clare; Gerber, Don; Harrison-Felix, Cynthia] Craig Hosp, Englewood, CO USA		Braden, C (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO USA.	cbraden@craighospital.org			Colorado Traumatic Brain Injury Trust	This research was supported by the Colorado Traumatic Brain Injury Trust Fund, a 2-year research award from 1 July through 30 June 2008. The opinions expressed in this manuscript are those of the authors and do not necessarily reflect the views of the Colorado Traumatic Brain Injury Trust Fund.	[Anonymous], 2008, GULF WAR HLTH, V7; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bellack A.S., 2004, SOCIAL SKILLS TRAINI; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corrigan J.D., 2003, TECHNICAL REPORT PRO; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; *CRAIG HOSP RES DE, 2004, TBI MOD SYST PART SP; *CTR TBIMSND, 2002, TRAUM BRAIN INJ MOD; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIJKERS M, 2003, COMMUNITY INTERGRATI, V2; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Dowd T., 1992, TEACHING SOCIAL SKIL; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fleming JM, 1996, BRAIN INJURY, V10, P1; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; HAGEN C, 1974, RANCHO AMIGOS SCALES; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; HANSEN DJ, 1989, BEHAV MODIF, V13, P4, DOI 10.1177/01454455890131001; Hawley L., 2008, GROUP INTERACTIVE ST; Hawley L, 2006, SOCIAL SKILLS TRAUMA; Hays SJ, 2004, APHASIOLOGY, V18, P693, DOI 10.1080/02687030444000183; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LINSCOTT R, 2010, COMMUNICATION; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Lynch WJ, 2002, J HEAD TRAUMA REHAB, V17, P66, DOI 10.1097/00001199-200202000-00009; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Malec JF, 2003, MANUAL MAYOPORTLAND; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; NELSON DGK, 1988, MEM COGNITION, V16, P79, DOI 10.3758/BF03197748; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; *PREV CFDCA, 1998, BEH RISK FACT SURV S; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; RANKIN KP, 2006, HUMAN FRONTAL LOBES, P345; Reitan R. M., 1993, HALSTED REITAN NEURO; SanMiguel SK, 1996, LEARN DISABILITY Q, V19, P252; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Smith A., 1982, SYMBOL DIGIT MODALIT; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; *SPSS INC, 2004, SPSS 13 0 WIND 13 0; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Stuss D. T., 2006, HUMAN FRONTAL LOBES, P292; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TROWER P, 1978, J ADOLESCENCE, V1, P319, DOI 10.1016/S0140-1971(78)80035-9; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WechslerD, 2001, WECHSLER TEST ADULT; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Whiteneck G, 2001, COLORADO TRAUMATIC B; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	76	42	43	0	24	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	11					1298	1310		10.3109/02699052.2010.506859			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800004	20828228				2022-02-06	
J	Kikuchi, K; Tancharoen, S; Matsuda, F; Biswas, KK; Ito, T; Morimoto, Y; Oyama, Y; Takenouchi, K; Miura, N; Arimura, N; Nawa, Y; Meng, XJ; Shrestha, B; Arimura, S; Iwata, M; Mera, K; Sameshima, H; Ohno, Y; Maenosono, R; Tajima, Y; Uchikado, H; Kuramoto, T; Nakayama, K; Shigemori, M; Yoshida, Y; Hashiguchi, T; Maruyama, I; Kawahara, K				Kikuchi, Kiyoshi; Tancharoen, Salunya; Matsuda, Fumiyo; Biswas, Kamal Krishna; Ito, Takashi; Morimoto, Yoko; Oyama, Yoko; Takenouchi, Kazunori; Miura, Naoki; Arimura, Noboru; Nawa, Yuko; Meng, Xiaojie; Shrestha, Binita; Arimura, Shinichiro; Iwata, Masahiro; Mera, Kentaro; Sameshima, Hisayo; Ohno, Yoshiko; Maenosono, Ryuichi; Tajima, Yutaka; Uchikado, Hisaaki; Kuramoto, Terukazu; Nakayama, Kenji; Shigemori, Minoru; Yoshida, Yoshihiro; Hashiguchi, Teruto; Maruyama, Ikuro; Kawahara, Ko-ichi			Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Edaravone; Aquaporin-4; Cerebral ischemic injury	FREE-RADICAL SCAVENGER; TRANSIENT FOCAL ISCHEMIA; BRAIN EDEMA; ARTERY OCCLUSION; STROKE; RATS; MCI-186; MICE; MODEL; ASTROCYTES	Aquaporin-4 (AQP4) plays a role in the generation of post-ischemic edema, Pharmacological modulation of AQP4 function may thus provide a novel therapeutic strategy for the treatment of stroke, tumor-associated edema, epilepsy, traumatic brain injury, and other disorders of the central nervous system (CNS) associated with altered brain water balance. Edaravone, a free radical scavenger, is used for the treatment of acute ischemic stroke (AIS) in Japan. In this study, edaravone significantly reduced the infarct area and improved the neurological deficit scores at 24 h after reperfusion in a rat transient focal ischemia model. Furthermore, edaravone markedly reduced AQP4 immunoreactivity and protein levels in the cerebral infarct area. In light of observations that edaravone specifically inhibited AQP4 in a rat transient focal ischemia model, we propose that edaravone might reduce cerebral edema through the inhibition of AQP4 expression following cerebral infarction. (C) 2009 Elsevier Inc. All rights reserved.	[Kikuchi, Kiyoshi; Biswas, Kamal Krishna; Ito, Takashi; Oyama, Yoko; Takenouchi, Kazunori; Arimura, Noboru; Nawa, Yuko; Meng, Xiaojie; Shrestha, Binita; Arimura, Shinichiro; Sameshima, Hisayo; Ohno, Yoshiko; Maenosono, Ryuichi; Hashiguchi, Teruto; Maruyama, Ikuro; Kawahara, Ko-ichi] Kagoshima Univ, Div Lab & Vasc Med, Field Cardiovasc & Resp Disorders, Dept Adv Therapeut,Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Kikuchi, Kiyoshi; Tajima, Yutaka; Kuramoto, Terukazu; Nakayama, Kenji] Omuta City Gen Hosp, Dept Neurosurg, Fukuoka 8368567, Japan; [Tancharoen, Salunya] Mahidol Univ, Fac Dent, Dept Pharmacol, Bangkok 10400, Thailand; [Matsuda, Fumiyo; Yoshida, Yoshihiro] Kagoshima Univ, Div Phys Therapy, Sch Hlth Sci, Fac Med, Kagoshima 8908560, Japan; [Morimoto, Yoko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Restorat Dent & Endodontol, Kagoshima 8908544, Japan; [Miura, Naoki] Kagoshima Univ, Lab Vet Diagnost Imaging, Dept Vet Med, Fac Agr, Kagoshima 8900065, Japan; [Iwata, Masahiro; Mera, Kentaro] Kagoshima Univ, Dept Dermatol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Uchikado, Hisaaki; Shigemori, Minoru] Kurume Univ, Fac Med, Sch Med, Fukuoka 8300011, Japan		Kawahara, K (corresponding author), Kagoshima Univ, Div Lab & Vasc Med, Field Cardiovasc & Resp Disorders, Dept Adv Therapeut,Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	telo@m3.kufm.kagoshima-u.ac.jp	tancharoen, salunya/AAJ-4765-2020; Miura, Naoki/A-5734-2010; Miura, Naoki/O-6997-2016	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231; Takenouchi, Kazunori/0000-0003-1946-457X; TANCHAROEN, SALUNYA/0000-0002-2952-7952	Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [21390483]	We thank Nobue Uto, Tomoka Nagasato and Tomomi Morizono for their excellent technical assistance. This study was supported by Research Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Grant-in-Aid 21390483 (to K.K.).	ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; Abe S, 2004, CHEM PHARM BULL, V52, P186, DOI 10.1248/cpb.52.186; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Cuzzocrea S, 2000, J PINEAL RES, V29, P217, DOI 10.1034/j.1600-0633.2002.290404.x; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Green AR, 2006, DRUG DISCOV TODAY, V11, P681, DOI 10.1016/j.drudis.2006.06.001; Haberg A, 2001, J CEREBR BLOOD F MET, V21, P1451, DOI 10.1097/00004647-200112000-00010; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Kikuchi K, 2009, J PHARMACOL EXP THER, V329, P865, DOI 10.1124/jpet.108.149484; Kikuchi K, 2009, BIOCHEM BIOPH RES CO, V385, P132, DOI 10.1016/j.bbrc.2009.04.041; Lapchak PA, 2009, EXP NEUROL, V215, P95, DOI 10.1016/j.expneurol.2008.09.004; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; MENZIES SA, 1992, NEUROSURGERY, V31, P106; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Noor JI, 2005, STROKE, V36, P2468, DOI 10.1161/01.STR.0000185653.49740.c6; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Shichinohe H, 2004, BRAIN RES, V1029, P200, DOI 10.1016/j.brainres.2004.09.055; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Torii K, 2004, J PINEAL RES, V36, P18, DOI 10.1046/j.1600-079X.2003.00097.x; van der Worp HB, 2002, NEUROLOGY, V58, P133, DOI 10.1212/WNL.58.1.133; Wang CX, 2007, DRUG AGING, V24, P537, DOI 10.2165/00002512-200724070-00002; Watanabe T, 2004, YAKUGAKU ZASSHI, V124, P99, DOI 10.1248/yakushi.124.99; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053	31	42	46	2	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	DEC 25	2009	390	4					1121	1125		10.1016/j.bbrc.2009.09.015			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	531GB	WOS:000272650800009	19737535				2022-02-06	
J	Zafonte, R; Friedewald, WT; Lee, SM; Levin, B; Diaz-Arrastia, R; Ansel, B; Eisenberg, H; Timmons, SD; Temkin, N; Novack, T; Ricker, J; Merchant, R; Jallo, J				Zafonte, Ross; Friedewald, William T.; Lee, Shing M.; Levin, Bruce; Diaz-Arrastia, Ramon; Ansel, Beth; Eisenberg, Howard; Timmons, Shelly D.; Temkin, Nancy; Novack, Thomas; Ricker, Joseph; Merchant, Randall; Jallo, Jack			The Citicoline Brain Injury Treatment (COBRIT) Trial: Design and Methods	JOURNAL OF NEUROTRAUMA			English	Article						citicoline; clinical trial; COBRIT; therapy; traumatic brain injury	ACUTE ISCHEMIC-STROKE; RANDOMIZED EFFICACY TRIAL; CDP-CHOLINE; HIPPOCAMPAL; SCALE; DISORDERS; PRECURSOR; EDEMA; TBI	Traumatic brain injury (TBI) is a major cause of death and disability. In the United States alone approximately 1.4 million sustain a TBI each year, of which 50,000 people die, and over 200,000 are hospitalized. Despite numerous prior clinical trials no standard pharmacotherapy for the treatment of TBI has been established. Citicoline, a naturally occurring endogenous compound, offers the potential of neuroprotection, neurorecovery, and neurofacilitation to enhance recovery after TBI. Citicoline has a favorable side-effect profile in humans and several meta-analyses suggest a benefit of citicoline treatment in stroke and dementia. COBRIT is a randomized, double-blind, placebo-controlled, multi-center trial of the effects of 90 days of citicoline on functional outcome in patients with complicated mild, moderate, and severe TBI. In all, 1292 patients will be recruited over an estimated 32 months from eight clinical sites with random assignment to citicoline (1000mg twice a day) or placebo (twice a day), administered enterally or orally. Functional outcomes are assessed at 30, 90, and 180 days after the day of randomization. The primary outcome consists of a set of measures that will be analyzed as a composite measure using a global test procedure at 90 days. The measures comprise the following core battery: the California Verbal Learning Test II; the Controlled Oral Word Association Test; Digit Span; Extended Glasgow Outcome Scale; the Processing Speed Index; Stroop Test part 1 and Stroop Test part 2; and Trail Making Test parts A and B. Secondary outcomes include survival, toxicity, and rate of recovery.	[Lee, Shing M.; Levin, Bruce] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA USA; [Friedewald, William T.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Ansel, Beth] NICHHD, TBI & Stroke Rehabil Res Program, Natl Ctr Med Rehabil Res, Bethesda, MD 20892 USA; [Eisenberg, Howard] Univ Maryland Hosp S, Dept Neurosurg, Baltimore, MD USA; [Timmons, Shelly D.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Timmons, Shelly D.] Univ Tennessee, Ctr Hlth Sci, Neurotrauma Div, Semmes Murphey Clin, Memphis, TN 38163 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Novack, Thomas] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Ricker, Joseph] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Merchant, Randall] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA		Friedewald, WT (corresponding author), Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, Room 647,722 W 168th St, New York, NY 10032 USA.	wtf1@columbia.edu	Friedewald, William T/C-8034-2011	Jallo, Jack/0000-0002-5512-1729; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Ricker, Joseph/0000-0003-3415-991X	National Institute AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HD042823, U01HD042738, U01HD042687, U01HD042736, U01HD042678, U01HD042686, U01HD042653, U01HD042689, U01HD042652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042686, U01HD042653, U01HD042689, U01HD042736, U01HD042738, U01HD042678, U01HD042823, U01HD042687] Funding Source: NIH RePORTER	The study is supported in part by National Institute Award numbers NICHD U01HD042823, U01HD042738, U01HD 042687, U01HD042736, U01HD042678, U01HD042686, U01H D042653, U01HD042689, and U01HD042652, to eight clinical sites and a data coordinating center.	Adibhatla RM, 2006, J BIOL CHEM, V281, P6718, DOI 10.1074/jbc.M512112200; Adibhatla RM, 2002, J NEUROSCI RES, V70, P133, DOI 10.1002/jnr.10403; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; Alexandrov A V, 2001, Curr Opin Investig Drugs, V2, P1757; Ali R, 2002, ADDICTION, V97, P1183; Alkan T., 2001, Archives of Physiology and Biochemistry, V109, P161, DOI 10.1076/apab.109.2.161.4273; Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Babb SM, 2002, PSYCHOPHARMACOLOGY, V161, P248, DOI 10.1007/s00213-002-1045-y; BAGIELLA E, MEASURING OUTC UNPUB; Barrachina M, 2003, J NEUROL SCI, V215, P105, DOI 10.1016/S0022-510X(03)00204-1; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Benton A., 1994, CONTRIBUTIONS NEUROP; Chua R, 2007, CEREBROVASC DIS, V23, P73; Clark WM, 1999, STROKE, V30, P2592, DOI 10.1161/01.STR.30.12.2592; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Clark WM, 2001, NEUROLOGY, V57, P1595, DOI 10.1212/WNL.57.9.1595; COHADON F, 1982, NEUROCHIRURGIE, V28, P287; Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; De la Cruz JP, 2000, N-S ARCH PHARMACOL, V361, P47; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; FIORAVANTI M, 2000, COCHRANE DB SYST REV; IKEDA Y, 1990, NEUROSURGERY, V27, P1; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Little R, 1996, BIOMETRICS, V52, P1324, DOI 10.2307/2532847; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ovbiagele Bruce, 2003, Curr Treat Options Cardiovasc Med, V5, P441, DOI 10.1007/s11936-003-0033-9; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Rao AM, 2001, BRAIN RES, V893, P268, DOI 10.1016/S0006-8993(00)03280-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM, 1992, TRAIL MAKING TEST MA; REITAN RM, 1993, HALSTEAD REITH NEURO; Rejdak R, 2002, OPHTHALMIC RES, V34, P146, DOI 10.1159/000063658; Ross BM, 2001, NEUROSCIENCE, V102, P899, DOI 10.1016/S0306-4522(00)00501-7; Rubin D.B., 1997, MULTIPLE IMPUTATION; Sample PL, 2004, BRAIN INJURY, V18, P1177, DOI 10.1080/02699050410001719925; Saver Jeffrey L, 2008, Rev Neurol Dis, V5, P167; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; TANG DI, 1993, BIOMETRICS, V49, P23, DOI 10.2307/2532599; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	57	42	46	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2207	2216		10.1089/neu.2009.1015			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200008	19803786	Green Published			2022-02-06	
J	Figaji, AA; Zwane, E; Fieggen, AG; Argent, AC; Le Roux, PD; Siesjo, P; Peter, JC				Figaji, Anthony A.; Zwane, Eugene; Fieggen, A. Graham; Argent, Andrew C.; Le Roux, Peter D.; Siesjo, Peter; Peter, Jonathan C.			Pressure autoregulation, intracranial pressure, and brain tissue oxygenation in children with severe traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						autoregulation; brain tissue oxygen tension; intracranial pressure; blood pressure; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW; HEAD-INJURY; INDUCED HYPERTENSION; REACTIVITY; METABOLISM; MANAGEMENT; RESPONSES; ARTERIES; HYPOXIA	Object. Cerebral pressure autoregulation is an important neuroprotective mechanism that stabilizes cerebral blood flow when blood pressure (BP) changes In this study the authors examined the association between autoregulation and clinical factors. BR. intracranial pressure (ICP), brain tissue oxygen tension (PbtO(2)), and outcome after pediatric severe traumatic brain injury (TBI). In particular we examined how the Status 01: autoregulation influenced the effect of BP changes on ICP and PbtO(2) Methods In this prospective observational study. 52 autoregulation tests were performed in 24 patients with severe. TBI. The patients had a mean age of 6.3 +/- 3.2 years. and a postresuscitation Glasgow Coma Scale score of 6 (range 3-8). All patients underwent continuous ICP and MID, monitoring. and transcranial Doppler ultrasonography was, used to examine the autoregulatory index (ARI) based on blood flow velocity of the middle cerebral artery after increasing mean arterial pressure by 20% of the baseline value Impaired autoregulation was defined as an ARI < 0 4 and intact autoregulation as an ART >= 0 4 The relationships between autoregulation (measured as both a Continuous and dichotomous variable), outcome, and clinical and physiological variables were examined using Multiple logistic regression analysis Results. Autoregulation was impaired (ART < 0 4) in 29% of patients (7 patients). The initial Glasgow Coma Scale score was significantly associated with the ARI (p = 0.02, r = 0.32) but no other clinical factors were associated with autoregulation Status. Baseline values at the time of testing for ICP, PbtO(2), the ratio PbtO(2)/PaO2, mean arterial pressure, and middle cerebral artery blood flow velocity were similar in the patients with impaired or intact autoregulation. There was an inverse relationship between ART (continuous and dichotomous) with a chancle in ICP (continuous ARI, p 0.005, dichotomous ARI, p = 0 02): that is. ICP increased with the BP increase when ARI was low (weak autoregulation) The ART (continuous and dichotomous) was also inversely associated with a change in PbtO(2). (continuous ART. p 0.002. dichotomous ARI, p = 0 02). The PbtO(2) increased when BP was increased in most patients, even when the ARI was relatively high (stronger autoregulation). but the magnitude of this response was still associated with the ART. There was no relationship between the ART and Outcome Conclusion. These data demonstrate the influence of the strength of autoregulation on the response of ICP and MO. to BP changes and the variability of this response between individuals The findings suggest that autoregulation testing may assist clinical decision-making in pediatric severe TBI and help better define optimal BP or cerebral perfusion pressure targets for individual patients. (DOI: 10.3171/2009.6.PEDS096)	[Figaji, Anthony A.; Fieggen, A. Graham; Peter, Jonathan C.] Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, Cape Town, South Africa; [Argent, Andrew C.] Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, Div Pediat Crit Care, Cape Town, South Africa; [Zwane, Eugene] Univ Cape Town Observ, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit Biostat, Cape Town, South Africa; [Le Roux, Peter D.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Siesjo, Peter] Lund Univ, Univ Lund Hosp, Dept Neurosurg, Lund, Sweden		Figaji, AA (corresponding author), Red Cross War Mem Childrens Hosp, Inst Child Hlth 617, Klipfontein Rd, ZA-7700 Rondebosch, South Africa.	AnthonyFigaji@uct.ac.za	Argent, Andrew/J-1605-2019; Fieggen, Anthony Graham/AAT-6510-2021	Argent, Andrew/0000-0001-9333-2036; Fieggen, Anthony Graham/0000-0001-6541-8377; Figaji, Anthony/0000-0002-3357-6490; Siesjo, Peter/0000-0002-5848-690X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Bruzzone P, 1998, ACT NEUR S, V71, P111; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Fog M, 1938, J NEUROL PSYCHIATRY, V1, P187, DOI 10.1136/jnnp.1.3.187; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Nordstrom Carl-Henrik, 2006, Neurosurgery, V58, pE590; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Stocchetti N, 1998, ACT NEUR S, V71, P162; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	50	42	42	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2009	4	5					420	428		10.3171/2009.6.PEDS096			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	512JO	WOS:000271244400005	19877773				2022-02-06	
J	Nakase-Richardson, R; Yablon, SA; Sherer, M; Nick, TG; Evans, CC				Nakase-Richardson, R.; Yablon, S. A.; Sherer, M.; Nick, T. G.; Evans, C. C.			Emergence from minimally conscious state Insights from evaluation of posttraumatic confusion	NEUROLOGY			English	Article							PATIENTS OWN NAME; COGNITIVE TEST; RECOVERY; ORIENTATION; DEFINITION; VALIDATION; DISORDERS; DELIRIUM; SCALE; COMA	Background: Guidelines for defining the minimally conscious state (MCS) specify behaviors that characterize emergence, including "reliable and consistent" functional communication (accurate yes/no responding). Guidelines were developed by consensus because of lack of empirical data. Objective: To evaluate the utility of the operational threshold for emergence from posttraumatic MCS, by determining yes/no accuracy to questions of varied difficulty, including simple orientation questions, using all items from the Yes/No Subscale of the Mississippi Aphasia Screening Test. Method: Prospective observational study of a cohort of responsive patients recovering from traumatic brain injury in an acute inpatient brain injury rehabilitation program. Results: Of the 629 observations from 144 participants, name recognition was the easiest yes/no question, with nonconfused individuals responding with 100% accuracy, whereas only 75% to 78% of confused participants on initial evaluation answered this question correctly. Generalized Estimating Equations analysis revealed that confused participants were more likely to respond inaccurately to all yes/no questions. Nonconfused participants had a reduction in odds of inaccuracy ranging from 45.6% to 99.7% (p = 0.001 to 0.02) depending on the type of yes/no question. Conclusions: Accuracy for simple orientation yes/no questions remains challenging for responsive patients in early recovery from traumatic brain injury. Although name recognition questions are relatively easier than other types of yes/no questions, including situational orientation questions, confused patients still may answer these incorrectly. Results suggest the operational threshold for yes/no response accuracy as a diagnostic criterion for emergence from the minimally conscious state should be revisited, with particular consideration of the type of yes/no questions and the requisite accuracy threshold for responses. Neurology (R) 2009; 73: 1120-1126	[Nakase-Richardson, R.] James A Haley VAMC, Tampa, FL USA; [Nakase-Richardson, R.; Yablon, S. A.; Evans, C. C.] Methodist Rehabil Ctr, Jackson, MI USA; [Nakase-Richardson, R.; Yablon, S. A.; Evans, C. C.] Univ Mississippi, Med Ctr, Jackson, MI USA; [Sherer, M.] TIRR Mem Hermann & Baylor Coll Med, Houston, TX USA; [Nick, T. G.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, MH & BS Polytrauma 116B,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	risa.richardson@va.gov			National Institute on Disability Rehabilitation and Research [H133A020514]	This study was part of the Traumatic Brain Injury Model System of Mississippi funded by the National Institute on Disability Rehabilitation and Research (H133A020514 Dr. Risa Nakase-Richardson, PI).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P124; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Coleman D, 2002, NEUROLOGY, V58, P506, DOI 10.1212/WNL.58.3.506; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; KISTALOVA M, 2008, BRAIN, V22, P793; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Mack A, 2002, CONSCIOUS COGN, V11, P488, DOI 10.1016/S1053-8100(02)00028-4; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; NAKASETHOMPSON R, 2003, J INT NEUROPSYCH SOC, V9, P303; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; *TRAUM BRAIN INJ M, ON LIN SYLL	25	42	42	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 6	2009	73	14					1120	1126		10.1212/WNL.0b013e3181bacf34			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	502QG	WOS:000270474500007	19805728				2022-02-06	
J	Israelsson, C; Wang, Y; Kylberg, A; Pick, CG; Hoffer, BJ; Ebendal, T				Israelsson, Charlotte; Wang, Yun; Kylberg, Annika; Pick, Chaim G.; Hoffer, Barry J.; Ebendal, Ted			Closed Head Injury in a Mouse Model Results in Molecular Changes Indicating Inflammatory Responses	JOURNAL OF NEUROTRAUMA			English	Article						closed head injury; GeneChip array; inflammation; mild trauma; quantitative RT-PCR; weight drop impact	TRAUMATIC BRAIN-INJURY; RAT CEREBRAL-CORTEX; GENE-EXPRESSION; COGNITIVE DEFICITS; HYPOXIA-ISCHEMIA; MICE; MECHANISMS; CHEMOKINES; PATTERNS; SEQUELAE	Cerebral gene expression changes in response to traumatic brain injury will provide useful information in the search for future trauma treatment. In order to characterize the outcome of mild brain injury, we studied C57BL/6J mice in a weight-drop, closed head injury model. At various times post-injury, mRNA was isolated from neocortex and hippocampus and transcriptional alterations were studied using quantitative reverse transcriptase PCR and gene array analysis. At three days post-injury, the results showed unilateral injury responses, both in neocortex and hippocampus, with the main effect seen on the side of the skull hit by the dropping weight. Upregulated transcripts encoded products characterizing reactive astrocytes, phagocytes, microglia, and immune-reactive cells. Markers for oligodendrocytes and T-cells were not altered. Notably, strong differences in the responses among individual mice were seen (e. g., for the Gfap transcript expressed by reactive astrocytes and the chemokine Ccl3 transcript expressed by activated microglial cells). In conclusion, mild TBI chiefly activates transcripts leading to tissue signaling, inflammatory processes, and chemokine signaling, as in focal brain injury, suggesting putative targets for drug development.	[Israelsson, Charlotte; Kylberg, Annika; Ebendal, Ted] Uppsala Univ, Biomed Ctr, Dept Neurosci, SE-75124 Uppsala, Sweden; [Wang, Yun; Hoffer, Barry J.] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA; [Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel		Ebendal, T (corresponding author), Uppsala Univ, Biomed Ctr, Dept Neurosci, POB 593, SE-75124 Uppsala, Sweden.	Ted.Ebendal@neuro.uu.se	Pick, Chaim/D-4789-2009		Swedish Research CouncilSwedish Research CouncilEuropean Commission [2006-3014]; Swedish Brain Research Foundation; Sparbanksstiftelsen Upland; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000461, ZIADA000429] Funding Source: NIH RePORTER	This work was supported by the Swedish Research Council (grant no. 2006-3014 [T. E.]), the Swedish Brain Research Foundation/Sparbanksstiftelsen Upland (T. E. and C. I.), and intramural grants from NIH/NIDA (B. J. H.). Hanna Goransson and Maria Rydaker carried out the GeneChip procedures.	Byrne E, 2000, J CLIN NEUROSCI, V7, P473, DOI 10.1054/jocn.2000.0779; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1317, DOI 10.1097/01.WCB.0000141558.40491.75; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Potts Mathew B, 2006, NeuroRx, V3, P143; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	23	42	42	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1307	1314		10.1089/neu.2008.0676			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900013	19317611	Green Published			2022-02-06	
J	Jumisko, E; Lexell, J; Soderberg, S				Jumisko, Eija; Lexell, Jan; Soderberg, Siv			The meaning of feeling well in people with moderate or severe traumatic brain injury	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; hermeneutics; interpretation; phenomenological; traumatic; wellbeing	QUALITY-OF-LIFE; SATISFACTION; SELF; INDIVIDUALS; EXPERIENCE; NARRATIVES; ISSUES; SAMPLE; MODEL	Aim. The aim of this study was to elucidate the meaning of feeling well for people with moderate or severe traumatic brain injury. Background. Considerable attention has been given to research consequences, quality of life and satisfaction with life in people with traumatic brain injury. Most studies reveal negative aspects of living with traumatic brain injury. Knowledge that provides an understanding of the meaning of feeling well for people with a traumatic brain injury entails the possibility that they could receive support to feel well, despite their injury. Design. This study used a qualitative research approach, as the aim was to elucidate meaning. Methods. Data were collected through qualitative research interviews with two women and six men with moderate or severe traumatic brain injury who had lived with the injury for between 7-15 years. A phenomenological hermeneutic method was used to interpret the data. Results. The meaning of feeling well for people with moderate or severe traumatic brain injury was that the initially unfamiliar life with traumatic brain injury became familiar. This included finding strength, regaining control over everyday life, being close to someone and being good enough. People with traumatic brain injury felt well when they became reconciled with the circumstances of their life and created a new entity in that life, in which their complete health had been lost. Relevance to clinical practice. This study helps professionals to enhance their understanding and awareness of the possibilities for people with moderate or severe traumatic brain injury to feel well. The study showed that people with traumatic brain injury needed a lot of strength to achieve this. Professionals can help them to feel well by getting to know them and thus find ways to support the person's feeling of wellbeing.	[Jumisko, Eija; Soderberg, Siv] Lulea Univ Technol, Div Nursing, Dept Hlth Sci, SE-97187 Lulea, Sweden; [Lexell, Jan] Univ Lund Hosp, Dept Rehabil, S-22185 Lund, Sweden		Soderberg, S (corresponding author), Lulea Univ Technol, Div Nursing, Dept Hlth Sci, SE-97187 Lulea, Sweden.	siv.soderberg@hu.se		Lexell, Jan/0000-0001-5294-3332	Patient Association for People with Brain Injuries in Sweden (Hjarnkraft)	We thank the participants of this study and the Patient Association for People with Brain Injuries in Sweden (Hjarnkraft). We also thank Pat Shrimpton for editing the language of this manuscript.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ARISTOTELES, 1967, NIKOMACHISKA ETIKEN; Backhouse M, 1999, AUST OCCUP THER J, V46, P99, DOI DOI 10.1046/J.1440-1630.1999.00183.X; BREWIN J, 2001, BRIT J THERAPY REHAB, V8, P218; Buber M., 1997, DISTANS RELATION; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Duff Diane, 2006, Axone, V27, P9; Eriksson K., 2006, SUFFERING HUMAN BEIN; Eriksson K, 1987, PAUSEN BESKRIVNING V; Gadamer H-G, 2003, GATFULLA HALSAN ESSA; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Guba EG., 1989, 4 GENERATION EVALUAT; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Johnson B P, 1995, J Neurosci Nurs, V27, P113; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; JUMISKO E, 2005, J NEUROSCIENCE NURSI, V36, P20; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Lindseth A, 2004, SCAND J CARING SCI, V18, P145, DOI 10.1111/j.1471-6712.2004.00258.x; McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1016/S0003-9993(00)90117-5; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; PATERSON B, 2003, QUALITATIVE HLTH RES, V12, P987; Paterson BL, 2001, J NURS SCHOLARSHIP, V33, P21, DOI 10.1111/j.1547-5069.2001.00021.x; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; PAULI E, 1937, KAMP ELLER RESIGNATI; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Ricoeur P., 1976, INTERPRETATION THEOR; Robertson-Malt S, 1999, J ADV NURS, V29, P290, DOI 10.1046/j.1365-2648.1999.00830.x; Sandelowski M, 1998, RES NURS HEALTH, V21, P467, DOI 10.1002/(SICI)1098-240X(199810)21:5<467::AID-NUR9>3.3.CO;2-X; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Strandberg T, 2006, VUXNA MED FORVARVAD; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; TOOMBS SK, 1993, MEANING ILLNESS PHEN; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WIKLUND L, 2000, THESIS ABO AKAD ABO; 1998, CONSENS STATEME 1026, V16, P1	48	42	42	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	AUG	2009	18	16					2273	2281		10.1111/j.1365-2702.2008.02738.x			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	467PS	WOS:000267753400004	19583660				2022-02-06	
J	Kwon, BK; Roy, J; Lee, JHT; Okon, E; Zhang, HB; Marx, JC; Kindy, MS				Kwon, Brian K.; Roy, Josee; Lee, Jae H. T.; Okon, Elena; Zhang, Hongbin; Marx, Jeffrey C.; Kindy, Mark S.			Magnesium Chloride in a Polyethylene Glycol Formulation as a Neuroprotective Therapy for Acute Spinal Cord Injury: Preclinical Refinement and Optimization	JOURNAL OF NEUROTRAUMA			English	Article						magnesium chloride; neuroprotection; polyethylene glycol; spinal cord injury	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; ACUTE-STROKE-THERAPIES; INDUSTRY-ROUND-TABLE; INTRAVENOUS MAGNESIUM; PILOT TRIAL; SULFATE; RATS; METHYLPREDNISOLONE	Intravenously administered magnesium has been extensively investigated as a neuroprotective agent traumatic brain injuries and stroke. Numerous investigators have reported the neuroprotective benefits of magnesium in animal models of spinal cord injury (SCI) as well, but typically with doses that far exceed human tolerability. To develop magnesium into a clinically relevant therapy for SCI, further refinement and improvement of the magnesium formulation is necessary. In this series of experiments, we evaluated the neuroprotective efficacy of magnesium in a polyethylene glycol (PEG) formulation using an acute model of thoracic SCI. Following thoracic contusion (Infinite Horizon) rat SCI model, we independently confirmed the neuroprotective efficacy of the magnesium and PEG combination which had been previously reported in a thoracic clip compression model of SCI (Ditor et al., 2007). We established that the 254 mu mol/ kg dose of MgCl2 was superior to 127 mu mol/ kg MgCl2 with respect to tissue sparing and locomotor recovery. Additionally, the number of infusions (2, 4, or 6), time between infusions (6 vs 8 hours), and different magnesium salts (MgCl2 vs MgSO4) were evaluated to determine an "optimal" treatment regimen. We observed that an "optimized" regimen of MgCl2 within PEG conferred greater tissue neuroprotection and improved locomotor recovery compared to methylprednisolone. Further a 4 hour time window of histologic and behavioral efficacy was established. The goal of these experiments was to help guide the treatment parameters for a clinical trial of magnesium within a polyethylene glycol formulation in acute human spinal cord injury.	[Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, CNOSP, Vancouver, BC V5Z 3J5, Canada; [Kwon, Brian K.; Lee, Jae H. T.; Okon, Elena; Zhang, Hongbin] Univ British Columbia, ICORD, Vancouver, BC V5Z 3J5, Canada; [Roy, Josee; Marx, Jeffrey C.] Medtron Spine & Biol, Memphis, TN USA; [Kindy, Mark S.] Med Univ S Carolina, Charleston, SC 29425 USA		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver Gen Hosp, D6 Heather Pavil,2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	brian.kwon@vch.ca		Okon, Elena/0000-0001-8568-5771			Antman E, 2002, LANCET, V360, P1189, DOI 10.1016/S0140-6736(02)11278-5; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chan MTV, 2005, ACT NEUR S, V95, P107; Demediuk P, 1990, Adv Neurol, V52, P225; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Dohi K, 2005, CRIT CARE MED, V33, P698, DOI 10.1097/01.CCM.0000155907.21185.C0; Duerstock BS, 2002, J EXP BIOL, V205, P13; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Durlach J, 2005, MAGNESIUM RES, V18, P187; Eck JC, 2006, SPINE, V31, pE250, DOI 10.1097/01.brs.0000214886.21265.8c; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Fisher M, 2003, STROKE, V34, P1539, DOI 10.1161/01.STR.0000072983.64326.53; Fisher M, 2007, STROKE, V38, P245, DOI 10.1161/01.STR.0000255951.37434.aa; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Gowda RM, 2004, INT J CARDIOL, V96, P467, DOI 10.1016/j.ijcard.2003.04.067; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Jellish WS, 2008, ANESTHESIOLOGY, V108, P78, DOI 10.1097/01.anes.0000296109.04010.82; Jiang S, 2004, INT J IMMUNOPATH PH, V17, P353, DOI 10.1177/039463200401700315; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Li J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002755.pub2; Luo J, 2004, NEUROSCI LETT, V359, P167, DOI 10.1016/j.neulet.2004.02.027; Mami A, 2006, NEUROCHEM RES, V31, P63, DOI 10.1007/s11064-005-9076-5; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; MUIR KW, 1995, STROKE, V26, P1183, DOI 10.1161/01.STR.26.7.1183; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Ozdemir M, 2005, MAGNESIUM RES, V18, P170; Poschel KA, 2000, KIDNEY INT, V58, P2478, DOI 10.1046/j.1523-1755.2000.00431.x; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Solaroglu I, 2005, SURG NEUROL, V64, P17, DOI 10.1016/j.surneu.2005.07.058; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Yang Y, 2000, NEUROSCI LETT, V285, P119, DOI 10.1016/S0304-3940(00)01048-X; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	60	42	42	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1379	1393		10.1089/neu.2009.0884			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900021	19317592				2022-02-06	
J	Schlenk, F; Vajkoczy, P; Sarrafzadeh, A				Schlenk, Florian; Vajkoczy, Peter; Sarrafzadeh, Asita			Inpatient Hyperglycemia Following Aneurysmal Subarachnoid Hemorrhage: Relation to Cerebral Metabolism and Outcome	NEUROCRITICAL CARE			English	Article						Cerebral metabolism; Microdialysis; Subarachnoid hemorrhage; Hyperglycemia; Glucose; Outcome	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; ENERGY-METABOLISM; PLASMA-GLUCOSE; COMPLICATIONS; IMPACT; VALUES; VASOSPASM	Despite its clear association with impaired prognosis, it remains controversial whether hyperglycemia after aneurysmal subarachnoid hemorrhage (SAH) actively contributes to neuronal damage. This study aimed to identify a threshold for blood glucose predicting unfavorable outcome, and to evaluate differences in cerebral metabolism in normo and hyperglycemic SAH patients. Prospectively, blood glucose and cerebral metabolism, measured by cerebral microdialysis, were evaluated in 178 patients (WFNS grade I-V; age 51.6 +/- A 12.4 years) during days 1-7 after SAH. Patients were classified into groups with mean blood glucose levels a parts per thousand currency sign/> 6.1 mmol/l (110 mg/dl) and 7.8 mmol/l (140 mg/dl). Glasgow Outcome Score was assessed after 12 months. Higher inpatient blood glucose was associated with impaired prognosis, with a threshold of 7.5 mmol/l (135 mg/dl) distinguishing best between favorable and unfavorable outcome. Inpatient glucose levels > 6.1 mmol/l (110 mg/dl) were associated with higher cerebral lactate and lactate/pyruvate ratio (P < 0.05). Cerebral glucose was elevated only at blood levels > 7.8 mmol/l (140 mg/dl). Inpatient glucose levels above 7.8 mmol/l (140 mg/dl) were independent predictors of unfavorable outcome and mortality. Blood glucose levels > 7.8 mmol/l (140 mg/dl), but not levels > 6.1 mmol/l (110 mg/dl), independently predicted unfavorable outcome. While blood glucose levels > 6.1 mmol/l (110 mg/dl) were already associated with slight metabolic derangements, cerebral glucose increased only at blood levels > 7.8 mmol/l (140 mg/dl). Considering the risks associated with tight glycemic control, a moderate regimen accepting blood glucose levels up to 7.8 mmol/l (140 mg/dl) might be more reasonable after SAH.	[Schlenk, Florian; Vajkoczy, Peter; Sarrafzadeh, Asita] Charite Univ Med Berlin, Charite Campus Virchow Med Ctr, Dept Neurosurg, D-13353 Berlin, Germany		Sarrafzadeh, A (corresponding author), Charite Univ Med Berlin, Charite Campus Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.	asita.sarrafzadeh@charite.de					Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Badjatia N, 2005, CRIT CARE MED, V33, P1603, DOI 10.1097/01.CCM.0000168054.60538.2B; Bell DA, 2005, BRIT J NEUROSURG, V19, P21, DOI 10.1080/02688690500089423; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; BLACK CT, 1990, J TRAUMA, V30, P830, DOI 10.1097/00005373-199007000-00012; BLACK CT, 1990, J TRAUMA, V30, P832, DOI DOI 10.1097/00005373-199007000-00012; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; DRAKE CG, 1988, J NEUROSURG, V68, P985; Falciglia M, 2007, CURR OPIN CLIN NUTR, V10, P498, DOI 10.1097/MCO.0b013e3281a3bf0a; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; JENNETT B, 1975, LANCET, V1, P480; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Nilsson OG, 1996, ACT NEUR S, V67, P45; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Prakash A, 2008, CURR OPIN ANESTHESIO, V21, P565, DOI 10.1097/ACO.0b013e32830f44e4; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; WOO E, 1988, STROKE, V19, P1359, DOI 10.1161/01.STR.19.11.1359	37	42	46	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2009	11	1					56	63		10.1007/s12028-009-9222-z			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	468AU	WOS:000267786400011	19418265				2022-02-06	
J	Sander, AM; Clark, AN; Atchison, TB; Rueda, M				Sander, Angelle M.; Clark, Allison N.; Atchison, Timothy B.; Rueda, Misty			A Web-Based Videoconferencing Approach to Training Caregivers in Rural Areas to Compensate for Problems Related to Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregivers; traumatic brain injury; Web-based videoconferencing	EXPRESSIVE VOCABULARY DELAYS; RANDOMIZED CONTROLLED-TRIAL; SEVERE HEAD-INJURY; LONG-TERM; COGNITIVE REHABILITATION; PRELIMINARY EFFICACY; FAMILY INTERVENTION; TELEREHABILITATION; SUPERVISION; DISTRESS	Objective: To describe the development and the implementation of a Web-based, videoconferencing training program for caregivers of adults with traumatic brain injury in rural areas to manage cognitive and behavioral changes in the person with the injury. Design: Feasibility study, with satisfaction and perceived utility assessed. Intervention: Six Web-based videoconference sessions, combining didactic education and problem-solving. Participants: Fifteen caregivers of persons with complicated mild, moderate, or severe traumatic brain injury, who were admitted to a level III trauma center in a rural area of Texas. Measures: Satisfaction survey and perceived utility questions conducted immediately following training and at an average of 18 months after training. Results: Participants' overall satisfaction and comfort with the training was high. They perceived that they gained knowledge that was applicable to the everyday problems being experienced. At follow-up, all participants reported having used the knowledge gained to help cope with problems and all had referred to the written materials at least once since the training. Conclusions: Web-based videoconferencing can be used to provide training to caregivers to manage cognitive and behavioral problems resulting from traumatic brain injury. However, there are obstacles related to willingness to seek help among persons in rural areas that must be overcome.	[Sander, Angelle M.; Clark, Allison N.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.; Clark, Allison N.] Harris Cty Hosp Dist, Houston, TX USA; [Atchison, Timothy B.; Rueda, Misty] W Texas A&M Univ, Dept Psychol Sociol & Social Work, Canyon, TX USA; [Sander, Angelle M.; Clark, Allison N.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Sander, AM (corresponding author), Brain Injury Res Ctr, TIRR, 2323 S Shepherd Ste 907, Houston, TX 77019 USA.	asander@bcm.tmc.edu			National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [H133B031117]	This work was supported by a grant from the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant no. H133B031117 Rehabilitation Research and Training Center on Community Integration in Persons With Traumatic Brain Injury). The authors thank staff at the West Texas A&M Interactive T V Center; Deann Hoececk, MA, Laura Rosas, MA, and Delisa West, PhD for contributing to the development of the sessions; and Jason and Susannah Terguson for consumer review of the sessions.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bell KR, 2003, J HEAD TRAUMA REHAB, V18, P504, DOI 10.1097/00001199-200311000-00004; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bushy Angeline, 2008, Annu Rev Nurs Res, V26, P221; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Carr E. G., 1999, POSITIVE BEHAV SUPPO; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; Diamond BJ, 2003, NEUROREHABILITATION, V18, P171; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Girolametto L, 1999, AM J SPEECH-LANG PAT, V8, P364, DOI 10.1044/1058-0360.0804.364; Girolametto L, 1996, J SPEECH HEAR RES, V39, P1274, DOI 10.1044/jshr.3906.1274; Goldberg D., 1972, DETECTION PSYCHIAT I; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hart-Hester S, 2003, SOUTH MED J, V96, P149, DOI 10.1097/01.SMJ.0000051180.92828.DD; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johnson ME, 2006, ADM POLICY MENT HLTH, V33, P504, DOI 10.1007/s10488-005-0001-7; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kaiser AP, 1996, TOP EARLY CHILD SPEC, V16, P375, DOI 10.1177/027112149601600307; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LEVIN HS, 1993, HEAD INJURY, P525; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Loftin WA, 2005, DIABETES EDUCATOR, V31, P251, DOI 10.1177/0145721705275517; Long K A, 1989, Sch Inq Nurs Pract, V3, P113; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McGrath N, 2008, J HEAD TRAUMA REHAB, V23, P388, DOI 10.1097/01.HTR.0000341434.74875.c8; MCLINLAY WW, 1999, REHABILITATION ADULT, P74; Millis S R, 1994, Int J Neurosci, V79, P165; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PRESSLEY M, 1995, EDUC PSYCHOL, V30, P207, DOI 10.1207/s15326985ep3004_6; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Savard L, 2003, NEUROREHABILITATION, V18, P93; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SMITH L, 1995, RAMILY SUPPORT PROGR; Sohlberg M., 2001, COGNITIVE REHABILITA; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winters JM, 2002, ANNU REV BIOMED ENG, V4, P287, DOI 10.1146/annurev.bioeng.4.112801.121923; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	66	42	42	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2009	24	4					248	261		10.1097/HTR.0b013e3181ad593a			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	506SK	WOS:000270796000004	19625864				2022-02-06	
J	Miller, WJ; Leventhal, I; Scarsella, D; Haydon, PG; Janmey, P; Meaney, DF				Miller, William J.; Leventhal, Ilya; Scarsella, David; Haydon, Philip G.; Janmey, Paul; Meaney, David F.			Mechanically Induced Reactive Gliosis Causes ATP-Mediated Alterations in Astrocyte Stiffness	JOURNAL OF NEUROTRAUMA			English	Article						glia cell response to injury; in vitro studies; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; ATOMIC-FORCE MICROSCOPY; STRETCH-INDUCED INJURY; VISCOELASTIC PROPERTIES; PURINERGIC RECEPTORS; CULTURED ASTROCYTES; EXTRACELLULAR ATP; KINASE; CELLS; ELASTICITY	Reactive gliosis is a process triggered in astrocytes after traumatic injury, yet the exact consequences of gliosis on cellular survival and neural regenerative processes in the injured brain remain only partly understood. One recently discovered feature influencing neuronal growth and differentiation is the physical stiffness of the environment surrounding pioneering neurites. In this study, the mechanical properties of cultured cortical astrocytes are measured following a mechanical stretch injury that induces reactive gliosis. In mechanically injured cultures, there was a significant increase in glial fibrillary acidic protein (GFAP) immunoreactivity 24 h following a rapid, transient 15% strain. In these same cultures, astrocytes in the surrounding region-the "mechanical penumbra''-also exhibited increased GFAP immunoreactivity compared to naive cultures. Correlated with these changes in GFAP was a general softening of the non-nuclear regions of the astrocytes, both in the injured and penumbra cells, as measured by atomic force microscopy (AFM). The elastic modulus in naive cultures was observed to be 57.7 +/- 5.8 kPa in non-nuclear regions of naive cultures, while 24 h after injury the modulus was observed to be 26.4 +/- 4.9 kPa in the same region of injured cells. In the penumbra of injured cultures, the modulus was 23.7 +/- 3.6 kPa. Alterations in astrocyte stiffness in the area of injury and mechanical penumbra were ameliorated by pretreating cultures with a nonselective P2 receptor antagonist (PPADS). Since neuronal cells generally prefer softer substrates for growth and neurite extension, these findings may indicate that the mechanical characteristics of reactive astrocytes are favorable for neuronal recovery after traumatic brain injury.	[Miller, William J.; Leventhal, Ilya; Scarsella, David; Janmey, Paul; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Janmey, Paul] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Janmey, Paul] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Haydon, Philip G.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA		Meaney, DF (corresponding author), 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 HD41699, NS35712]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035712] Funding Source: NIH RePORTER	Funds were provided by the National Institute of Health ( grants RO1 HD41699 and NS35712).	Abbracchio MP, 1996, CIBA F SYMP, V198, P142; AbdElBasset EM, 1997, J NEUROSCI RES, V49, P608, DOI 10.1002/(SICI)1097-4547(19970901)49:5<608::AID-JNR11>3.0.CO;2-R; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Brambilla R, 2002, J NEUROCHEM, V83, P1285, DOI 10.1046/j.1471-4159.2002.01239.x; Caille N, 2002, J BIOMECH, V35, P177, DOI 10.1016/S0021-9290(01)00201-9; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Costa KD, 1999, J BIOMECH ENG-T ASME, V121, P462, DOI 10.1115/1.2835074; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Floyd CL, 2004, J NEUROTRAUM, V21, P205, DOI 10.1089/089771504322778668; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hanbury R, 2003, J COMP NEUROL, V461, P307, DOI 10.1002/cne.10667; HOH JH, 1994, J CELL SCI, V107, P1105; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Landau L. D., 1970, THEORY ELASTICITY; Lenz G, 2000, BRIT J PHARMACOL, V129, P927, DOI 10.1038/sj.bjp.0703138; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Martens JC, 2008, PFLUG ARCH EUR J PHY, V456, P95, DOI 10.1007/s00424-007-0419-8; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Moreels M, 2008, NEUROPATH APPL NEURO, V34, P532, DOI 10.1111/j.1365-2990.2007.00910.x; Munsch N, 1998, BIOMED PHARMACOTHER, V52, P180, DOI 10.1016/S0753-3322(98)80208-4; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Neary JT, 1998, NEUROSCI LETT, V242, P159, DOI 10.1016/S0304-3940(98)00067-6; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Otani N, 2003, ACTA NEUROCHIR SUPPL, V86, P267; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2001, Prog Brain Res, V132, P23; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Ricci D, 1997, MICROSC RES TECHNIQ, V36, P165, DOI 10.1002/(SICI)1097-0029(19970201)36:3<165::AID-JEMT4>3.0.CO;2-O; Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; SHREIBER DI, 1997, 41 STAPP CAR CRASH C; Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI [DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4]; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yamane Y, 2000, J ELECTRON MICROSC, V49, P463, DOI 10.1093/oxfordjournals.jmicro.a023830; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	64	42	42	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2009	26	5					789	797		10.1089/neu.2008.0727			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	452XM	WOS:000266574500013	19331521	Green Accepted, Green Submitted			2022-02-06	
J	Scafidi, S; O'Brien, J; Hopkins, I; Robertson, C; Fiskum, G; McKenna, M				Scafidi, Susanna; O'Brien, Janet; Hopkins, Irene; Robertson, Courtney; Fiskum, Gary; McKenna, Mary			Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats	JOURNAL OF NEUROCHEMISTRY			English	Article; Proceedings Paper	3rd International-Society-of-Neurochemistry-Special-Neurochemistry Conference/8th International Meeting on Brain Energy Metabolism	JUN 27-JUL 01, 2008	Beijing, PEOPLES R CHINA	Int Soc Neurochem		C-13-NMR spectroscopy; GABA; glucose; glutamate; immature brain; metabolism; PC; PDHC; traumatic brain injury	GLIAL-NEURONAL INTERACTIONS; CONTROLLED CORTICAL IMPACT; MITOCHONDRIAL DYSFUNCTION; IMMATURE RATS; ENERGY-METABOLISM; GLUTAMATE RELEASE; HEAD-INJURY; CYCLE; INCREASES; PYRUVATE	Traumatic brain injury (TBI) results in a cerebral metabolic crisis that contributes to poor neurologic outcome. The aim of this study was to characterize changes in oxidative glucose metabolism in early periods after injury in the brains of immature animals. At 5 h after controlled cortical impact TBI or sham surgery to the left cortex, 21-22 day old rats were injected intraperitoneally with [1,6-C-13]glucose and brains removed 15, 30 and 60 min later and studied by ex vivo C-13-NMR spectroscopy. Oxidative metabolism, determined by incorporation of C-13 into glutamate, glutamine and GABA over 15-60 min, was significantly delayed in both hemispheres of brain from TBI rats. The most striking delay was in labeling of the C4 position of glutamate from neuronal metabolism of glucose in the injured, ipsilateral hemisphere which peaked at 60 min, compared with the contralateral and sham-operated brains, where metabolism peaked at 30 and 15 min, respectively. Our findings indicate that (i) neuronal-specific oxidative metabolism of glucose at 5-6 h after TBI is delayed in both injured and contralateral sides compared with sham brain; (ii) labeling from metabolism of glucose via the pyruvate carboxylase pathway in astrocytes was also initially delayed in both sides of TBI brain compared with sham brain; (iii) despite this delayed incorporation, at 6 h after TBI, both sides of the brain showed apparent increased neuronal and glial metabolism, reflecting accumulation of labeled metabolites, suggesting impaired malate aspartate shuttle activity. The presence of delayed metabolism, followed by accumulation of labeled compounds is evidence of severe alterations in homeostasis that could impair mitochondrial metabolism in both ipsilateral and contralateral sides of brain after TBI. However, ongoing oxidative metabolism in mitochondria in injured brain suggests that there is a window of opportunity for therapeutic intervention up to at least 6 h after injury.	[Scafidi, Susanna; O'Brien, Janet; Hopkins, Irene; Robertson, Courtney; McKenna, Mary] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Robertson, Courtney; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA		McKenna, M (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 655 W Baltimore St,R 13-019, Baltimore, MD 21201 USA.	mmckenna@umaryland.edu		Scafidi, Susanna/0000-0002-1229-8778	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD016596, HD16596, P01 HD016596-240001, P01 HD016596-24] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER		Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Haberg A, 2001, J CEREBR BLOOD F MET, V21, P1451, DOI 10.1097/00004647-200112000-00010; HASSEL B, 1995, J NEUROCHEM, V64, P2773; HASSEL B, 1995, J NEUROCHEM, V65, P2227; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HIGGINS JJ, 1994, J CHILD NEUROL, V9, P436, DOI 10.1177/088307389400900421; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Oz G, 2004, J NEUROSCI, V24, P11273, DOI 10.1523/JNEUROSCI.3564-04.2004; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Qu H, 2003, NEUROCHEM INT, V42, P101, DOI 10.1016/S0197-0186(02)00051-7; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Satrustegui J, 2007, J NEUROSCI RES, V85, P3359, DOI 10.1002/jnr.21299; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; TAKEUCHI H, 2008, EXP NEUROL; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; Waagepetersen HS, 2000, NEUROCHEM INT, V36, P349, DOI 10.1016/S0197-0186(99)00143-6; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	43	42	44	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2009	109			1			189	197		10.1111/j.1471-4159.2009.05896.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	430UF	WOS:000265013900027	19393027	Green Accepted, Bronze			2022-02-06	
J	Young, ME; Clark, MH; Goffus, A; Hoane, MR				Young, Michael E.; Clark, M. H.; Goffus, Andrea; Hoane, Michael R.			Mixed effects modeling of Morris water maze data: Advantages and cautionary notes	LEARNING AND MOTIVATION			English	Article						Learning curves; Nonlinear analysis; Repeated measures; Monte Carlo simulation	TRAUMATIC BRAIN-INJURY; LONGITUDINAL DATA; RATS	Morris water maze data are most commonly analyzed using repeated measures analysis of variance in which daily test sessions are analyzed as an unordered categorical variable. This approach, however, may lack power, relies heavily on post hoc tests of daily performance that can complicate interpretation, and does not target the nonlinear trends evidenced in learning data. The present project used Monte Carlo simulation to compare the relative strengths of the traditional approach with both linear and nonlinear mixed effects modeling that identifies the learning function for each animal and condition. Both trend-based mixed effects modeling approaches showed much greater sensitivity to identifying real effects, and the nonlinear approach provided uniformly better fits of learning trends. The common practice of removing a rat from the maze after 90 s, however, proved more problematic for the nonlinear approach and produced an underestimate of y-axis intercepts. (c) 2008 Elsevier Inc. All rights reserved.	[Young, Michael E.; Clark, M. H.; Goffus, Andrea; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA		Young, ME (corresponding author), So Illinois Univ, Dept Psychol, Mailcode 6502, Carbondale, IL 62901 USA.	meyoung@siu.edu	Young, Michael E./G-5388-2014	Young, Michael E./0000-0003-1493-9548; Hoane, Michael/0000-0001-7779-2657			Bates D.M., 1988, NONLINEAR REGRESSION, V2; Cohen J., 1983, APPL MULTIPLE REGRES; Creelman, 2004, DETECTION THEORY USE; Cudeck R, 2007, ANNU REV PSYCHOL, V58, P615, DOI 10.1146/annurev.psych.58.110405.085520; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; DeFord SM, 2001, PHARMACOL BIOCHEM BE, V69, P611, DOI 10.1016/S0091-3057(01)00559-7; ESTES WK, 1950, PSYCHOL REV, V57, P94, DOI 10.1037/h0058559; Everitt BS, 1998, BRIT J PSYCHIAT, V172, P7, DOI 10.1192/bjp.172.1.7; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Gulliksen H, 1942, PSYCHOMETRIKA, V7, P171, DOI 10.1007/BF02288615; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Jonsson EN, 2000, AAPS PHARMSCI, V2, part. no.; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; Pinheiro J.C., 2004, MIXED EFFECTS MODELS; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Shkedy Z, 2005, J BIOPHARM STAT, V15, P205, DOI 10.1081/BIP-200048815; Shull R. L., 1991, EXPT ANAL BEHAV, P243; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006	21	42	42	2	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0023-9690			LEARN MOTIV	Learn. Motiv.	MAY	2009	40	2					160	177		10.1016/j.lmot.2008.10.004			18	Psychology, Biological; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	429LG	WOS:000264921300005					2022-02-06	
J	Sparrey, CJ; Manley, GT; Keaveny, TM				Sparrey, Carolyn J.; Manley, Geoffrey T.; Keaveny, Tony M.			Effects of White, Grey, and Pia Mater Properties on Tissue Level Stresses and Strains in the Compressed Spinal Cord	JOURNAL OF NEUROTRAUMA			English	Article						age; finite element models; models of injury; traumatic spinal cord injury	MECHANICAL-PROPERTIES; BRAIN-TISSUE; GRAY-MATTER; IN-VITRO; INJURY; OUTCOMES	Recent demographics demonstrate an increase in the number of elderly spinal cord injury patients, motivating the desire for a better understanding of age effects on injury susceptibility. Knowing that age and disease affect neurological tissue, there is a need to better understand the sensitivity of spinal cord injury mechanics to variations in tissue behavior. To address this issue, a plane-strain, geometrically nonlinear, finite element model of a section of a generic human thoracic spinal cord was constructed to model the response to dorsal compression. The material models and stiffness responses for the grey and white matter and pia mater were varied across a range of reported values to observe the sensitivity of model outcomes to the assigned properties. Outcome measures were evaluated for percent change in magnitude and alterations in spatial distribution. In general, principal stresses (114-244% change) and pressure (75-119% change) were the outcomes most sensitive to material variation. Strain outcome measures were less sensitive (7-27% change) than stresses (74-244% change) to variations in material tangent modulus. The pia mater characteristics had limited (<4% change) effects on outcomes. Using linear elastic models to represent non-linear behavior had variable effects on outcome measures, and resulted in highly concentrated areas of elevated stresses and strains. Pressure measurements in both the grey and white matter were particularly sensitive to white matter properties, suggesting that degenerative changes in white matter may influence perfusion in a compressed spinal cord. Our results suggest that the mechanics of spinal cord compression are likely to be affected by changes in tissue resulting from aging and disease, indicating a need to study the biomechanical aspects of spinal cord injury in these specific populations.	[Sparrey, Carolyn J.; Keaveny, Tony M.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Manley, Geoffrey T.; Keaveny, Tony M.] Univ Calif Berkeley, Dept Neurol Surg, Berkeley, CA 94720 USA; [Keaveny, Tony M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA		Keaveny, TM (corresponding author), Univ Calif Berkeley, Dept Mech Engn, 6175 Etcheverry Hall, Berkeley, CA 94720 USA.	tmk@me.berkeley.edu		Sparrey, Carolyn/0000-0002-5524-4577	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [UCSF-3915SC]; University of California-BerkeleyUniversity of California System	This work was funded in part by Centers for Disease Control and Prevention grant UCSF-3915SC and a Chancellor's Professorship (T. M. K.) from the University of California-Berkeley.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; ANDERSON TE, 1985, J NEUROSURG, V62, P115, DOI 10.3171/jns.1985.62.1.0115; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bilston L, 1998, IRCOBI C GOT, P365; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; Carlson GD, 1997, SPINE, V22, P1285, DOI 10.1097/00007632-199706150-00002; Carlson GD, 2000, SPINE, V25, P1218, DOI 10.1097/00007632-200005150-00004; CHANG GL, 1988, J BIOMECH ENG-T ASME, V110, P115, DOI 10.1115/1.3108415; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Fiford RJ, 2005, J BIOMECH, V38, P1509, DOI 10.1016/j.jbiomech.2004.07.009; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Galle B, 2007, J BIOMECH, V40, P3029, DOI 10.1016/j.jbiomech.2007.03.014; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; HUNG TK, 1981, J BIOMECH ENG-T ASME, V103, P43, DOI 10.1115/1.3138244; Ichihara K, 2003, J NEUROSURG, V99, P278, DOI 10.3171/spi.2003.99.3.0278; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; JAWAD SA, 1978, J MATER SCI, V13, P1381, DOI 10.1007/BF00553190; Jin Xin, 2006, Stapp Car Crash J, V50, P637; KEARNEY P A, 1988, Journal of Neurotrauma, V5, P187, DOI 10.1089/neu.1988.5.187; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; McKinley W, 2003, NEUROREHABILITATION, V18, P83; McKinley W, 2007, J SPINAL CORD MED, V30, P215, DOI 10.1080/10790268.2007.11753929; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; NOYES DH, 1987, EXP NEUROL, V95, P535, DOI 10.1016/0014-4886(87)90298-6; Oakland RJ, 2006, P I MECH ENG H, V220, P489, DOI 10.1243/09544119JETM135; Ogden, 1984, NONLINEAR ELASTIC DE; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; SCHOENEN J, 2004, HUMAN NERVOUS SYSTEM, P1366; SCIFERT J, 2000, P 22 ANN EMBS INT C, P855; SPARREY CJ, 2004, MECH ENG	39	42	46	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2009	26	4					585	595		10.1089/neu.2008.0654			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	430OV	WOS:000264999300010	19292657	Green Published			2022-02-06	
J	Kraemer, WJ; Spiering, BA; Volek, JS; Martin, GJ; Howard, RL; Ratamess, NA; Hatfield, DL; Vingren, JL; Ho, JY; Fragala, MS; Thomas, GA; French, DN; Anderson, JM; Hakkinen, K; Maresh, CM				Kraemer, William J.; Spiering, Barry A.; Volek, Jeff S.; Martin, Gerard J.; Howard, Robert L.; Ratamess, Nicholas A.; Hatfield, Disa L.; Vingren, Jakob L.; Ho, Jen Yu; Fragala, Maren S.; Thomas, Gwendolyn A.; French, Duncan N.; Anderson, Jeffrey M.; Hakkinen, Keijo; Maresh, Carl M.			RECOVERY FROM A NATIONAL COLLEGIATE ATHLETIC ASSOCIATION DIVISION I FOOTBALL GAME: MUSCLE DAMAGE AND HORMONAL STATUS	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						competition; contact sports; collision injury; endocrine; performance; recovery; skeletal muscle	SALIVA CORTISOL; CREATINE-KINASE; RUGBY MATCH; T/C RATIO; EXERCISE; TESTOSTERONE; PERFORMANCE; RESPONSES; STRENGTH; COMPETITION	Kraemer, WJ, Spiering, BA, Volek, JS, Martin, GJ, Howard, RL, Ratamess, NA, Hatfield, DL, Vingren, JL, Ho, JY, Fragala, MS, Thomas, GA, French, DN, Anderson, JM, Hakkinen, K, and Maresh, CM. Recovery from a National Collegiate Athletic Association Division I football game: muscle damage and hormonal status. J Strength Cond Res 23(1): 2-10, 2009-Recovery from an American football game has had limited study. The purpose of this study was to examine markers of skeletal muscle tissue damage and circulating anabolic and catabolic hormones to gain insight into the recovery process from Friday until Monday, when a new practice week begins. Twenty-eight National Collegiate Athletic Association Division I football players gave consent to participate in the investigation in the ninth game of the season. Sixteen players started the game and played the entire game (PL), and 12 others did not play and were on the bench during the game (DNP). Each player had fasted blood samples obtained at the same time of day between 1000 and 1200 hours the day before the game (Friday; T1), 18-20 hours after the game (Sunday; T2), and then 42-44 hours after the game (Monday; T3). Blood samples were analyzed for concentrations of creatine kinase (CK), lactate dehydrogenase (LDH), myoglobin, testosterone, and cortisol. The PL players showed significantly (p <= 0.05) increased concentrations of CK (T2 > T1 and T3), myoglobin (T2 > T1 and T3), and LDH (T2 > T1). In contrast, DNP players showed significant differences in cortisol (T3 < T1 and T2) and testosterone: cortisol (T3 > T1). Few changes were observed in testosterone and cortisol changes, indicating stability of the anabolic/catabolic hormones. In conclusion, these data indicate that participation in a college football game late in the season results in some degree of tissue damage but with minimal hormonal responses, which seem to have stabilized at resting concentrations without predominance of cortisol's catabolic presence. As previously noted in the literature, some type of "contact adaptation'' to the season may have occurred with regard to tissue damage responses. However, by the ninth game of a season, players do carry soft tissue damage levels above resting ranges into subsequent games, indicating that recovery should be monitored, with coaches being careful with scheduling scrimmage and full-contact drills. How such data implicate overuse injuries remains unclear, considering that hormonal status in this study was highly stable, with catabolic influences minimized by the high level of athlete conditioning. These data again support that high-level conditioning can stabilize anabolic and catabolic hormonal signals and limit acute soft tissue injury, making cerebral concussion (acute and chronic) and traumatic injury the biggest threats to a student-athlete's health and well-being during an American football game.	[Kraemer, William J.; Spiering, Barry A.; Volek, Jeff S.; Howard, Robert L.; Ratamess, Nicholas A.; Hatfield, Disa L.; Vingren, Jakob L.; Ho, Jen Yu; Fragala, Maren S.; Thomas, Gwendolyn A.; French, Duncan N.; Anderson, Jeffrey M.; Maresh, Carl M.] Univ Connecticut, Dept Kinesiol, Human Performance Lab, Storrs, CT 06269 USA; [Howard, Robert L.; Anderson, Jeffrey M.] Univ Connecticut, Dept Sports Med, Storrs, CT USA; [Martin, Gerard J.] Univ Connecticut, Div Athlet, Storrs, CT USA; [Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Hakkinen, Keijo] Univ Jyvaskyla, Neuromuscular Res Ctr, Jyvaskyla, Finland		Kraemer, WJ (corresponding author), Univ Connecticut, Dept Kinesiol, Human Performance Lab, Storrs, CT 06269 USA.	William.Kraemer@uconn.edu					ADLERCREUTZ H, 1986, INT J SPORTS MED, V7, P27; Borsheim E, 2004, J APPL PHYSIOL, V96, P674, DOI 10.1152/japplphysiol.00333.2003; Duda GN, 2008, EXERC SPORT SCI REV, V36, P64, DOI 10.1097/JES.0b013e318168eb88; Ehlers GG, 2002, J ATHL TRAINING, V37, P151; Elloumi M, 2003, EUR J APPL PHYSIOL, V90, P23, DOI 10.1007/s00421-003-0868-5; Ferri A, 2006, EUR J APPL PHYSIOL, V97, P272, DOI 10.1007/s00421-006-0168-y; FRY AC, 1994, MED SCI SPORT EXER, V26, P1165; Garry J P, 2000, MedGenMed, V2, pE4; Gonzalez-Bono E, 1999, HORM BEHAV, V35, P55, DOI 10.1006/hbeh.1998.1496; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hawke TJ, 2005, EXERC SPORT SCI REV, V33, P63, DOI 10.1097/00003677-200504000-00002; Hoffman JR, 2005, MED SCI SPORT EXER, V37, P1237, DOI 10.1249/01.mss.0000170068.97498.26; Hoffman JR, 2002, MED SCI SPORT EXER, V34, P1845, DOI 10.1097/00005768-200211000-00023; Hubal MJ, 2007, MED SCI SPORT EXER, V39, P461, DOI 10.1249/01.mss.0000247007.19127.da; JAFFE AS, 1984, AM J CARDIOL, V53, P856, DOI 10.1016/0002-9149(84)90419-3; Kraemer WJ, 1997, J STRENGTH COND RES, V11, P131; Kraemer WJ, 2004, J STRENGTH COND RES, V18, P121; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1367, DOI 10.1097/00005768-200108000-00019; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Kraemer WJ, 2000, EXERCISE SPORT SCI, P798; Kvorning T, 2007, J PHYSIOL-LONDON, V578, P579, DOI 10.1113/jphysiol.2006.122671; Kvorning T, 2006, AM J PHYSIOL-ENDOC M, V291, pE1325, DOI 10.1152/ajpendo.00143.2006; Malm C, 2001, ACTA PHYSIOL SCAND, V171, P233, DOI 10.1046/j.1365-201x.2001.00825.x; Moore CA, 2007, J STRENGTH COND RES, V21, P793, DOI 10.1519/r-20906.1; Nosaka K, 1997, J SPORT SCI, V15, P477, DOI 10.1080/026404197367119; Passelergue P, 1999, INT J SPORTS MED, V20, P109; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Spiering BA, 2008, SPORTS MED, V38, P527, DOI 10.2165/00007256-200838070-00001; Spiering BA, 2008, MED SCI SPORT EXER, V40, P1039, DOI 10.1249/MSS.0b013e31816722bd; Stuart Michael J, 2005, Med Sport Sci, V49, P62, DOI 10.1159/000085392; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Tidball JG, 2002, CLIN ORTHOP RELAT R, pS100, DOI 10.1097/01.blo.0000031311.06353.d6	33	42	44	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	JAN	2009	23	1					2	10		10.1519/JSC.0b013e31819306f2			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	514NB	WOS:000271400500002	19077734				2022-02-06	
J	Yu, WR; Liu, TY; Fehlings, TK; Fehlings, MG				Yu, Wen Ru; Liu, Tianyi; Fehlings, Tara K.; Fehlings, Michael G.			Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; Bcl-2 family proteins; Fas; mitochondrial dysfunction; spinal cord injury	BCL-2 FAMILY PROTEINS; NEURONAL CELL-DEATH; FUNCTIONAL RECOVERY; CYTOCHROME-C; GRADED MODEL; CASPASE 8; ACTIVATION; MOUSE; RECEPTOR; LIGAND	Activation of the Fas receptor has been recently linked to apoptotic cell death after spinal cord injury (SCI). Although it is generally considered that Fas activation mediates apoptosis predominantly through the extrinsic pathway, we hypothesized that intrinsic mitochondrial signaling could be involved in the underlying mechanism of Fas-induced apoptosis after SCI. In the present study, we utilized the Fejota(TM) clip compression model of SCI at T5-6 in C57BL/6 Fas-deficient (lpr) and wild-type mice. Complementary studies were conducted using an in vitro model of trauma or a Fas-activating antibody to induce apoptosis in primary neuronal-glial mixed spinal cord cultures. After in vivo SCI, lpr mice, in comparison with wild-type mice, exhibited reduced numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells at the lesion, reduced expression of truncation of Bid (tBid), apoptosis-inducing factor, activated caspase-9 and activated caspase-3, and increased expression of the antiapoptotic proteins Bcl-2 and Bcl-xL. After in vitro neurotrauma or the induction of Fas signaling by the Jo2 activating antibody, lpr spinal cord cultures showed an increased proportion of cells retaining mitochondrial membrane integrity and a reduction of tBid expression, caspase-9 and caspase-3 activation, and TUNEL-positive cells as compared to wild-type spinal cord cultures. The neutralization of Fas ligand (FasL) protected against traumatically induced or Fas-mediated caspase-3 activation and the loss of mitochondrial membrane potential and tBid expression in wild-type spinal cord cultures. However, in lpr spinal cord cultures, FasL neutralization had no protective effects. In summary, these data provide direct evidence for the induction of intrinsic mitochondrial signaling pathways following Fas activation after SCI.	[Fehlings, Michael G.] Toronto Western Hosp, Univ Hlth Network, Krembil Chair Neural Repair & Regenerat, Toronto Western Res Inst,Div Genet & Dev & Neuros, Toronto, ON M5T 2S8, Canada; Toronto Western Hosp, Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada		Fehlings, MG (corresponding author), Toronto Western Hosp, Univ Hlth Network, Krembil Chair Neural Repair & Regenerat, Toronto Western Res Inst,Div Genet & Dev & Neuros, Room 4W-449,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	michael@uhnres.utoronto.ca		Fehlings, Michael/0000-0002-5722-6364	PSI Foundation; Krembil Chair in Neural Repair and Regeneration	This work was supported by an operating grant received from the PSI Foundation. M. G. Fehlings is supported by the Krembil Chair in Neural Repair and Regeneration.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Adachi S, 1997, J BIOL CHEM, V272, P21878, DOI 10.1074/jbc.272.35.21878; Aggarwal S, 1999, CLIN EXP IMMUNOL, V117, P285; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Castiglione M, 2004, NEUROSCIENCE, V126, P889, DOI 10.1016/j.neuroscience.2004.04.038; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Citron BA, 1997, NEUROSCI LETT, V230, P25, DOI 10.1016/S0304-3940(97)00468-0; Cittelly DM, 2008, EXP NEUROL, V210, P295, DOI 10.1016/j.expneurol.2007.03.001; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cruise MW, 2005, J LEUKOCYTE BIOL, V78, P412, DOI 10.1189/jlb.0105005; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Joshi M, 2002, J NEUROTRAUM, V19, P191, DOI 10.1089/08977150252806956; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu SS, 1996, SCI CHINA SER C, V39, P168; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Pasquini LA, 2000, J NEUROSCI RES, V59, P601, DOI 10.1002/(SICI)1097-4547(20000301)59:5<601::AID-JNR3>3.0.CO;2-1; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Seki T, 2003, NEUROSURGERY, V53, P192, DOI 10.1227/01.NEU.0000068988.28788.2C; Seko Y, 2002, J AM COLL CARDIOL, V39, P1399, DOI 10.1016/S0735-1097(02)01776-X; Shiraishi H, 2002, LAB INVEST, V82, P1121, DOI 10.1097/01.LAB.0000029148.88524.CE; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 2000, J NEUROSCI, V20, P7246; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Yin XM, 2000, J MOL MED-JMM, V78, P203, DOI 10.1007/s001090000099; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yu FS, 2006, J NEUROTRAUM, V23, P595, DOI 10.1089/neu.2006.23.595; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	63	42	48	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2009	29	1					114	131		10.1111/j.1460-9568.2008.06555.x			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	387OO	WOS:000261961700012	19120440				2022-02-06	
J	Huang, APH; Tu, YK; Tsai, YH; Chen, YS; Hong, WC; Yang, CC; Kuo, LT; Su, IC; Huang, SH; Huang, SJ				Huang, Abel Po-Hao; Tu, Yong-Kwang; Tsai, Yi-Hsin; Chen, Yuan-Shen; Hong, Wei-Chen; Yang, Chi-Cheng; Kuo, Lu-Ting; Su, I-Chang; Huang, She-Hao; Huang, Sheng-Jean			Decompressive Craniectomy as the Primary Surgical Intervention for Hemorrhagic Contusion	JOURNAL OF NEUROTRAUMA			English	Article						decompressive craniectomy; surgery; traumatic brain injury	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; GLASGOW OUTCOME SCALE; CEREBRAL-BLOOD-FLOW; INTRACEREBRAL HEMATOMAS; MANAGEMENT; GUIDELINES; EXPERIENCE; PERFUSION	The standard surgical treatment of hemorrhagic cerebral contusion is craniotomy with evacuation of the focal lesion. We assessed the safety and feasibility of performing decompressive craniectomy and duraplasty as the primary surgical intervention in this group of patients. Fifty-four consecutive patients with Glasgow Coma Scale (GCS) scores of less than or equal to 8, a frontal or temporal hemorrhagic contusion greater than 20 cm(3) in volume, and a midline shift of at least 5 mm or cisternal compression on computer tomography (CT) scan were studied. Sixteen (29.7%) underwent traditional craniotomy with hematoma evacuation, and 38 (70.4%) underwent craniectomy as the primary surgical treatment. Mortality, reoperation rate, Glasgow Outcome Scale-Extended (GOSE) scores, and length of stay in both the acute care and rehabilitation phase were compared between these two groups. Mortality (13.2% vs. 25.0%) and reoperation rate (7.9% vs. 37.5%) were lower in the craniectomy group, whereas the length of stay in both the acute care setting and the rehabilitation phase were similar between these two groups. The craniectomy group also had better GOSE score (5.55 vs. 3.56) at 6 months. Decompressive craniectomy is safe and effective as the primary surgical intervention for treatment of hemorrhagic contusion. This study also suggests that patient with hemorrhagic contusion can possibly have better outcome after craniectomy than other subgroup of patients with severe traumatic brain injury.	[Huang, Abel Po-Hao; Tu, Yong-Kwang; Tsai, Yi-Hsin; Chen, Yuan-Shen; Hong, Wei-Chen; Yang, Chi-Cheng; Kuo, Lu-Ting; Su, I-Chang; Huang, She-Hao; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Dept Neurosurg, Taipei 100, Taiwan; [Huang, Abel Po-Hao; Tu, Yong-Kwang; Tsai, Yi-Hsin; Chen, Yuan-Shen; Hong, Wei-Chen; Yang, Chi-Cheng; Kuo, Lu-Ting; Su, I-Chang; Huang, She-Hao; Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Yuan-Shen; Hong, Wei-Chen; Kuo, Lu-Ting; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Tsai, Yi-Hsin; Huang, Sheng-Jean] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Traumatol, Taipei 10764, Taiwan; [Yang, Chi-Cheng] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan		Huang, SJ (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Dept Neurosurg, 7 Chung Shan S Rd, Taipei 100, Taiwan.	sjhuang@mail.ylh.gov.tw	Kuo, Lu-Ting/AAU-3205-2021	HUANG, ABEL PO-HAO/0000-0002-5689-6761; Kuo, Lu-Ting/0000-0002-1405-8700; Tu, Yong-kwang/0000-0003-2113-1176			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marion DW, 2006, NEUROSURGERY, V58, P655; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; TEASDALE G, 1974, LANCET, V2, P81; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	25	42	44	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2008	25	11					1347	1354		10.1089/neu.2008.0625			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	384BP	WOS:000261718900007	19061378				2022-02-06	
J	Chiaretti, A; Antonelli, A; Riccardi, R; Genovese, O; Pezzotti, P; Di Rocco, C; Tortorolo, L; Piedimonte, G				Chiaretti, Antonio; Antonelli, Alessia; Riccardi, Riccardo; Genovese, Orazio; Pezzotti, Patrizio; Di Rocco, Concezio; Tortorolo, Luca; Piedimonte, Giovanni			Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						children; cytokines; neuroprotection; neurotrophic factors; traumatic brain injury	NECROSIS-FACTOR-ALPHA; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; HEAD-INJURY; CHOLINERGIC NEURONS; FACTOR PROTECTS; NEONATAL-RAT; INTERLEUKIN-6	Background: Secondary brain damage after traumatic brain injury (TBI) involves neuro-inflammatory mechanisms, mainly dependent on the intracerebral production of cytokines. In particular, interleukin 1 beta (IL-1 beta) is associated with neuronal damage, while interleukin 6 (IL-6) exerts a neuroprotective role due to its ability to modulate neurotrophins biosynthesis. However, the relationship between these cytokines and neurotrophins with the severity and outcome of TBI remains still controversial. Aims: To determine whether the concentration of IL-1 beta and IL-6 and neurotrophins (nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF)) in the cerebrospinal fluid (CSF) of children with TBI correlates with the severity of the injury and its neurologic outcome. Methods: Prospective observational clinical study in a university hospital. CSF samples were collected from 27 children at 2 h (Time T1) and 48 h (Time T2) after severe TBI, and from 21 matched controls. Severity of TBI was evaluated by GCS and neurologic outcome by GOS. CSF concentrations of cytokines and neurotrophins were measured by immunoenzymatic assays. Results: Early NGF and IL-1 beta concentrations (T1) correlated significantly with the severity of head injury, whereas no correlation was found for IL-6, BDNF, and GDNF. Furthermore, higher NGF and IL-6 and lower IL-1 beta expression at T2 were associated with better neurologic outcomes. No significant association was found between BDNF or GDNF expression and neurologic outcome. Conclusions: NGF concentration in CSF is a useful marker of brain damage following severe TBI and its up-regulation, in the first 48 h after head injury together with lower IL-1 beta expression, correlates with a favorable neurologic outcome. Clinical and prognostic information may also be obtained from IL-6 expression. (C) 2007 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Chiaretti, Antonio; Antonelli, Alessia; Genovese, Orazio; Tortorolo, Luca] Catholic Univ, Sch Med, Paediat Intens Care Unit, Rome, Italy; [Riccardi, Riccardo] Catholic Univ, Sch Med, Dept Paediat, Rome, Italy; [Pezzotti, Patrizio] Agcy Publ Hlth Lazio Reg, Rome, Italy; [Di Rocco, Concezio] Catholic Univ, Sch Med, Rome, Italy; [Piedimonte, Giovanni] W Virginia Univ, Sch Med, Dept Paediat, Morgantown, WV 26506 USA		Chiaretti, A (corresponding author), Catholic Univ, Sch Med, Paediat Intens Care Unit, Rome, Italy.	achiaretti@yahoo.it		RICCARDI, RICCARDO/0000-0001-7515-6622; GENOVESE, Orazio/0000-0002-1989-1363	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL061007] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL061007] Funding Source: Medline		Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chiaretti A, 2005, NEUROL RES, V27, P741, DOI 10.1179/016164105X35611; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; FINKLESTEIN SP, 1996, ADV NEUROL, V71, P7; FINKLESTEIN SP, 1996, ADV NEUROL, V71, P413; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Holtzman DM, 1996, ANN NEUROL, V39, P114, DOI 10.1002/ana.410390117; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LONGO FM, 1984, EXP NEUROL, V84, P207, DOI 10.1016/0014-4886(84)90016-5; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; OLSON L, 1992, J NEURAL TRANSM-PARK, V4, P79, DOI 10.1007/BF02257624; Oygur N, 1998, ARCH DIS CHILD-FETAL, V79, pF190, DOI 10.1136/fn.79.3.F190; PATTERSON SL, 1993, BRAIN RES, V605, P43, DOI 10.1016/0006-8993(93)91354-U; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217	50	42	46	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798			EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAY	2008	12	3					195	204		10.1016/j.ejpn.2007.07.016			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	311NW	WOS:000256607900006	17881264	Green Accepted			2022-02-06	
J	Kalmar, K; Novack, TA; Nakase-Richardson, R; Sherer, M; Frol, AB; Gordon, WA; Hanks, RA; Giacino, JT; Ricker, JH				Kalmar, Kathleen; Novack, Thomas A.; Nakase-Richardson, Risa; Sherer, Mark; Frol, Alan B.; Gordon, Wayne A.; Hanks, Robin A.; Giacino, Joseph T.; Ricker, Joseph H.			Feasibility of a brief neuropsychologic test battery during acute inpatient rehabilitation after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation	GALVESTON ORIENTATION; AMNESIA TEST; HEAD-INJURY; RECOVERY; LOG	Objectives: To determine (1) if more than 50% of patients with moderate to severe traumatic brain injury (TBI) who met study criteria can complete a battery of neuropsychologic tests in less than 75 minutes 2 to 6 weeks after injury regardless of posttraumatic amnesia (PTA) status; (2) which tests are most likely to be completed; and (3) range of scores obtained. Design: Prospective multicenter observational study. Setting: Acute inpatient neurorehabilitation hospitals. Participants: Screened 543 Traumatic Brain Injury Model System patients with moderate to severe TBI: 354 were tested at 2 to 6 weeks postinjury. Interventions: Not applicable. Main Outcome Measure: Percentage of patients able to complete the neuropsychologic tests in less than 75 minutes. Results: Two hundred eighteen (62%) patients completed the battery in 66 minutes on average. Mean interval from injury to testing was 28.3+/-7.1 days. Tests completed with the highest frequency were California Verbal Learning Test-II, FAS, and animal naming. Performance was less impaired (P<.001) on all measures for patients who had emerged from PTA. Conclusions: Approximately two thirds of screened patients were able to complete a brief neuropsychologic test battery at 2 to 6 weeks postinjury, reggardless of PTA status. Although patients out of PTA were less impaired on all test measures, confusion did not preclude participation in the test batter), or prohibit assignment of test scores. Early neuropsychologic assessment after TBI is feasible even for many patients who are still in PTA.	[Kalmar, Kathleen] JFK Med Ctr, JFK Johnson Rehabil Inst, Brain Trauma Unit, 3EA, Edison, NJ 08818 USA; [Novack, Thomas A.] Spain Rehabil Ctr, Birmingham, AL USA; [Nakase-Richardson, Risa] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA; [Sherer, Mark] Mem Hermann TIRR, Houston, TX USA; [Frol, Alan B.] Baylor Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX USA; [Gordon, Wayne A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Giacino, Joseph T.] JFK Med Ctr, New Jersey Neurosci Inst, Edison, NJ 08818 USA; [Ricker, Joseph H.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA		Kalmar, K (corresponding author), JFK Med Ctr, JFK Johnson Rehabil Inst, Brain Trauma Unit, 3EA, 65 James St, Edison, NJ 08818 USA.	kkalmar@solarishs.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Ricker, Joseph/0000-0003-3415-991X	National Institute on Disability and Rehabilitation Research [H133A020501, H133A020502, H133A020509, H133A020514, H133A020515, H133A020518, H133A020526]	Supported by the National Institute on Disability and Rehabilitation Research (grant nos. H133A020501, H133A020502, H133A020509, H133A020514, H133A020515, H133A020518, H133A020526).	Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DELIS DC, 2000, CALIFORNIA VERBAL LE; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; *PSYCH CORP, 2001, WECHSL TEST AD READ; Reitan R.M., 1993, HALSTEADREITAN NEURO; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sherer M, 2003, DEMONSTRATING UTILIT, P39; Smith, 1973, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412	22	42	42	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					942	949		10.1016/j.apmr.2008.01.008			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900021	18452744				2022-02-06	
J	Milroy, G; Dorris, L; McMillan, TM				Milroy, G.; Dorris, L.; McMillan, T. M.			Brief report: Sleep disturbances following mild traumatic brain injury in childhood	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						brain injury; childhood; pediatrics; sleep	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MINOR HEAD-INJURY; DIFFICULTIES QUESTIONNAIRE; CHILDREN; ADOLESCENTS; PREVALENCE; STRENGTHS; SYMPTOMS; PATTERNS	Objective To examine objective and subjective reports of sleep disturbance in school-aged children who had sustained mild traumatic brain injury (TBI) at least 6 months prior to the study. Methods Eighteen children aged 7-12 years with a history of mild TBI (GCS 13-15. LOC <15 min) were compared to 30 children with orthopedic injuries using actigraphy and parental and self-report sleep questionnaires. Results Parents reported greater sleep disturbance in the mild TBI group. No significant differences were found in parental ratings of daytime sleepiness, child-reported sleep difficulties, or objective (actigraph) sleep measures. Conclusions The finding of greater parental reports of sleep disturbance following mild TBI 6 months after injury requires greater exploration and future research with a larger sample followed from the point of injury would seem appropriate.	[Milroy, G.; McMillan, T. M.] Univ Glasgow, Dept Psychol Med, Glasgow G12 0XH, Lanark, Scotland; [Dorris, L.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk	Dorris, Liam/AAK-2273-2021; Sanguansri, Luz/B-6630-2011	Dorris, Liam/0000-0002-9502-3154; Sanguansri, Luz/0000-0003-1908-7604			Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blunden SL, 2006, SLEEP MED REV, V10, P109, DOI 10.1016/j.smrv.2005.11.003; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carstairs V., 1991, DEPRIVATION HLTH SCO; Corkum P, 2001, SLEEP, V24, P303, DOI 10.1093/sleep/24.3.303; Couturier JL, 2005, J AM ACAD CHILD PSY, V44, P815, DOI 10.1097/01.chi.0000166377.22651.87; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Gruber R, 2000, J AM ACAD CHILD PSY, V39, P495, DOI 10.1097/00004583-200004000-00019; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; Owens JA, 2000, SLEEP, V23, P1043; Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	22	42	42	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2008	33	3					242	247		10.1093/jpepsy/jsm099			6	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	272JW	WOS:000253856700003	17967815	Bronze			2022-02-06	
J	Tabelow, K; Polzehl, J; Spokoiny, V; Voss, HU				Tabelow, Karsten; Polzehl, Joerg; Spokoiny, Vladimir; Voss, Henning U.			Diffusion tensor imaging: Structural adaptive smoothing	NEUROIMAGE			English	Article						diffusion tenser imaging; spatially adaptive smoothing	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; B-MATRIX; ANISOTROPY; MRI; NOISE; REDUCTION; SPACE	Diffusion Tensor Imaging (DTI) data is characterized by a high noise level. Thus, estimation errors of quantities like anisotropy indices or the main diffusion direction used for fiber tracking are relatively large and may significantly confound the accuracy of DTI in clinical or neuroscience applications. Besides pulse sequence optimization, noise reduction by smoothing the data can be pursued as a complementary approach to increase the accuracy of DTI. Here, we suggest an anisotropic structural adaptive smoothing procedure, which is based on the Propagation-Separation method and preserves the structures seen in DTI and their different sizes and shapes. It is applied to artificial phantom data and a brain scan. We show that this method significantly improves the quality of the estimate of the diffusion tensor, by means of both bias and variance reduction, and hence enables one either to reduce the number of scans or to enhance the input for subsequent analysis such as fiber tracking. (C) 2007 Elsevier Inc. All rights reserved.	[Tabelow, Karsten; Polzehl, Joerg; Spokoiny, Vladimir] Weierstrass Inst Appl Anal & Stochast, D-10117 Berlin, Germany; [Voss, Henning U.] Cornell Univ, Weill Med Coll, Citigrp Biomed Imaging Ctr, New York, NY 10021 USA		Tabelow, K (corresponding author), Weierstrass Inst Appl Anal & Stochast, Mohrenstr 39, D-10117 Berlin, Germany.	tabelow@wias-berlin.de	Spokoiny, Vladimir G./L-5441-2015; Tabelow, Karsten/AAI-4490-2021; Spokoiny, Vladimir/AAF-4942-2021; Voss, Henning/C-2194-2009	Spokoiny, Vladimir G./0000-0002-2040-3427; Tabelow, Karsten/0000-0003-1274-9951; Spokoiny, Vladimir/0000-0002-2040-3427; Voss, Henning/0000-0003-2811-2074; Polzehl, Joerg/0000-0001-7471-2658			Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Basu S, 2006, LECT NOTES COMPUT SC, V4190, P117; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Carbon M, 2004, ANN NEUROL, V56, P283, DOI 10.1002/ana.20177; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; CHUNG MK, 2005, TR1109 U WISC DEP ST; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Fan JQ, 1996, J AM STAT ASSOC, V91, P674; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Fletcher PT, 2007, SIGNAL PROCESS, V87, P250, DOI 10.1016/j.sigpro.2005.12.018; Fletcher PT, 2004, THESIS U N CAROLINA; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HAHN KR, 2006, VISUALIZATION IMAGE; Heim S, 2007, COMPUT STAT DATA AN, V51, P6212, DOI 10.1016/j.csda.2007.01.005; Jones D., 2003, P INT SOC MAGN RESON, V11, P2118; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; LEBIHAN D, 1985, CR ACAD SCI II, V301, P1109; LEE JH, 2005, P 13 ANN M ISMRM, P2253; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MATTIELLO J, 1994, J MAGN RESON SER A, V108, P131, DOI 10.1006/jmra.1994.1103; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; MERBOLDT KD, 1985, J MAGN RESON, V64, P479, DOI 10.1016/0022-2364(85)90111-8; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neyman J, 1937, SKAND AKTUARIETIDSKR, V20, P149; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; Parker GJM, 2000, J MAGN RESON IMAGING, V11, P702, DOI 10.1002/1522-2586(200006)11:6<702::AID-JMRI18>3.0.CO;2-A; Pennec X, 2006, INT J COMPUT VISION, V66, P41, DOI 10.1007/s11263-005-3222-z; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Polzehl J, 2006, PROBAB THEORY REL, V135, P335, DOI 10.1007/s00440-005-0464-1; Schneider JFL, 2004, NEURORADIOLOGY, V46, P258, DOI 10.1007/s00234-003-1154-2; Schwartzman A, 2005, MAGN RESON MED, V53, P1423, DOI 10.1002/mrm.20503; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; TABELOW K, IN PRESS IEEE T MED; Tabelow K, 2006, NEUROIMAGE, V33, P55, DOI 10.1016/j.neuroimage.2006.06.029; TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009; TUCH DS, 1999, P 7 ANN M ISMRM PHIL, P321; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Weickert J, 1998, ANISOTROPIC DIFFUSIO, V1; Westin CF, 1999, LECT NOTES COMPUT SC, V1679, P441; Yoshiura T, 2003, NEUROIMAGE, V20, P413, DOI 10.1016/S1053-8119(03)00342-2; ZHANG F, 2006, MED IMAGE COMPUTING, V2, P234; Zhang F, 2006, LECT NOTES COMPUT SC, V4109, P83	59	42	42	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 15	2008	39	4					1763	1773		10.1016/j.neuroimage.2007.10.024			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	263UK	WOS:000253241800025	18060811				2022-02-06	
J	Holland, MA; Tan, AA; Smith, DC; Hoane, MR				Holland, Michael A.; Tan, Arlene A.; Smith, Douglas C.; Hoane, Michael R.			Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury	JOURNAL OF NEUROTRAUMA			English	Article						fluoro-jade; GFAP; neuroprotection; nicotinamide; therapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; WISTAR RATS; REACTIVE ASTROCYTES; INFARCT VOLUME; UNITED-STATES; PROTECTION; LONGEVITY; RECOVERY	Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP(+) astrocytes and FJ(+) neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP(+) astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP(+) astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.	[Holland, Michael A.; Tan, Arlene A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Brain & Cognit Sci Program, Ctr Integrat Res Cognit & Neural Sci,Restorat Neu, Carbondale, IL 62901 USA; [Tan, Arlene A.; Smith, Douglas C.] So Illinois Univ, Dept Psychol, Brain & Cognit Sci Program, Ctr Integrat Res Cognit & Neural Sci,Neurotrauma, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Brain & Cognit Sci Program, Ctr Integrat Res Cognit & Neural Sci,Restorat Neu, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045647, NS041551] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647, R01NS041551] Funding Source: NIH RePORTER		Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Burkle A, 2001, CHEMBIOCHEM, V2, P725, DOI 10.1002/1439-7633(20011001)2:10<725::AID-CBIC725>3.0.CO;2-3; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GREENGARD P, 1967, J BIOL CHEM, V242, P152; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Sakakibara Y, 2000, NEUROSCI LETT, V281, P111, DOI 10.1016/S0304-3940(00)00854-5; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	25	42	43	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2008	25	2					140	152		10.1089/neu.2007.0312			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	266RZ	WOS:000253456000007	18260797				2022-02-06	
J	Bodenburg, S; Dopslaff, N				Bodenburg, Sebastian; Dopslaff, Nina			The dysexecutive questionnaire advanced - Item and test score characteristics, 4-factor solution, and severity classification	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						frontal lobe; cognition disorders; social behavior; neuropsychological tests	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; NEUROPSYCHOLOGY	The Dysexecutive Questionnaire (DEX, Wilson et al., Behavioral assessment of the dysexecutive syndrome, 1996) is a standardized instrument to measure possible behavioral changes as a result of the dysexecutive syndrome. Although initially intended only as a qualitative instrument, the DEX has also been used increasingly to address quantitative problems. Until now there have not been more fundamental statistical analyses of the questionnaire's testing quality. The present study is based on an unselected sample of 191 patients with acquired brain injury and reports on the data relating to the quality of the items, the reliability and the factorial structure of the DEX Item 3 displayed too great an item difficulty, whereas item 11 was not sufficiently discriminating. The DEX's reliability in self-rating is r = 0.85. In addition to presenting the statistical values of the tests, a clinical severity classification of the overall scores of the 4 found factors and of the questionnaire as a whole is carried out on the basis of quartile standards.	[Bodenburg, Sebastian] Neuropsychol Praxis, D-20095 Hamburg, Germany; [Bodenburg, Sebastian; Dopslaff, Nina] Univ Hamburg, Dept Psychol, Hamburg, Germany		Bodenburg, S (corresponding author), Neuropsychol Praxis, Moenckebergstr 19, D-20095 Hamburg, Germany.	sb_nph@t-online.de					Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FOSTER JK, 1994, COGNITIVE NEUROPSYCH, V11, P133, DOI 10.1080/02643299408251971; Kim E, 2002, NEUROREHABILITATION, V17, P297; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lienert G.A., 1969, TESTAUFBAU TESTANALY; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; Mullan DJ, 2006, AM J PHYS, V74, P10, DOI 10.1119/1.2110548; RYLANDER G, 1939, ACTA PSYCH NEUROL S, V20, P5; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Spinella M, 2004, INT J NEUROSCI, V114, P1581, DOI 10.1080/00207450490509339; STEEGMANN AT, 1962, SURGERY, V52, P952; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Ufer K., 2000, BEHAV ASSESSMENT DYS; Wechsler D., 1981, WAIS R MANUAL	22	42	42	2	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	JAN	2008	196	1					75	78		10.1097/NMD.0b013e31815faa2b			4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	253IN	WOS:000252512000012	18195646				2022-02-06	
J	Curtis, KL; Thompson, LK; Greve, KW; Bianchini, KJ				Curtis, Kelly L.; Thompson, Laura K.; Greve, Kevin W.; Bianchini, Kevin J.			Verbal fluency indicators of malingering in traumatic brain injury: Classification accuracy in known groups	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	25th Annual Meeting of the National-Academy-of-Neuropsychology	OCT 19-22, 2005	Tampa, FL	Natl Acad Neuropsychol		COWAT : known-groups; malingering; traumatic brain injury; verbal fluency	WORD-ASSOCIATION TEST; FRONTAL-LOBE LESIONS; CARD SORTING TEST; NEUROCOGNITIVE DYSFUNCTION; ALZHEIMERS TYPE; PERFORMANCE; DEMENTIA; RELIABILITY	A known-groups design was used to determine the classification accuracy of verbal fluency variables in detecting Malingered Neurocognitive Dysfunction (MND) in traumatic brain injury (TBI). Participants were 204 TBI and 488 general clinical patients. The Slick et al. (1999) criteria were used to classify the TBI patients into non-MND and MND groups. An educationally corrected FAS Total Correct word T-score proved to be the most accurate of the several verbal fluency indicators examined. Classification accuracy of this variable at specific cutoffs is presented in a cumulative frequency table. This variable accurately differentiated non-MND from MND mild TBI patients but its accuracy was unacceptable in moderate/severe TBI. The clinical application of these findings is discussed.	[Curtis, Kelly L.; Thompson, Laura K.; Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Curtis, Kelly L.; Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Benton AL, 1994, MULTILINGUAL APHASIA; BIANCHINI KJ, 2001, CLIN NEUROPSYCHOL, V17, P255; BINDER LM, 1993, PORTLAND DIGIT RECOG; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; CHERTKOW H, 1990, BRAIN, V113, P397, DOI 10.1093/brain/113.2.397; Demakis GJ, 2003, CLIN NEUROPSYCHOL, V17, P322, DOI 10.1076/clin.17.3.322.18081; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Gouvier WD, 1998, CRIT ISS NE, P55; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; MARGOLIN DI, 1990, J CLIN EXP NEUROPSYC, V12, P597, DOI 10.1080/01688639008401004; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; MITTENBERG W, 1995, PROFESSIONAL PSYCHOL, V26, P492; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Spreen O, 1991, COMPENDIUM NEUROPSYC; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER	41	42	43	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	5					930	945		10.1080/13854040701563591			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	342HP	WOS:000258775500012	18756393				2022-02-06	
J	Feighery, L; Smyth, A; Keely, S; Baird, AW; O'Connor, WT; Callanan, JJ; Brayden, DJ				Feighery, Linda; Smyth, Aoife; Keely, Simon; Baird, Alan W.; O'Connor, William T.; Callanan, John J.; Brayden, David J.			Increased intestinal permeability in rats subjected to traumatic frontal lobe percussion brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	44th Annual Meeting of the American-Society-for-Cell-Biology	DEC 04-08, 2004	Washington, DC	Amer Soc Cell Biol		traumatic brain injury; intestinal permeability; gut-brain axis	TIGHT JUNCTION PERMEABILITY; BACTERIAL TRANSLOCATION; BARRIER DYSFUNCTION; CHLORIDE SECRETION; IN-VITRO; TRANSPORT; SODIUM; MUCOSA; PATHOGENESIS; JEJUNUM	Background: Dysfunction of the gastrointestinal tract is a common occurrence after traumatic brain injury (TBI). We hypothesized that increased intestinal permeability may result from a precisely controlled percussion injury to the exposed brains of anesthetized rats and that such an effect could be assessed in vitro using excised intestinal mucosae mounted in Ussing chambers. Methods: After craniotomy over the left medial prefrontal cortex on anesthetized rats, neurotrauma was produced using a pneumatically driven impactor on the exposed brain. Control rats were subjected to identical procedures but did not receive an impact. Muscle-stripped rat intestinal ileal and colonic segments were mounted in Ussing chambers within 30 minutes of death. Transepithelial electrical resistance (TEER) and the apparent permeability coefficient (Papp) of [C-14]-mannitol were recorded from intestinal tissue for 120 minutes. Histopathologic analysis was also performed to determine any gross morphologic changes in the intestine. Results: Ileal and colonic mucosae showed no differences in TEER in ileum or colon of TBI rats compared with controls. The Papp of mannitol was significantly increased in ilea from rats previously exposed to TBI compared with controls. Histologic analysis showed gross changes to 50% of the ileal but not the colonic sections from TBI rats. Conclusion: TBI results in significantly reduced ileal barrier function, most likely mediated by open tight junctions. For patients with acute head injury, this may have implications for subsequent oral absorption of nutrients. Systemic delivery of luminal endotoxins may contribute to multiple organ failure.	[Feighery, Linda; Smyth, Aoife; Keely, Simon; Baird, Alan W.; O'Connor, William T.; Callanan, John J.; Brayden, David J.] Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland; [Feighery, Linda; Smyth, Aoife; Keely, Simon; Baird, Alan W.; O'Connor, William T.; Callanan, John J.; Brayden, David J.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 4, Ireland		Brayden, DJ (corresponding author), Univ Coll Dublin, UCD Conway Inst, Vet Sci Bldg, Dublin 4, Ireland.	david.brayden@ucd.ie	O'Connor, William T./I-7459-2015; Keely, Simon/AAV-9973-2020; Brayden, David J/J-3215-2019	Keely, Simon/0000-0002-1248-9590; Brayden, David J/0000-0002-8781-8344; Callanan, John/0000-0003-4356-1783; Baird, Alan/0000-0002-3926-9838; O'Connor, William/0000-0003-0082-1119			ADEKOYA N, 2004, MMWR SURVEIL SUMM, V51, P1; Aydin S, 2005, SURG TODAY, V35, P751, DOI 10.1007/s00595-005-3034-3; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Brayden D, 1997, PHARM RES-DORDR, V14, P1772, DOI 10.1023/A:1012192115828; Castillo L, 1999, REV MED CHILE, V127, P639; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; CUTHBERT AW, 1987, BRIT J PHARMACOL, V91, P503, DOI 10.1111/j.1476-5381.1987.tb11243.x; CUTHBERT AW, 1982, BRIT J PHARMACOL, V75, P587, DOI 10.1111/j.1476-5381.1982.tb09178.x; Dublineau I, 1998, DIGEST DIS SCI, V43, P652, DOI 10.1023/A:1018839930552; Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005; GAO J, 2000, CURR PROTOCOLS PHARM; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hang CH, 2004, WORLD J GASTROENTERO, V10, P875; KAMADA T, 1977, J TRAUMA, V17, P44, DOI 10.1097/00005373-197701000-00006; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kiliaan AJ, 1998, AM J PHYSIOL-GASTR L, V275, pG1037, DOI 10.1152/ajpgi.1998.275.5.G1037; Lemaire LCJM, 1997, BRIT J SURG, V84, P1340; Lindhardt K, 2003, INT J PHARM, V252, P181, DOI 10.1016/S0378-5173(02)00629-4; Mayer Emeran A., 1999, American Journal of Medicine, V107, p12S; MERTSOLA J, 1991, J INFECT DIS, V164, P353, DOI 10.1093/infdis/164.2.353; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; RUSSELL DH, 1995, SHOCK, V4, P50, DOI 10.1097/00024382-199507000-00008; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Saunders PR, 2002, DIGEST DIS SCI, V47, P208, DOI 10.1023/A:1013204612762; SAUNDERS PR, 1994, AM J PHYSIOL, V367, pG794; Schurmann G, 1999, INT J COLORECTAL DIS, V14, P41, DOI 10.1007/s003840050181; SHELDON RJ, 1990, J PHARMACOL EXP THER, V252, P636; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Soderholm JD, 1998, DIGEST DIS SCI, V43, P1547, DOI 10.1023/A:1018823100761; Soni J, 2006, J CONTROL RELEASE, V115, P68, DOI 10.1016/j.jconrel.2006.06.021; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Tsutsumi K, 2003, J PHARM SCI, V92, P344, DOI 10.1002/jps.10278; Van Oudenhove L, 2004, BEST PRACT RES CL GA, V18, P663, DOI 10.1016/j.bpg.2004.04.010; Vyrostek Sara B., 2004, Morbidity and Mortality Weekly Report, V53, P1; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	39	42	43	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2008	64	1					131	137		10.1097/TA.0b013e3181568d9f			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	250UE	WOS:000252325700028	18188111	Green Submitted			2022-02-06	
J	Field, EL; Norman, P; Barton, J				Field, Emma Louise; Norman, Paul; Barton, Jane			Cross-sectional and prospective associations between cognitive appraisals and posttraumatic stress disorder symptoms following stroke	BEHAVIOUR RESEARCH AND THERAPY			English	Article						PTSD; anxiety; depression; cognitive appraisals; stroke	TRAUMATIC BRAIN-INJURY; SEXUAL ASSAULT; PTSD; VALIDATION; SCALE	This study examined cross-sectional and prospective associations between cognitive appraisals and posttraumatic stress disorder (PTSD) symptoms following stroke. While in hospital, stroke patients (n = 81) completed questionnaires assessing cognitive appraisals (i.e., negative cognitions about the self, negative cognitions about the world, and self-blame) and PTSD symptoms. PTSD symptoms were assessed again 3 months later when all patients had been discharged from hospital (n = 70). Significant correlations were found between the time 1 measures of negative cognitions about the self and the world, but not self-blame, and the severity of PTSD symptoms measured at time 1 and at time 2. Regression analyses revealed that cognitive appraisals explained a significant amount of variance in the severity of PTSD symptoms at time 1, with negative cognitions about the self-emerging as a significant predictor. In contrast, time 1 cognitive appraisals were unable to explain additional variance in time 2 PTSD severity over and above that explained by time I PTSD severity. The findings therefore provide only weak support for Ehlers and Clark's cognitive model of PTSD. (c) 2007 Elsevier Ltd. All rights reserved.	[Norman, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; [Field, Emma Louise] Univ Sheffield, Clin Psychol Unit, Sheffield S10 2TP, S Yorkshire, England; [Barton, Jane] Nether Edge Hosp, Sheffield Care Trust, Sheffield S11 9BJ, S Yorkshire, England		Norman, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	p.norman@sheffield.ac.uk					Agar E, 2006, BEHAV COGN PSYCHOTH, V34, P437, DOI 10.1017/S1352465806002943; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Bruggimann L, 2006, NEUROLOGY, V66, P513, DOI 10.1212/01.wnl.0000194210.98757.49; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Caspi Y, 2005, J LOSS TRAUMA, V10, P319, DOI 10.1080/15325020590956756; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dunmore E, 1999, BEHAV RES THER, V37, P809, DOI 10.1016/S0005-7967(98)00181-8; Dunmore E, 2001, BEHAV RES THER, V39, P1063, DOI 10.1016/S0005-7967(00)00088-7; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fairbrother N, 2006, J BEHAV THER EXP PSY, V37, P74, DOI 10.1016/j.jbtep.2004.08.004; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Foa EB, 1998, TREATING TRAUMA RAPE; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Kangas M, 2005, HEALTH PSYCHOL, V24, P579, DOI 10.1037/0278-6133.24.6.579; KUTZ I, 1994, ISRAEL J PSYCHIAT, V31, P48; Marshall GN, 2006, J ABNORM PSYCHOL, V115, P624, DOI 10.1037/0021-843X.115.3.624; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; Merriman Charlotte, 2007, Psychol Health Med, V12, P592, DOI 10.1080/13548500601162747; *NAT I CLIN EXC, 2005, POST TRAUM STRESS DI; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Sembi S, 1998, INT J GERIATR PSYCH, V13, P315, DOI 10.1002/(SICI)1099-1166(199805)13:5<315::AID-GPS766>3.3.CO;2-G; SHALEV AY, 1993, BRIT J CLIN PSYCHOL, V32, P247, DOI 10.1111/j.2044-8260.1993.tb01052.x; Shemesh E, 2001, GEN HOSP PSYCHIAT, V23, P215, DOI 10.1016/S0163-8343(01)00150-5; *STROK ASS, 2006, INF; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	30	42	43	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967			BEHAV RES THER	Behav. Res. Ther.	JAN	2008	46	1					62	70		10.1016/j.brat.2007.10.006			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	264GQ	WOS:000253276200005	18005937	Green Accepted			2022-02-06	
J	Turkstra, LS; Williams, WH; Tonks, J; Frampton, I				Turkstra, Lyn S.; Williams, W. Huw; Tonks, James; Frampton, Ian			Measuring social cognition in adolescents: Implications for students with TBI returning to school	NEUROREHABILITATION			English	Article						Social cognition; theory of mind; adolescent; emotion recognition	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSION; CHILDREN; MIND; EMOTION; COMPREHENSION; RECOGNITION; LANGUAGE; BELIEFS; SKILLS	In everyday adolescent communication, the ability to empathise with the mental state of others, recognise or infer intentions, or make judgements about emotional state, is a non-conscious but vital prerequisite of relating. Execution of these skills in social interactions supports both the exchange of social knowledge and also the development and maintenance of personal relationships. Thus, adolescents with impairments in these skills are at risk for a variety of negative outcomes. In this paper, we present data to illustrate that adolescents with traumatic brain injury (TBI) are likely to have impairments in processes such as emotion recognition and mental state attribution, and that these might not be identified on standardised tests. This is considered from the perspective of clinical assessment and intervention in school contexts.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA; [Williams, W. Huw; Tonks, James] Univ Exeter, Exeter, Devon, England; [Frampton, Ian] Cornwall Partnership NHS Trust, Cornwall, England		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; williams, huw/0000-0003-0670-2620; Tonks, James/0000-0003-3930-9294			ASHER SR, 1986, SOCIAL WORK ED, V8, P205; Bach LJ, 2006, BRAIN COGNITION, V60, P196; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S., 2001, J DEV LEARN DISORD, V5, P47, DOI [10.1177/1362361303007002005, DOI 10.1177/1362361303007002005]; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bernet W, 1999, J AM ACAD CHILD PSY, V38, p1S, DOI 10.1016/S0890-8567(99)80001-X; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLAZYK S, 1983, SOC WORK HEALTH CARE, V8, P55, DOI 10.1300/J010v08n04_05; BURGESS S, 2008, SOCIAL COGNITI UNPUB; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; CHERULNIK PD, 1978, J SOC PSYCHOL, V104, P263, DOI 10.1080/00224545.1978.9924068; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; DAMASIO Antonio, 2003, LOOKING SPINOZA JOY; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAWSON G, 2001, NEURAL BASES SOCIAL; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fiske S. T., 1991, SOCIAL COGNITION, V2nd; FLAVELL JH, 1968, DEV ROLE TAKING COMM; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hansen DJ, 1996, BEHAV MODIF, V20, P281, DOI 10.1177/01454455960203003; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hendry, 1999, NATURE ADOLESCENCE; HENRY JD, 2006, NEUROPSYCHOLOGIA; HOMBERG V, 1993, NEUROSCI LETT, V150, P187, DOI 10.1016/0304-3940(93)90532-P; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; LENO AB, 2004, SALLY ANDY TASK; LILES BZ, 1993, J SPEECH HEAR RES, V36, P868, DOI 10.1044/jshr.3605.868; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; MCDONALD S, 2005, BRAIN IMPAIR, V6, P58; McDonald S, 2007, CLINICAL APHASIOLOGY: FUTURE DIRECTIONS, P42; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miller CA, 2006, AM J SPEECH-LANG PAT, V15, P142, DOI 10.1044/1058-0360(2006/014); Morton JB, 2001, CHILD DEV, V72, P834, DOI 10.1111/1467-8624.00318; *NFER NELS, 2005, EM LIT ASS INT; Ninio A, 1996, PRAGMATIC DEV; Nippold MA, 2003, J SPEECH LANG HEAR R, V46, P788, DOI 10.1044/1092-4388(2003/062); Nippold MA, 2000, J SPEECH LANG HEAR R, V43, P621, DOI 10.1044/jslhr.4303.621; Nippold MA, 1996, J SPEECH HEAR RES, V39, P166, DOI 10.1044/jshr.3901.166; Nippold MA, 2000, TOP LANG DISORD, V20, P15, DOI 10.1097/00011363-200020020-00004; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; PLACE KS, 1991, DISCOURSE PROCESS, V14, P227, DOI 10.1080/01638539109544783; SHATZ M, 1973, MONOGR SOC RES CHILD, V38, P1, DOI 10.2307/1165783; SHATZ M, 1978, J CHILD LANG, V5, P39, DOI 10.1017/S0305000900001926; STALLARD P, 2002, THINK GOOD FEEL GOOD; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; STRONACH ST, 2007, REVISION; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Tchanturia Kate, 2007, Ann Gen Psychiatry, V6, P14, DOI 10.1186/1744-859X-6-14; TONKS J, 2007, BRAIN IMPAIR, V8, P143, DOI DOI 10.1375/BRIM.8.2.143; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; TURKSTRA L, 2007, NEUROPHYSIOLOGY NEUR, V17, P15, DOI DOI 10.1044/NNSLD17.3.15; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Williams WH, 2003, STUD NEUROPSYCHOL DE, P115; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wykes T, 2005, COGNITIVE REMEDIATIO; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203	71	42	42	0	19	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2008	23	6					501	509					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	391CI	WOS:000262210200006	19127003				2022-02-06	
J	Hoffman, JM; Pagulayan, KF; Zawaideh, N; Dikmen, S; Temkin, N; Bell, KR				Hoffman, Jeanne M.; Pagulayan, Kathleen F.; Zawaideh, Nadya; Dikmen, Sureyya; Temkin, Nancy; Bell, Kathleen R.			Understanding pain after traumatic brain injury - Impact on community participation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						pain; traumatic brain injury; rehabilitation	PRACTICAL SCALE; HEAD-INJURY; QUESTIONNAIRE; DISABILITY; TBI; INTEGRATION; MANAGEMENT; COGNITION; DISORDER	Objective: To examine the prevalence of pain 1 yr after moderate to severe traumatic brain injury (TBI) and identify predictors from the time of injury. Additionally, factors related to pain at 1 yr after injury were examined along with the impact of pain on community participation. Design: Prospective cohort study of 146 individuals enrolled during acute inpatient rehabilitation for TBI and community follow-up at 1 yr after injury. Results: Higher reports of depressive symptoms during inpatient rehabilitation and at 1 yr after injury were significantly related to reports of pain at 1 yr when controlling for demographic and injury characteristics. Being female and nonwhite were also factors related to increased reports of pain. Pain and community participation were significantly related until depression was entered into the model. Depression is a significant factor in the relationship between pain and community participation. Conclusion: Whereas pain was frequently reported 1 yr after injury, injury-related factors were surprisingly unrelated. Further evaluation of the role that depression plays in the relationship between pain and community participation will be important to determine appropriate management of pain and depression and to optimize participation in individuals with TBI.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Hoffman, JM (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA.		Pagulayan, Kati/AAR-9225-2020	Bell, Kathleen/0000-0002-0928-2046			Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BELL KR, 2005, REHABILITATION TRAUM; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Chiu TT, 2005, ARCH PHYS MED REHAB, V86, P534, DOI 10.1016/j.apmr.2004.02.030; Cook AKR, 1999, INT J GERIATR PSYCH, V14, P421, DOI 10.1002/(SICI)1099-1166(199906)14:6<421::AID-GPS932>3.0.CO;2-Y; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dudgeon BJ, 2005, ARCH PHYS MED REHAB, V86, P109, DOI 10.1016/j.apmr.2004.01.034; Edwards RR, 2005, PAIN MED, V6, P88, DOI 10.1111/j.1526-4637.2005.05007.x; Ehde DM, 2003, CLIN J PAIN, V19, P3, DOI 10.1097/00002508-200301000-00002; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Martelli MF, 2007, BRAIN INJURY MED PRI, P723; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Nicholson K, 2004, J HEAD TRAUMA REHAB, V19, P2, DOI 10.1097/00001199-200401000-00002; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; TEASDALE G, 1974, LANCET, V2, P81; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; ZASLER ND, 2007, BRAIN INJURY MED PRI, P697	35	42	42	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2007	86	12					962	969		10.1097/PHM.0b013e31815b5ee5			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	237DG	WOS:000251352600002	18090437				2022-02-06	
J	Kerby, JD; MacLennan, PA; Burton, JN; McGwin, G; Rue, LW				Kerby, Jeffrey D.; MacLennan, Paul A.; Burton, Jon N.; McGwin, Gerald, Jr.; Rue, Loring W., III			Agreement between prehospital and emergency department Glasgow Coma Scores	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	65th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 28-30, 2006	New Orleans, LA	Amer Assoc Surg Trauma		traumatic brain injury; Glasgow Coma Score; prehospital GCS assessment; emergency department GCS assessment	TRAUMA PATIENTS; SCALE; RELIABILITY; TRIAGE	Background:. The Glasgow Coma Scale (GCS) score is widely accepted as the cornerstone in the assessment of neurologic function after trauma and is being used to select patients for enrollment in prehospital (Ph) intervention trials. This study was performed to assess the degree of agreement between Ph-GCS and emergency department (ED)-GCS scores in our trauma system patients. Methods: From January 1, 2000, through November 30, 2003, 3,669 Emergency Medical System records were linked to our institution's trauma registry. Patients were classified according to their Ph-GCS and ED-GCS scores: 13 to 15, mild; 9 to 12, moderate; and 3 to 8, severe injury. Weighted kappa-coefficients and their 95% confidence intervals were used to examine the agreement between Ph-GCS and ED-GCS patient classifications. Results: Percent agreement was high for the mild category (97.9%) but diminished for moderate (9.3%) and severe (63.3%) groups. Overall, the kappa-coefficient was 0.53 (95% confidence interval 0.48-0.58), indicating moderate agreement. By GCS component, kappa-coefficients were similar, ranging from 0.52 for the verbal component to 0.48 for the eye and motor components. kappa-values decreased even further for those with longer (i.e. >= 20 minutes) transport times. Conclusion: In this study, differences between Ph-GCS and ED-GCS were seen in the patient population with moderate to severe head injury. Individual component score agreement was moderate for all categories, with agreement worsening for patients with longer transport times. Although this suggests improvement in the patient's condition during transport, inter-rater variability between Ph and ED personnel cannot be excluded. The utility of Ph-GCS in Ph interventional trials for determining the presence of significant head injury will need to be further evaluated.	Univ Alabama, Sch Med, Dept Surg, Div Gen Surg, Birmingham, AL USA; Univ Alabama, Ctr Injury Sci, Birmingham, AL USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol & Intl Hlth, Birmingham, AL USA		MacLennan, PA (corresponding author), Univ Alabama, 120 Kracke Bldg, 1922 7th Ave S, Birmingham, AL 35294 USA.	paul.maclennan@ccc.uab.edu		Kerby, Jeffrey/0000-0001-7368-1124			Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; BOUZARTH WF, 1978, J NEUROSURG, V49, P477; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JENNETT B, 1977, LANCET, V1, P878; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; STOKES ME, 1995, CATEGORICAL DATA ANA, P99; TEASDALE G, 1974, LANCET, V2, P81; REGIONAL SYSTEM TRAU; RESUSCITATION OUTCOM	16	42	49	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2007	63	5					1026	1031		10.1097/TA.0b013e318157d9e8			6	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	232BX	WOS:000250994200013	17993947				2022-02-06	
J	Raghupathi, R; Huh, JW				Raghupathi, Ramesh; Huh, Jimmy W.			Diffuse brain injury in the immature rat: Evidence for an age-at-injury effect on cognitive function and histopathologic damage	JOURNAL OF NEUROTRAUMA			English	Article						children; closed head injury; cognition; infants; traumatic axonal injury; traumatic brain injury	TRAUMATIC AXONAL INJURY; CLOSED-HEAD INJURY; FLUID PERCUSSION; CORTICAL IMPACT; NERVOUS-SYSTEM; NEONATAL PIG; CHILDREN; MODEL; VULNERABILITY; MATURATION	Diffuse axonal injury is a significant component of the pathology of moderate-severe pediatric traumatic brain injury in children less than 4 years of age, and is associated with poor cognitive outcome. However, cognitive deficits or gross histopathologic abnormalities are typically not observed following moderate-severe diffuse brain injury in the immature (17-day-old) rat. In order to test whether the age of the immature animal may influence post-traumatic outcome, non-contusive brain trauma was induced in post-natal day (PND) 11 or 17 rats. Brain injury in the PND11 rat, but not in the. PND17 rat, was associated with a significant acquisition deficit at 28 days post-injury (p < 0.0005 compared with age-matched sham rats, and with brain-injured PND17 rats). All brain-injured animals exhibited a retention deficit in the probe trial (p < 0.001), but also demonstrated a significant visual deficit in the visible platform trial (p < 0.05 compared to sham animals). Although significantly longer times of apnea and loss of righting reflex were observed in brain-injured PND17 rats compared to PND11 rats (P < 0.05), overt cytoarchitectural alterations and reactive gliosis were not observed in the older age group. No focal pathology was observed in the cortex below the impact site in the PND11 rat but by 28 days, the brain-injured PND11 rat exhibited atrophy in multiple brain regions and an enlarged lateral ventricle in the impact hemisphere. Quantitative analysis revealed a time-dependent increase in tissue loss in the injured hemisphere (7-10%) in the younger animals, and a modest extent of tissue loss in the older animals (3-4%). Traumatic axonal injury was observed to similar extents in the white matter and thalamus below the impact site in both brain-injured PND11 and 17 rats. These data demonstrate that non-contusive (diffuse) brain injury of moderate severity in the immature rat is associated with chronic cognitive deficits and long-term histopathologic alterations and suggest that the age-at-injury is an important parameter of behavioral and pathologic outcome following closed head injury in the immature age group.	Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu	Raghupathi, Ramesh/AAX-5538-2021		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS053651, R01-NS41561] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041561, K08NS053651] Funding Source: NIH RePORTER		Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Chiaretti A, 1998, Pediatr Med Chir, V20, P393; Ciurea AV, 2005, ACT NEUR S, V93, P209; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; LANGLOIS JA, 1997, MMWR-MORBID MORTAL W, V52, P1; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PORTERFIELD SP, 1994, ENVIRON HEALTH PERSP, V102, P125, DOI 10.2307/3431829; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Verger K, 2000, BRAIN INJURY, V14, P495; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1	40	42	43	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2007	24	10					1596	1608		10.1089/neu.2007.3790			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227HZ	WOS:000250649100006	17970623				2022-02-06	
J	Verhaeghe, STL; van Zuuren, FJ; Defloor, T; Duijnstee, MSH; Grypdonck, MHF				Verhaeghe, Sofie T. L.; van Zuuren, Florence J.; Defloor, Tom; Duijnstee, Mia S. H.; Grypdonck, Mieke H. F.			The process and the meaning of hope for family members of traumatic coma patients in intensive care	QUALITATIVE HEALTH RESEARCH			English	Article						hope; traumatic coma; intensive care; experiences; family members	OF-THE-LITERATURE; CRITICALLY ILL PATIENTS; QUALITATIVE-ANALYSIS; PERCEIVED NEEDS; ADULT PATIENTS; BRAIN-INJURY; NURSES; PERCEPTIONS; EXPERIENCES; RELATIVES	In this study, the authors examined the process that family members go through when they are confronted with traumatic coma. They conducted 24 semistructured interviews with 22 family members of 16 coma patients and analyzed the data using the constant comparative method as proposed by grounded theory. Hope was the most prominent theme. It can be described as keeping a possible positive outcome in mind in an uncertain situation, knowing that this outcome is unlikely to happen. Hope was found to evolve stepwise up and down, dependent on further events and information: big steps at first, smaller later on. Hope helps family members to keep going and to manage care for the patient and for each other. Family members were found to protect themselves against false or unjustified hope by seeking valid information. They alternate their moments of despair, and in their interactions they respect each other's hope.	Univ Ghent, B-9000 Ghent, Belgium; Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; Univ Utrecht, Med Ctr, Utrecht, Netherlands		Verhaeghe, STL (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.			Verhaeghe, Sofie/0000-0002-2063-5033; Beeckman, Dimitri/0000-0003-3080-8716			Bijttebier P, 2001, INTENS CARE MED, V27, P160, DOI 10.1007/s001340000750; Campbell C H, 1988, Rehabil Nurs, V13, P320; Centers LC, 2001, J PALLIATIVE CARE, V17, P259, DOI 10.1177/082585970101700407; CLAEYS M, 2002, NAH VLAANDEREN VANDA; Cutcliffe J, 1996, Br J Nurs, V5, P687; Cutcliffe John R, 2002, Br J Nurs, V11, P1190; DALEY L, 1984, HEART LUNG, V13, P231; DAVISMARTIN S, 1994, HEART LUNG, V23, P515; Eliott J, 2002, QUAL HEALTH RES, V12, P173, DOI 10.1177/104973230201200204; Engli M, 1993, J Neurosci Nurs, V25, P78; Engstrom Asa, 2004, Intensive Crit Care Nurs, V20, P299; FORRESTER DA, 1990, HEART LUNG, V19, P655; FREICHELS T A, 1991, Critical Care Nursing Quarterly, V14, P16; Gelling L, 1999, Nurs Stand, V14, P33; Gelling L., 1999, NURSING CRITICAL CAR, V4, P214; Glaser B., 1967, DISCOVERY GROUNDED T; HAMPE SO, 1975, NURS RES, V24, P113; JACONO J, 1990, HEART LUNG, V19, P72; Jamerson PA, 1996, HEART LUNG, V25, P467, DOI 10.1016/S0147-9563(96)80049-5; Johnson L H, 1996, J Trauma Nurs, V3, P72; Johnson L H, 1996, J Neurosci Nurs, V28, P259; Johnson S K, 1995, Image J Nurs Sch, V27, P238, DOI 10.1111/j.1547-5069.1995.tb00866.x; KARS MC, 2003, ZIJN WIJZE WAAROP OU; Kleiber C, 1994, Am J Crit Care, V3, P70; Kleinpell R M, 1992, Appl Nurs Res, V5, P2; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kuyper MB, 1998, QUAL HEALTH RES, V8, P237, DOI 10.1177/104973239800800207; Kylma J, 1997, J ADV NURS, V25, P364, DOI 10.1046/j.1365-2648.1997.1997025364.x; LASKIWSKI S, 1993, CAN J REHABIL, V6, P143; LYNNMCHALE DJ, 1988, HEART LUNG, V17, P447; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mendonca D, 1998, Crit Care Nurs Q, V21, P58; Miller J F, 1991, AACN Clin Issues Crit Care Nurs, V2, P307; MILLER JD, 1989, REACTIONS COORDINATE, V2, P1; MOLTER NC, 1979, HEART LUNG, V8, P332; Morse J M, 1995, Image J Nurs Sch, V27, P277; Morse J. M., 1996, NURSING RES APPL QUA; MORSE JM, 1995, J ADV NURS, V21, P886, DOI 10.1046/j.1365-2648.1995.21050886.x; MURPHY PA, 1992, HEART LUNG, V21, P25; Neabel B, 2000, HEART LUNG, V29, P196, DOI 10.1067/mhl.2000.106938; NORRIS LO, 1986, HEART LUNG, V15, P194; OMALLEY P, 1991, HEART LUNG, V20, P189; Penrod J, 1997, Oncol Nurs Forum, V24, P1055; PRICE DM, 1991, HEART LUNG, V20, P183; ROSENSTEIN JM, 1995, CELL TRANSPLANT, V4, P83, DOI 10.1016/0963-6897(94)00041-H; STEPHENSON C, 1991, J ADV NURS, V16, P1456, DOI 10.1111/j.1365-2648.1991.tb01593.x; Van Dongen-Melman JEWM, 1998, PATIENT EDUC COUNS, V34, P185, DOI 10.1016/S0738-3991(98)00031-7; VANDALEN EA, 1998, KIND ADOLESCENT, V19, P250; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Verhaeghe S, 2005, J CLIN NURS, V14, P501, DOI 10.1111/j.1365-2702.2004.01081.x; VERHAEGHE S, IN PRESS J CLIN NURS; Warren N A, 1993, Crit Care Nurs Q, V16, P56; Warren N A, 1994, Crit Care Nurs Q, V17, P67; WERTZ FJ, 1987, ADV QUALITATIVE PSYC, P1; Wester F., 1987, STRATEGIEEN KWALITAT; YATES P, 1993, J ADV NURS, V18, P701, DOI 10.1046/j.1365-2648.1993.18050701.x	56	42	42	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	JUL	2007	17	6					730	743		10.1177/1049732307303242			14	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	180EV	WOS:000247346000003	17582017				2022-02-06	
J	Marcotte, AL; Osterman, AL				Marcotte, Anthony L.; Osterman, A. Lee			Longitudinal radioulnar dissociation: Identification and treatment of acute and chronic injuries	HAND CLINICS			English	Article							ONE-BONE FOREARM; TRIANGULAR FIBROCARTILAGE COMPLEX; SYMPTOMATIC PROXIMAL TRANSLATION; RADIAL HEAD FRACTURES; INTEROSSEOUS MEMBRANE; CLOSED FRACTURE; LOAD-TRANSFER; ULNAR JOINT; RECONSTRUCTION; EXCISION	In this article we describe the fundamental concepts that were established by Essex-Lopresti over 50 years ago and explore the current concepts in anatomy, biomechanics, diagnosis, and treatment for longitudinal radioulnar dissociation. Moreover, we present encouraging results for treating chronic injuries to the IOM achieved by bone-ligament-bone (BLB) reconstruction using a patellar tendon graft, giving hope for this seemingly unforgiving injury. A treatment algorithm is also provided to aid in the management of acute and chronic longitudinal radioulnar dissociation.	Philadelphia Hand Ctr, King Of Prussia, PA 19406 USA; Ohio Univ, Dept Orthopaed, Grandview Med Ctr, Dayton, OH 45405 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA		Osterman, AL (corresponding author), Philadelphia Hand Ctr, Merion Bldg,Suite 200,700 S Henderson Rd, King Of Prussia, PA 19406 USA.	alosterman@handcenters.com					Allende C, 2004, J BONE JOINT SURG AM, V86A, P364, DOI 10.2106/00004623-200402000-00022; Birkbeck DP, 1997, J HAND SURG-AM, V22A, P975, DOI 10.1016/S0363-5023(97)80035-4; Boulas H J, 1998, Chir Main, V17, P314; Brockman E P, 1931, Proc R Soc Med, V24, P904; CASTLE ME, 1974, J BONE JOINT SURG AM, VA 56, P1223, DOI 10.2106/00004623-197456060-00014; Chandler JW, 2003, J HAND SURG-AM, V28A, P111, DOI 10.1053/jhsu.2003.50033; Chen F, 2001, Am J Orthop (Belle Mead NJ), V30, P486; Chen F, 1998, J HAND SURG-AM, V23A, P1091, DOI 10.1016/S0363-5023(98)80021-X; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; CURR JF, 1946, BRIT J SURG, V34, P74, DOI 10.1002/bjs.18003413312; EDWARDS GS, 1988, CLIN ORTHOP RELAT R, P61; ESSEXLOPRESTI P, 1951, J BONE JOINT SURG BR, V33, P244, DOI 10.1302/0301-620X.33B2.244; Failla JM, 1999, J HAND SURG-AM, V24A, P257; Fester EW, 2002, J HAND SURG-AM, V27A, P418, DOI 10.1053/jhsu.2002.32961; Geel C W, 1990, J Orthop Trauma, V4, P270, DOI 10.1097/00005131-199004030-00006; GEEL CW, 1992, CLIN ORTHOP RELAT R, P79; GOLDBERG I, 1986, J BONE JOINT SURG AM, V68A, P675, DOI 10.2106/00004623-198668050-00006; HALLS AA, 1964, ANAT REC, V150, P243, DOI 10.1002/ar.1091500305; Harman TW, 2005, CURR OPIN ORTHOP, V16, P285; Hotchkiss, 1997, J Am Acad Orthop Surg, V5, P1; HOTCHKISS RN, 1989, J HAND SURG-AM, V14, P256, DOI 10.1016/0363-5023(89)90017-8; Jaakkola JI, 2001, J HAND SURG-AM, V26A, P1053, DOI 10.1053/jhsu.2001.27187; Karlstad R, 2005, J BONE JOINT SURG AM, V87A, P1828, DOI 10.2106/JBJS.D.02351; KUZMA G, 2003, AAHS 33 AN M KAUI HI; Manson TT, 2000, J HAND SURG-AM, V25A, P1058, DOI 10.1053/jhsu.2000.17869; MCDOUGALL A, 1957, J BONE JOINT SURG BR, V39, P278, DOI 10.1302/0301-620X.39B2.278; McGinley JC, 2006, SKELETAL RADIOL, V35, P275, DOI 10.1007/s00256-005-0069-x; McGinley JC, 2001, CLIN ORTHOP RELAT R, P108, DOI 10.1097/00003086-200102000-00013; Moro JK, 2001, J BONE JOINT SURG AM, V83A, P1201, DOI 10.2106/00004623-200108000-00010; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; MORREY BF, 1979, J BONE JOINT SURG AM, V61, P63, DOI 10.2106/00004623-197961010-00012; PALMER AK, 1981, J HAND SURG-AM, V6, P153, DOI 10.1016/S0363-5023(81)80170-0; PALMER AK, 1984, CLIN ORTHOP RELAT R, P26; PETERSON CA, 1995, J HAND SURG-AM, V20A, P609, DOI 10.1016/S0363-5023(05)80277-1; Pfaeffle HJ, 2005, J HAND SURG-AM, V30A, P319, DOI 10.1016/j.jhsa.2004.10.005; Pfaeffle HJ, 2000, J HAND SURG-AM, V25A, P683, DOI 10.1053/jhsu.2000.9416; RABINOWITZ RS, 1994, J HAND SURG-AM, V19A, P385, DOI 10.1016/0363-5023(94)90050-7; RADIN EL, 1966, J BONE JOINT SURG AM, VA 48, P1055, DOI 10.2106/00004623-196648060-00003; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; SELLMAN DC, 1995, J ORTHOP TRAUMA, V9, P516, DOI 10.1097/00005131-199509060-00010; Skahen JR, 1997, J HAND SURG-AM, V22A, P986, DOI 10.1016/S0363-5023(97)80037-8; Skahen JR, 1997, J HAND SURG-AM, V22A, P981, DOI 10.1016/S0363-5023(97)80036-6; Smith AM, 2002, J BONE JOINT SURG AM, V84A, P1970, DOI 10.2106/00004623-200211000-00010; Smith G R, 1996, J Shoulder Elbow Surg, V5, P113, DOI 10.1016/S1058-2746(96)80005-X; SOWA DT, 1995, CLIN ORTHOP RELAT R, P106; Stabile KJ, 2002, HAND CLIN, V18, P195, DOI 10.1016/S0749-0712(02)00003-3; Starch DW, 2001, J BONE JOINT SURG AM, V83A, P235, DOI 10.2106/00004623-200102000-00011; STEPHEN IBM, 1981, ACTA ORTHOP SCAND, V52, P409, DOI 10.3109/17453678109050121; SWANSON AB, 1981, J BONE JOINT SURG AM, V63, P1039, DOI 10.2106/00004623-198163070-00001; Szabo RM, 1997, J HAND SURG-AM, V22A, P269, DOI 10.1016/S0363-5023(97)80163-3; TAYLOR TKF, 1964, J BONE JOINT SURG BR, V46, P83, DOI 10.1302/0301-620X.46B1.83; Tomaino MM, 2003, J HAND SURG-BRIT EUR, V28B, P267, DOI 10.1016/S0266-7681(03)00012-3; TROUSDALE RT, 1992, J BONE JOINT SURG AM, V74A, P1486, DOI 10.2106/00004623-199274100-00007; Wallace AL, 1997, J BONE JOINT SURG BR, V79B, P422, DOI 10.1302/0301-620X.79B3.7142	54	42	49	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0712	1558-1969		HAND CLIN	Hand Clin.	MAY	2007	23	2					195	+		10.1016/j.hcl.2007.01.005			15	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	182XF	WOS:000247536600007	17548011				2022-02-06	
J	Drew, AS; Langan, J; Halterman, C; Osternig, LR; Chou, LS; van Donkelaar, P				Drew, Anthony S.; Langan, Jeanne; Halterman, Charlene; Osternig, Louis R.; Chou, Li-Shan; van Donkelaar, Paul			Attentional disengagement dysfunction following mTBI assessed with the gap saccade task	NEUROSCIENCE LETTERS			English	Article						mild traumatic brain injury; saccade; attention	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; POSITRON-EMISSION-TOMOGRAPHY; NEURONAL-ACTIVITY; FIXATION POINT; EYE-MOVEMENTS; REACTION-TIME; DEFICITS; CONCUSSION; INITIATION	Concussion, or mild traumatic brain injury (mTBI), leads to a number of cognitive, attentional, and sensorimotor deficits that can last a surprisingly long time after the initial injury. We have previously shown that the ability to orient visuospatial attention is deficient in participants with mTBI within 2 days of their injury, but then recovers to normal levels within a week. Orienting attention requires disengagement from the point of fixation, movement of attention to the location of interest, and reengagement at that location. Deficits in any or all of these processes could lead to the difficulties with orienting attention that we have observed in mTBI. To address this issue, we tested participants with mTBI using a gap saccade task. Because this task manipulates the temporal gap between the offset of the fixation target and the appearance of the peripheral saccade target, it isolates the contribution of the disengagement process to saccadic reaction time. We found that participants with mTBI had significantly longer saccadic reaction times than controls when the temporal gap was short but not when it was long. This gap-dependent difference in saccadic reaction time was present within 2 days of the injury and resolved within 1 week. This pattern of results suggests that as the contribution of the disengagement process is reduced, so too is the extent of the reaction time deficit in the participants with mTBI. Taken together, this is consistent with the idea that the deficits in orienting visuospatial attention in participants with mTBI are fully accounted for by difficulties with the initial disengagement process. (c) 2007 Published by Elsevier Ireland Ltd.	Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA		van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	paulvd@uoregon.edu		Langan, Jeanne/0000-0003-1417-2180	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR 023203, R49/CCR 021735] Funding Source: Medline		Abrams RA, 1998, PERCEPT PSYCHOPHYS, V60, P201, DOI 10.3758/BF03206029; Biscaldi M, 1996, J NEUROPHYSIOL, V76, P199, DOI 10.1152/jn.1996.76.1.199; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Connolly JD, 2005, J NEUROPHYSIOL, V94, P605, DOI 10.1152/jn.00830.2004; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Dorris MC, 1997, J NEUROSCI, V17, P8566; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Forbes K, 1996, J COGNITIVE NEUROSCI, V8, P344, DOI 10.1162/jocn.1996.8.4.344; Giza CC, 2001, J ATHL TRAINING, V36, P228; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kelly JP, 1997, NEUROLOGY, V48, P581; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; KLEIN R, 1993, BEHAV BRAIN SCI, V16, P583, DOI 10.1017/S0140525X00031769; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Pratt J, 1999, ACTA PSYCHOL, V102, P1, DOI 10.1016/S0001-6918(99)00014-1; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; Ruff RM, 1999, BRAIN INJURY, V13, P943; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860	36	42	42	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 24	2007	417	1					61	65		10.1016/j.neulet.2007.02.038			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	167ZR	WOS:000246492000013	17363165				2022-02-06	
J	Ent, DV; Lehn, H; Derks, EM; Hudziak, JJ; Van Strien, NM; Veltman, DJ; De Geus, EJC; Todd, RD; Boomsma, DI				Ent, D. Van 't; Lehn, H.; Derks, E. M.; Hudziak, J. J.; Van Strien, N. M.; Veltman, D. J.; De Geus, E. J. C.; Todd, R. D.; Boomsma, D. I.			A structural MRI study in monozygotic twins concordant or discordant for attention/hyperactivity problems: Evidence for genetic and environmental heterogeneity in the developing brain	NEUROIMAGE			English	Article						twin study; anatomical MRI; VBM; attention and hyperactivity problems; ADHD; genetic risk factors; environmental risk factors	DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VOXEL-BASED MORPHOMETRY; OPERATING CHARACTERISTIC ANALYSIS; CHILD-BEHAVIOR CHECKLIST; CLOSED-HEAD INJURY; GRAY-MATTER; HYPERKINETIC DISORDER; UNAFFECTED SIBLINGS; EXECUTIVE FUNCTIONS	Several structural brain abnormalities have been reported in patients with Attention Deficit Hyperactivity Disorder (ADHD). However, the etiology of these brain changes is still unclear. To investigate genetic and environmental influences on ADHD related neurobiological changes, we performed Voxel-Based Morphometry on MRI scans from monozygotic (MZ) twins selected from a large longitudinal population database to be highly concordant or highly discordant for ratings on the Child Behavior Checklist Attention Problem scale (CBCL-AP). Children scoring low on the CBCL-AP are at low risk for ADHD, whereas children scoring high on this scale are at high-risk for ADHD. Brain differences between concordant high-risk twin pairs and concordant low-risk twin pairs likely reflect the genetic risk for ADHD; brain differences between the low-risk and high-risk twins from discordant MZ twin pairs reflect the environmental risk for ADRD. A major difference between comparisons of high and low-risk twins from concordant pairs and high/low twins from discordant pairs was found for the prefrontal lobes. The concordant high-risk pairs showed volume loss in orbitofrontal subdivisions. High-risk members from the discordant twin pairs exhibited volume reduction in the right inferior dorsolateral prefontal cortex. In addition, the posterior corpus callosum was compromised in concordant high-risk pairs, only. Our findings indicate that inattention and hyperactivity symptoms are associated with anatomical abnormalities of a distributed action-attentional network. Different brain areas of this network appear to be affected in in attention/hyperactivity caused by genetic (i.e., high concordant MZ pairs) vs. environmental (i.e., high-low discordant MZ pairs) risk factors. These results provide clues that further our understanding of brain alterations in ADHD. (C) 2007 Elsevier Inc. All rights reserved.	Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; Univ Vermont, Dept Psychiat, Burlington, VT USA; VU Med Ctr, Dept Psychiat, Amsterdam, Netherlands; VU Med Ctr, Clin PET Ctr, Amsterdam, Netherlands; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA		Ent, DV (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Van Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	d.vant.ent@psy.vu.nl	Derks, Eske M/A-1652-2017; de Geus, Eco J.C./M-9318-2015	Derks, Eske M/0000-0002-6292-6883; de Geus, Eco J.C./0000-0001-6022-2666; van 't Ent, Dennis/0000-0003-2001-1375	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058799, R21MH066148] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH058799, R21 MH66148-01, R21 MH066148-01, R21 MH066148, R01 MH58799-03] Funding Source: Medline		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Auerbach JG, 2001, PSYCHIATR GENET, V11, P31, DOI 10.1097/00041444-200103000-00006; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bhutta AT, 2001, TRENDS NEUROSCI, V24, P129, DOI 10.1016/S0166-2236(00)01747-1; Boomsma DI, 2002, TWIN RES, V5, P401, DOI 10.1375/136905202320906174; Brookes KJ, 2006, ARCH GEN PSYCHIAT, V63, P74, DOI 10.1001/archpsyc.63.1.74; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2003, AM J PSYCHIAT, V160, P1693, DOI 10.1176/appi.ajp.160.9.1693; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; CHEN WJ, 1994, J CONSULT CLIN PSYCH, V62, P1017, DOI 10.1037/0022-006X.62.5.1017; DEGEUS EJ, 2006, BIOL PSYCHIAT; Derks EM, 2006, COMPR PSYCHIAT, V47, P116, DOI 10.1016/j.comppsych.2005.05.006; DERKS EM, 2006, UNPUB GENETIC ENV IN; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Durston S, 2003, MENT RETARD DEV D R, V9, P184, DOI 10.1002/mrdd.10079; Eaves LJ, 2005, TWIN RES HUM GENET, V8, P283, DOI 10.1375/1832427054936736; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Gerring J, 2000, BRAIN INJURY, V14, P205; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hill DE, 2003, NEUROPSYCHOLOGY, V17, P496, DOI 10.1037/0894-4105.17.3.496; Hudziak JJ, 2004, J CHILD PSYCHOL PSYC, V45, P1299, DOI 10.1111/j.1469-7610.2004.00314.x; Hudziak JJ, 2000, J AM ACAD CHILD PSY, V39, P469, DOI 10.1097/00004583-200004000-00016; Hudziak JJ, 2003, J AM ACAD CHILD PSY, V42, P357, DOI 10.1097/00004583-200303000-00017; Hudziak JJ, 2005, AM J PSYCHIAT, V162, P1614, DOI 10.1176/appi.ajp.162.9.1614; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Kahn RS, 2003, J PEDIATR-US, V143, P104, DOI 10.1016/S0022-3476(03)00208-7; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; KRAIN AL, 2006, CLIN PSYCHOL REV; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Lehn H, 2007, J AM ACAD CHILD PSY, V46, P83, DOI 10.1097/01.chi.0000242244.00174.d9; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lou HC, 2004, DEV MED CHILD NEUROL, V46, P179; LOU HC, 1989, ARCH NEUROL-CHICAGO, V46, P48, DOI 10.1001/archneur.1989.00520370050018; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Neuman RJ, 1999, J AM ACAD CHILD PSY, V38, P25, DOI 10.1097/00004583-199901000-00016; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Powell AL, 1997, NEUROPSY NEUROPSY BE, V10, P151; Rietveld MJH, 2004, J CHILD PSYCHOL PSYC, V45, P577, DOI 10.1111/j.1469-7610.2004.00247.x; Rietveld MJH, 2003, AM J MED GENET B, V117B, P102, DOI 10.1002/ajmg.b.10024; Schubert R, 2005, PEDIATR NEUROL, V32, P1, DOI 10.1016/j.pediatrneurol.2004.06.007; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; SEMRUDCLIKEMAN M, 1994, J AM ACAD CHILD PSY, V33, P875, DOI 10.1097/00004583-199407000-00014; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Thapar A, 1999, BRIT J PSYCHIAT, V174, P105, DOI 10.1192/bjp.174.2.105; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vaidya CJ, 1999, MOL PSYCHIATR, V4, P206, DOI 10.1038/sj.mp.4000533; Verhulst F, 1996, HANDLEIDING CBCL 4 1; Voeller KKS, 2004, J CHILD NEUROL, V19, P798, DOI 10.1177/08830738040190100901; Wait JWV, 2002, J TROP PEDIATRICS, V48, P294, DOI 10.1093/tropej/48.5.294; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	78	42	42	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	APR 15	2007	35	3					1004	1020		10.1016/j.neuroimage.2007.01.037			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	160PZ	WOS:000245956100003	17346990	Green Accepted, Green Published			2022-02-06	
J	Lemke, DM				Lemke, Denise M.			Sympathetic storming - After severe traumatic brain injury	CRITICAL CARE NURSE			English	Article							AUTONOMIC DYSFUNCTION; DYSAUTONOMIA; MANAGEMENT		Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53033 USA		Lemke, DM (corresponding author), Med Coll Wisconsin, Dept Neurol, 9200 W Wisconsin Ave, Milwaukee, WI 53033 USA.	dlemke@mcw.edu					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; FRANCOIS B, 2000, J TRAUMA INJ INFECT, V50, P158; King ML, 1997, BRAIN INJURY, V11, P445; KISHNER S, POST HEAD INJURY AUT; LEMKE DM, 2003, J NEUROSCI NURS, V36, P4; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SAHR YL, 2002, PROG CARDIOVASC DIS, V45, P67; Scott JS, 1997, AM J PHYS MED REHAB, V76, P200, DOI 10.1097/00002060-199705000-00007; Stanford G G, 1994, Crit Care Nurs Clin North Am, V6, P693; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698	17	42	47	0	2	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	FEB	2007	27	1					30	37					8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	135QF	WOS:000244167400005	17244857				2022-02-06	
J	Chu, BC; Millis, S; Arango-Lasprilla, JC; Hanks, R; Novack, T; Hart, T				Chu, Bong-Chul; Millis, Scott; Arango-Lasprilla, Juan Carlos; Hanks, Robin; Novack, Thomas; Hart, Tessa			Measuring recovery in new learning and memory following traumatic brain injury: A mixed-effects modeling approach	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; PREDICTION; AWARENESS; 1-YEAR; LEVEL	Patterns of recovery from traumatic brain injury ( TBI) vary greatly across individuals. Using archival data from the Traumatic Brain Injury Model Systems, recovery of memory following TBI as measured by scores on the Rey Auditory Verbal Learning Test ( RAVLT) through 5 years postinjury was examined via mixed-effects modeling. Individual-level variables of age and posttraumatic amnesia duration were significant predictors of 1-year RAVLT total score. None of the variables examined predicted the trajectory of memory recovery after 1 year. Mixed-effects analyses can be helpful in determining the effect of intervention while allowing for missing data across time points.	Medstat Grp, Santa Barbara, CA USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, W Orange, NJ 07052 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Univ Alabama Birmingham, Rehabil Inst Med, Birmingham, AL USA; Moss Rehabil Res Inst, Philadelphia, PA USA		Chu, BC (corresponding author), 5425 Hollister Ave,Suite 140, Santa Barbara, CA 93111 USA.	bongchul.chu@thomson.com					BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; FINLAYSON MAJ, 1977, J CONSULT CLIN PSYCH, V45, P536, DOI 10.1037/0022-006X.45.4.536; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Lee D, 2004, REHABIL PSYCHOL, V49, P167, DOI 10.1037/0090-5550.49.2.167; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1982, NEUROBEHAV CONSEQUEN; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Sohlberg M., 2001, COGNITIVE REHABILITA; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Wong PP, 2001, BRAIN INJURY, V15, P519, DOI 10.1080/02699050010005995; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	28	42	42	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2007	29	6					617	625		10.1080/13803390600878893			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	208ZS	WOS:000249358500005	17691034				2022-02-06	
J	Fischer, FR; Peduzzi, JD				Fischer, Florence R.; Peduzzi, Jean D.			Functional recovery in rats with chronic spinal cord injuries after exposure to an enriched environment	JOURNAL OF SPINAL CORD MEDICINE			English	Article						spinal cord injuries; rats; motor score; locomotor testing; enriched environment; exercise; rehabilitation	EARLY-ONSET STIMULATION; TRAUMATIC BRAIN-INJURY; ADULT-RAT; NEUROTROPHIC FACTOR; SPATIAL MEMORY; MESSENGER-RNA; DENTATE GYRUS; CELL-PROLIFERATION; LOCOMOTOR RECOVERY; HOUSING CONDITIONS	Background/Objective: The objective of this study was to determine the effect of environmental enrichment on the sensorimotor function of rats with chronic spinal cord injuries. Design: Adult Sprague-Dawley rats received a contusive injury of moderate severity at vertebral level T8 using a weight-drop device. Three months after injury, 1 randomized group (n = 16) of rats was placed in an enriched environment, whereas the control group (n = 16) remained housed in standard laboratory cages (2/cage). Methods: Animals were placed in an enriched environment for 4 weeks beginning at 3 months after injury. The enriched environment consisted of a large cage (5-6 rats/cage) with access to items such as tubes, ramps, and running wheel, with items changed daily. Main Outcome Measures: Functional evaluation consisted of the open field Basso, Beattie and Bresnahan (BBB) locomotor test and the tests that form the combined behavioral score (CBS). The CBS includes motor score, toe spread, placing, withdrawal, righting, inclined plane, hot plate, and swim tests. Behavioral testing was repeated 7 times before and after the period of intervention. Results: The group placed in the enriched environment scored significantly better on the BBB (ANOVA repeated-measures, P < 0.01) test and CBS (ANOVA repeated-measures, P < 0.01). Conclusions: Environmental enrichment results in significant functional improvement in animals with spinal cord injury even with a substantial delay in initiating treatment after injury. The features of an enriched environment that may be responsible for the improvement include social interactions, exercise, and novel items in an interesting environment. These findings suggest a continued plasticity of the chronically injured rat spinal cord and a possible therapeutic intervention for people with spinal cord injury.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Peduzzi, JD (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 8137 Scott Hall, Detroit, MI 48201 USA.	jpeduzzi@med.wayne.edu					Aberg E, 2005, NEUROREPORT, V16, P1419; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bennett E.L, 1970, MOL APPROACHES LEARN, P55; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Briones TL, 2004, BRAIN RES, V1018, P130, DOI 10.1016/j.brainres.2004.06.001; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Dahlqvist P, 2003, NEUROSCIENCE, V119, P643, DOI 10.1016/S0306-4522(03)00195-7; Dobrossy MD, 2005, REV NEUROSCIENCE, V16, P1; Dobrossy MD, 2000, EXP NEUROL, V165, P172, DOI 10.1006/exnr.2000.7462; Elphick GF, 2003, J APPL PHYSIOL, V94, P660, DOI 10.1152/japplphysiol.00547.2002; Erschbamer MK, 2006, EXP NEUROL, V201, P154, DOI 10.1016/j.expneurol.2006.04.003; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FERCHMIN PA, 1970, BRAIN RES, V20, P49, DOI 10.1016/0006-8993(70)90153-8; Fernandez CI, 2004, ANN NY ACAD SCI, V1019, P53, DOI 10.1196/annals.1297.012; Fischer F. R., 1997, Society for Neuroscience Abstracts, V23, P2188; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; GREENOUGH WT, 1975, AM SCI, V63, P37; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Iuvone L, 1996, EXP NEUROL, V139, P25, DOI 10.1006/exnr.1996.0077; Ji BX, 2005, EUR J NEUROSCI, V22, P587, DOI 10.1111/j.1460-9568.2005.04241.x; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Johansson BB, 1997, MATURATION PHENOMENON IN CEREBRAL ISCHEMIA II, P159; KELCHE C, 1982, BRAIN RES, V245, P107, DOI 10.1016/0006-8993(82)90343-2; KELCHE C, 1995, NEUROBIOL LEARN MEM, V63, P155, DOI 10.1006/nlme.1995.1016; KELCHE C, 1988, BEHAV BRAIN RES, V28, P287, DOI 10.1016/0166-4328(88)90131-3; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; KERASIDIS H, 1987, J NEUROSCI METH, V20, P167, DOI 10.1016/0165-0270(87)90048-3; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; KUENZLE CC, 1974, PHYSIOL BEHAV, V13, P205, DOI 10.1016/0031-9384(74)90036-5; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Lankhorst AJ, 1999, NEUROSCI RES COMMUN, V24, P135; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Li LZ, 2005, BIOCHEM BIOPH RES CO, V334, P293, DOI 10.1016/j.bbrc.2005.05.162; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Mattsson B, 1997, STROKE, V28, P1225, DOI 10.1161/01.STR.28.6.1225; MCCALL RB, 1969, J COMP PHYSIOL PSYCH, V69, P644, DOI 10.1037/h0028198; Mohammed AH, 2002, PROG BRAIN RES, V138, P109, DOI 10.1016/S0079-6123(02)38074-9; Nantwi KD, 2003, J SPINAL CORD MED, V26, P364, DOI 10.1080/10790268.2003.11753707; NOBLE LJ, 1987, EXP NEUROL, V95, P530, DOI 10.1016/0014-4886(87)90162-2; PANJABI MM, 1988, SPINE, V13, P1365, DOI 10.1097/00007632-198812000-00007; Pikov V, 2001, J NEUROSCI, V21, P559, DOI 10.1523/JNEUROSCI.21-02-00559.2001; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Puurunen K, 2001, EXP NEUROL, V167, P348, DOI 10.1006/exnr.2000.7563; Puurunen K, 1997, STROKE, V28, P623, DOI 10.1161/01.STR.28.3.623; Puurunen K, 2001, NEUROPHARMACOLOGY, V40, P440, DOI 10.1016/S0028-3908(00)00172-6; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; ROSENZWEIG MR, 1984, AM PSYCHOL, V39, P365, DOI 10.1037/0003-066X.39.4.365; Roy RR, 1998, MUSCLE NERVE, V21, P63, DOI 10.1002/(SICI)1097-4598(199801)21:1<63::AID-MUS9>3.0.CO;2-E; Schrott LM, 1997, ACTA PAEDIATR, V86, P45; SCHWARTZ S, 1964, J COMP PHYSIOL PSYCH, V57, P72, DOI 10.1037/h0045518; Svensson J, 2005, AM J PHYSIOL-ENDOC M, V289, pE466, DOI 10.1152/ajpendo.00425.2004; Takami T, 2002, J NEUROSCI, V22, P6670; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Torasdotter M, 1996, NEUROSCI LETT, V218, P107, DOI 10.1016/S0304-3940(96)13127-X; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; Van Meeteren NLU, 2003, J NEUROTRAUM, V20, P1029, DOI 10.1089/089771503770195876; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wernig A, 2000, PROG BRAIN RES, V128, P89; WHISHAW IQ, 1984, BEHAV NEURAL BIOL, V42, P183, DOI 10.1016/S0163-1047(84)91046-X; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhao LR, 2001, NEUROSCI LETT, V305, P169, DOI 10.1016/S0304-3940(01)01837-7	81	42	45	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2007	30	2					147	155		10.1080/10790268.2007.11753926			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171BO	WOS:000246710100012	17591227	Green Published			2022-02-06	
J	Atkins, CM; Chen, SY; Alonso, OF; Dietrich, WD; Hu, BR				Atkins, Coleen M.; Chen, Shaoyi; Alonso, Ofelia F.; Dietrich, W. Dalton; Hu, Bing-Ren			Activation of calcium/calmodulin-dependent protein kinases after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						CaMKI; CaMKII; CaMKIV; CPEB; GluR1; traumatic brain injury	LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY PROTEIN; TRANSIENT CEREBRAL-ISCHEMIA; ELEMENT-BINDING PROTEIN; FLUID PERCUSSION INJURY; HIPPOCAMPAL CA1 REGION; SIGNAL-REGULATED KINASE; CLOSED-HEAD-INJURY; RAT HIPPOCAMPUS; SPATIAL MEMORY	A prominent cognitive impairment after traumatic brain injury (TBI) is hippocampal-dependent memory loss. Although the histopathologic changes in the brain are well documented after TBI, the underlying biochemical mechanisms that contribute to memory loss have yet to be thoroughly delineated. Thus, we determined if calcium/calmodulin-dependent protein kinases (CaMKs), known to be necessary for the formation of hippocampal-dependent memories, are regulated after TBI. Sprague-Dawley rats underwent moderate parasagittal fluid-percussion brain injury on the right side of the parietal cortex. The ipsilateral hippocampus and parietal cortex were Western blotted for phosphorylated, activated alpha-calcium/calmodulin-dependent protein kinase 11 (alpha-CaMKII), CaMKIV, and CaMKI. alpha-Calcium/calmodulin-dependent protein kinase 11 was activated in membrane subcellular fractions from the hippocampus and parietal cortex 30 mins after TBI. CaMKI and CaMKIV were activated in a more delayed manner, increasing in phosphorylation 1 h after TBI. The increase in activated alpha-CaMKII in membrane fractions was accompanied by a decrease in cytosolic total alpha-CaMKII, suggesting redistribution to the membrane. Using confocal microscopy, we observed that alpha-CaMKII was activated within hippocampal neurons of the dentate gyrus, CA3, and CA1 regions. Two downstream substrates of alpha-CaMKII, the AMPA-type glutamate receptor GluR1, and cytoplasmic polyadenylation element-binding protein, concomitantly increased in phosphorylation in the hippocampus and cortex 1 h after TBI. These results demonstrate that several of the biochemical cascades that subserve memory formation are activated unselectively in neurons after TBI. As memory formation requires activation of CaMKII signaling pathways at specific neuronal synapses, unselective activation of CaMKII signaling in all synapses may disrupt the machinery for memory formation, resulting in memory loss after TBI.	Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Neurotrauma Res Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA		Hu, BR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, POB 16960, Miami, FL 33136 USA.	bhu@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS042133] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291, NS42133] Funding Source: Medline		ARIZA M, 2005, IN PRESS NEUROPSYCHO; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bevilaqua LR, 2005, NEUROSCIENCE, V136, P397, DOI 10.1016/j.neuroscience.2005.08.007; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Carbonell WS, 2003, J NEUROTRAUM, V20, P327, DOI 10.1089/089771503765172282; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fu XZ, 2004, NEUROSCI RES, V48, P85, DOI 10.1016/j.neures.2003.09.009; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GOLDENRING JR, 1984, J NEUROCHEM, V42, P1077, DOI 10.1111/j.1471-4159.1984.tb12713.x; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hu BR, 1999, NEUROSCIENCE, V89, P437, DOI 10.1016/S0306-4522(98)00352-2; HU BR, 1995, J NEUROCHEM, V64, P1361; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; HU BR, 1995, J NEUROCHEM, V64, P277; Hu BR, 1998, J NEUROSCI, V18, P625; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu CL, 2004, J CEREBR BLOOD F MET, V24, P1219, DOI 10.1097/01.WCB.0000136706.77918.21; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lovell Mark R., 1994, P133; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Selcher JC, 2002, NEUROSCIENTIST, V8, P122, DOI 10.1177/107385840200800208; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Stratmann T, 1997, PROTEIN EXPRES PURIF, V11, P72, DOI 10.1006/prep.1997.0768; Takagi Y, 2003, NEUROSCI LETT, V341, P33, DOI 10.1016/S0304-3940(03)00153-8; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Yan XB, 2004, NEUROSCI LETT, V355, P197, DOI 10.1016/j.neulet.2003.11.001; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	90	42	44	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2006	26	12					1507	1518		10.1038/sj.jcbfm.9600301			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	111HJ	WOS:000242441700005	16570077	Bronze			2022-02-06	
J	Yadav, YR; Basoor, A; Jain, G; Nelson, A				Yadav, Yad R.; Basoor, Abhijeet; Jain, Gaurav; Nelson, Adam			Expanding traumatic intracerebral contusion/hematoma	NEUROLOGY INDIA			English	Article						delayed Intracerebral hematoma; head injury; secondary insult	PROGRESSIVE BRAIN INJURY; HEAD TRAUMA; INTRACRANIAL HEMATOMAS; HEMORRHAGE	Background and Alms: Delayed traumatic hematomas and expansion of already detected hematomas are not uncommon. Only few studies are available on risk factors of expanding hematomas. A prospective study was aimed to find out risk factors associated with such traumatic lesions. Materials and Methods: Present study is based on 262 cases of intracerebral hematomas / contusions out of which 43 (16.4%) hematomas expanded in size. computerized tomography (CT) scan was done in all the patients at the time of admission and within 24 hours of injury. Repeat CT scan was done within 24 hours, 4 days and 7 days. Midline shift if any, prothrombin time, activated partial thromboplastin time, bleeding time, clotting time and platelet counts, Glasgow coma scale at admission and discharge and Glasgow outcome score at 6 months follow up were recorded. Results: Twenty six percent, 11.3 and 0% patients developed expanding hematoma in Glasgow Coma scale (GCS) of 8 and below, 9-12 and 13-15 respectively. The chances of expanding hematomas were higher in patients with other associated hematomas (17.4%) as compared to isolated hematoma (4.8%) (Fisher's exact results P=0.216). All the cases of expanding hematoma had some degree of midline shift and considerably higher proportion had presence of coagulopathy. The results of logistic regression analysis showed GCS, midline shift and coagulopathy as significant predictors for the expanding hematoma. Thirty nine patients (90.7%) of the total expanding hematomas developed within 24 hours of injury. Conclusions: Enlargement of intracerebral hematomas is quite common and majority of them expand early after the injury. These lesions were common in patients with poor GCS, associated hematomas, associated coagulopathy and midline shift.	NSCB Med Coll, Neurosurg Unit, Jabalpur 482003, India		Yadav, YR (corresponding author), NSCB Med Coll, Neurosurg Unit, 105 Nehru Nagar, Jabalpur 482003, India.			Jain, Gaurav/0000-0001-7064-3763			Borthne Arne, 1992, Tidsskrift for den Norske Laegeforening, V112, P3425; Erol FS, 2004, PEDIATR NEUROSURG, V40, P238, DOI 10.1159/000082299; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Halatsch ME, 1999, FUNCT NEUROL, V14, P155; HIRSH LF, 1979, NEUROSURGERY, V5, P653, DOI 10.1227/00006123-197912000-00001; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KOJIMA N, 1991, Neurologia Medico-Chirurgica, V31, P165, DOI 10.2176/nmc.31.165; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; MLAY SM, 1990, E AFR MED J, V67, P717; NINEHOJI T, 1984, ACTA NEUROCHIR WIEN, V71, P69; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Okada T, 1989, Nihon Ika Daigaku Zasshi, V56, P545; Park YS, 1997, NEUROL SURG TOKYO, V25, P1081; Sawauchi S, 2001, NEUROL SURG TOKYO, V29, P131; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Xia G D, 1989, Zhonghua Wai Ke Za Zhi, V27, P674; XIA GD, 1989, ZHONGHUA WAI KE ZA Z, V27, P702; Zhang G, 1995, Zhonghua Wai Ke Za Zhi, V33, P430; ZHANG G, 1998, FA YI XUE ZA ZHI, V14, P61; Zhang GH, 1998, ACTA MECH SINICA, V14, P1	22	42	54	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	DEC	2006	54	4					377	381		10.4103/0028-3886.28109			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WW	WOS:000242413000016	17114846	Green Submitted			2022-02-06	
J	Jiang, Y; Sun, XC; Xia, YX; Tang, WY; Cao, YQ; Gu, YJ				Jiang, Yong; Sun, Xiaochuan; Xia, Yuxian; Tang, Wenyuan; Cao, Yueqing; Gu, Yingjiang			Effect of APOE polymorphisms on early responses to traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						APOE; polymorphism; traumatic brain injury; early response	APOLIPOPROTEIN-E GENOTYPE; HEAD-INJURY; E EPSILON-4; ASSOCIATION; RECOVERY; DEPOSITION; ALLELE; E4	To investigate the relationship between apolipoprotein E (APOE) polymorphisms and the severity of traumatic brain injury (TBI) in acute stage in the cohort of mainland Chinese patients. We prospectively identified admissions to the two neurosurgical departments for head injury. A total of 110 subjects with TBI (80 males and 30 females, with mean age of 43.87 years) were enrolled from December 2003 to May 2004, and demographic and clinical data were collected. Venous blood was collected from patients with TBI on admission to determine the APOE genotype polymorphisms. The APOE genotyping was performed by means of PCR-RFLP. The deterioration of patients' condition in acute stage (< 7 days after TBI) was judged by either of following criteria: decrease of GCS, increase in hematoma volume or delayed hematoma both detected by repeated CT scanning. chi(2)-test and logistic regression analyses were done by SPSS. The distributions of APOE genotypes and alleles matched Hardy-Weinberg law. In I 10 Chinese patients, 19 subjects presented with deteriorated clinical condition after hospitalization, and seven of 17 patients with APOE epsilon 4 (41.2%) had a deteriorated condition which was significantly different from those without APOE epsilon 4 (12 of 93 patients, 119%, P = 0.01). However, neither the presence of epsilon 2 nor of epsilon 3 was significantly different from those absent of it (P > 0.05). Logistic regression analyses showed that APOE epsilon 4 was a risk factor (OR = 4.836, P = 0.011, 95% CI 1.443-16.208) to predispose to clinical deterioration after adjusting for patient age, sex, smoking or not, alcohol-drinking or not, injury severity, injury mechanisms, treatments, and pattern of TBI. This finding suggests that the patients with APOE epsilon 4 predispose to clinical deterioration in acute phase after TBI and APOE polymorphisms play a role in early responses to TBI. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Chongqing Univ Med Sci, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China; Luzhou Med Coll, Dept Neurosurg, Affiliated Hosp 1, Luzhou 646000, Peoples R China; Chongqing Univ, Ctr Gene Res, Chongqing 400044, Peoples R China		Sun, XC (corresponding author), Chongqing Univ Med Sci, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		sun, xiao chuan/0000-0001-6992-332X			ALLSOP D, 1990, AM J PATHOL, V136, P255; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Graham DI, 1999, ACT NEUR S, V73, P89; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655	32	42	58	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 13	2006	408	2					155	158		10.1016/j.neulet.2006.08.082			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102SW	WOS:000241834600016	16997460				2022-02-06	
J	Jimenez, R; Casado-Flores, J; Nieto, M; Garcia-Teresa, MA				Jimenez, Raquel; Casado-Flores, Juan; Nieto, Monserrat; Garcia-Teresa, Maria Angeles			Cerebral salt wasting syndrome in children with acute central nervous system injury	PEDIATRIC NEUROLOGY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HYPONATREMIA; MENINGITIS; HORMONE; DISEASE	The purpose of this investigation was to describe the causes, clinical pattern, and treatment of cerebral salt wasting syndrome in children with acute central nervous system injury. This retrospective study focused on patients <= 15 years old diagnosed with cerebral salt wasting syndrome, over a period of 7 years, in the pediatric intensive care unit of a tertiary care hospital. Selection criteria included evidence of hyponatremia (serum sodium < 130 mEq/L), polyuria, elevated urine sodium (> 120 mEq/L), and volume depletion. Fourteen patients were identified with cerebral salt wasting syndrome, 12 after a neurosurgical procedure (8 brain tumor, 4 hydrocephalus) and 2 after severe brain trauma. In 11 patients the cerebral salt wasting syndrome was diagnosed during the first 48 hours of admission. Prevalence of cerebral salt wasting syndrome in neurosurgical children was 11.3/1000 surgical procedures. The minimum sodium was 122 +/- 7 mEq/L, the maximum urine osmolarity 644 +/- 59 mOsm/kgH(2)O. The maximum sodium supply was 1 mEq/kg/h (range, 0.1-2.4). The mean duration of cerebral salt wasting syndrome was 6 +/- 5 days (range 1-9). In conclusion, cerebral salt wasting syndrome can complicate the postoperative course of children with brain injury; it is frequently present after surgery for brain tumors and hydrocephalus and in patients with severe head trauma. Close monitoring of salt and fluid balance is essential to prevent severe neurologic and hemodynamic complications. (c) 2006 by Elsevier Inc. All rights reserved.	Univ Autonoma Madrid, Pediat Intens Care Unit, Hosp Infant Nino Jesus, Madrid, Spain		Casado-Flores, J (corresponding author), Univ Autonoma Madrid, Pediat Intens Care Unit, Hosp Infant Nino Jesus, Avenida Menendez Pelayo 65, Madrid, Spain.	jcasadof@line-pro.es		Garcia Teresa, Maria de los Angeles/0000-0002-3474-7087			Brouh Y, 2004, ANN FR ANESTH, V23, P39, DOI 10.1016/j.annfar.2003.09.009; Bussmann C, 2001, CHILD NERV SYST, V17, P58; Erduran E, 1997, ACTA PAEDIATR, V86, P1150, DOI 10.1111/j.1651-2227.1997.tb14830.x; ESPINER EA, 1994, J INTERN MED, V235, P527, DOI 10.1111/j.1365-2796.1994.tb01261.x; GANONG CA, 1993, AM J DIS CHILD, V147, P167, DOI 10.1001/archpedi.1993.02160260057022; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Ibarra de la Rosa I, 1999, AN ESP PEDIATR, V51, P27; Kappy M S, 1996, Adv Pediatr, V43, P271; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; NAROTAM PK, 1994, NEUROSURGERY, V34, P982, DOI 10.1227/00006123-199406000-00005; OSTER JR, 1983, ARCH INTERN MED, V143, P2187, DOI 10.1001/archinte.143.11.2187; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; WEINAND ME, 1989, NEUROSURGERY, V25, P781, DOI 10.1227/00006123-198911000-00014	13	42	45	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	OCT	2006	35	4					261	263		10.1016/j.pediatrneurol.2006.05.004			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	095PK	WOS:000241319700006	16996399				2022-02-06	
J	Muller, K; Elverland, A; Romner, B; Waterloo, K; Langbakk, B; Unden, J; Ingebrigtsen, T				Muller, Kay; Elverland, Astrid; Romner, Bertil; Waterloo, Knut; Langbakk, Bodil; Unden, Johan; Ingebrigtsen, Tor			Analysis of protein S-100B in serum: a methodological study	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						methods; protein S-100B; serum analysis; serum markers; traumatic brain injury	TRAUMATIC BRAIN-DAMAGE; SEX-RELATED CHANGES; MINOR HEAD-INJURY; S100B; BLOOD; S100-BETA; STABILITY; MARKERS; STORAGE; DISEASE	Background: Dysfunction and damage of the human central nervous system can be detected with biochemical markers, and protein S-100B is the best-established such marker. The aim of this study was to evaluate whether the protein is stable during longterm storage, to establish reference values for the new Elecsys((R)) S100 test and to compare this new method with the Liaison((R)) Sangtec((R)) 100 test. Methods: We analysed blood samples from 118 blood donors and 196 patients with subarachnoid haemorrhage or head injury. The long-term stability of S-100B in frozen serum samples was evaluated with repeated analysis in 1997 and 2003 using an immunoradiometric assay. Method comparison between the Liaison((R)) Sangtec((R)) 100 and Elecsys((R)) S100 tests was performed using Bland-Altman difference plots. Results: Serum concentrations increased significantly during long-term storage (mean difference 0.15 mu g/L; +/- 2 SD, 0.55 mu g/L). Serum measurements using the Elecsys ((R)) S100 method in 118 healthy blood donors showed S-100B levels between 0.02 and 0.08 mu g/L (mean 0.05). The 95th percentile was 0.07 mu g/L. The Liaison ((R)) Sangtec((R)) 100 test usually measured higher concentrations than the Elecsys((R)) S100 method, and the difference between the two methods increased with increasing concentrations. The mean difference between the methods was 0.14 mu g/L (+/- 2 SD, 0.39 mu g/L). Conclusions: Protein S-100B is not stable during longterm storage and the two analytical methods are not interchangeable.	Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; Univ Hosp N Norway, Dept Neurol, N-9038 Tromso, Norway; Univ Hosp N Norway, Dept Clin Chem, N-9038 Tromso, Norway; Univ Lund Hosp, Dept Neurosurg, Lund, Sweden; Univ Tromso, Inst Clin Med, Dept Neurosurg, Tromso, Norway		Muller, K (corresponding author), Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway.	kay.muller@unn.no		Ingebrigtsen, Tor/0000-0001-5966-9786			Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Dewitte K, 2002, CLIN CHEM, V48, P799; Djukanovic D, 2001, BRIT J DERMATOL, V145, P1030, DOI 10.1046/j.1365-2133.2001.04545.x; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Nygaard O, 1997, CLIN CHEM, V43, P541; Portela LVC, 2002, CLIN CHEM, V48, P950; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wiesmann M, 1998, CLIN CHEM, V44, P1056	19	42	43	0	0	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621			CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2006	44	9					1111	1114		10.1515/CCLM.2006.211			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	093TT	WOS:000241193800013	16958605				2022-02-06	
J	Schiff, ND				Schiff, Nicholas D.			Multimodal neuroimaging approaches to disorders of consciousness	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	2nd Federal Interagency Conference on Traumatic Brain Injury	MAR 10, 2006	Bethesda, MD			axonal regrowth; minimally conscious state; traumatic brain injury; vegetative state	PERSISTENT VEGETATIVE STATE; BRAIN-INJURED PATIENTS; RECOVERY; COMA; NEUROPATHOLOGY; DIAGNOSIS; STIMULI	Advances in neuroimaging techniques hold significant promise for improving understanding of disorders of consciousness arising from severe brain injuries. We review neuroimaging studies of the vegetative state (VS) and minimally conscious state (MCS), and findings in an unusual case of late emergence from MCS. Multimodal neuroimaging studies using positron emission tomography techniques, functional magnetic resonance imaging, and quantitative electroencephalography and magnetoencephalography quantify variations of residual cerebral activity across these patient populations. The results suggest models to distinguish the pathophysiologic basis of VS and MCS. Less clear are potential brain mechanisms underlying late recovery of communication in rare MCS patients. Diffusion tensor magnetic resonance imaging studies and recent experimental findings suggest that structural remodeling of the brain following severe injury may play a role in late functional recoveries. More generally, relatively long time courses of recovery following severe brain injury emphasize the need to develop markers for identifying patients who may harbor potential for further meaningful recovery. Introduction of neuroimaging into the clinical evaluation process will require developing frameworks for longitudinal assessments of cerebral function. Although limited in number, available studies already provide important insights into underlying brain mechanisms that may help guide development of such assessment strategies.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA		Schiff, ND (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 1300 York Ave,Room F610, New York, NY 10021 USA.	nds2001@med.cornell.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS043451] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS43451, NS02172] Funding Source: Medline		Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Burruss JW, 1999, J NEUROPSYCH CLIN N, V11, P100, DOI 10.1176/jnp.11.1.100; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clauss P, 2001, SAMJ S AFR MED J, V91, P788; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, IN PRESS ARCH PHYS M; GOLDFINE AM, 2005, 35 ANN M NOV 12 16 2; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jennett B., 2002, VEGETATIVE STATE; Kobylarz EJ, 2005, NEUROPSYCHOL REHABIL, V15, P323, DOI 10.1080/09602010443000605; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Macniven JA, 2003, BRAIN INJURY, V17, P525, DOI 10.1080/0269905031000086254; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Menon DK, 1998, LANCET, V352, P1148, DOI 10.1016/S0140-6736(05)79795-6; Onofrj M, 1997, J NEUROL NEUROSUR PS, V63, P759, DOI 10.1136/jnnp.63.6.759; Owen AM, 2005, PROG BRAIN RES, V150, P457, DOI 10.1016/S0079-6123(05)50032-3; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schirrmacher A, 2003, PHYS PERSPECT, V5, P4, DOI 10.1007/s000160300001; Shiel A, 2004, BRIT J NEUROSURG, V18, P5, DOI 10.1080/02688690410001660625; Tavalaro J, 1997, LOOK YES; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; VOSS HU, 2005, ISMRM ABSTR; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	47	42	44	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2006	21	5					388	397		10.1097/00001199-200609000-00003			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	084JM	WOS:000240529200003	16983224				2022-02-06	
J	Schroth, M; Plank, C; Meissner, U; Eberle, KP; Weyand, M; Cesnjevar, R; Dotsch, J; Rascher, W				Schroth, Michael; Plank, Christian; Meissner, Udo; Eberle, Klaus-Peter; Weyand, Michael; Cesnjevar, Robert; Doetsch, Joerg; Rascher, Wolfgang			Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery	PEDIATRICS			English	Article						hypertonic-hyperoncotic solutions; pediatrics; capillary leakage; low-output failure; cardiopulmonary bypass	TRAUMATIC BRAIN-INJURY; LEUKOCYTE-ENDOTHELIUM INTERACTION; SMALL-VOLUME RESUSCITATION; HYDROXYETHYL-STARCH; CAPILLARY LEAKAGE; HEMORRHAGIC-SHOCK; SALINE INFUSION; DEXTRAN; OUTPUT; HYPERNATREMIA	OBJECTIVES. Hypertonic-hyperoncotic solutions are used for the improvement of micro- and macrocirculation in various types of shock. In pediatric intensive care medicine, controlled, randomized studies with hypertonic-hyperoncotic solutions are lacking. Hypertonic-hyperoncotic solutions may improve cardiac function in children. The primary objective of this controlled, randomized, blinded study was to evaluate the hemodynamic effects and safety of hypertonic-hyperoncotic solution infusions in children shortly after open-heart surgery for congenital cardiac disease. The secondary objective was to determine whether the administration of hypertonic-hyperoncotic solutions could be a potential and effective therapeutic option for preventing a probable capillary leakage syndrome that frequently occurs in children after open-heart surgery. METHODS. The children were randomly assigned to 2 groups of 25. The hypertonic-hyperoncotic solution group received Poly-(O-2)-hydroxyethyl-starch 60.0 g, with molecular weight of 200 kDa, Na+ 1232 mmol/L and osmolality of 2464 mOsmol/L (7.2% sodium chloride with 6% hydroxyethyl-starch 200 kDa). The isotonic saline solution group received isotonic saline solution (0.9% sodium chloride). Atrial and ventricular septal defects were corrected using a homograft patch. Monitoring consisted of an arterial, a central venous, and a thermodilution catheter (PULSIOCATH). Cardiac index, extravascular lung water index, stroke volume index, mean arterial blood pressure, and systemic vascular resistance index were measured (Pulse Contour Cardiac Output technique). Immediately after surgery, patients were loaded either with hypertonic-hyperoncotic solution or with isotonic saline solution (4 mL/kg). Blood samples (sodium concentration, osmolality, thrombocyte count, fibrinogen, and arterial blood gases) were drawn directly before; immediately after; 15 minutes after; and, 1, 4, 12, and 24 hours after the end of volume loading. Hemodynamic parameters were registered at the same time. The total amount of dobutamine required was documented, as well as the 24- and 48-hour fluid balances. RESULTS. In the hypertonic-hyperoncotic solution group, cardiac index was 3.6 +/- 0.26 L/min per m(2) before volume administration and increased to 5.96 +/- 0.27 after the administration of the study solution (64%). Fifteen and 60 minutes after administration, the cardiac index remained significantly elevated (5.55 +/- 0.29 L/min per m(2) and 4.65 +/- 0.18 L/min per m2, respectively) and returned to preadministration values after 4 hours. In the isotonic saline solution group, the cardiac index did not change during the entire observation period (3.39 +/- 0.21 before and 3.65 +/- 0.23 L/min per m(2) after isotonic saline solution). The systemic vascular resistance index decreased in the hypertonic-hyperoncotic solution group after administration from 1396 +/- 112 to 868 +/- 63 dyn/sec per cm(-5)/m(2). The decrease of systemic vascular resistance index in the hypertonic-hyperoncotic solution group was transiently significant within 60 minutes after administration but stayed lower than before volume load (999 +/- 70 dyn/sec per cm(-5)/m(2)). In the isotonic saline solution group, we found no statistically relevant change in systemic vascular resistance index. Stroke volume index significantly increased after hypertonic-hyperoncotic solution infusion (53.9 +/- 3.0 mL/m(2) directly after, 48.8 +/- 2.46 mL/m(2) 15 minutes after, and 41.4 +/- 2.2 mL/m(2) 60 minutes after) when compared with stroke volume index before administration (32.4 +/- 2.6 mL/m(2)). In the hypertonic-hyperoncotic solution group, an increase in mean arterial blood pressure remained transiently significant within 60 minutes after administration when compared with the isotonic saline solution group, in which the mean arterial blood pressure remained unchanged. Both central venous pressure and heart rate were unchanged during the whole time of observation in both groups. In the hypertonic-hyperoncotic solution group, extravascular lung water index decreased from 10.6 +/- 1.2 to 5.6 +/- 1.2 mL/kg and remained significantly decreased 15 minutes after (6.5 +/- 1.2 mL/kg) when compared with before volume administration. In the isotonic saline solution group, extravascular lung water index increased from 12.3 +/- 1.1 mL/kg to 18.1 +/- 1.7 mL/kg directly after administration and remained elevated for 60 minutes after volume loading (15.6 +/- 1.5 mL/kg). In all patients, no hypoxia (Pao(2) < 60 mm Hg) or hypercapnia (Paco(2) > 60 mm Hg) was observed. Arterial blood gas analysis showed pH and base excess within physiologic range, and this did not change throughout the whole period of observation. After infusion of hypertonic-hyperoncotic solution, sodium concentration increased from 139.2 +/- 0.7 to 147.5 +/- 0.7 mmol/L. The maximum sodium concentration was 153 mmol/L, measured immediately after hypertonic-hyperoncotic solution in 1 patient. The total amount of fluid infused was similar in both groups. The postoperative need for infused dobutamine in the patients in the hypertonic-hyperoncotic solution group was decreased compared with the isotonic saline solution group 46.9 +/- 8.8 mu g/kg vs 308.2 +/- 46.6 mu g/kg). No patient presented with severe bleeding. Short- and long-term cardiac and neurologic outcome was not reduced and all patients left the hospital in a clinically sufficient state. DISCUSSION. This study demonstrates a profound increase of cardiac index after the administration of hypertonic-hyperoncotic solution in children after uncomplicated open-heart surgery, suggesting a positive inotropic effect. The total amount of catecholamine was lower, assuming that hypertonic-hyperoncotic solution reduces the need for positive inotropic support. The observed positive cardiac effect of hypertonic-hyperoncotic solution may even be intensified by the decreased afterload (decreased systemic vascular resistance index). According to the Frank-Starling relation, an effective tool in the treatment of low cardiac output are an elevated preload while afterload is diminished. Therefore, we postulate that hypertonic-hyperoncotic solution may be helpful in preventing or attenuating low cardiac output failure in childhood. Capillary leakage syndrome also is a frequent problem after cardiopulmonary bypass. For quantification of edema formation, extravascular lung water index measurement is a useful tool. Using this approach, we provided evidence that the infusion of hypertonic-hyperoncotic solution is transiently able to reduce extravascular lung water index. This reduction was transient but might prevent the triggering of a clinically relevant capillary leakage syndrome. This is in line with in vitro studies demonstrating that hypertonic-hyperoncotic solution improves microcirculation by reducing vascular permeability. The single administration of hypertonic-hyperoncotic solution infusion was safe, and no adverse effects, such as hemostatic disturbances, were observed. CONCLUSIONS. A single infusion of hypertonic-hyperoncotic saline solution after cardiac surgery is safe despite the hypertonicity and the colloid component of the hypertonic-hyperoncotic saline solution. In children after cardiopulmonary bypass surgery, the administration of hypertonic-hyperoncotic saline solution increased cardiac index by elevating stroke volume index in combination with a lowered systemic vascular resistance index. Extravascular lung water index transiently decreased, suggesting that hypertonic-hyperoncotic saline solution effectively counteracts the capillary leakage that often occurs after cardiac surgery in children. Additional investigations might elucidate whether the temporary effects of hypertonic-hyperoncotic saline solution are beneficial in the treatment of severe capillary leakage after complicated cardiac surgery. It has to be shown that hypertonic-hyperoncotic saline solution is a long-lasting, effective treatment strategy for low cardiac output failure in children that is caused by sepsis, multiorgan failure, and endothelial edema. We have provided evidence to pediatric intensive care clinicians that the single administration of hypertonic-hyperoncotic saline solution might be a useful and safe treatment in the amelioration of contractility, inotropy, and the possible treatment of early-onset capillary leakage.	Univ Erlangen Nurnberg, Kinder & Jugendklin, Dept Pediat, Pediat Intens Care Unit, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Cardiac Surg, D-91054 Erlangen, Germany		Schroth, M (corresponding author), Univ Erlangen Nurnberg, Kinder & Jugendklin, Dept Pediat, Pediat Intens Care Unit, Loschgestr 15, D-91054 Erlangen, Germany.	michael_schroth@yahoo.de	Cesnjevar, Robert/AAD-6215-2019	Cesnjevar, Robert/0000-0002-3575-6647			ALBRECHT MD, 1995, SHOCK, V3, P152, DOI 10.1097/00024382-199503020-00011; BERG RA, 1993, J PHARMACOL EXP THER, V265, P1232; BOLDT J, 1994, CRIT CARE MED, V22, P1913; BOLDT J, 1993, BRIT J ANAESTH, V70, P661, DOI 10.1093/bja/70.6.661; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; Cecchetti C, 2003, Minerva Anestesiol, V69, P907; Christ F, 1997, ACTA ANAESTH SCAND, V41, P62, DOI 10.1111/j.1399-6576.1997.tb04614.x; Corso CO, 1999, J TRAUMA, V46, P417, DOI 10.1097/00005373-199903000-00011; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; DEFELIPPE J, 1980, LANCET, V2, P1002; ELLINGER K, 1995, SHOCK, V3, P167, DOI 10.1097/00024382-199503000-00002; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hazelzet JA, 1998, INFECT IMMUN, V66, P5350, DOI 10.1128/IAI.66.11.5350-5356.1998; KAPIOTIS S, 1994, CRIT CARE MED, V22, P606, DOI 10.1097/00003246-199404000-00016; Khabar KSA, 1997, CLIN IMMUNOL IMMUNOP, V85, P97, DOI 10.1006/clin.1997.4413; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KIEN ND, 1991, ANESTH ANALG, V73, P597; KREIMEIER U, 1995, LANCET, V346, P49, DOI 10.1016/S0140-6736(95)92677-1; KREIMEIER U, 1990, J SURG RES, V49, P493, DOI 10.1016/0022-4804(90)90174-Z; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; LANG RM, 1986, CIRCULATION, V74, P1114, DOI 10.1161/01.CIR.74.5.1114; Levy RJ, 2004, ANESTH ANALG, V99, P1642, DOI 10.1213/01.ANE.0000136952.85278.99; MATTOX KL, 1991, MULTICENTER TRIAL AN, V213, P482; Michard F, 2003, CHEST, V124, P1900, DOI 10.1378/chest.124.5.1900; MODER KG, 1990, MAYO CLIN PROC, V65, P1587, DOI 10.1016/S0025-6196(12)62194-6; Moritz ML, 1999, PEDIATRICS, V104, P435, DOI 10.1542/peds.104.3.435; NOLTE D, 1991, AM J PHYSIOL, V261, pH651, DOI 10.1152/ajpheart.1991.261.3.H651; NOLTE D, 1992, N-S ARCH PHARMACOL, V346, P234, DOI 10.1007/BF00165307; Nurnberger W, 1997, ANN HEMATOL, V75, P95, DOI 10.1007/s002770050321; Pickelmann S, 1998, AM J PHYSIOL-HEART C, V275, pH361; PRIEN T, 1993, ZBL CHIR, V118, P257; PRIEN T, 1993, ZENTRALBL CHIR, V118, P264; Rocha-e-Silva R, 2003, SHOCK, V20, P427, DOI 10.1097/01.SHK.0000094037.09886.d2; ROCHAESILVA M, 1986, CIRC SHOCK, V19, P165; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; SCHRANZ D, 1994, Z KARDIOL, V83, P83; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; TAKEDA A, 1995, J VET MED SCI, V57, P481, DOI 10.1292/jvms.57.481; Tollofsrud S, 1998, ACTA ANAESTH SCAND, V42, P154, DOI 10.1111/j.1399-6576.1998.tb05101.x; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VOLLMAR B, 1994, AM J PHYSIOL, V266, pH1927; White PA, 1997, AM J PHYSIOL-HEART C, V273, pH295, DOI 10.1152/ajpheart.1997.273.1.H295	43	42	55	1	10	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2006	118	1					E76	E84		10.1542/peds.2005-2795			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	059II	WOS:000238726100073	16751617				2022-02-06	
J	Mazzeo, AT; Kunene, NK; Gilman, CB; Hamm, RJ; Hafez, N; Bullock, MR				Mazzeo, Anna Teresa; Kunene, Niki K.; Gilman, Charlotte B.; Hamm, Robert J.; Hafez, Naiel; Bullock, M. Ross			Severe human traumatic brain injury, but not cyclosporin A treatment, depresses activated T lymphocytes early after injury	JOURNAL OF NEUROTRAUMA			English	Article						cyclosporin A; immunity; immunosuppression; infection; severe head injury; T cells	MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSIENT FOREBRAIN ISCHEMIA; HEAD-INJURY; IMMUNE FUNCTION; CELL FUNCTION; DAMAGE; PHARMACOKINETICS; AUTOIMMUNITY; DYSFUNCTION; IMPAIRMENT	Severe traumatic brain injury (TBI) leads to an immunocompromised state responsible for an increased morbidity and mortality. Our understanding of the mechanisms responsible for this brain damage is incomplete. Damage maybe mediated by a complex cascade of neuroinflammation, and cytokine activation. In addition, translocation and accumulation of T cells in the brain parenchyma could take place and be related to detrimental effects. Our aims in this prospective randomized pilot study, were to detect the early effect of severe TBI upon cell-mediated immunity, to verify if early immunologic impairment correlates with neurologic outcome, and finally, to test the effect of early administration of iv infusion of cyclosporin A upon cell-mediated immunologic function. Forty-nine patients with severe TBI were studied. Thirty-six of these patients received a 24-h intravenous infusion of Cyclosporin A, or two 24-h infusions of the drug. 10 patients were in the placebo group. Three patients, not enrolled in the cyclosporin trial, were studied only for the relationship between cellular immunity, neurological outcome, and infection rate. T cell counts and microbiological cultures were performed in all patients. Sixty-five percent of patients demonstrated reduced T lymphocyte counts on admission. Furthermore, reduction of T cell numbers was related with significantly worse neurologic outcome and an increase in pulmonary infection. There was no significant difference between the placebo and CsA treated patients for the studied immunological parameters, or for incidence of infection. We also observed sequestration/diapedesis of T cells into the brain parenchyma, around contusions, after human TBI and we speculate that this could be responsible for further brain damage.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Messina, Italy; Virginia Commonwealth Univ, Dept Informat Syst, Richmond, VA USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Div Neuropathol, Dept Pathol, Richmond, VA 23284 USA		Bullock, MR (corresponding author), West Hosp, 1200 E Broad St,8th Fl,S Wing,POB 980631, Richmond, VA 23298 USA.	robulloc@hsc.vcu.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [12587] Funding Source: Medline		Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; Danovitch GM, 2005, HDB KIDNEY TRANSPLAN, P72; DEITCH EA, 1997, SCI FDN TRAUMA, P729; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Foradori A, 1998, TRANSPLANT P, V30, P1685, DOI 10.1016/S0041-1345(98)00393-5; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Jones TE, 1997, CLIN PHARMACOKINET, V32, P357, DOI 10.2165/00003088-199732050-00002; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; KROCZEK RA, 1987, J IMMUNOL, V139, P3597; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; McLachlan AJ, 1998, THER DRUG MONIT, V20, P390, DOI 10.1097/00007691-199808000-00007; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; MILLER AC, 1999, RADIAT RES, V1, P117; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORGANTIKOSSMANN MC, 2001, MO CL BI CC, V2, P99; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; QUATTROCCHI KB, 1992, J NEUROSURG, V77, P694, DOI 10.3171/jns.1992.77.5.0694; Rieves R. Dwaine, 1997, P303; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; ZENKE G, 1993, ANN NY ACAD SCI, V685, P330, DOI 10.1111/j.1749-6632.1993.tb35882.x	48	42	45	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2006	23	6					962	975		10.1089/neu.2006.23.962			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	056TW	WOS:000238549000012	16774480				2022-02-06	
J	Vallee, M; McFadyen, BJ; Swaine, B; Doyon, J; Cantin, JF; Dumas, D				Vallee, Marie; McFadyen, Bradford J.; Swaine, Bonnie; Doyon, Julien; Cantin, Jean-Francois; Dumas, Denyse			Effects of environmental demands on locomotion after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						attention; gait; rehabilitation	DIVIDED ATTENTION; BALANCE; GAIT; RECOVERY; DEFICITS; TASK; SWAY; IDENTIFICATION; REHABILITATION; ADJUSTMENTS	Objective: To determine the effects of increasingly demanding environments related to simultaneous visual tasks and physical obstructions on the locomotor ability of people with traumatic brain injury (TBI). Design: Group comparison study. Setting: Gait analysis laboratory within a postacute rehabilitation facility. Participants: Volunteer sample of 9 people (8 men, 1 woman; age, 39.3 +/- 13.0 y) with moderate to severe TBI and a comparison group of 9 subjects without neurologic problems matched for age and sex (8 men, 1 woman; age, 39.7 +/- 12.3y). Interventions: Not applicable. Main Outcome Measures: Reading times for the Stroop bar and Stroop word tasks, walking speeds, stride lengths, and obstacle clearance margin. Results: The TBI group was slower than the control group in performing the Stroop bar task during sitting (P = .002), and while avoiding the narrow obstacle (P = .05), and in performing 9 the Stroop word task while avoiding the wide obstacle (P = .019). Despite their relatively normal gait speeds on level ground, subjects with TBI walked more slowly than control subjects for the narrow (P = .024) and the wide (P = .019) obstacle conditions and for the most complex dual task (P = .042). Greater lead-limb clearance margins were observed for the TBI group than for control subjects for all conditions whereas no differences were found for the trail limb except at the far end of the wide obstacle. Conclusions: Despite their good recovery of locomotor function, with respect to normal level walking speeds and ability to avoid obstacles, subjects with moderate and severe TBI showed residual deficits in relation to greater difficulties in dealing with environments that challenge their locomotor and attentional abilities. The use of such naturally based dual tasks may help identify some of the environmental obstructions to social participation after TBI.	Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, Fac Med, Quebec City, PQ G1M 2S8, Canada; Univ Laval, Dept Rehabil, Fac Med, Quebec City, PQ G1M 2S8, Canada; Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada; Montreal Rehabil Inst, Montreal, PQ, Canada; Univ Montreal, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Quebec Rehabil Inst, Quebec City, PQ, Canada		McFadyen, BJ (corresponding author), Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, Fac Med, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@rea.ulaval.ca		McFadyen, Bradford/0000-0003-1992-4927			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Gadoury M, 2001, CADRE REFERENCE CLIN; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McFadyen BJ, 1997, EXP BRAIN RES, V114, P500, DOI 10.1007/PL00005659; MCFADYEN BJ, 1991, NEUROSCI RES COMMUN, V9, P37; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; PATLA AE, 1991, ADAPTABILITY HUMAN Q; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tappan RS, 2002, PHYS THER, V82, P473, DOI 10.1093/ptj/82.5.473; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	35	42	43	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2006	87	6					806	813		10.1016/j.apmr.2006.02.031			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	052AP	WOS:000238203100010	16731216				2022-02-06	
J	Saunders, JC; McDonald, S; Richardson, R				Saunders, JC; McDonald, S; Richardson, R			Loss of emotional experience after traumatic brain injury: Findings with the startle probe procedure	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; affective processing; startle reflex	HEAD-INJURY; AFFECTIVE MODULATION; REFLEX MODIFICATION; FACIAL EXPRESSIONS; SOCIAL-PERCEPTION; LOBE DAMAGE; RECOGNITION; ATTENTION; BLINK; FACES	The authors used affective modulation of the eyeblink startle response to examine the impact of traumatic brain injury (TBI) on emotional reactions to pictures. Participants were 13 individuals with severe TBI and 24 controls. Participants were presented with pictures that differed in affective valence (e.g., mutilated bodies, erotic couples, and household objects) while the eyeblink startle response to an acoustic probe was measured. Startle amplitude was used to assess valence of emotional response, and startle latency was used to index interest in the pictures. Subjective ratings of the affect and arousal elicited by the various pictures were also obtained. TBI impaired startle potentiation to unpleasant pictures but not startle attenuation to pleasant pictures. Further, subjective ratings indicated that TBI participants found unpleasant pictures less arousing than did controls. The results are consistent with recent evidence of differential impairment in negative versus positive emotions after TBI and are discussed in relation to 2 competing explanations of startle modulation.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Richardson, Rick/0000-0003-1833-9777			Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; ANTHONY BJ, 1985, BIOL PSYCHOL, V21, P43, DOI 10.1016/0301-0511(85)90052-3; Berg W.K., 1999, STARTLE MODIFICATION, P21, DOI DOI 10.1017/CB09780511665523.004; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; Bradley M. M., 1999, STARTLE MODIFICATION, P157, DOI DOI 10.1017/CBO9780511665523.010; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; COOK EW, 1991, J ABNORM PSYCHOL, V100, P3; COURVILLE CB, 1945, PATHLOGY NERVOUS SYS; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Davis M., 1999, STARTLE MODIFICATION, P95, DOI DOI 10.1017/CBO9780511665523.007; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Ekman P., 1976, PICTURES FACIAL AFFE; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Koch M, 1996, NEUROREPORT, V7, P1442, DOI 10.1097/00001756-199605310-00024; Lacey J. I., 1967, PSYCHOL STRESS ISSUE, P4; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LANG PJ, 1999, A4 CTR RES PSYCH U F; Lang PJ., 1997, INT AFFECTIVE PICTUR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levenston GK, 2000, J ABNORM PSYCHOL, V109, P373, DOI 10.1037//0021-843X.109.3.373; LEY RG, 1979, BRAIN LANG, V7, P127, DOI 10.1016/0093-934X(79)90010-5; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; REUTERLORENZ P, 1981, NEUROPSYCHOLOGIA, V19, P609, DOI 10.1016/0028-3932(81)90030-0; SCHLENKER R, 1995, EUR ARCH PSY CLIN N, V245, P309, DOI 10.1007/BF02191873; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Vanman EJ, 1998, PERS SOC PSYCHOL B, V24, P994, DOI 10.1177/0146167298249007; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; [No title captured]	56	42	42	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2006	20	2					224	231		10.1037/0894-4105.20.2.224			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	031IW	WOS:000236699000010	16594783				2022-02-06	
J	Rochkind, S; Shahar, A; Fliss, D; El-Ani, D; Astachov, L; Hayon, T; Alon, M; Zamostiano, R; Ayalon, O; Biton, I; Cohen, Y; Halperin, R; Schneider, D; Oron, A; Nevo, Z				Rochkind, S; Shahar, A; Fliss, D; El-Ani, D; Astachov, L; Hayon, T; Alon, M; Zamostiano, R; Ayalon, O; Biton, I; Cohen, Y; Halperin, R; Schneider, D; Oron, A; Nevo, Z			Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats	EUROPEAN SPINE JOURNAL			English	Article						olfactory mucosa; spinal cord; transection; transplantation	NEURAL PROGENITOR CELLS; OLFACTORY ENSHEATHING CELLS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; ADULT-RAT; AXONAL REGENERATION; FUNCTIONAL RECOVERY; STEM-CELLS; EXTRACELLULAR-MATRIX; DELAYED TRANSPLANTATION	This study was designed to assess a new composite implant to induce regeneration of injured spinal cord in paraplegic rats following complete cord transection. Neuronal xenogeneic cells from biopsies of adult nasal olfactory mucosa (NOM) of human origin, or spinal cords of human embryos, were cultured in two consecutive stages: stationary cultures in a viscous semi-solid gel (NVR-N-Gel) and in suspension on positively charged microcarriers (MCs). A tissue-engineered tubular scaffold, containing bundles of parallel nanofibers, was developed. Both the tube and the nanofibers were made of a biodegradable dextran sulphate-gelatin co-precipitate. The suturable scaffold anchored the implant at the site of injury and provided guidance for the regenerating axons. Implants of adult human NOM cells were implanted into eight rats, from which a 4 mm segment of the spinal cord had been completely removed. Another four rats whose spinal cords had also been transected were implanted with a composite implant of cultured human embryonic spinal cord cells. Eight other cord-transected rats served as a control group. Physiological and behavioral analysis, performed 3 months after implantation, revealed partial recovery of function in one or two limbs in three out of eight animals of the NOM implanted group and in all the four rats that were implanted with cultured human embryonic spinal cord cells. Animals of the control group remained completely paralyzed and did not show transmission of stimuli to the brain. The utilization of an innovative composite implant to bridge a gap resulting from the transection and removal of a 4 mm spinal cord segment shows promise, suggesting the feasibility of this approach for partial reconstruction of spinal cord lesions. Such an implant may serve as a vital bridging station in acute and chronic cases of paraplegia.	Neural & Vasc Reconstruct Labs, Ness Ziona, Israel; Tel Aviv Univ, Div Peripheral Nerve Reconstruct, Tel Aviv Sourasky Med Ctr, Dept Neurosurg, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Div Peripheral Nerve Reconstruct, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem,Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Assaf Harofeh Med Ctr, Dept Gynecol, IL-70300 Zerifin, Israel; Assaf Harofeh Med Ctr, Dept Obstet, IL-70300 Zerifin, Israel; Assaf Harofeh Med Ctr, Dept Orthoped, IL-70300 Zerifin, Israel		Shahar, A (corresponding author), Neural & Vasc Reconstruct Labs, Ness Ziona, Israel.	abrahams@nvrlab.com	Rochkind, Shimon/AAO-6447-2020	Shahar, Abraham/0000-0003-4894-2593; Rochkind, Shimon/0000-0002-9590-9764			Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.3.CO;2-2; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2003, EXP NEUROL, V184, P726, DOI 10.1016/S0014-4886(03)00274-7; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; CALOF AL, 2000, MICROSC RES TECHNIQ, V58, P176; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Condic ML, 2002, NEUROREPORT, V13, pA37, DOI 10.1097/00001756-200203040-00002; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cunningham AM, 1999, NEUROSCIENCE, V93, P1301, DOI 10.1016/S0306-4522(99)00193-1; David S, 2002, NEUROSCIENTIST, V8, P33, DOI 10.1177/107385840200800108; Galvin KA, 2002, MED J AUSTRALIA, V177, P316, DOI 10.5694/j.1326-5377.2002.tb04791.x; GOLDMANSA, 1997, ANN NY ACAD SCI, V835, P30; Gorio A, 2004, NEUROSCIENCE, V125, P179, DOI 10.1016/j.neuroscience.2003.10.046; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115; Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Keirstead HS, 2001, J NEUROSCI RES, V63, P233, DOI 10.1002/1097-4547(20010201)63:3<233::AID-JNR1016>3.0.CO;2-B; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Krautstrunk M, 2002, ACTA NEUROPATHOL, V104, P592, DOI 10.1007/s00401-002-0589-6; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Meijs MFL, 2004, J NEUROTRAUM, V21, P1415, DOI 10.1089/neu.2004.21.1415; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; PEARSE AGE, 1972, HISTOCHEMISTRY THEOR, V1; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Ruitenberg MJ, 2005, BRAIN, V128, P839, DOI 10.1093/brain/awh424; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Schwartz Michal, 2003, J Spinal Cord Med, V26 Suppl 1, pS6; SHAHAR A, 1990, METHODS NEUROSCI, V2, P195; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041; Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16; Yoshii S, 2001, J BIOMED MATER RES, V56, P400, DOI 10.1002/1097-4636(20010905)56:3<400::AID-JBM1109>3.3.CO;2-Z; Zigova T, 2002, CELL TRANSPLANT, V11, P265	61	42	46	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	FEB	2006	15	2					234	245		10.1007/s00586-005-0981-8			12	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	023CD	WOS:000236101900012	16292587	Green Published			2022-02-06	
J	Suh, SW; Frederickson, CJ; Danscher, G				Suh, SW; Frederickson, CJ; Danscher, G			Neurotoxic zinc translocation into hippocampal neurons is inhibited by hypothermia and is aggravated by hyperthermia after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						hippocampus; hyperthermia; hypothermia; rats; traumatic brain injury; zinc	CONTROLLED CORTICAL IMPACT; ACID-INDUCED SEIZURES; PROTEIN-KINASE-II; MODERATE HYPOTHERMIA; CEREBRAL-ISCHEMIA; POSTTRAUMATIC HYPOTHERMIA; CELL-DEATH; CALCIUM ACCUMULATION; FOREBRAIN ISCHEMIA; RADICAL PRODUCTION	Hypothermia reduces excitotoxic neuronal damage after seizures, cerebral ischemia and traumatic brain injury (TBI), while hyperthermia exacerbates damage from these insults. Presynaptic release of ionic zinc (Zn2+), translocation and accumulation of Zn2+ ions in postsynaptic neurons are important mechanisms of excitotoxic neuronal injury. We hypothesized that temperature-dependent modulation of excitotoxicity is mediated in part by temperature-dependent changes in the synaptic release and translocation of Zn2+. In the present studies, we used autometallographic (AMG) and fluorescent imaging of N-(6-methoxy-8-quinolyl)-para-toluenesulfonamide (TSQ) staining to quantify the influence of temperature on translocation of Zn2+ into hippocampal neurons in adult rats after weight drop-induced TBI. The central finding was that TBI- induced Zn2+ translocation is strongly influenced by brain temperature. Vesicular Zn2+ release was detected by AMG staining 1 h after TBI. At 30 degrees C, hippocampus showed almost no evidence of vesicular Zn2+ release from presynaptic terminals; at 36.5 degrees C, the hippocampus showed around 20% to 30% presynaptic vesicular Zn2+ release; and at 39 degrees C vesicular Zn2+ release was significantly greater (40% to 60%) than at 36.5 degrees C. At 6 h after TBI, intracellular Zn2+ accumulation was detected by the TSQ staining method, which showed that Zn2+ translocation also paralleled the vesicular Zn2+ release. Neuronal injury, assessed by counting eosinophilic neurons, also paralleled the translocation of Zn2+, being minimal at 30 degrees C and maximal at 39 degrees C. We conclude that pathological Zn2+ translocation in brain after TBI is temperature-dependent and that hypothermic neuronal protection might be mediated in part by reduced Zn2+ translocation.	Univ Calif San Francisco, Vet Adm Med Ctr, Dept Neurol 127, San Francisco, CA 94121 USA; NeuroBioTex Inc, Galveston, TX USA; Univ Aarhus, Inst Anat, Dept Neurobiol, Aarhus C, Denmark		Suh, SW (corresponding author), Univ Calif San Francisco, Vet Adm Med Ctr, Dept Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	swsuh@itsa.ucsf.edu					ARAI H, 1993, NEUROSCI LETT, V163, P132, DOI 10.1016/0304-3940(93)90363-P; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CRAWFORD IL, 1972, J NEUROCHEM, V19, P1451, DOI 10.1111/j.1471-4159.1972.tb05088.x; Danscher G, 1996, HISTOCHEM J, V28, P361, DOI 10.1007/BF02331399; DANSCHER G, 1975, BRAIN RES, V94, P167, DOI 10.1016/0006-8993(75)90887-2; DANSCHER G, 1973, EXP BRAIN RES, V16, P521, DOI 10.1007/BF00234478; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Frederickson CJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1659, DOI 10.1177/002215540205001210; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Haug F M, 1975, J Hirnforsch, V16, P151; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; ITO U, 1975, ACTA NEUROPATHOL, V32, P209, DOI 10.1007/BF00696570; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JOHANSEN FF, 1993, MOL CHEM NEUROPATHOL, V18, P161, DOI 10.1007/BF03160030; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Lee JY, 2000, J NEUROSCI, V20; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; Suh SW, 2000, BRAIN RES, V879, P7, DOI 10.1016/S0006-8993(00)02675-5; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 1999, J HISTOCHEM CYTOCHEM, V47, P969, DOI 10.1177/002215549904700715; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TANIMOTO M, 1987, BRAIN RES, V417, P239, DOI 10.1016/0006-8993(87)90448-3; TIMM F, 1958, Dtsch Z Gesamte Gerichtl Med, V46, P706, DOI 10.1007/BF00665092; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Tsuchiya D, 2002, J CEREBR BLOOD F MET, V22, P1231, DOI 10.1097/01.wcb.0000037995.34930.F5; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022	62	42	44	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2006	26	2					161	169		10.1038/sj.jcbfm.9600176			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	021HZ	WOS:000235975600002	15988476	Bronze			2022-02-06	
J	Zygun, D; Berthiaume, L; Laupland, K; Kortbeek, J; Doig, C				Zygun, David; Berthiaume, Luc; Laupland, Kevin; Kortbeek, John; Doig, Christopher			SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study	CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; ACUTE LUNG INJURY; SUBARACHNOID HEMORRHAGE; INTENSIVE-CARE; CEREBROSPINAL-FLUID; FAILURE; MULTICENTER	Introduction The objective of the present study was to compare the discriminative ability of the Sequential Organ Failure Assessment ( SOFA) and Multiple Organ Dysfunction ( MOD) scoring systems with respect to hospital mortality and unfavorable neurologic outcome in patients with severe traumatic brain injury admitted to the intensive care unit. Method We performed a prospective cohort study at Foothills Medical Centre, the sole adult tertiary care trauma center servicing southern Alberta ( population about 1.3 million). All patients aged 16 years or older with severe traumatic brain injury and intensive care unit length of stay greater than 48 hours between 1 May 2000 and 31 April 2003 were included. Non-neurologic organ dysfunction was measured using the SOFA and MODS scoring systems. Determination of organ dysfunction for each non-neurologic organ system was compared between the two systems by calculating the proportion of patients with SOFA and MOD component score defined organ failure. Consistent with previous literature, organ system failure was defined as a component score of three or greater. Results The odds of death and unfavorable neurologic outcome in patients with SOFA defined cardiovascular failure were 14.7 times (95% confidence interval [CI] 5.9 - 36.3) and 7.6 times ( 95% CI 3.5 - 16.3) that of those without cardiovascular failure, respectively. The development of SOFA-defined cardiovascular failure was a reasonable discriminator of hospital mortality and unfavorable neurologic outcome ( area under the receiver operating characteristic [ROC] curve 0.75 and 0.73, respectively). The odds of death and unfavorable neurologic outcome in patients with MOD-defined cardiovascular failure were 2.6 times ( 95% CI 1.24 - 5.26) and 4.1 times ( 95% CI 1.3 - 12.4) that of those without cardiovascular failure, respectively. The development of MOD-defined cardiovascular failure was a poor discriminator of hospital mortality and unfavorable neurologic outcome ( area under the ROC curve 0.57 and 0.59, respectively). Neither SOFA-defined nor MOD-defined respiratory failure was significantly associated with hospital mortality. Conclusion In patients with brain injury, the SOFA scoring system has superior discriminative ability and stronger association with outcome compared with the MOD scoring system with respect to hospital mortality and unfavorable neurologic outcome.	Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Surg, Calgary, AB, Canada		Zygun, D (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	david.zygun@calgaryhealthregion.ca	Laupland, Kevin/AAG-3656-2020; Laupland, kevin/AAJ-6339-2020; Doig, Christopher/AAC-7949-2020; Kortbeek, John B/AAO-5298-2020	Laupland, kevin/0000-0002-1205-5354; Doig, Christopher/0000-0002-8576-9139; 			Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cook R, 2001, CRIT CARE MED, V29, P2046, DOI 10.1097/00003246-200111000-00002; Doig CJ, 2004, CRIT CARE MED, V32, P384, DOI 10.1097/01.CCM.0000108881.14082.10; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Hirashima Y, 1997, NEUROCHEM RES, V22, P1249, DOI 10.1023/A:1021985030331; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; KIKUCHI T, 1995, NEUROL RES, V17, P106, DOI 10.1080/01616412.1995.11740296; Kossmann T, 1997, SHOCK, SEPSIS AND ORGAN FAILURE, P263; Marshall J., 1995, CLIN TRIALS TREATMEN; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zimmerman JE, 1996, CRIT CARE MED, V24, P1633, DOI 10.1097/00003246-199610000-00006; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2002, YB INTENSIVE CARE EM, P899	22	42	42	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2006	10	4							R115	10.1186/cc5007			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185LK	WOS:000247712300018	16882348	Green Published, gold			2022-02-06	
J	von Steinbuechel, N; Richter, S; Morawetz, C; Riemsma, R				von Steinbuechel, N; Richter, S; Morawetz, C; Riemsma, R			Assessment of subjective health and health-related quality of life in persons with acquired or degenerative brain injury	CURRENT OPINION IN NEUROLOGY			English	Article						acquired brain injury; cognitive impairment; dementia; disease-specific; generic; health-related quality of life; health status; outcome; Parkinson's disease; stroke; traumatic brain injury	PARKINSONS-DISEASE PATIENTS; RANDOMIZED CONTROLLED-TRIAL; EXPERIENCING WEARING-OFF; STROKE SURVIVORS; OUTCOME MEASURES; DOUBLE-BLIND; DEMENTIA; RELIABILITY; SATISFACTION; ENTACAPONE	Purpose of review Health-related quality of life is a new outcome variable in neurology. Several generic measures aim at assessing this variable in adults with neurological diseases. Disease-specific measures are still rare; however, individuals with neurological diseases frequently suffer from cognitive impairment, yet are often excluded from health-related quality of life investigations. When included in such studies, cognitive functioning is not monitored via neuropsychological evaluation, possibly leading to methodological problems. Papers from May 2004 until July 2005 are reviewed with respect to psychometric quality and information about persons after traumatic brain injury, stroke, Parkinson's disease or dementia. Recent findings Several new cross-sectional and longitudinal outcome studies are reviewed. The Medical Outcome Study Short Form with 36 items, the Sickness Impact Profile and the Nottingham Health Profile were identified as the most frequently used measures in neurology. For traumatic brain injury, two new generic instrument validations (Life Satisfaction Index-A, Subjective Quality of Life Profile) and one internationally validated disease-specific development (Quality of Life after Brain Injury) were found; for stroke, one disease-specific tool (Burden of Stroke Scale) was identified, In Parkinson's disease, the disease-specific health-related quality of life measure Parkinson's Disease Questionnaire-39 is well validated. In dementia, three dementia-specific instruments (Quality of Life for Dementia, Quality of Life in Late-Stage Dementia Scale and Quality of Life in Alzheimer's Disease Scale) seem to be valid. Summary In neurology, only a few measures have been developed and validated for respondents with cognitive impairment, often showing poorer validity results than studies involving healthy persons. Health-related quality of life assessment should therefore be validated in the specific diseases and, if necessary, combined with a neuropsychological evaluation and a disease-specific health-related quality of life measure.	Univ Gottingen, MR Res Neurol & Psychiat, D-37073 Gottingen, Germany; Univ Gottingen, Fac Psychol & Gerontopsychol, D-37073 Gottingen, Germany; Univ Clin, Dept Psychogeriatr, Geneva, Switzerland; Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England		von Steinbuechel, N (corresponding author), Univ Gottingen, MR Res Neurol & Psychiat, Waldweg 37, D-37073 Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de	Riemsma, Rob/E-2319-2016; Morawetz, Carmen/G-9485-2017	Riemsma, Rob/0000-0001-8892-0861; Morawetz, Carmen/0000-0003-3607-7627			Ahmed S, 2005, QUAL LIFE RES, V14, P611, DOI 10.1007/s11136-004-3708-0; Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Behari A, 2005, PARKINSONISM RELAT D, V11, P221, DOI 10.1016/j.parkreldis.2004.12.005; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bluvol A, 2004, J ADV NURS, V48, P322, DOI 10.1111/j.1365-2648.2004.03004.x; Bohannon RW, 2004, INT J REHABIL RES, V27, P151, DOI 10.1097/01.mrr.0000127349.25287.de; Bohannon RW, 2004, INT J REHABIL RES, V27, P149, DOI 10.1097/01.mrr.0000127350.25287.08; Boter H, 2004, STROKE, V35, P2867, DOI 10.1161/01.STR.0000147717.57531.e5; Boyer F, 2004, INT J GERIATR PSYCH, V19, P1026, DOI 10.1002/gps.1191; Bullinger M, 2001, CURR PROB E, V16, P277; Callahan CD, 2005, REHABIL PSYCHOL, V50, P65, DOI 10.1037/0090-5550.50.1.65; Carlsson GE, 2004, DISABIL REHABIL, V26, P1373, DOI 10.1080/09638280400000211; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chapuis S, 2005, MOVEMENT DISORD, V20, P224, DOI 10.1002/mds.20279; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Clarke CE, 2004, MOVEMENT DISORD, V19, P491, DOI 10.1002/mds.20057; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; De Leo D, 1998, BEHAV MED, V24, P17, DOI 10.1080/08964289809596377; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Doyle PJ, 2004, J CLIN EPIDEMIOL, V57, P997, DOI 10.1016/j.jclinepi.2003.11.016; Edelman P, 2004, AGING MENT HEALTH, V8, P514, DOI 10.1080/13607860412331303801; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Erola T, 2005, PARKINSONISM RELAT D, V11, P89, DOI 10.1016/j.parkreldis.2004.08.006; Ettema TP, 2005, QUAL LIFE RES, V14, P675, DOI 10.1007/s11136-004-1258-0; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finlayson TL, 2004, AM J MANAG CARE, V10, P336; Fjaertoft H, 2004, CLIN REHABIL, V18, P580, DOI 10.1191/0269215504cr773oa; Foerch C, 2004, J NEUROL NEUROSUR PS, V75, P988, DOI 10.1136/jnnp.2003.021014; Gallien P., 2005, Annales de Readaptation et de Medecine Physique, V48, P225, DOI 10.1016/j.annrmp.2005.02.001; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Gokkaya NKO, 2005, INT J REHABIL RES, V28, P229, DOI 10.1097/00004356-200509000-00005; Haapaniemi TH, 2004, J NEUROL NEUROSUR PS, V75, P976, DOI 10.1136/jnnp.2003.015693; HEEL S, 2000, LEBENSQUALITAT GESUN, P243; HENRY JD, IN PRESS NEUROPSYCHO; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; James BD, 2005, AM J GERIAT PSYCHIAT, V13, P484, DOI 10.1176/appi.ajgp.13.6.484; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Jonsson AC, 2005, STROKE, V36, P803, DOI 10.1161/01.STR.0000160873.32791.20; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kapapa T, 2005, NEUROL REHABIL, V11, P21; Kern RZ, 2004, J CLIN EPIDEMIOL, V57, P1033, DOI 10.1016/j.jclinepi.2004.03.004; Kim DH, 2005, STROKE, V36, P792, DOI 10.1161/01.STR.0000157594.58180.97; Koller W, 2005, J NEURAL TRANSM, V112, P221, DOI 10.1007/s00702-004-0184-1; Lai JCK, 2004, J TELEMED TELECARE, V10, P199, DOI 10.1258/1357633041424340; Leeds L, 2004, CLIN REHABIL, V18, P924, DOI 10.1191/0269215504cr807oa; Lezcano E, 2004, EUR J NEUROL, V11, P451, DOI 10.1111/j.1468-1331.2004.00804.x; Lobello SG, 2004, BRAIN INJURY, V18, P1127, DOI 10.1080/02699050410001672378; Ma HI, 2005, QUAL LIFE RES, V14, P565, DOI 10.1007/s11136-004-0687-0; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Martin-Cook K, 2005, DEMENT GERIATR COGN, V19, P82, DOI 10.1159/000082353; McMillan AS, 2005, J ORAL REHABIL, V32, P495, DOI 10.1111/j.1365-2842.2005.01451.x; McRae C, 2004, ARCH GEN PSYCHIAT, V61, P412, DOI 10.1001/archpsyc.61.4.412; Merchant C, 2004, J CLIN NURS, V13, P105, DOI 10.1111/j.1365-2702.2004.01050.x; Meyers AR, 2000, ARCH NEUROL-CHICAGO, V57, P1224, DOI 10.1001/archneur.57.8.1224; Moon YS, 2004, J NEUROL SCI, V224, P37, DOI 10.1016/j.jns.2004.05.018; Muller-Nordhorn J, 2005, NEUROEPIDEMIOLOGY, V24, P196, DOI 10.1159/000084712; Murrell R, 1999, NEUROPSYCHOL REV, V9, P209, DOI 10.1023/A:1021686606648; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Nyholm D, 2005, NEUROLOGY, V64, P216, DOI 10.1212/01.WNL.0000149637.70961.4C; Olanow CW, 2004, ARCH NEUROL-CHICAGO, V61, P1563, DOI 10.1001/archneur.61.10.1563; Onofrj M, 2004, J NEURAL TRANSM, V111, P1053, DOI 10.1007/s00702-004-0149-4; Perry J, 2005, AM J MENT RETARD, V110, P121, DOI 10.1352/0895-8017(2005)110<121:FAWOIC>2.0.CO;2; PICKARD SA, 2005, QUAL LIFE RES, V14, P207; Quittenbam BH, 2004, PARKINSONISM RELAT D, V10, P129, DOI 10.1016/j.parkreldis.2003.12.001; Reichmann H, 2005, ACTA NEUROL SCAND, V111, P21, DOI 10.1111/j.1600-0404.2004.00363.x; Riemsma R P, 2001, Health Technol Assess, V5, P1; Saeki Satoru, 2005, Journal of UOEH, V27, P171; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Salter K, 2005, DISABIL REHABIL, V27, P507, DOI 10.1080/0963828040008552; Samsa GP, 2004, J REHABIL RES DEV, V41, P279, DOI 10.1682/JRRD.2003.08.0117; Sands LP, 2004, AM J GERIAT PSYCHIAT, V12, P272, DOI 10.1176/appi.ajgp.12.3.272; Schielke E, 2005, J NEUROL, V252, P648, DOI 10.1007/s00415-005-0711-5; Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271; Serrano-Duenas M, 2004, PARKINSONISM RELAT D, V10, P433, DOI 10.1016/j.parkreldis.2004.05.002; Smith KW, 1999, QUAL LIFE RES, V8, P447, DOI 10.1023/A:1008928518577; Smith SC, 2005, HEALTH TECHNOL ASSES, V9, P1; Studenski S, 2005, STROKE, V36, P1764, DOI 10.1161/01.STR.0000174192.87887.70; Sturm JW, 2004, STROKE, V35, P2340, DOI 10.1161/01.STR.0000141977.18520.3b; Tan LCS, 2004, PARKINSONISM RELAT D, V10, P493, DOI 10.1016/j.parkreldis.2004.05.007; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; VONSTEINBUECHEL N, 1998, NEUE HERAUSFORDERUNG, V7, P50; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; *WHOQOL GROUP, 1993, QUAL LIFE RES, V2, P153, DOI DOI 10.1007/BF00435734; Widar M, 2004, J CLIN NURS, V13, P497, DOI 10.1046/j.1365-2702.2003.00815.x; Zimmerman GJ, 2004, ACTA NEUROCHIR, V146, P1293, DOI 10.1007/s00701-004-0385-2	90	42	42	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2005	18	6					681	691		10.1097/01.wco.0000194140.56429.75			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	989MT	WOS:000233678800010	16280680				2022-02-06	
J	Holbrook, TL; Hoyt, DB; Coimbra, R; Potenza, B; Sise, M; Anderson, JP				Holbrook, TL; Hoyt, DB; Coimbra, R; Potenza, B; Sise, M; Anderson, JP			High rates of acute stress disorder impact quality-of-life outcomes in injured adolescents: Mechanism and gender predict acute stress disorder risk	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	34th Annual Meeting of the Western-Trauma-Association	FEB 22-27, 2004	Steamboat Springs, CO	Western Trauma Assoc		acute stress disorder; adolescents; quality-of-life outcomes; posttraumatic stress disorder	MOTOR-VEHICLE ACCIDENTS; TRAUMA RECOVERY PROJECT; POSTTRAUMATIC-STRESS; MAJOR TRAUMA; MULTIPLE TRAUMA; GENERAL HEALTH; CHILDREN; WOMEN; MEN; CONSEQUENCES	Background: Injury is the leading cause of death and functional disability in adolescent children. Little is known about quality of life and psychological outcomes after trauma in adolescents. The Trauma Recovery Project in Adolescents is a prospective epidemiologic study designed to examine multiple outcomes after major trauma in adolescents aged 12 to 19 years, including quality of life (QoL) and psychological sequelae such as acute stress disorder (ASD) and posttraumatic stress disorder (PTSD). The specific objectives of the present report are to examine ASD rates and the association of ASD with QoL outcomes in injured adolescents. Methods: Between April 26, 1999, and November 13, 2002, 401 eligible trauma patients aged 12 to 19 years triaged to five participating trauma center hospitals in a regionalized trauma system were enrolled in the study. The admission criteria for patients were as follows: (1) age 12 to 19 years and (2) injury diagnoses excluding severe traumatic brain injury (TBI) or spinal cord injury. QoL after trauma was measured using the Quality of Well-being (QWB) scale, a sensitive and well-validated functional index (range, 0 = death to 1.000 = optimum functioning). ASD (before discharge) was diagnosed with the Impact of Events Scale-Revised. Scores of 24+ were used to diagnose ASD. Patient outcomes were assessed at discharge and at 3, 6, 12, 18, and 24 months after discharge. Results: ASD before discharge was diagnosed in 40% of adolescent trauma survivors. ASD status was associated with large QoL deficits during follow-up, as follows: 3-month, ASD-positive QWB score = 0.667 vs. ASD-negative QWB score = 0.710, p < 0.01; 6-month, ASD-positive QWB score 0.704 vs. ASD-negative QWB score 0.742, p < 0.001; 12-month: ASD-positive QWB score = 0.718 vs. ASD-negative QWB score = 0.757, p < 0.01; 24-month, ASD-positive QWB score = 0.725 vs. ASD-negative QWB score = 0.769, p < 0.01. Female sex and violent mechanism predicted ASD risk (47% female vs. 36% male; odds ratio, 1.6; p < 0.05; violence 54% vs. 38%; odds ratio, 1.9; p < 0.01). Conclusions: Adolescent trauma survivors have high rates of ASD. ASD severely impacts QoL outcomes and is associated with female sex and mechanism of injury in adolescents. Early recognition and treatment of ASD in seriously injured adolescents will improve QoL outcomes.	Univ Calif San Diego, Med Ctr, Dept Family & Prevent Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Surg, Div Trauma, San Diego, CA 92103 USA; Mercy Hosp, Ctr Trauma, San Diego, CA USA		Holbrook, TL (corresponding author), Univ Calif San Diego, Med Ctr, Dept Family & Prevent Med, 8896,200 W Arbor Dr, San Diego, CA 92103 USA.	tholbrook@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS007611] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01 HS 07611] Funding Source: Medline		ANDERSON JP, 1986, MED CARE, V24, P454, DOI 10.1097/00005650-198605000-00008; ANDERSON JP, 1988, J CLIN EPIDEMIOL, V41, P127, DOI 10.1016/0895-4356(88)90087-X; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Bryant RA, 1996, J TRAUMA STRESS, V9, P223, DOI 10.1002/jts.2490090206; Bush JW., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Caffo E, 2003, CHILD ADOL PSYCH CL, V12, P493, DOI 10.1016/S1056-4993(03)00004-X; Chaffin M, 2001, CHILD ABUSE NEGLECT, V25, P401, DOI 10.1016/S0145-2134(00)00257-X; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; KAPLAN J, 2000, WORKING PREVENT CONT; KAPLAN RM, 1984, J CHRON DIS, V37, P85, DOI 10.1016/0021-9681(84)90050-X; KAPLAN RM, 1988, J CONSULT CLIN PSYCH, V56, P1; KAPLAN RM, 1978, P AM STAT ASSOC, P704; LANDSMAN IS, 1990, J BEHAV MED, V13, P561, DOI 10.1007/BF00844735; MacKenzie EJ, 1996, J TRAUMA, V41, P799, DOI 10.1097/00005373-199611000-00006; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Ott R, 1996, UNFALLCHIRURG, V99, P267; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; Schlesselman JJ., 1982, CASE CONTROL STUDIES; Seekamp A, 1996, INJURY, V27, P133, DOI 10.1016/0020-1383(95)00178-6; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90	41	42	43	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2005	59	5					1126	1130		10.1097/01.ta.0000196433.61423.f2			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	001DO	WOS:000234514000018	16385290				2022-02-06	
J	Arriaza, R; Leyes, M				Arriaza, R; Leyes, M			Injury profile in competitive karate: prospective analysis of three consecutive World Karate Championships	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						karate; martial arts; injuries; trauma; prevention	SHOTOKAN KARATE; MARTIAL ARTS; CHILDREN; RATES	The goal of this paper was to document the injury rate in modern competitive karate. A prospective recording of the injuries resulting from 2,837 matches in three consecutive World Karate Championships (WKC) was performed. Eight hundred and ninety-one injuries were recorded, with an incidence of 0.31 injuries per match or 157.03 injuries per 1,000 athlete exposures. Occurrence of injuries was higher among lighter categories, under 60 kg in males (0.56) and under 53 kg in females (0.42). Punches (737, 82.7%) caused more injuries than kicks (75, 7.3%). The injuries were most commonly located in the face (646, 72.5%) followed by the head (103, 11.6%) and lower limbs (57, 6.4%). The injuries consisted primarily of contusions (448, 50.3%) epistaxis (144, 16.2%) and lacerations (122, 13.7%) followed by concussions (34, 3.8%) and sprains (31, 3.5%). There was some kind of external haemorrhage in 296 injuries (33.7%). The injury rate was similar in the three WKC but the number of severe injuries declined from 1996 to 2000. We conclude that competitive karate is associated with a relatively high injury rate; in one in every three matches medical attention is required, but mainly for minor injuries. Severe injuries are rare.	Clin CEMTRO, Dept Orthopaed Surg, Madrid 20035, Spain; USP Hosp Santa Teresa, Dept Orthopaed Surg, World Karate Fdn Med Comm, La Coruna 15008, Spain		Leyes, M (corresponding author), Clin CEMTRO, Dept Orthopaed Surg, Avda Ventisquero de la Condesa 42, Madrid 20035, Spain.	leyesm@yahoo.com					ADAMS CWM, 1989, J NEUROL NEUROSUR PS, V52, P600, DOI 10.1136/jnnp.52.5.600; ARRIAZA R, 1990, Journal of Sports Traumatology and Related Research, V12, P255; ARRIAZA R, 1989, ARCH MED DEPORTE, V21, P85; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; BIRRER RB, 1996, AM J SPORTS MED, V24, P72; Buschbacher R M, 1999, Phys Med Rehabil Clin N Am, V10, P35; CORSELLIS J, 1975, PSYCHOL MED, V3, P270; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Johannsen H V, 1986, Ugeskr Laeger, V148, P1786; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; McLatchie G, 1981, Br J Sports Med, V15, P84; Muller-Rath R, 2000, SPORTVERLETZ SPORTSC, V14, P20, DOI 10.1055/s-2000-3818; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Pieter W, 1997, J TRAUMA, V43, P89, DOI 10.1097/00005373-199707000-00020; Pieter W, 1999, J SPORT MED PHYS FIT, V39, P147; Plancher KD, 1996, CLIN SPORT MED, V15, P207; SCHMID L, 1969, J SPORTS MED PHYS FI, V8, P171; STRICEVIC MV, 1983, AM J SPORT MED, V11, P320, DOI 10.1177/036354658301100507; Trojanowski D, 1987, Lakartidningen, V84, P1858; Tuominen Risto, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P44; Wilkerson Leonard A., 1997, Journal of the American Osteopathic Association, V97, P221; Zetaruk MN, 2000, CLIN J SPORT MED, V10, P117, DOI 10.1097/00042752-200004000-00006; Zetaruk MN, 2000, ACCIDENT ANAL PREV, V32, P421, DOI 10.1016/S0001-4575(99)00120-7	23	42	43	1	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	OCT	2005	13	7					603	607		10.1007/s00167-004-0593-6			5	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	971RM	WOS:000232401700019	15678297				2022-02-06	
J	Matsuda, W; Komatsu, Y; Yanaka, K; Matsumura, A				Matsuda, W; Komatsu, Y; Yanaka, K; Matsumura, A			Levodopa treatment for patients in persistent vegetative or minimally conscious states	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Joint Conference of the International-Neuropsychological-Society/German-Society-for-Neuropsychology	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc, German Soc Neuropsychol			CLOSED-HEAD INJURY; BRAIN-STEM LESIONS; REMARKABLE IMPROVEMENT; L-DOPA; PARKINSONISM; AMANTADINE; NEUROTRANSMITTERS; RECOVERY; SYMPTOMS; DAMAGE	The persistent vegetative state (PVS) and the minimally conscious state (MCS) are conditions of altered consciousness after severe brain damage due to a variety of pathologies. However, the specific pathophysiological mechanisms and a therapeutic strategy for intervention have not as yet been established. We review previous reports of levodopa treatment for patients in PVS, MCS, or other mental disorders, and have focused on five representative cases: four of PVS and one of MCS after severe brain injury. In summary, our review suggests the effectiveness of levodopa treatment is probably dependent upon the following criteria: (1) Diagnosis of PVS or MCS as distinct from other related conditions, (2) Concomitant symptoms of parkinsonism, and (3) Concomitant neuroradiological findings of high intensity lesions in the dopaminergic pathway on T2 weighted MRI. The apparent success of levodopa in the five cases described may reflect a specific subgroup of PVS and MCS patients, where the administration of levodopa is effective. However, we should not regard PVS or MCS as a single entity, since levodopa is unlikely to be effective in all cases. Therapeutic strategies should aim to identify the key pathophysiological mechanism for each patient and target interventions accordingly.	Kyoto Univ, Dept Morphol Brain Sci, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; Tsukuba Med Ctr Hosp, Tsukuba, Ibaraki, Japan; Inst Clin Med, Ibaraki, Japan		Matsuda, W (corresponding author), Kyoto Univ, Dept Morphol Brain Sci, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.	wako@mua.biglobe.ne.jp	Matsuda, Wakoto/D-2143-2018	Matsuda, Wakoto/0000-0001-8313-6103			ABRAMSKY O, 1974, SURGERY, V75, P188; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bhatt M, 2000, MOVEMENT DISORD, V15, P313, DOI 10.1002/1531-8257(200003)15:2<313::AID-MDS1017>3.0.CO;2-P; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; DALY DD, 1958, NEUROLOGY, V8, P238, DOI 10.1212/WNL.8.3.238; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; Evans AH, 2004, NEUROLOGY, V62, P2333, DOI 10.1212/01.WNL.0000130350.54120.09; FISCHER JE, 1971, LANCET, V2, P75, DOI 10.1016/s0140-6736(71)92048-4; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HORIGUCHI J, 1990, CLIN NEUROPHARMACOL, V13, P84, DOI 10.1097/00002826-199002000-00009; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P1082; JENNETT B, 1972, LANCET, V1, P734; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; KOTCHOUBEY B, 2004, J NEUROLOGY NEUROSUR; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MATSUDA W, 2004, J NEUROLOGY NEUROSUR; MATSUDA W, 1999, BRAIN NERVE, V51, P1071; MATSUMURA A, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P192; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Nestler EJ, 2001, MOL NEUROPHARMACOLOG; PARKES JD, 1970, LANCET, V2, P1341; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; SACKS OW, 1972, NEUROLOGY, V22, P516, DOI 10.1212/WNL.22.5.516; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; Yoshikawa H, 1999, BRAIN DEV-JPN, V21, P140; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zeman A, 1997, LANCET, V350, P795, DOI 10.1016/S0140-6736(97)06447-7; Zijlmans J, 2002, MOVEMENT DISORD, V17, P1086, DOI 10.1002/mds.10203; [No title captured]	44	42	46	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					414	427		10.1080/09602010443000588			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900026	16350982				2022-02-06	
J	Mendez, CV; Hurley, RA; Lassonde, M; Zhang, LY; Taber, KH				Mendez, CV; Hurley, RA; Lassonde, M; Zhang, LY; Taber, KH			Mild traumatic brain injury: Neuroimaging of sports-related concussion	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							HIGH-SCHOOL; PROFESSIONAL FOOTBALL; AXONAL INJURY; HEAD TRAUMA; COLLEGIATE; GUIDELINES; MR; MANAGEMENT; EVOLUTION; SYMPTOMS		Wake Forest Univ, Sch Med, Dept Psychiat, Vet Affairs Mid Atlantic Mentall Illness Res Educ, Winston Salem, NC 27109 USA; Salisbury Vet Affairs Med Ctr, Salisbury, NC USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; Baylor Coll Med, Meninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; Wayne State Univ, Ctr Bioengn, Detroit, MI USA		Hurley, RA (corresponding author), Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Robin.Hurley@med.va.gov	Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			ALVES WM, 1987, CLIN SPORT MED, V6, P211; [Anonymous], 2000, AM HERITAGE DICT ENG; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Binder S, 2003, REPORT C MILD TRAUMA; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Easdon C, 2004, BRAIN COGNITION, V54, P136; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; KOH JO, 2005, BRAIN INJURY, V17, P901; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; *NCAA, 2000, NCAA CENT SER 1; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sosin DM, 1996, BRAIN INJURY, V10, P47; STRAUSS I, 1934, ARCH NEUROL PSYCHIAT, V31, P955; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wheless JW, 2004, NEUROLOGIST, V10, P138, DOI 10.1097/01.nrl.0000126589.21840.a1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; 2005, NEWSLETTER VOLUNTEER, P1	57	42	44	0	9	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2005	17	3					297	303		10.1176/appi.neuropsych.17.3.297			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	962BB	WOS:000231704900001	16179650				2022-02-06	
J	Jang, SH; Cho, SH; Kim, YH; You, SH; Kim, SH; Kim, O; Yang, DS; Son, SM				Jang, SH; Cho, SH; Kim, YH; You, SH; Kim, SH; Kim, O; Yang, DS; Son, SM			Motor recovery mechanism of diffuse axonal injury: A combined study of transcranial magnetic stimulation and functional MRI	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						diffuse axonal injury; functional MRI; magnetic stimulation; motor recovery	TRAUMATIC BRAIN-INJURY; REORGANIZATION; CORTEX; STROKE; LOCALIZATION	Purpose: The purpose of this study was to investigate the motor recovery mechanism following diffuse axonal injury (DAI) using transcranial magnetic stimulation (TMS) and functional MRI (fMRI). Methods: Twenty-six hands of 13 control subjects and 14 affected hands of 8 patients (two hemiparetics and six quadriparetics) were evaluated. All the patients were initially diagnosed with DAI and were evaluated after they had reached their maximal motor recovery. fMRI was performed at 1.5 T using a hand grasp-release movement paradigm and TMS was applied with a round coil over the vertex. Results: fMRI revealed that both normal subjects and patients with DAI showed increased contralateral primary sensori-motor cortex activation during affected hand movement. The motor evoked potentials (MEPs) of the patient group was slightly delayed in latency and significantly increased in duration and turns. The relative MEP amplitude, phase, and excitatory threshold were not significantly different between the groups. Conclusions: These findings may indicate the heterogeneity of the axons in the recovery process of the corticospinal tract. It seems that the motor recovery in patients who had suffered DAI was attributable to the recovery of the corticospinal tract.	Yonsei Univ, Coll Hlth Sci, Dept Phys Therapy, Wonju 220710, Kangwondo, South Korea; Pochon Jungmoon Univ, Coll Med, Bundang CHA Gen Hosp, Dept Phys Med & Rehabil, Sungnam, South Korea; Hampton Univ, Phys Therapy Program, Hampton, VA 23668 USA		Cho, SH (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Phys Therapy, Wonju 220710, Kangwondo, South Korea.	davinci@dragon.yonsei.ac.kr					Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Bastings EP, 1997, J NEUROL REHABIL, V11, P97; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; HALLET M, 1996, J CLIN NEUROPHYSIOL, V13, P348; Hallett M, 1998, NEUROREHABILITATION, V10, P131, DOI 10.3233/NRE-1998-10205; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; Jang SH, 2001, ARCH PHYS MED REHAB, V82, P1733, DOI 10.1053/apmr.2001.25101; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Macdonell RAL, 1999, NEUROLOGY, V53, P1462, DOI 10.1212/WNL.53.7.1462; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; SCHEFF S, 1977, SCIENCE, V197, P795, DOI 10.1126/science.887924; SELZER ME, 1995, J NEUROL REHABIL, V9, P73; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; WEBER RJ, 1997, PRACTICAL ELECTROMYO, P131; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	20	42	43	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2005	23	1					51	56					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944HG	WOS:000230417200006	15846032				2022-02-06	
J	Lee, BHY; Schofer, JL; Koppelman, FS				Lee, BHY; Schofer, JL; Koppelman, FS			Bicycle safety helmet legislation and bicycle-related non-fatal injuries in California	ACCIDENT ANALYSIS AND PREVENTION			English	Article						bicycle safety helmet; legislation; non-fatal injuries; case-control; odds ratio; multinomial logit model	HEAD-INJURIES; EDUCATION; CHILDREN; LAWS	The objective of this study was to determine whether the bicycle safety helmet legislation in California, enacted in 1994, was associated with statistically significant reductions in head injuries among bicyclists aged 17 years and under who were subjected to the law. The study used 44.069 patient discharge cases from all public hospitals in California, from 1991 through 2000, and a case-control design to make direct comparisons between those subjected to the law (Youth) and those who were not (Adult) across the pre- and post-legislation periods. An aggregate data analysis approach and a pooled disaggregate data fitting technique using multinomial logit models were applied. The legislation was found to be associated with a reduction of 18.2% (99% confidence interval: 11.5-24.3%) in the proportion of traumatic brain injuries (Head-TBI) among Youth bicyclists. The proportions of other head, face, and neck injuries were not significantly changed across the pre- and post-legislation periods in this age group but there was a corresponding increase of 9% (5-13%) in the proportion of all other injuries. On the other hand, there was no statistically significant change in the proportions of injury outcomes for Adult bicyclists. The youngest riders, aged 0-9 years, had the greatest decrease in the proportion of Head-TBI. The reduction was the same for motor vehicle and non-motor-vehicle-related incidents. The bicycle safety helmet legislation was associated with a decrease in the likelihood of Head-TBI for non-urban residents but not for urbanites, for males but not for females, and for Whites, Asians, and Hispanics, but not Blacks and others. (C) 2004 Elsevier Ltd. All rights reserved.	Univ Washington, Coll Architecture & Urban Planning, Dept Urban Design & Planning, Seattle, WA 98195 USA; Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Civil & Environm Engn, Inst Technol, Evanston, IL 60208 USA		Lee, BHY (corresponding author), Univ Washington, Coll Architecture & Urban Planning, Dept Urban Design & Planning, 3949 15th Ave NE,410 Gould Hall,Box 355740, Seattle, WA 98195 USA.	bhylee@u.washington.edu	Schofer, Joseph L/B-7090-2009; Koppelman, Frank S/B-7024-2009				Abularrage JJ, 1997, ARCH PEDIAT ADOL MED, V151, P41, DOI 10.1001/archpedi.1997.02170380045007; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Borgialli D A, 1997, J Am Osteopath Assoc, V97, P399; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; COTE TR, 1992, PEDIATRICS, V89, P1216; Cryer P C, 1998, Inj Prev, V4, P106; DANNENBERG AL, 1993, AM J PUBLIC HEALTH, V83, P667, DOI 10.2105/AJPH.83.5.667; Dowswell T, 1996, Inj Prev, V2, P140, DOI 10.1136/ip.2.2.140; EPPERSON B, 1995, TRANSPORT RES REC, V1502, P58; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; Finch C.F., 1993, 45 MON U ACC RES CTR; Gilchrist J, 2000, PEDIATRICS, V106, P6, DOI 10.1542/peds.106.1.6; Graitcer P L, 1995, Inj Prev, V1, P122, DOI 10.1136/ip.1.2.122; GRANT D, 2002, EFFECT BICYCLE HELME; HATZIANDREU EJ, 1995, 110 PUBL HLTH REP, P251; HEATHCOTE B, 1994, TB941 TRAFF BOARD W; HENDRIE D, 1999, P C ROAD SAF SPEAK P, P29; KING M, 1994, P 1994 AUSTR PED BIC, P177; Lajunen T, 2001, J SAFETY RES, V32, P323, DOI 10.1016/S0022-4375(01)00056-1; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Linn S, 1998, Inj Prev, V4, P122; MACKNIN ML, 1994, ARCH PEDIAT ADOL MED, V148, P255, DOI 10.1001/archpedi.1994.02170030025005; Macpherson A K, 2001, Inj Prev, V7, P228, DOI 10.1136/ip.7.3.228; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Marshall J, 1994, EVALUATION COMPULSOR; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; Ni HY, 1997, ARCH PEDIAT ADOL MED, V151, P59, DOI 10.1001/archpedi.1997.02170380063010; Povey LJ, 1999, ACCIDENT ANAL PREV, V31, P763, DOI 10.1016/S0001-4575(99)00033-0; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; Rodgers GB, 2002, INJ PREV, V8, P42, DOI 10.1136/ip.8.1.42; RODGERS GB, 1998, BICYCLE BICYCLE HELM, V31, P149; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Schieber RA, 1996, ARCH PEDIAT ADOL MED, V150, P707, DOI 10.1001/archpedi.1996.02170320053009; Schiffrin D, 2000, NARRAT INQ, V10, P1, DOI 10.1075/ni.10.1.01sch; Scuffham P, 2000, ACCIDENT ANAL PREV, V32, P565, DOI 10.1016/S0001-4575(99)00081-0; Smith N. C., 1994, P 1994 PED BIC SAF T, P153; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON DC, 2002, HELMETS PREVENTING H; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101	41	42	42	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2005	37	1					93	102		10.1016/j.aap.2004.07.001			10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	886VO	WOS:000226261100012	15607280				2022-02-06	
J	Yi, JH; Pow, DV; Hazell, AS				Yi, JH; Pow, DV; Hazell, AS			Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury	GLIA			English	Article						traumatic brain injury; glutamate transporter; excitoxicity; GLT-1; fluid percussion injury	TRAUMATIC BRAIN-INJURY; CORTICAL EXTRACELLULAR LEVELS; AMINO-ACID TRANSPORTER; HUMAN HEAD-INJURY; DOWN-REGULATION; ANTISENSE KNOCKDOWN; NEURONAL DAMAGE; BLOOD-FLOW; CELL-DEATH; EXPRESSION	Glutamate transporter proteins are essential for the control of interstitial glutamate levels, with an impairment of their function or levels being a major potential contributor to excitotoxicity. We have investigated the effects of lateral fluid percussion on the levels of the glutamate transporter proteins GLT-1alpha, its splice variant GLT-1v, GLAST, and EAAC1 in the rat in order to evaluate their pathogenetic role in this model of traumatic brain injury (TBI). Immunoblot analysis revealed neuronal loss in the cerebral cortex was accompanied by a 54% decrease in GLT-1v 6 h following the insult which progressed to an 83% loss of the transporter after 24 h. No changes in GLT-1alpha, GLAST, or EAAC1 were observed in this brain region at either time point. GLT-1v content was also decreased by 55% and 68% in the hippocampus and thalamus, respectively, at 6 h post-injury, but recovered fully after 24 h in both brain regions. In contrast, levels of GLT-1alpha were increased in the hippocampus at 6 h and 24 h post-TBI. These alterations in transporter protein content were also confirmed using immunohistochemical methods. Our results show for the first time a pattern of early, dynamic changes in the levels of GLT-1 transporter splice variants in different brain regions in this trauma model. In addition, correlation of GLT-1v levels with both neuronal cell loss and a-internexin content in the injured cortex suggests that loss of this novel glutamate transporter may be a key factor in determining cerebral vulnerability following this type of brain injury. (C) 2004 Wiley-Liss, Inc.	Univ Montreal, Dept Med, Hop St Luc, Montreal, PQ H2X 3J4, Canada; Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia		Hazell, AS (corresponding author), Univ Montreal, Dept Med, Hop St Luc, 1058 St Denis St, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca	Pow, David V/A-2064-2016; Pow, David/F-8198-2010	Pow, David V/0000-0001-8522-4465; 			Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chan SO, 1998, NEUROCHEM RES, V23, P393, DOI 10.1023/A:1022417819356; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Danbolt NC, 1998, PROG BRAIN RES, V116, P23, DOI 10.1016/S0079-6123(08)60428-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; GELGELASHVILI G, 1997, J NEUROCHEM, V69, P2612; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hazell AS, 2003, GLIA, V43, P175, DOI 10.1002/glia.10241; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kanai Y, 1997, CURR OPIN CELL BIOL, V9, P565, DOI 10.1016/S0955-0674(97)80035-X; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Knecht K, 1997, NEUROSCI LETT, V229, P201, DOI 10.1016/S0304-3940(97)00444-8; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Miller HP, 1997, J NEUROCHEM, V68, P1564; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; PAXINOS G, 1998, AT BRAIN STEREOTAXIC; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Pow DV, 1999, CELL TISSUE RES, V297, P57, DOI 10.1007/s004410051333; Rao VLR, 2001, BRAIN RES, V911, P96; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reye P, 2002, GLIA, V38, P246, DOI 10.1002/glia.10059; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TORP R, 1995, EXP BRAIN RES, V103, P51; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Wilson JMB, 2003, NEUROMOL MED, V3, P105, DOI 10.1385/NMM:3:2:105; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; Zauner A, 1996, ACT NEUR S, V67, P40	55	42	42	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JAN 1	2005	49	1					121	133		10.1002/glia.20099			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	879CW	WOS:000225695000011	15390098				2022-02-06	
J	Koponen, S; Taiminen, T; Kairisto, V; Portin, R; Isoniemi, H; Hinkka, S; Tenovuo, O				Koponen, S; Taiminen, T; Kairisto, V; Portin, R; Isoniemi, H; Hinkka, S; Tenovuo, O			APOE-epsilon 4 predicts dementia but not other psychiatric disorders after traumatic brain injury	NEUROLOGY			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; HEAD-INJURY	The authors studied the association between APOE-epsilon4 genotype and axis I and II psychiatric disorders an average of 30 years after traumatic brain injury. Sixty patients were dichotomized into subjects with and without APOE-epsilon4 allele. Dementia and subclinical dementia were significantly more common with the presence of APOE-epsilon4. The occurrence of other psychiatric disorders did not differ between patients with and without APOE-epsilon4 allele.	Turku Univ Hosp, Dept Psychiat, FIN-20521 Turku, Finland; Turku Univ Hosp, Dept Clin Chem & Hematol, FIN-20521 Turku, Finland; Turku Univ Hosp, Dept Neurol, FIN-20521 Turku, Finland; Turku Univ Hosp, Dept Biostat, FIN-20521 Turku, Finland		Koponen, S (corresponding author), Turku Univ Hosp, Dept Psychiat, PL 52, FIN-20521 Turku, Finland.	salla.koponen@utu.fi		Hinkka-Yli-Salomaki, Susanna/0000-0001-7785-9196			Donohoe GG, 1999, CLIN CHEM, V45, P143; EHNHOLM C, 1986, J LIPID RES, V27, P227; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mauricio M, 2000, AM J GERIAT PSYCHIAT, V8, P196, DOI 10.1176/appi.ajgp.8.3.196; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Sorbi S, 1998, NEUROSCI LETT, V244, P118, DOI 10.1016/S0304-3940(98)00144-X; Spitzer R., 1989, STRUCTURED CLIN INTE; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	10	42	44	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	AUG 24	2004	63	4					749	750		10.1212/01.WNL.0000134603.57107.2F			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	848UP	WOS:000223493800035	15326261				2022-02-06	
J	Harradine, PG; Winstanley, JB; Tate, R; Cameron, ID; Baguley, IJ; Harris, RD				Harradine, PG; Winstanley, JB; Tate, R; Cameron, ID; Baguley, IJ; Harris, RD			Severe traumatic brain injury in New South Wales: comparable outcomes for rural and urban residents	MEDICAL JOURNAL OF AUSTRALIA			English	Article							SCALE	Objective: To compare differences in functional outcomes between urban and rural patients with traumatic brain injury (TBI). Design: A longitudinal, prospective, multicentre study of a 2-year cohort from the Brain Injury Rehabilitation Program (BIRP) for New South Wales, with follow-up at 18 months after injury. Participants: 198 patients (147 urban, 51 rural) with severe TBI from the 11 participating rehabilitation units. Main outcome measures: Demographic and injury details collected prospectively using a standardised questionnaire, and measures from five validated instruments (Disability Rating Scale, Mayo-Portland Adaptability Inventory, Sydney Psychosocial Reintegration Scale, Medical Outcomes Study Short Form and the General Health Questionnaire -28-item version) administered at follow-up to document functional, psychosocial, emotional and vocational outcomes. Results: Demographic details, injury severity, lengths of stay in intensive and acute care wards were similar for both rural and urban groups. There were no significant group differences in functional outcomes, including return to work, at follow-up. Conclusions: Our findings contrast with previous research that has reported poorer outcomes after TBI for rural residents, and suggest that the integrated network of inpatient, outpatient and outreach services provided throughout NSW through the BIRP provides effective rehabilitation for people with severe TBI regardless of where they live.	Tamworth Base Hosp, New England Brain Injury Rehabil Program, Tamworth, NSW, Australia; Univ Sydney, Fac Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia; Univ Sydney, Pain Management & Res Ctr, St Leonards, NSW 2065, Australia		Harradine, PG (corresponding author), Univ Sydney, Fac Med, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	jwin6139@mail.usyd.edu.au	Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Baguley, Ian J/0000-0001-5650-3705; Winstanley, Julie/0000-0002-9353-6757			Commonwealth Department of Health and Aged Care National Key Centre for Social Applications of Geographical Information Systems, 2001, MEAS REM ACC REM IND, Vrevised; Department of Primary Industries and Energy and Department of Human Services and Health, 1994, RUR REM METR AR CLAS; Doherty SR, 2001, MED J AUSTRALIA, V175, P585, DOI 10.5694/j.1326-5377.2001.tb143735.x; ELASHOF JD, 2002, NQUERY ADVISIOR VERS; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; GLABELLA B, 1997, ANN EPIDEMIOL, V7, P207; Goldberg D. P., 1988, USERS GUIDE GENERAL; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; NORUSIS M, 1986, STAT PACKAGE SOC SCI; *NSW HLTH, 2002, NSW RUR HLTH REP REP; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schootman M, 1999, BRAIN INJURY, V13, P995; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WARE JE, 2001, SF36 PHYS MENTAL HLT; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x	20	42	42	0	1	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	AUG 2	2004	181	3					130	134		10.5694/j.1326-5377.2004.tb06202.x			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	848RW	WOS:000223485800004	15287829	Green Submitted			2022-02-06	
J	Suzuki, T; Bramlett, HM; Ruenes, G; Dietrich, WD				Suzuki, T; Bramlett, HM; Ruenes, G; Dietrich, WD			The effects of early post-traumatic hyperthermia in female and ovariectomized rats	JOURNAL OF NEUROTRAUMA			English	Article						fever; gender; hyperthermia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; INDUCED AXONAL INJURY; CEREBRAL-BLOOD-FLOW; MODERATE HYPOTHERMIA; FOREBRAIN ISCHEMIA; PROTEIN; DAMAGE; PROGESTERONE; TEMPERATURE; GENDER	Episodes of post-traumatic hyperthermia commonly occur in the head-injured patient population. Although post-traumatic hyperthermia has been shown to worsen outcome in experimental studies using male rats, the consequences of secondary hyperthermia following traumatic brain injury (TBI) have not been investigated in female animals. Thus, the purpose of this study was to examine the effects of post-traumatic hyperthermia after fluid-percussion (F-P) brain injury in intact and ovariectomized female rats. Thirty-eight female Sprague-Dawley rats were used in these experiments. Intact female rats underwent TBI followed 30 min later by a 4-h period of normothermia (37degreesC) or brain hyperthermia (40degreesC). Female rats that had been ovariectomized 10 days prior to TBI were also traumatized and followed by a period of normothermia or hyperthermia. At 72 h after TBI, rats were perfusion-fixed for quantitative histopathological and immunocytochemical evaluation. Following normothermic TBI, intact female rats demonstrated significantly smaller contusion volumes, decreased frequency of axonal beta-amyloid precursor protein (beta-APP) profiles, and greater numbers of NeuN-positive cortical neurons compared to traumatized ovariectomized females. Although post-traumatic hyperthermia increased contusion volume, cortical neuronal cell death and axonal damage in both intact and ovariectomized female groups, the effects of the induced hyperthermic period were more pronounced in ovariectomized animals. These findings demonstrate for the first time that post-traumatic hyperthermia worsens histopathological outcome in female rats, and that neural hormones, including estrogen and progesterone, may protect against secondary hyperthermic insults.	Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33152 USA		Dietrich, WD (corresponding author), Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, POB 016960,R-48, Miami, FL 33152 USA.	ddietrich@miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291, NS42133] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS042133] Funding Source: NIH RePORTER		Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Behr R, 1997, ANN NY ACAD SCI, V813, P722, DOI 10.1111/j.1749-6632.1997.tb51774.x; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Graham D.I., 1996, NEUROTRAUMA, P43; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Kamme F, 1996, ADV NEUROL, V71, P199; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kumar K, 1996, MOL BRAIN RES, V42, P337, DOI 10.1016/S0169-328X(96)00181-7; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Marion DW, 2001, CURR PHARM DESIGN, V7, P1533, DOI 10.2174/1381612013397302; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Morimoto T, 1997, BRAIN RES, V746, P43, DOI 10.1016/S0006-8993(96)01154-7; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Segatore M, 1992, J Neurosci Nurs, V24, P104; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Wagner AK, 2003, J NEUROTRAUM, V20, P1121; WIDMANN R, 1993, J NEUROCHEM, V61, P200, DOI 10.1111/j.1471-4159.1993.tb03556.x; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9; ZILLES L, 1985, CORTEX RAT STEREOTAX	51	42	43	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2004	21	7					842	853		10.1089/0897715041526186			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	842AE	WOS:000222973800002	15307897				2022-02-06	
J	Gupta, AK; Zygun, DA; Johnston, AJ; Steiner, LA; Al-Rawi, PG; Chatfield, D; Shepherd, E; Kirkpatrick, PJ; Hutchinson, PJ; Menon, DK				Gupta, AK; Zygun, DA; Johnston, AJ; Steiner, LA; Al-Rawi, PG; Chatfield, D; Shepherd, E; Kirkpatrick, PJ; Hutchinson, PJ; Menon, DK			Extracellular brain pH and outcome following severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue pH; outcome; traumatic brain injury	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; VENOUS OXYGEN-SATURATION; NEUROSURGICAL PATIENTS; SUBSTRATE DELIVERY; MICRODIALYSIS; METABOLISM; HYPEROXIA; ISCHEMIA	The ability to measure brain tissue chemistry has led to valuable information regarding pathophysiological changes in patients with traumatic brain injury (TBI). Over the last few years, the focus has been on monitoring changes in brain tissue oxygen to determine thresholds of ischemia that affect outcome. However, the variability of this measurement suggests that it may not be a robust method. We have therefore investigated the relationship of brain tissue pH (pH(b)) and outcome in patients with TBI. We retrospectively analyzed prospectively collected data of 38 patients admitted to the Neurosciences Critical Care Unit with TBI between 1998 and 2003, and who had a multiparameter tissue gas sensor inserted into the brain. All patients were managed using an evidence-based protocol targeting CPP > 70 min Hg. Physiological variables were averaged over 4 min and analyzed using a generalized least squares random effects model to determine the temporal profile of pHb and its association with outcome. Median (IQR) minimum pHb was 7.00 (6.89, 7.08), median (IQR) maximum pHb was 7.25 (7.18, 7.33), and median (IQR) patient averaged pH(b) was 7.13 (7.07, 7.17). pH(b) was significantly lower in those who did not survive their hospital stay compared to those that survived. In addition, those with unfavorable neurological outcome had lower pH(b) values than those with favorable neurological outcome. pH(b) differentiated between survivors and non-survivors. Measurement of pH(b) may be a useful indicator of outcome in patients with TBI.	Addenbrookes Hosp, Neurosci Crit Care Unit, Dept Anesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Anesthesia, Cambridge CB2 2QQ, England; Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada		Gupta, AK (corresponding author), Addenbrookes Hosp, Neurosci Crit Care Unit, Dept Anesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	akg01@globalnet.co.uk	Steiner, Luzius/J-1987-2019				Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouma G J, 1995, New Horiz, V3, P384; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; INOA S, 1988, J NEUROSURG, V69, P736; Johnston AJ, 2003, ACTA ANAESTH SCAND, V47, P391, DOI 10.1034/j.1399-6576.2003.00078.x; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LJUNGGREN B, 1974, BRAIN RES, V73, P277, DOI 10.1016/0006-8993(74)91049-X; Marchal G, 1999, BRAIN, V122, P2387, DOI 10.1093/brain/122.12.2387; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; VANSANTBRINK H, 2003, ACTA NEUROSURG, V46, P868; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	25	42	42	2	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2004	21	6					678	684		10.1089/0897715041269722			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	836EG	WOS:000222537600004	15253796				2022-02-06	
J	Giacino, JT; Trott, CT				Giacino, JT; Trott, CT			Rehabilitative management of patients with disorders of consciousness grand rounds	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						coma; diagnosis; minimally conscious state; prognosis; rehabilitation; vegetative state	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; SENSORY STIMULATION; AMANTADINE; RECOVERY; COMA	Background: There are no standards of care to guide the selection of rehabilitation assessment and treatment procedures for patients with disorders of consciousness. Recently, consensus-based recommendations for management of patients in the vegetative and minimally conscious states have been developed and disseminated in neurology and neurorehabilitation. This is an important first step toward achieving evidence-based guidelines of care. Objective: Using a "Grand Rounds" format, we illustrate the application of consensus-based diagnostic, prognostic, and treatment recommendations in a patient who sustained severe traumatic brain injury with prolonged alteration in consciousness. After discussing the salient features of the case, we summarize the basic tenets of clinical care for this population.	New Jersey Neurosci Inst, JFK Med Ctr, Edison, NJ 08818 USA; JFK Johnson Rehabil Inst, Ctr Head Injuries, Edison, NJ USA		Giacino, JT (corresponding author), New Jersey Neurosci Inst, JFK Med Ctr, 65 James St, Edison, NJ 08818 USA.	jgiacino@solarishs.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; *ASP NEUR C WORKGR, 1996, P ASP NEUR C MARCH 1; CHATHAMSHOWALTE.PE, 2000, BRAIN INJURY, V14, P997; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; DiPasquale MC, 1996, J HEAD TRAUMA REHAB, V11, P9, DOI 10.1097/00001199-199612000-00004; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; GIACINO JT, REHABILITATION INTER; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KANNO T, 1987, PACE, V10, P207, DOI 10.1111/j.1540-8159.1987.tb05949.x; Katz DI, 2002, NEUROLOGY, V58, pA6; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Ottenbacher KJ, 1999, AM J PHYS MED REHAB, V78, P169, DOI 10.1097/00002060-199903000-00021; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Schneider WN, 1999, BRAIN INJURY, V13, P863; SHIFF N, 2002, BRAIN, V125, P1; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Tsubokawa T, 1990, Brain Inj, V4, P315; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Zafonte RD, 1998, BRAIN INJURY, V12, P617	34	42	45	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					254	265		10.1097/00001199-200405000-00006			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300006	15247847				2022-02-06	
J	Marion, DW				Marion, DW			Controlled normothermia in neurologic intensive care	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	2nd Annual Safar Symposium	OCT   30, 2003	UNIV PITTSBURGH, PITTSBURGH, PENNSYLVANIA		UNIV PITTSBURGH	controlled normothermia; therapeutic hypothermia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-SIGNIFICANCE; CARDIAC-ARREST; HYPOTHERMIA; HYPERTHERMIA; TEMPERATURE; FEVER; HEMORRHAGE; ISCHEMIA		Boston Univ, Sch Med, Dept Neurol Surg, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA		Marion, DW (corresponding author), Boston Univ, Sch Med, Dept Neurol Surg, Boston, MA 02118 USA.		Marion, Donald/AAR-5749-2021	Marion, Donald/0000-0003-4627-7702			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; AZZIMINDI G, 1995, STROKE, V26, P2043; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; CASTILLO J, 1994, CEREBROVASC DIS, V4, P56; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; DIETRICH WD, 1992, J NEUROTRAUMA, V9, P475; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; HINDFELT B, 1976, ACTA NEUROL SCAND, V53, P72, DOI 10.1111/j.1600-0404.1976.tb04326.x; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Morimoto T, 1997, BRAIN RES, V746, P43, DOI 10.1016/S0006-8993(96)01154-7; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Safar P, 2001, NEW ENGL J MED, V345, P66; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354	20	42	44	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	FEB	2004	32	2		S			S43	S45		10.1097/01.CCM.0000110731.69637.16			3	Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775TP	WOS:000189077000008	15043227				2022-02-06	
J	Drew, LB; Drew, WE				Drew, LB; Drew, WE			The contrecoup-coup phenomenon - A new understanding of the mechanism of closed head injury	NEUROCRITICAL CARE			English	Article						biomechanics; traumatic brain injury; pathology; contrecoup lesion	CEREBRAL CONTUSIONS; IMPACT	A common observation in closed head injuries is the contrecoup brain injury. As the in vivo brain is less dense than the cerebrospinal fluid (CSF), one hypothesis explaining this observation is that upon skull impact, the denser CSF moves toward the site of skull impact displacing the brain in the opposite direction, such that the initial impact of the brain parenchyma is at the contrecoup location. A simple model was developed consisting of a balloon filled with water of density 1.00 g/mL enclosed in a clear plastic jar containing salt water of density 1.04 g/mL, simulating the same relative densities of the CSF and brain. The initial movement of the balloon, modeling the brain, was toward the contrecoup location with subsequent movement toward the coup location. The pattern of brain injury in which the contrecoup injury is greater than the coup injury is a result of initial movement of the brain in the contrecoup location. During the process of closed head injury, the brain parenchyma is initially displaced away from the site of skull impact and toward the contrecoup site resulting in the more severe brain contusion.	Oakwood High Sch, Dayton, OH 45419 USA; Wright Patterson Med Ctr, Wright Patterson AFB, OH USA		Drew, LB (corresponding author), Oakwood High Sch, 1200 Far Hills Ave, Dayton, OH 45419 USA.	BrightEyesDear@Hotmail.com					DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; Graham D.I., 2002, GREENFIELDS NEUROPAT; GURDJIAN ES, 1968, GEN PRACT, V37, P78; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; GURDJIAN ES, 1962, JAMA-J AM MED ASSOC, V182, P509, DOI 10.1001/jama.1962.03050440001001; Guyton AC, 2000, TXB MED PHYSL; Halliday D., 1970, FUNDAMENTALS PHYS; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Knight B., FORENSIC PATHOLOGY, V3rd; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDENBERG R, 1973, MEDICOLEGAL INVESTIG; VINKEN PJ, 1990, HEAD INJURY, V57; [No title captured]	15	42	43	0	18	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2004	1	3					385	390		10.1385/NCC:1:3:385			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FQ	WOS:000230488800017	16174940				2022-02-06	
J	Martelli, MF; Zasler, ND; Bender, MC; Nicholson, K				Martelli, MF; Zasler, ND; Bender, MC; Nicholson, K			Psychological, neuropsychological, and medical considerations in assessment and management of pain	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; biopsychosocial; brain injury; pain; treatment	COPING STRATEGIES; ILLNESS BEHAVIOR; DISABILITY; DEPRESSION; INJURY; PERFORMANCE; IMPAIRMENT; VALIDATION; INVENTORY; DISORDER	Pain is a common yet challenging problem, particularly following traumatic injuries to the head or neck. It is a complex, multidimensional subjective experience with no clear or objective measures; yet it can have a significantly disabling effect across a wide range of functions. Persisting misconceptions owing to mind-body dualism have hampered advances in its understanding and treatment. In this article, a conceptualization of pain informed by recent research and derived from a more useful biopsychosocial model guides discussion of relevant medical, psychological, and neuropsychological considerations. This pain process model explains chronicity in terms of hyperresponsiveness and dysregulation of inhibitory or excitatory pain modulation mechanisms. Related neurocognitive effects of chronic pain are examined and recommendations for minimizing its confounding effects in neuropsychological evaluations are offered. A biopsychosocial assessment model is presented to guide understanding of the myriad of factors that contribute to chronicity. A brief survey of general classes and samples of the more useful pain assessment instruments is included. Finally, this model offers a rational means of organizing and planning individually tailored pain interventions, and some of the most useful pharmacologic, physical, and behavioral strategies are reviewed.	Concuss Care Ctr Virginia & Tree Life, Glen Allen, VA 23060 USA; Pinnacle Rehabil Inc, Richmond, VA USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA USA; Univ Virginia, Charlottesville, VA USA; Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada		Martelli, MF (corresponding author), Concuss Care Ctr Virginia & Tree Life, 10120 W Broad St,Suites G-H, Glen Allen, VA 23060 USA.	mfmartelli@cccv-ltd.com					ANDRASIK F, 1990, NEUROL CLIN, V8, P961, DOI 10.1016/S0733-8619(18)30329-3; Auerbach SM, 1998, STRESS MANAGEMENT PS; BABITSKY S, 2000, SYMTOM MAGNIFICATION; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BLANCHARD EB, 1994, HDB PSYCHOTHERAPY BE; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; BRUNS D, 2003, HLTH PSYCHOL REHABIL; Butler R. W., 1989, PSYCHOL ASSESSMENT J, V1, P41; CHAPMAN CR, 1995, ADV PAIN RES THER, V22, P283; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; *COLL PHYS SURG ON, 2000, EV REC MED MAN CHRON; Dahlstrom W.G., 1975, MMPI HDB RES APPL, V2; DeVore JR, 2002, FUNCTIONAL MED DISOR, P21; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; EIMER BN, 1995, USERS GUIDE PAIN ASS; Fishbain DA, 1999, CLIN J PAIN, V15, P244, DOI 10.1097/00002508-199912000-00002; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; FLOR H, 1985, J CONSULT CLIN PSYCH, V53, P354, DOI 10.1037/0022-006X.53.3.354; FORDYCE WE, 1988, AM PSYCHOL, V43, P276, DOI 10.1037/0003-066X.43.4.276; Fors EA, 2002, J PSYCHIATR RES, V36, P179, DOI 10.1016/S0022-3956(02)00003-1; Gabriel, 1993, NEUROBIOLOGY CINGULA, P313; Gabriel M, 1995, FRONTIER PAIN RES, P197; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Gatchel RJ, 1999, PSYCHOSOCIAL FACTORS; Gonzales VA, 2000, NEUROREHABILITATION, V14, P69; Gramling SE, 1996, J BEHAV THER EXP PSY, V27, P245, DOI 10.1016/S0005-7916(96)00027-4; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; HENDLER N, 1979, PSYCHOSOMATICS, V20, P801; HINNANT DW, 1994, HDB CHRONIC PAIN MAN, P18; HOLROYD KA, 1978, J CONSULT CLIN PSYCH, V46, P1036; JAY GW, 2001, CURRENT TREND DIAGNO; JENSEN MP, 1991, PAIN, V44, P263, DOI 10.1016/0304-3959(91)90095-F; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kirsch D. L., 1999, SCI CRANIAL ELECTROT; Kirsch DL, 2000, NEUROREHABILITATION, V14, P85; KIRSCH DL, 2002, PAIN MANAGEMENT PRAC, P759; Kulich RJ, 1999, EVALUATION TREATMENT, P301; Lorenz J, 1997, PAIN, V73, P369, DOI 10.1016/S0304-3959(97)00123-1; MAILIS A, 2002, FUNCTIONAL MED DISOR, P131; Main C.J., 2000, PAIN MANAGEMENT INTE; Martelli M. F., 2002, PAIN MANAGEMENT PRAC, P125; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Martelli MF, 2002, FUNCTIONAL MED DISOR, P147; MARTELLI MF, 2001, J CONTROVERSIAL MED, V8, P1; Martelli MF, 2002, PAIN MANAGEMENT PRAC, P895; MARTELLI MF, 2003, VILLAMARTELLI DISABI; MARTELLI MF, 2002, FUNCTIONAL MED DISOR, P167; MARTELLI MF, 2003, INT J FORENSIC PSYCH, V1, P26; MARTELLI MF, 1999, GUIDE FUNCTIONAL CAP, V3, P1; MARTELLI MF, IN PRESS CASEBOOK ET; MARTIN PR, 1993, PSYCHOSOCIAL MANAGME; McQuay HJ, 1998, EVIDENCE BASED RESOU; Merskey H, 1994, CLASSIFICATION CHRON; Miller L, 2000, NEUROREHABILITATION, V14, P25; MILLER L, 1993, PSYCHOTHERAPY BRAIN; MILLER L, 1990, COGNITIVE REHABILITA, V8, P12; MILLON T, 1977, MCMI II MANUAL; MILLON T, 1999, INTERPRETIVE STRATEG; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Morey, 1991, PERSONALITY ASSESSME; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Nicholson K, 2000, NEUROREHABILITATION, V14, P57; Nicholson K, 2000, NEUROREHABILITATION, V14, P3; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nicholson K, 2002, PAIN MANAGEMENT PRAC, P465; NICHOLSON K, IN PRESS CASEBOOK ET; Olness K, 1999, HEADACHE, V39, P101, DOI 10.1046/j.1526-4610.1999.3902101.x; PACKARD RC, 1993, HEADACHE, V33, P359, DOI 10.1111/j.1526-4610.1993.hed3307359.x; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; PILOWSKY I, 1975, J PSYCHOSOM RES, V19, P279, DOI 10.1016/0022-3999(75)90026-4; PILOWSKY I, 1976, PAIN, V2, P61, DOI 10.1016/0304-3959(76)90047-6; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Price DD, 1988, PSYCHOL NEURAL MECH; RICE DD, 2001, HDB PAIN ASSESSMENT, P53; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Rudy TE, 1989, MULTIAXIAL ASSESSMEN; Senior G, 2001, NEUROREHABILITATION, V16, P203; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Todd D., 1998, COGNIPHOBIA SCALE C, pdomain; Todd D, 1998, FORENSIC EXAMINER, V7, P14; TURK DC, 1990, PAIN, V43, P27, DOI 10.1016/0304-3959(90)90047-H; Turk DC, 1986, PAIN MANAGEMENT HDB, P1; Turk DC, 1992, HDB PAIN ASSESSMENT; Tyrer S, 2003, NEUROPSYCHOL REHABIL, V13, P189, DOI 10.1080/09602010244000381; WADE JB, 1992, PAIN, V51, P67, DOI 10.1016/0304-3959(92)90010-9; WILLIMS A, 2000, PAIN EUROPE, V3, P162; ZASLER ND, IN PRESS NEUROPSYCHI; ZASLER ND, 2002, PAIN MANAGEMENT PRAC, P789; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004; [No title captured]	95	42	42	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2004	19	1					10	28		10.1097/00001199-200401000-00003			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	768UT	WOS:000188554000003	14732828				2022-02-06	
J	Li, JF; Li, WY; Su, J; Liu, WM; Altura, BT; Altura, BM				Li, JF; Li, WY; Su, J; Liu, WM; Altura, BT; Altura, BM			Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes	BRAIN RESEARCH BULLETIN			English	Article						hydrogen peroxide (H2O2); apoptosis; cerebral vascular smooth muscle cells; brain injury; strokes	HUMAN HEPATOMA-CELLS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; DNA FRAGMENTATION; INJURY; DEATH; MECHANISMS; NECROSIS; MEDIATOR; CALCIUM	Recently, reactive oxygen species (ROS) have been suggested as important mediators of brain damage in a number of disease states, including traumatic brain injury, neurodegenerative diseases and strokes. Apoptosis has been suggested to play an important role in neurodegenerative diseases, traumatic brain injury and strokes. The aim of this study was to determine whether or not cerebral vascular smooth muscle cells (CVSMCs) undergo apoptosis following treatment with hydrogen peroxide (H2O2). Herein, we demonstrate, for the first time, that H2O2 can induce apoptosis in a concentration-dependent manner in primary cultured CVSMCs, as measured by several morphological and biochemical criteria. H2O2-induced apoptosis may be initiated by stimulating Ca2+-dependent endonuclease activity. The present new data suggest that apoptosis in cerebral VSMCs, induced by ROS, such as H2O2, could play important roles in nemodegenerative processes, traumatic brain injury and strokes. (C) 2003 Elsevier Inc. All rights reserved.	SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Med, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Ctr Cardiovasc & Muscle Res, Brooklyn, NY 11203 USA		Li, JF (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA008674] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-08674] Funding Source: Medline		Altura BM, 1996, NEUROSCI LETT, V220, P207, DOI 10.1016/S0304-3940(96)13268-7; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; Bennett MR, 1999, CARDIOVASC RES, V41, P361, DOI 10.1016/S0008-6363(98)00212-0; Bondy SC, 2002, NEUROCHEM INT, V40, P123, DOI 10.1016/S0197-0186(01)00084-5; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; de Klaver MJM, 2002, ANESTHESIOLOGY, V97, P24, DOI 10.1097/00000542-200207000-00005; Deshpande SS, 2002, HUM EXP TOXICOL, V21, P63, DOI 10.1191/0960327102ht211oa; Diez J, 1998, CURR OPIN CARDIOL, V13, P317, DOI 10.1097/00001573-199809000-00005; Fairbairn DW, 1996, SCANNING, V18, P407; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENG YJ, 1995, AM J PATHOL, V147, P251; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Groc L, 2001, NEUROCHEM INT, V39, P127, DOI 10.1016/S0197-0186(01)00013-4; HAN DKM, 1995, AM J PATHOL, V147, P267; He JL, 2001, J PHARMACOL EXP THER, V298, P180; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Jin N, 2000, FREE RADICAL BIO MED, V29, P736, DOI 10.1016/S0891-5849(00)00376-2; Kalyankrishna S, 2002, PROSTAG OTH LIPID M, V70, P13, DOI 10.1016/S0090-6980(02)00010-2; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOLBER MA, 1990, FASEB J, V4, P3021, DOI 10.1096/fasebj.4.12.2394319; KONTOS HA, 1981, AM J PHYSIOL, V240, P511; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Li JF, 2001, CELL BIOL INT, V25, P1213, DOI 10.1006/cbir.2001.0792; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Li PF, 1997, CIRCULATION, V96, P3602; LING YH, 1993, CANCER RES, V53, P1845; Liu XM, 2002, CARDIOVASC RES, V55, P396, DOI 10.1016/S0008-6363(02)00410-8; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; MALLAT Z, 2001, BRIT J PHARMACOL, V133, P967; Orzechowski A, 2002, LIFE SCI, V71, P1793, DOI 10.1016/S0024-3205(02)01942-2; Peiro C, 2001, BRIT J PHARMACOL, V133, P967, DOI 10.1038/sj.bjp.0704184; Rollet-Labelle E, 1998, FREE RADICAL BIO MED, V24, P563, DOI 10.1016/S0891-5849(97)00292-X; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Yang ZW, 1999, N-S ARCH PHARMACOL, V360, P646, DOI 10.1007/s002109900128; ZHANG A, 1992, ALCOHOL CLIN EXP RES, V16, P55, DOI 10.1111/j.1530-0277.1992.tb00635.x; Zhang AM, 1997, ALCOHOL, V14, P367, DOI 10.1016/S0741-8329(96)00185-1	40	42	45	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230			BRAIN RES BULL	Brain Res. Bull.	DEC 15	2003	62	2					101	106		10.1016/j.brainresbull.2003.08.011			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	750JG	WOS:000186987100003	14638383				2022-02-06	
J	Anderson, KJ; Fugaccia, I; Scheff, SW				Anderson, KJ; Fugaccia, I; Scheff, SW			Fluoro-Jade B stains quiescent and reactive astrocytes in the rodent spinal cord	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; brain; neuropathology; spinal cord	TRAUMATIC BRAIN-INJURY; CELL-DEATH; NEURONAL DEGENERATION; INTERMEDIATE FILAMENT; CORTICAL CONTUSION; STATUS EPILEPTICUS; RAT HIPPOCAMPUS; ADULT RATS; APOPTOSIS; CORTEX	In an attempt to label dying neurons in the injured spinal cord, we used the novel fluorescein derivative Fluoro-Jade B, which has been reported to specifically label dead or dying neurons in the brain. Rats and mice were subjected to a moderate level of spinal cord injury using an IH impact device and sacrificed at 1, 2, 4, 7, 14, and 21 days post injury. Spinal cord tissue was processed for Fluoro-Jade B histochemistry and included sections throughout the injured region of the cord. No Fluoro-Jade positive neurons were observed in sections from any time point postinjury at any level of the spinal cord. Instead, Fluoro-Jade labeled astrocytes in uninjured control animals and injured animals. The specificity of astrocytic staining was confirmed by co-localizaton of Fluoro-Jade with glial fibrillary acidic protein. We also subjected a group of rats to a sequential cortical contusion injury and spinal cord injury. Sections from these animals showed numerous Fluoro-Jade positive neurons in the hippocampal formation and thalamus underlying the cortical contusion; however, the staining pattern in the spinal cord was identical to those animals that had received spinal cord injury alone.	Univ Kentucky, Sanders Brown Ctr Aging 233, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA		Anderson, KJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging 233, Lexington, KY 40536 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39828] Funding Source: Medline		Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Baldwin SA, 1996, GLIA, V16, P266; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bonde C, 2002, NEUROSCI LETT, V327, P49, DOI 10.1016/S0304-3940(02)00382-8; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Colombo JA, 2002, J HISTOCHEM CYTOCHEM, V50, P1135, DOI 10.1177/002215540205000815; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Harkany T, 2001, NEUROSCIENCE, V108, P611, DOI 10.1016/S0306-4522(01)00443-2; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Krinke GJ, 2001, EXP TOXICOL PATHOL, V53, P365, DOI 10.1078/0940-2993-00202; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Liu XZ, 1997, J NEUROSCI, V17, P5395; LIUZZI FJ, 1987, BRAIN RES, V403, P385, DOI 10.1016/0006-8993(87)90081-3; O'Dell SJ, 2000, SYNAPSE, V37, P32, DOI 10.1002/(SICI)1098-2396(200007)37:1<32::AID-SYN4>3.0.CO;2-X; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Savaskan NE, 2000, BRAIN RES, V864, P44, DOI 10.1016/S0006-8993(00)02148-X; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Sriram K, 2002, NEUROSCIENCE, V115, P1335, DOI 10.1016/S0306-4522(02)00306-8; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116	34	42	43	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2003	20	11					1223	1231		10.1089/089771503770802899			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	747BE	WOS:000186784600007	14651809				2022-02-06	
J	Gyulkhandanyan, AV; Feeney, CJ; Pennefather, PS				Gyulkhandanyan, AV; Feeney, CJ; Pennefather, PS			Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes	JOURNAL OF NEUROCHEMISTRY			English	Article						antioxidants; astrocytes; copper; copper chelators; mitochondrial membrane potential; reactive oxygen species	TRAUMATIC BRAIN-INJURY; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CELL-DEATH; PERMEABILITY TRANSITION; SUPEROXIDE DISMUTASES; LIVER-MITOCHONDRIA; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; HEART-MITOCHONDRIA	In monolayers of cultured rat astrocytes a number of agents that induce oxidative stress act synergistically with exposure to copper leading to rapid depolarization of the mitochondrial membrane potential (Psi(m)) and increased reactive oxygen species (ROS) production. Copper sensitized astrocytes to the action of menadione, an intracellular generator of superoxide anion radical, exogenous hydrogen peroxide (H2O2) and rotenone, an inhibitor of mitochondrial electron transport chain complex I. However, significant differences were observed in the ability to modulate the copper-enhanced oxidative stress depending on which stressor was used. The inhibitor of mitochondrial permeability transition cyclosporin A attenuated the effect of copper and rotenone, but had no protective action in the case of H2O2/copper and menadione/copper combinations. The H2O2 scavenger pyruvate was effective at protecting mitochondria against damage associated with the combined exposure to H2O2/copper and menadione/copper but not to the rotenone/copper combination. The antioxidant Trolox was ineffective at protecting against any of these actions and indeed had a damaging effect when combined with copper. The membrane-permeable copper chelator neocuproine combined with sensitizing concentrations of menadione caused a decrease in Psi(m), mimicking the action of copper. Penicillamine, a membrane-impermeable copper chelator, was effective at reducing copper sensitization. Endogenous copper, mobilized during periods of oxidative stress, may play a role in the pathophysiology of brain injury. Our results suggest that this might be particularly dangerous in dysfunctional conditions in which the mitochondrial electron transport chain is compromised.	Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 2S2, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 2S2, Canada		Pennefather, PS (corresponding author), Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, 19 Russell St, Toronto, ON M5S 2S2, Canada.						Albertini R, 1999, FREE RADICAL RES, V30, P181, DOI 10.1080/10715769900300201; Arnaiz SL, 1999, NITRIC OXIDE-BIOL CH, V3, P235, DOI 10.1006/niox.1999.0229; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Bayol-Denizot C, 2000, BBA-MOL CELL RES, V1497, P115, DOI 10.1016/S0167-4889(00)00047-1; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Camakaris J, 1999, BIOCHEM BIOPH RES CO, V261, P225, DOI 10.1006/bbrc.1999.1073; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CINO M, 1989, ARCH BIOCHEM BIOPHYS, V269, P623, DOI 10.1016/0003-9861(89)90148-3; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; CONSTANTINI P, 1996, J BIOL CHEM, V271, P6746; De Vizcaya-Ruiz A, 2000, TOXICOL IN VITRO, V14, P1, DOI 10.1016/S0887-2333(99)00082-X; Desagher S, 1997, J NEUROSCI, V17, P9060; DESAGHER S, 1996, J NEUROSCI, V16, P25; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; Ferruzza S, 2000, BIOMETALS, V13, P179, DOI 10.1023/A:1009271622356; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Garcia N, 2000, MOL CELL BIOCHEM, V209, P119, DOI 10.1023/A:1007151511817; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Heininger K, 2000, HUM PSYCHOPHARM CLIN, V15, P1, DOI 10.1002/(SICI)1099-1077(200001)15:1<1::AID-HUP153>3.0.CO;2-1; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Hippeli S, 1999, FEBS LETT, V443, P1, DOI 10.1016/S0014-5793(98)01665-2; Hirrlinger J, 2002, J NEUROSCI RES, V69, P318, DOI 10.1002/jnr.10308; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; LEBLONDEL G, 1984, J INORG BIOCHEM, V21, P241, DOI 10.1016/0162-0134(84)83007-X; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Montal M, 1998, BBA-BIOENERGETICS, V1366, P113, DOI 10.1016/S0005-2728(98)00124-8; NAKATANI T, 1994, LIFE SCI, V54, P967, DOI 10.1016/0024-3205(94)00498-6; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Oikawa S, 1996, BIOCHEMISTRY-US, V35, P4584, DOI 10.1021/bi9527000; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; POOLE RC, 1993, AM J PHYSIOL, V264, P761; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rinaldi AC, 2000, BIOMETALS, V13, P9, DOI 10.1023/A:1009228824220; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; SARIS NEL, 1991, ACTA CHEM SCAND, V45, P1042, DOI 10.3891/acta.chem.scand.45-1042; SHEINBERG IH, 1981, J RHEUMATOL, V8, P90; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; THOR H, 1982, J BIOL CHEM, V257, P2419; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang XF, 2001, J NEUROSCI, V21, P3322, DOI 10.1523/JNEUROSCI.21-10-03322.2001; Wojtczak L, 1996, BIOCHEM BIOPH RES CO, V223, P468, DOI 10.1006/bbrc.1996.0917; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; YOSHIDA Y, 1994, BBA-GEN SUBJECTS, V1200, P85, DOI 10.1016/0304-4165(94)90121-X; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; [No title captured]	79	42	42	0	4	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	2003	87	2					448	460		10.1046/j.1471-4159.2003.02029.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	726JN	WOS:000185596100018	14511122	Bronze			2022-02-06	
J	Walker, R; Hiller, M; Staton, M; Leukefeld, CG				Walker, R; Hiller, M; Staton, M; Leukefeld, CG			Head injury among drug abusers: An indicator of co-occurring problems	JOURNAL OF PSYCHOACTIVE DRUGS			English	Article; Proceedings Paper	63rd Annual Meeting of the College-on-Problems-of-Drug-Dependence	JUN 16-21, 2001	SCOTTSDALE, AZ	Coll Problems Drug Dependence		co-occurring disorders; head injury; substance abuse	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SHORT-TERM-MEMORY; SUBSTANCE-ABUSE; FORENSIC ISSUES; CHRONIC PAIN; IMPAIRMENT; ALCOHOL; USERS; RISK	Alcohol and other drug use has been associated with traumatic brain injury both as a contributing factor to the injury and as a complicating factor for rehabilitation. Brain injury is associated with an increase in mental health and other problems that may be related to drug and alcohol abuse and that may influence recovery. This study examined self-reports of 661 drug-abusing inmates with self-reported head injury, health problems and mental health problems. Three groups were examined for this study: those having no head injury, one head injury, and two or more head injuries. Results indicate that inmates with head injuries had a significantly greater number of health problems, higher levels of alcohol and marijuana use, and significantly more mental health problems including depression, anxiety, suicidal thinking, and difficulties in concentrating and controlling violent behavior. This study suggests that questions regarding head injuries during assessment may identify drug abusers who need a treatment approach that accommodates their co-occurring problems and difficulties with processing and complying with treatment interventions.	Univ Kentucky, Ctr Drug & Alcohol Res, Lexington, KY 40536 USA		Walker, R (corresponding author), Univ Kentucky, Ctr Drug & Alcohol Res, Bowman Hall,Room 333, Lexington, KY 40536 USA.				NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA 11309] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA011309] Funding Source: NIH RePORTER		Amen DG, 1997, J PSYCHOACTIVE DRUGS, V29, P307, DOI 10.1080/02791072.1997.10400557; BOND MR, 1986, NEUROPSYCHOLOGICAL A; BOYLE MJ, 1991, J ROY SOC MED, V84, P608; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Bremner JD, 1995, PSYCHIAT RES, V59, P97; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BROWN BS, 1997, TREATING DRUG ABUSER; Chitwood DD, 1999, SUBST USE MISUSE, V34, P727, DOI 10.3109/10826089909037240; COLLINS JG, 1990, 911503 DHHS PUBL; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Davis M., 1992, AMYGDALA NEUROBIOLOG; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; EDWARDSLEE TA, 1999, HUMAN FRONTAL LOBES; FOGLE BS, 1994, J NEUROPSYCHIAT, V6, P343; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; Giancola PR, 1996, ALCOHOL CLIN EXP RES, V20, P740, DOI 10.1111/j.1530-0277.1996.tb01680.x; Giancola PR, 1999, PSYCHOL SCI, V10, P203, DOI 10.1111/1467-9280.00135; GOLDMANRAKIC PS, 1990, BRAIN ORG MEMORY CEL; GOLDMANRAKIE PS, 1998, PREFRONTAL CORTEX EX; HALGREN E, 1995, COGNITIVE NEUROSCIEN; HARDEN PW, 1995, ADDICTIVE BEHAV READ; HART T, 1999, EVALUATION TREATMENT; HESTAD K, 1995, SCAND J PSYCHOL, V36, P246, DOI 10.1111/j.1467-9450.1995.tb00984.x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kaplan HI, 1998, SYNOPSIS PSYCHIAT BE; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KRAUS J, 1994, NEUROPSYCHIATRY TRAU; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LeDoux J., 1996, EMOTIONAL BRAIN MYST; Leukefeld CG, 2002, INT J OFFENDER THER, V46, P715, DOI 10.1177/0306624X02238164; LEUKEFELD CG, 1992, NIDA MONOGRAPH, V118; LITVAN I, 1999, HUMAN FRONTAL LOBES; MALEC JF, 1999, EVALUATION TREATMENT; MATEER CA, 2000, NEUROPSYCHOLOGICAL M; MCALLISTER TW, 1999, EVALUATION TREATMENT; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P119; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; MICHELSON D, 1995, NEUROBIOLOGY CLIN CO; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; MOES EJ, 1994, PSYCHOTHERAPISTS GUI; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; MORSE PA, 1994, PSYCHOTHERAPISTS GUI; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; PIHL RO, 1995, ALCOHOL HEALTH RES W, V19, P142; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Raine A, 1993, PSYCHOPATHOLOGY CRIM; ROLLS ET, 1995, COGNITIVE NEUROSCIEN; SAPOLSKY RM, 1990, MOL CELLULAR MECH NE; SCHNIDER A, 1999, HUMAN FRONTAL LOBES; Shallice T., 1998, PREFRONTAL CORTEX EX; Silver JM, 1997, J NEUROPSYCH CLIN N, V9, P102; SILVER JM, 1997, AM PSYCHIAT PRESS TX; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOLOMON D, 1992, NEUROREHABILITATION, V2, P16; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; SPARADEO FR, 1992, NEUROREHABILITATION, V2, P65; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Volavka J., 1995, NEUROBIOLOGY VIOLENC; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089	69	42	42	0	8	HAIGHT-ASHBURY PUBL	SAN FRANCISCO	409 CLAYTON ST, SAN FRANCISCO, CA 94117 USA	0279-1072			J PSYCHOACTIVE DRUGS	J. Psychoact. Drugs	JUL-SEP	2003	35	3					343	353		10.1080/02791072.2003.10400017			11	Psychology, Clinical; Substance Abuse	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology; Substance Abuse	732ZL	WOS:000185975400005	14621132				2022-02-06	
J	Hlatky, R; Goodman, JC; Valadka, AB; Robertson, CS				Hlatky, R; Goodman, JC; Valadka, AB; Robertson, CS			Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						nitric oxide; cerebral blood flow; brain injury; intracerebral microdialysis	CEREBROSPINAL-FLUID; SYNTHASE; NITRATE; NO	Nitric oxide (NO) has important regulatory functions within the central nervous system. NO is oxidized in vivo to nitrate and nitrite (NOx). Measurement of these products gives an index of NO production. The purpose of this study was to examine the relation between the brain extracellular concentration of NO metabolites and cerebral blood flow (CBF) after severe traumatic brain injury. Using a chemiluminescence method, NOx concentrations were measured in 6,701 microdialysate samples obtained from 60 patients during the first 5 d after severe head injury. Regional and global values of CBF obtained by xenon-enhanced computed tomography were used for analyses. Dialysate NOx values were the highest within the first 24 h after brain trauma and gradually decreased over the 5 postinjury d (time effect, P < 0.001). Mean dialysate concentration of NOx was 15.5 +/- 17.6 mumol/L (minimum 0.3, maximum 461 mumol/L) and 65% of samples were between 5 and 20 mumol/L. There was a significant relation between regional CBF and dialysate NOx levels (r(2) = 0.316, P < 0.001). Dialysate NOx levels (9.5 +/- 2.2 mumol/L) in patients with critical reduction of regional CBF (<18 mL (.) 100 g(-1) (.) min(-1)) were significantly lower than in patients with normal CBF (18.6 +/- 8.1 mumol/L; P < 0.001). This relation between the dialysate concentration of NOx and regional CBF suggests some role for NO in the abnormalities of CBF that occur after traumatic brain injury.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Univ Hosp Hradec Kralove, Dept Neurosurg, Hradec Kralove, Czech Republic		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin,Ste 944, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS38660] Funding Source: Medline		ALBINA JE, 1993, J IMMUNOL, V150, P5080; BALCIOGLU A, 1993, J NEUROCHEM, V61, P2311, DOI 10.1111/j.1471-4159.1993.tb07475.x; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHAO CC, 1992, J IMMUNOL, V149, P2736; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CLARK RS, 1994, CRIT CARE MED, V24, P1243; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gebhard F, 1998, SHOCK, V10, P237, DOI 10.1097/00024382-199810000-00002; GOADSBY PJ, 1992, BRAIN RES, V595, P167, DOI 10.1016/0006-8993(92)91470-Y; Goodman JC, 2002, ACTA NEUROCHIR SUPPL, V81, P343; Iadecola C, 1996, AM J PHYSIOL-REG I, V271, pR990, DOI 10.1152/ajpregu.1996.271.4.R990; Khaldi A, 2001, NEUROSURGERY, V49, P33; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Sakowitz OW, 2002, ACT NEUR S, V81, P351; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; White RP, 2000, CLIN SCI, V99, P555, DOI 10.1042/CS20000064; Zecca L, 1998, J NEURAL TRANSM, V105, P627, DOI 10.1007/s007020050084	24	42	43	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2003	23	5					582	588		10.1097/01.WCB.0000059586.71206.F3			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	675RK	WOS:000182708900008	12771573	Bronze			2022-02-06	
J	Pelinka, LE; Bahrami, S; Szalay, L; Umar, F; Redl, H				Pelinka, LE; Bahrami, S; Szalay, L; Umar, F; Redl, H			Hemorrhagic shock induces an S100Bincrease associated with shock severity	SHOCK			English	Article						traumatic brain injury; extracerebral trauma; soft tissue injury; laparotomy; acidosis; rats	TRAUMATIC BRAIN INJURY; SERUM S-100 PROTEIN; HEAD-INJURY; CARDIAC-SURGERY; NERVOUS-SYSTEM; DAMAGE; RELEASE; RESUSCITATION; MARKERS; ENOLASE	S 100 B is a glial marker of cerebral injury. In a previous clinical study, we found an S 100 B increase within the first 24 h in patients with multiple trauma and hemorrhagic shock but without cerebral trauma. The aim of our current experimental study was to determine whether this posttraumatic S 100 B increase is caused by extracerebral soft tissue injury or by hemorrhagic shock and whether it is associated with the severity of hemorrhagic shock. Hemorrhagic shock was achieved by bleeding anesthetized rats to a mean arterial pressure (MAP) of 30-35 mmHg through a femoral catheter and maintaining this MAP until incipient decompensation. At incipient decompensation, MAP was either increased immediately to 40-45 mmHg (moderate shock) or was maintained until 40% of shed blood had been returned (severe shock), and then increased to 40-45 mmHg. Resuscitation was provided after 40-45 mmHg MAP had been maintained for 40 min. Soft tissue injury was achieved by midline laparotomy performed at the onset of hemorrhagic shock or without shock and was maintained for 30 min. Hemorrhagic shock caused an early S 100 B increase at the onset of decompensation. S 100 B remained increased for 24 h and was significantly higher after severe than after moderate shock. In contrast, soft tissue injury without hemorrhagic shock caused no S 100 B increase. The data presented demonstrate for the first time that the S 100 B increase is induced by hemorrhagic shock and is associated with the severity of shock.	Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; Allgemeine Unfallversicherungsanstalt, Res Ctr, Vienna, Austria		Pelinka, LE (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.		Redl, Heinz/AAD-8157-2019	Bahrami, Soheyl/0000-0002-4563-6251			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P366, DOI 10.1177/000456329703400405; Ali MS, 2000, BRIT J ANAESTH, V85, P936; Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; ISOBE T, 1984, J NEUROCHEM, V43, P1494, DOI 10.1111/j.1471-4159.1984.tb05415.x; Kilminster S, 1999, STROKE, V30, P1869, DOI 10.1161/01.STR.30.9.1869; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; PELINKA G, 2000, RECONSTR NEUROL NEUR, V16, P282; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wong CH, 1999, ANN THORAC SURG, V67, P1911, DOI 10.1016/S0003-4975(99)00425-7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	20	42	49	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	MAY	2003	19	5					422	426		10.1097/01.shk.0000055345.58165.52			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	669RZ	WOS:000182365400005	12744484				2022-02-06	
J	Thompson, HJ; Pinto-Martin, J; Bullock, MR				Thompson, HJ; Pinto-Martin, J; Bullock, MR			Neurogenic fever after traumatic brain injury: an epidemiological study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CRITICAL CARE; HEAD-INJURY; HYPERTHERMIA; REHABILITATION; CONSCIOUSNESS; TEMPERATURE; STATE; RATS	Objectives: To determine the incidence of neurogenic fever (NF) in a population of patients in the acute phase following severe traumatic brain injury (TBI); to identify factors associated with the development of NF following severe TBI in adults. Methods: Charts of patients admitted from 1996 to 1999 with severe TBI at a large, urban mid-Atlantic teaching hospital were retrospectively evaluated based on diagnostic criteria for each episode of hyperthermia to determine the diagnosis of NF. Data were collected regarding mechanism and area of injury, severity of injury, and demographic factors to determine potential predictors of NF. Results: Diffuse axonal injury (DAI) ( OR 9.06, 95% CI 0.99 to 82.7) and frontal lobe injury of any type (OR 6.68, 95% CI 1.1 to 39.3) are independently predictive of an increased risk of development of NF following severe TBI. The presence of a skull fracture and lower initial Glasgow Coma Score (GCS) were individual predictors of development of NF, but did not contribute to the final model. Conclusions: These findings examine known and novel risk factors for this phenomenon in comparison to previously published literature on NF. A set of predictor variables was identified to help clinicians target patients at high risk for development of NF following severe TBI. It is hoped that earlier diagnosis and appropriate intervention for fever in the TBI patient will lead to improved outcomes.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Virginia Commonwealth Univ Hlth Syst, Div Neurosurg, Richmond, VA USA		Thompson, HJ (corresponding author), Univ Penn, Dept Neurosurg, 105C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.				NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [NR 7694] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR007694] Funding Source: NIH RePORTER		Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BENEDEK G, 1987, CAN J NEUROL SCI, V14, P145; BRITT RH, 1983, MED INSTRUM, V17, P172; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; Clinchot DM, 1997, AM J PHYS MED REHAB, V76, P323, DOI 10.1097/00002060-199707000-00012; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; CUNHA BA, 1984, HEART LUNG, V13, P460; CUNHA BA, 1988, HEART LUNG, V17, P608; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1992, J NEUROTRAUMA, V9, P475; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; HOLTZCLAW BJ, 1992, HEART LUNG, V21, P482; KAKUDA W, 1997, J CEREB BLOOD FLO S1, V17, pS43; KERN KB, 1984, J TRAUMA, V24, P69, DOI 10.1097/00005373-198401000-00012; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; KUROIWA T, 1990, J CEREBR BLOOD F MET, V10, P550, DOI 10.1038/jcbfm.1990.97; Lausberg G, 1971, Cah Anesthesiol, V19, P315; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Powers JH, 1996, INFECT DIS CLIN N AM, V10, P45, DOI 10.1016/S0891-5520(05)70285-3; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Segatore M, 1992, J Neurosci Nurs, V24, P104; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON HJ, 1997, P 29 ANN M AM ASS NE, P10; WHYTE J, 1993, AM J PHYS MED REHAB, V72, P281, DOI 10.1097/00002060-199310000-00006	29	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2003	74	5					614	619		10.1136/jnnp.74.5.614			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	668GC	WOS:000182281100016	12700304	Green Published, Bronze			2022-02-06	
J	Reynolds, FD; Dietz, PA; Higgins, D; Whitaker, TS				Reynolds, FD; Dietz, PA; Higgins, D; Whitaker, TS			Time to deterioration of the elderly, anticoagulated, minor head injury patient who presents without evidence of neurologic abnormality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						warfarin; Coumadin; anticoagulation; minor head injury; elderly; neurologic; decompensation	COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; BRAIN INJURY; WARFARIN	Background: Generally accepted guidelines regarding the care of the elderly, anticoagulated minor head injury patient do not exist within the trauma literature. Methods. Charts were reviewed on all anticoagulated, minor head injury patients older than 65 years between January 1993 and May 2000. Postinjury course was examined for neurologic changes, times, coagulation/radiographic studies, reversal, operative intervention, and outcome. Results. Thirty-two patients were identified. Twenty-four patients were discharged from the Emergency Department. Three of the remaining eight patients had initial Glasgow Coma Scale scores of 15, 15, and 14 but became comatose over a mean course of 3.83 hours. A fourth patient presented comatose 6 hours postinjury, down from "acting normal." Three of these four patients died. Conclusion. Elderly, anticoagulated patients with minor head trauma risk neurologic deterioration within 6 hours of injury, despite an initially normal neurologic examination. Early cranial computed tomographic scanning and close observation for a minimum of 6 hours are indicated.	Mary Imogene Bassett Hosp, Dept Surg, Cooperstown, NY 13326 USA; Mary Imogene Bassett Hosp, Dept Gen & Vasc Surg, Cooperstown, NY 13326 USA		Reynolds, FD (corresponding author), Mary Imogene Bassett Hosp, Dept Surg, 1 Atwell Rd, Cooperstown, NY 13326 USA.						Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Horton JD, 1999, AM FAM PHYSICIAN, V59, P635; *IMS, 1998, NAT PRESCR AUD PHYS; Inamasu J, 2000, AM J EMERG MED, V18, P810, DOI 10.1053/ajem.2000.18111; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Saab M, 1996, J ACCID EMERG MED, V13, P208; SIFTON DW, 2000, PHYSICIANS DESK REFE, P969; Snyder RW, 1997, AM J MED, V102, P488, DOI 10.1016/S0002-9343(97)89445-4; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Volans AP, 1998, J ACCID EMERG MED, V15, P159	19	42	47	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2003	54	3					492	496		10.1097/01.TA.0000051601.60556.FC			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	660EA	WOS:000181819800010	12634528				2022-02-06	
J	Chan, RCK; Hoosain, R; Lee, TMC; Fan, YW; Fong, D				Chan, RCK; Hoosain, R; Lee, TMC; Fan, YW; Fong, D			Are there sub-types of attentional deficits in patients with persisting post-concussive symptoms? A cluster analytical study	BRAIN INJURY			English	Article; Proceedings Paper	29th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 2001	CHICAGO, IL	Int Neuropsychol Soc			CLOSED-HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; SUSTAINED ATTENTION; QUESTIONNAIRE; PERFORMANCE; FAILURES; RECOVERY; AROUSAL	Aim : The present study aimed to examine attentional deficits in patients with persisting post-concussive symptoms using a multi-componential framework of attention. Design : A cross-sectional investigation using standardized tests and questionnaires of attention including 92 patients. Method : Participants were administered comprehensive measures of attention assessing sustained attention (Sustained Attention Response to Task, Backward Digit Span), selective attention (Stroop Word-Colour Test, Colour Trails Test), divided attention (Paced Auditory Serial Addition Test, Symbol Digit Modalities Test), and attentional control (Tower of Hanoi, Six Elements Test). Ecological tests of attention were used to validate the cluster solution. Main outcome : Three clusters of patients with different combinations of attentional deficits were identified. They were mild sustained attentional deficits, selective and divided attentional deficits, and general attentional deficit. A MANOVA indicated that these three clusters were statistically and clinically different from one another in terms of different attentional components proposed. Conclusion : This study provides preliminary evidence suggesting that sub-types of attentional impairments exit in patients with post-concussive symptoms.	Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; Tuen Mun Hosp, Dept Neurosurg, Hong Kong, Hong Kong, Peoples R China		Chan, RCK (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	rckchan@hkucc.hku.hk	Chan, Raymond CK/B-6717-2009; Lee, Tatia Mei Chun/D-4922-2009	Chan, Raymond CK/0000-0002-3414-450X; 			Benson D.F., 1986, FRONTAL LOBES; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BINDER LM, 1997, J CLIN EXPT NEUROPSY, V19, P529; BLASHFIELD RK, 1980, J CONSULT CLIN PSYCH, V48, P456; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Chan RCK, 1999, ARCH CLIN NEUROPSYCH, V14, P735, DOI 10.1016/S0887-6177(99)80228-5; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CHAN RCK, IN PRESS J CLIN EXPT; CHAN RCK, IN PRESS CLIN REHABI; DELIA LF, 1996, COLOUR TRAILS TEST P; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Hair JF, 1995, MULTIVARIATE DATA AN; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MORRIS RD, 1980, J CLIN EXPT NEUROPSY, V10, P640; Morris RG, 1997, COGN NEUROPSYCHOL, V14, P1007, DOI 10.1080/026432997381330; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Wechsler, 1981, WAISR MANUAL WECHSLE; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3	49	42	42	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	2					131	148		10.1080/0269905021000010168			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	633LL	WOS:000180284700003	12519640				2022-02-06	
J	Ahmed, SM; Weber, JT; Liang, S; Willoughby, KA; Sitterding, HA; Rzigalinski, BA; Ellis, EF				Ahmed, SM; Weber, JT; Liang, S; Willoughby, KA; Sitterding, HA; Rzigalinski, BA; Ellis, EF			NMDA receptor activation contributes to a portion of the decreased mitochondrial membrane potential and elevated intracellular free calcium in strain-injured neurons	JOURNAL OF NEUROTRAUMA			English	Article						APV; calcium; glutamate; mitochondria; MK-801; traumatic brain injury	STRETCH-INDUCED INJURY; ENERGY-METABOLISM; CORTICAL-NEURONS; BRAIN INJURY; IN-VITRO; GLUTAMATE EXCITOTOXICITY; DELAYED DEPOLARIZATION; SIGNAL-TRANSDUCTION; HEAD-INJURY; CELL INJURY	In our previous studies, we have shown that in vitro biaxial strain (stretch) injury of neurons in neuronal plus glial cultures increases intracellular free calcium ([Ca2+](i)) and decreases mitochondrial membrane potential (Deltapsi(m)). The goal of this study was to determine whether strain injury, without the addition of exogenous agents, causes glutamate release, and whether NMDA receptor antagonists affect the post-strain injury rise in [Ca2+](i) and decrease in Deltapsi(m). [Ca2+](i) and Deltapsi(m). were measured using the fluorescent indicators fura-2 AM and rhodamine-1,2,3 (rh123). Strain injury of neuronal plus glial cultures caused an immediate 100-200 nM elevation in neuronal [Ca2+](i) and a decline in neuronal Deltapsi(m) by 15 min post-injury. Pretreatment with the NMDA receptor antagonist MK-801 (10 muM) attenuated the [Ca2+](i) elevation after mild, but not moderate and severe injury. MK-801 pretreatment reduced the decline in Deltapsi(m) after mild and moderate, but not after severe injury. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoic acid (APV; 100 muM) had effects similar to MK-801. Simultaneous measurement of [Ca2+](i) and Deltapsi(m). demonstrated a significant correlation and a temporal relationship between [Ca2+](i) elevation and depression of Deltapsi(m). We conclude that NMDA receptor stimulation contributes to some of the changes in [Ca2+](i) and Deltapsi(m) after less severe strain injury. However, after more pronounced injury other mechanisms appear to be more involved.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Erasmus Univ, Dept Anat, Rotterdam, Netherlands; Guilford Pharmaceut Res & Dev, Baltimore, MD USA; Univ Cent Florida, Dept Mol Biol & Microbiol, Coll Hlth & Publ Affairs, Orlando, FL 32816 USA		Ellis, EF (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Campus Virginia Commonwealth Univ,POB 980613, Richmond, VA 23298 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS07288, NS27214] Funding Source: Medline		Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Budd SL, 1996, J NEUROCHEM, V67, P2282; Bullock MR, 1999, ANN NY ACAD SCI, V890, P51, DOI 10.1111/j.1749-6632.1999.tb07980.x; BUNTING JR, 1992, BIOPHYS CHEM, V42, P163, DOI 10.1016/0301-4622(92)85006-P; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; MCCORMACK JG, 1994, NEWS PHYSIOL SCI, V9, P71; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Peng TI, 1998, MOL PHARMACOL, V53, P974; Peng TI, 1998, EXP NEUROL, V149, P1, DOI 10.1006/exnr.1997.6599; Peuchen S, 1996, NEUROSCIENCE, V71, P855, DOI 10.1016/0306-4522(95)00480-7; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; Reynolds IJ, 1999, ANN NY ACAD SCI, V893, P33, DOI 10.1111/j.1749-6632.1999.tb07816.x; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; RZIGALINSKI BA, 1998, J NEUROTRAUM, V15, P894; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; White RJ, 1996, J NEUROSCI, V16, P5688; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	42	42	43	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2002	19	12					1619	1629		10.1089/089771502762300274			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	629UY	WOS:000180070700009	12542862				2022-02-06	
J	Seale, GS; Caroselli, JS; High, WH; Becker, CL; Neese, LE; Scheibel, R				Seale, GS; Caroselli, JS; High, WH; Becker, CL; Neese, LE; Scheibel, R			Use of the Community Integration Questionnaire (CIQ) to characterize changes in functioning for individuals with traumatic brain injury who participated in a post-acute rehabilitation programme	BRAIN INJURY			English	Article							CLINICAL-SIGNIFICANCE; OUTCOME RESEARCH; RELIABILITY; IMPACT	Objective: Evaluate changes in community integration for survivors of traumatic brain injury (TBI) who participated in a post-acute rehabilitation programme. Design: Cohort, prospective study investigating change from admission to post-discharge. Participants: Individuals, the majority of whom were diagnosed with severe TBI, were placed into one of two groups as follows: (1) admitted for treatment less than 1 year post-injury (L1Y) or (2) admitted for treatment between 1-5 years post-injury (G1Y). Measure: The Community Integration Questionnaire (CIQ). Results: Both groups showed significant improvements from admission to follow-up; however, some CIQ findings were more pronounced for the L1Y group. Reliable change (RC) methodology was used to assess individual change. Results of this approach were consistent with group results, but tempered the perception of degree of change. Conclusions: Findings cannot simply be attributed to neurological recovery and individual factors are important to examine when assessing change.	Transit Learning Ctr, Galveston, TX 77550 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Inst Rehabil & Res, Sect Brain Injury Res Ctr, Houston, TX USA		Seale, GS (corresponding author), Transit Learning Ctr, 1528 Postoffice St, Galveston, TX 77550 USA.						Bontke C F, 1991, Neurosurg Clin N Am, V2, P473; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hermann BP, 1996, EPILEPSIA, V37, P942, DOI 10.1111/j.1528-1157.1996.tb00531.x; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Jennett B, 1981, MANAGEMENT HEAD INJU; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Ling JS, 1997, J HEAD TRAUMA REHAB, V12, P51, DOI 10.1097/00001199-199702000-00009; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P88, DOI 10.1097/00001199-199608000-00011; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thobaben JR, 1997, J HEAD TRAUMA REHAB, V12, P10, DOI 10.1097/00001199-199702000-00004; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1993, INT CLASS IMP DIS HA	34	42	42	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2002	16	11					955	967		10.1080/02699050210155258			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	609PQ	WOS:000178914500003	12455520				2022-02-06	
J	Gavelli, G; Canini, R; Bertaccini, P; Battista, G; Bna, C; Fattori, R				Gavelli, G; Canini, R; Bertaccini, P; Battista, G; Bna, C; Fattori, R			Traumatic injuries: imaging of thoracic injuries	EUROPEAN RADIOLOGY			English	Article						chest trauma; thorax; thoracic injuries; imaging	TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AORTIC RUPTURE; DIAPHRAGMATIC RUPTURE; CHEST RADIOGRAPHY; CT AORTOGRAPHY; BLUNT TRAUMA; DIAGNOSIS; MANAGEMENT; PNEUMOTHORAX; SENSITIVITY	Chest trauma is one of the most important causes of death, in particular in individuals under the age of 40 years. The mortality rate for chest trauma, often related to motor vehicle accidents, is approximately 15.5%; it increases dramatically to 77% with associated shock and head injury (Glasgow scores of 3-4). The accurate diagnosis of pathologies consequent to blunt chest trauma depends on a complete knowledge of the different clinical and radiological manifestations. The first diagnostic approach is classically based on chest X-ray often carried out on supine position at the hospital admission. A CT study must then be performed in all chest trauma patients in whom there is even the smallest diagnostic doubt on plain film. In particular, spiral CT (SCT) assumes a fundamental role in the demonstration of mediastinal hemorrhage and direct signs of aortic lesions. At present, SCT is routinely part of a diagnostic evaluation which also includes scans of the brain and the abdomen in polytraumatized patients. Magnetic resonance is the ideal method for visualizing diaphragmatic lesions. Furthermore, recent reports have demonstrated the high diagnostic value of MR in evaluating aortic injuries. The purpose of this article is to review the most common radiological patterns related to chest trauma.	Univ Bologna, Policlin S Orsola Malpighi, Dpto Clin Sci Radiol & Istocitopatol Radiodiagn, I-40136 Bologna, Italy		Gavelli, G (corresponding author), Univ Bologna, Policlin S Orsola Malpighi, Dpto Clin Sci Radiol & Istocitopatol Radiodiagn, Via Massarenti, I-40136 Bologna, Italy.	ggavelli@orsola-malpighi.med.unibo.it	Battista, Giuseppe/AAC-3362-2021; Fattori, Rossella/L-1017-2016	Battista, Giuseppe/0000-0003-3639-3494; 			BALL T, 1982, AM J ROENTGENOL, V138, P633, DOI 10.2214/ajr.138.4.633; BARMADA H, 1994, CHEST, V106, P74, DOI 10.1378/chest.106.1.74; BENMENACHEM Y, 1993, J TRAUMA, V35, P363, DOI 10.1097/00005373-199309000-00006; Bergin D, 2001, AM J ROENTGENOL, V177, P1137, DOI 10.2214/ajr.177.5.1771137; BUCKMASTER MJ, 1994, J TRAUMA, V37, P989, DOI 10.1097/00005373-199412000-00021; CASKEY CI, 1989, RADIOLOGY, V171, P385, DOI 10.1148/radiology.171.2.2704802; CHEN JC, 1991, AM SURGEON, V57, P810; Cohn SM, 1997, J TRAUMA, V42, P973, DOI 10.1097/00005373-199705000-00033; DELROSSI AJ, 1990, SURGERY, V108, P864; Fattori R, 1997, EUR RADIOL, V7, P51; Fattori R, 1996, CIRCULATION, V94, P2865, DOI 10.1161/01.CIR.94.11.2865; Fattori R, 1998, EUR J CARDIO-THORAC, V13, P582, DOI 10.1016/S1010-7940(98)00071-2; FERMANIS GG, 1985, AUST NZ J SURG, V55, P383, DOI 10.1111/j.1445-2197.1985.tb00905.x; Gavant ML, 1996, AM J ROENTGENOL, V166, P955, DOI 10.2214/ajr.166.4.8610581; GELMAN R, 1991, AM J ROENTGENOL, V156, P51, DOI 10.2214/ajr.156.1.1898570; Glasser DL, 1998, RADIOGRAPHICS, V18, P799, DOI 10.1148/radiographics.18.3.9599403; GORDON R, 1980, RADIOLOGY, V136, P25, DOI 10.1148/radiology.136.1.7384513; Greene R, 1987, J Thorac Imaging, V2, P1, DOI 10.1097/00005382-198707000-00004; Hunt JP, 1996, J TRAUMA, V40, P547, DOI 10.1097/00005373-199604000-00005; KRAM HB, 1987, J VASC SURG, V6, P168, DOI 10.1067/mva.1987.avs0060168; Ma OJ, 1997, ANN EMERG MED, V29, P312, DOI 10.1016/S0196-0644(97)70341-X; MARNOCHA KE, 1985, AM J ROENTGENOL, V144, P19, DOI 10.2214/ajr.144.1.19; Mirvis SE, 1996, RADIOLOGY, V200, P413, DOI 10.1148/radiology.200.2.8685335; MIRVIS SE, 1987, RADIOLOGY, V163, P487, DOI 10.1148/radiology.163.2.3562831; MORRIS L, 1999, RADIOL CLIN N AM, V37, P553; MORSE SS, 1988, AM J ROENTGENOL, V150, P793, DOI 10.2214/ajr.150.4.793; Murray JG, 1996, AM J ROENTGENOL, V166, P1035, DOI 10.2214/ajr.166.5.8615237; Olsovsky MR, 1997, ANGIOLOGY, V48, P423, DOI 10.1177/000331979704800506; PATE JW, 1995, WORLD J SURG, V19, P119, DOI 10.1007/BF00316994; PERCHINSKY MJ, 1995, ARCH SURG-CHICAGO, V40, P852; RAPTOPOULOS V, 1994, AM J ROENTGENOL, V162, P1053, DOI 10.2214/ajr.162.5.8165980; RHEA JT, 1979, RADIOLOGY, V133, P593, DOI 10.1148/133.3.593; RIZOLI SB, 1994, ANN THORAC SURG, V58, P1404, DOI 10.1016/0003-4975(94)91923-2; Rossbach MM, 1998, ANN THORAC SURG, V65, P182, DOI 10.1016/S0003-4975(97)01001-1; SHAH R, 1995, ANN THORAC SURG, V60, P1444, DOI 10.1016/0003-4975(95)00629-Y; Shanmuganathan K, 1999, RADIOL CLIN N AM, V37, P533, DOI 10.1016/S0033-8389(05)70110-X; SMITH MD, 1995, NEW ENGL J MED, V332, P356, DOI 10.1056/NEJM199502093320603; STARK P, 1993, RADIOLOGY THORACIC T, P54; Tack D, 2000, EUR RADIOL, V10, P719, DOI 10.1007/s003300050992; Tocino I, 1987, J Thorac Imaging, V2, P45, DOI 10.1097/00005382-198707000-00008; TOCINO IM, 1985, AM J ROENTGENOL, V144, P901, DOI 10.2214/ajr.144.5.901; VIGNON P, 1995, CIRCULATION, V92, P2959, DOI 10.1161/01.CIR.92.10.2959; Vignon P, 2001, ANESTHESIOLOGY, V94, P615, DOI 10.1097/00000542-200104000-00015; WALL SD, 1983, AM J ROENTGENOL, V141, P919, DOI 10.2214/ajr.141.5.919; Wan YL, 1997, AM J EMERG MED, V15, P176, DOI 10.1016/S0735-6757(97)90096-6; Wicky S, 1998, EUR RADIOL, V8, P828, DOI 10.1007/s003300050480; Wicky S, 2000, EUR RADIOL, V10, P1524, DOI 10.1007/s003300000435; WORTHY SA, 1995, RADIOLOGY, V194, P885, DOI 10.1148/radiology.194.3.7862996	48	42	44	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	JUN	2002	12	6					1273	1294		10.1007/s00330-002-1439-6			22	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	562LC	WOS:000176197400005	12042932				2022-02-06	
J	Meldrum, B				Meldrum, B			Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs	EPILEPSY RESEARCH			English	Article; Proceedings Paper	Workshop on New Horizons in the Development of Antiepileptic Drugs	NOV 28-29, 2001	PHILADELPHIA, PENNSYLVANIA			epilepsy; antiepileptic drugs; sodium channels; GABA(A) receptors; side effects; benzodiazepines	LEVETIRACETAM UCB L059; SODIUM-CHANNEL; ANTICONVULSANT ACTIVITY; RECEPTOR SUBTYPES; ALPHA-SUBUNIT; PAPIO-PAPIO; DBA/2 MICE; RAT-BRAIN; D-CPP; EPILEPSY	Classical screening tests (maximal electroshock, MES, and threshold pentylenetetrazol, PTZ) employ non-epileptic rodents and identify antiepileptic drugs (AEDs) with mechanisms of action associated with significant CNS side effects. Thus MES identifies drugs acting on Na+ channels that produce cerebellar toxicity. It may be possible to produce novel AEDs more selectively targeted at voltage-sensitive (VS) ion channels. There is little specific evidence for the likely success of this strategy with subunit selective agents targeted at the different VS Na+ channels. Drugs targeted at specific VS Ca++ channels J, N, P/Q types) may be useful in generalised seizures. There are many as yet unexplored possibilities relating to K + channels. GABA related drugs acting on PTZ clonic seizures tend to induce sedation and muscle hypotonia. Studies in mice, particularly with knock-in mutations, but also with subunit selective agents acting via the GABA(A) benzodiazepine site, suggest that it is possible to produce agents which do or do not induce particular side effects (sedative, hypnotic, anxiolytic, muscle relaxant, amnesia, anaesthesia). Whether these findings transfer to man has yet to be established. Acquired epilepsy in rodents (e.g. kindling or spontaneous seizures following chemically- or electrically-induced status epilepticus) or acquired epilepsy in man (following prolonged febrile seizures or traumatic brain injury) is associated with multiple changes in the function and subunit composition of ion channels and receptor molecules. Optimal screening of novel AEDs, both for efficacy and side effects, requires models with receptor and ion channel changes similar to those in the target human syndrome. (C) 2002 Elsevier Science B.V. All rights reserved.	GKT Sch Biomed Sci, London SE1 1UL, England		Meldrum, B (corresponding author), GKT Sch Biomed Sci, Henriette Raphael House,Guys Campus,London Bridge, London SE1 1UL, England.						BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CHAPMAN AG, 1991, EPILEPSIA, V32, P578, DOI 10.1111/j.1528-1157.1991.tb04695.x; CHAPMAN AG, 1990, EUR J PHARMACOL, V178, P97, DOI 10.1016/0014-2999(90)94798-3; COULTER DA, 1990, BRIT J PHARMACOL, V100, P800, DOI 10.1111/j.1476-5381.1990.tb14095.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; GOWER AJ, 1992, EUR J PHARMACOL, V222, P193, DOI 10.1016/0014-2999(92)90855-X; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HONACK D, 1995, EPILEPSIA, V36, P763, DOI 10.1111/j.1528-1157.1995.tb01613.x; Hosford DA, 1997, EPILEPSIA, V38, P408, DOI 10.1111/j.1528-1157.1997.tb01729.x; Klapstein GJ, 1999, NEUROPHARMACOLOGY, V38, P927, DOI 10.1016/S0028-3908(99)00016-7; KRALL RL, 1978, EPILEPSIA, V19, P404; Leresche N, 1998, J NEUROSCI, V18, P4842; Lombardo AJ, 1996, MOL BRAIN RES, V35, P84, DOI 10.1016/0169-328X(95)00194-W; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Meadows HJ, 1998, BRIT J PHARMACOL, V123, P1253, DOI 10.1038/sj.bjp.0701721; Merritt HH, 1938, J AMER MED ASSOC, V111, P1068, DOI 10.1001/jama.1938.02790380010004; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NOYER M, 1995, EUR J PHARMACOL, V286, P137, DOI 10.1016/0014-2999(95)00436-O; PATEL S, 1990, EPILEPSY RES, V7, P3, DOI 10.1016/0920-1211(90)90049-2; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; Richards R.K., 1944, FED PROC, V3, P39; Rogawski M., 2002, ANTIEPILEPTIC DRUGS, V5th, P3; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SASHIHARA S, 1994, NEUROSCIENCE, V62, P803, DOI 10.1016/0306-4522(94)90478-2; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Smith AJ, 2001, MOL PHARMACOL, V59, P1108, DOI 10.1124/mol.59.5.1108; SMITH SE, 1992, EUR J PHARMACOL, V211, P109, DOI 10.1016/0014-2999(92)90270-E; SVEINBJORNSDOTTIR S, 1993, EPILEPSY RES, V16, P165, DOI 10.1016/0920-1211(93)90031-2; TURSKI L, 1990, J PHARMACOL EXP THER, V253, P344; White H.S., 2002, ANTIEPILEPTIC DRUGS; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200	35	42	43	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	JUN	2002	50	1-2					33	40	PII S0920-1211(02)00066-9	10.1016/S0920-1211(02)00066-9			8	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	592LU	WOS:000177939800005	12151115				2022-02-06	
J	Bode, RK; Heinemann, AW				Bode, RK; Heinemann, AW			Course of functional improvement after stroke, spinal cord injury, and traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the American-Congress-of-Rehabilitation-Medicine	SEP, 1998	SEATTLE, WASHINGTON	Amer Congress Rehabil Med		brain injuries; length of stay; rehabilitation; stroke; spinal cord injuries; treatment outcome	INPATIENT REHABILITATION; MEDICAL REHABILITATION; DISABILITY; OUTCOMES; LENGTH; STAY	Objective: To examine functional improvement patterns of persons with stroke. traumatic brain injury (TBI), and spinal cord injury (SCI). Design: Statistical analysis of data from a multisite study evaluating rehabilitation outcomes. Setting: Eight inpatient rehabilitation facilities. Participants: A total of 314 consecutive admissions of persons with stroke, SCI, and TBI who received acute medical rehabilitation between 1994 and 1998. Intervention: Calibration of motor and cognitive items from the FIM(TM) instrument. grouping of cases by number of weeks of rehabilitation (length of stay [LOS] groups). and plotting of weekly averages across time. Main Outcome Measures: Weekly motor and cognitive functional status. Results: With the exception of cognitive functioning for persons with SCI, LOS was related to initial functional status, with patients with greater disability having longer LOS (eg, initial motor status for persons with stroke was 48.3 for those with a 2-week stay. 36.8 for a 6-week stay, with the averages between decreasing monotonically). With the exception of cognitive gains for person with TBIs, the amount of functional C gain during rehabilitation was essentially the same for all LOS group, (eg, the overall average total motor gain for persons with SCI is 22.3. with no patterns of increase or decrease across LOS groups) however, the rate of improvement in motor (but not cognitive) functioning differed across LOS groups, with patients with shorter stays having the greater rates of improvement leg, the overall average weekly motor gain for persons with SCI was 3.6, with the averages by LOS group monotonically decreasing from 6.4 for those with 4-week stays to 2.7 for those with 9-week stays). Conclusions: When examined separately for persons grouped by LOS, functional status improved linearly during the rehabilitation stay. with differences in rate of improvement depending on initial functional status.	Rehabil Inst Chicago, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA		Bode, RK (corresponding author), Rehabil Inst Chicago, 345 E Super St,Rm 1378, Chicago, IL 60611 USA.		Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326			Bryk, 1992, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P47; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; GRANGER CV, 1989, ARCH PHYS MED REHAB, V70, P100; GRANGER CV, 1988, ARCH PHYS MED REHAB, V69, P506; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P1167, DOI 10.1001/archneur.1987.00520230051013; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 2000, J REHABIL OUTCOMES M, V4, P18; Leiter P, 1997, MED CARE, V35, pJS113, DOI 10.1097/00005650-199706001-00021; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Rasch Georg, 1980, PROBABILISTIC MODELS; ROGOSA DR, 1985, PSYCHOMETRIKA, V50, P203, DOI 10.1007/BF02294247; SCHULZ EM, 1992, OBJECTIVE MEASUREMEN, V1, P138; SETLZER MH, 1994, EDUC EVAL POLICY AN, V16, P41; Stineman M G, 1995, Am J Med Qual, V10, P190, DOI 10.1177/0885713X9501000405; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P241, DOI 10.1016/S0003-9993(98)90001-6; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; STINEMAN MG, 1994, ARCH PHYS MED REHAB, V75, P1277; STINEMAN MG, 1990, ARCH PHYS MED REHAB, V71, P881; WILLETT JB, 1988, REV RES EDUC, V15, P345, DOI 10.3102/0091732X015001345; Wilson M., 1997, OBJECTIVE MEASUREMEN, V4, P297; Wright B, 1996, RASCH MEAS T, V10, P478; Wright B, 1982, RATING SCALE ANAL RA; Wright B.D., 1996, RASCH MEASUREMENT T, V10, P506; WRIGHT BD, 2000, WINSTEPS COMPUTER PR; YARKONY GM, 1988, ARCH PHYS MED REHAB, V69, P111	30	42	59	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2002	83	1					100	106		10.1053/apmr.2002.26073			7	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	509JU	WOS:000173145300016	11782839				2022-02-06	
J	Adams, JH; Graham, DI; Jennett, B				Adams, JH; Graham, DI; Jennett, B			The structural basis of moderate disability after traumatic brain damage	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injury; disability; neuropathology	DIFFUSE AXONAL INJURY; MISSILE HEAD-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; NEUROPATHOLOGY; DIAGNOSIS	The objective was to discover the nature of brain damage in survivors of head injury who are left with moderate disability. Macroscopic and microscopic examination was carried out on the brains of 20 persons who had died long after a head injury that had been treated in a neurosurgical unit. All had become independent but had various disabilities (moderate disability on the Glasgow outcome scale) Most deaths had been sudden, which had led to their referral from forensic pathologists. Post-traumatic epilepsy was a feature in 75%. An intracranial haematoma had been evacuated in 75%, and in 11 of the 15 with epilepsy. Diffuse axonal injury was found in six patients, five of the mi est type (grade 1) and one of grade 2. No patient had diffuse thalamic damage but one had a small focal ischaemic lesion in the thalamus. No patient had severe ischaemic brain damage, but three had moderate lesions which were bilateral in only one. No patient had severe cortical contusions. In conclusion, the dominant lesion was focal damage from an evacuated intracranial haematoma. Severe diffuse damage was not found, with diffuse axonal injury only mild and thalamic damage in only one patient.	S Glasgow Univ Hosp NHS Trust, Inst Neurol Sci, Univ Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; S Glasgow Univ Hosp NHS Trust, Inst Neurol Sci, Univ Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland		Graham, DI (corresponding author), S Glasgow Univ Hosp NHS Trust, Inst Neurol Sci, Univ Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.						ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Griffin WST, 1998, BRAIN PATHOL, V8, P65; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kloster R, 1999, J NEUROL NEUROSUR PS, V67, P439, DOI 10.1136/jnnp.67.4.439; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Thomas JD, 1997, FRESHWATER BIOL, V38, P1, DOI 10.1046/j.1365-2427.1997.00206.x	19	42	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	OCT	2001	71	4					521	524		10.1136/jnnp.71.4.521			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	478ZQ	WOS:000171379800019	11561038	Green Published, Bronze			2022-02-06	
J	Chapman, SB; McKinnon, L; Levin, HS; Song, J; Meier, MC; Chiu, S				Chapman, SB; McKinnon, L; Levin, HS; Song, J; Meier, MC; Chiu, S			Longitudinal outcome of verbal discourse in children with traumatic brain injury: Three-year follow-up	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							WRITTEN LANGUAGE PRODUCTION; DEVELOPMENTAL PLASTICITY; HEAD-INJURY; RECOVERY	Purpose: This study compared changes in discourse ability between two groups of children age 5 to 10 years after brain injury: those with severe traumatic brain injury (TBI) and those with mild/moderate injury over 3-year follow-up testing. Materials and Methods: Forty-three children with TBI were recruited from a larger research project examining cognitive and linguistic recovery after injury. Twenty-two of these patients had severe injuries and 21 sustained mild/moderate injuries. AD children were presented an ordered sequence of pictures and asked to verbally produce a story/narrative discourse. Each child was then asked to produce a lesson relating to the story. Results: The severe group performed significantly worse than the mild/moderate group when performance across all four discourse domains was considered. Both groups improved across time on selected discourse measures. Qualitative analysis suggested that the severe group showed differential rates of improvement across the individual discourse variables over the 3-year interval. Conclusions: Severe TBI can have a pernicious effect on discourse abilities in children years after injury compared with children with mild/moderate injuries. The major caveat is that the discourse measures must be sufficiently challenging when used to assess older children and children with milder forms of TBI.	Univ Texas, Dept Human Dev, Dallas, TX 75230 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Chapman, SB (corresponding author), Univ Texas, Ctr BrainHlth, 1966 Inwood Rd, Dallas, TX 75235 USA.	schapman@utdallas.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Applebee A., 1978, CHILDS CONCEPT STORY; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CHAPMAN SB, UNPUB NEUROIMAGING D; CHAPMAN SB, 1996, DIAGNOZA ITERAPIS OS; CHAPMAN SB, 1999, ADV SPEECH LANGUAGE, V1, P19; CHAPMAN SB, 1999, BRAIN DAM B, P235; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DELIS DC, 1990, ADV PSYCHOL ASSESS, P101; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dunn LM., 1981, PEABODY PICTURE VOCA; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P225; EWINGCOBBS L, 1992, BRAIN LANG, V43, P42; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Frederiksen C. H., 1990, DISCOURSE ABILITY BR; Hunt K. W., 1965, 3 NAT COUNC TEACH EN; Jackendoff Ray, 1992, LANGUAGES MIND ESSAY; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JOANETTE Y, 1990, DISCOURSE ABILITY BR; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; LABOV W, 1972, LANGUAGE CITY STUDIE; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MROSS EF, 1990, DISCOURSE ABILITY BR; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sparrow SS., 1989, MAJOR PSYCHOL ASSESS, P199; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; SUTTONSMITH B, 1976, HUM DEV, V19, P1, DOI 10.1159/000271510; TEASDALE G, 1974, LANCET, V2, P81; Westby C. E., 1984, LANGUAGE LEARNING DI, P103; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9; Yorkston KM, 1999, APHASIOLOGY, V13, P691, DOI 10.1080/026870399401803	40	42	42	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2001	16	5					441	455		10.1097/00001199-200110000-00004			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483JF	WOS:000171631700004	11574040				2022-02-06	
J	Ruchholtz, S; Waydhas, C; Aufmkolk, M; Tager, G; Piepenbrink, K; Stolke, D; Nast-Kolb, D				Ruchholtz, S; Waydhas, C; Aufmkolk, M; Tager, G; Piepenbrink, K; Stolke, D; Nast-Kolb, D			A multidisciplinary quality management system (QMS) for the early treatment of severely injured patients in a trauma center in Germany	UNFALLCHIRURG			German	Article						quality management system; quality circle; trauma center; severely injured patients	ACUTE SUBDURAL-HEMATOMA; MULTIPLE INJURIES; MISSED INJURIES; PREVENTABLE DEATHS; COMATOSE PATIENTS; ABDOMINAL-TRAUMA; SEVERITY SCORE; CARE; IMPROVEMENT; MORTALITY	A multidisciplinary quality management system (QMS) for the early treatment of severely injured patients was validated in a trauma center in Germany. In the presented prospective study a QMS developed at another trauma center was implemented at the department of trauma surgery of the university of Essen for the presented study. The essential elements of the QMS were the establishment of (1) an adequate protocol for documentation, (2) 20 criteria for the assessment of treatment quality, (3) regular statistical analysis of treatment quality and (4) a quality circle comprising all medical specialties for data discussion. From 5/98-9/99 a cohort of 447 patients with an average injury severity score (ISS) of 22+/-17 was treated in the emergency department. The impact of the QMS was assessed in 4 periods (1: 5/1998-8/1998;2:9-12/1998; 3:1-4/1999; 4: 5-8/1999). The quality circle met 8 times. For the improvement of the process 16 long-term changes were introduced. In 60% (n=12) of the 20 assessment criteria significant improvements were detected. In diagnostics there were significant reductions of the time needed for basic radiological and sonographic check-up (from 24+/-12 min in the first to 14+/-8 min in the last period) and of the duration until performance of a cranial computed tomography in severe traumatic brain injury (sTBI; from 45+/-22 to 28+/-8 min). The rate of delayed diagnoses remained low (4% in the first, 5% in the last period). Further positive changes were the time savings in transfusion (from 35+/-20 to 20+/-4 min) and emergency operations (from 67+/-20 to 48+/-4 min) in hemorraghic shock as well as for craniotomies (77+/-41 to 54+/-19 min) in sTBI. Apart from the significant time reductions other improvements were found. Overall mortality was diminished from 17% in the first to 10% in the last observation period. In conclusion the study revealed that the quality of the early therapy of severely inured patients was significantly improved by implementation of a multidisciplinary quality management system especially with respect to treatment efficiency.	Univ Klinikum Essen, Klin & Poliklin Unfallchirurg, D-47145 Essen, Germany		Ruchholtz, S (corresponding author), Univ Klinikum Essen, Klin & Poliklin Unfallchirurg, Hufelandstr 55, D-47145 Essen, Germany.						*AM COLL SURG COMM, 1993, RES OPT CAR INJ PAT; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BISHOP M, 1991, AM SURGEON, V57, P736; BLUMENTHAL D, 1991, HOSPIMEDICA, V10, P26; BRAUN KH, 1993, HAV BIS MANAGER, V2, P77; CAMPBELL S, 1989, AM SURGEON, V55, P478; CAYTEN CG, 1991, ANN SURG, V214, P510, DOI 10.1097/00000658-199110000-00015; CHAMPION HR, 1992, ARCH SURG-CHICAGO, V127, P333; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; *COMM INJ SCAL, 1999, ABBR INJ SCAL 1990 R; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; DAVIS JW, 1991, J TRAUMA, V31, P813, DOI 10.1097/00005373-199106000-00012; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; DEMING WE, 1985, OUT CRISIS; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DRAAISMA JMT, 1989, J TRAUMA, V29, P1552; *DTSCH I NORM, 1990, QUAL EL QUAL; EASTHAM JN, 1993, JEMS, V1, P43; EKKERNKAMP A, 1992, UNFALLCHIRURG, V95, P380; HIRSHBERG A, 1994, AM J SURG, V168, P299, DOI 10.1016/S0002-9610(05)80152-7; HOYT DB, 1992, J TRAUMA, V33, P586, DOI 10.1097/00005373-199210000-00016; HOYT DB, 1988, J TRAUMA, V28, P435, DOI 10.1097/00005373-198804000-00003; HOYT DB, 1994, J TRAUMA, V36, P377, DOI 10.1097/00005373-199403000-00017; Ishikawa K, 1985, WHAT IS TOTAL QUALIT; IUA PT, 1998, AUST NZ J SURG, V68, P820; Juran J.M., 1989, JURAN LEADERSHIP QUA; KREIS DJ, 1986, J TRAUMA, V26, P649, DOI 10.1097/00005373-198607000-00010; LIEBIG, 1999, MFU MATERIALIEN, V9, P1; LIU M, 1988, CRIT CARE MED, V16, P1191, DOI 10.1097/00003246-198812000-00004; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; MUCKART DJJ, 1991, AM J SURG, V162, P457, DOI 10.1016/0002-9610(91)90260-K; Nast-Kolb D, 1999, UNFALLCHIRURG, V102, P338, DOI 10.1007/s001130050415; NASTKOLB D, 1993, CHIRURG, V64, P552; NASTKOLB D, 1994, UNFALLCHIRURG, V97, P292; NERLICH ML, 1987, ZBL CHIR, V112, P1465; REEDER L, 1993, JEMS, V9, P46; REGEL G, 1993, UNFALLCHIRURG, V96, P350; Robertson R, 1996, AM J SURG, V172, P564, DOI 10.1016/S0002-9610(96)00247-4; Ruchholtz S, 1998, INJURY, V29, P115, DOI 10.1016/S0020-1383(97)00150-2; RUCHHOLTZ S, 1994, UNFALLCHIRURG, V97, P285; RUCHHOLTZ S, 1999, LANGENBECKS ARCH S, V116, P1029; SCHWARTZ ML, 1991, J TRAUMA, V31, P962, DOI 10.1097/00005373-199107000-00013; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHOEMAKER WC, 1988, CRIT CARE MED, V16, P1199, DOI 10.1097/00003246-198812000-00005; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; STOCCHETTI N, 1994, J TRAUMA, V36, P401, DOI 10.1097/00005373-199403000-00022; STOTHERT JC, 1990, J TRAUMA, V30, P1021, DOI 10.1097/00005373-199008000-00012; Sung CK, 1996, J TRAUMA, V41, P276, DOI 10.1097/00005373-199608000-00013; TRUNKEY D, 1991, NEW ENGL J MED, V324, P1259; WAYDHAS C, 1994, LANGENBECKS ARCH C S, V111, P1140; WENNEKER WW, 1990, AM J SURG, V160, P655, DOI 10.1016/S0002-9610(05)80768-8; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILSON DS, 1992, J TRAUMA, V32, P45, DOI 10.1097/00005373-199201000-00010; Zintl B, 1997, UNFALLCHIRURG, V100, P811, DOI 10.1007/s001130050198	59	42	44	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	2001	104	10					927	937		10.1007/s001130170033			11	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	483AF	WOS:000171611000003	11572129				2022-02-06	
J	Whyte, J; Cifu, D; Dikmen, S; Temkin, N				Whyte, J; Cifu, D; Dikmen, S; Temkin, N			Prediction of functional outcomes after traumatic brain injury: A comparison of 2 measures of duration of unconsciousness	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; Glasgow Coma Scale; neuropsychological tests; rehabilitation	HEAD-INJURY; RECOVERY; SCALE	Objective: To compare the usefulness of time until motor localization occurs versus time until commands are followed in predicting outcome after traumatic brain injury (TBI). Design: A retrospective analysis of data from a prospective cohort study of subjects with severe TBI. Setting: Seventeen Traumatic Brain Injury Model System programs. Participants: A total of 496 subjects, recruited through the TBI Model System programs, with loss of consciousness greater than 1 day, with no late neurosurgical complications, and complete data for all measures. Interventions: Not applicable. Main Outcome Measures: Time until Glasgow Coma Scale (GCS) motor score of 5 (time to motor localization) and time until GCS motor score of 6 (time until commands were followed) were abstracted from medical records. Functional outcomes were assessed at inpatient rehabilitation admission and discharge, along with acute and rehabilitation lengths of stay and charges. Results: Time until commands were followed was a better predictor of all of the outcomes assessed than time until motor localization occurred. In multiple regression models, time until motor localization did not add significantly to the prediction provided by time until commands were followed. The predictive power of time to command following was superior even in the subgroup with poor language comprehension as measured by the Token Test. Conclusion: Despite the theoretical appeal of time to motor localization (eg, in persons with language comprehension problems), time to command following appears to be a more powerful predictor of outcome after severe brain injury.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd,Korman Bldg,Ste 211, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474; Cifu, David/0000-0003-1600-9387			CHOI SC, 1977, BIOMETRIKA, V64, P645, DOI 10.1093/biomet/64.3.645; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Hagen C., 1972, LEVELS COGNITIVE FUN; Hamsher K., 1989, MULTILINGUAL APHASIA; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764	18	42	42	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2001	82	10					1355	1359		10.1053/apmr.2001.26091			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	479NQ	WOS:000171410800002	11588737				2022-02-06	
J	Cusick, CP; Brooks, CA; Whiteneck, GG				Cusick, CP; Brooks, CA; Whiteneck, GG			The use of proxies in community integration research	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						disabled persons; health surveys; outcomes research; rehabilitation; reliability and validity	QUALITY-OF-LIFE; FUNCTIONAL STATUS; SIGNIFICANT OTHERS; PATIENT HEALTH; AGREEMENT; RELIABILITY; INJURY	Objective: To assess the level of agreement between persons with various disabilities and their proxies in reporting community integration outcomes using the Craig Handicap Assessment and Reporting Technique (CHART). Design: Reliability study. Setting: Participants living in the community for a minimum of 6 months after onset of disability or completion of inpatient rehabilitation. Participants: Persons (n = 983) with disability resulting from amputation, burn, multiple sclerosis, spinal cord injury (SCI), stroke, or traumatic brain injury and their self-selected proxies. Interventions: Telephone inter-view of subjects (FIM(TM) instrument, CHART); proxies (CHART). FIM instrument assesses the degree of assistance with physical and cognitive subscales; CHART measures community integration in 6 subscales: physical, cognitive, and economic independence, and mobility, social integration. and occupation. Main Outcome Measures: Intraclass correlation coefficients (ICCs) were used to assess participant-proxy agreement, and stepwise multiple regressions were used to identify patterns of difference in agreement based on disability type and demographic variables. Results: Thirty-seven of the 38 items examined for the entire sample yielded moderate to strong ICCs. Multiple regression analyses indicated that proxies overrated participants gr with severe functional cognitive disabilities on the mobility subscale (p <.001), overrated participants with less than a high school education on the total CHART score (p <.01), and underrated participants with SCIs on the occupation subscale (p <.01). Differences in all cases, however, were less than 6 points out of a possible score of 100 per subscale. Conclusions: Participant-proxy agreement across the 6 disability groups provided evidence in support of the inclusion of proxy data for persons with various types of disabilities in community integration research.	Craig Hosp, Dept Res, Englewood, CO 80110 USA		Cusick, CP (corresponding author), Craig Hosp, Dept Res, 3425 S Clarkson St, Englewood, CO 80110 USA.						American Spinal Injury Association/International Medical Society of Paraplegia, 1996, INT STAND NEUR FUNCT; BASSETT SS, 1990, PSYCHOL AGING, V5, P127, DOI 10.1037/0882-7974.5.1.127; BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F; CLARRIDGE BR, 1989, MED CARE, V27, P352, DOI 10.1097/00005650-198904000-00003; CORNONIHUNTLEY J, 1986, NIH PUBLICATION; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; GRANGER CV, 1997, ASSESSING MED REHABI, P103; HAYS RD, 1995, QUAL LIFE RES, V4, P159, DOI 10.1007/BF01833609; KOLONEL LN, 1977, AM J EPIDEMIOL, V106, P476, DOI 10.1093/oxfordjournals.aje.a112494; KOONS DA, 1973, VITAL HLTH STAT SER, V2; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MCCUSKER J, 1984, MED CARE, V22, P789, DOI 10.1097/00005650-198409000-00002; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; RUBENSTEIN LZ, 1984, J GERONTOL, V39, P686, DOI 10.1093/geronj/39.6.686; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Sneeuw KCA, 1997, MED CARE, V35, P490, DOI 10.1097/00005650-199705000-00006; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; *STAT U NY BUFF, 1996, GUID UN DAT SET MED; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1997, HANDICAP ASSESSMENT; World Health Organization, 1980, INT CLASS IMP DIS HA	23	42	42	0	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2001	82	8					1018	1024		10.1053/apmr.2001.25098			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	459WT	WOS:000170275000002	11494179				2022-02-06	
J	Sander, AM; Roebuck, TM; Struchen, MA; Sherer, M; High, WM				Sander, AM; Roebuck, TM; Struchen, MA; Sherer, M; High, WM			Long-term maintenance of gains obtained in postacute rehabilitation by persons with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						long-term services; postacute rehabilitation; TBI	DISABILITY RATING-SCALE; COMMUNITY INTEGRATION QUESTIONNAIRE; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; COGNITIVE REHABILITATION; IMPAIRED AWARENESS; RECOVERY; PREDICTION; LENGTH; STAY	Objective: To investigate maintenance of gains after discharge from a postacute rehabilitation program. Design: Longitudinal cohort study, with inclusion based on availability of subjects at three time points. Setting: Comprehensive postacute rehabilitation program in the Southern United States. Participants: Thirty-four persons with medically documented complicated mild to severe traumatic brain injury; primarily male Caucasians with some college. Main Outcome Measures: Disability Rating Scale and the Community Integration Questionnaire completed at admission, discharge. and two follow-up time points, Results: Repeated measures analyses, using time from injury to discharge as a covariate, revealed significant improvements on all measures from admission to discharge, with no significant change from discharge to either of the follow-up periods. However, substantial changes were noted in individual cases. Conclusions: The results indicate that gains made by persons with traumatic brain injury during postacute rehabilitation are generally maintained at long-term follow-up, but changes occur in individual cases. Long-term services may help prevent decline in individual cases.	Baylor Coll Med, Dept Phys Med & Rehabil, Brain Injury Res Ctr, TIRR, Houston, TX 77030 USA; Univ Mississippi, Med Ctr, Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS 39216 USA		Sander, AM (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Brain Injury Res Ctr, TIRR, 2455 S Braeswood, Houston, TX 77030 USA.	sandea@tirr.tmc.edu					Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCCAULEY SR, IN PRESS J INT NEURO; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Sherer M, 1999, BRAIN INJURY, V13, P973; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII	37	42	42	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2001	16	4					356	373		10.1097/00001199-200108000-00006			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	459YA	WOS:000170278000006	11461658				2022-02-06	
J	Bailes, JE; Hudson, V				Bailes, JE; Hudson, V			Classification of sport-related head trauma: A spectrum of mild to severe injury	JOURNAL OF ATHLETIC TRAINING			English	Article						diffuse brain injury; hematoma	CHRONIC SUBDURAL-HEMATOMA; EXTRACELLULAR POTASSIUM; EXTRADURAL HEMATOMA; BRAIN-INJURY; CONCUSSION; MANAGEMENT	Objective: To identify the types of injuries the human brain incurs as a result of traumatic forces applied to the cranium. In athletic events and endeavors, the full spectrum of intracranial hemorrhages in various compartments, raised intracranial pressure, and diffuse nonhemorrhagic damage may be seen. In this review, we describe these serious injuries and the more common mild traumatic brain injury in their clinical presentations and relate concussion classification to the overall picture of traumatic brain injury. Methods: Our cumulative experience with athletic injuries, both at the catastrophic and mild traumatic brain injury levels, has led us to a management paradigm that serves to guide us in the classification and treatment of these athletes. Discussion: The occurrence of intracranial injuries in sports has now been well documented. Intracranial hematomas (epidural, subdural, and parenchymal) and cerebral contusions can result from head injury. Many patients sustain a diffuse brain injury, resulting in elevated intracranial pressures, without a blood clot or mass lesion. The classification of concussion and the use of concussion guidelines are not uniform. However, the major emphases are agreed upon: the close and careful scrutiny of the athlete, an expeditious but reliable neurologic examination, and proper on-field management. Return-to-play decisions are based on many factors that affect normal functioning, both on and off the playing field. Conclusions: Sufficient knowledge now exists to allow us to carefully evaluate the injured athlete, to place him or her in the management scheme to minimize the potential for permanent cerebral dysfunction, and to know when the athlete can safely return to contact sport participation.	W Virginia Univ, Dept Neurosurg, Sch Med, Morgantown, WV 26506 USA; Univ Cent Florida, Orlando, FL 32816 USA		Bailes, JE (corresponding author), W Virginia Univ, Dept Neurosurg, Sch Med, POB 9183, Morgantown, WV 26506 USA.	jbailes@hsc.wvu.edu					Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; *COL MED SOC, 1991, GUID MAN CONC SPORTS; Gennarelli TA, 1993, HEAD INJURY, P137; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; *INT TASK FORC APP, 2001, PREH CAR SPIN INJ AT; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; KASTE M, 1979, ACTA NEUROCHIR, V48, P231, DOI 10.1007/BF02056971; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Meek T D, 1970, Tex Med, V66, P58; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SATO S, 1975, J NEUROSURG, V43, P569, DOI 10.3171/jns.1975.43.5.0569; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Schonauer M, 1979, J Neurosurg Sci, V23, P279; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; STRICH SJ, 1961, LANCET, V2, P443; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	34	42	42	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					236	243					8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	557NC	WOS:000175913800004	12937490				2022-02-06	
J	Axelrod, BN; Fichtenberg, NL; Liethen, PC; Czarnota, MA; Stucky, K				Axelrod, BN; Fichtenberg, NL; Liethen, PC; Czarnota, MA; Stucky, K			Performance characteristics of postacute traumatic brain injury patients on the WAIS-III and WMS-III	CLINICAL NEUROPSYCHOLOGIST			English	Article								Publication of the third editions of the Wechsler intelligence and memory batteries in 1997 created a need for research identifying Wechsler Adult Intelligence Scale-Third Edition / Wechsler Memory Scale-Third Edition (WAIS-III/WMS-III) profile patterns associated with neuropathology. The WAIS-III/WMS-III Technical Manual offers data on various diagnostic groups, including traumatic brain injury (TBI). Hawkins (1998) employed Technical Manual data to propose certain diagnostic guidelines. In order to validate the conclusions put forth by Hawkins as they apply to brain injury, we examined WAIS-III and WMS-III profiles in an independent sample of 46 TBI cases. As expected, the WAIS-III Processing Speed Index (PSI) was more sensitive to brain injury than other WAIS-III composites; and specific WAIS-III scores were stronger than certain WMS-III scores. On the other hand, the predicted relationship for WMS-III auditory and visual indexes was not found. The lack of specificity for TBI of the proposed index comparisons confirms the need to validate such hypotheses in independent samples.	John D Dingell Dept Vet Affairs Med Ctr, Detroit, MI USA; Rehabil Inst Michigan, Detroit, MI USA; Wayne State Univ, Sch Med, Detroit, MI USA; Beaumont Hosp, Hlth & Rehabil Ctr, Royal Oak, MI USA; Lakeland Neurocare Ctr, Southfield, MI USA; Hurley Med Ctr, Flint, MI USA		Axelrod, BN (corresponding author), Psychol Sect 11MH PS, 4646 John R, Detroit, MI 48201 USA.						Cimino C. R., 2000, CLIN GUIDE NEUROPSYC, P69; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Keith TZ, 2000, SCHOOL PSYCHOL QUART, V15, P373, DOI 10.1037/h0088794; *PSYCH CORP, 1997, WMS 3 ADM SCOR MAN; *PSYCH CORP, 1997, WAIS 3 ADM SCOR MAN; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; VANDERPLOEG RD, 2000, CLIN GUIDE NEUROPSYC, P111	8	42	43	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2001	15	4					516	520		10.1076/clin.15.4.516.1884			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	535QR	WOS:000174656100010	11935453				2022-02-06	
J	Leclercq, PD; McKenzie, JE; Graham, DI; Gentleman, SM				Leclercq, PD; McKenzie, JE; Graham, DI; Gentleman, SM			Axonal injury is accentuated in the caudal corpus callosum of head-injured patients	JOURNAL OF NEUROTRAUMA			English	Article						amyloid precursor protein; corpus callosum; diffuse axonal injury; head injury; image analysis; immunohistochemistry	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN INJURY; INTRACRANIAL-PRESSURE; WHITE-MATTER; BETA-APP; DAMAGE; ACCUMULATION; RAT; DIAGNOSIS; MARKER	Amyloid precursor protein (APP) accumulation is a sensitive marker for the axonal damage that is commonly seen in the brain as the result of head injury. This form of damage is particularly associated with midline structures such as the corpus callosum, although it is not clear whether some areas are more susceptible than others. The aim of this study was to determine if there was a differential distribution of axonal injury throughout the corpus callosum after head injury in an unselected group of cases. Coronal tissue sections from eight cases were taken at different levels through the corpus callosum, including the genu, body, and splenium, The sections were immunostained with an antibody to APP, and the amount of axonal damage at the different levels was quantified using computer image analysis to build up a rostro-caudal profile for each case. The profiles revealed a significantly higher APP load in caudal parts of the corpus callosum, This supports previous non-quantitative reports in the literature and has important implications in terms of choosing where tissue should be sampled to maximize the chance of detecting axonal injury post mortem.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Div Neurosci & Psychol Med, Dept Neuroinflammat, London W6 8RP, England; Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Dept Neuropathol, Glasgow, Lanark, Scotland		Gentleman, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Div Neurosci & Psychol Med, Dept Neuroinflammat, Charing Cross Campus,St Dunstans Rd, London W6 8RP, England.						AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; ESIRI MM, 1996, OPPENHEIMERS DIAGNOS, P15; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1987, 31ST P STAPP CAR CRA, P49; Gentleman SM, 1999, NEUROPATH APPL NEURO, V25, P41; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Maxwell WL, 1997, J NEUROTRAUM, V14, P755; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; NUKINA N, 1992, GERONTOLOGY, V38, P10; Pierce JES, 1996, J NEUROSCI, V16, P1083; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SUENAGA T, 1994, ACTA NEUROPATHOL, V87, P450; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4; [No title captured]	39	42	42	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2001	18	1					1	9		10.1089/089771501750055721			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	390EU	WOS:000166283400001	11200244				2022-02-06	
J	Wahl, F; Grosjean-Piot, O; Bareyre, F; Uzan, A; Stutzmann, JM				Wahl, F; Grosjean-Piot, O; Bareyre, F; Uzan, A; Stutzmann, JM			Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; enoxaparin; low-molecular-weight heparin; memory; neuroscore; neuroprotection; traumatic brain injury	MOLECULAR-WEIGHT HEPARIN; NITRIC-OXIDE SYNTHASE; INHIBIT LEUKOCYTE ACCUMULATION; POLYMORPHONUCLEAR LEUKOCYTES; REDUCTION; RILUZOLE; ISCHEMIA; REPERFUSION; RECRUITMENT; NEUTROPHILS	Traumatic brain injury (TBI) is often accompanied by secondary ischemia due, in part, to edema-induced blood vessel compression. Enoxaparin, a low-molecular weight heparin, which is efficacious in models of myocardial and brain ischemia was studied in lateral fluid percussion-induced TBI in rats. Enoxaparin was administered 2 h post-TBI at 0.5 mg/kg i.v. followed by 4 x 0.5, 4 x 1, or 4 x 2 mg/kg s.c. over 30 fi. Brain edema was measured in the hippocampus, temporal cortex and parietal cortex. Edema was reduced by enoxaparin (0.5 + 4 x 0.5 mg/kg) in the hippocampus (-53%, p = 0.07) and the parietal cortex (-39%, ns). At 0.5 + 4 x 1 mg/kg edema was reduced in the hippocampus (-63%, p < 0.05) and the parietal cortex (-47%, p = 0.06). At 0.5 + 4 x 2 mg/kg, the reduction was more important in the hippocampus (-69%, p < 0.01) and in the parietal cortex (-50%, p < 0.05). No reduction was seen in the temporal cortex. The lesion size was reduced by enoxaparin at 0.5 + 4 x 1 mg/kg (-50%,p < 0.05), and at 0.5 + 4 x 2 mg/kg (-35%, ns). The neurological deficit evaluated with a 9-point scale was also improved with enoxaparin at 0.5 + 4 x 1 mg/kg 1 week post-TBI (p < 0.05). The cognitive impairment evaluated with a Lashley maze task was improved with enoxaparin (0.5 + 4 x 1 mg/kg) from 48 h (p < 0.05) to 2 weeks post-TBI (p < 0.01). Our results demonstrate for the first time that enoxaparin significantly reduces the brain contusion and edema, and improves the functional outcomes induced by a TBI. Therefore, enoxaparin could be a candidate drug to treat acute brain-injured patients.	Aventis Pharma, CNS Res Dept, F-94400 Vitry Sur Seine, France; Aventis Pharma, Ischemia Trauma Dept, F-94400 Vitry Sur Seine, France; Aventis Pharma, Behav Pharmacol Dept, F-94400 Vitry Sur Seine, France		Wahl, F (corresponding author), Aventis Pharma, CNS Dept, 13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France.	florence.wahl@aventis.com					Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; BAZZONI G, 1993, J LAB CLIN MED, V121, P268; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Bonmann E, 1998, NEUROSCI LETT, V253, P95, DOI 10.1016/S0304-3940(98)00613-2; CADE JF, 1984, THROMB RES, V35, P613, DOI 10.1016/0049-3848(84)90265-2; CARLOS TM, 1994, BLOOD, V84, P2068; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CARNEY JM, 1992, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1992, P321; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLARK WM, 1991, STROKE, V22, P877, DOI 10.1161/01.STR.22.7.877; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dagenais P, 1997, FASEB J, V11, P1805; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dietz BE, 1996, SOCIOL SPECTRUM, V16, P1, DOI 10.1080/02732173.1996.9982117; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HALL ED, 1993, RES P ARNMD, V71, P81; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; Jonas S, 1997, ANN NY ACAD SCI, V825, P389, DOI 10.1111/j.1749-6632.1997.tb48449.x; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Lashley KS, 1933, PHYSIOL REV, V13, P0001, DOI 10.1152/physrev.1933.13.1.1; Li PA, 1998, BRAIN RES, V801, P220, DOI 10.1016/S0006-8993(98)00559-9; Libersan D, 1998, CARDIOVASC RES, V37, P656, DOI 10.1016/S0008-6363(97)00292-7; Maeda T, 1997, ACT NEUR S, V70, P102; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; McIntosh TK, 1996, LAB INVEST, V74, P315; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Noble S, 1998, DRUGS, V56, P259, DOI 10.2165/00003495-199856020-00013; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; OYANAGUI Y, 1990, FREE RADICAL RES COM, V9, P87, DOI 10.3109/10715769009148576; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pratt J, 1998, HAEMOSTASIS, V28, P78; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; ROYO NC, 1999, J CEREB BLOOD FLOW M, V19, pS389; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Soares HD, 1995, J NEUROSCI, V15, P8223; Sugimori M., 1995, Society for Neuroscience Abstracts, V21, P2019; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; TYRRELL DJ, 1995, TRENDS PHARMACOL SCI, V16, P198, DOI 10.1016/S0165-6147(00)89022-7; Upchurch GR, 1997, CIRCULATION, V95, P2115, DOI 10.1161/01.CIR.95.8.2115; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WAHL F, 1999, J CEREB BLOOD FLOW M, V19, pS379; WARD PA, 1988, FREE RADICAL BIO MED, V5, P403, DOI 10.1016/0891-5849(88)90114-1; Yanaka K, 1996, J NEUROSURG, V85, P1108, DOI 10.3171/jns.1996.85.6.1108; Yanaka K, 1996, J NEUROSURG, V85, P1102, DOI 10.3171/jns.1996.85.6.1102	54	42	43	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2000	17	11					1055	1065		10.1089/neu.2000.17.1055			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	374KY	WOS:000165345400005	11101208				2022-02-06	
J	Nath, R; Huggins, M; Glantz, SB; Morrow, JS; McGinnis, K; Nadimpalli, R; Wang, KKW				Nath, R; Huggins, M; Glantz, SB; Morrow, JS; McGinnis, K; Nadimpalli, R; Wang, KKW			Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis	NEUROCHEMISTRY INTERNATIONAL			English	Article						caspase; excitotoxicity; neuronal death; fodrin; necrosis; apoptosis	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; CEREBELLAR GRANULE NEURONS; SPINAL-CORD INJURY; DNA FRAGMENTATION; RAT-BRAIN; INTERLEUKIN-1-BETA-CONVERTING ENZYME; PROTEASE ACTIVATION; NEUROBLASTOMA-CELLS	Alpha II-spectrin (alpha-fodrin) is a demonstrated endogenous substrate for caspase-3 in neurons undergoing unscheduled apoptotic death. We have previously identified the caspase cleavage site that yields the distinctive 120 kDa spectrin breakdown product (SBDP120) as (DSLD(1478*)SVEAL). Here, by using a synthetic peptide (NH2-SVEALC) mimicking the neo-N-terminal of SBDP120 as antigen, we report the development of chicken antibodies that specifically recognize the SBDP120 generated by in vitro caspase-3 digestion of bovine alpha-spectrin on Western blot. These anti-SBDP120 antibodies recognize SBDP120 generated by two apoptotic challenges (staurosporine, EGTA) to human neuroblastoma SH-SY5Y cells. Yet they neither react with intact alpha-spectrin nor its other fragments on Western blots. These anti-SBDP120 work equally well in detecting SBDP120 generated in rat cerebellar granule neurons undergoing potassium withdrawal-induced apoptosis. In immunocytochemical studies, these antibodies also specifically stained apoptotic SH-SY5Y or CGN's undergoing apoptosis in a caspase- inhibitor-sensitive manner. These anti-SBDP120s might become powerful markers for apoptotic neurons in various neurological or neurodegenerative conditions in vivo. (C) 2000 Elsevier Science Ltd. All rights reserved.	Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Lab Neurobiochem, Ann Arbor, MI 48105 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA		Nath, R (corresponding author), Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Lab Neurobiochem, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	rathna.nath@wl.com; kevin.wang@wl.com		Wang, Kevin/0000-0002-9343-6473			Armstrong RC, 1997, J NEUROSCI, V17, P553; BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; Campagne MV, 1996, NEUROSCI LETT, V213, P111, DOI 10.1016/0304-3940(96)12839-1; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; CHARRIAUTMARLANGUE C, 1995, J CEREBR BLOOD F MET, V15, P385, DOI 10.1038/jcbfm.1995.48; Chen J, 1997, J NEUROCHEM, V69, P232; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; DELCOSTE MC, 1992, NEUROSCIENCE, V18, P558; DESSI F, 1993, J NEUROCHEM, V60, P1953, DOI 10.1111/j.1471-4159.1993.tb13427.x; DOLLE RE, 1994, J MED CHEM, V37, P563, DOI 10.1021/jm00031a003; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FILIPKOWSKI RK, 1994, NEUROREPORT, V5, P1538, DOI 10.1097/00001756-199407000-00032; Guo-Ross S, 1998, NEUROCHEM INT, V33, P277, DOI 10.1016/S0197-0186(98)00032-1; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HERON A, 1993, J NEUROCHEM, V61, P1973, DOI 10.1111/j.1471-4159.1993.tb09843.x; HILL IE, 1995, BRAIN RES, V676, P398, DOI 10.1016/0006-8993(95)00145-G; HONG WJ, 1989, J BIOL CHEM, V264, P12758; Juan TSC, 1997, GENOMICS, V40, P86, DOI 10.1006/geno.1996.4548; Kerr JFR, 1991, APOPTOSIS MOL BASIS, P5; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; LI Y, 1995, MOL BRAIN RES, V28, P164, DOI 10.1016/0169-328X(94)00220-9; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Loddick SA, 1996, NEUROREPORT, V7, P1465, DOI 10.1097/00001756-199606170-00004; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; MA YP, 1993, MOL BRAIN RES, V18, P87, DOI 10.1016/0169-328X(93)90176-P; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Marks N, 1999, NEUROCHEM INT, V35, P195, DOI 10.1016/S0197-0186(99)00061-3; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; MCMAHON AP, 1987, DIFFERENTIATION, V34, P68, DOI 10.1111/j.1432-0436.1987.tb00052.x; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1998, J NEUROCHEM, V71, P186; Ni BH, 1997, J NEUROSCI, V17, P1561; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Posmantur R, 1997, J NEUROCHEM, V68, P2328; RINK A, 1995, AM J PATHOL, V147, P1575; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Scott RJ, 1997, NEUROPATH APPL NEURO, V23, P307; Siman R, 1999, NEUROSCIENCE, V92, P1425, DOI 10.1016/S0306-4522(99)00034-2; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	51	42	42	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	OCT	2000	37	4					351	361		10.1016/S0197-0186(00)00040-1			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	350AT	WOS:000089078800003	10825575				2022-02-06	
J	Proctor, MR; Cantu, RC				Proctor, MR; Cantu, RC			Head and neck injuries in young athletes	CLINICS IN SPORTS MEDICINE			English	Article							CERVICAL-SPINE; NERVOUS-SYSTEM; 2ND IMPACT; CHILDREN; SPORTS; CORD; CONCUSSION; PREVENTION; PLAYERS; SAFETY	Although injuries to the head and cervical spine are considered relatively uncommon in sports medicine, they can have a major impact on the individual athlete and the sport. These injuries account for some of the most catastrophic injuries seen in all levels of athletic participation. Concussion in sports is have a major impact on professional and college levels and is reaching epidemic proportions. The effects of paralyzing neck injuries in sports are devastating and are followed closely by our national media. In this article, the epidemiology, pathophysiology, and types of injury are reviewed, with in-depth discussion of cranial and spinal injuries.	Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Emerson Hosp, Dept Neurosurg, Concord, MA USA		Proctor, MR (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	proctor_m@al.tch.harvard.edu					ALEXANDER E, 1958, ARCH NEURO PSYCHIATR, V79, P146, DOI 10.1001/archneurpsyc.1958.02340020026006; BLAHD W H JR, 1985, Journal of Emergency Medicine, V2, P243, DOI 10.1016/0736-4679(85)90102-7; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1981, HLTH MAINTENANCE PHY; CANTU RC, 1987, EXERCISING ADULT, P129; Chorley Joseph N., 1998, Current Opinion in Pediatrics, V10, P350, DOI 10.1097/00008480-199808000-00004; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; COPE R, 1987, SOUTHERN MED J, V80, P33, DOI 10.1097/00007611-198701000-00008; EISMONT FJ, 1984, SPINE, V9, P663, DOI 10.1097/00007632-198410000-00001; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; FELDICK HG, 1976, PHYSICIAN SPORTSMED, V4, P77; GRUBER R, 1985, Z KINDERCHIR, V40, P199; Gundry C R, 1999, Magn Reson Imaging Clin N Am, V7, P85; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; GUTHKELCH AN, 1980, EUR NEUROL, V19, P91, DOI 10.1159/000115133; HAMILTON MG, 1993, J TRAUMA, V34, P227, DOI 10.1097/00005373-199302000-00008; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JENNET B, 1971, SCI FDN NEUROLOGY, P441; Katoh S, 1996, SPINAL CORD, V34, P416, DOI 10.1038/sc.1996.74; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR, P333; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon J C, 1980, Clin Neurosurg, V27, P414; Maroon JC, 1996, SPINE, V21, P2294, DOI 10.1097/00007632-199610010-00025; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MATSUURA P, 1989, J BONE JOINT SURG AM, V71A, P183, DOI 10.2106/00004623-198971020-00003; MAYFIELD FH, 1955, CLIN NEUROSURGERY, V2; McAbee GN, 1996, PEDIATR NEUROL, V15, P235, DOI 10.1016/S0887-8994(96)00162-2; McGuffie AC, 1998, SCOT MED J, V43, P139, DOI 10.1177/003693309804300504; MEEUSEN R, 1992, SPORTS MED, V13, P337, DOI 10.2165/00007256-199213050-00004; Meggyesy Dave, 1970, OUT THEIR LEAGUE, P125; MUELLER F, 1996, CATASTROPHIC INJURIE, P41; MURPHEY F, 1959, AM J SURG, V98, P379, DOI 10.1016/0002-9610(59)90530-6; MYLES ST, 1992, CAN J SURG, V35, P643; NELSON DE, 1992, AM J DIS CHILD, V146, P611, DOI 10.1001/archpedi.1992.02160170091022; NOAKES TD, 1995, SPORTS MED, V20, P348, DOI 10.2165/00007256-199520050-00006; NUGENT GR, 1959, NEUROLOGY, V9, P273; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; PENNING L, 1962, NEUROLOGY, V12, P513; PIZZUTILLO PD, 1993, AAOS INSTR COURSE LE, V42, P463; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; ROSENBAUM DM, 1986, AM J ROENTGENOL, V146, P1269, DOI 10.2214/ajr.146.6.1269; Rosenow JM, 1998, SURG NEUROL, V50, P608; Rotem TR, 1998, MED J AUSTRALIA, V168, P379, DOI 10.5694/j.1326-5377.1998.tb138989.x; ROWE BH, 1994, CAN FAM PHYSICIAN, V40, P68; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHLER AT, 1998, CLIN SPORTS MED, V17, P195; Schneider RC., 1973, HEAD NECK INJURIES F; Smith GA, 1998, PEDIATRICS, V101, P406, DOI 10.1542/peds.101.3.406; TATOR CH, 1984, CAN MED ASSOC J, V130, P875; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; TORG JS, 1985, CLIN SPORT MED, V4, P45; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Waltzman ML, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e58; WOLF BERNARD S., 1956, JOUR MT SINAI HOSP, V23, P283; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196	64	42	43	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2000	19	4					693	+		10.1016/S0278-5919(05)70233-7			24	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	358AX	WOS:000089536000008	11019736				2022-02-06	
J	Jurado, MA; Mataro, M; Verger, K; Bartumeus, F; Junque, C				Jurado, MA; Mataro, M; Verger, K; Bartumeus, F; Junque, C			Phonemic and semantic fluencies in traumatic brain injury patients with focal frontal lesions	BRAIN INJURY			English	Article							DAMAGED RIGHT-HANDERS; VERBAL-FLUENCY; WORD FLUENCY; LOBE; DEMENTIA; CORTEX; FMRI; PET	The purpose of this study was to investigate the effect of focal frontal lesions, identified by magnetic resonance imaging (MRI), in a group of traumatic brain injured (TBI) patients, in order to clarify the sensitivity of phonemic and semantic fluency tasks as tests of frontal lobe functioning. Thirteen TBI patients were included and matched with a normal control group of 26 subjects. Frontal lobe patients produced significantly fewer words than the control group in the phonemic fluency condition. Semantic performance correlated with lesion size, but phonemic performance did not, corroborating the idea that the two have different brain-based substrates. Although, as a group effect, frontal lesions impaired fluency, not all patients were impaired, even in the presence of large bilateral frontal lesions.	Univ Barcelona, Fac Psicol, Dept Psiquiatria & Psicobiol Clin, Barcelona 08035, Spain; St Pau Hosp, Barcelona, Spain		Jurado, MA (corresponding author), Univ Barcelona, Fac Psicol, Dept Psiquiatria & Psicobiol Clin, Passeig Vall Dhebron 171, Barcelona 08035, Spain.		Junque, Carme/B-4400-2011; JURADO, MARIA ANGELES/E-1745-2011; Mataro, Maria/B-4524-2011	Junque, Carme/0000-0002-6381-3063; JURADO, MARIA ANGELES/0000-0002-9403-1670; Mataro, Maria/0000-0002-9946-2656			Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BOIVIN MJ, 1992, CORTEX, V28, P231, DOI 10.1016/S0010-9452(13)80051-2; Crossley M, 1997, J CLIN EXP NEUROPSYC, V19, P52, DOI 10.1080/01688639708403836; Damasio H., 1989, LESION ANAL NEUROPSY; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Goulet P, 1997, NEUROPSYCHOLOGIA, V35, P1565, DOI 10.1016/S0028-3932(97)00081-X; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JOANETTE Y, 1988, BRAIN LANG, V34, P54, DOI 10.1016/0093-934X(88)90124-1; JOANETTE Y, 1986, NEUROPSYCHOLOGIA, V24, P875, DOI 10.1016/0028-3932(86)90087-4; Jurado MA, 1997, NEUROPSYCHOLOGIA, V35, P635, DOI 10.1016/S0028-3932(96)00112-1; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; MARTIN RC, 1990, NEUROPSYCHOLOGIA, V28, P823, DOI 10.1016/0028-3932(90)90006-A; MICELI G, 1981, Journal of Clinical Neuropsychology, V3, P53, DOI 10.1080/01688638108403113; Milner B., 1964, FRONTAL GRANULAR COR, P313; Newcombe F., 1969, MISSILE WOUNDS BRAIN; PARKS RW, 1988, J CLIN EXP NEUROPSYC, V10, P565, DOI 10.1080/01688638808402795; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Phelps EA, 1997, NEUROREPORT, V8, P561, DOI 10.1097/00001756-199701200-00036; Pujol J, 1996, ACTA NEUROL SCAND, V93, P403; RAMIER AM, 1970, REV NEUROL, V123, P17; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; WECHSLER D, 1976, ESCALA INTELIGENCIA	27	42	45	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2000	14	9					789	795					7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357YT	WOS:000089530300003	11030453				2022-02-06	
J	van der Naalt, J; Van Zomeren, AH; Sluiter, WJ; Minderhoud, JM				van der Naalt, J; Van Zomeren, AH; Sluiter, WJ; Minderhoud, JM			Acute behavioural disturbances related to imaging studies and outcome in mild-to-moderate head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; AGITATION; REHABILITATION; SEQUELAE; PATIENT	The frequency of behavioural disturbances early after injury in relation to outcome was prospectively investigated in a series of 67 patients with mild-to-moderate head injury (as defined by GCS on admission). In more than half of the patients, behavioural disturbances were observed. Restlessness occured in 40% of patients, whereas agitation was seen in 19% of patients. In all patients, restlessness and agitation disappeared before resolution of PTA. In multiple regression analysis, restlessness and PTA were found to be separate factors in predicting outcome. On imaging studies, twice as many lesions were seen in patients with restlessness and agitation (81% compared to 39%), mainly localized in the frontotemporal region. In two thirds of patients with early behavioural disturbances, residual emotional and cognitive impairments were seen 1 year after injury. This study suggests that behavioural disturbances in the early phase after injury are related to frontotemporal lesions and lends support for the view of the existence of a separate profile of patient behaviour in mild-to-moderate head injury.	Univ Groningen Hosp, Dept Neurol, NL-9700 RB Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen Hosp, Dept Neurol, POB 30-001, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@neuro.azg.nl		van der Naalt, Joukje/0000-0001-9873-2418			BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; MCLAURIN RL, 1965, J NEUROSURG, V23, P296, DOI 10.3171/jns.1965.23.3.0296; Minderhoud J M, 1979, Acta Neurochir Suppl (Wien), V28, P63; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Silver BV, 1996, BRAIN INJURY, V10, P609; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207	19	42	42	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2000	14	9					781	788					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	357YT	WOS:000089530300002	11030452				2022-02-06	
J	Giri, BK; Krishnappa, IK; Bryan, RM; Robertson, C				Giri, BK; Krishnappa, IK; Bryan, RM; Robertson, C			Regional cerebral blood flow after cortical impact injury complicated by a secondary insult in rats	STROKE			English	Article						brain injuries; cerebral blood flow; cerebral ischemia; trauma	SEVERE HEAD-INJURY; FLUID-PERCUSSION INJURY; TRAUMATIC BRAIN INJURY; AUTO-REGULATION; AUTOREGULATION; ISOFLURANE; METABOLISM; HYPOTENSION; HYPOXIA; PO2	Background and Purpose-Traumatic injury makes the brain susceptible to secondary insults. An uncomplicated mild lateral cortical impact injury (3 m/s, 2.5-mm deformation) that causes little or no permanent sequelae results in a large contusion at the impact site when the traumatic injury is complicated by a secondary insult, such as 40 minutes of bilateral carotid occlusion. Methods-To determine whether the increased sensitivity to secondary insults in this model is caused by a vascular mechanism, cerebral blood flow (CBF) was measured with C-14-isopropyliodoamphetamine quantitative autoradiography, and brain tissue Po-2 (Pbto(2)) was measured at the impact site and in the contralateral parietal cortex. Results-In animals that underwent bilateral carotid occlusion 1 hour after the impact injury, CBF and Pbto(2) were lower at the impact site than they were in animals that had either the impact injury or the carotid occlusion alone. In the immediate area of the impact, CBF was 14+/-6 mL . 100 g(-1) . min(-1) in the animals with the impact injury followed by carotid occlusion compared with 53+/-24 mL . 100 g(-1) . min(-1) in the animals with the impact injury alone and 74+/-14 mL . 100 g(-1) . min(-1) in the animals with the carotid occlusion alone (P<0.001). At the time of this very low CBF value in the animals with the carotid occlusion after the impact injury, Pbto(2) at the impact site averaged 1.3+/-1.6 mm Hg and was <3 mm Hg in 5 of the 6 animals. In contrast, Pbto(2) in the animals with the impact injury alone averaged 9.3+/-2.9 mm Hg, and none of the animals had a Pbto(2) of <3 mm Hg (P=0.008). Conclusions-The CBF and Pbto(2) findings in this model suggest that the reduced CBF after traumatic injury predisposes the brain to secondary insults and results in ischemia when confronted with a reduction in cerebral perfusion pressure.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA		Robertson, C (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BRYAN RM, 1988, AM J PHYSIOL, V255, pR295, DOI 10.1152/ajpregu.1988.255.2.R295; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DEWITT DS, 1995, NEW HORIZ, V3, P76; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HOFFMAN WE, 1991, ANESTH ANALG, V73, P753; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1993, J NEUROTRAUMA S1, V10, pS102; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; KOHMURA E, 1990, J CEREBR BLOOD F MET, V10, P877, DOI 10.1038/jcbfm.1990.144; LEE JG, 1994, ANESTH ANALG, V79, P58; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MURR R, 1993, ANESTH ANALG, V77, P898; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Palkovits M., 1988, MAPS GUIDE MICRODISS; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; TSUJI O, 1994, INTRACRANIAL PRESSUR, V9, P268; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; WALD S, 1991, Journal of Trauma, V31, P1041, DOI 10.1097/00005373-199107000-00102; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	41	42	43	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	APR	2000	31	4					961	967		10.1161/01.STR.31.4.961			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	300WR	WOS:000086277200030	10754006	Bronze, Green Published			2022-02-06	
J	Goozee, JV; Murdoch, BE; Theodoros, DG; Stokes, PD				Goozee, JV; Murdoch, BE; Theodoros, DG; Stokes, PD			Kinematic analysis of tongue movements in dysarthria following traumatic brain injury using electromagnetic articulography	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; ARTICULATORY MOVEMENTS; DYNAMICS	Electromagnetic articulography (EMA), a technique that uses alternating magnetic fields to track the movement of miniature receiver coils affixed to the articulators, was used to assess the speed and accuracy of tongue movements exhibited by an individual with dysarthria following severe traumatic brain injury (TBI). Three receiver coils were attached to the TBI subject's tongue and the movements of these coils were recorded during five productions of three single syllable real words consisting of the lingual consonants /t, s, k/ in the word-initial position. A non-neurologically impaired adult male served as a control subject. A range of kinematic parameters was analysed from the consonant productions including the movement trajectories, velocity, acceleration, distance, and duration of tongue movements. Examination of the complex interactions between the kinematic parameters recorded for the TBI subject revealed a disturbance in the 'control' of tongue speed rather than a disturbance in speed per se, as it was found that the TBI subject exhibited difficulty in decelerating his tongue movements appropriately on the approach up to the palate during consonant production. The difficulty noted in deceleration resulted in inaccurate tongue movements that overshot the point of intent (in the case of /t/) and may have been instrumental in reducing the length of time that the tongue remained at the palate (in the case of /s/ and /k/) in comparison to the control subject. The disturbances identified in the kinematic parameters recorded provided objective insights into the nature of the articulatory disturbances responsible for the deviant speech feature, consonant imprecision, perceived in the TBI subject's speech. The study stresses the importance of examining a range of kinematic parameters and the interactions between these parameters in attempting to determine the nature of articulatory disturbances exhibited by individuals with dysarthria following TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia		Murdoch, BE (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.		Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				Brown J.R., 1975, MOTOR SPEECH DISORDE; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; HARDCASTLE WJ, 1981, WORK PROGR, V3, P51; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HIROSE H, 1982, FOLIA PHONIATR, V34, P210, DOI 10.1159/000265651; HIROSE H, 1978, J SPEECH HEAR DISORD, V43, P96, DOI 10.1044/jshd.4301.96; KENT R, 1975, J SPEECH HEAR DISORD, V40, P115, DOI 10.1044/jshd.4001.115; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; KIRITANI S, 1986, SPEECH COMMUN, V5, P119, DOI 10.1016/0167-6393(86)90003-8; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; MURDOCH BE, 1997, CLIN MANAGEMENT SENS, P287; PERKELL JS, 1992, J ACOUST SOC AM, V92, P3078, DOI 10.1121/1.404204; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; TULLER B, 1990, J ACOUST SOC AM, V88, P674, DOI 10.1121/1.399771; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	20	42	44	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2000	14	2					153	174		10.1080/026990500120817			22	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	281GW	WOS:000085151000005	10695571				2022-02-06	
J	Quinto, C; Gellido, C; Chokroverty, S; Masdeu, J				Quinto, C; Gellido, C; Chokroverty, S; Masdeu, J			Posttraumatic delayed sleep phase syndrome	NEUROLOGY			English	Article						sleep disorders; delayed sleep phase syndrome	DISORDERS	Circadian rhythm sleep disorders may occur after traumatic brain injury. We describe a 48-year-old man who presented with sleep onset insomnia and cognitive dysfunction after a car accident. A diagnosis of delayed sleep phase syndrome (DSPS) was confirmed by sleep logs and actigraphy, which revealed sleep onset in the early morning hours and awakening around noon.	New York Med Coll, St Vincents Hosp, Dept Neurol, New York, NY 10011 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA		Quinto, C (corresponding author), New York Med Coll, St Vincents Hosp, Dept Neurol, 153 W 11th St, New York, NY 10011 USA.		Masdeu, Joseph C/B-5052-2010				*AM SLEEP DIS ASS, 1997, INT CLASS SLEEP DIS, P132; Ando K, 1995, SLEEP RES, V24, P509; KLEIN DC, 1991, SUPRACHIASMATIC NUCL; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; PELAYO RP, 1988, SLEEP RES, V17, P392; Richardson GS, 1996, J CLIN NEUROPHYSIOL, V13, P17, DOI 10.1097/00004691-199601000-00003; SCHREIBER S, 1997, J NEUROPSYCHIAT, V9, P640; Wagner DR, 1996, NEUROL CLIN, V14, P651, DOI 10.1016/S0733-8619(05)70278-4; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737	9	42	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	JAN 11	2000	54	1					250	252		10.1212/WNL.54.1.250			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273VE	WOS:000084727900049	10636163				2022-02-06	
J	Morrow, TJ; Paulson, PE; Brewer, KL; Yezierski, RP; Casey, KL				Morrow, TJ; Paulson, PE; Brewer, KL; Yezierski, RP; Casey, KL			Chronic, selective forebrain responses to excitotoxic dorsal horn injury	EXPERIMENTAL NEUROLOGY			English	Article						spinal cord injury; regional cerebral blood flow; plasticity; somatosensory; diencephalon; cortex; quisqualic acid	SPINAL-CORD INJURY; HYPOTHALAMIC ARCUATE NUCLEUS; INDUCED NOXIOUS-STIMULATION; CHRONIC CENTRAL PAIN; BLOOD-FLOW; FUNCTIONAL-ACTIVITY; SPINOHYPOTHALAMIC TRACT; INTRASPINAL INJECTIONS; QUISQUALIC ACID; AMINO-ACIDS	Intraspinal injection of the AMPA/metabotropic receptor agonist quisqualic acid (QUIS) results in excitotoxic injury which develops pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI) (R. P. Yezierski et at, 1998, Pain 75: 141-155; R, P. Yezierski ct at, 1993, J. Neurotrauma 10: 445-456), Since spinal injury can lead to partial or complete deafferentation of ascending supraspinal structures, it is likely that secondary to the disruption of spinal pathways these regions could undergo significant reorganization. Recently, T. J. Morrow et at. (Pain 75: 355-365) showed that autoradiographic estimates of regional cerebral blood flow (rCBF) can be used to simultaneously identify alterations in the activation of multiple forebrain structures responsive to noxious formalin stimulation. Accordingly, we examined whether excitotoxic SCI produced alterations in the activation of supraspinal structures using rCBF as a marker of neuronal activity. Twenty-four to 41 days after unilateral injection of QUIS into the T12 to L3 spinal segments, we found significant increases in the activation of 7 of 22 supraspinal structures examined. As compared to controls, unstimulated SCI rats exhibited a significant bilateral increase in rCBF within the arcuate nucleus (ARC), the hindlimb region of S1 cortex (HL), parietal cortex (PAR), and the thalamic posterior (PO), ventral lateral (VL), ventral posterior lateral (VPL), and ventral posterior medial (VPM) nuclei. All structures showing significantly altered rCBF are associated with the processing of somatosensory information. These changes constitute remote responses to injury and suggest that widespread functional changes occur within cortical and subcortical regions following injury to the spinal cord. (C) 2000 Academic Press.	VA Med Ctr, Neurol Res Lab, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; E Carolina Univ, Dept Anat & Cell Biol, Greenville, NC 27858 USA; Univ Miami, Miami Project, Miami, FL 33136 USA		Morrow, TJ (corresponding author), VA Med Ctr, Neurol Res Lab, Ann Arbor, MI 48105 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD033986] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01-HD33986] Funding Source: Medline		Bach FW, 1997, ACTA ANAESTH SCAND, V41, P133, DOI 10.1111/j.1399-6576.1997.tb04627.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Brewer K. L., 1997, Society for Neuroscience Abstracts, V23, P438; BUNGE MB, 1994, EXP NEUROL, V127, P76, DOI 10.1006/exnr.1994.1082; Burstein R, 1996, J COMP NEUROL, V373, P549, DOI 10.1002/(SICI)1096-9861(19960930)373:4<549::AID-CNE6>3.0.CO;2-1; BURSTEIN R, 1991, J NEUROPHYSIOL, V66, P261, DOI 10.1152/jn.1991.66.1.261; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; HAMBA M, 1988, BRAIN RES BULL, V21, P757, DOI 10.1016/0361-9230(88)90043-3; HAO JX, 1992, J NEUROPHYSIOL, V68, P384, DOI 10.1152/jn.1992.68.2.384; Iadecola C, 1996, J NEUROPHYSIOL, V75, P940, DOI 10.1152/jn.1996.75.2.940; Jain N, 1998, NEWS PHYSIOL SCI, V13, P143; KOYAMA S, 1993, BRAIN RES, V612, P345, DOI 10.1016/0006-8993(93)91684-K; LENZ FA, 1994, J NEUROPHYSIOL, V72, P1570, DOI 10.1152/jn.1994.72.4.1570; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; LOMBARD MC, 1979, ADV PAIN RES THER, V3, P767; LOU HC, 1987, ANN NEUROL, V22, P289, DOI 10.1002/ana.410220302; MADSEN PW, 1994, J NEUROTRAUM, V11, P241, DOI 10.1089/neu.1994.11.241; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; Morrow T. J., 1998, Society for Neuroscience Abstracts, V24, P2083; Morrow TJ, 1998, PAIN, V75, P355, DOI 10.1016/S0304-3959(98)00016-5; Ness TJ, 1998, PAIN, V78, P139, DOI 10.1016/S0304-3959(98)00153-5; *NIH, 1996, NIH GUID CAR US LAB; PALKOVITS M, 1986, BRAIN RES, V373, P252, DOI 10.1016/0006-8993(86)90339-2; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PORRO CA, 1991, NEUROSCIENCE, V41, P667, DOI 10.1016/0306-4522(91)90358-U; PORRO CA, 1991, NEUROSCIENCE, V41, P655, DOI 10.1016/0306-4522(91)90357-T; Price DD, 1988, PSYCHOL NEURAL MECH; SIDDALL P, 1995, NEUROREPORT, V6, P1241, DOI 10.1097/00001756-199506090-00003; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SOKOLOFF L, 1981, FED PROC, V40, P2311; TAKESHIGE C, 1991, BRAIN RES BULL, V26, P779, DOI 10.1016/0361-9230(91)90175-J; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; WANG Q, 1990, BRAIN RES, V526, P221, DOI 10.1016/0006-8993(90)91225-6; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; WILLIS WD, 1985, PAIN SYSTEM NEURAL M; XU XJ, 1994, PAIN, V56, P271, DOI 10.1016/0304-3959(94)90165-1; Yezierski RP, 1996, PAIN, V68, P185, DOI 10.1016/S0304-3959(96)03178-8; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; Yezierski RP, 1996, J CEREBR BLOOD F MET, V16, P996, DOI 10.1097/00004647-199609000-00025; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	47	42	42	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JAN	2000	161	1					220	226		10.1006/exnr.1999.7246			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	290FU	WOS:000085666300020	10683288				2022-02-06	
J	Sarrafzadeh, AS; Thomale, UW; Kroppenstedt, SN; Unterberg, AW				Sarrafzadeh, AS; Thomale, UW; Kroppenstedt, SN; Unterberg, AW			Neuroprotective effect of melatonin on cortical impact injury in the rat	ACTA NEUROCHIRURGICA			English	Article						melatonin; antioxidant; cortical impact injury; brain contusion	PINEAL HORMONE MELATONIN; TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; PROTECTION; KAINATE; DAMAGE; LIGHT; RADICALS; MODEL	The pineal hormone melatonin is a highly efficient physiological scavenger of free radicals involved in secondary brain damage. A variety of experimental studies have demonstrated a neuroprotective effect for melatonin, based on its antioxidant activity. The purpose of the present study was to investigate the time-dependency and a possible protective effect of exogenous melatonin in the cortical impact model in rats. The protective effect was quantified determining contusion volume, brain edema and brain water content. 45 anesthetized male Sprague-Dawley rats (250-350 mg) were subjected to cortical impact injury of moderate severity (7 mis, deformation 2 mm). Melatonin (100 mg/kg bw i.p.), or a vehicle was injected 20 min before trauma, immediately after, and 1 and 2 hours after trauma during daytime and nighttime. Posttraumatic lesion volume using hematoxylin-eosin staining, hemispheric swelling, brain water content, cerebral perfusion pressure and intracranial pressure 24 hours after injury were investigated. Melatonin, given during nighttime, significantly reduced contusion volume corresponding to a mean reduction of contusion volume of 27% (placebo, n = 7: 41.9 +/- 5.2 mm(3), melatonin, n = 8: 30.5 +/- 4.2 mm(3), p < 0.05). Given during daytime, the reduction in contusion volume was not significant (placebo, n = 8: 42.1 <plus/minus> 5.1 mm(3), melatonin, n = 8: 35.9 +/- 2.2 mm(3), reduction of 15%, p = 0.08, n.s.). Hemispheric swelling was unchanged by melatonin treatment. Mean arterial blood pressure and rectal temperature remained stable before and after the cortical impact injury and injection of melatonin. This study shows that melatonin significantly reduces contusion volume with major effects during night.	Humboldt Univ, Virchow Med Ctr, Charite, Dept Neurosurg, D-13353 Berlin, Germany		Sarrafzadeh, AS (corresponding author), Humboldt Univ, Virchow Med Ctr, Charite, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.						Arendt J, 1997, J BIOL RHYTHM, V12, P604, DOI 10.1177/074873049701200616; CIPOLLANETO J, 1993, J NEURAL TRANSM-GEN, V92, P117, DOI 10.1007/BF01244871; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Guerrero JM, 1997, J PINEAL RES, V23, P24, DOI 10.1111/j.1600-079X.1997.tb00331.x; HARDELAND R, 1995, J PINEAL RES, V18, P104, DOI 10.1111/j.1600-079X.1995.tb00147.x; ILLNEROVA H, 1971, LIFE SCI, V10, P955, DOI 10.1016/0024-3205(71)90360-2; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Manev H, 1996, RESTOR NEUROL NEUROS, V9, P251, DOI 10.3233/RNN-1996-9408; Manev H, 1997, ANN NY ACAD SCI, V825, P85, DOI 10.1111/j.1749-6632.1997.tb48417.x; Melchiorri D, 1996, EUR J PHARMACOL, V305, P239, DOI 10.1016/0014-2999(96)00241-5; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; Pappolla MA, 1997, J NEUROSCI, V17, P1683; Pierre C., 1994, LIFE SCI, V55, P271; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Reiter RJ, 1997, HORM METAB RES, V29, P363, DOI 10.1055/s-2007-979057; Scaiano JC, 1995, J PINEAL RES, V19, P189, DOI 10.1111/j.1600-079X.1995.tb00188.x; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Uz T, 1996, NEUROSCIENCE, V73, P631, DOI 10.1016/0306-4522(96)00155-8; Viswanathan Mohan, 1993, Biological Signals, V2, P221; WirzJustice A, 1996, J AFFECT DISORDERS, V37, P109, DOI 10.1016/0165-0327(95)00081-X; YERESWARAM K, 1997, J PINEAL RES, V22, P45; [No title captured]	28	42	45	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2000	142	11					1293	1299		10.1007/s007010070028			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	387GW	WOS:000166115700030	11201646				2022-02-06	
J	Yeo, RA; Hill, D; Campbell, R; Vigil, J; Brooks, WM				Yeo, RA; Hill, D; Campbell, R; Vigil, J; Brooks, WM			Developmental instability and working memory ability in children: A magnetic resonance spectroscopy investigation	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE LESIONS; TRAUMATIC BRAIN INJURY; PROTON MR SPECTROSCOPY; FLUCTUATING ASYMMETRY; TEMPORAL-ORDER; CORTICAL ACTIVATION; PREFRONTAL CORTEX; AMNESIC PATIENTS; CHILDHOOD-ONSET; HAND PREFERENCE	This study of children (ages 7 through 12) wishes to determine (a) whether variation in frontal lobe brain chemistry, determined from proton magnetic resonance spectroscopy (H-1-MRS), is related to performance on a working memory task in children, and (b) whether developmental instability (DI; the imprecise expression of the genetic plan for development due to several known genetic and environmental effects) underlies phenotypic variation in brain chemistry. H-1-MRS assessed neurometabolites in a right frontal white matter voxel. The Visual Two-Back test assessed working memory. A composite measure of DI was created from measures of minor physical anomalies, fluctuating asymmetry of body characteristics, and fluctuating asymmetry of dermatoglyphic features. Greater DI strongly predicted lower concentrations of creatine-phosphocreatine (Cre) and choline-containing compounds, whereas Cre and N-acetyl-aspartate positively correlated with working memory skills. Working memory skills thus seem related to frontal lobe energy metabolism, which in turn is related to DI.	Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; Univ New Mexico, Coll Educ, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Clin & Magnet Resonance Imaging Ctr, Albuquerque, NM 87131 USA		Yeo, RA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	ryeo@unm.edu		brooks, william/0000-0001-6227-7636			Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; Bertolino A, 1998, AM J PSYCHIAT, V155, P1376, DOI 10.1176/ajp.155.10.1376; Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.3.CO;2-G; Brooks WM, 1998, BIOL PSYCHIAT, V43, P263, DOI 10.1016/S0006-3223(97)00462-9; Brooks WM, 1999, J RHEUMATOL, V26, P81; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; Chugani Harry T., 1994, P153; CLARKE GM, 1992, EVOLUTION, V46, P753, DOI 10.1111/j.1558-5646.1992.tb02081.x; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Conners C.K., 1990, CONNERS RATING SCALE; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; Denckla MB, 1996, J DEV BEHAV PEDIATR, V17, P114; FORD CC, 1992, NEUROLOGY, V42, P1408, DOI 10.1212/WNL.42.7.1408; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Furlow FB, 1997, P ROY SOC B-BIOL SCI, V264, P823, DOI 10.1098/rspb.1997.0115; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; FUSTER JM, 1991, FRONTAL LOBE FUNCTIO, P83; GADOW KD, 1994, CHILD S INVENTORY MA; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1991, FRONTAL LOBE FUNCTIO, P117; GORENSTEIN EE, 1989, J CLIN PSYCHOL, V45, P619, DOI 10.1002/1097-4679(198907)45:4<619::AID-JCLP2270450419>3.0.CO;2-M; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Huttenlocher Peter R., 1994, P137; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; LEARY RF, 1983, NATURE, V301, P71, DOI 10.1038/301071a0; LopezVillegas D, 1997, P NATL ACAD SCI USA, V94, P9854, DOI 10.1073/pnas.94.18.9854; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; Manning JT, 1997, EVOL HUM BEHAV, V18, P15, DOI 10.1016/S1090-5138(96)00072-4; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Moore GJ, 1998, PEDIATR RADIOL, V28, P805, DOI 10.1007/s002470050470; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Rae C, 1996, P ROY SOC B-BIOL SCI, V263, P1061, DOI 10.1098/rspb.1996.0156; Rajanayagam V, 1997, AM J NEURORADIOL, V18, P1909; Richards TL, 1997, INT J NEURORADIOL, V3, P490; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; SCHEIBEL A, 1990, BRAIN COGNITION, V12, P85, DOI 10.1016/0278-2626(90)90006-A; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Shimamura Arthur P., 1995, P803; Smith Edward E., 1995, P1009; Spindler KA, 1997, SCHIZOPHR RES, V27, P1, DOI 10.1016/S0920-9964(97)00074-1; Stevens AA, 1998, ARCH GEN PSYCHIAT, V55, P1097, DOI 10.1001/archpsyc.55.12.1097; Swaddle, 1997, ASYMMETRY DEV STABIL; SWARTZ BE, 1994, NEUROREPORT, V5, P925, DOI 10.1097/00001756-199404000-00018; THOMA R, IN PRESS LATERALITY; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; VANVALEN L, 1962, EVOLUTION, V16, P125; WALDROP MF, 1989, UNPUB MANUAL ASSESSM; WALDROP MF, 1971, EXCEPTIONAL INFANT S, P343; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; YEO RA, 1993, GENETICA, V89, P281, DOI 10.1007/BF02424521; Yeo RA, 1997, NEUROPSYCHOLOGY, V11, P552, DOI 10.1037/0894-4105.11.4.552; Yeo RA, 1999, SCHIZOPHR RES, V39, P197, DOI 10.1016/S0920-9964(99)00074-2; YEO RA, 1993, PSYCHOBIOLOGY, V21, P161; Yeo RA, 1997, PSYCHIAT RES-NEUROIM, V76, P1, DOI 10.1016/S0925-4927(97)00056-5; YEO RA, 1998, DEV EXCEPTIONALITY P, P1; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	69	42	42	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2000	17	2					143	159		10.1207/S15326942DN1702_01			17	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	342TK	WOS:000088661100001	10955200				2022-02-06	
J	Chiaretti, A; De Benedictis, R; Langer, A; Di Rocco, C; Bizzarri, C; Iannelli, A; Polidori, G				Chiaretti, A; De Benedictis, R; Langer, A; Di Rocco, C; Bizzarri, C; Iannelli, A; Polidori, G			Prognostic implications of hyperglycaemia in paediatric head injury	CHILDS NERVOUS SYSTEM			English	Article						children; head injury; hyperglycaemia; outcome	ADMISSION HYPERGLYCEMIA; CEREBRAL-ISCHEMIA; BRAIN; GLUCOSE; ACIDOSIS; CHILDREN; INSULIN	Fifty children with head injury were evaluated in an attempt to estabilish a correlation between post-traumatic hyperglycaemia and long-term outcome. In all the patients, the blood glucose level was measured on admission and on the days following the trauma (threshold of normal value set at 150 mg/dl). Hyperglycaemia was seen more frequently in children with severe head injury than in those with mild and moderate head injury. It was present in 87.5% of the patients with a Glasgow Coma Score (GCS) less than or equal to 8 (the average blood glucose level on admission was 237.8+/-92 mg/dl), in 60% of the patients with a GCS of 9-12 (178+/-78.7 mg/dl) and only in 25% of those with a GCS of 13-15 (131.5+/-39 mg/dl). A close correlation was also seen between the outcome and the blood glucose level. In fact, the blood glucose on admission was higher in the patients with a poor outcome, i.e. in those having a Glasgow Outcome Score (COS) of 2 or 3 and in those who died (GOS 1), than in the patients with a good outcome (GOS of 4 or 5). Finally, hyperglycaemia persisted beyond the first 24 h after trauma in all the children who died or who survived with a poor outcome. Hyperglycaemia, and especially its persistence over time, appears to be an important negative prognostic factor in children with head injury.	Univ Cattolica Sacro Cuore, Inst Paediat, Paediat Intens Care Unit, I-00168 Rome, Italy; Univ Cattolica Sacro Cuore, Dept Paediat Neurosurg, I-00168 Rome, Italy		Chiaretti, A (corresponding author), Univ Cattolica Sacro Cuore, Inst Paediat, Paediat Intens Care Unit, Largo A Gemelli 8, I-00168 Rome, Italy.		Bizzarri, Carla/AAI-2429-2019	Bizzarri, Carla/0000-0002-5616-9185			DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; FLAKALL PJ, 1995, AM J PHYSIOL, V269, P636; FUKUOKA S, 1989, STROKE, V20, P396, DOI 10.1161/01.STR.20.3.396; ISSEKUTZ B, 1965, AM J PHYSIOL, V209, P1137, DOI 10.1152/ajplegacy.1965.209.6.1137; JEEVANANDAM M, 1990, J TRAUMA, V30, P582, DOI 10.1097/00005373-199005000-00010; KUSHNER M, 1990, ANN NEUROL, V28, P129, DOI 10.1002/ana.410280204; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; MERGUERIAN PA, 1981, CRIT CARE MED, V9, P838, DOI 10.1097/00003246-198112000-00007; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Pentelenyi T, 1979, Acta Neurochir Suppl (Wien), V28, P103; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; ROLIH CA, 1995, MED CLIN N AM, V79, P211, DOI 10.1016/S0025-7125(16)30093-1; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SIEBER FE, 1992, CRIT CARE MED, V20, P104, DOI 10.1097/00003246-199201000-00022; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	18	42	44	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	SEP	1998	14	9					455	459		10.1007/s003810050259			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	126BK	WOS:000076272700006	9808254				2022-02-06	
J	Kant, R; Smith-Seemiller, L; Zeiler, D				Kant, R; Smith-Seemiller, L; Zeiler, D			Treatment of aggression and irritability after head injury	BRAIN INJURY			English	Article; Proceedings Paper	8th Annual Meeting of the American-Neuropsychiatric-Association	FEB 02-04, 1997	ORLANDO, FLORIDA	Amer Neuropsychiat Assoc			DISORDERS	Thirteen patients who experienced problems with irritability and aggression following closed head injury (CHI) participated in a non-blind, 8 week open trial of sertraline Hcl. Significant reduction in irritability and aggressive outbursts was observed. No significant changes were observed in depressive symptomatology. Results suggest that serotonergic agents may be useful in treating aggression and irritability after head injury. Further placebo-controlled studies using serotonergic agents are indicated.	St Francis Med Ctr, Head Injury Clin, Pittsburgh, PA 15524 USA; St Francis Med Ctr, Dept Psychiat, Pittsburgh, PA 15524 USA; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA		Kant, R (corresponding author), St Francis Med Ctr, Head Injury Clin, 4608 Penn Ave, Pittsburgh, PA 15524 USA.		Kant, Ravi/F-7025-2013	Kant, Ravi/0000-0003-3878-9775			BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; COCCARO EF, 1992, INT CLIN PSYCHOPHARM, V7, P3, DOI 10.1097/00004850-199200710-00001; JOHNSON D, 1993, BRIT J NEUROSURG, V7, P53, DOI 10.3109/02688699308995056; LINNOILA VMI, 1992, J CLIN PSYCHIAT, V53, P46; LOPEZIBOR JJ, 1992, INT CLIN PSYCHOPHARM, V7, P5, DOI 10.1097/00004850-199210002-00003; MARKOVITZ PJ, 1991, AM J PSYCHIAT, V148, P1064; MOSS HB, 1990, BIOL PSYCHIAT, V28, P325, DOI 10.1016/0006-3223(90)90660-T; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; SPOTZER RL, 1978, SCHEDULE AFFECTIVE D; VANPRAAG HM, 1986, SUICIDE LIFE-THREAT, V16, P103; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; [No title captured]	13	42	42	1	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1998	12	8					661	666		10.1080/026990598122223			6	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	108AN	WOS:000075243800003	9724837				2022-02-06	
J	Max, JE; Koele, SL; Lindgren, SD; Robin, DA; Smith, WL; Sato, Y; Arndt, S				Max, JE; Koele, SL; Lindgren, SD; Robin, DA; Smith, WL; Sato, Y; Arndt, S			Adaptive functioning following traumatic brain injury and orthopedic injury: A controlled study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; CHILDREN; PREDICTORS; SEQUELAE; SEVERITY; SCALE; COMA	Objective: To study adaptive functioning after severe traumatic brain injury (TBI). Design: Case-control study. Setting: A university hospital and three regional and four community hospitals. Subjects: A consecutive series (n = 24) of children age 5 through 14 years who suffered severe TBI were individually matched to subjects who sustained a mild TBI and to a second group who sustained an orthopedic injury with no evidence of TBI. Main Outcome Measures: Standardized adaptive functioning, intellectual, psychiatric, and neuroimaging assessments were conducted on average 2 years after injury. Results: Severe TBI was associated with significantly (p <.05) lower Vineland Adaptive Behavior composite, communication, and socialization standard scores and lower Child Behavior Checklist parent-rated social competence scores compared with children with orthopedic injury. Severe TBI and mild TBI subjects were significantly (p <.05) more impaired than orthopedic subjects on teacher-rated adaptive function. Family functioning, psychiatric disorder in the child, and IQ were significant variables, explaining between 22% and 47% of the variance in adaptive functioning outcomes. Conclusions: Severe TBI is associated with significant deficits in child adaptive functioning. This association appears to be mediated by family dysfunction, child psychiatric disorder, and intellectual deficits. (C) 1998 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Speech Pathol & Audiol, Iowa City, IA 52242 USA		Max, JE (corresponding author), Univ Iowa, Dept Psychiat, 1876 JPP, Iowa City, IA 52242 USA.		Robin, Donald/F-2109-2010; Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204; Sato, Yutaka/0000-0002-5245-232X	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH40856, MH31593, MHCRC43271] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH043271, R01MH040856, R01MH031593, R37MH031593, P50MH043271] Funding Source: NIH RePORTER		Achenbach, 1991, MANUAL TEACHERS REPO; Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ciccetti D., 1984, VINELAND ADAPTIVE BE; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EPSTEIN NB, 1981, HDB FAMILY THERAPY, P444; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; MAX JE, 1992, RULES BEST ESTIMATE; MAX JE, 1997, J AM ACAD CHILD ADOL, V36, P96; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; SAMEROFF AJ, 1975, MERRILL PALMER QUART, V21, P267; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1974, MANUAL WECHSLER INTE; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	34	42	42	1	8	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1998	79	8					893	899		10.1016/S0003-9993(98)90084-3			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	108MJ	WOS:000075269800003	9710159				2022-02-06	
J	Aloe, L; Fiore, M				Aloe, L; Fiore, M			TNF-alpha expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior	NEUROSCIENCE LETTERS			English	Article						tumor necrosis factor-alpha; transgenic mice; behavior; grooming; tyroxine hydroxylase; nerve growth factor; nerve growth factor-antibody	NERVE GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; RATS	Tumor necrosis factor-alpha (TNF-alpha) is a cytokine involved in a wide range of biological effects both in physiological and non-physiological conditions. It is also produced in the central nervous system (CNS) where it has been implicated in reparative processes after traumatic injuries and in CNS demyelination, neurodegeneration and inflammation. Using transgenic mice (Tg-m) expressing TNF-alpha specifically in the CNS, we showed that the overexpression of this cytokine reduced tyroxine hydroxilase immunoreactivity (TH-ir) in the caudate-putamen and in the dorsomedial hypothalamic areas and impaired grooming behavior. We also showed that this behavior is increased following anti-nerve growth factor injection. These findings support the hypothesis, proposed by others, that TNF-alpha is involved in the degenerative processes which occur in Parkinson's disease. (C) 1997 Elsevier Science Ireland Ltd.	CNR, Inst Neurobiol, I-00137 Rome, Italy		Aloe, L (corresponding author), CNR, Inst Neurobiol, Viale Marx 15, I-00137 Rome, Italy.		Fiore, Marco/B-6112-2015	Fiore, Marco/0000-0001-6806-9715			AGID Y, 1993, ADV NEUROL, V60, P148; Alleva E, 1993, Rev Neurosci, V4, P41; Aloe L, 1997, NEUROPSYCHOBIOLOGY, V36, P65, DOI 10.1159/000119364; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; BOCCHINI G, 1966, P NATL ACAD SCI USA, V64, P787; Date I, 1996, J NEUROSURG, V84, P1006, DOI 10.3171/jns.1996.84.6.1006; FLORE M, 1996, BRAIN BEHAV IMMUNOL, V10, P126; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Hattori A, 1996, FEBS LETT, V379, P157, DOI 10.1016/0014-5793(95)01502-7; Labandeira-Garcia JL, 1996, EXP BRAIN RES, V108, P69; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MERRILL JE, 1992, DEV NEUROSCI-BASEL, V14, P1, DOI 10.1159/000111642; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; OLSON L, 1997, TRENDS NEUROSCI, V20, P227; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; STOECKEL K, 1976, J NEUROCHEM, V26, P1207, DOI 10.1111/j.1471-4159.1976.tb07008.x; TORRE E, 1986, NEUROCHEM INT, V9, P85, DOI 10.1016/0197-0186(86)90035-5; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Tseng JL, 1997, J NEUROSCI, V17, P325, DOI 10.1523/JNEUROSCI.17-01-00325.1997; Wang CX, 1996, J NEUROIMMUNOL, V69, P151	21	42	44	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 28	1997	238	1-2					65	68		10.1016/S0304-3940(97)00850-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP383	WOS:000071271400017	9464656				2022-02-06	
J	Hartl, R; Medary, MB; Ruge, M; Arfors, KE; Ghajar, J				Hartl, R; Medary, MB; Ruge, M; Arfors, KE; Ghajar, J			Early white blood cell dynamics after traumatic brain injury: Effects on the cerebral microcirculation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						blood-brain barrier; cranial window inflammation; leukocytes; microcirculation; traumatic brain injury; videomicroscopy	ISCHEMIA-REPERFUSION INJURY; FLUID-PERCUSSION MODEL; TUMOR-NECROSIS-FACTOR; SEVERE HEAD-INJURY; RAT-BRAIN; NEUTROPHIL ACCUMULATION; INTRACRANIAL-PRESSURE; LEUKOCYTE ADHESION; ENDOTHELIAL DYSFUNCTION; TIME-COURSE	Increasing clinical and experimental evidence suggests that traumatic brain injury (TBI) elicits an acute inflammatory response. In the present study we investigated whether white blood cells (WBC) are activated in the cerebral microcirculation early after TBI and whether WBC accumulation affects the posttraumatic cerebrovascular response. Twenty-four anesthetized rabbits had chronic cranial windows implanted 3 weeks before experimentation. Animals were divided into four experimental groups and were studied for 7 hours (groups I, IIa, and III) or 2 hours (group IIb). Intravital fluorescence videomicroscopy was used to visualize WBC (rhodamine 6G, intravenously), pial vessel diameters, and blood-brain barrier (BBB) integrity (Na+-fluorescein) at 6 hours (groups I, IIa, and III) or 1 hour (group IIb) after TBI. Group I (n = 5) consisted of sham-operated animals. Groups IIa (n = 7) and IIb (n = 5) received fluid-percussion injury at 1 hour. Group III (n = 7) received fluid-percussion injury and 1 mg/kg anti-adhesion monoclonal antibody (MoAb) ''IB4'' 5 minutes before injury. Venular WBC sticking, intracranial pressure (ICP), and arterial vessel diameters increased significantly for 6 hours after trauma. IB4 reduced WBC margination and prevented vasodilation. Intracranial pressure was not reduced by treatment with IB4. Blood-brain barrier damage occurred at 1 hour but not at 6 hours after TBI and was independent of WBC activation. This first report using intravital videomicroscopy to study the inflammatory response after TBI reveals upregulated interaction between WBC and cerebral endothelium that can be manipulated pharmacologically. White blood cell activation is associated with pial arteriolar vasodilation. White blood cells do not induce BBB breakdown less than 6 hours after TBI and do not contribute to posttraumatic ICP elevation. The role of WBC more than 6 hours after TBI should be investigated further.	CORNELL UNIV,COLL MED,NEW YORK,NY		Hartl, R (corresponding author), AITKEN NEUROSCI CTR,523 E 72ND ST,8TH FLOOR,NEW YORK,NY 10021, USA.						AKOPOV SE, 1994, STROKE, V25, P2246, DOI 10.1161/01.STR.25.11.2246; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bednar MM, 1996, NEUROL RES, V18, P171; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; CARDEN DL, 1990, CIRC RES, V66, P1436, DOI 10.1161/01.RES.66.5.1436; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CORVIN S, 1990, ACT NEUR S, V51, P55; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIRNAGL U, 1994, STROKE, V25, P1028, DOI 10.1161/01.STR.25.5.1028; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; ENTERS EK, 1992, BRAIN RES, V576, P271; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; GIDDAY J, 1995, J CEREB BLOOD FLO S1, V15, pS135; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; HELMKE B, 1996, INT J MICROCIRC, V10, P164; HORNER HC, 1992, SOC NEUR ABSTR, V8, P173; HOUSE SD, 1987, MICROVASC RES, V34, P363, DOI 10.1016/0026-2862(87)90068-9; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; KESKIL S, 1994, ACTA NEUROCHIR, V131, P211, DOI 10.1007/BF01808615; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KONTOS HA, 1985, ANN BIOMED ENG, V13, P329, DOI 10.1007/BF02584251; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; KUBES P, 1990, AM J PHYSIOL, V259, pG859, DOI 10.1152/ajpgi.1990.259.5.G859; KUBES P, 1992, CELLULAR MOL MECH IN; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Lindauer U, 1996, J CEREBR BLOOD F MET, V16, P1143, DOI 10.1097/00004647-199611000-00008; LUNDBERG C, 1990, BLOOD, V76, P1240; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEDARY M, 1997, UNPUB J TRAUMA; MENGER MD, 1992, AM J PHYSIOL, V263, pH1892, DOI 10.1152/ajpheart.1992.263.6.H1892; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; NOLTE D, 1994, AM J PHYSIOL-HEART C, V267, pH1320, DOI 10.1152/ajpheart.1994.267.4.H1320; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; RUBIN BB, 1992, SURGERY, V112, P263; Scalia R, 1996, SHOCK, V6, P177, DOI 10.1097/00024382-199609000-00004; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHURER L, 1990, ACT NEUR S, V51, P49; SHIGA Y, 1991, NEUROSCI LETT, V125, P110, DOI 10.1016/0304-3940(91)90003-C; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SIEMIONOW M, 1995, J RECONSTR MICROSURG, V11, P7, DOI 10.1055/s-2007-1006504; Soares HD, 1995, J NEUROSCI, V15, P8223; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; UNTERBERG A, 1988, ACTA NEUROPATHOL, P238; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WELBOURN CRB, 1991, BRIT J SURG, V78, P651, DOI 10.1002/bjs.1800780607; WHALEN MJ, 1997, 10 INT S INTR PRESS; WILSON JT, 1995, J TRAUMA, V39, P473; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	73	42	43	0	4	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	1997	17	11					1210	1220					11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	YH666	WOS:A1997YH66600010	9390653				2022-02-06	
J	Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T				Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T			A concussive-like brain injury model in mice .2. Selective neuronal loss in the cortex and hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						concussive brain injury (CBI); cortex; hippocampus; mouse; neuronal cell loss; traumatic brain injury (TBI); weight-drop impact	FLUID-PERCUSSION MODEL; MILD HEAD-INJURY; CORTICAL IMPACT; RATS; ACID; DEATH; GLUTAMATE; PATHOPHYSIOLOGY; VULNERABILITY; ANTAGONISTS	A novel concussive-like brain injury (CLBI) model characterized by transient neurobehavioral depression, short duration of brain edema, and long-lasting memory deficits has been reported in our companion paper. This was achieved by dropping a 21-g weight from a height of 25 cm onto the head of a mouse. In the present study, we examined the histopathological changes in this model. Male ddY mice were subjected to either the trauma or sham injury. Gross pathological examination of the brain 1 h posttrauma did not demonstrate subdural, subarachnoid, intraventricular, periventricular, and intraparenchymatous hemorrhage, focal lesions or contusions. Microscopic examination 24 h posttrauma with Nissl staining (cresyl violet), however, revealed a selective bilateral neuronal cell loss in the cerebral cortex and hippocampus but not in the regions of the thalamus, cerebellum, and brain stem. The characteristics of neuronal cell loss in the cortex suggested that this pathology was related in part, to the head impact dynamics, since the cell loss was noted in the central portion of the supraventricular cerebral cortex (p < 0.001), the site of the weight impact, gradually decreasing peripheral to this site, and disappearing in the areas remote from this locus. In contrast, neuronal cell loss seen in the hippocampus did not suggest that this pathology was directly associated with the impact site. Neuronal cell loss was concentrated in the pyramidal cell layer of CA2 (p < 0.01) and CA3 (p < 0.01), and a lesser degree was noted in the subfields of CA3c (p < 0.05) and the hilar region (p < 0.05) but not in the subfields of CA1 and the dentate gyrus layers. The present study characterized the histopathological change seen in the CLBI model, demonstrating the selective neuronal cell loss following weight-drop concussion in mice.	NAGOYA UNIV,SCH MED,DEPT NEUROPHARMACOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,SCH MED,HOSP PHARM,SHOWA KU,NAGOYA,AICHI 466,JAPAN				Tang, Ya-Ping/A-1035-2011				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADAN AI, 1989, SCIENCE, V244, P798; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LIDVALL HF, 1975, LANCET, V1, P100; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1985, TRENDS NEUROSCI, V8, P47, DOI 10.1016/0166-2236(85)90024-4; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MODY I, 1994, HIPPOCAMPUS, V4, P275, DOI 10.1002/hipo.450040309; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; NABESHIMA T, 1991, J PHARMACOL EXP THER, V256, P378; Nelson S, 1966, HEAD INJURY, P444; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NIQUET J, 1994, J NEUROCYTOL, V23, P641, DOI 10.1007/BF01191558; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P211; RINK A, 1995, AM J PATHOL, V147, P1575; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STORMMATHISEN J, 1984, NEUROSCIENCE, V111, P79; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SYMONDS C, 1962, LANCET, V1, P1; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; WALKER AE, 1994, J NEUROSURG, V81, P493, DOI 10.3171/jns.1994.81.3.0493; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMSON A, 1994, HIPPOCAMPUS, V4, P226, DOI 10.1002/hipo.450040213	55	42	48	0	9	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	1997	14	11					863	873		10.1089/neu.1997.14.863			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YK511	WOS:A1997YK51100005	9421457				2022-02-06	
J	Rodriguez, DJ; Benzel, EC; Clevenger, FW				Rodriguez, DJ; Benzel, EC; Clevenger, FW			The metabolic response to spinal cord injury	SPINAL CORD			English	Article						spinal cord injury; nitrogen balance; nutrition; metabolism; indirect calorimetry	ENERGY-EXPENDITURE; FUNCTIONAL RECOVERY; NITROGEN-BALANCE; OPERATION; FRACTURES	The metabolic response to trauma, including neurotrauma in general, has been studied extensively, but the acute metabolic response to spinal cord injury (SCI) has not. Therefore, 12 patients with SCI are presented in whom intensive nutrition assessment and management were instituted immediately after injury. Nitrogen balance (NB), predicted energy expenditure (PEE), and actual energy expenditure (MEE) were calculated or measured in each patient. A persistent negative NE was observed in all but one of the 12 patients. The single patient who did not exhibit persistent negative NE (no positive NE from week 2 to week 4 in the face of appropriate feeding) had an incomplete myelopathy, thus implying that the degree of motor dysfunction correlates with the obligatory nature of the negative NE. The negative NE observed in several of the patients did not occur until the second or third post-injury week. In addition, calculations of PEE by successively multiplying the Harris-Benedict equation by an activity factor of 1.2 and then by a stress factor of 1.6, resulted in excessive feeding (as assessed by metabolic cart measurements; ie indirect calorimetry) in the majority of the patients. In all of the 11 patients with persistent negative NBs, protein administration in the amount of 2 g/k of ideal body weight and aggressive caloric delivery did not alter the negative pattern of the NBs. Therefore, it is concluded that the negative NE following SCI is obligatory. Furthermore, the extent of SCI (extent of myelopathy or of neurological injury) correlates with the obligatory nature of the negative NE. In addition, the results from using the above method for estimating caloric requirements and the delayed manifestation of the negative NE may cause an additional tendency to acutely overfeed SCI patients. Therefore, eliminating the activity factor of 1.2 (due to the diminished activity arising from paralysis) and a diminution of the stress factor is recommended for initial PEE calculations. Serial metabolic cart (indirect calorimetry) measurements are recommended to accurately assess the patient's subsequent metabolic requirements.	UNIV NEW MEXICO, SCH MED, DEPT SURG, DIV NEUROSURG, ALBUQUERQUE, NM 87131 USA								AGARWAL N, 1984, JPEN-PARENTER ENTER, V8, P98; *AM DIAB ASS AM DI, 1977, GUID PROF EFF APPL E, P17; BENZEL EC, 1987, NEUROSURGERY, V20, P742, DOI 10.1227/00006123-198705000-00012; BENZEL EC, 1986, NEUROSURGERY, V19, P772, DOI 10.1227/00006123-198611000-00009; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUNKER VW, 1987, BRIT J NUTR, V57, P211, DOI 10.1079/BJN19870027; CLEVENGER FW, 1992, J SURG RES, V52, P135, DOI 10.1016/0022-4804(92)90294-A; COX SAR, 1985, J TRAUMA, V25, P419, DOI 10.1097/00005373-198505000-00008; Daley BJ, 1994, NUTR CRITICAL CARE, P9; DEITRICK JE, 1948, AM J MED, V4, P3, DOI 10.1016/0002-9343(48)90370-2; FRY DE, 1987, PROB GEN SURG, V4, P427; Greenway R M, 1970, Paraplegia, V7, P301; KAUFMAN HH, 1985, NEUROSURGERY, V16, P309, DOI 10.1227/00006123-198503000-00005; KEARNS PJ, 1982, JPEN, V6, P577; KINNEY JM, 1970, J CLIN PATHO, V14, P65; KOLPEK JH, 1989, JPEN-PARENTER ENTER, V13, P277, DOI 10.1177/0148607189013003277; LONG CL, 1979, JPEN-PARENTER ENTER, V3, P69, DOI 10.1177/014860717900300269; MCKENZIE TA, 1985, AM C NUTR, V4, P575; RODRIGUEZ D J, 1990, Journal of Parenteral and Enteral Nutrition, V14, p15S; RODRIGUEZ DJ, 1991, JPEN-PARENTER ENTER, V15, P319, DOI 10.1177/0148607191015003319; Shronts E, 1989, NUTR SUPPORT CORE CU, P199; Young B, 1991, Neurosurg Clin N Am, V2, P301	22	42	45	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	SEP	1997	35	9					599	604		10.1038/sj.sc.3100439			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XV931	WOS:A1997XV93100008	9300966	Bronze			2022-02-06	
J	Lang, EW; Pitts, LH; Damron, SL; Rutledge, R				Lang, EW; Pitts, LH; Damron, SL; Rutledge, R			Outcome after severe head injury: An analysis of prediction based upon comparison of neural network versus logistic regression analysis	NEUROLOGICAL RESEARCH			English	Article; Proceedings Paper	10th European Congress of Neurosurgery	MAY 07-12, 1995	BERLIN, GERMANY			neural network; prognosis; outcome prediction; severe head injury	CEREBRAL BLOOD-FLOW; GLASGOW COMA SCALE; BRAIN INJURY; PERFUSION-PRESSURE; EVOKED-POTENTIALS; LACTIC-ACIDOSIS; TRAUMATIC COMA; RESUSCITATION; MANAGEMENT; PROGNOSIS	More reliable prediction of outcome would be helpful for clinicians who treat severely head-injured patients. To determine if neural network modeling would improve outcome prediction compared with standard logistic regression analysis and to determine if data available 24 h after severe head injury allows better prediction than data obtained within 6 h, we tested the ability of both techniques at these two times to predict outcome (dead versus alive) at 6 months. One thousand sixty-six consecutive patients with Glasgow Coma Scale scores of 8 or less during the first 24 h after injury were randomly divided into two groups. Data from the first group (n = 799) were used to develop the models; data from the second group (n = 267) were used to test the accuracy, sensitivity, and specificity of the models by comparing predicted and actual outcomes. The 6-month mortality race was 63.5%. Our findings confirm the importance of age, Glasgow Coma Scale scores, and hypotension in predicting outcome. Using data available al 24 h improved the predictive power of both models compared with admission data; at both time points, however, the differences in the results obtained with the two models were negligible. We conclude that outcome (dead versus alive) at 6 months after severe head injury can be predicted with logistic regression or neural network models based on data available at 24 h. Critical therapeutic decisions, such as cessation of therapy should be based on the patient's status 1 day after injury and only rarely on admission status alone.	UNIV CALIF SAN FRANCISCO, SCH MED, SAN FRANCISCO GEN HOSP, DEPT NEUROL SURG, SAN FRANCISCO, CA USA; UNIV N CAROLINA, SCH MED, DEPT SURG, DIV GEN SURG, CHAPEL HILL, NC USA								BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Braakman R, 1986, Acta Neurochir Suppl (Wien), V36, P112; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; BURKE HB, 1994, SEMIN SURG ONCOL, V10, P73, DOI 10.1002/ssu.2980100111; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DOYLE HR, 1994, ANN SURG, V219, P408, DOI 10.1097/00000658-199404000-00012; EBELL MH, 1993, J FAM PRACTICE, V36, P297; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; FACCO E, 1986, CHILD NERV SYST, V2, P67; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FOLTZ EL, 1988, SURG NEUROL, V30, P273, DOI 10.1016/0090-3019(88)90298-4; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Green D. M., 1974, SIGNAL DETECTION THE; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENWOOD D, 1991, BEHAV SCI, V36, P1, DOI 10.1002/bs.3830360102; HANS P, 1987, BRIT J HOSP MED, V37, P535; HARTUNG HJ, 1992, ANAESTHESIST, V41, P468; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; KAPPEN HJ, 1993, ANN ONCOL         S4, V4, pS31; Katz S, 1994, J Heart Valve Dis, V3, P49; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SHUFFLEBARGER CM, 1992, ANN EMERG MED, V21, P1461, DOI 10.1016/S0196-0644(05)80060-5; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; THOMAS DGT, 1977, LANCET, V1, P113; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	61	42	43	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	1997	19	3					274	280		10.1080/01616412.1997.11740813			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	XC468	WOS:A1997XC46800012	9192380				2022-02-06	
J	Ferraro, FR				Ferraro, FR			Cognitive slowing in closed-head injury	BRAIN AND COGNITION			English	Article; Proceedings Paper	22nd Annual Meeting of the International-Neuropsychological-Society	FEB 02-06, 1994	CINCINNATI, OH	Int Neuropsychol Soc			REACTION-TIME; PERFORMANCE; RECOVERY; DEFICITS; SPEED	Mean response times (RTs) from a sample of 13 simple- and choice-reaction time studies (which included 353 Closed-Head Injury (CHI) subjects at various stages of injury and 329 Control, non-CHI, subjects; mean age of both groups, approximately 28 years) were analyzed using Brinley Plot/multiple regression analysis techniques to provide support for the observation that CHI results in a slowing of basic cognitive information processing. Across 101 experimental conditions, the best-fit equation that resulted from regressing the CHI data onto the Control data for matched conditions was Y (CHI) = 1.54 X (Control) - 59, and this specific regression equation accounted for approximately 89% of the variance (based on R(2)). These results suggest that the basic cognition processes involved in simple- and choice-reaction time performance were approximately 1.54 times slower in CHI individuals in this sample as compared to non-CHI individuals. This pattern of performance substantiates the observation the CHI results in a slowing of even very basic cognition information processes. (C) 1996 Academic Press, Inc.			Ferraro, FR (corresponding author), UNIV N DAKOTA,DEPT PSYCHOL,BOX 8380,GRAND FORKS,ND 58202, USA.						BENTON AL, 1958, J ABNORMAL SOCIAL PS, V54, P109; BIRREN JE, 1965, BEHAV AGING NERVOUS, V7, P191; BLACKBURN H L, 1955, Confin Neurol, V15, P327; BLEIBERG J, 1994, INCONSISTENCY MARKER; Brinley JF, 1965, BEHAV AGING NERVOUS, P114; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; DENCKER SJ, 1958, ACTA PSYCHIAT NEUROL, V33, P122; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HALE S, 1990, CHILD DEV, V61, P653, DOI 10.1111/j.1467-8624.1990.tb02809.x; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; KAIL R, 1992, AM J MENT RETARD, V97, P333; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Mahurin RK, 1986, DEV NEUROPSYCHOL, V2, P345, DOI 10.1080/87565648609540353; MATTSON AJ, 1994, J NEUROL NEUROSUR PS, V57, P818, DOI 10.1136/jnnp.57.7.818; Miller E, 1970, Cortex, V6, P121; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; MYERSON J, 1992, PSYCHOL AGING, V7, P257, DOI 10.1037/0882-7974.7.2.257; MYERSON J, 1994, J GERONTOL, V49, pP72, DOI 10.1093/geronj/49.2.P72; NEBES RD, 1992, J CLIN EXP NEUROPSYC, V14, P317, DOI 10.1080/01688639208402831; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; PERFECT TJ, 1994, J GERONTOL, V49, pP60, DOI 10.1093/geronj/49.2.P60; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Poon, 1980, AGING 1980S PSYCHOL, P332, DOI [10.1037/10050-024, DOI 10.1037/10050-024]; SALTHOUSE TA, 1982, J GERONTOL, V37, P59, DOI 10.1093/geronj/37.1.59; Salthouse TimothyA., 1985, HDB PSYCHOL AGING, V2nd ed., P400; SANDERSON J, 1988, COGNITIVE APPROACHES; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1986, CANADIAN J NEUROLOGI, V16, P161; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452	36	42	42	0	1	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	DEC	1996	32	3					429	440		10.1006/brcg.1996.0075			12	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	WD489	WOS:A1996WD48900005	8975681				2022-02-06	
J	Sosin, DM; Sacks, JJ; Webb, KW				Sosin, DM; Sacks, JJ; Webb, KW			Pediatric head injuries and deaths from bicycling in the United States	PEDIATRICS			English	Article						children; traumatic brain injury; head injury; mortality; injury; bicycles; helmets	HELMET USE; SAFETY HELMETS; CHILDREN	Objective. To estimate the potential benefit of increasing bicycle helmet use among children and adolescents in the United States. Design. All bicycle-related deaths (Multiple Cause-of-Death Public Use Data Tapes, 1989 through 1992) and bicycle-related injuries treated in sampled emergency departments (National Electronic Injury Surveillance System, 1989 through 1993) were used to calculate traumatic brain injury-associated death and head injury rates per 1000000 US residents. Preventable injuries and deaths were estimated by calculating the population-attributable risk of head injury due to nonuse of bicycle helmets. Patients. US residents aged 0 through 19 years who were injured or who died as a result of a bicycle crash. Results. An average of 247 traumatic brain injury deaths and 140000 head injuries among children and adolescents younger than 20 years were related to bicycle crashes each year in the United States. As many as 184 deaths and 116000 head injuries might have been prevented annually if these riders had worn helmets. An additional 19000 mouth and chin injuries were treated each year. The youngest age groups had the highest proportions of both head and mouth injuries. Conclusion. There continues to be a need to advocate for greater use of bicycle helmets, particularly among young children. Helmet design changes should be considered to prevent mouth injuries.			Sosin, DM (corresponding author), CTR DIS CONTROL & PREVENT,NATL CTR INJURY PREVENT & CONTROL,ATLANTA,GA 30341, USA.						*AM AC PED, 1989, TIPP INJ PREV PROGR; BUCCINI RV, 1987, AM PUBL HLTH ASS 115; *BUR CENS, 1993, CURR POP REP SER P, V25; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V44, P1; *CONS PROD SAF COM, 1994, NAT EL INJ SURV SYST; *CTR DIS CONTR, 1992, MMWR, V41, P1; *CTR DIS CONTR PRE, 1993, MMWR-MORBID MORTAL W, V42, P359; DANNENBERG AL, 1993, PUBLIC HEALTH REP, V108, P212; DIGUISEPPI CG, 1990, AM J DIS CHILD, V144, P83, DOI 10.1001/archpedi.1990.02150250093041; FIFE D, 1983, J TRAUMA, V23, P745, DOI 10.1097/00005373-198308000-00011; Grimard G, 1995, Inj Prev, V1, P21, DOI 10.1136/ip.1.1.21; HOWLAND J, 1989, AM J DIS CHILD, V143, P741, DOI 10.1001/archpedi.1989.02150180123033; KANN L, 1995, MMWR-MORBID MORTAL W, V44, pSS1; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; NAKAYAMA DK, 1990, J TRAUMA, V30, P1390, DOI 10.1097/00005373-199011000-00012; RIVARA FP, 1994, PEDIATRICS, V93, P567; Rodgers GB, 1994, BICYCLE USE HAZARD P; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SPENCE LJ, 1993, J PEDIATR SURG, V28, P214, DOI 10.1016/S0022-3468(05)80278-7; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; *WHO, 1977, MAN INT CLASS DIS	24	42	43	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098	0031-4005			PEDIATRICS	Pediatrics	NOV	1996	98	5					868	870					3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	VR466	WOS:A1996VR46600002	8909479				2022-02-06	
J	Tchelingerian, JL; LeSaux, F; Jacque, C				Tchelingerian, JL; LeSaux, F; Jacque, C			Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain trauma; cytokines; TNF alpha; IL-1 alpha; neurons	NERVE GROWTH-FACTOR; CORTICOTROPIN-RELEASING FACTOR; CULTURED SYMPATHETIC NEURONS; RAT-BRAIN; HYPOTHALAMUS INVIVO; CYTOKINE REGULATION; MESSENGER-RNA; INTERLEUKIN-1; LOCALIZATION; FOREBRAIN	In previous studies, we have shown that a traumatic lesion to the hippocampus of adult mice induces the transitory expression of TNF alpha and IL-1 alpha. by neurons of different brain areas and also by glial cells at the site of injury, The aim of the present study was to establish whether the expression of TNF alpha and IL-1 alpha is restricted to defined subpopulations, or else is common to most of the central neuronal populations, Using polyclonal anti-GAD 67, anti-TH and monoclonal anti-ChAT, and anti-5-HT antibodies in a double-labeling immunohistochemical procedure in combination with murine anti-TNF alpha and anti-IL-1 alpha polyclonal antibodies, we show that most GABAergic, catecholaminergic, and serotoninergic neurons, and a subgroup of the cholinergic neurons, express these cytokines, Although not immunohistochemically characterized, neurons in some glutamatergic structures such as the hippocampus and the prefrontal cortex also express these cytokines. Thus, we conclude that the capacity of central neurons to express cytokines like TNF alpha and IL-1 alpha in reaction to a brain injury is not restricted to peculiar neuronal subtypes, but could include most of the neuronal populations of the brain. (C) 1996 Wiley-Liss, Inc.			Tchelingerian, JL (corresponding author), HOP LA PITIE SALPETRIERE, INSERM U134, 47 BLD HOP, F-75651 PARIS 13, FRANCE.						ALHEIM K, 1991, P NATL ACAD SCI USA, V88, P9302, DOI 10.1073/pnas.88.20.9302; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BARTFAI T, 1993, NEUROCHEM INT, V22, P435, DOI 10.1016/0197-0186(93)90038-7; BERKENBOSCH F, 1987, SCIENCE, V238, P524, DOI 10.1126/science.2443979; BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171; ELENKOV IJ, 1992, J NEUROIMMUNOL, V41, P117, DOI 10.1016/0165-5728(92)90203-W; FREIDIN M, 1992, P NATL ACAD SCI USA, V89, P10440, DOI 10.1073/pnas.89.21.10440; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; LI ZH, 1992, NEUROREPORT, V3, P91, DOI 10.1097/00001756-199201000-00024; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MILENKOVIC L, 1989, P NATL ACAD SCI USA, V86, P2418, DOI 10.1073/pnas.86.7.2418; MILLER LG, 1991, MOL PHARMACOL, V39, P105; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; MOHANKUMAR PS, 1991, LIFE SCI, V48, P925, DOI 10.1016/0024-3205(91)90040-I; MOHANKUMAR PS, 1993, BRAIN RES BULL, V31, P745, DOI 10.1016/0361-9230(93)90151-Z; POUSSET F, 1994, DEV BRAIN RES, V81, P143, DOI 10.1016/0165-3806(94)90078-7; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; SCARBOROUGH DE, 1989, ENDOCRINOLOGY, V124, P549, DOI 10.1210/endo-124-1-549; Schettini G, 1990, PROG NEUROENDOCRINIM, V3, P157; SHINTANI F, 1993, J NEUROSCI, V13, P3574; SOLIVEN B, 1992, J NEUROSCI, V12, P2665; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; TCHELINGERIAN JL, 1994, NEUROREPORT, V5, P585, DOI 10.1097/00001756-199401000-00013; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; YOSHIDA K, 1992, BRAIN RES, V569, P14, DOI 10.1016/0006-8993(92)90364-F	32	42	42	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN 1	1996	43	1					99	106		10.1002/jnr.490430113			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT360	WOS:A1996TT36000012	8838580				2022-02-06	
J	CHOE, BY; SUH, TS; CHOI, KH; SHINN, KS; PARK, CK; KANG, JK				CHOE, BY; SUH, TS; CHOI, KH; SHINN, KS; PARK, CK; KANG, JK			NEURONAL DYSFUNCTION IN PATIENTS WITH CLOSED-HEAD INJURY EVALUATED BY IN-VIVO H-1 MAGNETIC-RESONANCE SPECTROSCOPY	INVESTIGATIVE RADIOLOGY			English	Article						MAGNETIC RESONANCE SPECTROSCOPY; CLOSED HEAD INJURY	DIFFUSE AXONAL INJURY; STIMULATED ECHOES; NMR-SPECTROSCOPY; MR SPECTROSCOPY; CONSCIOUSNESS; INVIVO; TUMORS; MILD; COMA	RATIONALE AND OBJECTIVES. With the use of localized, water-suppressed in vivo H-1 magnetic resonance spectroscopy (MRS), the proton metabolic alterations of white matter in patients with closed head injury (CHI) and healthy controls are evaluated, and metabolic alterations with Glasgow Outcome Scale (GOS) scores are compared, METHODS. Patients with CHI (n = 10) and healthy control subjects (n = 10) underwent MRS examinations using a stimulated-echo acquisition mode pulse sequence that provided 2 X 2 X 2 cm(3) volume of interest in the left frontoparietal white matter, Proton metabolite ratios relative to creatine were obtained using a Marquart algorithm, RESULTS. The specific feature in patients with CHI was significant decrease of N-acetylaspartate (NAA)/creatine ratio compared with normal controls, No clear correlation of other metabolite ratios such as choline/creatine and inositols creatine was established, The level of NAA/creatine ratio was significantly correlated with GOS, CONCLUSIONS. Results of this preliminary study suggest that the reduction of NAA/creatine ratio may indicate neuronal loss in patients with CHI. The NAA/creatine ratio may serve as a metabolic criterion to predict the GOS of patients with CHI, Thus, in vivo H-1 MRS may be a useful modality in the clinical evaluation of patients with CHI based on the proton metabolite concentrations of cerebral white matter.	CATHOLIC UNIV, KANGNAM ST MARYS HOSP, COLL MED, DEPT NEUROSURG, SEOUL 137040, SOUTH KOREA		CHOE, BY (corresponding author), CATHOLIC UNIV, KANGNAM ST MARYS HOSP,COLL MED,DEPT RADIOL, SEOUCHO KU, 505 BANPO DONG, SEOUL 137040, SOUTH KOREA.						ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; AUE WP, 1987, ANN NY ACAD SCI, V508, P360, DOI 10.1111/j.1749-6632.1987.tb32917.x; BOTTOMLEY PA, 1989, RADIOLOGY, V170, P1; BREITER SN, 1992, SOC MAGNETIC RESONAN, V1, P644; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P421, DOI 10.1111/j.1365-2990.1991.tb00742.x; FRAHM J, 1987, J MAGN RESON, V72, P502, DOI 10.1016/0022-2364(87)90154-5; FRAHM J, 1989, MAGNET RESON MED, V9, P79, DOI 10.1002/mrm.1910090110; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; HARDY CJ, 1988, MAGNET RESON MED, V8, P104, DOI 10.1002/mrm.1910080113; JARVIK JG, 1993, RADIOLOGY, V186, P739, DOI 10.1148/radiology.186.3.8430182; JENNETT B, 1975, LANCET, V1, P480; KREIS R, 1991, NMR BIOMED, V4, P109, DOI 10.1002/nbm.1940040214; KUGEL H, 1992, RADIOLOGY, V183, P701, DOI 10.1148/radiology.183.3.1584924; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; NADJMI MR, 1981, KRANIELLE COMPUTER T; NADLER JV, 1972, J NEUROCHEM, V19, P313, DOI 10.1111/j.1471-4159.1972.tb01341.x; ORDIDGE RJ, 1985, MAGNETIC RESONANCE B, P00387; PETROFF OAC, 1992, NEUROLOGY, V42, P1349, DOI 10.1212/WNL.42.7.1349; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POSNER MI, 1987, NEUROBEHAVIORAL RECO, P390; PRAYER L, 1993, ACTA RADIOL, V34, P593; ROSS B, 1992, EUR J RADIOL, V14, P128, DOI 10.1016/0720-048X(92)90226-Y; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1989, NEUROPSYCHOLOGY, V3, P255, DOI 10.1037//0894-4105.3.4.255; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; ZOMEREN AHV, 1987, NEUROBEHAVIORAL RECO, P398	30	42	44	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	AUG	1995	30	8					502	506		10.1097/00004424-199508000-00008			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RW469	WOS:A1995RW46900008	8557517				2022-02-06	
J	LEVIN, HS				LEVIN, HS			NEUROBEHAVIORAL OUTCOME OF CLOSED-HEAD INJURY - IMPLICATIONS FOR CLINICAL-TRIALS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		CLOSED HEAD INJURY; GLASGOW OUTCOME SCALE; POSTTRAUMATIC AMNESIA; NEUROBEHAVIORAL SEQUELAE	TRAUMATIC BRAIN INJURY; BEHAVIORAL SEQUELAE; RATING-SCALE; MEMORY; RECOVERY; DISABILITY; ADOLESCENTS; ORIENTATION; COGNITION; SYMPTOMS	This review encompasses the neurobehavioral sequelae of moderate to severe closed head injury (CHI). Following a discussion of posttraumatic amnesia and its measurement, the paper discusses assessment of the global outcome of CHI using the Glasgow Outcome Scale, Domains of residual neurobehavioral sequelae that are reviewed include attention/information processing speed, memory, language, intellectual ability, executive functions, and motor speed. The contribution of behavioral disturbance and psychosocial maladjustment to overall outcome is reviewed, as is the impact on the family, Finally, the neurobehavioral outcome measures for clinical trials involving moderate to severe head-injured patients are presented, Caveats for completing clinical trials that involve assessment of neurobehavioral functioning are provided.			LEVIN, HS (corresponding author), UNIV MARYLAND,MED SYST,DIV NEUROSURG,22 S GREEN ST,12TH FLOOR,BALTIMORE,MD 21201, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; [Anonymous], 1944, ARMY INDIVIDUAL TEST; Benton A., 1976, MULTILINGUAL APHASIA; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P605; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT WB, 1969, CURRENT PROBLEMS NEU; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1994, J AFFECT DISORDERS, V27, P233; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, MILD MODERATE HEAD I, P153; LEVIN HS, 1982, NEUROBEHAVIORAL CONS, P63; LEWIS RJ, 1990, ANN EMERG MED, V19, P1047, DOI 10.1016/S0196-0644(05)82570-3; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MANDELSOHN D, 1992, CHILD NERV SYST, V8, P445; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MATTSON AJ, 1994, J NEUROL NEUROSUR PS, V57, P818, DOI 10.1136/jnnp.57.7.818; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN RM, 1985, HALSTEAD REITAN NEUR, P10; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; STARKSTEIN SE, 1991, BIOL PSYCHIAT, V29, P149, DOI 10.1016/0006-3223(91)90043-L; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; [No title captured]	60	42	43	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					601	610		10.1089/neu.1995.12.601			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000011	8683611				2022-02-06	
J	KROPFL, A; NAGLIK, H; PRIMAVESI, C; HERTZ, H				KROPFL, A; NAGLIK, H; PRIMAVESI, C; HERTZ, H			UNREAMED INTRAMEDULLARY NAILING OF FEMORAL FRACTURES	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SHAFT FRACTURES; MULTIPLE INJURIES; FEMUR; FIXATION; DOG	Seventy-five patients with 81 femoral shaft fractures were treated with unreamed antegrade intramedullary nailing using a titanium alloy implant (AIM femoral nail, ACE Medical) with static interlocking. There were 73 closed fractures and 8 open fractures. Six patients had bilateral femoral shaft fractures. In two cases there was an ipsilateral fracture of the femoral neck, two patients had an ipsilateral intertrochanteric fracture, in one case there was a concomitant subtrochanteric fracture, and four patients had sustained an ipsilateral fracture of the acetabulum in addition to their femoral shaft fractures. In 43 cases (53%) the fracture of the femoral shaft was a comminuted type fracture. Thirty-nine patients (52%) had suffered multiple injuries; the mean Injury Severity Score was 41.2. Sixty-nine fractures were stabilized primarily within 8 hours after admission and 12 fractures were treated secondarily, in a mean of 5.8 days after injury. Closed intramedullary nailing was performed in 73 femora and open nailing with cerclage wiring was done in 8. All 81 nails were implanted unreamed and static was used in every case. The diameters of the nails used were 9 mm (n = 68) and 10 mm (n = 13). Proximal interlocking was distally directed in 76 cases and proximally directed in 5 cases. Two patients died of severe head injuries and one patient died of multiple organ failure. The infection rate was 0%, and uneventful consolidation of the fractures was seen in all cases within a mean of 3.8 months. Neither in the case of nails nor in the case of interlocking bolts did an implant failure occur.			KROPFL, A (corresponding author), UNFALLKRANKENHAUS,TRAUMA CTR SALZBURG,DR FRANZ REHRL PL 5,A-5010 SALZBURG,AUSTRIA.						ALHO A, 1991, J TRAUMA, V31, P49, DOI 10.1097/00005373-199101000-00011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BUCHOLZ RW, 1987, J BONE JOINT SURG AM, V69A, P1391; CUBBERLY WH, 1988, METALS HDB, V3, P389; FRANKLIN JL, 1988, J BONE JOINT SURG AM, V70A, P1463, DOI 10.2106/00004623-198870100-00004; HAAS N, 1993, INJURY, V24, P49, DOI 10.1016/0020-1383(93)90084-J; HEIM D, 1993, INJURY S3, V24, P56; KEMPF I, 1985, J BONE JOINT SURG AM, V67A, P709, DOI 10.2106/00004623-198567050-00005; KLEIN MPM, 1990, ARCH ORTHOP TRAUM SU, V109, P314, DOI 10.1007/BF00636168; Kuntscher G., 1967, PRACTICE INTRAMEDULL; KYLE RF, 1991, CLIN ORTHOP RELAT R, V267, P169; LATTA L, 1992, S CURR CONC TRAUM CA, P55; MANNING JB, 1983, J TRAUMA, V23, P322, DOI 10.1097/00005373-198304000-00009; OBRIEN PJ, 1991, J TRAUMA, V31, P113, DOI 10.1097/00005373-199101000-00022; PAPE HC, 1992, J TRAUMA, V33, P574, DOI 10.1097/00005373-199210000-00014; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; PAPE HC, 1992, UNFALLCHIRURG, V95, P634; PELL ACH, 1993, J BONE JOINT SURG BR, V75, P921, DOI 10.1302/0301-620X.75B6.8245083; Piccioni L, 1992, Orthop Rev, V21, P1213; PRATT DJ, 1987, INJURY, V18, P177, DOI 10.1016/0020-1383(87)90131-8; RHINELANDER FW, 1974, CLIN ORTHOPAEDICS, V105, P34; SCHANDELMAIER P, 1991, CHIRURGISCHES FORUM, P251; STROMBERG L, 1978, ACTA ORTHOP SCAND, V49, P448, DOI 10.3109/17453677808993261; STURMER KM, 1980, UNFALLHEILKUNDE, V83, P346; UHTHOFF HK, 1981, J BONE JOINT SURG BR, V63, P427, DOI 10.1302/0301-620X.63B3.7263759; WENDA K, 1990, UNFALLCHIRURG, V93, P56; Wenda K, 1993, INJURY S3, V24, P73; WHITE GM, 1986, J BONE JOINT SURG AM, V68A, P865, DOI 10.2106/00004623-198668060-00008; WHITTLE AP, 1992, J BONE JOINT SURG AM, V74A, P1162, DOI 10.2106/00004623-199274080-00005; WINQUIST RA, 1984, J BONE JOINT SURG AM, V66A, P529, DOI 10.2106/00004623-198466040-00006; Wiss D A, 1992, J Orthop Trauma, V6, P159, DOI 10.1097/00005131-199206000-00005; WOZASEK GE, 1994, J TRAUMA, V36, P202, DOI 10.1097/00005373-199402000-00010; ZIMMERMAN KW, 1983, J BONE JOINT SURG BR, V65, P274, DOI 10.1302/0301-620X.65B3.6841394	33	42	45	1	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Inf. Crit. Care	MAY	1995	38	5					717	726					10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	RD569	WOS:A1995RD56900007	7760398				2022-02-06	
J	BIGLER, ED; SNYDER, JL				BIGLER, ED; SNYDER, JL			NEUROPSYCHOLOGICAL OUTCOME AND QUANTITATIVE NEUROIMAGING IN MILD HEAD-INJURY	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	Meeting of the National-Academy-of-Neuropsychology	NOV, 1992	PITTSBURGH, PA	NATL ACAD NEUROPSYCHOL			TRAUMATIC BRAIN INJURY; DEGENERATIVE CHANGES; SYMPTOMS; SEQUELAE	Four cases of well-documented mild traumatic brain injury (Glasgow Coma scares greater than or equal to 13) in whom preinjury neuroimaging studies were available (three with computerized tomography and one with magnetic resonance [MR] imaging) were examined in terms of postinjury MR imaging and neuropsychological outcome. All scans were subjected to quantitative analysis by measuring ventricular volumes and calculating a ventricle-to-brain ratio Since ventricular measurements provide an index of parenchymal integrity, any systematic increase in postinjury ventricle size would be an indication of tissue loss. In addition to using the preinjury scan for a within-subject design in comparing postinjury changes, similar MR measures were obtained on a group of medical controls. Despite neuropsychological findings that suggested significant sequelae, quantitative postinjury MR studies did not shot; differences between preinjury neuroimaging or medical control subjects. These findings show no major anatomic abnormalities in mild TBI. Results are discussed in terms of metabolic and/or neurophysiological factors as the basis for persistent neuropsychological sequelae in most cares of mild TBI.	UTAH VALLEY REG MED CTR, REHABIL UNIT, PROVO, UT USA		BIGLER, ED (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, 1086 SWKT, PROVO, UT 84602 USA.						ADAMS KM, 1991, J CLIN EXP NEUROPSYC, V13, P388, DOI 10.1080/01688639108401053; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bigler E D, 1991, Arch Clin Neuropsychol, V6, P113, DOI 10.1016/0887-6177(91)90028-8; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLATTER DD, IN PRESS AM J NEUROR; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; EVANS RW, 1992, PHYSICAL MED REHAB C, V3, P427; FASCHINGBAUER TR, 1974, J CONSULT CLIN PSYCH, V42, P645, DOI 10.1037/h0037049; GENARELLI T, 1986, J HEAD TRAUMA REHAB, V1, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gronwall D, 1989, MILD HEAD INJURY, P153; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton RK, 1992, COMPREHENSIVE NORMS; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Pawlik G, 1989, NEUROPSYCHOLOGICAL F, P65; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Ruff R. M., 1989, NEUROPSY NEUROPSY BE, V2, P103; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1989, NEUROPSYCHOLOGICAL F, P161; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Spreen O, 1991, COMPENDIUM NEUROPSYC; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B	51	42	42	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR-APR	1995	10	2					159	174		10.1016/0887-6177(94)E0003-8			16	Psychology, Clinical; Psychology	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	QJ432	WOS:A1995QJ43200008	14589737	Bronze			2022-02-06	
J	WONG, CW				WONG, CW			CRITERIA FOR CONSERVATIVE TREATMENT OF SUPRATENTORIAL ACUTE SUBDURAL HEMATOMAS	ACTA NEUROCHIRURGICA			English	Article						SUBDURAL HEMATOMA; HEAD INJURY; CONSERVATIVE TREATMENT	TRAUMATIC INTRACEREBRAL HEMATOMAS; EXTRADURAL HEMATOMAS; EPIDURAL HEMATOMAS; HEAD-INJURY; MULTIPLE TRAUMA; HEMORRHAGE; MANAGEMENT; MORTALITY; CHILDREN; PATIENT	Without mortality, 31 patients underwent conservative treatment for traumatic supratentorial acute subdural haematoma (SDH). Later on six of them had the haematoma surgically evacuated mainly because of a deterioration of the Glasgow Coma Scale (GCS)scores. It was found that patients with a midline shift of less than 10 mm on the computed tomography (CT) scans and with a GCS score of 15 initially might be treated conservatively under close observation, reserving urgent craniotomy and evacuation of the SDH for those with deteriorating neurological conditions. A smaller degree of midline shift was tolerated by patients with an GCS score of less than 15: a shift of more than 5 mm on the initial CT scans predicted an exhaustion of the cerebral compensatory mechanism within 3 days of injury. In such cases the GCS score worsened, and surgical evacuation of the SDH became necessary. A total hospital stay of 6 to 7 days may suffice for those who have become fully conscious. Repeal CT studies before discharge should be done and a close follow-up during the first 3 to 4 weeks is advisable.	CHANG GUNG MEM HOSP & MED COLL,DEPT SURG,DIV NEUROSURG,TAIPEI,TAIWAN								AMBROSETTO C, 1962, ARCH NEUROL-CHICAGO, V6, P287, DOI 10.1001/archneur.1962.00450220029005; BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; ELSNER H, 1990, J NEUROSURG, V72, P813, DOI 10.3171/jns.1990.72.5.0813; GANNON WE, 1962, J NEUROSURG, V19, P865, DOI 10.3171/jns.1962.19.10.0865; INZELBERG R, 1989, CLIN NEUROL NEUROSUR, V91, P85, DOI 10.1016/S0303-8467(89)80014-9; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; KOBRINE AI, 1977, J NEUROSURG, V46, P256, DOI 10.3171/jns.1977.46.2.0256; LEE ST, 1991, ACTA NEUROCHIR, V113, P121, DOI 10.1007/BF01403196; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LUSINS JO, 1989, MT SINAI J MED, V56, P68; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller JD, 1992, NEUROSURG QUART, V2, P28; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; TANAKA T, 1988, J NEUROSURG, V69, P203, DOI 10.3171/jns.1988.69.2.0203; TEASDALE G, 1974, LANCET, V2, P81; VERLOOY P, 1987, J NEUROL, V234, P254, DOI 10.1007/BF00618260; WAGA S, 1979, SURG NEUROL, V11, P191; WEAVER D, 1981, J NEUROSURG, V54, P248, DOI 10.3171/jns.1981.54.2.0248; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WONG CW, 1994, ACTA NEUROCHIR, V126, P124, DOI 10.1007/BF01476421; WONG CW, 1995, ACTA NEUROCHIR, V135, P131, DOI 10.1007/BF02187756	33	42	44	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1995	135	1-2					38	43		10.1007/BF02307412			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RL342	WOS:A1995RL34200006	8748790				2022-02-06	
J	WEHMAN, P; SHERRON, P; KREGEL, J; KREUTZER, J; TRAN, S; CIFU, D				WEHMAN, P; SHERRON, P; KREGEL, J; KREUTZER, J; TRAN, S; CIFU, D			RETURN TO WORK FOR PERSONS FOLLOWING SEVERE TRAUMATIC BRAIN INJURY - SUPPORTED EMPLOYMENT OUTCOMES AFTER 5 YEARS	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN; INJURY; WORK; EMPLOYMENT	HEAD-INJURY	Supported employment is a recently developed rehabilitation alternative that is being used to assist individuals with traumatic brain injury to return to work. The present study reports the results of a supported employment program that has placed 80 individuals into competitive employment during a 5-year time period. All individuals had sustained a severe traumatic brain injury; 72% of the injuries involved a motor vehicle. A mean of 6.1 years had passed since injury for all participants, who had been unconscious an average of 48 days. Neuropsychologic evaluation revealed defective cognitive functioning, which contributed to diminished employment potential. A key outcome indicator used to assess return to work capacity is the monthly employment ratio, which is computed by dividing the number of months employed during an employment phase (i.e., pre/post injury) by the total possible months an individual would have the opportunity to be employed. The monthly employment ratio increased from 13% after injury with no supported employment to 67% with supported employment services. The majority of individuals were employed in warehouse, clerical and service-related occupations. A mean of 250 staff intervention hours were required to train and provide follow-up services to program participants.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CTR TRAUMAT BRAIN INJURY,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,RICHMOND,VA 23298		WEHMAN, P (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV REHABIL RES,RICHMOND,VA, USA.			Cifu, David/0000-0003-1600-9387			Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; DRESSER AC, 1973, PSYCH MED, V12, P286; KREGEL J, 1992, UNPUB IMPACT BEHAVIO; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; PECK G, 1984, ANN M INT NEUROPSYCH; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127; 1987, DATA MANAGEMENT SYST	17	42	42	0	4	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	1993	72	6					355	363					9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MP702	WOS:A1993MP70200004	8260128				2022-02-06	
J	BEHRMANN, DL; BRESNAHAN, JC; BEATTIE, MS				BEHRMANN, DL; BRESNAHAN, JC; BEATTIE, MS			A COMPARISON OF YM-14673, U-50488H, AND NALMEFENE AFTER SPINAL-CORD INJURY IN THE RAT	EXPERIMENTAL NEUROLOGY			English	Article							THYROTROPIN-RELEASING-HORMONE; RECEPTOR ANTAGONIST NALMEFENE; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; TRH-ANALOG; OPIATE ANTAGONIST; CEREBRAL-ISCHEMIA; MOTOR FUNCTION; PHARMACOLOGICAL ACTIONS; NEUROLOGICAL DEFICITS		OHIO STATE UNIV, NEUROSCI GRAD STUDIES PROGRAM, COLUMBUS, OH 43210 USA		BEHRMANN, DL (corresponding author), OHIO STATE UNIV, DEPT CELL BIOL NEUROBIOL & ANAT, 333 W 10TH AVE, COLUMBUS, OH 43210 USA.		Beattie, Michael S/A-8953-2009		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-07291, NS-10165] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS010165] Funding Source: NIH RePORTER		ARIAS MJ, 1985, SURG NEUROL, V23, P440, DOI 10.1016/0090-3019(85)90226-5; ASKANAS V, 1989, ANN NY ACAD SCI, V553, P325; BAKSHI R, 1990, J NEUROSCI, V10, P3793, DOI 10.1523/JNEUROSCI.10-12-03793.1990; BANDA R W, 1987, Neurology, V37, P285; BANDA RW, 1989, ANN NY ACAD SCI, V553, P588; BEATTIE MS, 1989, C P CRITERIA ASSESSI, P16; BEATTIE MS, 1988, PHARM APPROACHES TRE, P43; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BEHRMANN DL, 1991, SOC NEUR ABSTR, P163; BERMAN D, 1982, PAIN, V13, P307, DOI 10.1016/0304-3959(82)90020-3; BHARGAVA HN, 1986, BRAIN RES, V368, P262, DOI 10.1016/0006-8993(86)90570-6; Black P, 1991, J NEUROTRAUM, V8, P157, DOI 10.1089/neu.1991.8.157; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; CLARK JA, 1989, J PHARMACOL EXP THER, V251, P461; CONTRERAS PC, 1991, BRAIN RES, V546, P79, DOI 10.1016/0006-8993(91)91161-S; DAS S, 1987, GEN PHARMACOL, V18, P99, DOI 10.1016/0306-3623(87)90178-9; DECOSTA BR, 1989, J MED CHEM, V32, P1996, DOI 10.1021/jm00128a050; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; FADEN AI, 1981, SCIENCE, V211, P493, DOI 10.1126/science.7455690; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1983, PEPTIDES, V4, P631, DOI 10.1016/0196-9781(83)90009-8; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P608; FADEN AI, 1988, BRAIN RES, V448, P287, DOI 10.1016/0006-8993(88)91265-6; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P451; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; FONE KCF, 1988, BRAIN RES, V455, P157, DOI 10.1016/0006-8993(88)90126-6; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAYES AG, 1988, J PHARM PHARMACOL, V40, P718, DOI 10.1111/j.2042-7158.1988.tb07002.x; HENSCHEN A, 1988, EXP NEUROL, V102, P125, DOI 10.1016/0014-4886(88)90085-4; HOLADAY JW, 1978, LIFE SCI, V22, P1537, DOI 10.1016/0024-3205(78)90009-7; HOLTZ A, 1989, ACTA NEUROL SCAND, V80, P215, DOI 10.1111/j.1600-0404.1989.tb03865.x; IWASAKI Y, 1989, NEUROSCI LETT, V101, P316, DOI 10.1016/0304-3940(89)90552-1; KIM JP, 1987, EUR J PHARMACOL, V138, P133, DOI 10.1016/0014-2999(87)90349-9; KOREH K, 1981, BIOCHEM BIOPH RES CO, V102, P1317, DOI 10.1016/S0006-291X(81)80155-6; KOSKINEN LOD, 1989, ANN NY ACAD SCI, V553, P353; LUX WE, 1983, NATURE, V302, P822, DOI 10.1038/302822a0; LUX WE, 1983, CIRC SHOCK, V10, P262; MARTINEZARIZALA A, 1988, BRAIN RES, V473, P385, DOI 10.1016/0006-8993(88)90871-2; MCINTOSH TK, 1988, AM J PHYSIOL, V254, pR785, DOI 10.1152/ajpregu.1988.254.5.R785; MEANS ED, 1981, J NEUROSURG, V55, P200, DOI 10.3171/jns.1981.55.2.0200; MICHEL ME, 1985, METHOD FIND EXP CLIN, V7, P175; NOYES DH, 1987, EXP NEUROL, V95, P535, DOI 10.1016/0014-4886(87)90298-6; NOYES DH, 1987, MED BIOL ENG COMPUT, V25, P335, DOI 10.1007/BF02447434; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; SCHMIDTACHERT KM, 1984, J NEUROCHEM, V43, P586, DOI 10.1111/j.1471-4159.1984.tb00939.x; SILVIA RC, 1987, BRAIN RES, V403, P52, DOI 10.1016/0006-8993(87)90121-1; STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L; STOKES BT, 1984, BRAIN RES, V290, P187, DOI 10.1016/0006-8993(84)90753-4; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; TANG A H, 1986, Society for Neuroscience Abstracts, V12, P64; TANG AH, 1985, LIFE SCI, V37, P1475, DOI 10.1016/0024-3205(85)90178-X; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; VANDENBERGH P, 1988, NEUROLOGY, V38, P452, DOI 10.1212/WNL.38.3.452; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; VINK R, 1990, J NEUROSCI, V10, P3524; VONVOIGTLANDER PF, 1982, PROG NEURO-PSYCHOPH, V6, P467, DOI 10.1016/S0278-5846(82)80130-9; VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; VONVOIGTLANDER PF, 1986, FASEB J, V45, P677; VONVOIGTLANDER PF, 1987, MOL MECHANISMS NEURO, P345; WALLACE MC, 1986, NEUROSURGERY, V19, P489; WEILL C L, 1984, Society for Neuroscience Abstracts, V10, P641; WINER BJ, 1962, STATISTICAL PRINCIPL; YAMAMOTO M, 1989, ARCH INT PHARMACOD T, V300, P29; YAMAMOTO M, 1990, CURR THER RES CLIN E, V47, P781; YAMAMOTO M, 1989, ARCH INT PHARMACOD T, V299, P55; YAMAMOTO M, 1990, ARCH INT PHARMACOD T, V306, P5; YAMAMOTO M, 1991, EUR J PHARMACOL, V192, P165, DOI 10.1016/0014-2999(91)90084-4; YAMAMOTO M, 1989, STROKE, V20, P1089, DOI 10.1161/01.STR.20.8.1089; YAMAMOTO M, 1989, STROKE, V20, P362, DOI 10.1161/01.STR.20.3.362; YAMAMOTO M, 1987, N-S ARCH PHARMACOL, V336, P561; YAMAMOTO M, 1990, EUR J PHARMACOL, V181, P207, DOI 10.1016/0014-2999(90)90080-P; YOUNG W, 1981, J NEUROSURG, V55, P209, DOI 10.3171/jns.1981.55.2.0209; YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277, DOI 10.1001/archneur.1990.00530030043014; ZUKIN RS, 1988, P NATL ACAD SCI USA, V85, P4061, DOI 10.1073/pnas.85.11.4061	81	42	46	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	1993	119	2					258	267		10.1006/exnr.1993.1028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KL778	WOS:A1993KL77800013	8432363				2022-02-06	
J	YLVISAKER, M				YLVISAKER, M			COMMUNICATION OUTCOME IN CHILDREN AND ADOLESCENTS WITH TRAUMATIC BRAIN INJURY	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CLOSED-HEAD-INJURY; FRONTAL-LOBE DAMAGE; ACQUIRED APHASIA; NEUROPSYCHOLOGICAL SEQUELAE; COGNITIVE SEQUELAE; PREFRONTAL CORTEX; CHILDHOOD; LANGUAGE; DISCOURSE; ADULTS	This article gives a brief review of investigations of speech and language impairment after paediatric traumatic brain injury (TBI) and describes possible effects of frontal lobe injury on non-aphasic disorders of communication. The relation between age and outcome after brain injury in children is also considered. Procedures for overcoming chronic obstacles to effective supports and services for students returning to school after TBI are described briefly. Although most children with normal development of language at the time of their injury experience generally satisfactory recovery of speech and language skills, there is considerable variation within this population. The most likely communication challenges relate to the socially skilled application of available speech and language skills, not their possession.	COLL ST ROSE,DEPT COMMUN DISORDERS,ALBANY,NY 12203								Ackerly SS, 1964, FRONTAL GRANULAR COR, P192; ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ARAM D, 1988, LANGUAGE COMMUNICATI; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P72; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COOPER JA, 1987, J SPEECH HEAR DISORD, V52, P251, DOI 10.1044/jshd.5203.251; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; FINGER S, 1991, DEV NEUROPSYCHOL, V7, P261, DOI 10.1080/87565649109540494; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Golden C. J., 1981, NEUROPSYCHOLOGICAL A, P277; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDMAN PS, 1977, NATURE, V267, P613, DOI 10.1038/267613a0; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HARTLEY L, 1991, BRAIN INJURY, V8, P267; Hartley Leila L., 1992, Seminars in Speech and Language, V13, P264, DOI 10.1055/s-2008-1064202; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; HECAEN H, 1984, EARLY BRAIN DAMAGE, V1, P277; HOLLAND A, 1985, PROSPECTIVE STUDY OU; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KENNARD MA, 1942, MT SINAI J MED, V9, P594; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOLB B, 1989, AM PSYCHOL, V44, P1203, DOI 10.1037/0003-066X.44.9.1203; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1983, ARCH NEUROL-CHICAGO, V40, P601, DOI 10.1001/archneur.1983.04050090037004; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Luria A.R., 1966, HIGHER CORTICAL FUNC; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; PANG D, 1985, HEAD INJURY REHABILI, P1; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PETTERSON L, 1988, THESIS U MINNESOTA; RAHN A, 1991, 12TH ANN S RES CHILD; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; SAVAGE R, IN PRESS ED PROGRAMM; STELLING MW, 1986, AM J DIS CHILD, V140, P710, DOI 10.1001/archpedi.1986.02140210108037; SZEKERES SF, 1985, HEAD INJURY REHABILI, P219; VANDONGEN HR, 1977, CORTEX, V13, P131, DOI 10.1016/S0010-9452(77)80004-X; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; WOODS BT, 1979, ANN NEUROL, V6, P405, DOI 10.1002/ana.410060505; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; YLVISAKER M, IN PRESS ED PROGRAMM; YLVISAKER M, 1992, ADV CHILD NEUROPSYCH, V1, P168; YLVISAKER M, 1985, NOV WORKSH PRES PED; YLVISAKER M, 1981, OCT INT S TRAUM BRAI; [No title captured]	76	42	43	0	12	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE, EAST SUSSEX, ENGLAND BN3 2FA	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		1993	3	4					367	387		10.1080/09602019308401447			21	Neurosciences; Psychology	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MR361	WOS:A1993MR36100005					2022-02-06	
J	HEINEMANN, AW; DOLL, MD; ARMSTRONG, KJ; SCHNOLL, S; YARKONY, GM				HEINEMANN, AW; DOLL, MD; ARMSTRONG, KJ; SCHNOLL, S; YARKONY, GM			SUBSTANCE USE AND RECEIPT OF TREATMENT BY PERSONS WITH LONG-TERM SPINAL-CORD INJURIES	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						SPINAL CORD INJURIES; SUBSTANCE ABUSE; SUBSTANCE-USE DISORDERS	HEAD-INJURY; PROBLEM DRINKING; ALCOHOL ABUSERS; SELF-REPORTS; FOLLOW-UP; DRUG; RELIABILITY; ADULTHOOD; VETERANS	The purpose of this study was to assess the rate of self-reported substance use, consequent problems, perceived need for treatment, and receipt of treatment by persons with long-term spinal cord injury (SCI). Information was obtained from 86 persons with traumatic SCI who were between 13 and 58 years of age at injury, cognitively intact, injured more than two years earlier, English speaking, and recruited from two SCI organizations. The mean age of the sample was 39.5 years at recruitment: 69% were men. Participants reported substance use information across four periods covering six months before injury to an average of 13 years after injury. All participants reported use of substances with abuse potential at some time in their lives; the time of greatest use was injury to six months before first interview. The duration of this period ranged from 18 months to 43 years. Problems resulting from substance use were reported by 70%; more than half (52%) the sample reported problems during this postinjury period. Sixteen percent of the sample believed they needed treatment at some time; the time of greatest perceived need was in the period after injury. Treatment for substance abuse was received by 7%. Problems attributable to abuse of both prescription and nonprescription medication were reported, suggesting the importance of close monitoring of substance-use patterns in persons with SCI who are prescribed sedating or narcotic medications. Timely assessment of problems related to substance use and provision of treatment services to persons with traumatic injury are indicated to prevent a potential dual disability.	IIT,DEPT PSYCHOL,CHICAGO,IL 60616; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298		HEINEMANN, AW (corresponding author), NORTHWESTERN UNIV,SCH MED,REHABIL INST CHICAGO,DEPT REHABIL MED,345 E SUPER ST,CHICAGO,IL 60611, USA.		Heinemann, Allen W/K-6283-2012	Heinemann, Allen W/0000-0003-2782-7326	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AAO711] Funding Source: Medline		Anderson P, 1980, ALCOHOL HEALTH RES W, V5, P37; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BUSS A, 1989, INCIDENCE ALCOHOL US; DEAN JC, 1985, INT J ADDICT, V20, P629, DOI 10.3109/10826088509044942; DiClemente C. C., 1985, COPING SUBSTANCE USE, P319; DICLEMENTE CC, 1982, ADDICT BEHAV, V7, P133, DOI 10.1016/0306-4603(82)90038-7; DONOVAN JE, 1983, J STUD ALCOHOL, V44, P109, DOI 10.15288/jsa.1983.44.109; FILLMORE KM, 1974, Q J STUD ALCOHOL, V35, P819; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; FULLETON D, 1981, ARCH GEN PSYCHIAT, V28, P1369; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; KIRUBAKARAN VR, 1986, J STUD ALCOHOL, V47, P223, DOI 10.15288/jsa.1986.47.223; Lowenthal A, 1980, ALCOHOL HEALTH RES W, V5, P16; MAISTO SA, 1979, J BEHAV ASSESS, V0001, P00315, DOI DOI 10.1007/BF01321373; MARLATT GA, 1988, ANNU REV PSYCHOL, V39, P223, DOI 10.1146/annurev.psych.39.1.223; O'Donnell JJ, 1981, ALCOHOL HEALTH RES W, V6, P27; Rasmussen GA, 1980, ALCOHOL HEALTH RES W, V5, P48; SOBELL LC, 1988, J STUD ALCOHOL, V49, P225, DOI 10.15288/jsa.1988.49.225; SWEENEY TT, 1982, INT J ADDICT, V17, P897, DOI 10.3109/10826088209056336; [No title captured]; 1989, HOUSEHOLD SURVEY DRU; [No title captured]	24	42	43	1	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1991	72	7					482	487					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FP702	WOS:A1991FP70200008	2059120				2022-02-06	
J	LEVIN, HS; EISENBERG, HM; GARY, HE; MARMAROU, A; FOULKES, MA; JANE, JA; MARSHALL, LF; PORTMAN, SM				LEVIN, HS; EISENBERG, HM; GARY, HE; MARMAROU, A; FOULKES, MA; JANE, JA; MARSHALL, LF; PORTMAN, SM			INTRACRANIAL HYPERTENSION IN RELATION TO MEMORY FUNCTIONING DURING THE 1ST YEAR AFTER SEVERE HEAD-INJURY	NEUROSURGERY			English	Article						HEAD INJURY; INTRACRANIAL PRESSURE; MEMORY	INTRA-CRANICAL PRESSURE; COMA	The relationship between intracranial hypertension and residual memory deficit after closed head injury was evaluated using the 6-month and 1-year neurobehavioral outcome data obtained by the Traumatic Coma Data Bank. Intracranial pressure was analyzed using the percentage of time that it exceeded 20 mm Hg and the maximum value recorded during the first 72 hours after injury. Memory measures included recall of word lists, prose recall, and visual memory for designs that were obtained 6 months (n = 149) and 1 year (n = 132) after injury. Intracranial hypertension occurred in more than half of the Traumatic Coma Data Bank cohort who met the criteria for the neurobehavioral follow-up study. Linear regression analysis disclosed an effect of elevated intracranial pressure on some, but not all, measures of memory at 6 months, whereas the results were negative for the 1-year follow-up examination. We conclude that the elevation of intracranial pressure exerts little if any effect on later memory functioning, and that any effect it does have diminishes over 1 year in survivors of severe head injury.	UNIV TEXAS,MED BRANCH,DEPT NEUROL,GALVESTON,TX 77550; CTR DIS CONTROL,ATLANTA,GA 30333; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23298; UNIV CALIF SAN DIEGO,DIV NEUROSURG,LA JOLLA,CA 92093; NIH,OFF BIOMETRY,BETHESDA,MD 20892; UNIV VIRGINIA,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22903		LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG D-73,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032340, N01NS032339, N01NS032341] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-NS-3-2340, N01-NS-3-2339, N01-NS-3-2341] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Benton A. L., 1974, VISUAL RETENTION TES; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1945, WECHSLER MEMORY SCAL	12	42	43	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	FEB	1991	28	2					196	200		10.1227/00006123-199102000-00004			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EU430	WOS:A1991EU43000004	1997886				2022-02-06	
J	KIMELBERG, HK; ROSE, JW; BARRON, KD; WANIEWSKI, RA; CRAGOE, EJ				KIMELBERG, HK; ROSE, JW; BARRON, KD; WANIEWSKI, RA; CRAGOE, EJ			ASTROCYTIC SWELLING IN TRAUMATIC-HYPOXIC BRAIN INJURY - BENEFICIAL-EFFECTS OF AN INHIBITOR OF ANION-EXCHANGE TRANSPORT AND GLUTAMATE UPTAKE IN GLIAL-CELLS	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article									UNION UNIV ALBANY MED COLL, DEPT NEUROL, ALBANY, NY 12208 USA; VET ADM MED CTR, ALBANY, NY 12208 USA; NEW YORK STATE DEPT HLTH, WADSWORTH CTR LABS & RES, ALBANY, NY 12208 USA; MERCK SHARP & DOHME RES LABS, West Point, PA 19486 USA		KIMELBERG, HK (corresponding author), UNION UNIV ALBANY MED COLL, DEPT NEUROSURG, ALBANY, NY 12208 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023750] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS23750] Funding Source: Medline		BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BAKAY L, 1968, BRAIN, V91, P697, DOI 10.1093/brain/91.4.697; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; BEVAN S, 1985, PROC R SOC SER B-BIO, V225, P299, DOI 10.1098/rspb.1985.0063; BONTING SL, 1970, MEMBRANES TRANSPORT, V1, P258; BOURKE RS, 1983, NEUROCHEM RES, V8, P5, DOI 10.1007/BF00965650; BOURKE RS, 1966, J NEUROCHEM, V13, P1099, DOI 10.1111/j.1471-4159.1966.tb04268.x; BOURKE RS, 1979, NEURAL TRAUMA, P95; BOWMAN CL, 1984, NATURE, V311, P656, DOI 10.1038/311656a0; BRAZY PC, 1976, J GEN PHYSIOL, V68, P583, DOI 10.1085/jgp.68.6.583; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; CASPER DS, 1982, J COMP NEUROL, V209, P79, DOI 10.1002/cne.902090108; CHAN PH, 1982, J NEUROCHEM, V38, P525, DOI 10.1111/j.1471-4159.1982.tb08659.x; CHAN PH, 1988, BIOCH PATHOLOGY ASTR, P327; Coles J. A., 1981, Ion-selective microelectrodes and their use in excitable tissues, P345; CRAGOE EJ, 1986, J MED CHEM, V29, P825, DOI 10.1021/jm00155a038; CRAGOE EJ, 1982, J MED CHEM, V25, P567, DOI 10.1021/jm00347a017; DIETZEL I, 1980, EXP BRAIN RES, V40, P432; DUFFY PE, 1983, ASTROCYTES NORMAL RE; FRANCK G, 1983, ADV CELL NEUROBIOL, V4, P133; FRANGAKIS MV, 1984, NEUROCHEM RES, V9, P1689, DOI 10.1007/BF00968079; FRELIN C, 1986, BIOCHEM BIOPH RES CO, V134, P326, DOI 10.1016/0006-291X(86)90566-8; GARAY RP, 1986, N-S ARCH PHARMACOL, V334, P202, DOI 10.1007/BF00505823; GARCIA JH, 1977, VIRCHOWS ARCH B, V25, P191; GARCIA JH, 1979, CEREBROVASC DIS, P125; GRAY PTA, 1986, PROC R SOC SER B-BIO, V228, P267, DOI 10.1098/rspb.1986.0055; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; HERNDON RM, 1980, NEUROSCIENCE, V5, P1015, DOI 10.1016/0306-4522(80)90182-7; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; HIRANO A, 1981, GUIDE NEUROPATHOLOGY, P204; HIRATA H, 1983, BRAIN RES, V270, P358, DOI 10.1016/0006-8993(83)90614-5; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; Jenkins L.W., 1984, RECENT PROGR STUDY T, P523; JENKINS LW, 1979, ACTA NEUROPATHOL, V48, P113, DOI 10.1007/BF00691152; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; KIMELBERG HK, 1986, ANN NY ACAD SCI, V481, P334, DOI 10.1111/j.1749-6632.1986.tb27162.x; KIMELBERG HK, 1979, BRAIN RES, V177, P533, DOI 10.1016/0006-8993(79)90470-0; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; KIMELBERG HK, 1985, BRAIN RES, V361, P125, DOI 10.1016/0006-8993(85)91282-X; KIMELBERG HK, 1979, BRAIN RES, V173, P111; KIMELBERG HK, 1981, BIOCHIM BIOPHYS ACTA, V646, P179, DOI 10.1016/0005-2736(81)90285-6; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; KIMELBERG HK, 1979, NEURAL TRAUMA, P137; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; KIMELBERG HK, 1986, ADV BIOSCI, V61, P177; KIMELBERG HK, IN PRESS SOC NEUR AB; KIMELBERG HK, 1982, HEAD INJURY BASIC CL, P31; Klatzo I, 1980, Adv Neurol, V28, P359; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Klatzo I, 1984, RECENT PROGR STUDY T, P1; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; KOECHEL DA, 1981, ANNU REV PHARMACOL, V21, P265, DOI 10.1146/annurev.pa.21.040181.001405; KRAIG RP, 1985, BRAIN RES, V342, P281, DOI 10.1016/0006-8993(85)91127-8; KRAIG RP, 1985, PROG BRAIN RES, V63, P155; KREGENOW FM, 1981, ANNU REV PHYSIOL, V43, P493, DOI 10.1146/annurev.ph.43.030181.002425; LOWE AG, 1982, BIOCHIM BIOPHYS ACTA, V694, P353, DOI 10.1016/0304-4157(82)90002-8; LUNDANDERSEN H, 1970, EXP BRAIN RES, V11, P199; MARTIN DL, 1979, J BIOL CHEM, V254, P7076; MATAKAS F, 1978, ACTA NEUROPATHOL, V41, P207, DOI 10.1007/BF00690437; MATYJA E, 1986, EXP NEUROL, V92, P609, DOI 10.1016/0014-4886(86)90303-1; NELSON LR, 1979, NEURAL TRAUMA, P297; NELSON LR, 1982, HEAD INJURY BASIC CL, P117; NORENBERG MD, 1974, J NEUROPATH EXP NEUR, V33, P422, DOI 10.1097/00005072-197407000-00008; NORENBERG MD, 1986, ASTROCYTES, V3, P425; PAPPIUS HM, 1956, CAN J BIOCHEM PHYS, V34, P1053; PLUM F, 1983, NEUROLOGY, V33, P222, DOI 10.1212/WNL.33.2.222; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1984, CEREBRAL ISCHEMIA, P157; SONTHEIMER H, 1988, GLIA, V1, P328, DOI 10.1002/glia.440010505; SYKOVA E, 1983, PROG BIOPHYS MOL BIO, V42, P135, DOI 10.1016/0079-6107(83)90006-8; Trachtenberg MC., 1982, HEAD INJURY BASIC CL, P169; VANHARREVELD A, 1982, J NEUROBIOL, V13, P519, DOI 10.1002/neu.480130607; VANHARREVELD A, 1971, EXP MOL PATHOL, V15, P61, DOI 10.1016/0014-4800(71)90019-0; WALZ W, 1985, BRAIN RES, V343, P44, DOI 10.1016/0006-8993(85)91156-4; WALZ W, 1984, J CEREBR BLOOD F MET, V4, P301, DOI 10.1038/jcbfm.1984.42; WANIEWSKI RA, 1983, BRAIN RES, V268, P390, DOI 10.1016/0006-8993(83)90511-5; WANIEWSKI RA, 1984, J NEUROSCI, V4, P2237; WARNOCK DG, 1984, FED PROC, V43, P2473; YU MC, 1972, ACTA NEUROPATHOL, V22, P222, DOI 10.1007/BF00684525	80	42	42	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	AUG	1989	11	1					1	31		10.1007/BF03160036			31	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AP450	WOS:A1989AP45000001	2570584				2022-02-06	
J	FOLTZ, EL; JENKNER, FL; WARD, AA				FOLTZ, EL; JENKNER, FL; WARD, AA			EXPERIMENTAL CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; de No RL, 1938, AM J PHYSIOL, V121, P331, DOI 10.1152/ajplegacy.1938.121.2.331; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; EICHELBERGER L, 1949, AM J PHYSIOL, V156, P129, DOI 10.1152/ajplegacy.1949.156.1.129; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; RHINES R, 1946, AM J PHYSIOL, V146, P344, DOI 10.1152/ajplegacy.1946.146.3.344; SPIEGEL EA, 1948, J NEUROPATH EXP NEUR, V7, P162, DOI 10.1097/00005072-194804000-00004; TOWER DB, 1948, J CLIN INVEST, V27, P558; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; Webster JE, 1941, ANN SURG, V113, P556, DOI 10.1097/00000658-194104000-00009; WHITE JC, 1943, ANN SURG, V118, P619; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223	15	42	43	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1953	10	4					342	352		10.3171/jns.1953.10.4.0342			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YD698	WOS:A1953YD69800003	13070057				2022-02-06	
J	Long, XB; Yao, XL; Jiang, Q; Yang, YP; He, XJ; Tian, WD; Zhao, K; Zhang, HQ				Long, Xiaobing; Yao, Xiaolong; Jiang, Qian; Yang, Yiping; He, Xuejun; Tian, Weidong; Zhao, Kai; Zhang, Huaqiu			Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Exosome; Traumatic brain injury; Microglia; Astrocyte; M1; M2; miR-873a-5p	CONTRIBUTES; GROWTH	Background The interaction between astrocytes and microglia plays a vital role in the damage and repair of brain lesions due to traumatic brain injury (TBI). Recent studies have shown that exosomes act as potent mediators involved in intercellular communication. Methods In the current study, the expression of inflammatory factors and miR-873a-5p in the lesion area and oedema area was evaluated in 15 patients with traumatic brain injury. Exosomes secreted by astrocytes were detected by immunofluorescence, Western blot and electron microscopy. A mouse model of TBI and an in vitro model of LPS-induced primary microglia were established to study the protective mechanism of exosomes from miR-873a-5p overexpressing in TBI-induced nerve injury. Results We discovered that exosomes derived from activated astrocytes promote microglial M2 phenotype transformation following TBI. More than 100 miRNAs were detected in these astrocyte-derived exosomes. miR-873a-5p is a major component that was highly expressed in human traumatic brain tissue. Moreover, miR-873a-5p significantly inhibited LPS-induced microglial M1 phenotype transformation and the subsequent inflammation through decreased phosphorylation of ERK and NF-kappa B p65. This effect also greatly improved the modified neurological severity score (mNSS) and attenuated brain injury in a strictly controlled cortical impact mouse model. Conclusions Taken together, our research indicates that miRNAs in the exosomes derived from activated astrocytes play a key role in the astrocyte-microglia interaction. miR-873a-5p, as one of the main components of these astrocyte-derived exosomes, attenuated microglia-mediated neuroinflammation and improved neurological deficits following TBI by inhibiting the NF-kappa B signalling pathway. These findings suggest a potential role for miR-873a-5p in treating traumatic brain injury.	[Long, Xiaobing; Yao, Xiaolong; Jiang, Qian; Yang, Yiping; He, Xuejun; Tian, Weidong; Zhao, Kai; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China; [Tian, Weidong] Shihezi Univ, Med Coll, Affiliated Hosp 1, Dept Neurosurg, Shihezi, Peoples R China		Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China.	zhanghq_04@yahoo.com		zhang, huaqiu/0000-0003-3023-2040	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371381]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81602204]	This article was founded by the National Natural Science Foundation of China (No.81371381) and the National Natural Science Foundation for Youth of China (No. 81602204).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Cui J, 2015, ONCOGENE, V34, P3895, DOI 10.1038/onc.2014.430; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gao YS, 2015, AM J TRANSL RES, V7, P2519; Hu GK, 2020, J NEUROIMMUNE PHARM, V15, P538, DOI 10.1007/s11481-019-09869-8; Hu GK, 2018, MOL THER-NUCL ACIDS, V13, P450, DOI 10.1016/j.omtn.2018.09.019; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Lafourcade C, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S39916; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu XM, 2014, J BIOL CHEM, V289, P28971, DOI 10.1074/jbc.M114.577429; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Quek C, 2017, BIOCHEM BIOPH RES CO, V483, P1178, DOI 10.1016/j.bbrc.2016.09.090; Sobue A, 2018, GLIA, V66, P1034, DOI 10.1002/glia.23299; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Wang LQ, 2019, J CELL COMMUN SIGNAL, V13, P549, DOI 10.1007/s12079-019-00522-w; Wang Q, 2019, EXP THER MED, V18, P1291, DOI 10.3892/etm.2019.7713; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xia CY, 2015, INT IMMUNOPHARMACOL, V25, P377, DOI 10.1016/j.intimp.2015.02.019; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu LL, 2019, BRAIN RES, V1717, P66, DOI 10.1016/j.brainres.2019.04.009; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang YY, 2019, AM J CANCER RES, V9, P927	30	41	43	14	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 19	2020	17	1							89	10.1186/s12974-020-01761-0			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KX6NS	WOS:000521996500003	32192523	Green Published, Green Submitted, gold	Y	N	2022-02-06	
J	Khan, M; Tisdall, M; James, G; Tahir, MZ				Khan, Mehdi; Tisdall, Martin; James, Greg; Tahir, Muhammad Zubair			Resistant Pseudomeningocele following Craniotomy for Non-Traumatic Acute Intracranial Haematoma in Very Young Children: Report of Four Cases	PEDIATRIC NEUROSURGERY			English	Article						Decompressive craniectomy; Traumatic brain injury; Intracranial haemorrhage; Leptomeningeal cyst	DECOMPRESSIVE CRANIECTOMY; HEMORRHAGE; REPAIR	Background: The incidence of non-traumatic intracranial haemorrhage among neonates is less than among adults. However, the outcomes are generally poor, with high rates of morbidity and mortality. Non-traumatic intracranial haemorrhage can cause a sudden increase in intracranial pressure, requiring emergency craniotomy for evacuation. Methods: We report 4 cases following craniotomy for non-traumatic acute intracranial haematoma in very young children. The surgical technique and postoperative course are discussed, with emphasis on dural repair to avoid resistant pseudomeningocele. Results: Despite successful management of the acutely raised intracranial pressure, all patients afterwards developed tense pseudomeningoceles and required formal dural repair. This led to a change in institutional practice and modifications to the surgical technique. Conclusion: The authors highlight the postoperative occurrence of resistant pseudomeningoceles in young children after clot evacuations and leaving the dura open. They describe the surgical procedures to avoid these pseudomeningoceles.	[Khan, Mehdi; Tisdall, Martin; James, Greg; Tahir, Muhammad Zubair] Children NHS Fdn Trust, Great Ormond St Hosp, London, England; [Tisdall, Martin; James, Greg; Tahir, Muhammad Zubair] UCL, Great Ormond St Inst Child Hlth, London, England		Tahir, MZ (corresponding author), Great Ormond St Hosp Sick Children, Dept Neurosurg, Great Ormond St, London WC1N 3JH, England.	zubair.tahir@gosh.nhs.uk		James, Greg/0000-0003-3014-7428; Tisdall, Martin/0000-0001-8880-8386			Aquilina K, 2012, J NEUROSURG-PEDIATR, V10, P529, DOI 10.3171/2012.8.PEDS11386; Aryan HE, 2004, NEUROSURGERY, V55, P235, DOI 10.1227/01.NEU.0000126951.74653.A6; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Lo WD, 2008, ARCH NEUROL-CHICAGO, V65, P1629, DOI 10.1001/archneurol.2008.502; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Riyaz M, 2015, CHILD NERV SYST, V31, P2117, DOI 10.1007/s00381-015-2808-1; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954	10	41	41	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	OCT	2019	54	5					319	323		10.1159/000502360			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JF4GF	WOS:000491345100004	31533115				2022-02-06	
J	Clark, DPQ; Perreau, VM; Shultz, SR; Brady, RD; Lei, E; Dixit, S; Taylor, JM; Beart, PM; Boon, WC				Clark, David P. Q.; Perreau, Victoria M.; Shultz, Sandy R.; Brady, Rhys D.; Lei, Enie; Dixit, Shilpi; Taylor, Juliet M.; Beart, Philip M.; Boon, Wah Chin			Inflammation in Traumatic Brain Injury: Roles for Toxic A1 Astrocytes and Microglial-Astrocytic Crosstalk	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Inflammation; Astrocyte; Toxic phenotype; Glial crosstalk	REACTIVE ASTROCYTES; SCAR FORMATION; CELLS; NEUROINFLAMMATION; SENSOR; MODEL; STEREOLOGY; MECHANISMS; RESPONSES; OUTCOMES	Traumatic brain injury triggers neuroinflammation that may contribute to progressive neurodegeneration. We investigated patterns of recruitment of astrocytes and microglia to inflammation after brain trauma by firstly characterising expression profiles over time of marker genes following TBI, and secondly by monitoring glial morphologies reflecting inflammatory responses in a rat model of traumatic brain injury (i.e. the lateral fluid percussion injury). Gene expression profiles revealed early elevation of expression of astrocytic marker glial fibrillary acidic protein relative to microglial marker allograft inflammatory factor 1 (also known as ionized calcium-binding adapter molecule 1). Adult rat brains collected at day 7 after injury were processed for immunohistochemistry with allograft inflammatory factor 1, glial fibrillary acidic protein and complement C3 (marker of bad/disruptive astrocytic A1 phenotype). Astrocytes positive for glial fibrillary acidic protein and complement C3 were significant increased in the injured cortex and displayed more complex patterns of arbourisation with significantly increased bifurcations. Our observations suggested that traumatic brain injury changed the phenotype of microglia from a ramified appearance with long, thin, highly branched processes to a swollen amoeboid shape in the injured cortex. These findings suggest differential glial activation with astrocytes likely undergoing strategic changes in morphology and function. Whilst a detailed analysis is needed of temporal patterns of glial activation, ours is the first evidence of a role for the bad/disruptive astrocytic A1 phenotype in an open head model of traumatic brain injury.	[Clark, David P. Q.; Perreau, Victoria M.; Lei, Enie; Dixit, Shilpi; Beart, Philip M.; Boon, Wah Chin] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3051, Australia; [Shultz, Sandy R.; Brady, Rhys D.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Shultz, Sandy R.; Brady, Rhys D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [Taylor, Juliet M.; Beart, Philip M.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia		Beart, PM (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3051, Australia.; Beart, PM (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia.	philip.beart@florey.edu.au		Dixit, Shilpi/0000-0003-4837-0548; Perreau, Victoria/0000-0002-0773-7246	J and M Nolan Family Trust; Victorian Government through the Operational Infrastructure Scheme	PMB is pleased to contribute a paper to this Special Issue honouring Tony Turner who has been a colleague furthering the neurochemical cause via the Journal of Neurochemistry and internationally (ISN) and in Europe (ESN) for some 20 years. This work is partly funded by the J and M Nolan Family Trust. This work was supported by the Victorian Government through the Operational Infrastructure Scheme.	Abeysinghe HCS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030288; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouvier DS, 2015, J ALZHEIMERS DIS, V45, P1001, DOI 10.3233/JAD-143156; Burda JE, 2017, CELL RES, V27, P726, DOI 10.1038/cr.2017.37; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Lenz KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00698; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martinez-Lozada Z, 2016, ADV PHARMACOL, V76, P103, DOI 10.1016/bs.apha.2016.01.004; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Namihira M, 2013, CURR OPIN NEUROBIOL, V23, P921, DOI 10.1016/j.conb.2013.06.002; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Norden DM, 2014, GLIA, V62, P881, DOI 10.1002/glia.22647; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; RStudio Team, 2015, RSTUDIO INT DEV R; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Verkhratsky A, 2017, ADV NEUROBIOL, V15, P427, DOI 10.1007/978-3-319-57193-5_17; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	81	41	42	3	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2019	44	6			SI		1410	1424		10.1007/s11064-019-02721-8			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HY8CL	WOS:000468364900015	30661228				2022-02-06	
J	Smith, DH; Johnson, VE; Trojanowski, JQ; Stewart, W				Smith, Douglas H.; Johnson, Victoria E.; Trojanowski, John Q.; Stewart, William			Chronic traumatic encephalopathy - confusion and controversies	NATURE REVIEWS NEUROLOGY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOID PROTEIN DEPOSITION; BRAIN-INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; TDP-43 PROTEINOPATHY; BETA; DEMENTIA; RISK; ACCUMULATION	The term chronic traumatic encephalopathy (CTE) has recently entered public consciousness via media reports and even a Hollywood movie. However, in contrast to general impressions, the incidence of CTE is unknown, the clinical diagnostic criteria have not been agreed upon and the current neuropathological characterization of CTE is acknowledged as preliminary. Additionally, few studies have compared the pathologies of CTE with those of other neurodegenerative disorders or of age-matched controls. Consequently, disagreement continues about the neuropathological aspects that make CTE unique. Furthermore, CTE is widely considered to be a consequence of exposure to repeated head blows, but evidence suggests that a single moderate or severe traumatic brain injury can also induce progressive neuropathological changes. These unresolved aspects of CTE underlie disparate claims about its clinical and pathological features, leading to confusion among the public and health-care professionals alike.	[Smith, Douglas H.; Johnson, Victoria E.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA USA; [Trojanowski, John Q.] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland		Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.	smithdou@pennmedicine.upenn.edu		Stewart, William/0000-0003-2199-2582	US National Institute of Neurological Disorders and Stroke of the NIH [R01NS092398, R01NS094003, R01NS038104]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, R01NS094003, R01NS092398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	The authors' work is supported by funding from the US National Institute of Neurological Disorders and Stroke of the NIH under award numbers R01NS092398, R01NS094003 and R01NS038104.	BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Drachman DA, 1999, NEW ENGL J MED, V340, P1269, DOI 10.1056/NEJM199904223401609; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Josephs KA, 2017, LANCET NEUROL, V16, P917, DOI 10.1016/S1474-4422(17)30284-3; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Landesman P., 2015, CONCUSSION; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SPILLANE J D, 1962, Br Med J, V2, P1205; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Ward J, 2017, NYTIMES; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	64	41	41	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	MAR	2019	15	3					179	183		10.1038/s41582-018-0114-8			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN8WE	WOS:000460477200011	30664683	Green Accepted			2022-02-06	
J	Kerr, N; Lee, SW; Perez-Barcena, J; Crespi, C; Ibanez, J; Bullock, MR; Dietrich, WD; Keane, RW; Vaccari, JPD				Kerr, Nadine; Lee, Stephanie W.; Perez-Barcena, Jon; Crespi, Catalina; Ibanez, Javier; Bullock, M. Ross; Dietrich, W. Dalton; Keane, Robert W.; Vaccari, Juan Pablo de Rivero			Inflammasome proteins as biomarkers of traumatic brain injury	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; CEREBROSPINAL-FLUID; ACTIVATION; HYPOTHERMIA; INHIBITION; MICROGLIA	Background The inflammasome plays an important role in the inflammatory innate immune response after central nervous system (CNS) injury. Inhibition of the inflammasome after traumatic brain injury (TBI) results in improved outcomes by lowering the levels of caspase-1 and interleukin (IL)-1b. We have previously shown that inflammasome proteins are elevated in the cerebrospinal fluid (CSF) of patients with TBI and that higher levels of these proteins were consistent with poorer outcomes after TBI when compared to patients that presented these inflammasome proteins at lower levels. Methods and findings Here we extend our work by analyzing serum from 21 TBI patients and CSF from 18 TBI patients compared to 120 serum samples and 30 CSF samples from no-TBI donor controls for the expression of caspase-1, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), interleukin(IL)-1b and IL-18. Analysis was carried out using the Ella Simple Plex system (Protein Simple) to determine the sensitivity and specificity of inflammasome proteins as biomarkers of TBI. Receiver operator characteristic (ROC) curves, confidence intervals and likelihood ratios for each biomarker was determined. ROC curves, confidence intervals, sensitivity and specificity for each biomarker examined revealed that caspase-1 (0.93 area under the curve (AUC)) and ASC (0.90 AUC) in serum and ASC (1.0 AUC) and IL-18 (0.84 AUC) in CSF are promising biomarkers of TBI pathology. Importantly, higher protein levels (above 547.6 pg/ml) of ASC (0.91 AUC) were consistent with poorer outcomes after TBI as determined by the Glasgow Outcome Scale-Extended (GOSE). Conclusion These findings indicate that inflammasome proteins are excellent diagnostic and predictive biomarkers of TBI.	[Kerr, Nadine; Lee, Stephanie W.; Bullock, M. Ross; Dietrich, W. Dalton; Keane, Robert W.; Vaccari, Juan Pablo de Rivero] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg,Neurosci Program, Miami, FL 33136 USA; [Kerr, Nadine; Lee, Stephanie W.; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Perez-Barcena, Jon] Son Espases Hosp, Intens Care Dept, Palma De Mallorca, Spain; [Crespi, Catalina] Son Espases Hosp, Fundacio Inst Invest Sanitaria Illes Balears IdIS, Palma De Mallorca, Spain; [Ibanez, Javier] Son Espases Hosp, Dept Neurol Surg, Palma De Mallorca, Spain; [Bullock, M. Ross; Dietrich, W. Dalton; Vaccari, Juan Pablo de Rivero] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Vaccari, JPD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg,Neurosci Program, Miami, FL 33136 USA.; Vaccari, JPD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA.	JdeRivero@med.miami.edu	de Rivero Vaccari, Juan Pablo/H-5718-2019; de Rivero Vaccari, Juan Pablo/ABE-3248-2020; Crespi, Catalina/A-5543-2013	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; Crespi, Catalina/0000-0003-0781-9708; Ibanez, Javier/0000-0003-3735-8332	STTR grant from the NINDS/NIH [4R42NS086274-012]; Fondo de Investigacion SanitariaInstituto de Salud Carlos III [FIS PI16/00737]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS086274, R01NS042133, R01NS089443] Funding Source: NIH RePORTER	This work was supported by a STTR grant (4R42NS086274-012) from the NINDS/NIH to RWK: https://www.nih.gov/; and by a public grant from Fondo de Investigacion Sanitaria (FIS PI16/00737) to JPB: https://portalfis.isciii.es/es/Paginas/inicio.aspx.No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a STTR grant (4R42NS086274-012) from the NINDS/NIH to RWK and WDD and by a public grant from Fondo de Investigacion Sanitaria (FIS PI16/00737) to JPB.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brand FJ, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0137-0; Cai X, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023580; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Goldmann T, 2013, CELL RES, V23, P595, DOI 10.1038/cr.2013.24; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IRRERA N, 2017, FRONT PHARMACOL, V8; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Keane RW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00135; Kerr N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00309; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Schnaars Mareike, 2013, Methods Mol Biol, V1040, P1, DOI 10.1007/978-1-62703-523-1_1; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Syed SA, 2018, NEURON, V99, P914, DOI 10.1016/j.neuron.2018.08.001; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	40	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210128	10.1371/journal.pone.0210128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	WOS:000454627200146	30596792	Green Published, gold, Green Submitted			2022-02-06	
J	Treangen, TJ; Wagner, J; Burns, MP; Villapol, S				Treangen, Todd J.; Wagner, Justin; Burns, Mark P.; Villapol, Sonia			Traumatic Brain Injury in Mice Induces Acute Bacterial Dysbiosis Within the Fecal Microbiome	FRONTIERS IN IMMUNOLOGY			English	Article						microbiome; gut-brain axis; Lactobacillus; brain damage; gut microbes; traumatic brain injury; bacterial dysbiosis; controlled cortical impact injury	LACTOBACILLUS-HELVETICUS R0052; BIFIDOBACTERIUM-LONGUM R0175; GUT-MICROBIOTA; INFLAMMATION; STRESS; AXIS	The secondary injury cascade that is activated following traumatic brain injury (TBI) induces responses from multiple physiological systems, including the immune system. These responses are not limited to the area of brain injury; they can also alter peripheral organs such as the intestinal tract. Gut microbiota play a role in the regulation of immune cell populations and microglia activation, and microbiome dysbiosis is implicated in immune dysregulation and behavioral abnormalities. However, changes to the gut microbiome induced after acute TBI remains largely unexplored. In this study, we have investigated the impact of TBI on bacterial dysbiosis. To test the hypothesis that TBI results in changes in microbiome composition, we performed controlled cortical impact (CCI) or sham injury in male 9-weeks old C57BL/6J mice. Fresh stool pellets were collected at baseline and at 24 h post-CCI. 16S rRNA based microbiome analysis was performed to identify differential abundance in bacteria at the genus and species level. In all baseline vs. 24 h post-CCI samples, we evaluated species-level differential abundances via clustered and annotated operational taxonomic units (OTU). At a high-level view, we observed significant changes in two genera after TBI, Marvinbryantia, and Clostridiales. At the species-level, we found significant decreases in three species (Lactobacillus gasseri, Ruminococcus flavefaciens, and Eubacterium ventriosum), and significant increases in two additional species (Eubacterium sulci, and Marvinbryantia formatexigens). These results pinpoint critical changes in the genus-level and species-level microbiome composition in injured mice compared to baseline; highlighting a previously unreported acute dysbiosis in the microbiome after TBI.	[Treangen, Todd J.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Wagner, Justin] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Burns, Mark P.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Villapol, Sonia] Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA		Villapol, S (corresponding author), Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA.	svillapol@houstonmethodist.org		Burns, Mark P/0000-0003-4750-2000; Villapol, Sonia/0000-0002-6174-4113	National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS106640]; Houston Methodist Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS106640] Funding Source: NIH RePORTER	This work was supported by an R21NS106640 (SV) grant from the National Institute for Neurological Disorders and Stroke (NINDS), and funds from the Houston Methodist Research Institute.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Druart C, 2014, LIPIDS, V49, P397, DOI 10.1007/s11745-014-3881-z; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kasai C, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0330-2; Kelly JR, 2016, J PSYCHIATR RES, V82, P109, DOI 10.1016/j.jpsychires.2016.07.019; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Luczynski P, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw020; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113; Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859; Messaoudi M, 2011, GUT MICROBES, V2, P256, DOI 10.4161/gmic.2.4.16108; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Park JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14726-w; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pigrau M, 2016, NEUROGASTROENT MOTIL, V28, P463, DOI 10.1111/nmo.12717; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Robertson RC, 2017, BRAIN BEHAV IMMUN, V59, P21, DOI 10.1016/j.bbi.2016.07.145; Rowin J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13443; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Sirisinha S, 2016, ASIAN PAC J ALLERGY, V34, P249, DOI 10.12932/AP0803; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Villapol S, 2007, J NEUROSCI RES, V85, P3545, DOI 10.1002/jnr.21450; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner J, 2018, NUCLEIC ACIDS RES, V46, P2777, DOI 10.1093/nar/gky136; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961	43	41	46	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 27	2018	9								2757	10.3389/fimmu.2018.02757			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB9XZ	WOS:000451449400001	30546361	Green Published, gold			2022-02-06	
J	Chen, J; Hu, J; Liu, H; Xiong, Y; Zou, YC; Huang, WT; Shao, MJ; Wu, JM; Yu, L; Wang, XJ; Wang, X; Lin, L				Chen, Jun; Hu, Jian; Liu, Huan; Xiong, Ye; Zou, Yuchi; Huang, Wenting; Shao, Mingjie; Wu, Jiamin; Yu, Li; Wang, Xiaojie; Wang, Xue; Lin, Li			FGF21 Protects the Blood-Brain Barrier by Upregulating PPAR gamma via FGFR1/beta-klotho after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BBB; FGF21; FGF21; FGFR1; beta-klotho complex; PPAR gamma; traumatic brain injury	GROWTH-FACTOR 21; TIGHT JUNCTIONS; DAMAGE; DYSFUNCTION; BREAKDOWN; THERAPY; PATHWAY; FGF-21; TARGET; ALPHA	Blood-brain barrier (BBB) disruption and dysfunction result in brain edema, which is responsible for more than half of all deaths after severe traumatic brain injury (TBI). Fibroblast growth factor 21 (FGF21) has a potential neuroprotective function in the brain. However, the effects and underlying possible mechanism of action on BBB integrity following TBI remain unknown. The purpose of the current study was to determine the effects of FGF21 on BBB protection and TBI treatment. The effects of recombinant human FGF21 (rhFGF21) on BBB integrity and on tight junction (TJ) and adhesion junction (AJ) proteins were investigated both in a TBI mouse model and an in vitro BBB disruption model established with tumor necrosis factor alpha (TNF-alpha)-induced human brain microvascular endothelial cells (HBMECs). The ability of rhFGF21 to form an FGF21/FGFR1/beta-klotho complex was confirmed by in vitro beta-klotho small interfering RNA (siRNA) transfection and FGFR1 co-immunoprecipitation. In addition, the specific FGFR1 and peroxisome proliferator-activated receptor gamma (PPAR gamma) inhibitors PD173074 and GW9662, respectively, were applied to further explore the possible mechanism of rhFGF21 in BBB maintenance after TBI. rhFGF21 markedly reduced neurofunctional behavior deficits and cerebral edema degree, preserved BBB integrity, and recued brain tissue loss and neuron apoptosis in the mouse model after TBI. Both in vivo and in vitro, rhFGF21 upregulated TJ and AJ proteins, thereby preserving the BBB. Moreover, rhFGF21 activated PPAR gamma in TNF-alpha-induced HBMECs through formation of an FGF21/FGFR1/beta-klotho complex. rhFGF21 protected the BBB through FGF21/FGFR1/beta-klotho complex formation and PPAR gamma activation, which upregulated TJ and AJ proteins.	[Chen, Jun; Hu, Jian; Liu, Huan; Wu, Jiamin; Wang, Xiaojie; Wang, Xue; Lin, Li] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Huang, Wenting; Shao, Mingjie] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou, Zhejiang, Peoples R China; [Xiong, Ye; Zou, Yuchi] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Yu, Li] Ningbo Univ, Med Sch, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China		Wang, X; Lin, L (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China.	xinyuw001@163.com; linliwz@163.com			Public Welfare Technology Application Research Foundation of Zhejiang Province [2017C33080]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771284]; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences	This study was supported by research grants from the Public Welfare Technology Application Research Foundation of Zhejiang Province (No. 2017C33080), National Natural Science Foundation of China (Grant No. 81771284), and the Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences.	Abbasloo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31866; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Hu YY, 2017, ONCOTARGET, V8, P31638, DOI 10.18632/oncotarget.15780; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kniesel U, 1996, DEV BRAIN RES, V96, P229, DOI 10.1016/S0165-3806(96)00117-4; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; [刘银华 Liu Yinhua], 2016, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V21, P6; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Miller F, 2005, EUR J NEUROSCI, V22, P835, DOI 10.1111/j.1460-9568.2005.04273.x; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ouk T, 2013, CURR DRUG TARGETS, V14, P752, DOI 10.2174/1389450111314070005; Potts Mathew B, 2006, NeuroRx, V3, P143; Pulicherla KK, 2015, AAPS PHARMSCITECH, V16, P223, DOI 10.1208/s12249-015-0287-z; Rochfort KD, 2015, MICROVASC RES, V100, P48, DOI 10.1016/j.mvr.2015.04.010; Sa-nguanmoo P, 2016, METAB BRAIN DIS, V31, P239, DOI 10.1007/s11011-015-9789-3; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Staiger H, 2017, ENDOCR REV, V38, P468, DOI 10.1210/er.2017-00016; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Tanajak P, 2016, ACTA PHYSIOL, V217, P287, DOI 10.1111/apha.12698; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Verkman AS, 2011, ACTA PHARMACOL SIN, V32, P702, DOI 10.1038/aps.2011.27; Wang F, 2017, J MOL NEUROSCI, V62, P123, DOI 10.1007/s12031-017-0917-x; Wang QZ, 2018, MOL NEUROBIOL, V55, P4702, DOI 10.1007/s12035-017-0663-7; Wang XM, 2014, CELL PHYSIOL BIOCHEM, V34, P658, DOI 10.1159/000363031; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu JS, 2016, MOL NEUROBIOL, V53, P3626, DOI 10.1007/s12035-015-9294-z; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yang WQ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601075; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao LW, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0368-z; Zheng YG, 2015, J CARDIOVASC PHARM, V66, P504, DOI 10.1097/FJC.0000000000000302	57	41	42	2	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2091	2103		10.1089/neu.2017.5271			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000441923700009	29648978				2022-02-06	
J	Andelic, N; Howe, EI; Hellstrom, T; Sanchez, MF; Lu, J; Lovstad, M; Roe, C				Andelic, Nada; Howe, Emilie, I; Hellstrom, Torgeir; Sanchez, Maria Fernandez; Lu, Juan; Lovstad, Marianne; Roe, Cecilie			Disability and quality of life 20 years after traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						functional outcomes; long-term follow-up; quality of life; traumatic brain injury	SF-36 HEALTH SURVEY; MODERATE; PREDICTORS; OUTCOMES; ADULTS	Objectives: The study describes functional outcomes and health-related quality of life (HRQL) in patients with traumatic brain injury (TBI) 20 years postinjury. Materials and Methods: Forty-four survivors who acquired moderate and severe TBI during 1995-1996 were followed 10 and 20 years postinjury. Outcomes were Glasgow Outcome Scale Extended (GOSE), Community Integration Questionnaire (CIQ), and SF-36 questionnaire (SF-36). Multiple regressions were performed to examine the relationship between follow-up measurements, controlling for baseline demographics and injury severity. Results: There were no significant differences in baseline age and civil status between moderate and severe TBI, but patients with severe injury had significantly lower employment rates (p = 0.05). Mean age at 20-years follow-up was 50.8 (SD 11.4) years, and 73% were males. Most patients showed good recovery (52%) or moderate disability (43%). Disability levels remained stable between and within severity groups from 10 to 20 years. Community integration including social integration improved from 10 to 20 years (p = 0.01 and p = 0.005, respectively). HRQL remained stable, except for subscales Bodily Pain and Role Emotional (p = 0.02 and p = 0.06). Depression at 10 years and females were associated with poorer mental health, while productive activity at 10 years indicated better physical and mental health at 20 years postinjury, respectively. Conclusions: Functional limitations persist even decades after moderate and severe TBI, with poorer prognosis for females and persons who were depressed at the 10-year follow-up. Development and evaluation of targeted long-term follow-up programs and access to rehabilitation services for these groups should be highlighted. Improved community integration despite stable functional limitations draws attention to long-term adaptation to adversity and illness.	[Andelic, Nada; Howe, Emilie, I; Hellstrom, Torgeir; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Andelic, Nada; Lu, Juan] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Howe, Emilie, I; Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Sanchez, Maria Fernandez] Univ Salamanca, Fac Psychol, Inst Community Integrat INICO, Salamanca, Spain; [Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Richmond, VA USA; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Howe, EI (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway.	emilie.howe@medisin.uio.no	Fernandez, Maria/H-2632-2018; Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021	Fernandez, Maria/0000-0002-3398-6086; Hellstrom, Torgeir/0000-0003-0831-3274; Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Gray M, 2018, ARCH PHYS MED REHAB, V99, pS33, DOI 10.1016/j.apmr.2017.08.465; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Lexell J, 2016, BRAIN INJURY, V30, P969, DOI 10.3109/02699052.2016.1148196; Loge JH, 1998, SCAND J SOC MED, V26, P250; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Sandhaug M, 2015, BRAIN INJURY, V29, P915, DOI 10.3109/02699052.2015.1022880; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Soberg HL, 2015, J TRAUMA ACUTE CARE, V78, P628, DOI 10.1097/TA.0000000000000541; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	37	41	41	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JUL	2018	8	7								10.1002/brb3.1018			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GM8PT	WOS:000438495400012	29888869	Green Published, gold			2022-02-06	
J	Curley, WH; Forgacs, PB; Voss, HU; Conte, MM; Schiff, ND				Curley, William H.; Forgacs, Peter B.; Voss, Henning U.; Conte, Mary M.; Schiff, Nicholas D.			Characterization of EEG signals revealing covert cognition in the injured brain	BRAIN			English	Article						arousal; brain-computer interface (BCI); consciousness; electroencephalography (EEG); traumatic brain injury (TBI)	FALSE DISCOVERY RATE; VEGETATIVE STATE; BEDSIDE DETECTION; FUNCTIONAL MRI; DISORDERS; CONSCIOUSNESS; AWARENESS; STIMULATION; PARADIGM; DYNAMICS	Patients with severe brain injury are difficult to assess and frequently subject to misdiagnosis. 'Cognitive motor dissociation' is a term used to describe a subset of such patients with preserved cognition as detected with neuroimaging methods but not evident in behavioural assessments. Unlike the locked-in state, cognitive motor dissociation after severe brain injury is prominently marked by concomitant injuries across the cerebrum in addition to limited or no motoric function. In the present study, we sought to characterize the EEG signals used as indicators of cognition in patients with disorders of consciousness and examine their reliability for potential future use to re-establish communication. We compared EEG-based assessments to the results of using similar methods with functional MRI. Using power spectral density analysis to detect EEG evidence of task performance (Two Group Test, P40.05, with false discovery rate correction), we found evidence of the capacity to follow commands in 21 of 28 patients with severe brain injury and all 15 healthy individuals studied. We found substantial variability in the temporal and spatial characteristics of significant EEG signals among the patients in contrast to only modest variation in these domains across healthy controls; the majority of healthy controls showed suppression of either 8-12Hz 'alpha' or 13-40Hz 'beta' power during task performance, or both. Nine of the 21 patients with EEG evidence of command-following also demonstrated functional MRI evidence of command-following. Nine of the patients with command-following capacity demonstrated by EEG showed no behavioural evidence of a communication channel as detected by a standardized behavioural assessment, the Coma Recovery Scale - Revised. We further examined the potential contributions of fluctuations in arousal that appeared to co-vary with some patients' ability to reliably generate EEG signals in response to command. Five of nine patients with statistically indeterminate responses to one task tested showed a positive response after accounting for variations in overall background state (as visualized in the qualitative shape of the power spectrum) and grouping of trial runs with similar background state characteristics. Our findings reveal signal variations of EEG responses in patients with severe brain injuries and provide insight into the underlying physiology of cognitive motor dissociation. These results can help guide future efforts aimed at re-establishment of communication in such patients who will need customization for brain-computer interfaces.	[Curley, William H.] Harvard Med Sch, Boston, MA USA; [Forgacs, Peter B.; Conte, Mary M.; Schiff, Nicholas D.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, 1300 York Ave,Room F610, New York, NY 10065 USA; [Forgacs, Peter B.; Schiff, Nicholas D.] Weill Cornell Med, Dept Neurol, New York, NY USA; [Forgacs, Peter B.; Schiff, Nicholas D.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Voss, Henning U.] Weill Cornell Med, Dept Radiol, New York, NY USA; [Voss, Henning U.] Weill Cornell Med, Citigrp Biomed Imaging Ctr, New York, NY USA		Schiff, ND (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, 1300 York Ave,Room F610, New York, NY 10065 USA.	nds2001@med.cornell.edu	Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074; Curley, William/0000-0002-0393-4998	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD51912]; James S. McDonnell Foundation; Jerold B. Katz Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD051912] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000457, UL1TR000043, UL1TR002384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS096222] Funding Source: NIH RePORTER	This study was supported by NIH HD51912, the James S. McDonnell Foundation, and the Jerold B. Katz Foundation.	Adapa R, 2012, 18 ANN M ORG HUM BRA; Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Bai O, 2008, J NEURAL ENG, V5, P24, DOI 10.1088/1741-2560/5/1/003; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Chaudhary U, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002593; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Fernandez-Espejo D, 2015, JAMA NEUROL, V72, P1442, DOI 10.1001/jamaneurol.2015.2614; Fins JJ, 2015, RIGHTS COME MIND BRA; Fins JJ, 2016, SCI AM MIND, P44; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Friston KJ, 2008, STAT PARAMETRIC MAPP; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gibson RM, 2016, ANN NEUROL, V80, P412, DOI 10.1002/ana.24726; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Hauger SL, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/145913; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hjorth B., 1980, AM J EEG TECHNOL, V20, P121, DOI DOI 10.1080/00029238.1980.11080015; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Liu YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023839; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Owen AM, 2007, SCIENCE, V315, DOI 10.1126/science.1135583; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Percival D.B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2016, J NEURAL TRANSM, V123, P797, DOI 10.1007/s00702-016-1547-0; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schiff ND, 2014, CURR OPIN NEUROBIOL, V25, P7, DOI 10.1016/j.conb.2013.10.007; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; THICKBROOM GW, 1984, ELECTROEN CLIN NEURO, V59, P279, DOI 10.1016/0168-5597(84)90045-5; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157	58	41	42	1	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2018	141		5				1404	1421		10.1093/brain/awy070			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF7VS	WOS:000432177000023	29562312	Green Published, Bronze			2022-02-06	
